FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Liu, XY
   Chu, PK
   Ding, CX
AF Liu, XY
   Chu, PK
   Ding, CX
TI Surface modification of titanium, titanium alloys, and related materials
   for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING R-REPORTS
LA English
DT Review
DE titanium; titanium alloys; surface modification; biomedical engineering
ID SPRAYED HYDROXYAPATITE COATINGS; SELF-ASSEMBLED MONOLAYERS; DIAMOND-LIKE
   CARBON; IMMERSION ION-IMPLANTATION; SIMULATED BODY-FLUID;
   CALCIUM-PHOSPHATE PRECIPITATION; CHEMICALLY TREATED TITANIUM; CONTAINING
   THIN COATINGS; METAL-OXIDE SURFACES; BONE-BONDING ABILITY
AB Titanium and titanium alloys are widely used in biomedical devices and components, especially as hard tissue replacements as well as in cardiac and cardiovascular applications, because of their desirable properties, such as relatively low modulus, good fatigue strength, formability, machinability, corrosion resistance, and biocompatibility. However, titanium and its alloys cannot meet all of the clinical requirements. Therefore, in order to improve the biological, chemical, and mechanical properties, surface modification is often performed. This article reviews the various surface modification technologies pertaining to titanium and titanium alloys including mechanical treatment, thermal spraying, sol-gel, chemical and electrochemical treatment, and ion implantation from the perspective of biomedical engineering. Recent work has shown that the wear resistance, corrosion resistance, and biological properties of titanium and titanium alloys can be improved selectively using the appropriate surface treatment techniques while the desirable bulk attributes of the materials are retained. The proper surface treatment expands the use of titanium and titanium alloys in the biomedical fields. Some of the recent applications are also discussed in this paper. (C) 2004 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM xyliu@mail.sic.ac.cn; paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013; Liu, Xuanyong/J-2609-2018
OI Chu, Paul/0000-0002-5581-4883; 
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   Anderson James M., 1996, P165
   Andreazza P, 1998, THIN SOLID FILMS, V319, P62, DOI 10.1016/S0040-6090(97)01086-9
   [Anonymous], 1989, ILLUSTRATED ENCY DIC, P1800
   Aronoff YG, 1997, J AM CHEM SOC, V119, P259, DOI 10.1021/ja953848+
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   *ASTM, 1997, B600 ASTM, P6
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   Baek SH, 2002, CHEM VAPOR DEPOS, V8, P29, DOI 10.1002/1521-3862(20020116)8:1<29::AID-CVDE29>3.0.CO;2-Q
   BAIER RE, 1983, PHYSICOCHEMICAL ASPE, V2, P895
   Baleani M, 2000, ARTIF ORGANS, V24, P296, DOI 10.1046/j.1525-1594.2000.06486.x
   Bania P. J., 1993, TITANIUM ALLOYS 1990, P3
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   Baumann H, 2002, NUCL INSTRUM METH B, V196, P286, DOI 10.1016/S0168-583X(02)01298-3
   BEHRNDT H, 1991, MAT SCI ENG A-STRUCT, V139, P58, DOI 10.1016/0921-5093(91)90596-F
   Berberich F, 2001, APPL SURF SCI, V179, P13, DOI 10.1016/S0169-4332(01)00256-2
   BJORLING M, 1992, MACROMOLECULES, V25, P3956
   BLAHA P, 1985, PHYS REV B, V31, P2316, DOI 10.1103/PhysRevB.31.2316
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Boehm HP, 1971, DISCUSS FARADAY SOC, V52, P264
   Bouos M.I., 1993, PLASMA SPRAYING THEO, P3
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Brovelli D, 1999, LANGMUIR, V15, P4324, DOI 10.1021/la981758n
   Browne M, 2000, BIOMATERIALS, V21, P385, DOI 10.1016/S0142-9612(99)00200-8
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P367, DOI 10.1002/jbm.820210309
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   Cao Y, 1996, BIOMATERIALS, V17, P419, DOI 10.1016/0142-9612(96)89658-X
   Chai CS, 1998, BIOMATERIALS, V19, P2291, DOI 10.1016/S0142-9612(98)90138-7
   Chandra L, 1996, DIAM RELAT MATER, V5, P674, DOI 10.1016/0925-9635(95)00431-9
   Chang E, 1997, J MATER SCI-MATER M, V8, P193, DOI 10.1023/A:1018583522322
   Cheang P, 1996, BIOMATERIALS, V17, P1901, DOI 10.1016/0142-9612(95)00146-8
   CHEN J, 1993, J MATER ENG PERFORM, V2, P839, DOI 10.1007/BF02645683
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chen YM, 2001, SURF COAT TECH, V141, P156, DOI 10.1016/S0257-8972(01)01201-4
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   CLEMENCE JF, 1995, BIOCONJUGATE CHEM, V6, P411, DOI 10.1021/bc00034a011
   Collier J P, 1993, J Arthroplasty, V8, P389, DOI 10.1016/S0883-5403(06)80037-9
   COLLINGS EW, 1984, ASM SERIES METAL PRO
   COLLIOUD A, 1993, BIOCONJUGATE CHEM, V4, P528, DOI 10.1021/bc00024a016
   COLLIS JJ, 1992, BIOMATERIALS, V13, P548, DOI 10.1016/0142-9612(92)90107-Y
   COOLEY DR, 1992, J PROSTHET DENT, V67, P93, DOI 10.1016/0022-3913(92)90057-H
   CORNELL RM, 1975, J COLLOID INTERF SCI, V53, P6, DOI 10.1016/0021-9797(75)90028-4
   de Andrade MC, 1999, J BIOMED MATER RES, V46, P441, DOI 10.1002/(SICI)1097-4636(19990915)46:4<441::AID-JBM1>3.0.CO;2-9
   De Aza PN, 2000, BIOMATERIALS, V21, P1735, DOI 10.1016/S0142-9612(00)00058-2
   DeAza PN, 1997, BIOMATERIALS, V18, P1285, DOI 10.1016/S0142-9612(97)00063-X
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   DeAza PN, 1996, J MICROSC-OXFORD, V182, P24, DOI 10.1111/j.1365-2818.1996.tb04794.x
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DEGROOT K, 1987, HIGH TECH CERAMICS, P381
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   Ding SJ, 2003, BIOMATERIALS, V24, P4233, DOI 10.1016/S0142-9612(03)00315-6
   Ding SJ, 1999, J BIOMED MATER RES, V47, P551, DOI 10.1002/(SICI)1097-4636(19991215)47:4<551::AID-JBM12>3.0.CO;2-C
   Ding SJ, 1999, J BIOMED MATER RES, V44, P266, DOI 10.1002/(SICI)1097-4636(19990305)44:3<266::AID-JBM5>3.0.CO;2-4
   DISCHLER B, 1983, SOLID STATE COMMUN, V48, P105, DOI 10.1016/0038-1098(83)90936-5
   Dowson D, 1981, INTRO BIOMECHANICS J
   DRISKELL TD, 1994, EARLY HIST CALCIUM O, P3
   EBERT R, 1982, P WORLD C MED PHYS B, P307
   ELWING H, 1987, J BIOMED MATER RES, V21, P263, DOI 10.1002/jbm.820210209
   ERDTMANN M, 1994, BIOMATERIALS, V15, P1043, DOI 10.1016/0142-9612(94)90089-2
   Fazan F, 2000, J MATER SCI-MATER M, V11, P787, DOI 10.1023/A:1008901512273
   FINKLEA HO, 1979, J PHYS CHEM-US, V83, P353, DOI 10.1021/j100466a011
   FOLKERS JP, 1995, LANGMUIR, V11, P813, DOI 10.1021/la00003a024
   Fraker A. C., 1983, ASTM STP, V786, P206
   FREEMAN MAR, 1994, J BONE JOINT SURG BR, V76B, P432
   Freese H. L., 2001, TITANIUM MED, P25
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Fukumoto S, 1999, MAT SCI ENG A-STRUCT, V263, P205, DOI 10.1016/S0921-5093(98)01166-6
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   GABBI C, 1995, BIOMATERIALS, V16, P515, DOI 10.1016/0142-9612(95)91123-G
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   GEESINK RGT, 1989, ORTHOPEDICS, V12, P1239
   Gledhill HC, 1999, BIOMATERIALS, V20, P315, DOI 10.1016/S0142-9612(98)00166-5
   Gnedenkov S.V., 1999, PROT METAL, V35, P480
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   Grill A., 1994, SYNTHETIC DIAMOND EM, P91
   Gross KA, 1998, J BIOMED MATER RES, V39, P407, DOI 10.1002/(SICI)1097-4636(19980305)39:3<407::AID-JBM9>3.0.CO;2-N
   Gross KA, 1998, J MATER SCI-MATER M, V9, P839, DOI 10.1023/A:1008948228880
   GROSS KA, 1998, P 15 INT THERM SPRAY, P1133
   GRUNER H, 1985, Patent No. 0222853
   Haman JD, 1999, J BIOMED MATER RES, V48, P856, DOI 10.1002/(SICI)1097-4636(1999)48:6<856::AID-JBM14>3.0.CO;2-I
   HAMAN JD, 1995, J THERM SPRAY TECHN, V4, P179, DOI 10.1007/BF02646110
   Hammerl C, 1999, NUCL INSTRUM METH B, V148, P851, DOI 10.1016/S0168-583X(98)00660-0
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   HANAWA T, 1995, MATER T JIM, V36, P438, DOI 10.2320/matertrans1989.36.438
   HANAWA T, 1994, AM SOC TEST MATER, V1196, P170, DOI 10.1520/STP25192S
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   HANAWA T, 1993, J ELECTRON SPECTROSC, V63, P347, DOI 10.1016/0368-2048(93)80032-H
   Hanawa T, 1998, J MATER SCI-MATER M, V9, P89, DOI 10.1023/A:1008847014938
   HANAWA T, 1994, P S COMP BIOM IMPL S, P126
   HANAWA T, 1997, J JPN SOC BIOMATER, V15, P249
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   HEGDE RI, 1993, J VAC SCI TECHNOL B, V11, P1287, DOI 10.1116/1.586931
   Heiman R. B., 1996, PLASMA SPRAY COATING
   Heinrich G, 1997, SURF COAT TECH, V94-5, P514, DOI 10.1016/S0257-8972(97)00459-3
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   HENDRICH VE, 1985, REP PROG PHYS, V48, P1481
   Henry P J, 1987, Int J Oral Maxillofac Implants, V2, P23
   Herbert CB, 1997, CHEM BIOL, V4, P731, DOI 10.1016/S1074-5521(97)90311-2
   Hignett B., 1987, METALS HDB, V5, P107
   HIMENO T, 2001, BIOCERAMICS, V14, P641
   Hohl F, 1995, SURF COAT TECH, V74-75, P765, DOI 10.1016/0257-8972(95)08274-3
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   HOWIE DW, 1990, IMPLANT BONE INTERFA
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Hypolite CL, 1997, BIOCONJUGATE CHEM, V8, P658, DOI 10.1021/bc9701252
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Itoh Y, 1999, SURF COAT TECH, V111, P172, DOI 10.1016/S0257-8972(98)00728-2
   Iwasaki Y, 2003, COLLOID SURFACE B, V32, P77, DOI 10.1016/S0927-7765(03)00147-4
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   JONES LC, 1987, CLIN ORTHOP RELAT R, P192
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Jung MJ, 2003, THIN SOLID FILMS, V435, P145, DOI 10.1016/S0040-6090(03)00344-4
   KANE KR, 1994, J APPL BIOMATER, V5, P353, DOI 10.1002/jab.770050411
   Kang GH, 1996, SURF COAT TECH, V86, P421, DOI 10.1016/S0257-8972(96)02980-5
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   KARRHOLM J, 1994, J BONE JOINT SURG BR, V76B, P912
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   KERN M, 1994, J DENT, V22, P300, DOI 10.1016/0300-5712(94)90067-1
   Khor KA, 1997, J THERM SPRAY TECHN, V6, P109, DOI 10.1007/BF02646320
   Khor KA, 2004, BIOMATERIALS, V25, P1177, DOI 10.1016/j.biomaterials.2003.08.008
   Khor KA, 2003, BIOMATERIALS, V24, P2233, DOI 10.1016/S0142-9612(03)00027-9
   Khor KA, 2003, BIOMATERIALS, V24, P723, DOI 10.1016/S0142-9612(02)00404-0
   Khor KA, 2003, BIOMATERIALS, V24, P769, DOI 10.1016/S0142-9612(02)00413-1
   Khor KA, 1998, J THERM SPRAY TECHN, V7, P254, DOI 10.1361/105996398770351007
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Knob LJ, 1987, METALS HDB CORROSION, V13, P669
   KNOTEK O, 1992, SURF COAT TECH, V54, P536
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   KOZHUKHAROV V, 1993, J MATER SCI, V28, P1283, DOI 10.1007/BF01191965
   Krupa D, 2002, BIOMATERIALS, V23, P3329, DOI 10.1016/S0142-9612(02)00020-0
   Krupa D, 1999, SURF COAT TECH, V111, P86, DOI 10.1016/S0257-8972(98)00714-2
   Krupa D, 2001, VACUUM, V63, P715, DOI 10.1016/S0042-207X(01)00263-9
   Krupa D, 1999, SURF COAT TECH, V114, P250, DOI 10.1016/S0257-8972(99)00052-3
   Krupa D, 2001, BIOMATERIALS, V22, P2139, DOI 10.1016/S0142-9612(00)00405-1
   Krupa D, 1996, SURF COAT TECH, V79, P240, DOI 10.1016/0257-8972(95)02457-3
   Kurrat R, 1998, COLLOID SURFACE B, V11, P187, DOI 10.1016/S0927-7765(98)00039-3
   Kweh SWK, 2002, BIOMATERIALS, V23, P775, DOI 10.1016/S0142-9612(01)00183-1
   Lacefield WR, 1993, INTRO BIOCERAMICS, P223
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Lausmaa J., 2001, TITANIUM MED, P231
   LeClair P, 2000, THIN SOLID FILMS, V376, P9, DOI 10.1016/S0040-6090(00)01192-5
   Lee BH, 2004, J BIOMED MATER RES A, V69A, P279, DOI 10.1002/jbm.a.20126
   Lee BH, 2002, J BIOMED MATER RES, V61, P466, DOI 10.1002/jbm.10190
   Lee DH, 1998, APPL PHYS LETT, V73, P2423, DOI 10.1063/1.122469
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   Li H, 2004, SURF COAT TECH, V182, P227, DOI 10.1016/j.surfcoat.2003.08.081
   Li H, 2002, BIOMATERIALS, V23, P2105, DOI 10.1016/S0142-9612(01)00326-X
   Li H, 2000, MAT SCI ENG A-STRUCT, V293, P71, DOI 10.1016/S0921-5093(00)01245-4
   Li H, 2002, BIOMATERIALS, V23, P85, DOI 10.1016/S0142-9612(01)00082-5
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Liang FH, 2003, J MATER SCI LETT, V22, P1665, DOI 10.1023/B:JMSL.0000004643.03120.ca
   Liu JX, 2003, THIN SOLID FILMS, V429, P225, DOI 10.1016/S0040-6090(03)00146-9
   Liu XH, 1996, J BIOMATER APPL, V10, P330
   Liu Xuanyong, 2002, Journal of the Chinese Ceramic Society, V30, P20
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Liu XY, 2003, SURF COAT TECH, V172, P270, DOI 10.1016/S0257-8972(03)00344-X
   Liu XY, 2002, BIOMATERIALS, V23, P4065, DOI 10.1016/S0142-9612(02)00143-6
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   LOMG M, 1998, BIOMATERIALS, V19, P1621
   Lu X, 2004, BIOMATERIALS, V25, P1779, DOI 10.1016/j.biomaterials.2003.08.028
   Lucchini JP, 1996, CLIN ORAL IMPLAN RES, V7, P397, DOI 10.1034/j.1600-0501.1996.070414.x
   Lynn AK, 2002, BIOMATERIALS, V23, P1947, DOI 10.1016/S0142-9612(01)00320-9
   Maege I, 1998, MACROMOL SY, V126, P7, DOI 10.1002/masy.19981260104
   Maitz MF, 2002, SURF COAT TECH, V158, P151, DOI 10.1016/S0257-8972(02)00189-5
   Maitz MF, 2002, BIOMOL ENG, V19, P269, DOI 10.1016/S1389-0344(02)00039-4
   Makino Y, 1998, SURF COAT TECH, V98, P934, DOI 10.1016/S0257-8972(97)00309-5
   Mandl S, 2002, SURF COAT TECH, V156, P276, DOI 10.1016/S0257-8972(02)00085-3
   Mantese JV, 1996, MRS BULL, V21, P52
   Mardare CC, 2003, J EUR CERAM SOC, V23, P1027, DOI 10.1016/S0955-2219(02)00278-9
   Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f
   MASUDA Y, 1990, NIPPON SERAM KYO GAK, V98, P1255
   MATEJKA D, 1989, PLASMA SPRAYING META, P25
   Matsue T, 2002, VACUUM, V66, P435, DOI 10.1016/S0042-207X(02)00167-7
   Mattox D. M., 1994, HDB DEPOSITION TECHN
   MCCOLL IR, 1994, DIAM RELAT MATER, V3, P83, DOI 10.1016/0925-9635(94)90035-3
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   MERRITT K, 1988, J BIOMED MATER RES, V22, P111, DOI 10.1002/jbm.820220204
   MEZGER PR, 1992, J DENT, V20, P342, DOI 10.1016/0300-5712(92)90021-4
   Michel R, 2002, LANGMUIR, V18, P3281, DOI 10.1021/la011715y
   Milella E, 2001, BIOMATERIALS, V22, P1425, DOI 10.1016/S0142-9612(00)00300-8
   MITAMURA Y, 1986, T AM SOC ART INT ORG, V32, P444
   Mittal K. L., 1979, SURFACE CONTAMINATIO, V1, P3
   Miyayama N, 1999, JPN J DENT MAT, V18, P109
   Morra M, 2001, WATER BIOMATERIALS S
   Morscher E., 1995, ENDOPROSTHETICS
   MORSCHER EW, 1991, J BONE JOINT SURG BR, V73, P705
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   MU Y, 2000, J BIOMED MATER RES, V49, P283
   Mueller H J, 1970, J Biomed Mater Res, V4, P29, DOI 10.1002/jbm.820040105
   MULLERMAI C, 1994, BIOCERAMICS, V7, P159
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nie X, 2002, SURF COAT TECH, V149, P245, DOI 10.1016/S0257-8972(01)01453-0
   Nie X, 2001, J BIOMED MATER RES, V57, P612, DOI 10.1002/1097-4636(20011215)57:4<612::AID-JBM1208>3.0.CO;2-H
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.3.CO;2-N
   Nonami T, 1999, J MATER SCI-MATER M, V10, P475, DOI 10.1023/A:1008996908797
   Ogden HR, 1961, RARE METALS HDB, P559
   OHRING M, MAT SCI THIN FILM DE, P277
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   OKABE Y, 1991, NUCL INSTRUM METH B, V61, P44, DOI 10.1016/0168-583X(91)95558-U
   OKABE Y, 1989, NUCL INSTRUM METH B, V39, P619, DOI 10.1016/0168-583X(89)90861-6
   OKABE Y, 1994, SURF COAT TECH, V66, P384, DOI 10.1016/0257-8972(94)90035-3
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1998, J BIOMED MAT RES, V40
   Parfitt G., 1976, PROGR SURFACE MEMBRA, V11, P181
   Park CH, 1998, THIN SOLID FILMS, V312, P182, DOI 10.1016/S0040-6090(97)00719-0
   PARK K, 1986, J COLLOID INTERF SCI, V111, P197, DOI 10.1016/0021-9797(86)90019-6
   PARK SS, 1991, J APPL PHYS, V69, P2618, DOI 10.1063/1.348653
   PARKER TE, 1975, J PHYS CHEM SOLIDS, V36, P377, DOI 10.1016/0022-3697(75)90062-1
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002
   PARTENFELDER U, 1993, J MATER SCI-MATER M, V4, P292, DOI 10.1007/BF00122283
   Patsi ME, 1998, J SOL-GEL SCI TECHN, V11, P55, DOI 10.1023/A:1008684815735
   Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E
   Peltola T, 1998, J BIOMED MATER RES, V41, P504, DOI 10.1002/(SICI)1097-4636(19980905)41:3<504::AID-JBM22>3.3.CO;2-5
   Peng XL, 1998, THIN SOLID FILMS, V312, P207, DOI 10.1016/S0040-6090(97)00588-9
   PETERSON CD, 1988, J BIOMED MATER RES, V22, P887, DOI 10.1002/jbm.820221005
   Pham MT, 2000, THIN SOLID FILMS, V379, P50, DOI 10.1016/S0040-6090(00)01553-4
   PIVETEAU LD, 2001, TITANIUM MED, P267
   POLMEAR JJ, 1981, LIGHT ALLOYS, pCH6
   Prevey PS, 2000, J THERM SPRAY TECHN, V9, P369, DOI 10.1361/105996300770349827
   PRICE JB, 1993, THIN SOLID FILMS, V236, P311, DOI 10.1016/0040-6090(93)90688-L
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Ratner B. D., 2001, TITANIUM MED, P1
   Rats D, 1995, THIN SOLID FILMS, V270, P177, DOI 10.1016/0040-6090(95)06913-5
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   RINTOUL TC, 1993, AM SOC ARTIF INTERN, V39, P168
   ROSTOKER W, 1981, BIOMATERIALS, V2, P221, DOI 10.1016/0142-9612(81)90061-2
   SALSBURY RL, 1991, NATL THERMAL SPRAY C, P471
   SAMUNEVA B, 1993, J MATER SCI, V28, P2353, DOI 10.1007/BF01151665
   SCHINDLER PW, 1990, REV MINERAL, V23, P281
   SCHUTZ RW, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P75
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SCHWARZ K, 1987, CRC CR REV SOL STATE, V13, P211, DOI 10.1080/10408438708242178
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Shigematsu I, 2000, J MATER SCI LETT, V19, P967, DOI 10.1023/A:1006720306017
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Silva PL, 1998, SURF COAT TECH, V102, P191, DOI 10.1016/S0257-8972(97)00576-8
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   SKARTVEIT L, 1990, ACTA ODONTOL SCAND, V48, P169, DOI 10.3109/00016359009005872
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   Sobiecki J.R., 2002, VACUUM, V64, P41
   SOOD DK, 1992, SURF COAT TECH, V51, P307, DOI 10.1016/0257-8972(92)90255-9
   SPITSYN BV, 1981, J CRYST GROWTH, V52, P219, DOI 10.1016/0022-0248(81)90197-4
   SUGIMOTO T, 1995, INTERNAL MED VER 6, P2004
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Sumitomo Chemical Co, 1975, Patent Application, Patent No. 158745
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V113, P530, DOI 10.1016/S0021-9797(86)90446-7
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   Swart K M, 1992, J Oral Implantol, V18, P130
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Takebe J, 2000, J BIOMED MATER RES, V51, P398, DOI 10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-#
   Takeuchi M, 2003, BIOMATERIALS, V24, P1821, DOI 10.1016/S0142-9612(02)00576-8
   Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Tang ZY, 2000, LANGMUIR, V16, P1696, DOI 10.1021/la981491s
   TAO S, 1999, Patent No. 991240340
   Tao SY, 2000, J BIOMED MATER RES, V52, P572
   Tegoulia VA, 2001, LANGMUIR, V17, P4396, DOI 10.1021/la001790t
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Textor M, 2000, LANGMUIR, V16, P3257, DOI 10.1021/la990941t
   Textor M., 2001, TITANIUM MED, P171
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Thorwarth G, 2001, SURF COAT TECH, V136, P236, DOI 10.1016/S0257-8972(00)01021-5
   TORREGROSA F, 1995, THIN SOLID FILMS, V266, P245, DOI 10.1016/0040-6090(96)80028-9
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p
   TRAPALIS C, 1993, J MATER SCI, V28, P1276, DOI 10.1007/BF01191964
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Tsyganov I, 2002, SURF COAT TECH, V158, P318, DOI 10.1016/S0257-8972(02)00190-1
   Tung M. S., 1998, CALCIUM PHOSPHATE BI
   Uchida M, 2004, SURF COAT TECH, V177, P627, DOI 10.1016/S0257-8972(03)00937-X
   ULMAN A, 1990, ADV MATER, V2, P573, DOI 10.1002/adma.19900021203
   VAUDAUX P, 1990, CLIN IMPLANT MATERIA, V9, P31
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Viviente JL, 1999, VACUUM, V52, P141, DOI 10.1016/S0042-207X(98)00213-9
   Voevodin AA, 1996, SURF COAT TECH, V86-7, P516, DOI 10.1016/S0257-8972(96)03069-1
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Walivaara Bengt, 1993, Clinical Materials, V12, P141, DOI 10.1016/0267-6605(93)90065-F
   WANG BC, 1993, J BIOMED MATER RES, V27, P1315, DOI 10.1002/jbm.820271012
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wang CX, 2002, MATER LETT, V54, P30, DOI 10.1016/S0167-577X(01)00532-8
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Wang XX, 2000, J BIOMED MATER RES, V52, P171, DOI 10.1002/1097-4636(200010)52:1<171::AID-JBM22>3.0.CO;2-O
   Wang Y, 1998, J THERM SPRAY TECHN, V7, P50, DOI 10.1007/s11666-006-5003-9
   Wang YL, 2000, CHEM COMMUN, P587, DOI 10.1039/b000419g
   Watanabe H, 2003, SURF COAT TECH, V169, P452, DOI 10.1016/S0257-8972(03)00190-7
   Weber M, 1998, HELV CHIM ACTA, V81, P1359, DOI 10.1002/hlca.19980810546
   Wen F, 2002, SURF COAT TECH, V156, P208, DOI 10.1016/S0257-8972(02)00088-9
   Wen HB, 1997, BIOMATERIALS, V18, P1471, DOI 10.1016/S0142-9612(97)82297-1
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
   Weng W, 1997, J EUR CERAM SOC, V17, P1151, DOI 10.1016/S0955-2219(96)00215-4
   Weng WJ, 1999, J AM CERAM SOC, V82, P27
   Weng WJ, 1998, BIOMATERIALS, V19, P125, DOI 10.1016/S0142-9612(97)00177-4
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1996, J BIOMED MATER RES, V30, P251, DOI 10.1002/(SICI)1097-4636(199602)30:2<251::AID-JBM16>3.0.CO;2-P
   Wieser E, 1999, SURF COAT TECH, V111, P103, DOI 10.1016/S0257-8972(98)00717-8
   Williams D. F., 1987, DEFINITIONS BIOMATER
   WILLIAMS DF, 2001, TITANIUM MED, P13
   WILLIAMS JM, 1985, P ASM C APPL ION PLA, P141
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P181, DOI 10.1016/0142-9612(88)90119-6
   WISBEY A, 1987, BIOMATERIALS, V8, P477, DOI 10.1016/0142-9612(87)90085-8
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
   Woodward JT, 1996, LANGMUIR, V12, P3626, DOI 10.1021/la9510689
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   XIAO SJ, 2001, TITANIUM MED, P417
   Xu GC, 2003, SURF COAT TECH, V169, P299, DOI 10.1016/S0257-8972(03)00113-0
   Xue WB, 1998, J AM CERAM SOC, V81, P1365
   Xue WC, 2004, SURF COAT TECH, V185, P340, DOI 10.1016/j.surfcoat.2003.12.018
   Xue WC, 2004, BIOMATERIALS, V25, P415, DOI 10.1016/S0142-9612(03)00545-3
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yang BC, 1999, J BIOMED MATER RES, V47, P213, DOI 10.1002/(SICI)1097-4636(199911)47:2<213::AID-JBM11>3.0.CO;2-C
   Yang CY, 1997, J BIOMED MATER RES, V36, P39
   YANG P, 2002, SURF COAT TECH, V156, P2840
   Yang ZH, 1999, LANGMUIR, V15, P1731, DOI 10.1021/la980839g
   Yatsuzuka M, 2000, VACUUM, V59, P330, DOI 10.1016/S0042-207X(00)00286-4
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Yoshida K, 1999, J BIOMED MATER RES, V48, P778, DOI 10.1002/(SICI)1097-4636(1999)48:6<778::AID-JBM3>3.0.CO;2-C
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Yoshinari M, 2001, BIOMATERIALS, V22, P709, DOI 10.1016/S0142-9612(00)00234-9
   Zeiler E, 1999, SURF COAT TECH, V116, P599, DOI 10.1016/S0257-8972(99)00136-X
   ZHANG D, 1991, CORR CONTR 7 APCCC C, P793
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
   Zhu XL, 2002, J BIOMED MATER RES, V60, P333, DOI 10.1002/jbm.10105
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
NR 377
TC 1633
Z9 1702
U1 85
U2 898
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0927-796X
EI 1879-212X
J9 MAT SCI ENG R
JI Mater. Sci. Eng. R-Rep.
PD DEC 24
PY 2004
VL 47
IS 3-4
BP 49
EP 121
DI 10.1016/j.mser.2004.11.001
PG 73
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 899JZ
UT WOS:000227142000001
OA Green Published
DA 2018-10-20
ER

PT J
AU Pernegger, H
   Frais-Kolbl, H
   Griesmayer, E
   Kagan, H
AF Pernegger, H
   Frais-Kolbl, H
   Griesmayer, E
   Kagan, H
TI Design and test of a high-speed single-particle beam monitor
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 10th International Vienna Conference on Instrumentation
CY FEB 16-21, 2004
CL Vienna, AUSTRIA
SP Fed Minist Educ, Sci & Culture, Fed Minist Transport, Innovat & Technol, Austrian Acad Sci, Univ Technol, Vienna, Vienna Convent Bur, European Phys Soc
DE CVD diamond; semiconductor radiation detectors; proton detectors; proton
   accelerators; high-speed electronics; biomedical nuclear imaging
AB The paper presents the first test results of a charged-particle solid-state detector with very fast signal response. We used polycrystalline Chemical-Vapor-Deposition (pCVD) diamond as active sensor material and high-bandwidth RF amplifiers to develop a charged-particle detector suitable for high counting rates. The pCVD diamond is segmented with large and small pads for position sensitivity. The detector is intended as a high-speed beam monitor and diagnostics system for proton accelerators in the field of medical ion therapy and high-energy physics experiments. (C) 2004 Elsevier B.V. All rights reserved.
C1 CERN, Dept Phys, Geneva, Switzerland.
   Fachhsch Wirschaft & Tech, Wiener Neustadt, Austria.
   Ohio State Univ, Dept Phys, Columbus, OH 43210 USA.
RP Pernegger, H (reprint author), CERN, Dept Phys, Geneva, Switzerland.
EM heinz.pernegger@cern.ch
CR ADAM W, 1997, ELECTROCHEMICAL SOC, V97, P491
   FERNANDEZHERNAN.L, 2004, P 2004 IEEE INSTR ME
   FRAISKOLBI H, UNPUB IEEE T NUCL SC
   HUHTINEN M, 2003, COMMUNICATION
   MOTTER R, 1998, MEDAUSTRON MACHBARKE
NR 5
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD DEC 11
PY 2004
VL 535
IS 1-2
BP 108
EP 114
DI 10.1016/j.nima.2004.07.213
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 877OS
UT WOS:000225580500014
DA 2018-10-20
ER

PT J
AU Katti, KS
AF Katti, KS
TI Biomaterials in total joint replacement
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Review
DE THR; biomedical; review; bone; mechanical properties
ID HYDROXYAPATITE HA PARTICLES; L-LACTIDE PLLA; COMPOSITE BIOMATERIALS;
   MECHANICAL-PROPERTIES; POLYETHYLENE COMPOSITES; BIODEGRADABLE POLYMERS;
   BIORESORBABLE DEVICES; POTENTIAL APPLICATION; FORGED COMPOSITES; BONE
AB The current state of materials systems used in total hip replacement is presented in this paper. An overview of the various material systems used in total hip replacement reported in literature is presented in this paper. Metals, polymers, ceramics and composites are used in the design of the different components of hip replacement implants. The merits and demerits of these material systems are evaluated in the context of mechanical properties most suitable for total joint replacement such as a hip implant. Current research on advanced polymeric nanocomposites and biomimetic composites as novel materials systems for bone replacement is also discussed. This paper examines the current research in the materials science and the critical issues and challenges in these materials systems that require further research before application in biomedical industry. (C) 2003 Elsevier B.V. All rights reserved.
C1 N Dakota State Univ, Dept Civil Engn, Fargo, ND 58105 USA.
RP Katti, KS (reprint author), N Dakota State Univ, Dept Civil Engn, CIE 201B, Fargo, ND 58105 USA.
EM Kalpana.katti@ndsu.nodak.edu
CR Abusafieh A, 1997, J APPL POLYM SCI, V63, P75, DOI 10.1002/(SICI)1097-4628(19970103)63:1<75::AID-APP8>3.0.CO;2-P
   Abusafieh A, 1997, J BIOMED MATER RES, V38, P314
   BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Barrows TH, 1986, CLIN MATER, V1, P233
   BLACK J, 1992, BIOL PERFORMANCE MAT
   Bleach NC, 2002, BIOMATERIALS, V23, P1579, DOI 10.1016/S0142-9612(01)00283-6
   BONFIELD W, 1993, INTRO BIOCERAMICS, V1, P290
   BRUNSKI JB, 1996, BIOMATERIALS SCI INT
   CHANG FK, 1990, J BIOMED MATER RES, V24, P873, DOI 10.1002/jbm.820240707
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2002, J MATER SCI-MATER M, V13, P993, DOI 10.1023/A:1019825132610
   Chang MC, 2002, J MATER SCI LETT, V20, P1129
   CHARNLEY J, 1970, CLIN ORTHOP RELAT R, P7
   CHARNLEY J, 1961, LANCET, V1, P1129
   CHEVALIER J, 1977, BIOCERAMICS, V10
   CHO S, 1997, KEY ENG MATER, P132
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Christel P., 1997, BIOL BIOMECHANICAL P, P81
   Christel P., 1980, MECHANICAL PROPERTIE, P367
   Claes L., 1997, BIOL BIOMECHANICAL P, P81
   Corvelli AA, 1999, J MATER SCI, V34, P2421, DOI 10.1023/A:1004562732460
   CURREY J, 1984, MECH ADAPTATIONS BON
   DAVIDSON JA, P SOC MAN ENG IT IL
   EHSANI N, 1995, KEY ENG MATER, V104, P373
   FRATZ P., 1997, J STRUCT BIOL, V122, P119
   Fujihara K, 2003, BIOMATERIALS, V24, P2661, DOI 10.1016/S0142-9612(03)00065-6
   Galego N, 2000, POLYM TEST, V19, P485, DOI 10.1016/S0142-9418(99)00011-2
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GILLETT A, 1986, BIOMATERIALS, V6, P113
   Greish YE, 2001, BIOMATERIALS, V22, P807, DOI 10.1016/S0142-9612(00)00243-X
   GROSS V, 1998, CRC CRITIC REV BIOCO, V4, P2
   Guo HB, 2003, BIOMATERIALS, V24, P667, DOI 10.1016/S0142-9612(02)00381-2
   HELLMICH C, 2002, ULM J ENG MECH, V123, P898
   HELMER JD, 1969, P S US CER SURG IMP
   Hench L. L., 1993, INTRO BIOCERAMICS, V1
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HEYWOOD BR, 1990, CONNECT TISSUE RES, V25, P103, DOI 10.3109/03008209009006985
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   HUANG J, 1997, J MATER SCI-MATER M, V8, P779
   HUISKES R, 1983, J BIOMECH, V16, P385, DOI 10.1016/0021-9290(83)90072-6
   Hulbert SF, 1987, HIGH TECH CERAMICS, P3
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 1999, J MICROSC-OXFORD, V196, P23
   Iooss P, 2001, BIOMATERIALS, V22, P2785, DOI 10.1016/S0142-9612(01)00022-9
   JOCKISCH KA, 1992, J BIOMED RES, V26, P113
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   KASUGA T, 2001, BIOMATERIALS, V22, P1923
   Kato K, 1997, J MATER SCI, V32, P5533, DOI 10.1023/A:1018616306104
   Katti K., 2002, P 15 ASCE ENG MECH C
   KATTI KS, 2001, P 2001 MRS FALL M S
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   KIKUCHI M, 1999, BIOCERAMICS, V12, P393
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LEWANDOWSKASZUMIEL, 1999, J BIOMED MATER RES, V48, P289
   LI J, 1995, BIOMATERIALS, V16, P417, DOI 10.1016/0142-9612(95)98860-G
   Liou SC, 2003, BIOMATERIALS, V24, P3981, DOI 10.1016/S0142-9612(03)00303-X
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopes MA, 1999, BIOMATERIALS, V20, P2085, DOI 10.1016/S0142-9612(99)00112-X
   MAGEE FP, 1988, CLIN ORTHOP RELAT R, V1, P235
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   Moursi AM, 2002, BIOMATERIALS, V23, P133, DOI 10.1016/S0142-9612(01)00088-6
   MOURTIER A, 1989, J SOLID STATE CHEM, V78, P215
   Ota Y, 1998, J AM CERAM SOC, V81, P1665
   Pazo A, 1998, ACTA MATER, V46, P2551, DOI 10.1016/S1359-6454(98)80039-6
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP, P422
   Reed CS, 1996, CHEM MATER, V8, P440, DOI 10.1021/cm9503644
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Rodriguez-Lorenzo LM, 2001, BIOMATERIALS, V22, P583, DOI 10.1016/S0142-9612(00)00218-0
   ROSATO DV, 1983, BIOCOMPATIBLE POLYM, P1022
   RUSTON N, 1984, BIOMATERIALS, V5, P352
   RUYS AJ, 1991, BIOCERAMICS, V4, P281
   SCHMITT FO, 1985, ANNU REV BIOPHYS BIO, V4, P1
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   SIMOES JA, 1999, COMPOS SCI TECHNOL, V60, P559
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tancred DC, 1998, BIOMATERIALS, V19, P1735, DOI 10.1016/S0142-9612(98)00082-9
   Toshihiro K., 2001, BIOMATERIALS, V22, P19
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   VALLO CI, 1999, J BIOMED RES, V48, P158
   Van Blitterswijk C A, 1986, BIOMATERIALS, V7, P553
   Vaz CM, 2002, BIOMATERIALS, V23, P629, DOI 10.1016/S0142-9612(01)00150-8
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   VERT M, 1986, POLYM MED, V2, P263
   VONRECUM, 1999, HDB BIOMATERIALS EVA, P915
   WALKER PS, 1971, WEAR, V17, P285, DOI 10.1016/0043-1648(71)90032-9
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M., 1996, P 7 EUR C COMP MAT L, P455
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Watari F, 1997, COMPOS PART B-ENG, V28, P5, DOI 10.1016/S1359-8368(96)00021-2
   Williams D. F., 1987, DEFINITIONS BIOMATER
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WONG H, 2002, MAT SCI ENG C-BIO S, V20, P111
   WOO SLY, 1974, J BIOMED MATER RES, V8, P321, DOI 10.1002/jbm.820080513
   Yasuda HY, 2000, BIOMATERIALS, V21, P2045, DOI 10.1016/S0142-9612(00)00090-9
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 103
TC 252
Z9 256
U1 4
U2 105
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC 10
PY 2004
VL 39
IS 3
BP 133
EP 142
DI 10.1016/j.colsurfb.2003.12.002
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 878HE
UT WOS:000225636600006
PM 15556342
DA 2018-10-20
ER

PT J
AU Kuo, SM
   Niu, GCC
   Chang, SJ
   Kuo, CH
   Bair, MS
AF Kuo, SM
   Niu, GCC
   Chang, SJ
   Kuo, CH
   Bair, MS
TI A one-step method for fabricating chitosan microspheres
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polysaccharides; extrusion; microgels; microspheres; crosslinking
ID DRUG-RELEASE; ISLETS; BIOCOMPATIBILITY; POLYSACCHARIDES; GLUTARALDEHYDE;
   MICROCAPSULES; MEMBRANES; DELIVERY; KINETICS; DESIGN
AB A simple and in situ method, by using a high-voltage electrostatic system, for the fabrication of chitosan microspheres (in a form of isolatable microgels) by an extrusion process, exhibiting variable sizes and different membrane structures, was presented. The chitosan microspheres exhibited good sphericity and were in the range of 185.8 +/- 13.8 to 380.9 +/- 11.5 mum in diameter. There were two significant factors, the pump flow rate and electrostatic field strength, that affected the chitosan microsphere size. The microsphere size decreased when the flow rate was increased from 0.1 to 0.4 mL/h. Also, the microsphere size decreased when the electrostatic field strength was increased from 5.5 to 6.5 kV/cm. However, when the electrostatic field strength was raised to 7 kV/cm and higher, the microsphere size increased. For the latter case, with other parameters fixed, chitosan microsphere size can be controlled by adjusting the electrostatic field strength and predetermined by a simple linear regression equation: Microsphere Diameter (D, in mum) = -(75.48) + 45.67 x (Electrostatic Field Strength, E, in kV/cm), at [7 less than or equal to (Electrostatic Field Strength) less than or equal to 10] (R-2 = 0.956, P < 0.001). Following treatment with various ratios of crosslinking/gelating (Na5P3O10/NaOH) agents, the prepared chitosan microspheres exhibited distinct membrane structures that yielded various mechanical strengths. In the Na5P3O10/NaOH ratio of 19, the chitosan microspheres had a distinct two-layer structure. The selection of crosslinking/gelating ratio provided an additional degree of freedom, permitting the simultaneous regulation of mechanical properties and permeability of the microspheres, without extra manipulation, and thus, improved applicability in the biomedical field. When the chitosan microsphere extrusion process was used to encapsulate (beta-tricalcium phosphate powder for application as bony material, we found that the ultra fine (beta-tricalcium phosphate powder was trapped inside of the membrane very well. After appropriate collecting procedures, stored microspheres also retained good spherical shape. (C) 2004 Wiley Periodicals.
C1 I SHOU Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
RP Niu, GCC (reprint author), I SHOU Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
EM gniu@isu.edu.tw
CR Acikgoz M, 1996, J MICROENCAPSUL, V13, P141, DOI 10.3109/02652049609052903
   Amiji MM, 1996, J BIOMAT SCI-POLYM E, V8, P281, DOI 10.1163/156856296X00309
   ETUK BR, 1995, J MICROENCAPSUL, V12, P173, DOI 10.3109/02652049509015288
   FAN MY, 1990, DIABETES, V39, P519, DOI 10.2337/diabetes.39.4.519
   Genta I, 1998, CARBOHYD POLYM, V36, P81, DOI 10.1016/S0144-8617(98)00022-8
   Genta I, 1997, INT J PHARM, V152, P237, DOI 10.1016/S0378-5173(97)00096-3
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   HALLE JP, 1994, CELL TRANSPLANT, V3, P365, DOI 10.1177/096368979400300503
   HALLE JP, 1993, TRANSPLANTATION, V55, P350, DOI 10.1097/00007890-199302000-00023
   He P, 1999, INT J PHARM, V187, P53, DOI 10.1016/S0378-5173(99)00125-8
   Hsu Brend Ray-Sea, 1994, Journal of the Formosan Medical Association, V93, P240
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Kuo SM, 2003, J APPL POLYM SCI, V89, P3897, DOI 10.1002/app.12590
   Lorenzo-Lamosa ML, 1998, J CONTROL RELEASE, V52, P109, DOI 10.1016/S0168-3659(97)00203-4
   LUM ZP, 1992, TRANSPLANTATION, V53, P1180, DOI 10.1097/00007890-199206000-00002
   Mi FL, 1999, BIOMATERIALS, V20, P1603, DOI 10.1016/S0142-9612(99)00064-2
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2000, CARBOHYD POLYM, V41, P389, DOI 10.1016/S0144-8617(99)00104-6
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   OHYA Y, 1993, J MICROENCAPSUL, V10, P1, DOI 10.3109/02652049309015307
   SU CH, 2003, 8 BIOCH ENG C TAIW
   Suzuki T, 1999, J BIOSCI BIOENG, V88, P194, DOI 10.1016/S1389-1723(99)80201-1
   THANOO BC, 1992, J PHARM PHARMACOL, V44, P283, DOI 10.1111/j.2042-7158.1992.tb03607.x
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
NR 24
TC 40
Z9 41
U1 3
U2 20
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 5
PY 2004
VL 94
IS 5
BP 2150
EP 2157
DI 10.1002/app.21131
PG 8
WC Polymer Science
SC Polymer Science
GA 866FR
UT WOS:000224759700038
DA 2018-10-20
ER

PT J
AU Cerri, G
   de' Gennaro, M
   Bonferoni, MC
   Caramella, C
AF Cerri, G
   de' Gennaro, M
   Bonferoni, MC
   Caramella, C
TI Zeolites in biomedical application: Zn-exchanged clinoptilolite-rich
   rock as active carrier for antibiotics in anti-acne topical therapy
SO APPLIED CLAY SCIENCE
LA English
DT Article; Proceedings Paper
CT Euroclay Conference
CY 2003
CL Modena, ITALY
DE zeolite; clinoptilolite; cation exchange capacity; acne; drug carrier;
   pharmaceutical application
ID SILVER-ZEOLITE; NATURAL CLINOPTILOLITE; ERYTHROMYCIN-RESISTANT; NORTHERN
   SARDINIA; ZINC; MINERALS; WATER
AB A clinoptilolite-rich rock was evaluated as inorganic Zn2+ releasing carrier for antibiotic erythromycin. The perspective is its use in the topical treatment of acne, a diffused skin pathology, given the efficacy of zinc-erythromycin combination against resistant Propionibacterium strains. The tested rock is an ash-rich epiclastite collected in Northern-Central part of Sardinia island (Italy). ICP chemical analyses of the bulk rock evidenced a composition compatible with topical applications. A 66 wt.% of clinoptilolite content was determined by means of XRD analysis (reference intensity ratio [RIR] technique). EDS chemical analyses of zeolite crystals were performed on polished thin section. The CEC of the rock is 1.45+/-0.08 meq/g. Using a specific exchange method, the material was previously Na-conditioned then Zn-conditioned. A substantially complete Zn-form was obtained, as demonstrated by AAS analyses. A back-exchange reaction toward Na-form was performed in the same conditions (65degreesC in 1 M NaCl solution): zinc release was fast and almost complete (94%). Zn-conditioned powder was then micronized to achieve a volume/surface ratio suitable for a topical therapy. After micronization, the specific surface area, determined by BET gas adsorption, was 30.2 m(2)/g, and 92% of the powdered rock was lower than 30 mum in size (measured by a Coulter Counter apparatus); the so-called "volume-surface diameter" was 6.48 mum, compatible with the intended topical application. Zn2+ release was measured on micronized rock at 37 degreesC both in physiologic solution as in 0.05 M KH2PO4/Na2HPO4 buffer. Also in these conditions, a prompt and significant zinc release was recorded: after 30 min, 68% and 60%, respectively. Erythromycin was charged onto the micronized material using a solvent evaporation method. HPLC determinations showed that 85% of the drug contacted with the carrier was loaded. The simultaneous release of zinc and erythromycin were evaluated in phosphate buffer. Eighty-two percent of the loaded antibiotic was released after 30 min. Zinc exchange is substantially unaffected by the contemporary drug release. The request to file an international patent for this pharmaceutical application has been accepted by the European International Preliminary Examination Office. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Sassari, Ist Sci Geol Mineral, I-07100 Sassari, Italy.
   Univ Naples Federico II, Dipartimento Sci Terra, I-80134 Naples, Italy.
   Univ Pavia, Dipartimento Chim Farmaceut, I-27100 Pavia, Italy.
RP Cerri, G (reprint author), Univ Sassari, Ist Sci Geol Mineral, Corso Angioj 10, I-07100 Sassari, Italy.
EM gcerri@uniss.it
RI de Gennaro, Maurizio/H-4404-2011; Bonferoni, Maria Cristina/G-2760-2017
OI Bonferoni, Maria Cristina/0000-0002-1194-9372; Cerri,
   Guido/0000-0002-6685-3351
CR *AAVV, 1995, US PHARM, P2391
   Abe Y, 2003, INT J PROSTHODONT, V16, P141
   Armbruster T, 2001, REV MINERAL GEOCHEM, V45, P1, DOI 10.2138/rmg.2001.45.1
   ARMBRUSTER T, 2001, STUDIES SURFACE CHEM, V135
   BOJAR RA, 1994, BRIT J DERMATOL, V130, P329, DOI 10.1111/j.1365-2133.1994.tb02929.x
   Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0
   CERJANSTEFANOVI.S, 1997, NATURAL ZEOLITES SOF, P121
   Cerri G, 2002, CLAY CLAY MINER, V50, P127, DOI 10.1346/000986002761002739
   Cerri G, 2001, CONTRIB MINERAL PETR, V140, P404, DOI 10.1007/s004100000196
   CERRI G, 2000, THESIS U SASSARI ITA
   Cerri G., 2002, B SOC GEOL ITAL, V121, P3
   Chipera Steve J., 1995, POWDER DIFFR, V10, P47
   Cik G, 2001, CHEMOSPHERE, V44, P313, DOI 10.1016/S0045-6535(00)00306-4
   Coombs DS, 1998, EUR J MINERAL, V10, P1037
   Cowan MM, 2003, J IND MICROBIOL BIOT, V30, P102, DOI 10.1007/s10295-002-0022-0
   deGennaro M, 1996, MINER DEPOSITA, V31, P452, DOI 10.1007/BF00196127
   Edmundson I C, 1967, Adv Pharm Sci, V2, P95
   FOYE WO, 1991, PRINCIPI CHIM FARMAC, P772
   FUJIMOTO T, 1998, FUEL ENERGY ABSTR, V39, P214
   HABBEMA L, 1989, BRIT J DERMATOL, V121, P497, DOI 10.1111/j.1365-2133.1989.tb15518.x
   HARUNA J, 1993, MICROPOROUS MATER, V1, P235
   HEBBORN P, 1976, Patent No. 4000263
   HOLLAND KT, 1992, BRIT J DERMATOL, V126, P505, DOI 10.1111/j.1365-2133.1992.tb15124.x
   Hotta M, 1998, J ORAL REHABIL, V25, P485, DOI 10.1046/j.1365-2842.1998.00265.x
   IZMIROVA N, 2001, STUDIES SURFACE SCI, V135
   Kallo D, 2001, REV MINERAL GEOCHEM, V45, P519, DOI 10.2138/rmg.2001.45.15
   Kirov G.N., 1997, NATURAL ZEOLITES SOF, P133
   KLEINER DM, 2003, OFF J SOC ACAD EMERG, V10, P570
   Langella A, 2000, MICROPOR MESOPOR MAT, V37, P337, DOI 10.1016/S1387-1811(99)00276-0
   LANGELLA A, 1999, CLINOPTILOLITE BEARI, P237
   LEOPHAIRATANA A, 2002, CORPORATE ENV REPORT
   Morishita M, 1998, J CLIN DENT, V9, P94
   Mumpton F.A., 2000, NATURAL ZEOLITES 3 M, P19
   Ozawa T., 1997, FUEL ENERGY ABSTR, V38, P29
   Papaioannou DS, 2002, RES VET SCI, V72, P61, DOI 10.1053/rvsc.2001.0524
   Pavelic K, 2002, J CANCER RES CLIN, V128, P37, DOI 10.1007/s00432-001-0301-6
   Pavelic K, 2001, J MOL MED-JMM, V78, P708, DOI 10.1007/s001090000176
   PAVELIC K, 2001, STUDIES SURFACE SCI, V135
   Pories WJ, 1966, ZINC METABOLISM, P378
   Quintavalla S, 2002, MEAT SCI, V62, P373, DOI 10.1016/S0309-1740(02)00121-3
   Rivera-Garza M, 2000, MICROPOR MESOPOR MAT, V39, P431, DOI 10.1016/S1387-1811(00)00217-1
   RodriguezFuentes G, 1997, ZEOLITES, V19, P441, DOI 10.1016/S0144-2449(97)00087-0
   Semmens M., 1978, NATURAL ZEOLITES OCC, P517
   SEMMENS MJ, 1988, WATER RES, V22, P537, DOI 10.1016/0043-1354(88)90052-8
   SHAKER SK, 1992, J HELMINTHOL, V66, P288, DOI 10.1017/S0022149X00014735
   Takai K, 2002, MICROBIOL IMMUNOL, V46, P75, DOI 10.1111/j.1348-0421.2002.tb02661.x
   Tanimoto T., 1996, ZEOLITES, V16, P82
   Thom DC, 2003, ORAL SURG ORAL MED O, V95, P101, DOI 10.1067/moe.2003.90
   TOTOKI S, 1995, ZEOLITES, V15, P666
   Toyoda M, 1998, DERMATOLOGY, V196, P130, DOI 10.1159/000017846
   VANDENBOSSCHE GMR, 1991, INT J PHARM, V67, P195, DOI 10.1016/0378-5173(91)90432-N
   YAMAMOTO T, 1997, ZEOLITES, V18, P235
   ZAMZOW MJ, 1990, SEPAR SCI TECHNOL, V25, P1555, DOI 10.1080/01496399008050409
NR 53
TC 55
Z9 57
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-1317
J9 APPL CLAY SCI
JI Appl. Clay Sci.
PD DEC
PY 2004
VL 27
IS 3-4
BP 141
EP 150
DI 10.1016/j.clay.2004.04.004
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy
SC Chemistry; Materials Science; Mineralogy
GA 878EJ
UT WOS:000225629100002
DA 2018-10-20
ER

PT J
AU Keselowsky, BG
   Collard, DM
   Garcia, AJ
AF Keselowsky, BG
   Collard, DM
   Garcia, AJ
TI Surface chemistry modulates focal adhesion composition and signaling
   through changes in integrin binding
SO BIOMATERIALS
LA English
DT Article
DE surface chemistry; focal adhesion; integrin; cell adhesion; signaling
ID CALVARIAL OSTEOBLAST DIFFERENTIATION; SELF-ASSEMBLED MONOLAYERS;
   EMBRYONIC STEM-CELLS; FIBRONECTIN CONFORMATION; FIBROBLAST ADHESION;
   PROTEIN ADSORPTION; LIVING CELLS; IN-VITRO; KINASE; GOLD
AB Biomaterial surface properties influence protein adsorption and elicit diverse cellular responses in biomedical and biotechnological applications. However, the molecular mechanisms directing cellular activities remain poorly understood. Using a model system with well-defined chemistries (CH3, OIL COOH, NH2) and a fixed density of the single adhesive ligand fibronectin, we investigated the effects of surface chemistry on focal adhesion assembly and signaling. Surface chemistry strongly modulated integrin binding and specificity-alpha(5)beta(1) integrin binding affinity followed the pattern OH > NH2 = COOH > CH3, while integrin alpha(5)beta(1) displayed the relationship COOH > NH2 much greater than OH = CH3. Immunostaining and biochemical analyses revealed that surface chemistry modulates the structure and molecular composition of cell-matrix adhesions as well as focal adhesion kinase (FAK) signaling. The neutral hydrophilic OH functionality supported the highest levels of recruitment of talin, alpha-actinin, paxillin, and tyrosine-phosphorylated proteins to adhesive structures. The positively charged NH2 and negatively charged COOH surfaces exhibited intermediate levels of recruitment of focal adhesion components, while the hydrophobic CH3 substrate displayed the lowest levels. These patterns in focal adhesion assembly correlated well with integrin alpha(5)beta(1) binding. Phosphorylation of specific tyrosine residues in FAK also showed differential sensitivity to surface chemistry. Finally, surface chemistry-dependent differences in adhesive interactions modulated osteoblastic differentiation. These differences in focal adhesion assembly and signaling provide a potential mechanism for the diverse cellular responses elicited by different material properties. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRANDS R, 1988, EXP CELL RES, V176, P309, DOI 10.1016/0014-4827(88)90333-3
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   BRASH JL, 1987, PROTEINS INTERFACES, P490
   BRODBECK WG, 2003, P NATL ACAD SCI USA, V99, P10287
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Cary LA, 1996, J CELL SCI, V109, P1787
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ilic Dusko, 1995, Nature (London), V377, P539
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KESELOWSKY BG, IN PRESS BIOMATERIAL
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   MERWIN JR, 1990, J CELL PHYSIOL, V142, P117, DOI 10.1002/jcp.1041420115
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121
   Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   ULMAN A, 1989, LANGMUIR, V5, P1147, DOI 10.1021/la00089a003
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
NR 59
TC 385
Z9 392
U1 9
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2004
VL 25
IS 28
BP 5947
EP 5954
DI 10.1016/j.biomaterials.2004.01.062
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 845AQ
UT WOS:000223208400005
PM 15183609
DA 2018-10-20
ER

PT J
AU Rosenbloom, AJ
   Sipe, DM
   Shishkin, Y
   Ke, Y
   Devaty, RP
   Choyke, WJ
AF Rosenbloom, AJ
   Sipe, DM
   Shishkin, Y
   Ke, Y
   Devaty, RP
   Choyke, WJ
TI Nanoporous SiC: A candidate semi-permeable material for biomedical
   applications
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE silicon carbide; ultrafiltration; membrane; microdialysis; biosensor
ID SILICON-CARBIDE; POLY(ETHYLENE GLYCOL); PROTEIN ADSORPTION;
   PLATELET-ADHESION; IN-VITRO; STENTS; HEMOCOMPATIBILITY;
   BIOCOMPATIBILITY; CONSTRUCTION; CULTURES
AB We have fabricated free-standing SiC nanoporous membranes in both p-type and n-type material. We showed that these membranes will permit the diffusion of proteins up to 29000 Daltons, while excluding larger proteins. By using radioactively labeled albumin, we also show that porous SiC has very low protein adsorption, comparable to the best commercially available polymer nanoporous membrane.
C1 Carnegie Mellon Univ, Mol Biosensors & Imaging Ctr, Pittsburgh, PA 15213 USA.
   Carnegie Mellon Univ, Inst Complex Engineered Syst, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.
RP Rosenbloom, AJ (reprint author), Carnegie Mellon Univ, Mol Biosensors & Imaging Ctr, Pittsburgh, PA 15213 USA.
EM alan2@andrew.cmu.edu
CR Auditore A, 2002, BIOMOL ENG, V19, P85, DOI 10.1016/S1389-0344(02)00042-4
   Bai S, 2003, MATER RES SOC SYMP P, V742, P151
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Bolz A, 1996, TEX HEART I J, V23, P162
   Carrie D, 2001, J Interv Cardiol, V14, P1, DOI 10.1111/j.1540-8183.2001.tb00702.x
   Chu WH, 1999, J MICROELECTROMECH S, V8, P34, DOI 10.1109/84.749400
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Elbaz M, 2002, CATHETER CARDIO INTE, V56, P305, DOI 10.1002/ccd.10240
   FISSELL WH, 4 ANN BIOMEMS NAN WO
   Hamm CW, 2003, CATHETER CARDIO INTE, V60, P375, DOI 10.1002/ccd.10656
   Jahnsen H, 1999, METHODS, V18, P160, DOI 10.1006/meth.1999.0769
   Kalnins U, 2002, MED SCI MONITOR, V8, pPI16
   Kim S, 2000, JPN J APPL PHYS 1, V39, P5875, DOI 10.1143/JJAP.39.5875
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Leoni L, 2002, SENSORS, V2, P111, DOI 10.3390/s20300111
   Monnink SHJ, 1999, J INVEST MED, V47, P304
   NAJI A, 1991, BIOMATERIALS, V12, P690, DOI 10.1016/0142-9612(91)90118-T
   Nurdin N., 2003, European Cells & Materials, V5, P17
   Santavirta S, 1998, ARCH ORTHOP TRAUM SU, V118, P89, DOI 10.1007/s004020050319
   SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106
   Sharma S, 2002, LANGMUIR, V18, P8728, DOI 10.1021/la026097f
   SHOR JS, 1994, J ELECTROCHEM SOC, V141, P778, DOI 10.1149/1.2054810
   Takami Y, 1998, J BIOMED MATER RES, V40, P24, DOI 10.1002/(SICI)1097-4636(199804)40:1<24::AID-JBM3>3.3.CO;2-U
   Tao SL, 2003, ADV DRUG DELIVER REV, V55, P315, DOI 10.1016/S0169-409X(02)00227-2
   Unverdorben Martin, 2003, J Interv Cardiol, V16, P325, DOI 10.1034/j.1600-6143.2003.08058.x
   Weisenberg BA, 2002, J BIOMED MATER RES, V60, P283, DOI 10.1002/jbm.10076
   Zhang F, 2001, J BIOMED MATER RES, V56, P324, DOI 10.1002/1097-4636(20010905)56:3<324::AID-JBM1100>3.0.CO;2-P
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
NR 28
TC 79
Z9 82
U1 1
U2 19
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2004
VL 6
IS 4
BP 261
EP 267
DI 10.1023/B:BMMD.0000048558.91401.1d
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 872AR
UT WOS:000225178600001
PM 15548873
DA 2018-10-20
ER

PT J
AU Iemma, F
   Spizzirri, U
   Muzzalupo, R
   Puoci, F
   Trombino, S
   Picci, N
AF Iemma, F
   Spizzirri, U
   Muzzalupo, R
   Puoci, F
   Trombino, S
   Picci, N
TI Spherical hydrophilic microparticles obtained by the radical
   copolymerisation of functionalised bovine serum albumin
SO COLLOID AND POLYMER SCIENCE
LA English
DT Article
DE acryloylated bovine serum albumin; reverse-phase suspension
   polymerisation; spherical microparticles; hydrogels
ID IN-VITRO EVALUATION; DRUG-DELIVERY; 2,4,6-TRINITROBENZENESULFONIC ACID;
   MICROSPHERES; RELEASE; NANOPARTICLES; HYDROGELS
AB Unsaturated groups were introduced onto proteins in order to produce macromers that are able to undergo radical polymerisation. The initial protein used was bovine serum albumin (BSA) because it is biodegradable, biocompatible and easily available. Methacrylic groups were introduced onto BSA by reaction with methacrylic anhydride at controlled pH and temperature. The experimental conditions allowed the protein to be kept water-soluble. This water-solubility of the derivatised protein was essential when realising spherical polymeric microparticles via reverse phase suspension copolymerisation with N,N-dimethyacrylamide (DMAA). During the derivatisation, the insertion of the polymerisable groups affects only the sterically-available chemical functions of the native protein. Therefore, chain growth during the copolymerisation process involves only these groups, achieving a polymeric network around a structurally unmodified protein. The polymeric systems show high water affinity, ascribable to the hydrophilic properties of BSA. We have demonstrated that the achievement of the spherical form during the polymerisation depends on two factors: the degree of derivatisation of BSA, and the weight/weight (w/w) ratio of the protein to the comonomer. The beads obtained were characterised by Fourier transform IR spectrophotometry, particle size distribution analysis, and scanning electron microscopy (SEM). The samples investigated showed a remarkable affinity for water and a high swelling capacity. These properties depend upon the degree of derivatisation of BSA and on the percentage of DMAA in the copolymerisation mixture. In this paper we describe the starting materials and the experimental conditions used to prepare protein hydrogels by radical copolymerisation, which are intended for use in pharmaceutical and biomedical applications.
C1 Univ Calabria, Dipartimento Sci Farmaceut, I-87036 Arcavacata Di Rende, CS, Italy.
RP Iemma, F (reprint author), Univ Calabria, Dipartimento Sci Farmaceut, I-87036 Arcavacata Di Rende, CS, Italy.
EM francesca.iemma@unical.it
OI Puoci, Francesco/0000-0002-5963-6762; Picci, Nevio/0000-0003-1985-2724;
   Trombino, Sonia/0000-0001-9939-4457; Iemma,
   Francesca/0000-0001-9548-0446; MUZZALUPO, RITA/0000-0003-3486-6120
CR Arnedo A, 2002, INT J PHARM, V244, P59, DOI 10.1016/S0378-5173(02)00300-9
   Chuo WH, 1996, INT J PHARM, V144, P241, DOI 10.1016/S0378-5173(96)04742-4
   Fundueanu G, 2001, INT J PHARM, V218, P13, DOI 10.1016/S0378-5173(01)00570-1
   GALLO JM, 1989, J PHARM SCI, V78, P190, DOI 10.1002/jps.2600780303
   Ghassabian S, 1996, INT J PHARM, V130, P49, DOI 10.1016/0378-5173(95)04255-5
   Kao WJ, 2003, MATER SCI FORUM, V426-4, P3145, DOI 10.4028/www.scientific.net/MSF.426-432.3145
   Katti D, 1999, J MICROENCAPSUL, V16, P231, DOI 10.1080/026520499289202
   Kriwet B, 1998, J CONTROL RELEASE, V56, P149, DOI 10.1016/S0168-3659(98)00078-9
   Kumar ABM, 1998, BIOMATERIALS, V19, P725, DOI 10.1016/S0142-9612(97)00188-9
   Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0
   LONGO WE, 1982, J PHARM SCI, V71, P1323, DOI 10.1002/jps.2600711205
   MacAdam AB, 1997, INT J PHARM, V151, P47, DOI 10.1016/S0378-5173(97)04886-2
   Merodio M, 2001, EUR J PHARM SCI, V12, P251, DOI 10.1016/S0928-0987(00)00169-X
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   Muzzalupo R, 2001, COLLOID POLYM SCI, V279, P688, DOI 10.1007/s003960000472
   Park HY, 1998, INT J PHARM, V175, P231, DOI 10.1016/S0378-5173(98)00289-0
   PARK K, 1988, BIOMATERIALS, V9, P435, DOI 10.1016/0142-9612(88)90009-9
   Pitarresi G, 2004, BIOMATERIALS, V25, P4333, DOI 10.1016/j.biomaterials.2003.11.015
   Sahin S, 2002, J CONTROL RELEASE, V82, P345, DOI 10.1016/S0168-3659(02)00141-4
   SNYDER SL, 1975, ANAL BIOCHEM, V64, P284, DOI 10.1016/0003-2697(75)90431-5
   Truter EJ, 2001, CELL BIOL INT, V25, P51, DOI 10.1006/cbir.2000.0677
   van Staden JF, 1998, ANAL CHIM ACTA, V369, P163, DOI 10.1016/S0003-2670(98)00228-1
   WIDDER KJ, 1983, PHARMACOL THERAPEUT, V20, P377, DOI 10.1016/0163-7258(83)90033-5
   Wunder A, 2003, J IMMUNOL, V170, P4793, DOI 10.4049/jimmunol.170.9.4793
   ZENG XM, 1995, EUR J PHARM SCI, V3, P87, DOI 10.1016/0928-0987(94)00078-E
NR 25
TC 21
Z9 21
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0303-402X
EI 1435-1536
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD DEC
PY 2004
VL 283
IS 3
BP 250
EP 256
DI 10.1007/s00396-004-1071-x
PG 7
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 881UD
UT WOS:000225894000003
DA 2018-10-20
ER

PT J
AU Frais-Kolbl, H
   Griesmayer, E
   Kagan, H
   Pernegger, H
AF Frais-Kolbl, H
   Griesmayer, E
   Kagan, H
   Pernegger, H
TI A fast low-noise charged-particle CVD diamond detector
SO IEEE TRANSACTIONS ON NUCLEAR SCIENCE
LA English
DT Article
DE biomedical nuclear imaging; diamond; high-speed electronics; proton
   accelerators; proton detectors; semiconductor radiation detectors
ID RADIATION DETECTORS
AB This paper presents the design and test results of a charged-particle solid-state detector with ultrafast signal response based on polycrystalline chemical-vapor-deposition (pCVD) diamond as active detector material and a high-bandwidth RF amplifier. We tested the detector at the Indiana University Cyclotron Facility Bloomington, IN, in a proton beam with a kinetic energy ranging from 55 to 200 MeV. The detector signals showed an average pulsewidth of 1.38 ns, which enables single-particle counting at instantaneous rates approaching the gigahertz range. The detector operated with a signal-to-noise ratio of 7 : 1 for 200-MeV protons and a single-particle detection efficiency up to 99%.
C1 Fachhsch Wirtschaft & Tech, A-2700 Wiener Neustadt, Austria.
   European Org Nucl Res, Dept Phys, CH-1211 Geneva, Switzerland.
   Ohio State Univ, Dept Phys, Columbus, OH 43210 USA.
RP Frais-Kolbl, H (reprint author), Fachhsch Wirtschaft & Tech, A-2700 Wiener Neustadt, Austria.
CR ADAM W, 1997, P ELECTROCHEM SOC, P491
   Berdermann E, 2001, DIAM RELAT MATER, V10, P1770, DOI 10.1016/S0925-9635(01)00443-5
   BERGER MJ, 2004, ESTAR PSTAR ASTAR CO
   Bergonzo P, 2001, PHYS STATUS SOLIDI A, V185, P167, DOI 10.1002/1521-396X(200105)185:1<167::AID-PSSA167>3.0.CO;2-F
   FRANKLIN M, 1992, NUCL INSTRUM METH A, V315, P39, DOI 10.1016/0168-9002(92)90677-V
   HAN S, 1993, DIAM RELAT MATER, V2, P835, DOI 10.1016/0925-9635(93)90234-S
   Han S, 1995, REV SCI INSTRUM, V66, P5516, DOI 10.1063/1.1146077
   Moritz P, 2001, DIAM RELAT MATER, V10, P1765, DOI 10.1016/S0925-9635(01)00434-4
   NAIL M, 1993, P MAT RES SOC S 5, V302, P263
   POTTER R, 1998, MEDAUSTRON MACHBARKE
   Ramo S., 1939, P IRE, V27, P584, DOI DOI 10.1109/JRPROC.1939.228757
   *RD42 COLL, 1994, DRDCP56 RD42 COLL
   Shockley W, 1938, J APPL PHYS, V9, P635, DOI 10.1063/1.1710367
   ZHAO S, 1994, THESIS OHIO STATE U
NR 14
TC 25
Z9 25
U1 0
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9499
J9 IEEE T NUCL SCI
JI IEEE Trans. Nucl. Sci.
PD DEC
PY 2004
VL 51
IS 6
BP 3833
EP 3837
DI 10.1109/TNS.2004.839366
PN 3
PG 5
WC Engineering, Electrical & Electronic; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA 879LE
UT WOS:000225718500001
OA Green Published
DA 2018-10-20
ER

PT J
AU Kiem, S
   Oh, WS
   Peck, KR
   Lee, NY
   Lee, JY
   Song, JH
   Hwang, ES
   Kim, EC
   Cha, CY
   Choe, KW
AF Kiem, S
   Oh, WS
   Peck, KR
   Lee, NY
   Lee, JY
   Song, JH
   Hwang, ES
   Kim, EC
   Cha, CY
   Choe, KW
TI Phase variation of biofilm formation in Staphylocloccus aureus by IS256
   insertion and its impact on the capacity adhering to polyurethane
   surface
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE bacterial adhesion; biofilms; cell adhesion molecules; Staphylococcus
   aureus
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; STAPHYLOCOCCUS-EPIDERMIDIS; SLIME
   PRODUCTION; VIRULENCE; MUTANTS
AB While ica gene of Staphylococcus epidermidis is known to undergo phase variation by insertion of IS256, the phenomenon in Staphylococcus aureus has not been evaluated. Six biofilm-positive strains were tested for the presence of biofilm-negative phase-variant strains by Congo red agar test. For potential phase-valiant strains, pulsed-field gel electrophoresis was done to exclude the possibility of contamination. To investigate the mechanism of the biofilm-negative phase variation, PCR for each ica genes were done. Changes of ica genes detected by PCR were confirmed by southern hybridization, and their nucleotides were analyzed by DNA sequencing. Influence of ica genes and biofilm formation on capacity for adherence to biomedical material was evaluated by comparing the ability of adhering to polyurethane surface among a biofilm-negative phase-variant strain and its parent strain. A biofilm-negative phase-variant S. aureus strain was detected from 6 strains tested. icaC gene of the phase-variant strain was found to be inactivated by insertion of additional gene segment, IS256. The biofilm-negative phase-variant strain showed lower adhering capacity to polyurethane than its parent strain. This study shows that phase variation of ica gene occurs in S. aureus by insertion of IS256 also, and this biofilm-negative phase variation reduces adhering capacity of the bacteria.
C1 Sungkyunkwan Univ, Sch Med, Div Infect Dis, Samsung Med Ctr, Seoul 135710, South Korea.
   Sungkyunkwan Univ, Sch Med, Dept Lab Med, Samsung Med Ctr, Seoul 135710, South Korea.
   ARFID, Seoul, South Korea.
   Seoul Natl Univ, Coll Med, Dept Microbiol, Seoul, South Korea.
   Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.
   Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea.
RP Kiem, S (reprint author), Sungkyunkwan Univ, Sch Med, Div Infect Dis, Samsung Med Ctr, 50 Ilwon Dong, Seoul 135710, South Korea.
EM smkimkor@smc.samsung.co.kr
RI Song, Jae Hoon/C-9602-2011; Hwang, Eung-Soo/J-5731-2012
CR BASELGA R, 1993, INFECT IMMUN, V61, P4857
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   GOERING RV, 1992, J CLIN MICROBIOL, V30, P577
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
NR 12
TC 26
Z9 29
U1 0
U2 4
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD DEC
PY 2004
VL 19
IS 6
BP 779
EP 782
DI 10.3346/jkms.2004.19.6.779
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA 895LH
UT WOS:000226863400001
PM 15608385
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Pereira, D
   Cachinho, S
   Ferro, MC
   Fernandes, MHV
AF Pereira, D
   Cachinho, S
   Ferro, MC
   Fernandes, MHV
TI Surface behaviour of high MgO-containing glasses of the Si-Ca-P-Mg
   system in a synthetic physiological fluid
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE surfaces; apatite; MgO; biomedical applications
ID SIMULATED BODY-FLUID; IN-VITRO BIOACTIVITY; DOT 2SIO(2) SYSTEM;
   COMPOSITIONAL DEPENDENCE; INVITRO EVALUATION; APATITE FORMATION;
   CAO.SIO2 GLASSES; CERAMICS; LAYER; BONE
AB Two glasses of the Si-Ca-P-Mg system with low SiO2 content (25 and 29 mol%) and high MgO contents (31 and 36 mol%, respectively) have been immersed in a Kokubo's synthetic physiological solution for different times up to 30 days. The surface modifications of the glasses were observed by SEM and the changes in the surface composition followed by EDS. ICP was used to assess the evolution of ionic concentrations in the solution, namely Ca and P.
   It was observed that both glasses induced the precipitation of Ca-P rich layers on their surfaces, although these were poorly attached to the glass substrate. Ca and P ions required for the apatite formation were mainly provided by the composition of the glass, which was severely dissolved in the solution.
   The observed apatite-forming ability of these glasses, notwithstanding their high MgO content, suggests that further improvements at the surface and in the glasses can lead to attractive potentially bioactive materials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
RP Fernandes, MHV (reprint author), Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
EM helena@cv.ua.pt
RI Fernandes, Maria Helena/K-6917-2014
OI Ferro, Marta/0000-0003-3716-8643; V Fernandes, Maria
   Helena/0000-0002-1240-2512
CR Agathopoulos S, 2003, KEY ENG MAT, V240-2, P217, DOI 10.4028/www.scientific.net/KEM.240-242.217
   ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   ANDERSSON OH, 1990, J MATER SCI-MATER M, V1, P219, DOI 10.1007/BF00701080
   ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   BIGI A, 1993, J INORG BIOCHEM, V49, P69, DOI 10.1016/0162-0134(93)80049-F
   Brink M, 1997, J BIOMED MATER RES, V36, P109, DOI 10.1002/(SICI)1097-4636(199707)36:1<109::AID-JBM13>3.0.CO;2-D
   BROMER H, 1977, SCI CERAM, V9, P219
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Ebisawa Y., 1992, J MATER SCI-MATER M, V4, P225
   GROSS UM, 1990, HDB BIOACTIVE CERAMI, V1, P25
   Hench L.L., 1993, ADV SERIES CERAMICS, V1
   Hench L. L., 1990, HDB BIOACTIVE CERAMI, VI, P7
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hill R, 1996, J MATER SCI LETT, V15, P1122, DOI 10.1007/BF00539955
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HOLAND W, 1983, GLASS TECHNOL, V24, P318
   Karlsson KH, 1998, GLASS PHYS CHEM+, V24, P280
   KASUGA T, 1987, J MATER SCI, V22, P3721, DOI 10.1007/BF01161484
   KIM CY, 1989, J NON-CRYST SOLIDS, V113, P195, DOI 10.1016/0022-3093(89)90011-2
   KITSUGI T, 1992, BIOMATERIALS, V13, P393, DOI 10.1016/0142-9612(92)90045-P
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   Kokubo T., 1990, HDB BIOACTIVE CERAMI, P41
   LI P, 1993, J MATER SCI-MATER M, V4, P127, DOI 10.1007/BF00120381
   LI P, 1993, THESIS LEIDEN
   LI PJ, 1994, J NON-CRYST SOLIDS, V168, P281, DOI 10.1016/0022-3093(94)90340-9
   LI PJ, 1990, J NON-CRYST SOLIDS, V119, P112, DOI 10.1016/0022-3093(90)90247-J
   MOYA JS, 1994, J MATER SCI-MATER M, V5, P529, DOI 10.1007/BF00124885
   Navarro JMF, 1991, VIDRIO CONSEJO SUPER
   OGINO M, 1980, J NON-CRYST SOLIDS, V38-9, P673, DOI 10.1016/0022-3093(80)90514-1
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTSUKI C, 1992, J MATER SCI-MATER M, V3, P119, DOI 10.1007/BF00705279
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   OKASAKI M, 1991, BIOMATERIALS, V12, P831
   OKASAKI M, 1995, BIOMATERIALS, V16, P703
   OLIVEIRA JM, 1995, BIOMATERIALS, V16, P849, DOI 10.1016/0142-9612(95)94146-C
   Oliveira JM, 2002, BIOMATERIALS, V23, P371, DOI 10.1016/S0142-9612(01)00115-6
   Pereira M.M., 1995, J AM CERAM SOC, V78, P463
   REHMAN I, 1994, BIOMATERIALS, V15, P865, DOI 10.1016/0142-9612(94)90044-2
   REIS RL, 1998, BIOCERAMICS, V11, P169
   Roman J, 2001, BIOMATERIALS, V22, P2013, DOI 10.1016/S0142-9612(00)00387-2
   Salinas AJ, 2000, BIOMATERIALS, V21, P251, DOI 10.1016/S0142-9612(99)00150-7
   VOGEL W, 1990, J NON-CRYST SOLIDS, V123, P349, DOI 10.1016/0022-3093(90)90807-X
   VOGEL W, 1986, J NON-CRYST SOLIDS, V80, P34, DOI 10.1016/0022-3093(86)90377-7
NR 49
TC 25
Z9 26
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. European Ceram. Soc.
PD DEC
PY 2004
VL 24
IS 15-16
BP 3693
EP 3701
DI 10.1016/j.jeurceramsoc.2004.02.006
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 859JN
UT WOS:000224259400001
DA 2018-10-20
ER

PT J
AU Zhao, H
   Li, LC
   Okino, ST
   Kane, CJ
   Carroll, PR
   Dahiya, R
AF Zhao, H
   Li, LC
   Okino, ST
   Kane, CJ
   Carroll, PR
   Dahiya, R
TI Kidney gene database: A curated and integrated database of genes
   involved in kidney disease
SO JOURNAL OF UROLOGY
LA English
DT Article
DE kidney; database; databases; genetic; gene expression; kidney diseases
AB Purpose: We have created a curated and integrated database, the Kidney Gene Database (KGDB) (http: / /www.urogene.org/kgdb) that contains current information about genes or genomic loci involved in human kidney disease.
   Materials and Methods: Genes that undergo molecular, genetic or epigenetic events that affect kidney function are identified through a biomedical literature search and catalogued in the database.
   Results: Events that are currently screened for are gene amplification, mutation, deletion, polymorphism, loss of heterozygosity, DNA methylation and DNA hypomethylation. In addition, genes that are uniquely expressed in the kidney, as determined by analyzing the expressed sequence tags database and the Serial Analysis of Gene Expression database, are also included in KGDB. For each gene KGDB provides basic information about the gene product, a tissue type gene expression profile, links to protein, mRNA and genomic DNA sequence information, relevant literature citations and cross-references to other databases.
   Conclusions: We present KGDB, which is to our knowledge the first curated and integrated database of genes involved in human kidney disease. KGDB is free, widely accessible and easy to use, and it provides a wealth of relevant information. In addition, KGDB will be continuously updated every 6 months to include new information published in the biomedical literature or in gene expression databases. We envision that KGDB will serve as a valuable resource for scientists and clinicians.
C1 Univ Calif San Francisco, Urol Res Ctr 112F, San Francisco, CA 94121 USA.
   Vet Affairs Med Ctr, Dept Urol, San Francisco, CA USA.
RP Dahiya, R (reprint author), Univ Calif San Francisco, Urol Res Ctr 112F, 4150 Clement St, San Francisco, CA 94121 USA.
EM rdahiya@urol.ucsf.edu
CR Hirschman L, 2002, BIOINFORMATICS, V18, P1553, DOI 10.1093/bioinformatics/18.12.1553
   Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051
   Levine AE, 2001, NUCLEIC ACIDS RES, V29, P300, DOI 10.1093/nar/29.1.300
   Li LC, 2003, NUCLEIC ACIDS RES, V31, P291, DOI 10.1093/nar/gkg008
   Mack R, 2002, DRUG DISCOV TODAY, V7, pS89, DOI 10.1016/S1359-6446(02)02286-9
   Schuler GD, 1997, J MOL MED, V75, P694, DOI 10.1007/s001090050155
   Tate R, 2003, EUR J CANCER, V39, P961, DOI 10.1016/S0959-8049(03)00070-4
   ZHENG F, 2003, SCI AGING KNOWLEDGE, pPE20
NR 8
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD DEC
PY 2004
VL 172
IS 6
BP 2344
EP 2346
DI 10.1097/01.ju.0000144106.91876.7a
PN 1
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 872GE
UT WOS:000225194900050
PM 15538263
DA 2018-10-20
ER

PT J
AU Kim, GH
AF Kim, GH
TI Electroactive polymer composites as a tactile sensor for biomedical
   applications
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE self-sensing; health monitoring; smart material; polymer composite;
   microstructure; electrostriction
ID ELECTRIC-FIELD; ELECTROSTRICTION; ELASTOMERS; ELECTRORHEOLOGY
AB Modern applications could benefit from multifunctional materials having anisotropic optical, electrical, thermal, or mechanical properties, especially when coupled with locally controlled distribution of the directional response. Such materials are difficult to engineer by conventional methods, but the electric field-aided technology presented herein is able to locally tailor electroactive composites. Applying an electric field to a polymer in its liquid state allows the orientation of chain- or fiber-like inclusions or phases from what was originally an isotropic material. Such composites can be formed from liquid solutions, melts, or mixtures of pre-polymers and cross-linking agents. Upon curing, a "created composite" results; it consists of these "pseudofibers" embedded in a matrix. One can also create oriented composites from embedded spheres, flakes, or fiber-like shapes in a liquid plastic. Orientation of the externally applied electric field defines the orientation of the field-aided self-assembled composites. The strength and duration of exposure of the electric field control the degree of anisotropy created. Results of electromechanical testing of these modified materials, which are relevant to sensing and actuation applications, are presented. The materials' micro/nanostructures were analyzed using microscopy and X-ray diffraction techniques.
C1 Samsung Elect Co LTD, Gyeonggi 449900, South Korea.
RP Kim, GH (reprint author), Samsung Elect Co LTD, San 24 Nongseo, Gyeonggi 449900, South Korea.
EM xrdghk@yahoo.com
CR Bowen CP, 1998, J MATER RES, V13, P205, DOI 10.1557/JMR.1998.0027
   BOWEN CP, 1995, J INTEL MAT SYST STR, V6, P159, DOI 10.1177/1045389X9500600203
   FILANCBOWEN TR, 2003, PRECEEDING SPIE, V5051, P218
   FILANCBOWEN TR, 2002, IEEE SENS 2002 ORL F, V2, P1648
   Guillot FM, 2001, J ACOUST SOC AM, V110, P2980, DOI 10.1121/1.1416905
   Happel J., 1965, LOW REYNOLDS NUMBER
   Hase M, 1999, J INTEL MAT SYST STR, V10, P508, DOI 10.1106/B6EX-9DXD-WP5D-KDJY
   Horvath AT, 2002, INT J MOD PHYS B, V16, P2690, DOI 10.1142/S0217979202012852
   Kim G, 2004, J MATER RES, V19, P1164, DOI 10.1557/JMR.2004.0151
   Kim GH, 2002, J INTEL MAT SYST STR, V13, P479, DOI 10.1106/104538902030335
   Landau L D, 1984, ELECTRODYNAMICS CONT
   Lehmann W, 2001, NATURE, V410, P447, DOI 10.1038/35068522
   Liu B, 2001, J RHEOL, V45, P641, DOI 10.1122/1.1366716
   Martin JE, 1999, J CHEM PHYS, V111, P4273, DOI 10.1063/1.479725
   Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836
   Peterson RE, 1974, STRESS CONCENTRATION
   RAUCH BJ, 1993, THERMOELASTIC STRESS, P581
   Shkel YM, 1996, J APPL PHYS, V80, P4566, DOI 10.1063/1.363439
   Shkel YM, 1999, J RHEOL, V43, P1307, DOI 10.1122/1.551023
   SHKEL YM, 2001, J RHEOL, V45, P447
   Stratton J. A., 1941, ELECTROMAGNETIC THEO
NR 21
TC 10
Z9 11
U1 0
U2 13
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD DEC
PY 2004
VL 12
IS 6
BP 564
EP 572
DI 10.1007/BF03218445
PG 9
WC Polymer Science
SC Polymer Science
GA 884UB
UT WOS:000226111000004
DA 2018-10-20
ER

PT J
AU Tvrdeic, A
   Durkovic, M
   Birus, I
AF Tvrdeic, A
   Durkovic, M
   Birus, I
TI Tail pressure pain in Wistar rats: influence of gender and time of day
SO PERIODICUM BIOLOGORUM
LA English
DT Article
DE gender; time of day; tail pressure; rat
ID SEX-DIFFERENCES; THERMAL NOCICEPTION; INDUCED ANALGESIA; DIURNAL RHYTHM;
   SENSITIVITY; MORPHINE; MICE; ANTINOCICEPTION; BEHAVIOR; AGE
AB Background and Purpose: The gender should be considered as a basic variable at all levels of biomedical and health related research. Thus, we tested the hypothesis whether gender and time of day affect tail pressure thresholds in Wistar rats.
   Materials and Methods: Eleven female and 11 male Wistar rats at the age of 6 months were used. After two days of habituation period, tail pressure thresholds were determined twice a day (9.00-10.00 h and 15.00-16.00 h) on 3 consecutive days. Expressed in grains (g), the pain thresholds were measured by applying increasing force on the tail, until the tail was withdrawn as the result of pain. Data were analyzed using analysis of variance (ANOVA) and expressed as the mean +/- S.E.M.
   Results: The pain thresholds were significantly higher in finale, as compared to female rats, when testing took place in the morning (days 1-3; F (5, 52) = 4.93; P < 0.01). When testing took place in the afternoon, there was no difference in the pain threshold values between female and finale rats (days 1-3; F (5, 52) = 2.19, not significant at P < 0.05). Significant decrease in afternoon pain threshold values, as compared to morning values, was detected within male (days 1-3; F (5, 56) = 3.5; P < 0.05), but not within female rats (days 1-3; F (5, 48) = 1.1 not significant at P < 0.05).
   Conclusion: The results presented here indicate that both gender and tune of day during the light phase of the day cycle affected tail pressure thresholds in Wistar rats.
C1 Univ JJ Strossmayer Osijek, Sch Med, Dept Pharmacol, Osijek 31000, Croatia.
   Univ JJ Strossmayer Osijek, Sch Med, Dept Chem & Biochem, Osijek 31000, Croatia.
RP Tvrdeic, A (reprint author), Univ JJ Strossmayer Osijek, Sch Med, Dept Pharmacol, Huttlerova 4, Osijek 31000, Croatia.
EM tvrdeic@mefos.hr
OI Tvrdeic, Ante/0000-0002-8881-2278
CR AKUNNE HC, 1994, PHARMACOL BIOCHEM BE, V48, P411, DOI 10.1016/0091-3057(94)90545-2
   Barrett AC, 2002, EUR J PHARMACOL, V452, P163, DOI 10.1016/S0014-2999(02)02274-4
   BEATTY WW, 1976, PHYSIOL BEHAV, V16, P413, DOI 10.1016/0031-9384(76)90319-X
   Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3
   COVINO BG, 1980, PAIN, V9, P141, DOI DOI 10.1016/0304-3959(80)90002-0
   Craft RM, 2003, LIFE SCI, V72, P2675, DOI 10.1016/S0024-3205(03)00178-4
   Endoh T, 1999, LIFE SCI, V65, P1685, DOI 10.1016/S0024-3205(99)00417-8
   FREDERICKSON RCA, 1977, SCIENCE, V198, P756, DOI 10.1126/science.561998
   GOLOMBEK DA, 1991, EUR J PHARMACOL, V194, P25, DOI 10.1016/0014-2999(91)90119-B
   GOMES MM, 1993, PHYSIOL BEHAV, V55, P651
   Jourdan D, 2000, EUR J PAIN, V4, P291, DOI 10.1053/eujp.2000.0188
   KAVALIERS M, 1983, BRAIN RES, V279, P387, DOI 10.1016/0006-8993(83)90216-0
   KAYSER V, 1996, BRAIN RES, V742, P777
   Keogh E, 2000, PAIN, V85, P225, DOI 10.1016/S0304-3959(99)00270-5
   KERDELHUE B, 1983, BRAIN RES, V261, P243, DOI 10.1016/0006-8993(83)90627-3
   Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4
   ONEILL MF, 1989, NEUROPHARMACOLOGY, V28, P243, DOI 10.1016/0028-3908(89)90099-3
   Perissin L, 2000, LIFE SCI, V67, P1477, DOI 10.1016/S0024-3205(00)00733-5
   RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409
   Rollman GB, 1995, PAIN FORUM, V4, P231, DOI 10.1016/S1082-3174(11)80026-7
   SCHLOSBERG AJ, 1978, PHYSIOL BEHAV, V20, P117, DOI 10.1016/0031-9384(78)90061-6
   STEIN C, 1988, PHARMACOL BIOCHEM BE, V31, P445, DOI 10.1016/0091-3057(88)90372-3
   WRIGHT DM, 1981, EUR J PHARMACOL, V69, P385
NR 23
TC 1
Z9 1
U1 0
U2 4
PU PERIODICUM BIOLOGORUM
PI ZAGREB
PA HRVATSKO PRIRODOSLOVNO DRUSTVO ILICA 16/111, 41000 ZAGREB, CROATIA
SN 0031-5362
J9 PERIOD BIOL
JI Period. Biol.
PD DEC
PY 2004
VL 106
IS 4
BP 427
EP 431
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 884QT
UT WOS:000226101600018
DA 2018-10-20
ER

PT J
AU Mirtaheri, P
   Omtveit, T
   Klotzbuecher, T
   Grimnes, S
   Martinsen, OG
   Tonnessen, TI
AF Mirtaheri, P
   Omtveit, T
   Klotzbuecher, T
   Grimnes, S
   Martinsen, OG
   Tonnessen, TI
TI Miniaturization of a biomedical gas sensor
SO PHYSIOLOGICAL MEASUREMENT
LA English
DT Article
DE conductivity; ischemia; miniaturization; PCO2 sensor
ID BIOLOGICAL-MATERIALS; PCO2; ISCHEMIA; ELECTRODES; SURFACE
AB In a previous study, we concluded that a conductivity based PCO2 sensor is an attractive solution for early detection of ischemia and presented two design geometries. For organ surface measurements, the planar design was suitable but it was difficult to insert the sensor into the tissue. A cylindrical design solution was favored for insertion due to the large membrane contact area and easy placement in a medical catheter. Since the previous cylindrical prototype was large and could damage the tissue, a more miniaturized sensor was needed. In the current paper, we present a miniaturized sensor with an outer diameter of 1 mm. The applied technology for manufacturing the sensor was a combination of mechanical turning, excimer laser drilling and conventional molding technique. The materials applied were PEEK (polyetherether ketone), PI (polyimide) with gold layers and polysiloxane. The membrane had to be gas permeable while acting as a barrier for ion transport, and was made of polysiloxane and had a thickness of 100-150 mum. The miniaturized sensor was tested for calibration, response time, drifting and pressure sensitivity. The results show that the miniaturized PCO2 sensor is capable of rapid and stable measurements both in vitro and ex vivo. The result from this study will be applied for the industrial manufacturing of such a biomedical sensor as a clinical product.
C1 Rikshosp Univ Hosp, Intervent Ctr, N-0027 Oslo, Norway.
   Univ Oslo, Dept Phys, N-1048 Blindern, Norway.
   Rikshosp Univ Hosp, Dept Clin Engn, Oslo, Norway.
   Alertis Med AS, Oslo, Norway.
   Inst Mikrotech Mainz GMBH, Dept Opt, Mainz, Germany.
   Rikshosp Univ Hosp, Dept Anesthesiol, Oslo, Norway.
RP Mirtaheri, P (reprint author), Rikshosp Univ Hosp, Intervent Ctr, N-0027 Oslo, Norway.
RI Martinsen, Orjan/M-4459-2014
OI Martinsen, Orjan/0000-0003-1632-4352; Klotzbucher,
   Thomas/0000-0002-4630-2966
CR ARQUINT P, 1994, THESIS U NEUCHATEL
   FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25
   Grimnes S, 2000, BIOIMPEDANCE BIOELEC
   Kvarstein G, 2004, CRIT CARE MED, V32, P232, DOI 10.1097/01.CCM.0000104948.41544.FC
   Kvarstein G, 2003, ACTA ANAESTH SCAND, V47, P675, DOI 10.1034/j.1399-6576.2003.00134.x
   Lide D. R., 2004, CRC HDB CHEM PHYS
   LIS K, 1979, PFLUG ARCH EUR J PHY, V381, P289, DOI 10.1007/BF00583262
   Mirtaheri P, 2004, PHYSIOL MEAS, V25, P421, DOI 10.1088/0967-3334/25/2/002
   NUNN JF, 1993, NUNNS APPL RESP PHYS
   ONARAL B, 1982, MED BIOL ENG COMPUT, V20, P299, DOI 10.1007/BF02442796
   SCHWAN HP, 1968, ANN NY ACAD SCI, V148, P191, DOI 10.1111/j.1749-6632.1968.tb20349.x
   SCHWAN HP, 1963, REV SCI INSTRUM, V36, P481
   SEVERINGHAUS JW, 1958, J APPL PHYSIOL, V13, P515
   STOW RW, 1957, ARCH PHYS MED REHAB, V7, P646
   Tonnessen TI, 1996, ACTA ANAESTH SCAND, V40, P510, DOI 10.1111/j.1399-6576.1996.tb04481.x
   Tonnessen TI, 1997, ACTA ANAESTH SCAND, V41, P659
NR 16
TC 10
Z9 10
U1 3
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0967-3334
EI 1361-6579
J9 PHYSIOL MEAS
JI Physiol. Meas.
PD DEC
PY 2004
VL 25
IS 6
BP 1511
EP 1522
AR PII S0967-3334(04)81668-X
DI 10.1088/0967-3334/25/6/015
PG 12
WC Biophysics; Engineering, Biomedical; Physiology
SC Biophysics; Engineering; Physiology
GA 891OW
UT WOS:000226591400015
PM 15712728
DA 2018-10-20
ER

PT J
AU Wang, LC
   Chen, JW
   Liu, HI
   Chen, ZQ
   Zhang, Y
   Wang, CY
   Feng, ZG
AF Wang, LC
   Chen, JW
   Liu, HI
   Chen, ZQ
   Zhang, Y
   Wang, CY
   Feng, ZG
TI Synthesis and evaluation of biodegradable segmented multiblock
   poly(ether ester) copolymers for biomaterial applications
SO POLYMER INTERNATIONAL
LA English
DT Article
DE poly(ether ester); degradation; cytotoxicity; cell adhesion;
   biocompatibility
ID HUMAN ENDOTHELIAL-CELLS; IN-VITRO DEGRADATION; BLOCK-COPOLYMERS;
   CONTROLLED-RELEASE; TEREPHTHALATE); POLYESTERS; POLYMERS; BONE;
   PROTEINS; ADHESION
AB Based on 1,4-succinic acid, 1,4-butanediol, poly(ethylene glycol)s and dimethyl terephthalate, biodegradable segmented multiblock copolymers of poly[(butylene terephthalate)-co-poly(butylene succinate)-block-poly(ethylene glycol)] (PTSG) were synthesized with different poly(butylene succinate) (PBS) molar fractions and varying the poly(ethylene glycol) (PEG) segment length, and were evaluated as biomedical materials. The copolymer extracts showed no in vitro cytotoxicity. However, sterilization of the copolymers by gamma irradiation had some limited effect on the cytotoxicity and mechanical properties. A copolymer consisting of PEG-1000 and 20 mol% PBS, assigned as 1000PBS20 after SO2 gas plasma treatment, sustained the adhesion and growth of dog vascular smooth muscle cells. The in vivo biocompatibility of this sample was also measured subcutaneously in rats for 4 weeks. The assessments indicated that these poly(ether ester) copolymers are good candidates for anti-adhesion barrier and drug controlled-release applications. (C) 2004 Society of Chemical Industry.
C1 Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China.
   Acad Mil Med Sci, Lab Tissue Engn, Beijing 100850, Peoples R China.
RP Feng, ZG (reprint author), Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China.
EM sainfeng@bit.edu.cn
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   BOUNEKHEL M, 1995, POLYM DEGRAD STABIL, V49, P347, DOI 10.1016/0141-3910(95)00097-6
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   Deschamps AA, 2001, POLYMER, V42, P9335, DOI 10.1016/S0032-3861(01)00453-0
   Deschamps AA, 2003, BIOMATERIALS, V24, P2643, DOI 10.1016/S0142-9612(03)00054-1
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   Du C, 2002, BIOMATERIALS, V23, P4649, DOI 10.1016/S0142-9612(02)00214-4
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   Kellomaki M, 2002, BIOMATERIALS, V23, P283, DOI 10.1016/S0142-9612(01)00107-7
   KIM HC, 2001, POLYMER, V42, P1849
   Kint DPR, 2003, POLYMER, V44, P1321, DOI 10.1016/S0032-3861(02)00938-2
   Muller RJ, 2001, J BIOTECHNOL, V86, P87, DOI 10.1016/S0168-1656(00)00407-7
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   REED AM, 1981, POLYMER, V22, P499, DOI 10.1016/0032-3861(81)90169-5
   Signori F, 2003, MACROMOL SYMP, V197, P289, DOI 10.1002/masy.200350726
   van Dorp AGM, 1999, J BIOMED MATER RES, V47, P292, DOI 10.1002/(SICI)1097-4636(19991205)47:3<292::AID-JBM2>3.0.CO;2-B
   VANDIJKHUIZENRADER, 2002, BIOMATERIALS, V23, P4719
   Witt U, 2001, CHEMOSPHERE, V44, P289, DOI 10.1016/S0045-6535(00)00162-4
   Witt U, 1999, ANGEW CHEM INT EDIT, V38, P1438, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1438::AID-ANIE1438>3.0.CO;2-U
   Zhang Y, 2003, POLYM INT, V52, P1351, DOI 10.1002/pi.1222
   Zhang Y, 2002, ACTA CHIM SINICA, V60, P2225
NR 25
TC 20
Z9 20
U1 1
U2 15
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD DEC
PY 2004
VL 53
IS 12
BP 2145
EP 2154
DI 10.1002/pi.1645
PG 10
WC Polymer Science
SC Polymer Science
GA 874JW
UT WOS:000225347700034
DA 2018-10-20
ER

PT J
AU Satoh, T
   Nishiyama, K
   Nagahata, M
   Teramoto, A
   Abe, K
AF Satoh, T
   Nishiyama, K
   Nagahata, M
   Teramoto, A
   Abe, K
TI The research on physiological property of functionalized hyaluronan:
   interaction between sulfated hyaluronan and plasma proteins
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE hyaluronan (hyaluronic acid); polysaccharides; plasma proteins;
   biomaterials; chromatography
ID POLYELECTROLYTE COMPLEX PEC; FIBROBLAST HPLF FUNCTION; HEPARIN
AB Hyaluronan (HA) is a natural polysaccharides which has no sulfated group but high molecular weight in comparison with other glycosaminoglycans (GAGs). Previously it has been cleared up that the cell function of human keratinocytes is affected by S-HA (HA substituted with sulfated groups). Most biomedical materials contact with blood components, proteins, cells, etc. In this study, the interaction between S-HA and blood components is discussed, that is, plasma proteins. And the application of S-HA for new analytical and separation method of some proteins is pointed out. None of the proteins were adsorbed to HA. Fibronectin and fibinogen were adsorbed to S-HA, but immunoglobulin-G and insulin were not adsorbed to it as well as heparin. However, albumin could interact only with heparin, and it did not interact with S-HA. Furthermore S-HA adsorbed the plasma proteins that did not adsorb to heparin. It is clear that S-HA showed different interaction with the plasma proteins in comparison with natural sulfated polysaccharides. Copyright (C) 2004 John Wiley Sons, Ltd.
C1 Shinshu Univ, Dept Funct Polymer Sci, Fac Text Sci & Technol, Nagano 3868567, Japan.
RP Abe, K (reprint author), Shinshu Univ, Dept Funct Polymer Sci, Fac Text Sci & Technol, Tokida 3-15-1, Nagano 3868567, Japan.
EM kojiabe@giptc.shinshu-u.ac.jp
CR ANDEREGG G, 1954, HELV CHIM ACTA, V37, P113, DOI 10.1002/hlca.19540370114
   Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y
   FERANDEZ JA, 1999, THROMB HAEMOSTASIS, V82, P1462
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Hamano T, 1998, J BIOMAT SCI-POLYM E, V9, P985, DOI 10.1163/156856298X00299
   Hamano T, 1998, J BIOMED MATER RES, V41, P270, DOI 10.1002/(SICI)1097-4636(199808)41:2<270::AID-JBM12>3.3.CO;2-B
   JALKANEN M, 1991, RECEPTORS EXTRACELLU, P1
   Kopp R, 2002, ASAIO J, V48, P598, DOI 10.1097/01.MAT.0000033639.23941.7E
   SATOH T, 2004, SENI GAKKAISHI, V74
   SCULLY MF, 1988, BIOCHEM J, V254, P547, DOI 10.1042/bj2540547
   Sears P, 1996, P NATL ACAD SCI USA, V93, P12086, DOI 10.1073/pnas.93.22.12086
   SEKIGUCHI K, 1983, J BIOL CHEM, V258, P4359
   Teramoto A, 1999, POLYM ADVAN TECHNOL, V10, P681, DOI 10.1002/(SICI)1099-1581(199912)10:12<681::AID-PAT920>3.3.CO;2-J
NR 13
TC 8
Z9 9
U1 0
U2 5
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD DEC
PY 2004
VL 15
IS 12
BP 720
EP 725
DI 10.1002/pat.486
PG 6
WC Polymer Science
SC Polymer Science
GA 881UV
UT WOS:000225895800005
DA 2018-10-20
ER

PT J
AU Dias, AMA
   Caco, AI
   Coutinho, JAP
   Santos, LMNBF
   Pineiro, MM
   Vega, LF
   Gomes, MFC
   Marrucho, IM
AF Dias, AMA
   Caco, AI
   Coutinho, JAP
   Santos, LMNBF
   Pineiro, MM
   Vega, LF
   Gomes, MFC
   Marrucho, IM
TI Thermodynamic properties of perfluoro-n-octane
SO FLUID PHASE EQUILIBRIA
LA English
DT Article
DE oxygen; perfluoro-n-octane; solubility; density; vapor pressure;
   thermodynamic functions; regular solution theory; soft-SAFT EoS
ID AQUEOUS-SOLUTIONS; SOLUBILITY; GASES; ALKANES; PRESSURE; ETHANE; OXYGEN;
   ACID
AB Fluorocarbons are attracting much attention nowadays because of their unique properties, which may provide interesting applications in areas as wide as environmental, biomedical and material science. However, the behavior of these compounds is not well understood and only scattered data can be found in the open literature and company technical reports.
   In this work, three important properties of perfluoro-n-octane were experimentally determined: the liquid density, the vapor pressure and the oxygen solubility. Liquid density was measured, in the temperature range between 288 and 313 K with a vibrating tube densimeter and vapor pressure was measured with an apparatus based on the static method up to 333 K.
   The solubility of oxygen in perfluoro-n-octane, in the temperature range between 288 and 313 K and at pressures close to atmospheric, was determined experimentally with a precision apparatus based on the saturation method at constant pressure. Experimental solubility data, density and vapor pressure were correlated with the soft-SAFT EoS. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Aveiro, Dept Chem, CICECO, P-3810193 Aveiro, Portugal.
   Univ Porto, Fac Ciencias, Dept Quim, CIQ, P-4169007 Oporto, Portugal.
   Univ Vigo, Fac Sci, Dept Appl Phys, E-36200 Vigo, Spain.
   CSIC, Inst Ciencia Mat Barcelona, ICMAB, E-08193 Barcelona, Spain.
   Univ Clermont Ferrand, Lab Thermodynam Solut & Polymeres, F-63177 Clermont Ferrand, France.
RP Marrucho, IM (reprint author), Univ Aveiro, Dept Chem, CICECO, P-3810193 Aveiro, Portugal.
EM imarrucho@dq.ua.pt
RI Dias, Ana/F-1858-2010
OI Dias, Ana/0000-0002-0865-0257; Coutinho, Joao/0000-0002-3841-743X;
   Santos, Luis/0000-0003-3040-0358; Vega, Lourdes/0000-0002-7609-4184;
   Pineiro, Manuel M/0000-0002-3955-3564; Marrucho,
   Isabel/0000-0002-8733-1958
CR BATTINO R, 1984, FLUID PHASE EQUILIBR, V15, P231, DOI 10.1016/0378-3812(84)87009-0
   BENNAIM A, 1985, J SOLUTION CHEM, V14, P245
   BENNAIM A, 1980, HYDROPHOBIC INTERACT
   BENSON BB, 1976, J CHEM PHYS, V64, P689, DOI 10.1063/1.432215
   CACO AI, 2004, J PHYS CHEM B, V108, P1450
   CACO AI, UNPUB
   CARNICER J, 1979, REV ACAD CIENCIAS ZA, V34, P115
   CHICKOS JS, 1992, J ORG CHEM, V57, P1897, DOI 10.1021/jo00032a052
   *DIPPR, 1998, THERM PROP DAT
   Dymond J. H., 1980, VIRIAL COEFFICIENTS
   GJALDBAEK JC, 1952, ACTA CHEM SCAND, V6, P623, DOI 10.3891/acta.chem.scand.06-0623
   HASZELDINE RN, 1951, J CHEM SOC, P603, DOI 10.1039/jr9510000603
   Hesse PJ, 1996, J CHEM ENG DATA, V41, P195, DOI 10.1021/je9502455
   HILDEBRAND JH, 1970, REGULAR RELATED SOLU
   KREGLEWSKI A, 1962, B ACAD POL SCI-CHIM, V10, P629
   MACK HG, 1987, J CHEM PHYS, P87
   Makranczy J., 1976, HUNG J IND CHEM, V4, P269
   Poling BE, 2001, PROPERTIES GASES LIQ
   Prausnitz J.M., 1999, MOL THERMODYNAMICS F
   PRAUSNITZ JM, 1961, AICHE J, V7, P682, DOI 10.1002/aic.690070430
   Riess J. C., 1998, BLOOD SUBSTITUTES PR, VII
   Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c
   Steele WV, 1997, J CHEM ENG DATA, V42, P1021, DOI 10.1021/je9701036
   THOMSEN ES, 1963, ACTA CHEM SCAND, V17, P127, DOI 10.3891/acta.chem.scand.17-0127
   VANDANA V, 1994, FLUID PHASE EQUILIBR, V99, P209, DOI 10.1016/0378-3812(94)80032-4
   WILHELM E, 1977, CHEM REV, V77, P219, DOI 10.1021/cr60306a003
NR 26
TC 45
Z9 45
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-3812
J9 FLUID PHASE EQUILIBR
JI Fluid Phase Equilib.
PD NOV 9
PY 2004
VL 225
IS 1-2
BP 39
EP 47
DI 10.1016/j.fluid.2004.07.004
PG 9
WC Thermodynamics; Chemistry, Physical; Engineering, Chemical
SC Thermodynamics; Chemistry; Engineering
GA 906JH
UT WOS:000227636500005
DA 2018-10-20
ER

PT J
AU Berkland, C
   Pack, DW
   Kim, K
AF Berkland, C
   Pack, DW
   Kim, K
TI Controlling surface nano-structure using flow-limited field-injection
   electrostatic spraying (FFESS) Of poly(D,L-lactide-co-glycolide)
SO BIOMATERIALS
LA English
DT Article
DE electrohydrodynamics; electrospraying; electrospinning; surface
   patterning; coating; poly(D,L-lactide-co-glycolide)
ID LIQUID CLUSTER BEAM; IONIZATION MASS-SPECTROMETRY; THIN-FILMS; IN-VITRO;
   BIODEGRADABLE NANOSPHERES; L-LACTIDE; RELEASE; SCAFFOLDS; FABRICATION;
   MEMBRANES
AB Improved control of surface micro- and nano-structure may lead to enhanced performance of degradable biomedical devices Such as surgical dressings, vascular grafts, tissue engineering scaffolds, sutures, and structures for guided tissue regeneration. An electrohydrodynamic method called flow-limited field-injection electrostatic spraying (FFESS) has been developed as an improved technique for the controlled deposition of polymeric material. Injecting charge using a nano-sharpened tungsten needle in a process called field ionization can efficiently induce an ionic state in a Solution Of poly(D,L-lactide-co-glycolide) increasing its capacity to carry charge. As a result, sprays have been produced that are finer and more precisely controlled than sprays produced by conventional electrospraying techniques, which employ hypodermic needles as the spray nozzle. Here, the effect of FFESS variables including applied voltage, polymer solution flow rate, and solvent properties (surface tension, viscosity, vapor pressure) on spray performance have been qualitatively evaluated. Under certain conditions, increasing the applied voltage produced an increasingly rough surface morphology. Similarly, by reducing solvent surface tension and increasing solvent vapor pressure, more distinct Surface structures could be formed including uniform nanoparticles. Working ranges of the important parameters for the production of Specific Structure types such as smooth Or Porous Surfaces, non-woven or melded fibers, and distinct or melded nanoparticles have been defined. FFESS technology provides a simple yet powerful technique for fabricating biomedical devices with a precisely defined nano-structure potentially capable Of utilizing a broad range of biocompatible polymeric materials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.
   Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
RP Kim, K (reprint author), Univ Illinois, Dept Elect & Comp Engn, 45 EL,MC 702 1406 W Green St, Urbana, IL 61801 USA.
EM kevinkim@uiuc.edu
CR Beck JL, 2001, MASS SPECTROM REV, V20, P61, DOI 10.1002/mas.1003
   Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Carino GP, 2000, J CONTROL RELEASE, V65, P261, DOI 10.1016/S0168-3659(99)00247-3
   Choi H, 2002, J MATER RES, V17, P1888, DOI 10.1557/JMR.2002.0279
   Cich M, 1998, APPL PHYS LETT, V73, P2116, DOI 10.1063/1.122396
   Cohen S, 1994, Int J Technol Assess Health Care, V10, P121
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Feng SS, 2001, J CONTROL RELEASE, V71, P53, DOI 10.1016/S0168-3659(00)00364-3
   Gaspar MM, 1998, J CONTROL RELEASE, V52, P53
   Gibson P, 2001, COLLOID SURFACE A, V187, P469, DOI 10.1016/S0927-7757(01)00616-1
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hirosue S, 2001, J CONTROL RELEASE, V70, P231, DOI 10.1016/S0168-3659(00)00353-9
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   JALIL R, 1990, J MICROENCAPSUL, V7, P297, DOI 10.3109/02652049009021842
   Jung T, 2000, J CONTROL RELEASE, V67, P157, DOI 10.1016/S0168-3659(00)00201-7
   Kapur A, 2002, PROTEIN SCI, V11, P147, DOI 10.1101/ps.27702
   Kawashima Y, 1999, J CONTROL RELEASE, V62, P279, DOI 10.1016/S0168-3659(99)00048-6
   KIM K, 1994, NANOSTRUCT MATER, V4, P597, DOI 10.1016/0965-9773(94)90069-8
   KIM K, 1976, J APPL PHYS, V47, P1964, DOI 10.1063/1.322920
   KITCHELL JP, 1985, METHOD ENZYMOL, V112, P436
   Kreitz MR, 1997, BIOMATERIALS, V18, P1645, DOI 10.1016/S0142-9612(97)00106-3
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   LEWIS D H, 1990, P1
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   Morozov VN, 1998, INT J MASS SPECTROM, V178, P143, DOI 10.1016/S1387-3806(98)14083-6
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Rayleigh J.W.S., 1882, PHILOS MAG, V4, P184
   Rhee SH, 2001, THIN SOLID FILMS, V396, P23, DOI 10.1016/S0040-6090(01)01183-X
   RYU CK, 1995, APPL PHYS LETT, V67, P3337, DOI 10.1063/1.115239
   RYU CK, 1995, APPL PHYS LETT, V66, P2496, DOI 10.1063/1.113145
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   STOLNIK S, 1995, COLLOID SURFACE A, V97, P235, DOI 10.1016/0927-7757(95)03081-N
   Tice T. R., 1991, PARENTERAL DRUG DELI, P315
   TICE TR, 1984, PHARM TECHNOL, V11, P26
   Wang DM, 2000, J MEMBRANE SCI, V169, P39, DOI 10.1016/S0376-7388(99)00330-0
   Wong DL, 2000, BIOCHEMISTRY-US, V39, P15410, DOI 10.1021/bi001164v
   WOOSLEY JP, 1988, J APPL PHYS, V64, P4278, DOI 10.1063/1.341301
   WU XS, 1995, SYNTHESIS PROPERTIES, P1015
   WU XS, 1995, PREPARATION CHARACTE
   Yang Y, 2001, THIN SOLID FILMS, V396, P97, DOI 10.1016/S0040-6090(01)01236-6
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   ZELLIN G, 1995, BIOMATERIALS, V16, P601, DOI 10.1016/0142-9612(95)93857-A
NR 46
TC 74
Z9 81
U1 3
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 25
BP 5649
EP 5658
DI 10.1016/j.biomaterials.2004.01.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829ID
UT WOS:000222040300010
PM 15159081
DA 2018-10-20
ER

PT J
AU Eisenbarth, E
   Velten, D
   Muller, M
   Thull, R
   Breme, J
AF Eisenbarth, E
   Velten, D
   Muller, M
   Thull, R
   Breme, J
TI Biocompatibility of beta-stabilizing elements of titanium alloys
SO BIOMATERIALS
LA English
DT Review
DE beta-titanium alloy; biocompatibility; cell morphology; osteoblast
ID CORROSION BEHAVIOR; PURE TITANIUM; IMPLANTS; NIOBIUM; BONE; FIBROBLASTS;
   CYTOTOXICITY; TI-6AL-7NB; PASSIVITY; TANTALUM
AB In comparison to the presently used alpha + beta titanium alloys for biomedical applications, beta-titanium alloys have many advantageous mechanical properties, such as an improved wear resistance, a high elasticity and an excellent cold and hot formability. This will promote their future increased application as materials for orthopaedic joint replacements. Not all elements with beta-stabilizing properties in titanium alloys are suitable for biomaterial applications-corrosion and wear processes cause a release of these alloying elements to the surrounding tissue. In this investigation, the biocompability of alloying elements for beta- and near beta-titanium alloys was tested in order to estimate their suitability for biomaterial components. Titanium (grade 2) and the implant steel X2CrNiMo18153 (AISI 316 L) were tested as reference materials. The investigation included the corrosion properties of the elements, proliferation, mitochondrial activity, cell morphology and the size of MC3T3-E1 cells and GM7373 cells after 7 days incubation in direct contact with polished slices of the metals. The statistical significance was considered by Weir-test and Lord-test (alpha = 0.05). The biocompatibility range of the investigated metals is (decreasing biocompatibility): niobium-tantalum, titanium, zirconium-aluminium-316 L-molybdenum. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Saarland, Lehrstuhl Met Werkstoffe, D-66041 Saarbrucken, Germany.
   Univ Wurzburg, Lehrstuhl Funkt Swerkstoffe Med & Zahnmed, D-97070 Wurzburg, Germany.
RP Eisenbarth, E (reprint author), Univ Saarland, Lehrstuhl Met Werkstoffe, D-66041 Saarbrucken, Germany.
EM e.eisenbarth@mx.uni-saarland.de
CR BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   BRUNETTE DM, 2001, TITANIUM MED MAT SCI, P174
   COLLINGS EW, 1994, TITANIUM ALLOYS MAT, P3
   EISENBARTH E, 2001, BIOMATERIALIEN, V2
   Helsen J. A., 1998, METALS BIOMATERIALS, P30
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   Jonsson AK, 2002, THIN SOLID FILMS, V402, P242, DOI 10.1016/S0040-6090(01)01715-1
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kobayashi E, 1998, J MATER SCI-MATER M, V9, P625, DOI 10.1023/A:1008927407556
   Messer RLW, 1999, DENT MATER, V15, P1, DOI 10.1016/S0109-5641(99)90023-4
   Messer RLW, 1999, BIOMATERIALS, V20, P1647, DOI 10.1016/S0142-9612(99)00044-7
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.0.CO;2-C
   Okazaki Y, 1998, MATER T JIM, V39, P1063, DOI 10.2320/matertrans1989.39.1063
   OKAZAKI Y, 2000, ADV ENG MATER, V2, pS278
   Peuster M, 2003, BIOMATERIALS, V24, P4057, DOI 10.1016/S0142-9612(03)00274-6
   Pypen CMJM, 1998, J MATER SCI-MATER M, V9, P761, DOI 10.1023/A:1008919422520
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   ROSENBERG HW, 1970, P 1 INT C TIT, P851
   SACHS L, 1984, ANGEWANDTE STAT
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   TANGVALL P, 2001, J BIOMED MATER RES, V57, P285
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Trentani L, 2002, BIOMATERIALS, V23, P2863, DOI 10.1016/S0142-9612(01)00413-6
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   UNGERSBOCK A, 1994, J MATER SCI-MATER M, V5, P788, DOI 10.1007/BF00213136
   VELTEN D, 2003, Z METALLKD, V94, P6
   Wack T, 1999, MATER SCI FORUM, V299-3, P348, DOI 10.4028/www.scientific.net/MSF.299-300.348
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   ZITTER H, 1988, WERKST KORROS, V39, P574, DOI 10.1002/maco.19880391204
   Zwicker R, 1980, P 4 INT C TIT KYOT J, P505
NR 37
TC 369
Z9 382
U1 7
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 26
BP 5705
EP 5713
DI 10.1016/j.biomaterials.2004.01.021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829QL
UT WOS:000222064600002
PM 15147816
DA 2018-10-20
ER

PT J
AU Errachid, A
   Zine, N
   Samitier, J
   Bausells, J
AF Errachid, A
   Zine, N
   Samitier, J
   Bausells, J
TI FET-based chemical sensor systems fabricated with standard technologies
SO ELECTROANALYSIS
LA English
DT Article
DE ISFET; MEMFET; multi-sensor needle; integrated sensor; FET biosensor
ID FIELD-EFFECT TRANSISTORS; ION-IMPLANTATION; SILICON; ISFET; MEMBRANE;
   PH; HYDROGEN; FILMS; MICROELECTRODES; ELECTRODES
AB Miniaturized solid-state ion sensors based on field-effect transistors on silicon can take advantage of the capabilities of microelectronics and microsystems technology for the integration of combined functionalities. Optimized solid-state chemical sensors usually require specific materials and fabrication processes. However, if standard fabrication processes can be used, integrated chemical sensor systems can be developed in a shorter time and in a cost effective way. We show that, for applications in which a long operating time is not required, such as in disposable biomedical sensors, good integrated sensor systems can be fabricated with standard materials and processes. Specific examples are presented, such as multisensor systems, sensors with integrated signal-processing circuits and sensors with particle manipulation electrodes.
C1 CSIC, IMB, Ctr Nacl Microelect, Bellaterra 08193, Spain.
   Parc Cient Barcelona, Ctr Bioelect & Nanobiociencia, Barcelona 08028, Spain.
RP Bausells, J (reprint author), CSIC, IMB, Ctr Nacl Microelect, Campus UAB, Bellaterra 08193, Spain.
EM Joan.Bausells@cnm.es
RI Bausells, Joan/K-1808-2014
OI Bausells, Joan/0000-0003-3706-4975
CR ABE H, 1979, IEEE T ELECTRON DEV, V26, P1939, DOI 10.1109/T-ED.1979.19799
   Andersson H, 2003, SENSOR ACTUAT B-CHEM, V92, P315, DOI 10.1016/S0925-4005(03)00266-1
   Baccar ZM, 1996, SENSOR ACTUAT B-CHEM, V32, P101, DOI 10.1016/0925-4005(96)80117-1
   Bausells J, 1999, SENSOR ACTUAT B-CHEM, V57, P56, DOI 10.1016/S0925-4005(99)00135-5
   BAUSELLS J, 1996, SPIE, V2882, P307
   Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5
   BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688
   BERGVELD P, 1989, SENSOR ACTUATOR, V18, P309, DOI 10.1016/0250-6874(89)87038-6
   BERGVELD P, 1981, SENSOR ACTUATOR, V1, P17, DOI 10.1016/0250-6874(81)80004-2
   Bousse L, 1996, SENSOR ACTUAT B-CHEM, V34, P270, DOI 10.1016/S0925-4005(96)01906-5
   BOUSSE L, 1982, J CHEM PHYS, V76, P5128, DOI 10.1063/1.442812
   BOUSSE L, 1988, IEEE ELECTR DEVICE L, V9, P44, DOI 10.1109/55.20408
   BOUSSE L, 1994, SENSOR ACTUAT B-CHEM, V17, P157, DOI 10.1016/0925-4005(94)87044-6
   BOUSSE L, 1990, SENSOR ACTUAT B-CHEM, V1, P361, DOI 10.1016/0925-4005(90)80231-N
   Cane C, 1996, SENSOR ACTUAT B-CHEM, V35, P136, DOI 10.1016/S0925-4005(97)80043-3
   CARAS S, 1980, ANAL CHEM, V52, P1935, DOI 10.1021/ac50062a035
   Casanella R, 2003, IEE Proc Nanobiotechnol, V150, P70, DOI 10.1049/ip-nbt:20031100
   COSOFRET VV, 1995, ANAL CHEM, V67, P1647, DOI 10.1021/ac00106a001
   COSOFRET VV, 1994, ANAL LETT, V27, P3039, DOI 10.1080/00032719408000310
   COSOFRET VV, 1994, TALANTA, V41, P931, DOI 10.1016/0039-9140(94)E0106-2
   Errachid A, 2002, MAT SCI ENG C-BIO S, V21, P9, DOI 10.1016/S0928-4931(02)00054-1
   Errachid A, 2001, SENSOR ACTUAT B-CHEM, V78, P279, DOI 10.1016/S0925-4005(01)00826-7
   Errachid A, 1999, SENSOR ACTUAT B-CHEM, V60, P43, DOI 10.1016/S0925-4005(99)00242-7
   ESASHI M, 1978, IEEE T BIO-MED ENG, V25, P184, DOI 10.1109/TBME.1978.326245
   FERNANDEZBUSQUETS, 2003, CELL MOL LIFE SCI, V60, P88
   FERNANDEZMORALE.FH, 2000, THESIS U BARCELONA S
   GOTOH M, 1989, J MEMBRANE SCI, V41, P291, DOI 10.1016/S0376-7388(00)82409-6
   HAAK JR, 1992, SENSOR ACTUAT B-CHEM, V8, P211, DOI 10.1016/0925-4005(92)85020-W
   HAMMOND PA, 2002, P EUR PRAG CZECH REP, V16, P840
   HARSANYI G, 2000, SENSORS BIOMEDICAL A
   ITO T, 1988, IEEE T ELECTRON DEV, V35, P56, DOI 10.1109/16.2415
   Ivorra A, 2003, BIOSENS BIOELECTRON, V19, P391, DOI 10.1016/S0956-5663(03)00204-5
   JOHANSSON G, 1975, TALANTA, V22, P953, DOI 10.1016/0039-9140(75)80109-3
   Kovacs GTA, 1998, P IEEE, V86, P1536, DOI 10.1109/5.704259
   LANTER F, 1982, ANAL CHIM ACTA, V135, P51, DOI 10.1016/S0003-2670(01)85264-8
   MADOU MJ, 1989, CHEM SENSING SOLID S
   MATSUO T, 1981, SENSOR ACTUATOR, V1, P77, DOI 10.1016/0250-6874(81)80006-6
   MOSS SD, 1978, IEEE T BIO-MED ENG, V25, P49, DOI 10.1109/TBME.1978.326377
   NAJAFI K, 1985, IEEE T ELECTRON DEV, V32, P1206, DOI 10.1109/T-ED.1985.22102
   Pethig R, 1997, TRENDS BIOTECHNOL, V15, P426, DOI 10.1016/S0167-7799(97)01096-2
   PHAM MT, 1984, SENSOR ACTUATOR, V5, P217, DOI 10.1016/0250-6874(84)80012-8
   PHAM MT, 1992, SENSOR ACTUAT B-CHEM, V7, P576, DOI 10.1016/0925-4005(92)80367-7
   POHL HA, 1978, DIELECTROPHORESIS
   SANADA Y, 1982, FRESEN Z ANAL CHEM, V312, P526, DOI 10.1007/BF00636072
   Sibbald A., 1986, Journal of Molecular Electronics, V2, P51
   SIBBALD A, 1983, IEE PROC-I, V130, P233, DOI 10.1049/ip-i-1.1983.0042
   SIU WM, 1979, IEEE T ELECTRON DEV, V26, P1805, DOI 10.1109/T-ED.1979.19690
   Sola A, 2003, TRANSPLANTATION, V75, P744, DOI 10.1097/01.TP.0000054683.72223.2D
   Sze SM, 1969, PHYS SEMICONDUCTOR D
   VANDERSPIEGEL J, 1983, SENSOR ACTUATOR, V4, P291, DOI 10.1016/0250-6874(83)85035-5
   WIKBY A, 1975, TALANTA, V22, P663, DOI 10.1016/0039-9140(75)80007-5
   WISE KD, 1970, IEEE T BIO-MED ENG, VBM17, P238, DOI 10.1109/TBME.1970.4502738
   WONG HS, 1989, IEEE T ELECTRON DEV, V36, P479, DOI 10.1109/16.19957
   YATES DE, 1974, J CHEM SOC FARAD T 1, V70, P1807, DOI 10.1039/f19747001807
   YOON E, 1990, IEEE SOL STAT SENS A, P161
   ZINE N, 2003, P EUR GUIM PORT, V17, P526
NR 56
TC 25
Z9 25
U1 1
U2 17
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1040-0397
J9 ELECTROANAL
JI Electroanalysis
PD NOV
PY 2004
VL 16
IS 22
BP 1843
EP 1851
DI 10.1002/elan.200403072
PG 9
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 876SX
UT WOS:000225518900004
DA 2018-10-20
ER

PT J
AU Kan, CW
   Fredlake, CP
   Doherty, EAS
   Barron, AE
AF Kan, CW
   Fredlake, CP
   Doherty, EAS
   Barron, AE
TI DNA sequencing and genotyping in miniaturized electrophoresis systems
SO ELECTROPHORESIS
LA English
DT Review
DE DNA sequencing and genotyping; microchannel electrophoresis;
   miniaturization; review
ID CAPILLARY-ARRAY ELECTROPHORESIS; DOUBLE-STRANDED DNA;
   POLYMERASE-CHAIN-REACTION; HUMAN-GENOME-PROJECT; LINEAR POLYACRYLAMIDE
   SOLUTIONS; INDUCED FLUORESCENCE DETECTION; IMPROVED HYDROLYTIC
   STABILITY; CONFORMATION POLYMORPHISM ANALYSIS; ASSEMBLED MAGNETIC
   MATRICES; THROUGHPUT GENETIC-ANALYSIS
AB Advances in microchannel electrophoretic separation systems for DNA analyses have had important impacts on biological and biomedical sciences, as exemplified by the successes of the Human Genome Project (HGP). As we enter a new era in genomic science, further technological innovations promise to provide other far-reaching benefits, many of which will require continual increases in sequencing and genotyping efficiency and throughput, as well as major decreases in the cost per analysis. Since the high-resolution size- and/or conformation-based electrophoretic separation of DNA is the most critical step in many genetic analyses, continual advances in the development of materials and methods for microchannel electrophoretic separations will be needed to meet the massive demand for high-quality, low-cost genomic data. In particular, the development (and commercialization) of miniaturized genotyping platforms is needed to support and enable the future breakthroughs of biomedical science. In this review, we briefly discuss the major sequencing and genotyping techniques in which high-throughput and high-resolution electrophoretic separations of DNA play a significant role. We review recent advances in the development of technology for capillary electrophoresis (CE), including capillary array electrophoresis (CAE) systems. Most of these CE/CAE innovations are equally applicable to implementation on microfabricated electrophoresis chips. Major effort is devoted to discussing various key elements needed for the development of integrated and practical microfluidic sequencing and genotyping platforms, including chip substrate selection, microchannel design and fabrication, microchannel surface modification, sample preparation, analyte detection, DNA sieving matrices, and device integration. Finally, we identify some of the remaining challenges, and some of the possible routes to further advances in high-throughput DNA sequencing and genotyping technologies.
C1 Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.
RP Barron, AE (reprint author), Northwestern Univ, Dept Biol & Chem Engn, 2145 Sheridan Rd,Rm136, Evanston, IL 60208 USA.
EM a-barron@northwestern.edu
RI Barron, Annelise/B-7639-2009
FU NHGRI NIH HHS [1 R01 HG019770-01]
CR Albargheuthi MN, 2000, ELECTROPHORESIS, V21, P4096, DOI 10.1002/1522-2683(200012)21:18<4096::AID-ELPS4096>3.0.CO;2-W
   Albarghouthi M, 2001, ELECTROPHORESIS, V22, P737, DOI 10.1002/1522-2683(200102)22:4<737::AID-ELPS737>3.0.CO;2-S
   Albarghouthi MN, 2002, ELECTROPHORESIS, V23, P1429, DOI 10.1002/1522-2683(200205)23:10<1429::AID-ELPS1429>3.0.CO;2-A
   ANSORGE W, 1992, ELECTROPHORESIS, V13, P616, DOI 10.1002/elps.11501301125
   Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t
   Barbier V, 2003, CURR OPIN BIOTECH, V14, P51, DOI 10.1016/S0958-1669(02)00007-1
   Barbier V, 2002, ELECTROPHORESIS, V23, P1441, DOI 10.1002/1522-2683(200205)23:10<1441::AID-ELPS1441>3.0.CO;2-H
   Barron AE, 1996, ELECTROPHORESIS, V17, P744, DOI 10.1002/elps.1150170421
   BARRON AE, 1993, J CHROMATOGR A, V652, P3, DOI 10.1016/0021-9673(93)80639-P
   Bashkin J, 1996, APPL THEOR ELECTROPH, V6, P23
   Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   BECKER H, 2000, SENSOR ACTUAT A-PHYS, V83, P120
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Belder D, 2002, ELECTROPHORESIS, V23, P3567, DOI 10.1002/1522-2683(200210)23:20<3567::AID-ELPS3567>3.0.CO;2-3
   Belder D, 2001, ELECTROPHORESIS, V22, P3813, DOI 10.1002/1522-2683(200109)22:17<3813::AID-ELPS3813>3.0.CO;2-D
   Berti L, 2001, BIOCONJUGATE CHEM, V12, P493, DOI 10.1021/bc000155w
   Berti L, 2001, ANAL BIOCHEM, V292, P188, DOI 10.1006/abio.2001.5069
   Blazej RG, 2003, GENOME RES, V13, P287, DOI 10.1101/gr.396203
   Brazill SA, 2001, ANAL CHEM, V73, P4882, DOI 10.1021/ac010521k
   Breadmore MC, 2003, ANAL CHEM, V75, P1880, DOI 10.1021/ac0204855
   Broyles BS, 2003, ANAL CHEM, V75, P2761, DOI 10.1021/ac025503x
   Buchholz BA, 2001, ELECTROPHORESIS, V22, P4118, DOI 10.1002/1522-2683(200111)22:19<4118::AID-ELPS4118>3.0.CO;2-Q
   Buchholz BA, 2002, ELECTROPHORESIS, V23, P1398, DOI 10.1002/1522-2683(200205)23:10<1398::AID-ELPS1398>3.0.CO;2-8
   Buchholz BA, 2001, ANAL CHEM, V73, P157, DOI 10.1021/ac001023z
   Bums M A, 1998, SCIENCE, V282, P484
   Butler JM, 1998, TRENDS BIOTECHNOL, V16, P158, DOI 10.1016/S0167-7799(98)01173-1
   Butler JM, 2004, ELECTROPHORESIS, V25, P1397, DOI 10.1002/elps.200305822
   Butler JM, 2001, FORENSIC DNA TYPING
   Carey L, 2002, ELECTROPHORESIS, V23, P1386, DOI 10.1002/1522-2683(200205)23:10<1386::AID-ELPS1386>3.0.CO;2-M
   Carrilho E, 2000, ELECTROPHORESIS, V21, P55
   Carrilho E, 1996, ANAL CHEM, V68, P3305, DOI 10.1021/ac960411r
   Chen XX, 2002, ANAL CHEM, V74, P1772, DOI 10.1021/ac0109422
   Chiari M, 2000, ELECTROPHORESIS, V21, P1521, DOI 10.1002/(SICI)1522-2683(20000501)21:8<1521::AID-ELPS1521>3.0.CO;2-Y
   CHIESL TN, 2004, IN PRESS ANAL CHEM
   Chou HP, 1999, P NATL ACAD SCI USA, V96, P11, DOI 10.1073/pnas.96.1.11
   Chu BJ, 2002, J CHROMATOGR A, V966, P1, DOI 10.1016/S0021-9673(02)00702-1
   Chung DT, 2004, J FORENSIC SCI, V49, P733
   COHEN AS, 1988, P NATL ACAD SCI USA, V85, P9660, DOI 10.1073/pnas.85.24.9660
   Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540
   Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626
   Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564
   Crabtree HJ, 2000, ELECTROPHORESIS, V21, P1329, DOI 10.1002/(SICI)1522-2683(20000401)21:7<1329::AID-ELPS1329>3.0.CO;2-2
   Cretich M, 2003, ELECTROPHORESIS, V24, P2322, DOI 10.1002/elps.200305479
   Culbertson CT, 2000, ANAL CHEM, V72, P5814, DOI 10.1021/ac0006268
   Culbertson CT, 1998, ANAL CHEM, V70, P3781, DOI 10.1021/ac9804487
   Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201
   Doherty EAS, 2004, ANAL CHEM, V76, P5249, DOI 10.1021/ac049721x
   Doherty EAS, 2003, ELECTROPHORESIS, V24, P4170, DOI 10.1002/elps.200305702
   Doherty EAS, 2002, ELECTROPHORESIS, V23, P2766, DOI 10.1002/1522-2683(200208)23:16<2766::AID-ELPS2766>3.0.CO;2-S
   Dolnik V, 1999, J BIOCHEM BIOPH METH, V41, P103, DOI 10.1016/S0165-022X(99)00041-X
   Dovichi N. J., 1997, ANAL NUCL ACIDS CAPI, P236
   Dovichi NJ, 2000, ANGEW CHEM INT EDIT, V39, P4463, DOI 10.1002/1521-3773(20001215)39:24<4463::AID-ANIE4463>3.0.CO;2-8
   Dovichi NJ, 1997, ELECTROPHORESIS, V18, P2393, DOI 10.1002/elps.1150181229
   Doyle PS, 2002, SCIENCE, V295, P2237, DOI 10.1126/science.1068420
   Du M, 2003, ELECTROPHORESIS, V24, P3147, DOI 10.1002/elps.200305572
   DUNN WC, 2000, ANAL CHEM, V77, P157
   Edman CF, 1997, NUCLEIC ACIDS RES, V25, P4907, DOI 10.1093/nar/25.24.4907
   EDWARDS A, 1991, AM J HUM GENET, V49, P746
   Emrich CA, 2002, ANAL CHEM, V74, P5076, DOI 10.1021/ac020236g
   Flanagan JH, 1998, ANAL CHEM, V70, P2676, DOI 10.1021/ac980018g
   Ford SM, 1999, J BIOMECH ENG-T ASME, V121, P13, DOI 10.1115/1.2798035
   Fu AY, 1999, NAT BIOTECHNOL, V17, P1109
   Fu AY, 2002, ANAL CHEM, V74, P2451, DOI 10.1021/ac0255330
   Gelfi C, 2000, ELECTROPHORESIS, V21, P785, DOI 10.1002/(SICI)1522-2683(20000301)21:4<785::AID-ELPS785>3.0.CO;2-E
   Gelfi C, 1996, ELECTROPHORESIS, V17, P738, DOI 10.1002/elps.1150170420
   Giordano BC, 2001, ELECTROPHORESIS, V22, P334, DOI 10.1002/1522-2683(200101)22:2<334::AID-ELPS334>3.0.CO;2-O
   Glazer AN, 1997, CURR OPIN BIOTECH, V8, P94, DOI 10.1016/S0958-1669(97)80163-2
   Goedecke N, 2004, ELECTROPHORESIS, V25, P1678, DOI 10.1002/elps.200305897
   Goetzinger W, 1998, ELECTROPHORESIS, V19, P242, DOI 10.1002/elps.1150190217
   Grover WH, 2003, SENSOR ACTUAT B-CHEM, V89, P315, DOI 10.1016/S0925-4005(02)00468-9
   Gurtner C, 2002, ELECTROPHORESIS, V23, P1543, DOI 10.1002/1522-2683(200205)23:10<1543::AID-ELPS1543>3.0.CO;2-#
   Hadd AG, 2000, J CHROMATOGR A, V894, P191, DOI 10.1016/S0021-9673(00)00459-3
   Hammer RP, 2002, BIOCONJUGATE CHEM, V13, P1244, DOI 10.1021/bc0155869
   HAMMOND HA, 1994, AM J HUM GENET, V55, P15
   Han J, 1999, J VAC SCI TECHNOL A, V17, P2142, DOI 10.1116/1.581740
   Han JY, 2002, ANAL CHEM, V74, P394, DOI 10.1021/ac0107002
   HASHIMOTO M, 2003, NUCLEIC ACIDS RES, V24, pE41
   He Y, 2000, J CHROMATOGR A, V894, P179, DOI 10.1016/S0021-9673(00)00676-2
   Heller C, 2000, ELECTROPHORESIS, V21, P593, DOI 10.1002/(SICI)1522-2683(20000201)21:3<593::AID-ELPS593>3.0.CO;2-U
   Heller C, 2001, ELECTROPHORESIS, V22, P629, DOI 10.1002/1522-2683(200102)22:4<629::AID-ELPS629>3.0.CO;2-S
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Heller MJ, 2000, ELECTROPHORESIS, V21, P157, DOI 10.1002/(SICI)1522-2683(20000101)21:1<157::AID-ELPS157>3.0.CO;2-E
   Henry AC, 2000, ANAL CHEM, V72, P5331, DOI 10.1021/ac000685l
   Henry C, 2003, CHEM ENG NEWS, V81, P12, DOI 10.1021/cen-v081n016.p012
   Hofmann O, 2001, LAB CHIP, V1, P108, DOI 10.1039/b105110p
   HUANG XHC, 1992, ANAL CHEM, V64, P2149, DOI 10.1021/ac00042a021
   HUANG XHC, 1992, ANAL CHEM, V64, P967, DOI 10.1021/ac00032a025
   Hung SC, 1998, ANAL BIOCHEM, V255, P32, DOI 10.1006/abio.1997.2451
   Hung SC, 1997, ANAL BIOCHEM, V252, P78, DOI 10.1006/abio.1997.2287
   Jackman RJ, 1998, ANAL CHEM, V70, P2280, DOI 10.1021/ac971295a
   Ju JY, 1996, NUCLEIC ACIDS RES, V24, P1144, DOI 10.1093/nar/24.6.1144
   JU JY, 1995, ANAL BIOCHEM, V231, P131, DOI 10.1006/abio.1995.1512
   KAMBARA H, 1993, NATURE, V361, P565, DOI 10.1038/361565a0
   Kan CW, 2004, ELECTROPHORESIS, V25, P1007, DOI 10.1002/elps.200305785
   Kan CW, 2003, ELECTROPHORESIS, V24, P4161, DOI 10.1002/elps.200305670
   Kan CW, 2003, ELECTROPHORESIS, V24, P55, DOI 10.1002/elps.200390031
   KARNEI T, 2003, ANAL CHEM, V75, P5300
   Kartalov EP, 2004, NUCLEIC ACIDS RES, V32, P2873, DOI 10.1093/nar/gkh613
   Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a
   Kheterpal I, 1996, ELECTROPHORESIS, V17, P1852, DOI 10.1002/elps.1150171209
   Kim Y, 1997, J CHROMATOGR A, V781, P315, DOI 10.1016/S0021-9673(97)00472-X
   Koonin SE, 1998, SCIENCE, V279, P36, DOI 10.1126/science.279.5347.36
   Kourkine IV, 2002, BIOTECHNIQUES, V33, P318, DOI 10.2144/02332st04
   Kourkine IV, 2002, ELECTROPHORESIS, V23, P1375, DOI 10.1002/1522-2683(200205)23:10<1375::AID-ELPS1375>3.0.CO;2-U
   Kourkine IV, 2002, ANAL CHEM, V74, P2565, DOI 10.1021/ac020025b
   Koutny L, 2000, ANAL CHEM, V72, P3388, DOI 10.1021/ac9913614
   Lagally ET, 2000, SENSOR ACTUAT B-CHEM, V63, P138, DOI 10.1016/S0925-4005(00)00350-6
   Lagally ET, 2001, LAB CHIP, V1, P102, DOI 10.1039/b109031n
   Lagally ET, 2001, ANAL CHEM, V73, P565, DOI 10.1021/ac001026b
   Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p
   Lai SY, 2004, ANAL CHEM, V76, P1175, DOI 10.1021/ac034990t
   Lammertink RGH, 2003, MACROMOLECULES, V36, P9154, DOI 10.1021/ma0258253
   Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536
   Lassiter SJ, 2000, ANAL CHEM, V72, P5373, DOI 10.1021/ac000744v
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   LERMAN LS, 1982, BIOPOLYMERS, V21, P995, DOI 10.1002/bip.360210511
   Li LL, 2004, ELECTROANAL, V16, P81, DOI 10.1002/elan.200302921
   Liang DH, 1999, ELECTROPHORESIS, V20, P2856, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2856::AID-ELPS2856>3.0.CO;2-#
   Liang DH, 1999, MACROMOLECULES, V32, P6326, DOI 10.1021/ma9901792
   Lieberwirth U, 1998, ANAL CHEM, V70, P4771, DOI 10.1021/ac980230k
   Lin YW, 2003, J CHROMATOGR A, V1014, P47, DOI 10.1016/S0021-9673(03)01408-0
   Linder V, 2001, ANAL CHEM, V73, P4181, DOI 10.1021/ac010421e
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   Liu J, 2002, ELECTROPHORESIS, V23, P1531, DOI 10.1002/1522-2683(200205)23:10<1531::AID-ELPS1531>3.0.CO;2-D
   Liu RH, 2002, J MICROELECTROMECH S, V11, P45, DOI 10.1109/84.982862
   Liu SR, 2003, ELECTROPHORESIS, V24, P3755, DOI 10.1002/elps.200305617
   Liu SR, 1999, ANAL CHEM, V71, P566, DOI 10.1021/ac980783v
   Liu TB, 2001, ELECTROPHORESIS, V22, P449, DOI 10.1002/1522-2683(200102)22:3<449::AID-ELPS449>3.3.CO;2-K
   LUCKEY JA, 1990, NUCLEIC ACIDS RES, V18, P4417, DOI 10.1093/nar/18.15.4417
   Madabhushi RS, 1998, ELECTROPHORESIS, V19, P224
   Manz A, 2001, PURE APPL CHEM, V73, P1555, DOI 10.1351/pac200173101555
   Manz A, 2001, LAB CHIP, V1, p1N, DOI 10.1039/b106826c
   MANZ A, 1991, TRAC-TREND ANAL CHEM, V10, P144, DOI 10.1016/0165-9936(91)85116-9
   McCormick RM, 1997, ANAL CHEM, V69, P2626, DOI 10.1021/ac9701997
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   McWhorter S, 2000, ELECTROPHORESIS, V21, P1267, DOI 10.1002/(SICI)1522-2683(20000401)21:7<1267::AID-ELPS1267>3.0.CO;2-C
   Melton L, 2003, NATURE, V422, P917, DOI 10.1038/422917b
   Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468
   Minc N, 2004, ANAL CHEM, V76, P3770, DOI 10.1021/ac035246b
   Mitchell P, 2001, NAT BIOTECHNOL, V19, P717, DOI 10.1038/90754
   Moritani T, 2003, ELECTROPHORESIS, V24, P2772, DOI 10.1002/elps.200305547
   Moritani T, 2003, ELECTROPHORESIS, V24, P2764, DOI 10.1002/elps.200305546
   MUNRO NJ, 2001, ANAL CHEM, V73, P1748
   Nataraj AJ, 1999, ELECTROPHORESIS, V20, P1177, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1177::AID-ELPS1177>3.0.CO;2-2
   Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8
   Nishimura A, 2000, CHEM PHARM BULL, V48, P774
   Oda RP, 1998, ANAL CHEM, V70, P4361, DOI 10.1021/ac980452i
   Olsen KG, 2002, ANAL CHEM, V74, P1436, DOI 10.1021/ac0156969
   ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8
   Paegel BM, 2002, ANAL CHEM, V74, P5092, DOI 10.1021/ac0203645
   Paegel BM, 2000, ANAL CHEM, V72, P3030, DOI 10.1021/ac000054r
   Paegel BM, 2003, CURR OPIN BIOTECH, V14, P42, DOI 10.1016/S0958-1669(02)00004-6
   Paegel BM, 2002, P NATL ACAD SCI USA, V99, P574, DOI 10.1073/pnas.012608699
   Pang HM, 1999, J BIOCHEM BIOPH METH, V41, P121, DOI 10.1016/S0165-022X(99)00042-1
   Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003
   Pethig R, 1998, J MICROMECH MICROENG, V8, P57, DOI 10.1088/0960-1317/8/2/004
   Piggee CA, 1997, J CHROMATOGR A, V781, P367, DOI 10.1016/S0021-9673(97)00637-7
   Pugmire DL, 2002, ANAL CHEM, V74, P871, DOI 10.1021/ac011026r
   Qi SZ, 2002, LAB CHIP, V2, P88, DOI [10.1039/b200370h, 10.1039/b20037h]
   Ramsey JM, 1999, NAT BIOTECHNOL, V17, P1061, DOI 10.1038/15044
   Ren H, 1999, ELECTROPHORESIS, V20, P2501, DOI 10.1002/(SICI)1522-2683(19990801)20:12<2501::AID-ELPS2501>3.0.CO;2-H
   Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435
   Righetti PG, 2002, ELECTROPHORESIS, V23, P1361, DOI 10.1002/1522-2683(200205)23:10<1361::AID-ELPS1361>3.0.CO;2-J
   Roberts MA, 1997, ANAL CHEM, V69, P2035, DOI 10.1021/ac961038q
   Ross D, 2002, ANAL CHEM, V74, P2556, DOI 10.1021/ac025528w
   Ruiz-Martinez MC, 1998, ANAL CHEM, V70, P1516, DOI 10.1021/ac971143f
   Salas-Solano O, 2000, ANAL CHEM, V72, P3129, DOI 10.1021/ac000055j
   Salas-Solano O, 1998, ANAL CHEM, V70, P3996, DOI 10.1021/ac980457f
   Salas-Solano O, 1998, ANAL CHEM, V70, P1528, DOI 10.1021/ac9711448
   Sanders JC, 2003, ANAL CHEM, V75, P986, DOI 10.1021/ac020425z
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Sassi AP, 1996, ELECTROPHORESIS, V17, P1460, DOI 10.1002/elps.1150170910
   SASSI AP, 1999, Patent No. 5883211
   Scherer JR, 1999, ELECTROPHORESIS, V20, P1508, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1508::AID-ELPS1508>3.0.CO;2-7
   Scherer JR, 2001, BIOTECHNIQUES, V31, P1150, DOI 10.2144/01315rr04
   Schmalzing D, 1999, ANAL BIOCHEM, V270, P148, DOI 10.1006/abio.1999.4067
   Schmalzing D, 1997, P NATL ACAD SCI USA, V94, P10273, DOI 10.1073/pnas.94.19.10273
   Schmalzing D, 1998, ANAL CHEM, V70, P2303, DOI 10.1021/ac971381a
   Shi YN, 2003, ELECTROPHORESIS, V24, P3371, DOI 10.1002/elps.200305553
   Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584
   SimoAlfonso E, 1996, ELECTROPHORESIS, V17, P732, DOI 10.1002/elps.1150170419
   SimoAlfonso E, 1996, ELECTROPHORESIS, V17, P723, DOI 10.1002/elps.1150170418
   Simpson PC, 1998, P NATL ACAD SCI USA, V95, P2256, DOI 10.1073/pnas.95.5.2256
   SLATER GW, 1992, ELECTROPHORESIS, V13, P574, DOI 10.1002/elps.11501301116
   Slater GW, 2002, ELECTROPHORESIS, V23, P3791, DOI 10.1002/elps.200290002
   Slater GW, 2003, CURR OPIN BIOTECH, V14, P58, DOI 10.1016/S0958-1669(02)00012-5
   Slater GW, 2000, ELECTROPHORESIS, V21, P3873, DOI 10.1002/1522-2683(200012)21:18<3873::AID-ELPS3873>3.0.CO;2-8
   SLATER GW, 1989, BIOPOLYMERS, V28, P1781, DOI 10.1002/bip.360281011
   Slyadnev MN, 2001, ANAL CHEM, V73, P4037, DOI 10.1021/ac010318p
   SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0
   Song LG, 2001, J CHROMATOGR A, V915, P231, DOI 10.1016/S0021-9673(01)00593-3
   Song LG, 2001, ELECTROPHORESIS, V22, P1987, DOI 10.1002/1522-2683(200106)22:10<1987::AID-ELPS1987>3.0.CO;2-K
   Song LG, 2001, ELECTROPHORESIS, V22, P729, DOI 10.1002/1522-2683(200102)22:4<729::AID-ELPS729>3.0.CO;2-O
   Song LG, 2001, ELECTROPHORESIS, V22, P3688, DOI 10.1002/1522-2683(200109)22:17<3688::AID-ELPS3688>3.0.CO;2-I
   Soper SA, 2002, ANAL CHIM ACTA, V470, P87, DOI 10.1016/S0003-2670(02)00356-2
   Soper SA, 1998, ANAL CHEM, V70, P4036, DOI 10.1021/ac980288z
   Soper SA, 1999, J CHROMATOGR A, V853, P107, DOI 10.1016/S0021-9673(99)00651-2
   Sudor J, 2001, ELECTROPHORESIS, V22, P720, DOI 10.1002/1522-2683(200102)22:4<720::AID-ELPS720>3.0.CO;2-N
   Tabuchi M, 2004, NAT BIOTECHNOL, V22, P337, DOI 10.1038/nbt939
   TAKAHASHI S, 1994, ANAL CHEM, V66, P1021, DOI 10.1021/ac00079a016
   TERRY SC, 1979, IEEE T ELECTRON DEV, V26, P1880, DOI 10.1109/T-ED.1979.19791
   Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886
   Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996
   Tian HJ, 2002, ANAL BIOCHEM, V309, P212, DOI 10.1016/S0003-2697(02)00297-X
   Tian HJ, 2000, ANAL BIOCHEM, V283, P175, DOI 10.1006/abio.2000.4577
   UENO K, 1994, ANAL CHEM, V66, P1424, DOI 10.1021/ac00081a010
   Vaidya B, 2002, ANALYST, V127, P1289, DOI 10.1039/b205801b
   VANDERSCHOOT B, 1985, SENSOR ACTUATOR, V8, P11, DOI 10.1016/0250-6874(85)80020-2
   Verpoorte E, 2002, ELECTROPHORESIS, V23, P677, DOI 10.1002/1522-2683(200203)23:5<677::AID-ELPS677>3.0.CO;2-8
   Vreeland WN, 2003, ANAL CHEM, V75, P3059, DOI 10.1021/ac0259921
   Vreeland WN, 2002, ANAL CHEM, V74, P4328, DOI 10.1021/ac0258094
   Wabuyele MB, 2001, ELECTROPHORESIS, V22, P3939, DOI 10.1002/1522-2683(200110)22:18<3939::AID-ELPS3939>3.0.CO;2-9
   Wang Y, 2003, ANAL CHEM, V75, P1130, DOI 10.1021/ac020683w
   Wang YM, 2002, ELECTROPHORESIS, V23, P1460, DOI 10.1002/1522-2683(200205)23:10<1460::AID-ELPS1460>3.0.CO;2-J
   Wei W, 2001, ANAL CHEM, V73, P1776, DOI 10.1021/ac0012997
   WILLIAMS DC, 1995, ANAL CHEM, V67, P3427, DOI 10.1021/ac00115a010
   Wolfe KA, 2002, ELECTROPHORESIS, V23, P727, DOI 10.1002/1522-2683(200203)23:5<727::AID-ELPS727>3.0.CO;2-O
   Wolfsberg TG, 2002, NAT GENET, V32, P4, DOI 10.1038/ng964
   Woolley AT, 1996, ANAL CHEM, V68, P4081, DOI 10.1021/ac960718q
   Woolley AT, 1998, ANAL CHEM, V70, P684, DOI 10.1021/ac971135z
   Woolley AT, 1997, ANAL CHEM, V69, P2181, DOI 10.1021/ac961237+
   WOOLLEY AT, 1995, ANAL CHEM, V67, P3676, DOI 10.1021/ac00116a010
   WOOLLEY AT, 1994, P NATL ACAD SCI USA, V91, P11348, DOI 10.1073/pnas.91.24.11348
   Wu CH, 1997, MACROMOLECULES, V30, P4574, DOI 10.1021/ma9701088
   Wu CH, 1998, ELECTROPHORESIS, V19, P231, DOI 10.1002/elps.1150190216
   Xiao DQ, 2004, ANAL CHEM, V76, P2055, DOI 10.1021/ac035254s
   Xu F, 2002, ELECTROPHORESIS, V23, P3608, DOI 10.1002/1522-2683(200210)23:20<3608::AID-ELPS3608>3.0.CO;2-3
   Xu JD, 2000, ANAL CHEM, V72, P1930, DOI 10.1021/ac991216q
   Xu YC, 2003, ANAL CHEM, V75, P2975, DOI 10.1021/ac030031n
   Xue G, 2001, J CHROMATOGR A, V914, P245, DOI 10.1016/S0021-9673(00)01167-5
   Zhou HH, 2000, ANAL CHEM, V72, P1045, DOI 10.1021/ac991117c
NR 231
TC 95
Z9 98
U1 3
U2 26
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD NOV
PY 2004
VL 25
IS 21-22
BP 3564
EP 3588
DI 10.1002/elps.200406161
PG 25
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 878WV
UT WOS:000225679000008
PM 15565709
DA 2018-10-20
ER

PT J
AU Yiannaki, EE
   Zintzaras, E
   Analatos, A
   Theodoridou, C
   Dalekos, GN
   Germenis, AE
AF Yiannaki, EE
   Zintzaras, E
   Analatos, A
   Theodoridou, C
   Dalekos, GN
   Germenis, AE
TI Evaluation of a microsphere-based flow cytometric assay for diagnosis of
   Celiac disease
SO JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
LA English
DT Article
DE flow cytometry; Celiac disease; ELISA; microspheres
ID ANTITISSUE TRANSGLUTAMINASE ANTIBODIES; TISSUE TRANSGLUTAMINASE;
   GUINEA-PIG; FOLLOW-UP; TESTS; ANTIGLIADIN; SPRUE; KITS
AB The multiplexed particle-based flow cytometric technology proposes a new approach for the diagnosis of autoimmune diseases combining the advantages of conventional methods with the ability to quantitatively determine multiple autoantibodies in the same sample, simultaneously and rapidly. Recently, a commercial kit (FIDIS Celiac, Biomedical Diagnostics, Marne la Valle, France) was introduced for the simultaneous detection of IgA anti-tissue transglutaminase (anti-tTG), IgG, and IgA anti-gliadin antibodies (AGA). This study was undertaken to evaluate and compare the FIDIS Celiac kit with standardized commercial ELISAs (QUANTA Lite, INOVA Diagnostics Inc., San Diego, CA). A disease group consisted of 21 samples from untreated patients with biopsy confirmed celiac disease (CD), and two control groups of historical sera (207 from regular blood donors and 181 from chronically infected hepatitis patients) were studied. All control sera were negative for IgA anti-endomysial antibodies (EmA) and had an IgA concentration above the lower normal limit. Concerning the reproducibility, intra- and inter-assay coefficients of variation (CVs) ranging between 2% and 12%, and between 3% and 21%, respectively, were observed. Regarding the diagnostic quality, each assay was compared to the disease diagnosis using the McNemar test and the kappa (K) parameter, while ROC analysis was applied. Generally, the performance of FIDIS assay was proved almost equally adequate to that of ELISA in the detection of IgA anti-tTG antibodies, IgA and IgG AGA. However, the performance of FIDIS assay was found surmounting that of ELISA among hepatitis patients, possibly due to the avoidance of debris and unbound cross contaminants and, hence, the "noise" of such materials in samples under analysis. Taking our results together with the simplicity and the high throughput of FIDIS assay, its overall performance in the diagnosis of CD seems better than that of ELISA.
C1 Univ Thessaly, Univ Hosp Larissa, Sch Med, Dept Immunol & Histocompatibil, GR-41110 Larisa, Greece.
   Univ Thessaly, Sch Med, Dept Biometr, GR-41110 Larisa, Greece.
   Univ Thessaly, Sch Med, Dept Internal Med, Acad Liver Unit, GR-41110 Larisa, Greece.
RP Germenis, AE (reprint author), Univ Thessaly, Univ Hosp Larissa, Sch Med, Dept Immunol & Histocompatibil, GR-41110 Larisa, Greece.
EM agermen@med.uth.gr
OI Germenis, Anastasios/0000-0002-3315-6947
CR Altman DG, 1994, PRACTICAL STAT MED R, P403
   Bardella MT, 2001, DIGEST LIVER DIS, V33, P426, DOI 10.1016/S1590-8658(01)80015-3
   Basso D, 2001, J CLIN LAB ANAL, V15, P112, DOI 10.1002/jcla.1012
   Carroccio A, 2002, CLIN CHEM, V48, P1546
   Carroccio A, 2001, GUT, V49, P506, DOI 10.1136/gut.49.4.506
   Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797
   Fabiani E, 2001, EUR J GASTROEN HEPAT, V13, P659, DOI 10.1097/00042737-200106000-00008
   Farrell RJ, 2002, NEW ENGL J MED, V346, P180, DOI 10.1056/NEJMra010852
   Fine KD, 2001, AM J GASTROENTEROL, V96, P138, DOI 10.1016/S0002-9270(00)02257-7
   Foldes-Papp Z, 2002, J IMMUNOASS IMMUNOCH, V23, P211, DOI 10.1081/IAS-120003662
   Horvath K, 2002, AM J GASTROENTEROL, V97, P2702
   Kellar KL, 2002, EXP HEMATOL, V30, P1227, DOI 10.1016/S0301-472X(02)00922-0
   Kumar V, 2001, CLIN DIAGN LAB IMMUN, V8, P678, DOI 10.1128/CDLI.8.4.678-685.2001
   Martini S, 2002, CLIN CHEM, V48, P960
   Martini S, 2001, CLIN CHEM, V47, P1722
   MILLER J, 1996, IN CONTACT WITH GODS, P65
   Rouquette AM, 2003, AM J CLIN PATHOL, V120, P676, DOI 10.1309/GJHKOD24YDDXWONF
   Sugai E, 2000, AM J GASTROENTEROL, V95, P2318
   Tesei N, 2003, ALIMENT PHARM THERAP, V17, P1415, DOI 10.1046/j.1365-2036.2003.01595.x
   Vecchi M, 2003, SCAND J GASTROENTERO, V38, P50, DOI 10.1080/00365520310000438
   Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6
   Vivas S, 2003, EUR J GASTROEN HEPAT, V15, P479, DOI [10.1097/00042737-200305000-00004, 10.1097/01.meg.0000059104.41030.1c]
   Wong RCW, 2002, J CLIN PATHOL, V55, P488, DOI 10.1136/jcp.55.7.488
   Woodward M, 1999, EPIDEMIOLOGY STUDY D, P94
   ZWEIG MH, 1993, CLIN CHEM, V39, P561
NR 25
TC 15
Z9 15
U1 0
U2 3
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1532-1819
J9 J IMMUNOASS IMMUNOCH
JI J. Immunoass. Immunoch.
PD NOV
PY 2004
VL 25
IS 4
BP 345
EP 357
DI 10.1081/IAS.200033832
PG 13
WC Biochemical Research Methods; Immunology; Medical Laboratory Technology
SC Biochemistry & Molecular Biology; Immunology; Medical Laboratory
   Technology
GA 869FM
UT WOS:000224968800004
PM 15552589
DA 2018-10-20
ER

PT J
AU Marin-Franch, P
   Cochran, S
   Kirk, K
AF Marin-Franch, P
   Cochran, S
   Kirk, K
TI Progress towards ultrasound applications of new single crystal materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article; Proceedings Paper
CT Annual Conference of the British-Association-for-Crystal-Growth
CY 2003
CL Oxford Univ, Oxford, ENGLAND
SP British Assoc Crystal Growth
HO Oxford Univ
ID 1-3 COMPOSITE PIEZOELECTRICS; TRANSDUCER APPLICATIONS
AB In recent years, single crystal materials with better piezoelectric properties than the existing ceramics have become available. These new materials will potentially provide improved performance in ultrasonic applications such as NDT, sonar and biomedical diagnosis. In order to select the best material and optimize transducer design, comparison must be carried out. However, due to material and transducer fabrication costs, initial comparisons can be based on simulation. In this paper, a comparison is reported between transducers based on the single crystal lead magnesium niobate-lead titanate (PMN-32% PT) and the ceramic lead zirconate titanate (PZT-5H). Material performance is assessed both for single materials and piezoelectric-polymer composite configurations by defining the relevant piezoelectric parameters. Furthermore, the effect of such parameters on the performance of different ultrasonic transducers is illustrated. Practical limitations are also discussed. We conclude that the new single crystal material will be capable of outperforming the present widely used ceramic for almost all practical applications. (C) 2004 Kluwer Academic Publishers.
C1 Univ Paisley, Sch ICT J123, Paisley PA1 2BE, Renfrew, Scotland.
RP Marin-Franch, P (reprint author), Univ Paisley, Sch ICT J123, Paisley PA1 2BE, Renfrew, Scotland.
EM mari-ph0@wpmail.paisley.ac.uk
RI Cochran, Sandy/M-4087-2017
OI Cochran, Sandy/0000-0001-7324-7790
CR Berlincourt D. A., 1964, PHYS ACOUSTICS, V1
   Caidahl K, 1998, LANCET, V352, P1264, DOI 10.1016/S0140-6736(98)02361-7
   Cheng KC, 2003, IEEE T ULTRASON FERR, V50, P1177, DOI 10.1109/TUFFC.2003.1235328
   HAYWARD G, 1989, J ACOUST SOC AM, V86, P1643, DOI 10.1121/1.398594
   HEDRICK WR, 1994, ULTRASOUND PHYS INST, P96
   Jaffe B, 1971, PIEZOELECTRIC CERAMI
   KRAUTKRAMER J, 1990, ULTRASONIC TESTING M, P187
   LEWIS G. K., 1980, ACOUST IMAGING, V8, P395
   Moulson A.J., 1990, ELECTROCERAMICS
   NEWNHAM RE, 1978, MATER RES BULL, V13, P525, DOI 10.1016/0025-5408(78)90161-7
   OAKLEY CG, 2000, IEEE ULTRASONICS S P, V2
   OAKLEY CG, 2000, IEEE ULTRASONICS S P, V1, P1157
   Park SE, 1997, IEEE T ULTRASON FERR, V44, P1140, DOI 10.1109/58.655639
   Ritter T, 2000, IEEE T ULTRASON FERR, V47, P792, DOI 10.1109/58.852060
   SHAULOV A, 1986, IEEE T ULTRASON FERR, V33, P812
   SMITH WA, 1991, IEEE T ULTRASON FERR, V38, P40, DOI 10.1109/58.67833
   SMITH WA, 1993, IEEE T ULTRASON FERR, V40, P41, DOI 10.1109/58.184997
   STANSFIELD D, 1991, UNDERWATER ELECTROAC, P18
NR 18
TC 17
Z9 17
U1 3
U2 11
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD NOV
PY 2004
VL 15
IS 11
BP 715
EP 720
DI 10.1023/B:JMSE.0000043418.10953.38
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA 857ZD
UT WOS:000224158700004
DA 2018-10-20
ER

PT J
AU Qiang, L
   Cao, CB
   Zhang, Y
   Man, XL
   Zhu, HS
AF Qiang, L
   Cao, CB
   Zhang, Y
   Man, XL
   Zhu, HS
TI The preparation of insoluble fibroin films induced by degummed fibroin
   or fibroin microspheres
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MORI SILK FIBROIN; PHYSICAL-PROPERTIES; TEMPERATURE; MEMBRANE
AB Blending degummed fibroin (DF) or insoluble fibroin microspheres with concentrated fibroin solution, the insoluble films were obtained through drying the solution at 40-45degreesC. The conformation of silk fibroin films was analyzed by infrared spectrum and X-ray diffractometry. The results demonstrated that beta-sheet conformation increased rapidly when the degummed silk or insoluble microspheres blended with fibroin, while the pure SF membrane was mainly composed of alpha/random coil conformation when the other conditions kept same. This suggested that fibroin microspheres and degummed fibroin could induce the formation of beta-sheet crystal and the insoluble films, without methanol after-treatment, could be obtained at approximately room temperature. Although the fibroin films blending with DF had many protuberances, the films containing fibroin microspheres had the smooth surface and could be used effectively in biotechnological materials and biomedical application. (C) 2004 Kluwer Academic Publishers.
C1 Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Cao, CB (reprint author), Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
EM cbcao@bit.edu.cn
RI Cao, Chuanbao/J-5396-2013
OI Cao, Chuanbao/0000-0003-2830-4383
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   CHIARINI A, BIOMATERIALS, V24, P789
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Kweon HY, 2001, J APPL POLYM SCI, V80, P1848, DOI 10.1002/app.1281
   MASUHIRO T, 1994, J POLYM SCI POL LETT, V32, P961
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Noishiki Y, 2002, J APPL POLYM SCI, V86, P3425, DOI 10.1002/app.11370
   NORIHIKO M, 1990, POLYMER, V31, P265
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sun YY, 1997, J APPL POLYM SCI, V65, P959, DOI 10.1002/(SICI)1097-4628(19970801)65:5<959::AID-APP14>3.0.CO;2-N
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P1745, DOI 10.1002/app.1990.070400928
NR 18
TC 31
Z9 35
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2004
VL 15
IS 11
BP 1193
EP 1197
DI 10.1007/s10856-004-5918-y
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 894SM
UT WOS:000226811900004
PM 15880927
DA 2018-10-20
ER

PT J
AU Wei, J
   Li, YB
   Zuo, Y
   Peng, XL
   Zhang, L
AF Wei, J
   Li, YB
   Zuo, Y
   Peng, XL
   Zhang, L
TI Development of biomimetic needle-like apatite nanocrystals by a simple
   new method
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE biomimetic; apatite; nanocrystals; biomedical applications
ID HYDROXYAPATITE
AB A new method of calcium nitrate and sodium phosphate as reactants was employed to prepare biomimetic apatite nanocrystals by a simple heating treatment in water. The structure and properties of the apatite crystals were investigated by TEM, XRD, IR, ICP and TG. It is found that the apatite nanocrystals contain OH-, CO32-, Na+ and HPO42- ions in their crystal structure. The crystal water is removed during heating from 200degreesC to 400degreesC. CO32- and HPO42- are decomposed at 600degreesC to 800degreesC, also there is lattice water lost at this temperature stage. The morphology of the apatite nanocrystals is needle-like with a length less than 80 nm. The size and crystallinity of the apatite nanocrystals increase with water treatment temperature and time. Compared to the apatite crystals sintered at 800degreesC, water treated apatite nanocrystals are poorly crystallized apatite. The results indicate that the apatite nanocrystals have similarity in composition, structure, morphology and crystallinity to that of bone apatite crystals. It can be used to make apatite crystals/polymer biomimetic bone repair materials or for other biomedical applications.
C1 Sichuan Univ, Res Ctr Nanobiomat, Chengdu 610064, Peoples R China.
RP Li, YB (reprint author), Sichuan Univ, Res Ctr Nanobiomat, Chengdu 610064, Peoples R China.
EM nic7504@scu.edu.cn
CR LI YB, 1994, J MATER SCI-MATER M, V5, P326
   LI YB, 1994, BIOMATERIALS, V15, P835
   LI YB, 1999, 4 AS S BIOM MAT SING, P89
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   MONMA H, 1987, J MATER SCI, V22, P4247, DOI 10.1007/BF01132015
   PARK JB, 1992, BIOMATERIALS INTRO, P123
   SADA E, 1991, CHEM ENG COMMUN, V103, P57, DOI 10.1080/00986449108910862
   SENYA I, 1987, J CERAM SOC JPN, V95, P759
   TAKEO H, 1989, J MATER SCI LETT, V8, P305
   TAKEO H, 1987, J CERAM SOC JPN, V95, P825
   WANG X, 2001, CHIN J BIOMED ENG, V10, P199
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   WANG XJ, 2001, T 27 ANN M SFB US, P305
   Yan YG, 2003, EUR POLYM J, V39, P411
   YI Z, 2003, HIGH TECHNOL LETT, V4, P58
   YOSHIO M, 1990, J CERAM SOC JPN, V98, P1255
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 18
TC 5
Z9 6
U1 0
U2 4
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD NOV
PY 2004
VL 20
IS 6
BP 665
EP 667
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 878CE
UT WOS:000225623300006
DA 2018-10-20
ER

PT J
AU Fu, Q
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
AF Fu, Q
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
TI Formation and characterization of bone-like nanoscale hydroxyapatite in
   glass bone cement
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE bioactivity; bone cement; hydroxyapatite; microstructure
ID BIOCERAMICS
AB Glass based bone cement (GBC) was synthesized by mixing CaO-SiO2-P2O5 based glass powder with ammonium phosphate liquid medium. Bone-like hydroxyapatite (HAP, Ca-10(PO4)(6)(OH)(2)) was found to form after GBC was immersed in simulated body fluid (SBF). HAP crystal grew with an increasing time along c axle and reached about 200 nm in length after 30 days, however, the end plane granularity remained 30similar to50 rim. The chemical composition, crystal structure and morphology of HAP formed from GBC were proved to have great resemblance with living HAP. It is believed that GBC was a desirable biomedical material with high bioactivity. Furthermore, the high compressive strength guaranteed the possibility of GBC in clinical application.
C1 Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
RP Huang, WH (reprint author), Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
EM whhuang@mail.tongji.edu.cn
RI Fu, Qiang/B-1972-2013
CR CHO SB, 1998, J MATER SCI-MATER M, V9, P278
   DeAza PN, 1996, J MATER SCI-MATER M, V7, P399, DOI 10.1007/BF00122007
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   GAN FX, 1990, MODERN GLASS SCI TEC, P282
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   Ohtsuki C., 1991, J CERAM SOC JPN, V99, P1
   Park JB, 1992, BIOMATERIALS INTRO, P192
   Shinzato S, 2001, J BIOMED MATER RES, V56, P571, DOI 10.1002/1097-4636(20010915)56:4<571::AID-JBM1129>3.0.CO;2-H
   Tamura J, 1996, J BIOMED MATER RES, V30, P85, DOI 10.1002/(SICI)1097-4636(199601)30:1<85::AID-JBM11>3.0.CO;2-P
   VOGGEL W, 1984, FRONTIER GLASS SCI T, P44
NR 12
TC 2
Z9 2
U1 0
U2 0
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD NOV
PY 2004
VL 20
IS 6
BP 772
EP 774
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 878CE
UT WOS:000225623300037
DA 2018-10-20
ER

PT J
AU Popat, KC
   Mor, G
   Grimes, C
   Desai, TA
AF Popat, KC
   Mor, G
   Grimes, C
   Desai, TA
TI Poly (ethylene glycol) grafted nanoporous alumina membranes
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE poly (ethylene glycol); nanoporous alumina membranes; anodization
ID PROTEIN SURFACE INTERACTIONS; INDUCED PLATELET ACTIVATION; POLY(ETHYLENE
   GLYCOL); TRIBLOCK COPOLYMERS; POLYETHYLENE OXIDE; SENSOR NETWORK; FILMS;
   ADSORPTION; PREVENTION; TEMPERATURE
AB Membranes currently used for separation of sub-micron particles in biomedical applications are of asymmetric or anisotropic variety and are made from polymers such as polysulfone or polyacrylonitrile. Several bioincompatibilities are associated with these polymeric membranes limiting their applications. Aluminum oxide substrates have been chosen for several reasons, including compatibility with our processing protocols, chemical and thermal stability, and ease in post-processing surface modification. Several studies have shown this material to be bioinert. However, the biocompatibility of the membrane material must be further investigated and improved. With proper surface modification, the protein adsorption can be lowered and the non-fouling characteristics can be improved. In this study we graft alumina membranes with a biocompatible polymer like poly (ethylene glycol) to investigate protein adsorption. Albumin and fibrinogen were selected as model proteins since they are important components in immunogenic and thrombogenic reactions. X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM) were used to characterize PEG films on alumina membranes. (C) 2004 Elsevier B.V. All rights reserved.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Penn State Univ, Dept Elect Engn, State Coll, PA USA.
RP Desai, TA (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
EM tdesai@bu.edu
OI Popat, Ketul C./0000-0002-2417-7789
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   AMIJI M, 1993, J COLLOID INTERF SCI, V155, P251, DOI 10.1006/jcis.1993.1031
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Band I. M., 1979, Atomic Data and Nuclear Data Tables, V23, P443, DOI 10.1016/0092-640X(79)90027-5
   CAI QY, 2002, SENSOR ACTUAT B-CHEM, V79, P144
   CUYPERS PA, 1983, J BIOL CHEM, V258, P2426
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Dickey EC, 2002, SENSORS-BASEL, V2, P91, DOI 10.3390/s20300091
   DUNLEAVY M, 1996, MED DEVICE TECHNOL, V7, P18
   Emoto K, 1996, ANAL CHEM, V68, P3751, DOI 10.1021/ac960114m
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   Grimes CA, 2003, SENSORS, V3, P69, DOI 10.3390/s30300069
   GRINGELL D, 1994, J BIOMED MATER RES, V28, P505
   HARMS J, 1979, J BIOMED MATER RES, V13, P67, DOI 10.1002/jbm.820130109
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kamath KR, 1996, J BIOMAT SCI-POLYM E, V7, P977, DOI 10.1163/156856296X00381
   *NAT I STAND TECHN, 2001, NIST EL EFF ATT LENG
   *NAT I STAND TECHN, 2001, NIST XRAY PHOT SPECT
   Patai S., 1989, CHEM ORGANIC SILICON
   Popat KC, 2003, J VAC SCI TECHNOL B, V21, P645, DOI 10.1116/1.1545733
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   SCHWEPPE J, 1994, J ELECTRON SPECTROSC, V67, P463, DOI 10.1016/0368-2048(93)02059-U
   Sharma S, 2002, LANGMUIR, V18, P8728, DOI 10.1021/la026097f
   Sharma S, 2003, APPL SURF SCI, V206, P218, DOI 10.1016/S0169-4332(02)01220-5
   STARK MB, 1989, BIOTECHNOL BIOENG, V34, P942, DOI 10.1002/bit.260340709
   STRASSER CM, 1989, J BIOMED MATER RES, V23, P1385
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Varghese OK, 2002, J MATER RES, V17, P1162
   Vasant EF, 1995, CHARACTERIZATION CHE
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   Yang XP, 2002, SENSORS-BASEL, V2, P455, DOI 10.3390/s21100455
   YINCHAO T, 1995, BIOMATERIALS, V16, P963
   Zhang R, 2002, SENSORS, V2, P331, DOI 10.3390/s20800331
NR 39
TC 22
Z9 23
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD NOV 1
PY 2004
VL 243
IS 1-2
BP 97
EP 106
DI 10.1016/j.memsci.2004.05.030
PG 10
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 860TL
UT WOS:000224366100011
DA 2018-10-20
ER

PT J
AU Covolan, VL
   Di Ponzio, R
   Chiellini, F
   Fernandes, EG
   Solaro, R
   Chiellini, E
AF Covolan, VL
   Di Ponzio, R
   Chiellini, F
   Fernandes, EG
   Solaro, R
   Chiellini, E
TI Polyurethane based materials for the production of biomedical materials
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 16th Italian Meeting on Science and Technology of Macromolecules
CY SEP 22-23, 2003
CL Pisa, ITALY
SP Macromol Italian Assoc
DE block copolymer; hexamethylene diisocyanate; poly(epsilon-caprolactone)
   diol; poly(ethylene glycol); polyurethane
ID RELEASE
AB Polyurethanes (PUs) composed by hard and soft segments have been extensively used in the manufacturing of biocompatible prosthesis and medical devices. A broad variety of PUs can be obtained by modifying the balance between both segments. In the present work, different basically-flexible PUs have been prepared by employing different combinations of aliphatic hexamethylene diisocyanate, poly(ethylene glycol) (Mw 400 Da), poly(epsilon-caprolacione) diol (Mw 530 Da), and 1,4-butanediol. Thermal analysis of the synthesized PUs demonstrated high thermal stability and the assumption of glassy state well Mow room temperature, in agreement with their marked flexibility. Morphological characterization of PUs films indicated that films prepared by spin coating were smoother and more homogeneous than those obtained by casting. Biological assays performed by using 3T3/BALB-C mouse embryo fibroblast cell line confirmed the absence of toxicity and hence the biocompatibility of PU-films.
C1 Univ Pisa, INSTM, Dept Chem & Ind Chem, Operat Unit, I-56126 Pisa, Italy.
RP Chiellini, E (reprint author), Univ Pisa, INSTM, Dept Chem & Ind Chem, Operat Unit, Via Risorgimento 35, I-56126 Pisa, Italy.
EM emochie@dcci.unipi.it
RI Chiellini, Federica/F-3233-2010; Fernandes, Elizabeth/I-6736-2013;
   Grillo Fernandes, Elizabeth/B-6084-2016
OI Chiellini, Federica/0000-0003-4680-9975; Grillo Fernandes,
   Elizabeth/0000-0003-4830-1286
CR Bizzarri R, 2002, MACROMOL CHEM PHYSIC, V203, P1684, DOI 10.1002/1521-3935(200207)203:10/11<1684::AID-MACP1684>3.0.CO;2-L
   Chiellini E, 2001, J BIOACT COMPAT POL, V16, P441, DOI 10.1106/6CFL-4E8A-L7XR-MUF7
   Chiellini F, 2003, MACROMOL SYMP, V197, P369, DOI 10.1002/masy.200350732
   Chiellini F, 2002, J APPL POLYM SCI, V85, P2729, DOI 10.1002/app.10799
   CHIELLINI F, 2001, MACROMOL RAPID COMM, V22, P1285
   IKADA Y, 1992, Patent No. 0482467A2
   KOBAYASHI H, 1991, J BIOMED MATER RES, V25, P1481, DOI 10.1002/jbm.820251206
   SHANTHA KL, 1993, J APPL POLYM SCI, V50, P1863, DOI 10.1002/app.1993.070501102
   Sheikh N, 2000, INT J ADHES ADHES, V20, P299, DOI 10.1016/S0143-7496(99)00060-3
   Solaro R, 2003, J MATER SCI-MATER M, V14, P705, DOI 10.1023/A:1024963700223
   SUBHAGA CS, 1995, J MICROENCAPSUL, V12, P617, DOI 10.3109/02652049509006792
   Ulrich H., 1983, ENCY CHEM TECHNOLOGY, P576
   YU T, 2000, ACS POLYM PREPR, V41, P1699
NR 13
TC 9
Z9 9
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD NOV
PY 2004
VL 218
BP 273
EP 282
DI 10.1002/masy.200451428
PG 10
WC Polymer Science
SC Polymer Science
GA 890QV
UT WOS:000226526800030
DA 2018-10-20
ER

PT J
AU Lin, XY
   Li, XD
   Fan, HS
   Wen, XT
   Lu, J
   Zhang, XD
AF Lin, XY
   Li, XD
   Fan, HS
   Wen, XT
   Lu, J
   Zhang, XD
TI In situ synthesis of bone-like apatite/collagen nano-composite at low
   temperature
SO MATERIALS LETTERS
LA English
DT Article
DE nanocomposite; bone-like apatite; collagen; low temperature; in situ
   synthesis
ID NANOCOMPOSITE
AB A nano-composite of bone-like apatite/collagen was prepared by a new method-low-temperature in situ synthesis using calcium nitrate, diammoniun hydrogen phosphate and cow hide collagen as starting materials. The composite was investigated via X-ray diffraction (XRD), Fourier transform infrared (FTIR), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). It was found that bone-like nanoapatite particles were distributed uniformly in collagen fibrils in the composite. The composite with homogeneous microstructure was similar to natural bone in crystallite phase composition and crystal size. The biomimetic composite is expected to exhibit desirable properties in biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Sichuan Univ, Biomed Engn Res Ctr, Chengdu 610064, Peoples R China.
   SW Univ Sci & Technol, Sichuan 621002, Mianyang, Peoples R China.
RP Li, XD (reprint author), Sichuan Univ, Biomed Engn Res Ctr, Chengdu 610064, Peoples R China.
EM xli20004@yahoo.com
RI Li, Xudong/D-4444-2011
OI Li, Xudong/0000-0002-7939-5150
CR AARON W, 2003, BIOMATERIALS, V24, P4881
   AOKI H, 1991, SCIENCE MED APPL HYD
   ARIF A, 1996, J COLLOID INTERF SCI, V179, P608
   Bilezikian J. P., 1996, PRINCIPLES BONE BIOL
   Chapman MW, 1997, J BONE JOINT SURG AM, V79A, P495, DOI 10.2106/00004623-199704000-00004
   FAN SJ, 1992, T 19 ANN M SOC BIOM, P104
   JOON BP, 1992, BIOMATERIALS INTRO
   KENNETH D, 1996, J ORTHOP RES, V14, P351
   Kevor S, 1995, J BIOMED MATER RES, V29, P803
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Li HY, 2003, MATER LETT, V57, P2848, DOI 10.1016/S0167-577X(02)01386-1
   LI Y, 2004, J MATER SCI-MATER M, V5, P326
   LIU YH, 1993, BIOMED MAT RES FAR E, P161
   MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
NR 16
TC 45
Z9 49
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD NOV
PY 2004
VL 58
IS 27-28
BP 3569
EP 3572
DI 10.1016/j.matlet.2004.06.044
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 861WO
UT WOS:000224449500042
DA 2018-10-20
ER

PT J
AU Silva, HM
   Schneider, SG
   Neto, CM
AF Silva, HM
   Schneider, SG
   Neto, CM
TI Study of nontoxic aluminum and vanadium-free titanium alloys for
   biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 2nd Meeting of the Brazilian-Society-for-Materials-Research (Brazil-MRS)
CY OCT 26-29, 2003
CL Rio de Janeiro, BRAZIL
SP Brazilian Soc Mat Res
DE beta-type Ti alloys; biomedical applications; microstructure; mechanical
   properties
AB Pure titanium and its alloys are the most attractive materials for biomedical applications. Studies have shown that P-type titanium alloys, containing the elements Mo, Zr, Nb, Ta and Fe, can exhibit an elastic modulus lower than Ti-6AI-4V alloy. This work describes the microstructures and mechanical properties of two beta-type titanium alloys, Ti-8Nb-13Zr and Ti-18Nb-13Zr (wt.%), which were produced by furnace arc-melting in argon atmosphere, heat treatment and rotary swaging. Microstructural analyses of the materials in as-cast and heat-treated conditions are performed using light microscopy and scanning electron microscopy (SEM). Mechanical characterization of these alloys is based on tensile and hardness tests. Results indicate that the route of thermomechanical processing is available to obtain a homogeneous martensitic alpha' microstructure and good mechanical properties for the alloys, which can be used for biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 ITA, BR-12228904 Sao Jose Dos Campos, SP, Brazil.
   Fac Engn Quim, FAENQUIL, DEMAR, BR-12600970 Lorena, SP, Brazil.
RP Silva, HM (reprint author), ITA, Pca Marechal Ar Eduardo Gomes,50 Vila Acacias, BR-12228904 Sao Jose Dos Campos, SP, Brazil.
EM helenam@ita.br
RI Schneider, Sandra/E-6087-2015
CR DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Helmus M.N., 1995, ENCY HDB BIOMATERIAL, V1, P27
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Ratner BD, 1996, INTRO MAT MED
   ROBARE EW, 1997, ADV SCI TECHNOLOGY T, P283
   ZAVAGLIA CAC, 1993, THESIS UNICAMP
NR 7
TC 42
Z9 45
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD NOV 1
PY 2004
VL 24
IS 5
BP 679
EP 682
DI 10.1016/j.msec.2004.08.051
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 879PY
UT WOS:000225730900017
DA 2018-10-20
ER

PT J
AU Kohn, J
AF Kohn, J
TI New approaches to biomaterials design
SO NATURE MATERIALS
LA English
DT Editorial Material
ID POLYMER SURFACES; CHEMISTRY; LIBRARY
AB The adoption of combinatorial and computational methods in biomaterials design is a highway towards the discovery and realization of tailored polymeric materials to satisfy the specific requirements of many diverse biomedical or prosthetic applications.
C1 Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
RP Kohn, J (reprint author), Rutgers State Univ, New Jersey Ctr Biomat, 610 Taylor Rd, Piscataway, NJ 08854 USA.
EM Joachim@rutchem.rutgers.edu
CR ANDERSON DG, 2004, NAT BIOTECHNOL, V22, P828
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Eberhart ME, 2004, NAT MATER, V3, P659, DOI 10.1038/nmat1229
   Eksterowicz JE, 2002, J MOL GRAPH MODEL, V20, P469, DOI 10.1016/S1093-3263(01)00148-6
   Garcia JG, 2003, METHOD ENZYMOL, V369, P391
   Lemmen C, 2000, J COMPUT AID MOL DES, V14, P215, DOI 10.1023/A:1008194019144
   LOWE G, 1995, JCS REV, P309
   MENGER FM, 1995, J ORG CHEM, V60, P6666, DOI 10.1021/jo00126a008
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Meredith JC, 2000, MACROMOLECULES, V33, P9747, DOI 10.1021/ma001298g
   Smith AP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015503
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   Zeltinger J, 2004, BIOMATER FORUM, V26, P8
NR 14
TC 72
Z9 72
U1 0
U2 36
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD NOV
PY 2004
VL 3
IS 11
BP 745
EP 747
DI 10.1038/nmat1249
PG 3
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 866QA
UT WOS:000224786800002
PM 15516948
DA 2018-10-20
ER

PT J
AU Regidor, E
AF Regidor, E
TI The use of personal data from medical records and biological materials:
   ethical perspectives and the basis for legal restrictions in health
   research
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE biological materials; medical records; personal data; health; ethics
ID GENETIC DISCRIMINATION; DEVELOPING-COUNTRIES; INFORMED CONSENT; PRIVACY;
   INSURANCE; EPIDEMIOLOGY; PROTECTION; WILL; INFORMATION; GUIDELINES
AB This paper discusses the moral justification for using personal data without informed consent, from both medical records and biological materials, in research where subjects are not physically present in the study and will never have any contact with the study investigators. Although the idea of waiving the requirement for informed consent in certain investigations has been mentioned in several ethical guidelines formulated by epidemiologists and physicians since the late 1980s, these guidelines are now of limited use due to legal restrictions on the use of personal data in most western countries. Several misconceptions that form the basis for legal restriction of health research are discussed: lack of knowledge of the need to link personal information from health services with personal information produced outside the health system in many biomedical investigations; the assumption of a deterministic model of disease causation in which the prediction of disease occurrence is based on a genetic association despite the fact that most genotypes for common diseases are incompletely penetrant; the lack of a logical rationale for the recommendation in the Declaration of Helsinki that only research that offers some benefit to study subjects is justified; the great lack of knowledge about research methodology revealed in some alternatives proposed to avoid using personal data; and the lack of a debate about the ethical double standard of institutions and investigators in countries that prohibit the use of personal data but finance and carry out studies in other countries where it is permitted. (C) 2004 Elsevier Ltd. All rights reserved,
C1 Univ Complutense Madrid, Fac Med, Dept Prevent Med Publ Hlth & Hish Sci, E-28040 Madrid, Spain.
RP Regidor, E (reprint author), Univ Complutense Madrid, Fac Med, Dept Prevent Med Publ Hlth & Hish Sci, Ciudad Univ, E-28040 Madrid, Spain.
EM enriqueregidor@hotmail.com
RI Sandall, Jane/D-4146-2009
OI Sandall, Jane/0000-0003-2000-743X; Regidor, Enrique/0000-0002-2374-9861
CR Abbott A, 2000, NATURE, V406, P340, DOI 10.1038/35019167
   Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209
   ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346
   Annas GJ, 2001, NEW ENGL J MED, V345, P385, DOI 10.1056/NEJM200108023450523
   [Anonymous], 2000, JAMA-J AM MED ASSOC, V284, P3043, DOI DOI 10.1001/JAMA.284.23.3043
   Beauchamp T, 1994, PRINCIPLES BIOMEDICA
   Beauchamp T. L., 1996, ETHICS EPIDEMIOLOGY, P24
   BEAUCHAMP TL, 1991, J CLIN EPIDEMIOL, V44, pS151
   Berkman L, 2000, SOCIAL EPIDEMIOLOGY
   BIROS MH, 1995, JAMA-J AM MED ASSOC, V273, P1283, DOI 10.1001/jama.273.16.1283
   CAPRON AM, 1991, J CLIN EPIDEMIOL, V44, pS81
   CHAMBERLAYNE R, 1998, CANADIAN J PUBLIC HL, V89, P279
   COUGHLIN SS, 1992, EPIDEMIOLOGY, V3, P343, DOI 10.1097/00001648-199207000-00009
   COUGHLIN SS, 1997, CASE STUDIES PUBLIC
   Coughlin SS, 1996, ETHICS EPIDEMIOLOGY, P145
   Council for International Organizations of Medical Sciences, 1991, INT GUID ETH REV EP
   DAVISON C, 1994, SOCIOL HEALTH ILL, V16, P340, DOI 10.1111/1467-9566.ep11348762
   Diez-Roux AV, 1998, AM J EPIDEMIOL, V148, P1027
   Doll R, 2001, BRIT MED J, V323, P1421
   Doyal L, 1997, BRIT MED J, V314, P1107, DOI 10.1136/bmj.314.7087.1107
   Evers K, 2002, NEW ENGL J MED, V346, P1579, DOI 10.1056/NEJMsb020527
   Gostin LO, 1998, ANN INTERN MED, V129, P833, DOI 10.7326/0003-4819-129-10-199811150-00017
   Gostin LO, 2001, JAMA-J AM MED ASSOC, V285, P3015, DOI 10.1001/jama.285.23.3015
   HARPER PS, 1993, LANCET, V341, P224, DOI 10.1016/0140-6736(93)90080-Z
   Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213
   Horner JS, 1998, PUBLIC HEALTH, V112, P217
   HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391
   KORN D, 2000, NATL BIOETHICS ADVIS, V2
   LAKO CJ, 1986, SOC SCI MED, V23, P293, DOI 10.1016/0277-9536(86)90350-3
   Lapham EV, 1996, SCIENCE, V274, P621, DOI 10.1126/science.274.5287.621
   LAST JM, 1990, INT J EPIDEMIOL, V19, P226, DOI 10.1093/ije/19.1.226
   Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212
   Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012
   NBAC, 2001, ETH POL ISS RES INV, V1
   NBAC, 1999, RES INV HUM BIOL MAT, V1
   Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701
   Riis P, 2000, JAMA-J AM MED ASSOC, V284, P3045, DOI 10.1001/jama.284.23.3045
   ROTHMAN KJ, 1981, NEW ENGL J MED, V304, P600, DOI 10.1056/NEJM198103053041010
   SMITH R, 1997, BRIT MED J, V313, P16
   Strobl J, 2000, BRIT MED J, V321, P890, DOI 10.1136/bmj.321.7265.890
   The National Commission for the Protection of Human Subjects of Biomedical & Behavioral Research, 1979, BELM REP ETH GUID PR
   Vandenbroucke JP, 1998, BRIT MED J, V316, P1331, DOI 10.1136/bmj.316.7141.1331
   Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411
   WALD N, 1994, BRIT MED J, V309, P1422, DOI 10.1136/bmj.309.6966.1422
   Walker AM, 1997, EPIDEMIOLOGY, V8, P671, DOI 10.1097/00001648-199710000-00010
   Watts G, 1999, BRIT MED J, V319, P273, DOI 10.1136/bmj.319.7205.273a
   WELCH CA, 2001, NEW ENGL J MED, V345, P271
   WOODWARD B, 1995, NEW ENGL J MED, V333, P1419, DOI 10.1056/NEJM199511233332112
   Woodward B, 1999, JAMA-J AM MED ASSOC, V282, P1947, DOI 10.1001/jama.282.20.1947
   *WORK GROUP ROYAL, 1994, J R COLL PHYSICIANS, V28, P439
   WRIGHT CE, 1995, JAMA-J AM MED ASSOC, V274, P1786
   WUKADINOVICH DM, 1999, EPIDEMIOLOGY, V10, P91
   1995, OFFICIAL J EUROPEA L, V38, P31
   1964, NEW ENGLAND J MED, V271, P473
NR 54
TC 17
Z9 17
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD NOV
PY 2004
VL 59
IS 9
BP 1975
EP 1984
DI 10.1016/j.socscimed.2004.02.032
PG 10
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 852CZ
UT WOS:000223734100018
PM 15312931
DA 2018-10-20
ER

PT J
AU Andersen, HM
AF Andersen, HM
TI "Villagers": Differential treatment in a Ghanaian hospital
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE health workers; hospitals; differential treatment; patient categories;
   bureaucracy; Ghana
ID PATIENT SATISFACTION; SERVICES; QUALITY; CARE
AB Differential treatment of patients by health workers in African medical institutions is acknowledged by patients, health workers and policy-makers alike to be an obstacle in the realization of government objectives of equity in health care. This qualitative study understands the production and legitimization of differential treatment from the perspective of health workers. On the basis of qualitative field material from a hospital in Northern Ghana the relation between socio-cultural, biomedical and bureaucratic aspects of hospital practice is explored through a focus on categorizations of patients. It is concluded that to blame the "bad attitudes" of health workers for differential treatment is not an adequate explanation. It is important to acknowledge that differential treatment can be understood as a form of agency, and is related to the conditions of hospital work and to the professional and social identities of health workers. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Copenhagen, Inst Anthropol, DK-1220 Copenhagen K, Denmark.
RP Andersen, HM (reprint author), Univ Copenhagen, Inst Anthropol, Frederiksholms Kanal 4, DK-1220 Copenhagen K, Denmark.
EM Helle.max.Andersen@anthro.ku.dk
CR Andaleeb SS, 2001, SOC SCI MED, V52, P1359, DOI 10.1016/S0277-9536(00)00235-5
   BRITAN GM, 1980, HIERARCHY SOC ANTHR, P1
   Cohen Ronald, 1980, HIERARCHY SOC ANTHR, P73
   Foster P. J., 1965, ED SOCIAL CHANGE GHA
   Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6
   FREIDSON E, 1970, PROFESSIONAL DOMINAN
   Gellner D., 2001, INSIDE ORG ANTHR WOR
   GILSON L, 1994, SOC SCI MED, V39, P767, DOI 10.1016/0277-9536(94)90038-8
   HERZFELD M, 1992, SOCIAL PRODUCTION IN
   Jackson JL, 2001, SOC SCI MED, V52, P609, DOI 10.1016/S0277-9536(00)00164-7
   JESPERSEN J, 1998, GHANA POLITISK OKONO
   Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8
   Keyes C. F., 1991, RESHAPING LOCAL WORL, P1
   KLEINMAN A, 1980, PATIENTS HEALERS CON
   Lentz Carola, 1994, SOCIAL ANTHR, V2, P149
   Lipsky M., 1978, STREET LEVEL BUREAUC
   Lupton D, 1994, MED CULTURE ILLNESS
   MacCormack C.P., 1992, SOCIAL BASIS HLTH HE
   Mann Kristin, 1985, MARRYING WELL MARRIA
   MASEMANN V, 1974, CAN J AFR STUD, V8, P479, DOI 10.2307/483708
   McPake B, 1999, SOC SCI MED, V49, P849, DOI 10.1016/S0277-9536(99)00144-6
   *MIN HLTH GHAN, 1995, MED TERM HLTH STRAT
   *MIN HLTH GHAN, 1996, HLTH SECT 5 YEAR PRO
   Oppong C., 1974, MARRIAGE MATRILINEAL
   Price R., 1975, SOC BUREAUCRACY CONT
   Senah KA, 1997, MONEY BE MAN POPULAR
   TURNER B, 1987, MED POWER SOCIAL KNO
   *WORLD BANK, 2003, GHAN HLTH SECT PROGR
   Wright Susan, 1994, ANTHR ORG
   1996, BOLGATANGA REGIONAL
NR 30
TC 41
Z9 41
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD NOV
PY 2004
VL 59
IS 10
BP 2003
EP 2012
DI 10.1016/j.socscimed.2004.03.005
PG 10
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 856BB
UT WOS:000224017500002
PM 15351468
DA 2018-10-20
ER

PT J
AU Loir, AS
   Garrelie, F
   Donnet, C
   Rogemond, F
   Subtil, JL
   Forest, B
   Belin, M
   Laporte, P
AF Loir, AS
   Garrelie, F
   Donnet, C
   Rogemond, F
   Subtil, JL
   Forest, B
   Belin, M
   Laporte, P
TI Towards the deposition of tetrahedral diamond-like carbon films on hip
   joints by femtosecond pulsed laser ablation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 31st International Conference on Metallurgical Coatings and Thin Films
CY APR 19-23, 2004
CL San Diego, CA
SP AVS Sci & Technol Soc, Adv Surface Engn Div
DE DLC; femtosecond pulsed laser deposition; adhesion; hip joint
ID AMORPHOUS-CARBON; THIN-FILMS; NANOCRYSTALLINE DIAMOND; BIOLOGICAL
   APPLICATIONS; DLC COATINGS; ADHESION
AB Compared to conventional nanosecond laser ablation, femtosecond pulsed laser deposition (PLD) allows the production of higher energy ions (up to a few keV) in the plasma plume, which strongly affect the structure and properties of the deposited films. In this work, tetrahedral diamond-like carbon (ta-C) films have been deposited by femtosecond PLD on various substrates, including 316L stainless steel, in order to extend the wear resistance of materials used for hip joint replacement. The deposition process has been optimized to obtain smooth and wear-resistant carbon films by ablating a graphite target in ultra-high vacuum conditions at room temperature, with a laser fluence (energy density) ranging from 1 to 6 J cm(-2). In situ sputter cleaning of the substrates in an argon atmosphere prior to carbon deposition has been widely investigated: tensile tests show that the adhesion of the films on stainless steel substrates is remarkably enhanced by removing the contamination and oxidized top-coats. The films exhibit high wear resistance (in the 10(-8) to 10(-9) mm(3) N-1 m(-1) range) with moderate hardness (in the 20-30 GPa range), which may be favorable for the accommodation motion between contacting surfaces in a hip joint. The ability of these films to satisfy the biomedical requirements is discussed and the possibility to deposit homogeneous ta-C films on a 22.2-mm diameter hemispherical surface is examined. Finally, homogeneous films have been deposited on a 316L stainless steel femoral head, whose wear behavior will be quantified using a walking simulator during several millions of cycles (corresponding to the human activity during several years). (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ St Etienne, Lab Traitement Signal & Instrumentat, UMR 5516, F-42000 St Etienne, France.
   Ecole Cent Lyon, Lab Tribol & Dyanm Syst, UMR 5513, F-69134 Ecully, France.
   Ecole Natl Super Mines, Ctr Sci Mat & Struct, F-42023 St Etienne, France.
RP Donnet, C (reprint author), Univ St Etienne, Lab Traitement Signal & Instrumentat, UMR 5516, Batiment F 10 Rue Barrouin, F-42000 St Etienne, France.
EM Christophe.Donnet@univ-st-etienne.fr
RI LOIR, Anne-Sophie/J-4041-2012
OI LOIR, Anne-Sophie/0000-0001-9169-1545
CR Bulir J, 1997, THIN SOLID FILMS, V292, P318, DOI 10.1016/S0040-6090(96)08951-1
   Chrisey D., 1994, PULSED LASER DEPOSIT
   ERDEMIR A, 2000, MODERN TRIBOLOGY HDB, V2, P871
   Garrelie F, 2003, SURF COAT TECH, V163, P306, DOI 10.1016/S0257-8972(02)00481-4
   Garrelie F, 2002, PROC SPIE, V4760, P301, DOI 10.1117/12.482098
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hou QR, 1999, APPL PHYS A-MATER, V68, P343, DOI 10.1007/s003390050900
   Loir AS, 2004, THIN SOLID FILMS, V453, P531, DOI 10.1016/j.tsf.2003.11.135
   Loir AS, 2003, APPL SURF SCI, V208, P553, DOI 10.1016/S0169-4332(02)01380-6
   Matsuyama N, 2001, J APPL PHYS, V89, P1938, DOI 10.1063/1.1334640
   Morshed MM, 2003, SURF COAT TECH, V174, P579, DOI 10.1016/S0257-8972(03)00701-1
   Morshed MM, 2003, SURF COAT TECH, V163, P541, DOI 10.1016/S0257-8972(02)00619-9
   PAPPAS DL, 1992, J APPL PHYS, V71, P5675, DOI 10.1063/1.350501
   Perriere J, 2002, J APPL PHYS, V91, P690, DOI 10.1063/1.1426250
   Podgornik B, 2001, DIAM RELAT MATER, V10, P2232, DOI 10.1016/S0925-9635(01)00514-3
   Qian F, 1999, J APPL PHYS, V86, P2281, DOI 10.1063/1.371043
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Schwan J, 1996, J APPL PHYS, V79, P1416, DOI 10.1063/1.360979
   Sharda T, 2001, DIAM RELAT MATER, V10, P1592, DOI 10.1016/S0925-9635(01)00415-0
   SHI X, 1997, PHILOS MAG B, V76, P351
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Tsui YY, 2000, SURF COAT TECH, V126, P96, DOI 10.1016/S0257-8972(99)00642-8
   Voevodin AA, 1996, SURF COAT TECH, V82, P199, DOI 10.1016/0257-8972(95)02734-3
   Wei Q, 2001, SURF COAT TECH, V146, P250, DOI 10.1016/S0257-8972(01)01394-9
NR 25
TC 12
Z9 17
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD NOV-DEC
PY 2004
VL 188
BP 728
EP 734
DI 10.1016/j.surfcoat.2004.07.046
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 872YQ
UT WOS:000225245800116
DA 2018-10-20
ER

PT J
AU Ahmed, W
   Sein, H
   Jackson, M
   Polini, R
AF Ahmed, W
   Sein, H
   Jackson, M
   Polini, R
TI Chemical vapour deposition of diamond films onto tungsten carbide dental
   burs
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article
DE wear; diamond; HFCVD; cutting tools
ID CVD DIAMOND; CEMENTED CARBIDE; COATINGS; WEAR; TOOLS
AB Considerable literature is now available on the deposition of CVD diamond onto flat substrates the most common being silicon. However, very little work has been reported on the deposition of diamond onto complex three-dimensional substrates such as dental burs, micro drills and biomedical implants. Diamond is hard, wear resistant, biocompatible and corrosion resistant and therefore is an attractive candidate for uses in dental tools and for medical devices. This study focuses on the deposition of diamond, using a hot filament CVD system, on cobalt-cemented tungsten carbide (WC-Co) rotary cutting dental burs. Conventional dental burs are generally made of sintered polycrystalline diamond (PCD). These have a number of problems associated with heterogeneity of the crystallite, decreased cutting efficiency and a short life. A preferential (1 1 1) faceted diamond has been obtained after 12 h deposition at a growth rate of 1.2 mum/h. Diamond coated WC-Co dental burs and conventional sintered burs are used in turning, milling and drilling operations for machining materials made from metal alloys and borosilicate glass. After machining with excessive cutting performance, calculations can be made on flank and crater wear areas. Diamond coated WC-Co dental bur offer significantly lower erosion and higher wear resistance compared to uncoated WC-Co tools and sintered burs. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
   Tennessee Technol Univ, Dept Mech Engn, Cookeville, TN 38505 USA.
   Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy.
RP Ahmed, W (reprint author), Manchester Metropolitan Univ, Dept Chem & Mat, Chester St, Manchester M1 5GD, Lancs, England.
EM w.ahmed@mmu.ac.uk
RI Polini, Riccardo/D-2289-2017
OI Polini, Riccardo/0000-0002-6551-0883; Ahmed, Waqar/0000-0003-4152-5172
CR Ahmed W, 2000, VACUUM, V56, P153, DOI 10.1016/S0042-207X(99)00147-5
   Amirhaghi S, 2001, SURF COAT TECH, V135, P126, DOI 10.1016/S0257-8972(00)01083-5
   Amirhaghi S, 1999, DIAM RELAT MATER, V8, P845, DOI 10.1016/S0925-9635(98)00319-7
   BORGES CM, 1999, J PROSTHET DENT, P73
   Endler I, 1999, DIAM RELAT MATER, V8, P834, DOI 10.1016/S0925-9635(98)00359-8
   Gabler J, 2000, DIAM RELAT MATER, V9, P921, DOI 10.1016/S0925-9635(99)00278-2
   Guseva MB, 1997, DIAM RELAT MATER, V6, P89, DOI 10.1016/S0925-9635(96)00729-7
   Inspektor A, 1997, INT J REFRACT MET H, V15, P49, DOI 10.1016/S0263-4368(96)00045-5
   Kamiya S, 2000, DIAM RELAT MATER, V9, P191, DOI 10.1016/S0925-9635(00)00229-6
   MAY PW, 1994, DIAM RELAT MATER, V3, P810, DOI 10.1016/0925-9635(94)90274-7
   PINES MS, 1979, J AM DENT ASSOC, V99, P831, DOI 10.14219/jada.archive.1979.0403
   Sein H, 2002, DIAM RELAT MATER, V11, P731, DOI 10.1016/S0925-9635(01)00579-9
   SEIN H, 2003, J SURFACE COATINGS T, V163, P196
   Tang W, 2001, DIAM RELAT MATER, V10, P1700, DOI 10.1016/S0925-9635(01)00398-3
   Wang WL, 1999, DIAM RELAT MATER, V8, P123, DOI 10.1016/S0925-9635(98)00317-3
NR 15
TC 9
Z9 9
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
J9 TRIBOL INT
JI Tribol. Int.
PD NOV-DEC
PY 2004
VL 37
IS 11-12
BP 957
EP 964
DI 10.1016/j.triboint.2004.07.013
PG 8
WC Engineering, Mechanical
SC Engineering
GA 869SE
UT WOS:000225003600013
OA Green Published
DA 2018-10-20
ER

PT J
AU Nsungwa-Sabiiti, J
   Kallander, K
   Nsabagasani, X
   Namusisi, K
   Pariyo, G
   Johansson, A
   Tomson, G
   Peterson, S
AF Nsungwa-Sabiiti, J
   Kallander, K
   Nsabagasani, X
   Namusisi, K
   Pariyo, G
   Johansson, A
   Tomson, G
   Peterson, S
TI Local fever illness classifications: implications for home management of
   malaria strategies
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE paediatric fever; illness classification; malaria; home treatment;
   Uganda
ID CHILDHOOD FEVERS; CONTROL PROGRAM; UGANDA; PERSPECTIVE; CARE;
   PHARMACEUTICALS; PERCEPTIONS; DIAGNOSIS; DISTRICT; SERVICES
AB BACKGROUND The Ugandan Ministry of Health has adopted the WHO Home Based Fever Management strategy (HBM) to improve access to antimalarial drugs for prompt (<24 h) presumptive treatment of all fevers in children under 5 years. Village volunteers will distribute pre-packed antimalarials free of charge to caretakers of febrile children 2 months to 5 years ('Homapaks').
   OBJECTIVE To explore the local understanding and treatment practices for childhood fever illnesses and discuss implications for the HBM strategy.
   METHODS Focus Group Discussions were held with child caretakers in three rural communities in Kasese district, West Uganda, and analysed for content in respect to local illness classifications and associated treatments for childhood fevers.
   RESULTS Local understanding of fever illnesses and associated treatments was complex. Some fever illness classifications were more commonly mentioned, including 'Fever of Mosquito', 'Chest Problem', 'the Disease', 'Stomach Wounds' and 'Jerks', all of which could be biomedical malaria. Although caretakers refer to all these classifications as 'fever' treatment differed; some were seen as requiring urgent professional western treatment and others were considered severe but 'non-western' and would preferentially be treated with traditional remedies.
   CONCLUSIONS The HBM strategy does not address local community understanding of 'fever' and its influence on treatment. While HBM improves drug access, Homapaks are likely to be used for only those fevers where 'western' treatment is perceived appropriate, implying continued delayed and under-treatment of potential malaria. Hence, HBM strategies also need to address local perceptions of febrile illness and adapt information and training material accordingly.
C1 Makerere Univ, Inst Publ Hlth, Kampala, Uganda.
   Karolinska Inst, IHCAR, Div Int Hlth, S-17176 Stockholm, Sweden.
   Makerere Univ, Makerere Inst Social Res, Kampala, Uganda.
   Makerere Univ, Dept Pharmacol & Therapeut, Kampala, Uganda.
   Karolinska Inst, Med Management Ctr, S-10401 Stockholm, Sweden.
   Minist Hlth, Child Hlth Div, Kampala, Uganda.
RP Nsungwa-Sabiiti, J (reprint author), Makerere Univ, Inst Publ Hlth, Box 7072, Kampala, Uganda.
EM jsabiiti@infocom.co.ug; karin.kallander@phs.ki.se;
   xnsabagasani@upholduganda.org; nyamurungi@yahoo.co.in;
   gpariyo@iph.ac.ug; annika.johansson@phs.ki.se; goran.tomson@phs.ki.se;
   stefan.peterson@phs.ki.se
RI Pariyo, George/K-2335-2017
OI Pariyo, George/0000-0002-4411-2309; Peterson, Stefan/0000-0001-7203-3096
CR Adome RO, 1996, POPULAR PILLS COMMUN
   Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x
   Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5
   Bender D E, 1994, Health Transit Rev, V4, P63
   BIRUNGI H, 1994, ESSENT DRUGS MONIT, V18, P11
   Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8
   Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x
   Comoro C, 2003, ACTA TROP, V87, P305, DOI 10.1016/S0001-706X(03)00113-X
   *DISH UG, 2002, KAS DISTR PROF
   Dunyo SK, 2000, T ROY SOC TROP MED H, V94, P285, DOI 10.1016/S0035-9203(00)90324-9
   HARDON A, 2001, APPL HLTH RES ANTHR
   Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x
   Iyun BF, 1996, SOC SCI MED, V42, P437, DOI 10.1016/0277-9536(95)00103-4
   JITTA J, 1996, KAMPALA WOMEN GETTIN
   Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013
   KENGEYAKAYONDO JF, 1994, ACTA TROP, V58, P267, DOI 10.1016/0001-706X(94)90020-5
   Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0
   Kilian AHD, 2003, TROP MED INT HEALTH, V8, P431, DOI 10.1046/j.1365-3156.2003.01044.x
   Lambrechts T, 1999, B WORLD HEALTH ORGAN, V77, P582
   Lubanga RGN, 1997, ACTA TROP, V68, P53, DOI 10.1016/S0001-706X(97)00071-5
   Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x
   *MIN HLTH TANZ, 2004, AD MORB MORT PROJ
   *MIN HLTH UG, 2002, IMPL GUID HOM BAS MA
   MUELA SH, 2000, THESIS U BASEL
   Nuwaha F, 2002, TROP MED INT HEALTH, V7, P462, DOI 10.1046/j.1365-3156.2002.00877.x
   OGDEN J, 1996, KAMPALA WOMEN GETTIN
   Reynolds-Whyte S., 1991, CONTEXT MED DEV COUN, P299
   ROOTH I, 1991, J TROP MED HYG, V94, P195
   SACHS L, 1992, SOC SCI MED, V34, P307, DOI 10.1016/0277-9536(92)90272-R
   Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x
   vanderGeest S, 1997, TROP MED INT HEALTH, V2, P903, DOI 10.1046/j.1365-3156.1997.d01-410.x
   VANDERGEEST S, 1987, SOC SCI MED, V25, P273, DOI 10.1016/0277-9536(87)90230-9
   *WHO, 2002, IMCI AD GUID 1A
   *WHO, 2004, WHOHTMMAL20041096 ID
   WHYTE SR, 1992, CULT MED PSYCHIAT, V16, P163, DOI 10.1007/BF00117017
   Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010
   Winch PJ, 1996, SOC SCI MED, V42, P1057, DOI 10.1016/0277-9536(95)00293-6
NR 37
TC 52
Z9 52
U1 0
U2 3
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD NOV
PY 2004
VL 9
IS 11
BP 1191
EP 1199
DI 10.1111/j.1365-3156.2004.01319.x
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 872DR
UT WOS:000225188100008
PM 15548315
OA Bronze
DA 2018-10-20
ER

PT J
AU Li, SJ
   Yang, R
   Li, S
   Hao, YL
   Cui, YY
   Niinomi, M
   Guo, ZX
AF Li, SJ
   Yang, R
   Li, S
   Hao, YL
   Cui, YY
   Niinomi, M
   Guo, ZX
TI Wear characteristics of Ti-Nb-Ta-Zr and Ti-6Al-4V alloys for biomedical
   applications
SO WEAR
LA English
DT Article
DE titanium-niobium-tantalum-zirconium alloy; biomaterial; wear
ID MOLECULAR-WEIGHT POLYETHYLENE; TITANIUM-ALLOYS; STAINLESS-STEEL;
   CORROSIVE WEAR
AB The influences of heat treatment, variation in Nb content, surface modification and counterface materials on the wear characteristics of new beta type Ti-Nb-Ta-Zr alloys and conventional metallic implant alloy Ti-6Al-4V were investigated, using a reciprocal pin-on-disc wear device in a 0.9% NaCl solution. For the wear test of sliding on stainless steel disc, experimental results show that the wear resistance of Ti-29Nb-13Ta-4.6Zr and Ti-6Al-4V is insensitive to their mechanical properties, such as hardness and ultimate tensile strength. Increase in Nb content results in an improvement of the wear resistance of the beta type alloy to some degree. The wear resistance of Ti-29Nb-13Ta-4.6Zr improved significantly after oxidation treatment, due to the presence of Nb2O5 oxide particles on the diffusion hardened surface of the alloy. For wear test of sliding on ultra-high molecular weight polyethylene (UHMWPE) and bone of pig, the wear losses of both Ti-Nb-Ta-Zr and Ti-6Al-4V are much less compared with that sliding on stainless steel and there is almost no wear on the surface of oxided Ti-29Nb-13Ta-4.6Zr. (C) 2004 Elsevier B.V. All rights reserved.
C1 Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Univ London Queen Mary & Westfield Coll, Dept Mat, London E1 4NS, England.
RP Yang, R (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
EM ryang@imr.ac.cn
RI Guo, Zheng Xiao/C-1706-2009; Niinomi, Mitsuo/B-5965-2011
OI Guo, Zheng Xiao/0000-0001-5404-3215; 
CR ALLEN C, 1981, WEAR, V74, P287, DOI 10.1016/0043-1648(81)90169-1
   BLACK J, 1992, BIOL PERFORMANCE MAT
   BLANCHET TA, 1989, TRIBOL T, V32, P371, DOI 10.1080/10402008908981902
   GROBLER PE, 1990, WEAR, V135, P339, DOI 10.1016/0043-1648(90)90035-9
   IJZERMANS AB, 1969, WEAR, V14, P397, DOI 10.1016/0043-1648(69)90002-7
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   Li HD, 1990, SURFACE INTERFACE MA, P106
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MARCUS K, 1991, WEAR, V151, P323, DOI 10.1016/0043-1648(91)90259-W
   MARCUS K, 1993, SOV J FRICT WEAR, V14, P27
   Mishra A. K., 1996, ASTM STP, V1272, P96
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   PARR GR, 1985, J PROSTHET DENT, V54, P410, DOI 10.1016/0022-3913(85)90562-1
   PETERSON MB, 1989, INT8617231 NSF CHIN
   PETERSON MB, 1989, P 16 LEEDS LYON S VI
   PETERSON MB, 1992, 124248 NTIS ADA US D
   Poggie RA, 1996, MATER MANUF PROCESS, V11, P185, DOI 10.1080/10426919608947472
   RODENBECK GM, 1992, WEAR, V154, P305
   SILVER FH, 1994, BIOMATERIALS MED DEV, P5
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Song Y, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P273
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   TUMMLER HP, 1985, TITANIUM 84 SCI TECH, V2, P1335
   Wagner CD, 1979, HDB XRAY PHOTOELECTR
   Wang KK, 1996, ASTM STP, V1272, P76
   ZWICKER J, 1985, TITANIUM 84 SCI TECH, V2, P1343
NR 26
TC 67
Z9 74
U1 2
U2 41
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD NOV
PY 2004
VL 257
IS 9-10
BP 869
EP 876
DI 10.1016/j.wear.2004.04.001
PG 8
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 866BH
UT WOS:000224747400002
DA 2018-10-20
ER

PT J
AU Zhou, YL
   Niinomi, M
   Akahori, T
AF Zhou, YL
   Niinomi, M
   Akahori, T
TI Decomposition of martensite alpha '' during aging treatments and
   resulting mechanical properties of Ti-Ta alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Young's modulus; Ti-Ta alloy; aging treatment; mechanical property;
   biomedical implant material
ID TITANIUM-TANTALUM ALLOYS; YOUNGS MODULUS; BIOMEDICAL APPLICATIONS;
   TENSILE PROPERTIES; HEAT-TREATMENT; CAST-IRON; BIOCOMPATIBILITY;
   CORROSION; IMPLANTS; TI-29NB-13TA-4.6ZR
AB Effects of Ta content and aging temperature on the decomposition of martensite alpha" in the Ti-Ta alloys with Ta contents from 30 mass% to 50 mass% and the resulting mechanical properties, including the dynamic Young's modulus, were investigated for biomedical applications. The microstructures were examined using a scanning electron microscopy (SEM), a transmission electron microscopy (TEM) and an X-ray diffraction (XRD) analysis. The decomposition of martensite alpha" phase in the Ti-Ta alloys depends on both Ta content and aging temperature. Various microstructures such as alpha, (beta + omega) and (alpha + beta) phases precipitate in the Ti-Ta alloys after the aging treatments are performed between 723 K and 873 K for 259.2 ks. The dynamic Young's modulus and mechanical properties of the Ti-Ta alloys are found to be sensitive to the microstructures caused by Ta content and aging temperature. The Ti-30% Ta alloy with alpha phase values much lower modulus and higher strength-to-modulus ratio than the currently used implant biomaterials, and thus has a great potential to become a new candidate alloy for biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Zhou, YL (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
EM shuu@sp-mac4.tutpse.tut.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Bagariatskii IA, 1958, SOV PHYS DOKL, V3, P1014
   Bania P. J., 1984, BETA TITANIUM ALLOYS, P209
   Boccaccini AR, 1997, Z METALLKD, V88, P23
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   BOYER R, 1994, MAT PROPERTIES HDB T
   BOYER RR, 1997, MINERAL METALS MAT, P349
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   BYWATER KA, 1972, PHILOS MAG, V25, P1275, DOI 10.1080/14786437208223853
   BYWATER KA, 1972, PHILOS MAG, V25, P1249, DOI 10.1080/14786437208223852
   COLLINGS EW, 1984, PHYSICAL METALLURGY
   Cui Z., 2000, METALLOGRAPHY HEAT T
   DAVIS R, 1979, ACTA METALL MATER, V27, P1041, DOI 10.1016/0001-6160(79)90192-5
   FAN ZY, 1993, SCRIPTA METALL MATER, V29, P1427, DOI 10.1016/0956-716X(93)90331-L
   Fedotov S G, 1986, PHYS MET METALLOGR, V62, P109
   GANESAN P, 1974, J LESS-COMMON MET, V34, P209, DOI 10.1016/0022-5088(74)90161-1
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   HUNT M, 1991, MATER ENG, V113, P27
   LEDBETTER H, 1992, Z METALLKD, V83, P195
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   LEE YT, 1991, METALL TRANS A, V22, P709, DOI 10.1007/BF02670293
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LOPATA SL, 1965, T METALL SOC AIME, V233, P288
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   MATTHEW J, 1982, TITANIUM TITANIUM AL
   MENDIRATTA MG, 1975, METALL TRANS, VA  6, P940, DOI 10.1007/BF02672324
   MURAKAMI Y, 1980, TITANIUM 80 SCI TECH, P153
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   PILLIAR RM, 1991, MRS BULL, V16, P55
   PLENK H, 1990, CONCISE ENCY MED DEN, P355
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   SOLAR RJ, 1979, J BIOMED MATER RES, V13, P217, DOI 10.1002/jbm.820130206
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, V274, P202
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   WILLIAMS JC, 1970, METALL TRANS, V1, P2648
   WOOD JR, 1997, MINERALS METALS MAT, P421
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 45
TC 82
Z9 89
U1 2
U2 26
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD OCT 25
PY 2004
VL 384
IS 1-2
BP 92
EP 101
DI 10.1016/j.msea.2004.05.084
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 862KK
UT WOS:000224489300012
DA 2018-10-20
ER

PT J
AU Baranoski, GVG
   Krishnaswamy, A
   Kimmel, B
AF Baranoski, GVG
   Krishnaswamy, A
   Kimmel, B
TI An investigation on the use of data-driven scattering profiles in Monte
   Carlo simulations of ultraviolet light propagation in skin tissues
SO PHYSICS IN MEDICINE AND BIOLOGY
LA English
DT Article
ID OPTICAL-PROPERTIES; MODEL; RADIATION; CELLS
AB Ultraviolet light can affect the appearance and medical condition of the human skin by triggering biophysical processes such as erythema, melanogenesis, photoaging and carcinogenesis. The evolution of these processes is related to the amount of ultraviolet light absorbed by skin pigments. This amount may vary with the wavelength and path length of the radiation that is propagated within the skin tissues. For many years, biomedical researchers have been investigating the propagation of ultraviolet light in skin tissues through Monte Carlo simulations. The scattering of the incident radiation by tissue internal structures, a key component in this process, is usually approximated by functions without a plausible connection with the underlying physical phenomena. In this paper, we examine the origins of such an approach, and question its generalized use with respect to wavelengths and biological materials for which there is no supporting data available. Furthermore, we perform comparisons to demonstrate that the accuracy and predictability of Monte Carlo simulations of ultraviolet propagation in skin tissues can be improved by using a data-driven approach to represent the scattering profile of these tissues.
C1 Univ Waterloo, Nat Phenomena Simulat Grp, Sch Comp Sci, Waterloo, ON N2L 3G1, Canada.
RP Baranoski, GVG (reprint author), Univ Waterloo, Nat Phenomena Simulat Grp, Sch Comp Sci, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
EM gvgbaran@curumin.math.uwaterloo.ca
RI Baranoski, Gladimir/A-1944-2008
CR ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191
   BARANOSKI, 2003, CS200345 U WAT SCH C
   BARTH J, 1999, CIE 134 COLLECTION P
   BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x
   BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P231, DOI 10.1111/j.1751-1097.1984.tb04581.x
   Burden R., 1993, NUMERICAL ANAL
   Churmakov DY, 2003, J PHYS D APPL PHYS, V36, P1722, DOI 10.1088/0022-3727/36/14/311
   Cotton SD, 1996, P SOC PHOTO-OPT INS, V2708, P814, DOI 10.1117/12.237846
   CULLEN JJ, 1994, PHOTOSYNTH RES, V39, P303, DOI 10.1007/BF00014589
   DIFFEY BL, 1983, PHYS MED BIOL, V28, P647, DOI 10.1088/0031-9155/28/6/005
   Dunn A, 1996, IEEE J SEL TOP QUANT, V2, P898, DOI 10.1109/2944.577313
   Everett M A, 1966, Photochem Photobiol, V5, P533
   FITZPATRICK T, 1995, ITS ROLE HUMAN PHOTO, P177
   FLOCK ST, 1989, IEEE T BIO-MED ENG, V36, P1162, DOI 10.1109/TBME.1989.1173624
   Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246
   Jacques S. L., 1987, Lasers in the Life Sciences, V1, P309
   KELFKENS G, 1989, PHYS MED BIOL, V34, P599, DOI 10.1088/0031-9155/34/5/004
   KOLLIAS N, 1995, ITS ROLE HUMAN PHOTO, P31
   Krishnaswamy A., 2004, J GRAPHICS TOOLS, V9, P31
   KRISHNASWAMY A, 2002, CS200221 U WAT SCH C
   Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470
   Meglinski IV, 2003, COMPUT METH PROG BIO, V70, P179, DOI 10.1016/S0169-2607(02)00099-8
   METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232
   Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586
   Nicodemus F.E., 1992, PHYS BASED VISION PR, P94
   Pathak M. A., 1974, SUNLIGHT MAN, P725
   PATHAKM, 1995, ITS ROLE HUMAN PHOTO, P125
   Prahl S., 1988, THESIS U TEXAS AUSTI
   Prahl SA, 1989, P SPIE IS, V5, P102
   REYNOLDS LO, 1980, J OPT SOC AM, V70, P1206, DOI 10.1364/JOSA.70.001206
   Shimada M, 2001, PHYS MED BIOL, V46, P2397, DOI 10.1088/0031-9155/46/9/309
   Simpson CR, 1998, PHYS MED BIOL, V43, P2465, DOI 10.1088/0031-9155/43/9/003
   STANZL K, 1995, ITS ROLE HUMAN PHOTO, P59
   Talreja P.S., 2001, AAPS PHARMSCI, V3, P1
   TAYLOR HR, 1998, NEW ENGL J MED, V319, P1429
   Tessendorf J., 1994, SPIE CHARACTERIZATIO, P75
   Tuchin V, 2000, TISSUE OPTICS LIGHT
   van der Leun J., 1966, THESIS U UTRECHT NET
   Van Der Leun Jan C., 1993, P95
   VANGEMERT MJC, 1989, IEEE T BIO-MED ENG, V36, P1146, DOI 10.1109/10.42108
   WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P493, DOI 10.1111/j.1751-1097.1981.tb09030.x
   WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F
   WILSON BC, 1983, MED PHYS, V10, P824, DOI 10.1118/1.595361
   WITT A, 1977, ASTROPHYS J SUPPL SE, V15, P1
   YOON G, 1987, IEEE J QUANTUM ELECT, V23, P1721, DOI 10.1109/JQE.1987.1073224
   Zimnyakov D. A., 2002, HDB OPTICAL MED DIAG, P987
NR 46
TC 3
Z9 3
U1 0
U2 1
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0031-9155
J9 PHYS MED BIOL
JI Phys. Med. Biol.
PD OCT 21
PY 2004
VL 49
IS 20
BP 4799
EP 4809
AR PII S0031-9155(04)81824-4
DI 10.1088/0031-9155/49/4799
PG 11
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 869EE
UT WOS:000224965400011
PM 15566176
DA 2018-10-20
ER

PT J
AU Rapacz-Kmita, A
   Slosarczyk, A
   Paszkiewicz, Z
   Paluszkiewicz, C
AF Rapacz-Kmita, A
   Slosarczyk, A
   Paszkiewicz, Z
   Paluszkiewicz, C
TI Phase stability of hydroxyapatite-zirconia (HAp-ZrO2) composites for
   bone replacement
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Molecular Spectroscopy
CY SEP 11-14, 2003
CL Wroclaw, POLAND
SP Matl State Comm Sci Res, Univ Wroclaw, Polish Acad Sci, Inst Low Temperature & Structure Res
DE hydroxyapatite; hydroxyapatite composite; zirconia; X-ray diffraction;
   fourier transform infrared spectroscopy
ID THERMAL-DECOMPOSITION; COATED HYDROXYAPATITE; MECHANICAL-PROPERTIES
AB During the production of biomedical hydroxyapatite-zirconia (HAp-ZrO2) composites new phases which determine the biocompatibility of implant materials may occur in the system. These phenomena may be associated both with the phase decomposition of hydroxyapatite itself and the interactions between the matrix material and particles of reinforcing zirconia phase. The work deals with the investigations of phase stability of HAp-ZrO2 composites at high temperature. The composites studied have been in the form of dense sinters obtained by the hot pressing process. (C) 2004 Elsevier B.V. All rights reserved.
C1 Jagiellonian Univ, Reg Lab Physicochem, PL-30060 Krakow, Poland.
   AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
RP Paluszkiewicz, C (reprint author), Jagiellonian Univ, Reg Lab Physicochem, Ul Ingardena 3, PL-30060 Krakow, Poland.
EM kmita@uci.agh.edu.pl; aslosar@uci.agh.edu.pl; ucpalusz@cyf-kr.edu.pl
CR ANDRONESCU E, 2002, KEY ENG MAT, V206
   Bucko MM, 1995, J AM CERAM SOC, V78, P3397, DOI 10.1111/j.1151-2916.1995.tb07985.x
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   Heimann RB, 1997, J MATER SCI LETT, V16, P437, DOI 10.1023/A:1018591605388
   LI J, 1993, J MATER SCI-MATER M, V4, P50, DOI 10.1007/BF00122977
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Matsuno T, 2000, J MATER SCI LETT, V19, P573, DOI 10.1023/A:1006722110462
   Pampuch R., 1992, NAUKA PROCESACH CERA
   Park E, 1998, MATER LETT, V36, P38, DOI 10.1016/S0167-577X(97)00287-5
   PYDA W, 2001, COMPOSITES, V1, P2
   Silva VV, 2001, COMPOS SCI TECHNOL, V61, P301, DOI 10.1016/S0266-3538(00)00222-0
   STUBICAN VS, 1981, ADV CERAM, V3
NR 12
TC 38
Z9 42
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD OCT 18
PY 2004
VL 704
IS 1-3
SI SI
BP 333
EP 340
DI 10.1016/j.molstruc.2004.02.047
PG 8
WC Chemistry, Physical
SC Chemistry
GA 847BW
UT WOS:000223364800052
DA 2018-10-20
ER

PT J
AU Zhu, HG
   Ji, J
   Barbosa, MA
   Shen, JC
AF Zhu, HG
   Ji, J
   Barbosa, MA
   Shen, JC
TI Protein electrostatic self-assembly on poly(DL-Lactide) scaffold to
   promote osteoblast growth
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell adhesion; cell-material interactions; surface modification; tissue
   engineering
ID ALTERNATE LAYERS; ULTRATHIN FILMS; POLYELECTROLYTES; ADSORPTION; CELLS;
   PROLIFERATION; REFLECTIVITY; BIOMATERIALS; SURFACES; NEUTRON
AB The development of protein coating on 3D biodegradable scaffold based on electrostatic self-assembly (ESA) to promote osteoblast growth is reported. Poly (ethylenimine) (PEI) was employed to obtain a stable positively charged surface on poly(DL-lactide) (PDL-LA) substrate. An extracellular-matrix (ECM)-like biomacromolecule, gelatin, was chosen as the polyelectrolyte to deposit on the activated PDL-LA substrate via ESA technique. Osteoblast (MC3T3) was then cultured on unmodified and gelatin-modified PDL-LA scaffolds. Osteoblast testing regarding total intracellular protein content, total DNA content, cell activity, and cell morphology on the ECM-like multilayer-modified PDL-LA scaffold showed that osteoblast growth was promoted. It will be easy to replace the gelatin with osteoinductive proteins or other pollyelectrolytes to promote specific osteoblast functions. In comparison with conventional coating methods, polyelectrolyte multilayers are easy and stable to prepare. They may be a good choice for the surface modification of complex biomedical devices, especially for the 3D tissue-engineering scaffold. These very flexible systems allow broad medical applications for drug delivery and tissue engineering. (C) 2004 Wiley Periodicals, Inc.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
   INEB, Lab Biomat, Oporto, Portugal.
RP Ji, J (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
EM jianji@mail.hz.zj.cn
RI Zhu, Huiguang/A-8591-2010
OI Barbosa, Mario/0000-0003-3568-7482; Ji, Jian/0000-0001-9870-4038
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, BER BUNSEN PHYS CHEM, V95, P1430, DOI 10.1002/bbpc.19910951122
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   HONG JD, 1993, PROG COLL POL SCI S, V93, P98
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KLEINFELD ER, 1994, SCIENCE, V265, P370, DOI 10.1126/science.265.5170.370
   KORNEEV D, 1995, PHYSICA B, V213, P954, DOI 10.1016/0921-4526(95)00333-5
   LASCHEWSKY A, 1997, EUR CHEM CHRON, V2, P13
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020
   LVOV Y, 1994, LANGMUIR, V10, P4232, DOI 10.1021/la00023a052
   Mikos A. G., 1996, U.S. patent, Patent No. [5,514,378, 5514378]
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Park SY, 2001, MACROMOLECULES, V34, P3384, DOI 10.1021/ma001601d
   Sano M, 1996, ANNU REV MATER SCI, V26, P153
   SCHMITT J, 1993, MACROMOLECULES, V26, P7058, DOI 10.1021/ma00077a052
   *SIGMA, 1998, PROD INF DNA QUANT K
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sullivan DM, 2001, J AM CHEM SOC, V123, P11805, DOI 10.1021/ja016536h
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X
   Zhu HG, 2003, BIOMACROMOLECULES, V4, P378, DOI 10.1021/bm025773p
   Zhu YB, 2003, BIOMACROMOLECULES, V4, P446, DOI 10.1021/bm025723k
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 29
TC 24
Z9 25
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT 15
PY 2004
VL 71B
IS 1
BP 159
EP 165
DI 10.1002/jbm.b.30080
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 858KK
UT WOS:000224190500020
PM 15368240
DA 2018-10-20
ER

PT J
AU Bureau, B
   Zhang, XH
   Smektala, F
   Adam, JL
   Troles, J
   Ma, HL
   Boussard-Pledel, C
   Lucas, J
   Lucas, P
   Le Coq, D
   Riley, MR
   Simmons, JH
AF Bureau, B
   Zhang, XH
   Smektala, F
   Adam, JL
   Troles, J
   Ma, HL
   Boussard-Pledel, C
   Lucas, J
   Lucas, P
   Le Coq, D
   Riley, MR
   Simmons, JH
TI Recent advances in chalcogenide glasses
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on the Physics of Non-Crystalline Solids
   (PNCS)
CY JUL 13-17, 2003
CL Univ Parma, Parma, ITALY
HO Univ Parma
AB Compared to oxide-based glasses, vitreous materials involving chalcogens form a rather new family of glasses which have received attention, mainly because of their transmission in the mid-infrared. Indeed as low phonon compounds, these heavy-anion glasses allow the fabrication of molded optics for infrared cameras as well as infrared fibers operating in a large spectral range. These waveguides, when correctly tapered, allows the development of a new generation of sensitive evanescent-wave optical sensors which have been used for biomedical applications. Here we will focus on the spectral analysis of biomolecules present in human lung cells by measuring their infrared signatures. Because they contain heavy polarizable anions as well as lone-pair electrons, these glasses exhibit very large non-linear properties compared to silica and are candidates for fast optical switching and signal regeneration in telecom. Due to the technological interest in chalcogenide glasses, more information is needed on their structural organization and Se-77 MR spectroscopy appears to be a useful tool for checking the local environment of the Se atoms. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Rennes 1, CNRS, Lab Verres & Ceram, UMR 6512, F-35042 Rennes, France.
   Univ Arizona, Arizona Mat Lab, Tucson, AZ 85712 USA.
RP Bureau, B (reprint author), Univ Rennes 1, CNRS, Lab Verres & Ceram, UMR 6512, Campus Beaulieu, F-35042 Rennes, France.
EM bruno.bureau@univ-rennes1.fr
RI SMEKTALA, Frederic/T-2155-2017
OI SMEKTALA, Frederic/0000-0002-6787-9289; Le Coq,
   David/0000-0001-7898-3463; ZHANG, Xiang-Hua/0000-0002-2180-6543
CR Bureau B, 2003, SOLID STATE SCI, V5, P219, DOI 10.1016/S1293-2558(02)00102-4
   Harbold JM, 2002, IEEE PHOTONIC TECH L, V14, P822, DOI 10.1109/LPT.2002.1003105
   Hocde S, 2001, SOLID STATE SCI, V3, P279, DOI 10.1016/S1293-2558(00)01135-3
   Keirsse J, 2003, VIB SPECTROSC, V32, P23, DOI 10.1016/S0924-2031(03)00044-4
   KEIRSSE J, 2003, NONCRYST SOLIDS, V327, P430
   KOKORINA VF, 1996, LASER OPTICAL SCI TE
   Le Coq D, 2001, INT J INORG MATER, V3, P233, DOI 10.1016/S1466-6049(01)00007-1
   Naumann D, 2000, INFRARED SPECTROSCOP, P102
   Quemard C, 2001, J PHYS CHEM SOLIDS, V62, P1435, DOI 10.1016/S0022-3697(01)00059-2
   RIGAS B, 1990, P NATL ACAD SCI USA, V87, P8140, DOI 10.1073/pnas.87.20.8140
   Schardt CR, 2000, J NON-CRYST SOLIDS, V274, P23, DOI 10.1016/S0022-3093(00)00200-3
   Tanaka K, 2002, CR CHIM, V5, P805, DOI 10.1016/S1631-0748(02)01441-8
NR 12
TC 212
Z9 220
U1 10
U2 70
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD OCT 15
PY 2004
VL 345
BP 276
EP 283
DI 10.1016/j.jnoncrysol.2004.08.096
PG 8
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 877PT
UT WOS:000225583200054
DA 2018-10-20
ER

PT J
AU Xiao, H
   Nayak, BR
   Lowe, TL
AF Xiao, H
   Nayak, BR
   Lowe, TL
TI Synthesis and characterization of novel
   thermoresponsive-co-biodegradable hydrogels composed of
   N-isopropylacrylamide, poly(L-lactic acid), and dextran
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE hydrogels; thermoresponsive; biodegradable; LCST; N-isopropylacrylamide;
   poly(L-lactic acid); dextran; dynamic swelling; drug delivery; tissue
   engineering
ID DRUG-DELIVERY; MOLECULAR-WEIGHT; COPOLYMER GELS; IN-VITRO; SENSITIVE
   HYDROGELS; SWELLING PROPERTIES; CONTROLLED-RELEASE; POLYMER NETWORKS;
   RESPONSIVE GELS; LACTIC-ACID
AB A series of novel multifunctional hydrogels that combined the merits of both thermoresponsive and biodegradable polymeric materials were designed, synthesized, and characterized. The hydrogels were copolymeric networks composed of Nisopropylacrylamide (NIPAAM) as a thermoresponsive component, poly(L-lactic acid) (PLLA) as a hydrolytically degradable and hydrophobic component, and dextran as an enzymatically degradable and hydrophilic component. The chemical structures of the hydrogels were characterized by an attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) technique. The hydrogels were thermoresponsive, showing a lower critical solution temperature (LCST) at approximately 32 degreesC, and their swelling properties strongly depended on temperature changes, the balance of the hydrophilic/hydrophobic components, and the degradation of the PLLA component. The degradation of the hydrogels caused by hydrolytic cleavage of ester bonds in the PLLA component was faster at 25 degreesC below the LCST than at 37 degreesC above the LCST, determined by the ATR-FTIR technique. Due to their multifunctional properties, the designed hydrogels show great potential for biomedical applications, including drug delivery and tissue engineering. (C) 2004 Wiley Periodicals, Inc.
C1 Penn State Univ, Dept Surg, Hershey, PA 17033 USA.
   Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
   Penn State Univ, Dept Mat Sci & Engn, Hershey, PA 17033 USA.
RP Lowe, TL (reprint author), Penn State Univ, Dept Surg, Hershey, PA 17033 USA.
EM tlowe@psu.edu
CR Berkland C, 2001, J CONTROL RELEASE, V73, P59, DOI 10.1016/S0168-3659(01)00289-9
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Cadee JA, 2000, J BIOMED MATER RES, V50, P397
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Crotts G, 1998, J MICROENCAPSUL, V15, P699, DOI 10.3109/02652049809008253
   Dunne M, 2000, BIOMATERIALS, V21, P1659, DOI 10.1016/S0142-9612(00)00040-5
   Finne A, 2003, J POLYM SCI POL CHEM, V41, P1296, DOI 10.1002/pola.10682
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Guilherme MR, 2003, POLYMER, V44, P4213, DOI 10.1016/S0032-3861(03)00370-7
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   Huang L, 1999, J APPL POLYM SCI, V74, P937, DOI 10.1002/(SICI)1097-4628(19991024)74:4<937::AID-APP20>3.0.CO;2-K
   Iwasaki Y, 2003, J POLYM SCI POL CHEM, V41, P68, DOI 10.1002/pola.10554
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jiang CF, 2001, J POLYM SCI POL CHEM, V39, P3780, DOI 10.1002/pola.10023
   KAMATH KR, 1993, ADV DRUG DELIVER REV, V11, P59, DOI 10.1016/0169-409X(93)90027-2
   KANEKO Y, 1995, J MEMBRANE SCI, V101, P13, DOI 10.1016/0376-7388(94)00268-4
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Katime I, 2001, POLYM INT, V50, P869, DOI 10.1002/pi.707
   KENLEY RA, 1987, MACROMOLECULES, V20, P2398, DOI 10.1021/ma00176a012
   Kurian P, 2002, J POLYM SCI POL CHEM, V40, P3093, DOI 10.1002/pola.10391
   Kurian P, 2002, J POLYM SCI POL CHEM, V40, P1209, DOI 10.1002/pola/10209
   Kurisawa M, 1998, MACROMOL CHEM PHYSIC, V199, P705, DOI 10.1002/(SICI)1521-3935(19980401)199:4<705::AID-MACP705>3.3.CO;2-0
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Lee WF, 2001, J APPL POLYM SCI, V81, P2888, DOI 10.1002/app.1739
   Lowe TL, 1999, MACROMOL CHEM PHYSIC, V200, P51, DOI 10.1002/(SICI)1521-3935(19990101)200:1<51::AID-MACP51>3.0.CO;2-H
   Lowe TL, 1999, LANGMUIR, V15, P4259, DOI 10.1021/la981194n
   Meyer T, 2002, J POLYM SCI POL CHEM, V40, P3144, DOI 10.1002/pola.10400
   Neradovic D, 1999, MACROMOL RAPID COMM, V20, P577, DOI 10.1002/(SICI)1521-3927(19991101)20:11<577::AID-MARC577>3.0.CO;2-D
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1
   PARK TG, 1995, J CONTROL RELEASE, V33, P211, DOI 10.1016/0168-3659(94)00084-8
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Ramkissoon-Ganorkar C, 1999, J CONTROL RELEASE, V59, P287, DOI 10.1016/S0168-3659(99)00006-1
   Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449
   Shibayama M, 1996, MACROMOLECULES, V29, P2019, DOI 10.1021/ma951390q
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Tsuji F, 2002, POLYMER, V43, P1789
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   vanDijkWolthuis WNE, 1997, POLYMER, V38, P6235, DOI 10.1016/S0032-3861(97)00189-4
   Vernon B, 1996, MACROMOL SYMP, V109, P155, DOI 10.1002/masy.19961090115
   Vernon B, 2000, J BIOMED MATER RES, V51, P69
   Vishalakshi B, 2003, J POLYM SCI POL CHEM, V41, P2288, DOI 10.1002/pola.10771
   Wang CH, 2002, J POLYM SCI POL CHEM, V40, P1112, DOI 10.1002/pola.10201
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1375, DOI 10.1021/bm025652p
   WU XS, 1992, J POLYM SCI POL CHEM, V30, P2121, DOI 10.1002/pola.1992.080301005
   Zhang JT, 2004, J POLYM SCI POL CHEM, V42, P1249, DOI 10.1002/pola.11092
   Zhang YL, 2002, J MATER SCI-MATER M, V13, P773, DOI 10.1023/A:1016123125046
   Zhang YL, 2002, J BIOMATER APPL, V16, P305, DOI 10.1106/088532802024248
   Zhang YL, 2002, J BIOMED MATER RES, V59, P318, DOI 10.1002/jbm.1248
   Zhang YL, 2000, J POLYM SCI POL CHEM, V38, P2392, DOI 10.1002/1099-0518(20000701)38:13<2392::AID-POLA120>3.0.CO;2-P
   Zhang YL, 1999, J POLYM SCI POL CHEM, V37, P4554, DOI 10.1002/(SICI)1099-0518(19991215)37:24<4554::AID-POLA13>3.0.CO;2-T
NR 53
TC 6
Z9 6
U1 1
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD OCT 15
PY 2004
VL 42
IS 20
BP 5054
EP 5066
DI 10.1002/pola.20327
PG 13
WC Polymer Science
SC Polymer Science
GA 858YS
UT WOS:000224229400003
DA 2018-10-20
ER

PT J
AU Kholodovych, V
   Smith, JR
   Knight, D
   Abramson, S
   Kohn, J
   Welsh, WJ
AF Kholodovych, V
   Smith, JR
   Knight, D
   Abramson, S
   Kohn, J
   Welsh, WJ
TI Accurate predictions of cellular response using QSPR: a feasibility test
   of rational design of polymeric biomaterials
SO POLYMER
LA English
DT Article
DE biomaterials; tyrosine degradable polyarylates; QSPR model
ID TYROSINE-DERIVED POLYCARBONATES; HIV-1 PROTEASE INHIBITORS; DEGRADABLE
   BIOMATERIALS; POLY(ETHER CARBONATE)S; STATISTICAL QUALITY;
   ESTROGEN-RECEPTOR; MODELS; CHEMISTRY; BINDING; FIBRINOGEN
AB We present a Surrogate (semi-empirical) model for prediction of cellular response to the surfaces of biodegradable polymers that have been designed for tissue engineering applications. The predictions of our model, when tested against experimental results, show a high degree of accuracy that is sufficient for rational design of polymeric materials for biomedical applications. The model was determined by fitting experimental data for a series of 62 polyarylates to a small number of polymer structure-based 'molecular descriptors' using the technique of partial least squares (PLS) regression. While PLS is commonly applied in quantitative structure activity relationship (QSAR) analysis employed in the pharmaceutical industry, this study marks the first time the technique has been extended to the problem of biomaterials discovery/design. Quantitative predictions of cellular response to six polymers (untested prior to model building) concurred with experiment within 15.8% on average. This performance compares quite favorably with the overall variation in experimental values for the library of polyarylates. Examination of the PLS 'loadings' reveals those structure-based features most associated with variations in the polymer performance properties, thereby providing direct guidance to the synthetic chemist in biomaterials design. (C) 2004 Published by Elsevier Ltd.
C1 Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.
   Univ Med & Dent New Jersey, Inst Informat, Piscataway, NJ 08854 USA.
   Univ Med & Dent New Jersey, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA.
   Univ Med & Dent New Jersey, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
   Rutgers State Univ, Dept Mech & Aerosp Engn, New Brunswick, NJ 08903 USA.
RP Kholodovych, V (reprint author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.
EM welshwj@umdnj.edu
CR Anderson T. W., 2003, INTRO MULTIVARIATE S
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   BROCCHINI S, 1997, PRELIMINARY STUDIES
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   DRAPER NR, 1981, APPL REGRESSION ANAL
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   HARNETT D, 1980, INTRO STAT ANAL
   James K, 1999, BIOMATERIALS, V20, P2203, DOI 10.1016/S0142-9612(99)00151-9
   Jayatilleke PRN, 2000, J MED CHEM, V43, P4446, DOI 10.1021/jm9905357
   Joliffe IT, 1986, PRINCIPLES COMPONENT
   KNIGHT D, 2003, DATA DRIVEN DESIGN O, P329
   Knight D., 2002, 20025636 AIAA
   LEFANTZI S, 2001, 20013294 AIAA
   LOWE G, 1995, JCS REV, P309
   MALINOWSKI ER, 1980, FACTOR ANAL CHEM
   MENGER FM, 1995, J ORG CHEM, V60, P6666, DOI 10.1021/jo00126a008
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Nair AC, 2002, J MED CHEM, V45, P973, DOI 10.1021/jm010417v
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   Puri S, 2002, J CHEM INF COMP SCI, V42, P109, DOI 10.1021/ci010081y
   PURI S, 2002, J CHEM INF COMP SCI, V42, P209
   Reynolds CH, 1999, J COMB CHEM, V1, P297, DOI 10.1021/cc9900044
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   TODESCHINI R, 2003, DRAGON WEB VERSION
   Tong W, 1998, J CHEM INF COMP SCI, V38, P669, DOI 10.1021/ci980008g
   Tong WD, 1997, ENDOCRINOLOGY, V138, P4022, DOI 10.1210/en.138.9.4022
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   WOLD S, 1983, ACTA PHARMACOL TOX, V52, P158
   Wold S, 1984, CHEMOMETRICS MATH ST, P17
   Wold S, 1995, METHODS PRINCIPLES M
   Yu C, 1999, BIOMATERIALS, V20, P265, DOI 10.1016/S0142-9612(98)00170-7
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
   Yu SJ, 2002, CHEM RES TOXICOL, V15, P1229, DOI 10.1021/tx0255875
NR 36
TC 38
Z9 40
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD OCT 13
PY 2004
VL 45
IS 22
BP 7367
EP 7379
DI 10.1016/j.polymer.2004.09.002
PG 13
WC Polymer Science
SC Polymer Science
GA 862NO
UT WOS:000224497900001
OA Other Gold
DA 2018-10-20
ER

PT J
AU Murata, H
   Chang, BJ
   Prucker, O
   Dahm, M
   Ruhe, J
AF Murata, H
   Chang, BJ
   Prucker, O
   Dahm, M
   Ruhe, J
TI Polymeric coatings for biomedical devices
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT INternational Conference on BIOSURF V - Functional Polymeric Surfaces in
   Biotechnology
CY SEP 25-26, 2003
CL Univ Zurich, Zurich, SWITZERLAND
HO Univ Zurich
DE coatings; biological compounds; glass surfaces; self-assembly;
   photochemistry
ID CELL-ADHESION; CARBON-BLACK; MONOLAYERS; SURFACES; BRUSHES
AB To improve the properties of materials in biomedical applications and to allow a better interaction of the medical device with the biological system surrounding it, frequently polymeric coatings are applied. However, the adhesion of the coating to the substrate usually poses a problem as the materials involved have either rather inert surfaces or strongly varying surface chemistries. We describe a new approach which allows to attach a wide variety of polymer films to organic substrates either of polymeric or biological origin. The technique is based on photochemical processes occurring in benzophenone group containing polymers, which lead to simultaneous crosslinking of the polymer in the coating and surface-attachment of the forming polymer network. The synthesis and characterization of monolayers and surface-attached polymer networks through this route are described and possible applications of this approach in the biomedical area are discussed. (C) 2004 Published by Elsevier B.V.
C1 Univ Freiburg, IMTEK, D-79110 Freiburg, Germany.
   Univ Hosp Mainz, Dept Cardiothorac & Vasc Surg, Mainz, Germany.
RP Ruhe, J (reprint author), Univ Freiburg, IMTEK, Kohler Alee 103, D-79110 Freiburg, Germany.
EM ruehe@imtek.de
RI Prucker, Oswald/E-3578-2010; Ruehe, Juergen/G-6157-2012
OI Prucker, Oswald/0000-0001-8683-7730; 
CR BRIDGER K, 1980, EUR POLYM J, V16, P1017, DOI 10.1016/0014-3057(80)90185-8
   Chang BJ, 2002, COLLOID SURFACE A, V198, P519, DOI 10.1016/S0927-7757(01)00952-9
   Dahm M, 2001, ANN THORAC SURG, V71, pS437, DOI 10.1016/S0003-4975(01)02513-9
   KRENKLER KP, 1978, ANGEW MAKROMOL CHEM, V53, P101
   LAIBLE R, 1980, ADV COLLOID INTERFAC, V13, P65, DOI 10.1016/0001-8686(80)87002-3
   Ouada H. Ben, 1988, J COLLOID INTERF SCI, V122, P441
   Prucker O, 1999, J AM CHEM SOC, V121, P8766, DOI 10.1021/ja990962+
   PRUCKER O, 2003, EUR COAT J, P40
   Ratner BD, 1996, INTRO MAT MED
   Ruhe J, 2002, J MACROMOL SCI-POL R, VC42, P91
   Toomey R, 2004, MACROMOLECULES, V37, P882, DOI 10.1021/ma034737v
   TSUBOKAWA N, 1989, J POLYM SCI POL CHEM, V27, P1701, DOI 10.1002/pola.1989.080270521
   TSUBOKAWA N, 1990, J MACROMOL SCI CHEM, VA27, P445
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
NR 15
TC 43
Z9 43
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 10
PY 2004
VL 570
IS 1-2
BP 111
EP 118
DI 10.1016/j.susc.2004.06.185
PG 8
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 863DH
UT WOS:000224540300010
DA 2018-10-20
ER

PT J
AU Lin, YS
   Hung, Y
   Su, JK
   Lee, R
   Chang, C
   Lin, ML
   Mou, CY
AF Lin, YS
   Hung, Y
   Su, JK
   Lee, R
   Chang, C
   Lin, ML
   Mou, CY
TI Gadolinium(III)-incorporated nanosized mesoporous silica as potential
   magnetic resonance imaging contrast agents
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID MOLECULAR-SIEVES; RELAXATION; RELEASE; SYSTEM
AB A new class of potential magnetic resonance imaging contrast agents with nanosized mesoporous silica as the metal carrier is reported. Gadolinium-incorporated mesoporous silicas were synthesized by using longchain surfactant as a template. The products were characterized with X-ray powder diffraction, nitrogen adsorption-desorption isotherms, high-resolution transmission electron microscopy, X-ray photoelectron spectroscopy, Si-29-MAS NMR, and proton relaxivity. The materials showed much higher relaxivities, r(1) and r(2), than Gd-DTPA. The particles are nanosized and can enter cells easily. This is a completely novel biomedical application of mesoporous silica materials.
C1 Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan.
   Natl Taiwan Univ, Ctr Condensed Matter Sci, Taipei 106, Taiwan.
   Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.
RP Mou, CY (reprint author), Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan.
EM cymou@ntu.edu.tw
RI Chang, Chen/B-5079-2009
OI MOU, CHUNG-YUAN/0000-0001-7060-9899
CR BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   BRESINSKA I, 1994, J PHYS CHEM-US, V98, P12989, DOI 10.1021/j100100a029
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Ciobanu L, 2003, PROG NUCL MAG RES SP, V42, P69, DOI 10.1016/S0079-6565(03)00004-9
   Gries H, 2002, TOP CURR CHEM, V221, P1
   GUERON M, 1975, J MAGN RESON, V19, P58, DOI 10.1016/0022-2364(75)90029-3
   JUNG CW, 1995, MAGN RESON IMAGING, V13, P661, DOI 10.1016/0730-725X(95)00024-B
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Lin HP, 2003, CHEM LETT, V32, P1092, DOI 10.1246/cl.2003.1092
   Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362
   Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403
   Matos JR, 2001, J MATER CHEM, V11, P2580, DOI 10.1039/b102056k
   MERBACH AE, 2001, CHEM CONTRAST AGENTS
   Platas-Iglesias C, 2002, CHEM-EUR J, V8, P5121, DOI 10.1002/1521-3765(20021115)8:22<5121::AID-CHEM5121>3.0.CO;2-W
   Rodriguez-Castellon E, 2003, J SOLID STATE CHEM, V175, P159, DOI 10.1016/S0022-4596(03)00218-4
   RUMMENY E, 1991, INVEST RADIOL, V26, pS142, DOI 10.1097/00004424-199111001-00048
   STAKHEEV AY, 1993, J PHYS CHEM-US, V97, P5668, DOI 10.1021/j100123a034
   SUR SK, 1993, J MAGN RESON SER A, V103, P27, DOI 10.1006/jmra.1993.1127
   Weinmann HJ, 2003, EUR J RADIOL, V46, P33, DOI 10.1016/S0720-048X(02)00332-7
   WEISSLEDER R, 2002, NAT REV CANCER, V2, P1
   Yin W, 2003, J ALLOY COMPD, V360, P231, DOI 10.1016/S0925-8388(03)00304-9
NR 21
TC 105
Z9 106
U1 3
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD OCT 7
PY 2004
VL 108
IS 40
BP 15608
EP 15611
DI 10.1021/jp047829a
PG 4
WC Chemistry, Physical
SC Chemistry
GA 858TA
UT WOS:000224213500026
DA 2018-10-20
ER

PT J
AU Pavlov, KM
   Gureyev, TE
   Paganin, D
   Nesterets, YI
   Morgan, MJ
   Lewis, RA
AF Pavlov, KM
   Gureyev, TE
   Paganin, D
   Nesterets, YI
   Morgan, MJ
   Lewis, RA
TI Linear systems with slowly varying transfer functions and their
   application to X-ray phase-contrast imaging
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Article
ID SYNCHROTRON-RADIATION; APPROXIMATION; RETRIEVAL; OBJECTS
AB A novel theoretical treatment of linear shift-invariant imaging systems is developed, which allows explicit solution of forward and inverse problems in the case of large values of the generalized Fresnel number. The method will be useful in a variety of domains including optical instrumentation, biomedical imaging and materials science. Our approach is used to integrate two particularly topical x-ray imaging methods, namely propagation-based and analyser-crystal-based x-ray phase-contrast imaging.
C1 Monash Univ, Sch Phys & Mat Engn, Clayton, Vic 3800, Australia.
   Monash Univ, Ctr Synchrotron Sci, Clayton, Vic 3800, Australia.
   CSIRO Mfg & Infrastruct Technol, Clayton, Vic 3169, Australia.
RP Pavlov, KM (reprint author), Monash Univ, Sch Phys & Mat Engn, Clayton, Vic 3800, Australia.
RI Nesterets, Yakov/A-7981-2010; Gureyev, Timur/A-9209-2011; Pavlov,
   Konstantin/A-3802-2008; paganin, david/B-9717-2009
OI Gureyev, Timur/0000-0002-1103-0649; Pavlov,
   Konstantin/0000-0002-1756-4406; Paganin, David/0000-0002-7758-7140
CR Bushuev VA, 1999, TECH PHYS LETT+, V25, P83, DOI 10.1134/1.1262407
   Bushuev VA, 1998, CRYSTALLOGR REP+, V43, P538
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023
   DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0
   DAVIS TJ, 1994, ACTA CRYSTALLOGR A, V50, P686, DOI 10.1107/S0108767394003478
   FORSTER E, 1980, KRIST TECH, V15, P937, DOI 10.1002/crat.19800150812
   Gureyev TE, 1998, J OPT SOC AM A, V15, P579, DOI 10.1364/JOSAA.15.000579
   Gureyev TE, 1997, NUOVO CIMENTO D, V19, P545, DOI 10.1007/BF03041015
   INGAL VN, 1995, J PHYS D APPL PHYS, V28, P2314, DOI 10.1088/0022-3727/28/11/012
   Mayo SC, 2002, J MICROSC-OXFORD, V207, P79, DOI 10.1046/j.1365-2818.2002.01046.x
   Nesterets YI, 2004, J PHYS D APPL PHYS, V37, P1262, DOI 10.1088/0022-3727/37/8/016
   Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961
   Paganin D, 2004, OPT COMMUN, V234, P87, DOI 10.1016/j.optcom.2004.02.015
   Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x
   Paganin D, 2001, ADV IMAG ELECT PHYS, V118, P85, DOI 10.1016/S1076-5670(01)80104-X
   Pagot E, 2003, APPL PHYS LETT, V82, P3421, DOI 10.1063/1.1575508
   PAPOULIS A, 1968, SYSTEMS TRANSFORMS A
   Pavlov KM, 2001, J PHYS D APPL PHYS, V34, pA168, DOI 10.1088/0022-3727/34/10A/335
   Rigon L, 2003, J PHYS D APPL PHYS, V36, pA107, DOI 10.1088/0022-3727/36/10A/322
   Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073
   Somenkov V. A., 1991, Soviet Physics - Technical Physics, V36, P1309
   TEAGUE MR, 1983, J OPT SOC AM, V73, P1434, DOI 10.1364/JOSA.73.001434
   Treves F, 1980, INTRO PSEUDODIFFEREN, V2
   Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0
NR 25
TC 50
Z9 50
U1 0
U2 3
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD OCT 7
PY 2004
VL 37
IS 19
BP 2746
EP 2750
AR PII S0022-3727(04)80720-4
DI 10.1088/0022-3727/37/19/021
PG 5
WC Physics, Applied
SC Physics
GA 864YO
UT WOS:000224669500023
DA 2018-10-20
ER

PT J
AU Wang, ZL
   Kong, XY
   Ding, Y
   Gao, PX
   Hughes, WL
   Yang, RS
   Zhang, Y
AF Wang, ZL
   Kong, XY
   Ding, Y
   Gao, PX
   Hughes, WL
   Yang, RS
   Zhang, Y
TI Semiconducting and piezoelectric oxide nanostructures induced by polar
   surfaces
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID SINGLE-CRYSTAL NANORINGS; NANOWIRE BUILDING-BLOCKS; ZINC-OXIDE;
   SPONTANEOUS POLARIZATION; INDUCED NANOHELIXES; ZNO NANOBELTS;
   NANOSPRINGS; MECHANISM; CONSTANTS; STABILITY
AB Zinc oxide, an important semiconducting and piezosecond material, has three key characteristics. First, it is a semiconductor, with a direct bandgap of 3.37 eV and a large exicitation binding energy (60 meV), and exhibits near-UV emission and transport conductivity. Secondly, due to its non-centrosymmetric symmetry, it is piezoelectric, which is a key phenomenon in building electro-mechanical coupled sensors and transductors. Finally, ZnO is bio-safe and bio-compatible, and can be used for biomedical applications without coating. With these unique advantages ZnO is one of the most important nanomaterials for integration with microsystems and biotechnology. Structurally, due to the three types of fastest growth directions - <0001>, <0 (11) over bar0>, and <2 (11) over bar0> - as well as the +/-(0001) polar surfaces, a diverse group of ZnO nanostructures have been grown in our laboratory. These included nanocombs, nanosprings, nanorings, nanobows, and nanopropellors. This article reviews our recent progress in the synthesis and characterisation of polar-surface-induced ZnO nanostructures, their growth mechanisms, and possible applications as sensors, transducters, and resonators. It is suggested that ZnO could be the next most important nanomaterial after carbon nanotubes.
C1 Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   Beijing Univ Sci & Technol, Dept Mat Phys, Beijing 100083, Peoples R China.
   Beijing Univ Sci & Technol, State Key Lab Adv Met & Mat, Beijing 100083, Peoples R China.
RP Wang, ZL (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM zhong.wang@mse.gatech.edu
RI Gao, Puxian/E-1461-2011; Wang, Zhong Lin/E-2176-2011; Yang,
   Rusen/D-5536-2009; Kong, Xiang Yang/E-1593-2012; Kong,
   Xiangyang/F-2999-2013; Ding, Yong/F-3705-2017
OI Wang, Zhong Lin/0000-0002-5530-0380; Yang, Rusen/0000-0002-4019-4642;
   Kong, Xiang Yang/0000-0003-0659-4084; Ding, Yong/0000-0001-5805-347X
CR ARNOLD M, 2002, J PHYS CHEM B, V107, P659
   Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878
   Bernardini F, 1998, PHYS REV B, V58, P15292, DOI 10.1103/PhysRevB.58.15292
   Bernardini F, 1997, PHYS REV B, V56, P10024, DOI 10.1103/PhysRevB.56.R10024
   CAHN JW, 1964, SURF SCI, V1, P387, DOI 10.1016/0039-6028(64)90006-8
   Comini E, 2002, APPL PHYS LETT, V81, P1869, DOI 10.1063/1.1504867
   COWLEY JM, 1957, ACTA CRYSTALLOGR, V10, P609, DOI 10.1107/S0365110X57002194
   Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851
   Dai R.Z., 2003, ADV FUNCT MATER, V13, P9
   Dai Y, 2003, SOLID STATE COMMUN, V126, P629, DOI 10.1016/S0038-1098(03)00277-1
   Dai Y, 2002, CHEM PHYS LETT, V358, P83, DOI 10.1016/S0009-2614(02)00582-1
   Ding Y, 2004, J AM CHEM SOC, V126, P2066, DOI 10.1021/ja039354r
   DING Y, 2004, UNPUB PHYS REV B
   Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047
   Dulub O, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.016102
   Dulub O, 2002, SURF SCI, V519, P201, DOI 10.1016/S0039-6028(02)02211-2
   Gao PX, 2002, J PHYS CHEM B, V106, P12653, DOI 10.1021/jp0265485
   Gao PX, 2004, APPL PHYS LETT, V84, P2883, DOI 10.1063/1.1702137
   Gao PX, 2003, NANO LETT, V3, P1315, DOI 10.1021/nl034548q
   GAO PX, 2004, IN PRESS J PHYS CH B
   Hashimoto S, 1996, J AM CERAM SOC, V79, P1121, DOI 10.1111/j.1151-2916.1996.tb08559.x
   Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192
   Hughes WL, 2004, J AM CHEM SOC, V126, P6703, DOI 10.1021/ja049266m
   Hughes WL, 2003, APPL PHYS LETT, V82, P2886, DOI 10.1063/1.1570497
   Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356
   Kong XY, 2004, APPL PHYS LETT, V84, P975, DOI 10.1063/1.1646453
   Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p
   Li C, 2000, MICRON, V31, P543, DOI 10.1016/S0968-4328(99)00136-5
   Lieber C.M., 1998, SOLID STATE COMMUN, V107, P106
   Ma C, 2004, J AM CHEM SOC, V126, P708, DOI 10.1021/ja0395644
   MAO S, 2002, APPL PHYS LETT, V83, P993
   Meyer B, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035403
   MOORE D, 2004, PHYS LETT, V385, P8
   Nishio K, 1997, PHILOS MAG A, V76, P889, DOI 10.1080/01418619708214216
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Parish R. V., 1977, METALLIC ELEMENTS
   SHI L, 2004, IN PRESS APPL PHYS L
   Staemmler V, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.106102
   TAKEUCHI S, 1994, PHILOS MAG A, V69, P1125, DOI 10.1080/01418619408242243
   TASKER PW, 1979, J PHYS C SOLID STATE, V12, P4977, DOI 10.1088/0022-3719/12/22/036
   Vigue F, 2001, APPL PHYS LETT, V79, P194, DOI 10.1063/1.1384907
   Wander A, 2001, PHYS REV LETT, V86, P3811, DOI 10.1103/PhysRevLett.86.3811
   Wang Z. L., 1998, FUNCTIONAL SMART MAT
   Wang Z.L., 2003, NANOWIRES NANOBELTS, V1
   Wang ZL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.185502
   Wang ZL, 2003, NANOWIRES NANOBELTS, V2
   Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087
   Yan Y, 1998, APPL PHYS LETT, V73, P2585, DOI 10.1063/1.122513
   Yang RS, 2004, NANO LETT, V4, P1309, DOI 10.1021/nl049317d
   Zhao MH, 2004, NANO LETT, V4, P587, DOI 10.1021/nl035198a
NR 50
TC 465
Z9 473
U1 11
U2 205
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD OCT
PY 2004
VL 14
IS 10
BP 943
EP 956
DI 10.1002/adfm.200400180
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 866ZD
UT WOS:000224811000001
DA 2018-10-20
ER

PT J
AU Etienne, O
   Picart, C
   Taddei, C
   Haikel, Y
   Dimarcq, JL
   Schaaf, P
   Voegel, JC
   Ogier, JA
   Egles, C
AF Etienne, O
   Picart, C
   Taddei, C
   Haikel, Y
   Dimarcq, JL
   Schaaf, P
   Voegel, JC
   Ogier, JA
   Egles, C
TI Multilayer polyelectrolyte films functionalized by insertion of
   defensin: A new approach to protection of implants from bacterial
   colonization
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL) LAYERS; METAL-OXIDE SURFACES;
   STAPHYLOCOCCUS-EPIDERMIDIS; ANTIMICROBIAL ACTIVITIES; BIOMEDICAL
   POLYMERS; PROTEIN ADSORPTION; RESISTANCE; ADHESION; NISIN; BIOMATERIALS
AB Infection of implanted materials by bacteria constitutes one of the most serious complications following prosthetic surgery. In the present study, we developed a new strategy based on the insertion of an antimicrobial peptide (defensin from Anopheles gambiae mosquitoes) into polyelectrolyte multilayer films built by the alternate deposition of polyanions and polycations. Quartz crystal microbalance and streaming potential measurements were used to follow step by step the construction of the multilayer films and embedding of the defensin within the films. Antimicrobial assays were performed with two strains: Micrococcus luteus (a gram-positive bacterium) and Escherichia coli D22 (a gram-negative bacterium). The inhibition of E. coli D22 growth at the surface of defensin-functionalized films was found to be 98% when 10 antimicrobial peptide layers were inserted in the film architecture. Noticeably, the biofunctionalization could be achieved only when positively charged poly(L-lysine) was the outermost layer of the film. On the basis of the results of bacterial adhesion experiments observed by confocal or electron microscopy, these observations could result from the close interaction of the bacteria with the positively charged ends of the films, which allows defensin to interact with the bacterial membrane structure. These results open new possibilities for the use of such easily built and functionalized architectures onto any type of implantable biomaterial. The modified surfaces are active against microbial infection and represent a novel means of local host protection.
C1 Univ Strasbourg 1, INSERM U595, Fac Chirurg Dent, F-67085 Strasbourg, France.
   Inst Charles Sadron, UPR 22 CNRS, F-67083 Strasbourg, France.
   Entomed SA, Illkirch Graffenstaden, France.
RP Egles, C (reprint author), Univ Strasbourg 1, INSERM U595, Fac Chirurg Dent, 11 Rue Humann, F-67085 Strasbourg, France.
EM christophe.egles@odonto-ulp.u-strasbg.fr
RI SCHAAF, Pierre/J-2751-2016; ETIENNE, olivier/D-1601-2013; etienne,
   olivier/D-9542-2011
OI SCHAAF, Pierre/0000-0001-7423-5492; ETIENNE,
   olivier/0000-0001-8870-4659; PICART, Catherine/0000-0003-0130-1000;
   PICART, Catherine/0000-0002-4854-6366
CR BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Bower CK, 2002, COLLOID SURFACE B, V25, P81, DOI 10.1016/S0927-7765(01)00318-6
   Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4
   Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   COCIANCICH S, 1993, J BIOL CHEM, V268, P19239
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DARVEAU RP, 1991, ANTIMICROB AGENTS CH, V35, P1153, DOI 10.1128/AAC.35.6.1153
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Dielbandhoesing SK, 1998, APPL ENVIRON MICROB, V64, P4047
   Dimarcq JL, 2003, DRUG DISCOV TODAY, V8, P107, DOI 10.1016/S1359-6446(02)02582-5
   Ganzle MG, 1999, INT J FOOD MICROBIOL, V48, P37, DOI 10.1016/S0168-1605(99)00026-4
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Ladam G, 2002, BIOMOL ENG, V19, P273, DOI 10.1016/S1389-0344(02)00031-X
   Martin I, 1996, EUR J BIOCHEM, V239, P156, DOI 10.1111/j.1432-1033.1996.0156u.x
   OFEK I, 1994, BACTERIAL ADHESION C
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Rodahl M, 1996, SENSOR ACTUAT B-CHEM, V37, P111, DOI 10.1016/S0925-4005(97)80077-9
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   STICKLER DJ, 1995, CELL MATER, V5, P167
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Vautier D, 2003, CELL MOTIL CYTOSKEL, V56, P147, DOI 10.1002/cm.10140
   Vizioli J, 2001, INSECT BIOCHEM MOLEC, V31, P241, DOI 10.1016/S0965-1748(00)00143-0
   Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
NR 39
TC 142
Z9 143
U1 0
U2 40
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD OCT
PY 2004
VL 48
IS 10
BP 3662
EP 3669
DI 10.1128/AAC.48.10.3662-3669.2004
PG 8
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 858UH
UT WOS:000224217000003
PM 15388417
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU El-Amin, SF
   Kofron, MD
   Attawia, MA
   Lu, HH
   Tuan, RS
   Laurencin, CT
AF El-Amin, SF
   Kofron, MD
   Attawia, MA
   Lu, HH
   Tuan, RS
   Laurencin, CT
TI Molecular regulation of osteoblasts for tissue engineered bone repair
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID INTEGRIN EXPRESSION; BIOERODIBLE POLYMERS; DYNAMIC REGULATION; IMPLANT
   MATERIALS; RECOGNITION SITE; CELL-ADHESION; MATRICES; BINDING; CULTURE;
   GROWTH
AB The use of biodegradable polymers in medicine and biomedical research is increasing. A key growth area has been the use of these materials in tissue engineering, especially for guided regeneration of bone and cartilage. Our interest has been in determining the mechanisms by which cellular attachment and growth occurs on these materials. In the current study, we examined human osteoblast cell adhesion, growth, and morphologic changes on polymeric scaffolds composed of polylactic-co-glycolic acid and polylactic acid materials. We examined these characteristics in association with measurements of levels of key adhesion integrin receptors in the presence and absence of antibodies against alpha(2), alpha(3), alpha(4), alpha(5), alpha(6), and beta(1) subunits, and the adhesion ligand peptides RGD (Arg-Gly-Asp) and RGE (Arg-Gly-Ser). At 2 hours, results showed initial cell adhesion was considerably decreased on polylactic-co-glycolic acid and polylactic acid in the presence of the alpha(2) and beta(1) antibodies with a 70% adhesion rate difference observed among the groups evaluated. Higher levels of inhibition were observed on polylactic-co-glycolic acid relative to polylactic acid, which may be correlated to a higher number of cells being able to interact with the surface initially. The presence of known competitive peptide (RGD) at 2 hours, revealed its ability to block cellular adhesion to these matrices relative to the control and noncompetitive peptide RGE on polylactic-co-glycolic acid matrices. Overall adhesion rate was affected by the presence of the integrin antibodies to the alpha(2), alpha(3), alpha(4), alpha(5), alpha(6), and beta(1) subunits with highest differences among polylactic-co-glycolic acid relative to its control, therefore suggesting that initial osteoblastic cell adhesion to commonly used biomaterials is regulated through integrin binding.
C1 Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.
   Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA.
   Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.
   Depuy Johnson & Johnson, Raymond, MA USA.
   Natl Inst Musculoskeletal Res, NIH, Bethesda, MD USA.
   Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
RP Laurencin, CT (reprint author), Univ Virginia, Dept Orthopaed Surg, 400 Ray C Hunt Dr,Suite 330, Charlottesville, VA 22903 USA.
EM ctlf3f@virginia.edu
FU NIDCR NIH HHS [DE12864]; NIAMS NIH HHS [AR44051, AR39740, AR08562-01]
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P843, DOI 10.1002/jbm.820290709
   Attawia MA, 1996, J ORTHOPAED RES, V14, P445, DOI 10.1002/jor.1100140315
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1
   DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922
   El-Amin SF, 2002, J ORTHOPAED RES, V20, P20, DOI 10.1016/S0736-0266(01)00062-6
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   FAULL RJ, 1995, STEM CELLS, V13, P38, DOI 10.1002/stem.5530130106
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   Ibim SEM, 1997, BIOMATERIALS, V18, P1565, DOI 10.1016/S0142-9612(97)00099-9
   Jackson D W, 1999, Clin Orthop Relat Res, pS31, DOI 10.1097/00003086-199910001-00005
   KAMATA T, 1994, J BIOL CHEM, V269, P26006
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   Laurencin CT, 1998, CELLS MAT, V8, P175
   LAURENCIN CT, 1992, POLYM ADVAN TECHNOL, V3, P359
   Mould AP, 1996, J CELL SCI, V109, P2613
   Norman Maria E., 1994, Clinical Materials, V17, P85, DOI 10.1016/0267-6605(94)90016-7
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   PUELO DA, 1991, BONE, V12, P271
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 31
TC 15
Z9 15
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD OCT
PY 2004
IS 427
BP 220
EP 225
DI 10.1097/01.blo.0000137556.51604.0c
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 861NC
UT WOS:000224422500035
PM 15552161
DA 2018-10-20
ER

PT J
AU Mucalo, MR
   Foster, DL
AF Mucalo, MR
   Foster, DL
TI A method for avoiding the xanthoproteic-associated discolouration in
   reprecipitated (nitric-acid-digested) hydroxyapatite prepared from
   mammalian bone tissue
SO CROATICA CHEMICA ACTA
LA English
DT Article
DE hydroxyapatite; mammalian bone; pyrolysis; reprecipitation;
   xanthoproteic discolouration; biomedical
ID ANIMAL-DERIVED BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS
AB A procedure for producing kilogram quantities of a biornedically suitable reprecipitated hydroxyapatite (HAp) powder, which is free of the xanthoproteic-associated discolouration caused by nitric acid interaction with the protein content in bones during digestion, has been developed. Essentially bones were defatted by boiling and then pyrolysed at 1000 degreesC to burn off the collagenous proteins and produce flakey bleached bones. This bone was then crushed and ground and digested in nitric acid solution to produce digest solutions free of the highly staining orange colouration normally associated with nitric acid digestions of bone material.. Finely divided, white solids could then be reprecipitated as usual from the digests by addition of NaOH solution under a nitrogen atmosphere with heating and stirring at 70 degreesC of the precipitate to enable its maturation into an HAp phase. The products derived from this procedure were characterised using spectroscopic, microscopic and particle sizing techniques. These analyses showed the resultant powders to be low crystallinity hydroxyapatite of consistent morphology and which possessed either acceptably low or below detection limit levels of heavy metals so rendering it as a potentially valuable source of powder for biomedical applications such as plasma spraying or for implant or prosthesis manufacture.
C1 Univ Waikato, Dept Chem, Hamilton, New Zealand.
RP Mucalo, MR (reprint author), Univ Waikato, Dept Chem, Private Bag 3105, Hamilton, New Zealand.
EM m.mucalo@waikato.ac.nz
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR ABDELFATTAH WI, 1993, THERMOCHIM ACTA, V218, P465, DOI 10.1016/0040-6031(93)80445-G
   Aoki H., 1994, MED APPL HYDROXYAPAT
   DOWKER SEP, 1979, CALCIFIED TISSUE INT, V29, P177, DOI 10.1007/BF02408075
   EGIAZAROV GM, 1961, VOEN MED ZH, P34
   JOBLING A, 1983, P 36 UPGR WAST FEEDS, P183
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P427, DOI 10.1023/A:1008987908917
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P725, DOI 10.1023/A:1008979929632
   LINDHOLM TS, 2002, ADV SKELETAL RECONST
   Mucalo MR, 2003, KEY ENG MAT, V240-2, P427, DOI 10.4028/www.scientific.net/KEM.240-242.427
   TAYLOR DM, 1991, DEV BIOLOGICALS, V75, P97
   TILLMANS J, 1928, BIOCHEM Z, P198
NR 11
TC 1
Z9 1
U1 0
U2 2
PU CROATIAN CHEMICAL SOC
PI ZAGREB
PA MARULICEV TRG 19/II, 41001 ZAGREB, CROATIA
SN 0011-1643
J9 CROAT CHEM ACTA
JI Croat. Chem. Acta
PD OCT
PY 2004
VL 77
IS 3
BP 509
EP 517
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 870KM
UT WOS:000225056000014
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Reynolds, MM
   Frost, MC
   Meyerhoff, ME
AF Reynolds, MM
   Frost, MC
   Meyerhoff, ME
TI Nitric oxide-releasing hydrophobic polymers: Preparation,
   characterization, and potential biomedical applications
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Review
DE nitric oxide; polymers; biocompatibility; thromboresistant; controlled
   release; diazeniumdiolates; nitrosothiols; free radicals
ID CONTROLLED BIOLOGICAL RELEASE; IN-VIVO EVALUATION; NITROGEN(II) OXIDE;
   CHEMICAL SENSORS; AQUEOUS-SOLUTION; RELAXING FACTOR; DIETHYLAMINE;
   ENDOTHELIUM; THROMBORESISTANT; IDENTIFICATION
AB The synthetic methods used recently in this laboratory to prepare a variety of novel nitric oxide (NO)-releasing hydrophobic polymers are reviewed. Nitric oxide is a well known inhibitor of platelet adhesion and activation. Thus, such NO release polymers have potential applications as thromboresistant coatings for a large number of blood-contacting biomedical devices (e.g., in vivo sensors, arteriovenous grafts, stents, catheters, extracorporeal circuits). The approaches taken to prepare NO releasing poly(vinyl chloride) (PVC), silicone rubber (SR), polymethacrylate (PM), and polyurethane (PU) materials are grouped into three categories: (1) dispersion/doping of discrete diazenium-diolated molecules within the polymeric films; (2) chemical derivatization of polymeric filler microparticles (e.g., silicon dioxide, titanium dioxide) to possess NO release chemistry and then their dispersion within the hydrophobic polymers; and (3) covalent attachment of NO release moieties to polymer backbones. Specific chemical examples of each of these approaches are summarized and the advantages and disadvantages of each are discussed. Other related work in the field of NO release polymers is also cited. It is further shown that several of the NO-releasing polymeric materials already prepared exhibit the expected improved thromboresistivity when tested in vivo using appropriate animal models. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
EM mmeyerho@umich.edu
CR Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   COLEMAN RW, 1993, CARDIOVASC PATHOL, V2, pS23
   Davies KM, 2001, J AM CHEM SOC, V123, P5473, DOI 10.1021/ja002899q
   DIODATI JG, 1993, THROMB HAEMOSTASIS, V70, P654
   DRAGO RS, 1960, J AM CHEM SOC, V82, P96, DOI 10.1021/ja01486a021
   DRAGO RS, 1961, J AM CHEM SOC, V83, P1819, DOI 10.1021/ja01469a012
   DRAGO RS, 1961, J AM CHEM SOC, V83, P4337, DOI 10.1021/ja01482a008
   DRAGO RS, 1962, ADV CHEM SER, V36, P143
   Fleming I, 1995, Adv Pharmacol, V34, P187
   FLESER PS, UNPUB NITRIC OXIDE R
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Frost MC, 2003, MICROCHEM J, V74, P277, DOI 10.1016/S0026-265X(03)00033-X
   Frost MC, 2002, ANAL CHEM, V74, P5942, DOI 10.1021/ac025944g
   Frost MC, 2002, CURR OPIN CHEM BIOL, V6, P633, DOI 10.1016/S1367-5931(02)00371-X
   Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008
   Gagliardi S, 2001, PHYSICA B, V301, P110, DOI 10.1016/S0921-4526(01)00520-8
   GOLDSTEIN S, 1995, J AM CHEM SOC, V117, P12078, DOI 10.1021/ja00154a007
   Gries A, 1998, CIRCULATION, V97, P1481
   Hampl V, 1996, METHODS NITRIC OXIDE, P309
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   Karim A, 2000, POLYMER, V41, P8455, DOI 10.1016/S0032-3861(00)00245-7
   LIJINSKY W, 1994, NITROSOAMINES RELATE, P250
   Majerus PW, 1990, PHARMACOL BASIS THER, P1311
   MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013
   MARLETTA M A, 1990, Biofactors, V2, P219
   MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5
   MONCADA S, 1991, CARDIOVASC PHARM, V17, pS1
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   OH BK, 2003, J AM CHEM SOC, V125, P552
   Parzuchowski PG, 2002, J AM CHEM SOC, V124, P12182, DOI 10.1021/ja020268l
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   RAGSDALE RO, 1965, INORG CHEM, V4, P420, DOI 10.1021/ic50025a038
   Saavedra JE, 1999, J ORG CHEM, V64, P5124, DOI 10.1021/jo9901539
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   TELTINGDIAZ M, 1994, ANAL CHEM, V66, P576, DOI 10.1021/ac00076a025
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163
   WEN J, 1999, ADHESIVES SEALAN AUG
   Williams DLH, 1999, ACCOUNTS CHEM RES, V32, P869, DOI 10.1021/ar9800439
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 43
TC 71
Z9 74
U1 6
U2 60
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD OCT 1
PY 2004
VL 37
IS 7
BP 926
EP 936
DI 10.1016/j.freeradbiomed.2004.06.019
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 855YX
UT WOS:000224011900003
PM 15336308
DA 2018-10-20
ER

PT J
AU Tanaka, T
   Montanari, GC
   Mulhaupt, R
AF Tanaka, T
   Montanari, GC
   Mulhaupt, R
TI Polymer nanocomposites as dielectrics and electrical
   insulation-perspectives for processing technologies, material
   characterization and future applications
SO IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION
LA English
DT Article
DE nanocomposite; polymer nanocomposite; nanofillers; advanced materials;
   dielectrics; electrical insulation
ID MECHANICAL-PROPERTIES; LAYERED SILICATES; EPOXY-RESINS; MORPHOLOGY;
   FUNCTIONALITY; BEHAVIOR; ETHENE; RUBBER
AB Polymer nanocomposites are defined as polymers in which small amounts of nanometer size fillers are homogeneously dispersed by only several weight percentages. Addition of just a few weight percent of the nano-fillers has profound impact on the physical, chemical, mechanical and electrical properties of polymers. Such change is often favorable for engineering purpose. This nanocomposite technology has emerged from the field of engineering plastics, and potentially expanded its application to structural materials, coatings, and packaging to medical/biomedical products, and electronic and photonic devices. Recently these 'hi-tech' materials with excellent properties have begun to attract research people in the field of dielectrics and electrical insulation. Since new properties are brought about from the interactions of nanofillers with polymer matrices, mesoscopic properties are expected to come out, which would be interesting to both scientists and engineers. Improved characteristics are expected as dielectrics and electrical insulation. Several interesting results to indicate foreseeable future have been revealed, some of which are described on materials and processing in the paper together with basic concepts and future direction.
C1 Waseda Univ, Grad Sch Informat Prod & Syst LSI, Kitakyushu, Fukuoka 8080135, Japan.
   Univ Bologna, Dept Elect Engn, High Voltage & Mat Engn Lab, I-40136 Bologna, Italy.
   Univ Freiburg, Inst Macromol Chem, D-7904 Freiburg, Germany.
RP Tanaka, T (reprint author), Waseda Univ, Grad Sch Informat Prod & Syst LSI, 2-7 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.
CR Becker O, 2003, MACROMOLECULES, V36, P1616, DOI 10.1021/ma0213448
   Berndt H, 1996, MICROPOROUS MATER, V6, P1, DOI 10.1016/0927-6513(95)00092-5
   BRINKER CJ, 1990, SOL GEL SCI
   Cao Y., 2003, IEEE C EL INS DIEL P, P116
   Chang S, 2000, CERAM ENG SCI P, V21, P653
   CHUJO K, 2002, TECHNOLOGICAL TRENDS, P1
   CHUJO K, 2001, ADV TECHNOLOGY APPL, P1
   Dietsche F, 2000, J APPL POLYM SCI, V75, P396, DOI 10.1002/(SICI)1097-4628(20000118)75:3<396::AID-APP9>3.0.CO;2-E
   Frechette M., 2001, IEEE C EL INS DIEL P, P92
   Ganter M, 2001, RUBBER CHEM TECHNOL, V74, P221, DOI 10.5254/1.3544946
   GILMAN JW, 1999, P NEW ADV FLAM RET T
   Heinemann J, 1999, MACROMOL RAPID COMM, V20, P423, DOI 10.1002/(SICI)1521-3927(19990801)20:8<423::AID-MARC423>3.0.CO;2-N
   HUBER D, 1998, INTERFACIAL ASPECTS
   IMAI T, 2002, IEEE INT S EL INS IS, P379
   Irwin P. C., 2003, IEEE C EL INS DIEL P, P120
   Kozak M., 2003, IEEE C EL INS DIEL P, P75
   Ladouce-Stelandre L, 2003, RUBBER CHEM TECHNOL, V76, P145, DOI 10.5254/1.3547730
   LAN L, 2003, P 8 ISH DELFT, P4
   LEWIS TJ, 1994, IEEE T DIELECT EL IN, V1, P812, DOI 10.1109/94.326653
   Muh E, 2001, ADV FUNCT MATER, V11, P425, DOI 10.1002/1616-3028(200112)11:6<425::AID-ADFM425>3.0.CO;2-0
   Mulhaupt R, 2001, KUNSTST-PLAST EUR, V91, P178
   MULHAUPT R, 2001, PLAST EUROPE, V91, P63
   Nelson J. K., 2003, IEEE C EL INS DIEL P, P719
   Nelson J. K., 2002, IEEE C EL INS DIEL P, P295
   Pernot H, 2002, NAT MATER, V1, P54, DOI 10.1038/nmat711
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Reichert P, 2000, MACROMOL MATER ENG, V275, P8, DOI 10.1002/(SICI)1439-2054(20000201)275:1<8::AID-MAME8>3.0.CO;2-6
   Sternstein SS, 2002, MACROMOLECULES, V35, P7262, DOI 10.1021/ma020482u
   SUN LM, 1994, POLYM J, V26, P939, DOI 10.1295/polymj.26.939
   TAKEZAWA Y, 2004, NAT CONV IEE JAP, P1
   TAKEZAWA Y, 2003, IEEE 7 ICPADM, P1146
   Tsuchida A, 1997, MACROMOLECULES, V30, P2818, DOI 10.1021/ma960846g
   Yin Y., 2003, IEEE 7 INT C PROP AP, P913
   YIN Y, 2003, IEEE 7 ICPADM NAG, P575
   Zanetti M, 2001, POLYMER, V42, P4501, DOI 10.1016/S0032-3861(00)00775-8
   ZHANG MY, 2003, IEEE 7 ICPADM NAG, P753
   ZHANG P, 2003, IEEE 7 ICPADM NAG, P1138
   Zilg C, 1999, MACROMOL CHEM PHYSIC, V200, P661, DOI 10.1002/(SICI)1521-3935(19990301)200:3<661::AID-MACP661>3.3.CO;2-W
   Zilg C, 2000, MACROMOL MATER ENG, V280, P41, DOI 10.1002/1439-2054(20000801)280:1<41::AID-MAME41>3.0.CO;2-Z
   Zilg C., 2003, IEEE C EL INS DIEL P, P546
NR 40
TC 509
Z9 543
U1 4
U2 143
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1070-9878
J9 IEEE T DIELECT EL IN
JI IEEE Trns. Dielectr. Electr. Insul.
PD OCT
PY 2004
VL 11
IS 5
SI SI
BP 763
EP 784
DI 10.1109/TDEI.2004.1349782
PG 22
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 862KQ
UT WOS:000224490000004
DA 2018-10-20
ER

PT J
AU Ellis, G
   Marco, C
   Gomez, M
AF Ellis, G
   Marco, C
   Gomez, M
TI Highly resolved transmission infrared microscopy in polymer science
SO INFRARED PHYSICS & TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Interantional Workshop on the Infrared Microscopy and Spectroscopy with
   Accelerator-Bases Sources
CY JUL 08-11, 2003
CL Lake Tahoe, CA
DE synchrotron infrared microscopy; polymer; morphology; composite
ID SYNCHROTRON LIGHT-SOURCE; ISOTACTIC POLYPROPYLENE MELTS; BIOMEDICAL
   APPLICATIONS; IR SPECTROSCOPY; FT-IR; MICROSPECTROSCOPY; RADIATION;
   RESOLUTION; MORPHOLOGY; SPECTROMICROSCOPY
AB Over the last few years, the use of synchrotron-based IR sources for high-resolution microspectroscopy has been a subject of great interest. The special characteristics of synchrotron radiation allow one to obtain high quality IR spectra at high spatial resolution using commercial grade IR microscopes situated at IR beamlines. The application of this technique to the study of polymeric materials is discussed, with examples from a series of heterogeneous polymeric materials, which include polymer blends and fibre-reinforced polymer composites, from studies undertaken at the MIRAGE Beamline, LURE, Paris, France. (C) 2004 Elsevier B.V. All rights reserved.
C1 CSIC, Dept Fis & Ingn, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
RP Ellis, G (reprint author), CSIC, Dept Fis & Ingn, Inst Ciencia & Tecnol Polimeros, C-Juan Cierva 3, E-28006 Madrid, Spain.
EM gary@ictp.csic.es
RI GOMEZ-FATOU RODRIGUEZ, MARIAN/C-9900-2012; Ellis, Gary/C-1617-2010
OI GOMEZ-FATOU RODRIGUEZ, MARIAN/0000-0002-0212-0634; Ellis,
   Gary/0000-0003-4851-6092
CR Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI DOI 10.1007/BF02956173
   ADE H, 1993, SCIENCE, V262, P1427, DOI 10.1126/science.262.5138.1427
   ADE H, 1992, SCIENCE, V258, P972, DOI 10.1126/science.1439809
   ADE H, 2002, CHEM APPL SYNCHROTRO
   Anderson MS, 2002, REV SCI INSTRUM, V73, P1198, DOI 10.1063/1.1445864
   BADGER RM, 1951, REV SCI INSTRUM, V22, P935, DOI 10.1063/1.1745832
   Bailey JA, 2000, APPL SPECTROSC, V54, P159, DOI 10.1366/0003702001949122
   Bantignies J.-L., 1998, International Journal of Cosmetic Science, V20, P381, DOI 10.1046/j.1467-2494.1998.177055.x
   Bantignies JL, 2000, J COSMET SCI, V51, P73
   Bantignies JL, 1997, P SOC PHOTO-OPT INS, V3153, P125
   BERGIN FJ, 1989, APPL SPECTROSC, V43, P511, DOI 10.1366/0003702894202797
   BLOUNT ER, 1951, J OPT SOC AM, V51, P547
   Bouchon P, 2001, J FOOD SCI, V66, P918, DOI 10.1111/j.1365-2621.2001.tb08212.x
   BOWER DI, 1989, VIB SPECTROSC, P165
   Bozec L, 2001, J APPL PHYS, V90, P5159, DOI 10.1063/1.1403671
   CARR GL, 1995, REV SCI INSTRUM, V66, P1643, DOI 10.1063/1.1145870
   CARR GL, 1995, REV SCI INSTRUM, V66, P1490, DOI 10.1063/1.1145951
   Carr GL, 1998, NUOVO CIMENTO D, V20, P375, DOI 10.1007/BF03185537
   Carr GL, 2001, REV SCI INSTRUM, V72, P1613, DOI 10.1063/1.1347965
   Carr GL, 1999, VIB SPECTROSC, V19, P53, DOI 10.1016/S0924-2031(98)00048-4
   CARR GL, 1998, SYNCHR RAD NEWS, V11, P31
   CHALMERS JM, 1995, MACROMOL SYMP, V94, P33, DOI 10.1002/masy.19950940105
   Chalmers JM, 1998, ANALYST, V123, P579, DOI 10.1039/a707070e
   Cossy-Favre A, 1998, MACROMOLECULES, V31, P4957, DOI 10.1021/ma980029b
   Cricenti A, 2000, APPL SURF SCI, V162, P275, DOI 10.1016/S0169-4332(00)00204-X
   DINSMORE HL, 1959, SPECTROCHIM ACTA, V12, P1025
   Dumas P, 2000, ANALUSIS, V28, P68, DOI 10.1051/analusis:2000280068
   Dumas P, 2003, J BIOL PHYS, V29, P201, DOI 10.1023/A:1024448910761
   Dumas P., 2002, ADV SER PHYS CHEM A, V12A, P356
   DUNCAN WD, 1983, APPL OPTICS, V22, P2914, DOI 10.1364/AO.22.002914
   EGERTON RF, 1996, ELECT ENERGY LOSS SP
   Ellis G, 2004, J MACROMOL SCI PHYS, VB43, P253, DOI [10.1081/MB-120027762, 10.1018/MB-120027762]
   Ellis G, 2004, J MACROMOL SCI PHYS, VB43, P191, DOI [10.1018/MB-120027758, 10.1081/MB-120027758]
   Ellis G, 2002, MACROMOL SYMP, V184, P37, DOI 10.1002/1521-3900(200208)184:1<37::AID-MASY37>3.0.CO;2-4
   ELLIS G, 2001, INT J VIBR SPECTROSC, V5, P7
   ELLIS GFR, UNPUB
   Geller JT, 2000, J CONTAM HYDROL, V43, P63, DOI 10.1016/S0169-7722(99)00095-9
   Glerup M, 2002, SPECTROCHIM ACTA A, V58, P129, DOI 10.1016/S1386-1425(01)00516-9
   Guilhaumou N, 1998, APPL SPECTROSC, V52, P1029, DOI 10.1366/0003702981944797
   HALADA GP, 2001, P ELECTROCHEM SOC, V5, P149
   Hammiche A, 1999, APPL SPECTROSC, V53, P810, DOI 10.1366/0003702991947379
   HARTHCOCK MA, 1986, APPL SPECTROSC, V40, P210, DOI 10.1366/0003702864509529
   Hemley RJ, 1998, NUOVO CIMENTO D, V20, P539, DOI 10.1007/BF03185547
   Hitchcock AP, 2001, J SYNCHROTRON RADIAT, V8, P66, DOI 10.1107/S0909049500016447
   Holman HN, 2000, BIOPOLYMERS, V57, P329
   Holman HYN, 1999, GEOMICROBIOL J, V16, P307, DOI 10.1080/014904599270569
   Horiuchi S, 2003, J ELECTRON MICROSC, V52, P255, DOI 10.1093/jmicro/52.3.255
   HOULT R, 2002, INT J VIBR SPECTROSC, V6, P4
   HUMECKI HJ, 1996, PRACTICAL SPECTROSCO, V19
   Jackson M, 1997, J MOL STRUCT, V408, P105, DOI 10.1016/S0022-2860(96)09461-6
   Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837
   KATON JE, 1994, VIB SPECTROSC, V7, P201, DOI 10.1016/0924-2031(94)85012-7
   KIELMANN F, 2002, VIB SPECTROSC, V29, P109
   KILCOYNE ALD, 2001, ALS NEWS         FAL
   Knoll B, 1999, NATURE, V399, P134, DOI 10.1038/20154
   Kreplak L, 2001, Int J Cosmet Sci, V23, P369, DOI 10.1046/j.0412-5463.2001.00118.x
   KRISHNAN K, 1990, FTIR MICROSAMPLING T, pCH3
   Lahrech A, 1996, OPT LETT, V21, P1315, DOI 10.1364/OL.21.001315
   Liu Z, 2002, J PHYS-CONDENS MAT, V14, P10641, DOI 10.1088/0953-8984/14/44/349
   Lotz B, 1996, POLYMER, V37, P4979, DOI 10.1016/0032-3861(96)00370-9
   Lustiger A, 1995, J ADHESION, V53, P1, DOI 10.1080/00218469508014368
   Marco C, 1997, J APPL POLYM SCI, V65, P2665, DOI 10.1002/(SICI)1097-4628(19970926)65:13<2665::AID-APP8>3.0.CO;2-9
   Marco C, 2002, J APPL POLYM SCI, V84, P1669, DOI 10.1002/app.10546
   Marco C, 2002, RECENT RES DEV APPL, V1, P587
   MESSERSCHMIDT RG, 1988, PRACTICAL SPECTROSCO, V6
   Michaels CA, 2000, J APPL PHYS, V88, P4832, DOI 10.1063/1.1309034
   Miller LM, 2002, REV SCI INSTRUM, V73, P1357, DOI 10.1063/1.1435824
   Miller LM, 2003, J BIOL PHYS, V29, P219, DOI 10.1023/A:1024401027599
   Miller LM, 2002, VIB SPECTROSC, V28, P159, DOI 10.1016/S0924-2031(01)00154-0
   Miyazawa T., 1964, J POLYM SCI C, V7, P59
   NEDKOV E, 2002, E-POLYMERS, V42, P1
   NORTON DR, 1985, POLYMER, V26, P704, DOI 10.1016/0032-3861(85)90108-9
   PARK C, 2004, NANOTECHNOLOGY, V14, pL11
   Piot O, 2001, J CEREAL SCI, V34, P191, DOI 10.1006/jcrs.2001.0391
   Polack F, 1999, P SOC PHOTO-OPT INS, V3775, P13, DOI 10.1117/12.366647
   Ratner B. D., 1998, ACS S SERIES, V694
   Raynal PI, 2000, PLANET SPACE SCI, V48, P1329, DOI 10.1016/S0032-0633(00)00113-6
   REFFNER JA, 1995, REV SCI INSTRUM, V66, P1298, DOI 10.1063/1.1145958
   REFFNER JA, 1997, MIKROCHIM ACTA S, V14, P339
   SCHMIDT PG, 1963, J POLYM SCI PART A, V1, P2317, DOI 10.1002/pol.1963.100010709
   Smith AP, 1996, APPL PHYS LETT, V69, P3833, DOI 10.1063/1.117120
   Smith DA, 1995, ULTRAMICROSCOPY, V61, P247
   Snively CM, 1999, J POLYM SCI POL PHYS, V37, P2353, DOI 10.1002/(SICI)1099-0488(19990901)37:17<2353::AID-POLB6>3.0.CO;2-Y
   Stohr J., 1996, NEXAFS SPECTROSCOPY, V25
   THEODORE K, 2001, PLANTA, V213, P881
   Tisinger LG, 2002, APPL SPECTROSC, V56, P1397, DOI 10.1366/00037020260377689
   Tordjeman P, 2001, EUR PHYS J E, V4, P459, DOI 10.1007/s101890170101
   Turrell G., 1996, RAMAN MICROSCOPY DEV
   Varga J, 1996, J POLYM SCI POL PHYS, V34, P657, DOI 10.1002/(SICI)1099-0488(199603)34:4<657::AID-POLB6>3.0.CO;2-N
   Varga J., 1995, POLYPROPYLENE STRUCT, VI, P56
   Varlot K, 1999, POLYMER, V40, P5691, DOI 10.1016/S0032-3861(98)00782-4
   Varlot K, 1997, ULTRAMICROSCOPY, V68, P123, DOI 10.1016/S0304-3991(97)00019-3
   WEIR CE, 1959, J RES NBS A PHYS CH, V63, P55, DOI 10.6028/jres.063A.003
   Wetzel DL, 1999, SCIENCE, V285, P1224, DOI 10.1126/science.285.5431.1224
   Wetzel DL, 2003, VIB SPECTROSC, V31, P109, DOI 10.1016/S0924-2031(02)00100-5
   Wilkinson TJ, 2002, APPL SPECTROSC, V56, P800, DOI 10.1366/000370202760076875
   WILKINSON TJ, 2001, ABSTR PAP AM CHEM S, V222, P36
   WILKINSON TJ, 2001, ABSTR PAP AM CHEM S, V223, P78
   WILLIAMS GP, 1982, NUCL INSTRUM METHODS, V195, P383, DOI 10.1016/0029-554X(82)90805-9
   Wu CM, 1999, POLYMER, V40, P4195, DOI 10.1016/S0032-3861(98)00682-X
   Wu CM, 1998, POLYM BULL, V41, P493, DOI 10.1007/s002890050392
   Zhang X, 2001, J ELECTROCHEM SOC, V148, pA463, DOI 10.1149/1.1362541
NR 102
TC 23
Z9 23
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1350-4495
J9 INFRARED PHYS TECHN
JI Infrared Phys. Technol.
PD OCT
PY 2004
VL 45
IS 5-6
BP 349
EP 364
DI 10.1016/j.infrared.2004.01.015
PG 16
WC Instruments & Instrumentation; Optics; Physics, Applied
SC Instruments & Instrumentation; Optics; Physics
GA 848WT
UT WOS:000223499500005
DA 2018-10-20
ER

PT J
AU Morrison, ML
   Buchanan, RA
   Peker, A
   Peter, WH
   Horton, JA
   Liaw, PK
AF Morrison, ML
   Buchanan, RA
   Peker, A
   Peter, WH
   Horton, JA
   Liaw, PK
TI Cyclic- anodic-polarization studies of a Zr41.2Ti13.8Ni10Cu12.5Be22.5
   bulk metallic glass
SO INTERMETALLICS
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Bulk Metallic Glasses
CY OCT 12-16, 2003
CL Beijing, PEOPLES R CHINA
DE corrosion; glasses, metallic; biomedical applications
ID CORROSION BEHAVIOR; MECHANICAL-PROPERTIES; SUPERCOOLED LIQUID;
   FRACTURE-TOUGHNESS; FATIGUE BEHAVIOR; AMORPHOUS-ALLOYS; DEFORMATION;
   SUPERPLASTICITY; ZR55AL10CU30NI5; MICROSTRUCTURE
AB Cyclic-anodic-polarization tests were conducted on a Zr-based bulk metallic glass (BMG) with a chemical composition of Zr41.2Ti13.8Ni10Cu12.5Be22.5 [Liquidmetal-001, LM-001 (at.%)]. Samples were compared in two different electrolytes at two different temperatures.. Tests were conducted at 22 and 37 degreesC in both, an aerated 0.6 M NaCl electrolyte and a phosphate-buffered saline (PBS) electrolyte with a physiologically relevant dissolved oxygen content. For all tested conditions, the alloy demonstrated passive behavior at the open-circuit potential with low corrosion rates. However, a susceptibility to localized pitting corrosion was observed in all of the tested conditions. At both temperatures, statistical analyses revealed that the LM-001 BMG exhibited comparable or improved values for every corrosion parameter in the PBS electrolyte, as compared to the NaCl electrolyte. The mean differences between the protection potentials and the open-circuit corrosion potentials were determined to be positive values with greater magnitudes for the PBS electrolyte. Thus, the material may undergo pitting corrosion at surface flaws or after incubation-time periods, depending on the local and bulk environments, with lower probabilities for the PBS electrolyte. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   Liquidmet Technol, Lake Forest, CA 92630 USA.
   Oak Ridge Natl Lab, Div Met & Ceram, Oak Ridge, TN 37831 USA.
RP Morrison, ML (reprint author), Univ Tennessee, Dept Mat Sci & Engn, 434 Dougherty Engn Bldg, Knoxville, TN 37996 USA.
EM mmorrison@utk.edu
RI BAI, JIE/D-7448-2016
OI Morrison, Mark/0000-0003-1956-0932
CR Bian Z, 2000, SCRIPTA MATER, V43, P1003, DOI 10.1016/S1359-6462(00)00524-8
   Chieh TC, 2003, MATER LETT, V57, P3022, DOI 10.1016/S0167-577X(02)01424-6
   Flores KM, 1999, SCRIPTA MATER, V41, P937, DOI 10.1016/S1359-6462(99)00243-2
   Gilbert CJ, 1997, APPL PHYS LETT, V71, P476, DOI 10.1063/1.119610
   Hays CC, 2000, PHYS REV LETT, V84, P2901, DOI 10.1103/PhysRevLett.84.2901
   He G, 2001, MATER TRANS, V42, P1109, DOI 10.2320/matertrans.42.1109
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   Hiromoto S, 2002, J ELECTROCHEM SOC, V149, pB117, DOI 10.1149/1.1456921
   Hiromoto S, 2001, MATER TRANS, V42, P656, DOI 10.2320/matertrans.42.656
   Inoue A, 1999, MAT SCI ENG A-STRUCT, V267, P171, DOI 10.1016/S0921-5093(99)00089-1
   Inoue A, 1999, MATER T JIM, V40, P1382, DOI 10.2320/matertrans1989.40.1382
   INOUE A, 1994, MATER T JIM, V35, P85, DOI 10.2320/matertrans1989.35.85
   Inoue A, 1997, MATER SCI FORUM, V243-2, P197
   INOUE A, 1995, MATER T JIM, V36, P689, DOI 10.2320/matertrans1989.36.689
   Inoue A, 1996, MATER T JIM, V37, P1726, DOI 10.2320/matertrans1989.37.1726
   Kawamura Y, 1996, APPL PHYS LETT, V69, P1208, DOI 10.1063/1.117413
   Kawamura Y, 1997, SCRIPTA MATER, V37, P431, DOI 10.1016/S1359-6462(97)00105-X
   Kawamura Y, 1998, ACTA MATER, V46, P253, DOI 10.1016/S1359-6454(97)00235-8
   Koster U, 2001, SCRIPTA MATER, V44, P1649, DOI 10.1016/S1359-6462(01)00875-2
   Pang SJ, 2003, J MATER RES, V18, P1652, DOI 10.1557/JMR.2003.0227
   PECKER A, 1993, APPL PHYS LETT, V63, P2342
   Peter WH, 2003, J NON-CRYST SOLIDS, V317, P187, DOI 10.1016/S0022-3093(02)02009-4
   Peter WH, 2002, INTERMETALLICS, V10, P1157, DOI 10.1016/S0966-9795(02)00130-9
   Peter WH, 2002, INTERMETALLICS, V10, P1125, DOI 10.1016/S0966-9795(02)00152-8
   Schneibel JH, 2001, METALL MATER TRANS A, V32, P2819, DOI 10.1007/s11661-001-1032-7
   Schroeder V, 1998, SCRIPTA MATER, V38, P1481, DOI 10.1016/S1359-6462(98)00089-X
   Stansbury E. E., 2000, FUNDAMENTALS ELECTRO
   Vaidyanathan R, 2001, ACTA MATER, V49, P3781, DOI 10.1016/S1359-6454(01)00263-4
   Wang C, 2002, ACTA METALL SIN, V38, P765
NR 29
TC 61
Z9 66
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-9795
J9 INTERMETALLICS
JI Intermetallics
PD OCT-NOV
PY 2004
VL 12
IS 10-11
BP 1177
EP 1181
DI 10.1016/j.intermet.2004.04.005
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 863MT
UT WOS:000224566700024
DA 2018-10-20
ER

PT J
AU Gomes, ME
   Reis, RL
AF Gomes, ME
   Reis, RL
TI Biodegradable polymers and composites in biomedical applications: from
   catgut to tissue engineering - Part 1 - Available systems and their
   properties
SO INTERNATIONAL MATERIALS REVIEWS
LA English
DT Review
DE biodegradable polymers; natural polymers; synthetic polymers; biomedical
   applications; biocompatibility; degradation
ID STARCH-BASED POLYMERS; IN-VITRO DEGRADATION; CALCIUM-PHOSPHATE
   FORMATION; BIOACTIVE GLASS-CERAMICS; CRUCIATE LIGAMENT RECONSTRUCTION;
   SYNTHETIC ABSORBABLE SUTURE; DRUG-DELIVERY SYSTEMS; SIMULATED
   BODY-FLUID; GEL-PREPARED SILICA; ULTRA-HIGH-STRENGTH
AB Biodegradable polymers form a unique class of materials that created an entirely new concept when originally proposed as biomaterials. That is, for the first time, a material performing a structural application was designed to be completely resorbed and to become weaker over time. This concept was first applied successfully with catgut sutures and later, with more arguable results, on bone fixation plates and pins. Current research on new and improved biodegradable polymers is focused on more sophisticated biomedical applications to solve patients' problems with higher efficacy and the least possible pain. One example is tissue engineering, in which a biodegradable scaffold seeded with an appropriate cell type provides a substitute for damaged human tissue while the natural process of regeneration is completed. An overview is given of the degradation properties and mechanisms of biodegradable polymers, their processability and biocompatibility, focusing on the aspects most relevant to biomedical applications. The main families of biodegradable polymeric systems are described and the systems that are commercially available or that are currently being studied and proposed for specific medical applications are reviewed.
C1 Univ Minho, 3Bs Res Grp, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4810058 Guimaraes, Portugal.
RP Reis, RL (reprint author), Univ Minho, 3Bs Res Grp, Campus Gualtar, P-4710057 Braga, Portugal.
EM rgreis@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008; Gomes,
   Manuela/B-6282-2009
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Gomes,
   Manuela/0000-0002-2036-6291
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Aggarwal N, 1999, CAN J VET RES, V63, P148
   Agrawal C M, 1995, Tissue Eng, V1, P241, DOI 10.1089/ten.1995.1.241
   Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   AIZAWA M, 1995, J CERAM SOC JPN, V103, P992, DOI 10.2109/jcersj.103.992
   ALLOCK HR, 1990, BIODEGRADABLE POLYM, P163
   An YHH, 1997, J MATER SCI-MATER M, V8, P493, DOI 10.1023/A:1018530327291
   ANDRIANO KP, 1993, J APPL BIOMATER, V4, P1, DOI 10.1002/jab.770040102
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ANTIKAINEN T, 1994, PEDIATR NEUROSURG, V21, P77, DOI 10.1159/000120819
   BANNON BP, 1983, 796 STP, P7
   Barbucci R, 2000, J INORG BIOCHEM, V81, P229, DOI 10.1016/S0162-0134(00)00127-6
   BARTHOLOMEW RS, 1981, OPHTHALMOLOGICA, V183, P81, DOI 10.1159/000309144
   Benahmed M, 1996, BIOMATERIALS, V17, P2173, DOI 10.1016/0142-9612(96)00046-4
   Blanco MD, 2000, INT J PHARM, V202, P29, DOI 10.1016/S0378-5173(00)00408-7
   BOEREE NR, 1993, BIOMATERIALS, V14, P793, DOI 10.1016/0142-9612(93)90046-5
   BONFIELD W, 1987, J BIOMECH, V20, P1071, DOI 10.1016/0021-9290(87)90025-X
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOS RRM, 1988, IMPL MAT BIOFUNCT, V8, P245
   BROWN SA, 1990, CLIN IMPL MAT, V9, P123
   BUCHOLZ RW, 1994, J BONE JOINT SURG AM, V76A, P319, DOI 10.2106/00004623-199403000-00001
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Calandrelli L, 2000, POLYMER, V41, P8027, DOI 10.1016/S0032-3861(00)00165-8
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   CASCONE MG, 1993, CYTOTECHNOLOGY, V11, P137, DOI 10.1007/BF00746079
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   CHESMEL K, 1999, BIOMATERIALS, V20, P342
   Cho SB, 1996, J BIOMED MATER RES, V33, P145, DOI 10.1002/(SICI)1097-4636(199623)33:3<145::AID-JBM4>3.0.CO;2-Q
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   Ciapetti G, 1998, J BIOMED MATER RES, V39, P286, DOI 10.1002/(SICI)1097-4636(199802)39:2<286::AID-JBM16>3.0.CO;2-B
   CLAES L, 1990, ADV BIOMAT, V9, P161
   CLEMENS JAM, 1995, THESIS U LEIDEN
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   de Mestral F., 1989, Journal of the European Ceramic Society, V5, P47, DOI 10.1016/0955-2219(89)90008-3
   DEKKER A, 1994, CELL MATER, V4, P101
   DELECRIN J, 1994, CELL MATER, V4, P51
   DelGuerra RS, 1996, J MATER SCI-MATER M, V7, P8, DOI 10.1007/BF00121182
   DelGuerra RS, 1995, J MATER SCI-MATER M, V6, P824
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Dobkowski J, 1999, J BIOMED MATER RES, V47, P234, DOI 10.1002/(SICI)1097-4636(199911)47:2<234::AID-JBM14>3.0.CO;2-X
   Doddi N., 1977, United States Patent, DOI 4,052,988, Patent No. 4052988
   Du C, 2002, BIOMATERIALS, V23, P4649, DOI 10.1016/S0142-9612(02)00214-4
   Dubois JC, 1999, BIOMATERIALS, V20, P1841, DOI 10.1016/S0142-9612(99)00082-4
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   El-Hadi A, 2002, POLYM TEST, V21, P665, DOI 10.1016/S0142-9418(01)00142-8
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   Fu BX, 2002, POLYMER, V43, P5527, DOI 10.1016/S0032-3861(02)00389-0
   FUZUZAKI H, 1991, J BIOMED MATER RES, V25, P315
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2004, INT MATER REV, V49, P274, DOI 10.1179/095066004225021927
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   HANEIN D, 1995, CELL MATER, V5, P197
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Hanson Stephen, 1996, P215
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   HE S, 2000, BIOMATERIALS, V20, P2389
   HENCH LL, 1991, MRS BULL, V16, P62
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   HOLLAND SJ, 1990, BIOMATERIALS, V11, P206, DOI 10.1016/0142-9612(90)90157-L
   HOSSAINY SFA, 1994, BIOMATERIALS, V15, P921, DOI 10.1016/0142-9612(94)90118-X
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   Huang J., 1997, J MATER SCI-MATER M, V8, P808
   IBNABDDJALIL M, 1994, J BIOMED MATER RES, V28, P289, DOI 10.1002/jbm.820280303
   IRTEL SI, 1994, J BIOMED MATER RES, V28, P919
   Karlsson JO, 1997, POLYMER, V38, P4727, DOI 10.1016/S0032-3861(96)01075-0
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   KELLER TS, 1990, J ORTHOPAED RES, V8, P592, DOI 10.1002/jor.1100080416
   Khor HL, 2002, MAT SCI ENG C-BIO S, V20, P71, DOI 10.1016/S0928-4931(02)00015-2
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KIRKPATRICK CJ, 1992, ADV BIOMATER, V10, P53
   KIRKPATRICK J, 1998, MED DEVICE TECHNOL, V9, P22
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1463, DOI 10.1002/jbm.820261106
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1583, DOI 10.1002/jbm.820261205
   KOBAYASHI H, 1991, BIOMATERIALS, V12, P747, DOI 10.1016/0142-9612(91)90024-5
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1996, BIOMATERIALS SCI, V64
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1995, EUR J SOL STATE INOR, V32, P819
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   KOOTEN TG, 1997, J MATER SCI-MATER M, V8, P835
   Koskikare K, 1996, J BIOMED MATER RES, V30, P417, DOI 10.1002/jbm.820300402
   Kunze C, 2003, BIOMATERIALS, V24, P967, DOI 10.1016/S0142-9612(02)00433-7
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kurisawa M, 1997, J BIOMAT SCI-POLYM E, V8, P691, DOI 10.1163/156856297X00506
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   LAITINEN O, 1993, ARCH ORTHOP TRAUM SU, V112, P270, DOI 10.1007/BF00452963
   Langer R, 1999, J CONTROL RELEASE, V62, P7, DOI 10.1016/S0168-3659(99)00057-7
   LANGER R, 1999, SCI AM, V280, P62
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   LEONOR IB, 2002, J MATER SCI-MATER M, V13, P1
   LEONOR IB, 2002, J MATER SCI-MATER M, V13, P935
   Li P, 1997, J BIOMED MATER RES, V34, P79, DOI 10.1002/(SICI)1097-4636(199701)34:1<79::AID-JBM11>3.0.CO;2-K
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   LI PJ, 1995, J BIOMED MATER RES, V29, P325, DOI 10.1002/jbm.820290307
   LI PJ, 1994, J NON-CRYST SOLIDS, V168, P281, DOI 10.1016/0022-3093(94)90340-9
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   Li SH, 1997, BIOMATERIALS, V18, P389, DOI 10.1016/S0142-9612(96)00122-6
   Li SH, 1996, J MATER SCI LETT, V15, P1882, DOI 10.1007/BF00264085
   LIN H, 1992, J BIOMED MATER RES, V26, P7
   Lin HR, 2003, MATER SCI FORUM, V426-4, P3043, DOI 10.4028/www.scientific.net/MSF.426-432.3043
   LITSKY AS, 1993, J APPL BIOMATER, V4, P109, DOI 10.1002/jab.770040116
   Liu Q, 1998, J MATER SCI-MATER M, V9, P23, DOI 10.1023/A:1008826410395
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   MALAFAYA PB, 2003, BIOCERAMICS, V240, P39
   MANNINEN MJ, 1993, J MATER SCI-MATER M, V4, P179, DOI 10.1007/BF00120389
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Marois Y, 2000, J BIOMED MATER RES, V49, P216, DOI 10.1002/(SICI)1097-4636(200002)49:2<216::AID-JBM9>3.0.CO;2-X
   Marques AP, 2003, J MATER SCI-MATER M, V14, P167, DOI 10.1023/A:1022028114896
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   MARTIN RB, 1989, STRUCTURE FUNCTION A
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIDDLETON JC, 1998, MED PLAST BIOMAT MAR, P30
   MOLIU D, 1994, J MATER SCI-MATER M, V5, P7
   NAGAI M, 1991, PHOSPHORUS RES B, V1, P167
   Nguyen NC, 1997, J MATER SCI-MATER M, V8, P473, DOI 10.1023/A:1018574109544
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Ogawa Y, 1997, J BIOMAT SCI-POLYM E, V8, P391, DOI 10.1163/156856297X00173
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   OLIVEIRA JM, 1995, BIOMATERIALS, V16, P849, DOI 10.1016/0142-9612(95)94146-C
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Pachence JM, 1997, PRINCIPLES TISSUE EN, P273
   Park DJ, 2000, ANN OTO RHINOL LARYN, V109, P1157, DOI 10.1177/000348940010901214
   PENICHECOVAS C, 1995, POLYM INT, V38, P45, DOI 10.1002/pi.1995.210380105
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PEREGO G, 1994, BIOMATERIALS, V15, P189, DOI 10.1016/0142-9612(94)90066-3
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   PILLIAR RM, 1984, NATO ASI SER, P97
   PIZZOFERRATO A, 1992, ADV BIOMAT, V10, P63
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Poustis J., 1994, Clinical Materials, V16, P119, DOI 10.1016/0267-6605(94)90106-6
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Radder AM, 1996, J BIOMED MATER RES, V30, P341
   RADDER AM, 1994, J BIOMED MATER RES, V28, P141, DOI 10.1002/jbm.820280202
   RAO JK, 1994, BIOMATERIALS, V15, P5
   Ratner BD, 1997, NATO ADV SCI I E-APP, V346, P453
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   Rawlings Rees D., 1993, Clinical Materials, V14, P155, DOI 10.1016/0267-6605(93)90038-9
   RAY JA, 1981, SURG GYNECOL OBSTET, V153, P497
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.3.CO;2-9
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   Reis RL, 1997, J MATER SCI-MATER M, V8, P897, DOI 10.1023/A:1018514107669
   REIS RL, 1998, J APPL MED POLYM, V2, P49
   REY C, 1990, Biomaterials, V11, P13
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   Rizvi Azam H., 1994, Clinical Materials, V16, P73, DOI 10.1016/0267-6605(94)90100-7
   Roessler M, 2000, J BIOMED MATER RES, V53, P167, DOI 10.1002/(SICI)1097-4636(2000)53:2<167::AID-JBM6>3.3.CO;2-A
   ROKKANEN PU, 1991, ANN MED, V23, P109, DOI 10.3109/07853899109148033
   ROVIRA A, 1993, J MATER SCI-MATER M, V4, P372, DOI 10.1007/BF00122195
   RUIJGROK JM, 1993, THESIS U LEIDEN NETH
   Sahlin JJ, 1997, J BIOMAT SCI-POLYM E, V8, P421, DOI 10.1163/156856297X00362
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   SANTOS JD, 1994, BIOMATERIALS, V15, P5, DOI 10.1016/0142-9612(94)90188-0
   SANTOS JD, 1994, BIOCERAMICS, V7, P243
   SANTOS JD, 1995, J MATER SCI-MATER M, V6, P448
   SARTI B, 1995, BIOMATERIALS, V16, P785, DOI 10.1016/0142-9612(95)99641-X
   SAWADA Y, 1994, BRIT J PLAST SURG, V47, P158, DOI 10.1016/0007-1226(94)90046-9
   Schwarte LM, 1998, POLYMER, V39, P6057, DOI 10.1016/S0032-3861(98)00087-1
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   SHALABY SW, 1995, J APPL BIOMATER, V6, P219, DOI 10.1002/jab.770060313
   SILVA RM, 2003, BIOCERAMICS, V240
   SLIEDREGT A, 1993, THESIS U LEIDEN NETH
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Solchaga LA, 2000, INT CONGR SER, V1196, P233
   SOUEIDAN A, 1995, CELL MATER, V5, P31
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   Sousa RA, 2000, J APPL POLYM SCI, V77, P1303, DOI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
   STOHELIN A, 1995, MED PLASTICS, V9, P8
   STRNAD Z, 1992, BIOMATERIALS, V13, P317, DOI 10.1016/0142-9612(92)90056-T
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   TANAHASHI M, 1995, J MATER SCI-MATER M, V6, P319, DOI 10.1007/BF00120299
   TATEISHI T, 1992, ADV BIOMAT, V10, P89
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thomson R. C., 1995, ADV POLYM SCI, V122, P247
   TORMALA P, 1991, J BIOMED MATER RES, V25, P1, DOI 10.1002/jbm.820250102
   TORMALA P, 1993, CLIN MATER, V13, P35, DOI 10.1016/0267-6605(93)90087-N
   TORMALA P, 1992, Clinical Materials, V10, P29, DOI 10.1016/0267-6605(92)90081-4
   TORMALA P, 1990, Patent No. 4968317
   TORMALA P, 1988, Patent No. 4743257
   UNYI T, 1995, KEY ENG MATER, V103, P221, DOI 10.4028/www.scientific.net/KEM.103.221
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   VAINIONPAA S, 1992, CLIN MAT, V9, P77
   VANBLITTERSWIJK CA, 1993, CELL MATER, V3, P11
   VASENIUS J, 1993, J BIOMED MATER RES, V26, P14
   Vasudev SC, 1997, BIOMATERIALS, V18, P375, DOI 10.1016/S0142-9612(96)00131-7
   Vaz CM, 2002, BIOMATERIALS, V23, P629, DOI 10.1016/S0142-9612(01)00150-8
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   WALLIN R, 1995, MED DEVICE TECHNOL, P34
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   Williams D.F., 1992, ADV BIOMATER, V10, P525
   Xiao YL, 1999, J MATER SCI-MATER M, V10, P773, DOI 10.1023/A:1008946832443
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   YAO KD, 1995, POLYM INT, V38, P77, DOI 10.1002/pi.1995.210380110
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Yoon JS, 1999, POLYMER, V40, P2303, DOI 10.1016/S0032-3861(98)00463-7
   YUEHUEI A, 1997, J MATER SCI-MATER M, V8, P493
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 231
TC 60
Z9 61
U1 0
U2 47
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0950-6608
J9 INT MATER REV
JI Int. Mater. Rev.
PD OCT
PY 2004
VL 49
IS 5
BP 261
EP 273
DI 10.1179/095066004225021918
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA 866RJ
UT WOS:000224790300001
DA 2018-10-20
ER

PT J
AU Gomes, ME
   Reis, RL
AF Gomes, ME
   Reis, RL
TI Biodegradable polymers and composites in biomedical applications: from
   catgut to tissue engineering - Part 2 - Systems for temporary
   replacement and advanced tissue regeneration
SO INTERNATIONAL MATERIALS REVIEWS
LA English
DT Review
DE tissue engineering; biomaterials; biodegradable polymers; scaffolds;
   temporary applications
ID DRUG-DELIVERY SYSTEMS; POROUS POLYESTERURETHANE FOAM; IN-VITRO RELEASE;
   CELL-ADHESION; MECHANICAL-PROPERTIES; DEGRADATION-PRODUCTS; ORTHOPEDIC
   DEVICES; FIBER STRUCTURES; SEEDING DENSITY; BONE-CEMENT
AB During the past century, and particularly in the past three decades, the application of conventional materials technology has resulted in clear advances in substitution medicine. For example, the development of artificial hips and knees have brought enormous benefits to patients. However, there are still no materials available that can adequately replace or aid the regeneration of functional tissues such as bones or large bone segments. In an increasingly aging population, malfunction or loss of tissue from injury or disease has led to reduced quality of life for many patients at significant socio-economic cost. There is thus demand for the development of new therapies through a multidisciplinary, biology driven approach in which biological tissues are engineered using both materials and bio-technologies. Tissue engineering has created a new field of application for biodegradable polymers, paving the way for the development of new classes of biomaterials from synthetic or natural origin and for the design of new materials formats for hybrid tissues. A general overview is provided of the main applications of biodegradable polymers in medicine, with particular emphasis on tissue engineering. The approaches available to tissue engineers and the requirements scaffold materials must fulfil to promote adequate interaction with cells and tissues are described; predictable trends and future developments are discussed. Processing routes for biodegradable polymeric scaffolds are also considered, presenting examples of three-dimensional materials fabricated by different methodologies.
C1 Univ Minho, 3Bs Res Grp, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4810058 Guimaraes, Portugal.
RP Reis, RL (reprint author), Univ Minho, 3Bs Res Grp, Campus Gualtar, P-4710057 Braga, Portugal.
EM rgreis@dep.uminho.pt
RI Gomes, Manuela/B-6282-2009; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012
OI Gomes, Manuela/0000-0002-2036-6291; Reis, Rui L./0000-0002-4295-6129;
   Group, 3Bs/0000-0002-5195-3456
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   AMINABHAVI TM, 1990, POLYM-PLAST TECHNOL, V29, P235, DOI 10.1080/03602559008049843
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   BERSCHT PC, 1995, J MATER SCI-MATER M, V6, P201, DOI 10.1007/BF00146856
   BRAYBROOK JH, 1990, PROG POLYM SCI, V15, P715, DOI 10.1016/0079-6700(90)90009-P
   BREM H, 1994, J NEUROSURG, V80, P283, DOI 10.3171/jns.1994.80.2.0283
   BRONDSTED H, 1991, BIOMATERIALS, V12, P584, DOI 10.1016/0142-9612(91)90056-G
   BRUDER SP, 2000, PRINCIPLES TISSUE EN, V683
   BUCHOLZ RW, 1994, J BONE JOINT SURG AM, V76A, P319, DOI 10.2106/00004623-199403000-00001
   Bures P, 2001, J CONTROL RELEASE, V72, P25, DOI 10.1016/S0168-3659(01)00259-0
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   CHESMEL K, 1999, BIOMATERIALS, V20, P342
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   Coombes AGA, 1997, BIOMATERIALS, V18, P1153, DOI 10.1016/S0142-9612(97)00051-3
   Dee KC, 1996, BIOTECHNOL BIOENG, V50, P438, DOI 10.1002/(SICI)1097-0290(19960520)50:4<438::AID-BIT11>3.0.CO;2-F
   Di Silvio L., 1994, Clinical Materials, V16, P91, DOI 10.1016/0267-6605(94)90102-3
   Dobkowski J, 1999, J BIOMED MATER RES, V47, P234, DOI 10.1002/(SICI)1097-4636(199911)47:2<234::AID-JBM14>3.0.CO;2-X
   Dubois JC, 1999, BIOMATERIALS, V20, P1841, DOI 10.1016/S0142-9612(99)00082-4
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Gomes M., 2002, J APPL MED POLYM, V6, P75
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Gutsche AT, 1996, BIOMATERIALS, V17, P387, DOI 10.1016/0142-9612(96)85577-3
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   HELLER J, 1990, BIOMATERIALS, V11, P345, DOI 10.1016/0142-9612(90)90112-4
   HENCH LL, 1991, MRS BULL, V16, P62
   Holder WD, 1998, J BIOMED MATER RES, V41, P412, DOI 10.1002/(SICI)1097-4636(19980905)41:3<412::AID-JBM11>3.0.CO;2-K
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   HUNT JA, 1992, J MATER SCI-MATER M, V3, P160, DOI 10.1007/BF00713443
   Hutmacher D W, 2000, Med Device Technol, V11, P33
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   HUTMACHER DW, 2002, NATO ASI, V333
   HUTMACHER DW, 2002, 313 NATO ASI
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Ito Y, 1997, BIOMATERIALS, V18, P197, DOI 10.1016/S0142-9612(96)00119-6
   IWAMOTO M, 1993, EXP CELL RES, V207, P413, DOI 10.1006/excr.1993.1209
   Jiang GW, 1998, J BIOMED MATER RES, V43, P77, DOI 10.1002/(SICI)1097-4636(199821)43:1<77::AID-JBM9>3.0.CO;2-J
   Jones DA, 1996, BIOMATERIALS, V17, P337, DOI 10.1016/0142-9612(96)85572-4
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim HD, 1998, TISSUE ENG, V4, P35, DOI 10.1089/ten.1998.4.35
   King TW, 2000, J BIOMED MATER RES, V51, P383, DOI 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D
   KOSE GT, 2002, TISSUE ENG BIODEGRAD, V301
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   Langer K, 1997, INT J PHARM, V158, P211, DOI 10.1016/S0378-5173(97)00256-1
   Langer R, 1999, J CONTROL RELEASE, V62, P7, DOI 10.1016/S0168-3659(99)00057-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Li Y, 2001, BIOMATERIALS, V22, P609, DOI 10.1016/S0142-9612(00)00224-6
   Lin HR, 2002, J BIOMED MATER RES, V63, P271, DOI 10.1002/jbm.10183
   LITSKY AS, 1993, J APPL BIOMATER, V4, P109, DOI 10.1002/jab.770040116
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   MANNINEN MJ, 1993, J MATER SCI-MATER M, V4, P179, DOI 10.1007/BF00120389
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Narasimhan B, 1997, J PHARM SCI, V86, P297, DOI 10.1021/js960372z
   Nguyen NC, 1997, J MATER SCI-MATER M, V8, P473, DOI 10.1023/A:1018574109544
   Nitsch M J, 1994, J Biomater Appl, V8, P247, DOI 10.1177/088532829400800305
   Ogawa Y, 1997, J BIOMAT SCI-POLYM E, V8, P391, DOI 10.1163/156856297X00173
   Ooya T, 1997, J BIOMAT SCI-POLYM E, V8, P437, DOI 10.1163/156856297X00371
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   PEPPAS NA, 1987, J PHARM SCI, V76, P267, DOI 10.1002/jps.2600760319
   PEREGO G, 1994, BIOMATERIALS, V15, P189, DOI 10.1016/0142-9612(94)90066-3
   Poustis J., 1994, Clinical Materials, V16, P119, DOI 10.1016/0267-6605(94)90106-6
   RIVARD CH, 1995, J APPL BIOMATER, V6, P65, DOI 10.1002/jab.770060109
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   SAWADA Y, 1994, BRIT J PLAST SURG, V47, P158, DOI 10.1016/0007-1226(94)90046-9
   Schachter DM, 2002, J CONTROL RELEASE, V78, P143, DOI 10.1016/S0168-3659(01)00487-4
   SCHWARTE LM, 1997, POLYM PREPR, V38, P596
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Tabata Y, 2001, DRUG DISCOV TODAY, V6, P483, DOI 10.1016/S1359-6446(01)01753-6
   Teijon JM, 1997, BIOMATERIALS, V18, P383, DOI 10.1016/S0142-9612(96)00139-1
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thomson R. C., 1995, ADV POLYM SCI, V122, P247
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Thomson RC, 1997, PRINCIPLES TISSUE EN, P263
   TORMALA P, 1991, J BIOMED MATER RES, V25, P1, DOI 10.1002/jbm.820250102
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   VACANTI CA, 1999, CLIN ORTHOP S, V367, P375
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   VERDONSCHOT N, 1995, J BIOMED MATER RES, V29, P575, DOI 10.1002/jbm.820290504
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zignani M, 2000, EUR J PHARM BIOPHARM, V50, P251, DOI 10.1016/S0939-6411(00)00107-7
NR 123
TC 41
Z9 41
U1 1
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0950-6608
EI 1743-2804
J9 INT MATER REV
JI Int. Mater. Rev.
PD OCT
PY 2004
VL 49
IS 5
BP 274
EP 285
DI 10.1179/095066004225021927
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 866RJ
UT WOS:000224790300002
DA 2018-10-20
ER

PT J
AU Hong, YS
   Lau, LS
   Legge, RL
   Chen, P
AF Hong, YS
   Lau, LS
   Legge, RL
   Chen, P
TI Critical self-assembly concentration of an ionic-complementary peptide
   EAK16-I
SO JOURNAL OF ADHESION
LA English
DT Article
DE self-assembly; peptides; critical self-assembly concentration; surface
   tension; nanostructural transition; atomic force microscopy;
   axisymmetric drop shape analysis-profile
ID BIOLOGICAL-MATERIALS; OLIGOPEPTIDE; SALT; MICELLIZATION; ADSORPTION;
   SCAFFOLDS; PROTEINS; MICELLES; KINETICS; TENSION
AB Understanding the process of self-assembly of peptides has been important in various biomedical engineering applications. This work focuses on the effect of peptide concentration on the molecular self-assembly of an ionic-complementary peptide, EAK16-I(AEAKAEAKAEAKAEAK), in aqueous solution. The surface tension and self-assembled nanostructures were determined for a wide range of peptide concentrations using axisymmetric drop shape analysis-profile(ADSA-P)and atomic force microscopy(AFM), respectively. Surface tension measurements revealed a critical self-assembly concentration of 0.3 mg peptide/ml water, below which the surface tension decreased rapidly with increasing peptide concentration, and above which the surface tension remained at a constant, plateau value. There were two structural transitions observed with increasing peptide concentration: the first was from globular nanostructures to fibrils, and the second from the fibrils to relatively thick fibers. The second structural transition occurred at the critical self-assembly concentration as determined by the surface tension measurements. The nanostructural behavior of EAK16-I was compared with that of EAK16-II, which has the same amino acid composition but a different charge distribution. Salt effects were also examined by adding NaCl to the peptide solution. The salt addition facilitated the formation of peptide fibrils at low peptide concentrations but increased the critical self-assembly concentration, which occurred at 0.8 mg peptide/ml water in the presence of 20mM NaCl. The structural transitionsinvolved in the self-assembly of EAK16-I resemble those from protofibrils to fibrils observed with numerous naturally occurring peptides. An understanding of this structural transition may have relevance in the analysis and treatment of peptide/protein conformational diseases and have application in the production of self-assembled protein nanostructures.
C1 Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
RP Chen, P (reprint author), Univ Waterloo, Dept Chem Engn, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
EM p4chen@cape.uwaterloo.ca
RI Legge, Raymond/B-6460-2009
OI Legge, Raymond/0000-0001-9308-8870
CR Borisov OV, 2002, MACROMOLECULES, V35, P4472, DOI 10.1021/ma010934n
   BRACK A, 1975, NATURE, V256, P383, DOI 10.1038/256383a0
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Chen P, 1996, COLLOID SURFACE B, V6, P279, DOI 10.1016/0927-7765(96)01265-9
   Clint J. H., 1992, SURFACTANT AGGREGATI
   de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199
   Dutkiewicz E, 2002, COLLOID POLYM SCI, V280, P1009, DOI 10.1007/s00396-002-0723-y
   Fung SY, 2003, BIOPHYS J, V85, P537, DOI 10.1016/S0006-3495(03)74498-1
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   HIEMENZ PC, 1997, PRINCIPLES COLLOID S, P355
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Jun S, 2004, BIOPHYS J, V87, P1249, DOI 10.1529/biophysj.103.038166
   Khan MO, 1999, MACROMOLECULES, V32, P8836, DOI 10.1021/ma9905627
   KNICHEL M, 1995, SENSOR ACTUAT B-CHEM, V28, P85, DOI 10.1016/0925-4005(94)01543-Q
   Korolev N, 2000, BIOMACROMOLECULES, V1, P648, DOI 10.1021/bm000042f
   Lowe CR, 2000, CURR OPIN STRUC BIOL, V10, P428, DOI 10.1016/S0959-440X(00)00110-X
   Miller R, 2001, COLLOID SURFACE A, V183, P381, DOI 10.1016/S0927-7757(01)00523-4
   MIYAHISHI S, 2001, J COLLOID INTERF SCI, V179, P57
   NANDI PK, 1972, J AM CHEM SOC, V94, P1299, DOI 10.1021/ja00759a042
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   PICULELL L, 1990, PROG COLL POL SCI S, V82, P198
   Ropers MH, 2003, J PHYS CHEM B, V107, P5281, DOI 10.1021/jp0264329
   Strong AE, 1999, J MATER CHEM, V9, P1097, DOI 10.1039/a806860g
   STRONG AE, 1998, CHEM COMMUN, V4, P473
   Tu EB, 1997, LANGMUIR, V13, P4234, DOI 10.1021/la9620770
   vanderVegt W, 1996, J COLLOID INTERF SCI, V179, P57, DOI 10.1006/jcis.1996.0188
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Whaley SR, 2000, NATURE, V405, P665
   Zhang L, 1996, LANGMUIR, V12, P2371, DOI 10.1021/la950670w
   ZHANG S, 2002, BIOTECHNOL ADV, V20, P339
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 35
TC 30
Z9 33
U1 1
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0021-8464
J9 J ADHESION
JI J. Adhes.
PD OCT-NOV
PY 2004
VL 80
IS 10-11
BP 913
EP 931
DI 10.1080/00218460490508616
PG 19
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 865LN
UT WOS:000224704700003
DA 2018-10-20
ER

PT J
AU Silva, RM
   Silva, GA
   Coutinho, OP
   Mano, JF
   Reis, RL
AF Silva, RM
   Silva, GA
   Coutinho, OP
   Mano, JF
   Reis, RL
TI Preparation and characterisation in simulated body conditions of
   glutaraldehyde crosslinked chitosan membranes
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID N-ACETYLATED CHITOSANS; STARCH-BASED POLYMERS; IN-VITRO DEGRADATION;
   HYDROGEL MEMBRANES; BIOCOMPATIBILITY; LINKING; CHITIN; FILMS; ACID;
   PROLIFERATION
AB Chitosan membranes, aimed at biomedical applications, were prepared by a solvent casting methodology. Crosslinking was previously performed in acetic acid solution with glutaraldehyde, in order to obtain different degrees of crosslinking. Some membranes were neutralised in a NaOH solution. Mechanical tensile tests comprised quasi-static experiments at constant stress rate and temperature sweep dynamic mechanical analysis tests. This included measurements with the samples immersed in isotonic saline solution at 37degreesC, in order to simulate physiological conditions, that were performed using a specific liquid container. It was observed that for higher crosslinking levels the membranes become stiffer but their strength decreases; these results are in agreement with swelling tests, also performed at body temperature. All the membranes exhibited similar and significant damping properties in wet conditions, which were stable in a broad temperature range. Weight loss measurements showed that the developed membranes degrade slowly up to 60 days. Cytotoxicity screening, using cell culture tests, showed that eventually such materials could be adequate for use in biomedical applications. (C) 2004 Kluwer Academic Publishers.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   3Bs Res Grp, P-4710053 Braga, Portugal.
   Univ Minho, Dept Biol, P-4710053 Braga, Portugal.
RP Silva, RM (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
EM ricardosilva@dep.uminho.pt
RI Mano, Joao/A-4418-2009; silva, gabriela/F-4409-2012; da Silva,
   Ricardo/C-1143-2011; Reis, Rui L./A-8938-2008; Coutinho,
   Olga/K-7155-2013; Group, 3Bs/E-4374-2012
OI Mano, Joao/0000-0002-2342-3765; silva, gabriela/0000-0001-5946-1918; da
   Silva, Ricardo/0000-0003-1456-8724; Reis, Rui L./0000-0002-4295-6129;
   Group, 3Bs/0000-0002-5195-3456; Coutinho, Olga/0000-0002-0647-080X
CR AIBA S, 1994, CARBOHYD RES, V261, P297, DOI 10.1016/0008-6215(94)84025-3
   Begin A, 1999, INT J BIOL MACROMOL, V26, P63, DOI 10.1016/S0141-8130(99)00064-1
   Ge JJ, 2000, J MEMBRANE SCI, V165, P75, DOI 10.1016/S0376-7388(99)00228-8
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Hwang KT, 2003, J APPL POLYM SCI, V89, P3476, DOI 10.1002/app.12561
   Krajewska B, 2001, J CHEM TECHNOL BIOT, V76, P636, DOI 10.1002/jctb.429.abs
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kurita K, 2000, CARBOHYD POLYM, V42, P19, DOI 10.1016/S0144-8617(99)00127-7
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Li F, 2002, BIOMATERIALS, V23, P343, DOI 10.1016/S0142-9612(01)00111-9
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mi FL, 2000, J POLYM SCI POL CHEM, V38, P2804, DOI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.3.CO;2-P
   Mi FL, 2001, J BIOMAT SCI-POLYM E, V12, P835, DOI 10.1163/156856201753113051
   Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Musale DA, 2000, SEP PURIF TECHNOL, V21, P27, DOI 10.1016/S1383-5866(00)00188-X
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   Reis RL, 1997, POLYM INT, V43, P347
   Rinaudo M, 1999, POLYMER, V40, P7029, DOI 10.1016/S0032-3861(99)00056-7
   Risbud MV, 2001, J MATER SCI-MATER M, V12, P75, DOI 10.1023/A:1026769422026
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sridhar S, 2001, POLYM INT, V50, P1156, DOI 10.1002/pi.761
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   TUZLAKOGLU K, IN PRESS MACROMOL BI
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Varum KM, 1996, BBA-GEN SUBJECTS, V1291, P5, DOI 10.1016/0304-4165(96)00038-4
   Wang XP, 2000, J APPL POLYM SCI, V75, P740, DOI 10.1002/(SICI)1097-4628(20000207)75:6<740::AID-APP2>3.0.CO;2-3
   Winblade ND, 2002, J BIOMED MATER RES, V59, P618, DOI 10.1002/jbm.1273
NR 33
TC 64
Z9 65
U1 3
U2 31
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2004
VL 15
IS 10
BP 1105
EP 1112
DI 10.1023/B:JMSM.0000046392.44911.46
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 866VR
UT WOS:000224802000007
PM 15516871
DA 2018-10-20
ER

PT J
AU Neumann, A
   Reske, T
   Held, M
   Jahnke, K
   Ragoss, C
   Maier, HR
AF Neumann, A
   Reske, T
   Held, M
   Jahnke, K
   Ragoss, C
   Maier, HR
TI Comparative investigation of the biocompatibility of various silicon
   nitride ceramic qualities in vitro
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IMPLANT MATERIALS; CELLS; INVITRO; TOXICITY; CULTURE; TISSUE; INVIVO;
   SYSTEM
AB There is a controversy about the biocompatibility of silicon nitride ceramics contained in the literature, which appears to be related to a factor of the individual chemical composition of different qualities of silicon nitride ceramics and of the different surface properties. This study attempts to investigate the cytotoxicity of different qualities of industrial silicon nitride ceramics applying an L929-cell culture model in a direct contact assay combined with a cell viability assessment. Five different qualities of industrial standard silicon nitride ceramics were chosen for in vitro testing. The chemical composition was determined by EDS analysis. Different biomedically approved aluminium oxide qualities, a titanium alloy, glass and polyvinylchloride (PVC) served as control materials. L929 mice fibroblasts were incubated directly on the materials for 24 h, stained with bisbenzimide and propidium iodine for double fluorochromasia viability testing, and evaluated by inversion-fluorescence microscopy to control cell morphology, viability and cell counts compared to empty well values. Scanning electron microscopy was applied to additionally investigate cell morphology. There was no observation of cytotoxic effects on the silicon nitride ceramic samples; moreover cell morphology remained the same as on aluminium oxide and titanium. Viability testing revealed the presence of avital cells exclusively on PVC, which served as a negative control. Cell counts on all polished surfaces showed significantly higher numbers, whereas some rough surface samples showed significantly lower numbers. We conclude that silicon nitride ceramics show no cytotoxic effects and should be considered for biomedical application owing to its favourable physiochemical properties, especially its superior resistance to mechanical stress, which would be useful for compression loaded conditions. Polished surfaces would appear to promote advanced biocompatibility. (C) 2004 Kluwer Academic Publishers.
C1 Univ Essen Gesamthsch, Dept Otorhinolaryngol, D-45122 Essen, Germany.
   Inst Ceram Components Engn, D-52072 Aachen, Germany.
RP Neumann, A (reprint author), Univ Essen Gesamthsch, Dept Otorhinolaryngol, Hufelandstr 55, D-45122 Essen, Germany.
EM andreas.neumann@uni-essen.de
CR Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   AMMAR A, 1984, ACTA NEUROCHIR, V72, P45, DOI 10.1007/BF01406813
   CHAWLA AS, 1982, J BIOMED MATER RES, V16, P501, DOI 10.1002/jbm.820160415
   CRISSMAN HA, 1987, EXP CELL RES, V173, P256, DOI 10.1016/0014-4827(87)90350-8
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   Doran A, 1998, BIOMATERIALS, V19, P751, DOI 10.1016/S0142-9612(97)00209-3
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   GROSS U, 1987, ADV BIOMATER, V7, P547
   HEIMKE G, 1980, MED BIOL ENG COMPUT, V18, P503, DOI 10.1007/BF02443328
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   JAHNKE K, 1983, BIOMATERIALS, V4, P137, DOI 10.1016/0142-9612(83)90056-X
   JOHNSON HJ, 1983, J BIOMED MATER RES, V17, P571, DOI 10.1002/jbm.820170403
   Johnsson R I, 1968, Ann N Y Acad Sci, V146, P66, DOI 10.1111/j.1749-6632.1968.tb20271.x
   KAWAHARA H, 1983, INT DENT J, V33, P350
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   LATT SA, 1976, J HISTOCHEM CYTOCHEM, V24, P24, DOI 10.1177/24.1.943439
   MENGUCCI P, 1998, BIOMATERIALS, V17, P1339
   Neumann A, 2003, MATERIALWISS WERKST, V34, P1052, DOI 10.1002/mawe.200300704
   NORTHUP SJ, 1988, HDB BIOMATERIALS EVA, P209
   PLESTER D, 1981, AM J OTOL, V3, P104
   Polonchuk L, 2000, BIOMATERIALS, V21, P539, DOI 10.1016/S0142-9612(99)00189-1
   RICE RM, 1978, J BIOMED MATER RES, V12, P43, DOI 10.1002/jbm.820120105
   RICHERSON DW, 1989, MATER SCI FORUM, V47, P282
   ROSENBLUTH SA, 1965, J PHARM SCI-US, V54, P156, DOI 10.1002/jps.2600540139
   SOHRABI A, 1998, BIOCERAMICS, V11, P309
   Svensson I, 1997, AM J IND MED, V31, P335, DOI 10.1002/(SICI)1097-0274(199703)31:3<335::AID-AJIM10>3.0.CO;2-1
   TAS J, 1981, J HISTOCHEM CYTOCHEM, V29, P929, DOI 10.1177/29.8.6168679
   Wilsnack R E, 1973, Biomater Med Devices Artif Organs, V1, P543
NR 28
TC 58
Z9 67
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2004
VL 15
IS 10
BP 1135
EP 1140
DI 10.1023/B:JMSM.0000046396.14073.92
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 866VR
UT WOS:000224802000011
PM 15516875
DA 2018-10-20
ER

PT J
AU Kricheldorf, HR
AF Kricheldorf, HR
TI Biodegradable polymers with variable architectures via ring-expansion
   polymerization
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE A-B-A triblock copolymers; biodegradable; lactide; lactones; networks;
   ring-opening polymerization
ID CYCLIC TIN-ALKOXIDE; MACROCYCLIC POLYMERIZATION; EPSILON-CAPROLACTONE;
   L-LACTIDE; OPENING POLYCONDENSATION; TELECHELIC POLYLACTONES; MULTIBLOCK
   COPOLYESTERS; TRIMETHYLENE CARBONATE; TRIBLOCK COPOLYMERS; INITIATORS
AB Kinetically controlled ring-expansion polymerizations (REPs) are defined syntheses generating cyclic oligomers and polymers without linear intermediates and without equilibration reactions. This review reports syntheses of cyclic metal alkoxides and their use as initiators for REPs of lactones, cyclic diesters, and cyclocarbonates. In addition to homopolyesters. telechelic oligoesters or polyesters. random copolyesters, and A-B-A triblock copolymers can be prepared by these REPs. The in situ combination of REPs with condensation (mostly acylation) reactions allows a broad variation of end groups. The in situ combination of REPs with polycondensation enables various chain-extension reactions, including the syntheses of multiblock copolymers. With spirocyclic initiators, four-armed stars with functional end groups may be prepared. The in situ combination of REPs with condensation reactions of trifunctional or multifunctional reagents makes a broad variety of networks accessible. The average segment lengths may be controlled via the monomer/initiator ratios of the REP. All materials produced via the aforementioned REP processes are biodegradable and nontoxic, and this allows for biomedical and pharmaceutical applications. (C) 2004 Wiley Periodicals, Inc.
C1 Inst Tech & Makromol Chem, D-20146 Hamburg, Germany.
RP Kricheldorf, HR (reprint author), Inst Tech & Makromol Chem, Bundesstr 45, D-20146 Hamburg, Germany.
EM kricheld@chemie.uni-hamburg.de
CR BORNSTEIN J, 1959, J ORG CHEM, V24, P886, DOI 10.1021/jo01088a627
   CONSIDIN.WJ, 1966, J ORGANOMET CHEM, V5, P263, DOI 10.1016/S0022-328X(00)80364-2
   Kowalski A, 2000, MACROMOLECULES, V33, P1964, DOI 10.1021/ma991751s
   Kricheldorf H., 1994, POLYM PREPR, V35, P502
   Kricheldorf HR, 2003, MACROMOL RAPID COMM, V24, P359, DOI 10.1002/marc.200390063
   Kricheldorf HR, 2004, MACROMOL CHEM PHYSIC, V205, P1031, DOI 10.1002/macp.200400027
   Kricheldorf HR, 2004, POLYMER, V45, P3205, DOI 10.1016/j.polymer.2004.02.059
   KRICHELDORF HR, 1991, MACROMOLECULES, V24, P1944, DOI 10.1021/ma00008a035
   Kricheldorf HR, 2000, J MACROMOL SCI PURE, V37, P379, DOI 10.1081/MA-100101099
   Kricheldorf HR, 2003, BIOMACROMOLECULES, V4, P950, DOI 10.1021/bm0300148
   Kricheldorf HR, 2003, MACROMOLECULES, V36, P2302, DOI 10.1021/ma020812a
   Kricheldorf HR, 2002, POLYMER, V43, P1973, DOI 10.1016/S0032-3861(01)00745-5
   Kricheldorf HR, 1999, MACROMOL CHEM PHYSIC, V200, P587, DOI 10.1002/(SICI)1521-3935(19990301)200:3<587::AID-MACP587>3.0.CO;2-D
   Kricheldorf HR, 2002, MACROMOL CHEM PHYSIC, V203, P405, DOI 10.1002/1521-3935(20020101)203:2<405::AID-MACP405>3.0.CO;2-N
   Kricheldorf HR, 2001, BIOMACROMOLECULES, V2, P1110, DOI 10.1021/bm0100561
   Kricheldorf HR, 2002, J POLYM SCI POL CHEM, V40, P1047, DOI 10.1002/pola.10177
   Kricheldorf HR, 2001, MACROMOLECULES, V34, P3517, DOI 10.1021/ma001999d
   KRICHELDORF HR, 1988, MACROMOLECULES, V21, P286, DOI 10.1021/ma00180a002
   Kricheldorf HR, 2001, MACROMOL CHEM PHYSIC, V202, P1219, DOI 10.1002/1521-3935(20010401)202:7<1219::AID-MACP1219>3.0.CO;2-U
   Kricheldorf HR, 2000, MACROMOLECULES, V33, P696, DOI 10.1021/ma9909915
   Kricheldorf HR, 1999, MACROMOL CHEM PHYSIC, V200, P1726, DOI 10.1002/(SICI)1521-3935(19990701)200:7<1726::AID-MACP1726>3.0.CO;2-B
   Kricheldorf HR, 1999, MACROMOL CHEM PHYSIC, V200, P1183, DOI 10.1002/(SICI)1521-3935(19990501)200:5<1183::AID-MACP1183>3.0.CO;2-K
   Kricheldorf HR, 1999, J MACROMOL SCI PURE, VA36, P795, DOI 10.1081/MA-100101564
   Kricheldorf HR, 1999, MACROMOL RAPID COMM, V20, P319, DOI 10.1002/(SICI)1521-3927(19990601)20:6<319::AID-MARC319>3.3.CO;2-6
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P273, DOI 10.1002/(SICI)1521-3935(19980201)199:2<273::AID-MACP273>3.3.CO;2-4
   Kricheldorf HR, 1999, J POLYM SCI POL CHEM, V37, P2179, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2179::AID-POLA33>3.0.CO;2-X
   Kricheldorf HR, 1998, MACROMOLECULES, V31, P614, DOI 10.1021/ma971055x
   Kricheldorf HR, 1999, MACROMOL CHEM PHYSIC, V200, P1174, DOI 10.1002/(SICI)1521-3935(19990501)200:5<1174::AID-MACP1174>3.0.CO;2-G
   Kricheldorf HR, 1998, J POLYM SCI POL CHEM, V36, P1373, DOI 10.1002/(SICI)1099-0518(19980715)36:9<1373::AID-POLA4>3.0.CO;2-U
   Kricheldorf HR, 1998, MACROMOLECULES, V31, P6403, DOI 10.1021/ma980246c
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P283, DOI 10.1002/(SICI)1521-3935(19980201)199:2<283::AID-MACP283>3.3.CO;2-0
   Kricheldorf HR, 1996, MACROMOLECULES, V29, P8689, DOI 10.1021/ma960927c
   KRICHELDORF HR, 1995, MACROMOLECULES, V28, P6718, DOI 10.1021/ma00124a004
   Kricheldorf HR, 1999, MACROMOLECULES, V32, P3559, DOI 10.1021/ma981134o
   Kricheldorf HR, 2001, MACROMOL CHEM PHYSIC, V202, P2525, DOI 10.1002/1521-3935(20010801)202:12<2525::AID-MACP2525>3.0.CO;2-C
   Kricheldorf HR, 2001, MACROMOL BIOSCI, V1, P364, DOI 10.1002/1616-5195(20011101)1:8<364::AID-MABI364>3.0.CO;2-Q
   Kricheldorf HR, 1996, MACROMOLECULES, V29, P1375, DOI 10.1021/ma9509826
   KRICHELDORF HR, 2002, BIOMACROMOLECULES, V3, P699
   KRICHELDORF HR, 2004, UNPUB
   KRICHELDORF HR, 2003, MACROMOLECULES
   KRICHELDORF HR, UNPUB MACROMOLECULES
   KRICHELDORF HR, IN PRESS BIOMACROMOL
   MCLAINE SJ, 1992, POLYM PREPR, V33, P179
   MEKROTRA RG, 1965, J ORGANOMET CHEM, V4, P145
   PASCH H, 1995, J CHROMATOGR A, V699, P24
   POMMIER JC, 1968, J ORGANOMET CHEM, V12, P433, DOI 10.1016/S0022-328X(00)88696-9
   RAMESDEN HE, 1957, Patent No. 2789994
   Ryner M, 2001, MACROMOLECULES, V34, P7281, DOI 10.1021/ma0106898
   SMITH PJ, 1972, J ORGANOMET CHEM, V40, P341, DOI 10.1016/S0022-328X(00)93372-2
   SOSNOWSKI S, 2002, COLLOID POLYM SCI, P280
   Stridsberg K, 1999, J POLYM SCI POL CHEM, V37, P3407, DOI 10.1002/(SICI)1099-0518(19990815)37:16<3407::AID-POLA40>3.3.CO;2-O
   Stridsberg K, 2000, MACROMOLECULES, V33, P2862, DOI 10.1021/ma991811u
NR 52
TC 81
Z9 87
U1 1
U2 26
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD OCT 1
PY 2004
VL 42
IS 19
BP 4723
EP 4742
DI 10.1002/pola.20261
PG 20
WC Polymer Science
SC Polymer Science
GA 854SD
UT WOS:000223922700001
OA Bronze
DA 2018-10-20
ER

PT J
AU Schultz-Darken, NJ
   Pape, RM
   Tannenbaum, PL
   Saltzman, W
   Abbott, DH
AF Schultz-Darken, NJ
   Pape, RM
   Tannenbaum, PL
   Saltzman, W
   Abbott, DH
TI Novel restraint system for neuroendocrine studies of socially living
   common marmoset monkeys
SO LABORATORY ANIMALS
LA English
DT Article
DE marmoset; restraint; long-term sampling; reproductive
   neuroendocrinology; behavioural adaptation; methods; cortisol
ID CALLITHRIX-JACCHUS; LUTEINIZING-HORMONE; NONHUMAN-PRIMATES;
   BIOMEDICAL-RESEARCH; RHESUS-MONKEY; LH-SECRETION; SEX STEROIDS; STRESS;
   SUPPRESSION; CORTISOL
AB We describe a novel soft jacket and sling-harness restraint that permits species-typical postures for small-bodied primates, such as the common marmoset (Callithrix jacchus), during long-term (> 6 h), continuous restraint. The restraint system is straightforward to use and manipulate, it is easily repaired, and the materials used are readily available. The soft jacket allows for increased versatility and longevity, and the sling-harness provides for greater movement and much longer duration of continuous restraint (up to 3 days) compared to a previously described, more conventional chair restraint for small-bodied primates. The new restraint system prevents the normal diurnal decrease in plasma cortisol levels across the daylight hours; however, it does not disrupt ovulatory cycles. Unlike the previously available techniques, therefore, this new restraint system is applicable to many neurobiological and neuroendocrine studies involving small-bodied, non-human primates and is especially suited to investigations requiring the maintenance of relationships within social groups.
C1 Univ Wisconsin, Natl Primate Res Ctr, Madison, WI 53715 USA.
   Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.
   Pharmaceut Res & Dev, Raritan, NJ 08869 USA.
   Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.
RP Schultz-Darken, NJ (reprint author), Univ Wisconsin, Natl Primate Res Ctr, 1220 Capitol Court, Madison, WI 53715 USA.
EM darken@primate.wisc.edu
FU NIMH NIH HHS [MH11417, MH53709]; NICHD NIH HHS [HD07678]; NCRR NIH HHS
   [RR000167]
CR Abbott D.H., 1991, P295
   Abbott D. H., 1993, P152
   Abbott D.H., 1992, P245
   Abbott D. H., 1993, PRIMATE SOCIAL CONFL, P331
   Abbott DH, 1997, ANN NY ACAD SCI, V807, P219, DOI 10.1111/j.1749-6632.1997.tb51923.x
   Abbott DH, 1998, COMP BIOCHEM PHYS C, V119, P261, DOI 10.1016/S0742-8413(98)00015-2
   ABBOTT DH, 1988, J ENDOCRINOL, V117, P329, DOI 10.1677/joe.0.1170329
   ABBOTT DH, 1987, J ZOOL, V213, P455, DOI 10.1111/j.1469-7998.1987.tb03720.x
   Abbott DH, 2003, COMPARATIVE MED, V53, P339
   ABBOTT DH, 1984, AM J PRIMATOL, V6, P169, DOI 10.1002/ajp.1350060305
   *APN NONH PRIM NUT, 1978, NUTR REQ NONH PRIM
   Baker JV, 1999, ANIM BEHAV, V58, P501, DOI 10.1006/anbe.1999.1200
   BARRETT J, 1990, J REPROD FERTIL, V90, P411
   BARRETT J, 1993, J REPROD FERTIL, V97, P301
   BLUM B, 1983, BRAIN RES BULL, V11, P399, DOI 10.1016/0361-9230(83)90174-0
   Bogert L.J., 1973, NUTR PHYS FITNESS
   Cameron JL, 1997, SEMIN REPROD ENDOCR, V15, P37, DOI 10.1055/s-2008-1067966
   CHEN MD, 1992, NEUROENDOCRINOLOGY, V56, P666, DOI 10.1159/000126291
   COE CL, 1992, AM J PRIMATOL, V28, P81, DOI 10.1002/ajp.1350280202
   COELHO AM, 1990, LAB ANIM SCI, V40, P388
   Collins P, 1998, J COGNITIVE NEUROSCI, V10, P332, DOI 10.1162/089892998562771
   DEELVIRA MCR, 1986, LAB ANIM, V20, P329, DOI 10.1258/002367786780808811
   Ferris CF, 2001, NEUROREPORT, V12, P2231, DOI 10.1097/00001756-200107200-00037
   French Jeffrey A., 1997, P34
   FRIDAY KE, 1990, AM J CLIN NUTR, V51, P470
   GEARING M, 1988, BRAIN RES BULL, V21, P117, DOI 10.1016/0361-9230(88)90126-8
   HARLOW CR, 1983, J ZOOL, V201, P273
   Hearn J.P., 1983, P181
   HEARN JP, 1977, LAB ANIM, V11, P261, DOI 10.1258/002367777780936459
   Kam K, 2000, ENDOCRINE, V12, P279, DOI 10.1385/ENDO:12:3:279
   KERR GR, 1972, PHYSIOL REV, V52, P415
   Mansfield K, 2003, COMPARATIVE MED, V53, P383
   NORMAN RL, 1994, BIOL REPROD, V50, P16, DOI 10.1095/biolreprod50.1.16
   OBYRNE KT, 1988, LAB ANIM, V22, P148, DOI 10.1258/002367788780864501
   OBYRNE KT, 1988, LAB ANIM, V22, P151, DOI 10.1258/002367788780864475
   OBYRNE KT, 1989, PHYSIOL BEHAV, V45, P1077, DOI 10.1016/0031-9384(89)90241-2
   Owen S, 1997, LAB ANIM, V31, P289, DOI 10.1258/002367797780596149
   PRYCE CR, 1993, BEHAV PROCESS, V30, P201, DOI 10.1016/0376-6357(93)90133-C
   PRYCE CR, 1993, J COMP PSYCHOL, V107, P99, DOI 10.1037//0735-7036.107.1.99
   Saltzman W, 1996, ANIM BEHAV, V51, P657, DOI 10.1006/anbe.1996.0070
   Saltzman W, 1998, HORM BEHAV, V33, P58, DOI 10.1006/hbeh.1998.1436
   SALTZMAN W, 1994, PHYSIOL BEHAV, V56, P801, DOI 10.1016/0031-9384(94)90246-1
   Scott L, 1994, MARMOSET ROLE PHARM, P1
   Smith TE, 1997, PHYSIOL BEHAV, V62, P225, DOI 10.1016/S0031-9384(97)00103-0
   Sokal R.R, 1995, BIOMETRY
   Stevenson M. F., 1988, ECOLOGY BEHAVIOUR NE, V2, P131
   SUMMERS PM, 1985, J REPROD FERTIL, V73, P133
   Tan Zhengguo, 2002, Journal of UOEH, V24, P361
   Tardif Suzette D., 1997, P11
   Tilbrook AJ, 2002, STRESS, V5, P83, DOI 10.1080/10253890290027912
   Tilbrook AJ, 1999, J ENDOCRINOL, V160, P469, DOI 10.1677/joe.0.1600469
   Turner AI, 2002, J ENDOCRINOL, V173, P113, DOI 10.1677/joe.0.1730113
   Wade CE, 1997, CONTEMP TOP LAB ANIM, V36, P55
NR 53
TC 17
Z9 17
U1 1
U2 3
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0023-6772
J9 LAB ANIM-UK
JI Lab. Anim.
PD OCT
PY 2004
VL 38
IS 4
BP 393
EP 405
DI 10.1258/0023677041958918
PG 13
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 860LV
UT WOS:000224346000006
PM 15479554
OA Bronze
DA 2018-10-20
ER

PT J
AU Han, HD
   Nam, DE
   Seo, DH
   Kim, TW
   Shin, BC
   Choi, HS
AF Han, HD
   Nam, DE
   Seo, DH
   Kim, TW
   Shin, BC
   Choi, HS
TI Preparation and biodegradation of thermosensitive chitosan hydrogel as a
   function of pH and temperature
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE sol-gel transition; chitosan hydrogel; biodegradation
ID BIOMEDICAL APPLICATIONS; N-ISOPROPYLACRYLAMIDE; CONTROLLED-RELEASE;
   IN-VITRO; DELIVERY; TISSUE; DRUG; BIOCOMPATIBILITY; COPOLYMERS;
   LIPOSOMES
AB We have developed an injectable thermosensitive hydrogel for local drug delivery to treat cancers clinically. We selected chitosan as a polymer matrix because of its biocompatibility and biodegradability. Glycerol 2-phosphate disodium salt hydrate (beta-GP) was used to neutralize the chitosan solution to physiological pH. The chitosan solution displayed a sol-gel phase transition in a pH- and temperature-dependent manner and formed an endothermic hydrogel after subcutaneous injection into mouse in the presence of beta-GP Additionally, we evaluated the biodegradation of chitosan hydrogel in mice by measuring the volume of injected chitosan hydrogel after subcutaneous injection. The injected chitosan hydrogel in mice was sected and stained with hematoxylin-eosin reagent for histological observation to confirm biodegradation of the hydrogel by the infiltrated cells. Chitosan hydrogel systems that possess biocompatibility and biodegradability could be promising thermosensitive injectable materials useful as depot systems for local anti-cancer drug delivery.
C1 Korea Res Inst Chem Technol, Adv Mat Div, Taejon 305606, South Korea.
   Chungnam Natl Univ, Dept Chem Engn, Taejon 305764, South Korea.
RP Shin, BC (reprint author), Korea Res Inst Chem Technol, Adv Mat Div, POB 107, Taejon 305606, South Korea.
EM bcshin@pado.krict.re.kr
CR Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kofuji K, 2004, INT J PHARM, V272, P65, DOI 10.1016/j.ijpharm.2003.11.036
   Lee JW, 2003, MACROMOL RES, V11, P189, DOI 10.1007/BF03218351
   Lee SB, 2004, MACROMOL RES, V12, P269, DOI 10.1007/BF03218399
   Liu HF, 2004, J BIOMAT SCI-POLYM E, V15, P25, DOI 10.1163/156856204322752219
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Matthew H. W. T., 2000, BIOMATERIALS, V21, P2589
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Paavola A, 2000, INT J PHARM, V199, P85, DOI 10.1016/S0378-5173(00)00376-8
   Park YS, 2004, POLYM-KOREA, V28, P59
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   Ruel-Gariepy E, 2000, INT J PHARM, V203, P89, DOI 10.1016/S0378-5173(00)00428-2
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Unezaki S, 1996, INT J PHARM, V144, P11, DOI 10.1016/S0378-5173(96)04674-1
   Zhao HR, 2002, BIOMATERIALS, V23, P4459, DOI 10.1016/S0142-9612(02)00162-X
NR 22
TC 33
Z9 34
U1 5
U2 39
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD OCT
PY 2004
VL 12
IS 5
BP 507
EP 511
DI 10.1007/BF03218435
PG 5
WC Polymer Science
SC Polymer Science
GA 868XX
UT WOS:000224947500013
DA 2018-10-20
ER

PT J
AU Loong, CK
   Thiyagarajan, P
   Kolesnikov, AI
AF Loong, CK
   Thiyagarajan, P
   Kolesnikov, AI
TI Neutron-scattering characterization of nanostructured materials relevant
   to biotechnology
SO NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Nanoscale Devices and System Integration Conference (NDSI-2004)
CY FEB 15-19, 2004
CL Miami, FL
ID MECHANICAL FORCE-FIELDS; NUCLEIC-ACID BASES; VIBRATIONAL DYNAMICS;
   OPTICAL SPECTROSCOPIES; INELASTIC-SCATTERING; PROTEIN DYNAMICS;
   AMORPHOUS ICE; REFLECTIVITY; FIBRIL; BONE
AB Biomedical nanotechnology is a rapidly emerging field that encompasses many disciplines including medicine, molecular biology, materials physics and chemistry, engineering, etc. The complexity of the targeted systems demands cross-disciplinary research and international collaboration. In the materials front, understanding the fundamental properties at molecular level is important to the realization of the full potential of substances and the fruition of eventual technological applications. Neutron-scattering characterization of biomolecular systems can in principle provide unique information pertinent to nanotechnological applications. But the method is not widely utilized because neutron facilities are not normally located at industrial laboratories and university campuses. We introduce the techniques of neutron scattering for studying the organization of nanoscale structural units and their dynamic response to physical-chemical conditions. Examples are given to illustrate neutron characterization of nanostructured biomaterials and the implications for biotechnology.
C1 Argonne Natl Lab, Intense Pulsed Neutron Source Div, Argonne, IL 60439 USA.
RP Loong, CK (reprint author), Argonne Natl Lab, Intense Pulsed Neutron Source Div, 9700 S Cass Ave, Argonne, IL 60439 USA.
EM ckloong@anl.gov
RI Kolesnikov, Alexander/I-9015-2012
OI Kolesnikov, Alexander/0000-0003-1940-4649
CR Aamouche A, 1996, J PHYS CHEM-US, V100, P5224, DOI 10.1021/jp952485x
   Aamouche A, 1997, J PHYS CHEM A, V101, P1808, DOI 10.1021/jp962318c
   Aamouche A, 1997, J PHYS CHEM A, V101, P10063, DOI 10.1021/jp972037k
   Burkoth TS, 2000, J AM CHEM SOC, V122, P7883, DOI 10.1021/ja000645z
   Charitat T, 1999, EUR PHYS J B, V8, P583, DOI 10.1007/s100510050725
   CHEN SH, 1986, ANNU REV PHYS CHEM, V37, P351, DOI 10.1146/annurev.pc.37.100186.002031
   Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445
   DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0
   Dresselhaus M.S., 1996, SCI FULLERENES CARBO
   Gilbert RJC, 1999, J MOL BIOL, V293, P1145, DOI 10.1006/jmbi.1999.3210
   GLIMCHER MJ, 1998, NATURE MINERAL PHASE, P23
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001
   Kolesnikov AI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035503
   Kolesnikov AI, 1999, PHYSICA B, V263, P650, DOI 10.1016/S0921-4526(98)01438-0
   Kolesnikov AI, 1999, PHYS REV B, V59, P3569, DOI 10.1103/PhysRevB.59.3569
   Levicky R, 1998, J AM CHEM SOC, V120, P9787, DOI 10.1021/ja981897r
   Loong CK, 2000, BONE, V26, P599, DOI 10.1016/S8756-3282(00)00273-8
   Lu K, 2003, J AM CHEM SOC, V125, P6391, DOI 10.1021/ja0341642
   Parak FG, 2003, REP PROG PHYS, V66, P103, DOI 10.1088/0034-4885/66/2/201
   Pawlukojc A, 2002, SPECTROCHIM ACTA A, V58, P2897, DOI 10.1016/S1386-1425(02)00086-0
   Pawlukojc A, 1997, SPECTROCHIM ACTA A, V53, P927, DOI 10.1016/S1386-1425(96)01875-6
   Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   RICHTER D, 2000, POLYM DYNAMICS NEUTR, P535
   Russell TP, 1996, PHYSICA B, V221, P267, DOI 10.1016/0921-4526(95)00937-X
   SKOLD K, 1986, NEUTRON SCATTERING, VA
   STUHRMANN HB, 2000, STRUCTURE DYNAMICS B, P391
   Tatke SS, 2004, NANOTECHNOLOGY, V15, pS684, DOI 10.1088/0957-4484/15/10/030
   Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1
   Thiyagarajan P, 2000, J APPL CRYSTALLOGR, V33, P535, DOI 10.1107/S0021889899014387
   Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604
   Zaccai G, 2003, J PHYS-CONDENS MAT, V15, pS1673, DOI 10.1088/0953-8984/15/18/301
NR 33
TC 4
Z9 4
U1 0
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD OCT
PY 2004
VL 15
IS 10
SI SI
BP S664
EP S671
AR PII S0957-4484(04)76289-3
DI 10.1088/0957-4484/15/10/027
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 866ZP
UT WOS:000224812200028
DA 2018-10-20
ER

PT J
AU Zhu, YT
   Lowe, TC
   Langdon, TG
AF Zhu, YT
   Lowe, TC
   Langdon, TG
TI Performance and applications of nanostructured materials produced by
   severe plastic deformation
SO SCRIPTA MATERIALIA
LA English
DT Article
DE applications; manufacturing; nanostructured materials; severe plastic
   deformation
ID STRAIN RATE SUPERPLASTICITY; ULTRAFINE-GRAINED TITANIUM; COMMERCIAL
   ALUMINUM-ALLOYS; BONDING ARB PROCESS; MICROSTRUCTURAL EVOLUTION;
   NANOCRYSTALLINE MATERIALS; AL-ALLOY; THERMAL-STABILITY; METALS;
   REFINEMENT
AB Nanostructured materials produced by severe plastic deformation can be tailored to have both superior performance and superior properties. These materials are attractive for use in a range of applications from biomedical to aerospace industries. (C) 2004 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Los Alamos Natl Lab, Div Technol, Los Alamos, NM 87545 USA.
   Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA.
   Univ So Calif, Dept Mat Sci, Los Angeles, CA 90089 USA.
RP Zhu, YT (reprint author), Los Alamos Natl Lab, Div Technol, MS G755, Los Alamos, NM 87545 USA.
EM yzhu@lanl.gov
RI Langdon, Terence/B-1487-2008; Zhu, Yuntian/B-3021-2008
OI Zhu, Yuntian/0000-0002-5961-7422
CR Agnew SR, 2000, MAT SCI ENG A-STRUCT, V285, P391, DOI 10.1016/S0921-5093(00)00669-9
   Ball A., 1969, MET SCI J, V3, P1, DOI DOI 10.1179/MSC.1969.3.1.1
   BALYANOV A, 2004, ASTIPTA MAT, V51, P225
   Barnes AJ, 2001, MATER SCI FORUM, V357-3, P3, DOI 10.4028/www.scientific.net/MSF.357-359.3
   GLEITER H, 1989, PROG MATER SCI, V33, P223, DOI 10.1016/0079-6425(89)90001-7
   Horita Z, 2000, METALL MATER TRANS A, V31, P691, DOI 10.1007/s11661-000-0011-8
   Horita Z, 2001, MAT SCI ENG A-STRUCT, V318, P34, DOI 10.1016/S0921-5093(01)01339-9
   Huang JY, 2001, ACTA MATER, V49, P1497, DOI 10.1016/S1359-6454(01)00069-6
   Jia D, 2001, APPL PHYS LETT, V79, P611, DOI 10.1063/1.1384000
   Jiang HG, 2000, MAT SCI ENG A-STRUCT, V290, P128, DOI 10.1016/S0921-5093(00)00919-9
   Kamachi M, 2003, MAT SCI ENG A-STRUCT, V361, P258, DOI 10.1016/S0921-5093(03)00522-7
   LANGDON TG, 1994, ACTA METALL MATER, V42, P2437, DOI 10.1016/0956-7151(94)90322-0
   Lee JC, 2002, ACTA MATER, V50, P4005, DOI 10.1016/S1359-6454(02)00200-8
   Lee SM, 2001, MATER SCI FORUM, V357-3, P321, DOI 10.4028/www.scientific.net/MSF.357-359.321
   Liao XZ, 2004, APPL PHYS LETT, V84, P592, DOI 10.1063/1.1644051
   Liao XZ, 2003, APPL PHYS LETT, V83, P5062, DOI 10.1063/1.1633975
   Liao XZ, 2003, APPL PHYS LETT, V83, P632, DOI 10.1063/1.1594836
   LIAO XZ, IN PRESS J APPL PHYS
   McFadden SX, 1999, NATURE, V398, P684
   Mishra RS, 1999, SCRIPTA MATER, V42, P163, DOI 10.1016/S1359-6462(99)00329-2
   RAABE GJ, IN PRESS MAT SCI E A
   Saito Y, 2000, SCRIPTA MATER, V42, P1139, DOI 10.1016/S1359-6462(00)00349-3
   Saito Y, 1998, SCRIPTA MATER, V39, P1221, DOI 10.1016/S1359-6462(98)00302-9
   Sato YS, 2004, SCRIPTA MATER, V50, P57, DOI 10.1016/j.scriptamat.2003.09.037
   Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328
   Segal VM, 2002, MAT SCI ENG A-STRUCT, V338, P331, DOI 10.1016/S0921-5093(02)00066-7
   Siegel R.W., 1993, FUNDAMENTAL PROPERTI, P3
   Stolyarov VV, 1999, NANOSTRUCT MATER, V11, P947, DOI 10.1016/S0965-9773(99)00384-0
   Stolyarov VV, 2003, MAT SCI ENG A-STRUCT, V343, P43, DOI 10.1016/S0921-5093(02)00366-0
   STOLYAROV VV, IN PRESS MAT SCI E A
   Su JQ, 2003, J MATER RES, V18, P1757, DOI 10.1557/JMR.2003.0243
   SURYANARAYANA C, 1995, INT MATER REV, V40, P41, DOI 10.1179/imr.1995.40.2.41
   Suryanarayana C, 1999, NONEQUILIBRIUM PROCE
   Tsuji N, 1999, SCRIPTA MATER, V40, P795, DOI 10.1016/S1359-6462(99)00015-9
   Valiev R., UNPUB
   Valiev RZ, 2002, J MATER RES, V17, P5, DOI 10.1557/JMR.2002.0002
   Valiev RZ, 1997, SCRIPTA MATER, V37, P1945, DOI 10.1016/S1359-6462(97)00387-4
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Vinogradov A, 2003, ADV ENG MATER, V5, P351, DOI 10.1002/adem.200310078
   Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133
   Wang ZB, 2003, MAT SCI ENG A-STRUCT, V352, P144, DOI 10.1016/S0921-5093(02)00870-5
   YANG NYC, SCRIPTA MAT
   Zhilyaev AP, 2003, ACTA MATER, V51, P753, DOI 10.1016/S1359-6454(02)00466-4
   Zhilyaev AP, 2003, PHYS STATUS SOLIDI A, V198, P263, DOI 10.1002/pssa.200306608
   Zhou F, 2003, ACTA MATER, V51, P2777, DOI 10.1016/S1359-6454(03)00083-1
   Zhu YT, 2001, METALL MATER TRANS A, V32, P1559, DOI 10.1007/s11661-001-0245-0
NR 46
TC 203
Z9 211
U1 3
U2 44
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD OCT
PY 2004
VL 51
IS 8
BP 825
EP 830
DI 10.1016/j.scriptamat.2004.05.006
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 847JW
UT WOS:000223389500014
DA 2018-10-20
ER

PT J
AU Arshak, K
   Morris, D
   Korostynska, O
   Jafer, E
   Arshak, A
   Harris, J
   Clifford, S
   Lyons, G
AF Arshak, K
   Morris, D
   Korostynska, O
   Jafer, E
   Arshak, A
   Harris, J
   Clifford, S
   Lyons, G
TI Novel silicone-based capacitive pressure sensors with high sensitivity
   for biomedical applications
SO E-POLYMERS
LA English
DT Article
ID POLYMER; COMPOSITES; RUBBERS
AB In this work, an investigation of the pressure-sensing properties of a silicone rubber was conducted. Small amounts of carbon black were added to the silicone during fabrication and the effect on the sensitivity was explored. A full investigation of the mechanical and electrical properties of each composition shows that adding carbon black to the material greatly increases its sensitivity to pressure. This increase in sensitivity appears to be related to improvements in the material's permittivity, which increases with carbon loading.
C1 Univ Limerick, Dept Elect & Comp Engn, Limerick, Ireland.
   Univ Limerick, Dept Phys, Limerick, Ireland.
RP Arshak, K (reprint author), Univ Limerick, Dept Elect & Comp Engn, Plassey Technol Pk, Limerick, Ireland.
EM arousian.arshak@ul.ie; arousian.arshak@ul.ie
RI OLaighin, Gearoid/A-5239-2009
OI OLaighin, Gearoid/0000-0002-1885-814X; Korostynska,
   Olga/0000-0003-0387-6609
CR Arshak KI, 2000, SENSOR ACTUAT A-PHYS, V79, P102, DOI 10.1016/S0924-4247(99)00275-7
   Chang CL, 2004, POLYM DEGRAD STABIL, V85, P769, DOI 10.1016/j.polymdegradstab.2003.12.001
   CRISTALLI C, 1995, IEEE EMBC CMBEC, P1541
   DARGAHI J, 1998, INT C INT ROB SYST, P1503
   Flick BB, 2000, IEEE T BIO-MED ENG, V47, P12, DOI 10.1109/10.817613
   Foulger SH, 1999, J APPL POLYM SCI, V72, P1573, DOI 10.1002/(SICI)1097-4628(19990620)72:12<1573::AID-APP10>3.3.CO;2-Y
   Hussain M, 2001, SCRIPTA MATER, V44, P1203, DOI 10.1016/S1359-6462(01)00685-6
   Hussain M, 2001, COMPOS PART A-APPL S, V32, P1689, DOI 10.1016/S1359-835X(01)00035-5
   JACKSON HW, 1989, INTRO ELECT CIRCUITS
   Leisen J, 1999, RUBBER CHEM TECHNOL, V72, P1, DOI 10.5254/1.3538790
   Liu KK, 2004, REV SCI INSTRUM, V75, P524, DOI 10.1063/1.1638894
   NEUMAN MR, 1994, IEEE ENG MED BIOL, V13, P409, DOI 10.1109/51.294013
   O'Sullivan S, 2003, J PHYS D APPL PHYS, V36, P1910, DOI 10.1088/0022-3727/36/15/324
   OSSWALD TA, 2003, MAT SCI POLYM ENGN
   PUERS R, 1993, SENSOR ACTUAT A-PHYS, V37-8, P93, DOI 10.1016/0924-4247(93)80019-D
   RADHAKRISHNAN S, 1994, MATER LETT, V18, P358, DOI 10.1016/0167-577X(94)90023-X
   Sichel E. K., 1982, CARBON BLACK POLYM C
   Tiwari A, 2004, THERMOCHIM ACTA, V417, P133, DOI 10.1016/j.tca.2003.10.003
   Wycisk R, 2002, J ELECTROSTAT, V56, P55, DOI 10.1016/S0304-3886(01)00204-2
NR 19
TC 0
Z9 0
U1 0
U2 4
PU EUROPEAN POLYMER FEDERATION
PI STRASBOURG
PA 1, QUAI LEZAY-MARNESIA, F067000 STRASBOURG, FRANCE
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD SEP 29
PY 2004
AR 061
PG 11
WC Polymer Science
SC Polymer Science
GA 858HL
UT WOS:000224182800001
DA 2018-10-20
ER

PT J
AU Gongora-Rubio, MR
   Fontes, MBA
   da Rocha, ZM
   Richter, EM
   Angnes, L
AF Gongora-Rubio, MR
   Fontes, MBA
   da Rocha, ZM
   Richter, EM
   Angnes, L
TI LTCC manifold for heavy metal detection system in biomedical and
   environmental fluids
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article; Proceedings Paper
CT 17th European Conference on Solid-State Transducers (Eurosensors XVII)
CY SEP 21-24, 2003
CL Univ Minho, Guimaraes, PORTUGAL
HO Univ Minho
DE low temperature cofired ceramics (LTCC); chemical sensors; FlA; heavy
   metals detection
ID TECHNOLOGY
AB This work gives a description of how low temperature cofired ceramics (LTCC) technology is a suitable material for the fabrication of a flow injection analysis (FIA) meso-analytical system applicable for detection of heavy metals (in trace levels) in biological and environmental fluids. This paper presents the design processing, fabrication and materials characterization issues of a LTCC manifold integrated with sensor electrodes. The requirement of on-line measurement tests with high sensitivity for heavy metals has motivated the development of sensors for electrochemical stripping techniques in flow. Experiments involving short time pre-concentration scheme (60 s), for mercury and cooper, indicate a lower detection limit of 0.9 and 0.45 mug L-1, respectively, which is much lower than the maximum tolerable concentration for urinary fluids. Lower limits can be attained utilizing longer deposition times in order to achieve requirements for fresh waters. (C) 2004 Elsevier B.V. All rights reserved.
C1 IPT, DITT, Lab Instrumentacao, Sao Paulo, Brazil.
   Univ Sao Paulo, LSI, EPUSP, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil.
RP Gongora-Rubio, MR (reprint author), IPT, DITT, Lab Instrumentacao, Sao Paulo, Brazil.
EM gongoram@ipt.br
RI Richter, Eduardo/G-5711-2011; Gongora-Rubio, Mario/P-2211-2018;
   Institute of Chemistry - USP, Dept. of Chemistry/B-8988-2012
OI Richter, Eduardo/0000-0002-3840-8277; Gongora-Rubio,
   Mario/0000-0002-1267-055X; 
CR Bauer R., 1997, INTS MICR, P659
   DAROCHA ZM, 2004, IMAPS C EXH CER INT, V5
   ESPINOZAVALLEJO.P, 1998, MRS C P, V518
   FONBTES MBA, 2001, 16 INT C MICR EL PAC
   Fontes M. B. A., 1999, Journal of Solid-State Devices and Circuits, V7, P12
   Gongora-Rubio M, 1999, SENSOR ACTUAT A-PHYS, V73, P215, DOI 10.1016/S0924-4247(98)00238-6
   Gongora-Rubio MR, 2001, SENSOR ACTUAT A-PHYS, V89, P222, DOI 10.1016/S0924-4247(00)00554-9
   GONGORUBIO MR, 2002, P IBERSENSOR 2002, P72
   Hellio C, 2001, BIOFOULING, V17, P189, DOI 10.1080/08927010109378478
   Reay RJ, 1996, SENSOR ACTUAT B-CHEM, V34, P450, DOI 10.1016/S0925-4005(97)80018-4
   Richter EM, 2000, FRESEN J ANAL CHEM, V366, P444, DOI 10.1007/s002160050090
   Roosen A, 2001, J EUR CERAM SOC, V21, P1993, DOI 10.1016/S0955-2219(01)00158-3
   ROOSEN A, 2002, INT S MICR
   WAGNER M, 2002, INT S MICR
   WEGENG RS, 1996, 1996 SPRING NATK M A
NR 15
TC 33
Z9 33
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD SEP 29
PY 2004
VL 103
IS 1-2
BP 468
EP 473
DI 10.1016/j.snb.2004.05.007
PG 6
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 856SC
UT WOS:000224064100072
DA 2018-10-20
ER

PT J
AU Peppas, NA
   Ward, JH
AF Peppas, NA
   Ward, JH
TI Biomimetic materials and micropatterned structures using iniferters
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE biomimetic materials; synthesis; polymerization; fractional groups
ID LIVING RADICAL POLYMERIZATIONS; SURFACE-CHEMISTRY; POLYMER SURFACES;
   STAR POLYMERS; CELLS; DITHIOCARBAMATE; RECOGNITION; ATTACHMENT;
   COPOLYMERS; MONOLAYERS
AB In the preparation of biomimetic materials it is often required that efficient methods of polymerization be used, often methods that can lead to biomimetic polymers with relatively narrow molecular weight distribution. Living radical polymerization techniques have successfully been used to create low polydispersity linear polymers by free-radical polymerizations. Although this technique slows down the polymerization of multifunctional monomers, there is little effect on the network structure due to the high concentration of pendent double bonds. There are applications of the living radical polymerization in the synthesis of block copolymers. Essentially, the technique involves polymerizing a single type of monomer first to create a macromonomer that is capable of acting as an initiator because of the reversible bond between the polymer end group and the terminating group. This terminating group may be a thiol or a halogen and, under the right conditions, will dissociate to form radicals. A second monomer is then added to the system and the polymerization proceeds with the second monomer chemically attached to the polymer of the first monomer. We review methods of creating biomimetic block copolymers using the iniferter radical polymerization technique. The block copolymers would be used in the synthesis of micropatterned polymer films for use in biomaterials and other biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, Div Pharmaceut, Austin, TX 78712 USA.
RP Peppas, NA (reprint author), Univ Texas, Dept Chem Engn, CPE 3-466,C-0400,1 Univ Stn, Austin, TX 78712 USA.
EM peppas@che.utexas.edu
CR Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BUCK RP, 1995, BIOMEDICAL ENG HDB, P779
   BYME ME, 2002, POLYM ADVAN TECHNOL, V13, P798
   CHINN JA, 1995, BIOMEDICAL ENG HDB
   de Boer B, 2000, MACROMOLECULES, V33, P349, DOI 10.1021/ma9910944
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Higashi J, 1999, LANGMUIR, V15, P2080, DOI 10.1021/la9810511
   Hilt JZ, 2002, MATER RES SOC SYMP P, V729, P173
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   KANE RS, 1999, BIOMATERIALS, V20, P2362
   Kannurpatti AR, 1996, MACROMOLECULES, V29, P7310, DOI 10.1021/ma951914m
   Kannurpatti AR, 1997, J POLYM SCI POL PHYS, V35, P2297, DOI 10.1002/(SICI)1099-0488(199710)35:14<2297::AID-POLB10>3.0.CO;2-7
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG
   Macilwain C, 1999, NATURE, V400, P95, DOI 10.1038/21937
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   MATSUDA T, 1995, J BIOMED MATER RES, V29, P749, DOI 10.1002/jbm.820290611
   Matyjaszewski K, 1999, MACROMOLECULES, V32, P6526, DOI 10.1021/ma9904823
   Mayer J, 2000, J CONTROL RELEASE, V64, P81, DOI 10.1016/S0168-3659(99)00136-4
   MOORE JE, 1977, CHEM PROPERTIES CROS, P535
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   NEUMAN MR, 1995, BIOMEDICAL ENG HDB, P725
   OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P133
   OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P127
   Patel N, 1998, FASEB J, V12, P1447
   Patel N, 1999, LANGMUIR, V15, P7252, DOI 10.1021/la981268v
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   PEPPAS NA, 2000, P EUR S CONTROL DRUG, V6, P21
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   SCOTT R, 2000, HDB PHARM CONTROLLED, P47
   Sebenik A, 1998, PROG POLYM SCI, V23, P875, DOI 10.1016/S0079-6700(98)00001-X
   Shi HQ, 2000, J BIOMED MATER RES, V49, P1
   Shi HQ, 1999, NATURE, V398, P593
   SHINGHVI R, 1994, SCIENCE, V264, P296
   Shipp DA, 1998, MACROMOLECULES, V31, P8005, DOI 10.1021/ma981033q
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tharanikkarasu K, 1997, J APPL POLYM SCI, V66, P1551
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   TURNER SR, 1990, MACROMOLECULES, V23, P1856, DOI 10.1021/ma00208a050
   Ward JH, 2000, MACROMOLECULES, V33, P5137, DOI 10.1021/ma000001b
   Ward JH, 2002, POLYMER, V43, P1745, DOI 10.1016/S0032-3861(01)00779-0
   Ward JH, 2000, PROC SPIE, V4097, P221, DOI 10.1117/12.390582
   Ward JH, 2001, J BIOMED MATER RES, V56, P351, DOI 10.1002/1097-4636(20010905)56:3<351::AID-JBM1103>3.0.CO;2-A
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   Zhang X, 2000, MACROMOLECULES, V33, P2340, DOI 10.1021/ma991076m
NR 45
TC 15
Z9 15
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP 22
PY 2004
VL 56
IS 11
BP 1587
EP 1597
DI 10.1016/j.addr.2003.10.046
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 857QK
UT WOS:000224133200006
PM 15350290
DA 2018-10-20
ER

PT J
AU Li, HX
   Rothberg, LJ
AF Li, HX
   Rothberg, LJ
TI DNA sequence detection using selective fluorescence quenching of tagged
   oligonucleotide probes by gold nanoparticles
SO ANALYTICAL CHEMISTRY
LA English
DT Article
AB Simple, fast, economical, and sensitive detection of specific DNA sequences is crucial to pathogen detection and biomedical research. We have designed a novel fluorescent assay for DNA hybridization based on the electrostatic properties of DNA. We exploit the ability to create conditions where single-stranded DNA adsorbs on negatively charged gold nanoparticles while double-stranded DNA does not. Dye-tagged probe sequences have their fluorescence efficiently quenched when they are mixed with gold nanoparticles unless they hybridize with components of the analyte. Subfemtomole amounts of untagged target are detected in minutes using commercially available materials. Target sequences in complex mixtures of DNA and single-base mismatches in DNA sequences are easily detected.
C1 Univ Rochester, Dept Chem, Rochester, NY 14627 USA.
RP Rothberg, LJ (reprint author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.
EM rothberg@chem.rochester.edu
FU NIA NIH HHS [AG18231]
CR Alivisatos AP, 2004, NAT BIOTECHNOL, V22, P47, DOI DOI 10.1038/NBT927
   Brockman JM, 2000, ANNU REV PHYS CHEM, V51, P41, DOI 10.1146/annurev.physchem.51.1.41
   Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536
   Chan S, 2001, MAT SCI ENG C-BIO S, V15, P277, DOI 10.1016/S0928-4931(01)00219-3
   Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610
   Du H, 2003, J AM CHEM SOC, V125, P4012, DOI 10.1021/ja0290781
   Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762
   Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078
   Epstein JR, 2002, ANAL CHIM ACTA, V469, P3, DOI 10.1016/S0003-2670(02)00030-2
   Gaylord BS, 2003, J AM CHEM SOC, V125, P896, DOI 10.1021/ja027152+
   Gradar K. C., 1995, ANAL CHEM, V67, P735
   LI HX, IN PRESS J AM CHEM S
   LI HX, IN PRESS P NAT AC SC
   Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840
   LU J, IN PRESS ANAL CHEM
   Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p
   Pan SL, 2003, NANO LETT, V3, P811, DOI 10.1021/nl034055l
   Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003
   ROLFS A, 1992, PCR CLIN DIAGNOSTICS
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757
NR 21
TC 227
Z9 231
U1 2
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD SEP 15
PY 2004
VL 76
IS 18
BP 5414
EP 5417
DI 10.1021/ac049173n
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 854UL
UT WOS:000223928800022
PM 15362900
DA 2018-10-20
ER

PT J
AU Lee, JY
   Buxton, GA
   Balazs, AC
AF Lee, JY
   Buxton, GA
   Balazs, AC
TI Using nanoparticles to create self-healing composites
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Article
ID LATTICE SPRING MODEL; MIXTURES; NANOCOMPOSITES; SIMULATIONS; DEPLETION;
   POLYMERS; FRACTURE; BLENDS
AB The need for viable materials for optical communications, display technologies, and biomedical engineering is driving the creation of multilayer composites that combine brittle materials, such as glass, with moldable polymers. However, crack formation is a critical problem in composites where thin brittle films lie in contact with deformable polymer layers. Using computer simulations, we show that adding nanoparticles to the polymers yields materials in which the particles become localized at nanoscale cracks and effectively form "patches" to repair the damaged regions. Through micromechanics simulations, we evaluate the properties of these systems in the undamaged, damaged, and healed states and determine optimal conditions for harnessing nanoparticles to act as responsive, self-assembled "band aids" for composite materials. The results reveal situations where the mechanical properties of the repaired composites can potentially be restored to 75%-100% of the undamaged material. (C) 2004 American Institute of Physics.
C1 Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
RP Balazs, AC (reprint author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
EM balazsl@engr.pitt.edu
OI Balazs, Anna/0000-0002-5555-2692
CR ASAKURA S, 1958, J POLYM SCI, V33, P183, DOI 10.1002/pol.1958.1203312618
   BANASZAK M, 1992, MACROMOLECULES, V25, P3406, DOI 10.1021/ma00039a015
   Bockstaller MR, 2003, J AM CHEM SOC, V125, P5276, DOI 10.1021/ja034523t
   Buxton GA, 2004, MOL SIMULAT, V30, P249, DOI 10.1080/08927020310001659142
   Buxton GA, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031802
   Buxton GA, 2002, J CHEM PHYS, V117, P7649, DOI 10.1063/1.1509447
   Buxton GA, 2001, MODEL SIMUL MATER SC, V9, P485, DOI 10.1088/0965-0393/9/6/302
   Calvert P, 2002, PHILOS T ROY SOC A, V360, P199, DOI 10.1098/rsta.2001.0925
   Cuesta JA, 1997, J CHEM PHYS, V107, P6379, DOI 10.1063/1.474298
   Dinsmore AD, 1999, LANGMUIR, V15, P314, DOI 10.1021/la981243w
   Dinsmore AD, 1996, NATURE, V383, P239, DOI 10.1038/383239a0
   Doxastakis M, 2004, J CHEM PHYS, V120, P9335, DOI 10.1063/1.1704634
   Drolet F, 1999, PHYS REV LETT, V83, P4317, DOI 10.1103/PhysRevLett.83.4317
   Gersappe D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058301
   Huh J, 2000, MACROMOLECULES, V33, P8085, DOI 10.1021/ma000708y
   Kickelbick G, 2003, PROG POLYM SCI, V28, P83, DOI 10.1016/S0079-6700(02)00019-9
   Kim JU, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.238301
   Lee J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.136103
   Lee JY, 2003, MACROMOLECULES, V36, P7730, DOI 10.1021/ma034765d
   Lee JY, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.155503
   Lin KH, 2000, PHYS REV LETT, V85, P1770, DOI 10.1103/PhysRevLett.85.1770
   Matsen MW, 2002, J PHYS-CONDENS MAT, V14, pR21, DOI 10.1088/0953-8984/14/2/201
   McGuigan AP, 2003, THIN SOLID FILMS, V424, P219, DOI 10.1016/S0040-6090(02)01124-0
   MONETTE L, 1994, J APPL PHYS, V75, P1442, DOI 10.1063/1.356378
   MONETTE L, 1994, MODEL SIMUL MATER SC, V2, P53, DOI 10.1088/0965-0393/2/1/004
   Picu RC, 2003, J CHEM PHYS, V118, P11239, DOI 10.1063/1.1576216
   Rountree CL, 2002, ANNU REV MATER RES, V32, P377, DOI 10.1146/annurev.matsci.32.111201.142017
   Shou ZY, 2003, COMPOS INTERFACE, V10, P343, DOI 10.1163/156855403771953632
   Sinani VA, 2003, NANO LETT, V3, P1177, DOI 10.1021/nl0255045
   Spoerke ED, 2003, J BIOMED MATER RES A, V67A, P960, DOI 10.1002/jbm.a.10102
   Suo Z, 2003, J MECH PHYS SOLIDS, V51, P2169, DOI 10.1016/j.jmps.2003.09.022
   Thompson RB, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031801
   Thompson RB, 2001, SCIENCE, V292, P2469, DOI 10.1126/science.1060585
   Trau M, 1997, LANGMUIR, V13, P6375, DOI 10.1021/la970568u
   Tuinier R, 2003, ADV COLLOID INTERFAC, V103, P1, DOI 10.1016/S0001-8686(02)00081-7
   *U KONST, 1995, PHYSICA A, V18
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
NR 37
TC 114
Z9 117
U1 7
U2 100
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-9606
EI 1089-7690
J9 J CHEM PHYS
JI J. Chem. Phys.
PD SEP 15
PY 2004
VL 121
IS 11
BP 5531
EP 5540
DI 10.1063/1.1784432
PG 10
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 851XU
UT WOS:000223720600058
PM 15352848
DA 2018-10-20
ER

PT J
AU Zhang, JT
   Chua, LS
   Lynn, DM
AF Zhang, JT
   Chua, LS
   Lynn, DM
TI Multilayered thin films that sustain the release of functional DNA under
   physiological conditions
SO LANGMUIR
LA English
DT Article
ID BY-LAYER DEPOSITION; QUARTZ-CRYSTAL MICROBALANCE; ULTRATHIN
   POLYMER-FILMS; IN-VIVO REPAIR; POLYELECTROLYTE MULTILAYERS; GENE
   DELIVERY; PLASMID DNA; CORONARY-ARTERIES; BLOOD-VESSELS; MICROCAPSULES
AB The development of thin films and coatings that control the release of DNA from the surfaces of materials could have a significant impact on localized approaches to gene therapy. Here, we report multilayered polyelectrolyte assemblies that sustain the release of functional plasmid DNA from the surfaces of model substrates under physiological conditions. Multilayered assemblies consisting of alternating layers of plasmid DNA encoding for enhanced green fluorescent protein (EGFP) and a synthetic degradable polyamine were deposited on planar silicon and quartz substrates using a layer-by-layer fabrication process. Film growth was monitored by ellipsometry and UV spectrophotometry and correlated linearly with the number of polymer and plasmid layers deposited. In general, the thickness of deposited layers was found to be a function of both the pH and the ionic strength of the polyelectrolyte solutions used. Films up to 100 nm thick were investigated in this study. These assemblies erode gradually upon incubation in phosphate-buffered saline at 37 degreesC, as determined by ellipsometry and UV spectrophotometry, and sustain the release of incorporated plasmid into the incubation medium for a period of up to 30 h. Characterization of the released plasmid by agarose gel electrophoresis revealed that the DNA was released in a relaxed, open circular, rather than supercoiled, topology; subsequent cell transfection experiments demonstrated that the released plasmid is transcriptionally viable and promotes the expression of EGFP in the COS-7 cell line. These layered materials could represent an approach to the controlled administration of one or more functional DNA constructs from the surfaces of biomedical materials and devices.
C1 Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.
RP Lynn, DM (reprint author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.
RI Zhang, Jingtao/D-2590-2011
FU NIBIB NIH HHS [EB02746]
CR Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
   Antipov AA, 2002, COLLOID SURFACE A, V198, P535, DOI 10.1016/S0927-7757(01)00956-6
   Antipov AA, 2001, J PHYS CHEM B, V105, P2281, DOI 10.1021/jp002184+
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Caruso F, 1998, COLLOID SURFACE B, V10, P199, DOI 10.1016/S0927-7765(97)00067-2
   Caruso F, 1997, ANAL CHEM, V69, P2043, DOI 10.1021/ac961220r
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Cho J, 2003, MACROMOLECULES, V36, P2845, DOI 10.1021/ma021049n
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dubas ST, 2001, J AM CHEM SOC, V123, P5368, DOI 10.1021/ja015774+
   Dubas ST, 2001, MACROMOLECULES, V34, P3736, DOI 10.1021/ma001720t
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   Jin W, 2001, J AM CHEM SOC, V123, P8121, DOI 10.1021/ja015807l
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Lang J, 1999, J PHYS CHEM B, V103, P11393, DOI 10.1021/jp9915073
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   LVOV Y, 1993, MACROMOLECULES, V26, P5396, DOI 10.1021/ma00072a016
   Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   NELSON DL, 2000, LEHNINGER PRINCIPLES, P916
   Pei RJ, 2001, BIOMACROMOLECULES, V2, P463, DOI 10.1021/bm0001289
   Qiu XP, 2001, LANGMUIR, V17, P5375, DOI 10.1021/la010201w
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Saltzman WM, 1999, NAT BIOTECHNOL, V17, P534, DOI 10.1038/9835
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Sambrook JF, 2001, MOL CLONING LAB MANU, V1, p[17, 1]
   Schuler C, 2001, BIOMACROMOLECULES, V2, P921, DOI 10.1021/bm010052w
   Schwinte P, 2002, BIOMACROMOLECULES, V3, P1135, DOI 10.1021/bm025547f
   Schwinte P, 2001, J PHYS CHEM B, V105, P11906, DOI 10.1021/jp0123031
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Serizawa T, 2003, ANGEW CHEM INT EDIT, V42, P1115, DOI 10.1002/anie.200390293
   Serizawa T, 2002, MACROMOLECULES, V35, P8656, DOI 10.1021/ma012153s
   Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027
   Shchukin DG, 2004, J AM CHEM SOC, V126, P3374, DOI 10.1021/ja036952x
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shi XY, 2002, J PHYS CHEM B, V106, P1173, DOI 10.1021/jp0132634
   Shi XY, 2001, LANGMUIR, V17, P2036, DOI 10.1021/la001550d
   Singh M, 2000, P NATL ACAD SCI USA, V97, P811, DOI 10.1073/pnas.97.2.811
   Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Sukhorukov GB, 2001, MACROMOL RAPID COMM, V22, P44, DOI 10.1002/1521-3927(20010101)22:1<44::AID-MARC44>3.0.CO;2-U
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.0.CO;2-Y
   Trimaille T, 2003, COLLOID SURFACE A, V221, P39, DOI 10.1016/S0927-7757(03)00105-5
   Trubetskoy VS, 1999, NUCLEIC ACIDS RES, V27, P3090, DOI 10.1093/nar/27.15.3090
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
NR 52
TC 216
Z9 219
U1 1
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 14
PY 2004
VL 20
IS 19
BP 8015
EP 8021
DI 10.1021/la048888i
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 853SF
UT WOS:000223847300020
PM 15350066
DA 2018-10-20
ER

PT J
AU Kumar, S
   Kumar, R
   Kumar, S
   Chakarvarti, SK
AF Kumar, Sanjeev
   Kumar, Rajesh
   Kumar, Shyam
   Chakarvarti, S. K.
TI Electrochemical synthesis of metallic microstructures using etched ion
   tracks in nuclear track filters
SO CURRENT SCIENCE
LA English
DT Article
AB Interest in nano/microstructures results from their numerous potential applications in various areas such as materials and biomedical sciences, electronics, optics, magnetism, energy storage and electrochemistry. Materials with micro/nanoscopic dimensions not only have potential technological applications in areas such as device technology and drug delivery, but also are of fundamental interest in that the properties of a material can change in this regime of transition between the bulk and molecular scales. Electrodeposition is a versatile technique combining low processing cost with ambient conditions that can be used to prepare metallic, polymeric and semiconducting microstructures. In the present work ion track membranes of Makrofol ( KG) have been used as templates for synthesis of metallic microstructures using the technique of electrodeposition.
C1 [Kumar, Sanjeev; Kumar, Shyam] Kurukshetra Univ, Dept Phys, Kurukshetra 136119, Haryana, India.
   [Kumar, Rajesh; Chakarvarti, S. K.] Deemed Univ, Nat Inst Technol, Dept Appl Phys, Kurukshetra 136119, Haryana, India.
RP Kumar, S (reprint author), Kurukshetra Univ, Dept Phys, Kurukshetra 136119, Haryana, India.
EM bhogrask@yahoo.co.in
CR Bate R. T., 1990, Nanotechnology, V1, P1, DOI 10.1088/0957-4484/1/1/001
   Bean C.P, 1969, U.S. Patent, Patent No. [34 483095, 3483095]
   CAI ZH, 1989, J AM CHEM SOC, V111, P4138, DOI 10.1021/ja00193a077
   CHAKARVARTI SK, 1991, NUCL INSTRUM METH B, V62, P109, DOI 10.1016/0168-583X(91)95936-8
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   Dobrev D, 1999, APPL PHYS A-MATER, V69, P233, DOI 10.1007/s003390050995
   Dobrev D., ELECTROCHEMICAL CELL
   FISCHER BE, 1983, REV MOD PHYS, V55, P907, DOI 10.1103/RevModPhys.55.907
   FOSS CA, 1994, J PHYS CHEM-US, V98, P2963, DOI 10.1021/j100062a037
   Frazier A. B., 1993, Journal of Microelectromechanical Systems, V2, P87, DOI 10.1109/84.232605
   GRANSTROM M, 1995, SCIENCE, V267, P1479, DOI 10.1126/science.267.5203.1479
   KLEIN JD, 1993, CHEM MATER, V5, P902, DOI 10.1021/cm00031a002
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   MOLARES MET, 2001, NUCL INSTRUM METH B, V185, P192
   Pra LDD, 2002, NUCL INSTRUM METH B, V196, P81
   Schuchert IU, 2003, J ELECTROCHEM SOC, V150, pC189, DOI 10.1149/1.1554722
   Tian ML, 2003, NANO LETT, V3, P919, DOI 10.1021/nl034217d
   Toimil-Molares ME, 2003, APPL PHYS LETT, V82, P2139, DOI 10.1063/1.1563741
NR 18
TC 7
Z9 7
U1 0
U2 4
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD SEP 10
PY 2004
VL 87
IS 5
BP 642
EP 645
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V43RP
UT WOS:000202952500021
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Lee, KG
   Kweon, HY
   Yeo, JH
   Woo, SO
   Lee, JH
   Park, YH
AF Lee, KG
   Kweon, HY
   Yeo, JH
   Woo, SO
   Lee, JH
   Park, YH
TI Structural and physical properties of silk fibroin/alginate blend
   sponges
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE silk fibroin; alginate; conformational analysis; mechanical properties;
   blends
ID FIBROIN MEMBRANES; ALGINATE; FILMS; IMMOBILIZATION; GROWTH; CELLS; FORM;
   GEL
AB Silk fibroin/alginate blend sponges were examined through IR spectroscopy, X-ray diffractometry, and differential scanning calorimetry to determine the structural changes of silk fibroin. The effects of fibroin/alginate blend ratios on the physical and mechanical properties were investigated to discover the feasibility of using these blend sponges as biomedical materials such as wound dressings. The compressive modulus of silk fibroin was increased up to 30 kPa, from 7.1 kPa, by blending with alginate. Thermal crystallization behavior of fibroin induced by heat treatment was restricted by blending with alginate. In spite of that, the structural characteristics of fibroin were not changed by incorporation with alginate. (C) 2004 Wiley Periodicals, Inc.
C1 Natl Inst Agr Sci & Technol, Dept Sericulture & Entomol, Suwon 441100, South Korea.
   Seoul Natl Univ, Coll Vet Med, Suwon 441744, South Korea.
   Seoul Natl Univ, Sch Biol Resources & Mat Engn, Suwon 441744, South Korea.
RP Kweon, HY (reprint author), Natl Inst Agr Sci & Technol, Dept Sericulture & Entomol, Suwon 441100, South Korea.
EM hykweon@rda.go.kr
CR ASAKURA T, 1984, MACROMOLECULES, V17, P1075, DOI 10.1021/ma00135a017
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742
   Kikuchi A, 1999, J CONTROL RELEASE, V58, P21, DOI 10.1016/S0168-3659(98)00141-2
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   KWEON HY, 1994, KOR J SER SCI, V36, P138
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   LIANG CX, 1990, SEN-I GAKKAISHI, V46, P535
   MAGOSHI J, 1975, J APPL POLYM SCI, V19, P1013, DOI 10.1002/app.1975.070190410
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MIYAIRI S, 1978, AGR BIOL CHEM TOKYO, V42, P1661, DOI 10.1080/00021369.1978.10863228
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Xiao CB, 2002, J APPL POLYM SCI, V84, P2554, DOI 10.1002/app.10582
   YAMAURA K, 1990, J APPL POLYM SCI, V41, P2409, DOI 10.1002/app.1990.070410941
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
NR 20
TC 27
Z9 28
U1 2
U2 30
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 5
PY 2004
VL 93
IS 5
BP 2174
EP 2179
DI 10.1002/app.20714
PG 6
WC Polymer Science
SC Polymer Science
GA 842QX
UT WOS:000223020200023
DA 2018-10-20
ER

PT J
AU Lou, X
   Munro, S
   Wang, S
AF Lou, X
   Munro, S
   Wang, S
TI Drug release characteristics of phase separation pHEMA sponge materials
SO BIOMATERIALS
LA English
DT Article
DE pHEMA; porous hydrogel; drug delivery/release; porosity; optimisation
ID CROSS-LINKING AGENT; 2-HYDROXYETHYL METHACRYLATE; POLY(2-HYDROXYETHYL
   METHACRYLATE); BIOMEDICAL APPLICATIONS; POLYMER MEMBRANES; HYDROGELS;
   REACTIVITY; SOLUTES; MATRIX; CORNEA
AB A number of phase separation pHEMA sponge hydrogels have been prepared based on variations in monomer contents, concentration of cross-linking agent, solvent mixture and temperature of polymerization. The loading levels and release profiles of the anti-inflammatory drug prednisolone were examined for each of the pHEMA sponge materials. An effective diffusion coefficient determined by an optimization approach based on the experimental data was used to measure their release characteristics. The effect of morphological variations, revealed by the environmental scanning electron microscopy, and polymer/solvent volume fractions on these properties were discussed. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Western Australia, Ctr Ophthalmol & Visual Sci, Nedlands, WA 6009, Australia.
   Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia.
   Univ Western Australia, Sch Math & Stat, Crawley, WA 6009, Australia.
RP Lou, X (reprint author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, 2 Verdun St, Nedlands, WA 6009, Australia.
EM xlou@cyllene.uwa.edu.au
RI Wang, Song/B-9809-2008; Lou, Xia/A-7333-2010
OI Wang, Song/0000-0002-5198-8173; Lou, Xia/0000-0002-4052-8200
CR Ainaoui A, 2001, EUR J PHARM BIOPHARM, V51, P17, DOI 10.1016/S0939-6411(00)00139-9
   ATKINS TW, 1995, J BIOMED MATER RES, V29, P291, DOI 10.1002/jbm.820290303
   CHIRILA TV, 1993, POLYM INT, V32, P221, DOI 10.1002/pi.4990320303
   Chirila TV, 1998, PROG POLYM SCI, V23, P447, DOI 10.1016/S0079-6700(97)00036-1
   Chirila TV, 1998, CELL POLYM, V17, P141
   Clayton AB, 1997, POLYM INT, V44, P201, DOI 10.1002/(SICI)1097-0126(199710)44:2<201::AID-PI846>3.0.CO;2-B
   Clayton AB, 1997, POLYM INT, V42, P45, DOI 10.1002/(SICI)1097-0126(199701)42:1<45::AID-PI658>3.0.CO;2-W
   Crank J., 1975, MATH DIFFUSION
   FLYNN GL, 1974, J PHARM SCI-US, V63, P479, DOI 10.1002/jps.2600630403
   GOUDA JH, 1970, J POLYM SCI POL LETT, V8, P225, DOI 10.1002/pol.1970.110080402
   Haldon R.A., 1972, BR POLYM J, V4, P491
   HASA J, 1967, J POLYM SCI C, V16, P317
   Hicks CR, 2003, EYE, V17, P385, DOI 10.1038/sj.eye.6700333
   KORSMEYER RW, 1991, POLYM CONTROLLED DRU, P5
   KRAUCH CH, 1968, NATURWISSENSCHAFTEN, V55, P539, DOI 10.1007/BF00660126
   LEE P I, 1985, Journal of Controlled Release, V2, P277, DOI 10.1016/0168-3659(85)90051-3
   Lou X, 1999, J BIOMED MATER RES, V47, P404, DOI 10.1002/(SICI)1097-4636(19991205)47:3<404::AID-JBM16>3.0.CO;2-F
   Lou X, 2000, J MATER SCI-MATER M, V11, P319, DOI 10.1023/A:1008977818135
   Lou X, 1997, INT J POLYM MATER, V37, P1
   MURPHY SM, 1992, J MATER CHEM, V2, P1007, DOI 10.1039/jm9920201007
   OXLEY HR, 1993, BIOMATERIALS, V14, P1064, DOI 10.1016/0142-9612(93)90207-I
   PAPPAS NA, 1996, HYDROGELS MED PHARM, P65
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   PEPPAS NA, 1985, ANN NY ACAD SCI, V446, P26, DOI 10.1111/j.1749-6632.1985.tb18388.x
   ROHSENOW WM, 1961, HEAT MASS MOMENTUM T, P39
   ROSENBERG M, 1960, J ULTRA MOL STRUCT R, V4, P298, DOI 10.1016/S0022-5320(60)80024-X
   RUDIN A, 1999, ELEMENTS POLYM SCI E, P232
   SINGH H, 1980, J SCI IND RES INDIA, V39, P162
   Vijayasekaran S, 1997, CORNEA, V16, P352
   WARREN TC, 1972, MACROMOLECULES, V5, P506, DOI 10.1021/ma60028a029
   YASUDA H, 1971, J MACROMOL SCI PHYS, VB  5, P111, DOI 10.1080/00222347108212523
   YASUDA H, 1966, J POLYM SCI A1, V4, P2913, DOI 10.1002/pol.1966.150041201
   YASUDA H, 1969, MAKROMOLEKUL CHEM, V126, P177
NR 33
TC 49
Z9 49
U1 6
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2004
VL 25
IS 20
BP 5071
EP 5080
DI 10.1016/j.biomaterials.2004.01.058
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820DF
UT WOS:000221366300025
PM 15109870
DA 2018-10-20
ER

PT J
AU Greene, JA
AF Greene, JA
TI An ethnography of nonadherence: Culture, poverty, and tuberculosis in
   urban Bolivia
SO CULTURE MEDICINE AND PSYCHIATRY
LA English
DT Article
DE anthropology; Aymara; Bolivia; ethnography; patient nonadherence;
   tuberculosis
ID NONCOMPLIANCE
AB The author conducted a focused descriptive ethnographic study of nonadherence with tuberculosis (TB) therapy among Aymara-speaking residents of the city of La Paz, Bolivia. A cohort of patient-inform ants was identified from the District III TB Control Registry of La Paz as having been nonadherent with their TB medication protocol. From June to August 1998, ethnographic material was collected through participant-observation and repeated interviews and visits in homes, workplaces, clinics, and the community. Ethnographic analysis revealed structural barriers to be more important than cultural differences in the production of nonadherence. Though informants maintained a variety of beliefs and practices related to Aymara medicine, the majority of patients were comfortable with a biomedical model of tuberculosis and maintained belief in the efficacy of antituberculosis chemotherapy and desire to finish treatment. Patients overwhelmingly cited hidden costs of treatments, poor access to care, ethnic discrimination, and prior maltreatment by the health system as reasons for abandoning treatment. These data suggest that overemphasis of cultural difference without exploration of other social dimensions of health care delivery can obscure a more practical understanding of nonadherence in marginalized populations.
C1 Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA.
RP Greene, JA (reprint author), Harvard Univ, Sch Med, Dept Social Med, 641 Huntington Ave, Boston, MA 02115 USA.
EM greene@fas.harvard.edu
CR Abos-Hernandez R, 2002, INT J TUBERC LUNG D, V6, P470
   ALBO X, 1991, AM INDIGENA, V51, P107
   BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q
   BARRAGAN LB, 1998, FDN S GABRIEL ORIGEN
   Bastien J, 1992, DRUM STETHOSCOPE INT
   BASTIEN JW, 1995, SOC SCI MED, V41, P77, DOI 10.1016/0277-9536(94)00297-7
   BELL J, 1988, S AFR MED J, V73, P31
   Buechler H. C., 1971, BOLIVIAN AYMARA
   Buechler Hans, 1996, WORLD S VELASQUEZ AU
   Classen C., 1991, S AFRICAN J ETHNOLOG, V14, P69
   CRANDON L, 1983, ETHNOLOGY, V22, P153, DOI 10.2307/3773577
   CRANDONMALAMUD L, 1991, FAT OUR SOULS SOCIAL
   CUELLAR JM, 1986, BOLIVIA SALUD CONCIE
   DUBANOSKI JP, 1988, DISS ABSTR INT B, V48, P3152
   Farmer P, 1991, Semin Respir Infect, V6, P254
   Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8
   Farmer P., 2001, INFECT INEQUALITIES
   HENDERSON MA, 1984, J ROY ARMY MED CORPS, V130, P22
   Hudelson P, 1995, SOC SCI MED, V41, P1677, DOI 10.1016/0277-9536(95)00128-T
   KLEINMAN A, 1988, ILLNESS NARRATIVES S
   LANGLEY GM, 1917, GEOGR REV, V4, P193
   Lerner BH, 1997, SOC SCI MED, V45, P1423, DOI 10.1016/S0277-9536(97)00067-1
   Mata J I, 1985, Med Anthropol, V9, P57
   *MDHSNS, 1996, PUBL TECHN MDHSNS, V11
   MOLLINEDO J, 1998, SEM ACT PROGR TUB
   *PAHO, 2001, COUNTR HLTH PROF BOL
   *PAHO, 1996, COUNTR HLTH PROF BOL
   *PNVCT, 1997, INF 1996 TUB
   SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311
   TROTTER RT, 1991, TRAINING MANUAL APPL, P180
   WEISE HJC, 1974, SOC SCI MED, V8, P359
   *WHO, 1998, REP TUB EP 1997
   [WHO World Health Organization], 2003, WHO REP 2003 GLOB TU
   WOOD B, 1994, INDIGENOUS PEOPLE PO, P55
NR 34
TC 40
Z9 42
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0165-005X
J9 CULT MED PSYCHIAT
JI Cult. Med. Psychiatr.
PD SEP
PY 2004
VL 28
IS 3
BP 401
EP 425
DI 10.1023/B:MEDI.0000046429.55801.c8
PG 25
WC Anthropology; Psychiatry; Social Sciences, Biomedical
SC Anthropology; Psychiatry; Biomedical Social Sciences
GA 877LS
UT WOS:000225572700008
PM 15600119
DA 2018-10-20
ER

PT J
AU Drotleff, S
   Lungwitz, U
   Breunig, M
   Dennis, A
   Blunk, T
   Tessmar, J
   Gopferich, A
AF Drotleff, S
   Lungwitz, U
   Breunig, M
   Dennis, A
   Blunk, T
   Tessmar, J
   Gopferich, A
TI Biomimetic polymers in pharmaceutical and biomedical sciences
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Review
DE biomaterial; biomimetic; tissue engineering; cell signaling; surface
   attachment; gene therapy; drug targeting
ID RECEPTOR-MEDIATED ENDOCYTOSIS; EPIDERMAL-GROWTH-FACTOR; POLYLYSINE DNA
   COMPLEXES; CELL-ADHESION PEPTIDES; MATRIX PROTEIN EXPRESSION;
   GENE-DELIVERY; EXTRACELLULAR-MATRIX; IN-VITRO; DRUG-DELIVERY;
   POLY(ETHYLENE GLYCOL)
AB This review describes recent developments in the emerging field of biomimetic polymeric biomaterials, which signal to cells via biologically active entities. The described biological effects are, in contrast to many other known interactions, receptor mediated and therefore very specific for certain cell types. As an introduction into this field, first some biological principles are illustrated such as cell attachment, cytokine signaling and endocytosis, which are some of the mechanisms used to control cells with biomimetic polymers. The next topics are then the basic design rules for the creation of biomimetic materials. Here, the major emphasis is on polymers that are assembled in separate building blocks, meaning that the biologically active entity is attached to the polymer in a separate chemical reaction. In that respect, first individual chemical standard reactions that may be used for this step are briefly reviewed. In the following chapter, the emphasis is on polymer types that have been used for the development of several biomimetic materials. There is, thereby, a delineation made between materials that are processed to devices exceeding cellular dimensions and materials predominantly used for the assembly of nanostructures. Finally, we give a few current examples for applications in which biomimetic polymers have been applied to achieve a better biomaterial performance. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Regensburg, Dept Pharmaceut Technol, D-93053 Regensburg, Germany.
   Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Gopferich, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, Univ Str 31, D-93053 Regensburg, Germany.
EM achim.goepferich@chemie.uni-regensburg.de
RI Goepferich, Achim/G-1151-2016; Breunig, Miriam/K-2978-2016; Tessmar,
   Joerg/H-3606-2012
OI Goepferich, Achim/0000-0002-7646-0252; Breunig,
   Miriam/0000-0002-1320-6820; Tessmar, Joerg/0000-0001-7057-5369
CR ALBERTS B, 1994, MOL BIOL CELL, P502
   ALBERTS B, 1994, MOL BIOL CELL, P769
   ALBERTS B, 1994, MOL BIOL CELL, P618
   ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
   BARANY G, 1980, PEPTIDES, P1
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   BAZILE DV, 1992, BIOMATERIALS, V13, P1093, DOI 10.1016/0142-9612(92)90142-B
   Bettinger T, 1999, BIOCONJUGATE CHEM, V10, P558, DOI 10.1021/bc990006h
   Bhadriraju K, 2000, BIOMATERIALS, V21, P267, DOI 10.1016/S0142-9612(99)00175-1
   Bieber T, 2002, J CONTROL RELEASE, V82, P441, DOI 10.1016/S0168-3659(02)00129-3
   BLUMENTHAL R, 1986, BIOCHEMISTRY-US, V25, P2231, DOI 10.1021/bi00356a057
   Blunk T, 2003, BIOMATERIALS, V24, P4335, DOI 10.1016/S0142-9612(03)00336-3
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   BOBBITT JM, 1956, ADV CARBOHYD CHEM, V11, P1
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   BREWER CF, 1967, ANAL BIOCHEM, V18, P248, DOI 10.1016/0003-2697(67)90007-3
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   CHEN JB, 1994, FEBS LETT, V338, P167, DOI 10.1016/0014-5793(94)80357-9
   CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547
   Cho CW, 2000, BIOTECHNOL APPL BIOC, V32, P21, DOI 10.1042/BA20000022
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   COTTEN M, 1990, P NATL ACAD SCI USA, V87, P4033, DOI 10.1073/pnas.87.11.4033
   CRISTIANO RJ, 1993, P NATL ACAD SCI USA, V90, P11548, DOI 10.1073/pnas.90.24.11548
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850, DOI 10.1073/pnas.88.19.8850
   DONAHUE RE, 1992, J EXP MED, V176, P1125, DOI 10.1084/jem.176.4.1125
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Erbacher P, 1999, J GENE MED, V1, P210
   ERBACHER P, 1995, BIOCONJUGATE CHEM, V6, P401, DOI 10.1021/bc00034a010
   Erbacher P, 1999, GENE THER, V6, P138, DOI 10.1038/sj.gt.3300783
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Fischbach C, 2001, SURF SCI, V491, P333, DOI 10.1016/S0039-6028(01)01297-3
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   GILLES MA, 1990, ANAL BIOCHEM, V184, P244, DOI 10.1016/0003-2697(90)90675-Y
   Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q
   Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177
   GREEN NM, 1971, BIOCHEM J, V125, P781, DOI 10.1042/bj1250781
   Gref R, 2003, BIOMATERIALS, V24, P4529, DOI 10.1016/S0142-9612(03)00348-X
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   Harma H, 2000, LUMINESCENCE, V15, P351, DOI 10.1002/1522-7243(200011/12)15:6<351::AID-BIO624>3.0.CO;2-3
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   HEITZ JR, 1968, ARCH BIOCHEM BIOPHYS, V127, P627, DOI 10.1016/0003-9861(68)90271-3
   Hermanson T. H., 1996, BIOCONJUGATE TECHNIQ, P139
   HERMANSON TH, 2004, BIOCONJUGATE TECHNIQ, P114
   HERMANSON TH, 1996, BIOCONJUGATE TECHNIQ, P169
   HERMANSON TH, 1996, BIOCONJUGATE TECHNIQ, P138
   HERMANSON TH, 1996, BIOCONJUGATE TECHNIQ, P177
   HERMANSON TH, 2004, BIOCONJUGATE TECHNIQ, P185
   HERMANSON TH, 2004, BIOCONJUGATE TECHNIQ, P64
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HOECKER H, 1998, MACROMOL S, V130, P161
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, MAT SCI ENG C-BIO S, V6, P267, DOI 10.1016/S0928-4931(98)00061-7
   James K, 1996, MRS BULL, V21, P22, DOI 10.1557/S0883769400031808
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Jo S, 2000, POLYMER, V41, P7595, DOI 10.1016/S0032-3861(00)00117-8
   KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kircheis R, 2001, J CONTROL RELEASE, V72, P165, DOI 10.1016/S0168-3659(01)00272-3
   Kircheis R, 2001, GENE THER, V8, P28, DOI 10.1038/sj.gt.3301351
   Klee D, 1999, ADV POLYM SCI, V149, P1
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Langer R, 1995, CHEM ENG SCI, V50, P4109, DOI 10.1016/0009-2509(95)00226-X
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   Leamon CP, 1999, BIOCONJUGATE CHEM, V10, P947, DOI 10.1021/bc990066n
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Lee H, 2002, J CONTROL RELEASE, V83, P109, DOI 10.1016/S0168-3659(02)00166-9
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li YP, 2003, INT J PHARM, V259, P93, DOI 10.1016/S0378-5173(03)00211-4
   Lilli C, 2002, J BIOMED MATER RES, V63, P577, DOI 10.1002/jbm.10301
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Matthew H. W. T., 2000, BIOMATERIALS, V21, P2589
   Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575
   MERWIN JR, 1995, J IMMUNOL METHODS, V186, P257, DOI 10.1016/0022-1759(95)00150-9
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Mineo C, 2001, HISTOCHEM CELL BIOL, V116, P109
   MISLICK KA, 1995, BIOCONJUGATE CHEM, V6, P512, DOI 10.1021/bc00035a002
   Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X
   Murphy WL, 2002, NAT BIOTECHNOL, V20, P30, DOI 10.1038/nbt0102-30
   Na K, 2003, EUR J PHARM SCI, V18, P165, DOI 10.1016/S0928-0987(02)00257-9
   Nishikawa M, 2001, HUM GENE THER, V12, P861, DOI 10.1089/104303401750195836
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Olivier JC, 2002, PHARMACEUT RES, V19, P1137, DOI 10.1023/A:1019842024814
   OMULLANE JE, 1990, INT J PHARM, V63, P177, DOI 10.1016/0378-5173(90)90169-5
   Pan D, 2003, CHEM COMMUN, P2400, DOI 10.1039/b307878g
   Park KH, 2002, BIOTECHNOL LETT, V24, P1401, DOI 10.1023/A:1019890229822
   PARTHASARATHI S, 1995, J VIROL, V69, P7991
   PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358
   PATCHORNIK A, 1957, J AM CHEM SOC, V79, P5227, DOI 10.1021/ja01576a043
   PENG L, 1987, APPL BIOCHEM BIOTECH, V14, P91, DOI 10.1007/BF02798427
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PLANK C, 1994, J BIOL CHEM, V269, P12918
   PLANK C, 1992, BIOCONJUGATE CHEM, V3, P533, DOI 10.1021/bc00018a012
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165
   Purcell DFJ, 1996, J VIROL, V70, P887
   Putnam E A, 1992, Surg Oncol, V1, P49, DOI 10.1016/0960-7404(92)90056-Q
   Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Ratner BD, 1998, MACROMOL SYMP, V130, P327, DOI 10.1002/masy.19981300128
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Smith LC, 1998, ADV DRUG DELIVER REV, V30, P115, DOI 10.1016/S0169-409X(97)00111-7
   Stayton PS, 2000, J CONTROL RELEASE, V65, P203, DOI 10.1016/S0168-3659(99)00236-9
   Stella B, 2000, J PHARM SCI, V89, P1452, DOI 10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
   Stewart J.M., 1984, SOLID PHASE PEPTIDE, P31
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   STOCKERT RJ, 1995, PHYSIOL REV, V75, P591
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   STUART CA, 1979, ENDOCRINOLOGY, V105, P1293, DOI 10.1210/endo-105-6-1293
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Tessmar J, 2003, BIOMATERIALS, V24, P4475, DOI 10.1016/S0142-9612(03)00345-4
   Tessmar JK, 2002, BIOMACROMOLECULES, V3, P194, DOI 10.1021/bn015608u
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Trippel S B, 1995, J Rheumatol Suppl, V43, P129
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   von Harpe A, 2000, J CONTROL RELEASE, V69, P309, DOI 10.1016/S0168-3659(00)00317-5
   VONSTEENIS JH, 2003, J CONTROL RELEASE, V87, P167
   WAGNER E, 1994, ADV DRUG DELIVER REV, V14, P113, DOI 10.1016/0169-409X(94)90008-6
   WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255
   WAGNER E, 1991, BIOCONJUGATE CHEM, V2, P226, DOI 10.1021/bc00010a006
   WAGNER E, 1992, P NATL ACAD SCI USA, V89, P6099, DOI 10.1073/pnas.89.13.6099
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   WANG CY, 1984, BIOCHEMISTRY-US, V23, P4409, DOI 10.1021/bi00314a026
   Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Ward JH, 2001, J BIOMED MATER RES, V56, P351, DOI 10.1002/1097-4636(20010905)56:3<351::AID-JBM1103>3.0.CO;2-A
   Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6
   Xu B, 1998, GENE THER, V5, P1235, DOI 10.1038/sj.gt.3300719
   Yoon JJ, 2002, BIOTECHNOL BIOENG, V78, P1, DOI 10.1002/bit.10239
   Zanta MA, 1997, BIOCONJUGATE CHEM, V8, P839, DOI 10.1021/bc970098f
   Zhou SB, 2003, J CONTROL RELEASE, V86, P195, DOI 10.1016/S0168-3659(02)00423-6
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 171
TC 107
Z9 111
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0935-1221
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD SEP
PY 2004
VL 58
IS 2
BP 385
EP 407
DI 10.1016/j.ejpb.2004.03.018
PG 23
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 849GQ
UT WOS:000223527100016
PM 15296963
DA 2018-10-20
ER

PT J
AU Abele, MG
   Rusinek, H
AF Abele, MG
   Rusinek, H
TI Permanent conical magnet for interventional magnetic resonance imaging
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article
DE biomedical imaging; boundary-element methods; ferrites; Laplace
   equations; magnetic fields; magnetic resonance imaging; neodymium
   alloys; permanent magnets; surgery
ID COMPACT; SYSTEM
AB We describe an open structure of permanently magnetized material for interventional magnetic resonance imaging of the brain. We transformed the ideal magnet, contained between two coaxial cones, into a practical device by a series of geometrical steps that minimize field perturbations. By taking advantage of the quasi-linear demagnetization characteristics of rare-earth materials, we could analyze the structure with an exact mathematical model. The magnet, built of material of remanence 1.38 T, generates a field of 0.45 T within its central gap 30 cm wide. Our numerical computations show a remarkable 0.25% field uniformity in the imaging region. The large opening makes the conical magnet suitable for interventional and surgical imaging.
C1 NYU, Sch Med, Dept Radiol, New York, NY 10016 USA.
RP Abele, MG (reprint author), NYU, Sch Med, Dept Radiol, 550 1St Ave, New York, NY 10016 USA.
EM hr18@nyu.edu
CR ABELE MG, 1992, IEEE T MAGN, V28, P931, DOI 10.1109/20.120031
   ABELE MG, 1993, STRUCTURES PERMANENT, P76
   Hadani M, 2001, NEUROSURGERY, V48, P799, DOI 10.1097/00006123-200104000-00021
   LUFKIN RB, 1999, INTERVENTIONAL MRI
   Masciocchi C, 1996, EUR J RADIOL, V22, P7, DOI 10.1016/0720-048X(95)00703-S
   Messineo D, 1998, MAGN RESON IMAGING, V16, P731, DOI 10.1016/S0730-725X(98)00080-0
   MIYAMOTO T, 1989, P 10 INT WORKSH RAR, P113
   MIYAMOTO T, 1989, J MAGN SOC JAPAN, V13, P465
   Schulder M, 2001, J NEUROSURG, V94, P936, DOI 10.3171/jns.2001.94.6.0936
   Steinmeier R, 1998, NEUROSURGERY, V43, P739, DOI 10.1097/00006123-199810000-00005
   STRNAT KJ, 1990, P IEEE, V78, P923, DOI 10.1109/5.56908
   Wutke R, 2001, Rontgenpraxis, V54, P43
NR 12
TC 2
Z9 2
U1 1
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD SEP
PY 2004
VL 40
IS 5
BP 3382
EP 3386
DI 10.1109/TMAG.2004.834039
PG 5
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 853TS
UT WOS:000223852400021
DA 2018-10-20
ER

PT J
AU Giavaresi, G
   Tschon, M
   Daly, JH
   Liggat, JJ
   Fini, M
   Torricelli, P
   Giardino, R
AF Giavaresi, G
   Tschon, M
   Daly, JH
   Liggat, JJ
   Fini, M
   Torricelli, P
   Giardino, R
TI Natural and synthetic polyesters for musculoskeletal tissue repair:
   Experimental in vitro and in vivo evaluations
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE polyesters; murine fibroblasts; animal model; biocompatibility; implant
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; CRUCIATE LIGAMENT
   RECONSTRUCTION; BIODEGRADABLE MEDICAL DEVICES; ANTIBIOTIC RELEASE;
   HYDROLYTIC DEGRADATION; BONE DEFECTS; FOLLOW-UP; DELIVERY; SYSTEMS;
   POLYMER
AB Two natural Biopol(TM) polyesters, containing 8% (D400G) and 12% (D600G) of hydroxyvalerate component, and a synthetic polyester based on 1,4 cyclohexanediol [Poly(cyclohexyl-sebacate) - PCS] were studied to investigate their in vitro and in vivo behavior for application in musculoskeletal tissue repair. The polyesters were placed in direct contact with L929 fibroblasts and cell proliferation (WST-1), cytotoxic effect (LDH), synthetic activity (total proteins) and cytokine production (IL-1beta, IL-6, TNFalpha) were assessed after an incubation period of 72 hours and 7 days. Then, 12 Sprague-Dawley rats underwent dorsal subcutaneous implants of tested polyesters under general anesthesia. After 1 and 4 weeks from surgery, the animals were pharmacologically euthanized and the implants retrieved with surrounding tissue for histologic and histomorphometric investigations. In vitro results showed that D600G behaved a little worse in comparison to other tested polyesters in terms of cell proliferation and TNFalpha at 7 days. PCS presented the lowest total protein value at 7 days. In vivo results indicated that PCS implants produced a higher (p < 0.01) extent of inflammatoty tissue in comparison to D600G at 1 week and to D40OG at 4 weeks, and the lowest vascular densities at both experimental times. D40OG seems to be the most suitable material for biomedical application when tested in fibroblast cultures and in the subcutaneous tissue of rats.
C1 Ist Ortopedici Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, I-40136 Bologna, Italy.
   Univ Strathclyde, Dept Pure & Appl Chem, Glasgow, Lanark, Scotland.
RP Giavaresi, G (reprint author), Ist Ortopedici Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM gianluca.giavaresi@ior.it
RI TORRICELLI, PAOLA/J-5298-2016; Fini, Milena/J-4808-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970; Fini, Milena/0000-0002-3732-3570;
   Giavaresi, Gianluca/0000-0001-7843-5969; Liggat,
   John/0000-0003-4460-5178
CR AMCDONALD P, 2003, ARTHROSCOPY, V19, pE22
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Baran ET, 2002, J MICROENCAPSUL, V19, P363, DOI 10.1080/02652040110105355
   Barber FA, 1999, ARTHROSCOPY, V15, P360, DOI 10.1016/S0749-8063(99)70052-6
   BRAUN D, 1993, ANGEW MAKROMOL CHEM, V210, P173, DOI 10.1002/apmc.1993.052100114
   Cao T, 2003, TISSUE ENG, V9, pS103, DOI 10.1089/10763270360697012
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chambers R, 2001, J MATER SCI, V36, P3785, DOI 10.1023/A:1017938203630
   Chen A, 1998, Zhonghua Wai Ke Za Zhi, V36, P96
   Chen J, 2002, J MICROENCAPSUL, V19, P191, DOI 10.1080/02652040110065431
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   COX MK, 1990, BIODEGRADABLE POLYM
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Fini M, 1995, INT J ARTIF ORGANS, V18, P772
   Fini M, 2003, J Appl Biomater Biomech, V1, P155
   GALGUT P, 1991, J CLIN PERIODONTOL, V18, P581, DOI 10.1111/j.1600-051X.1991.tb00093.x
   Giardino R, 1998, INT J ARTIF ORGANS, V21, P473
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOWEN M, 1992, CYTOKINES BONE METAB, P71
   Gursel I, 2001, BIOMATERIALS, V22, P73, DOI 10.1016/S0142-9612(00)00170-8
   Gursel I, 2002, J MICROENCAPSUL, V19, P153, DOI 10.1080/02652040110065413
   GURSEL I, 1995, J MICROENCAPSUL, V12, P185, DOI 10.3109/02652049509015289
   HAMMOND T, 1995, DEGRADABLE POLYM PRI, P88
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   Hurel C, 2000, KNEE SURG SPORT TR A, V8, P46, DOI 10.1007/s001670050010
   Hutcheon GA, 2001, BIOMATERIALS, V22, P667, DOI 10.1016/S0142-9612(00)00229-5
   Kazimoglu C, 2003, INT J ARTIF ORGANS, V26, P804
   Khang G, 2001, BIO-MED MATER ENG, V11, P89
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   KNOWLES JC, 1993, J MED ENG TECHNOL, V17, P129, DOI 10.3109/03091909309087593
   Kontio R, 2001, INT J ORAL MAX SURG, V30, P278, DOI 10.1054/ijom.2001.0067
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Lajtai G, 2001, ARTHROSCOPY, V17, P597, DOI 10.1053/jars.2001.21535
   Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7
   Luklinska ZB, 2003, J MICROSC-OXFORD, V211, P121, DOI 10.1046/j.1365-2818.2003.01204.x
   Moran JM, 2003, TISSUE ENG, V9, P63, DOI 10.1089/107632703762687546
   Nakayama Y, 1997, Nihon Ika Daigaku Zasshi, V64, P512
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   SAITO T, 1991, BIOMATERIALS, V12, P309, DOI 10.1016/0142-9612(91)90039-D
   Schwendeman SP, 2002, CRIT REV THER DRUG, V19, P73, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.20
   Sendil D, 1999, J CONTROL RELEASE, V59, P207, DOI 10.1016/S0168-3659(98)00195-3
   Senkoylu A, 2002, INT J ARTIF ORGANS, V25, P1174
   Turesin F, 2001, J BIOMAT SCI-POLYM E, V12, P195, DOI 10.1163/156856201750180924
   van der Walle GAM, 2001, ADV BIOCHEM ENG BIOT, V71, P263
   Vesala AL, 2002, J CRANIOFAC SURG, V13, P607, DOI 10.1097/01.SCS.0000026452.58930.19
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Yagmurlu MF, 1999, J BIOMED MATER RES, V46, P494
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 54
TC 7
Z9 7
U1 4
U2 16
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2004
VL 27
IS 9
BP 796
EP 805
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 864MF
UT WOS:000224636900010
PM 15521220
DA 2018-10-20
ER

PT J
AU Bagno, A
   Di Bello, C
AF Bagno, A
   Di Bello, C
TI Surface treatments and roughness properties of Ti-based biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; MODIFIED TITANIUM IMPLANTS; SCREW-SHAPED
   IMPLANTS; BONE RESPONSE; IN-VITRO; COATED TITANIUM; REMOVAL TORQUE;
   BIOLOGICAL PROPERTIES; CHEMICAL-MODIFICATION; ADHESIVE PEPTIDES
AB Nowadays, the use of implanted devices is a well-acknowledged practice in the field of orthopaedic and dental surgery. Scientific research and clinical experience suggest that the successful exploitation of these devices mainly depends on osseointegration, considered as both anatomical congruency and load-bearing capacity. Indeed, the osseointegration process is influenced by a wide range of factors: anatomical location, implant size and design, surgical procedure, loading effects, biological fluids, age and sex, and, in particular, surface characteristics. For this reason, several attempts have been aimed at modifying implant surface composition and morphology to optimise implant-to-bone contact and improve integration.
   Preliminary interactions between implanted materials and biological environment are deemed to be governed by the surface properties; they control the amount and quality of cell adhesion on the surface and, consequently, cell/tissue growth. Thus, surface properties govern new bone tissue formation and implant osseointegration.
   This paper reviews the state of art in the field of physical, chemical and biochemical treatments commonly used on Ti-based biomaterials for the production of biomedical devices. In particular, roughness characteristics due to physical and chemical techniques are investigated; the development of biologically active surfaces by means of biochemical functionalisation is also considered. (C) 2004 Kluwer Academic Publishers.
C1 Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy.
RP Bagno, A (reprint author), Univ Padua, Dept Chem Proc Engn, Via Marzolo 9, I-35131 Padua, Italy.
EM andrea.bagno@unipd.it
OI Bagno, Andrea/0000-0002-4296-3601
CR Abrahamsson I, 2002, J CLIN PERIODONTOL, V29, P448, DOI 10.1034/j.1600-051X.2002.290510.x
   ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Agrawal CM, 1997, J BIOMED MATER RES, V36, P516, DOI 10.1002/(SICI)1097-4636(19970915)36:4<516::AID-JBM9>3.0.CO;2-H
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1991, BONE-BIOMATERIAL INTERFACE, P357
   Amstutz H. C., 1996, CLIN ORTHOP S, V319S, P297
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   Browne M, 1996, J MATER SCI-MATER M, V7, P323, DOI 10.1007/BF00154543
   BRUNSKI B, 1998, INT J ORAL MAXILLOF, V3, P85
   Brunski J B, 1999, Adv Dent Res, V13, P99
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Callen BW, 1995, PROG SURF SCI, V50, P269, DOI 10.1016/0079-6816(95)00061-5
   Carlsson L, 1988, Int J Oral Maxillofac Implants, V3, P21
   Castellani R, 1999, CLIN ORAL IMPLAN RES, V10, P369, DOI 10.1034/j.1600-0501.1999.100504.x
   CLAES L, 1976, ARCH ORTHOP TRAUM SU, V85, P155, DOI 10.1007/BF00415453
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   Glass JR, 1996, BIOMATERIALS, V17, P1101, DOI 10.1016/0142-9612(96)85911-4
   Goransson A, 2003, BIOMATERIALS, V24, P197, DOI 10.1016/S0142-9612(02)00277-6
   GOTFREDSEN K, 1995, J BIOMED MATER RES, V29, P1223, DOI 10.1002/jbm.820291009
   Gotfredsen K, 1992, Clin Oral Implants Res, V3, P77, DOI 10.1034/j.1600-0501.1992.030205.x
   Hall J, 2000, APPL OSSEOINTEGRATIO, V1, P5
   Hansson S, 1999, CLIN ORAL IMPLAN RES, V10, P394, DOI 10.1034/j.1600-0501.1999.100506.x
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   JANSEN JA, 1991, CLIN ORAL IMPLAN RES, V74, P28
   Jansson E, 2002, BIOMATERIALS, V23, P2803, DOI 10.1016/S0142-9612(02)00021-2
   Jansson E, 2001, BIOMATERIALS, V22, P1803, DOI 10.1016/S0142-9612(00)00359-8
   Kapanen A, 2002, BIOMATERIALS, V23, P3733, DOI 10.1016/S0142-9612(02)00107-2
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Klokkevold PR, 2001, CLIN ORAL IMPLAN RES, V12, P350, DOI 10.1034/j.1600-0501.2001.012004350.x
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lee SJ, 2000, YONSEI MED J, V41, P704, DOI 10.3349/ymj.2000.41.6.704
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Liao HH, 1999, J BIOMED MATER RES, V47, P220, DOI 10.1002/(SICI)1097-4636(199911)47:2<220::AID-JBM12>3.0.CO;2-9
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mustafa K, 1998, CLIN ORAL IMPLAN RES, V9, P195, DOI 10.1034/j.1600-0501.1998.090307.x
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Perrin D, 2002, CLIN ORAL IMPLAN RES, V13, P465, DOI 10.1034/j.1600-0501.2002.130504.x
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Puleo DA, 1996, BIOMATERIALS, V17, P217, DOI 10.1016/0142-9612(96)85766-8
   Ramires PA, 2002, BIOMATERIALS, V23, P397, DOI 10.1016/S0142-9612(01)00118-1
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Schmidmaier G, 2001, BONE, V28, P341, DOI 10.1016/S8756-3282(00)00456-7
   STOUT KJ, 1993, 15178EN EUR U BIRM C
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Takuma M, 1990, J Osaka Univ Dent Sch, V30, P86
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   VANDIJK K, 1998, J BIOMED MATER RES, V41, P41
   Vercaigne S, 2000, CLIN ORAL IMPLAN RES, V11, P305, DOI 10.1034/j.1600-0501.2000.011004305.x
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   WENNERBERG A, 1992, J BIOMED ENG, V14, P412, DOI 10.1016/0141-5425(92)90087-2
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
NR 84
TC 153
Z9 158
U1 0
U2 64
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2004
VL 15
IS 9
BP 935
EP 949
DI 10.1023/B:JMSM.0000042679.28493.7f
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 856RE
UT WOS:000224061500001
PM 15448401
DA 2018-10-20
ER

PT J
AU Bae, IJ
   Standard, OC
   Roger, GJ
   Brazil, D
AF Bae, IJ
   Standard, OC
   Roger, GJ
   Brazil, D
TI Phase and microstructural development in alumina sol-gel coatings on
   CoCr alloy
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ALPHA-ALUMINA; TRANSFORMATION; BOEHMITE; POLYETHYLENE; MECHANISM; METAL;
   WEAR; FABRICATION; AL2O3-CR2O3; GAMMA-AL2O3
AB Phase transformation of gamma-Al2O3 to alpha-Al2O3 in alumina sol gel coatings on biomedical CoCr alloy was studied as function of heat treatment temperature and time. Transformation in unseeded coatings was significant only above similar to 1200 degreesC. Addition of alpha-Al2O3 seed particles having an average size of approximately 40 nm lowered the phase transformation temperature to around 800 C. These particles were considered to act as heterogeneous nucleation sites for epitaxial growth of the alpha-Al2O3 phase. The kinetics and activation energy (420 kJ/mol) for the phase transformation in the seeded coatings were similar to those reported for seeded monolithic alumina gels indicating that the transformation mechanism is the same in the two material configurations. Avrami growth parameters indicated that the mechanism was diffusion controlled and invariant over the temperature range studied but that growth was possibly constrained by the finite size of the seed particles and/or coating thickness. The phase transformation occurred by the growth of alpha-Al2O3 grains at the expense of the precursor fine-grained gamma-Al2O3 matrix and near-complete transformation coincided with physical impingement of the growing grains. The grain size at impingement was similar to 100 nm which agreed well with that predicted from the theoretical linear spacing of seed particles in the initial sol. (C) 2004 Kluwer Academic Publishers.
C1 Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia.
   Australian Surg Design & Mfg PL, St Leonards, NSW 2065, Australia.
RP Standard, OC (reprint author), Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia.
EM o.standard@unsw.edu.au
CR Al-Saffar N, 1999, J LONG-TERM EFF MED, V9, P319
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, V276, P7
   ARMINI AJ, 1998, ASTM STP, V1346
   *ASTM, 1996, F7592 ASTM
   BADKAR PA, 1976, J MATER SCI, V11, P1794, DOI 10.1007/BF00708257
   BAE IJ, 2003, UNPUB U NEW S WALES
   Beltran AM., 1987, SUPERALLOYS, P135
   Brown M.E., 1980, REACTIONS SOLID STAT, V22
   Bunting EN, 1931, BUR STAND J RES, V6, P947
   BYE GC, 1974, J AM CERAM SOC, V57, P367, DOI 10.1111/j.1151-2916.1974.tb10925.x
   CHRISTIAN JW, 1975, TRANSFORMATION MET 1
   CORBETT S, 1998, NITRIC OXIDE BONE JO, P178
   Goodman S, 1996, ACTA ORTHOP SCAND, V67, P599, DOI 10.3109/17453679608997764
   HAM FS, 1958, J PHYS CHEM SOLIDS, V6, P335, DOI 10.1016/0022-3697(58)90053-2
   *INT CTR POWD DIFF, 2003, 421468 INT CTR POWD
   *INT CTR POWD DIFF, 2003, 231009 INT CTR POWD
   *INT CTR POWD DIFF, 2003, 211307 INT CTR POWD
   *INT CTR POWD DIFF, 2003, 160394 INT CTR POWD
   *INT CTR POWD DIFF, 2003, 100425 INT CTR POWD
   Kao HC, 2000, J AM CERAM SOC, V83, P362
   Kim SS, 2001, J AM CERAM SOC, V84, P1881
   KUMAGAI M, 1985, J AM CERAM SOC, V68, P500, DOI 10.1111/j.1151-2916.1985.tb15818.x
   Levin I, 1998, J AM CERAM SOC, V81, P1995
   Li YS, 1999, J RAMAN SPECTROSC, V30, P97, DOI 10.1002/(SICI)1097-4555(199902)30:2<97::AID-JRS352>3.0.CO;2-X
   LIVINGSTON BJ, 1997, T 4O ANN M ORTH RES, P141
   MCARDLE JL, 1986, J AM CERAM SOC, V69, pC98
   MCARDLE JL, 1993, J AM CERAM SOC, V76, P214, DOI 10.1111/j.1151-2916.1993.tb03710.x
   MCARDLE JL, 1989, J AM CERAM SOC, V72, P864, DOI 10.1111/j.1151-2916.1989.tb06235.x
   MOORE RL, 1993, J VAC SCI TECHNOL, V11, P168
   Oh CS, 1996, J MATER SCI, V31, P5321, DOI 10.1007/BF01159299
   OONISHI H, 2003, BIOCERAMICS, V15, P735
   PACH L, 1990, J MATER RES, V5, P278, DOI 10.1557/JMR.1990.0278
   RAJENDRAN S, 1994, J MATER SCI, V29, P5664, DOI 10.1007/BF00349962
   ROY DM, 1972, NATURE-PHYS SCI, V235, P118, DOI 10.1038/physci235118a0
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   SCHULLER HM, 1990, ACTA ORTHOP SCAND, V61, P240, DOI 10.3109/17453679008993508
   Semlitsch M, 1997, P I MECH ENG H, V211, P73, DOI 10.1243/0954411971534700
   SHELLEMAN RA, 1986, J NON-CRYST SOLIDS, V82, P277, DOI 10.1016/0022-3093(86)90142-0
   Simpson TW, 1998, J AM CERAM SOC, V81, P61
   TSUCHIDA T, 1983, THERMOCHIM ACTA, V64, P337, DOI 10.1016/0040-6031(83)85009-6
   WILSON SJ, 1979, J SOLID STATE CHEM, V30, P247, DOI 10.1016/0022-4596(79)90106-3
   WILSON SJ, 1980, J SOLID STATE CHEM, V34, P315, DOI 10.1016/0022-4596(80)90429-6
   Yarbrough W. A., 1987, Journal of Materials Research, V2, P494, DOI 10.1557/JMR.1987.0494
   YOLDAS BE, 1982, J AM CERAM SOC, V65, P387, DOI 10.1111/j.1151-2916.1982.tb10490.x
   YOLDAS BE, 1973, J APPL CHEM BIOTECHN, V23, P803, DOI 10.1002/jctb.5020231103
   ZICHNER LP, 1992, CLIN ORTHOP RELAT R, P86
NR 46
TC 11
Z9 12
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2004
VL 15
IS 9
BP 959
EP 966
DI 10.1023/B:JMSM.0000042681.25746.74
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 856RE
UT WOS:000224061500003
PM 15448403
DA 2018-10-20
ER

PT J
AU Forsythe, KM
   Robertson, DH
   Zheng, QH
AF Forsythe, KM
   Robertson, DH
   Zheng, QH
TI Ab initio MO calculation studies for several novel entries to tropane
   compounds
SO JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY
LA English
DT Article
DE tropane compounds; conjugate addition reaction; isomerization;
   ring-opening reaction; ab initio MO calculation
ID ENANTIOSELECTIVE DEPROTONATION STRATEGY; DOPAMINE TRANSPORTERS;
   LIGAND-BINDING; ESTERS; SITES; SEROTONIN; ISOMERS; COCAINE; ANALOGS;
   DISEASE
AB Tropane alkaloids are generally known as anticholinergics. Radiolabeled tropane compounds could be brain imaging agents used in biomedical imaging technique positron emission tomography (PET). A novel entry to aryltropane analogs of cocaine was developed based on the conjugate addition reaction of Grignard reagents phenylmagnesium (10), (4'-isopropenylptienyl)magnesium (11), or 2-naphthylmagnesium bromide (12) to a,)3-unsaturated esters anhydroecgonine methyl ester (9) or t-butyl ester (13) which gave several aryltropanes (1-8) with high binding affinities for dopamine and serotonin transporters. Basic conditions are frequently employed in the radiolabeling chemistry of many aryltropane cocaine analogs (1-8b, 14-24b). However, isomerization at C-2 position can also occur under basic conditions, resulting in loss of the biologically potent 2beta-isomers (1-8b, 14-24b) by conversion to the much less active 2alpha-isomer (1-8a, 14-24a). Tropinone (25) could be envisaged as a convenient starting material for the synthesis of diverse tropane alkaloids. A novel entry into tropane alkaloid intermediates was developed based on the ring-opening reaction of tropinone. In this reaction, the enolate of tropinone, resulting from deprotonation with lithium diisopropylamide [LDA, LiN(CHMe2)(2)] or sodium bis(trimethylsilyl)amide [NaN(SiMe3)(2)] Was treated with alkyl chloroformate to give a novel, structurally unique class of tropane alkaloid intermediates 6-N-carboalkyoxy-N-methyl-2-cycloheptenone (26), 1-alkyoxycarboxy-6-N-carboalkoxy-N-methyl-2,7-cyclohept-dien (27) and 6-N-carboalkyoxy-N-methyl-7-carboalkoxy-2,7-cyclohept-dien-ol (28). In this paper we study the conjugate addition reaction of Grignard reagents to alpha, beta-unsaturated esters, the isomerization of aryltropane cocaine analogs, and the ring-opening reaction of tropinone by ab initio MO calculation at the Hartree-Fock (HF) level. The calculation results solely in terms of energetics indicate that the 2alpha-isomers (equatorial configurations) of aryltropane cocaine analogs are more stable than their 2beta-isomers (axial configurations), at the AMI, STO-3G and 3-21G(*) levels, and the Grignard 1,4- and then 1,2-addition (double addition) products (2, 4, 5 and 7) are likely more stable than the Grignard 1,4-addition (single addition) products (1, 3, 6 and 8), respectively, at the STO-3G and 3-21G(*) levels except at the AMI level. Therefore the tendency of Grignard addition toward double addition is competitive with single addition, and the isomerization tends to the formation of more stable 2a-isomers. Likewise, the calculation results solely in terms of energetics indicate that the stability of the reaction product forms is 28 > 27 > 26, at the AMI, STO-3G and 3-21G(*) levels, and the tendency of alkyl chloroformate addition toward double addition to the products 27 and 28 is competitive with single addition to the products 26. Ab initio MO calculations provide a theoretical rationalization for the chemoselectivity of the conjugate addition reaction and the ring-opening reaction, the most stable configurations of reaction products (1-8, 14-24, 26-28), and the isomerization between 1-8b, 14-24b and 1-8a, 14-24a, and between 27 and 28.
C1 Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA.
   Indiana Univ Purdue Univ, Dept Chem, Indianapolis, IN 46202 USA.
   Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.
RP Zheng, QH (reprint author), Indiana Univ, Sch Med, Dept Radiol, 1345 W 16th St,L-3 Room 202, Indianapolis, IN 46202 USA.
EM qzheng@iupui.edu
CR Aggarwal VK, 1999, ANGEW CHEM INT EDIT, V38, P1985, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1985::AID-ANIE1985>3.0.CO;2-7
   BOJA JW, 1991, EUR J PHARMACOL, V194, P133, DOI 10.1016/0014-2999(91)90137-F
   Brashear A, 1999, MOVEMENT DISORD, V14, P132, DOI 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.3.CO;2-A
   CARROLL FI, 1991, J MED CHEM, V34, P883, DOI 10.1021/jm00107a003
   CARROLL FI, 1991, J MED CHEM, V34, P2719, DOI 10.1021/jm00113a008
   CLARKE RL, 1973, J MED CHEM, V16, P1260, DOI 10.1021/jm00269a600
   DAVIES HML, 1994, J MED CHEM, V37, P1262, DOI 10.1021/jm00035a005
   FROST JJ, 1993, ANN NEUROL, V34, P423, DOI 10.1002/ana.410340331
   Hicks FA, 2000, ORG LETT, V2, P219, DOI 10.1021/ol991310t
   INNIS RB, 1993, P NATL ACAD SCI USA, V90, P11965, DOI 10.1073/pnas.90.24.11965
   Lee JC, 1999, TETRAHEDRON LETT, V40, P7675, DOI 10.1016/S0040-4039(99)01589-0
   Majewski M, 1997, CAN J CHEM, V75, P754, DOI 10.1139/v97-091
   MAJEWSKI M, 1994, TETRAHEDRON LETT, V35, P3653, DOI 10.1016/S0040-4039(00)73063-2
   MAJEWSKI M, 1992, CAN J CHEM, V70, P2618, DOI 10.1139/v92-330
   MELTZER PC, 1996, J MED CHEM, V38, P855
   Mulholland GK, 1996, J NUCL MED, V37, P150
   MULHOLLAND GK, 1996, ABSTR PAP AM CHEM S, V212, DOI UNSP 76-NUCL
   MULHOLLAND GK, 1996, ABSTR PAP AM CHEM S, V212, DOI UNSP 162-MEDI
   SIMPKINS NS, 1990, CHEM SOC REV, V19, P335, DOI 10.1039/cs9901900335
   *WAV INC, SPART 5 1
   Zheng QH, 2000, SYNTHETIC COMMUN, V30, P333, DOI 10.1080/00397910008087326
   Zheng QH, 1996, NUCL MED BIOL, V23, P981, DOI 10.1016/S0969-8051(96)00133-3
   ZHENG QH, 2000, ABSTR PAP AM CHEM S, V230, DOI UNSP 231-MEDI
   ZHENG QH, 2000, ABSTR PAP AM CHEM S, V220, DOI UNSP 209-MEDI
   ZHENG QH, 2002, ABSTR PAP AM CHEM S, V223, DOI UNSP 112-MEDI
   ZHENG QH, 1995, J LABELLED COMPD RAD, V37, P139
   ZHENG QH, 1996, ABSTR PAP AM CHEM S, V212, DOI UNSP 371-ORGN
   Zheng Qi-Huang, 1997, Journal of Labelled Compounds and Radiopharmaceuticals, V40, P548
   Zheng Qi-Huang, 1997, Journal of Labelled Compounds and Radiopharmaceuticals, V40, P551
   ZIRKLE CL, 1962, J ORG CHEM, V27, P1269, DOI 10.1021/jo01051a037
NR 30
TC 1
Z9 1
U1 0
U2 4
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-6336
J9 J THEOR COMPUT CHEM
JI J. Theor. Comput. Chem.
PD SEP
PY 2004
VL 3
IS 3
BP 305
EP 323
DI 10.1142/S0219633604001069
PG 19
WC Chemistry, Multidisciplinary
SC Chemistry
GA 868RH
UT WOS:000224930200004
DA 2018-10-20
ER

PT J
AU Amornchai, W
   Hoven, VP
   Tangpasuthadol, V
AF Amornchai, W
   Hoven, VP
   Tangpasuthadol, V
TI Surface modification of chitosan films-grafting ethylene glycol oligomer
   and its effect on protein adsorption
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 8th Pacific Polymer Conference
CY 2003
CL Bangkok, THAILAND
SP Pacific Polymer Federat
DE biomaterials; chitosan; poly(ethylene glycol); protein adsorption;
   surface modification
ID BLOOD-COMPATIBILITY; MEMBRANES
AB This work is a part of a series on surface modification of materials made of chitosan. This report focused on grafting monomethoxy ethylene glycol oligomers (mPEG) on the surface of chitosan films. The chemical reactions were performed by immersing the films in organic solvent containing aldehyde derivative of mPEG. The presence of ethylene glycol moieties was determined by attenuated total reflectance-infrared spectroscopy (ATR-IR) and nuclear magnetic resonance (NMR). The hydrophobicity of the modified surface, determined by air-water contact angle, decreased when the ethylene glycol derivatives were grafted on the film. The modified films were also subjected to protein adsorption study in order to assess their uses in biomedical applications. It was found that the presence of ethylene glycol units reduced the adsorption of proteins (albumin and lysozyme) on the films. We therefore have shown that manipulation of the interaction between chitosan and bio-macromolecules is possible by chemically modifying the surface of chitosan.
C1 Chulalongkorn Univ, Dept Chem, Fac Sci, Organ Synth Res Unit, Bangkok 10330, Thailand.
   Chulalongkorn Univ, Petrochem & Polymer Sci Program, Fac Sci, Bangkok 10330, Thailand.
RP Amornchai, W (reprint author), Chulalongkorn Univ, Dept Chem, Fac Sci, Organ Synth Res Unit, Bangkok 10330, Thailand.
EM varawut.t@chula.ac.th
RI Hoven, Voravee/F-9275-2010; Tangpasuthadol, Varawut/F-9260-2010
CR AIBA SI, 1998, 3 AS PAC CHIT CHIT S, V3, P424
   Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Anderson D, 2001, J APPL POLYM SCI, V80, P1274, DOI 10.1002/app.1213
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   Hojo K, 2000, J PHARM PHARMACOL, V52, P67, DOI 10.1211/0022357001773526
   Khang G, 2002, J APPL POLYM SCI, V85, P1253, DOI 10.1002/app.10680
   Kiss E, 2002, J COLLOID INTERF SCI, V245, P91, DOI 10.1006/jcis.2001.7954
   KOYANO T, 1998, J BIOMED MATER RES, V39, P468
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Qu X, 2001, POLYM BULL, V46, P223, DOI 10.1007/s002890170078
   Sashiwa H, 2000, BIOMACROMOLECULES, V1, P303, DOI 10.1021/bm005536r
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TANGPASUTHADOL V, 2003, CARBOHYD RES, V338, P537
   Wang HT, 2001, J MATER CHEM, V11, P1374, DOI 10.1039/b009688l
NR 16
TC 15
Z9 15
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD SEP
PY 2004
VL 216
BP 99
EP 107
DI 10.1002/masy.200451211
PG 9
WC Polymer Science
SC Polymer Science
GA 868JR
UT WOS:000224910400012
DA 2018-10-20
ER

PT J
AU Li, N
   Jie, Q
   Zhu, SM
   Wang, RD
AF Li, N
   Jie, Q
   Zhu, SM
   Wang, RD
TI A new route to prepare macroporous bioactive sol-gel glasses with high
   mechanical strength
SO MATERIALS LETTERS
LA English
DT Article
DE glasses; sol-gel; bioactive; strength
ID BIOMEDICAL MATERIALS; SCAFFOLDS
AB This paper reports a new method to obtain macroporous bioactive glasses by sol-gel and pore former technologies. The in vitro tests showed that the samples had good apatite-forming ability. Noticeably, these bioglasses exhibit high specific surface areas and excellent mechanical performances. The compressive strength is as high as 34.4 +/- 5.7 MPa. This method may be a useful approach for preparation of scaffolds for tissue engineering. (C) 2004 Elsevier B.V. All rights reserved.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Li, N (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, 1295 Ding Xi Rd, Shanghai 200050, Peoples R China.
EM lina@mail.sic.ac.cn
RI Jie, Qing/H-3780-2011; Jie, Qing/N-8673-2013; Zhu, Sumin/D-3686-2009
CR Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   HAMADOUCHE M, 2000, BIOCERAMICS, V13, P593
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Lenza RFS, 2002, J MATER SCI-MATER M, V13, P837, DOI 10.1023/A:1016592127407
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Perez-Pariente J., 2002, J BIOMED MATER RES, V61, P524
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhong J., 1997, BIOCERAMICS, V10, P265
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 14
TC 15
Z9 17
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP
PY 2004
VL 58
IS 22-23
BP 2747
EP 2750
DI 10.1016/j.matlet.2004.03.049
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 844NC
UT WOS:000223164200009
DA 2018-10-20
ER

PT J
AU Bhat, N
   Kim, WJ
AF Bhat, N
   Kim, WJ
TI Precision force and position control of an ionic polymer metal composite
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART I-JOURNAL OF
   SYSTEMS AND CONTROL ENGINEERING
LA English
DT Article
DE ionic polymer metal composite; microscale force control; microscale
   position control; smart material actuator; hybrid control
ID MUSCLES; DESIGN
AB In this paper, model-based precision force and position control of an ionic polymer metal composite (IPMC) is presented. A 23.8 mm x 3.4 mm x 0.16 mm IPMC strip was used as an actuator in a cantilever configuration. Open-loop force and position responses of an IPMC are not repeatable, and hence closed-loop precision control is of critical importance to ensure proper functioning, repeatability and reliability. After feedback controllers were designed and implemented with empirically obtained fourth-order plant transfer functions, the overshoot decreased from 460 to 2.8 per cent and the settling time was reduced from 37.5 to 3.22 s in force control. In position control the overshoot decreased from 333 to 20.3 per cent and the settling time was reduced from 21.5 to 2.56 s. Microscale precision force and position control capabilities of the IPMC actuator were also demonstrated experimentally. An 8 muN force resolution was achieved with a force noise of 0.5 muN r.m.s., and the position resolution was 6 pm with a position noise of 2.5 mum r.m.s. The maximum force and tip displacement achieved with the IPMC actuator under closed-loop control were 2 mN and 5 mm respectively. The IPMC actuator could follow various commanded force and position trajectories such as sinusoidal and trapezoidal position profiles, and a velocity profile with a 3 mm/s maximum velocity. A novel hybrid force and position control strategy demonstrated its utility in practical micromanipulation applications where the actuator force must be limited to prevent damaging micro-objects. High-precision control of the IPMC at low force level proved its potential for micromanufacturing and micromanipulation applications such as robotic and biomedical microgrippers.
C1 Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.
RP Kim, WJ (reprint author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.
EM wjkim@mengr.tamu.edu
CR BARCOHEN Y, 2000, P SPIE S SMART STRUC, V3987
   BARCOHEN Y, 1998, P ASCE SPEC C ROB CH, P15
   BARCOHEN Y, 2001, SPIE PUBLICATION, pCH1
   BHAT N, 2003, P ASME INT MECH ENG
   Hunter I. W., 1992, Technical Digest. IEEE Solid-State Sensor and Actuator Workshop (Cat. No.92TH0403-X), P178, DOI 10.1109/SOLSEN.1992.228297
   KANNO R, 1994, P JAP US S FLEX AUT, V2, P691
   KIM WJ, 2002, MICROGRIPPER DIS FEB
   Konyo M., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), P3416, DOI 10.1109/ROBOT.2000.845250
   Kothera CS, 2002, THESIS VIRGINIA POLY
   Lumia R, 1999, PROC SPIE, V3669, P322, DOI 10.1117/12.349689
   MALLAVARAPU K, 2001, THESIS VIRGINIA POLY
   *MATHW INC, 2002, OPT TOOLB
   OGURO K, 1992, J MICROMACHINE SOC, V5, P27
   Richardson RC, 2003, IEEE-ASME T MECH, V8, P245, DOI 10.1109/TMECH.2003.812835
   Sadeghipour K., 1992, Smart Materials and Structures, V1, P172, DOI 10.1088/0964-1726/1/2/012
   Shaheen HM, 2000, J CAMEL PRACT RES, V7, P15
   Shahinpoor M., 1994, Smart Materials and Structures, V3, P367, DOI 10.1088/0964-1726/3/3/012
   Shahinpoor M., 1992, Smart Materials and Structures, V1, P91, DOI 10.1088/0964-1726/1/1/014
NR 18
TC 45
Z9 45
U1 0
U2 10
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI BURY ST EDMUNDS
PA NORTHGATE AVENUE, BURY ST EDMUNDS IP32 6BW, SUFFOLK, ENGLAND
SN 0959-6518
J9 P I MECH ENG I-J SYS
JI Proc. Inst. Mech. Eng. Part I-J Syst Control Eng.
PD SEP
PY 2004
VL 218
IS I6
BP 421
EP 432
DI 10.1243/0959651052010133
PG 12
WC Automation & Control Systems
SC Automation & Control Systems
GA 870GL
UT WOS:000225045500001
DA 2018-10-20
ER

PT J
AU Werner, A
   Isaksen, LW
   Malterud, K
AF Werner, A
   Isaksen, LW
   Malterud, K
TI 'I am not the kind of woman who complains of everything' - Illness
   stories on self and shame in women with chronic pain
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE chronic pain; medically unexplained pain; somatisation; illness
   narratives; gender; Norway
ID CHRONIC-FATIGUE-SYNDROME; CHRONIC MUSCULAR PAIN; BACK-PAIN;
   FIBROMYALGIA; EXPERIENCE; NARRATIVES; PERSPECTIVES; SOMATIZATION;
   GUIDELINES; KNOWLEDGE
AB In this study, we explore issues of self and shame in illness accounts from women with chronic pain. We focused on how these issues within their stories were shaped according to cultural discourses of gender and disease. A qualitative study was conducted with in-depth interviews including a purposeful sampling of 10 women of varying ages and backgrounds with chronic muscular pain. The women described themselves in various ways as 'strong', and expressed their disgust regarding talk of illness of other women with similar pain. The material was interpreted within a feminist frame of reference, inspired by narrative theory and discourse analysis. We read the women's descriptions of their own (positive) strength and the (negative) illness talk of others as a moral plot and argumentation, appealing to a public audience of health personnel, the general public, and the interviewer: As a plot, their stories attempt to cope with psychological and alternative explanations of the causes of their pain. As performance, their stories attempt to cope with the scepticism and distrust they report having been met with. Finally, as arguments, their stories attempt to convince us about the credibility of their pain as real and somatic rather than imagined or psychological. In several ways, the women negotiated a picture of themselves that fits with normative, biomedical expectations of what illness is and how it should be performed or lived out in 'storied form' according to a gendered work of credibility as woman and as ill. Thus, their descriptions appear not merely in terms of individual behaviour, but also as organized by medical discourses of gender and diseases. Behind their stories, we hear whispered accounts relating to the medical narrative about hysteria; rejections of the stereotype medical discourse of the crazy, lazy, illness-fixed or weak woman. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Oslo, Ctr Womens Studies & Gender Res, N-0315 Oslo, Norway.
   Univ Bergen, Inst Sociol, N-5007 Bergen, Norway.
   Univ Bergen, Dept Publ & Primary Hlth Care, Sect Gen Practice, N-5009 Bergen, Norway.
   Univ Copenhagen, Inst Publ Hlth, Dept Gen Practice, DK-1168 Copenhagen, Denmark.
   Univ Copenhagen, Inst Publ Hlth, Res Unit, DK-1168 Copenhagen, Denmark.
RP Werner, A (reprint author), Univ Oslo, Ctr Womens Studies & Gender Res, POB 1040, N-0315 Oslo, Norway.
EM anne.werner@skk.uio.no
CR Album D., 1996, NAERE FREMMEDE PASIE
   Asbring P, 2002, QUAL HEALTH RES, V12, P148, DOI 10.1177/104973230201200202
   Asbring P, 2003, SOC SCI MED, V57, P711, DOI 10.1016/S0277-9536(02)00420-3
   Asbring P, 2001, J ADV NURS, V34, P312, DOI 10.1046/j.1365-2648.2001.01767.x
   Brodwin P, 1992, PAIN HUMAN EXPERIENC, P100
   Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939
   Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512
   Douglas M., 1999, IMPLICIT MEANINGS SE
   Eccleston C, 1997, SOC SCI MED, V45, P699, DOI 10.1016/S0277-9536(96)00404-2
   Epstein RM, 1999, ARCH INTERN MED, V159, P215, DOI 10.1001/archinte.159.3.215
   Ford CV, 1997, SCAND J WORK ENV HEA, V23, P7
   Frank A, 1995, WOUNDED STORYTELLER
   Frank AW, 2000, QUAL HEALTH RES, V10, P354, DOI 10.1177/104973200129118499
   FROBERG S, 1995, RES VIOLENCE THREATS, P38
   Giorgi A., 1985, PHENOMENOLOGY PSYCHO, P8
   Glenton C, 2003, SOC SCI MED, V57, P2243, DOI 10.1016/S0277-9536(03)00130-8
   GOOD BJ, 1994, MED RATIONALITY EXPE
   HAUG F, 1992, FEMALE MASOCHISM MEM, P31
   Honkasalo M L, 2001, Med Anthropol, V19, P319
   Hyden LC, 1997, SOCIOL HEALTH ILL, V19, P48, DOI 10.1111/1467-9566.00040
   Jackson J. E., 1992, PAIN HUMAN EXPERIENC, P138
   Johannisson K., 2001, GENDER INEQUALITIES, P99
   Johannsen FR, 1996, ISSUES SCI TECHNOL, V13, P6
   Kugelmann R, 1999, SOC SCI MED, V49, P1663, DOI 10.1016/S0277-9536(99)00240-3
   Kvale S., 1996, INTERVIEWS INTRO QUA
   Leira H. K., 2002, GENDER VIOLENCE NORD, V545, P285
   LILLEAAS UB, 1995, 8 U OSL CTR WOM STUD
   Lillrank A, 2003, SOC SCI MED, V57, P1045, DOI 10.1016/S0277-9536(02)00479-3
   Malterud K, 2000, FAM MED, V32, P603
   MALTERUD K, 1993, FAM PRACT, V10, P201, DOI 10.1093/fampra/10.2.201
   MALTERUD K, 2002, NZ FAMILY PHYS, V29, P374
   MATTINGLY C, 1994, SOC SCI MED, V38, P811, DOI 10.1016/0277-9536(94)90153-8
   Miczo N, 2003, QUAL HEALTH RES, V13, P469, DOI 10.1177/1049732302250756
   OCHBERG RL, 1997, EXPLORING IDENTITY G, V2, P113
   Paulson M, 1999, J ADV NURS, V30, P1097, DOI 10.1046/j.1365-2648.1999.01162.x
   Pierret J, 2003, SOCIOL HEALTH ILL, V25, P4, DOI 10.1111/1467-9566.t01-1-00337
   PLUMMER K, 1995, TELLING SEXUAL STORI
   RIESSMAN CK, 1990, SOC SCI MED, V30, P1195, DOI 10.1016/0277-9536(90)90259-U
   Scheurich N, 2000, PERSPECT BIOL MED, V43, P461
   Shorter E, 1992, PARALYSIS FATIGUE HI
   Showalter E., 1997, HYSTORIES HYSTERICAL
   Steihaug S, 2002, SCAND J PUBLIC HEALT, V30, P281, DOI 10.1080/14034940210133960
   Steihaug S, 2001, SCAND J PRIM HEALTH, V19, P249
   WARE NC, 1992, MED ANTHROPOL Q, V6, P347, DOI 10.1525/maq.1992.6.4.02a00030
   Werner A, 2003, SOC SCI MED, V57, P1409, DOI 10.1016/S0277-9536(02)00520-8
   Werner A, 2003, QUAL HEALTH RES, V13, P491, DOI 10.1177/1049732302250755
   WIDERBERG K, 2001, HIST KVALITATIVT FOR
   Wood B, 1999, J PSYCHOSOM RES, V47, P385, DOI 10.1016/S0022-3999(99)00025-2
   WOODGUSH G, 1995, J ROY SOC MED, V88, P6
NR 49
TC 140
Z9 142
U1 1
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD SEP
PY 2004
VL 59
IS 5
BP 1035
EP 1045
DI 10.1016/j.socscimed.2003.12.001
PG 11
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 834ST
UT WOS:000222431800012
PM 15186903
DA 2018-10-20
ER

PT J
AU Zhao, XJ
   Zhang, SG
AF Zhao, XJ
   Zhang, SG
TI Fabrication of molecular materials using peptide construction motifs
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID SURFACTANT-LIKE PEPTIDES; SELF-COMPLEMENTARY OLIGOPEPTIDE; BETA-SHEET;
   AMPHIPHILE NANOFIBERS; REVERSIBLE HYDROGELS; BIOLOGICAL-MATERIALS;
   DESIGNED PEPTIDE; FORM NANOTUBES; PROTEINS; NANOWIRES
AB Biotechnology has generally been associated with gene cloning and expression, genomics, high throughput drug discovery, biomedical advancement and agricultural development. That is about to change. Biotechnology will expand to encompass discovery and fabrication of biological and molecular materials with diverse structures, functionalities and utilities. The advent of nanobiotechnology and nanotechnology have accelerated this trend. Analogous to the construction of an intricate architectural structure, diverse and numerous structural motifs are used to assemble a sophisticated complex. Nature has selected, produced and evolved numerous molecular architectural motifs over billions of years for particular functions. These molecular motifs can now be used to build materials from the bottom up. Biotechnology will continue to harness nature's enormous power to benefit other disciplines and society as a whole.
C1 MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   MIT, Ctr Bits & Atom, Cambridge, MA 02139 USA.
RP Zhang, SG (reprint author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave,Technol Sq 500,NE47-379, Cambridge, MA 02139 USA.
EM Shuguang@mit.edu
CR Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Altman M, 2000, PROTEIN SCI, V9, P1095, DOI 10.1110/ps.9.6.1095
   Branden C., 1999, INTRO PROTEIN STRUCT
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Fields GB, 1999, BIOORGAN MED CHEM, V7, P75, DOI 10.1016/S0968-0896(98)00216-8
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5
   MADDOX J, 1998, REMAINS DISCOVERED
   Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   PETSKO GA, 2003, PROTEIN STRUCTURE FU
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   SANJANA N, IN PRESS J NEUROSCI
   Santoso S, 2002, NANO LETT, V2, P687, DOI [10.1021/nl025563i, 10.1021/n1025563i]
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   SEMINO A, 2003, DIFFERENTIATION, V71, P262
   Takahashi Y, 2004, BIOORGAN MED CHEM, V12, P693, DOI 10.1016/j.bmc.2003.11.022
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+
   Wallin E, 1998, PROTEIN SCI, V7, P1029
   Whaley SR, 2000, NATURE, V405, P665
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Yu YC, 1997, METHOD ENZYMOL, V289, P571
   ZHANG S, 2001, DIS CONFORMATION COM, P63
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
   Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 43
TC 101
Z9 108
U1 1
U2 19
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD SEP
PY 2004
VL 22
IS 9
BP 470
EP 476
DI 10.1016/j.tibech.2004.07.011
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 856ZM
UT WOS:000224084800011
PM 15331228
DA 2018-10-20
ER

PT J
AU Latham, R
   Linford, R
   Schlindwein, W
AF Latham, R
   Linford, R
   Schlindwein, W
TI Biomedical applications of batteries
SO SOLID STATE IONICS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on the Reactivity of Solids
CY NOV 09-13, 2003
CL Kyoto, JAPAN
DE batteries; biological physics instrumentation; implants; fuel cells;
   medical applications
ID IMPLANTABLE CARDIAC DEFIBRILLATOR; LITHIUM-ION BATTERIES; DRUG-DELIVERY;
   TRANSDERMAL IONTOPHORESIS; MEDICAL APPLICATIONS; THALAMIC NUCLEUS; HUMAN
   SKIN; IN-VITRO; STIMULATION; ELECTROPORATION
AB An over-view is presented of the many ways in which batteries and battery materials are used in medicine and in biomedical studies. These include the use of batteries as power sources for motorised wheelchairs, surgical tools, cardiac pacemakers and defibrillators, dynamic prostheses, sensors and monitors for physiological parameters, neurostimulators, devices for pain relief, and iontophoretic, electroporative and related devices for drug administration. The various types of battery and fuel cell used for this wide range of applications will be considered, together with the potential harmful side effects, including accidental ingestion of batteries and the explosive nature of some of the early cardiac pacemaker battery systems. (C) 2004 Elsevier B.V. All rights reserved.
C1 De Montfort Univ, Res Off, Leicester LE1 9BH, Leics, England.
   De Montfort Univ, Sch Pharm, Leicester LE1 9BH, Leics, England.
   De Montfort Univ, Fac Hlth & Life Sci, Leicester LE1 9BH, Leics, England.
RP Linford, R (reprint author), De Montfort Univ, Res Off, Leicester LE1 9BH, Leics, England.
EM rgl@dmu.ac.uk
CR Adlhart OJ, 1997, ASAIO J, V43, P214
   ALESCH F, 1995, ACTA NEUROCHIR, V136, P75, DOI 10.1007/BF01411439
   Antonioli G, 1973, Minerva Med, V64, P2298
   AYLOR JH, 1992, IEEE T IND ELECTRON, V39, P398, DOI 10.1109/41.161471
   BALL GR, 1997, Patent No. 5624376
   BANGA AK, 1998, ELECTRICALLY ASSISTE, P11
   Bassen HI, 1998, PACE, V21, P1709, DOI 10.1111/j.1540-8159.1998.tb00268.x
   Ben-Zeev B, 2003, J CHILD NEUROL, V18, P254, DOI 10.1177/08830738030180041001
   BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344
   BRO P, 1979, POWER SOURCES, V7, P571
   Cleland MJ, 2000, J EMERG MED, V18, P305, DOI 10.1016/S0736-4679(99)00219-X
   CONNORS JD, 1992, Patent No. 5153495
   COOPER RA, 1995, J REHABIL RES DEV, V32, P255
   Crespi AM, 2001, J POWER SOURCES, V96, P33, DOI 10.1016/S0378-7753(01)00499-2
   Dawson TW, 2002, IEEE T BIO-MED ENG, V49, P254, DOI 10.1109/10.983460
   Delgado-Charro MB, 2001, STP PHARMA SCI, V11, P403
   Denet AR, 2003, J CONTROL RELEASE, V88, P253, DOI 10.1016/S0168-3659(03)00010-5
   Drews J, 2001, J POWER SOURCES, V97-8, P747, DOI 10.1016/S0378-7753(01)00649-8
   Droog EJ, 2003, MICROVASC RES, V65, P172, DOI 10.1016/S0026-2862(03)00002-5
   Gale CP, 2002, J ROY SOC MED, V95, P353, DOI 10.1258/jrsm.95.7.353
   Geier L, 1999, ANN OTO RHINOL LARYN, V108, P80
   GEORG G, 2001, HERTZ, V26, P64
   Gertner ME, 2003, ELECTROCHEM SOLID ST, V6, pJ4, DOI 10.1149/1.1558354
   GERTNER ME, 2003, INTERFACE, V12, P20
   Gong WS, 2000, ANN BIOMED ENG, V28, P572, DOI 10.1114/1.293
   Goto H, 1999, MED BIOL ENG COMPUT, V37, P377, DOI 10.1007/BF02513315
   Graupe D, 1998, SURG NEUROL, V50, P202, DOI 10.1016/S0090-3019(98)00074-3
   Greatbatch W, 1996, PACE, V19, P1836, DOI 10.1111/j.1540-8159.1996.tb03236.x
   GREATBATCH W, 1959, P NEW ENGL RES ENG M, V1, P8
   Halhal M, 2003, J FR OPHTALMOL, V26, P391
   Hashmi SA, 1997, IONICS, V3, P177, DOI 10.1007/BF02375614
   Helmstadter A, 2001, PHARMAZIE, V56, P583
   Holmes C.F., 2003, INTERFACE, V12, P26
   Holmes CF, 2001, J POWER SOURCES, V97-8, P739, DOI 10.1016/S0378-7753(01)00601-2
   HOLMES CF, 1999, ITE BATT LETT, V1, P132
   HORNING RJ, 1980, P 29 POW SOURC C CHE, P64
   Hu QH, 2003, PHARMAZIE, V58, P192
   Huggins RA, 2000, SOLID STATE IONICS, V134, P179, DOI 10.1016/S0167-2738(00)00725-6
   Ishikawa O, 2002, INT J PHARM, V249, P81, DOI 10.1016/S0378-5173(02)00476-3
   Kanikkannan N, 2002, BIODRUGS, V16, P339, DOI 10.2165/00063030-200216050-00003
   Latham RJ, 2002, SOLID STATE IONICS: TRENDS IN THE NEW MILLENNIUM, PROCEEDINGS, P283, DOI 10.1142/9789812776259_0030
   Latham RJ, 2003, IONICS, V9, P41, DOI 10.1007/BF02376535
   LIANG CC, 1982, Patent No. 4310609
   Lopez RF, 2003, J CONTROL RELEASE, V88, P65, DOI 10.1016/S0168-3659(02)00456-X
   Marro D, 2001, PHARMACEUT RES, V18, P1701, DOI 10.1023/A:1013318412527
   MEYER PF, 2003, J NEUROSCI METH, V25, P309
   MIROWSKI M, 1980, AM HEART J, V100, P1089, DOI 10.1016/0002-8703(80)90218-5
   Moser J. R, 1972, U.S. Patent, Patent No. [3,660,163, 3660163, 3,660,163, US]
   Newsom RL, 2002, IEEE T IND ELECTRON, V49, P1146, DOI 10.1109/TIE.2002.803240
   O'Suilleabhain PE, 2003, NEUROLOGY, V60, P786, DOI 10.1212/01.WNL.0000044156.56643.74
   OWNES BB, 1979, FAST ION TRANSPROT S, P61
   Passerini S, 2001, J POWER SOURCES, V97-8, P750, DOI 10.1016/S0378-7753(01)00602-4
   Perron M, 2003, PHYS THER, V83, P71
   Petley GW, 1998, MED ENG PHYS, V20, P33, DOI 10.1016/S1350-4533(97)00043-X
   PHIPPS JB, 1986, SOLID STATE IONICS, V18-9, P1073, DOI 10.1016/0167-2738(86)90311-5
   Rosenow JM, 2003, J NEUROSURG, V99, P167, DOI 10.3171/jns.2003.99.1.0167
   RUBEN SR, 1947, Patent No. 244045
   Rubino RS, 2001, J ELECTROCHEM SOC, V148, pA1029, DOI 10.1149/1.1390344
   Sasaki H, 1999, CRIT REV THER DRUG, V16, P85
   Saudek CD, 1996, JAMA-J AM MED ASSOC, V276, P1322, DOI 10.1001/jama.276.16.1322
   SCHLESINGER M, 2003, INTERFACE, V12, P19
   Schmidt CL, 2001, J POWER SOURCES, V97-8, P742, DOI 10.1016/S0378-7753(01)00648-6
   SCHOENFISCH MH, 1999, J BIOMED MATER RES, V51, P209
   Sekkat N, 2002, J CONTROL RELEASE, V81, P83, DOI 10.1016/S0168-3659(02)00046-9
   Sugibayashi K, 2000, J PHARM PHARMACOL, V52, P1179, DOI 10.1211/0022357001777306
   Takeuchi ES, 2002, MRS BULL, V27, P624, DOI 10.1557/mrs2002.199
   TAKEUCHI ES, 1995, J POWER SOURCES, V54, P115, DOI 10.1016/0378-7753(94)02050-D
   Tchin-Iou AVD, 1999, INT J ARTIF ORGANS, V22, P823
   TERRY R, 1990, EPILEPSIA S2, V31, P33
   Tezel A, 2003, J PHARM SCI, V92, P381, DOI 10.1002/jps.10299
   TILLER RG, 1991, Patent No. 4991069
   Uitto OD, 2003, PHARMACEUT RES, V20, P646, DOI 10.1023/A:1023259102279
   WEBB WA, 1995, GASTROINTEST ENDOSC, V41, P39, DOI 10.1016/S0016-5107(95)70274-1
   WHITE HS, 2003, INTERFACE, V12, P30
   Yokoyama K, 2000, J CLIN LASER MED SUR, V18, P9, DOI 10.1089/clm.2000.18.9
   Zempsky WT, 2003, DERMATOL SURG, V29, P627, DOI 10.1046/j.1524-4725.2003.29142.x
NR 76
TC 17
Z9 18
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-2738
J9 SOLID STATE IONICS
JI Solid State Ion.
PD AUG 31
PY 2004
VL 172
IS 1-4
SI SI
BP 7
EP 11
DI 10.1016/j.ssi.2004.04.024
PG 5
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 871MZ
UT WOS:000225139100003
OA Green Published
DA 2018-10-20
ER

PT J
AU Vallet-Regi, M
   Pena, J
   Izquierdo-Barba, I
AF Vallet-Regi, M
   Pena, J
   Izquierdo-Barba, I
TI Synthesis of beta-tricalcium phosphate in layered or powdered fon-ns for
   biomedical applications
SO SOLID STATE IONICS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on the Reactivity of Solids
CY NOV 09-13, 2003
CL Kyoto, JAPAN
DE bioceramics; calcium phosphates (beta-TCP); coating; dip-coating;
   nanopowder
AB The objective of this work is to obtain p-tricalcium phosphate (beta-TCP) both in powdered form and as coatings onto polycrystalline alumina. The Liquid Mix Technique was utilized to prepare solutions with Ca/P ratio of 1.5 which were employed either to obtain powder or to dip-coat Al2O3 substrates 1, 5 or 10 times. All the coatings yielded a porous morphology that increased with their thickness. Two calcium phosphate polymorphs beta-TCP (stable up to 1100 degreesC) and alpha-TCP (obtained after a thermal treatment at 1450 degreesC) can be prepared in the powdered form. The prepared materials were characterised by X-ray diffraction (XRD), Fourier transform infrared (FTIR), scanning electron microscopy (SEM), EDAX and Elemental Analysis. The topography of the layers was studied by SFM. The theological properties of the precursor solutions were determined by viscosimetry. The bioactivity of these materials was tested by immersion in a simulated body fluid (SBF). (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
EM vallet@farm.ucm.es
RI Vallet-Regi, Maria/M-3378-2014; pena, juan/E-5913-2018; IZQUIERDO-BARBA,
   ISABEL/M-9921-2014
OI Vallet-Regi, Maria/0000-0002-6104-4889; pena, juan/0000-0002-5992-908X;
   IZQUIERDO-BARBA, ISABEL/0000-0002-4139-4646
CR Izquierdo-Barba I, 2003, EUR J INORG CHEM, P1608
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Pechini M. P., 1967, US Patent, Patent No. [3 330 697, 3330697]
   Pena J, 2003, J EUR CERAM SOC, V23, P1687, DOI 10.1016/S0955-2219(02)00369-2
   TAI LW, 1992, J MATER RES, V7, P502, DOI 10.1557/JMR.1992.0502
   Vallet-Regi M., 1995, PERSPECTIVES SOLID S, P37
NR 6
TC 9
Z9 11
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-2738
J9 SOLID STATE IONICS
JI Solid State Ion.
PD AUG 31
PY 2004
VL 172
IS 1-4
SI SI
BP 445
EP 449
DI 10.1016/j.ssi.2004.04.038
PG 5
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 871MZ
UT WOS:000225139100090
DA 2018-10-20
ER

PT J
AU Yang, P
   Chen, JY
   Leng, YX
   Sun, H
   Huang, N
   Chu, PK
AF Yang, P
   Chen, JY
   Leng, YX
   Sun, H
   Huang, N
   Chu, PK
TI Effect of annealing on structure and biomedical properties of amorphous
   hydrogenated carbon films
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE plasma immersion ion implantation-deposition; hydrogenated amorphous
   carbon (a-C : H) film; annealing; blood compatibility
ID DIAMOND-LIKE CARBON; IMMERSION ION-IMPLANTATION; BLOOD COMPATIBILITY;
   PROTEIN ADSORPTION; TITANIUM; PLASMA; DLC; COATINGS; HEMOCOMPATIBILITY;
   BIOCOMPATIBILITY
AB The usual failure of blood-contacting biomedical materials and devices arises from thrombogenesis. When a biomaterial comes in contact with a biological body, interface interaction will be concomitant between the biomaterial surface and biological substance, such as blood protein denaturation resulting from electrical charge transfer of proteins and platelet activation induced by interface thermodynamics. Diamond-like carbon (DLC) has been proposed for use in blood contacting devices. Further understanding of the intrinsic relationship between biomedical properties and structure of amorphous carbon films will promote improvement of their biocompatibility. In this study, hydrogenated amorphous carbon (a-C:H) films were fabricated at room temperature using plasma immersion ion implantation-deposition (PIII-D). A series of a-C:H films with different structures and chemical bonds were obtained by adjusting the DC bias voltage from - 75 to - 900 V, then their structure and physical properties were further modified by thermal anneal in vacuum at 600 degreesC. Raman, elastic recoil detection (ERD) and atomic force microscope (AFM) were used to characterize their structures and chemical bonds. The physical properties and surface characteristics of the films were also examined, including the carrier concentration and mobility, resistivity, and surface wettability. The anticoagulation of the films was evaluated employing in vitro platelet adhesion test. The adhesion, activation, and morphology of the platelets were investigated using scanning electron microscopy (SEM). The relationship between their structure and blood compatibility was elucidated. (C) 2004 Elsevier B.V. All rights reserved.
C1 SW Jiaotong Univ, Chinese Educ Minist, Sch Mat Sci & Engn, Key Lab Biomat Surface Modificat Sichuan, Chengdu 610031, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Chinese Educ Minist, Sch Mat Sci & Engn, Key Lab Biomat Surface Modificat Sichuan, Chengdu 610031, Peoples R China.
EM huangnan1956@163.com
RI Leng, Yongxiang/G-5488-2010; Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR Alanazi A, 2000, ASAIO J, V46, P440, DOI 10.1097/00002480-200007000-00014
   Alanazi A, 2000, ARTIF ORGANS, V24, P624, DOI 10.1046/j.1525-1594.2000.06576.x
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   FENG L, 1994, J COLLOID INTERF SCI, V166, P419, DOI 10.1006/jcis.1994.1313
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   LYMAN DJ, 1972, T AM SOC ART INT ORG, V18, P19
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   Ogwu AA, 1999, PHYSICA B, V269, P335, DOI 10.1016/S0921-4526(99)00138-6
   PINZARI F, 2000, DIAM RELAT MATER, V10, P781
   Robertson J, 1997, DIAM RELAT MATER, V6, P212, DOI 10.1016/S0925-9635(96)00627-9
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   TANG Z, 2001, J APPL PHYS, V89, P1956
   THOMSON A, 1991, BIOMATERIALS, V2, P37
   Tran HS, 1999, J INVEST SURG, V12, P133
   VANOSS CJ, 1988, J CHEM REV, V88, P92
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
NR 24
TC 22
Z9 22
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 125
EP 130
DI 10.1016/j.surfcoat.2004.04.039
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200024
DA 2018-10-20
ER

PT J
AU McKenzie, DR
   Newton-McGee, K
   Ruch, P
   Bilek, MM
   Gan, BK
AF McKenzie, DR
   Newton-McGee, K
   Ruch, P
   Bilek, MM
   Gan, BK
TI Modification of polymers by plasma-based ion implantation for biomedical
   applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE polymer; ion implantation; biomedical applications
ID SURFACE MODIFICATION; PEEK
AB |We describe the modification of the polymer poly(aryl ether ether ketone) (PEEK) carried out with the aim of improving its performance for biomedical applications. Polymer samples were exposed to plasmas of oxygen, argon, hydrogen and deuterium by placing them on a substrate holder to which 15 [is pulses of 10 and 15 kV were applied. We found that the treatment with oxygen decreased the contact angle with water drops to nearly zero while argon modification decreased the contact angle to half that of the untreated material. The deeper the treatment the longer the time required to recover the original hydrophobic character. We also found that the hydrogen treatment produced the deepest modification and that the electrical resistivity of the treated material was the same for hydrogen and argon but was higher for oxygen. The effects of the treatment on the infrared spectrum were observed using attenuated total reflection infrared spectroscopy and it was shown that oxygen produces a distinctly different modification to that produced by the other gases.
C1 Univ Sydney, Dept Appl Sci, Sch Phys, Sydney, NSW 2006, Australia.
RP McKenzie, DR (reprint author), Univ Sydney, Dept Appl Sci, Sch Phys, Sydney, NSW 2006, Australia.
EM mckenzie@physics.usyd.edu.au
RI Ruch, Patrick/K-3583-2012; Gan, Bee/B-3818-2009
OI McKenzie, David/0000-0002-2476-1301; Bilek, Marcela/0000-0003-3363-2664
CR Alterovitz S.A., 1991, HDB OPTICAL CONSTANT, VII, P837
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   Ha SW, 1997, SURF COAT TECH, V96, P293, DOI 10.1016/S0257-8972(97)00179-5
   Han S, 1997, SURF COAT TECH, V93, P261, DOI 10.1016/S0257-8972(97)00057-1
   Narushima K, 2002, JPN J APPL PHYS 1, V41, P6506, DOI 10.1143/JJAP.41.6506
   ZHANG RJ, 1995, WEAR, V181, P613, DOI 10.1016/0043-1648(95)90177-9
NR 6
TC 29
Z9 31
U1 0
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 239
EP 244
DI 10.1016/j.surfcoat.2004.04.093
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200046
DA 2018-10-20
ER

PT J
AU Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Wan, GJ
AF Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Wan, GJ
TI Inhibition of adherent platelet activation produced by Ti-O thin film
   fabricated by PIII
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE blood compatibility; platelet activation; protein adsorption; Ti-O film
ID BLOOD COMPATIBILITY; BIOMATERIALS; MARKERS
AB Thrombogenesis is the principal problem associated with blood-contacting biomedical. devices. One of the important reasons is that most of the materials used in these devices cannot avoid inducing platelet adhesion and activation. Our recent investigation suggested that Ti-O thin film could be an alternative antithrombotic material. In this work, we focus our attention on behavior of platelets adhered on Ti-O film. Platelet adhesion experiments were conducted to examine the platelets/material interaction in vitro and the effect of protein adsorption on platelet adhesion and activation. The specific resultants of platelet release (GMP 140) were tested for evaluating the platelet activation. In vivo implantation was used to investigate formation of thrombus.
   The excellent anticoagulation performance of Ti-O films has been shown in in vivo long-term implantation. The release of specific resultants GMP140 from platelets contacting to Ti-O film was the lower than LTI-carbon. The morphology of adherent platelets maintains round and isolated. Apparently, the activation of platelets adhered on Ti-O film was suppressed. The results of in vitro test also suggest that the suppression of platelet activation is related to plasma protein adsorption. Preadsorbing fibrinogen doesn't cause the exacerbation of platelet activation. It seems reasonable to suggest that its excellent anticoagulation is caused by inhibition of adherent platelet activation produced by Ti-O film. (C) 2004 Elsevier B.V. All rights reserved.
C1 SW Jiaotong Univ, Inst Biomat & Surface Engn, Coll Mat Sci & Engn,Chinese Educ Minist, Key Lab Biomat Surface Modificat Sichuan,Lab Adv, Chengdu 610031, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Inst Biomat & Surface Engn, Coll Mat Sci & Engn,Chinese Educ Minist, Key Lab Biomat Surface Modificat Sichuan,Lab Adv, Chengdu 610031, Peoples R China.
EM huangnan1956@163.com
RI Leng, Yongxiang/G-5488-2010; Wan, Guojiang/A-6651-2013
OI Wan, Guojiang/0000-0002-1636-5405; Leng, Y.X./0000-0001-6823-1233
CR BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Cenni E, 1997, J BIOMED MATER RES, V36, P289, DOI 10.1002/(SICI)1097-4636(19970905)36:3<289::AID-JBM3>3.0.CO;2-A
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   Heublein B, 1998, J ENDOVASC SURG, V5, P32, DOI 10.1583/1074-6218(1998)005<0032:SCCSCE>2.0.CO;2
   HORBETT T, 2000, ANN BIOMED ENG, V28, P16
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Mollnes TE, 1999, THROMB HAEMOSTASIS, V82, P1132
   RHODES NP, 1994, J BIOMED MATER RES, V28, P435, DOI 10.1002/jbm.820280405
   SIXMA JJ, 1991, J BIOMAT SCI-POLYM E, V3, P17
NR 11
TC 11
Z9 14
U1 1
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 265
EP 269
DI 10.1016/j.surfcoat.2004.03.031
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200051
DA 2018-10-20
ER

PT J
AU Wang, J
   Huang, N
   Pan, CJ
   Kwok, SCH
   Yang, P
   Leng, YX
   Chen, JY
   Sun, H
   Wan, GJ
   Liu, Z
   Chu, PK
AF Wang, J
   Huang, N
   Pan, CJ
   Kwok, SCH
   Yang, P
   Leng, YX
   Chen, JY
   Sun, H
   Wan, GJ
   Liu, Z
   Chu, PK
TI Bacterial repellence from polyethylene terephthalate surface modified by
   acetylene plasma immersion ion implantation-deposition
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE plasma immersion ion implantation; hydrogenated amorphous carbon (a-C :
   H); polyethylene terephthalate (PET); bacterial adhesion
ID PROSTHETIC VALVE ENDOCARDITIS; AMORPHOUS-CARBON; POLY(VINYL CHLORIDE);
   DEVICES; ADHESION; SPECTROSCOPY; INFECTIONS; EFFICACY; ENERGY; SILVER
AB There is an increasing interest in developing new methods to reduce bacterial adhesion onto polymeric materials used in biomedical implants. The antibacterial adsorption behavior on polyethylene terephthalate (PET) treated by plasma immersion ion implantation,re deposition (PIII-D) using acetylene (C2H2) at different working pressures is investigated. The surface structure of the treated PET is determined by Rutherford backscattering spectrometry (RBS), laser Raman spectroscopy, and X-ray photoelectron spectroscopy (XPS). The results show the formation of thin hydrogenated amorphous carbon (a-C:H) films with different structures and chemical bonds on the PET surface. The ability of Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE) to adhere to PET is quantitatively determined by plate counting and Gamma-ray counting of the I-125-labeled bacteria in vitro. The adhesion efficiency of SA on the a-C:H film deposited at 0.5 Pa of working pressure is about 16% of that on the untreated PET surface, and the adhered bacterial concentration of SE on the carbon film deposited at 1.0 Pa is about 1/6 of that of the PET surface. Bacterial adhesion onto a-C:H films is influenced by the structures and chemical bonds of the materials. The reduction in bacterial adhesion can be explained by the free energy of adhesion (DeltaF(Adh)), which predicts whether microbial adhesion is energetically favorable (DeltaF(Adh) < 0) or not (DeltaF(Adh) > 0). Our results show that bacterial adhesion is energetically unfavorable on the a-C:H films deposited at 0.5 and 1.0 Pa, and this study suggests one possible method to repel bacteria from polymeric surfaces. (C) 2004 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
   Southeast Univ, Affiliated Hosp, Coll Med, Nanjing 210009, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 88 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Wan, Guojiang/A-6651-2013; Chu, Paul/B-5923-2013; Leng,
   Yongxiang/G-5488-2010
OI Wan, Guojiang/0000-0002-1636-5405; Chu, Paul/0000-0002-5581-4883; Leng,
   Y.X./0000-0001-6823-1233
CR ARNOW PM, 1993, CLIN INFECT DIS, V16, P778, DOI 10.1093/clind/16.6.778
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   CALDERWOOD SB, 1985, CIRCULATION, V72, P31, DOI 10.1161/01.CIR.72.1.31
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Davenas J, 2002, BIOMOL ENG, V19, P263, DOI 10.1016/S1389-0344(02)00037-0
   Gray JE, 2003, BIOMATERIALS, V24, P2759, DOI 10.1016/S0142-9612(03)00057-7
   Ivanov-Omskii VI, 2000, CARBON, V38, P495, DOI 10.1016/S0008-6223(99)00121-9
   IVERT TSA, 1984, CIRCULATION, V69, P223, DOI 10.1161/01.CIR.69.2.223
   James NR, 2003, BIOMATERIALS, V24, P2205, DOI 10.1016/S0142-9612(03)00022-X
   KI DP, 1998, BIOMATERIALS, V19, P851
   Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q
   MATIN MA, 1989, ANN INTERN MED, V110, P9
   Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438
   PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   ROBERTSON J, 1987, PHYS REV B, V35, P2946, DOI 10.1103/PhysRevB.35.2946
   Schneider RP, 1996, J COLLOID INTERF SCI, V182, P204, DOI 10.1006/jcis.1996.0452
   Schwan J, 1996, J APPL PHYS, V80, P440, DOI 10.1063/1.362745
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Sodhi RNS, 2001, J ELECTRON SPECTROSC, V121, P249, DOI 10.1016/S0368-2048(01)00338-3
   SUGARMAN B, 1986, AM J MED, V81, P78, DOI 10.1016/0002-9343(86)90517-6
   THRELKELD MG, 1995, PRINCIPLES PRACTICE, P783
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   Valentini L, 2001, DIAM RELAT MATER, V10, P1088, DOI 10.1016/S0925-9635(00)00391-5
   Van Oss CJ, 1997, J ADHESION, V63, P71, DOI 10.1080/00218469708015214
   Wantanabe S, 2002, THIN SOLID FILMS, V420, P253, DOI 10.1016/S0040-6090(02)00803-9
   Yoshida M, 2003, NUCL INSTRUM METH B, V206, P712, DOI 10.1016/S0168-583X(03)00869-3
NR 28
TC 62
Z9 65
U1 1
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 299
EP 304
DI 10.1016/j.surfcoat.2004.02.046
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200058
DA 2018-10-20
ER

PT J
AU Smith, T
AF Smith, T
TI Biomedical testing
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
AB Biomechanical testing of materials for medical devices provides information critical to design of implants that will give life-long service.
C1 Instron Corp, Canton, MA 02021 USA.
RP Smith, T (reprint author), Instron Corp, 100 Royall St, Canton, MA 02021 USA.
EM info_news@instron.com
NR 0
TC 77
Z9 77
U1 0
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 0882-7958
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD AUG
PY 2004
VL 162
IS 8
BP 41
EP 43
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 847JX
UT WOS:000223389600004
DA 2018-10-20
ER

PT J
AU Casas, J
   Persson, PV
   Iversen, T
   Cordova, A
AF Casas, J
   Persson, PV
   Iversen, T
   Cordova, A
TI Direct organocatalytic ring-opening polymerizations of lactones
SO ADVANCED SYNTHESIS & CATALYSIS
LA English
DT Article
DE lactones; organic acids; organic catalysis; polyesters; ring-opening
   polymerizations
ID EPSILON-CAPROLACTONE; ASYMMETRIC-SYNTHESIS; LIPASE CATALYSIS; AMINO;
   DERIVATIVES; KETONES
AB We have developed a novel organocatalytic, direct synthesis of aliphatic polyesters. The synthesis was based on a novel direct organic acid-catalyzed living ring-opening polymerization (ROP) of epsilon-caprolactone and delta-valerolactone with benzyl alcohol as the initiator. The organic acid-catalyzed ROPs were performed without solvent and the catalyst was recovered by precipitation of the polyester products. In addition, they were operationally simple, inexpensive and environmentally benign. Organic acid catalysis provides a new entry for the synthesis of valuable biodegradable materials as well as polyesters for biomedical applications.
C1 Stockholm Univ, Arrhenius Lab, Dept Organ Chem, S-10691 Stockholm, Sweden.
   Swedish Pulp & Paper Res Inst, STFI, S-11486 Stockholm, Sweden.
RP Cordova, A (reprint author), Stockholm Univ, Arrhenius Lab, Dept Organ Chem, S-10691 Stockholm, Sweden.
EM acordova@organ.su.se
RI Cordova, Armando/B-8885-2011
OI Cordova, Armando/0000-0001-9620-8698
CR Bogevig A, 2004, ANGEW CHEM INT EDIT, V43, P1109, DOI 10.1002/anie.200353018
   Chiellini E, 1996, ADV MATER, V8, P305, DOI 10.1002/adma.19960080406
   CONNOR EF, 2001, J AM CHEM SOC, V123, P914
   Cordova A, 1998, POLYMER, V39, P6519, DOI 10.1016/S0032-3861(98)00068-8
   Cordova A, 2003, SYNLETT, P1651, DOI 10.1055/s-2003-41423
   Cordova A, 2001, BIOMACROMOLECULES, V2, P1347, DOI 10.1021/bm0101015
   Cordova A, 2002, J ORG CHEM, V67, P301, DOI 10.1021/jo015881m
   Cordova A, 2002, J AM CHEM SOC, V124, P1866, DOI 10.1021/ja017833p
   Cordova A, 1998, J AM CHEM SOC, V120, P13521, DOI 10.1021/ja982252u
   Cordova A, 1998, MACROMOLECULES, V31, P1040, DOI 10.1021/ma971297x
   CORDOVA A, 2004, CHEM-EUR J, V10, P1957
   Dalko PI, 2001, ANGEW CHEM INT EDIT, V40, P3726, DOI 10.1002/1521-3773(20011015)40:20<3726::AID-ANIE3726>3.0.CO;2-D
   Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h
   Duthaler RO, 2003, ANGEW CHEM INT EDIT, V42, P975, DOI 10.1002/anie.200390283
   EISSEN M, 2001, ANGEW CHEM INT EDIT, V40, P414
   FERSHT A. R., 1985, ENZYME STRUCTURE MEC
   Fujisato T, 1996, MACROMOL SYMP, V103, P73
   Gross RA, 2001, CHEM REV, V101, P2097, DOI 10.1021/cr0002590
   Jarvo ER, 2002, TETRAHEDRON, V58, P2481, DOI 10.1016/S0040-4020(02)00122-9
   JENCKS WP, 1969, CATALYSIS CHEM ENZYM
   Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l
   List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1
   Nederberg F, 2001, ANGEW CHEM INT EDIT, V40, P2712, DOI 10.1002/1521-3773(20010716)40:14<2712::AID-ANIE2712>3.0.CO;2-Z
   OKEEFE BJ, 2001, J CHEM SOC DA, V15, P2215
   Ovitt TM, 1999, J AM CHEM SOC, V121, P4072, DOI 10.1021/ja990088k
   Shibasaki Y, 2000, MACROMOLECULES, V33, P4316, DOI 10.1021/ma992138b
   Slomkowski S, 1996, MACROMOL SYMP, V103, P213
   VION JM, 1986, MACROMOLECULES, V19, P1828, DOI 10.1021/ma00161a009
   Wahlberg J, 2003, BIOMACROMOLECULES, V4, P1068, DOI 10.1021/bm0340725
NR 29
TC 61
Z9 62
U1 6
U2 46
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1615-4150
J9 ADV SYNTH CATAL
JI Adv. Synth. Catal.
PD AUG
PY 2004
VL 346
IS 9-10
BP 1087
EP 1089
DI 10.1002/adsc.200404082
PG 3
WC Chemistry, Applied; Chemistry, Organic
SC Chemistry
GA 858UO
UT WOS:000224217700009
DA 2018-10-20
ER

PT J
AU Carlsson, HE
   Schapiro, SJ
   Farah, I
   Hau, J
AF Carlsson, HE
   Schapiro, SJ
   Farah, I
   Hau, J
TI Use of primates in research: A global overview
SO AMERICAN JOURNAL OF PRIMATOLOGY
LA English
DT Article
DE nonhuman primates; research use; animal models
ID BIOMEDICAL-RESEARCH; LABORATORY-ANIMALS; NONHUMAN-PRIMATES; SCIENTIFIC
   PAPERS; RHESUS MACAQUES; RESPONSES; STATEMENT
AB We assessed the use of nonhuman primates and nonhuman primate biological material in research by reviewing studies published in 2001 in peer-reviewed journals. The number and species of primates used, the origin of the animals, the type of study, the area of research of the investigation, and the location at which the research was performed were tabulated. Additionally, factors related to the animals that may have affected the outcome of the experiments were recorded. A total of 2,937 articles involving 4,411 studies that employed nonhuman primates or nonhuman primate biological material were identified and analyzed. More than 41,000 animals were represented in the studies published in 2001. In the 14% of studies for which re-use could be determined, 69% involved animals that had been used in previous experiments. Published studies most commonly used nonhuman primates or nonhuman primate biological material from the species Chlorocebus aethaops (19%), Macaca mulatta (18%), M. fascicularis (9%), and Papio spp. (6%). Of these studies, 54% were classified as in vitro studies, 14% as noninvasive, 30% as chronic, and 1% were considered acute. Nonhuman primates were primarily used in research areas in which they appear to be the most appropriate models for humans. The most common areas of research were microbiology (including HIV/AIDS (26%)), neuroscience (19%), and biochemistry/chemistry (12%). Most (84%) of the primate research published in 2001 was conducted in North America, Europe, and Japan. The animals and conditions under which they were housed and used were rarely described. Although it is estimated that nonhuman primates account for an extremely small fraction of all animals used in research, their special status makes it important to report the many husbandry and environmental factors that influence the research results generated. This analysis has identified that editors rarely require authors to provide comprehensive information concerning the subjects (e.g., their origin), treatment conditions, and experimental procedures utilized in the studies they publish. The present analysis addresses the use of primates for research, including the effects of a shortage of suitable nonhuman primate subjects in many research areas. (C) 2004 Wiley-Liss, Inc.
C1 Univ Uppsala, Dept Neurosci, Div Comparat Med, SE-75123 Uppsala, Sweden.
   Univ Texas, MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX USA.
RP Carlsson, HE (reprint author), Univ Uppsala, Dept Neurosci, Div Comparat Med, BMC Box 572, SE-75123 Uppsala, Sweden.
EM Hans-Erik.Carlsson@bmc.uu.se
RI Hau, Jann/C-8692-2012
OI Hau, Jann/0000-0001-8586-5705; Schapiro, Steven J./0000-0001-5406-1739
CR Balls M, 2000, DEV AN VET, V31, P1587
   BOCCIA ML, 1995, LAB ANIM, V29, P250, DOI 10.1258/002367795781088315
   BOISVERT DPJ, 1997, DEV ANIMAL VET SCI, V31, P399
   Bontrop RE, 2001, IMMUNOL REV, V183, P5, DOI 10.1034/j.1600-065x.2001.1830101.x
   Bowden D M, 1996, Contemp Top Lab Anim Sci, V35, P55
   Bowden D. M., 1992, I LAB ANIMAL RESOURC, V34, P53
   CLOUGH G, 1982, BIOL REV, V57, P487, DOI 10.1111/j.1469-185X.1982.tb00705.x
   Cohen J, 2000, SCIENCE, V287, P959, DOI 10.1126/science.287.5455.959
   CROOK G, 1991, AUSTR PRIMATOL, V6, P5
   ERWIN J, 1981, AM J PRIMATOL, V1, P261, DOI 10.1002/ajp.1350010302
   FRIDMAN EP, 1988, J MED PRIMATOL, V17, P309
   FRIDMAN EP, 1983, J MED PRIMATOL, V12, P287
   Goodman S, 2002, NATURE, V417, P684, DOI 10.1038/417684a
   Granados-Zuniga J, 1997, REV BIOL TROP, V45, P979
   *GREAT BRIT HOM OF, 2002, REP AN PROC COMM 200
   *GREAT BRIT HOM OF, 1998, REP AN PROC COMM 199
   Hagelin J, 1999, ACAD MED, V74, P1135, DOI 10.1097/00001888-199910000-00018
   HAMPSON J, 1990, ATLA-ALTERN LAB ANIM, V17, P335
   Hau J, 2000, DEV AN VET, V31, P1593
   Kaup F.-J., 2002, Primate Report, V62, P3
   KING FA, 1988, SCIENCE, V240, P1475, DOI 10.1126/science.3287624
   KINGSTON WR, 1994, PRIMATE EYE, V54, P23
   LANG CM, 1976, FED PROC, V35, P1123
   *NAT RES COUNC, 2003, INT PERSP FUT NONH P
   National Research Council, 1997, CHIMP RES STRAT THEI
   Obrink KJ, 2000, LAB ANIM, V34, P121, DOI 10.1258/002367700780457608
   PIFER L, 1994, SOC ANIM, V2, P95, DOI 10.1163/156853094X00126
   PRESCOTT MJ, 2002, COUNTING COST WELFAR
   RHIM JS, 1969, P SOC EXP BIOL MED, V132, P670
   Schapiro SJ, 2000, APPL ANIM BEHAV SCI, V68, P67, DOI 10.1016/S0168-1591(00)00090-3
   Schapiro SJ, 1996, AM J PRIMATOL, V40, P247
   SCHAPIRO SJ, 1994, LAB ANIM SCI, V44, P229
   *SCI STEER COMM, 2002, NEED NONH PRIM BIOM
   Sibal L R, 2001, ILAR J, V42, P74
   Smith JA, 1997, LAB ANIM, V31, P312, DOI 10.1258/002367797780596176
   Smith O.A., 1975, P127
   STEPHENS ML, 1995, ATLA-ALTERN LAB ANIM, V23, P579
   VANVLISSINGEN JMF, 1997, PRIMATE REP, V49, P81
   WEBER A, 1997, PRIMATE REP, V49, P11
   WILDE J, 1994, PRIMATE REP, V38, P1
   Yamamoto ME, 1999, INT J PRIMATOL, V20, P281, DOI 10.1023/A:1020578604925
   ZUCKER EL, 1996, LAB PRIMATOL NEWSL, V35, P8
   1976, LANCET, V308, P726
NR 43
TC 109
Z9 113
U1 3
U2 22
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0275-2565
J9 AM J PRIMATOL
JI Am. J. Primatol.
PD AUG
PY 2004
VL 63
IS 4
BP 225
EP 237
DI 10.1002/ajp.20054
PG 13
WC Zoology
SC Zoology
GA 848PB
UT WOS:000223478500003
PM 15300710
DA 2018-10-20
ER

PT J
AU Kobayashi, M
   Oka, M
AF Kobayashi, M
   Oka, M
TI Composite device for attachment of polyvinyl alcohol-hydrogel to
   underlying bone
SO ARTIFICIAL ORGANS
LA English
DT Article
DE attachment method; composite device; injection-molding; polyvinyl
   alcohol-hydrogel; titanium fiber mesh
ID ARTIFICIAL ARTICULAR-CARTILAGE; LOAD-BEARING CONDITIONS;
   BIOCOMPATIBILITY; PANCREAS
AB Polyvinyl alcohol-hydrogels (PVA-H) have been specifically proposed as promising prosthetic biomaterials because of their excellent mechanical properties and biocompatibility. However, it is very difficult to obtain stable long-term fixation of implanted PVA-H and this problem is the key point to be solved in the further development of PVA-H in biomedical applications more widely in various fields. Orthopedic implants using PVA-H have been developed and in the process this problem was solved using a composite device. This device consists of PVA-H and a titanium fiber mesh (TFM) as a porous tissue-ingrowth material. In the present study, the mechanical properties of this composite device produced using a new improved production method (injection molding) were investigated and animal experiments for in vivo evaluation were performed. In vitro tests showed that the shear strength at the interface of the PVA-H and TFM, and the mechanical properties of PVA-H itself were promising. Moreover, the histological appearance of the composite device implant in vivo showed abundant bone ingrowth into the deep pore spaces of TFM, which indicated that this device attached firmly to the adjacent bone. These results indicated this composite device prepared by this new method can supply firm attachment of PVA-H onto underlying bone, and that it will be available for various biomedical applications using PVA-H.
C1 Harvard Univ, Sch Med, Brigham & Womens Hosp, Orthoped Res Lab, Boston, MA USA.
   Kyoto Univ, Inst Frontier Med Sci, Tissue Regenerat Dept, Kyoto, Japan.
RP Kobayashi, M (reprint author), 75 Francis St, Boston, MA 02115 USA.
EM m-bear@rf7.so-net.ne.jp
CR Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   Castelli F, 2000, BIOMATERIALS, V21, P821, DOI 10.1016/S0142-9612(99)00252-5
   Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5
   CHANG YS, 1994, CLIN MATER, V17, P181, DOI 10.1016/0267-6605(94)90034-5
   HYON SH, 1989, POLYM BULL, V22, P119, DOI 10.1007/BF00255200
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   Ohgawara H, 1998, ARTIF ORGANS, V22, P788, DOI 10.1046/j.1525-1594.1998.06185.x
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   OKAMURA S, 1992, WORLD PVA
   PEPPAS NA, 1977, J BIOMED MATER RES, V11, P423, DOI 10.1002/jbm.820110309
   YOUNG TH, 2002, BIOMATERIALS, V23, P495
   Yura S, 1999, SIROT 99, P371
NR 14
TC 13
Z9 13
U1 2
U2 10
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 2004
VL 28
IS 8
BP 734
EP 738
DI 10.1111/j.1525-1594.2004.00079.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 840ED
UT WOS:000222839000006
PM 15270955
OA Bronze
DA 2018-10-20
ER

PT J
AU Tan, J
   Saltzman, WM
AF Tan, J
   Saltzman, WM
TI Biomaterials with hierarchically defined micro- and nanoscale structure
SO BIOMATERIALS
LA English
DT Article
DE biomineralization; biomimetic materials; microstructure; nanostructure;
   bone tissue engineering; hydroxyapatite; osteoblast
ID SELF-ASSEMBLED MONOLAYERS; TOPOGRAPHICAL CONTROL; SURFACE;
   BIOMINERALIZATION; NUCLEATION; SUBSTRATA; CHEMISTRY; CERAMICS; PROTEINS;
   APATITE
AB Biomaterials and tissue engineering are becoming increasingly important in biomedical practice, particularly as the population ages. It is clear that cellular responses to materials depend on structural properties of the material at both the micrometer- and nanometer scale, but general methods for controlling material properties on both of these scales are lacking. Using a hierarchical approach that mimics natural material formation processes, we developed a method to produce materials with controlled physical structures at both the micrometer- and nanometer scale. Our method is based upon a pre-organized micropatterned template and conformal transformation of the architecture with nanostructured minerals, namely hydroxyapatite. The newly developed materials were biocompatible with bone cells, induced a range of desirable cellular responses, and may therefore have direct application in bone tissue engineering. In addition, the design principles employed in this study can be extrapolated to the other classes of biomedical materials, including polymers, metals, ceramics or hybrid combinations. (C) 2003 Published by Elsevier Ltd.
C1 Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
   Yale Univ, Dept Chem Engn, New Haven, CT 06511 USA.
RP Tan, J (reprint author), Cornell Univ, Sch Chem & Biomol Engn, 120 Olin Hall Cornell Univ, Ithaca, NY 14853 USA.
EM jt75@cornell.edu
FU NIDCR NIH HHS [DE-14097]
CR ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Chance JJ, 1997, LANGMUIR, V13, P4487, DOI 10.1021/la970081l
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dan N, 2000, TRENDS BIOTECHNOL, V18, P370, DOI 10.1016/S0167-7799(00)01482-7
   FISHMAN RB, 1993, J NEUROSCI, V13, P3485
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   HOCH HC, 1996, NANOFABRICATION BIOS
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   LEGEROS RZ, 1991, CALCIUM PHOSPHATE OR
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Lowenstam HA, 1989, BIOMINERALIZATION
   MADOU MJ, 1996, FUNDAMENTALS MICROFA
   MANN S, 1995, J MATER CHEM, V5, P935, DOI 10.1039/jm9950500935
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   MANN S, 1989, BIOMINERALIZATION CH
   Morse DE, 1999, TRENDS BIOTECHNOL, V17, P230, DOI 10.1016/S0167-7799(99)01309-8
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354
   Simon A, 2002, J COLLOID INTERF SCI, V251, P278, DOI 10.1006/jcis.2002.8385
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Tai HC, 1998, BIOTECHNOL PROGR, V14, P364, DOI 10.1021/bp980035r
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tan J, 2001, BIOPHYS J, V81, P2569, DOI 10.1016/S0006-3495(01)75901-2
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Wood MA, 2002, NANOTECHNOLOGY, V13, P605, DOI 10.1088/0957-4484/13/5/312
NR 40
TC 155
Z9 160
U1 2
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3593
EP 3601
DI 10.1016/j.biomaterials.2003.10.034
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200027
PM 15020133
DA 2018-10-20
ER

PT J
AU Duan, YY
   Clark, GM
   Cowan, RSC
AF Duan, YY
   Clark, GM
   Cowan, RSC
TI A study of intra-cochlear electrodes and tissue interface by
   electrochemical impedance methods in vivo
SO BIOMATERIALS
LA English
DT Article
DE electrode-tissue interfaces; intra-cochlear electrodes; electrochemical
   impedance methods; implantable device; biomedical materials; neural
   prostheses
ID POROUS FILM ELECTRODES; CHRONIC ELECTRICAL-STIMULATION; GUINEA-PIG
   COCHLEA; AUDITORY-NERVE; SURFACE-AREA; DIFFUSION; MODEL; SPECTROSCOPY;
   PERILYMPH; BEHAVIOR
AB This paper presents methods, results and analysis for measurements of the electrochemical impedance of platinum electrodes (similar to0.43 mm(2)) over a 6-month implantation in the cat cochlea. The study aimed to improve our understanding of the effects of tissue response on impedance behaviour. An increase in impedance in the post-operative period was evident with a rise of the distorted arc at high frequencies in the complex plane, correlating to anomalous charge transport at the electrode-tissue interface. The impedance at low frequencies generally showed a capacitive dispersion modelled as a constant phase element, indicating a blocking characteristic of the electrodes. The study suggests that a reduction and changes in composition of perilymph or extracellular fluid adjacent to the electrodes, as a consequence of tissue response, causes the elevated "contact impedance". This affects the efficiency and quality of neural stimulating electrodes and neural recording electrodes. The finding of the crucial role of perilymph or extracellular fluid thin layer provides a new strategy for surface materials of neural electrodes, which is discussed in the paper. The interface characteristics must be considered during interpretation of studies undertaken in vitro or in acute experiments in vivo, where physiological fluid is abundant. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Cooperat Res Ctr Cochlear Implant & Hearing Aid I, Bion Ear Inst, Melbourne, Vic 3002, Australia.
RP Duan, YY (reprint author), Cooperat Res Ctr Cochlear Implant & Hearing Aid I, Bion Ear Inst, 2F-32 Gisborne St, Melbourne, Vic 3002, Australia.
EM yduan@bionicear.org
CR Barcia OE, 2002, ELECTROCHIM ACTA, V47, P2109, DOI 10.1016/S0013-4686(02)00081-6
   Bisquert J, 2002, J PHYS CHEM B, V106, P325, DOI [10.1021/jp011941g, 10.1021/jp01194lg]
   Bisquert J, 1998, J ELECTROANAL CHEM, V452, P229, DOI 10.1016/S0022-0728(98)00115-6
   Bisquert J, 1999, J ELECTROANAL CHEM, V475, P152, DOI 10.1016/S0022-0728(99)00346-0
   Bisquert J, 2002, ELECTROCHIM ACTA, V47, P3977, DOI 10.1016/S0013-4686(02)00372-9
   Bisquert J, 2001, J ELECTROANAL CHEM, V499, P112, DOI 10.1016/S0022-0728(00)00497-6
   Bisquert J, 2000, PHYS CHEM CHEM PHYS, V2, P4185, DOI 10.1039/b001708f
   Bisquert J, 1999, ELECTROCHEM COMMUN, V1, P429, DOI 10.1016/S1388-2481(99)00084-3
   Bisquert J, 2000, J PHYS CHEM B, V104, P2287, DOI 10.1021/jp993148h
   Bisquert J, 2000, ELECTROCHEM COMMUN, V2, P601, DOI 10.1016/S1388-2481(00)00089-8
   BOSHER SK, 1976, SCI FDN OTOLARYNGOLO, P290
   Brett CMA, 1999, ELECTROCHIM ACTA, V44, P4233, DOI 10.1016/S0013-4686(99)00138-3
   Clark G, 2000, IND PHYS, V6, P12
   Cotran RS, 1999, ROBBINS PATHOLOGIC B, P50
   Cotran RS, 1999, TISSUE REPAIR CELLUL, P89
   Diard JP, 1999, J ELECTROANAL CHEM, V471, P126, DOI 10.1016/S0022-0728(99)00262-4
   Elliott JM, 2000, PHYS CHEM CHEM PHYS, V2, P5653, DOI 10.1039/b006462i
   FLETCHER S, 1992, J ELECTROANAL CHEM, V337, P127, DOI 10.1016/0022-0728(92)80533-A
   Fogel R, 1996, PACE, V19, P188, DOI 10.1111/j.1540-8159.1996.tb03310.x
   FOSTER KR, 1995, BIOMEDICAL ENG HDB, P1385
   FOX WC, 1993, J BIOMED MATER RES, V27, P763
   HANNAN WJ, 1995, CLIN SCI, V89, P651, DOI 10.1042/cs0890651
   HARUTA A, 1995, ACTA OTO-LARYNGOL, V115, P504, DOI 10.3109/00016489509139356
   HATSUSHIKA S, 1990, ANN OTO RHINOL LARYN, V99, P871, DOI 10.1177/000348949009901104
   Hibbert DB, 2001, J ELECTROCHEM SOC, V148, pE1, DOI 10.1149/1.1344543
   Lang G, 1998, J ELECTROANAL CHEM, V457, P257, DOI 10.1016/S0022-0728(98)00301-5
   MACDONALD JR, 1992, ANN BIOMED ENG, V20, P289, DOI 10.1007/BF02368532
   OHYAMA K, 1988, HEARING RES, V35, P119, DOI 10.1016/0378-5955(88)90111-6
   Ovadia M, 1998, ELECTROANAL, V10, P262, DOI 10.1002/(SICI)1521-4109(199804)10:4<262::AID-ELAN262>3.0.CO;2-W
   PAASCH G, 1993, ELECTROCHIM ACTA, V38, P2653, DOI 10.1016/0013-4686(93)85083-B
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Rossberg K, 1998, J ELECTROANAL CHEM, V443, P49, DOI 10.1016/S0022-0728(97)00494-4
   Roth B. J., 1995, BIOMEDICAL ENG HDB, P126
   SALT AN, 1991, ACTA OTO-LARYNGOL, V111, P899, DOI 10.3109/00016489109138428
   Tykocinski M, 2001, HEARING RES, V159, P53, DOI 10.1016/S0378-5955(01)00320-3
   Vassal N, 2000, ELECTROCHIM ACTA, V45, P1527, DOI 10.1016/S0013-4686(99)00369-2
   Weiland JD, 2000, IEEE T BIO-MED ENG, V47, P911, DOI 10.1109/10.846685
   Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1
NR 38
TC 41
Z9 42
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3813
EP 3828
DI 10.1016/j.biomaterials.2003.09.107
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200051
PM 15020157
DA 2018-10-20
ER

PT J
AU Markaki, AE
   Clyne, TW
AF Markaki, AE
   Clyne, TW
TI Magneto-mechanical stimulation of bone growth in a bonded array of
   ferromagnetic fibres
SO BIOMATERIALS
LA English
DT Article
DE porosity; magnetism; scaffold
ID IN-VIVO; CORROSION; ALLOYS; BEHAVIOR; IMPLANTS; SURFACE; FUSION; VITRO;
   SPINE
AB A brief experimental and theoretical study is presented into the elastic deformation of bonded arrays of ferromagnetic fibres. when subjected to an external magnetic field. Material made of such fibre arrays is of potential interest for certain biomedical applications, such as prosthetic implants. Externally imposed magnetic fields could be used to generate mechanical strains in surrounding tissue, with possible physiological benefits. It is shown that it should be possible to generate strains within embryonic bone cell networks. forming, within such a fibre array. which are sufficient to stimulate enhanced growth. The effects outlined here could thus form the basis of surgical or therapeutic advances. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Clyne, TW (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
EM twe10@cam.ac.uk
RI Markaki, Athina/H-9676-2012
FU Engineering and Physical Sciences Research Council [GR/R95364/01]
CR Adair RK, 2000, REP PROG PHYS, V63, P415, DOI 10.1088/0034-4885/63/3/204
   Akhouayri O, 2000, J CELL BIOCHEM, V76, P217, DOI 10.1002/(SICI)1097-4644(20000201)76:2<217::AID-JCB6>3.3.CO;2-B
   ANGELINI E, 1991, J PROSTHET DENT, V65, P848, DOI 10.1016/S0022-3913(05)80026-5
   Ashby M.F., 2000, METAL FOAMS DESIGN G
   CRAVEN TG, 1994, SPINE, V19, P1664, DOI 10.1097/00007632-199408000-00003
   Delannay F., 1999, METFOAM 99, P293
   DUCHEYNE P, 1978, J MATER SCI, V13, P2650, DOI 10.1007/BF00552695
   GOEHLICH V, 1990, DENT MATER, V6, P103, DOI 10.1016/S0109-5641(05)80039-9
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kang SB, 2002, MATER TRANS, V43, P1045, DOI 10.2320/matertrans.43.1045
   Kim HM, 2000, BIOMATERIALS, V21, P353, DOI 10.1016/S0142-9612(99)00190-8
   Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Linovitz RJ, 2002, SPINE, V27, P1383, DOI 10.1097/00007632-200207010-00002
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Mosley JR, 2000, J REHABIL RES DEV, V37, P189
   Oka M, 1997, J BONE JOINT SURG BR, V79B, P1003, DOI 10.1302/0301-620X.79B6.7606
   Paulus JA, 1997, BIOMATERIALS, V18, P1609, DOI 10.1016/S0142-9612(97)00102-6
   RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711
   RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012
   RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   SIVAKUMAR M, 1993, J MATER SCI, V28, P6081, DOI 10.1007/BF00365025
   SYVERUD M, 1987, DENT MATER, V3, P102, DOI 10.1016/S0109-5641(87)80039-8
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   UNDERWOOD EE, 1970, QUANTITATIVE STEREOL
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
NR 27
TC 42
Z9 42
U1 2
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 19
BP 4805
EP 4815
DI 10.1016/j.biomaterials.2003.11.041
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 817XY
UT WOS:000221211400032
PM 15120527
DA 2018-10-20
ER

PT J
AU Sciacovelli, L
   Zardo, L
   Secchiero, S
   Plebani, M
AF Sciacovelli, L
   Zardo, L
   Secchiero, S
   Plebani, M
TI Quality specifications in EQA schemes: from theory to practice
SO CLINICA CHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT International Conference on Laboratory Medicine
CY OCT   24, 2003
CL Padova, ITALY
DE external quality assessment; analytical performance laboratory;
   analytical total error; EQA control material; EQA statistical procedure
ID MEDICAL LABORATORIES; BIOLOGICAL VARIATION; PROGRAMS; APPROPRIATENESS;
   CHOLESTEROL; STANDARDS; GOALS; NEED
AB Background: External quality assessment (EQA) is a tool for quality management in clinical laboratories and its main objectives are assessment of participants and methods performance, training and advice. This paper describes the quality specifications used in EQA schemes of the Centre of Biomedical Research (CRB), in order to design schemes that can assess laboratory reliability performances, meet the changing needs and quality recommendations. Methods: Quality specifications for control materials, statistical procedures and goals to assess laboratory performance have been applied and introduced in EQA schemes managed by CRB. Results: The application of well-defined quality specifications has demonstrated effective. In particular, we report results on alkaline phosphatase and cholesterol obtained using commercial control materials and human serum controls, in two different EQA surveys; the inter-laboratory variability (CVinter%) for troponin I analysed with a diagnostic system and assigned values of CK-MB mass obtained using four different diagnostic systems; the percentage of acceptable performances obtained by means of the application of goals based on clinical criteria, biological variation, state-of-the-art and used for EQA schemes, and referring to some analytes with significant clinical values such as cholesterol, glucose, glycated hemoglobin and sodium. Conclusions: The design of reliable EQA schemes based on evidence-based quality specifications is a pre-requisite for supporting the quality improvement of clinical laboratories. (C) 2004 Elsevier B.V. All rights reserved.
C1 Ctr Ric Biomed, I-31033 Castelfranco Veneto, TV, Italy.
RP Sciacovelli, L (reprint author), Ctr Ric Biomed, Via Osped 18, I-31033 Castelfranco Veneto, TV, Italy.
EM laurasciacovelli@libero.it
OI Sciacovelli, Laura/0000-0003-3156-1399
CR *CLIN PATH ACCR, 2003, STAND EQA SCHEM LAB
   FRASER CG, 1993, CLIN CHEM, V39, P1447
   FRASER CG, 1993, SCAND J CLIN LAB INV, V53, P8, DOI 10.3109/00365519309085446
   Fraser CG, 1999, SCAND J CLIN LAB INV, V59, P487, DOI 10.1080/00365519950185210
   Fraser CG, 1997, ANN CLIN BIOCHEM, V34, P1
   Garde AH, 2000, CLIN CHEM, V46, P551
   International Federation of Clinical Chemistry (IFCC), 1997, FUND EXT QUAL ASS EQ
   *ISO, 1997, ISO GUID 43 PROF TES
   LEWIS LS, QUALITY CONTROL GOOD
   Libeer JC, 2001, CLIN CHIM ACTA, V309, P173, DOI 10.1016/S0009-8981(01)00518-6
   Libeer JC, 2001, ACCREDIT QUAL ASSUR, V6, P151, DOI 10.1007/PL00013513
   LIBEER JP, 1993, EXTERNAL QUALITY ASS
   *NCCLS, 1999, GP27A NCCLS, P19
   PETERSEN HP, 1994, ELEMENTS ANAL QUALIT, P187
   PETERSEN HP, 1993, UPPSALA J MED SCI, V98, P195
   PETERSEN PH, 1999, SCAND J CLIN LAB INV, V59, P475
   Plebani M, 2003, CLIN CHIM ACTA, V333, P131, DOI 10.1016/S0009-8981(03)00177-3
   Plebani M, 1999, CLIN CHIM ACTA, V280, P35, DOI 10.1016/S0009-8981(98)00196-X
   Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491
   Sciacovelli L, 2001, CLIN CHIM ACTA, V309, P183, DOI 10.1016/S0009-8981(01)00521-6
   Sebastian-Gambaro MA, 1997, EUR J CLIN CHEM CLIN, V35, P845
   Secchiero S, 2003, CLIN CHIM ACTA, V333, P221, DOI 10.1016/S0009-8981(03)00189-X
   STOCKL D, 1995, EUR J CLIN CHEM CLIN, V33, P157
   Waise A, 1999, CLIN CHIM ACTA, V280, P47, DOI 10.1016/S0009-8981(98)00197-1
   Westgard JO, 1999, SCAND J CLIN LAB INV, V59, P483, DOI 10.1080/00365519950185201
   WONG ET, 1995, CLIN CHEM, V41, P1241
   2000, ILACG13
NR 27
TC 28
Z9 31
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0009-8981
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD AUG
PY 2004
VL 346
IS 1
BP 87
EP 97
DI 10.1016/j.cccn.2004.02.037
PG 11
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 838WQ
UT WOS:000222744400012
PM 15234640
DA 2018-10-20
ER

PT J
AU Cheng, RP
AF Cheng, RP
TI Beyond de novo protein design - de novo design of non-natural folded
   oligomers
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Review
ID CONTRACTION/EXTENSION MOLECULAR-MOTION; PHENYLENE ETHYNYLENE OLIGOMERS;
   HELICAL SECONDARY STRUCTURE; DYNAMIC CHEMICAL-DEVICES; BETA-PEPTIDE
   12-HELIX; SIDE-CHAIN CONTROL; AQUEOUS-SOLUTION; AMINO-ACIDS;
   ELECTROSTATIC INTERACTIONS; REVERSIBLE POLYMERIZATION
AB The mystery of how a protein sequence specifies a unique structure has intrigued chemists, leading to the design and study of foldamers, non-natural oligomeric molecules that adopt well-defined structures. Recently, the sequence specificity of the various regular repeating structures has been revealed for bioinspired foldamers and such foldamers have been created to adopt helical bundle tertiary structures. One major strategy for the generation of abiotic foldamers has involved molecular design of the monomer geometry. These advances in foldamer research may lead to future applications in biomedical and materials science.
C1 SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.
RP Cheng, RP (reprint author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.
EM chengr@buffalo.edu
CR Archer EA, 2002, J AM CHEM SOC, V124, P5074, DOI 10.1021/ja012696h
   Arvidsson PI, 2003, CHEMBIOCHEM, V4, P1345, DOI 10.1002/cbic.200300698
   Arvidsson PI, 2003, HELV CHIM ACTA, V86, P1522, DOI 10.1002/hlca.200390133
   ARVIDSSON PI, 2001, CHEM COMMUN, V7, P649
   Barboiu M, 2003, CHEM-EUR J, V9, P763, DOI 10.1002/chem.200390085
   Barboiu M, 2002, P NATL ACAD SCI USA, V99, P5201, DOI 10.1073/pnas.082099199
   Blatchly RA, 2003, J ORG CHEM, V68, P8780, DOI 10.1021/jo034827y
   Bruckner AM, 2003, ANGEW CHEM INT EDIT, V42, P4395, DOI 10.1002/anie.200351871
   Burkoth TS, 2002, CHEM BIOL, V9, P647, DOI 10.1016/S1074-5521(02)00140-0
   Cary JM, 2002, ORG LETT, V4, P4663, DOI 10.1021/ol0270982
   Cheng RP, 2002, J AM CHEM SOC, V124, P11564, DOI 10.1021/ja020728a
   Cheng RP, 2001, CHEM REV, V101, P3219, DOI 10.1021/cr000045i
   Cheng RP, 2001, J AM CHEM SOC, V123, P5162, DOI 10.1021/ja010438e
   Cubberley MS, 2001, CURR OPIN CHEM BIOL, V5, P650, DOI 10.1016/S1367-5931(01)00261-7
   De Pol S, 2004, ANGEW CHEM INT EDIT, V43, P511, DOI 10.1002/anie.200352267
   Doerksen RJ, 2003, CHEM COMMUN, P2534, DOI 10.1039/b309584c
   Dolain C, 2003, ANGEW CHEM INT EDIT, V42, P2738, DOI 10.1002/anie.200351080
   Etezady-Esfarjani T, 2002, HELV CHIM ACTA, V85, P1197, DOI 10.1002/1522-2675(200205)85:5<1197::AID-HLCA1197>3.0.CO;2-E
   Gabriel GJ, 2002, J AM CHEM SOC, V124, P15174, DOI 10.1021/ja0275358
   Gademann K, 2003, ANGEW CHEM INT EDIT, V42, P1534, DOI 10.1002/anie.200250290
   Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r
   Gong B, 2001, CHEM-EUR J, V7, P4336, DOI 10.1002/1521-3765(20011015)7:20<4336::AID-CHEM4336>3.0.CO;2-1
   Gong B, 2002, P NATL ACAD SCI USA, V99, P11583, DOI 10.1073/pnas.162277099
   Gopi HN, 2002, HELV CHIM ACTA, V85, P3313, DOI 10.1002/1522-2675(200210)85:10<3313::AID-HLCA3313>3.0.CO;2-P
   Gruner Sibylle A W, 2002, Chemistry, V8, P4365, DOI 10.1002/1521-3765(20021004)8:19<4365::AID-CHEM4365>3.0.CO;2-U
   Hart SA, 2003, J AM CHEM SOC, V125, P4022, DOI 10.1021/ja029868a
   Hayen A, 2004, ANGEW CHEM INT EDIT, V43, P505, DOI 10.1002/anie.200352125
   Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t
   Hill DJ, 2002, P NATL ACAD SCI USA, V99, P5053, DOI 10.1073/pnas.072642799
   Huc I, 2004, EUR J ORG CHEM, P17, DOI 10.1002/ejoc.200300495
   Huc I, 2002, CHEM COMMUN, P578, DOI 10.1039/b111612f
   Huck BR, 2003, J AM CHEM SOC, V125, P9035, DOI 10.1021/ja034561c
   Jiang H, 2004, J AM CHEM SOC, V126, P1034, DOI 10.1021/ja039511m
   Jiang H, 2003, J AM CHEM SOC, V125, P3448, DOI 10.1021/ja029887k
   Jones TV, 2003, ORG LETT, V5, P3297, DOI 10.1021/ol0352254
   Kimmerlin T, 2003, HELV CHIM ACTA, V86, P2098, DOI 10.1002/hlca.200390166
   Kimmerlin T, 2002, HELV CHIM ACTA, V85, P1812, DOI 10.1002/1522-2675(200206)85:6<1812::AID-HLCA1812>3.0.CO;2-E
   Kolomiets E, 2003, CHEM COMMUN, P2868, DOI 10.1039/b311578j
   Langenhan JM, 2003, ANGEW CHEM INT EDIT, V42, P2402, DOI 10.1002/anie.200350932
   Lee HS, 2001, J AM CHEM SOC, V123, P7721, DOI 10.1021/ja010734r
   LePlae PR, 2002, J AM CHEM SOC, V124, P6820, DOI 10.1021/ja017869h
   Martinek TA, 2003, EUR J BIOCHEM, V270, P3657, DOI 10.1046/j.1432-1033.2003.03756.x
   Matsuda K, 2002, J AM CHEM SOC, V124, P11836, DOI 10.1021/ja027437m
   Nishinaga T, 2002, J AM CHEM SOC, V124, P5934, DOI 10.1021/ja025698q
   ODRIOZOLA L, 2004, CHEM COMMUN     0107, P62, DOI DOI 10.1039/b311045a
   Oh K, 2003, J ORG CHEM, V68, P8397, DOI 10.1021/jo035007o
   Oh K, 2001, NATURE, V414, P889, DOI 10.1038/414889a
   Park JS, 2003, J AM CHEM SOC, V125, P8539, DOI 10.1021/ja034180z
   Patch JA, 2002, CURR OPIN CHEM BIOL, V6, P872, DOI 10.1016/S1367-5931(02)00385-X
   Porter EA, 2002, ORG LETT, V4, P3317, DOI 10.1021/ol0266370
   Raguse TL, 2002, HELV CHIM ACTA, V85, P4154, DOI 10.1002/hlca.200290001
   Raguse TL, 2003, J AM CHEM SOC, V125, P5592, DOI 10.1021/ja0341485
   Raguse TL, 2001, ORG LETT, V3, P3963, DOI 10.1021/ol016868r
   Rueping M, 2004, CHEM-EUR J, V10, P1607, DOI 10.1002/chem.200305571
   Rueping M, 2002, HELV CHIM ACTA, V85, P2577, DOI 10.1002/1522-2675(200209)85:9<2577::AID-HLCA2577>3.0.CO;2-D
   Sanford AR, 2003, CURR ORG CHEM, V7, P1649, DOI 10.2174/1385272033486260
   Schmitt JL, 2003, HELV CHIM ACTA, V86, P1598, DOI 10.1002/hlca.200390137
   Seebach D, 2002, CHEM-EUR J, V8, P573, DOI 10.1002/1521-3765(20020201)8:3<573::AID-CHEM573>3.0.CO;2-H
   Seebach D, 1997, CHEM COMMUN, P2015, DOI 10.1039/a704933a
   Semetey V, 2002, ANGEW CHEM INT EDIT, V41, P1893, DOI 10.1002/1521-3773(20020603)41:11<1893::AID-ANIE1893>3.0.CO;2-F
   Sharma GVM, 2003, J AM CHEM SOC, V125, P13670, DOI 10.1021/ja035752i
   Stone MT, 2004, ORG LETT, V6, P469, DOI 10.1021/ol036238k
   van Gorp JJ, 2004, CHEM COMMUN, P60, DOI 10.1039/b312407j
   Woll MG, 2002, J AM CHEM SOC, V124, P12447, DOI 10.1021/ja0258778
   Woll MG, 2001, J AM CHEM SOC, V123, P11077, DOI 10.1021/ja011719p
   Wu CW, 2003, J AM CHEM SOC, V125, P13525, DOI 10.1021/ja037540r
   Wu YD, 1999, J AM CHEM SOC, V121, P9352, DOI 10.1021/ja990955l
   Yang XW, 2003, J AM CHEM SOC, V125, P9932, DOI 10.1021/ja0361897
   Yang XW, 2003, CHEM COMMUN, P56, DOI 10.1039/b209809a
   Zeng HQ, 2003, CHEM COMMUN, P1556, DOI 10.1039/b301791e
   Zeng HQ, 2002, J AM CHEM SOC, V124, P2903, DOI 10.1021/ja01701b
   Zhao DH, 2003, MACROMOLECULES, V36, P2712, DOI 10.1021/ma034159i
   Zhao DH, 2002, J AM CHEM SOC, V124, P9996, DOI 10.1021/ja026957e
   Zych AJ, 2002, HELV CHIM ACTA, V85, P3294, DOI 10.1002/1522-2675(200210)85:10<3294::AID-HLCA3294>3.0.CO;2-9
NR 74
TC 116
Z9 116
U1 2
U2 22
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD AUG
PY 2004
VL 14
IS 4
BP 512
EP 520
DI 10.1016/j.sbi.2004.07.001
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 852TT
UT WOS:000223780100018
PM 15313247
DA 2018-10-20
ER

PT J
AU Copty, A
   Golosovsky, M
   Davidov, D
   Frenkel, A
AF Copty, A
   Golosovsky, M
   Davidov, D
   Frenkel, A
TI Localized heating of biological media using a 1-W microwave near-field
   probe
SO IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES
LA English
DT Article
DE microwave heating; microwave microscopy; near-field
ID CLINICAL-APPLICATIONS; CARDIAC ABLATION; ANTENNA; HYPERTHERMIA;
   MICROSCOPY; RADIATION; MAGNETITE; MECHANISM
AB A medium power microwave near-field probe operating at 9 GHz has been designed and tested. The probe radiates microwave energy through a very narrow slot microfabricated at the apex of the dielectric resonator. The radiation is very intensive at near-field distances from the slot and is capable of heating different materials. A temperature of similar to60degreesC - 100degreesC is achieved in an irradiated soot of a size as small as 270 x 500 mum(2). This probe may be used for selective irradiation of biological tissues and tissue welding. We demonstrate the probe ability to produce irreversible changes in biological media with a relatively low power source of similar to1 W. This feature makes it safe for usage in biomedical settings and opens the way to development of an inexpensive portable handheld device.
C1 Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.
   Anafa Electromagnet Solut Ltd, IL-27000 Kiriat Bialik, Israel.
RP Copty, A (reprint author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.
RI Golosovsky, Michael/L-8303-2013; Golosovsky, Michael/E-1401-2012
OI Golosovsky, Michael/0000-0003-3814-4539; 
CR ABE M, 1985, INT J RADIAT BIOL, V47, P347
   Abu-Teir M, 2001, REV SCI INSTRUM, V72, P2073, DOI 10.1063/1.1351837
   Alpert Y, 1999, IEEE T PLASMA SCI, V27, P555, DOI 10.1109/27.772285
   Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   CERRI G, 1993, IEEE T MICROW THEORY, V41, P1135, DOI 10.1109/22.238538
   CHERRY PC, 1993, IEEE T BIO-MED ENG, V40, P771, DOI 10.1109/10.238461
   Dodd GD, 2000, RADIOGRAPHICS, V20, P9, DOI 10.1148/radiographics.20.1.g00ja019
   Fletcher DA, 2000, APPL PHYS LETT, V77, P2109, DOI 10.1063/1.1313368
   FRENKEL A, 2003, Patent No. 6538454
   Golosovsky M, 2002, IEEE T INSTRUM MEAS, V51, P1090, DOI 10.1109/TIM.2002.806006
   Golosovsky M, 2000, REV SCI INSTRUM, V71, P3927, DOI 10.1063/1.1289680
   Gu ZJ, 1999, IEEE T BIO-MED ENG, V46, P1480, DOI 10.1109/10.804576
   Gu ZJ, 2000, IEEE T MICROW THEORY, V48, P1892, DOI 10.1109/22.883868
   Hiraoka M, 2000, IEEE T MICROW THEORY, V48, P1789, DOI 10.1109/22.883855
   HURTER W, 1991, IEEE T MICROW THEORY, V39, P1048, DOI 10.1109/22.81680
   Jerby E, 2002, SCIENCE, V298, P587, DOI 10.1126/science.1077062
   Kaganovskii Y, 2001, J APPL PHYS, V89, P8273, DOI 10.1063/1.1373704
   Kirschvink JL, 1996, BIOELECTROMAGNETICS, V17, P187, DOI 10.1002/(SICI)1521-186X(1996)17:3<187::AID-BEM4>3.0.CO;2-#
   LAX M, 1977, J APPL PHYS, V48, P3919, DOI 10.1063/1.324265
   Lin JC, 1996, IEEE T BIO-MED ENG, V43, P657, DOI 10.1109/10.495286
   Lobel B, 2000, LASER SURG MED, V26, P4, DOI 10.1002/(SICI)1096-9101(2000)26:1<4::AID-LSM3>3.0.CO;2-J
   Phillips ABM, 1999, LASER SURG MED, V24, P264, DOI 10.1002/(SICI)1096-9101(1999)24:4<264::AID-LSM3>3.0.CO;2-#
   POLLEY SL, 1980, FOOD TECHNOL-CHICAGO, V34, P76
   Rappaport C, 2002, IEEE MICROW MAG, V3, P57, DOI 10.1109/6668.990686
   Rosner BT, 2002, REV SCI INSTRUM, V73, P2505, DOI 10.1063/1.1482150
   Sakran F, 2004, APPL PHYS LETT, V84, P4499, DOI 10.1063/1.1756682
   SHARP NC, 1995, LANCET, V346, P1003, DOI 10.1016/S0140-6736(95)91689-X
   Sterzer F, 2000, IEEE T MICROW THEORY, V48, P1885, DOI 10.1109/22.883867
   Wright AS, 2003, ANN SURG ONCOL, V10, P275, DOI 10.1245/ASO.2003.03.045
NR 29
TC 7
Z9 10
U1 1
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9480
J9 IEEE T MICROW THEORY
JI IEEE Trans. Microw. Theory Tech.
PD AUG
PY 2004
VL 52
IS 8
BP 1957
EP 1963
DI 10.1109/TMTT.2004.831986
PN 2
PG 7
WC Engineering, Electrical & Electronic
SC Engineering
GA 843BW
UT WOS:000223051400013
DA 2018-10-20
ER

PT J
AU Nguon, B
   Jouaneh, M
AF Nguon, B
   Jouaneh, M
TI Design and characterization of a precision fluid dispensing valve
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE dispensing valve; fluid dispensing; time-pressure dispensing; adhesive
   jetting dispensing
AB Precision fluid dispensing is a complicated but yet relevant process where fluid is dispensed in a controlled manner. It is important and applicable in an array of applications ranging from dispensing of food products, biomedical applications to dispensing of adhesive and encapsulants in the semi-conductor industry. This paper discusses the design and characterization of a precision fluid dispensing hybrid valve based on the time-pressure, positive displacement pump, and adhesive jetting technologies. The main advantage of this dispensing method is that the amount of fluid dispensed is independent of the standoff height and does not rely on surface tension between the substrate and the fluid for clean dispensation. Specifically, the dispensed fluid is jetted from a fixed needle height, and hence, repeatability and accuracy is improved while eliminating vertical travel. A prototype valve was built and tested for precision and accuracy of milligrams over a range of pressures and time. The test results are promising, indicating high repeatability and accuracy for low to medium viscous materials and are comparable to existing commercially available precision dispensing systems.
C1 Univ Rhode Isl, Dept Mech Engn & Appl Mech, Kingston, RI 02881 USA.
RP Nguon, B (reprint author), Univ Rhode Isl, Dept Mech Engn & Appl Mech, Kingston, RI 02881 USA.
EM jouaneh@egr.uri.edu
OI Jouaneh, Musa/0000-0001-5754-0364
CR Bush R., 1997, Electronic Packaging and Production, V37, P56
   BUSH R, 1997, ELECT PACKAG PROD, V37, P62
   BUSH R, 1997, ELECT PACKAGING PROD, V37, P60
   Chen XB, 2000, IEEE T ELECTRON PA M, V23, P300, DOI 10.1109/6104.895075
   DIXON D, 1997, CIRCUITS ASSEMBLY, P36
   HOLDSWORTH SD, 1993, T I CHEM ENG C3, V71, P137
   LEE C, 2000, ADV PACKAG
   MURCH F, 2000, ISSUES PRACTICAL PRO
   NGUON B, 2002, THESIS U RHODE ISLAN
   Piracci AF, 2000, ADVANTAGES NONCONTAC
   SKELLAND AHP, 1967, NONNEWTONIAN FLOW H
NR 11
TC 21
Z9 30
U1 1
U2 8
PU SPRINGER LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PD AUG
PY 2004
VL 24
IS 3-4
BP 251
EP 260
DI 10.1007/s00170-003-1738-3
PG 10
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 843ZE
UT WOS:000223125800011
DA 2018-10-20
ER

PT J
AU Jackson, MJ
   Hyde, LJ
   Ahmed, W
   Sein, H
   Flaxman, RP
AF Jackson, MJ
   Hyde, LJ
   Ahmed, W
   Sein, H
   Flaxman, RP
TI Diamond-coated cutting tools for biomedical applications
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article; Proceedings Paper
CT 2nd International Surface Engineering Congress
CY SEP 15-17, 2003
CL Indianapolis, IN
SP ASM Int
DE biomedical applications; CVD diamond; dental burs; microtools; wear
ID CHEMICAL-VAPOR-DEPOSITION; CEMENTED TUNGSTEN CARBIDE; CVD DIAMOND;
   FILMS; COATINGS; NUCLEATION; WEAR; GROWTH; STRESS; COBALT
AB Diamond coatings are attractive for cutting processes due to their high-hardness, low-friction coefficient; excellent wear resistance, and chemical inertness. The application of diamond coatings on cemented, tungsten carbide (WC-Co) burs has been the subject of much attention in recent years as a method to improve cutting performance and tool life. WC-Co burs containing 6% Co and 94% WC substrate, with an average grain size of 1-3 mum, were used in this study. To improve the adhesion between diamond and WC substrates, it is necessary to etch away the surface Co and prepare the surface for subsequent diamond growth. Hot filament chemical vapor deposition (HFCVD), with a modified vertical filament arrangement, has been used for the deposition of diamond films. Diamond film quality and purity has been characterized using scanning electron microscopy (SEM) and micro-Raman spectroscopy. The performance of diamond-coated WC-Co burs, uncoated WC-Co burs, and diamond-embedded (sintered) burs have been compared by drilling a series of holes into various materials such as human teeth, borosilicate glass, and acrylic teeth. Flank wear has been used to assess the wear rates of the burs when machining biomedical materials such as those just described.
C1 Tennessee Technol Univ, Ctr Mfg Res, Cookeville, TN 38505 USA.
   Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
   Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.
RP Jackson, MJ (reprint author), Tennessee Technol Univ, Ctr Mfg Res, POB 5014, Cookeville, TN 38505 USA.
EM mjackson@tntech.edu
OI Ahmed, Waqar/0000-0003-4152-5172
CR AGER JW, 1993, PHYS REV B, V48, P2601, DOI 10.1103/PhysRevB.48.2601
   Amirhaghi S, 2001, SURF COAT TECH, V135, P126, DOI 10.1016/S0257-8972(00)01083-5
   BORGES CM, 1999, J PROSTHET DENT, P73
   BRADEN M, 1976, FRONTIERS ORAL PHYSL
   Buck V, 1998, DIAM RELAT MATER, V7, P1544, DOI 10.1016/S0925-9635(98)00237-4
   CAPELLI E, 1996, DIAM RELAT MATER, V5, P292
   CHEN X, 1993, J APPL PHYS, V74, P1468
   Endler I, 1999, DIAM RELAT MATER, V8, P834, DOI 10.1016/S0925-9635(98)00359-8
   HAUBNER R, 1993, DIAM RELAT MATER, V2, P1505, DOI 10.1016/0925-9635(93)90021-S
   Inspektor A, 1997, INT J REFRACT MET H, V15, P49, DOI 10.1016/S0263-4368(96)00045-5
   INSPEKTOR A, 1994, SURF COAT TECH, V68, P359, DOI 10.1016/0257-8972(94)90186-4
   ITOH H, 1991, J MATER SCI, V26, P3763, DOI 10.1007/BF01184968
   Kamiya S, 2000, DIAM RELAT MATER, V9, P191, DOI 10.1016/S0925-9635(00)00229-6
   KLASS W, 1997, DIAM RELAT MATER, V6, P240
   LEYENDECKER T, 1991, SURF COAT TECH, V48, P253, DOI 10.1016/0257-8972(91)90013-M
   Lin JC, 1996, HYDROMETALLURGY, V43, P47, DOI 10.1016/0304-386X(96)00023-0
   Lopez JM, 1998, J MATER RES, V13, P2841, DOI 10.1557/JMR.1998.0388
   Lux B, 1996, CERAM INT, V22, P347, DOI 10.1016/0272-8842(95)00109-3
   LUX B, 1991, NATO ADV SCI I B-PHY, V266, P579
   MAY PW, 1994, DIAM RELAT MATER, V3, P810, DOI 10.1016/0925-9635(94)90274-7
   MURAKAWA M, 1991, SURF COAT TECH, V49, P359, DOI 10.1016/0257-8972(91)90083-9
   OAKES J, 1991, SURF COAT TECH, V47, P600, DOI 10.1016/0257-8972(91)90330-Y
   PINES MS, 1979, J AM DENT ASSOC, V99, P831, DOI 10.14219/jada.archive.1979.0403
   Polini R, 2003, SURF COAT TECH, V166, P127, DOI 10.1016/S0257-8972(02)00775-2
   Polo MC, 1997, DIAM RELAT MATER, V6, P579, DOI 10.1016/S0925-9635(96)00643-7
   REINECK I, 1993, SURF COAT TECH, V57, P47, DOI 10.1016/0257-8972(93)90335-L
   SAIJO K, 1990, SURF COAT TECH, V43-4, P30, DOI 10.1016/0257-8972(90)90057-J
   Sein H, 2003, SURF COAT TECH, V163, P196, DOI 10.1016/S0257-8972(02)00618-7
   Sein H, 2002, DIAM RELAT MATER, V11, P731, DOI 10.1016/S0925-9635(01)00579-9
   Trava-Airoldi VJ, 1998, SURF COAT TECH, V108, P437, DOI 10.1016/S0257-8972(98)00590-8
   WANG DY, 1993, DIAM RELAT MATER, V2, P304, DOI 10.1016/0925-9635(93)90072-A
   Weast R. C., 1989, HDB CHEM PHYS
   YASKIKI T, 1992, SURF COAT TECH, V52, P81
   ZHU W, 1995, J MATER RES, V10, P1455, DOI 10.1557/JMR.1995.1455
NR 34
TC 9
Z9 9
U1 0
U2 7
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 1059-9495
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD AUG
PY 2004
VL 13
IS 4
BP 421
EP 430
DI 10.1361/10599490419973
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 846YE
UT WOS:000223354700007
DA 2018-10-20
ER

PT J
AU De Bartolo, L
   Gugliuzza, A
   Morelli, S
   Cirillo, B
   Gordano, A
   Drioli, E
AF De Bartolo, L
   Gugliuzza, A
   Morelli, S
   Cirillo, B
   Gordano, A
   Drioli, E
TI Novel PEEK-WC membranes with low plasma protein affinity related to
   surface free energy parameters
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PLATELET-ADHESION; POLYMER SURFACES; HEPATOCYTES; ADSORPTION; ORGANS
AB There has been growing interest in innovative materials with specific physico-chemical properties that provide an improved blood/cell compatibility.
   In this paper we evaluated the performance of new membranes prepared from a modified polyetheretherketone (PEEK-WC) contacting human plasma proteins. These membranes were prepared by using the phase inversion technique. Membrane wettability and affinity to proteins were evaluated by means of contact angle experiments, roughness measurements, and quantitative UV analysis. The energy parameters of membrane surfaces were determined according to Good, van Oss and Chaudhury's theory.
   The extent of human albumin, fibrinogen and immunoglobulin G adsorption was related to quantitative expressions of the membrane surface hydrophilicity: the base parameter of surface free energy and the free energy of interfacial interaction. The performance of PEEK-WC membranes was compared to that of commercial membranes, which conventionally are used in biomedical applications. The experimental results showed a reduction of protein adsorption on PEEK-WC membranes with respect to other commercial membranes.
   The low protein affinity of PEEK-WC membranes is due to the intrinsic physico-chemical characteristics of the polymeric material which makes these membranes interesting for potential use in biomedical applications. (C) 2004 Kluwer Academic Publishers.
C1 Univ Calabria, CNR, ITM, I-87030 Arcavacata Di Rende, CS, Italy.
RP De Bartolo, L (reprint author), Univ Calabria, CNR, ITM, Via P Bucci Cubo 17-C, I-87030 Arcavacata Di Rende, CS, Italy.
EM l.debartolo@itm.cnr.it
RI De Bartolo, Loredana/E-5074-2015
OI De Bartolo, Loredana/0000-0003-3774-9114; Drioli,
   Enrico/0000-0003-1092-5368; MORELLI, SABRINA/0000-0001-7551-8427;
   Gugliuzza, Annarosa/0000-0002-2656-8695
CR *ASME, 1985, B461 ANSIASME
   Bismarck A, 1999, J COLLOID INTERF SCI, V217, P377, DOI 10.1006/jcis.1999.6345
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   De Bartolo L, 1999, J BIOMAT SCI-POLYM E, V10, P641, DOI 10.1163/156856299X00856
   De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   de Bartolo L, 1998, BIOM HLTH R, V16, P167
   De Bartolo L, 2001, J MATER SCI-MATER M, V12, P959, DOI 10.1023/A:1012857031409
   DEBARTOLO L, 2004, IN PRESS MAT SCI FOR
   DEBARTOLO L, 2003, MATER RES SOC S P, V752, DOI UNSP AA14.2.1
   Good R. J., 1992, MODERN APPROACHES WE
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Gugliuzza A, 2002, EUR POLYM J, V38, P235, DOI 10.1016/S0014-3057(01)00186-0
   JANSEN B, 1984, J BIOMED MATER RES, V18, P655, DOI 10.1002/jbm.820180607
   KIMMERLE K, 1990, DESALINATION, V79, P283, DOI 10.1016/0011-9164(90)85012-Y
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   MATSUDA T, 1994, BIOMATERIALS, V15, P417, DOI 10.1016/0142-9612(94)90219-4
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   Taniguchi M, 2001, LANGMUIR, V17, P4312, DOI 10.1021/la001791l
   VANOSS CJ, 1986, J PROTEIN CHEM, V5, P385, DOI 10.1007/BF01025572
   VANOSS CJ, 1994, INTERFACIAL FORCES A
NR 22
TC 18
Z9 19
U1 2
U2 14
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2004
VL 15
IS 8
BP 877
EP 883
DI 10.1023/B:JMSM.0000036275.60508.50
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 841YB
UT WOS:000222967400006
PM 15477739
DA 2018-10-20
ER

PT J
AU Gordin, DM
   Gloriant, T
   Texier, G
   Thibon, I
   Ansel, D
   Duval, JL
   Nagel, MD
AF Gordin, DM
   Gloriant, T
   Texier, G
   Thibon, I
   Ansel, D
   Duval, JL
   Nagel, MD
TI Development of a beta-type Ti-12Mo-5Ta alloy for biomedical
   applications: cytocompatibility and metallurgical aspects
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TITANIUM-ALLOYS; SURFACE-ROUGHNESS; IMPLANT MATERIALS; MEDICAL IMPLANTS;
   CELL VIABILITY; TI; BEHAVIOR; MICROSTRUCTURE; TOPOGRAPHY; STRENGTH
AB Ti-based biocompatible alloys are especially used for replacing failed hard tissue. Some of the most actively investigated materials for medical implants are the beta-Ti alloys, as they have a low elastic modulus (to inhibit bone resorption). They are alloyed with elements such as Nb, Ta, Zr, Mo, and Fe. We have prepared a new beta-Ti alloy that combines Ti with the non-toxic elements Ta and Mo using a vacuum arc-melting furnace and then annealed at 950 degreesC for one hour. The alloy was finally quenched in water at room temperature. The Ti-12Mo-5Ta alloy was characterised by X-ray diffraction, optical microscopy, SEM and EDS and found to have a body-centred-cubic structure (beta-type). It had a lower Young's modulus (about 74 GPa) than the classical alpha/beta Ti-6Al-4V alloy (120 GPa), while its Vickers hardness remained very high (about 303 HV). This makes it a good compromise for a use as a bone substitute. The cytocompatibility of samples of Ti-12Mo-5Ta and Ti-6Al-4V titanium alloys with various surface roughnesses was assessed in vitro using organotypic cultures of bone tissue and quantitative analyses of cell migration, proliferation and adhesion. Mechanically polished surfaces were prepared to produce unorientated residual polished grooves and cells grew to a particularly high density on the smoother Ti-12Mo-5Ta surface tested. (C) 2004 Kluwer Academic Publishers.
C1 Inst Natl Sci Appl Rennes, Grp Rech Chim Met, GRCM EA 2620, CS 14315, F-35043 Rennes, France.
   Univ Technol Compiegne, UMR CNRS Genie Biomed 6600, F-60205 Compiegne, France.
RP Gloriant, T (reprint author), Inst Natl Sci Appl Rennes, Grp Rech Chim Met, GRCM EA 2620, CS 14315, F-35043 Rennes, France.
EM Thierry.Gloriant@insa-rennes.fr
OI Gordin, Doina Margareta/0000-0003-2200-9930
CR Ankem S, 1999, MAT SCI ENG A-STRUCT, V263, P127, DOI 10.1016/S0921-5093(98)01170-8
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Bania P. J., 1993, TITANIUM ALLOYS 1990, P3
   Boyan B. D., 2001, TITANIUM MED, P561
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BUSHER D, 1991, J BIOMED MATER RES, V25, P889
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Davidson J. A., 1986, P IMPL MAN MAT TECHN, P122
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Ikeda M, 2002, METALL MATER TRANS A, V33, P487, DOI 10.1007/s11661-002-0110-9
   Jaeger N.A.F., 2001, TITANIUM MED, P343
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lausmaa J., 2001, TITANIUM MED, P231
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LUTTEROTTI L, 1992, J APPL CRYSTALLOGR, V25, P459, DOI 10.1107/S0021889892001122
   Michael J., 2000, ELECT BACKSCATTER DI, P75
   NIIOMI M, 1998, MAT SCI ENG A-STRUCT, V243, P231
   NIIOMI M, 2002, METALL MATER TRANS A, V33, P477
   OKASAKI Y, 2002, MAT T, V43, P3134
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1998, MATER T JIM, V39, P1053, DOI 10.2320/matertrans1989.39.1053
   Okazaki Y, 1998, MATER T JIM, V39, P1070, DOI 10.2320/matertrans1989.39.1070
   SCHUTZ RW, 1993, TITANIUM ALLOYS 1990, P75
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SIGOT MF, 1992, SCI TECH TECHNOL, V20, P14
   SIGOTLUIZARD MF, 1986, IN VITRO CELL DEV B, V22, P234
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Sittig C, 1999, J MATER SCI-MATER M, V10, P191, DOI 10.1023/A:1008997726370
   Song Y, 2002, MATER TRANS, V43, P3028, DOI 10.2320/matertrans.43.3028
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Steinemann SG, 1986, BIOL BIOMECHANICAL P, P409
   WILKE HJ, 1990, ADV BIOMAT, V9, P309
NR 38
TC 49
Z9 51
U1 1
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2004
VL 15
IS 8
BP 885
EP 891
DI 10.1023/B:JMSM.0000036276.32211.31
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 841YB
UT WOS:000222967400007
PM 15477740
DA 2018-10-20
ER

PT J
AU Choudhury, NR
AF Choudhury, NR
TI Template mediated hybrid from dendrimer
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 12th International Workshop on Sol-Gel-Science and Technology (Sol-Gel
   2003)
CY AUG 24-29, 2003
CL Sydney, AUSTRALIA
DE hybrid; template; nanocomposite; dendrimer
ID NANOCOMPOSITES
AB Novel dendrimer-titania hybrids were prepared in this work from hydroxy and amine terminated polyamidoamine dendrimer (PAMAM generation 4) and titanium alkoxide by an in-situ sol-gel process in presence of a ligand. Dendritic polymers are chosen because of their unique architectural features. Such dendrimer nanocomposite (DNC) can then be used for optical, catalytic, biomedical applications. The hybrid material formed in situ is found to be transparent, brittle and yellow in colour. The hybrids show higher thermal stability than their organic precursors. This is due to enhanced interaction of the inorganic material with the dendrimer through hydrogen bonding as evidenced by PA-FTIR. XPS studies show predominantly the existence of tetravalent titanium due to titania formation.
C1 Univ S Australia, Ian Wark Res Inst, ARC Special Res Ctr Particles & Mat Interfaces, Mawson Lakes, SA 5095, Australia.
RP Choudhury, NR (reprint author), Univ S Australia, Ian Wark Res Inst, ARC Special Res Ctr Particles & Mat Interfaces, Mawson Lakes, SA 5095, Australia.
EM namita.choudhury@unisa.edu.au
RI Roy Choudhury, Namita/F-8278-2011
CR Balogh L, 1998, J AM CHEM SOC, V120, P7355, DOI 10.1021/ja980861w
   Balogh L, 2001, NANO LETT, V1, P18, DOI 10.1021/nl005502p
   Balogh L, 1999, J NANOPART RES, V1, P353, DOI 10.1023/A:1010060404024
   CHUJO Y, 1996, ORGANIC INORGANIC PO, V6, P4793
   Gao Y, 2002, CHEM MATER, V14, P4522, DOI 10.1021/cm0211249
   Gao Y, 2001, CHEM MATER, V13, P3644, DOI 10.1021/cm010179s
   Gong AJ, 2000, J APPL POLYM SCI, V78, P2186, DOI 10.1002/1097-4628(20001213)78:12<2186::AID-APP150>3.0.CO;2-#
   Hu Q, 1999, POLYMER, V40, P4833, DOI 10.1016/S0032-3861(98)00264-X
   Ribot F, 1997, J SOL-GEL SCI TECHN, V8, P529, DOI 10.1023/A:1018374932557
   SANCHEZ C, 1990, INORGANIC ORGANOMETA, P267
   Tamaki R, 1998, APPL ORGANOMET CHEM, V12, P755, DOI 10.1002/(SICI)1099-0739(199810/11)12:10/11<755::AID-AOC783>3.0.CO;2-A
   Zhao MQ, 1999, CHEM MATER, V11, P3379, DOI 10.1021/cm990435p
NR 12
TC 8
Z9 8
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD AUG-SEP
PY 2004
VL 31
IS 1-3
BP 37
EP 45
DI 10.1023/B:JSST.0000047957.82633.a1
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 870FH
UT WOS:000225042500006
DA 2018-10-20
ER

PT J
AU Kim, JG
   Sim, SJ
   Kim, JH
   Kim, SH
   Kim, YH
AF Kim, JG
   Sim, SJ
   Kim, JH
   Kim, SH
   Kim, YH
TI Synthesis and polymerization of methacryloyl-PEG-Sulfonic acid as a
   functional macromer for biocompatible polymeric surfaces
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE biomaterials; blood-compatibiltity; surface modification; PEG macromer;
   methacryloyl group
ID POLYURETHANE; COPOLYMERS
AB Poly(ethylene glycol)s (PEGs) are unique in their material properties, such as biocompatibility, non-toxicity, and water-solublizing ability, which are extremely useful for a variety of biomedical applications. In addition, a variety of functional PEGs with specific functionality at one or both chain ends have been synthesized for many specialized applications. Surface modifications using PEG have been demonstrated to decrease protein adsorption and platelet or cell adhesion on biomaterials. Furthermore, PEGs having anionic sulfonate terminal units have been proven to enhance the blood compatibility of materials, which has been demonstrated by the negative cilia concept. The preparation of telechelic PEGs having a sulfonic acid group at one end and a polymerizable methacryloyl group at the other is an interesting undertaking for providing macromers that can be used in various vinyl copolymerization and gel systems. In this paper, preliminary results on the synthesis and polymerization behavior of a novel PEG macromer is described with the aim of identifying a biocompatible material for applications in various blood-contacting devices.
C1 Sungkyunkwan Univ, Dept Chem Engn, Suwon 440746, South Korea.
   Korea Adv Inst Sci & Technol, Biomat Res Ctr, Seoul 130650, South Korea.
RP Kim, JH (reprint author), Sungkyunkwan Univ, Dept Chem Engn, Suwon 440746, South Korea.
EM kimjh@skku.edu
RI Sim, Sang Jun/F-6697-2013
OI Sim, Sang Jun/0000-0003-1045-0286
CR Guo SR, 2001, POLYMER, V42, P1017, DOI 10.1016/S0032-3861(00)00472-9
   HAN DK, 1998, J BIOMAT SCI-POLYM E, V9, P164
   Han DK, 2003, J BIOMED MATER RES, V24, P2213
   Inoue H, 1997, J BIOMED MATER RES, V35, P255
   Ishihara K, 2000, J BIOMAT SCI-POLYM E, V11, P1183, DOI 10.1163/156856200744264
   Klement P, 2002, BIOMATERIALS, V23, P527, DOI 10.1016/S0142-9612(01)00135-1
   Lee SH, 2002, MACROMOL RES, V10, P85, DOI 10.1007/BF03218295
   Maiti S, 2001, J COLLOID INTERF SCI, V240, P630, DOI 10.1006/jcis.2001.7683
   SRINIVASAN S, 1971, BIOMEDICAL POLYM, P51
   WISE DL, 1995, ENCY HDB BIOMATERI B, V2, P1071
NR 10
TC 7
Z9 7
U1 2
U2 8
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD AUG
PY 2004
VL 12
IS 4
BP 379
EP 383
DI 10.1007/BF03218415
PG 5
WC Polymer Science
SC Polymer Science
GA 852FC
UT WOS:000223739600008
DA 2018-10-20
ER

PT J
AU Goller, G
   Oktar, FN
   Ozyegin, LS
   Kayali, ES
   Demirkesen, E
AF Goller, G
   Oktar, FN
   Ozyegin, LS
   Kayali, ES
   Demirkesen, E
TI Plasma-sprayed human bone-derived hydroxyapatite coatings: effective and
   reliable
SO MATERIALS LETTERS
LA English
DT Article
DE human-derived hydroxyapatite; calcination; plasma spraying; bond
   coating; bone grafts; transmitting infectious diseases; economic
ID MECHANICAL-PROPERTIES; RECONSTRUCTION; COMPOSITES; DENTIN
AB Human bone-derived hydroxyapatite (HHA) was used as plasma-spraying powder in this study. The starting powder was derived with the calcination method as described in recent literature. There have been very few researchers who were seriously interested in calcined HHA as a grafting material. Instead, demineralized HHA (from other humans) was usually preferred among surgeons. This brings some possible danger of transmission of infectious diseases like hepatitis B and C, human immunodeficiency virus (HIV), and almost incurable prion diseases like Creutzfeldt-Jakob disease (CJD) and bovine spongiform encephalopathy (BSE). Due to very high temperature application (850 degreesC), calcined HA seems to be safe and promising as an alternative product to other HA materials in the biomaterial market. As it is known, HA is very weak at load-bearing applications. To overcome this weakness, it is suggested to use it as a coating on metallic substrates. The HA plasma spraying process is a well-known process for such durable coatings. In addition, in order to gain higher strength, it is recommended to use a very thin bond-coating layer to prevent the mismatch of the thermal coefficients between metal and ceramic. Bond coatings are used very widely in industrial applications. Some biomedical bond-coating research has been conducted, but the reports are not yet commercialized. In this study, tensile strength, SEM and X-ray diffraction studies were performed. Bonding strength was found to be 6.91 MPa for nonbond-coated and 13.15 MPa for bond-coated HHA coatings. These results indicate that the application of bond coating with HHA had strengthened the structure of this material. The X-ray diffraction analysis showed a relatively high crystalline phase. SEM pictures indicate very good adhesion of the bond coating on the metal and on the main coating. The production of HHA with the calcination method is economic, and the resulting material (in combination with plasma spraying) can be used for bone grafting purposes. (C) 2004 Elsevier B.V. All rights reserved.
C1 Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
   Marmara Univ, Fac Engn, Dept Ind Engn, Istanbul, Turkey.
   Marmara Univ, Sch Hlth Related Profess, Dept Dent Technol, Istanbul, Turkey.
RP Goller, G (reprint author), Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
EM goller@itu.edu.tr; foktar@gmx.net; ozyeginsevgi@yahoo.com;
   kayali@itu.edu.tr; demirkesen@itu.edu.tr
OI Goller, Gultekin/0000-0003-4680-3936
CR BERNECKER F, 1993, HNO, V41, P250
   BLAKESLEE S, 2000, NY TIMES        0523
   CANN AJ, 2001, PRINCIPLES MOL VIROL, P258
   Celik E, 1997, SURF COAT TECH, V97, P361, DOI 10.1016/S0257-8972(97)00383-6
   Clemens JAM, 1997, J BIOMED MATER RES, V36, P55, DOI 10.1002/(SICI)1097-4636(199707)36:1<55::AID-JBM7>3.0.CO;2-K
   Entezarian M, 1996, JOM-J MIN MET MAT S, V48, P53, DOI 10.1007/BF03222969
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Goller G, 2002, MATER LETT, V56, P142
   GREEN E, 2000, LA TIMES        0521
   HEDGES SJ, 2000, CHICAGO TRIBUNE 0522
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   HUTTENBRINK KB, 1993, HNO, V41, P440
   JOSHI SV, 1993, J MATER SCI-MATER M, V4, P251, DOI 10.1007/BF00122276
   LIN JHC, 1995, MATER CHEM PHYS, V41, P282
   Oktar FN, 2003, KEY ENG MAT, V240-2, P315, DOI 10.4028/www.scientific.net/KEM.240-242.315
   Oktar FN, 2002, CERAM INT, V28, P617, DOI 10.1016/S0272-8842(02)00017-2
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   OKTAR FN, 1999, THESIS BOGAZICI U IS, P26
   STEELMAN VM, 1999, AORN J, P1
   UZE M, 1992, P INT ENG DAYS BOG U, P239
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
NR 21
TC 48
Z9 49
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2004
VL 58
IS 21
BP 2599
EP 2604
DI 10.1016/j.matlet.2004.03.032
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 842PF
UT WOS:000223015700009
DA 2018-10-20
ER

PT J
AU Ozyegin, LS
   Oktar, FN
   Goller, G
   Kayali, ES
   Yazici, T
AF Ozyegin, LS
   Oktar, FN
   Goller, G
   Kayali, ES
   Yazici, T
TI Plasma-sprayed bovine hydroxyapatite coatings
SO MATERIALS LETTERS
LA English
DT Article
DE bovine derived hydroxyapatite; plasma spraying; bond-coating; economic
ID REINFORCED HYDROXYAPATITE; TITANIUM
AB With the increase in the life expectancy of humans, the maintenance of bone in our bodies has become crucial. Allografts extracted from different human and bovine sources bring the problem of potential disease transmittal, particularly the transmittal of disease that are difficult to detect. Autogen grafts bring another problem in surgery because the bone harvesting procedure creates cause for an additional surgery. In this study, the hydroxyapatite (HA) material was produced from bovine bones with the calcination method prohibits the transmission of various disease like mad cow disease (bovine spongiform encephalopathy (BSE)). In this study, the calcinated powder was used as plasma feeding powder for the plasma spraying process in biomedical applications. In industrial applications, the use of bond-coating prevents thermal coefficient mismatching and usually results in a stronger material. However, it was seen than bovine hydroxyapatite (BHA) was so strong that it does not need any bond-coating application. Nonetheless, bond-coating can be used to prevent the formation of micro-cracks. BHA material produced with the calcination method can be a very economic biomaterial for plasma spraying purposes when compared to other commercially available biomaterials. (C) 2004 Elsevier B.V. All rights reserved.
C1 Marmara Univ, Fac Engn, Dept Ind Engn, Istanbul, Turkey.
   Marmara Univ, Sch Hlth Related Profess, Dept Dent Technol, Istanbul, Turkey.
   Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Fac Engn, Dept Ind Engn, Istanbul, Turkey.
EM ozyeginsevgi@yahoo.com; foktar@gmx.net; goller@itu.edu.tr;
   kayali@itu.edu.tr; tokayyazici@hotmail.com
OI Goller, Gultekin/0000-0003-4680-3936
CR Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Entezarian M, 1996, JOM-J MIN MET MAT S, V48, P53, DOI 10.1007/BF03222969
   Goldberg V M, 1993, Semin Arthroplasty, V4, P58
   Goller G, 2003, KEY ENG MAT, V240-2, P939
   Goller G, 2003, KEY ENG MAT, V240-2, P619
   Goller G, 2003, KEY ENG MAT, V240-2, P283
   HONG L, 1992, Journal of Biomedical Materials Research, V26, P7, DOI 10.1002/jbm.820260103
   Oktar FN, 2003, KEY ENG MAT, V240-2, P315, DOI 10.4028/www.scientific.net/KEM.240-242.315
   Oktar FN, 2003, KEY ENG MAT, V240-2, P327, DOI 10.4028/www.scientific.net/KEM.240-242.327
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   RITTER SK, CHEM ENG NEWS   0825
   TOMIN E, 2002, ARTHROPLAS ARTHROS S, V13, P114
   UZEL M, 1992, P INT ENG DAYS BOG U, P239
   Valerio P, 2004, KEY ENG MAT, V254-2, P837, DOI 10.4028/www.scientific.net/KEM.254-256.837
NR 14
TC 62
Z9 62
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2004
VL 58
IS 21
BP 2605
EP 2609
DI 10.1016/j.matlet.2004.03.033
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 842PF
UT WOS:000223015700010
DA 2018-10-20
ER

PT J
AU Pothmann, D
   Ulusans, S
   Prols, F
   Klisch, J
AF Pothmann, D
   Ulusans, S
   Prols, F
   Klisch, J
TI Liquid 2-P-HEMA for endovascular tumor therapy: in vivo feasibility
   study
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE hilar malignancy; liver tumors; mesenchymal hamartoma
ID POLY(2-HYDROXYETHYL METHACRYLATE) PARTICLES; RADIOPAQUE POLYMERIC
   BIOMATERIALS; ETHYLENE-VINYL ALCOHOL; ARTERIOVENOUS-MALFORMATIONS;
   POLYVINYL-ALCOHOL; BIOMEDICAL APPLICATIONS; ARTERIAL EMBOLIZATION;
   ETHANOL EMBOLIZATION; CELLULOSE-ACETATE; FUNCTIONAL-GROUPS
AB Background: To evaluate a new liquid polymer developed for selective arterial tumor embolization.
   Material/Methods: In six rabbits we embolized the renal artery with pure 2-P-HEMA. Three rabbits were killed immediately after embolization, one after 12 h, and two animals underwent follow-up angiography after two weeks. In a second part of the study we embolized the left renal artery in three mini-swine with pure 2-P-HEMA. The kidneys were examined post mortem by soft-tissue radiography and kidney-tissue section microscopy.
   Results: Complete occlusion of small distal arteries, most of the arterioles together with the precapillary vascular bed, was achieved in all animals. The speed of injection influenced the grade of distal occlusion; repeated injections through the same microcatheter were possible. The relatively fast injection speed of 0.3 ml/min led to an optimal distribution of the liquid embolic. There was no reperfusion in the two follow-up angiographies two weeks after embolization. Histopathologically, there was no angionecrosis and subintimal bleeding. No marked inflammatory reaction in the vessel wall or perivascular tissue was observed in the embolized arteries.
   Conclusions: This study suggests that liquid 2-P-HEMA may be feasible for the treatment of tumors.
C1 Univ Hosp Freiburg, Neuroctr,Res Grp Intervent Neuroradiol, Neuroradiol Sect, Dept Neuroradiol, D-79106 Freiburg, Germany.
   Univ Freiburg, Dept Cardiol & Angiol, Res Grp Expt & Clin Arteriogenesis, Freiburg, Germany.
   Univ Freiburg, Inst Anat 2, Freiburg, Germany.
RP Pothmann, D (reprint author), Univ Hosp Freiburg, Neuroctr,Res Grp Intervent Neuroradiol, Neuroradiol Sect, Dept Neuroradiol, Breisacher Str 64, D-79106 Freiburg, Germany.
EM pothmann@nz11.ukl.uni-freiburg.de
CR APSIMON HT, 1984, RADIOLOGY, V151, P59, DOI 10.1148/radiology.151.1.6701337
   BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   BERTHOLD F, 1986, KLIN PADIATR, V198, P257, DOI 10.1055/s-2008-1026886
   Blanco MD, 2000, J PHARM PHARMACOL, V52, P1319, DOI 10.1211/0022357001777469
   Choe DH, 1997, INVEST RADIOL, V32, P260, DOI 10.1097/00004424-199705000-00002
   CIVERCHIAPEREZ L, 1980, P NATL ACAD SCI-BIOL, V77, P2064, DOI 10.1073/pnas.77.4.2064
   CRAWFORD GJ, 1993, CORNEA, V12, P348, DOI 10.1097/00003226-199307000-00012
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   EDLING NPG, 1964, ACTA RADIOL DIAGN, V2, P316, DOI 10.1177/028418516400200406
   ELLMAN BA, 1980, INVEST RADIOL, V15, P318, DOI 10.1097/00004424-198007000-00008
   GERMANO IM, 1992, J NEUROSURG, V76, P607, DOI 10.3171/jns.1992.76.4.0607
   HALPERN BD, 1987, ENCY POLYM SCI ENG, V9, P486
   HOCHMUTH A, IN PRESS ACTA OTOLAR
   Horak D, 1997, BIOMATERIALS, V18, P1355, DOI 10.1016/S0142-9612(97)00059-8
   HORAK D, 1986, BIOMATERIALS, V7, P188, DOI 10.1016/0142-9612(86)90100-6
   Horak D, 2000, J BIOMED MATER RES, V51, P184, DOI 10.1002/(SICI)1097-4636(200008)51:2<184::AID-JBM6>3.0.CO;2-O
   Horak D, 1991, Polim Med, V21, P31
   HORAK D, 1992, BIOMATERIALS, V13, P521, DOI 10.1016/0142-9612(92)90103-U
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   HORAK D, 1992, BIOMATERIALS, V6, P361
   HORAK D, 1996, J BIOMED MATER RES, V33, P1
   HORTON JA, 1983, AM J NEURORADIOL, V4, P143
   Janik V, 1990, Cesk Radiol, V44, P44
   JAYAKRISHNAN A, 1990, J BIOMED MATER RES, V24, P993, DOI 10.1002/jbm.820240803
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   Kaminou T, 1996, EUR RADIOL, V6, P502
   Kazekawa K, 1997, J BIOMED MATER RES, V38, P79, DOI 10.1002/(SICI)1097-4636(199722)38:2<79::AID-JBM1>3.0.CO;2-D
   Kerber CW, 2000, NEUROSURG CLIN N AM, V11, P85, DOI 10.1016/S1042-3680(18)30148-7
   KERBER CW, 2000, J NEUROSURG, V96, P196
   Kiremitci M, 1993, J Biomater Appl, V7, P250, DOI 10.1177/088532829300700304
   Klisch J, 2002, NEURORADIOLOGY, V44, P503, DOI 10.1007/s00234-001-0761-z
   Klisch J, 2002, AM J NEURORADIOL, V23, P422
   Komemushi A, 2002, ACTA RADIOL, V43, P186, DOI 10.1034/j.1600-0455.2002.430217.x
   KOMEMUSHI A, 2002, ACTA RADIOL, V43, P188
   KONCHANIN RP, 1987, J UROLOGY, V137, P199, DOI 10.1016/S0022-5347(17)43949-8
   KOOLE LH, 1996, Patent No. 9605872
   Kruft MAB, 1997, BIOMATERIALS, V18, P31, DOI 10.1016/S0142-9612(96)00085-3
   Kruft MAB, 1996, BIOMATERIALS, V17, P1803, DOI 10.1016/0142-9612(95)00339-8
   KRUFT MAB, 1994, J BIOMED MATER RES, V28, P1259, DOI 10.1002/jbm.820281103
   KUHNE D, 1982, NEURORADIOLOGY, V23, P253
   LATSHAW RF, 1985, CARDIOVASC INTER RAD, V8, P24, DOI 10.1007/BF02552636
   Manke C, 2001, AM J NEURORADIOL, V22, P997
   Mason KP, 2000, RADIOLOGY, V217, P127, DOI 10.1148/radiology.217.1.r00se30127
   MONTAGUTI P, 1994, ARZNEIMITTEL-FORSCH, V44-1, P566
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Norbash AM, 2001, AM J NEURORADIOL, V22, P334
   Oowaki H, 2000, BIOMATERIALS, V21, P1039, DOI 10.1016/S0142-9612(99)00278-1
   PARK JH, 1986, INVEST RADIOL, V21, P577, DOI 10.1097/00004424-198607000-00011
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   PEREGRIN JH, 1984, CARDIOVASC INTER RAD, V7, P97, DOI 10.1007/BF02552689
   Phatouros CC, 1999, AM J NEURORADIOL, V20, P1329
   PURDY PD, 1992, J NEUROSURG, V77, P217, DOI 10.3171/jns.1992.77.2.0217
   QUISLING RG, 1984, AM J NEURORADIOL, V5, P101
   RADHAKRISHNAN VV, 1992, ACTA NEUROCHIR, V117, P30, DOI 10.1007/BF01400631
   Rassweiler J, 1980, Rofo, V133, P644, DOI 10.1055/s-2008-1056808
   RICHTER G, 1981, FORTSCHR RONTG NEUEN, V135, P85, DOI 10.1055/s-2008-1056836
   RICHTER G, 1984, INVEST RADIOL, V19, P36, DOI 10.1097/00004424-198401000-00009
   SADATO A, 1994, NEURORADIOLOGY, V36, P634, DOI 10.1007/BF00600429
   Sampei K, 1996, NEURORADIOLOGY, V38, P291
   SCHUMACHER M, 2002, KLIN NEURORADIOLGIE, V4, P160
   SETTON A, 2001, P AM SOC NEUR 39 ANN, P288
   SHIGEMITSU T, 1991, JPN J OPHTHALMOL, V35, P354
   Siskin GP, 2000, AM J ROENTGENOL, V175, P767, DOI 10.2214/ajr.175.3.1750767
   SKUBA N D, 1989, Byulleten' Eksperimental'noi Biologii i Meditsiny, V107, P379
   SMETANA K, 1991, J BIOACT COMPAT POL, V6, P377
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   Suh DC, 2000, AM J NEURORADIOL, V21, P1277
   VETVICKA V, 1983, FOLIA BIOL-PRAGUE, V29, P424
   WHITE RI, 1977, RADIOLOGY, V125, P677, DOI 10.1148/125.3.677
   Wright KC, 1999, J VASC INTERV RADIOL, V10, P1207, DOI 10.1016/S1051-0443(99)70221-6
   YAMAMOTO M, 2001, J BIOMAT SCI-POLYM E, P77
NR 73
TC 0
Z9 5
U1 0
U2 2
PU INT SCIENTIFIC LITERATURE, INC
PI ALBERTSON
PA 1125 WILLIS AVE, ALBERTSON, NY 11507 USA
SN 1234-1010
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD AUG
PY 2004
VL 10
IS 8
BP BR286
EP BR293
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 867HQ
UT WOS:000224833700008
PM 15277990
DA 2018-10-20
ER

PT J
AU Bermudez, PM
   Polini, NN
   Casanave, EB
AF Bermudez, PM
   Polini, NN
   Casanave, EB
TI A study of platelets in the armadillo Chaetophractus villosus
   (Xenarthra, Dasypodidae)
SO PLATELETS
LA English
DT Article
ID CONNECTED CANALICULAR SYSTEM; COMPARATIVE HEMATOLOGY; MEGAKARYOCYTE
   GROWTH; BLOOD-PLATELETS; AGGREGATION; THROMBOCYTES; COAGULATION;
   HEMOSTASIS; AGONISTS; ULTRASTRUCTURE
AB Nothing is known about haemostasis in Xenarthra, a widely distributed Order of American mammalians. Chaetophractus villosus, a member of the Dasypodidae family of this group, which is easily adapted to captivity, is of growing interest for biomedical research. In this work, we studied platelet number, MPV, ultrastructure of the platelets by SEM and TEM, and aggregation responses to ADP and ristocetin in this species. Blood samples were obtained by cardiac puncture in 20 anaesthetised animals. Platelet count and MPV were evaluated at the beginning and at the end of a 3-year experimental period, to detect possible variations related to time of captivity. SEM and TEM were done by routine methods adapted to the material, and aggregation response to ADP and ristocetin were evaluated by the Born method. The parameters studied did not show any sex-related differences, nor did the platelet count change during captivity. Nevertheless, MPV decreased during this period. Platelets were ultrastructurally similar to those of other mammals and human beings and responded to proven agonists. Data provided in this study will contribute to the understanding of the haemostatic process in this species.
C1 UNS, Dpt Biol Bioquim & Farm, Lab Fisiol Anim, Catedra Fisiol Anim, RA-8000 Bahia Blanca, Argentina.
   UNS, DBByF, Catedra Anal Clin 2, Bahia Blanca, Buenos Aires, Argentina.
   Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.
RP Casanave, EB (reprint author), UNS, Dpt Biol Bioquim & Farm, Lab Fisiol Anim, Catedra Fisiol Anim, San Juan 670,B 8000 FWB, RA-8000 Bahia Blanca, Argentina.
EM casanave@criba.edu.ar
OI Casanave, Emma Beatriz/0000-0003-3482-8175
CR Bancroft AJ, 2000, PLATELETS, V11, P379
   BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
   BOUDREAUX MK, 1988, LAB ANIM SCI, V38, P448
   CHEWYK LA, 1998, J ZOO WILDLIFE MED, V29, P177
   CHUVIROV GN, 1978, EXP PATHOL-JENA, V15, P319, DOI 10.1016/S0014-4908(78)80038-6
   DAIMON T, 1979, CELL TISSUE RES, V201, P431
   DAIMON T, 1985, J ANAT, V141, P193
   DAIMON T, 1987, J ANAT, V153, P185
   DAWSONSAUNDERS B, 1997, MANUAL MODERNO BIOES, P34
   DOTSON RL, 1987, COMP BIOCHEM PHYS A, V88, P553, DOI 10.1016/0300-9629(87)90080-6
   Du Plessis L, 1999, J MORPHOL, V239, P245
   du Plessis L, 2002, J COMP PATHOL, V127, P208, DOI 10.1053/jcpa.2002.0565
   duPlessis L, 1997, TISSUE CELL, V29, P217, DOI 10.1016/S0040-8166(97)80021-3
   DuPlessis L, 1996, J MORPHOL, V229, P309, DOI 10.1002/(SICI)1097-4687(199609)229:3<309::AID-JMOR5>3.0.CO;2-T
   EMERSON JD, 1983, UNDERSTANDING ROBUST, V3, P58
   Field CL, 2001, THROMB RES, V101, P267, DOI 10.1016/S0049-3848(00)00392-3
   George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9
   GEWIRTZ H, 1985, P SOC EXP BIOL MED, V179, P324
   GLAUERT AM, 1975, FIXATION DEHYDRATION, P207
   HAOGLIN DC, 1983, UNDERSTANDING ROBUST, P447
   Harker LA, 1996, BLOOD, V88, P511
   Harker LA, 2000, BLOOD, V95, P2514
   Hart S, 1991, Tierarztl Prax, V19, P413
   HAYAT MA, 1986, TRANSMISSION ELECT M
   Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x
   Johnson EH, 2002, ANAT HISTOL EMBRYOL, V31, P148, DOI 10.1046/j.1439-0264.2002.00379.x
   JOHNSTONE IB, 1980, CAN J PHYSIOL PHARM, V58, P1128, DOI 10.1139/y80-170
   Killingsworth C R, 1985, Vet Clin Pathol, V14, P19
   KRAFT W, 2000, DIAGNOSTICO LAB CLIN, P340
   LASSEN ED, 1995, VET CLIN N AM-EQUINE, V11, P351, DOI 10.1016/S0749-0739(17)30306-1
   LEWIS J, 1977, COMP BIOCH PHYSL
   LEWIS J C, 1986, Scanning Electron Microscopy, P199
   LEWIS JH, 1985, COMP BIOCHEM PHYS A, V82, P211, DOI 10.1016/0300-9629(85)90728-5
   LEWIS JH, 1976, AM J VET RES, V37, P601
   MATEO J, 2001, HEMATOLOGIA CLIN, P597
   MCCURMIN DM, 1993, DIAGNOSTICO FISICO P, P197
   MERCK NJ, 1991, MERCK VET MANUAL, P1832
   Meyer D, 2000, LAB MED VET INTERPRE
   MEYERS KM, 1979, AM J VET RES, V40, P260
   Norman EJ, 2001, VET CLIN PATH, V30, P137, DOI 10.1111/j.1939-165X.2001.tb00422.x
   PATTERSON WR, 1993, THROMB RES, V70, P225, DOI 10.1016/0049-3848(93)90129-C
   Pelagalli A, 2002, J COMP PATHOL, V127, P126, DOI 10.1053/jcpa.2002.0570
   PICA A, 1990, Archivio Italiano di Anatomia e di Embriologia, V95, P187
   Polini NN, 1999, COMP HAEMATOL INT, V9, P162
   POLINI NN, 2000, REV IBEROAMER THROMB, V13, P107
   QUINTANAGONZALE.S, 2002, GAC MED MEX, V138, P47
   Redford K. H., 1992, MAMMALS NEOTROPICS S, V2, P46
   Roussi J, 1996, THROMB RES, V81, P297, DOI 10.1016/0049-3848(96)00001-1
   RUIZ AOP, 1997, REV CUBANA INVEST BI, V16, P150
   Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0
   SNEDECOR GW, 1980, STAT METHODS
   Soloviev MV, 1999, J SURG RES, V82, P180, DOI 10.1006/jsre.1998.5543
   SOSLAU G, 1993, THROMB RES, V72, P127, DOI 10.1016/0049-3848(93)90214-9
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   STAHL K, 1978, HAEMOSTASIS, V7, P242
   Takahashi O, 2000, FOOD CHEM TOXICOL, V38, P203, DOI 10.1016/S0278-6915(99)00155-6
   TVEDTEN H, 1993, DIAGNOSTICO CLINICOP
   VANDERVELDEN P, 1988, BRIT J HAEMATOL, V70, P345
   WEISER MG, 1984, AM J VET RES, V45, P518
   Wetzel P. M., 1982, SPECIAL PUBL SER U P, P345
   Wetzel R.M., 1985, P5
   Wetzel R.M., 1985, P23
   WINTROBE MM, 1999, CLIN HEMATOLOGY
   WITHE JG, 1987, BLOOD, V69, P878
   Zar JH, 1999, BIOSTAT ANAL, P663
   ZUCKERFRANKLIN D, 1985, BLOOD, V65, P241
NR 66
TC 0
Z9 1
U1 0
U2 3
PU CARFAX PUBLISHING
PI BASINGSTOKE
PA RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND
SN 0953-7104
J9 PLATELETS
JI Platelets
PD AUG
PY 2004
VL 15
IS 5
BP 279
EP 285
DI 10.1080/09537100410001710272
PG 7
WC Cell Biology; Hematology
SC Cell Biology; Hematology
GA 843FM
UT WOS:000223063900001
PM 15370098
DA 2018-10-20
ER

PT J
AU Hinojosa, SZ
AF Hinojosa, SZ
TI Authorizing tradition: vectors of contention in Highland Maya midwifery
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE Guatemala; Maya midwifery; biomedical change; maternal health; child
   care
ID EXTERNAL CEPHALIC VERSION; RURAL GUATEMALA; CARE; MIDWIVES; LABOR
AB In Guatemala, midwives deliver the majority of children and play an important health care role in rural areas. Maya midwives, using time-proven methods, are the chief providers of care for mothers and infants in these areas. In recent decades, however, the medical establishment has become interested in Maya midwives, and is currently engaged in training and certifying many of them. This study examines how Guatemalan health authorities have sought to change Maya midwifery, refashioning its vocational framework and retooling it in accordance with Western medical principles. I focus on the place of obligatory formal training and the use of biomedical materials in the experience of Kaqchikel Maya midwives, and consider how the health officials employ these means to undermine the midwives' knowledge base. Encounters between midwives and formal health personnel reveal an ongoing privileging of biomedical knowledge, one that preserves asymmetrical relationships between these practitioners. This creates an environment favorable to health personnel, and helps them to extend their influence through the midwives into the community. Given this, I contend that health personnel value local Maya midwives primarily for their role in furthering the goals of biomedicine. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Texas Pan Amer, Dept Psychol & Anthropol, Edinburg, TX 78541 USA.
RP Hinojosa, SZ (reprint author), Univ Texas Pan Amer, Dept Psychol & Anthropol, Edinburg, TX 78541 USA.
EM hinojosas@panam.edu
RI Sandall, Jane/D-4146-2009
OI Sandall, Jane/0000-0003-2000-743X
CR Acevedo D, 1997, DEMOGRAPHIC DIVERSITY AND CHANGE IN THE CENTRAL AMERICAN ISTHMUS, P271
   CALI EMR, 1995, THESIS U SAN CARLOS
   Camey XC, 1996, SOC SCI MED, V43, P199, DOI 10.1016/0277-9536(95)00362-2
   *CCAM, 1990, INCAP PUBL C, V275
   Cosminksy S, 2001, Med Anthropol, V20, P345
   COSMINSKY S, 1980, SOC SCI MED-MED ANTH, V14, P267, DOI 10.1016/0160-7987(80)90052-6
   COSMINSKY S, 2001, MESOAMERICAN HEALERS, P179
   Cosminsky S., 1982, ANTHR HUMAN BIRTH, P233
   COSMINSKY S, 1977, MED ANTHROPOL, V1, P69
   DAY MM, IN PRESS MEXICAN MID
   DOUGLAS BG, 1969, THESIS STANFORD U
   FLYNN AM, 1978, BRIT MED J, V2, P591, DOI 10.1136/bmj.2.6137.591
   Glei DA, 2000, ETHNIC HEALTH, V5, P5, DOI 10.1080/13557850050007301
   Goldman N, 2003, SOC SCI MED, V56, P685, DOI 10.1016/S0277-9536(02)00065-5
   GREEN L B, 1989, Medical Anthropology Quarterly, V3, P246, DOI 10.1525/maq.1989.3.3.02a00030
   GREENBERG L, 1982, SOC SCI MED, V16, P1599, DOI 10.1016/0277-9536(82)90290-8
   Groark Kevin P., 1997, J LATIN AMER LORE, V20, P3
   HINOJOSA SZ, 1994, HUMAN MOSAIC, V28, P41
   HINOJOSA SZ, 1999, THESIS TULANE U
   HINOJOSA SZ, 1994, ANTHROPOLOGY-UCLA, V21, P1
   *HLTH CTR, 2000, MUNC HLTH REP
   *HLTH CTR, 1999, MUN HLTH REP
   *HLTH CTR, 1998, MUN HLTH REP
   *HLTH CTR, 2001, MUN HLTH REP
   *HLTH CTR, 1995, MUN HLTH REP
   Huber Brad R., 2001, MESOAMERICAN HEALERS, P139
   Hurtado E, 2001, MESOAMERICAN HEALERS, P211
   JORDAN B, 1989, SOC SCI MED, V28, P925, DOI 10.1016/0277-9536(89)90317-1
   JORDAN B, 1984, SOC SCI MED, V18, P637, DOI 10.1016/0277-9536(84)90292-2
   Jordan B, 1997, CHILDBIRTH AUTHORITA, P55
   Jordan B., 1993, BIRTH 4 CULTURES CRO
   KELLY I, 1956, J Trop Pediatr (Lond), V1, P200
   KLEIN S, 1995, BOOK MIDWIVES MANUAL
   Lang JB, 1997, J NURSE-MIDWIFERY, V42, P25, DOI 10.1016/S0091-2182(96)00069-9
   MELZACK R, 1991, J PAIN SYMPTOM MANAG, V6, P476, DOI 10.1016/0885-3924(91)90003-M
   Metz B, 2001, HUM ORGAN, V60, P259, DOI 10.17730/humo.60.3.2n9rx53ck001yn6w
   METZGER D, 1963, SOUTHWEST J ANTHROP, V19, P216, DOI 10.1086/soutjanth.19.2.3629170
   MOEDANO N., 1961, TLATOANI, V14, P40
   NEUBERG R, 1995, OBSTETRICS PRACTICAL
   *PAHO, 1994, SCI PUBL, V549
   *PAHO, 1986, SCI PUBL, V500
   PAINTER J, 1989, GUATEMALA FALSE HOPE
   Pan American Health Organization, 1998, HLTH AM, V1
   Paul L, 1975, Ethos, V3, P449, DOI 10.1525/eth.1975.3.3.02a00050
   Paul L., 1975, AM ETHNOL, V2, P707
   PINEDA MAG, 1988, B ESCUELA CIENCIAS A, V16, P3
   RANNEY B, 1973, AM J OBSTET GYNECOL, V116, P239, DOI 10.1016/0002-9378(73)91058-2
   Schwarz R A, 1981, Med Anthropol, V5, P51, DOI 10.1080/01459740.1981.9986975
   SHINZON C, 1987, OBSTET GYNECOL, V69, P67
   Tedlock Barbara, 1992, TIME HIGHLAND MAYA
   VARNEY H, 1980, NURSE MIDWIFERY
   VILLATORO EM, 1986, TRADICION POPULAR, V59, P1
   Ward V. M., 1992, International Family Planning Perspectives, V18, P59, DOI 10.2307/2133395
   WARD VM, 1990, COMPORTAMIENTO SEXUA
   *WHO UNICEF UNFPA, 2001, MAT MORT 1995 EST DE
   WOODS C, 1973, PROCESS MED CHANGE H
   World Health Organization Maternal and Newborn Health/Safe Motherhood Division of Reproductive Health, 1997, WHOFRHMSM9624
NR 57
TC 20
Z9 20
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD AUG
PY 2004
VL 59
IS 3
BP 637
EP 651
DI 10.1016/j.socscimed.2003.11.011
PG 15
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 826SB
UT WOS:000221847800015
PM 15144771
DA 2018-10-20
ER

PT J
AU Varma, AJ
   Kennedy, JF
   Galgali, P
AF Varma, AJ
   Kennedy, JF
   Galgali, P
TI Synthetic polymers functionalized by carbohydrates: a review
SO CARBOHYDRATE POLYMERS
LA English
DT Review
DE polymers; carbohydrates; monosaccharides
ID RING-OPENING POLYMERIZATION; LIPOPHILIC RADICAL INITIATOR;
   NUCLEAR-MAGNETIC-RESONANCE; ANHYDRO SUGAR-DERIVATIVES; CHEMICAL
   SYNTHESIS; CATIONIC POLYMERIZATION; MOLECULAR-WEIGHT; D-GLUCOSE;
   SUBSTITUTED 2,6-DIOXABICYCLO<3.1.1>HEPTANES; GLYCOPOLYMERIC INHIBITORS
AB Polymers based on carbohydrates have re-emerged as exciting topics of polymer research, due to a worldwide focus on sustainable materials. However, multi-step synthesis of these polymers have made their use as commodity plastics uneconomical, and currently their applications are restricted to biomedical fields. Functionalization of polymers has emerged as another important area of polymer science and technology. Chemically linking sugar moeities onto synthetic polymers is a unique method of functionalization of synthetic polymers, whereby not only is the polymer functionalized, but it can also get other desirable properties such as biodegradability-a property much debated and researched in modem times. This paper reviews several methods of anchoring carbohydrates onto polymers and the advantages and the disadvantages associated with each method, their current and potential applications, and their characterization methods. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Chem Lab, Div Chem Engn, Polymer Sci & Engn Grp, Pune 411008, Maharashtra, India.
   Univ Birmingham, Sch Chem Sci, Birmingham Carbohydrate & Prot Technol Grp, Birmingham B15 2TT, W Midlands, England.
RP Varma, AJ (reprint author), Natl Chem Lab, Div Chem Engn, Polymer Sci & Engn Grp, Pune 411008, Maharashtra, India.
EM ajvarma@che.ncl.res.in; jfk@chembiotech.co.uk
RI Varma, Dr. A. J./B-8731-2009
CR AKIRA Y, 1999, LANGMUIR, V15, P462
   ALVAREZ C, 1988, POLYM BULL, V19, P521
   ALVAREZ C, 1991, POLYM COMMUN, V32, P504
   ANDRESZ H, 1978, MAKROMOL CHEM, V179, P301
   Aoi K, 1996, MACROMOLECULES, V29, P4456, DOI 10.1021/ma9601068
   Bahulekar R, 1998, BIOTECHNOL TECH, V12, P721, DOI 10.1023/A:1008856416274
   Bahulekar R, 1998, CARBOHYD POLYM, V37, P71, DOI 10.1016/S0144-8617(98)00027-7
   BAMFORD CH, 1990, B SOC CHIM BELG, V99, P919
   BEEREBOOM JJ, 1983, J AGR FOOD CHEM, V31, P664, DOI 10.1021/jf00117a049
   BIRD TP, 1960, CHEM IND-LONDON, P1331
   BLACK WAP, 1962, CHEM IND-LONDON, P1624
   BLACK WAP, 1963, J CHEM SOC, P4433, DOI 10.1039/jr9630004433
   BLUHM T, 1973, MACROMOLECULES, V6, P578, DOI 10.1021/ma60034a021
   BON AFS, 1999, POLYM PREPARATION AC, V40, P248
   BREDERECK H, 1963, J KLAR CHEM ZEITUNG, V87, P731
   Buchholz K., 1995, German Patent DE, Patent No. 4408391
   CALLSTROM MR, 1992, Patent No. 9208790
   CANEIRO MJ, 2001, CARBOHYD POLYM, V45, P135
   CARPINO LA, 1976, MAKROMOL CHEM, V177, P1631
   CARRAHER CE, 1981, ORG COAT PLAST CHEM, V45, P564
   CHEN XM, 1995, MACROMOLECULES, V28, P6014, DOI 10.1021/ma00122a005
   CHERNYAK AY, 1985, CARBOHYD RES, V141, P199, DOI 10.1016/S0008-6215(00)90452-X
   Chung T. C., 2002, FUNCTIONALIZATION PO
   COLSON P, 1974, J AM CHEM SOC, V96, P8081, DOI 10.1021/ja00833a038
   DORDICK JS, 1991, Patent No. 9117255
   DUNCAN R, 1989, J CONTROL RELEASE, V10, P51, DOI 10.1016/0168-3659(89)90017-5
   EBY R, 1982, CARBOHYD RES, V102, P131, DOI 10.1016/S0008-6215(00)88056-8
   EMMERLING WN, 1983, MAKROMOL CHEM, V184, P1441
   FAULKNER RN, 1977, ACS SYM SER, V41, P176
   FRASER C, 1995, MACROMOLECULES, V28, P7248, DOI 10.1021/ma00125a030
   FRECHET J, 1969, J AM CHEM SOC, V91, P1161, DOI 10.1021/ja01033a021
   FURUIKE T, 1995, MACROMOLECULES, V28, P7241, DOI 10.1021/ma00125a029
   GALGALI P, 2002, JCS CHEM COMMUNICATI, P2884
   GALGALI P, 2001, S POL SCI ENG IND SO
   GALGALI P, 2004, IN PRESS CARBOHYDRAT
   GERD J, 1991, MAKROMOLECULAR CHEM, V12, P625
   Goldstein I J, 1966, Adv Carbohydr Chem Biochem, V21, P431
   GOLDSTEIN IJ, 1968, ARCH BIOCHEM BIOPHYS, V127, P787, DOI 10.1016/0003-9861(68)90290-7
   GOOD C, 1985, MACROMOLECULES, V18, P595
   Goto M, 2001, MACROMOL CHEM PHYS, V202, P1161, DOI 10.1002/1521-3935(20010401)202:7<1161::AID-MACP1161>3.0.CO;2-0
   GRANDE D, 2000, POLYM PREPR AM CHEM, V41, P1000
   Gruber H, 2000, MACROMOL SYMP, V152, P95, DOI 10.1002/1521-3900(200003)152:1<95::AID-MASY95>3.0.CO;2-M
   GRUBER H, 1991, CARBOHYDRATES ORGANI, pCH4
   Hashimoto K, 1999, J POLYM SCI POL CHEM, V37, P303, DOI 10.1002/(SICI)1099-0518(19990201)37:3<303::AID-POLA7>3.0.CO;2-4
   Hashimoto K, 1999, J POLYM SCI POL CHEM, V37, P2773, DOI 10.1002/(SICI)1099-0518(19990801)37:15<2773::AID-POLA11>3.3.CO;2-T
   Havard JM, 1999, MACROMOLECULES, V32, P86, DOI 10.1021/ma981372j
   HAW S, 1956, NATURE, V178, P1222
   HAWORTH WN, 1946, J CHEM SOC, P488, DOI 10.1039/jr9460000488
   HELFERICH B, 1952, CHEM BER-RECL, V85, P175, DOI 10.1002/cber.19520850219
   HELFERICH B, 1958, HOPPESEYLERS Z PHYSL, V54, P311
   HOREJSI V, 1978, BIOCHIM BIOPHYS ACTA, V538, P293, DOI 10.1016/0304-4165(78)90357-4
   HUBBELL JA, 1994, TRENDS POLYM SCI, V2, P20
   IMOTO M, 1962, MAKROMOLECULAR CHEM, V53, P219
   ITO H, 1979, J AM CHEM SOC, V101, P5797, DOI 10.1021/ja00513a055
   JIRI C, 1978, Patent No. 2819522
   KABAT EA, 1954, J AM CHEM SOC, V76, P3709, DOI 10.1021/ja01643a034
   KABAT EA, 1957, J CELL COMPAR PHYSL, V50, P79, DOI 10.1002/jcp.1030500406
   KABAT EA, 1960, J IMMUNOL, V84, P82
   KALLIN E, 1989, J CARBOHYD CHEM, V8, P597, DOI 10.1080/07328308908048020
   KAREL F, 1980, Patent No. 3014632
   KEISUKE K, 1985, Patent No. 60192704
   KEISUKE K, 1985, Patent No. 60204795
   Khan R., 1976, Advances in Carbohydrate Chemistry and Biochemistry, V33, P235, DOI 10.1016/S0065-2318(08)60283-8
   KIMURA S, 1961, MAKROMOLEKUL CHEM, V50, P155
   KIMURA S, 1962, MAKROMOLEKUL CHEM, V58, P232
   KITANO H, 1994, LANGMUIR, V10, P4131, DOI 10.1021/la00023a036
   KITANO H, 1995, BIOCONJUGATE CHEM, V6, P131, DOI 10.1021/bc00031a016
   KITUGAWA M, 2001, MACROMOLECULAR CHEM, V202, P231
   KLEIN J, 1989, MAKROMOL CHEM-RAPID, V10, P629
   KLEIN J, 1987, MAKROMOL CHEM, V188, P1217
   KLEIN J, 1989, MAKROMOL CHEM, V190, P2527
   KLEIN J, 1990, MAKROMOL CHEM-RAPID, V11, P477
   KLEIN J, 1990, MAKROMOL CHEM, V191, P517
   KLEIN J, 1986, MAKROMOL CHEM-RAPID, V7, P621
   KLEIN J, 1988, MAKROMOL CHEM, V189, P805
   KLEIN J, 1985, MAKROMOL CHEM-RAPID, V6, P675
   KLEIN J, 1982, 1077A BMFT ET
   KOBAYASHI A, 1986, MAKROMOL CHEM-RAPID, V7, P645
   KOBAYASHI A, 1994, J BIOMAT SCI-POLYM E, V6, P325, DOI 10.1163/156856295X00030
   KOBAYASHI K, 1980, MACROMOLECULES, V13, P234, DOI 10.1021/ma60074a006
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   KOBAYASHI K, 1985, POLYM J, V17, P567, DOI 10.1295/polymj.17.567
   KOBAYASHI K, 1980, NIPPON KAGAKU KAISHI, P406, DOI 10.1246/nikkashi.1980.406
   KOBAYASHI K, 1977, BIOPOLYMERS, V16, P415, DOI 10.1002/bip.1977.360160214
   KOBAYASHI K, 1994, J CARBOHYD CHEM, V13, P753, DOI 10.1080/07328309408011678
   KOBAYASHI K, 1994, METHOD ENZYMOL, V247, P409
   Kobayashi K, 1996, MACROMOLECULES, V29, P8670, DOI 10.1021/ma9603443
   KOBAYASHI K, 1983, POLYM J, V15, P667, DOI 10.1295/polymj.15.667
   Kobayashi K., 2001, BAIOSAIENSU TO INDAS, V59, P679
   Kobayashi Kazukiyo, 1994, P261
   KONG F, 1984, MACROMOLECULES, V17, P983, DOI 10.1021/ma00135a001
   KOPS J, 1965, J POLYM SCI        C, V11, P119
   KORSHAK VV, 1961, VYSOKOMOL SOEDIN, V3, P477
   KOSMA P, 1987, CARBOHYD RES, V167, P39, DOI 10.1016/0008-6215(87)80266-5
   KOYAMA Y, 1986, SEIKEI DAIGAKU KOGAK, V41, P2749
   KRASKA B, 1978, TETEHEDRON LETT, V46, P4583
   KRAUSE F, 1984, Patent No. 9401476
   KUNZ M, 1993, CARBOHYDRATES ORGANI
   LEE J, 1999, BIOORGAN MED CHEM, V7, P1549
   LIN JWP, 1972, J POLYM SCI POL CHEM, P2045
   Liu XC, 1999, J POLYM SCI POL CHEM, V37, P1665, DOI 10.1002/(SICI)1099-0518(19990601)37:11<1665::AID-POLA12>3.3.CO;2-V
   MANDEVILLE WH, 1997, Patent No. 5700458
   MARK HF, 1988, ENCY POLYM SCI ENG, V13, P154
   MARTIN BD, 1992, MACROMOLECULES, V25, P7081, DOI 10.1021/ma00052a001
   MARUYAMA A, 1994, BIOMATERIALS, V15, P1035, DOI 10.1016/0142-9612(94)90088-4
   MASURA V, 1970, CARBOHYD RES, V15, P65, DOI 10.1016/S0008-6215(00)80295-5
   MATSUOKA K, 1995, MACROMOLECULES, V28, P2961, DOI 10.1021/ma00112a049
   MICHEEL F, 1974, LIEBIGS ANN CHEM, P702
   MICHEEL F, 1974, LIEBIGS ANN CHEM, P124
   MORIGUCHI K, 1994, Patent No. 06279631
   Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q
   MOSSL E, 1993, ANGEW MAKROMOL CHEM, V205, P185, DOI 10.1002/apmc.1993.052050116
   MUELLER HP, 1991, Patent No. 4006521
   NAKAGAWA T, 1993, Patent No. 05148314
   NAKAGAWA T, 1994, Patent No. 06145074
   Nichols PL, 1944, J AM CHEM SOC, V66, P1625, DOI 10.1021/ja01238a004
   NICHOLS PL, 1945, J AM CHEM SOC, V67, P1038
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P157, DOI 10.1021/ma00079a023
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P4876, DOI 10.1021/ma00096a004
   NISHIMURA SI, 1990, MACROMOLECULES, V23, P4182, DOI 10.1021/ma00220a024
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4236, DOI 10.1021/ma00015a002
   NISHIO K, 1978, MAKROMOL CHEM, V179, P1117
   NOLTE RJM, 1978, J ORG CHEM, V43, P1972, DOI 10.1021/jo00404a027
   Ohno K, 1998, J POLYM SCI POL CHEM, V36, P2473, DOI 10.1002/(SICI)1099-0518(199810)36:14<2473::AID-POLA5>3.0.CO;2-U
   Ohno K, 1999, MACROMOL CHEM PHYSIC, V200, P1619, DOI 10.1002/(SICI)1521-3935(19990701)200:7<1619::AID-MACP1619>3.0.CO;2-1
   OKUBO Y, 1980, J BACTERIOL, V144, P92
   OUCHI T, 1984, MAKROMOL CHEM, V185, P255
   PACITTI S, 2003, PLASTICS PACKAGING, P14
   PANZER HP, 1959, CHEM ENG NEWS, V37, P41
   PATIL DR, 1991, BIOTECHNOL BIOENG, V37, P639, DOI 10.1002/bit.260370706
   PATIL DR, 1991, MACROMOLECULES, V24, P2462
   Pictet A, 1918, HELV CHIM ACTA, V1, P226, DOI 10.1002/hlca.19180010124
   Pinilla IM, 2002, MACROMOLECULES, V35, P2977, DOI 10.1021/ma011301b
   REPPE W, 1930, Patent No. 714490
   REPPE W, 1936, Patent No. 2157347
   Reppe W., 1936, Ger. Pat., Patent No. [715 268, 715268]
   Rios P, 1997, J APPL POLYM SCI, V64, P1195
   ROBINSON R, 1970, CARBOHYD RES, V13, P425, DOI 10.1016/S0008-6215(00)80599-6
   ROY R, 1988, J CHEM SOC CHEM COMM, P1058, DOI 10.1039/c39880001058
   RUCKEL ER, 1966, J ORG CHEM, V31, P2233, DOI 10.1021/jo01345a035
   RUCKEL ER, 1967, BIOPOLYMERS, V5, P515, DOI 10.1002/bip.1967.360050606
   RUCKEL ER, 1966, J AM CHEM SOC, V88, P2605, DOI 10.1021/ja00963a052
   SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018
   SCHUERCH C, 1981, ADV CARBOHYD CHEM BI, V39, P157
   SHARKEY PF, 1981, CARBOHYD RES, V96, P223, DOI 10.1016/S0008-6215(00)81872-8
   SHOWA, 1981, Patent No. 56047415
   SO LL, 1968, J BIOL CHEM, V243, P2003
   SPALTENSTEIN A, 1991, J AM CHEM SOC, V113, P686, DOI 10.1021/ja00002a053
   STIPANOVIC AJ, 1980, ABSTR PAP AM CHEM S, V179, P45
   Tirkistani FAA, 1997, CARBOHYD POLYM, V34, P329, DOI 10.1016/S0144-8617(97)00065-9
   TKACZ JS, 1972, CARBOHYD RES, V21, P465, DOI 10.1016/S0008-6215(00)84930-7
   Tokiwa Y, 2000, MACROMOLECULES, V33, P1636, DOI 10.1021/ma981451v
   TREADWAY RH, 1945, J AM CHEM SOC, V67, P1038, DOI 10.1021/ja01222a508
   TRUMBO DL, 1985, CARBOHYD RES, V135, P195, DOI 10.1016/S0008-6215(00)90771-7
   TWEEDDALE HJ, 1994, GLYCOCONJUGATE J, V11, P586, DOI 10.1007/BF00731310
   URYU T, 1971, MACROMOLECULES, V4, P342, DOI 10.1021/ma60021a018
   URYU T, 1981, J POLYM SCI POL CHEM, V19, P2313, DOI 10.1002/pol.1981.170190917
   URYU T, 1980, MAKROMOL CHEM, V181, P2137
   URYU T, 1979, J POLYM SCI POL LETT, V17, P673, DOI 10.1002/pol.1979.130171009
   URYU T, 1978, MAKROMOL CHEM, V179, P1773
   URYU T, 1970, MACROMOLECULES, V3, P345, DOI 10.1021/ma60015a014
   URYU T, 1984, MACROMOLECULES, V17, P1307, DOI 10.1021/ma00137a002
   URYU T, 1983, J AM CHEM SOC, V105, P6865, DOI 10.1021/ja00361a021
   URYU T, 1981, MACROMOLECULES, V14, P1, DOI 10.1021/ma50002a001
   URYU T, 1979, POLYM PREPARATION AM, V20, P813
   USMANI AM, 1983, POLYM SCI TECHNOL, V21, P247
   Vaidya U. R., 1993, Patent No. [9323456, WO9323456 A1]
   VARMA AJ, 1981, J ORG CHEM, V46, P799, DOI 10.1021/jo00317a030
   VARMA AJ, 2003, CHEM IND DIG MUMB IN
   VERUOVIC B, 1970, CARBOHYD RES, V14, P199, DOI 10.1016/S0008-6215(00)80487-5
   VETTER D, 1994, Patent No. 9412540
   VONVOLKER B, 1998, POLYMER, V39, P1617
   WANG P, 1992, J AM CHEM SOC, V114, P378, DOI 10.1021/ja00027a068
   WHISTLER RL, 1962, J ORG CHEM, V27, P2961, DOI 10.1021/jo01055a533
   WHISTLER RL, 1961, J ORG CHEM, V26, P1583, DOI 10.1021/jo01064a067
   WOLFROM ML, 1959, J AM CHEM SOC, V81, P4623, DOI 10.1021/ja01526a043
   WOLFROM ML, 1959, J AM CHEM SOC, V81, P5701, DOI 10.1021/ja01530a043
   Wulff G, 1996, MACROMOL CHEM PHYSIC, V197, P259, DOI 10.1002/macp.1996.021970120
   Wulff G, 1999, MACROMOL CHEM PHYSIC, V200, P774
   WULFF G, 1998, POLYM PREPR, V39, P124
   YAMAGUCHI H, 1980, BIOPOLYMERS, V19, P297, DOI 10.1002/bip.1980.360190208
   YAMAGUCHI S, 1994, Patent No. 06298866
   YOSHIDA T, 2000, CARBOHYD POLYM, V44, P141
   YURA H, 1997, Patent No. 09221524
   ZACHOVAL J, 1969, J AM CHEM SOC, V91, P1165, DOI 10.1021/ja01033a022
   Zhou WJ, 1997, MACROMOLECULES, V30, P7063, DOI 10.1021/ma970873m
   Zhou WJ, 1999, MACROMOLECULES, V32, P5507, DOI 10.1021/ma990397v
   1930, Patent No. 584840
NR 188
TC 90
Z9 94
U1 3
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUL 15
PY 2004
VL 56
IS 4
BP 429
EP 445
DI 10.1016/j.carbpol.2004.03.007
PG 17
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 838XQ
UT WOS:000222747100006
DA 2018-10-20
ER

PT J
AU Hsu, SH
   Chu, WP
   Lin, YS
   Chiang, YL
   Chen, DCH
   Tsai, CL
AF Hsu, SH
   Chu, WP
   Lin, YS
   Chiang, YL
   Chen, DCH
   Tsai, CL
TI The effect of an RGD-containing fusion protein CBD-RGD in promoting
   cellular adhesion
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE RGD-containing peptides; polyurethane; poly(L-lactide);
   poly(lactide-co-glycolide)
ID EXTRACELLULAR-MATRIX PROTEINS; ENDOTHELIAL-CELLS; PEPTIDES; FIBRONECTIN;
   ATTACHMENT; RECEPTOR; CULTURE; CHONDROCYTES; CARTILAGE; SURFACE
AB The effect of a recombinant RGD (arginine-glycine-aspartic acid)-containing fusion protein, cellulose-binding domain (CBD)RGD, on the cellular adhesion to a biomedical polyurethane (PU) was evaluated. A series of different cell lines, as well as freshly harvested animal cells, were grown on the PU surfaces with or without CBD-RGD, in serum or serum-free media. The results showed that the enhancement of cellular attachment by CBD-RGD varied with cell types. This is believed to be a result of the unique integrin receptors on each type of cell surface. The existence of certain divalent ions (Mg2+ and Mn2+) may increase the efficacy of the CBD-RGD, in a cell type-dependent manner. The fusion protein was also found to inhibit the platelet activation. The effect of CBD-RGD was further examined in two other substrate materials, poly(L-lactide) (PLLA) and poly(lactide-co-glycolide) (PLGA). The effect on cellular adhesion correlated with the amount of CBD-RGD physically adsorbed on the material surface. (C) 2004 Elsevier B.V. All rights reserved.
C1 Natl Chung Hsing Univ, Dept Chem Engn, Taichung 402, Taiwan.
   Natl Chung Hsing Univ, Grad Inst Vet Microbiol, Taichung 40227, Taiwan.
   Natl Taiwan Univ, Coll Med, Dept Orthopaed, Taipei 10764, Taiwan.
RP Hsu, SH (reprint author), Natl Chung Hsing Univ, Dept Chem Engn, 250 Kao Kung Rd, Taichung 402, Taiwan.
EM shhsu@nchu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
CR Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159
   CHEN DC, 2002, Patent No. 6407208B1
   CHEN DC, 2002, Patent No. 6407208
   Cheresh D., 1993, ADV MOL CELL BIOL, V6, P225
   Chiba M, 1996, J IMMUNOL METHODS, V191, P55, DOI 10.1016/0022-1759(96)00021-X
   FRESHNEY RI, 1994, CULTURE ANIMAL CELLS, P331
   GAILIT J, 1988, J BIOL CHEM, V263, P12927
   GARCIA AJ, 1998, BIOCHEMISTRY-US, V41, P9063
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   HSU JJ, 1999, P GLOB CHIN S BIOM C, P642
   HSU S, 2003, ARTIF ORGANS, V27, P1090
   HSU SH, 2003, Patent No. 6579322
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jeschke B, 2002, BIOMATERIALS, V23, P3455, DOI 10.1016/S0142-9612(02)00052-2
   KEMPCZINSKI RF, 1987, ENDOTHELIAL SEEDING, P57
   LARSSON CF, 2000, BIOMATERIALS, V21, P307
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   LOESER RF, 1994, EXP CELL RES, V211, P17, DOI 10.1006/excr.1994.1053
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Ohno S, 1999, BBA-MOL CELL RES, V1451, P196, DOI 10.1016/S0167-4889(99)00093-2
   PATTERSON RB, 1995, ASAIO J, V41, pM625, DOI 10.1097/00002480-199507000-00086
   PENKE B, 1984, J MED CHEM, V27, P845, DOI 10.1021/jm00373a006
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAMANEN J, 1991, J MED CHEM, V34, P3114, DOI 10.1021/jm00114a022
   TORD, 1994, J MOL CELL CARDIOL, V26, pR86
   TORDAY L, 1994, J MOL CELL CARDIOL, V26, pR86
   VARANI J, 1993, CYTOTECHNOLOGY, V13, P89, DOI 10.1007/BF00749935
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
   Yasuda T, 1996, J BONE MINER RES, V11, P1430
NR 30
TC 23
Z9 24
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD JUL 15
PY 2004
VL 111
IS 2
BP 143
EP 154
DI 10.1016/j.jbiotec.2004.03.014
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 837HY
UT WOS:000222620800004
PM 15219401
DA 2018-10-20
ER

PT J
AU Manso-Silvan, M
   Ceccone, G
   Rossi, F
AF Manso-Silvan, M
   Ceccone, G
   Rossi, F
TI Surface analysis of plasma-patterned biofunctional hybrid
   titanate-aminosilane xerogel films
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE amino groups; sol-gel; plasma etching; surface functionalization; X-ray
   photoelectron spectroscopy; confocal microscopy
ID THIN-FILM; MONOLAYERS; ADSORPTION; ACID
AB The functionalization and patterning of biomedical materials with enhanced surface activity is a main objective for the development of high-specificity biosensors. The surfaces of sol-gel condensed aminopropyltriethoxysilane-tetraisopropyl orthotitanate hybrid materials have been studied in order to describe the mechanisms that allow the fixation of amino groups. X-ray photoelectron spectra obtained from these surfaces are compared with those coming from the surfaces of plasma-etched coatings. The results show that aminopropyl radicals remain on the surface after room-temperature condensation and that they are drastically removed after partial etching of the coating in an Ar plasma. This confirms that the functionalization is effectively a surface feature and suggests that amino groups may remain at the surface covalently bonded to the original amorphous Si-O- structure. Further evidence of the surface functionalization efficiency is illustrated with contact angle and zeta-potential measurements. It is complementarily proved by confocal microscopy that masked regions conserve their molecular activity and are not affected by the etching process. These facts suggest that these materials could play an active role when incorporated into biosensor devices. (C) 2004 Elsevier Inc. All rights reserved.
C1 European Commiss, Inst Hlth & Consumer Protect, I-21020 Ispra, VA, Italy.
RP Manso-Silvan, M (reprint author), European Commiss, Inst Hlth & Consumer Protect, Via Enrico Fermi TP 203, I-21020 Ispra, VA, Italy.
EM miguel.manso@jrc.it
RI Manso Silvan, Miguel/B-4947-2010
OI Manso Silvan, Miguel/0000-0002-5063-1607; Rossi,
   Francois/0000-0003-3090-1398
CR Basyuk V.A., 1990, ZH PRIKL SPEKTROSK, V52, P935
   BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1
   Briggs D., 1994, PRACTICAL SURFACE AN, V1, P635
   Briggs D., 1998, SURFACE ANAL POLYM X
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Della Volpe C, 1997, J COLLOID INTERF SCI, V195, P121
   Kam L, 1999, BIOMATERIALS, V20, P2343, DOI 10.1016/S0142-9612(99)00163-5
   Kondo H, 1997, WEAR, V202, P149, DOI 10.1016/S0043-1648(96)07265-1
   Kowalczyk D, 1996, INT J ADHES ADHES, V16, P227, DOI 10.1016/0143-7496(95)00052-6
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   Liu XW, 2002, THIN SOLID FILMS, V409, P178, DOI 10.1016/S0040-6090(02)00146-3
   Manso M, 2002, BIOMATERIALS, V23, P349, DOI 10.1016/S0142-9612(01)00112-0
   Muller M, 1999, SURF COAT TECH, V116, P802, DOI 10.1016/S0257-8972(99)00268-6
   PUGGELLI M, 1994, THIN SOLID FILMS, V244, P1050, DOI 10.1016/0040-6090(94)90628-9
   SETHI RS, 1994, BIOSENS BIOELECTRON, V9, P243, DOI 10.1016/0956-5663(94)80127-4
   SOKOLL R, 1986, J CHEM SOC FARAD T 1, V82, P3391, DOI 10.1039/f19868203391
   Talroze RV, 1998, THIN SOLID FILMS, V325, P232, DOI 10.1016/S0040-6090(98)00505-7
   vanOss CJ, 1996, J DISPER SCI TECHNOL, V17, P433, DOI 10.1080/01932699608943513
   VASILJEVA LL, 1995, THIN SOLID FILMS, V261, P296, DOI 10.1016/S0040-6090(94)06458-X
   Wagner D., 1979, HDB XRAY PHOTOELECTR
   WANG D, 1993, J MATER SCI, V28, P2481, DOI 10.1007/BF01151683
   WHITESELL JK, 1994, MOL CRYST LIQ CRYS A, V240, P251, DOI 10.1080/10587259408029736
   Yu JG, 2001, J MATER SCI LETT, V20, P671, DOI 10.1023/A:1010994022745
   ZHANG L, 1998, THIN SOLID FILMS, V221, P327
NR 24
TC 6
Z9 6
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUL 15
PY 2004
VL 275
IS 2
BP 577
EP 583
DI 10.1016/j.jcis.2004.02.087
PG 7
WC Chemistry, Physical
SC Chemistry
GA 829QN
UT WOS:000222064800031
PM 15178289
DA 2018-10-20
ER

PT J
AU Raman, VI
   Palmese, GR
AF Raman, VI
   Palmese, GR
TI Design and characterization of nanoporous polymeric materials via
   reactive encapsulation of a chemically inert solvent
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT 3rd International TRI/Princeton Workshop on Characterization of Porous
   Materials - From Angstroms to Millimeters
CY JUN 23-25, 2003
CL Princeton, NJ
SP Quantachrome Corp
DE thermosetting; polymer; reactive encapsulation; porous; nanoporous
ID REVERSED-PHASE CHROMATOGRAPHY; HOLLOW-FIBER MEMBRANES; CARBON-DIOXIDE;
   TRANSPORT; ROD
AB Nanoporous polymeric materials are used as polyelectrolytes in fuel cells, separation membranes, sensors and actuators, templates for nanoparticle synthesis, and electroactive material in biomedical applications. Design of nanoporous polymeric materials for such applications entails controlling permeability by tailoring the pore size and pore chemistry. A novel method of synthesizing nanoporous polymeric materials is employed in this work. This technique involves the synthesis of nanoporous polymeric materials by reactive encapsulation of an inert solvent using a step-growth cross-linking polymerization reaction carried out until completion without micro/macroscopic phase separation. Key structural features of the porous materials synthesized in this way were investigated by scanning electron microscopy (SEM) after extraction and supercritical drying using carbon dioxide. Micrographs of the materials synthesized using the reactive encapsulation technique showed that materials with pore sizes less than 100 nm are obtained. Micrographs also showed that the reactive encapsulation technique can be employed to synthesize nanoporous polymeric materials of desired porosity and pore size by changing the solvent content. (C) 2004 Elsevier B.V. All rights reserved.
C1 Drexel Univ, Dept Chem Engn, Philadelphia, PA 19104 USA.
RP Palmese, GR (reprint author), Drexel Univ, Dept Chem Engn, Philadelphia, PA 19104 USA.
EM palmese@coe.drexel.edu
CR Chieng TH, 1996, LANGMUIR, V12, P319, DOI 10.1021/la950493z
   Chung YM, 2003, CATAL LETT, V85, P159, DOI 10.1023/A:1022181327349
   Drzal PL, 2000, POLYMER, V41, P4671, DOI 10.1016/S0032-3861(99)00652-7
   KIM JJ, 1994, J MEMBRANE SCI, V93, P209, DOI 10.1016/0376-7388(94)00070-0
   KIM JJ, 1995, J MEMBRANE SCI, V108, P25, DOI 10.1016/0376-7388(95)00148-7
   Krause B, 2002, DESALINATION, V144, P5, DOI 10.1016/S0011-9164(02)00280-1
   Liu Y, 2001, REACT FUNCT POLYM, V47, P201, DOI 10.1016/S1381-5148(01)00030-X
   Peled E, 2002, J POWER SOURCES, V106, P245, DOI 10.1016/S0378-7753(01)01028-X
   Piletsky SA, 1998, MACROMOLECULES, V31, P2137, DOI 10.1021/ma970818d
   QUAN H, 1999, J MEMBRANE SCI, V161, P287
   Raab M, 2001, J APPL POLYM SCI, V80, P214, DOI 10.1002/1097-4628(20010411)80:2<214::AID-APP1089>3.3.CO;2-H
   Saleh OA, 2003, NANO LETT, V3, P37, DOI 10.1021/nl0255202
   Su XC, 2002, SUPRAMOL CHEM, V14, P41, DOI 10.1080/10610270290006619
   Toimil-Molares ME, 2001, NUCL INSTRUM METH B, V185, P192, DOI 10.1016/S0168-583X(01)00755-8
   Unlusu B, 2001, J NON-CRYST SOLIDS, V279, P110, DOI 10.1016/S0022-3093(00)00398-7
   VANBOMMEL MJ, 1995, J NON-CRYST SOLIDS, V186, P78, DOI 10.1016/0022-3093(95)00072-0
   Wang HY, 1997, LANGMUIR, V13, P5396, DOI 10.1021/la970114x
   WANG QC, 1993, ANAL CHEM, V65, P2243, DOI 10.1021/ac00065a013
   WANG QC, 1994, J CHROMATOGR A, V669, P230, DOI 10.1016/0021-9673(94)80352-8
   Yoshikawa M, 1999, REACT FUNCT POLYM, V42, P93, DOI 10.1016/S1381-5148(98)00063-7
   Zhu XX, 1999, MACROMOLECULES, V32, P277, DOI 10.1021/ma980599b
NR 21
TC 15
Z9 15
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD JUL 14
PY 2004
VL 241
IS 1-3
SI SI
BP 119
EP 125
DI 10.1016/j.colsurfa.2004.04.032
PG 7
WC Chemistry, Physical
SC Chemistry
GA 851VM
UT WOS:000223714100017
DA 2018-10-20
ER

PT J
AU Uchida, M
   Oyane, A
   Kim, HM
   Kokubo, T
   Ito, A
AF Uchida, M
   Oyane, A
   Kim, HM
   Kokubo, T
   Ito, A
TI Biomimetic coating of laminin-apatite composite on titanium metal and
   its excellent cell-adhesive properties
SO ADVANCED MATERIALS
LA English
DT Article
ID BODY ENVIRONMENT; FORMING ABILITY; PERI-IMPLANT; TI METAL; ATTACHMENT;
   EPITHELIUM
AB Titanium metal and its alloys are widely used as biomedical implant materials, since they exhibit good biocompatibility and superior mechanical properties.([1-3]) One important application of these metallic materials is in percutaneous implants, such as artificial tooth roots or skin terminals.([1]) Their bonding ability to epithelial tissue is not high enough, however, and the weak adhesion between an implant and its surrounding tissue leads to a deficient barrier against bacterial infection.([4-7]) For this reason, the development of titanium metal that has the ability to bond to epithelial tissue is strongly desired.
   Since teeth are natural skin-penetrating tissues, a tooth is believed to be a good model for an artificial percutaneous implant. Healthy natural teeth bond to their surrounding soft tissue through a strong adhesion to the epithelial cells that constitute the gingival epithelial tissue, and so prevent the invasion of bacteria.([4.5]) The biologically strong adhesion between a tooth and its surrounding epithelial tissue is attributed the cell-adhesive protein, laminin.([4]) Laminin is contained in the basement membranes and is believed to be a crucial molecule involved in the adhesion of epithelial cells to the surface of organ substrata, such as enamel.([8]) Therefore, it is expected that if laminin can be immobilized on the surface of titanium metal without any associated inactivation, then the surrounding epithelial tissue would strongly attach to the surface of the metal, analogous to natural teeth.
C1 Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Biomed Engn, Tsukuba, Ibaraki 3050046, Japan.
   Natl Inst Adv Ind Sci & Technol, Res Ctr Macromol Technol, Koto Ku, Tokyo 1350064, Japan.
   Yonsei Univ, Sch Adv Mat Engn, Dept Ceram Engn, Seoul 120749, South Korea.
   Chubu Univ, Sci & Technol Res Inst, Kasugai, Aichi 4878501, Japan.
RP Uchida, M (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Biomed Engn, 1-1-1 Higashi, Tsukuba, Ibaraki 3050046, Japan.
EM uchida-m@aist.go.jp
RI Ito, Atsuo/M-6785-2018; Uchida, Masaki/E-5416-2016
OI Ito, Atsuo/0000-0003-3318-040X; Uchida, Masaki/0000-0003-0710-8834
CR Brunette D. M., 2001, TITANIUM MED MAT SCI
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ikeda H, 2002, CLIN ORAL IMPLAN RES, V13, P243, DOI 10.1034/j.1600-0501.2002.130303.x
   Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961
   JANSEN JA, 1985, J DENT RES, V64, P891, DOI 10.1177/00220345850640060601
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   MANN S, 1989, BIOMINERALIZATION CH
   MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cb.03.110187.000421
   Shiraiwa M, 2002, J PERIODONTOL, V73, P852, DOI 10.1902/jop.2002.73.8.852
   Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   WAKAMATU Y, 1991, NIHON U DENT J, V65, P1070
NR 18
TC 115
Z9 117
U1 4
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JUL 5
PY 2004
VL 16
IS 13
BP 1071
EP +
DI 10.1002/adma.200400152
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 842KO
UT WOS:000223003200002
DA 2018-10-20
ER

PT J
AU Signori, F
   Solaro, R
   Lips, PAM
   Dijkstra, PJ
   Feijen, J
   Chiellini, E
AF Signori, F
   Solaro, R
   Lips, PAM
   Dijkstra, PJ
   Feijen, J
   Chiellini, E
TI Segmented multifunctional poly(ether ester) polymers containing
   H-bonding units. Preparation and characterization
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE biodegradable; multifunctional polymers; poly(ether-ester);
   polycondensation; structure-property relations
ID MULTIBLOCK COPOLYMERS; CONTROLLED-RELEASE; MATRICES; SYSTEMS
AB A series of poly(ether ester)s containing amide and carbarnate groups as H-bonding units and 13-50 mol-% of poly(ehtylene glycel) (PEG) segments were prepared by polycondensation in bulk using Ti(OBu)(4) as a catalyst. The copolymers were obtained starting from PEG/1,4-butanediol mixtures and a synthetic monomer carrying H-bonding groups. These polymers were designed for biomedical applications, where material biodegradability is required. The influence of the nature of the H-bonding units, the lenght of the polymethylene spacer between the H-bonding groups and the PEG content on the thermal and solubility properties of copolymers was investigated. Amide-containing copolymers were more thermally stable than those containing carbarnate groups. The PEG content also slightly affected the polymer thermal stability. The PEG content also slightly affected the presented multiple transitions, whose shape and peak temperature were strongly dependent on the PEG content. Polymer hydrophobicity, surface free energy and equilibrium swelling in phosphate buffer solution (PBS) at 37 degreesC were mainly influenced by the PEG content, whereas the nature of the H-bonding groups had little effect.
C1 Univ Pisa, Dept Chem & Ind Chem, INSTM, UdR, I-56126 Pisa, Italy.
   Univ Twente, Dept Chem Technol, NL-7500 AE Enschede, Netherlands.
RP Chiellini, E (reprint author), Univ Pisa, Dept Chem & Ind Chem, INSTM, UdR, Via Risorgimento 35, I-56126 Pisa, Italy.
EM emochie@dcci.unipi.it
RI Dijkstra, Pieter/N-9328-2013; Signori, Francesca/G-1937-2010
OI Signori, Francesca/0000-0002-9211-5352
CR Bezemer JM, 2000, J CONTROL RELEASE, V67, P249, DOI 10.1016/S0168-3659(00)00212-1
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   Bizzarri R, 1999, J BIOACT COMPAT POL, V14, P504, DOI 10.1177/088391159901400605
   CHIELLINI E, 1995, J BIOMAT SCI-POLYM E, V7, P307
   Chiellini E, 2001, J BIOACT COMPAT POL, V16, P441, DOI 10.1106/6CFL-4E8A-L7XR-MUF7
   CHIELLINI E, 1992, J CONTROL RELEASE, V22, P273, DOI 10.1016/0168-3659(92)90102-W
   Deschamps AA, 2002, J BIOMAT SCI-POLYM E, V13, P1337, DOI 10.1163/15685620260449732
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   INTVELD PJA, 1992, MAKROMOL CHEM, V193, P1927
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   SEEBACH D, 1982, SYNTHESIS-STUTTGART, P138
   Signori F, 2003, MACROMOL CHEM PHYSIC, V204, P1971, DOI 10.1002/macp.200350057
   Solaro R, 2003, J MATER SCI-MATER M, V14, P705, DOI 10.1023/A:1024963700223
   Solaro R, 2003, MACROMOL CHEM PHYSIC, V204, P500, DOI 10.1002/macp.200390023
   Solaro R, 1997, J BIOACT COMPAT POL, V12, P27, DOI 10.1177/088391159701200103
   Stapert HR, 1999, MACROMOL CHEM PHYSIC, V200, P1921, DOI 10.1002/(SICI)1521-3935(19990801)200:8<1921::AID-MACP1921>3.0.CO;2-R
   STAPERT HR, 1998, Patent No. 1003459
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
NR 19
TC 0
Z9 0
U1 1
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD JUL 5
PY 2004
VL 205
IS 10
BP 1299
EP 1308
DI 10.1002/macp.200400113
PG 10
WC Polymer Science
SC Polymer Science
GA 838RU
UT WOS:000222731600001
DA 2018-10-20
ER

PT J
AU Wang, HF
   Deng, XY
   Wang, J
   Gao, XF
   Xing, GM
   Shi, ZJ
   Gu, ZN
   Liu, YF
   Zhao, YL
AF Wang, HF
   Deng, XY
   Wang, J
   Gao, XF
   Xing, GM
   Shi, ZJ
   Gu, ZN
   Liu, YF
   Zhao, YL
TI XPS study of C-I covalent bond on single-walled carbon nanotubes (SWNTs)
SO ACTA PHYSICO-CHIMICA SINICA
LA English
DT Article
DE SWNTs; C-I covalent bond; X-ray photoelectron spectroscopy (XPS)
ID FLUORINATION
AB A simple method was used to synthesize the iodinated multi hydroxylated SWNTs (SWNTols) by the reaction of SWNTols with NaI in the presence of strong oxidant N-chloro-p-toluenesulfonamide. The formation of the C-I covalent bond was verified by comparing the electron binding energies of iodine of I-SWNTols and the reference materials, which were measured with the synchrotron radiation X-ray photoemission spectroscopy (SRXPS) as well as the conventional X-ray photoelectron spectroscopy (XPS). This result will be useful in applications of SWNTs in the biomedical and pharmaceutical sciences.
C1 Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.
   Chinese Acad Sci, Inst High Energy Phys, Beijing 100039, Peoples R China.
RP Liu, YF (reprint author), Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.
EM yliu@pku.edu.cn
RI Wang, Jing/D-8136-2012; Gao, Xingfa/E-5691-2010; Deng,
   Xiaoyong/A-5682-2012; Wang, Haifang/I-2776-2014
OI Gao, Xingfa/0000-0002-1636-6336; Deng, Xiaoyong/0000-0001-6967-7050;
   Wang, Haifang/0000-0002-7660-2089
CR Boltalina OV, 2000, J FLUORINE CHEM, V101, P273, DOI 10.1016/S0022-1139(99)00170-0
   GAARENSTROOM SW, 1977, J CHEM PHYS, V67, P3500, DOI 10.1063/1.435347
   HUSSAIN AA, 1995, ANAL BIOCHEM, V224, P221, DOI 10.1006/abio.1995.1033
   Khabashesku VN, 2002, ACCOUNTS CHEM RES, V35, P1087, DOI 10.1021/ar020146y
   MORGAN WE, 1973, J AM CHEM SOC, V95, P751, DOI 10.1021/ja00784a018
   Nakajima T, 1996, EUR J SOL STATE INOR, V33, P831
   Pan HL, 2003, NANO LETT, V3, P29, DOI 10.1021/nl025856b
   Sheng WW, 2003, NANOTECHNOLOGY, V14, P1203
   Shi ZJ, 1999, SOLID STATE COMMUN, V112, P35, DOI 10.1016/S0038-1098(99)00278-1
   Terrones M, 2003, ANNU REV MATER RES, V33, P419, DOI 10.1146/annurev.matsci.33.012802.100255
   VENKATESWARAN UD, 2002, PHYS REV B, V65
   Williams KA, 2002, NATURE, V420, P761, DOI 10.1038/420761a
   Zhou WY, 2002, APPL PHYS LETT, V80, P2553, DOI 10.1063/1.1468269
NR 13
TC 18
Z9 21
U1 2
U2 17
PU PEKING UNIV PRESS
PI BEIJING
PA PEKING UNIV, CHEMISTRY BUILDING, BEIJING 100871, PEOPLES R CHINA
SN 1000-6818
J9 ACTA PHYS-CHIM SIN
JI Acta Phys.-Chim. Sin.
PD JUL
PY 2004
VL 20
IS 7
BP 673
EP 675
DI 10.3866/PKU.WHXB20040701
PG 3
WC Chemistry, Physical
SC Chemistry
GA 839OM
UT WOS:000222794400001
DA 2018-10-20
ER

PT J
AU Preoteasa, EA
   Georgescu, R
   Ciortea, C
   Fluerasu, D
   Harangus, L
   Iordan, A
   Severcan, F
   Boyar, H
   Preoteasa, E
   Piticu, I
   Pantelica, D
   Gheordunescu, V
AF Preoteasa, EA
   Georgescu, R
   Ciortea, C
   Fluerasu, D
   Harangus, L
   Iordan, A
   Severcan, F
   Boyar, H
   Preoteasa, E
   Piticu, I
   Pantelica, D
   Gheordunescu, V
TI Standardless PIXE analysis of thick biomineral structures
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Instrumental Methods of Analysis
CY SEP 23-27, 2003
CL Thessaloniki, GREECE
DE PIXE; trace elements; biomaterials; dental enamel; bone; multivariate
   statistics
ID X-RAY-EMISSION; TRACE-ELEMENTS; NUCLEAR MICROPROBE; ARTIFICIAL MOUTH;
   SECONDARY CARIES; TARGET PIXE; IN-VITRO; ENAMEL; BONE; TISSUES
AB The particle-induced X-ray emission (PIXE) of thick biomineral targets provides pertinent surface analysis, but if good reference materials are missing then complementary approaches are required to handle the matrix effects. This is illustrated by our results from qualitative and semiquantitative analysis of biornaterials and calcified tissues in which PIXE usually detected up to 20 elements with Z > 14 per sample, many at trace levels. Relative concentrations allow the classification of dental composites according to the mean Z and by multivariate statistics. In femur bones from streptozotocin-induced diabetic rats, trace element changes showed high individual variability but correlated to each other, and multivariate statistics improved discrimination of abnormal pathology. Changes on the in vitro demineralization of dental enamel suggested that a dissolution of Ca compounds in the outermost layer results in the uncovering of deeper layers containing higher trace element levels. Thus, in spite of significant limitations, standardless PIXE analysis of thick biomineral samples together with proper additional procedures can provide relevant information in biomedical research.
C1 Horia Hulubei Natl Inst Phys & Nucl Engn, Bucharest 76900, Romania.
   Middle E Tech Univ, Fac Sci, Dept Biol, TR-06531 Ankara, Turkey.
   Helident Dent Surg Ltd, Campina 2150, Romania.
   Inst Biochem, Bucharest 77700, Romania.
RP Preoteasa, EA (reprint author), Horia Hulubei Natl Inst Phys & Nucl Engn, POB MG-6, Bucharest 76900, Romania.
EM eugpre@ifin.nipne.ro
RI Neagu, Livia/E-8818-2011
OI Severcan, Feride/0000-0002-1717-2517
CR AHLBERG M, 1976, INT J APPL RADIAT IS, V27, P279, DOI 10.1016/0020-708X(76)90145-9
   Allolio B, 1996, Z Arztl Fortbild (Jena), V90, P19
   Andersen H. H, 1977, HYDROGEN STOPPING PO
   ANDERSON TW, 1984, INTRO MULTIVARIATE S
   Andrade E, 1998, NUCL INSTRUM METH B, V136, P908, DOI 10.1016/S0168-583X(97)00892-6
   ANTILLA A, 1986, ARCH ORAL BIOL, V31, P723
   Arai N, 1999, NUCL INSTRUM METH B, V150, P267, DOI 10.1016/S0168-583X(98)00952-5
   BADER A, 2003, INT J ARTIF ORGANS, V26, P840
   Barbotteau Y, 2004, NUCL INSTRUM METH B, V215, P214, DOI 10.1016/S0168-583X(03)01785-3
   Barbour J. C., 1995, HDB MODERN ION BEAM
   BAUMAN S, 1984, NUCL INSTRUM METH B, V3, P203, DOI 10.1016/0168-583X(84)90363-X
   BAVINGTON PR, 1969, DATA REDUCTION ERROR
   BISWAS SK, 1984, NUCL INSTRUM METH B, P337
   Boyar H, 2003, SPECTROSC-INT J, V17, P627, DOI 10.1155/2003/826545
   BRAZDES L, 2000, OSTEOPOROSIS S3, V11, pP102
   Brazdes L, 1999, ROM J PHYS, V44, P149
   BURTSCHER P, 2003, COMMUNICATION
   CALASTRINI F, 1998, NUCL INSTRUM METH B, V137, P975
   CAMPBELL JL, 1993, NUCL INSTRUM METH B, V77, P95, DOI 10.1016/0168-583X(93)95530-I
   CAMPBELL JL, 1984, NUCL INSTRUM METH B, V3, P185, DOI 10.1016/0168-583X(84)90361-6
   CAMUSSI A, 1986, METODISTAISTICI SPER
   CARUSO E, 1986, PHYS ENV BIOMEDICAL
   Carvalho ML, 1998, NUCL INSTRUM METH B, V136, P913, DOI 10.1016/S0168-583X(97)00760-X
   Chaudhri MA, 1995, NUTRITION, V11, P538
   CHOLEWA M, 1987, NUCL INSTRUM METH B, V22, P423, DOI 10.1016/0168-583X(87)90370-3
   CLAYTON E, 1985, ANAL CHEM, V57, P1075, DOI 10.1021/ac00283a025
   CLAYTON E, 1987, NUCL INSTRUM METH B, V22, P145, DOI 10.1016/0168-583X(87)90312-0
   COHEN DD, 1987, NUCL INSTRUM METH B, V22, P59, DOI 10.1016/0168-583X(87)90294-1
   Cohen DD, 2002, NUCL INSTRUM METH B, V189, P81, DOI 10.1016/S0168-583X(01)01011-4
   COHEN DD, 1985, ATOM DATA NUCL DATA, V33, P255, DOI 10.1016/0092-640X(85)90004-X
   Craig RG, 1997, RESTORATIVE DENT MAT
   Dahl JE, 1999, SCAND J WORK ENV HEA, V25, P285, DOI 10.5271/sjweh.436
   Ekmekcioglu C, 2001, NAHRUNG, V45, P309, DOI 10.1002/1521-3803(20011001)45:5<309::AID-FOOD309>3.0.CO;2-0
   Finet B, 2000, MATER LETT, V43, P159, DOI 10.1016/S0167-577X(99)00251-7
   Fontana M, 1999, AM J DENT, V12, pS8
   GARTEN RPH, 1984, TRAC-TREND ANAL CHEM, V3, P152, DOI 10.1016/0165-9936(84)88009-7
   Georgescu R., 1998, P S BALK PHYS LETT, V5, P1757
   Gomez S, 1999, BONE, V25, P33, DOI 10.1016/S8756-3282(99)00102-7
   Heintze SD, 1999, AM J DENT, V12, pS4
   HIRVONEN JP, 1995, HDB MODERN ION BEAM
   Jankuhn S, 2000, NUCL INSTRUM METH B, V161, P894, DOI 10.1016/S0168-583X(99)00954-4
   Johansson S A E, 1995, CHEM ANAL, V133
   JOHANSSON SAE, 1976, NUCL INSTRUM METHODS, V137, P473, DOI 10.1016/0029-554X(76)90470-5
   JOHANSSON SAE, 1988, PIXE NOVEL TECHNIQUE
   JOHNSON RA, 1988, APPL MULTIVARIATE ST
   KAJFOSZ J, 1984, NUCL INSTRUM METH B, V3, P147, DOI 10.1016/0168-583X(84)90352-5
   KAUFMANN HC, 1984, NUCL INSTRUM METH B, V3, P198, DOI 10.1016/0168-583X(84)90362-8
   Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2
   KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P307, DOI 10.1063/1.555594
   Kruse-Jarres J D, 1987, J Trace Elem Electrolytes Health Dis, V1, P5
   Lane DW, 1996, NUCL INSTRUM METH B, V118, P392, DOI 10.1016/0168-583X(95)01181-1
   LAZZARI E, 1976, DENT BIOCH
   Leavitt J. A., 1995, HDB MODERN ION BEAM
   LINDH U, 1980, J RADIOANAL CHEM, V59, P167, DOI 10.1007/BF02516846
   MAXWELL JA, 1995, NUCL INSTRUM METH B, V95, P407, DOI 10.1016/0168-583X(94)00540-0
   MORENO EC, 1974, J DENT RES, V53, P226, DOI 10.1177/00220345740530020901
   MORO R, 1986, PHYS ENV BIOM RES
   Morohashi T, 2002, ARCH ORAL BIOL, V47, P499, DOI 10.1016/S0003-9969(02)00016-X
   NENITESCU CD, 1984, GEN CHEM
   Nie HL, 1999, BIOL TRACE ELEM RES, V71-2, P623, DOI 10.1007/BF02784252
   ORLIC I, 1990, NUCL INSTRUM METH B, V49, P166, DOI 10.1016/0168-583X(90)90236-N
   OSTROWSKI K, 1974, ANN NY ACAD SCI, V238, P186, DOI 10.1111/j.1749-6632.1974.tb26788.x
   PETRASCU M, 1984, NUCL INSTRUM METH B, V4, P396, DOI 10.1016/0168-583X(84)90585-8
   POPESCU A, 1981, SPECIAL BIOCH DENT
   POPESCU A, 1980, MED BIOCH
   Potocek V, 1996, NUCL INSTRUM METH B, V109, P197, DOI 10.1016/0168-583X(95)00905-1
   Prasad AS, 1988, ESSENTIAL TOXIC TRAC
   Preoteasa E. A., 2003, International Journal of Artificial Organs, V26, P840
   PREOTEASA EA, 1991, J RADIOAN NUCL CH AR, V151, P261, DOI 10.1007/BF02035484
   Preoteasa EA, 2002, NUCL INSTRUM METH B, V189, P426, DOI 10.1016/S0168-583X(01)01119-3
   PREOTEASA EA, 2003, IN PRESS ANN U BUCHA
   PREOTEASA EA, 2003, P 3 INT C INSTR METH, P417
   PREOTEASA EA, 2003, IN PRESS P INT C APP
   PREOTEASA EA, 2003, 33 C SPECTR 7 12 SEP, P718
   PREOTEASA EA, 2003, P 3 INT C INSTR METH, P413
   PREOTEASA EA, 2003, 33 C SPECTR 7 12 SEP, P566
   Prozesky VM, 2000, NUCL INSTRUM METH B, V161, P852, DOI 10.1016/S0168-583X(99)00895-2
   Randall LE, 2002, CONNECT TISSUE RES, V43, P205, DOI 10.1080/03008200290000538
   Reiche I, 1999, NUCL INSTRUM METH B, V150, P656, DOI 10.1016/S0168-583X(98)00949-5
   Reinert T, 1998, NUCL INSTRUM METH B, V136, P936, DOI 10.1016/S0168-583X(97)00784-2
   RESPALDIZA MA, 1987, NUCL INSTRUM METH B, V22, P446, DOI 10.1016/0168-583X(87)90376-4
   ROGERS PSZ, 1987, NUCL INSTRUM METH B, V22, P133, DOI 10.1016/0168-583X(87)90310-7
   ROKITA E, 1994, INT J PIXE, V4, P37
   Ryan CG, 2001, NUCL INSTRUM METH B, V181, P170, DOI 10.1016/S0168-583X(01)00374-3
   Salem S. I., 1974, Atomic Data and Nuclear Data Tables, V14, P91, DOI 10.1016/S0092-640X(74)80017-3
   Schiffner U, 1999, AM J DENT, V12, pS10
   SEIGEL RC, 1979, INT REV CONNECT TISS, V8, P73
   Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73
   Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159
   Sletten GBG, 1999, ACTA ODONTOL SCAND, V57, P316, DOI 10.1080/000163599428544
   SOMMER F, 1987, NUCL INSTRUM METH B, V22, P128, DOI 10.1016/0168-583X(87)90309-0
   SVALBE ID, 1984, NUCL INSTRUM METH B, V3, P651, DOI 10.1016/0168-583X(84)90456-7
   SVALBE ID, 1984, NUCL INSTRUM METH B, V3, P648, DOI 10.1016/0168-583X(84)90455-5
   TALREGA R, 1994, DAMAGE MECH COMPOSIT
   THELLIER M, 1993, METHOD ENZYMOL, V227, P535, DOI 10.1016/0076-6879(93)27023-A
   TORRISI L, 1986, PHYS ENV BIOMEDICAL
   VALKOVIC V, 1980, ANAL BIOL MAT TRACE
   Veigele Wm. J., 1973, Atomic Data, V5, P51, DOI 10.1016/S0092-640X(73)80015-4
   *VIV SCHAAN, 1999, TETR CER PROD INF
   VIZKELETHY G, 1995, HDB MODERN ION BEAM
   Warren MW, 2002, FORENSIC SCI INT, V125, P37, DOI 10.1016/S0379-0738(01)00614-4
   WOITTIEZ JRW, 1980, J RADIOANAL CHEM, V59, P213, DOI 10.1007/BF02516849
   Woltgens J H, 1991, J Biol Buccale, V19, P125
   WOOLSON RF, 1987, STAT METHODS ANAL BI
   YAMADA G, 1988, BIOL TRACE ELEM RES, V62, P75
   Ynsa MD, 2002, NUCL INSTRUM METH B, V189, P431, DOI 10.1016/S0168-583X(01)01120-X
   Ytrehus B, 1999, J WILDLIFE DIS, V35, P204, DOI 10.7589/0090-3558-35.2.204
   Zaichick V, 1999, APPL RADIAT ISOTOPES, V50, P283, DOI 10.1016/S0969-8043(97)10150-6
   Zhang YX, 2002, BIOL TRACE ELEM RES, V86, P65, DOI 10.1385/BTER:86:1:65
   Zipkin I., 1973, BIOL MINERALIZATION
NR 110
TC 14
Z9 14
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD JUL
PY 2004
VL 379
IS 5-6
BP 825
EP 841
DI 10.1007/s00216-004-2656-4
PG 17
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 848NK
UT WOS:000223474200015
PM 15179536
DA 2018-10-20
ER

PT J
AU Lavik, E
   Langer, R
AF Lavik, E
   Langer, R
TI Tissue engineering: current state and perspectives
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
ID NEURAL STEM-CELLS; GROWTH-FACTOR DELIVERY; RAT SPINAL-CORD; IN-VIVO;
   DRUG-DELIVERY; BIODEGRADABLE POLYMER; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; FUNCTIONAL-PROPERTIES; SURFACE MODIFICATION
AB Tissue engineering is an interdisciplinary field that involves cell biology, materials science, reactor engineering, and clinical research with the goal of creating new tissues and organs. Significant advances in tissue engineering have been made through improving singular aspects within the overall approach, e.g., materials design, reactor design, or cell source. Increasingly, however, advances are being made by combining several areas to create environments which promote the development of new tissues whose properties more closely match their native counterparts. This approach does not seek to reproduce all the complexities involved in development, but rather seeks to promote an environment which permits the native capacity of cells to integrate, differentiate, and develop new tissues. Progenitors and stem cells will play a critical role in understanding and developing new engineered tissues as part of this approach.
C1 Yale Univ, New Haven, CT 06520 USA.
   MIT, Cambridge, MA 02139 USA.
RP Lavik, E (reprint author), Yale Univ, POB 208284, New Haven, CT 06520 USA.
EM erin.lavik@yale.edu
CR Alison MR, 2002, J PATHOL, V197, P417, DOI 10.1002/path.1188
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Arevalo-Silva CA, 2000, ARCH OTOLARYNGOL, V126, P1448, DOI 10.1001/archotol.126.12.1448
   Atala A, 2000, WORLD J UROL, V18, P364, DOI 10.1007/s003450000152
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3
   Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen XY, 2003, POLYM J, V35, P148, DOI 10.1295/polymj.35.148
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Dang WB, 1996, J CONTROL RELEASE, V42, P83, DOI 10.1016/0168-3659(96)01371-5
   Dang WB, 1996, PHARMACEUT RES, V13, P683, DOI 10.1023/A:1016035229961
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freyman TM, 2001, BIOMATERIALS, V22, P2883, DOI 10.1016/S0142-9612(01)00034-5
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   Fu K, 2003, J PHARM SCI, V92, P1582, DOI 10.1002/jps.10414
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Garellick G, 1999, J ARTHROPLASTY, V14, P407, DOI 10.1016/S0883-5403(99)90095-5
   Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Hori Y, 2002, J SURG RES, V102, P156, DOI 10.1006/jsre.2001.6294
   HRKACH JS, 1995, MACROMOLECULES, V28, P4736, DOI 10.1021/ma00117a055
   Hrkach JS, 1996, ACS SYM SER, V627, P93
   Hunkeler D, 1997, TRENDS POLYM SCI, V5, P286
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5
   Jackson KA, 2002, J CELL BIOCHEM, P1, DOI 10.1002/jcb.10045
   Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Kipper MJ, 2002, BIOMATERIALS, V23, P4405, DOI 10.1016/S0142-9612(02)00181-3
   Kwon KW, 2002, POLYMER, V43, P3353, DOI 10.1016/S0032-3861(02)00155-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Lavik EB, 2001, J BIOMED MATER RES, V58, P291, DOI 10.1002/1097-4636(2001)58:3<291::AID-JBM1019>3.0.CO;2-N
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   LEWIS DD, 1990, BIODEGRADABLE POLYM
   Liu S, 1997, J NEUROSCI RES, V49, P425, DOI 10.1002/(SICI)1097-4547(19970815)49:4<425::AID-JNR4>3.0.CO;2-A
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Liu YC, 2002, TISSUE ENG, V8, P709, DOI 10.1089/107632702760240616
   Lu B, 2002, BRAIN RES, V943, P292, DOI 10.1016/S0006-8993(02)02906-2
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8
   Murayama A, 2002, J NEUROSCI RES, V69, P837, DOI 10.1002/jnr.10339
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nam YS, 1999, J MICROENCAPSUL, V16, P625
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nicolau DV, 1999, BIOSENS BIOELECTRON, V14, P317, DOI 10.1016/S0956-5663(98)00133-X
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   O'Connell P, 2002, XENOTRANSPLANTATION, V9, P367, DOI 10.1034/j.1399-3089.2002.02056_1.x
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Pomahac B, 1998, CRIT REV ORAL BIOL M, V9, P333, DOI 10.1177/10454411980090030601
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   PORT F, 2002, OPTN SRTS ANN REPORT
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Ruiz L, 1999, J BIOMAT SCI-POLYM E, V10, P931, DOI 10.1163/156856299X00540
   Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970
   Shaw D, 2003, J CRANIOFAC SURG, V14, P308, DOI 10.1097/00001665-200305000-00008
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435
   Sodian R, 2002, TISSUE ENG, V8, P863, DOI 10.1089/10763270260424222
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Solter D, 1999, SCIENCE, V283, P1468, DOI 10.1126/science.283.5407.1468
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thomas PA, 1997, J CONTROL RELEASE, V43, P273, DOI 10.1016/S0168-3659(96)01497-6
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Vacanti JP, 1999, LANCET, V354, pSI32
   Vacanti MP, 2001, TRANSPLANT P, V33, P592, DOI 10.1016/S0041-1345(00)02158-8
   Vert M, 1998, J CONTROL RELEASE, V53, P85, DOI 10.1016/S0168-3659(97)00240-X
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Watson MS, 2002, ADV MATER, V14, P1802, DOI 10.1002/adma.200290003
   Weber M, 2002, BIOMATERIALS, V23, P2003, DOI 10.1016/S0142-9612(01)00329-5
   WEISSMAN I, 1997, STEM CELLS LESSONS H
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 129
TC 206
Z9 233
U1 3
U2 40
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUL
PY 2004
VL 65
IS 1
BP 1
EP 8
DI 10.1007/s00253-004-1580-z
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 831UM
UT WOS:000222221800001
PM 15221227
DA 2018-10-20
ER

PT J
AU Puskas, JE
   Chen, YH
AF Puskas, JE
   Chen, YH
TI Biomedical application of commercial polymers and novel
   polyisobutylene-based thermoplastic elastomers for soft tissue
   replacement
SO BIOMACROMOLECULES
LA English
DT Article; Proceedings Paper
CT 160th Meeting of the Rubber Division of the American-Chemical-Society
CY APR 28-30, 2003
CL San Francisco, CA
SP Amer Chem Soc
ID SILICONE BREAST IMPLANTS; POLYURETHANE-COATED PROSTHESES; BIOPROSTHETIC
   HEART-VALVES; VASCULAR GRAFTS; BLOCK-COPOLYMERS; CARBOCATIONIC
   POLYMERIZATION; MECHANICAL ANALYSIS; CORONARY-ARTERIES; MEME IMPLANT;
   VEIN GRAFTS
AB Novel polyisobutylene-based thermoplastic elastomers are introduced as prospective implant materials for soft tissue replacement and reconstruction. In comparison, poly(ethylene terephthalate) (PET), poly(tetrafluoroethylene) (PTFE), polypropylene (PP), polyurethanes (PU), and silicones are outlined from well-established implant history as being relatively inert and biocompatible biomaterials for soft tissue replacement, especially in vascular grafts and breast implants. Some general considerations for the design and development of polymers for soft tissue replacement are reviewed from the viewpoint of material science and engineenng, with special attention to synthetic materials used in vascular grafts and breast implants.
C1 Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Puskas, JE (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
CR Allison AC, 1996, CURR TOP MICROBIOL, V210, P147
   AMIN P, 1993, J BIOMED MATER RES, V27, P655, DOI 10.1002/jbm.820270513
   [Anonymous], 2001, U.S. Patent, Patent No. [6,197,240, 6197240]
   ASAKURA T, 1990, CIRC RES, V66, P1045, DOI 10.1161/01.RES.66.4.1045
   AUTIAN J, 1961, Am J Hosp Pharm, V18, P329
   BAKKER D, 1990, J BIOMED MATER RES, V24, P489, DOI 10.1002/jbm.820240407
   Batich C, 1996, CURR TOP MICROBIOL, V210, P13
   BATICH C, 1992, J LONG-TERM EFF MED, V1, P255
   Black J, 1998, HDB BIOMATERIALS PRO
   BORETOS JW, 1973, CONCISE GUIDE BIOMED
   BOWLIN GL, 2000, BIOMATERIALS ENG DEV, V1, P85
   Brandon HJ, 2001, PLAST RECONSTR SURG, V108, P647, DOI 10.1097/00006534-200109010-00008
   Braybrook J.H., 1997, BIOCOMPATIBILITY ASS
   BRODY GS, 1984, PLAST RECONSTR SURG, V73, P420
   Bronzino J.D, 2000, BIOMEDICAL ENG HDB, V1
   Brown SL, 1997, LANCET, V350, P1531, DOI 10.1016/S0140-6736(97)03164-4
   BRUCK SD, 1985, INT J ARTIF ORGANS, V8, P65
   BURTON AC, 1965, PHYSL BIOPHYSICS CIR, P76
   Cadieux P., 2002, J COLL SURF B, V28, P95
   CAEUANA CM, 1999, CHEM ENG PROG
   CALRSON SJ, 1993, SILOXANE POLYM
   Chinn JA, 1998, J BIOMED MATER RES, V39, P130, DOI 10.1002/(SICI)1097-4636(19980101)39:1<130::AID-JBM15>3.0.CO;2-J
   CHRIST FR, 1992, J BIOMED MATER RES, V26, P607
   Cook RR, 1998, LANCET, V351, P520, DOI 10.1016/S0140-6736(05)78710-9
   Crawford DM, 2001, THERMOCHIM ACTA, V367, P125, DOI 10.1016/S0040-6031(00)00692-4
   Deacon J, 1985, P 11 ANN M SOC BIOM, P205
   Dumitriu S., 2002, POLYM BIOMATERIALS
   EDWARDS WS, 1978, ARCH SURG-CHICAGO, V113, P1225
   Elices M., 2000, STRUCTURAL BIOL MAT
   EYSSEN JE, 1984, PLAST RECONSTR SURG, V73, P415, DOI 10.1097/00006534-198403000-00013
   FELDMAN DS, 1995, ENCY HDB BIOMATERIAL, V1, P223
   FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488
   GLAGOV S, 1984, BLOOD VESSELS LYMPHA, pCH1
   Goldberg EP, 1997, PLAST RECONSTR SURG, V99, P258, DOI 10.1097/00006534-199701000-00050
   Goldberg EP, 1985, P 11 ANN M SOC BIOM, P208
   Greenwald DP, 1996, PLAST RECONSTR SURG, V98, P269, DOI 10.1097/00006534-199608000-00008
   Guidoin R, 1997, ASAIO J, V43, P69, DOI 10.1097/00002480-199701000-00013
   HAMLIN GW, 1978, BRIT J SURG, V65, P272, DOI 10.1002/bjs.1800650416
   Hardhammar PA, 1996, CIRCULATION, V93, P423, DOI 10.1161/01.CIR.93.3.423
   Harper CA, 2000, MODERN PLASTICS HDB
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HERGENROTHER RW, 1992, J APPL BIOMATER, V3, P17, DOI 10.1002/jab.770030104
   HERMAN S, 1984, PLAST RECONSTR SURG, V73, P411, DOI 10.1097/00006534-198403000-00012
   JO H, 1991, AM J PHYSIOL, V260, pH1992
   Jones D., 1988, ELASTOMERICS, V120, P12
   *KAN CORP, 2002, TECHN INF MSDS DAT S
   Kennedy J.P., 1990, U.S. Patent, Patent No. [4,946,899, 4946899]
   KENNEDY JP, 1993, MACROMOLECULES, V26, P567, DOI 10.1021/ma00056a002
   Kennedy JP, 2001, MACROMOL SYMP, V175, P127, DOI 10.1002/1521-3900(200110)175:1<127::AID-MASY127>3.0.CO;2-X
   KENNEDY JP, 2000, DESIGNED RUBBERY BIO, V2, P712
   KENNEDY JP, 1994, TAILORING POLYM BIOL, P24
   KIM HG, 1983, J COLLOID INTERF SCI, V157, P82
   KINLEY CE, 1980, J CARDIOVASC SURG, V21, P163
   KLIPADI DV, 2000, BIOMATERIALS ENG DEV, V1, P57
   KOSSOVSKY N, 1992, J APPL BIOMATER, V3, P239, DOI 10.1002/jab.770030313
   *KUR CO LTD TSUK R, 1997, TS POLYM DAT SHEET
   Kwon Y, 2002, POLYM PREPR, V43, P266
   Laemmel E, 1998, J BIOMED MATER RES, V39, P446, DOI 10.1002/(SICI)1097-4636(19980305)39:3<446::AID-JBM14>3.0.CO;2-8
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lane TH, 1996, CURR TOP MICROBIOL, V210, P3
   LEE H, 1971, HDB BIOMEDICAL PLAST, P6
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LEE JH, 1994, J POLYM SCI POL CHEM, V32, P1569, DOI 10.1002/pola.1994.080320818
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   Lykissa ED, 1997, ANAL CHEM, V69, P4912, DOI 10.1021/ac970710w
   NOJIRI C, 1995, ARTIF ORGANS, V19, P32, DOI 10.1111/j.1525-1594.1995.tb02241.x
   NUTTELMAN CR, 2000, POLYM PREPR, V41, P1685
   OJHA M, 1994, CIRC RES, V74, P1227, DOI 10.1161/01.RES.74.6.1227
   OKADOME K, 1989, J CARDIOVASC SURG, V30, P932
   Pangman W.J., 1958, US Patent, Patent No. 2842775
   PANGMAN WJ, 1965, Patent No. 3189921
   Park JB, 1984, BIOMATERIALS SCI ENG
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Peters W J, 1981, Ann Plast Surg, V6, P179, DOI 10.1097/00000637-198103000-00002
   Phillips JW, 1996, PLAST RECONSTR SURG, V97, P1215, DOI 10.1097/00006534-199605000-00017
   Pinchuk L, 1988, J Biomater Appl, V3, P260, DOI 10.1177/088532828800300206
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Pinchuk L., 1993, U. S. patent, Patent No. [5, 229 , 431 -A, 5229431]
   PINCHUK L, 1991, T 17 ANN M SOC BIOM, P98
   PINCHUK L, 1993, T 19 ANN M SOC BIOM, P22
   PINCHUK L, 1992, Patent No. 5144742
   PINCHUK L, 2001, POLYISOBUTYLENE BASE, P1452
   Pinchuk L, 1998, US Patent, Patent No. [5,741,331, 5741331, no 5,741331]
   Pinchuk L, 2000, US Patent, Patent No. [6,102,939, 6102939]
   Prowans P, 2002, BIOMATERIALS, V23, P2973, DOI 10.1016/S0142-9612(02)00026-1
   Puskas J.E., 2002, [No title captured], Patent No. [6,495,647, 6495647]
   Puskas J.E., 2001, U.S. Patent, Patent No. [2,268,446, 2268446]
   Puskas JE, 2003, POLYM ADVAN TECHNOL, V14, P763, DOI 10.1002/pat.392
   Puskas JE, 2001, MACROMOL MATER ENG, V286, P565, DOI 10.1002/1439-2054(20011001)286:10<565::AID-MAME565>3.0.CO;2-E
   Puskas JE, 2000, PROG POLYM SCI, V25, P403, DOI 10.1016/S0079-6700(00)00010-1
   PUSKAS JE, IN PRESS J POLYM SCI
   PUSKAS JE, 2002, NOVEL HIGHLY BRANCHE
   QIN Y, 1996, ASAIO J, pM702
   RATTNER BD, 1996, BIOMATERIALS SCI INT
   RHEE K, 1994, J BIOMECH, V27, P329, DOI 10.1016/0021-9290(94)90009-4
   RITTGERS SE, 1978, CIRC RES, V42, P792, DOI 10.1161/01.RES.42.6.792
   Rohrich RJ, 1996, PLAST RECONSTR SURG, V98, P553, DOI 10.1097/00006534-199609000-00032
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   SCHOEN FJ, 1992, J THORAC CARDIOV SUR, V104, P1285
   Shadwick RE, 1998, AM SCI, V86, P535, DOI 10.1511/1998.43.798
   Song J, 2002, J POLYM SCI POL CHEM, V40, P1005, DOI 10.1002/pola.10193
   STOKES K, 1988, J BIOMATER APPL, V3, P284
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STRANDNESS DE, 1975, HEMODUNAMICS SURG
   SZYCHER M, 1988, J BIOMATER APPL, V3, P383
   SZYCHER M, 1985, ASTM STP, V859, P308
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P342
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   TOMIZAWA Y, 1995, ARTIF ORGANS, V19, P39, DOI 10.1111/j.1525-1594.1995.tb02242.x
   Toub MR, 1987, ELASTOMERICS, V119, P20
   Tse MF, 2000, POLYM ENG SCI, V40, P2182, DOI 10.1002/pen.11350
   Tseng DY, 1998, J BIOMED MATER RES, V42, P188, DOI 10.1002/(SICI)1097-4636(199811)42:2<188::AID-JBM4>3.0.CO;2-L
   vonRecum AF, 1999, HDB BIOMATERIALS EVA
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   WABERS HD, 1992, J BIOMAT SCI-POLYM E, V4, P107
   WALDEN R, 1980, ARCH SURG-CHICAGO, V115, P1166
   WHITE KA, 1985, P 11 ANN M SOC BIOMA, P57
   WILLIAMS DF, 1986, DEFINITIONS BIOMATER, P49
   WINTERMANTEL E, 2002, MEDIZINTESCHNIK BIOC, V3
   Wolf CJ, 2000, J BIOMAT SCI-POLYM E, V11, P1007, DOI 10.1163/156856200743544
   Wolf CJ, 1996, CURR TOP MICROBIOL, V210, P25
   YU J, 1994, INT J ARTIF ORGANS, V17, P499
   YU L, 1995, PLAST RECONSTR SURG, V97, P756
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zhuang YJ, 1998, EUR J VASC ENDOVASC, V16, P301, DOI 10.1016/S1078-5884(98)80049-X
   2000, BREAST IMPLANTS INTR
   1995, PERMEABILITY FILM PR
   1965, USP PHARM USA, P902
NR 129
TC 153
Z9 159
U1 4
U2 68
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL-AUG
PY 2004
VL 5
IS 4
BP 1141
EP 1154
DI 10.1021/bm034513k
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 837VG
UT WOS:000222668500001
PM 15244424
DA 2018-10-20
ER

PT J
AU Fussell, GW
   Cooper, SL
AF Fussell, GW
   Cooper, SL
TI Synthesis and characterization of acrylic terpolymers with RGD peptides
   for biomedical applications
SO BIOMATERIALS
LA English
DT Article
DE acrylic; RGD; vascular grafts; neutralization; chain transfer
ID ENDOTHELIAL-CELLS; VASCULAR GRAFTS; ATTACHMENT; ADHESION; BIOMATERIALS;
   FIBRONECTIN; RECEPTORS; POLYMERS; SURFACES
AB The goal of this research was to design a biomaterial, using acrylic terpolymers, which could support endothelial cells and function in small diameter vascular graft applications. Hexyl methacrylate (HMA) and octyl methacrylate (OMA) were used as comonomers to produce a material with a low glass transition temperature (T-g). Methacrylic acid (MAA) was used to provide ionic character. and methyl methacrylate (MMA) was selected because of its wide usage in biomedical applications. Cation neutralization was employed to modify the mechanical properties. RGD-based peptide sequences were attached to promote endothelial cell adhesion, because vascular grafts seeded with endothelial cells have fewer problems with thrombosis. The two methods used to incorporate peptide sequences were a chain transfer reaction during polymerization, and a coupling reaction attaching the peptides to carboxyl groups on the polymer after polymerization.
   The compositions that produced T(g)s of approximately 0degreesC were 75 mol% OMA and 92 mol% HMA. The Young's modulus of the HMA copolymer was approximately 0.37 MPa, well below the desired value of 0.9 MPa. Likewise, the Young's modulus of approximately 0.50 MPa for the OMA copolymer was also below the desired value. After partial neutralization with sodium cations, the Young's moduli increased to approximately 0.93 and 0.99 MPa, respectively. The chain transfer reaction lowered the molecular weights and mechanical properties of the copolymers, while the coupling reaction method had little effect on these properties. The chain transfer method appears to be a promising one-step method to produce polymers with a wide range of peptide concentrations. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.
RP Fussell, GW (reprint author), Drexel Univ, 2710 Jacqueline Dr,Apt L-12, Wilmington, DE 19810 USA.
EM gwf25@drexel.edu; scooper@unity.ncsu.edu
FU NHLBI NIH HHS [HL57917]
CR Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Bos GW, 1999, J BIOMED MATER RES, V44, P330, DOI 10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O
   Bowlin GL, 2001, J BIOMATER APPL, V16, P157, DOI 10.1106/NCQT-JFV9-2EQ1-EBGU
   BOYD KL, 1988, J BIOMED MATER RES, V22, P163, DOI 10.1002/jbm.820220302
   Bruining MJ, 2002, BIOMATERIALS, V23, P1213, DOI 10.1016/S0142-9612(01)00237-X
   BURKEL WE, 1987, ANN NY ACAD SCI, V516, P131, DOI 10.1111/j.1749-6632.1987.tb33036.x
   CARRUTHERS JDA, 1986, CAN J OPHTHALMOL, V21, P84
   Casazza E, 2002, POLYMER, V43, P1207, DOI 10.1016/S0032-3861(01)00722-4
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471
   COLEMAN MM, 1990, MACROMOLECULES, V23, P2339, DOI 10.1021/ma00210a033
   Coury Arthur J., 1996, P243
   DIDISHEIM P, 1996, BIOMATERIALS SCI INT, P283
   Fox G., 1956, B AM PHYS SOC, V1, P123
   FOXALL TL, 1986, J SURG RES, V41, P158, DOI 10.1016/0022-4804(86)90021-1
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Iayadene F, 1998, EUR POLYM J, V34, P219, DOI 10.1016/S0014-3057(97)00099-2
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Kerby RE, 2003, J ORAL REHABIL, V30, P780, DOI 10.1046/j.1365-2842.2003.01153.x
   KRALOVICH K, 2000, COMMUNICATION
   Krasia T, 2003, CHEM COMMUN, P538, DOI 10.1039/b212634f
   Lamba NMK, 1998, FRONTIERS TISSUE ENG, P121
   LAMBA NMK, 1999, TISSUE ENG VASCULAR, P553
   Ma YH, 2003, BIOMACROMOLECULES, V4, P864, DOI 10.1021/bm034118u
   MAZZUCOTELLI JP, 1994, INT J ARTIF ORGANS, V17, P112
   MILLERMJ, 1998, FRONTIERS TISSUE ENG, P213
   Murugesan G, 2000, J BIOMED MATER RES, V49, P396, DOI 10.1002/(SICI)1097-4636(20000305)49:3<396::AID-JBM13>3.0.CO;2-H
   NEMEC JW, 1985, ENCY POLYM SCI ENG, P201
   PAINTER PC, 1997, FUNDAMENTALS POLYM S, P478
   Parzuchowski PG, 2002, J AM CHEM SOC, V124, P12182, DOI 10.1021/ja020268l
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RAVVE A, 1995, PRINCIPLES POLYM CHE, P496
   Risbud MV, 2002, J BIOMAT SCI-POLYM E, V13, P1067, DOI 10.1163/156856202320813792
   ROBINS D, 1992, BR J THEATRE NURS, V12, P9
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   SAKARIASSEN KS, 1987, ANN NY ACAD SCI, V516, P52, DOI 10.1111/j.1749-6632.1987.tb33029.x
   Salacinski HJ, 2001, ARTIF ORGANS, V25, P974, DOI 10.1046/j.1525-1594.2001.06716.x
   SANK A, 1992, AM J SURG, V164, P199, DOI 10.1016/S0002-9610(05)81070-0
   SCHARF RE, 1987, BLUT, V55, P131, DOI 10.1007/BF00320567
   SZYMANSKI HA, 1968, NMR BAND HDB, P399
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   VANE JR, 1990, NEW ENGL J MED, V323, P27
   Williams DF, 1999, WILLIAMS DICT BIOMAT, P343
NR 45
TC 34
Z9 35
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2004
VL 25
IS 15
BP 2971
EP 2978
DI 10.1016/j.biomaterials.2003.09.062
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778CM
UT WOS:000189221600008
PM 14967529
DA 2018-10-20
ER

PT J
AU Wang, J
   Huang, N
   Yang, P
   Leng, Y
   Sun, H
   Liu, ZY
   Chu, PK
AF Wang, J
   Huang, N
   Yang, P
   Leng, Y
   Sun, H
   Liu, ZY
   Chu, PK
TI The effects of amorphous carbon films deposited on polyethylene
   terephthalate on bacterial adhesion
SO BIOMATERIALS
LA English
DT Article
DE plasma immersion ion implantation-D (PIII-D); amorphous polymer-like
   carbon film (PLC); polyethylene terephthalate (PET); bacteria adhesion
ID PROSTHETIC VALVE ENDOCARDITIS; CONTACT-ANGLE GONIOMETRY; SOURCE
   ION-IMPLANTATION; MEDICAL DEVICES; SOLID-SURFACES; PLASMA; INFECTION;
   RELEASE; ENERGY
AB There is an increasing interest in developing new methods to reduce bacteria adhesion onto polymeric materials that are used in biomedical implants. The antibacterial behavior on polyethylene terephthalate (PET) treated by acetylene (C2H2) plasma immersion ion implantation-deposition (PIII-D) is investigated. The surface structure of the treated PET is determined by laser Raman spectroscopy, X-ray photoelectron spectroscopy (XPS) and attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR). The results show that a thin amorphous polymer-like carbon (PLC) layer is formed on the PET surface. Atomic force micrographs (AFM) show that C2H2 PIII-D significantly changes the surface morphology of PET. The capacities of Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE) to adhere onto PET are quantitatively determined by plate counting and Gamma-ray counting of I-125 radio labeled bacteria in vitro. The results indicate that the adhesion of the two kinds of bacteria to PET is suppressed by PLC. The adhesion efficiency of SE on the coated surface is only about 14% of that of the untreated PET surface, and that of SA is about 35% of that of the virgin surface. The electrokinetic potentials of the bacterial cells and substrates are determined by zeta potential measurement. All the substrates as well as the bacterial strain have negative zeta potentials, and it means that bacterial adhesion is not mediated by electrostatic interactions. The surface energy components of the various substrates and bacteria are calculated based on measurements in water, formamide and diiodomethane. The surface free energies obtained are used to calculate the interfacial free energies of adhesion (DeltaF(Adh)) of SA and SE onto various substrates, and it is found that bacterial adhesion is energetically unfavorable on the PLC deposited on PET by C2H2 PIII-D. (C) 2003 Elsevier Ltd. All rights reserved.
C1 SW Jiaotong Univ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Southeast Univ, Coll Med, Affiliated Hosp, Nanjing 210009, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Leng, Y.X./C-2278-2012; Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   CALDERWOOD SB, 1985, CIRCULATION, V72, P31, DOI 10.1161/01.CIR.72.1.31
   Davenas J, 2002, BIOMOL ENG, V19, P263, DOI 10.1016/S1389-0344(02)00037-0
   Desgranges P, 2001, J BIOMED MATER RES, V58, P1, DOI 10.1002/1097-4636(2001)58:1<1::AID-JBM10>3.0.CO;2-8
   Dewanjee MK, 1999, J HEART VALVE DIS, V8, P324
   HOLLANDER A, 1995, J COLLOID INTERF SCI, V169, P493, DOI 10.1006/jcis.1995.1060
   IVERT TSA, 1984, CIRCULATION, V69, P223, DOI 10.1161/01.CIR.69.2.223
   James NR, 2003, BIOMATERIALS, V24, P2205, DOI 10.1016/S0142-9612(03)00022-X
   KARCK M, 1993, CLIN MATER, V13, P149, DOI 10.1016/0267-6605(93)90102-D
   MCALLISTER EW, 1993, GASTROINTEST ENDOSC, V39, P422, DOI 10.1016/S0016-5107(93)70120-0
   Schneider RP, 1996, J COLLOID INTERF SCI, V182, P204, DOI 10.1006/jcis.1996.0452
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Smith TP, 2003, J NEUROSURG, V98, P421, DOI 10.3171/jns.2003.98.2.0421
   Sodhi RNS, 2001, J ELECTRON SPECTROSC, V121, P249, DOI 10.1016/S0368-2048(01)00338-3
   STAMM WE, 1978, ANN INTERN MED, V89, P764, DOI 10.7326/0003-4819-89-5-764
   Tanaka T, 2002, J VAC SCI TECHNOL A, V20, P625, DOI 10.1116/1.1458942
   THRELKELD MG, 1994, PRINCIPLES PRACTICE, P783
   Van Oss CJ, 1997, J ADHESION, V63, P71, DOI 10.1080/00218469708015214
   WAN CX, 2000, J BIOMED ENG, V17, P10
   Wantanabe S, 2002, THIN SOLID FILMS, V420, P253, DOI 10.1016/S0040-6090(02)00803-9
   Watanabe T, 2002, SURF COAT TECH, V156, P317, DOI 10.1016/S0257-8972(02)00096-8
   Weinstein RA, 2001, CLIN INFECT DIS, V33, P1386, DOI 10.1086/324190
   Yoshida M, 2003, NUCL INSTRUM METH B, V206, P712, DOI 10.1016/S0168-583X(03)00869-3
NR 24
TC 95
Z9 103
U1 1
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2004
VL 25
IS 16
BP 3163
EP 3170
DI 10.1016/j.biomaterials.2003.10.010
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 800OV
UT WOS:000220038500005
PM 14980411
DA 2018-10-20
ER

PT J
AU Kemp, JD
   Bowser, R
AF Kemp, JD
   Bowser, R
TI PhD graduate training programs in pathology: 2003 report from the
   American Society for Investigative Pathology workshop on pathology
   graduate education
SO HUMAN PATHOLOGY
LA English
DT Article
DE graduate education; curriculum
ID BASIC SCIENCE; GAP
AB Graduate training is one of the most important activities in which we engage. Through PhD training programs in pathology, we continually renew the intellectual vigor of our discipline and assure its position as a vibrant force in the life sciences. To focus on this important issue, the Education Committee of the American Society for Investigative Pathology (ASIP) organized a workshop on April 11, 2003 for pathology graduate program directors from across the United States and Canada. The goals of this workshop were to better define the current models of pathology graduate training programs, to identify key issues pertaining to the curriculum of pathology training programs and strategies to better market pathology graduate training opportunities, and to identify challenges for the future. Twenty-three program directors and other faculty interested in pathology graduate education, as well as 2 invited PhD students, attended the workshop. Workshop participants concluded that the integration of more and better disease-related education into graduate training programs would attract more and better-qualified students into pathology career pathways that will ultimately fulfill important societal needs and train future leaders of the biomedical research community. The ASIP is facilitating this goal by taking a leadership role in publicizing educational efforts in pathology and by making systematic use of its Website for sharing information about curriculum ideas and materials, as well as course syllabi. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA.
   Univ Iowa Hlth Care, Dept Pathol, Iowa City, IA USA.
RP Bowser, R (reprint author), Univ Pittsburgh, Sch Med, Dept Pathol, BST S-420,200 Lothrop St, Pittsburgh, PA 15261 USA.
CR ARIAS IM, 1989, NEW ENGL J MED, V321, P972, DOI 10.1056/NEJM198910053211412
   BUNN HF, 1995, FASEB J, V9, P1392
   Gray ML, 2002, NAT MED, V8, P433, DOI 10.1038/nm0502-433
   Juliano RL, 2001, ACAD MED, V76, P1005, DOI 10.1097/00001888-200110000-00007
   Mallon WT, 2003, ACAD MED, V78, P302, DOI 10.1097/00001888-200303000-00014
NR 5
TC 2
Z9 2
U1 0
U2 2
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0046-8177
J9 HUM PATHOL
JI Hum. Pathol.
PD JUL
PY 2004
VL 35
IS 7
BP 785
EP 789
DI 10.1016/j.humpath.2004.03.014
PG 5
WC Pathology
SC Pathology
GA 843CK
UT WOS:000223052900003
PM 15257540
DA 2018-10-20
ER

PT J
AU Liu, BS
   Yao, CH
   Hsu, SH
   Yeh, TS
   Chen, YS
   Kao, ST
AF Liu, BS
   Yao, CH
   Hsu, SH
   Yeh, TS
   Chen, YS
   Kao, ST
TI A novel use of genipin-fixed gelatin as extracellular matrix for
   peripheral nerve regeneration
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE gelatin; genipin; peripheral nerve regeneration
ID CROSS-LINKING; SCIATIC-NERVE; SCHWANN-CELLS; IN-VITRO; SILICONE TUBES;
   COLLAGEN; LAMININ; FIBRONECTIN; CHAMBERS; BIOADHESIVES
AB Application of combining herbal medicine and biomedical material science to nerve regeneration is a new approach. In this study, we describe a novel use of purified genipin, which can be extracted from Gardenia jasminoides Ellis, fixing the gelatin to be an extracellular matrix for peripheral nerve regeneration. A 10-mm gap of rat sciatic nerve was created between the proximal and distal nerve stumps, which were sutured into silicone rubber tubes filled with either the genipin-fixed gelatin or collagen gel. Silicone rubber tubes filled with saline were used as controls. Six weeks after implantation, regeneration across the nerve gaps occurred in 80 and 90% of the animals from the groups of genipin-fixed gelatin and collagen, respectively, whereas only 30% in them control group. Large numbers of myelinated axons were also seen in the genipin-fixed gelatin (5104 +/- 3278) and the collagen groups (8063 +/- 1807). These findings indicated that the genipin-fixed gelatin could be an acceptable extracellular matrix for nerve regeneration.
C1 China Med Univ, Inst Chinese Med Sci, Taichung, Taiwan.
   Chungtai Inst Hlth Sci & Technol, Dept Radiol Technol, Taichang, Taiwan.
   Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan.
RP Chen, YS (reprint author), China Med Univ, Inst Chinese Med Sci, Taichung, Taiwan.
EM yuehsc@mail.cmu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
CR BAILEY SB, 1993, J NEUROCYTOL, V22, P176, DOI 10.1007/BF01246356
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Cenni E, 2000, J BIOMAT SCI-POLYM E, V11, P685, DOI 10.1163/156856200743959
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   Dahlin LB, 2001, SCAND J PLAST RECONS, V35, P29, DOI 10.1080/02844310151032510
   Danielsen N, 1988, Brain Res, V467, P39
   den Dunnen WFA, 2000, J BIOMED MATER RES, V51, P575, DOI 10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.3.CO;2-Q
   FIELDS RD, 1989, PROG NEUROBIOL, V33, P87, DOI 10.1016/0301-0082(89)90036-1
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HOLLOWELL JP, 1990, EXP NEUROL, V110, P45, DOI 10.1016/0014-4886(90)90050-3
   KOSAKA M, 1990, EXP NEUROL, V107, P69, DOI 10.1016/0014-4886(90)90064-Y
   Mligiliche NL, 1999, E AFR MED J, V76, P400
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Mosahebi A, 2001, TISSUE ENG, V7, P525, DOI 10.1089/107632701753213156
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   SATOU T, 1986, ACTA PATHOL JAPON, V36, P199
   Strauch B, 2001, J RECONSTR MICROSURG, V17, P589, DOI 10.1055/s-2001-18812
   Sufan W, 2001, J NEUROTRAUM, V18, P329, DOI 10.1089/08977150151070991
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P751, DOI 10.1163/156856299X00621
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   TOMIHATA K, 1994, AM CHEM SOC S SERIES, V540
   VALENTINI RF, 1987, EXP NEUROL, V98, P350, DOI 10.1016/0014-4886(87)90247-0
   WANG GY, 1992, BRAIN RES, V583, P216, DOI 10.1016/S0006-8993(10)80027-7
   WOOLLEY AL, 1990, OTOLARYNG HEAD NECK, V103, P509, DOI 10.1177/019459989010300401
   Yamazaki M, 2001, J NEUROCHEM, V79, P45, DOI 10.1046/j.1471-4159.2001.00533.x
   Yoshii S, 2001, J HAND SURG-AM, V26A, P52, DOI 10.1053/jhsu.2001.20968
NR 29
TC 31
Z9 31
U1 0
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2004
VL 19
IS 1
BP 21
EP 34
DI 10.1177/0885328204042544
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 840AJ
UT WOS:000222829100002
PM 15245641
DA 2018-10-20
ER

PT J
AU Kwok, SCH
   Yang, P
   Wang, J
   Liu, XY
   Chu, PK
AF Kwok, SCH
   Yang, P
   Wang, J
   Liu, XY
   Chu, PK
TI Hemocompatibility of nitrogen-doped, hydrogen-free diamond-like carbon
   prepared by nitrogen plasma immersion ion implantation-deposition
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydrogen-free diamond-like carbon; nitrogen implantation; plasma
   immersion ion implantation-deposition; (PIII-D); blood compatibility;
   carbon nitride films
ID THIN-FILMS; BLOOD COMPATIBILITY; NITRIDE FILMS; ARC METHOD; COATINGS;
   BIOCOMPATIBILITY; BIOMATERIALS
AB Amorphous hydrogenated carbon (a-C:H) has been shown to be a potential material in biomedical devices such as artificial heart valves, bone implants, and so on because of its chemical inertness, low coefficient of friction, high wear resistance, and good biocompatibility. However, the biomedical characteristics such as blood compatibility of doped hydrogen-free diamond-like carbon (DLC) have not been investigated in details. We recently began to investigate the potential use of nitrogen-doped, hydrogen-free DLC in artificial heart valves. In our experiments, a series of hydrogen-free DLC films doped with nitrogen were synthesized by plasma immersion ion implantation-deposition (PIII-D) utilizing a pulsed vacuum arc plasma source and different N to Ar (F-N/F-Ar) gas mixtures in the plasma chamber. The structures and properties of the film were evaluated by Raman spectroscopy, Rutherford backscattering spectrometry (RBS), and X-ray photoelectron spectroscopy (XPS). To assess the blood compatibility of the films and the impact on the blood compatibility by the presence of nitrogen, platelet adhesion tests were conducted. Our results indicate that the blood compatibility of both hydrogen-free carbon films (a-C) and amorphous carbon nitride films are better than that of low-temperature isotropic pyrolytic carbon (LTIC). The experimental results are consistent with the relative theory of interfacial energy and surface tension including both dispersion and polar components. Our results also indicate that an optimal fraction of sp(2) bonding is desirable, but an excessively high nitrogen concentration degrades the properties to an extent that the biocompatibility can be worse than that of LTIC. (C) 2004 Wiley Periodicals, Inc.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu
RI Liu, Xuanyong/J-2609-2018; Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR Chang YY, 2003, DIAM RELAT MATER, V12, P2077, DOI 10.1016/S0925-9635(03)00290-5
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   CHENG YH, 2001, DIAMOND RELATIVE MAT, V10, P2107
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chu PK, 2001, REV SCI INSTRUM, V72, P1660, DOI 10.1063/1.1340029
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Dementjev AP, 2000, DIAM RELAT MATER, V9, P1904, DOI 10.1016/S0925-9635(00)00345-9
   Ferrari AC, 2003, DIAM RELAT MATER, V12, P905, DOI 10.1016/S0925-9635(02)00370-9
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Inaba H, 2002, JPN J APPL PHYS 1, V41, P5730, DOI 10.1143/JJAP.41.5730
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4
   Merel P, 1998, APPL SURF SCI, V136, P105, DOI 10.1016/S0169-4332(98)00319-5
   Petrov P, 2000, DIAM RELAT MATER, V9, P562, DOI 10.1016/S0925-9635(99)00348-9
   Rodil SE, 2003, DIAM RELAT MATER, V12, P931, DOI 10.1016/S0925-9635(02)00217-0
   Sheeja D, 2004, DIAM RELAT MATER, V13, P184, DOI 10.1016/j.diamond.2003.10.053
   Tessier PY, 2003, DIAM RELAT MATER, V12, P1066, DOI 10.1016/S0925-9635(02)00314-X
   Wang XH, 2000, SURF COAT TECH, V128, P36, DOI 10.1016/S0257-8972(00)00659-9
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   YANG P, 2003, NUCL INSTRUM METHO B, V206
   [杨萍 Yang Ping], 2002, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V21, P90
   Zhang XW, 2003, DIAM RELAT MATER, V12, P1, DOI 10.1016/S0925-9635(02)00246-7
   Zhou ZM, 2002, J PHYS D APPL PHYS, V35, P1991, DOI 10.1088/0022-3727/35/16/313
NR 26
TC 41
Z9 42
U1 2
U2 25
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2004
VL 70A
IS 1
BP 107
EP 114
DI 10.1002/jbm.a.30070
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 833EA
UT WOS:000222318000012
PM 15174114
DA 2018-10-20
ER

PT J
AU Zhang, DS
   Arola, DD
AF Zhang, DS
   Arola, DD
TI Applications tissues of digital image correlation to biological
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE digital image correlation; biological tissue; interferometry
ID HOLOGRAPHIC-INTERFEROMETRY; ALUMINUM-ALLOY; POISSONS RATIO; AORTA
AB Optical methods are becoming commonplace in investigations of the physical and mechanical behavior of biological tissues. Digital image correlation (DIC) is a versatile optical method that shows tremendous promise for applications involving biological tissues and biomaterials. We present the fundamentals of DIC with an emphasis on the application to biological materials. An approach for surface preparation is described that facilitates its application to hydrated substrates. Three examples are presented that highlight the use of DIC for biomedical research. The first example describes the use of DIC to study the mechanical behavior of arterial tissues up to 40% elongation. The second example describes an evaluation of the mechanical properties of bovine hoof horn in the dehydrated and fully hydrated states. Uniaxial tension experiments are performed to determine the elastic modulus (E) and Poisson's ratio (v) of both the arterial and dermal tissues. Spatial variations in the mechanical properties are evident from the full-field characterization of both tissues. Finally, an application of DIC to study the evolution of loosening in cemented total hip replacements is described. The noncontact analysis enables measurement of the relative displacement between the bone/bone cement and bone cement/prosthesis interfaces. Based on the elementary optical arrangement, the simple surface preparation, and the ability to acquire displacement/strain measurements over a large range of deformation, DIC should serve as a valuable tool for biomedical research. Further developments will enable the use of DIC for in vivo applications. (C) 2004 Society of Photo-Optical Instrumentation Engineers.
C1 Univ Maryland Baltimore Cty, Dept Mech Engn, Baltimore, MD 21250 USA.
   Shanghai Univ, Dept Mech, Shanghai 200436, Peoples R China.
RP Zhang, DS (reprint author), Univ Maryland Baltimore Cty, Dept Mech Engn, 1000 Hilltop Circle, Baltimore, MD 21250 USA.
CR Arola D, 2002, EXP MECH, V42, P380
   AROLA D, 2002, P 21 SO BIOM ENG C B, P147
   Bastawros AF, 2000, J MECH PHYS SOLIDS, V48, P301, DOI 10.1016/S0022-5096(99)00035-6
   Braun S, 2000, AM J ORTHOD DENTOFAC, V118, P257, DOI 10.1067/mod.2000.108254
   BROUGHER JA, 2002, P SEM ANN C THEOR EX, P238
   BRUCK HA, 1989, EXP MECH, V29, P261, DOI 10.1007/BF02321405
   CHU TC, 1985, EXP MECH, V25, P232, DOI 10.1007/BF02325092
   Fung Y, 1993, BIOMECHANICS MECH PR, P321
   HUMPHREY JD, 1987, J BIOMECH, V20, P59, DOI 10.1016/0021-9290(87)90267-3
   Kishen A, 2001, J BIOMED MATER RES, V55, P121, DOI 10.1002/1097-4636(200104)55:1<121::AID-JBM160>3.3.CO;2-X
   Lu H, 1997, EXP MECH, V37, P433, DOI 10.1007/BF02317310
   McGowan DM, 2001, J AIRCRAFT, V38, P122, DOI 10.2514/2.2743
   Niu X, 2000, EXP TECHNIQUES, V24, P27, DOI 10.1111/j.1747-1567.2000.tb01332.x
   OVRYN B, 1987, ANN BIOMED ENG, V15, P67, DOI 10.1007/BF02364168
   OVRYN B, 1989, CRIT REV BIOMED ENG, V16, P269
   PETERS WH, 1982, OPT ENG, V21, P427, DOI 10.1117/12.7972925
   RAJKONDAWAR P, 2002, P SEM ANN C THEOR EX, P256
   SILVER FH, 1989, CRIT REV BIOMED ENG, V17, P323
   SMOLEK MK, 1994, J CATARACT REFR SURG, V20, P277, DOI 10.1016/S0886-3350(13)80578-0
   SUTTON MA, 1993, ASME AMD, V176, P20317
   Tong W, 1997, EXP MECH, V37, P452, DOI 10.1007/BF02317313
   Wang RZ, 1998, J BIOMECH, V31, P135
   Wattrisse B, 2001, EXP MECH, V41, P29, DOI 10.1007/BF02323101
   WOISETSCHLAGER J, 1994, APPL OPTICS, V33, P5011, DOI 10.1364/AO.33.005011
   YANG DT, 2002, P ANN M SOC BIOM, P546
   YANG DT, 2002, P SEM ANN C THEOR EX, P75
   Zentner A, 1996, ANGLE ORTHOD, V66, P463
   Zhang D, 1999, EXP MECH, V39, P62, DOI 10.1007/BF02329302
   Zhang D, 2002, P ANN INT IEEE EMBS, P1276, DOI 10.1109/IEMBS.2002.1106385
   ZHANG D, 2002, P SEM ANN C THEOR EX
   ZHANG D, 2002, EXP TECH, V25, P32
   Zhang D., 2002, P 10 ACM INT C MULT, P315, DOI DOI 10.1145/641007.641073
   Zhang DS, 2002, EXP MECH, V42, P409, DOI 10.1007/BF02412146
   Zhao WZ, 1996, J APPL POLYM SCI, V60, P1083, DOI 10.1002/(SICI)1097-4628(19960523)60:8<1083::AID-APP1>3.0.CO;2-H
   Zhou J, 1997, P NATL ACAD SCI USA, V94, P14255, DOI 10.1073/pnas.94.26.14255
NR 35
TC 100
Z9 110
U1 2
U2 2
PU SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
EI 1560-2281
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD JUL-AUG
PY 2004
VL 9
IS 4
BP 691
EP 699
DI 10.1117/1.1753270
PG 9
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 840NM
UT WOS:000222865800003
PM 15250755
DA 2018-10-20
ER

PT J
AU Qhobosheane, M
   Zhang, P
   Tan, WH
AF Qhobosheane, M
   Zhang, P
   Tan, WH
TI Assembly of silica nanoparticles for two-dimensional nanomaterials
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE silica nanoparticles; two-dimensional; nanomaterials; glutamate
ID ZEOLITE CRYSTALS; SELF-ORGANIZATION; COVALENT LINKER; GLASS;
   SUPERLATTICES; MONOLAYERS; FILMS; GEL
AB To realize the great potential of nanoparticles as new materials for biomedical applications, the nanoparticles will have to be assembled in such a way that the newly created assembly will have unique properties that conventional materials do not possess. This will enable nanomaterials to be used for many novel applications. We have attempted to assemble silica nanoparticles to create a two-dimensional nanomaterial, which might be useful for biosensor and biochip production. The silica nanoparticles are synthesized and assembled in a monolayer fashion through the use of halogenated silanes. Photolithography techniques are used to pattern the glass surface prior to nanoparticle attachment. The concentration of the silica nanoparticles in the solution controls the surface coverage of nanoparticles on the glass surface. Different patterned silica arrays can be made with controlled surface coverage. The nanoparticle-covered surface is successfully tested for surface-enhanced enzymatic reactivity for the detection of a neurotransmitter, glutamate. This report demonstrates the feasibility of assembling nanoparticles for biosensor development.
C1 Univ Florida, Dept Chem, Gainesville, FL 32611 USA.
   Univ Florida, Ctr Res Interface Bio Nano, Gainesville, FL 32611 USA.
RP Tan, WH (reprint author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.
RI Zhou, Feng/E-9510-2011; Tan, Weihong/A-5412-2008
OI Tan, Weihong/0000-0002-8066-1524
FU NINDS NIH HHS [R01-NS39891]
CR Andres RP, 1996, SCIENCE, V273, P1690, DOI 10.1126/science.273.5282.1690
   Caruso F, 2001, ADV MATER, V13, P1090, DOI 10.1002/1521-4095(200107)13:14<1090::AID-ADMA1090>3.0.CO;2-H
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Choi SY, 2000, J AM CHEM SOC, V122, P5201, DOI 10.1021/ja000113i
   Cordek J, 1999, ANAL CHEM, V71, P1529, DOI 10.1021/ac980850l
   Fang XH, 1999, J AM CHEM SOC, V121, P2921, DOI 10.1021/ja9837809
   Ha K, 2001, ADV MATER, V13, P594, DOI 10.1002/1521-4095(200104)13:8<594::AID-ADMA594>3.0.CO;2-O
   Ingersoll CM, 1997, ANAL CHEM, V69, pA403, DOI 10.1021/ac9716901
   Jeng RJ, 2003, POLYMER, V44, P143, DOI 10.1016/S0032-3861(02)00730-9
   Kachan SM, 2002, SURF SCI, V507, P603, DOI 10.1016/S0039-6028(02)01322-5
   Kulak A, 2000, ANGEW CHEM INT EDIT, V39, P950, DOI 10.1002/(SICI)1521-3773(20000303)39:5<950::AID-ANIE950>3.0.CO;2-U
   Kulak A, 2000, J AM CHEM SOC, V122, P9308, DOI 10.1021/ja001321d
   Lee GS, 2000, TETRAHEDRON, V56, P6965, DOI 10.1016/S0040-4020(00)00517-2
   Lee GS, 2001, J AM CHEM SOC, V123, P9769, DOI 10.1021/ja010517q
   Li T, 1999, LANGMUIR, V15, P4328, DOI 10.1021/la970801o
   Liu XJ, 1999, ANAL CHEM, V71, P5054, DOI 10.1021/ac990561c
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335
   PANTANO P, 1995, ANAL CHEM, V67, pA481, DOI 10.1021/ac00111a002
   PARK JS, 2002, J CHEM SOC COMMUN
   PING DH, 2001, J APPL PHYS, V90, P9
   Qhobosheane M, 2001, ANALYST, V126, P1274, DOI 10.1039/b101489g
   RUTNAKORNPITUK M, 2002, POLYMER
   Santra S, 2001, ANAL CHEM, V73, P4988, DOI 10.1021/ac010406+
   Santra S, 2001, J BIOMED OPT, V6, P160, DOI 10.1117/1.1353590
   SBRANA F, 2002, CATAL TODAY
   Shenton W, 1997, NATURE, V389, P585
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Taleb A, 1997, CHEM MATER, V9, P950, DOI 10.1021/cm960513y
   Tapec R, 2002, J NANOSCI NANOTECHNO, V2, P405, DOI 10.1166/jnn.2002.114
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Um SH, 2002, LANGMUIR, V18, P4455, DOI 10.1021/la020118o
   Whitesides GM, 1999, SCIENCE, V284, P89, DOI 10.1126/science.284.5411.89
   Yu YY, 2003, POLYMER, V44, P593, DOI 10.1016/S0032-3861(02)00824-8
NR 34
TC 17
Z9 17
U1 1
U2 15
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUL
PY 2004
VL 4
IS 6
BP 635
EP 640
DI 10.1166/jnn.2004.014
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 865JK
UT WOS:000224698300015
PM 15518399
DA 2018-10-20
ER

PT J
AU Zhu, SL
   Yang, XJ
   Hu, F
   Deng, SH
   Cui, ZD
AF Zhu, SL
   Yang, XJ
   Hu, F
   Deng, SH
   Cui, ZD
TI Processing of porous TiNi shape memory alloy from elemental powders by
   Ar-sintering
SO MATERIALS LETTERS
LA English
DT Article
DE porous TiNi alloy; powder metallurgy; Ar-sintering; shape memory alloy
ID MECHANICAL-PROPERTIES; NITI
AB Porous TiNi shape memory alloys attracted extensive interests for their potential use as biomedical materials because of their similar microstructure to human bone and the unique mechanical properties. In this paper, an equiatomic porous TiNi alloy was prepared from elemental powders by Ar-sintering. The pore features of the porous TiNi alloy were studied by optical microscopy and scanning electronic microscopy (SEM). The mechanism of pore-formation and pore-development were proposed. X-ray diffraction (XRD) and differential scanning calometry (DSC) were used to investigate the microstructure and the temperature of phase transformation of the alloy. Compression and flexural test were carried out to determine the mechanical properties of the porous TiNi alloy. The porous TiNi alloy sintered at 980 degreesC in argon for 8 It was found to be composed mainly of TiNi phase with promising properties, of which the ultimate compressive and flexural strength was 677 and 246 MPa, respectively. The porosity ratio of porous TiNi alloy was up to 45%. The DSC measurements revealed the A, and A(f) temperatures of the alloy was 32.5 and 45.6 degreesC, respectively. (C) 2004 Elsevier B.V. All rights reserved.
C1 Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Cui, ZD (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM zdcui@tju.edu.cn
RI Zhu, Shengli/D-5281-2009
OI Zhu, Shengli/0000-0002-0190-2626
CR Chenglin C., 1997, T NONFERR METAL SOC, V7, P84
   Green SM, 1997, POWDER METALL, V40, P43, DOI 10.1179/pom.1997.40.1.43
   HEY JC, 1994, MAT SCI ENG A-STRUCT, V188, P291, DOI 10.1016/0921-5093(94)90384-0
   Hosoda H, 1998, INTERMETALLICS, V6, P291, DOI 10.1016/S0966-9795(97)00100-3
   IGHARO M, 1986, POWDER METALL, V29, P37, DOI 10.1179/pom.1986.29.1.37
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   LIPSCOMB IP, 1996, APPL SHAPE MEMORY AL, P5
   Massalski T B, 1996, BINARY ALLOY PHASE D, P2874
   McNeese MD, 2000, MAT SCI ENG A-STRUCT, V280, P334, DOI 10.1016/S0921-5093(99)00550-X
   Miller DA, 2001, MAT SCI ENG A-STRUCT, V308, P161, DOI 10.1016/S0921-5093(00)01982-1
   Munir Z. A., 1990, P 1 US JAP WORKSH CO, P123
   RHINES FN, 1950, J MET T AIME, V188, P378
   SAITO S, 1992, MAT SCI ENG A-STRUCT, V161, P91
   ZHANG N, 1992, MAT SCI ENG A-STRUCT, V150, P263, DOI 10.1016/0921-5093(92)90120-P
NR 14
TC 67
Z9 67
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL
PY 2004
VL 58
IS 19
BP 2369
EP 2373
DI 10.1016/j.matlet.2004.02.017
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 830ER
UT WOS:000222105000009
DA 2018-10-20
ER

PT J
AU Kim, HY
   Satoru, H
   Kim, JI
   Hosoda, H
   Miyazaki, S
AF Kim, HY
   Satoru, H
   Kim, JI
   Hosoda, H
   Miyazaki, S
TI Mechanical properties and shape memory behavior of ti-nb alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterial; smart material;
   titanium based alloy
ID MARTENSITIC TRANSFORMATIONS; MO ALLOYS; SUPERELASTICITY
AB Mechanical properties and shape memory behavior of Ti-(20-29)at%Nb alloys were investigated in order to develop Ni-free biomedical shape memory alloys. The Ti-Nb alloys were fabricated by arc melting method. The ingots were cold-rolled with a reduction up to 95% in thickness and then solution treated at 1173 K for 1.8 ks. The martensitic transformation temperature decreased by 43 K per 1 at% increase of Nb content. The shape memory effect and superelastic behavior were observed at room temperature in the Ti-(22-25)at%Nb alloys and Ti-(25.5-27)at%Nb alloys, respectively. A small enthalpy of the martensitic transformation and a large difference between Ms and Mf were observed in the Ti-Nb alloys compared to Ti-Ni shape memory alloys. The maximum recovered strain of 3% was obtained at room temperature in solution treated Ti-(25-27)at%Nb alloys. The heat treatment at 573 K for 3.6 ks stabilized superelastic behavior of Ti-Nb alloys by increasing the critical stress for slip.
C1 Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
   Tokyo Inst Technol, Precis & Intelligent Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678
CR Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Baker C., 1971, Metal Science Journal, V5, P92
   DAVIS R, 1979, ACTA METALL MATER, V27, P1041, DOI 10.1016/0001-6160(79)90192-5
   DAVIS R, 1979, J MATER SCI, V14, P712
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Hosoda H, 2001, T MRS J, V26, P243
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   TAKEI F, 1983, SCRIPTA METALL MATER, V17, P987, DOI 10.1016/0036-9748(83)90436-2
NR 17
TC 195
Z9 205
U1 4
U2 61
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2004
VL 45
IS 7
BP 2443
EP 2448
DI 10.2320/matertrans.45.2443
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 845LX
UT WOS:000223245300082
OA Bronze
DA 2018-10-20
ER

PT J
AU Hu, YQ
   Zhu, KJ
AF Hu, YQ
   Zhu, KJ
TI Synthesis, characterization and degradation of poly(2,2-dimethyl
   trimethylene carbonate-co-epsilon-caprolactone-co-glycolide)
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE biodegradable polymers; poly(epsilon-caprolactone); polyglycolide;
   random copolymers; poly(2,2-dimethyl trimethylene
   carbonate-co-epsilon-caprolactone-co-glycolide)
ID RING-OPENING POLYMERIZATION; EPSILON-CAPROLACTONE;
   2,2-DIMETHYLTRIMETHYLENE CARBONATE; HYDROLYTIC DEGRADATION;
   BIODEGRADABLE POLYMERS; L-LACTIDE; COPOLYMERS; GLYCOLIDE; ACID;
   DECOMPOSITION
AB Degradable tri-component copolymers were synthesized by the bulk copolymerisation of 2,2-dimethyl trimethylene carbonate (DTC), epsilon-caprolactone (CL) and glycolide (GA) using stannous octanoate as catalyst at 140 degreesC for 36 h. The mole fraction ratio in the feed of DTC and CL was fixed at 20/80 and the mole percent of GA was varied to obtain copolymers with different properties. The polymerisation products were characterized by H-1 NMR, C-13 NMR, FT-IR, GPC and DSC. It was found that the hydrophilicity of these materials increased with increasing GA content, according to measurements of static contact angles of distilled water on the surface of polymer films. Mechanical tests and hydrolytic degradation assays showed that copolymers of different degradability and mechanical properties could be tailored by adjusting the compositions. For the polymer P-3 (GA content about 10 mol%), the tensile strength and the elastic modulus could reach 4.3 MPa and 22 MPa, respectively. It took 4 weeks for the copolymer P-3 to degrade to about 82% (M-n,M-t/M-n,M-0) and 10 weeks to 40%. These low crystallinity copolymers could be processed into porous films with stable structures by means of combination of solvent volatilisation with salt leaching. These materials are expected to be useful for nerve reconstruction and other biomedical applications. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Zhu, KJ (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
EM kjzhu@ipsm.zju.edu.cn
CR BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   Cai J, 1998, POLYMER, V39, P4409, DOI 10.1016/S0032-3861(97)10346-9
   Cai J., 1996, POLYM INT, V41, P369
   Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698
   CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527
   COHN D, 1987, POLYMER, V28, P2018, DOI 10.1016/0032-3861(87)90035-8
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   ENDO M, 1987, MACROMOLECULES, V20, P2982, DOI 10.1021/ma00178a005
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   HOVESTADT W, 1992, POLYMER, V33, P1941, DOI 10.1016/0032-3861(92)90497-K
   KENLEY RA, 1987, MACROMOLECULES, V20, P2398, DOI 10.1021/ma00176a012
   KEUL H, 1988, MAKROMOL CHEM, V189, P2303
   KOHN FE, 1983, EUR POLYM J, V19, P1081, DOI 10.1016/0014-3057(83)90001-0
   Kowalski A, 2000, MACROMOLECULES, V33, P1964, DOI 10.1021/ma991751s
   KRICHELDORF HR, 1992, POLYMER, V33, P2817, DOI 10.1016/0032-3861(92)90459-A
   KRICHELDORF HR, 1984, MACROMOLECULES, V17, P2173, DOI 10.1021/ma00140a051
   KRICHELDORF HR, 1988, MACROMOLECULES, V21, P286, DOI 10.1021/ma00180a002
   KRICHELDORF HR, 1991, MAKROMOL CHEM, V192, P2391
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P283, DOI 10.1002/(SICI)1521-3935(19980201)199:2<283::AID-MACP283>3.3.CO;2-0
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   LUNDBERG RD, 1969, J POLYM SCI A1, V7, P2915, DOI 10.1002/pol.1969.150071014
   Pack JW, 2002, J POLYM SCI POL CHEM, V40, P544, DOI 10.1002/pola.10123
   PASCH H, 1995, J CHROMATOGR A, V699, P21, DOI 10.1016/0021-9673(95)00061-Q
   Qian HT, 2000, POLYM DEGRAD STABIL, V68, P423, DOI 10.1016/S0141-3910(00)00031-8
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Schmidt P, 1996, MACROMOLECULES, V29, P3674, DOI 10.1021/ma951489x
   SEARLES S, 1960, J AM CHEM SOC, V82, P2928, DOI 10.1021/ja01496a062
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WURM B, 1992, MAKROMOL CHEM-RAPID, V13, P9
NR 30
TC 13
Z9 17
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JUL
PY 2004
VL 85
IS 1
BP 705
EP 712
DI 10.1016/j.polymdegradstab.2003.12.010
PG 8
WC Polymer Science
SC Polymer Science
GA 836IM
UT WOS:000222549100020
DA 2018-10-20
ER

PT J
AU Wang, ZL
AF Wang, ZL
TI Zinc oxide nanostructures: growth, properties and applications
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Review
ID INDIVIDUAL CARBON NANOTUBES; ZNO NANOBELTS; INDUCED NANOHELIXES; SILICON
   NANOWIRES; WORK FUNCTION; TIN DIOXIDE; SURFACES; OXYGEN;
   PHOTODESORPTION; CONDUCTIVITY
AB Zinc oxide is a unique material that exhibits semiconducting and piezoelectric dual properties. Using a solid-vapour phase thermal sublimation technique, nanocombs, nanorings, nanohelixes/nanosprings, nanobelts, nanowires and nanocages of ZnO have been synthesized under specific growth conditions. These unique nanostructures unambiguously demonstrate that ZnO probably has the richest family of nanostructures among all materials, both in structures and in properties. The nanostructures could have novel applications in optoelectronics, sensors, transducers and biomedical sciences. This article reviews the various nanostructures of ZnO grown by the solid-vapour phase technique and their corresponding growth mechanisms. The application of ZnO nanobelts as nanosensors, nanocantilevers, field effect transistors and nanoresonators is demonstrated.
C1 Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Wang, ZL (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM zhong.wang@mse.gatech.edu
RI Wang, Zhong Lin/E-2176-2011; 李, 府中/H-4357-2011
OI Wang, Zhong Lin/0000-0002-5530-0380; 
CR ADVANI GN, 1980, J ELECT, V48, P403
   Arnold MS, 2003, J PHYS CHEM B, V107, P659, DOI 10.1021/jp0271054
   Avouris P, 2002, CHEM PHYS, V281, P429, DOI 10.1016/S0301-0104(02)00376-2
   Bai XD, 2003, NANO LETT, V3, P1147, DOI 10.1021/nl034342p
   Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878
   BONASEWICZ P, 1986, J ELECTROCHEM SOC, V133, P2270, DOI 10.1149/1.2108393
   Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782
   Comini E, 2002, APPL PHYS LETT, V81, P1869, DOI 10.1063/1.1504867
   Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   Dai ZR, 2003, ADV FUNCT MATER, V13, P9, DOI 10.1002/adfm.200390013
   Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019
   DING Y, 2003, J APPL PHYS, V95, P306
   DING Y, 2004, UNPUB PHYS REV B
   Dulub O, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.016102
   Dulub O, 2002, SURF SCI, V519, P201, DOI 10.1016/S0039-6028(02)02211-2
   Gallaso F. S, 1970, STRUCTURE PROPERTIES
   Gao PX, 2002, J PHYS CHEM B, V106, P12653, DOI 10.1021/jp0265485
   Gao PX, 2003, NANO LETT, V3, P1315, DOI 10.1021/nl034548q
   Gao PX, 2003, J AM CHEM SOC, V125, P11299, DOI 10.1021/ja035569p
   Gao RP, 2000, PHYS REV LETT, V85, P622, DOI 10.1103/PhysRevLett.85.622
   Gao RP, 2001, APPL PHYS LETT, V78, P1757, DOI 10.1063/1.1356442
   GOPEL W, 1989, SOLID STATE IONICS, V32-3, P440, DOI 10.1016/0167-2738(89)90253-1
   Hashimoto S, 1996, J AM CERAM SOC, V79, P1121, DOI 10.1111/j.1151-2916.1996.tb08559.x
   Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367
   Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H
   Hughes WL, 2003, APPL PHYS LETT, V82, P2886, DOI 10.1063/1.1570497
   Kamp B, 2001, SENSOR ACTUAT B-CHEM, V77, P534, DOI 10.1016/S0925-4005(01)00694-3
   Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502
   Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622
   Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356
   Kong XY, 2004, APPL PHYS LETT, V84, P975, DOI 10.1063/1.1646453
   Kong XY, 2004, J PHYS CHEM B, V108, P570, DOI 10.1021/jp036993f
   Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p
   Lao JY, 2003, NANO LETT, V3, P235, DOI 10.1021/nl025884u
   Ma C, 2004, J AM CHEM SOC, V126, P708, DOI 10.1021/ja0395644
   MA C, 2004, NATURE, V427, P497
   MEIROVICH L, 1986, ELEMENTS VIBRATION A
   Meyer B, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035403
   MIZUSAKI J, 1990, J SOLID STATE CHEM, V88, P443, DOI 10.1016/0022-4596(90)90240-X
   Moore D, 2004, CHEM PHYS LETT, V385, P8, DOI 10.1016/j.cplett.2003.12.063
   Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513
   Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660
   Ronning C, 2004, APPL PHYS LETT, V84, P783, DOI 10.1063/1.1645319
   SAMSON S, 1973, J APPL PHYS, V44, P4618, DOI 10.1063/1.1662011
   Schwab K, 2000, NATURE, V404, P974
   SHAPIRA Y, 1976, SURF SCI, V54, P43, DOI 10.1016/0039-6028(76)90086-8
   Shi L, 2004, APPL PHYS LETT, V84, P2638, DOI 10.1063/1.1697622
   Staemmler V, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.106102
   Sverdrup PG, 2001, J HEAT TRANS-T ASME, V123, P130, DOI 10.1115/1.1337651
   TASKER PW, 1979, J PHYS C SOLID STATE, V12, P4977, DOI 10.1088/0022-3719/12/22/036
   Vigue F, 2001, APPL PHYS LETT, V79, P194, DOI 10.1063/1.1384907
   Volz SG, 1999, APPL PHYS LETT, V75, P2056, DOI 10.1063/1.124914
   WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975
   Wander A, 2001, PHYS REV LETT, V86, P3811, DOI 10.1103/PhysRevLett.86.3811
   WANG XD, 2004, IN PRESS J PHYS CH B
   Wang ZL, 2000, APPL PHYS LETT, V77, P3349, DOI 10.1063/1.1327281
   Wang ZL, 2000, PURE APPL CHEM, V72, P209, DOI 10.1351/pac200072010209
   Wang ZL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.185502
   Westwater J, 1997, J VAC SCI TECHNOL B, V15, P554, DOI 10.1116/1.589291
   Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389
   Zhang DH, 1996, MATER CHEM PHYS, V45, P248, DOI 10.1016/0254-0584(96)80115-5
   Zhao MH, 2004, NANO LETT, V4, P587, DOI 10.1021/nl035198a
   Zhong J, 2003, APPL PHYS LETT, V83, P3401, DOI 10.1063/1.1621729
NR 66
TC 2295
Z9 2339
U1 102
U2 1407
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD JUN 30
PY 2004
VL 16
IS 25
BP R829
EP R858
AR PII S0953-8984(04)58969-5
DI 10.1088/0953-8984/16/25/R01
PG 30
WC Physics, Condensed Matter
SC Physics
GA 841SV
UT WOS:000222952800003
DA 2018-10-20
ER

PT J
AU Thornton, AJ
   Alsberg, E
   Albertelli, M
   Mooney, DJ
AF Thornton, AJ
   Alsberg, E
   Albertelli, M
   Mooney, DJ
TI Shape-defining scaffolds for minimally invasive tissue engineering
SO TRANSPLANTATION
LA English
DT Article
ID ALGINATE HYDROGELS; BIOMEDICAL APPLICATIONS; CHONDROCYTES; POLYMER;
   CULTURE; PHOTOPOLYMERIZATION; TRANSPLANTATION; CARTILAGE; DELIVERY;
   MEMORY
AB Background. Minimally invasive surgical procedures are increasingly important in medicine, but biomaterials consistent with this delivery approach that allow one to control the structure of the material after implantation are lacking. Biomaterials with shapememorizing properties could permit minimally invasive delivery of cell transplantation constructs and enable the formation of new tissues or structures in vivo in desired shapes and sizes.
   Methods. Macroporous alginate hydrogel scaffolds were prepared in a number of predefined geometries, compressed into significantly smaller, different "temporary" forms, and introduced into immunocompromised mice by means of minimally invasive surgical delivery through a small catheter. Scaffolds were rehydrated in situ with a suspension of cells (primary bovine articular chondrocytes) or cell-free medium and delivered through the same catheter. Specimens were harvested at 1 hr to evaluate the efficacy of cell delivery and the recovery of scaffold geometry, and at 8 and 24 weeks to evaluate neotissue formation.
   Results. A high percentage (88%) of scaffolds that were introduced with a catheter and rehydrated with cells had recovered their original shape and size within 1 hr. This delivery procedure resulted in cartilage structures with the geometry of the original scaffold by 2 months and histologically mature appearing tissue at 6 months.
   Conclusions. Shaped hydrogels, formed by covalently cross-linking, can be structurally collapsed into smaller, temporary shapes that permit their minimally invasive delivery in vivo. The rapid recovery of scaffold properties facilitates efficient cell seeding in vivo and permits neotissue formation in desired geometries.
C1 Univ Michigan, Dept Biol & Mat Sci, Sch Dent, Ann Arbor, MI 48109 USA.
   Univ Michigan, Unit Lab & Anim Med, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Biol & Mat Sci, Sch Dent, 1011 N Univ Ave,Room 5213, Ann Arbor, MI 48109 USA.
EM mooneyd@umich.edu
RI Albertelli, Megan/C-7650-2011
OI Albertelli, Megan/0000-0001-9433-229X; Alsberg, Eben/0000-0002-3487-4625
FU NIDCR NIH HHS [T32 DE 07057]; NCRR NIH HHS [T32 RR 07008]
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   ALSBERG E, 2001, J DENT RES, V80, P1
   Arevalo-Silva CA, 2000, ARCH OTOLARYNGOL, V126, P1448, DOI 10.1001/archotol.126.12.1448
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   Bratthall G, 2001, J CLIN PERIODONTOL, V28, P923, DOI 10.1034/j.1600-051x.2001.028010923.x
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Duerig TW, 1996, BIO-MED MATER ENG, V6, P255
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Fuchs KH, 2002, ENDOSCOPY, V34, P154, DOI 10.1055/s-2002-19857
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Halberstadt C, 2002, TISSUE ENG, V8, P309, DOI 10.1089/107632702753725067
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Kim SS, 1999, TRANSPLANTATION, V67, P227, DOI 10.1097/00007890-199901270-00007
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee H, 2002, TRANSPLANTATION, V73, P1589, DOI 10.1097/00007890-200205270-00011
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   Mongia NK, 1996, J BIOMAT SCI-POLYM E, V7, P1055, DOI 10.1163/156856296X00543
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   PAIGE KT, 1996, PLAST RECONSTR SURG, V97, P167
   Passaretti D, 2001, TISSUE ENG, V7, P805, DOI 10.1089/107632701753337744
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Suzuki K, 2000, J BIOMED MATER RES, V49, P528, DOI 10.1002/(SICI)1097-4636(20000315)49:4<528::AID-JBM11>3.0.CO;2-1
   Uyama S, 2001, TRANSPLANTATION, V71, P1226, DOI 10.1097/00007890-200105150-00008
NR 33
TC 62
Z9 68
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD JUN 27
PY 2004
VL 77
IS 12
BP 1798
EP 1803
DI 10.1097/01.tp.0000131152.71117.0e
PG 6
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 832XC
UT WOS:000222300000004
PM 15223894
DA 2018-10-20
ER

PT J
AU Ferruti, P
   Grigolini, M
   Ranucci, E
AF Ferruti, P
   Grigolini, M
   Ranucci, E
TI PHEMA hydrogels obtained by a novel low-heat curing procedure with a
   potential for in situ preparation
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE curing of polymers; functionalization of polymers; hydrogels; in situ
   polymerization; methacryloylating agent
ID TISSUE-REPAIR; METHACRYLATE; PROSTHESES; POLYMERS; IMPLANT; DISC
AB In this work, we report on poly(2-hydroxethyl methacrylate) (PHEMA) hydrogels obtained by a low heat curing reaction. These materials are suitable for in situ preparation and therefore endowed with a potential for several biomedical applications. The novel procedure adopted involves as the first step the synthesis of a soluble oligomeric PHEMA precursor containing polymerizable functions as side substituents. As the second step, the precursor is dissolved in equal amounts of 2-hydroxyethyl methacrylate (HEMA) and water, to form a viscous but still injectable syrup. A low temperature water soluble initiator is then added. The curing reaction starts promptly and is completed within a few minutes. During the entire process the internal temperature never rises above 40degreesC. Preliminary mechanical characterizations performed on the hydrogels in their water-swollen state and diffusion tests in absorption/desorption experiments clearly indicated that on all respects the novel hydrogels are comparable with conventional PHEMA hydrogels obtained according to literature from HEMA in the presence of divinyl crosslinkers. However, the much shorter curing time combined with the far lower curing temperature endow the new hydrogels with a higher potential in view of specific surgical requirements, and particularly for in situ preparation.
C1 Dipartimento Chim Organ & Ind, I-20123 Milan, Italy.
RP Ferruti, P (reprint author), Dipartimento Chim Organ & Ind, Via Venezia 21, I-20123 Milan, Italy.
EM elisabetta.ranucci@unimi.it
RI Ranucci, Elisabetta/J-3899-2015
OI Ranucci, Elisabetta/0000-0002-6402-2650; Ferruti,
   Paolo/0000-0002-5404-440X
CR Ambrosio L, 1996, J MATER SCI-MATER M, V7, P251, DOI 10.1007/BF00058561
   Bao QB, 1996, BIOMATERIALS, V17, P1157, DOI 10.1016/0142-9612(96)84936-2
   Bavaresco VP, 2000, ARTIF ORGANS, V24, P202, DOI 10.1046/j.1525-1594.2000.06518.x
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO;2-P
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   DAVIS PA, 1991, HIGH PERFORMANCE BIO, P343
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Hicks CR, 1999, BRIT J OPHTHALMOL, V83, P616, DOI 10.1136/bjo.83.5.616
   Khan AJ, 1999, J CATARACT REFR SURG, V25, P1404, DOI 10.1016/S0886-3350(99)00199-6
   KOLARIK K, 1981, J BIOMED MATER RES, V15, P147
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X
   Lindblad MS, 2001, MACROMOL RAPID COMM, V22, P962
   LUTOLF MP, 2003, ADV MATER, V11, P888
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Ranucci E, 2003, MACROMOL BIOSCI, V3, P742, DOI 10.1002/mabi.200350036
   Ranucci E, 1999, MACROMOL RAPID COMM, V20, P1
   Vernon B, 2003, J BIOMED MATER RES A, V64A, P447, DOI 10.1002/jbm.a.10369
NR 21
TC 4
Z9 5
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN 25
PY 2004
VL 4
IS 6
BP 591
EP 600
DI 10.1002/mabi.200300130
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 834VX
UT WOS:000222440100007
PM 15468253
DA 2018-10-20
ER

PT J
AU Brousmiche, DW
   Serin, JM
   Frechet, JMJ
   He, GS
   Lin, TC
   Chung, SJ
   Prasad, PN
   Kannan, R
   Tan, LS
AF Brousmiche, DW
   Serin, JM
   Frechet, JMJ
   He, GS
   Lin, TC
   Chung, SJ
   Prasad, PN
   Kannan, R
   Tan, LS
TI Fluorescence resonance energy transfer in novel multiphoton absorbing
   dendritic structures
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID ABSORPTION CROSS-SECTION; OPTICAL-DATA STORAGE; 2-PHOTON ABSORPTION;
   2-PHOTON-ABSORBING CHROMOPHORES; LASING PROPERTIES; ORGANIC MATERIALS;
   DYE-SOLUTION; MICROFABRICATION; SPECTROSCOPY; MOLECULES
AB A series of small dendritic structures containing one of two efficient multiphoton absorbing dyes at the periphery and a nile red derivative at the core have been synthesized. These molecules display efficient ( > 96%) fluorescence resonance energy transfer (FRET) from the periphery to the core on selective excitation of the two-photon absorbing chromophore by either UV (linear absorption) or high-intensity IR (nonlinear absorption) radiation. In addition, a significant increase in core emission is observed on excitation of the peripheral chromophores, compared to direct excitation of the core. This "antenna effect" essentially doubles between increasing dendrimer generations within a series. The combination of the ability of the peripheral chromophores to absorb high-intensity IR radiation, coupled with a very efficient energy transfer process and a significant increase in the fluorescence of the acceptor chromophore, makes these molecules potentially useful for a variety of applications, including optical power limiting and biomedical imaging.
C1 Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   SUNY Buffalo, Inst Lasers Photon & Biophoton, Berkeley, CA 94720 USA.
   Lawrence Berkeley Natl Lab, Div Sci Mat, Berkeley, CA 94720 USA.
   MLBP, AFRL, Polymer Branch, Wright Patterson AFB, OH 45433 USA.
RP Frechet, JMJ (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
EM frechet@cchem.berkeley.edu
RI Tan, Loon-Seng/F-6985-2012
OI Tan, Loon-Seng/0000-0002-2134-9290; Frechet, Jean/0000-0001-6419-0163
CR Adronov A, 2000, CHEM MATER, V12, P2838, DOI 10.1021/cm000586o
   Adronov A, 2000, J AM CHEM SOC, V122, P1175, DOI 10.1021/ja993272e
   Belfield KD, 2002, CHEM MATER, V14, P3663, DOI 10.1021/cm0107981
   Belfield KD, 2000, J ORG CHEM, V65, P4475, DOI 10.1021/jo991950+
   Bhawalkar J. D., 1997, J CLIN MED SURG, V37, P510
   Bhawalkar JD, 1996, REP PROG PHYS, V59, P1041, DOI 10.1088/0034-4885/59/9/001
   BIRGE RR, 1979, J CHEM PHYS, V70, P165, DOI 10.1063/1.437217
   Briggs M. S. J., 1997, J CHEM SOC P1, V7, P1051
   Brousmiche DW, 2003, J AM CHEM SOC, V125, P1448, DOI 10.1021/ja0288688
   Chung SJ, 1999, J PHYS CHEM B, V103, P10741, DOI 10.1021/jp992846z
   Chung SJ, 2001, CHEM MATER, V13, P4071, DOI 10.1021/cm010151g
   Cumpston BH, 1999, NATURE, V398, P51
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Drobizhev M, 2001, OPT LETT, V26, P1081, DOI 10.1364/OL.26.001081
   Fakis M, 2000, CHEM PHYS LETT, V323, P111, DOI 10.1016/S0009-2614(00)00494-2
   Fisher WG, 1997, PHOTOCHEM PHOTOBIOL, V66, P141, DOI 10.1111/j.1751-1097.1997.tb08636.x
   Frederiksen PK, 2001, J AM CHEM SOC, V123, P1215, DOI 10.1021/ja003468a
   Gil L, 1999, BIOORGAN MED CHEM, V7, P901, DOI 10.1016/S0968-0896(99)00045-0
   Gilat SL, 1999, ANGEW CHEM INT EDIT, V38, P1422, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1422::AID-ANIE1422>3.0.CO;2-V
   Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273
   HE GS, 1995, OPT LETT, V20, P1524, DOI 10.1364/OL.20.001524
   He GS, 1997, J APPL PHYS, V81, P2529, DOI 10.1063/1.364303
   HE GS, 1995, OPT LETT, V20, P2393, DOI 10.1364/OL.20.002393
   HE GS, 2003, J OPT LETT, V28, P768
   Joshi MP, 1998, OPT LETT, V23, P1742, DOI 10.1364/OL.23.001742
   Kannan R, 2001, CHEM MATER, V13, P1896, DOI 10.1021/cm000747o
   Kim OK, 2000, CHEM MATER, V12, P284, DOI 10.1021/cm990662r
   Lee WH, 2001, J AM CHEM SOC, V123, P10658, DOI 10.1021/ja004226d
   Lei H, 2001, CHEM PHYS LETT, V333, P387, DOI 10.1016/S0009-2614(00)01381-6
   MCCLAIN WM, 1974, ACCOUNTS CHEM RES, V7, P129, DOI 10.1021/ar50077a001
   MUGNIER J, 1985, J LUMIN, V33, P273, DOI 10.1016/0022-2313(85)90004-3
   Ohkuma S, 2002, J PHOTOPOLYM SCI TEC, V15, P23, DOI 10.2494/photopolymer.15.23
   Pan GL, 2001, CHEM COMMUN, P1744, DOI 10.1039/b102876f
   PARTHENOPOULOS DA, 1989, SCIENCE, V245, P843, DOI 10.1126/science.245.4920.843
   PETICOLA.WL, 1967, ANNU REV PHYS CHEM, V18, P233, DOI 10.1146/annurev.pc.18.100167.001313
   Pudavar HE, 1999, APPL PHYS LETT, V74, P1338, DOI 10.1063/1.123543
   Reinhardt BA, 1998, CHEM MATER, V10, P1863, DOI 10.1021/cm980036e
   Serin JM, 2002, CHEM COMMUN, P2605, DOI 10.1039/b207905d
   Serin JM, 2002, J AM CHEM SOC, V124, P11848, DOI 10.1021/ja027564i
   Shen YZ, 2000, APPL PHYS LETT, V76, P1, DOI 10.1063/1.125637
   So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399
   Spangler CW, 1999, J MATER CHEM, V9, P2013, DOI 10.1039/a902802a
   Tan LS, 2003, P SOC PHOTO-OPT INS, V4797, P171, DOI 10.1117/12.453273
   Tang XJ, 2002, CHEM PHYS LETT, V356, P573, DOI 10.1016/S0009-2614(02)00416-5
   Wang C, 2001, OPT COMMUN, V192, P315, DOI 10.1016/S0030-4018(01)01166-X
   Wang XM, 2001, J MATER CHEM, V11, P1600, DOI 10.1039/b009769l
   Zhou GY, 2002, APPL OPTICS, V41, P1120, DOI 10.1364/AO.41.001120
   Zhou WH, 2002, SCIENCE, V296, P1106, DOI 10.1126/science.296.5570.1106
   Zhou YF, 2000, SOLID STATE COMMUN, V116, P605, DOI 10.1016/S0038-1098(00)00387-2
NR 49
TC 73
Z9 73
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JUN 24
PY 2004
VL 108
IS 25
BP 8592
EP 8600
DI 10.1021/jp049948w
PG 9
WC Chemistry, Physical
SC Chemistry
GA 830MI
UT WOS:000222125900014
DA 2018-10-20
ER

PT J
AU Feddes, B
   Wolke, JGC
   Vredenberg, AM
   Jansen, JA
AF Feddes, B
   Wolke, JGC
   Vredenberg, AM
   Jansen, JA
TI Adhesion of calcium phosphate ceramic on polyethylene (PE) and
   polytetrafluoroethylene (PTFE)
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE adhesion test; radio frequency (RF); magnetron; sputtering;
   polyethylene; calcium phosphate ceramic
ID MAGNETRON SPUTTERING DEPOSITION; SURFACE MODIFICATION;
   ULTRAVIOLET-IRRADIATION; THIN-FILMS; POLYMERS; COATINGS
AB Calcium phosphate (CaP) ceramic coatings are often used on biomedical implants for its osteoinductive properties. In this work, the adhesion of r.f. magnetron sputter deposited CaP ceramic on PE and PTFE was studied by tensile and interface elongation tests. Both untreated and oxygen plasma pretreated substrates were used. The adhesion of CaP to PE was found to be good. In tensile tests, the coated material was glued to the pull rods using an epoxy adhesive. Usually, the epoxy failed instead of the CaP-PE interface. Moreover, the interfacial plane of the CaP coated PE could be extended to twice its normal size without the delamination of the coating. No significant difference was found between the untreated and plasma pretreated material. Additional experiments were performed to clarify what mechanism is responsible for the good adhesion of CaP to PE. Good adhesion is the result of a bombardment by energetic oxygen ions that originate from the sputtering target. The absence of this bombardment causes a lower number of chemical bonds between the polymer and the coating, and therefore the delamination of the coating. The PTFE showed a different behavior. The locus of failure in the tensile tests was within the PTFE. No significant difference was found whether or not a plasma pre-treatment was given. UV light induced damage of the PTFE is the most likely reason for the cohesive failure. The UV light is emitted from the plasma and is transmitted by the CaP coating. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Univ Utrecht, Debye Inst, Sect Interface Phys, NL-3508 TA Utrecht, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Wolke, J.G.C./L-4768-2015; Institute (DINS), Debye/G-7730-2014; Jansen,
   John/H-8055-2014
CR BAGLIN JEE, 1989, NUCL INSTRUM METH B, V39, P764, DOI 10.1016/0168-583X(89)90892-6
   BODO P, 1986, J APPL PHYS, V60, P1161, DOI 10.1063/1.337361
   CHANG CA, 1987, APPL PHYS LETT, V51, P103, DOI 10.1063/1.98637
   CHAPIRO A, 1988, NUCL INSTRUM METH B, V32, P111, DOI 10.1016/0168-583X(88)90191-7
   de Groot K, 1983, BIOCERAMICS CALCIUM
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   Durand AM, 1997, VIDE, V53, P242
   Feddes B, 2003, J APPL PHYS, V93, P9503, DOI 10.1063/1.1576894
   Feddes B, 2003, J APPL PHYS, V93, P662, DOI 10.1063/1.1525857
   Feddes B, 2003, J VAC SCI TECHNOL A, V21, P363, DOI 10.1116/1.1535176
   FEDDES B, UNPUB SURF COAT TECH
   FEDDES B, IN PRESS BIOMATERIAL
   Fujinami Y, 1998, MATER CHEM PHYS, V54, P102, DOI 10.1016/S0254-0584(98)00094-7
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hontsu S, 1998, JPN J APPL PHYS 2, V37, pL1169, DOI 10.1143/JJAP.37.L1169
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   Koh SK, 1997, MATER RES SOC SYMP P, V438, P523
   LEE EH, 1994, J MATER RES, V9, P1043, DOI 10.1557/JMR.1994.1043
   LISTON EM, 1993, J ADHES SCI TECHNOL, V7, P1091, DOI 10.1163/156856193X00600
   MATIENZO LJ, 1994, J VAC SCI TECHNOL A, V12, P2662, DOI 10.1116/1.579086
   Noh I, 1997, J POLYM SCI POL CHEM, V35, P1499
   PAWEL JE, 1990, NUCL INSTRUM METH B, V46, P392, DOI 10.1016/0168-583X(90)90735-D
   Ratchev BA, 1995, NUCL INSTRUM METH B, V106, P68, DOI 10.1016/0168-583X(95)00681-8
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   van Dijk K, 1998, J BIOMED MATER RES, V41, P624, DOI 10.1002/(SICI)1097-4636(19980915)41:4<624::AID-JBM15>3.0.CO;2-E
   Van Dijk K., 1995, Journal of Biomedical Materials Research, V29, P269
   Weast R. C., 1968, HDB CHEM PHYS
NR 28
TC 14
Z9 16
U1 0
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 22
PY 2004
VL 184
IS 2-3
BP 247
EP 254
DI 10.1016/j.surfcoat.2003.10.013
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 829JJ
UT WOS:000222044000017
DA 2018-10-20
ER

PT J
AU Ohgoe, Y
   Hirakuri, KK
   Tsuchimoto, K
   Friedbacher, G
   Miyashita, O
AF Ohgoe, Y
   Hirakuri, KK
   Tsuchimoto, K
   Friedbacher, G
   Miyashita, O
TI Uniform deposition of diamond-like carbon films on polymeric materials
   for biomedical applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE diamond-like carbon; chemical vapor deposition; biomaterials; IR
   spectroscopy; electron spectroscopy for chemical analysis; scanning
   electron microscopy observation
ID SOURCE ION-IMPLANTATION; PLASMA; SURFACE
AB Diamond-like carbon (DLC) films are interesting in biomedical application for the improvement of the histocompatibility, blood compatibility and durability of diaphragms in artificial hearts. In order to achieve uniform deposition of DLC films on hemispherical polymer diaphragms used in artificial hearts to prevent inter-diffusion of driving fluid (silicone oil) and blood, coating has been performed by chemical vapor deposition using improved electrodes. The chemical and physical properties of the produced films as well as their durability have been investigated with infrared spectroscopy and electron spectroscopy for chemical analysis before and after the driving operation of the diaphragm. The uniformity of the films has been compared with DLC films obtained with conventional electrodes showing that the uniformity could be improved, thus obtaining DLC films with good durability and excellent adhesion properties as required for biomedical application. (C) 2003 Elsevier B.V. All rights reserved.
C1 Tokyo Denki Univ, Fac Sci & Engn, Dept Elect & Comp Engn, Hatoyama, Saitama 35003, Japan.
   Aisin Cosmos Res & Dev Co Ltd, Kariya, Aichi 4488650, Japan.
   Tech Univ Vienna, Inst Chem Technol & Analyt, Div Analyt Chem, A-1060 Vienna, Austria.
RP Ohgoe, Y (reprint author), Tokyo Denki Univ, Fac Sci & Engn, Dept Elect & Comp Engn, Hatoyama, Saitama 35003, Japan.
EM yas@ff.f.dendai.ac.jp
CR Alanazi A, 2000, ASAIO J, V46, P440, DOI 10.1097/00002480-200007000-00014
   Alanazi A, 2000, ARTIF ORGANS, V24, P624, DOI 10.1046/j.1525-1594.2000.06576.x
   BERG S, 1979, THIN SOLID FILMS, V58, P117, DOI 10.1016/0040-6090(79)90220-7
   CONRAD JR, 1989, J APPL PHYS, V65, P1707, DOI 10.1063/1.342942
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   Cooke A. F., 1978, Engineering in Medicine, V7, P66
   DESCOEUDRES A, 2003, PLASMA SOURCES SCI T, V152, P12
   FABER JJ, 1967, J APPL PHYSIOL, V22, P793
   Hirakuri KK, 1997, THIN SOLID FILMS, V302, P5, DOI 10.1016/S0040-6090(97)00022-9
   HOLLAND L, 1975, THIN SOLID FILMS, V27, P185, DOI 10.1016/0040-6090(75)90026-7
   HOLLAND L, 1977, J VAC SCI TECHNOL, V14, P4
   KOBAYASHI K, 1988, THIN SOLID FILMS, V158, P233, DOI 10.1016/0040-6090(88)90025-9
   Komatsu Y, 1999, DIAM RELAT MATER, V8, P2018, DOI 10.1016/S0925-9635(99)00138-7
   MARTON D, 1994, PHYS REV LETT, V73, P10353
   Miyagawa S, 2000, SURF COAT TECH, V128, P260, DOI 10.1016/S0257-8972(00)00588-0
   Munson CP, 1996, SURF COAT TECH, V84, P528, DOI 10.1016/S0257-8972(95)02836-6
   MUTSUKURA N, 1992, J APPL PHYS, V72, P43, DOI 10.1063/1.352145
   OHGOE Y, 2002, TANSO, V202, P71
   VORONKIN MA, 1994, DIAM RELAT MATER, V4, P5, DOI 10.1016/0925-9635(94)90061-2
   WANG HS, 1994, SURF COAT TECH, V66, P525, DOI 10.1016/0257-8972(94)90062-0
   Watanabe T, 2003, DIAM RELAT MATER, V12, P105, DOI 10.1016/S0925-9635(03)00010-4
   WEISSMANTEL C, 1982, THIN SOLID FILMS, V96, P31, DOI 10.1016/0040-6090(82)90210-3
NR 22
TC 31
Z9 34
U1 0
U2 18
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 22
PY 2004
VL 184
IS 2-3
BP 263
EP 269
DI 10.1016/j.surfcoat.2003.10.009
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 829JJ
UT WOS:000222044000019
DA 2018-10-20
ER

PT J
AU Siegers, C
   Biesalski, M
   Haag, R
AF Siegers, C
   Biesalski, M
   Haag, R
TI Self-assembled monolayers of dendritic polyglycerol derivatives on gold
   that resist the adsorption of proteins
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE biocompatible materials; dendrimers; polymers; proteins; surface
   chemistry
ID THIOCTIC ACID; HYPERBRANCHED POLYGLYCEROLS; MOLECULAR-CONFORMATION;
   THIN-FILMS; SURFACES; ARCHITECTURES; ATTACHMENT; POLYETHER; ADHESION;
   ANTIGEN
AB Highly protein-resistant, self-assembled monolayers (SAMs) of dendritic polyglycerols (PGs) on gold can easily be obtained by simple chemical modification of these readily available polymers with a surface-active disulfide linker group. Several disulfide-functionalized PGs were synthesized by N,N'-dicyclohexylcarbodiimide-mediated ester coupling of thioctic acid. Monolayers of the disulfide-functionalized PG derivatives spontaneously form on a semitransparent gold surface and effectively prevent the adsorption of proteins, as demonstrated by surface plasmon resonance (SPR) kinetic measurements. A structure-activity relationship relating the polymer architecture to its ability to effectuate protein resistance has been derived from results of different surface characterization techniques (SPR, attenuated total reflectance infrared (ATR-IR), and contact-angle measurements). Dendritic PGs combine the characteristic structural features of several highly protein-resistant surfaces: a highly flexible aliphatic polyether, hydrophilic surface groups, and a highly branched architecture. PG monolayers are as protein resistant as poly(ethylene glycol) (PEG) SAMs and are significantly better than dextran-coated surfaces, which are currently used as the background for SPR spectroscopy. Due to the higher thermal and oxidative stability of the bulk PG as compared to the PEG and the easy accessibility of these materials, dendritic polyglycerols are novel and promising candidates as surface coatings for biomedical applications.
C1 Univ Freiburg, Inst Makromol Chem, D-79104 Freiburg, Germany.
   Freiburger Mat Forschungszentrum, D-79104 Freiburg, Germany.
   Univ Freiburg, Inst Mikrosyst Tech, D-79110 Freiburg, Germany.
RP Haag, R (reprint author), Univ Dortmund, Otto Hahn Str 6, D-44227 Dortmund, Germany.
EM rainer.haag@uni-dortmund.de
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Berggren C, 1997, ANAL CHEM, V69, P3651, DOI 10.1021/ac970203e
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Chapman RG, 2000, LANGMUIR, V16, P6927, DOI 10.1021/la9915791
   Dong YZ, 2003, LANGMUIR, V19, P8922, DOI 10.1021/la0261141
   Dong YZ, 2000, ANAL CHEM, V72, P2371, DOI 10.1021/ac991450g
   DUAN CM, 1995, MIKROCHIM ACTA, V117, P195, DOI 10.1007/BF01244890
   Falbe J, 1995, ROMPP CHEM LEXIKON
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   FRENTZEN M, 1988, DEUT ZAHNAERZTL Z, V43, P719
   Frey H., 2002, REV MOL BIOTECHNOL, V90, P257, DOI DOI 10.1016/S1389-0352(01)00063-0
   GOODMAN SL, 1990, J COLLOID INTERF SCI, V139, P561, DOI 10.1016/0021-9797(90)90129-C
   GORDIENOK NI, 1986, RUSS J APPL CHEM, V59, P1441
   Haag R, 2000, MACROMOLECULES, V33, P8158, DOI 10.1021/ma000831p
   Haag R, 2000, J AM CHEM SOC, V122, P2954, DOI 10.1021/ja994363e
   Haag R., 2002, [No title captured], Patent No. [DE10211664A1, 10211664]
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J. M., 1997, POLYETHYLENE GLYCOL
   Holland NB, 1998, NATURE, V392, P799
   JENKINS SH, 1988, ANAL BIOCHEM, V168, P292, DOI 10.1016/0003-2697(88)90321-1
   Jung LS, 2000, J PHYS CHEM B, V104, P11168, DOI 10.1021/jp001649t
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   KOMP A, UNPUB
   Lehmann T, 1999, MACROMOL SYMP, V142, P1, DOI 10.1002/masy.19991420103
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Madoz J, 1997, J AM CHEM SOC, V119, P1043, DOI 10.1021/ja963465r
   MATSUURA H, 1985, J MOL STRUCT, V126, P251, DOI 10.1016/0022-2860(85)80118-6
   Metzke M, 2003, J AM CHEM SOC, V125, P7760, DOI 10.1021/ja0349507
   MRKSICH M, 1995, LANGMUIR, V11, P4383, DOI 10.1021/la00011a034
   NAGAOKA S, 1984, POLYM BIOMATERIALS, P361
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RABINOW BE, 1994, J BIOMAT SCI-POLYM E, V6, P91, DOI 10.1163/156856295X00788
   Raether H., 1988, SURFACE PLASMONS SMO
   SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006
   SCHLENOFF JB, 1995, MACROMOLECULES, V28, P4280
   SCHLETTWEIN D, 1994, CHEM MATER, V6, P3, DOI 10.1021/cm00037a001
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sunder A, 1999, MACROMOLECULES, V32, P4240, DOI 10.1021/ma990090w
   Sunder A, 2000, ADV MATER, V12, P235, DOI 10.1002/(SICI)1521-4095(200002)12:3<235::AID-ADMA235>3.3.CO;2-P
   Sunder A, 2000, MACROMOLECULES, V33, P253, DOI 10.1021/ma9915881
   SUNDER A, 1998, Patent No. 19947631
   Tomizaki K, 2002, J ORG CHEM, V67, P6519, DOI 10.1021/jo0258002
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Wang Y, 1998, J PHYS CHEM B, V102, P9922, DOI 10.1021/jp982824x
NR 51
TC 199
Z9 201
U1 3
U2 64
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD JUN 7
PY 2004
VL 10
IS 11
BP 2831
EP 2838
DI 10.1002/chem.200306073
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 828JJ
UT WOS:000221969300022
PM 15195314
DA 2018-10-20
ER

PT J
AU Choi, HM
   Bide, M
   Phaneuf, M
   Quist, W
   LoGerfo, F
AF Choi, HM
   Bide, M
   Phaneuf, M
   Quist, W
   LoGerfo, F
TI Dyeing of wool with antibiotics to develop novel infection resistance
   materials for extracorporeal end use
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE wool; doxycycline; ciprofloxacin; biomaterials; absorption; FTIR
ID DACRON; CIPROFLOXACIN; SPECTROSCOPY; TECHNOLOGY; NYLON; FTIR
AB Two antibiotics, doxycycline (Doxy) and ciprofloxacin (Cipro), were applied under a variety of conditions to wool and to hydrolyzed wool at 40degreesC. Nylon was used as a synthetic control. Sorption of Doxy was much higher in wool than in nylon, whereas sorption of Cipro was similar in both fibers. FTIR spectroscopy confirmed that a drastic increase in sorption of antibiotics by hydrolyzed wool was attributed to an increase in polar functional groups by peptide scission and in oxidized sulfur groups by cystine oxidation. Both sorption and zone of inhibition (ZOI) values were improved by hydrolysis of wool. Wool hydrolyzed for 20 or 40 min at 40degreesC and dyed with Doxy at 45degreesC for 3.5 h maintained around 30 mm of ZOI after 24 h of challenge by a simulated flow of blood. Wool hydrolyzed for 60 min at 40degreesC and dyed with Cipro at 45degreesC for 3.5 h also maintained its antibiotic activity for an extended time. For the most part, ZOI values for nylon dyed by both antibiotics were zero within 24 h. This technique produced infection-resistant biomaterials of potential use in extra-corporeal biomedical and biological applications. (C) 2004 Wiley Periodicals, Inc.
C1 Soongsil Univ, Sch Text, Seoul, South Korea.
   Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
   Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
RP Choi, HM (reprint author), Soongsil Univ, Sch Text, Seoul, South Korea.
EM hchoi@ssu.ac.kr
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ASAI M, 1955, J PHYS CHEM-US, V59, P322, DOI 10.1021/j150526a011
   Benavides S, 2002, ANN PHARMACOTHER, V36, P334
   BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   BIDE M, 2001, ACS SYM SER, V792, P125
   BIDE M, 2002, 2002 AATCC INT C EXH
   BOCKER R, 1980, J CHROMATOGR, V187, P439, DOI 10.1016/S0021-9673(00)80479-3
   BURKINSHAW SM, 1990, CHEM APPL DYES, P365
   Carter EA, 1996, TEXT RES J, V66, P787, DOI 10.1177/004051759606601207
   CHANKOVA D, 1996, PROBL INF PARASIT DI, V23, P6
   CHOI H, IN PRESS TEXT RES J
   Cooper SJ, 2001, POLYMER, V42, P10119, DOI 10.1016/S0032-3861(01)00566-3
   Diz M, 1997, TEXT RES J, V67, P486, DOI 10.1177/004051759706700703
   Erra P, 1997, TEXT RES J, V67, P397, DOI 10.1177/004051759706700602
   FOX CL, 1986, Patent No. 4563485
   GLASBY JS, 1992, ENCY ANTIBIOTICS, P243
   HARVEY R, 1981, ANN SURG, P642
   HARVEY RA, 1984, AM J SURG, V147, P205, DOI 10.1016/0002-9610(84)90089-8
   HARVEY RA, 1982, SURGERY, V92, P504
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   Lin J, 2001, POLYMER, V42, P7903, DOI 10.1016/S0032-3861(01)00272-5
   MOHAMMED A, 1995, SMALL RUMINANT RES, V16, P191, DOI 10.1016/0921-4488(95)00617-T
   MURTY EM, 1990, POLYM ENG SCI, V30, P1595, DOI 10.1002/pen.760302407
   PETERS RH, 1963, TEXTILE CHEM, V1, P302
   Phaneuf MD, 2001, BIOMATERIALS, V22, P463, DOI 10.1016/S0142-9612(00)00202-7
   PHANEUF MD, 1995, J APPL BIOMATER, V6, P289, DOI 10.1002/jab.770060410
   PHANEUF MD, 1993, J BIOMED MATER RES, V27, P233, DOI 10.1002/jbm.820270213
   Rao C. N. R, 1963, CHEM APPL INFRARED S, P175
   SHALABY SW, 1985, HIGH TECHNOLOGY FI A, P87
   Torniainen K, 1996, INT J PHARM, V132, P53, DOI 10.1016/0378-5173(95)04332-2
   Yuan CQ, 2001, AATCC REV, V1, P35
NR 31
TC 11
Z9 11
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 5
PY 2004
VL 92
IS 5
BP 3343
EP 3354
DI 10.1002/app.20332
PG 12
WC Polymer Science
SC Polymer Science
GA 811GC
UT WOS:000220759400072
DA 2018-10-20
ER

PT J
AU Opdahl, A
   Koffas, TS
   Amitay-Sadovsky, E
   Kim, J
   Somorjai, GA
AF Opdahl, A
   Koffas, TS
   Amitay-Sadovsky, E
   Kim, J
   Somorjai, GA
TI Characterization of polymer surface structure and surface mechanical
   behaviour by sum frequency generation surface vibrational spectroscopy
   and atomic force microscopy
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Review
ID HYDROGEL CONTACT-LENSES; POLYSTYRENE SURFACE; SIDE BRANCHES; SFG;
   INTERFACES; WATER; FILMS; CONFORMATION; CATALYSIS; ALIGNMENT
AB Sum frequency generation (SFG) vibrational spectroscopy and atomic force microscopy (AFM) have been used to study polymer surface structure and surface mechanical behaviour, specifically to study the relationships between the surface properties of polymers and their bulk compositions and the environment to which the polymer is exposed. The combination of SFG surface vibrational spectroscopy and AFM has been used to study surface segregation behaviour of polyolefin blends at the polymer/air and polymer/solid interfaces. SFG surface vibrational spectroscopy and AFM experiments have also been performed to characterize the properties of polymer/liquid and polymer/polymer interfaces, focusing on hydrogel materials. A method was developed to study the surface properties of hydrogel contact lens materials at various hydration conditions. Finally, the effect of mechanical stretching on the surface composition and surface mechanical behaviour of phase-separated polyurethanes, used in biomedical implant devices, has been studied by both SFG surface vibrational spectroscopy and AFM.
C1 Univ Calif Berkeley, Dept Chem, Berkeley & Mat Sci Div, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.
RP Opdahl, A (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley & Mat Sci Div, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
EM somorjai@socrates.berkeley.edu
CR AKMAL N, 1998, POLYM SENSORS THEORY
   Amitay-Sadovsky E, 2003, J PHYS CHEM B, V107, P6377, DOI 10.1021/jp030169+
   Amitay-Sadovsky E, 2002, J APPL PHYS, V91, P375, DOI 10.1063/1.1417990
   Aoike T, 2001, LANGMUIR, V17, P2153, DOI 10.1021/la001326o
   Briggman KA, 2001, J PHYS CHEM B, V105, P2785, DOI 10.1021/jp0037495
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen CY, 2002, MACROMOLECULES, V35, P9130, DOI 10.1021/ma020614j
   Chen Z, 2002, ANNU REV PHYS CHEM, V53, P437, DOI 10.1146/annurev.physchem.53.091801.115126
   Davis KA, 2002, CRIT REV THER DRUG, V19, P385, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.30
   Dreesen L, 2001, CHEM PHYS LETT, V333, P327, DOI 10.1016/S0009-2614(00)01383-X
   EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FONTYN M, 1991, COLLOID SURFACE, V54, P349, DOI 10.1016/0166-6622(91)80073-W
   Gautam KS, 2000, PHYS REV LETT, V85, P3854, DOI 10.1103/PhysRevLett.85.3854
   Goodwin J. W., 1995, COLLOIDAL POLYM PART
   HIROSE C, 1992, APPL SPECTROSC, V46, P1051, DOI 10.1366/0003702924124385
   Horbett T. A., 1995, PROTEINS INTERFACES, VII
   Iler R. K., 1979, CHEM SILICA
   ISRAELACHVILI J, 1992, J VAC SCI TECHNOL A, V10, P2961, DOI 10.1116/1.577894
   Ito H., 1994, POLYM MAT MICROELECT
   Karp JM, 2003, MRS BULL, V28, P301, DOI 10.1557/mrs2003.85
   Kawaguchi H, 2000, PROG POLYM SCI, V25, P1171, DOI 10.1016/S0079-6700(00)00024-1
   Kim J, 2003, LANGMUIR, V19, P9551, DOI 10.1021/la035496n
   Kim SH, 2002, BIOMATERIALS, V23, P1657, DOI 10.1016/S0142-9612(01)00292-7
   Koffas TS, 2003, LANGMUIR, V19, P3453, DOI 10.1021/la026719x
   Kralik M, 2001, J MOL CATAL A-CHEM, V177, P113, DOI 10.1016/S1381-1169(01)00313-2
   Lin DT, 2001, BIOMATERIALS, V22, P1521, DOI 10.1016/S0142-9612(00)00308-2
   Lopez-Alemany A, 2002, J BIOMED MATER RES, V63, P319, DOI 10.1002/jbm.10186
   McConville P, 2001, POLYMER, V42, P3559, DOI 10.1016/S0032-3861(00)00714-X
   Miranda PB, 1999, J PHYS CHEM B, V103, P3292, DOI 10.1021/jp9843757
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   MULLER N, 1990, ACCOUNTS CHEM RES, V23, P23, DOI 10.1021/ar00169a005
   Oh-e M, 2002, APPL PHYS LETT, V80, P784, DOI 10.1063/1.1435069
   Opdahl A, 2003, J BIOMED MATER RES A, V67A, P350, DOI 10.1002/jbm.a.10054
   Opdahl A, 2002, MACROMOLECULES, V35, P4387, DOI 10.1021/ma011773q
   Opdahl A, 2002, LANGMUIR, V18, P9409, DOI 10.1021/la020537l
   Opdahl A, 2002, J PHYS CHEM B, V106, P5212, DOI 10.1021/jp013741a
   OPDAHL A, 2003, IN PRESS J POLYM S B
   PRITCHARD N, 1995, OPHTHAL PHYSL OPT, V15, P281, DOI 10.1046/j.1475-1313.1995.9500004w.x
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   Sinniah SK, 1996, J AM CHEM SOC, V118, P8925, DOI 10.1021/ja961295c
   STANNERS CD, 1995, CHEM PHYS LETT, V232, P407, DOI 10.1016/0009-2614(94)01362-Y
   STERN T, 1995, BIOMATERIALS, V16, P17, DOI 10.1016/0142-9612(95)91091-C
   Tanford C., 1991, HYDROPHOBIC EFFECT F
   Wang H, 2002, MACROMOLECULES, V35, P2799, DOI 10.1021/ma0116699
   Wang J, 2002, J AM CHEM SOC, V124, P7016, DOI 10.1021/ja012387r
   Wang J, 2001, J PHYS CHEM B, V105, P12118, DOI 10.1021/jp013161d
   Ward R.S., 1984, POLYURETHANES BIOMED
   Wei X, 2000, PHYS REV E, V62, P5160, DOI 10.1103/PhysRevE.62.5160
   Wicks Z. W., 1992, ORGANIC COATINGS SCI
   Wulff G, 2002, CHEM REV, V102, P1, DOI 10.1021/cr980039a
   Zhang D, 2000, LANGMUIR, V16, P4528, DOI 10.1021/1a991353i
   Zhang D, 1997, CHEM PHYS LETT, V281, P394, DOI 10.1016/S0009-2614(97)01311-0
   Zhang D, 1998, J PHYS CHEM B, V102, P6225, DOI 10.1021/jp981550a
   Zhang XY, 2001, J AM CHEM SOC, V123, P6736, DOI 10.1021/ja015960f
   Zhuang X, 1999, PHYS REV B, V59, P12632, DOI 10.1103/PhysRevB.59.12632
NR 56
TC 22
Z9 24
U1 3
U2 27
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD JUN 2
PY 2004
VL 16
IS 21
BP R659
EP R677
AR PII S0953-8984(04)59532-2
DI 10.1088/0953-8984/16/21/RO2
PG 19
WC Physics, Condensed Matter
SC Physics
GA 830CX
UT WOS:000222100300003
DA 2018-10-20
ER

PT J
AU Dunand, DC
AF Dunand, DC
TI Processing of titanium foams
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Review
ID ARGON-FILLED PORES; POROUS TITANIUM; MECHANICAL-PROPERTIES;
   TRANSFORMATION SUPERPLASTICITY; SANDWICH STRUCTURES; IMPLANT MATERIAL;
   CREEP EXPANSION; THERMAL HISTORY; METAL FOAMS; ALLOY
AB Because of their excellent mechanical properties, low density and biocompatibility, titanium foams are attractive for structural and biomedical applications. This paper.. reviews current techniques for, titanium foam processing, which are all based on powder-metallurgy because of the extreme reactivity of liquid titanium. A first group of processes is based on powder sintering with or without place-holder or scaffolds. A second group relies on expansion of pressurized pores created during prior powder densification.
C1 Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
RP Dunand, DC (reprint author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
EM dunand@northwestern.edu
RI Dunand, David/B-7515-2009
OI Dunand, David/0000-0001-5476-7379
CR Andersen O, 2000, ADV ENG MATER, V2, P192, DOI 10.1002/(SICI)1527-2648(200004)2:4<192::AID-ADEM192>3.0.CO;2-#
   Asaoka K, 2003, MATER SCI FORUM, V426-4, P3079, DOI 10.4028/www.scientific.net/MSF.426-432.3079
   ASAOKA K, 1985, J BIOMED MATER RES, V19, P699, DOI 10.1002/jbm.820190609
   Ashby M.F., 2000, METAL FOAMS DESIGN G
   Assad M, 2002, BIO-MED MATER ENG, V12, P225
   Banhart J, 2000, JOM-J MIN MET MAT S, V52, P22, DOI 10.1007/s11837-000-0062-8
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Banhart J, 2003, MRS BULL, V28, P290, DOI 10.1557/mrs2003.83
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Cirincione R, 2002, PROCESSSING AND PROPERTIES OF LIGHTWEIGHT CELLULAR METALS AND STRUCTURES, P189
   Davis NG, 2001, J MATER RES, V16, P1508, DOI 10.1557/JMR.2001.0210
   Degischer H-P, 2002, HDB CELLULAR METALS
   Donachie Jr M. J, 1988, TITANIUM TECHNICAL G
   Donachie M., 1998, ADV MATER PROCESS, V7, P63
   Dunand DC, 1996, ACTA MATER, V44, P1063, DOI 10.1016/1359-6454(95)00224-3
   Dunand DC, 1998, MATER RES SOC SYMP P, V521, P231, DOI 10.1557/PROC-521-231
   Elzey DM, 1999, METALL MATER TRANS A, V30, P2689, DOI 10.1007/s11661-999-0309-0
   Elzey DM, 2001, ACTA MATER, V49, P849, DOI 10.1016/S1359-6454(00)00395-5
   Frary M, 2002, METALL MATER TRANS A, V33, P1669, DOI 10.1007/s11661-002-0176-4
   GREENWOOD GW, 1965, PROC R SOC LON SER-A, V283, P403, DOI 10.1098/rspa.1965.0029
   Guo ZX, 2000, MATER SCI TECH SER, V16, P776, DOI 10.1179/026708300101508423
   Hurysz KM, 1998, MATER RES SOC SYMP P, V521, P191, DOI 10.1557/PROC-521-191
   Jee CSY, 2000, METALL MATER TRANS B, V31, P1345, DOI 10.1007/s11663-000-0021-3
   Kearns M. W., 1987, MET MAT, V3, P85
   KEARNS MW, 1988, INT J POWDER METALL, V24, P59
   KOSTORNOV AG, 1990, SOV POWDER METALL+, V29, P804, DOI 10.1007/BF00793541
   KOSTORNOV AG, 1986, SOV POWDER METALL+, V25, P909, DOI 10.1007/BF00795323
   KUPP P, 2002, PROCESSING PROPERTIE, P61
   Lagoudas DC, 2002, J INTEL MAT SYST STR, V13, P837, DOI 10.1177/104538902032790
   LI H, IN PRESS MAT T
   Li JP, 2003, KEY ENG MAT, V240-2, P547, DOI 10.4028/www.scientific.net/KEM.240-242.547
   Li JP, 2002, KEY ENG MAT, V218-2, P51, DOI 10.4028/www.scientific.net/KEM.218-220.51
   Li YH, 2002, J ALLOY COMPD, V345, P271, DOI 10.1016/S0925-8388(02)00412-7
   MARTIN RL, 1992, METAL POWDER REPORT, P30
   MCNAMARA BP, 1995, KEY ENG MAT, V99-1, P309, DOI 10.4028/www.scientific.net/KEM.99-100.309
   MURRAY GAW, 1981, J BONE JOINT SURG BR, V63, P138
   Murray NGD, 2003, COMPOS SCI TECHNOL, V63, P2311, DOI 10.1016/S0266-3538(03)00264-1
   Murray NGD, 2004, ACTA MATER, V52, P2279, DOI 10.1016/j.actamat.2004.01.019
   Murray NGD, 2004, ACTA MATER, V52, P2269, DOI 10.1016/j.actamat.2004.01.039
   Murray NGD, 2003, SCRIPTA MATER, V49, P879, DOI 10.1016/S1359-6462(03)00438-X
   NILLES JL, 1974, J BIOMED MATER RES, V8, P319, DOI 10.1002/jbm.820080411
   Oh IH, 2003, MATER TRANS, V44, P657, DOI 10.2320/matertrans.44.657
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Oh IH, 2002, MATER TRANS, V43, P443, DOI 10.2320/matertrans.43.443
   Queheillalt DT, 2000, METALL MATER TRANS A, V31, P261, DOI 10.1007/s11661-000-0070-x
   Rausch G, 2000, MATERIALWISS WERKST, V31, P412, DOI 10.1002/1521-4052(200006)31:6<412::AID-MAWE412>3.3.CO;2-2
   Rausch G, 2002, HDB CELLULAR METALS, P21
   Ricceri R, 2003, INT J POWDER METALL, V39, P53
   Ricceri R, 2001, INT J POWDER METALL, V37, P61
   Schuh C, 2000, ACTA MATER, V48, P1639, DOI 10.1016/S1359-6454(00)00018-5
   Schuh C, 2001, SCRIPTA MATER, V45, P631, DOI 10.1016/S1359-6462(01)01072-7
   Schuh C, 2001, J MATER RES, V16, P865, DOI 10.1557/JMR.2001.0115
   Schwartz DS, 1998, MATER RES SOC SYMP P, V521, P225, DOI 10.1557/PROC-521-225
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   Sypeck DJ, 1998, MATER RES SOC SYMP P, V521, P205, DOI 10.1557/PROC-521-205
   TAYLOR N, 1993, ACTA METALL MATER, V41, P955, DOI 10.1016/0956-7151(93)90030-V
   Thelen S, 2004, J BIOMED MATER RES A, V69A, P601, DOI 10.1002/jbm.a.20100
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   TUCHINSKIY L, 2003, MAT PROCESSES MED DE, P1
   Vancheeswaran R, 2001, METALL MATER TRANS A, V32, P1813, DOI 10.1007/s11661-001-0157-z
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   Wen CE, 2002, J MATER SCI-MATER M, V13, P397, DOI 10.1023/A:1014344819558
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   WHEELER KR, 1983, C TIT ALL SURG IMPL, P241
NR 64
TC 221
Z9 228
U1 8
U2 86
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD JUN
PY 2004
VL 6
IS 6
BP 369
EP 376
DI 10.1002/adem.200405576
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 836RM
UT WOS:000222573300006
DA 2018-10-20
ER

PT J
AU Combes, RD
AF Combes, RD
TI The use of human cells in biomedical research and testing
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article; Proceedings Paper
CT 4th World Congress on Alternatives and Animal Use in the Life Sciences
CY AUG 11-15, 2002
CL New Orleans, LA
DE biomedical research; cultured human cells; human cells; human research
   tissue banks
ID HUMAN TISSUE; PREDICTING TOXICITY; ALTERNATIVE METHODS; RECOMMENDATIONS;
   SYSTEMS; ESTABLISHMENT; AVAILABILITY; VALIDATION; LINES; DRUG
AB The ability to use human cells in biomedical research and testing has the obvious advantage over the use of laboratory animals that the need for species extrapolation is obviated, due to the presence of more-relevant morphological, physiological and biochemical properties, including receptors. Moreover, human cells exhibit the same advantages as animal cells in culture in that different cell types can be used, From different tissues, with a wide range of techniques, to investigate a wide variety of biological phenomena in tissue culture. Human cells can also be grown as organotypic cultures to facilitate the extrapolation from cells to whole organisms. Human cell lines have been available for many years on an ad hoc basis from individual researchers, and also from recognised sources, such as the European Collection of Animal Cell Cultures (ECACC) and, in the USA, the Human Cell Culture Centre (HCCC). Such cells have usually been derived from tumours and this has restricted the variety of types of cells available. This problem has been addressed by using primary human cells that can be obtained from a variety of sources, such as cadavers, diseased tissue, skin strips, peripheral blood, buccal cavity smears, hair follicles and surgical waste from biopsy material that is unsuitable for transplantation purposes. However, primary human cells need to be obtained, processed, distributed and handled in a safe and ethical manner. They also have to be made available at the correct time to researchers very shortly after they become available. It is only comparatively recently that the safe and controlled acquisition of surgical waste and non-transplantable human tissues has become feasible with the establishment of several human tissue banks. Recently, the formation of a UK and European centralised network for human tissue supply has been initiated. The problems of short longevity and loss of specialisation in culture are being approached by: a) cell immortalisation to generate a cell type possessing the properties of both primary cells and cell lines; b) the inhibition of intracellular activities resulting in oxidative stress; and c) the use of stem cells, both of embryonic and adult origin.
C1 FRAME, Nottingham NG1 4EE, England.
RP Combes, RD (reprint author), FRAME, Russell & Burch House,96-98 N Sherwood St, Nottingham NG1 4EE, England.
EM bob@frame.org.uk
CR ALEXANDRE E, 2002, CELL TISSUE BANKING, V3, P133
   Anderson R, 1999, TOXICOL IN VITRO, V13, P729, DOI 10.1016/S0887-2333(99)00051-X
   Anderson R, 1998, ATLA-ALTERN LAB ANIM, V26, P763
   Anderson R, 2001, ATLA-ALTERN LAB ANIM, V29, P125
   ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614
   Bach PH, 1996, ATLA-ALTERN LAB ANIM, V24, P893
   BLAAUBOER BJ, 2004, UNPUB ATLA
   Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660
   Clothier R, 2000, ATLA-ALTERN LAB ANIM, V28, P293
   CLOTHIER RH, 1995, ATLA-ALTERN LAB ANIM, V23, P75
   Coecke S, 1999, ATLA-ALTERN LAB ANIM, V27, P579
   COMBES RD, 1995, PESTIC SCI, V45, P179, DOI 10.1002/ps.2780450213
   Dearden JC, 1997, ATLA-ALTERN LAB ANIM, V25, P223
   Janusch A, 1997, ATLA-ALTERN LAB ANIM, V25, P411
   Kinsner A., 2001, Cell and Tissue Banking, V2, P165, DOI 10.1023/A:1020196504392
   Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403
   Pfaller W, 2001, Altern Lab Anim, V29, P393
   PFEIFER AMA, 1993, P NATL ACAD SCI USA, V90, P5123, DOI 10.1073/pnas.90.11.5123
   Todd M, 1998, ATLA-ALTERN LAB ANIM, V26, P13
   van de Sandt J, 1999, ATLA-ALTERN LAB ANIM, V27, P723
   WARD R, 1993, J ANAT, V182, P151
   Ward RK, 1997, TOXICOL IN VITRO, V11, P761, DOI 10.1016/S0887-2333(97)00025-8
   WARD RK, 1997, TOXICOLOGY ECOTOXICO, V4, P38
   Wiebel FJ, 1997, ATLA-ALTERN LAB ANIM, V25, P625
   Womack C, 2000, ATLA-ALTERN LAB ANIM, V28, P259
   WORTH AP, 2002, ATLA S1, V30, P1
   Zeilinger K, 2002, ATLA-ALTERN LAB ANIM, V30, P525
NR 27
TC 11
Z9 12
U1 0
U2 4
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD JUN
PY 2004
VL 32
SU 1A
BP 43
EP 49
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 833QB
UT WOS:000222352100006
PM 23577433
DA 2018-10-20
ER

PT J
AU Zimmermann, J
   Loontjens, T
   Scholtens, BJR
   Mulhaupt, R
AF Zimmermann, J
   Loontjens, T
   Scholtens, BJR
   Mulhaupt, R
TI The formation of poly(ester-urea) networks in the absence of isocyanate
   monomers
SO BIOMATERIALS
LA English
DT Article
DE poly(ester-urea); N,N ' carbonylbis (caprolactam); cell adhesion;
   polymer network; degradation
ID IN-VITRO; BEHAVIOR; GROWTH
AB The polymerization of N,N' carbonylbis (caprolactam) (CBC) and polyol in the presence of alcoholate as catalyst produced crosslinked poly(ester-urea)s via ring opening addition reaction. In contrast to conventional synthetic routes, the use of non-toxic CBC eliminates the need for toxic isocyanate-based monomers. The structure of the molecules resulting from model reactions was confirmed using FT-IR and H-1- and C-13-NMR spectroscopy. Poly(ester-urea) networks exhibit rubber-like mechanical properties and high-temperature stability. Cell adhesion and cell growth on the polymers evidenced the high biocompatibility of the material. Degradation of the poly(ester-urea)s was investigated at 70degreesC in neutral and basic aqueous solution. The degradation depends on the swelling behavior of the samples. Mechanical properties, good biocompatibility, and degradation behavior of the CBC/polyolbased polymers make them interesting materials for biomedical applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Freiburg, Inst Makromol Chem, D-79104 Freiburg, Germany.
   Univ Freiburg, FMF, D-79104 Freiburg, Germany.
   DSM Res & Patents, NL-6160 MD Geleen, Netherlands.
RP Mulhaupt, R (reprint author), Univ Freiburg, Inst Makromol Chem, Stefan Meier Str 21-31, D-79104 Freiburg, Germany.
EM mulhaupt@uni-freiburg.de
CR Abraham GA, 1998, J APPL POLYM SCI, V69, P2159, DOI 10.1002/(SICI)1097-4628(19980912)69:11<2159::AID-APP7>3.0.CO;2-F
   Abraham GA, 1997, J APPL POLYM SCI, V65, P1193, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Gugala Z, 2000, J BIOMED MATER RES, V49, P183, DOI 10.1002/(SICI)1097-4636(200002)49:2<183::AID-JBM5>3.0.CO;2-D
   Kartvelishvili T, 1997, MACROMOL CHEM PHYSIC, V198, P1921, DOI 10.1002/macp.1997.021980620
   Kobashi T, 1999, CELL TRANSPLANT, V8, P477, DOI 10.1177/096368979900800503
   Mandal TK, 2000, EUR J PHARM BIOPHARM, V50, P337, DOI 10.1016/S0939-6411(00)00124-7
   MCGILL DB, 1974, NEW ENGL J MED, V291, P278, DOI 10.1056/NEJM197408082910604
   MCKAY AF, 1958, J AM CHEM SOC, V80, P1510, DOI 10.1021/ja01539a058
   MEYER HR, 1956, KUNSTSTOFFE PLASTICS, V3, P160
   Pegoretti A, 1998, J APPL POLYM SCI, V70, P577, DOI 10.1002/(SICI)1097-4628(19981017)70:3<577::AID-APP20>3.0.CO;2-X
   Zhang JY, 2000, BIOMATERIALS, V21, P1247, DOI 10.1016/S0142-9612(00)00005-3
   ZILG C, 2000, THESIS ALBERT LUDWIG, P171
NR 13
TC 28
Z9 28
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2004
VL 25
IS 14
BP 2713
EP 2719
DI 10.1016/j.biomaterials.2003.09.110
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 776TG
UT WOS:000189133000002
PM 14962550
OA Green Published
DA 2018-10-20
ER

PT J
AU Ho, D
   Chu, B
   Schmidt, JJ
   Brooks, EK
   Montemagno, CD
AF Ho, D
   Chu, B
   Schmidt, JJ
   Brooks, EK
   Montemagno, CD
TI Hybrid protein-polymer biomimetic membranes
SO IEEE TRANSACTIONS ON NANOTECHNOLOGY
LA English
DT Article
DE biomedical engineering; biomedical materials; biomedical transducers;
   biomembranes; detectors; microelectromechanical devices; proteins;
   quantum dot
ID TRIBLOCK COPOLYMER MEMBRANES; RECONSTITUTION; VOLTAGE
AB Protein-functionalized polymers retain dramatically increased stability over lipid membranes and the unique ability to be deposited on solid substrates in the ABA complex. Furthermore, since these polymers can mimic hydrophilic/hydrophobic biological environments in a single molecular chain, direct adsorption of protein-functionalized biomembrane films is enabled, which is a significant advantage over conventional lipid systems. Following the demonstration of protein mutagenesis and nanoscale biomimetic membrane fabrication, monolayer arrays of pore proteins have been deposited onto silicon wafers for applications in sensing nanomolecules such as conjugated quantum dots and colloidal gold beads. Furthermore, we have characterized monolayer surface properties of custom tailored polymers with varied block length for biomimetic membrane applications, as well as developed a multiwell microelectromechanical-system-based membrane testing platform for enhanced versatility in film deposition. We have successfully demonstrated the reconstitution of a genetically engineered OmpF porin in block copolymer-based biomembranes, fabrication of large-area hybrid protein-polymer Langmuir-Blodgett films, as well as protein insertion via macromolecule detection using protein-polymer active materials with the goal of buildup toward a multicomponent microsystem while preserving inherent molecular function.
C1 Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90049 USA.
RP Ho, D (reprint author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90049 USA.
EM deanh@seas.ucla.edu
CR Alvarez O., 1986, ION CHANNEL RECONSTI, P115
   Hong Q, 2001, BIOCHEM SOC T, V29, P578, DOI 10.1042/BST0290578
   Meier W, 2000, ANGEW CHEM INT EDIT, V39, P4599, DOI 10.1002/1521-3773(20001215)39:24<4599::AID-ANIE4599>3.0.CO;2-Y
   MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Nardin C, 2000, LANGMUIR, V16, P7708, DOI 10.1021/la000204t
   Pantoja R, 2001, BIOPHYS J, V81, P2389, DOI 10.1016/S0006-3495(01)75885-7
   Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676
   Winterhalter M, 1995, ELECTROMANIPULATION, P137
NR 9
TC 24
Z9 24
U1 1
U2 19
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1536-125X
J9 IEEE T NANOTECHNOL
JI IEEE Trans. Nanotechnol.
PD JUN
PY 2004
VL 3
IS 2
BP 256
EP 263
DI 10.1109/tnano.2004.828530
PG 8
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Materials Science;
   Physics
GA 827KZ
UT WOS:000221899800006
DA 2018-10-20
ER

PT J
AU Gall, K
   Kreiner, P
   Turner, D
   Hulse, M
AF Gall, K
   Kreiner, P
   Turner, D
   Hulse, M
TI Shape-memory polymers for microelectromechanical systems
SO JOURNAL OF MICROELECTROMECHANICAL SYSTEMS
LA English
DT Article
DE indentation; microfludic; polymer; shape memory; soft lithograph
ID MARTENSITE START TEMPERATURES; TRANSFORMATION STRESS LEVELS; THIN-FILM;
   BIOMEDICAL APPLICATIONS; SOFT LITHOGRAPHY; FABRICATION; NITI; MEMS;
   BEHAVIOR; DESIGN
AB This paper investigates the use of shape-memory polymer thin films in microelectromechanical systems (MEMS). shape-memory polymers possess the capacity to recover large-strain deformations by the application of heat and are candidates for small-scale transduction. The key advantages of shape-memory polymers are their low material/fabrication cost coupled with their simplicity of integration/operation. In the present study, shape-memory polymers are spin coated onto a standard Si wafer and polymerized by thermal annealing. The thermomechanics of strain storage and recovery in the polymer films are studied using instrumented microindentation. The sharp microindents demonstrate full recovery at all load levels, establishing the feasibility of microscale actuation. The microindentation response of the polymer film is shown to depend on temperature and the cooling cycle during indentation. In turn, the subsequent recovery behavior of an indent depends on the thermal history during indentation. Indents performed at higher temperatures are larger in size, but have smaller stored strain energy compared to indents performed at low temperature. The larger stored strain energy in low temperature indents results in lower shape recovery temperatures. The effects of indentation temperature and load are systematically investigated to provide a framework for the use of shape-memory polymers in microsystems. Application of shape-memory polymers is demonstrated through the development of an active microfluidic reservoir. The reservoir was created by indentation at the end of a microfluidic channel and was activated by local heating. The collapse of the filled reservoir caused the motion of fluid down the microfluidic channel.
C1 Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
RP Gall, K (reprint author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
EM Kenneth.Gall@Colorado.edu
CR Arias F, 2001, J MICROELECTROMECH S, V10, P107, DOI 10.1109/84.911098
   Bao LR, 2002, J VAC SCI TECHNOL B, V20, P2881, DOI 10.1116/1.1526355
   Benard WL, 1998, J MICROELECTROMECH S, V7, P245, DOI 10.1109/84.679390
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Gall K, 2001, ACTA MATER, V49, P3205, DOI 10.1016/S1359-6454(01)00223-3
   Gall K, 1999, J ENG MATER-T ASME, V121, P28, DOI 10.1115/1.2815995
   Gall K, 1999, J ENG MATER-T ASME, V121, P19, DOI 10.1115/1.2815993
   Gall K, 2000, J INTEL MAT SYST STR, V11, P877, DOI 10.1106/EJGR-EWNM-6CLX-3X2M
   Gall K, 2002, ACTA MATER, V50, P5115, DOI 10.1016/S1359-6454(02)00368-3
   HAY JL, 2003, ASM HDB, V8
   Huang XY, 2003, NAT MATER, V2, P307, DOI 10.1038/nmat884
   Jackson WC, 2001, J VAC SCI TECHNOL B, V19, P596, DOI 10.1116/1.1350840
   Jameson R, 2003, MICROELECTRON ENG, V67-8, P930, DOI 10.1016/S0167-9317(03)00156-4
   JARDINE AP, 1994, MATER CHARACT, V32, P169
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   King WP, 2002, J MICROELECTROMECH S, V11, P765, DOI 10.1109/JMEMS.2002.803283
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Liu CD, 2002, MACROMOLECULES, V35, P9868, DOI 10.1021/ma021141j
   Liu YP, 2003, SMART MATER STRUCT, V12, P947, DOI 10.1088/0964-1726/12/6/012
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Metzger MF, 2002, BIOMED MICRODEVICES, V4, P89, DOI 10.1023/A:1014674912979
   Muralt P, 1997, INTEGR FERROELECTR, V17, P297, DOI 10.1080/10584589708013004
   NI W, APP PHYS LETT, V80, P3310
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K., 1998, SHAPE MEMORY MAT
   OUELLETTE J, 2003, IND PHYS         AUG, P14
   Pfeiffer K, 2003, MICROELECTRON ENG, V67-8, P266, DOI 10.1016/S0167-9317(03)00079-0
   POLLA DL, 1995, INTEGR FERROELECTR, V7, P359, DOI 10.1080/10584589508220246
   Polla DL, 1998, ANNU REV MATER SCI, V28, P563, DOI 10.1146/annurev.matsci.28.1.563
   Roberts DC, 2003, J MICROELECTROMECH S, V12, P81, DOI 10.1109/JMEMS.2002.807471
   Roch I, 2003, J MICROMECH MICROENG, V13, P330, DOI 10.1088/0960-1317/13/2/323
   Scheer HC, 1998, J VAC SCI TECHNOL B, V16, P3917, DOI 10.1116/1.590436
   Schift H, 1999, MICROELECTRON ENG, V46, P121, DOI 10.1016/S0167-9317(99)00030-1
   Schulz H, 2000, J VAC SCI TECHNOL B, V18, P1861, DOI 10.1116/1.1305331
   SILLION B, 2002, ACT CHIMIQUE, V3, P182
   Wang LP, 2003, J MICROELECTROMECH S, V12, P433, DOI 10.1109/JMEMS.2003.811749
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wolf RH, 1995, J MICROELECTROMECH S, V4, P206, DOI 10.1109/84.475547
NR 40
TC 125
Z9 128
U1 2
U2 59
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1057-7157
J9 J MICROELECTROMECH S
JI J. Microelectromech. Syst.
PD JUN
PY 2004
VL 13
IS 3
BP 472
EP 483
DI 10.1109/JMEMS.2004.828727
PG 12
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 826RH
UT WOS:000221845700010
DA 2018-10-20
ER

PT J
AU Wang, ZL
AF Wang, Zhong Lin
TI Nanostructures of zinc oxide
SO MATERIALS TODAY
LA English
DT Article
AB Zinc oxide (ZnO) is a unique material that exhibits semiconducting, piezoelectric, and pyroelectric multiple properties. Using a solid-vapor phase thermal sublimation technique, nanocombs, nanorings, nanohelixes/nanosprings, nanobows, nanobelts, nanowires, and nanocages of ZnO have been synthesized under specific growth conditions. These unique nanostructures unambiguously demonstrate that ZnO is probably the richest family of nanostructures among all materials, both in structures and properties. The nanostructures could have novel applications in optoelectronics, sensors, transducers, and biomedical science because it is bio-safe.
C1 Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Wang, ZL (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM zhong.wang@mse.gatech.edu
FU Defense Advanced Projects Research Agency; National Science Foundation;
   NASA
FX Thanks to Y. Ding, P. X. Gao, W. L. Hughes, X. Y. Kong, C. Ma, D. Moore,
   Z. W. Pan, C. J. Summers, X. D. Wang, and Y. Zhang for helpful
   discussion and their contributions to the work reviewed in this article.
   We acknowledge generous support by the Defense Advanced Projects
   Research Agency, National Science Foundation, and NASA.
CR Arnold MS, 2003, J PHYS CHEM B, V107, P659, DOI 10.1021/jp0271054
   Bai XD, 2003, NANO LETT, V3, P1147, DOI 10.1021/nl034342p
   Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878
   Comini E, 2002, APPL PHYS LETT, V81, P1869, DOI 10.1063/1.1504867
   Gao PX, 2002, J PHYS CHEM B, V106, P12653, DOI 10.1021/jp0265485
   Gao PX, 2004, APPL PHYS LETT, V84, P2883, DOI 10.1063/1.1702137
   Gao PX, 2003, NANO LETT, V3, P1315, DOI 10.1021/nl034548q
   Gao PX, 2003, J AM CHEM SOC, V125, P11299, DOI 10.1021/ja035569p
   Harnack O, 2003, NANO LETT, V3, P1097, DOI 10.1021/nl034240z
   Huang ZP, 2003, APPL PHYS LETT, V82, P460, DOI 10.1063/1.1539299
   Hughes WL, 2003, APPL PHYS LETT, V82, P2886, DOI 10.1063/1.1570497
   Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356
   Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p
   Liu CH, 2003, ADV MATER, V15, P838, DOI 10.1002/adma.200304430
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Park WI, 2002, APPL PHYS LETT, V80, P4232, DOI 10.1063/1.1482800
   Shi L, 2004, APPL PHYS LETT, V84, P2638, DOI 10.1063/1.1697622
   Wang X. D., 2004, J PHYS CH B IN PRESS
   Wang X. D., 2004, ADV MAT IN PRESS
   Wang XD, 2004, NANO LETT, V4, P423, DOI 10.1021/nl035102c
   Wang Z. L., 1998, FUNCTIONAL SMART MAT
   Yang PD, 2002, ADV FUNCT MATER, V12, P323, DOI 10.1002/1616-3028(20020517)12:5<323::AID-ADFM323>3.0.CO;2-G
   Zhao QX, 2003, APPL PHYS LETT, V83, P165, DOI 10.1063/1.1591069
NR 23
TC 933
Z9 961
U1 18
U2 195
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD JUN
PY 2004
VL 7
IS 6
BP 26
EP 33
DI 10.1016/S1369-7021(04)00286-X
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA V32DK
UT WOS:000208931700030
OA Other Gold
DA 2018-10-20
ER

PT J
AU Berry, E
   Handley, JW
   Fitzgerald, AJ
   Merchant, WJ
   Boyle, RD
   Zinov'ev, NN
   Miles, RE
   Chamberlain, JM
   Smith, MA
AF Berry, E
   Handley, JW
   Fitzgerald, AJ
   Merchant, WJ
   Boyle, RD
   Zinov'ev, NN
   Miles, RE
   Chamberlain, JM
   Smith, MA
TI Multispectral classification techniques for terahertz pulsed imaging: an
   example in histopathology
SO MEDICAL ENGINEERING & PHYSICS
LA English
DT Article
DE terahertz pulsed imaging; multispectral classification; clustering;
   histopathology; basal cell carcinoma; melanoma
ID TIME-DOMAIN SPECTROSCOPY; TISSUE; BEAMS
AB Terahertz pulsed imaging is a spectroscopic imaging modality using pulses of electromagnetic radiation (100 GHz-10 THz), and there has been recent interest in studying biomedical specimens. It is usual to display parametric images derived from the measured pulses. In this work, classification was achieved by applying multispectral clustering techniques to sets of parametric images. It was hypothesised that adequate information for clustering was carried in a small number of parametric images, providing these were weighted by complementary physical properties. Materials prepared for histopathological examination were chosen because their condition remained stable during long imaging periods and because their dehydrated state led to greater penetration of the radiation. Two specimens were examined in this pilot study, one of basal cell carcinoma and one of melanoma. Unsupervised ISODATA classification using three selected parametric terahertz pulsed images was compared qualitatively with k-means classification using the shape of the whole time series, and with conventional stained microscope slides. There was good qualitative agreement between the classifications. Classifications were consistent with the morphological appearances expected, but further work is required to determine if tumour discrimination is possible. The results have implications for the future development of the technique as the need for only a small number of features could lead to considerably reduced acquisition times. (C) 2004 IPEM. Published by Elsevier Ltd. All rights reserved.
C1 Univ Leeds, Gen Infirm, Acad Unit Med Phys, Leeds LS1 3EX, W Yorkshire, England.
   Univ Leeds, Sch Comp, Leeds LS2 9JT, W Yorkshire, England.
   Leeds Teaching Hosp, Dept Histopathol, NHS Trust, Leeds LS1 3EX, W Yorkshire, England.
   Univ Leeds, Sch Elect & Elect Engn, Leeds LS2 9JT, W Yorkshire, England.
RP Berry, E (reprint author), Univ Leeds, Gen Infirm, Acad Unit Med Phys, Wellcome Wing,Great George St, Leeds LS1 3EX, W Yorkshire, England.
EM e.berry@leeds.ac.uk
CR AUSTON DH, 1988, IEEE J QUANTUM ELECT, V24, P184, DOI 10.1109/3.114
   Berry E, 2003, PROC SPIE, V5030, P459, DOI 10.1117/12.479993
   Dorney TD, 2001, J OPT SOC AM A, V18, P1562, DOI 10.1364/JOSAA.18.001562
   Duda R. O., 1973, PATTERN CLASSIFICATI
   Duvillaret L, 1999, APPL OPTICS, V38, P409, DOI 10.1364/AO.38.000409
   Ferguson B, 2002, MICROELECTRON J, V33, P1043, DOI 10.1016/S0026-2692(02)00109-X
   Fitzgerald AJ, 2002, PHYS MED BIOL, V47, P3865, DOI 10.1088/0031-9155/47/21/326
   GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006
   Grischkowsky D. R., 2003, SENSING TERAHERTZ RA, P1
   Hecht E, 1974, OPTICS
   HU BB, 1995, OPT LETT, V20, P1716, DOI 10.1364/OL.20.001716
   IEEE, 1999, STAND SAF LEV RESP H
   Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g
   Knobloch P, 2002, PHYS MED BIOL, V47, P3875, DOI 10.1088/0031-9155/47/21/327
   Loffler T, 2002, PHYS MED BIOL, V47, P3847, DOI 10.1088/0031-9155/47/21/324
   Loffler T, 2001, OPT EXPRESS, V9, P616
   Lundervold A, 2000, MED IMAGE ANAL, V4, P123, DOI 10.1016/S1361-8415(00)00009-8
   Mittleman D., 2003, SENSING TERAHERTZ RA, P117, DOI 10.1007/978-3-540-45601-8
   Mittleman DM, 1999, APPL PHYS B-LASERS O, V68, P1085, DOI 10.1007/s003400050750
   Smye SW, 2001, PHYS MED BIOL, V46, pR101, DOI 10.1088/0031-9155/46/9/201
   Vinitski S, 1997, MAGNET RESON MED, V37, P457, DOI 10.1002/mrm.1910370325
   Wu Q, 1996, APPL PHYS LETT, V69, P1026, DOI 10.1063/1.116920
NR 22
TC 33
Z9 33
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1350-4533
J9 MED ENG PHYS
JI Med. Eng. Phys.
PD JUN
PY 2004
VL 26
IS 5
BP 423
EP 430
DI 10.1016/j.medengphy.2004.02.011
PG 8
WC Engineering, Biomedical
SC Engineering
GA 825SM
UT WOS:000221778600007
PM 15147750
DA 2018-10-20
ER

PT J
AU McHargue, CJ
AF McHargue, CJ
TI Radiation effects in insulators: past, present, future
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on Radiation Effects in Insulators
CY AUG 31-SEP 05, 2003
CL Gramado, BRAZIL
SP UFRGS, FAPERGS, CNPQ, FINEP, Elsevier, High Voltage Engn Europa BV
AB Interest in the structure and chemical and physical properties of irradiated ionic crystals in the 1960s and 1970s lead to the initiation of this series of conferences with REM at Arco, Lago di Garda (Italy) in 1981. The early programs focused on treatment of collisional events in insulators (mainly from ions) and the physical and chemical properties of defects. Studies were about evenly distributed among halides, oxides, glasses and organic polymers. Radiation effects in nuclear waste materials and "hot" chemistry were important subjects during the mid to late 1980s but interest in these areas has decreased.
   In recent years, the addition of laser-induced effects has grown and the interest in polymers has focused on tailoring surfaces for specific applications, e.g. biomedical. Researches on covalent-bonded materials (SiC and diamond), complex oxides (spinels, etc.) and nanoclusters have become more prevalent. Theoretical and modeling treatments have moved from treatment of single collision events to molecular dynamics modeling of events associated with cascades.
   Many fundamental questions remain that will be studied by increasingly improved experimental techniques and modeling. The modeling studies will progress from describing events that occur during the first few picoseconds to description of microstructural developments. There should be renewed interest in secondary effects such as the influence of electronic excitation on defect diffusion and stability. The future of ion beam produced nanoclusters rests upon a demonstration of its ability to satisfy the demands of some unique application. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Tennessee, Ctr Mat Proc, Knoxville, TN 37996 USA.
RP McHargue, CJ (reprint author), Univ Tennessee, Ctr Mat Proc, 100 Eastbrook Hall, Knoxville, TN 37996 USA.
EM crl@utk.edu
CR ALVES E, 2002, NUCL INSTR METH B, V191
   ARNOLD GW, 1984, NUCL INSTR METH, V1
   BELSON J, 1986, RAD EFF, V97
   Corrales LR, 2003, CURR OPIN SOLID ST M, V7, P35, DOI 10.1016/S1359-0286(03)00016-0
   DAVIES J, 1990, NUCL INSTR METH B, V46
   FOTI G, 1996, NUCL INSTR METH B, V116
   GOTZ G, 1992, NUCL INSTR METH B, V65
   IOTH N, 1994, NUCL INSTR METH B, V91
   MANNING I, 1974, COMPUT PHYS COMMUN, V7, P85, DOI 10.1016/0010-4655(74)90043-5
   MAZZOLDI P, 1982, RAD EFF, V64
   MCHARGUE CJ, 1998, NUCL INSTR METH B, V141
   Mie G, 1908, ANN PHYS-BERLIN, V25, P377
   MOLLER W, 2003, NUCL INSTR METH B, V202
   PEREZ A, 1980, SITE CHARACTERIZATIO
   ROESSLER K, 1988, NUCL INSTRUM METH B, V32, P519, DOI 10.1016/0168-583X(88)90265-0
   SIENDENTOPF H, 2005, Z PHYS, V6, P855
   THEVENARD P, 1988, NUCL INSTR METH B, V32
   WESCH W, 2000, NUCL INSTR METH B, V166
   Ziegler J F, 1985, STOPPING RANGE IONS
NR 19
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JUN
PY 2004
VL 218
BP 1
EP 8
DI 10.1016/j.nimb.2003.12.065
PG 8
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 822SR
UT WOS:000221561000002
DA 2018-10-20
ER

PT J
AU Jones, AN
   Ahmed, W
   Hassan, IU
   Sein, H
   Rego, CA
AF Jones, AN
   Ahmed, W
   Hassan, IU
   Sein, H
   Rego, CA
TI Pulsed biased growth of nanocrystalline diamond by hot filament chemical
   vapour deposition
SO SURFACE ENGINEERING
LA English
DT Article
DE diamond growth; diamond characterisation; bias enhanced nucleation;
   nanocrystalline; biocompatibility; CVD
ID MICROWAVE-PLASMA; FILMS; CVD; NUCLEATION
AB For many industrial applications such as biomedical instruments, optical devices and microelectromechanical systems, the control of the film structure, crystallinity and morphology is of critical importance. The crystallite size, orientation and surface roughness have a profound effect oil the mechanical, optical and electrical properties of the films and therefore the final product performance. In order to reduce the crystallite size and surface roughness, inert gases were added to the methane and hydrogen mixture during chemical vapour deposition of nanocrystalline diamond films. In addition, the results oil the influence of pulsed biasing Oil tire morphology of these films are reported Bias voltages in the range -300-0 V were investigated Increasing the bias voltage significantly alters tire crystallite size and morphology of the deposited films. Raman spectroscopy, SEM and atomic force microscopy were used to characterise the nanocrystalline diamond films. (C) 2004 IoM Communications Ltd. Published by Maney for the Institute of Materials, Minerals and Mining.
C1 Manchester Metropolitan Univ, Dept Chem & Mat, Surface Coatings & Characterisat Res Grp, Manchester M1 5GD, Lancs, England.
RP Jones, AN (reprint author), Manchester Metropolitan Univ, Dept Chem & Mat, Surface Coatings & Characterisat Res Grp, Manchester M1 5GD, Lancs, England.
EM Ahmed@unzmu.ac.uk
RI Jones, Abbie/A-2763-2012
OI Jones, Abbie/0000-0002-1350-4617; Ahmed, Waqar/0000-0003-4152-5172
CR Ahmed W, 2000, VACUUM, V56, P153, DOI 10.1016/S0042-207X(99)00147-5
   Ali N, 2003, VACUUM, V71, P445, DOI 10.1016/S0042-207X(03)00003-4
   ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913
   ANGUS JC, 1975, SURF SCI, V50, P157, DOI 10.1016/0039-6028(75)90180-6
   Chiang MJ, 2001, DIAM RELAT MATER, V10, P1470, DOI 10.1016/S0925-9635(00)00579-3
   Erdemir A, 1999, SURF COAT TECH, V120, P565, DOI 10.1016/S0257-8972(99)00443-0
   Hassan IU, 1999, THIN SOLID FILMS, V355, P134, DOI 10.1016/S0040-6090(99)00500-3
   Sharda T, 2000, DIAM RELAT MATER, V9, P1331, DOI 10.1016/S0925-9635(00)00247-8
   Sharda T, 2002, THIN SOLID FILMS, V406, P70, DOI 10.1016/S0040-6090(01)01774-6
   Sharda T, 2001, DIAM RELAT MATER, V10, P1592, DOI 10.1016/S0925-9635(01)00415-0
   Shim JY, 2001, DIAM RELAT MATER, V10, P847, DOI 10.1016/S0925-9635(01)00378-8
   Stockel R, 1996, DIAM RELAT MATER, V5, P321, DOI 10.1016/0925-9635(95)00355-X
   Yang TS, 2001, DIAM RELAT MATER, V10, P2161, DOI 10.1016/S0925-9635(01)00495-2
   Zaitsev A.M., OPTICAL PROPERTIES D
NR 14
TC 1
Z9 1
U1 0
U2 2
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0267-0844
J9 SURF ENG
JI Surf. Eng.
PD JUN
PY 2004
VL 20
IS 3
BP 181
EP 185
DI 10.1179/026708404225010720
PG 5
WC Materials Science, Coatings & Films
SC Materials Science
GA 840NV
UT WOS:000222866700007
DA 2018-10-20
ER

PT J
AU Chen, SQ
   Zhu, ZQ
   Zhu, JZ
   Zhang, JA
   Shi, YL
   Ke, Y
   Wang, WM
   Wang, XH
   Feng, XA
   Luo, LQ
   Li, S
AF Chen, SQ
   Zhu, ZQ
   Zhu, JZ
   Zhang, JA
   Shi, YL
   Ke, Y
   Wang, WM
   Wang, XH
   Feng, XA
   Luo, LQ
   Li, S
TI Hydroxyapatite coating on porous silicon substrate obtained by
   precipitation process
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE hydroxyapatite coating; porous silicon; bioactivity; biocompatible
ID SOL-GEL SYNTHESIS; ELECTROPHORETIC DEPOSITION; OPTICAL-PROPERTIES;
   CALCIUM-PHOSPHATE; THIN-FILMS; TITANIUM; POWDERS; SENSORS; STRESS;
   BODIES
AB Hydroxyapatite Ca-10(PO4)(6)(OH)(2) (HAP) is known as a bioactive and biocompatible material, HAP coatings were used to improve the biocompatible of substrate by many researcher, In this work, HAP thin films on porous silicon (PS) substrates have been prepared by aqueous precipitation method with rapid thermal annealing (RTA) processes. The HAP films had been prepared under the annealing temperature ranging from 300 to 1000 degreesC. By the measurement of X-ray diffraction (XRD), it was found that for the crystallinity optimization, the heat-treatment at 850-950 degreesC for I h would be favorable. Atomic force microscopy (AFM) and scanning electron microscope (SEM) measurements reveal a dense and smooth surface of the HAP film, and tightly adherence of the coating on porous silicon substrate after sintered. Thus, by this method, porous silicon could be increased its bioactivity and so that could be used in the biomedical area. (C) 2004 Elsevier B.V. All rights reserved.
C1 E China Normal Univ, Dept Elect Engn, Shanghai 200062, Peoples R China.
RP Zhu, ZQ (reprint author), E China Normal Univ, Dept Elect Engn, 3663 Zhongshan N Rd, Shanghai 200062, Peoples R China.
EM sophorate@163.com; zqzhu@ee.ecnu.edu.cn
CR Baratto C, 2002, SENSORS, V2, P121, DOI 10.3390/s20300121
   Bengtsson M, 2000, PHYS STATUS SOLIDI A, V182, P533, DOI 10.1002/1521-396X(200011)182:1<533::AID-PSSA533>3.0.CO;2-W
   Berndt C. C., 1990, Materials Forum, V14, P161
   Bisi O, 2000, SURF SCI REP, V38, P1, DOI 10.1016/S0167-5729(99)00012-6
   Carvalho FLS, 1999, J NON-CRYST SOLIDS, V247, P64, DOI 10.1016/S0022-3093(99)00033-2
   Chan S, 2001, MAT SCI ENG C-BIO S, V15, P277, DOI 10.1016/S0928-4931(01)00219-3
   Chen CH, 1999, SOLID STATE COMMUN, V111, P681, DOI 10.1016/S0038-1098(99)00271-9
   Craciun V, 1999, APPL SURF SCI, V138, P587, DOI 10.1016/S0169-4332(98)00457-7
   Fernandez-Pradas JM, 2002, APPL SURF SCI, V195, P31, DOI 10.1016/S0169-4332(02)00002-8
   FUJISHIRO Y, 1995, J COLLOID INTERF SCI, V173, P119, DOI 10.1006/jcis.1995.1304
   GRUNING U, 1995, THIN SOLID FILMS, V255, P135, DOI 10.1016/0040-6090(94)05638-T
   GUANGLIANG X, 2001, CERAMIC, V152, P32
   Guipont V, 2002, MAT SCI ENG A-STRUCT, V325, P9, DOI 10.1016/S0921-5093(01)01414-9
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   Hsieh MF, 2002, MATER CHEM PHYS, V74, P245, DOI 10.1016/S0254-0584(01)00474-6
   Hwang K, 1999, SURF COAT TECH, V115, P172, DOI 10.1016/S0257-8972(99)00174-7
   Kim HS, 2002, APPL PHYS LETT, V80, P2287, DOI 10.1063/1.1465130
   KWEH SWK, 1999, J MATER PROCESS TECH, V89, P373
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liua D.M., 2002, BIOMATERIALS, V23, P1227
   Liua DM, 2002, BIOMATERIALS, V23, P1679
   Lopatin CM, 1998, THIN SOLID FILMS, V326, P227, DOI 10.1016/S0040-6090(98)00531-8
   Lu YP, 2003, APPL SURF SCI, V206, P345, DOI 10.1016/S0169-4332(02)01308-9
   Luth H, 2000, MAT SCI ENG B-SOLID, V69, P104, DOI 10.1016/S0921-5107(99)00275-5
   Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5
   Manso-Silvan M, 2003, J EUR CERAM SOC, V23, P243, DOI 10.1016/S0955-2219(02)00187-5
   McGinnis SP, 2000, THIN SOLID FILMS, V365, P1, DOI 10.1016/S0040-6090(00)00729-X
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   Milella E, 2001, BIOMATERIALS, V22, P1425, DOI 10.1016/S0142-9612(00)00300-8
   Nelea V, 2000, APPL SURF SCI, V168, P127, DOI 10.1016/S0169-4332(00)00616-4
   Park E, 1999, MATER LETT, V40, P228, DOI 10.1016/S0167-577X(99)00080-4
   Reddy RRK, 2001, BIOSENS BIOELECTRON, V16, P313, DOI 10.1016/S0956-5663(01)00129-4
   Rodriguez-Lorenzo LM, 2004, MATER RES BULL, V39, P83, DOI 10.1016/j.materresbull.2003.09.014
   Rodriguez-Lorenzo LM, 2001, BIOMATERIALS, V22, P583, DOI 10.1016/S0142-9612(00)00218-0
   Setzu S, 2000, MAT SCI ENG B-SOLID, V69, P34, DOI 10.1016/S0921-5107(99)00261-5
   Shi W, 2002, MAT SCI ENG A-STRUCT, V337, P104, DOI 10.1016/S0921-5093(02)00003-5
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wei M, 1999, J BIOMED MATER RES, V45, P11, DOI 10.1002/(SICI)1097-4636(199904)45:1<11::AID-JBM2>3.0.CO;2-7
   Weng WJ, 1998, J MATER SCI-MATER M, V9, P159, DOI 10.1023/A:1008819703551
   Yang YC, 2001, BIOMATERIALS, V22, P1827, DOI 10.1016/S0142-9612(00)00364-1
   YUA LG, 2003, BIOMATERIALS, V24, P2695
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 45
TC 16
Z9 21
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 31
PY 2004
VL 230
IS 1-4
BP 418
EP 424
DI 10.1016/j.apsusc.2004.03.203
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 828IX
UT WOS:000221968100053
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Lawn, B
AF Zhang, Y
   Lawn, B
TI Long-term strength of ceramics for biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bilayers; brittle coatings; crack velocity; critical loads; dental
   crowns; lifetime; fracture
ID BRITTLE COATINGS; LAYER STRUCTURES; DENTAL CERAMICS; STATIC FATIGUE;
   DAMAGE MODES; CONTACT; FRACTURE; SPHERES; DESIGN; LOADS
AB The influence of slow crack growth on the initiation of radial cracks at the lower surfaces of ceramic layers bonded to polymeric substrates is studied, with particular relevance to biomechanical systems, e.g., dental crowns and hip replacement prostheses. Critical loads are measured as a function of loading rate (dynamic fatigue) for model bilayers fabricated by epoxy-bonding selected clinical ceramics to polycarbonate bases. Radial crack initiation is observed in situ by viewing from below the transparent base during loading. Declines in the critical loads with diminishing load rate are consistent with slow crack growth of intrinsic flaws prior to radial crack pop in. A simple fracture mechanics relation incorporating a crack velocity function is used to analyze the data. Extrapolation beyond the data range enables long-lifetime (10 yr) estimates of sustainable loads. The procedure provides a basis for ranking ceramic types, and in particular for eliminating vulnerable candidate materials, for use in biomechanical systems. While slow crack growth is an important factor in failure, other mechanisms could operate in concert and even dominate under severe testing conditions, especially under cyclic loading. (C) 2004 Wiley Periodicals, Inc.
C1 Natl Inst Stand & Technol, Mat Sci & Engn Lab, Gaithersburg, MD 20899 USA.
RP Lawn, B (reprint author), Natl Inst Stand & Technol, Mat Sci & Engn Lab, Gaithersburg, MD 20899 USA.
EM brian.lawn@nist.gov
FU NIDCR NIH HHS [P01DE10976]
CR Chai H, 1999, J MATER RES, V14, P3805
   Deng Y, 2002, J BIOMED MATER RES, V63, P137, DOI 10.1002/jbm.10091
   Holand W, 2000, J BIOMED MATER RES, V53, P297, DOI 10.1002/1097-4636(2000)53:4<297::AID-JBM3>3.0.CO;2-G
   Jung YG, 2000, J DENT RES, V79, P722, DOI 10.1177/00220345000790020501
   Jung YG, 1999, J DENT RES, V78, P887, DOI 10.1177/00220345990780040901
   Kelly JR, 1999, J PROSTHET DENT, V81, P652, DOI 10.1016/S0022-3913(99)70103-4
   Kelly JR, 1997, ANNU REV MATER SCI, V27, P443, DOI 10.1146/annurev.matsci.27.1.443
   Kim DK, 1999, ACTA MATER, V47, P4711, DOI 10.1016/S1359-6454(99)00246-3
   Kim HW, 2001, J AM CERAM SOC, V84, P2377
   Lakshminarayanan R, 1996, J AM CERAM SOC, V79, P79, DOI 10.1111/j.1151-2916.1996.tb07883.x
   Lawn B.R., 1993, FRACTURE BRITTLE SOL
   Lawn BR, 1998, J AM CERAM SOC, V81, P1977, DOI 10.1111/j.1151-2916.1998.tb02580.x
   LAWN BR, 1994, SCIENCE, V263, P1114, DOI 10.1126/science.263.5150.1114
   Lawn BR, 2002, CURR OPIN SOLID ST M, V6, P229, DOI 10.1016/S1359-0286(02)00016-5
   Lawn BR, 2000, ADV ENG MATER, V2, P745, DOI 10.1002/1527-2648(200011)2:11<745::AID-ADEM745>3.0.CO;2-E
   Lawn BR, 2001, J PROSTHET DENT, V86, P495, DOI 10.1067/mpr.2001.119581
   Lawn BR, 2002, J MATER RES, V17, P3019, DOI 10.1557/JMR.2002.0440
   Lee CS, 2002, J AM CERAM SOC, V85, P2019, DOI 10.1111/j.1151-2916.2002.tb00398.x
   Lohbauer U, 2002, J BIOMED MATER RES, V63, P780, DOI 10.1002/jbm.10468
   Miranda P, 2003, ACTA MATER, V51, P4347, DOI 10.1016/S1359-6454(03)00290-8
   Miranda P, 2001, ACTA MATER, V49, P3719, DOI 10.1016/S1359-6454(01)00280-4
   Rhee YW, 2001, J AM CERAM SOC, V84, P1066, DOI 10.1111/j.1151-2916.2001.tb00791.x
   Wiederhorn S. M., FRACTURE MECH CERAMI, P613
   WIEDERHORN SM, 1970, J AM CERAM SOC, V53, P543, DOI 10.1111/j.1151-2916.1970.tb15962.x
   WIEDERHORN SM, 1972, J AM CERAM SOC, V55, P81, DOI 10.1111/j.1151-2916.1972.tb11215.x
   Willmann G, 2001, ADV ENG MATER, V3, P135, DOI 10.1002/1527-2648(200103)3:3<135::AID-ADEM135>3.3.CO;2-2
NR 26
TC 54
Z9 57
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY 15
PY 2004
VL 69B
IS 2
BP 166
EP 172
DI 10.1002/jbm.b.20039
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 818XQ
UT WOS:000221278200008
PM 15116406
OA Green Published
DA 2018-10-20
ER

PT J
AU Peitl, O
   Orefice, RL
   Hench, LL
   Brennan, AB
AF Peitl, O
   Orefice, RL
   Hench, LL
   Brennan, AB
TI Effect of the crystallization of bioactive glass reinforcing agents on
   the mechanical properties of polymer composites
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE composites; glass-ceramic particles; crystallization
ID CERAMICS
AB Polymer composites based on the introduction of bioactive materials into polymer matrices can combine mechanical with bioactive properties suitable for many potential biomedical applications. In this work, glass-ceramics derived from the crystallization of bioactive glasses were tested as reinforcing agents in polymer composites. The kinetics of crystallization of soda-lime silica glasses containing phosphorous was studied to define conditions for obtaining glass-ceramics having different microstructures. This type of glass can be used in biomedical applications due to its ability to bind to bone (bioactive behavior). Evaluation of the mechanical properties of glass-ceramic bodies derived from bioactive glasses has allowed us to determine the relationship between microstructure and properties. A particular microstructure capable of leading to fine grained glass-ceramics with enhanced properties was then reproduced in bioactive glass particles. Thus, bioactive glass particles were crystallized to different levels and used as reinforcing agents in polymer (polysulfone) composites. Mechanical properties of composites were evaluated using a four-point bending test. Glass-ceramic reinforced composites showed higher elastic modulus than glass reinforced composites. Therefore, crystallization of silicate glasses used as reinforcing agents in polymer matrices is a possible way to enhance the mechanical properties of composites. Polymer composites having bioactive glass-ceramic particles display some mechanical properties comparable to human cortical bone. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Polymer & Composite Engn, LEPCom, BR-30160030 Belo Horizonte, MG, Brazil.
   Univ Fed Sao Carlos, BR-13560 Sao Carlos, SP, Brazil.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat Sci, London, England.
   Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
RP Orefice, RL (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Polymer & Composite Engn, LEPCom, Rue Espirito Santo 35,2 Andar, BR-30160030 Belo Horizonte, MG, Brazil.
EM opeitl@power.ufscar.br; rorefice@demet.ufmg.br
RI Brennan, Anthony/C-8552-2009; Orefice, Rodrigo/N-8055-2018
OI Brennan, Anthony/0000-0002-0431-8425; Orefice,
   Rodrigo/0000-0002-6046-4056
CR DEHOFF RT, 1961, T METALL SOC AIME, V221, P975
   FAN Z, 1994, J MATER SCI, V29, P141, DOI 10.1007/BF00356585
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 2000, CURR ORTHOPAED, V14, P7, DOI 10.1054/cuor.1999.0074
   Holand W, 1997, J NON-CRYST SOLIDS, V219, P192, DOI 10.1016/S0022-3093(97)00329-3
   KALININA AM, 1980, J NON-CRYST SOLIDS, V38-9, P723, DOI 10.1016/0022-3093(80)90522-0
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   MALLICK RK, 1993, FIBER REINFORCED COM
   Orefice RL, 2001, J BIOMED MATER RES, V55, P460, DOI 10.1002/1097-4636(20010615)55:4<460::AID-JBM1037>3.0.CO;2-3
   OREFICE RL, 1995, BIOCERAMICS, V8, P409
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Wang M, 2000, MATER LETT, V44, P119, DOI 10.1016/S0167-577X(00)00026-4
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
NR 14
TC 21
Z9 22
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAY 15
PY 2004
VL 372
IS 1-2
BP 245
EP 251
DI 10.1016/j.msea.2004.01.011
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 821TC
UT WOS:000221484600029
DA 2018-10-20
ER

PT J
AU Tolvanen, M
   Vihinen, M
AF Tolvanen, M
   Vihinen, M
TI Virtual bioinformatics distance learning suite
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION
LA English
DT Article
DE bioinformatics education; computer-aided education; sequence analysis;
   functional genomics
AB Distance learning as a computer-aided concept allows students to take courses from anywhere at any time. In bioinformatics, computers are needed to collect, store, process, and analyze massive amounts of biological and biomedical data. We have applied the concept of distance learning in virtual bioinformatics to provide university course material over the Internet. Currently, we provide two fully computer-based courses, "Introduction to Bioinformatics" and "Bioinformatics in Functional Genomics." Here we will discuss the application of distance learning in bioinformatics training and our experiences gained during the 3 years that we have run the courses, with about 400 students from a number of universities. The courses are available at bioinf.uta.fi.
C1 Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland.
   Tampere Univ Hosp, Res Unit, FI-33520 Tampere, Finland.
RP Vihinen, M (reprint author), Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland.
EM mauno.vihinen@uta.fi
RI Vihinen, Mauno/A-8452-2012
OI Vihinen, Mauno/0000-0002-9614-7976
CR Altman RB, 1998, BIOINFORMATICS, V14, P549, DOI 10.1093/bioinformatics/14.7.549
   Lim YP, 2003, BIOCHEM MOL BIOL EDU, V31, P20, DOI 10.1002/bmb.2003.494031010160
   MABEY JE, 2001, CAL LABORATE, V6, P13
   Pearson WR, 2001, BIOINFORMATICS, V17, P761, DOI 10.1093/bioinformatics/17.9.761
   WICKWARE P, 2001, NATUREJOBS, V413, P6
   2003, S STAR BIOINFORMATIC
   MANCHESTER DISTANCE
   2002, ENGLISH FINNISH ENGL
NR 8
TC 8
Z9 8
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1470-8175
J9 BIOCHEM MOL BIOL EDU
JI Biochem. Mol. Biol. Educ.
PD MAY-JUN
PY 2004
VL 32
IS 3
BP 156
EP 160
DI 10.1002/bmb.2004.494032030336
PG 5
WC Biochemistry & Molecular Biology; Education, Scientific Disciplines
SC Biochemistry & Molecular Biology; Education & Educational Research
GA 826FA
UT WOS:000221813500004
PM 21706714
OA Bronze
DA 2018-10-20
ER

PT J
AU Levy, I
   Paldi, T
   Shoseyov, O
AF Levy, I
   Paldi, T
   Shoseyov, O
TI Engineering a bifunctional starch-cellulose cross-bridge protein
SO BIOMATERIALS
LA English
DT Article
DE starch-binding domain; cellulose-binding domain; cross-bridging
ID CARBOHYDRATE-BINDING MODULE; WOUND DRESSING MATERIALS; ESCHERICHIA-COLI;
   IN-VITRO; PSEUDOMONAS XYLANASE; ASPERGILLUS-NIGER; HYBRID ENZYMES;
   ALPHA-AMYLASE; DOMAIN; FUSION
AB Biodegradable starch- and cellulose-based polymers have a range of properties which make them suitable for use in a wide array of biomedical applications ranging from bone replacement to engineering of tissue scaffolds and drug delivery systems. A novel polysaccharide cross-bridging protein was designed which was comprised of a cellulose-binding domain from Clostridium cellulovorans (CBDclos) and a starch-binding domain from Aspergillus niger B1 (SBDAsp). The two genes were fused in-frame via a synthetic elastin gene to construct a Cellulose/Starch Cross bridging Protein (CSCP). Recombinant CSCP was expressed in Escherichia coli, and successfully refolded from inclusion bodies. CSCP demonstrated cross-bridging ability in different model systems composed of insoluble or soluble starch and cellulose. The aspect that different carbohydrate-binding module maintain their binding capacity over a wide range of conditions, without the need for chemical reactions, makes them attractive domains for designing new classes of chimeric polysaccharide-binding domains which demonstrate potential for use in a wide range of biomaterials. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.
RP Shoseyov, O (reprint author), Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Fac Agr Food & Environm Qual Sci, POB 12, IL-76100 Rehovot, Israel.
EM shoseyov@agri.huji.ac.il
CR Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529
   Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065
   Beguin P, 1999, CURR OPIN BIOTECH, V10, P336, DOI 10.1016/S0958-1669(99)80061-5
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775
   Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0
   BULOW L, 1991, TRENDS BIOTECHNOL, V9, P226, DOI 10.1016/0167-7799(91)90075-S
   DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096
   DOI RH, 1994, CRIT REV MICROBIOL, V20, P87, DOI 10.3109/10408419409113548
   Duarte MG, 1997, J MATER SCI-MATER M, V8, P321, DOI 10.1023/A:1018568513662
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871
   GILKES NR, 1991, MICROBIOL REV, V55, P303
   Gill J, 1999, BIOCHEM J, V342, P473, DOI 10.1042/0264-6021:3420473
   Gokhale RS, 2000, CURR OPIN CHEM BIOL, V4, P22, DOI 10.1016/S1367-5931(99)00046-0
   GOLDSTEIN MA, 1993, J BACTERIOL, V175, P5762
   Gustavsson M, 2001, PROTEIN ENG, V14, P711, DOI 10.1093/protein/14.9.711
   HARSH DC, 1991, J CONTROL RELEASE, V17, P175, DOI 10.1016/0168-3659(91)90057-K
   Hoenich NA, 2000, BIOMATERIALS, V21, P317, DOI 10.1016/S0142-9612(99)00196-9
   Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016
   KETOLA H, 1999, PAPER MAKING CHEM, P269
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Leonor IB, 2003, BIOMATERIALS, V24, P579, DOI 10.1016/S0142-9612(02)00371-X
   Levy I, 2002, CELLULOSE, V9, P91, DOI 10.1023/A:1015848701029
   Levy I, 2002, BIOTECHNOL ADV, V20, P191, DOI 10.1016/S0734-9750(02)00006-X
   Levy I, 2002, BIOMOL ENG, V19, P17, DOI 10.1016/S1389-0344(02)00007-2
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   MATTHEW IR, 1995, BIOMATERIALS, V16, P275, DOI 10.1016/0142-9612(95)93254-B
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Michailova V, 2001, INT J PHARM, V222, P7, DOI 10.1016/S0378-5173(01)00706-2
   Moseley R, 2003, BIOMATERIALS, V24, P1549, DOI 10.1016/S0142-9612(02)00540-9
   Nixon AE, 1998, TRENDS BIOTECHNOL, V16, P258, DOI 10.1016/S0167-7799(98)01204-9
   Notenboom V, 2001, BIOCHEMISTRY-US, V40, P6248, DOI 10.1021/bi0101704
   Ohdan K, 2000, APPL ENVIRON MICROB, V66, P3058, DOI 10.1128/AEM.66.7.3058-3064.2000
   Paldi T, 2003, BIOCHEM J, V372, P905, DOI 10.1042/BJ20021527
   Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+
   Receveur V, 2002, J BIOL CHEM, V277, P40887, DOI 10.1074/jbc.M205404200
   Risbud MV, 2001, J BIOMED MATER RES, V54, P436, DOI 10.1002/1097-4636(20010305)54:3<436::AID-JBM180>3.3.CO;2-#
   Roberts J. C., 1996, CHEM PAPER
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sauer J, 2001, BIOCHEMISTRY-US, V40, P9336, DOI 10.1021/bi010515i
   SCHARF SJ, 1990, PCR PROTOCOLS GUIDE, P84
   Seo HS, 2000, APPL ENVIRON MICROB, V66, P2484, DOI 10.1128/AEM.66.6.2484-2490.2000
   SHOSEYOV O, 1992, P NATL ACAD SCI USA, V89, P3483, DOI 10.1073/pnas.89.8.3483
   Shpigel E, 1999, BIOTECHNOL BIOENG, V65, P17, DOI 10.1002/(SICI)1097-0290(19991005)65:1<17::AID-BIT3>3.0.CO;2-Y
   SHPIGEL E, 1998, PROTEIN EXPRES PURIF, V14, P1085
   Simpson PJ, 2002, BIOCHEMISTRY-US, V41, P5712, DOI 10.1021/bi012093i
   Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200
   SRISODSUK M, 1993, J BIOL CHEM, V268, P20756
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P30
   SWILLENS S, 1995, MOL PHARMACOL, V47, P1197
   Tibbot BK, 2000, J PROTEIN CHEM, V19, P663, DOI 10.1023/A:1007148202270
   Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5
   Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x
   Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2317, DOI 10.1021/bi002462v
   Urry DW, 1999, TRENDS BIOTECHNOL, V17, P249, DOI 10.1016/S0167-7799(99)01306-2
   URRY DW, 1996, PROTEIN BASED MAT, P133
   WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989
NR 62
TC 23
Z9 24
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 10
BP 1841
EP 1849
DI 10.1016/j.biomaterials.2003.08.041
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770CQ
UT WOS:000188706000013
PM 14738848
DA 2018-10-20
ER

PT J
AU Ji, J
   Zhu, HG
   Shen, JC
AF Ji, J
   Zhu, HG
   Shen, JC
TI Surface tailoring of poly(DL-lactic acid) by ligand-tethered amphiphilic
   polymer for promoting chondrocyte attachment and growth
SO BIOMATERIALS
LA English
DT Article
DE poly(DL-lactic acid) (PDL-LA); PEO-PPO-PEO amphiphilic copolymer; amino
   acid; tissue engineering; chondrocyte
ID POLY(ETHYLENE GLYCOL); POLYETHYLENE OXIDE; BIOMATERIALS; COPOLYMERS;
   PEPTIDES; IMMOBILIZATION; PROLIFERATION; ADHESION; HYDROGEL; ASSAY
AB The ligand-tethered poly(ethylene oxide-propylene oxide-ethylene oxide) (PEO-PPO-PEO) triblock copolymer was explored to engineer poly(DL-lactic acid) (PDL-LA) material to promote cell attachment and growth. The PEO-PPO-PEO was activated by methyl sulfonyl chloride and the amino acid, and peptide were attached. By blending the PDL-LA with the ligand-tethered PEO-PPO-PEO derivatives, the surface of modified PDL-LA film was investigated by ATR-FTIR, XPS and contact angle. The chondrocytes test on different PDL-LA films indicated that the PEO-PPO-PEO amino acid and RGD derivatives modified PDL-LA films could promote chondrocyte attachment and growth. This simple surface treatment method may have potentials for tissue engineering and other biomedical applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Ji, J (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
EM jianji@mail.hz.zj.cn
RI Zhu, Huiguang/A-8591-2010
OI Ji, Jian/0000-0001-9870-4038
CR Andreopoulos AG, 1999, J MATER SCI-MATER M, V10, P29, DOI 10.1023/A:1008887910068
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Bancel S, 1996, BIOTECHNOL PROGR, V12, P398, DOI 10.1021/bp960023a
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   BLUM RN, 1992, J GEN INTERN MED, V7, P140, DOI 10.1007/BF02598002
   Brown KC, 2000, CURR OPIN CHEM BIOL, V4, P16, DOI 10.1016/S1367-5931(99)00045-9
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   DELGADO C, 1990, BIOTECHNOL APPL BIOC, V12, P119
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   HAYASHI T, 1971, BIOCHIM BIOPHYS ACTA, V251, P208, DOI 10.1016/0005-2795(71)90104-8
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Irvine DJ, 1998, J BIOMED MATER RES, V40, P498, DOI 10.1002/(SICI)1097-4636(19980605)40:3<498::AID-JBM21>3.0.CO;2-E
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Klagsbrun M, 1979, Methods Enzymol, V58, P560
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Li JT, 1996, BIOCONJUGATE CHEM, V7, P592, DOI 10.1021/bc960048v
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   NILSSON K, 1984, METHOD ENZYMOL, V104, P56
   OKUDA M, 1994, INT ARCH ALLERGY IMM, V104, P6, DOI 10.1159/000236735
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Risbud MV, 2001, J BIOMED MATER RES, V57, P300, DOI 10.1002/1097-4636(200111)57:2<300::AID-JBM1171>3.0.CO;2-Q
   Salem AK, 2001, BIOMACROMOLECULES, V2, P575, DOI 10.1021/bm010030+
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050
   Tessmar JK, 2002, BIOMACROMOLECULES, V3, P194, DOI 10.1021/bn015608u
   Ydens I, 2000, MACROMOLECULES, V33, P6713, DOI 10.1021/ma0002803
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 33
TC 37
Z9 39
U1 2
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 10
BP 1859
EP 1867
DI 10.1016/j.biometerials.2003.08.031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770CQ
UT WOS:000188706000015
PM 14738850
DA 2018-10-20
ER

PT J
AU Speranza, G
   Gottardi, G
   Pederzolli, C
   Lunelli, L
   Canteri, R
   Pasquardini, L
   Carli, E
   Lui, A
   Maniglio, D
   Brugnara, M
   Anderle, M
AF Speranza, G
   Gottardi, G
   Pederzolli, C
   Lunelli, L
   Canteri, R
   Pasquardini, L
   Carli, E
   Lui, A
   Maniglio, D
   Brugnara, M
   Anderle, M
TI Role of chemical interactions in bacterial adhesion to polymer surfaces
SO BIOMATERIALS
LA English
DT Article
DE bacterial adhesion; acid-base interactions; XPS; Tof-SIMS; SEM; contact
   angle
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; BIOMEDICAL POLYMERS;
   MICROBIAL ADHESION; IONIC-STRENGTH; HYDROPHOBICITY; PREVENTION;
   INFECTIONS; CATHETERS; GROWTH
AB Development of biomaterial-related infections is attracting an increasing interest due to the significant percentage of implant failure in the hospital care. Recent literature puts in evidence the dependence of the infection risk on the different biomaterials used, because of the different interactions between material surface and micro-organisms. Despite this, the mechanisms underlying the adhesion of bacteria to the biomaterial surface are still unclear. Aim of this work is to study the initial events of the processes responsible for the bacterial adhesion on polymers in order to prevent the development of bacterial infections and the consequent failure and replacement of biomedical devices. Electrostatic and Lifshitz-van der Waals forces are usually considered responsible for the interactions at the biomaterial interface. A new term that involves Lewis acid-base interactions is here introduced to better describe the bacterial adhesion to the polymer surface. Two requirements are needed to test this hypothesis: the development of an ideal polymeric surface in terms of chemical and morphological properties and the choice of a specific bacterial strain to be utilized as "probe". Experiments were worked out using an Escherichia coli (Gram-) strain that represent one of the principal isolates from infected biomaterial implants and its adhesion was investigated on polymers having different acid/basic character. The findings indicate that the bacterial adhesion is influenced by the chemical properties of the polymeric surface. These results may be interpreted taking into account a mechanism in which the acid/base (Lewis) interaction plays an important role. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Ist Ric Sci & Tecnol, ITC, I-38050 Trent, Italy.
   Univ Trent, Dept Mat Engn & Ind Technol, Trent, Italy.
RP Speranza, G (reprint author), Ist Ric Sci & Tecnol, ITC, Sommarive Str 18, I-38050 Trent, Italy.
EM speranza@itc.it
RI Gottardi, Gloria/E-5334-2010; Speranza, Giorgio/G-6275-2011; Maniglio,
   Devid/C-4187-2014
OI Gottardi, Gloria/0000-0002-3472-8572; Speranza,
   Giorgio/0000-0003-1478-0995; Maniglio, Devid/0000-0002-1653-861X;
   Canteri, Roberto/0000-0002-0895-8884
CR An YH, 2000, HDB BACTERIAL ADHESI
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Beamson G., 1992, HIGH RESOLUTION XPS
   Boonaert CJP, 2001, COLLOID SURFACE B, V22, P171, DOI 10.1016/S0927-7765(01)00196-5
   Boonaert CJP, 2000, APPL ENVIRON MICROB, V66, P2548, DOI 10.1128/AEM.66.6.2548-2554.2000
   Briandet R, 1999, APPL ENVIRON MICROB, V65, P5328
   BRUNISMA GM, 2002, BIOMATERIALS, V22, P3217
   BUNT CR, 1993, INT J PHARMACEUT, V99, P93, DOI 10.1016/0378-5173(93)90350-O
   CARLEN A, 2000, BIOMATERIALS, V22, P481
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Della Volpe C, 2000, J ADHES SCI TECHNOL, V14, P235, DOI 10.1163/156856100742546
   Della Volpe C., 2002, COLLOID SURF A, V206, P46
   Della Volpe C, 2000, J ADHES SCI TECHNOL, V14, P239
   DELLAVOLLPE C, IN PRESS J ADHES SCI
   DELLAVOLPE C, 2002, ENCY SURFACE COLLOID, V1
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GARBASSI F, 2000, POLYM SURFACES
   GOOD RJ, 1991, FUNDAMENTALS ADHESIO, pCH3
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   JARVIS NL, 1964, CONTACT ANGLE WETTAB
   Jones DS, 1996, INT J PHARM, V131, P83, DOI 10.1016/0378-5173(95)04368-3
   Kiaie D., 1995, J BIOMED MATER RES, V29, P729
   Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q
   Maruyama N, 1998, THIN SOLID FILMS, V327, P854, DOI 10.1016/S0040-6090(98)00777-9
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Morra M, 1996, J BIOMED MATER RES, V31, P149
   Otto K, 1999, J BACTERIOL, V181, P5210
   PAGE B, 1993, INT J ONCOL, V3, P473
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   REID G, 1994, COLLOID SURFACE B, V2, P377
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Yousefi Rad A, 1998, J Biomater Sci Polym Ed, V9, P915, DOI 10.1163/156856298X00244
NR 42
TC 127
Z9 133
U1 2
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 11
BP 2029
EP 2037
DI 10.1016/j.biomaterials.2003.08.061
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771QB
UT WOS:000188796600007
PM 14741617
DA 2018-10-20
ER

PT J
AU Yuan, YL
   Ai, F
   Zang, XP
   Zhuang, W
   Shen, J
   Lin, SC
AF Yuan, YL
   Ai, F
   Zang, XP
   Zhuang, W
   Shen, J
   Lin, SC
TI Polyurethane vascular catheter surface grafted with zwitterionic
   sulfobetaine monomer activated by ozone
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE ozonization; graft copolymerization; PUVC-g-PDMMSA; platelet adhesion
ID BLOOD COMPATIBILITY; POLY(ETHER URETHANE); PLATELET-ADHESION
AB Polyurethane (PU) is a conventional biomedical material with favorable biocompatibility and excellent mechanical properties and widely used in making vascular catheter, but its anti thrombogenic property is not good enough to make it as a more demanding applicable biomaterial. Surface modification is an effective way to improve the hemocompatibility for biomaterials. The purpose of present study was to use ozonization method to modify the surface of PU vascular catheter slice to improve its antithrombogenicity by grafting N,N-dimethyl-N-methacrytoxyethyl-N-(3-sulfopropyl) ammonium (DMMSA), a zwitterionic sulfobetaine monomer. PU vascular catheter (PUVC) grafted with DMMSA (PUVC-g-PDMMSA) was characterized by ATR-FTIR and XPS. ATR-FTIR and XPS investigation confirmed the graft polymerization. The blood compatibility of the grafted films was evaluated by platelet rich plasma (PRP) platelet adhesion study and scanning electron microscopy (SEM) was used to observe the morphology of platelet using PU vascular catheter (PUVC) as the reference. No platelet adhesion was observed for the grafted PUVC slice incubated with PRP at 37degreesC for 120 min. It is significant that this new zwitterionic sulfobetaine grafted PUVC have improved antithrobogenicity. It is effective that the inner surface of vascular catheter with inner diameter in only 3 mm can be grafted with PDMMSA by using ozonization method. (C) 2004 Elsevier B.V. All rights reserved.
C1 Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Techol, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Techol, Nanjing 210093, Peoples R China.
EM sicong_lin@yahoo.com
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   FOUGNOT C, 1984, MACROMOLECULAR BIOMA
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   HORNING EC, 1955, ORGANIC SYNTHESES CO, V3, pP415
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Lin SC, 1998, POLYM B, V1, P1
   NEILL TO, 1972, J POLYM SCI POL CHEM, V10, P569
   PENN LS, 1994, POLYM ADVAN TECHNOL, V5, P809
   THOMPSON AR, 1983, MANUAL HEMOSTASIS TH
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   WANG CH, 1997, ACTA POLYM SIN, V1, P114
   Yuan J, 2003, CHEM J CHINESE U, V24, P916
   Yuan YL, 2003, COLLOID SURFACE B, V29, P247, DOI 10.1016/S0927-7765(02)00210-2
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   ZHANG J, 2003, BIOINTERFACES, V30, P249
NR 22
TC 74
Z9 81
U1 6
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2004
VL 35
IS 1
BP 1
EP 5
DI 10.1016/j.colsurfb.2004.01.005
PG 5
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 823RA
UT WOS:000221629500001
PM 15261048
DA 2018-10-20
ER

PT J
AU Kidd, KR
   Williams, SK
AF Kidd, KR
   Williams, SK
TI Laminin-5-enriched extracellular matrix accelerates angiogenesis and
   neovascularization in association with ePTFE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE ePTFE; angiogenesis; extracellular matrix; laminin-5
ID FIBROBLAST GROWTH-FACTOR; EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS;
   ENCAPSULATES SUBCUTANEOUS IMPLANTS; ENDOTHELIAL-CELL PROLIFERATION;
   HEPARINIZED COLLAGEN MATRICES; VASCULAR GRAFTS; INFLAMMATORY RESPONSE;
   GEOMETRIC CONTROL; HOST RESPONSE; IN-VIVO
AB The performance of biomedical implant devices is often limited by inappropriate tissue responses associated with synthetic materials used in device construction. Adverse healing responses, in particular the lack of an extensive vascular supply in the peri-implant tissue, are believed to lead to the ultimate failure of many of these medical devices. Accelerated formation of new blood vessels in the peri-implant tissue and within porous polymeric implants is hypothesized to improve the performance of such biomedical implant devices. The current study evaluated the use of cell-mediated, extracellular matrix modification of expanded polytetrafluoroethylene (ePTFE) to increase vessel growth in peri-implant tissue and within the pores of the implants. Discs of ePTFE were modified through cell-mediated matrix deposition using epithelial and endothelial cell lines with variable deposition of collagen types, fibronectin, and laminin types. Cell matrix-modified discs, Matrigel-coated discs, and nonmodified discs were implanted in both the adipose and subcutaneous tissues of the rat. Following a 5-week implant period, samples were removed and evaluated histologically and morphometrically for the presence of blood vessels in the peri-implant tissue and within the pores of-the polymer as well as for the presence of activated macrophages and monocytes. A significantly increased presence of activated macrophages and monocytes was associated only with the samples modified with the matrix from a human microvessel endothelial cell line. Increased vessel density was identified in association with those ePTFE samples modified with either the 804-G, HaCaT, or Pi-4 cell matrices, all of which have extracellular matrices enriched in the protein laminin-5. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Arizona, Biomed Engn Program, Tucson, AZ 85724 USA.
RP Williams, SK (reprint author), Univ Arizona, Biomed Engn Program, Tucson, AZ 85724 USA.
EM skwill@u.arizona.edu
FU NHLBI NIH HHS [HL63873]
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Black MM, 1995, J MED ENG TECHNOL, V19, P151, DOI 10.3109/03091909509009986
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DAVIS GE, 1995, EXP CELL RES, V216, P113, DOI 10.1006/excr.1995.1015
   DeVos P, 1997, TRANSPLANTATION, V63, P824, DOI 10.1097/00007890-199703270-00006
   DIDISHEIM P, 1993, CARDIOVASC PATHOL, V2, pS1
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200
   GARRIDO T, 1995, BRIT J CANCER, V71, P770, DOI 10.1038/bjc.1995.149
   Gerritsen M, 2000, DIABETES CARE, V23, P143, DOI 10.2337/diacare.23.2.143
   Giordano FJ, 2001, CURR OPIN GENET DEV, V11, P35, DOI 10.1016/S0959-437X(00)00153-2
   GREENHALGH RM, 1990, ACTA CHIR SCAND, P249
   GREISLER HP, 1987, J VASC SURG, V5, P393, DOI 10.1067/mva.1987.avs0050393
   GREISLER HP, 1992, SURGERY, V112, P244
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Homan SM, 1998, J CELL SCI, V111, P2717
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8
   Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.3.CO;2-9
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   Kidd KR, 2002, J BIOMED MATER RES, V59, P366, DOI 10.1002/jbm.1253
   Kikkawa Y, 1996, IN VITRO CELL DEV-AN, V32, P46
   Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854
   Kikkawa Y, 2000, J CELL SCI, V113, P869
   KLEIN S, 1993, MOL BIOL CELL, V4, P973
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853
   KOVEKER GB, 1991, SURGERY, V109, P313
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LINDNER V, 1990, J CLIN INVEST, V85, P2004, DOI 10.1172/JCI114665
   Marois Y, 2000, ARTIF ORGANS, V24, P533, DOI 10.1046/j.1525-1594.2000.06547.x
   Merzkirch C, 2001, ANAT REC, V263, P379, DOI 10.1002/ar.1118
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   PASSANITI A, 1992, LAB INVEST, V67, P519
   Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685
   Pepper MS, 1996, CURR TOP MICROBIOL, V213, P31
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rongish BJ, 1996, J MOL CELL CARDIOL, V28, P2203, DOI 10.1006/jmcc.1996.0212
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.0.CO;2-E
   Shireman PK, 2000, J VASC SURG, V31, P936, DOI 10.1067/mva.2000.106420
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   Tassiopoulos AK, 2000, J BIOMAT SCI-POLYM E, V11, P1275, DOI 10.1163/156856200744200
   Udipi K, 2000, J BIOMED MATER RES, V51, P549, DOI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
   Updike SJ, 2000, DIABETES CARE, V23, P208, DOI 10.2337/diacare.23.2.208
   VOHRA R, 1991, BRIT J SURG, V78, P417, DOI 10.1002/bjs.1800780411
   VOLDER JGR, 1974, T AM SOC ART INT ORG, VB 20, P521
   Wagner S, 2000, NEUROSCI LETT, V284, P105, DOI 10.1016/S0304-3940(00)00987-3
   Wagner S, 1997, STROKE, V28, P858, DOI 10.1161/01.STR.28.4.858
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   Williams SK, 1997, J BIOMED MATER RES, V35, P473
   WILLIAMS SK, 1994, J VASC SURG, V19, P916, DOI 10.1016/S0741-5214(94)70019-2
   WILLIAMS SK, 1991, J ELECTRON MICR TECH, V19, P439, DOI 10.1002/jemt.1060190406
   Wissink MJB, 2000, THROMB HAEMOSTASIS, V84, P325
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wissink MJB, 2000, J CONTROL RELEASE, V67, P141, DOI 10.1016/S0168-3659(00)00202-9
NR 61
TC 23
Z9 23
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY 1
PY 2004
VL 69A
IS 2
BP 294
EP 304
DI 10.1002/jbm.a.20133
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 812ST
UT WOS:000220859900011
PM 15058002
DA 2018-10-20
ER

PT J
AU Desroches, R
   Smith, B
AF Desroches, R
   Smith, B
TI Shape memory alloys in seismic resistant design and retrofit: A critical
   review of their potential and limitations
SO JOURNAL OF EARTHQUAKE ENGINEERING
LA English
DT Review
DE seismic, shape memory alloys; nitinol; retrofit
ID DAMPING CHARACTERISTICS; CYCLIC DEFORMATION; BEHAVIOR; NITI; WIRES
AB Shape memory alloys (SMAs) are a class of materials that have unique properties, including Young's modulus-temperature relations, shape memory effects, superelastic effects, and high damping characteristics. These unique properties, which have led to numerous applications in the biomedical and aerospace industries, are currently being evaluated for applications in the area of seismic resistant design and retrofit. This paper provides a critical review of the state-of-the-art in the use of shape memory alloys for applications in seismic resistant design. The paper reviews the general characteristics of shape memory alloys and highlights the factors affecting their properties. A review of current studies show that the superelastic and high-damping characteristics of SMAs result in applications in bridges and buildings that show significant promise. The barriers to the expanded use of SMAs include the high cost, lack of clear understanding of thermo-mechanical processing, dependency of properties on temperature, and difficulty in machining.
C1 Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.
RP Desroches, R (reprint author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.
RI DesRoches, Reginald/F-5875-2011
CR ADACHI Y, 1999, P SPIE SMART STRUCTU
   Aiken ID, 1990, UCBEERC9003
   BERNARDINI D, 1999, II169176 MANSIDE
   BRADY P, 1995, ASEE ANN C P
   Buehler W, 1961, 6175 NOLTR
   CASTELLANO M, 2001, P SPIE SMART STRUCT
   CHANG LC, 1951, T AM I MIN MET ENG, V191, P47
   Chute D., 1990, ENG ASPECTS SHAPE ME, P420
   CLARK PW, 1995, P PASSIVE DAMPING SA
   CROCI G, 2001, STRUTURAL ENG INT
   DAVOODI H, 1997, P 16 CAN CONGR APPL
   DEROCHES R, 2003, IN PRESS ASCE J STRU
   DESROCHES R, 2001, ENG STRUCT, V24, P325
   Dolce M, 2001, INT J MECH SCI, V43, P2657, DOI 10.1016/S0020-7403(01)00050-9
   DOLCE M, 1999, II105134 MANSIDE
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   DUERIG T, 1997, MED PLASTICS BIOMATE
   EATON JP, 1999, THESIS WORCESTER POL
   FRIEND C, 1999, P 1 EUR C SHAP MEM S, P115
   Higashino M., 1996, 2 INT WORKSH STRUCT, P221
   INANDI J, 1994, 1 WORLD C STRUCT CON, P127
   Indirli M., 2001, P SPIE SMART STRUCTU
   JACKSON CM, 1972, NASA SP, V5110
   KAOUNIDES L, 1995, FT MANAGEMENT REPORT
   KOLOMYTSEV, 1998, 28 S UIA MAY 13 15
   KOVEL Y, 1995, J PHYS IV, V5, P397
   KRUMME R, 1995, P SPIE INT SOC OPT E
   LIN HC, 1993, METALL TRANS A, V24, P2189, DOI 10.1007/BF02648593
   Liu Y, 1999, MAT SCI ENG A-STRUCT, V273, P673, DOI 10.1016/S0921-5093(99)00347-0
   Liu Y, 1997, J PHYS 6, V7, pC5
   MANSIDE, 1998, MEM ALL NEW STRUCT V
   Miyazaki S., 1990, ENG ASPECTS SHAPE ME, P394
   OCEL J, 2002, P 7 US NAT C EARTHQ
   OHI K, 2001, NSF JSPS US JAP SEM
   OLEARY JP, 1990, ENG ASPECTS SHAPE ME, P477
   PICORNELL C, 1994, METALL MATER TRANS A, V25, P687, DOI 10.1007/BF02665445
   Piedboeuf MC, 1998, J SOUND VIB, V214, P885, DOI 10.1006/jsvi.1998.1578
   Sachdeva R, 1990, ENG ASPECTS SHAPE ME, P452
   SCHETKY L, 1999, SMST 99, P248
   Sehitoglu H, 2001, MAT SCI ENG A-STRUCT, V314, P67, DOI 10.1016/S0921-5093(00)01924-9
   SERNEELS A, 1999, P 1 EUR C SHAP MEM S, P6
   SHERNGELL H, 1999, MAT SCI ENG A-STRUCT, V273, P400
   STRNADEL B, 1995, MAT SCI ENG A-STRUCT, V202, P148, DOI 10.1016/0921-5093(95)09801-1
   SWEENEY S, 1995, WIND SEISMIC EFFECTS
   TOBUSHI H, 1992, JSME INT J I-SOLID M, V35, P271, DOI 10.1299/jsmea1988.35.3_271
   Tobushi H, 1996, SMART MATER STRUCT, V5, P788, DOI 10.1088/0964-1726/5/6/008
   VALENTE C, 1999, II177192 MANSIDE
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
   WHITTAKER A, 1995, 22 US ARM CORPS ENG
   Wilde K, 2000, ENG STRUCT, V22, P222, DOI 10.1016/S0141-0296(98)00097-2
   Wolons D, 1998, J INTEL MAT SYST STR, V9, P116, DOI 10.1177/1045389X9800900205
   Xie ZL, 1998, ACTA MATER, V46, P1989, DOI 10.1016/S1359-6454(97)00379-0
   Zhao C, 2001, ADV MATER PROCESS, P33
NR 53
TC 72
Z9 73
U1 3
U2 24
PU IMPERIAL COLLEGE PRESS
PI LONDON
PA 57 SHELTON ST, COVENT GARDEN, LONDON WC2H 9HE, ENGLAND
SN 1363-2469
J9 J EARTHQ ENG
JI J. EARTHQU. ENG.
PD MAY
PY 2004
VL 8
IS 3
BP 415
EP 429
DI 10.1142/S1363246904001298
PG 15
WC Engineering, Civil; Engineering, Geological; Geosciences,
   Multidisciplinary
SC Engineering; Geology
GA 814MJ
UT WOS:000220978500004
DA 2018-10-20
ER

PT J
AU Kuckelhaus, S
   Reis, SC
   Carneiro, MF
   Tedesco, AC
   Oliveira, DM
   Lima, ECD
   Morais, PC
   Azevedo, RB
   Lacava, ZGM
AF Kuckelhaus, S
   Reis, SC
   Carneiro, MF
   Tedesco, AC
   Oliveira, DM
   Lima, ECD
   Morais, PC
   Azevedo, RB
   Lacava, ZGM
TI In vivo investigation of cobalt ferrite-based magnetic fluid and
   magnetoliposomes using morphological tests
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on Magnetism (ICM 2003)
CY JUL 27-AUG 01, 2003
CL Rome, ITALY
DE magnetic fluid; liposome; cobalt; citrate; biocompatibility
ID TOXICITY
AB Morphological studies were carried out after endovenous injection of a magnetic fluid and magnetoliposome samples, all containing cobalt ferrite magnetic nanoparticles (MNPs). Twenty four hours after injection, the three investigated samples presented differences concerning blood clearance, phagocytosis susceptibility, and MNP cluster size and amount. Our data suggest that the samples investigated are biocompatible and could be used as material basis for biomedical applications. Further, differences observed in the in vivo tests support application of the samples for different biomedical purposes. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Brasilia, Inst Ciencias Biol, Depto Genet & Morfol, BR-70910900 Brasilia, DF, Brazil.
   USP, FFCLRP, BR-14040901 Ribeirao Preto, SP, Brazil.
   Univ Fed Goias, Inst Quim, BR-74001970 Goiania, Go, Brazil.
   Univ Brasilia, Inst Fis Nucl Fis Aplicada, BR-70919970 Brasilia, DF, Brazil.
RP Lacava, ZGM (reprint author), Univ Brasilia, Inst Ciencias Biol, Depto Genet & Morfol, BR-70910900 Brasilia, DF, Brazil.
EM zulmira@unb.br
RI Azevedo, Ricardo/D-6273-2012; Tedesco, Antonio/B-7584-2012
OI Tedesco, Antonio/0000-0003-4198-9321
CR Ayala-Fierro F, 1999, J TOXICOL ENV HEAL A, V56, P571, DOI 10.1080/009841099157908
   Bulte JWM, 1999, J MAGN MAGN MATER, V194, P204, DOI 10.1016/S0304-8853(98)00556-3
   DECUYPER M, 1988, EUR BIOPHYS J BIOPHY, V15, P311, DOI 10.1007/BF00256482
   DECUYPER M, 1993, J MAGN MAGN MATER, V122, P340, DOI 10.1016/0304-8853(93)91105-G
   Garcia VAP, 2002, EUR CELLS MATER, V3, P154
   Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559
   Kuckelhaus S, 2003, J APPL PHYS, V93, P6707, DOI 10.1063/1.1558665
   Lacava LM, 2003, J APPL PHYS, V93, P7563, DOI 10.1063/1.1540178
   Lacava ZGM, 1999, J MAGN MAGN MATER, V194, P90, DOI 10.1016/S0304-8853(98)00583-6
   Lacava ZGM, 1999, J MAGN MAGN MATER, V201, P431, DOI 10.1016/S0304-8853(99)00002-5
   Morais PC, 2001, J MAGN MAGN MATER, V225, P37, DOI 10.1016/S0304-8853(00)01225-7
NR 11
TC 25
Z9 26
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD MAY
PY 2004
VL 272
SI SI
BP 2402
EP 2403
DI 10.1016/j.jmmm.2003.12.1218
PN 3
PG 2
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 831ZU
UT WOS:000222236800320
DA 2018-10-20
ER

PT J
AU Rodriguez-Lorenzo, LM
   Gross, KA
AF Rodriguez-Lorenzo, LM
   Gross, KA
TI Encapsulation of hydroxyapatite microspheres with fluorapatite using a
   diffusion process
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID FLUORIDE UPTAKE; ADSORPTION; ENAMEL; BONE
AB Modification of hydroxyapatite surfaces can improve the properties of biomedical devices. The objective of this work was to encapsulate hydroxyapatite particles with a fluorapatite layer. A suspension of hydroxyapatite microspheres was prepared in a solution at different pH and treated with ammonium fluoride. pH, calcium, and fluoride were monitored in real time and particles subjected to fluoride analysis. After addition of fluoride, it was found that more material is released from the particle surface at low pH conditions, but leads to a high fluoride uptake from solution. Low solution fluoride levels produce a fluorapatite layer, but higher fluoride levels produce calcium fluoride.
C1 Monash Univ, Sch Phys & Mat Engn, Clayton, Vic, Australia.
RP Gross, KA (reprint author), Monash Univ, Sch Phys & Mat Engn, Clayton, Vic, Australia.
EM karlis.gross@spme.monash.edu.au
RI Rodriguez-Lorenzo, Luis/A-1090-2008; Gross, Karlis/G-2793-2010
OI Rodriguez-Lorenzo, Luis/0000-0002-4816-1087; 
CR BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   CHANDER S, 1985, COLLOID SURFACE, V13, P137
   Chow LC, 1998, CALCIUM PHOSPHATES B, P67
   DASARATHY H, 1993, J BIOMED MATER RES, V27, P477, DOI 10.1002/jbm.820270408
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P100
   Demos LL, 2001, AUST DENT J, V46, P80, DOI 10.1111/j.1834-7819.2001.tb00561.x
   DRIESSENS FCM, 1980, Z NATURFORSCH C, V35, P357
   Elliott JC, 1994, STUDIES INORGANIC CH, V18
   *INT CTR DIFFR DAT, 1999, 2433 INT CTR DIFFR D
   *INT CTR DIFFR DAT, 1999, 35816 INT CTR DIFFR
   Jha LJ, 1997, J MATER SCI-MATER M, V8, P185, DOI 10.1023/A:1018531505484
   KRESAK M, 1977, J COLLOID INTERF SCI, V59, P283, DOI 10.1016/0021-9797(77)90010-8
   LARSEN MJ, 1977, SCAND J DENT RES, V85, P327
   Leach S. A., 1959, BRIT DENT J, V106, P133
   Leamy P, 1998, J BIOMED MATER RES, V42, P458, DOI 10.1002/(SICI)1097-4636(19981205)42:3<458::AID-JBM16>3.0.CO;2-C
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   LIN J, 1981, COLLOID SURFACE, V3, P357, DOI 10.1016/0166-6622(81)80062-5
   Liu Y, 1997, J COLLOID INTERF SCI, V186, P102, DOI 10.1006/jcis.1996.4621
   Liu Y, 1996, J CRYST GROWTH, V165, P116, DOI 10.1016/0022-0248(95)00981-7
   MCCANN HG, 1953, J BIOL CHEM, V201, P247
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   Murata H, 1996, CARIES RES, V30, P465, DOI 10.1159/000262361
   NELSON NG, 1970, J DENT RES, V49, P1541
   Okazaki M, 1999, BIOMATERIALS, V20, P1303, DOI 10.1016/S0142-9612(99)00030-7
   OKAZAKI M, 1992, BIOMATERIALS, V13, P749, DOI 10.1016/0142-9612(92)90012-D
   REY C, 1998, CALCIUM PHOSPHATES B, P217
   Scherrer WN, 1983, ADV XRAY ANAL, V26, P141
   SINGER L, 1968, ANAL CHEM, V40, P613, DOI 10.1021/ac60259a017
   SPINELLI MA, 1971, ARCH ORAL BIOL, V16, P187, DOI 10.1016/0003-9969(71)90106-3
   TENCATE JM, 1991, CRIT REV ORAL BIOL M, V2, P283, DOI 10.1177/10454411910020030101
   TODDA H, 1995, BOMATERIALS, V16, P945
   VEERBECK G, 1990, J CRYST GROWTH, V104, P820
NR 33
TC 1
Z9 1
U1 0
U2 3
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, PO BOX 6136, WESTERVILLE, OH 43086-6136 USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD MAY
PY 2004
VL 87
IS 5
BP 814
EP 818
DI 10.1111/j.1551-2916.2004.00814.x
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 826DA
UT WOS:000221808100007
DA 2018-10-20
ER

PT J
AU Lee, H
   Kim, HB
   Lee, CW
   Im, TG
   Jeong, JI
   Ahn, S
AF Lee, H
   Kim, HB
   Lee, CW
   Im, TG
   Jeong, JI
   Ahn, S
TI Characterization of a platinum electrode by using unbalanced magnetic
   field sputter for implantable biomedical applications
SO JOURNAL OF THE KOREAN PHYSICAL SOCIETY
LA English
DT Article; Proceedings Paper
CT 30th International Conference on Plasma Science
CY JUN 02-05, 2003
CL Jeju Isl, SOUTH KOREA
SP IEEE PSAC
DE platinum(Pt); unbalanced magnetic field (UBM); biocompatible
ID THIN-FILMS; ELECTROPLATING BATHS; PLASMA; DEPOSITION
AB Platinum (Pt) is a biocompatible material which exhibits strong thermal and electrical conductivity due to its high melting point and good durability. Thus, it is used commonly in bio-electrodes and bio-chips. In this study, a tungsten (W) wire was coated with a platinum film and was analyzed for its mechanical and biocompatibility properties. The platinum film was deposited by magnetron sputtering with an UnBalanced Magnetic (UBM) field system, The experiment was performed under a variety of conditions by changing the deposition temperature, the bias voltage, the magnetic field and the deposition time in order to deduce the optimum conditions. We examined the exfoliation and the sedimentation states of the anode and the cathode by using microscope and an electron probe microanalysis (EPMA) for the electro-chemical corrosion test using the Hank's solution. The film showed a very low impurity level, and the surface and the cross section of the film appeared elaborate. No sedimentation appeared in the film, and the crystallization in the (110), the (200), the (220) and the (222) directions observed. However, at a high current density (800 mA/cm(2)), sedimentation was observed in the corrosion test.
C1 Solco Biomed Co Ltd, Inst Biomed, Pyungteak 451852, South Korea.
   Res Inst Ind Sci & Technol, Pohang 790330, South Korea.
   Seoul Natl Univ, Coll Nat Sci, Seoul 151742, South Korea.
RP Lee, H (reprint author), Solco Biomed Co Ltd, Inst Biomed, Pyungteak 451852, South Korea.
EM hoonlee@solco.co.kr
CR Chou CK, 1997, BIOELECTROMAGNETICS, V18, P14, DOI 10.1002/(SICI)1521-186X(1997)18:1<14::AID-BEM4>3.3.CO;2-O
   Farooq M, 2002, J KOREAN PHYS SOC, V40, P511
   Gregory AJ, 1995, J ELECTROANAL CHEM, V399, P105, DOI 10.1016/0022-0728(95)04283-0
   GREGORY AJ, 1993, J ELECTROANAL CHEM, V348, P211, DOI 10.1016/0022-0728(93)80133-3
   Kim HW, 2003, J KOREAN PHYS SOC, V42, P667
   Kim SH, 2003, J KOREAN PHYS SOC, V42, P196
   Suzuki Y, 1997, NUCL INSTRUM METH B, V121, P107, DOI 10.1016/S0168-583X(96)00645-3
   Thompson MP, 2002, SENSOR ACTUAT A-PHYS, V101, P358, DOI 10.1016/S0924-4247(02)00267-4
NR 8
TC 3
Z9 3
U1 0
U2 0
PU KOREAN PHYSICAL SOC
PI SEOUL
PA 635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA
SN 0374-4884
J9 J KOREAN PHYS SOC
JI J. Korean Phys. Soc.
PD MAY
PY 2004
VL 44
IS 5
BP 1173
EP 1176
PN 1
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 821LC
UT WOS:000221461000030
DA 2018-10-20
ER

PT J
AU Lallas, CD
   Preminger, GM
   Pearle, MS
   Leveillee, RJ
   Lingeman, JE
   Schwope, JP
   Pietrow, PK
   Auge, BK
AF Lallas, CD
   Preminger, GM
   Pearle, MS
   Leveillee, RJ
   Lingeman, JE
   Schwope, JP
   Pietrow, PK
   Auge, BK
TI Internet based multi-institutional clinical research: A convenient and
   secure option
SO JOURNAL OF UROLOGY
LA English
DT Article
DE Internet; biomedical research; clinical trials; cooperative behavior;
   data collection
ID DATA-ACQUISITION; TRIALS; MULTICENTER; WEB; SURGERY; CARE
AB Purpose: As randomized, prospective trials have become an integral part of clinical research, multi-institutional, collaborative research has become a necessity. However, it may be cumbersome for participants at remote facilities to participate because the submission and compilation of data and results are at times lengthy processes. Internet based clinical studies have been found to be a rapid, easily accessible, safe and secure method of performing multi-institutional trials.
   Materials and Methods: The Internet was used at geographically distant medical centers to enroll patients into a multi-institutional, prospective, randomized trial for the management of lower pole renal calculi. The Clinical Research Web-based Information Center secure computer web based program (Simplified Clinical Data Systems, Amherst, New Hampshire) was established to input preliminary demographic and clinical data, randomize patients, and collect treatment and followup information without paper chart documentation. The primary investigators in the study were sent a questionnaire to determine the ease of use of this Internet based program. The results were tabulated.
   Results: A total of 112 patients from 21 participating institutions were randomized into the secure web site for inclusion into a lower pole renal stone clinical trial. Of the investigators 64% responded to the questionnaire. The majority of those having enrolled patients into the study reported no difficulties or only minimal difficulties in navigating the web site. Moreover, investigators from remote locations throughout North America described the improved convenience, rapid transmission of information, and ability to review and update patient data as benefits of enrolling patients using the Internet. The Internet based system also permits the prompt compilation of data at the host research site for performing interim data assessments and eventually the final analysis.
   Conclusions: A web based data collection center allows for large, multi-institutional trials to be done with unprecedented accuracy and efficiency. Through centralization of data capture, and real-time study monitoring and data analysis the system removes these responsibilities from those at individual test sites, permitting investigators to concentrate instead on other aspects of the study and its progress. State-of-the-art security protects all information to ensure confidentiality. The Internet may prove to be an invaluable tool in the future of clinical research.
C1 Natl Naval Med Res Inst, Dept Urol, San Diego, CA 92134 USA.
   Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA.
   Univ Texas, Dept Urol, Dallas, TX 75230 USA.
   Univ Miami, Dept Urol, Miami, FL 33152 USA.
   Methodist Hosp Indiana Inc, Dept Urol, Indianapolis, IN USA.
   Boston Sci Corp, Natick, MA USA.
   Univ Kansas, Med Ctr, Dept Urol, Kansas City, KS 66103 USA.
RP Auge, BK (reprint author), Natl Naval Med Res Inst, Dept Urol, 34730 Bob Wilson Dr,Bldg 3,Suite 200, San Diego, CA 92134 USA.
EM bkauge@nmcsd.med.navy.mil
RI Preminger, Glenn/B-3990-2011
OI Preminger, Glenn/0000-0003-4287-602X
CR Albala DM, 2001, J UROLOGY, V166, P2072, DOI 10.1016/S0022-5347(05)65508-5
   Dorman K, 2000, OBSTET GYNECOL, V96, P636, DOI 10.1016/S0029-7844(00)00978-9
   FDA, 1999, COMP SYST US CLIN TR
   Kelly MA, 1997, INT J MED INFORM, V47, P91, DOI 10.1016/S1386-5056(97)00091-9
   Kuchenbecker J, 2001, TELEMED J E-HEALTH, V7, P73, DOI 10.1089/153056201300093976
   Marks RG, 2001, STAT MED, V20, P2683, DOI 10.1002/sim.736
   Marshall W W, 2000, JAMA, V284, P1843, DOI 10.1001/jama.284.14.1843
   Mezzana P, 2002, PLAST RECONSTR SURG, V109, P1658, DOI 10.1097/00006534-200204150-00027
   Miravitlles M, 2002, ARCH BRONCONEUMOL, V38, P427, DOI 10.1016/S0300-2896(02)75256-3
   Mross K, 2001, ONKOLOGIE, V24, P24, DOI 10.1159/000055162
   Rangel SJ, 2002, J PEDIATR SURG, V37, P990, DOI 10.1053/jpsu.2002.33826
   Santoro E, 1999, CONTROL CLIN TRIALS, V20, P194, DOI 10.1016/S0197-2456(98)00060-9
   Unutzer J, 2002, PSYCHIATR SERV, V53, P671, DOI 10.1176/appi.ps.53.6.671
NR 13
TC 25
Z9 25
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAY
PY 2004
VL 171
IS 5
BP 1880
EP 1885
DI 10.1097/01.ju.0000120221.39184.3c
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 812XS
UT WOS:000220872800032
PM 15076298
DA 2018-10-20
ER

PT J
AU Li, L
   Leigh, JS
AF Li, L
   Leigh, JS
TI Quantifying arbitrary magnetic susceptibility distributions with MR
SO MAGNETIC RESONANCE IN MEDICINE
LA English
DT Article
DE magnetic susceptibility; spherical mean value; magnetic resonance;
   inverse problem; quantitative susceptibility imaging
ID SUSCEPTOMETRY; OBJECTS; BRAIN; NMR
AB Magnetic susceptibility, as a physical property of materials, plays important roles in many physical, chemical, engineering, and medical applications. Its quantification becomes of significant interest when MRI becomes a commonly used technique in biomedical applications. A general method is presented here for quantifying arbitrary magnetic susceptibility distributions in a localized region on the basis of first principles of magnetic induction field distributions in space. A proof of the concept was demonstrated by computer simulations. The study establishes the methodological basis for quantitative magnetic susceptibility imaging with MR. (C) 2004 Wiley-Liss, Inc.
C1 Univ Penn, Dept Radiol, Stellar Chance Labs 6100, MMRRCC, Philadelphia, PA 19104 USA.
RP Li, L (reprint author), Univ Penn, Dept Radiol, Stellar Chance Labs 6100, MMRRCC, B1, Philadelphia, PA 19104 USA.
EM lin@mail.mmrrcc.upenn.edu
RI Li, Lin/D-1157-2009
OI Li, Lin/0000-0001-9447-7982
FU NCRR NIH HHS [RR 02305]
CR Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6
   Beuf O, 1996, J MAGN RESON SER B, V112, P111, DOI 10.1006/jmrb.1996.0120
   BRITTENHAM G, 2002, BLOOD, V101, P15
   CHU SCK, 1990, MAGN RESON MED, V13, P239
   Craik D., 1995, MAGNETISM PRINCIPLES
   HOLT RW, 1994, JMRI-J MAGN RESON IM, V4, P809, DOI 10.1002/jmri.1880040612
   Hopkins JA, 1997, MAGNET RESON MED, V37, P494, DOI 10.1002/mrm.1910370404
   Jackson JD, 1998, CLASSICAL ELECTRODYN, P184
   Li L, 2003, MED PHYS, V30, P449, DOI 10.1118/1.1543574
   Li L, 2002, AM J PHYS, V70, P1029, DOI 10.1119/1.1491264
   Li L, 2001, MAGNET RESON MED, V46, P907
   NOBLE B, 1969, APPL LINEAR ALGEBRA
   Press W., 1992, NUMERICAL RECIPES C, P59
   RO YM, 1995, MAGNET RESON MED, V33, P521, DOI 10.1002/mrm.1910330410
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   SEPULVEDA NG, 1994, IEEE T MAGN, V30, P5062, DOI 10.1109/20.334296
   Wang ZYJ, 1999, J MAGN RESON, V140, P477, DOI 10.1006/jmre.1999.1873
   WEISSKOFF RM, 1992, MAGNET RESON MED, V24, P375, DOI 10.1002/mrm.1910240219
   YOUNG IR, 1987, J COMPUT ASSIST TOMO, V11, P2, DOI 10.1097/00004728-198701000-00002
NR 19
TC 76
Z9 79
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0740-3194
J9 MAGNET RESON MED
JI Magn. Reson. Med.
PD MAY
PY 2004
VL 51
IS 5
BP 1077
EP 1082
DI 10.1002/mrm.20054
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 818IO
UT WOS:000221239000028
PM 15122694
OA Bronze
DA 2018-10-20
ER

PT J
AU Karabanova, LV
   Mikhalovska, SV
   Sergeeva, LM
   Meikle, ST
   Helias, M
   Lloyd, A
AF Karabanova, LV
   Mikhalovska, SV
   Sergeeva, LM
   Meikle, ST
   Helias, M
   Lloyd, A
TI Semi-interpenetrating polymer networks based on polyurethane and
   poly(vinyl pyrrolidone) obtained by photopolymerization:
   Structure-property relationships and bacterial adhesion
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
ID THERMODYNAMIC STATE; TEMPERATURE TRANSITIONS; SPECTROSCOPY;
   PECULIARITIES; METHACRYLATE
AB A range of semi-interpenetrating polymer networks (semi-IPNs) based on polyurethane (PU) and poly(vinyl pyrrolidone) (PVP) have been synthesized and characterized with respect to their thermodynamic characteristics, morphology, mechanical properties, surface properties, water sorption and bacterial adhesion. The free energies of mixing of PU and PVP in semi-IPNs have been determined by the vapor sorption method and were shown to be positive for all compositions. The surface properties of semi-IPNs were investigated using the dynamic contact angle analysis. It was shown that the advancing contact angle changes from 83.1degrees to 65.3degrees with increasing PVP from 7.05% to 57.38%. Scanning electron microscopy demonstrated that the semi-IPNs are two-phase systems with incomplete phase separation. The mechanical properties reflect the changes in structure of semi-IPNs with increasing of amounts of PVP in the system. Incorporation of PVP into the semi-IPN with PU restricts the ability of PVP to sorb water. As infection is likely to be caused by bacterial adherence to biomedical implants, the bacterial adhesion data suggests that the semi-IPNs with PVP content below 22.52% may be useful for biomedical material applications.
C1 Inst Macromol Chem, UA-02660 Kiev, Ukraine.
   Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
RP Karabanova, LV (reprint author), Inst Macromol Chem, Kharkov Rd 48, UA-02660 Kiev, Ukraine.
OI Meikle, Steven/0000-0002-3846-5001
CR Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   ANDRADE JD, 1979, J POLYM SCI POL SYM, P313
   Bershtein VA, 1999, J POLYM SCI POL PHYS, V37, P429, DOI 10.1002/(SICI)1099-0488(19990301)37:5<429::AID-POLB3>3.0.CO;2-E
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   GUPTA N, 1994, POLYM INT, V35, P109, DOI 10.1002/pi.1994.210350201
   HSIEH KH, 1990, J MEMBRANE SCI, V49, P341, DOI 10.1016/S0376-7388(00)80647-X
   Kanapitsas A, 1998, POLYM GELS NETW, V6, P83, DOI 10.1016/S0966-7822(97)00018-X
   Karabanova L, 1998, J APPL POLYM SCI, V68, P161, DOI 10.1002/(SICI)1097-4628(19980404)68:1<161::AID-APP18>3.0.CO;2-3
   Karabanova LV, 2001, J APPL POLYM SCI, V80, P852, DOI 10.1002/1097-4628(20010509)80:6<852::AID-APP1163>3.0.CO;2-Y
   Lehah M. D., 1986, POLYURETHANE MED SUR, P158
   Lipatov Y. S., 1989, ADV INTERPENETRATING, P261
   Lipatov Y. S., 1994, ADV INTERPENETRATING, P191
   LIPATOV YS, 1990, J MACROMOL SCI R M C, VC30, P209
   LIPATOV YS, 1994, POLYM INT, V34, P7, DOI 10.1002/pi.1994.210340102
   LIPATOV YS, 1992, POLYMER, V33, P361, DOI 10.1016/0032-3861(92)90994-8
   LIPATOV YS, 1992, POLYM INT, V28, P99, DOI 10.1002/pi.4990280202
   LIPATOV YS, 1995, POLYM REINFORCEMENT, P286
   LIPATOV YS, 1979, INTERPENETRATING POL
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Lowe AB, 2000, J BIOMED MATER RES, V52, P88, DOI 10.1002/1097-4636(200010)52:1<88::AID-JBM11>3.0.CO;2-#
   Nielsen L. E., 1974, MECH PROPERTIES POLY
   OHTSUKA Y, 1973, APPL PHYS LETT, V23, P247, DOI 10.1063/1.1654876
   PAYNTER RW, 1987, BIOMATERIALS, V8, P94, DOI 10.1016/0142-9612(87)90096-2
   SPERLIG LH, 1994, ADV INTERPENETRATING, P1
   SPERLING LH, 1997, IPNS WORLD SCI ENG, P16
   SZYCHER M, 1984, T SOC BIOMATER, V7, P24
   Tager A. A., 1977, VYSOKOMOL SOEDIN, V19, P1654
   Thoma R J, 1987, J Biomater Appl, V1, P449
NR 28
TC 16
Z9 16
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0032-3888
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PD MAY
PY 2004
VL 44
IS 5
BP 940
EP 947
DI 10.1002/pen.20085
PG 8
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 833KD
UT WOS:000222335300012
DA 2018-10-20
ER

PT J
AU Satoh, T
   Hayakawa, H
   Nagahata, M
   Teramoto, A
   Abe, K
AF Satoh, T
   Hayakawa, H
   Nagahata, M
   Teramoto, A
   Abe, K
TI The basic research on physiological property of functionalized
   hyaluronan (II) : Effect of sulfated hyaluronan on histamine release
   from the mast cell
SO SEN-I GAKKAISHI
LA English
DT Article
ID POLYELECTROLYTE COMPLEX PEC; FIBROBLAST HPLF FUNCTION; HEPARIN
AB Hyaluronan (HA) is one of polysaccharides in living body that is found widely in connective tissue of the mammals. It has no sulfate group but high molecular weight in comparison with other glycosaminoglycans (GAGs). We synthesized sulfated HA (S-HA) with various degrees of substitution (D.S.) in order to give HA new biological functions, since GAGs with sulfate groups interact with various biocomponents to express some specific biofunctions. Moreover in order to develop biomedical polymers, immunological response against artificial polymer matrices must be evaluated. So we measured histamine release from the mast cell and discussed the effect of S-HA on the immunological response. It was confirmed that they could be used as biomedical materials with immunological safety. And S-HA inhibited the histamine release that was induced by compound 48/80 from the mast cell. The inhibitory effect of S-HA was seemed to be due to such various factors as D.S., molecular weight, substitution site of the sulfate group and the structure of a polysaccharide chain.
C1 Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
RP Satoh, T (reprint author), Shinshu Univ, Fac Text Sci & Technol, 3-15-1 Tokida, Ueda, Nagano 3868567, Japan.
CR AIBA S, 1987, BIOMATERIALS, V8, P481, DOI 10.1016/0142-9612(87)90086-X
   ANDEREGG G, 1954, HELV CHIM ACTA, V37, P113, DOI 10.1002/hlca.19540370114
   GHOSH TK, 1988, J BIOL CHEM, V263, P11075
   GLEICH GJ, 1986, MAST CELL DIFFERENTI, P347
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Hamano T, 1998, J BIOMAT SCI-POLYM E, V9, P985, DOI 10.1163/156856298X00299
   Hamano T, 1998, J BIOMED MATER RES, V41, P270, DOI 10.1002/(SICI)1097-4636(199808)41:2<270::AID-JBM12>3.3.CO;2-B
   JALKANEN M, 1991, RECEPTORS EXTRACELLU, P1
   Kikuchi T, 1996, INT J TISSUE REACT, V18, P87
   MATSUDA H, 1990, J IMMUNOL, V144, P259
   Meade CJ, 2001, LIFE SCI, V69, P1225, DOI 10.1016/S0024-3205(01)01231-0
   Niitsuma A, 1996, GEN PHARMACOL, V27, P123, DOI 10.1016/0306-3623(95)00082-8
   NINOMIYA Y, 1979, J BIOCHEM-TOKYO, V86, P111
   OKUNO T, 1990, J IMMUNOL, V136, P4652
   SAKAKIBARA Y, 1994, CLIN ORTHOP RELAT R, P282
   SEARS P, 1991, P NATL ACAD SCI USA, V96, P12086
   SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182
   STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975
   TONES MA, 1989, FEBS LETT, V252, P105, DOI 10.1016/0014-5793(89)80898-1
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P21
   YURT RW, 1977, J BIOL CHEM, V252, P518
NR 21
TC 0
Z9 0
U1 0
U2 1
PU SOC FIBER SCIENCE TECHNOLOGY
PI TOKYO
PA KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN
SN 0037-9875
J9 SEN-I GAKKAISHI
JI Sen-I Gakkaishi
PD MAY
PY 2004
VL 60
IS 5
BP 137
EP 143
PG 7
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 837KD
UT WOS:000222627700005
DA 2018-10-20
ER

PT J
AU Lund, E
   Gustafsson, H
   Danilczuk, M
   Sastry, MD
   Lund, A
AF Lund, E
   Gustafsson, H
   Danilczuk, M
   Sastry, MD
   Lund, A
TI Compounds of Li-6 and natural Li for EPR dosimetry in photon/neutron
   mixed radiation fields
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article; Proceedings Paper
CT 8th International Workshop on Electron Magnetic Resonance of Disordered
   Systems
CY JUN 07-16, 2003
CL Sofia, BULGARIA
DE EPR dosimetry; Li-6; Li-7; photon/neutron fields
ID LITHIUM FORMATE; ALANINE
AB Formates and dithionates of Li-6, enriched and Li-7 in natural composition of Li offer a possibility to measure the absorbed dose from photons and thermal neutrons in a mixed radiation field for instance at a boron neutron capture therapy (BNCT) facility. Tests with formates and dithionates of enriched 6Li and lithium compounds with natural composition have been performed at the BNCT facility at Studsvik, Sweden. Irradiations have been performed at 3 cm depth in a Perspex phantom in a fluence rate of thermal neutrons 1.8 x 10(9) n cm(-2) s(-1). The compounds were also irradiated in a pure X-ray field from a 4 MV linear accelerator at 5 cm depth in a phantom with accurately determined absorbed doses. The signal intensity and shape was investigated within 3 h after the irradiation. A single line spectrum attributed to the CO2- radical was observed after irradiation of lithium formate. An increase in line width occurring after neutron irradiation in comparison with photon irradiation of the Li-6 sample was attributed to dipolar broadening between CO2- radicals trapped in the tracks of the alpha particles. A spectrum due to the SO3- radical anion was observed after irradiation of lithium dithionate. The signal amplitude increased using the Li-6 in place of the Li with natural composition of isotopes, in studies with low energy X-ray irradiation. Due to the decreased line width, caused by the difference in g(N) and I between the isotopes, the sensitivity with Li-6 dithionate may be enhanced by an order of magnitude compared to alanine dosimetry. After comprehensive examination of the different combinations of compounds with different amounts of Li-6 and Li-7 regarding dosimetry, radiation chemistry and EPR properties these dosimeter material might be used for dose determinations at BNCT treatments and for biomedical experiments. Interesting properties of the radical formation might be visible due to the large difference in ionization density of neutrons compared to photons. (C) 2003 Elsevier B.V. All rights reserved.
C1 IMV, Fac Hlth Sci, Dept Radiat Phys, SE-58185 Linkoping, Sweden.
   Linkoping Univ, IFM, Chem Phys Lab, SE-58183 Linkoping, Sweden.
   Inst Nucl Chem & Technol, PL-03195 Warsaw, Poland.
RP Lund, E (reprint author), IMV, Fac Hlth Sci, Dept Radiat Phys, SE-58185 Linkoping, Sweden.
EM eva.lund@imv.liv.se
CR af Rosenschold PMM, 2003, MED PHYS, V30, P1569, DOI 10.1118/1.1580484
   Bogushevich SE, 2000, APPL RADIAT ISOTOPES, V52, P1217, DOI 10.1016/S0969-8043(00)00074-9
   Brauer G., 1954, HDB PRAPARATIVEN ANO
   BRUSTOLON M, 1994, APPL MAGN RESON, V7, P405, DOI 10.1007/BF03162621
   CHANTRY GW, 1962, MOL PHYS, V5, P233, DOI 10.1080/00268976200100251
   Coderre JA, 1999, RADIAT RES, V151, P1, DOI 10.2307/3579742
   GUSTAFSSON H, 2001, LITHIFMEX910
   Ikeya M, 2000, APPL RADIAT ISOTOPES, V52, P1209, DOI 10.1016/S0969-8043(00)00073-7
   Ikeya M., 1993, NEW APPL ELECT SPIN
   KANSIKAS J, 1989, ACTA CRYSTALLOGR C, V45, P187, DOI 10.1107/S0108270188010327
   KEIZER PN, 1991, J CHEM SOC FARADAY T, V87, P3147, DOI 10.1039/ft9918703147
   KOMAGUCHI K, EMARDIS C GRAD SCH E, P739
   Lund A, 2002, SPECTROCHIM ACTA A, V58, P1301, DOI 10.1016/S1386-1425(01)00719-3
   MAHGOUB AS, 1994, J MATER CHEM, V4, P223, DOI 10.1039/jm9940400223
   MAHGOUB ASA, 1983, RADIAT PHYS CHEM, V21, P527, DOI 10.1016/0146-5724(83)90008-0
   OLSSON S, 2001, 701 ESR
   Regulla D, 2000, APPL RADIAT ISOTOPES, V52, P1023, DOI 10.1016/S0969-8043(00)00043-9
   SUPE AA, 1986, LATVIJAS PSR ZINATNU, V4, P433
   TELLGREN R, 1974, FERROELECTRICS, V6, P191
   Vestad TA, 2003, APPL RADIAT ISOTOPES, V59, P181, DOI 10.1016/S0969-8043(03)00165-9
NR 20
TC 22
Z9 22
U1 1
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD MAY
PY 2004
VL 60
IS 6
BP 1319
EP 1326
DI 10.1016/j.saa.2003.10.029
PG 8
WC Spectroscopy
SC Spectroscopy
GA 822ZB
UT WOS:000221578400011
PM 15134730
DA 2018-10-20
ER

PT J
AU Tan, JL
   Liu, W
   Nelson, CM
   Raghavan, S
   Chen, CS
AF Tan, JL
   Liu, W
   Nelson, CM
   Raghavan, S
   Chen, CS
TI Simple approach to micropattern cells on common culture substrates by
   tuning substrate wettability
SO TISSUE ENGINEERING
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ENDOTHELIAL-CELLS; BLOCK-COPOLYMERS;
   ELASTOMERIC MEMBRANES; NEURONAL NETWORKS; GEOMETRIC CONTROL;
   MAMMALIAN-CELLS; SURFACES; PROTEINS; POLYMER
AB The ability to spatially control cell adhesion and multicellular organization is critical to many biomedical and tissue-engineering applications. This work describes a straightforward method to micropattern cells onto glass, silicone rubber, and polystyrene using commercially available reagents. An elastomeric polydimethylsiloxane stamp is used to contact-transfer extracellular matrix protein onto a surface followed by blocking cell adhesion in the surrounding regions by the physisorption of Pluronic surfactants. Using self-assembled monolayers of alkanethiols on gold as model surfaces to control surface wettability, we found that protein printing was most effective at intermediate to highly wetting surfaces whereas Pluronic adsorption occurred at intermediate to low wetting surfaces. Within a regimen of intermediate wettability both techniques were applied in conjunction to restrict cell adhesion to specified patterns. Adjusting the wettability of common tissue culture substrates to the same intermediate range again allowed the micropatterning of cells, suggesting that this approach is likely to be generally applicable to many types of materials. This technique therefore may allow for wider adoption of cell patterning.
C1 Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.
   Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA.
RP Chen, CS (reprint author), Johns Hopkins Univ, Dept Biomed Engn, 720 Rutland Ave,Traylor 718, Baltimore, MD 21205 USA.
EM cchen@bme.jhu.edu
FU NIBIB NIH HHS [EB00262]
CR Adams ML, 2003, J PHARM SCI, V92, P1343, DOI 10.1002/jps.10397
   Ahmed F, 2001, LANGMUIR, V17, P537, DOI 10.1021/la001305u
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Bhatia SN, 1999, BIOMED MICRODEVICES, V2, P131, DOI 10.1023/A:1009949704750
   Bhatia SN, 1999, FASEB J, V13, P1883
   Bohner M, 2002, MACROMOLECULES, V35, P6724, DOI 10.1021/ma0103324
   Branch DW, 1998, MED BIOL ENG COMPUT, V36, P135, DOI 10.1007/BF02522871
   CARTER SB, 1967, EXP CELL RES, V48, P189, DOI 10.1016/0014-4827(67)90298-4
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   DRELICH J, 2000, APPARENT MICROSCOPIC
   Duffy DC, 1999, ADV MATER, V11, P546, DOI 10.1002/(SICI)1521-4095(199905)11:7<546::AID-ADMA546>3.0.CO;2-E
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   Folch A, 1998, BIOTECHNOL PROGR, V14, P388, DOI 10.1021/bp980037b
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Frangos SG, 2001, ENDOTHELIUM-NEW YORK, V8, P1
   GROSS GW, 1995, BIOSENS BIOELECTRON, V10, P553, DOI 10.1016/0956-5663(95)96931-N
   HAMMARBACK JA, 1988, DEV BIOL, V126, P29, DOI 10.1016/0012-1606(88)90235-7
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Hyun JH, 2003, ADV MATER, V15, P576, DOI 10.1002/adma.200304496
   JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Lahann J, 2002, LANGMUIR, V18, P3632, DOI 10.1021/la011464t
   Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005
   MATSUSHIMA N, 1990, MOKUZAI GAKKAISHI, V36, P559
   McGurk SL, 1999, LANGMUIR, V15, P5136, DOI 10.1021/la981788q
   Nelson CM, 2003, LANGMUIR, V19, P1493, DOI 10.1021/la026178b
   Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m
   Patel N, 1998, FASEB J, V12, P1447
   PRASAD KN, 1979, J COLLOID INTERF SCI, V69, P225, DOI 10.1016/0021-9797(79)90151-6
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   STRANICK SJ, 1994, J PHYS CHEM-US, V98, P7636, DOI 10.1021/j100082a040
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tan JL, 2002, LANGMUIR, V18, P519, DOI 10.1021/la011351+
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   TIEN J, 2002, METHODS TISSUE ENG, P113
   Xia YN, 1996, ADV MATER, V8, P1015, DOI 10.1002/adma.19960081217
   XIA YN, 1995, ADV MATER, V7, P471, DOI 10.1002/adma.19950070513
NR 46
TC 151
Z9 155
U1 2
U2 33
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAY
PY 2004
VL 10
IS 5-6
BP 865
EP 872
DI 10.1089/1076327041348365
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 836DC
UT WOS:000222534500022
PM 15265304
DA 2018-10-20
ER

PT J
AU Nelea, V
   Morosanu, C
   Iliescu, M
   Mihailescu, IN
AF Nelea, V
   Morosanu, C
   Iliescu, M
   Mihailescu, IN
TI Hydroxyapatite thin films grown by pulsed laser deposition and
   radio-frequency magnetron sputtering: comparative study
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE hydroxyapatite thin films; pulsed laser deposition; radio-frequency
   magnetron sputtering; biomedical materials
ID CALCIUM-PHOSPHATE COATINGS; BEAM-ASSISTED DEPOSITION;
   MECHANICAL-PROPERTIES; TRANSFORMATION; TEMPERATURE; DISSOLUTION;
   PRESSURE; ABLATION; LAYERS
AB Hydroxyapatite (HA) thin films for applications in the biomedical field were grown by pulsed laser deposition (PLD) and radio-frequency magnetron sputtering (RF-MS) techniques. The depositions were performed from pure hydroxyapatite targets on Ti-5Al-2.5Fe (TiAlFe) alloys substrates. In order to prevent the HA film penetration by Ti atoms or ions diffused from the Ti-based alloy during and after deposition, the substrates were pre-coated with a thin buffer layer of TiN. In both cases, TiN was introduced by reactive PLD from TiN targets in low-pressure N-2. The PLD films were grown in vacuum onto room temperature substrates. The RF-MS films were deposited in low-pressure argon on substrates heated at 550 degreesC. The initially amorphous PLD thin films were annealed at 550 degreesC for 1 h in ambient air in order to restore the initial crystalline structure of HA target. The thickness of the PLD and RF-MS films were similar to1 mum and similar to350 nm, respectively. All films were structurally studied by scanning electron microscopy (SEM), grazing incidence X-ray diffraction (GIXRD), energy dispersive X-ray spectrometry (EDS) and white light confocal microscopy (WLCM). The mechanical properties of the films were tested by Berkovich nano-indentation. Both PLD and RF-MS films mostly contain HA phase and exhibit good mechanical characteristics. Peaks of CaO were noticed as secondary phase in the GIXRD patterns only for RF-MS films. By its turn, the sputtered films were smoother as compared to the ones deposited by PLD (50 nm versus 250 nm average roughness). The R-F-MS films were harder, more mechanically resistant and have a higher Young modulus. (C) 2004 Elsevier B.V. All rights reserved.
C1 Natl Inst Lasers Plasma & Radiat Phys, Lasers Dept, Bucharest 76900, Romania.
   Inst Natl Sci Appl, Lab Ingn Surfaces, F-67084 Strasbourg, France.
   Natl Inst Mat Phys, R-76900 Bucharest, Romania.
   Inst Phys & Chim Mat, Grp Surfaces Interfaces, F-67037 Strasbourg, France.
RP Mihailescu, IN (reprint author), Natl Inst Lasers Plasma & Radiat Phys, Lasers Dept, POB MG-36, Bucharest 76900, Romania.
EM mihailes@ifin.nipne.ro
RI Mihailescu, Ion/A-5403-2011
CR Arias JL, 1997, J MATER SCI-MATER M, V8, P873, DOI 10.1023/A:1018553821781
   Bauerle D., 1996, LASER PROCESSING CHE
   Campbell PA, 1996, J VAC SCI TECHNOL B, V14, P1167, DOI 10.1116/1.588422
   Chai CS, 1999, J MATER SCI-MATER M, V10, P465, DOI 10.1023/A:1008992807888
   Chen JY, 1997, J BIOMED MATER RES, V34, P15, DOI 10.1002/(SICI)1097-4636(199701)34:1<15::AID-JBM3>3.0.CO;2-Q
   Choi JM, 2000, BIOMATERIALS, V21, P469, DOI 10.1016/S0142-9612(99)00186-6
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   Cohen - Sabban J., 1999, MESURES, V179, P85
   COTELL CM, 1994, PULSED LASER DEPOSIT, P549
   Cui FZ, 1997, J MATER SCI-MATER M, V8, P403, DOI 10.1023/A:1018597320022
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Elliot J.C., 1994, STRUCTURE CHEM APATI
   Feng CF, 1999, SCRIPTA MATER, V42, P103, DOI 10.1016/S1359-6462(99)00321-8
   Fernandez-Pradas JM, 1998, THIN SOLID FILMS, V317, P393, DOI 10.1016/S0040-6090(97)00629-9
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Gyorgy E, 2004, THIN SOLID FILMS, V446, P178, DOI 10.1016/j.tsf.2003.09.071
   Gyorgy E, 2002, APPL SURF SCI, V195, P270, DOI 10.1016/S0169-4332(02)00561-5
   Hwang K, 1999, SURF COAT TECH, V115, P172, DOI 10.1016/S0257-8972(99)00174-7
   Li XD, 1997, BIOMATERIALS, V18, P1487, DOI 10.1016/S0142-9612(97)00085-9
   Lopatin CM, 1998, THIN SOLID FILMS, V326, P227, DOI 10.1016/S0040-6090(98)00531-8
   Luo ZS, 1999, J BIOMED MATER RES, V46, P80, DOI 10.1002/(SICI)1097-4636(199907)46:1<80::AID-JBM9>3.0.CO;2-9
   Mihailescu IN, 2002, P SOC PHOTO-OPT INS, V4762, P64, DOI 10.1117/12.478666
   MIHAILESCU IN, 1999, SPRINGER SERIES OPTI, P201
   Nelea V, 2002, APPL SURF SCI, V186, P483, DOI 10.1016/S0169-4332(01)00754-1
   Nelea V, 2000, APPL SURF SCI, V168, P127, DOI 10.1016/S0169-4332(00)00616-4
   Nieh TG, 2001, J MATER RES, V16, P3238, DOI 10.1557/JMR.2001.0446
   Oh KT, 1998, SURF COAT TECH, V110, P4, DOI 10.1016/S0257-8972(98)00537-4
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   SARDIN G, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P225
   Socol G, 2004, BIOMATERIALS, V25, P2539, DOI 10.1016/j.biomaterials.2003.09.044
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   vanDijk K, 1995, SURF COAT TECH, V76, P206, DOI 10.1016/02578-9729(50)25901-
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
   Wolke JGC, 1997, BIOMATERIALS, V18, P483, DOI 10.1016/S0142-9612(96)00164-0
   Zeng HT, 2000, BIOMATERIALS, V21, P23, DOI 10.1016/S0142-9612(99)00128-3
   Zeng HT, 2000, J BIOMED MATER RES, V50, P239, DOI 10.1002/(SICI)1097-4636(200005)50:2<239::AID-JBM19>3.0.CO;2-V
NR 37
TC 92
Z9 98
U1 3
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD APR 30
PY 2004
VL 228
IS 1-4
BP 346
EP 356
DI 10.1016/j.apsusc.2004.01.029
PG 11
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 820DL
UT WOS:000221367000048
DA 2018-10-20
ER

PT J
AU Etim, A
   Zhou, GH
   Wen, XY
   Liu, H
   Ruotti, V
   Twigger, S
   Jin, WH
   Matysiak, B
   Mathis, J
   Tonellato, PJ
   Datta, MW
AF Etim, A
   Zhou, GH
   Wen, XY
   Liu, H
   Ruotti, V
   Twigger, S
   Jin, WH
   Matysiak, B
   Mathis, J
   Tonellato, PJ
   Datta, MW
TI ChromSorter PC: A database of chromosomal regions associated with human
   prostate cancer
SO BMC GENOMICS
LA English
DT Article
AB Background: Our increasing use of genetic and genomic strategies to understand human prostate cancer means that we need access to simplified and integrated information present in the associated biomedical literature. In particular, microarray gene expression studies and associated genetic mapping studies in prostate cancer would benefit from a generalized understanding of the prior work associated with this disease. This would allow us to focus subsequent laboratory studies to genomic regions already related to prostate cancer by other scientific methods. We have developed a database of prostate cancer related chromosomal information from the existing biomedical literature. The input material was based on a broad literature search with subsequent hand annotation of information relevant to prostate cancer.
   Description: The database was then analyzed for identifiable trends in the whole scale literature. We have used this database, named ChromSorter PC, to present graphical summaries of chromosomal regions associated with prostate cancer broken down by age, ethnicity and experimental method. In addition we have placed the database information on the human genome using the Generic Genome Browser tool that allows the visualization of the data with respect to user generated datasets.
   Conclusions: We have used this database as an additional dataset for the filtering of genes identified through genetics and genomics studies as warranting follow-up validation studies. We would like to make this dataset publicly available for use by other groups. Using the Genome Browser allows for the graphical analysis of the associated data http://www.prostategenomics.org/datamining/chrom-sorter_pc.html. Additional material from the database can be obtained by contacting the authors (mdatta@ mcw.edu).
C1 Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA.
   Med Coll Wisconsin, Human & Mol Genet Ctr, Bioinformat Program, Milwaukee, WI 53226 USA.
   Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA.
RP Datta, MW (reprint author), Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA.
EM aetim@mcw.edu; guohui@rocketmail.com; xwen@mcw.edu; hliu@mcw.edu;
   vruotti@mcw.edu; simont@mcw.edu; weihong@mcw.edu; bmatysia@mcw.edu;
   jmathis@mcw.edu; tone@mcw.edu; mdatta@mcw.edu
FU NCI NIH HHS [R21 CA098032, R21CA098032]; NHLBI NIH HHS [R01 HL064541]
NR 0
TC 1
Z9 2
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD APR 28
PY 2004
VL 5
AR 27
DI 10.1186/1471-2164-5-27
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 824OU
UT WOS:000221696700001
PM 15113398
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Rudraiah, N
   Ng, CO
AF Rudraiah, N
   Ng, CO
TI A model for manufacture of nano-sized smart materials free from
   impurities
SO CURRENT SCIENCE
LA English
DT Review
ID RAYLEIGH-TAYLOR INSTABILITY; NONUNIFORM TEMPERATURE-GRADIENT; FINITE
   THICKNESS; SURFACE-TENSION; ELECTRIC-FIELD; MAGNETIC-FIELD;
   POROUS-MEDIUM; CONVECTION; LAYER; ACCELERATION
AB The importance of nano-sized smart materials in structural engineering, biomedical engineering, and in military applications is discussed. It is shown that the solidification of poorly conducting alloys involved in the manufacture of these materials gives rise to surface and convective instabilities. Different types of surface and convective instabilities are briefly discussed. These instabilities produce a mushy zone regarded as dendrites of nano-sized crystals. These dendrites arising from instabilities are regarded as impurities. To manufacture nano-sized smart materials free from impurities, it is essential to control both surface and convective instabilities. We discuss here briefly, different types of convective and surface instabilities in a poorly conducting fluid. We also discuss different mechanisms of control of these instabilities. Different analytical and numerical techniques used to investigate these instabilities under different boundary conditions are discussed. In this review the moment method is explained to find the condition for the onset of convection, and porous lining is used to suppress the growth rate of surface instability. This is useful in the manufacture of nano-sized smart materials free from impurities. Different methods to obtain the required basic equations and the corresponding boundary conditions are briefly discussed.
C1 Natl Res Inst Appl Math, Bangalore 560070, Karnataka, India.
   Bangalore Univ, Dept Math, UGC, CAS Fluid Mech, Bangalore 560001, Karnataka, India.
   Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.
RP Rudraiah, N (reprint author), Natl Res Inst Appl Math, 492G,7th Cross,7th Block W, Bangalore 560070, Karnataka, India.
EM nrudraiah@hotmail.com
RI Ng, Chiu-On/B-9205-2009
OI Ng, Chiu-On/0000-0002-3142-6691
CR BABCHIN AJ, 1983, PHYS FLUIDS, V26, P3159, DOI 10.1063/1.864083
   BEAVERS GS, 1967, J FLUID MECH, V30, P197, DOI 10.1017/S0022112067001375
   BETTI R, 1995, PHYS PLASMAS, V2, P3844, DOI 10.1063/1.871083
   Chandrasekhar S., 1961, HYDRODYNAMICS HYDROM
   HEMALATHA, 2001, THESIS BANGALORE U
   KANUER JP, 2000, PHYS PLASMAS, V7, P338
   Kaviany M., 1991, PRINCIPLES HEAT TRAN
   KILKENNY JD, 1994, PHYS PLASMAS, V1, P1374
   LEE C, 1972, PHYS FLUIDS, V15, P789, DOI 10.1063/1.1693986
   LEE CO, 1974, P 5 INT HEAT TRANSF, V3, P173
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   LING RY, 1990, FERROELECTRICS, V102, P215
   MIKAELIAN KO, 1990, PHYS FLUIDS A-FLUID, V2, P592, DOI 10.1063/1.857759
   NAGASHREE MS, 2001, THESIS BANGALORE U
   NAIR P, 2001, THESIS BANGALORE U
   NEUMANN RE, 1990, CROSS FERROELECTRICS, V102, P259
   Nield D. A., 1999, CONVECTION POROUS ME
   PEARSON JRA, 1958, J FLUID MECH, V4, P489, DOI 10.1017/S0022112058000616
   Plouraboue F, 2002, PHYS FLUIDS, V14, P922, DOI 10.1063/1.1446884
   RADHAKRISHNA, 2001, THESIS BANGALORE U
   RICHTMYER RD, 1960, COMMUN PUR APPL MATH, V13, P297, DOI 10.1002/cpa.3160130207
   RUDRAIAH N, 1984, INT J HEAT MASS TRAN, V27, P1825, DOI 10.1016/0017-9310(84)90164-9
   Rudraiah N., 1976, Vignana Bharathi, V2, P30
   Rudraiah N, 1997, P INDIAN AS-MATH SCI, V107, P213, DOI 10.1007/BF02837730
   Rudraiah N, 2003, ACTA MECH, V166, P217, DOI 10.1007/s00707-003-0018-5
   Rudraiah N, 1997, CURR SCI INDIA, V72, P391
   Rudraiah N, 2003, J POROUS MEDIA, V6, P1
   RUDRAIAH N, 1985, J FLUID ENG-T ASME, V107, P322, DOI 10.1115/1.3242486
   RUDRAIAH N, 1982, P INDIAN AS-MATH SCI, V91, P17, DOI 10.1007/BF02837258
   RUDRAIAH N, 1984, ARAB J SCI ENG, V9, P153
   RUDRAIAH N, 1985, INT J HEAT MASS TRAN, V28, P1621, DOI 10.1016/0017-9310(85)90264-9
   RUDRAIAH N, 1986, ACTA MECH, V61, P37, DOI 10.1007/BF01176361
   RUDRAIAH N, 1986, INDIAN J TECHNOL, V24, P279
   RUDRAIAH N, 1996, INT C POR MED THEIR, V30
   Rudraiah N., 2003, MODELLING NANO SMART
   RUDRAIAH N, 2004, LASER PART BEAM, V22, P1
   RUDRAIAH N, 2003, 2 IAEA TECHN COMM M, V43, P1
   RUDRAIAH N, 1997, INDIAN J PURE APPL M, V26, P969
   RUDRAIAH N, 2000, J AEROSPACE SCI TECH, V48, P517
   RUDRAIAH N, 1988, P CAN C CONT MECH AP
   RUDRAIAH N, 1998, NATL ACAD SCI LETT, V21
   RUDRAIAH N, 1998, ACTA MECH, V27, P235
   RUDRAIAH N, 1981, ASTRON SOC JAPAN, V33, P721
   RUDRAIAH N, 1974, ASTRON SOC JPN, V26, P221
   RUDRAIAH N, 1984, P INT C THEOR APPL M
   RUDRAIAH N, 2003, IJAME, V8
   SETHURAM HR, 2001, THESIS BANGALORE U
   Smorodin BL, 2000, J ELECTROSTAT, V48, P261, DOI 10.1016/S0304-3886(99)00074-1
   TAKABE H, 1985, PHYS FLUIDS, V28, P3676, DOI 10.1063/1.865099
   TURNBULL RJ, 1968, PHYS FLUIDS, V11, P2597, DOI 10.1063/1.1691865
NR 50
TC 8
Z9 8
U1 0
U2 6
PU CURRENT SCIENCE ASSN
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD APR 25
PY 2004
VL 86
IS 8
BP 1076
EP 1091
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 818FI
UT WOS:000221230600018
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhou, YL
   Niinomi, M
   Akahori, T
AF Zhou, YL
   Niinomi, M
   Akahori, T
TI Effects of Ta content on Young's modulus and tensile properties of
   binary Ti-Ta alloys for biomedical applications
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Young's modulus; microstructure; Ti-Ta alloy; solution treatment;
   tensile property; biomedical implant material
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; MARTENSITIC TRANSFORMATIONS;
   CAST-IRON; NB ALLOYS; MO ALLOYS; BIOCOMPATIBILITY; TANTALUM;
   TI-29NB-13TA-4.6ZR; IMPLANTS
AB The effects of Ta content on the microstructures, dynamic Young's modulus and tensile properties of the quenched Ti-Ta alloys were investigated for biomedical applications. The microstructures were examined using a scanning electron microscopy (SEM) and an X-ray diffraction (XRD) analysis. The results indicate that the microstructures of the quenched binary Ti-Ta alloys are sensitive to Ta content. The Ti-Ta alloys exhibit lamellar HCP martensite (alpha') structure at a Ta content below 20%, needle-like orthorhombic martensite (alpha") structure at a Ta content between 30-50%. metastable beta + alpha" structure at a Ta content of 60%, and single metastable structure at a Ta content above 60%. The dynamic Young's modulus and tensile properties of the binary Ti-Ta alloys depend strongly on Ta content. Ti-30% Ta and 70% Ta alloys have much lower modulus and a good combination of high strength and low modulus among all the studied Ii-Ta alloys. They have the great potential to become new candidates for biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Zhou, YL (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoku Cho, Toyohashi, Aichi 4418580, Japan.
EM shuu@sp-mac4.tutpse.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR BAGARIATSKII IA, 1959, TECH PHYS, P1014
   Boccaccini AR, 1997, Z METALLKD, V88, P23
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   BYWATER KA, 1972, PHILOS MAG, V25, P1249, DOI 10.1080/14786437208223852
   Collings E. W., 1984, PHYS METALLURGY TITA
   Cui Z., 2000, METALLOGRAPHY HEAT T
   DAVIS R, 1979, J MATER SCI, V14, P712
   DESOUZA KA, 2003, MATER LETT, V4280, P1
   Dieter G. E., 1976, MECH METALLURGY
   Dobromyslov AV, 2001, SCRIPTA MATER, V44, P905, DOI 10.1016/S1359-6462(00)00694-1
   ENTWISTLE KM, 1960, PHYS EXAMINATION MET, P487
   FAN ZY, 1993, SCRIPTA METALL MATER, V29, P1427, DOI 10.1016/0956-716X(93)90331-L
   Fedotov S G, 1986, PHYS MET METALLOGR, V62, P109
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   HUNT M, 1991, MATER ENG, V108, P27
   LEDBETTER H, 1992, Z METALLKD, V83, P195
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   LOPATA SL, 1965, T METALL SOC AIME, V233, P288
   MACK DJ, 1946, T AM I MIN MET ENG, V166, P68
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   Murray J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Perl D., 1980, SCIENCE, V208, P297
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   SOLAR RJ, 1979, J BIOMED MATER RES, V13, P217, DOI 10.1002/jbm.820130206
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, P3
NR 38
TC 172
Z9 183
U1 2
U2 62
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 25
PY 2004
VL 371
IS 1-2
BP 283
EP 290
DI 10.1016/j.msea.2003.12.011
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 818IL
UT WOS:000221238700038
DA 2018-10-20
ER

PT J
AU Kabir, A
   Hamlet, C
   Yoo, KS
   Newkome, GR
   Malik, A
AF Kabir, A
   Hamlet, C
   Yoo, KS
   Newkome, GR
   Malik, A
TI Capillary microextraction on sol-gel dendrimer coatings
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article
DE capillary microextraction; sol-gel dendrimer coating; sol-gel;
   solid-phase microextraction; aldehydes; ketones; phenols; alcohols;
   polynuclear aromatic hydrocarbons
ID PHASE MICROEXTRACTION; GAS-CHROMATOGRAPHY; STATIONARY PHASES;
   CARBONYL-COMPOUNDS; DRINKING-WATER; FIBERS; MACROMOLECULES;
   DERIVATIZATION; TECHNOLOGY; POLYMERS
AB Sol-gel capillary microextraction (CME) is a new direction in the solventless sample preparation for the preconcentration of trace analytes, and presents significant interest in environmental, pharmaceutical, petrochemical, biomedical, agricultural, food, flavor, and a host of other important areas. It utilizes advanced material properties of organic-inorganic hybrid sol-gel polymers to perform efficient extraction and preconcentration of target compounds from a wide variety of matrices. In the present work, a novel benzyl-terminated dendron-based sol-gel coating was developed for CME. A detailed investigation was conducted to evaluate the performance of the newly developed sol-gel dendrimer coatings to perform solventless extraction of a wide range of polar and nonpolar analytes. The characteristic branched architecture of dendrons makes them structurally superior extraction media compared with their traditional linear polymeric counterparts. Sol-gel chemistry was used to chemically immobilize dendritic macromolecules on fused silica capillary inner surface. Due to the strong chemical bonding with the capillary inner walls, sol-gel dendron coatings showed excellent thermal and solvent stability in capillary microextraction in hyphenation with chromatographic analysis. Efficient extraction of a wide range of analytes from their aqueous solutions was accomplished using sol-gel dendron coated fused silica capillaries. Low parts per trillion level detection limits were achieved in CME-GC for both polar and nonpolar analytes including polyaromatic hydrocarbons (PAHs), aldehydes, ketones, phenols, and alcohols. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ S Florida, Dept Chem, Tampa, FL 33620 USA.
   Univ Akron, Inst Polymer Sci, Dept Chem, Akron, OH 44325 USA.
RP Malik, A (reprint author), Univ S Florida, Dept Chem, 4202 E Fowler Ave, Tampa, FL 33620 USA.
EM Malik@chumal.cas.usf.edu
RI Kabir, Abuzar/D-1504-2011; Newkome, George/P-3093-2018
OI Newkome, George/0000-0001-6019-5071; Kabir, Abuzar/0000-0002-3740-8857
CR ALBRECHT M, 1998, J CHEM SOC CHEM COMM, V9, P1003
   AMDUR MO, 1991, CASARETT DOULLS TOXI, P866
   ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019
   Bao ML, 1998, J CHROMATOGR A, V809, P75, DOI 10.1016/S0021-9673(98)00188-5
   Bartak P, 1997, J CHROMATOGR A, V767, P171, DOI 10.1016/S0021-9673(96)01090-4
   Belardi R.G., 1989, WATER POLLUT RES J C, V24, P179
   Bigham S, 2002, ANAL CHEM, V74, P752, DOI 10.1021/ac0109523
   Blomberg L. G., 1990, J MICROCOLUMN SEP, V2, P62
   BUCHHOLZ KD, 1994, ANAL CHEM, V66, P160, DOI 10.1021/ac00073a027
   BYORSETH A, 1985, HDB POLYCYCLIC AROMA, V2, P1
   Cancho B, 2002, J CHROMATOGR A, V943, P1, DOI 10.1016/S0021-9673(01)01437-6
   Chao HC, 2002, J SEP SCI, V25, P345, DOI 10.1002/1615-9314(20020401)25:5/6<345::AID-JSSC345>3.0.CO;2-5
   Chong SL, 1997, ANAL CHEM, V69, P3889, DOI 10.1021/ac9703360
   CHORUS I, 1992, WATER SCI TECHNOL, V25, P251
   Clark TJ, 1997, J CHROMATOGR SCI, V35, P209, DOI 10.1093/chromsci/35.5.209
   Doong R, 2000, J CHROMATOGR A, V879, P177, DOI 10.1016/S0021-9673(00)00347-2
   *EPA, 1984, 604 EPA, P58
   Fresenius W., 1988, WATER ANAL PRACTICAL
   *GEN PUBL CORP, 1985, MAT SAF DAT SHEET PH
   Hayes JD, 1997, J CHROMATOGR B, V695, P3, DOI 10.1016/S0378-4347(97)00134-5
   KATAOKA H, 2002, JPN J FORENSIC TOXIC, V20, P251
   KIEBER RJ, 1990, ENVIRON SCI TECHNOL, V24, P1477, DOI 10.1021/es00080a003
   KUZDZAL SA, 1994, J CHEM SOC CHEM COMM, P2139, DOI 10.1039/c39940002139
   Lee MR, 1998, J CHROMATOGR A, V806, P317, DOI 10.1016/S0021-9673(98)00075-2
   LEIKAUF GD, 1992, ENV TOXICANTS HUMAN, P299
   Malik A., 1999, APPL SOLID PHASE MIC, P73
   MALIK A, 2002, COMPREHENSIVE ANAL C, P1023
   Mani V., 1999, APPL SOLID PHASE MIC, P57
   Mathews BT, 2001, CHROMATOGRAPHIA, V53, P147
   McElhanon JR, 1998, J AM CHEM SOC, V120, P1647, DOI 10.1021/ja970150i
   MILLS OE, 1998, J ACS S SER, V705, P85
   MISRA MK, 1999, STAR HYPERBRANCHED P
   Moder M, 1997, FRESEN J ANAL CHEM, V357, P326, DOI 10.1007/s002160050162
   MOORE JW, 1984, PHENOLS ORGANIC CHEM
   Muijselaar P, 1995, J HIGH RES CHROMATOG, V18, P121
   Mullett WM, 2001, ANAL CHEM, V73, P2383, DOI 10.1021/ac0100502
   NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052
   Newkome GR, 2001, TETRAHEDRON LETT, V42, P7537, DOI 10.1016/S0040-4039(01)01642-2
   NEWKOME GR, 1993, MACROMOLECULES, V26, P2394, DOI 10.1021/ma00061a041
   NEWKOME GR, 2001, DENDRIMERS DENDRON C
   Palmer CP, 1997, J CHROMATOGR A, V792, P105, DOI 10.1016/S0021-9673(97)00870-4
   Pollak KW, 1998, CHEM MATER, V10, P30, DOI 10.1021/cm970312+
   POTTER DW, 1994, ENVIRON SCI TECHNOL, V28, P298, DOI 10.1021/es00051a017
   ROWE WD, 1983, EVALUATION METHODS E
   Shende C, 2003, ANAL CHEM, V75, P3518, DOI 10.1021/ac0207224
   Stevens MP, 1999, POLYM CHEM
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   Wang DX, 1997, ANAL CHEM, V69, P4566, DOI 10.1021/ac970614v
   Wang PW, 1996, ADV MATER, V8, P237, DOI 10.1002/adma.19960080311
   Wang ZY, 2000, J CHROMATOGR A, V893, P157, DOI 10.1016/S0021-9673(00)00692-0
   WOOLEY KL, 1994, POLYMER, V35, P4489, DOI 10.1016/0032-3861(94)90793-5
   Wu JC, 2001, J CHROMATOGR A, V909, P37, DOI 10.1016/S0021-9673(00)01025-6
   Zeng ZR, 2001, ANAL CHEM, V73, P2429, DOI 10.1021/ac0012750
   Zeng ZR, 2001, J CHROMATOGR A, V934, P51, DOI 10.1016/S0021-9673(01)01303-6
   ZHANG ZY, 1994, ANAL CHEM, V66, pA844, DOI 10.1021/ac00089a001
NR 56
TC 57
Z9 57
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD APR 23
PY 2004
VL 1034
IS 1-2
BP 1
EP 11
DI 10.1016/j.chroma.2004.02.019
PG 11
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 808NS
UT WOS:000220576400001
PM 15116909
DA 2018-10-20
ER

PT J
AU Vandermeulen, GWM
   Klok, HA
AF Vandermeulen, GWM
   Klok, HA
TI Peptide/protein hybrid materials: Enhanced control of structure and
   improved performance through conjugation of biological and synthetic
   polymers
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE biomaterials; peptides; proteins; structure-property relations;
   supramolecular structures
ID ACID) BLOCK-COPOLYMER; POLYION COMPLEX MICELLES; POLY(ETHYLENE GLYCOL);
   POLYPEPTIDE BLOCK; AQUEOUS-MEDIUM; CELL-ADHESION; RGD-PEPTIDE;
   BETA-SHEETS; POLY(LACTIC ACID-CO-LYSINE); SENSITIVE STABILIZATION
AB The conjugation peptides/proteins and synthetic polymers is a useful strategy to overcome some of the limitations related to the use of the individual components. This review will highlight two aspects: enhanced structural control at the nanometer level and improved performance, in particular with respect to biomedical applications. In the former case, peptide sequences are mainly used to mediate I self-assembly of synthetic polymers. In the latter case, conjugation of an appropriate synthetic polymer to a pharmaceutically active peptide/protein can, for example, prevent premature enzymatic degradation and enhance blood circulation times, which is therapeutically advantageous.
C1 Ecole Polytech Fed Lausanne, Inst Mat, Lab Polymeres, CH-1015 Lausanne, Switzerland.
   Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Klok, HA (reprint author), Ecole Polytech Fed Lausanne, Inst Mat, Lab Polymeres, Batiment MX-D, CH-1015 Lausanne, Switzerland.
EM Harm-Anton.Klok@epfl.ch
CR Aoyagi T, 1999, COLLOID SURFACE B, V16, P237, DOI 10.1016/S0927-7765(99)00074-0
   Ayres L, 2003, MACROMOLECULES, V36, P5967, DOI 10.1021/ma025727h
   Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   BILLOT JP, 1977, MAKROMOL CHEM, V178, P1641
   BILLOT JP, 1976, MAKROMOL CHEM, V177, P1889
   Brodsky B, 1995, FASEB J, V9, P1537
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burkoth TS, 1999, J AM CHEM SOC, V121, P7429, DOI 10.1021/ja991233x
   Burkoth TS, 1998, J AM CHEM SOC, V120, P7655, DOI 10.1021/ja980566b
   Cammas S, 1996, MACROMOLECULES, V29, P3227, DOI 10.1021/ma951025z
   Checot F., 2002, ANGEW CHEM INT EDIT, V41, P1340
   Cho CS, 1999, KOREA POLYM J, V7, P203
   CIMA LG, 1993, CHEM ENG PROG, V6, P46
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Dai WG, 1996, BIOTECHNOL BIOENG, V50, P349, DOI 10.1002/(SICI)1097-0290(19960520)50:4<349::AID-BIT1>3.3.CO;2-D
   Davis FF, 2002, ADV DRUG DELIVER REV, V54, P457, DOI 10.1016/S0169-409X(02)00021-2
   Diwan M, 2001, J CONTROL RELEASE, V73, P233, DOI 10.1016/S0168-3659(01)00292-9
   DOUY A, 1977, POLYM ENG SCI, V17, P523, DOI 10.1002/pen.760170807
   DOUY A, 1982, POLYMER, V23, P1039, DOI 10.1016/0032-3861(82)90405-0
   Duncan R, 1996, STP PHARMA SCI, V6, P237
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   DUNCAN R, 1999, PHARM SCI TECHNOL TO, V2, P441, DOI DOI 10.1016/S1461-5347(99)00211-4
   Dvorak M, 1999, J CONTROL RELEASE, V60, P321, DOI 10.1016/S0168-3659(99)00087-5
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Elbert DL, 1998, J BIOMED MATER RES, V42, P55, DOI 10.1002/(SICI)1097-4636(199810)42:1<55::AID-JBM8>3.0.CO;2-N
   Elbert DL, 1998, CHEM BIOL, V5, P177, DOI 10.1016/S1074-5521(98)90062-X
   FLANAGAN PA, 1992, J CONTROL RELEASE, V18, P25, DOI 10.1016/0168-3659(92)90208-9
   FOSTER JA, 1973, J BIOL CHEM, V248, P2876
   Francis GE, 1998, INT J HEMATOL, V68, P1
   Gallot B, 1996, PROG POLYM SCI, V21, P1035, DOI 10.1016/S0079-6700(96)00010-X
   Gore T, 2001, LANGMUIR, V17, P5352, DOI 10.1021/la010223i
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   Griffith LG, 1998, BIOMATERIALS, V19, P979, DOI 10.1016/S0142-9612(97)00185-3
   Groth T, 1995, ATLA-ALTERN LAB ANIM, V23, P790
   Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224
   Han DK, 1996, MACROMOLECULES, V29, P5233, DOI 10.1021/ma9601070
   Harada A, 1998, MACROMOLECULES, V31, P288, DOI 10.1021/ma971277v
   Harada A, 1996, MACROMOLECULES, V29, P6183, DOI 10.1021/ma960487p
   Harada A, 1999, SCIENCE, V283, P65, DOI 10.1126/science.283.5398.65
   HARADA A, 1995, MACROMOLECULES, V28, P5294, DOI 10.1021/ma00119a019
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005
   HO DH, 1986, DRUG METAB DISPOS, V14, P349
   HO SP, 1994, ADV MATER, V6, P130, DOI 10.1002/adma.19940060205
   HODGES RS, 1972, COLD SPRING HARB SYM, V37, P299
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Iwai K, 1984, CANCER RES, V44, P2114
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Johnson-Saliba M, 2001, CURR DRUG TARGETS, V2, P371, DOI 10.2174/1389450013348245
   Kakizawa Y, 1999, J AM CHEM SOC, V121, P11247, DOI 10.1021/ja993057y
   Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0
   Kakizawa Y, 2001, BIOMACROMOLECULES, V2, P491, DOI 10.1021/bm000142I
   Kataoka K, 1998, MACROMOLECULES, V31, P6071, DOI 10.1021/ma971838i
   Katayose S, 1998, J PHARM SCI, V87, P160, DOI 10.1021/js970304s
   Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306
   KIN HB, 1992, BIOMATERIALS, V13, P905
   Klee D, 1999, ADV POLYM SCI, V149, P1
   Klok HA, 2001, ADV MATER, V13, P1217, DOI 10.1002/1521-4095(200108)13:16<1217::AID-ADMA1217>3.0.CO;2-D
   Klok HA, 2000, MACROMOLECULES, V33, P7819, DOI 10.1021/ma0009606
   Kochendoerfer GG, 2003, SCIENCE, V299, P884, DOI 10.1126/science.1079085
   Koga T, 2003, CHEM-EUR J, V9, P1146, DOI 10.1002/chem.200390132
   Koga T, 2002, CHEM COMMUN, P242, DOI 10.1039/b109574a
   Kopecek J, 2001, J CONTROL RELEASE, V74, P147, DOI 10.1016/S0168-3659(01)00330-3
   Kopecek J, 2001, MACROMOL SYMP, V174, P31, DOI 10.1002/1521-3900(200109)174:1<31::AID-MASY31>3.0.CO;2-6
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kukula H, 2002, J AM CHEM SOC, V124, P1658, DOI 10.1021/ja012091l
   Kwok KY, 1999, J PHARM SCI, V88, P996, DOI 10.1021/js990072s
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lecommandoux S, 2001, MACROMOLECULES, V34, P9100, DOI 10.1021/ma010940j
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3
   Maeda M, 1998, BIOCHEM BIOPH RES CO, V248, P485, DOI 10.1006/bbrc.1998.9018
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MILES AJ, 1994, J BIOL CHEM, V269, P30939
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nishiyama N, 1999, LANGMUIR, V15, P377, DOI 10.1021/la980572l
   Pechar M, 2002, MACROMOL BIOSCI, V2, P199, DOI 10.1002/1616-5195(200206)2:5<199::AID-MABI199>3.0.CO;2-2
   PERLY B, 1974, CR ACAD SCI C CHIM, V279, P1109
   PERLY B, 1976, MAKROMOL CHEM, V177, P2569
   PETERSON CM, 2001, ADV EXP MED BIOL, V519, P101
   RAMACHANDRAN GN, 1988, INT J PEPT PROT RES, V31, P1
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Rathore O, 2001, MACROMOLECULES, V34, P1477, DOI 10.1021/ma001553x
   Rathore O, 2000, J POLYM SCI POL CHEM, V38, P352, DOI 10.1002/(SICI)1099-0518(20000115)38:2<352::AID-POLA10>3.0.CO;2-P
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SAIKI I, 1993, JPN J CANCER RES, V84, P558, DOI 10.1111/j.1349-7006.1993.tb00176.x
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Schlaad H, 2002, POLYMER, V43, P5321, DOI 10.1016/S0032-3861(02)00360-9
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Tang A, 2001, J CONTROL RELEASE, V72, P57, DOI 10.1016/S0168-3659(01)00262-0
   Thiyagarajan P, 2000, J APPL CRYSTALLOGR, V33, P535, DOI 10.1107/S0021889899014387
   Urry D. W., 1997, PROTEIN BASED MAT
   Urry DW, 1998, BIOTECHNOL BIOENG, V58, P175, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<175::AID-BIT10>3.0.CO;2-C
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   VANDERMEULEN GWM, 2004, IN PRESS CHEMPHYSCHE
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang C, 2001, BIOMACROMOLECULES, V2, P912, DOI 10.1021/bm0155322
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Winblade ND, 2000, BIOMACROMOLECULES, V1, P523, DOI 10.1021/bm000040v
   Winningham MJ, 1997, MACROMOLECULES, V30, P862, DOI 10.1021/ma960804s
   YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269
   Yokoyama M, 1999, J DRUG TARGET, V7, P171, DOI 10.3109/10611869909085500
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   ZALIPSKY S, 1995, ADV DRUG DELIVER REV, V16, P157, DOI 10.1016/0169-409X(95)00023-Z
NR 118
TC 186
Z9 190
U1 2
U2 70
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR 19
PY 2004
VL 4
IS 4
BP 383
EP 398
DI 10.1002/mabi.200300079
PG 16
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 817II
UT WOS:000221170800001
PM 15468229
DA 2018-10-20
ER

PT J
AU Carlsson, HE
   Hagelin, J
   Hau, J
AF Carlsson, HE
   Hagelin, J
   Hau, J
TI Implementation of the 'Three Rs' in biomedical research
SO VETERINARY RECORD
LA English
DT Article
ID LABORATORY-ANIMALS; SCIENTIFIC PAPERS; EXPERIMENTATION
AB A systematic sample of 2800 articles published between 1970 and 2000 in 14 major biomedical journals was analysed to assess the implementation of the 'Three Rs' (replacement, reduction and refinement) in biomedical research. During this period the total number of articles published annually by the journals more than doubled, but the proportion of studies using animals decreased by 30 per cent. There was a significant increase, from 21 per cent to 35 per cent, in the proportion of animal studies which made use of untreated euthanased animals as donors of biological materials, a gradual decrease in the number of chronic studies on animals, and a 50 per cent decrease in the average number of animals used per published paper. There was an improvement in the reporting of the specification of the animals' husbandry, conditions of care and environment. Parameters of importance for the evaluation of the scientific quality of the research and the welfare of the animals were generally poorly reported, but the proportion of papers with adequate information on most of the parameters analysed increased between 1970 and 2000.
C1 Uppsala Univ, Div Comparat Med, Dept Neurosci, SE-75123 Uppsala, Sweden.
RP Carlsson, HE (reprint author), Uppsala Univ, Div Comparat Med, Dept Neurosci, BMC Box 572, SE-75123 Uppsala, Sweden.
RI Hau, Jann/C-8692-2012
OI Hau, Jann/0000-0001-8586-5705
CR Alder M, 2002, VET REC, V151, P221
   BIGGERS JD, 1958, NATURE, V182, P77, DOI 10.1038/182077a0
   Boisvert DPJ, 1997, DEV AN VET, V27, P399
   CHANCE MRA, 1957, COLLECTED PAPERS LAB, V6, P59
   CLOUGH G, 1982, BIOL REV, V57, P487, DOI 10.1111/j.1469-185X.1982.tb00705.x
   *EUR COMM, 1986, OFFICIAL J L, V358, P1
   FESTING MFW, 1995, STAT TOXICOLOGY, P1
   Granados-Zuniga J, 1997, REV BIOL TROP, V45, P979
   Hagelin J, 2003, LAB ANIM-UK, V37, P10, DOI 10.1258/002367703762226656
   Hagelin J, 2002, ANTHROZOOS, V15, P251, DOI 10.2752/089279302786992540
   Hagelin J, 1999, LANCET, V353, P1191, DOI 10.1016/S0140-6736(05)74419-6
   Hendriksen C. F. M., 1999, HUMANE ENDPOINTS ANI
   *HOUS LORD, 2002, SEL COMM AN SCI PROC
   LANG CM, 1976, FED PROC, V35, P1123
   Milstien J, 1996, DEV BIOL STAND, V86, P31
   NEWTON MW, 1978, ADV VET SCI COMP MED, V22, P1
   OBRINK KJ, 1996, FORSOKSDJURSVETENSKA, P197
   Roberts I, 2002, BRIT MED J, V324, P474, DOI 10.1136/bmj.324.7335.474
   Russell W. M. S., 1959, PRINCIPLES HUMAN EXP
   SCHOBERBENDIXEN S, 1997, ALTEX ALTERNATIVEN T, V14, P99
   Smith JA, 1997, LAB ANIM, V31, P312, DOI 10.1258/002367797780596176
   Stokstad E, 1999, SCIENCE, V286, P1068, DOI 10.1126/science.286.5442.1068
   Turner JZ, 1998, PUBLIC UNDERST SCI, V7, P27, DOI 10.1088/0963-6625/7/1/003
NR 23
TC 12
Z9 14
U1 1
U2 9
PU BRITISH VETERINARY ASSOC
PI LONDON
PA 7 MANSFIELD ST, LONDON W1M 0AT, ENGLAND
SN 0042-4900
J9 VET REC
JI Vet. Rec.
PD APR 10
PY 2004
VL 154
IS 15
BP 467
EP 470
DI 10.1136/vr.154.15.467
PG 4
WC Veterinary Sciences
SC Veterinary Sciences
GA 819HI
UT WOS:000221305400017
PM 15143737
DA 2018-10-20
ER

PT J
AU Lee, GB
   Huang, FC
   Lee, CY
   Miau, JJ
AF Lee, GB
   Huang, FC
   Lee, CY
   Miau, JJ
TI A new fabrication process for a flexible skin with temperature sensor
   array and its applications
SO ACTA MECHANICA SINICA
LA English
DT Article; Proceedings Paper
CT International Conference on Mico and Nano Systems (ICMNS 2002)
CY AUG 11-14, 2002
CL KUNMING, PEOPLES R CHINA
DE MEMS; flexible skin; temperature sensors; TCR; polyimide
ID TECHNOLOGY; POLYMERASE; DNA
AB This paper reports a novel technique for fabrication of a flexible skin with a temperature sensor array (40 x 1 sensors). A simplified MEMS technology using platinum resistors as sensing materials, which are sandwiched between two polyimide layers as flexible substrates is developed. The two polyimide layers are deposited on top of a thin aluminum layer, which serves as a sacrificial layer such that the flexible skin can be released by metal etching and peeled off easily. The flexible skin with a temperature sensor array has a high mechanical flexibility and can be handily attached on a highly curved surface to detect tiny temperature distribution inside a small area. The sensor array shows a linear output and has a sensitivity of 7.5 mV/degreesC (prior to amplifiers) at a drive current of 1 mA. To demonstrate its applications, two examples have been demonstrated, including measurement of temperature distribution around a micro heater of a micro PCR (polymerase chain reaction) chip for DNA amplification and detection of separation point for flow over a circular cylinder. The development of the flexible skin with a temperature sensor array may be crucial for measuring temperature distribution on any curved surface in the fields of aerodynamics, space exploration, auto making and biomedical applications etc.
C1 Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Inst Aeronaut & Astronaut, Tainan 701, Taiwan.
RP Lee, GB (reprint author), Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
EM gwobin@mail.ncku.edu.tw
RI Lee, Gwo-Bin/D-3032-2012
OI Lee, Gwo-Bin/0000-0001-6910-9133
CR ANTHONY RJ, 2001, AIAA20010553 P 39 AE
   BANG C, 1996, P AFOSR CONTR GRANT
   BARTH PW, 1985, IEEE T ELECTRON DEV, V32, P1202, DOI 10.1109/T-ED.1985.22101
   BEEBE DJ, 1994, SENSOR ACTUAT A-PHYS, V44, P57, DOI 10.1016/0924-4247(93)00775-Y
   Jiang FK, 2000, SENSOR ACTUAT A-PHYS, V79, P194, DOI 10.1016/S0924-4247(99)00277-0
   Jiang FK, 1997, PROC IEEE MICR ELECT, P465, DOI 10.1109/MEMSYS.1997.581894
   Kovacs G.T.A., 2000, MICROMACHINED TRANSD
   Lee GB, 2000, J AIRCRAFT, V37, P697, DOI 10.2514/2.2655
   Lee GB, 2002, J CHIN INST ENG, V25, P619, DOI 10.1080/02533839.2002.9670736
   Lin CH, 2002, INT J NONLINEAR SCI, V3, P177
   Liu RH, 1998, P ANN INT IEEE EMBS, V20, P1841, DOI 10.1109/IEMBS.1998.746950
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
NR 14
TC 4
Z9 8
U1 4
U2 20
PU CHINESE JOURNAL MECHANICS PRESS
PI BEIJING
PA 15 ZHONG-GUAN-CUN ST, BEIJING 100080, PEOPLES R CHINA
SN 0567-7718
J9 ACTA MECH SINICA
JI Acta Mech. Sin.
PD APR
PY 2004
VL 20
IS 2
BP 140
EP 145
PG 6
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA 822EH
UT WOS:000221518600005
DA 2018-10-20
ER

PT J
AU Dorner-Reisel, A
   Schurer, C
   Muller, E
AF Dorner-Reisel, A
   Schurer, C
   Muller, E
TI The wear resistance of diamond-like carbon coated and uncoated Co28Cr6Mo
   knee prostheses
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th European Conference on Diamond, Diamond-like Materials, Carbon
   Nanotubes, Nitrides and Silicon Carbide
CY SEP 08-12, 2003
CL Salzburg, AUSTRIA
SP AIXTRON AG, Elsevier Ltd, Iplas Innovat Plasma, Jobin Yvon GbmH, KINIK, Renishaw Plc, Roth & Rau, Seki Technotron, UralAlmazInvest Co
DE biomedical applications; diamond-like carbon; tribology;
   biocompatibility
ID POLYETHYLENE; UHMWPE; DEBRIS
AB Diamond-like carbon (DLC) coatings were deposited on medical grade Co28Cr6Mo femoral segments for knee joint prostheses by plasma decomposition of the gaseous hydrocarbon methane. In dependence on the DLC-coating thickness (0.8, 2.7 and 4.5 mum), the wear of the polymeric UHMW-PE (UHMW-PE: ultra high molecular weight polyethylene) counter face was increasing. In comparison with an uncoated Co28Cr6Mo femur, the surface modification with 0.8 and 2.7 mum thick DLCs resulted in improved wear resistance. A 4.5 mum thick DLC coating led to a strong decrease of the wear resistance of the UHMW-PE counter face. A possible reason for this phenomenon may be changes in the heat transfer. The heat transfer may be reduced due to lower fraction of defects, like pinholes, in thicker DLC coatings. Starting from a certain temperature level at the surface of the polymeric inlays, structural changes could be expected, causing a higher materials loss. Furthermore, in comparison with the uncoated Co28Cr6Mo femoral components, the release of metallic wear products is reduced due to the coverage of the metallic alloy with the DLCs. Hereby, an improved biocompatibility is expected. (C) 2003 Elsevier B.V. All rights reserved.
C1 Bergakad Freiberg, Inst Ceram Mat, D-9200 Freiberg, Germany.
RP Dorner-Reisel, A (reprint author), Bergakad Freiberg, Inst Ceram Mat, D-9200 Freiberg, Germany.
EM domer@mailtuba.tu-freiberg.de
CR Allen M, 1996, J BONE JOINT SURG BR, V78B, P32
   Chandrasekaran M, 2001, WEAR, V250, P237, DOI 10.1016/S0043-1648(01)00646-9
   Costa L, 2001, BIOMATERIALS, V22, P307, DOI 10.1016/S0142-9612(00)00182-4
   DOENERREISEL A, IN PRESS THIN SOLID
   Dorner A, 2001, WEAR, V249, P489, DOI 10.1016/S0043-1648(01)00587-7
   Dorner-Reisel A, 2003, DIAM RELAT MATER, V12, P1030, DOI 10.1016/S0925-9635(02)00293-5
   Hahn DW, 1996, J BIOMED MATER RES, V31, P355
   Jacobs J.J., 1996, CLIN ORTHOP RELAT R, V329, P5256
   Jordan ND, 2001, J BIOMED MATER RES, V55, P158
   KOIZUMI M, 1998, 44 ANN M ORTH RES SO, P811
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   SCHMALZRIED TP, 1994, J APPL BIOMATER, V5, P185, DOI 10.1002/jab.770050302
   Schmitt S, 2000, SCRIPTA MATER, V43, P523, DOI 10.1016/S1359-6462(00)00461-9
NR 13
TC 17
Z9 20
U1 1
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-AUG
PY 2004
VL 13
IS 4-8
BP 823
EP 827
DI 10.1016/j.diamond.2003.11.080
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 824MQ
UT WOS:000221691100054
DA 2018-10-20
ER

PT J
AU Smietana, M
   Smidt, J
   Dudek, M
   Niedzielski, P
AF Smietana, M
   Smidt, J
   Dudek, M
   Niedzielski, P
TI Optical properties of diamond-like cladding for optical fibres
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th European Conference on Diamond, Diamond-like Materials, Carbon
   Nanotubes, Nitrides and Silicon Carbide
CY SEP 08-12, 2003
CL Salzburg, AUSTRIA
SP AIXTRON AG, Elsevier Ltd, Iplas Innovat Plasma, Jobin Yvon GbmH, KINIK, Renishaw Plc, Roth & Rau, Seki Technotron, UralAlmazInvest Co
DE diamond-like carbon; plasma CVD; optical properties characterization;
   sensors
ID CARBON COATINGS; BIOMEDICAL APPLICATIONS; LAYERS
AB This article presents a novel application of DLC layers: cladding material for silica optical fibre's core. The coats were successfully obtained using the radio frequency plasma chemical vapour deposition (RF PCVD) method. A technological subject of depositing diamond-like carbon layers onto dielectric substrates is also raised. An original way of placing samples in a plasma reactor and a process taken in order to get a desirable effect were worked out. Different values of optical fibre transmission, which depend on the RF PCVD process parameters, can be observed. Obtained coats can be characterized by good adhesion and stability. Scanning electron microscopy (SEM) and atomic force microscopy (AFM) images of the deposited DLC layer were made. A partly uncoated optical fibre, covered by the DLC layer, can act as a sensing head. The experiments prove very high sensitivity to humidity depending on a length of the uncoated section and deposition process parameters. (C) 2003 Elsevier B.V. All rights reserved.
C1 Warsaw Univ Technol, Inst Micro & Optoelect, PL-00665 Warsaw, Poland.
   Tech Univ Lodz, Inst Mat Sci & Engn, PL-90924 Lodz, Poland.
RP Smietana, M (reprint author), Warsaw Univ Technol, Inst Micro & Optoelect, Koszykowa 75, PL-00665 Warsaw, Poland.
EM msmietan@elka.pw.edu.pl
RI Dudek, Mariusz/O-1242-2018
OI Dudek, Mariusz/0000-0003-4213-7673; Niedzielski,
   Piotr/0000-0002-6966-9154
CR Abderrahmane S, 2001, SENSOR ACTUAT B-CHEM, V75, P1, DOI 10.1016/S0925-4005(00)00677-8
   ADBERMALEK F, 1997, P 11 EUR C SOL STAT, P1529
   ALALUF M, 1995, THIN SOLID FILMS, V256, P1, DOI 10.1016/0040-6090(95)80024-7
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   Coad EJ, 1996, DIAM RELAT MATER, V5, P640, DOI 10.1016/0925-9635(95)00403-3
   DLUZNIEWSKI M, DIAMOND96
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Langer M, 1997, NATO ASI 3 HIGH TECH, V38, P211
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA E, 1994, DIAM RELAT MATER, V3, P868, DOI 10.1016/0925-9635(94)90288-7
   MITURA S, 1991, MATER SCI MONOG, V73, P795
   Robertson J, 2003, DIAM RELAT MATER, V12, P79, DOI 10.1016/S0925-9635(03)00006-2
   SZMIDT J, 1994, DIAM RELAT MATER, V3, P849, DOI 10.1016/0925-9635(94)90283-6
NR 15
TC 32
Z9 36
U1 1
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-AUG
PY 2004
VL 13
IS 4-8
BP 954
EP 957
DI 10.1016/j.diamond.2003.12.003
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 824MQ
UT WOS:000221691100080
DA 2018-10-20
ER

PT J
AU Okpalugo, TIT
   Ogwu, AA
   Maguire, PD
   McLaughlin, JAD
   Hirst, DG
AF Okpalugo, TIT
   Ogwu, AA
   Maguire, PD
   McLaughlin, JAD
   Hirst, DG
TI In-vitro blood compatibility of a-C : H : Si and a-C : H thin films
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th European Conference on Diamond, Diamond-like Materials, Carbon
   Nanotubes, Nitrides and Silicon Carbide
CY SEP 08-12, 2003
CL Salzburg, AUSTRIA
SP AIXTRON AG, Elsevier Ltd, Iplas Innovat Plasma, Jobin Yvon GbmH, KINIK, Renishaw Plc, Roth & Rau, Seki Technotron, UralAlmazInvest Co
DE blood compatibility; cell adhesion; silicon doping; surface bond energy
AB Carbon-based materials, for example pyrolytic carbon, have been successfully applied as artificial clinical heart valve coatings but due to ease of availability, processing, increased hardness, corrosion and scratch resistance, DLC has recently attracted attention for biomedical applications. Although often cited as having bio-compatible properties there has been little systematic study of DLC and how film structure may affect such properties. RF PECVD a-C:H and Si-doped a-C:H:Si films were deposited and in-vitro blood compatibility (haemocompatibility) investigated by the use of human microvascular endothelial cells (HMEC) on one end of the scale and platelets on the other, in order to assess the potential of DLC in biomedicine and surgical applications. Increased electronic conduction, decreased work function and decreased surface bond energy (with a high dispersive component) in the absence of graphitisation improved the blood compatibility of a-C:H and a-C:H:Si thin films. Changes in the nanostructure, surface energy and electrical properties was observed with silicon doping while thermal annealing also altered the electrical properties, reduced intrinsic compressive stress and at higher temperatures (> 400 degreesC) induced graphitisation. Increased HMEC adhesion (approx. 6x) and/or decreased platelets aggregation (approx. 6x) is associated with lower resistivity, work function and surface energy in the thin films where there is no graphitisation. Graphitisation, however, despite the lower resistivity and work function, leads to lower HMEC adhesion and increased platelets aggregation. Si-doped a-C:H coatings deposited under optimal conditions are a significant factor in developing haemocompatible medical implants and devices. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Ulster, Sch Elect & Mech Engn, NIBEC, Belfast BT37 0QB, Antrim, North Ireland.
   Univ Paisley, Thin Film Ctr, Paisley PA1 2BE, Renfrew, Scotland.
   Univ Ulster, Ctr Mol Biosci, Coleraine BT52 1SA, Londonderry, North Ireland.
RP Maguire, PD (reprint author), Univ Ulster, Sch Elect & Mech Engn, NIBEC, Shore Rd, Belfast BT37 0QB, Antrim, North Ireland.
EM pd.maguire@ulst.ac.uk
RI MAGUIRE, Paul/D-1568-2009
OI MAGUIRE, PAUL/0000-0002-2725-4647; McLaughlin, James/0000-0001-6026-8971
CR [Anonymous], 10993 ISO
   Baikie ID, 1998, REV SCI INSTRUM, V69, P3902, DOI 10.1063/1.1149197
   Gordan J. L., 1986, BLOOD SURFACE INTERA, P5
   Magill DP, 2001, J VAC SCI TECHNOL A, V19, P2456, DOI 10.1116/1.1387078
   Maguire PD, 2001, DIAM RELAT MATER, V10, P216, DOI 10.1016/S0925-9635(00)00470-2
   MARTINO BC, 1997, DIAM RELAT MATER, V6, P559
   MONCADA S, 1982, PATHOBIOLOGY ENDOTHE, P253
   OGWU AA, UNPUB APPL PHYS A
   OKPALUGO TIT, 2003, IN PRESS BIOMATERIAL
   WILCOX DC, 1996, GREER IMAGETOOL UTHS
NR 10
TC 41
Z9 42
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-AUG
PY 2004
VL 13
IS 4-8
BP 1088
EP 1092
DI 10.1016/j.diamond.2003.10.064
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 824MQ
UT WOS:000221691100106
DA 2018-10-20
ER

PT J
AU Bibby, JK
   Mummery, PM
   Bubb, N
   Wood, DJ
AF Bibby, JK
   Mummery, PM
   Bubb, N
   Wood, DJ
TI Novel bioactive coatings for biomedical applications deposited by
   electrophoretic deposition
SO GLASS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Crystallisation in Glasses and Liquids
CY JUL 06-09, 2003
CL Univ Sheffield, Sheffield, ENGLAND
HO Univ Sheffield
ID HYDROXYAPATITE COATINGS; GLASS-CERAMICS; SURFACE; INTERFACE
AB There are thousands of implant operations every year that give significant pain relief to patients. Even small improvements can reduce the need for further revision surgery. Improving the bonding of an implant, by using a bioactive coating, increases the rate of fixture of the implant, reducing the healing time The original artificial bioactive coatings, calcium phosphates and hydroxyapatite, were absorbed quickly by the body. This leaves the substrate bare, resulting in loosening of the implant. Hench developed bioactive glass ceramics in the 1970s that were longer lasting and bonded to hone. Due to the low fracture toughness ( of these glass ceramics, these materials are used for non-load hearing components, or more commonly, as coatings. This paper shows that fluorapatite-mullite coatings can be successfully deposited as a glass ceramic. Initial bioactivity tests using SBF show that this coaling is biologically active.
C1 Univ Manchester, Inst Sci & Technol, Ctr Mat Sci, Manchester M1 7HS, Lancs, England.
   Leeds Dent Inst, Div Restorat Dent, Leeds LS2 9LU, W Yorkshire, England.
RP Bibby, JK (reprint author), Univ Manchester, Inst Sci & Technol, Ctr Mat Sci, Grosvenor St, Manchester M1 7HS, Lancs, England.
EM jennifer_bibby@hotmail.com
CR Bao Y, 2002, J MATER SCI-MATER M, V13, P639, DOI 10.1023/A:1015773322821
   BREME J, 1995, BIOMATERIALS, V16, P239, DOI 10.1016/0142-9612(95)92123-N
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   GAM MS, 1994, IND CERAM, V14, P163
   Gomez-Vega JM, 1999, J BIOMED MATER RES, V46, P549, DOI 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
   Gomez-Vega JM, 2000, ADV MATER, V12, P894, DOI 10.1002/1521-4095(200006)12:12<894::AID-ADMA894>3.0.CO;2-4
   GREENSPAN DC, 1999, MED DIAGNOSTIC I MAR
   HENCH L, 1993, INTRO BIOCERAMICS
   HILL R, 1995, J MATER SCI-MATER M, V6, P311, DOI 10.1007/BF00120298
   Jallot E, 2000, SURF INTERFACE ANAL, V29, P314, DOI 10.1002/(SICI)1096-9918(200005)29:5<314::AID-SIA871>3.3.CO;2-C
   JANA C, 1995, GLASTECH BER-GLASS, V68, P117
   KOKUBO T, 1999, MAT SCI FORUM, V293
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   Massaro C, 2001, J BIOMED MATER RES, V58, P651, DOI 10.1002/jbm.1065
   MCDONALD DE, 2001, J BIOMED MATER RES, V54, P480
   Nobre MAL, 2001, MATER LETT, V50, P115, DOI 10.1016/S0167-577X(00)00426-2
   PEITL C, 2001, J NONCRYST SOLIDS, V292, P116
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   TOMSIA AP, 1999, ACTA MAT, V47, P4221
   VERNE E, IN PRESS J EUR CERAM
   Yue RF, 1998, APPL SURF SCI, V126, P255, DOI 10.1016/S0169-4332(97)00407-8
NR 22
TC 8
Z9 8
U1 0
U2 0
PU SOC GLASS TECHNOLOGY
PI SHEFFIELD
PA 9 CHURCHILL WAY, SHEFFIELD S35 2PY, CHAPELTOWN, ENGLAND
SN 0017-1050
J9 GLASS TECHNOL
JI Glass Technol.
PD APR
PY 2004
VL 45
IS 2
BP 80
EP 83
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 835ZZ
UT WOS:000222525800011
DA 2018-10-20
ER

PT J
AU Voskerician, G
   Shawgo, RS
   Hiltner, PA
   Anderson, JM
   Cima, MJ
   Langer, R
AF Voskerician, G
   Shawgo, RS
   Hiltner, PA
   Anderson, JM
   Cima, MJ
   Langer, R
TI In vivo inflammatory and wound healing effects of gold electrode
   voltammetry for MEMS micro-reservoir drug delivery device
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE bioelectric phenomena; biomedical materials; electrochemical process;
   microelectromechanical devices
ID ELECTRICAL-STIMULATION
AB The in vivo biocompatibility and biofouling of gold electrodes for a microelectromechanical systems drug delivery device were investigated in a rodent model. The role of the applied voltage and gold electrolysis products in modulating the inflammatory response (biocompatibility), and the temporal adhesion of cellular populations onto macroscopic gold film electrodes (biofouling) were analyzed in reference to two controls, devices to which voltage was not applied (uncorroded) or voltage was applied to inert platinum electrodes (electrical controls). Voltammetry was applied to the gold surfaces once (day 4, 7, 14, 21, 28, 35, 42, or 49), while voltage of identical magnitude was applied to the electrical controls. An inflammatory response characterized by a rapid decrease of leukocyte concentration to control levels was observed 48 h following voltage application with no significant cell concentration difference (p > 0.05) between the corroded devices and electrical controls. The histological evaluation of the direct implant fibrous capsule showed comparable thickness of voltage applied and control specimens. The gold corrosion peak current showed no significant difference (p > 0.05) among peak values at all time points. It was concluded that gold electrode corrosion was biocompatible and its electrochemical performance was not hindered by fibrous capsule formation.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Dept Biomed Engn, Cleveland, OH 44106 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Voskerician, G (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM gxv4@po.cwru.edu
FU NIAID NIH HHS [1 R24 AI47739-01]
CR Best S, 1996, GOLD BULL, V29, P87, DOI DOI 10.1007/BF03214741
   Cho MR, 2000, ANN BIOMED ENG, V28, P234, DOI 10.1114/1.263
   Gentzkow G D, 1991, Clin Podiatr Med Surg, V8, P827
   GENTZKOW GD, 1993, J DERMATOL SURG ONC, V19, P753, DOI 10.1111/j.1524-4725.1993.tb00420.x
   Jones D., 1996, PRINCIPLES PREVENTIO
   KAO WJ, 1999, HDB BIOMATERIALS EVA, P659
   KISZA A, 1973, B ACAD POL SCI-CHIM, V21, P37
   Merchant B, 1998, BIOLOGICALS, V26, P49, DOI 10.1006/biol.1997.0123
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   *OUT RES, HSC COMP PROGR VERS
   REICH J, 1990 INT C TISS REP
   ROSENBERG AD, 2001, THESIS MIT CAMBRIDGE
   Santini JT, 1999, NATURE, V397, P335
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   VOSKERICIAN G, IN PRESS BIOMATERIAL
   Weiss DS, 1989, J INVEST DERMATOL, P92
NR 17
TC 22
Z9 23
U1 0
U2 11
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD APR
PY 2004
VL 51
IS 4
BP 627
EP 635
DI 10.1109/TBME.2003.821034
PG 9
WC Engineering, Biomedical
SC Engineering
GA 805HJ
UT WOS:000220357100008
PM 15072217
DA 2018-10-20
ER

PT J
AU Hassed, CS
AF Hassed, CS
TI Bringing holism into mainstream biomedical education
SO JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
LA English
DT Article
AB Introducing holism and complementary medicine into mainstream medical education provides many scientific, philosophical, and personal challenges. The growth of new knowledge always necessitates venturing into areas, which are, by definition, unknown, hence arise potential clashes of ideology, knowledge, evidence, interpretation, language, and personality. This paper outlines some of the experience and progress made at Monash University Victoria, Australia, in teaching this material in undergraduate medical education. The Monash medical course has always been known for its commitment to an integrated curriculum, a holistic perspective, and the personal development of its students. Some of the points of integration in the core curriculum already achieved include health enhancement and mindfulness-based stress management programs right from first year, lectures and forums on complementary medicine, integration of this material into weekly case-based teaching, and health promotion and mind-body medicine. For very interested students, electives provide an opportunity to explore subjects in more depth. Experience has taught us that it is as important to learn how to deliver the message as it is to refine its content. This presents challenges that are as much personal as they are intellectual. Areas of particular importance are the academic environment, language, diplomacy, style, relevance, and evidence. In this process, building relationships, collegiality, patience, objectivity, impartiality, and humor are helpful.
C1 Monash Univ, Dept Gen Practice, Melbourne, Vic 3165, Australia.
RP Hassed, CS (reprint author), Monash Univ, Dept Gen Practice, 867 Ctr Rd, Melbourne, Vic 3165, Australia.
EM craig.hassed@med.monash.edu.au
CR Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548
NR 1
TC 13
Z9 13
U1 0
U2 8
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1075-5535
J9 J ALTERN COMPLEM MED
JI J. Altern. Complement Med.
PD APR
PY 2004
VL 10
IS 2
BP 405
EP 407
DI 10.1089/107555304323062428
PG 3
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 814VL
UT WOS:000221002100026
PM 15165424
DA 2018-10-20
ER

PT J
AU Matheson, LA
   Santerre, JP
   Labow, RS
AF Matheson, LA
   Santerre, JP
   Labow, RS
TI Changes in macrophage function and morphology due to biomedical
   polyurethane surfaces undergoing biodegradation
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID MONOCYTE-DERIVED MACROPHAGES; MULTINUCLEATED GIANT-CELLS; CHOLESTEROL
   ESTERASE; IN-VITRO; POLYETHYLENE; PHAGOCYTOSIS; CHEMISTRY; MEMBRANE;
   CYTOSKELETAL; ACTIVATION
AB Monocytes are recruited to the material surface of an implanted biomedical device recognizing it as a foreign body. Differentiation into macrophages subsequently occurs followed by fusion to form foreign body giant cells (FBGCs). Consequently, implants can become degraded, cause chronic inflammation or become isolated by fibrous encapsulation. In this study, a relationship between material surface chemistry and the FBGC response was demonstrated by seeding mature monocyte-derived macrophages (MDMs) on polycarbonate-based polyurethanes that differed in their chemical structures (synthesized with poly(1,6-hexyl 1,2-ethyl carbonate) diol, and either C-hexane diisocyanate and butanediol (BD) (referred to as HDI) or 4,4'-methylene bisphenyl diisocyanate and C-14-BD (referred to as MDI)) and material degradation assessed. At 48 h of cell-material interaction, the FBGC attached to HDI were more multinucleated (73%) compared to MDI or the polystyrene (PS) control (21 and 36%, respectively). There was a fivefold increase in the synthesis and secretion of a protein with an approximate molecular weight of 48 kDa and a pl of 6.1 (determined by two-dimensional gel electrophoresis) only from cells seeded on HDI. Immunoprecipitation confirmed that MSE and CE were synthesized and secreted de novo. Immunoblotting also showed an increase in se creted monocyte-specific esterase (MSE) and cholesterol esterase (CE) from cells seeded on HDI relative to PS and MDl. Significantly more radiolabel (C-14) release and esterase activity were elicited by MDMs on HDI than MDI (P < 0.05). The material that was more degradable (HDI), elicited greater protein synthesis and esterase secretion as well as more multi nucleated MDMs than MDI, suggesting that the material surface chemistry modulates the function of MDM at the site of an inflammatory response to an implanted device. (C) 2003 Wiley-Liss, Inc..
C1 Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
   Univ Toronto, Fac Dent, Toronto, ON, Canada.
   Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM rlabow@ottawaheart.ca
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   BOZDECH MJ, 1981, J EXP MED, V153, P182, DOI 10.1084/jem.153.1.182
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   CANNON GJ, 1992, J CELL SCI, V101, P907
   Crenshaw HC, 1996, EXP CELL RES, V227, P285, DOI 10.1006/excr.1996.0278
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092
   HUANG Y, 1991, J BIOL CHEM, V266, P6720
   Jacob SS, 2002, MOL CELL BIOCHEM, V233, P9, DOI 10.1023/A:1015593232347
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Korossis SA, 2000, BIO-MED MATER ENG, V10, P83
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3
   Reinhard G, 2002, BRIT J CANCER, V86, P1529, DOI 10.1038/sj/bjc/6600316
   Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003
   Saad B, 2000, J BIOMAT SCI-POLYM E, V11, P787, DOI 10.1163/156856200744011
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257
   Skarlatos S.I., 1992, J TISS CULT METH, V14, P113
   SMETANA K, 1987, EXP MOL PATHOL, V46, P258, DOI 10.1016/0014-4800(87)90048-7
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Tanaka H, 1999, J BIOCHEM, V125, P883, DOI 10.1093/oxfordjournals.jbchem.a022364
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   Uphoff CC, 2000, LEUKEMIA LYMPHOMA, V39, P257, DOI 10.3109/10428190009065825
   VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991
   WERB Z, 1989, AM J PATHOL, V134, P661
   WOLTER JR, 1983, OPHTHALMIC SURG LAS, V14, P839
   Xing S, 2002, J BIOMED MATER RES, V61, P619, DOI 10.1002/jbm.10078
   Xing S, 2002, BIOMATERIALS, V23, P3595, DOI 10.1016/S0142-9612(02)00088-1
   Yang ML, 2001, BIOMACROMOLECULES, V2, P134, DOI 10.1021/bm000087g
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 46
TC 57
Z9 57
U1 0
U2 14
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9541
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD APR
PY 2004
VL 199
IS 1
BP 8
EP 19
DI 10.1002/jcp.10412
PG 12
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 773EQ
UT WOS:000188885100002
PM 14978730
DA 2018-10-20
ER

PT J
AU Costa, SA
   Reis, RL
AF Costa, SA
   Reis, RL
TI Immobilisation of catalase on the surface of biodegradable starch-based
   polymers as a way to change its surface characteristics
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 18th European Conference on Biomaterials
CY OCT 01-04, 2003
CL Stuttgart, GERMANY
ID COVALENT IMMOBILIZATION; MECHANICAL-PROPERTIES; HYDROGEN-PEROXIDE;
   IN-VITRO; SCAFFOLDS; POLYETHYLENEIMINE; ACID); STABILIZATION;
   OPTIMIZATION; CHYMOTRYPSIN
AB In this study, a specific enzyme catalase was immobilised onto the surface of two different biodegradable materials, starch cellulose acetate (SCA) and starch polycrapolactone (SPCL) blends. This immobilisation was achieved by several different routes, mainly by covalent binding and an adsorption method using as activation agents epichlorohydrin, cyanogen bromide (CNBr), and aminopropyltriethoxysilane. The effect of the coupling pH of the enzyme-support reaction was determined in terms of activity recovery (%). The catalase immobilised on SCA showed higher activity recovery (%) for all the methods used as compared with results obtained with SPCL. The immobilisation process using epichlorohydrin as an activation agent and polyethylenimine as a spacer-arm enhanced the stability and the half-lives at pH 7.0, 30 degreesC, for immobilised catalase on both SCA and SPCL. The half-lives were respectively, 1162 and 870 h compared with other treatments and free enzyme (480 h). The free glycerol present in the immobilisation medium was also a factor that contributed toward the better performance regarding the long-term stability at 30 degreesC and neutral pH. The extension of the morphological modifications on the surface of the materials was observed by scanning electron microscopy. In general, the results indicated that the chemical modification with epichlorohydrin could provide a simple and rather efficient technique to modify the starch-based materials' surface that might be useful in several biomedical applications. (C) 2004 Kluwer Academic Publishers.
C1 3Bs Res Grp, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Costa, SA (reprint author), 3Bs Res Grp, Campus Gualtar, P-4710057 Braga, Portugal.
EM silgia@adep.uminho.pt
RI Reis, Rui L./A-8938-2008; Aparecida da Costa, Silgia/M-5901-2015; Group,
   3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Aparecida da Costa,
   Silgia/0000-0001-8331-538X; Group, 3Bs/0000-0002-5195-3456
CR Aebi H.E., 1983, METHODS ENZYME ANAL, V3, P273
   AKERTEK E, 1995, APPL BIOCHEM BIOTECH, V50, P291, DOI 10.1007/BF02788099
   AKOGOL S, 2001, J MOL CATAL B-ENZYM, V15, P197
   Albayrak N, 2002, BIOTECHNOL PROGR, V18, P240, DOI 10.1021/bp010167b
   Alves CM, 2003, J MATER SCI-MATER M, V14, P157, DOI 10.1023/A:1022023930825
   ARICA MY, 1995, BIOMATERIALS, V16, P761, DOI 10.1016/0142-9612(95)99638-3
   BAHULEKAR R, 1991, ENZYME MICROB TECH, V13, P858, DOI 10.1016/0141-0229(91)90101-F
   BICKERSTAFF GF, 1987, ENZYME IND MED
   Bilkova Z, 1999, J CHROMATOGR A, V852, P141, DOI 10.1016/S0021-9673(99)00234-4
   Broz ME, 2003, BIOMATERIALS, V24, P4181, DOI 10.1016/S0142-9612(03)00314-4
   Castro GR, 2000, ENZYME MICROB TECH, V27, P143, DOI 10.1016/S0141-0229(00)00197-6
   Cetinus SA, 2003, ENZYME MICROB TECH, V32, P889, DOI 10.1016/S0141-0229(03)00065-6
   Chae HJ, 1998, APPL BIOCHEM BIOTECH, V73, P195, DOI 10.1007/BF02785655
   Chung I, 2003, EUR POLYM J, V39, P1817
   Costa SA, 2002, ENZYME MICROB TECH, V30, P387, DOI 10.1016/S0141-0229(01)00505-1
   Costa SA, 2001, ENZYME MICROB TECH, V28, P815, DOI 10.1016/S0141-0229(01)00335-0
   DUNG NA, 1995, RADIAT PHYS CHEM, V46, P1037, DOI 10.1016/0969-806X(95)00316-P
   DYBKO A, 1997, SENSOR ACTUAT B-CHEM, V38, P207
   Eldin MSM, 2000, J MOL CATAL B-ENZYM, V10, P445
   Emerson D, 1996, BIOTECHNOL TECH, V10, P673
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Goth L, 2001, BLOOD CELL MOL DIS, V27, P512, DOI 10.1006/bcmd.2001.0415
   Goth L, 2001, CLIN CHIM ACTA, V311, P161, DOI 10.1016/S0009-8981(01)00609-X
   GREENWALD RA, 1990, FREE RADICAL BIO MED, V8, P201, DOI 10.1016/0891-5849(90)90092-W
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   HARTMEIR W, 1986, IMMOBILISED BIOCATAL, P206
   Johnson P, 2002, COMP BIOCHEM PHYS C, V133, P493, DOI 10.1016/S1532-0456(02)00120-5
   Jurado LA, 2003, J CHROMATOGR A, V984, P9, DOI 10.1016/S0021-9673(02)01770-3
   Koneracka M, 1999, J MAGN MAGN MATER, V201, P427, DOI 10.1016/S0304-8853(99)00005-0
   Kotze AC, 2003, INT J PARASITOL, V33, P393, DOI 10.1016/S0020-7519(03)00012-2
   Marolia KZ, 1999, J BIOCHEM BIOPH METH, V39, P115, DOI 10.1016/S0165-022X(98)00021-9
   Matsumoto M, 1997, J CHEM TECHNOL BIOT, V70, P188, DOI 10.1002/(SICI)1097-4660(199710)70:2<188::AID-JCTB745>3.0.CO;2-X
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   Oliveira P.C., 2000, BIOCH ENG J, V5, P63
   Ostrovidova GU, 2003, MAT SCI ENG C-BIO S, V23, P377, DOI 10.1016/S0928-4931(02)00307-7
   Petro M, 1996, BIOTECHNOL BIOENG, V49, P355, DOI 10.1002/(SICI)1097-0290(19960220)49:4<355::AID-BIT1>3.0.CO;2-O
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rocha JMS, 1998, J BIOTECHNOL, V66, P61, DOI 10.1016/S0168-1656(98)00157-6
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   SHULZ B, 1999, J MOL CATAL B-ENZYM, V7, P85
   SOARES CMF, 2001, APPL BIOCHEM BIOTECH, V91, P1
   SOLAS MT, 1994, J BIOTECHNOL, V33, P63, DOI 10.1016/0168-1656(94)90099-X
   SOUZA SF, 2001, PROCESS BIOCHEM, V36, P677
   Subramanian A, 1999, ENZYME MICROB TECH, V24, P26, DOI 10.1016/S0141-0229(98)00084-2
   SWAISGOOD HE, 1991, APPL BIOPROCESSING F
   Torres R, 2002, BIOTECHNOL PROGR, V18, P1221, DOI 10.1021/bp020082q
   Yang Y, 2003, NUCL INSTRUM METH B, V207, P165, DOI 10.1016/S0168-583X(03)00456-7
   Yang Z, 1996, ENZYME MICROB TECH, V18, P82, DOI 10.1016/0141-0229(95)00073-9
   Zamocky M, 2001, FEBS LETT, V492, P177, DOI 10.1016/S0014-5793(01)02237-2
   Zhao HQ, 2003, BLOOD CELL MOL DIS, V30, P90, DOI 10.1016/S1079-9796(03)00012-3
   Zhou SB, 2003, BIOMATERIALS, V24, P3563, DOI 10.1016/S0142-9612(03)00207-2
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
   Zuwei M, 2002, EUR POLYM J, V38, P2279
NR 55
TC 14
Z9 16
U1 1
U2 18
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2004
VL 15
IS 4
BP 335
EP 342
DI 10.1023/B:JMSM.0000021098.75103.3a
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 805XN
UT WOS:000220399100008
PM 15332596
DA 2018-10-20
ER

PT J
AU Heijkants, RGJC
   Van Calck, RV
   De Groot, JH
   Pennings, AJ
   Schouten, AJ
   Van Tienen, TG
   Ramrattan, N
   Buma, P
   Veth, RPH
AF Heijkants, RGJC
   Van Calck, RV
   De Groot, JH
   Pennings, AJ
   Schouten, AJ
   Van Tienen, TG
   Ramrattan, N
   Buma, P
   Veth, RPH
TI Design, synthesis and properties of a degradable polyurethane scaffold
   for meniscus regeneration
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 18th European Conference on Biomaterials
CY OCT 01-04, 2003
CL Stuttgart, GERMANY
ID BIOMEDICAL POLYURETHANE; REPAIR; ULTRASTRUCTURE; DOGS
AB Longitudinal lesions in menisci are among the most frequent orthopedic problems of the knee. Repair by simple techniques is only limited to the vascular part of the meniscus. For repair of the avascular part of the meniscus a scaffold, which will assist the body in the formation of new meniscus cell tissue, might be applicable. In this study a biomedical segmented polyurethane with poly(epsilon-caprolactone) as soft segment and 1,4-butanediisocyanate and 1,4-butanediol as uniform hard segments has been synthesised. The material has a micro phase separated morphology and excellent mechanical properties. A porous scaffold was prepared via a combination of liquid-liquid phase separation and salt leaching. The foams prepared combined a very high interconnectivity and porosity with the desired compression modulus. After six months of implantation in the knees of beagles full ingrowth with cells was obtained and it was found that meniscus like tissue had been formed in the scaffold. Moreover, compression behaviour appeared to be comparable to native meniscus tissue. (C) 2004 Kluwer Academic Publishers.
C1 Univ Groningen, Fac Math & Nat Sci, Dept Polymer Chem, NL-9747 AG Groningen, Netherlands.
   Univ Med Ctr, Orthopaed Res Lab, NL-6500 HB Nijmegen, Netherlands.
RP Schouten, AJ (reprint author), Univ Groningen, Fac Math & Nat Sci, Dept Polymer Chem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
EM A.J.Schouten@chem.rug.nl
RI Buma, Pieter/C-9828-2013; Buma, P./H-8019-2014
CR deGroot JH, 1997, POLYM BULL, V38, P211, DOI 10.1007/s002890050040
   deGroot JH, 1997, BIOMATERIALS, V18, P613, DOI 10.1016/S0142-9612(96)00169-X
   DEGROOT JH, 1990, COLLOID POLYM SCI, V268, P1071
   GHADIALLY FN, 1978, J ANAT, V125, P499
   GORIS A, 1968, ANN PHARM FR, V24, P781
   Goris R J, 1987, Free Radic Res Commun, V3, P13, DOI 10.3109/10715768709069764
   GORIS RJA, 1985, UNFALLCHIRURG, V88, P330
   KLOMPMAKER J, 1991, BIOMATERIALS, V12, P810, DOI 10.1016/0142-9612(91)90066-J
   KLOMPMAKER J, 1992, J ORTHOP RES, V10, P359, DOI 10.1002/jor.1100100308
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8
   MILES MJ, 1988, DEV CRYSTALLINE POLY, V2, P233
   Spaans CJ, 1998, J MATER SCI-MATER M, V9, P675, DOI 10.1023/A:1008922128455
   TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533
   Tienen TG, 2003, BIOMATERIALS, V24, P2541, DOI 10.1016/S0142-9612(03)00053-X
   VANTIENEN TG, 2003, IN PRESS GEN ORTHOP
   WEBBER RJ, 1985, J ORTHOPAED RES, V3, P171
NR 17
TC 75
Z9 79
U1 6
U2 34
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2004
VL 15
IS 4
BP 423
EP 427
DI 10.1023/B:JMSM.0000021114.39595.1e
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 805XN
UT WOS:000220399100023
PM 15332611
DA 2018-10-20
ER

PT J
AU Lyon, J
   Giuse, NB
   Williams, A
   Koonce, T
   Walden, R
AF Lyon, J
   Giuse, NB
   Williams, A
   Koonce, T
   Walden, R
TI A model for training the new bioinformationist
SO JOURNAL OF THE MEDICAL LIBRARY ASSOCIATION
LA English
DT Article
ID INFORMATICS CONSULT SERVICE; SCHOOL OBJECTIVES PROJECT;
   MEDICAL-LIBRARIES; HEALTH; EDUCATION; GENETICS
AB Objectives: The objectives were to examine the effectiveness of a curriculum designed to increase bioinformatics competencies of librarians with diverse backgrounds and to identify demographic factors that may affect the learning process.
   Methods: Sixteen professional staff participated in a 12-week training course consisting of 5 distinct modules: molecular biology, genetic analysis, biotechnology, research literature, and databases. Participants completed a 120-question pretest and an 88-question posttest designed to evaluate the effectiveness of the training.
   Results: Training was deemed successful as all participants scored higher on the posttest than the pretest. Data analysis was conducted in relation to participant background. Holding a biology degree did not seem to affect posttest results. Years of experience, however, had an impact on final scores in the databases section, as senior team members had greater difficulty learning the material.
   Discussion: As the need for specialized information in the area of molecular biology and genetics becomes more central for the effectiveness of organizations, it is crucial for libraries to quickly align with those needs by having a clear vision for increasing the skills and competencies of their staff in this subject area. This paper describes an effective model for learning that was developed and tested by the Eskind Biomedical Library.
C1 Vanderbilt Univ, Med Ctr, Res Informat Consult Serv, Eskind Biomed Lib, Nashville, TN 37232 USA.
   Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA.
RP Lyon, J (reprint author), Vanderbilt Univ, Med Ctr, Res Informat Consult Serv, Eskind Biomed Lib, 2009 Garland Ave, Nashville, TN 37232 USA.
EM Jennifer.Lyon@Vanderbilt.edu; Nunzia.Giuse@Vanderbilt.edu;
   Annette.Williams@Vanderbilt.edu; Taneya.Koonce@Vanderbilt.edu;
   Rachel.Walden@Vanderbilt.edu
RI Giuse, Nunzia/N-2032-2016; Lyon, Jennifer/B-6126-2011
OI Giuse, Nunzia/0000-0002-7644-9803; Lyon, Jennifer/0000-0001-9740-1270;
   Koonce, Taneya Y/0000-0002-4014-467X
CR ALPI K, 2003, ISSUES SCI TECHNOL L, P37
   Anderson MB, 1999, ACAD MED, V74, P13
   Delwiche Frances A., 2001, Medical Reference Services Quarterly, V20, P33, DOI 10.1300/J115v20n02_04
   Florance V, 2002, J MED LIBR ASSOC, V90, P49
   Friedman CP, 1999, ACAD MED, V74, P130
   Giuse N B, 1998, Bull Med Libr Assoc, V86, P412
   Giuse N B, 1999, Bull Med Libr Assoc, V87, P26
   Giuse NB, 1997, J AM MED INFORM ASSN, V4, P57, DOI 10.1136/jamia.1997.0040057
   Giuse NB, 1996, B MED LIBR ASSOC, V84, P534
   Huber JT, 1999, B MED LIBR ASSOC, V87, P74
   Jerome RN, 2001, B MED LIBR ASSOC, V89, P177
   KNOWLES M, 2003, SELF DIRECTED LEARNI
   Lynch C, 1999, B MED LIBR ASSOC, V87, P408
   LYON J, 2003, P SPEC LIB ASS 9I AN, P22
   Lyon Jennifer, 2003, Medical Reference Services Quarterly, V22, P67, DOI 10.1300/J115v22n01_07
   Owen David J., 1995, Science and Technology Libraries, V15, P3
   PROUD VK, 1989, AM J HUM GENET, V44, P597
   Stead WW, 1998, B MED LIBR ASSOC, V86, P26
   Tennant MR, 2002, J MED LIBR ASSOC, V90, P181
   Williams MD, 2001, B MED LIBR ASSOC, V89, P185
   Yarfitz S, 2000, B MED LIBR ASSOC, V88, P36
NR 21
TC 18
Z9 19
U1 0
U2 3
PU MEDICAL LIBRARY ASSOC
PI CHICAGO
PA 65 EAST WACKER PLACE, STE 1900, CHICAGO, IL 60601-7298 USA
SN 1536-5050
J9 J MED LIBR ASSOC
JI J. Med. Libr. Assoc.
PD APR
PY 2004
VL 92
IS 2
BP 188
EP 195
PG 8
WC Information Science & Library Science
SC Information Science & Library Science
GA 811NF
UT WOS:000220777900008
PM 15098047
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Van Loo, PLP
   de Weerd, HAV
   Van Zutphen, LFM
   Baumans, V
AF Van Loo, PLP
   de Weerd, HAV
   Van Zutphen, LFM
   Baumans, V
TI Preference for social contact versus environmental enrichment in male
   laboratory mice
SO LABORATORY ANIMALS
LA English
DT Article
DE aggression; enrichment; nesting material; male mice; preference; social
   contact
ID MUS-MUSCULUS L; NESTING MATERIAL; AGGRESSIVE-BEHAVIOR; HOUSING
   CONDITIONS; MOUSE; MODULATION; MOTIVATION; DECREASES; RATS
AB Due to their aggressive nature, male mice are less frequently used than female mice in biomedical research. When aggressive males are being used, individual housing is common practice. The question arises whether this is an acceptable housing for a social species. The present study was designed to gain more insight into the nature of inter-male social contact and into the potential of a form of environmental enrichment (nesting material) to compensate for the lack of social contact. In a series of tests, we analysed whether male mice of different ages preferred to spend time (1) near a familiar cage mate versus an empty cage, or (2) near to a familiar cage mate versus direct contact with nesting material (tissues). Dwelling time in each of the test cages and sleeping sites was recorded, as was the behaviour of the test mice. Results indicated that when other conditions were similar, male mice preferred to sleep in close proximity to their familiar cage mate. Furthermore, the need to engage in active social behaviour increased with age. Tissues were used to a large extent for sleeping and sleep-related behaviour. it is concluded that single housing in order to avoid aggression between male mice is a solution with evident negative consequences for the animals. When individual housing is inevitable due to excessive aggressive behaviour, the presence of nesting material could partly compensate for the deprivation of social contact.
C1 Univ Utrecht, Dept Lab Anim Sci, NL-3508 TD Utrecht, Netherlands.
   Univ Newcastle Upon Tyne, Dept Agr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   Karolinska Inst, S-17177 Stockholm, Sweden.
RP Van Loo, PLP (reprint author), Univ Utrecht, Dept Lab Anim Sci, POB 80166, NL-3508 TD Utrecht, Netherlands.
EM PL.P.vanloo@las.vet.uu.nl
CR BISAZZA A, 1981, Bollettino di Zoologia, V48, P157
   BLOM HJM, 1992, APPL ANIM BEHAV SCI, V35, P67, DOI 10.1016/0168-1591(92)90017-6
   BRAIN P, 1975, LIFE SCI, V16, P187, DOI 10.1016/0024-3205(75)90017-X
   BRAIN PF, 1990, BIOL J LINN SOC, V41, P257, DOI 10.1111/j.1095-8312.1990.tb00834.x
   CLAASSSEN V, 1994, TECHNIQUES BEHAV NEU, V12, P225
   *COMM INF DIS MIC, 1991, INF DIS MIC RATS, P195
   *COUNC EUR, 1997, RES ACC CAR LAB AN
   FRASER D, 1996, LAB ANIMAL, V25, P27
   GARTNER K, 1968, DTSCH TIERARZTLICHE, V2, P97
   HASEMAN JK, 1994, FUND APPL TOXICOL, V23, P44, DOI 10.1006/faat.1994.1077
   HATCH AM, 1965, TOXICOL APPL PHARM, V7, P737, DOI 10.1016/0041-008X(65)90132-8
   Hol T, 1999, BEHAV BRAIN RES, V100, P91, DOI 10.1016/S0166-4328(98)00116-8
   HUGHES BO, 1988, ANIM BEHAV, V36, P1696, DOI 10.1016/S0003-3472(88)80110-6
   HURST JL, 1993, ANIM BEHAV, V45, P997, DOI 10.1006/anbe.1993.1117
   Kudryavtseva NN, 2000, AGGRESSIVE BEHAV, V26, P241, DOI 10.1002/(SICI)1098-2337(2000)26:3<241::AID-AB4>3.0.CO;2-J
   Kudryavtseva NN, 2000, AGGRESSIVE BEHAV, V26, P386, DOI 10.1002/1098-2337(2000)26:5<386::AID-AB4>3.0.CO;2-#
   KUDRYAVTSEVA NN, 1994, BEHAV PROCESS, V32, P297, DOI 10.1016/0376-6357(94)90049-3
   KUDRYAVTSEVA NN, 1991, AGGRESSIVE BEHAV, V17, P285, DOI 10.1002/1098-2337(1991)17:5<285::AID-AB2480170505>3.0.CO;2-P
   *LAB AN SCI ASS, 1998, LASA TASK FORC M 12, V12
   Loo P. L. P. van, 2001, Journal of Applied Animal Welfare Science, V4, P91, DOI 10.1207/S15327604JAWS0402_1
   *MOUS GEN DAT, 2001, MOUS GEN INF WEB SIT
   PARMIGIANI S, 1989, AGGRESSIVE BEHAV, V15, P191, DOI 10.1002/1098-2337(1989)15:3<191::AID-AB2480150302>3.0.CO;2-U
   POOLE TB, 1976, ANIM BEHAV, V24, P476, DOI 10.1016/S0003-3472(76)80056-5
   POOLE TB, 1973, ANIM BEHAV, V21, P788, DOI 10.1016/S0003-3472(73)80105-8
   Rodent Refinement Working Party, 1998, LAB ANIM, V32, P233
   ROPER TJ, 1973, ANIM BEHAV, V21, P733, DOI 10.1016/S0003-3472(73)80099-5
   Sherwin CM, 1996, APPL ANIM BEHAV SCI, V48, P203, DOI 10.1016/0168-1591(96)01027-1
   Sherwin CM, 1997, LAB ANIM, V31, P125, DOI 10.1258/002367797780600134
   Van de Weerd HA, 1998, APPL ANIM BEHAV SCI, V55, P369, DOI 10.1016/S0168-1591(97)00043-9
   Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5
   Van Loo PLP, 2000, ANIM WELFARE, V9, P281
   VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152
   VANDEWEERD HA, 1994, J EXP ANIM SCI, V36, P117
   Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6
NR 34
TC 60
Z9 61
U1 3
U2 25
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0023-6772
J9 LAB ANIM-UK
JI Lab. Anim.
PD APR
PY 2004
VL 38
IS 2
BP 178
EP 188
DI 10.1258/002367704322968867
PG 11
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 816AR
UT WOS:000221083300009
PM 15070458
OA Bronze
DA 2018-10-20
ER

PT J
AU Kim, HY
   Ohmatsu, Y
   Kim, JI
   Hosoda, H
   Miyazaki, S
AF Kim, HY
   Ohmatsu, Y
   Kim, JI
   Hosoda, H
   Miyazaki, S
TI Mechanical properties and shape memory behavior of Ti-Mo-Ga alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterial; smart material;
   titanium based alloy
ID MARTENSITIC TRANSFORMATIONS
AB Mechanical properties and shape memory behavior of Ti-Mo-Ga alloys were investigated in order to develop Ni-free biomedical shape memory alloys. The Ti-Mo-Ga alloys were fabricated by arc melting method. The ingots were cold-rolled tip to 95% reduction in thickness. The cold-rolled specimens were heat treated in the temperature range 673-1273K for 60s-3.6ks. The martensitic transformation temperature decreased with increase in Mo and Ga content. The maximum shape recovery strain was obtained in a solution treated Ti-6 at%Mo-3 at%Ga alloy. Mechanical properties and shape memory behavior strongly depend on heat treatment condition in the Ti-6 at%Mo-3 at%Ga. Premature failure was observed in specimens heat treated in the temperature range 673-773 K. Ultimate tensile strength decreased and fracture strain increased with increasing heat treatment temperature. Shape memory effect was obtained in specimens heat treated in the temperature range 1073-1273 K. The shape memory effect was due to the stress induced martensitic transformation yielding tensile deformation and the reverse transformation upon heating after unloading. The martensitic transformation start temperature increased and the yield stress decreased with increasing heat treatment temperature and time. Stable superclastic behavior was obtained in a Ti-7 at%Mo-4 at%Ga alloy at room temperature by cyclic tensile tests. The recovery strain exceeding 4% was achieved in the pre-strained Ti-7 at%Mo-4 at%Ga alloy.
C1 Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
   Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678
CR Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Baker C., 1971, Metal Science Journal, V5, P92
   DAVIS R, 1979, ACTA METALL MATER, V27, P1041, DOI 10.1016/0001-6160(79)90192-5
   DAVIS R, 1979, J MATER SCI, V14, P712
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   MIYAZAKI S, 1990, ENG ASPECTS SHAPE ME, P452
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Ohmatsu Y, 2001, 4 PAC RIM INT C ADV, P1627
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
NR 16
TC 99
Z9 103
U1 0
U2 25
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1090
EP 1095
DI 10.2320/matertrans.45.1090
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900021
OA Bronze
DA 2018-10-20
ER

PT J
AU He, G
   Hagiwara, M
AF He, G
   Hagiwara, M
TI Ti-Cu-M(Fe,Cr,Co)-Sn-Ta(Nb) alloys with potential for biomedical
   applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium alloy; nanostructure; mechanical properties; biomaterials;
   microstructure
ID NANOSTRUCTURE-DENDRITE COMPOSITE; ENHANCED PLASTICITY; MATERIALS SCIENCE
AB A group of multicomponent Ti-Cu-Ni(Cr, Fe, Co)-Sn-Ta(Nb) alloys were investigated in terms of the microstructure and the mechanical properties. A composite microstructure with a micrometer-sized dendritic bcc-beta-Ti(RM) (RM = Nb, Ta) phase dispersed in a matrix was obtained. The TEM observation on the Ti60Cu14Ni12Sn4Ta10 alloy shows that the matrix is composed of a nano/ultrafine bcc-phase with the size of 50-100 nm which is isolated by a tetragonal-phase. The designed Ti alloy exhibit very high yield strength (1050-1472 MPa) and relative lower Young's modulus (67-105 GPa). Such combined properties, not easily achievable in previous Ti alloys, make these new designed Ti alloys promising candidates as biomedical materials.
C1 Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RP He, G (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
CR Eckert J, 2003, MATER TRANS, V44, P1999, DOI 10.2320/matertrans.44.1999
   GLEITER H, 1992, ADV MATER, V4, P474, DOI 10.1002/adma.19920040704
   GRIMME P, 1992, METALLURGY, V46, P365
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   He G, 2003, ACTA MATER, V51, P5223, DOI [10.1016/S1359-6454(03)00386-0, 10.1016/s1359-6454(03000386-0]
   He G, 2002, J MATER RES, V17, P3015, DOI 10.1557/JMR.2002.0439
   He G, 2003, NAT MATER, V2, P33, DOI 10.1038/nmat792
   INOUE A, 1995, MATER T JIM, V36, P866, DOI 10.2320/matertrans1989.36.866
   Lee BH, 2003, BIOMATERIALS, V24, P2257, DOI 10.1016/S0142-9612(03)00034-6
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MASSALSKI TB, 1992, BINARY ALLOY PHASE D, P1485
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   PETCH NJ, 1953, J IRON STEEL I, V174, P25
   Valiev R, 2002, NATURE, V419, P887, DOI 10.1038/419887a
NR 17
TC 8
Z9 8
U1 0
U2 3
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1120
EP 1123
DI 10.2320/matertrans.45.1120
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900026
OA Bronze
DA 2018-10-20
ER

PT J
AU Bram, M
   Laptev, A
   Buchkremer, HP
   Stover, D
AF Bram, M
   Laptev, A
   Buchkremer, HP
   Stover, D
TI Near-net-shape manufacturing of highly porous titanium parts for
   biomedical applications
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
DE titanium; porous; implant; green machining; near-net-shape
ID STAINLESS-STEEL
AB The production of highly porous titanium parts is attractive for biomedical applications. Preferrentially, these parts are produced by powdermetallurgical means using suitable spacer materials. Porosities up to 75 % and well defined pore sizes in the range of 0.1 to 2.0 mm. are achieved adjusting the amount and the particle size of the spacer material. Up to now, near-net-shape manufacturing of highly porous parts was hindered by the plastic deformation of the sintered network during machining leading to a partial or complete closing of the open porosity. A new manufacturing route is presented, where the shaping is already done in the unsintered state starting from pressed compacts. The stability of the compacts was found to be sufficient to machine the compacts without additional binders. The manufacturing route was successfully applied to the prototype of an acetabular cup. Additionally, some investigations are presented characterizing the highly porous titanium.
C1 Forschungszentrum Julich GmbH, Inst Werkstoffe & Verfahren Energietech 1, D-52425 Julich, Germany.
RP Bram, M (reprint author), Forschungszentrum Julich GmbH, Inst Werkstoffe & Verfahren Energietech 1, Postfach 1913, D-52425 Julich, Germany.
EM m.bram@fz-juelich.de
OI Laptev, Alexander/0000-0001-9077-5747; Bram, Martin/0000-0002-1203-2777
CR [Anonymous], 1999, 58322 ISO
   ASHMAN A, 1977, J PROSTHET DENT, V37, P657, DOI 10.1016/0022-3913(77)90216-5
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Bram M, 2000, MATERIALWISS WERKST, V31, P497, DOI 10.1002/1521-4052(200006)31:6<497::AID-MAWE497>3.3.CO;2-O
   BRAM M, 2001, CELLULAR METALS MATA, P215
   BREME J, 1996, TITAN TITANLEGIERUNG, P205
   KAMPMANN C, 2003, ADV ENG MATER, V5, P441
   LI JP, 2003, P BIOCERAMICS 15 KEY, V240, P547
   TENCER E, 1994, BIOMECHANICS ORTHOPE, P31
   WEN CE, 2002, J MATER SCI-MATER M, V13, P412
NR 10
TC 5
Z9 5
U1 1
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD APR
PY 2004
VL 35
IS 4
BP 213
EP 218
DI 10.1002/mawe.200400731
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 815AQ
UT WOS:000221015600008
DA 2018-10-20
ER

PT J
AU Tadic, D
   Beckmann, F
   Donath, T
   Epple, M
AF Tadic, D
   Beckmann, F
   Donath, T
   Epple, M
TI Comparison of different methods for the preparation of porous bone
   substitution materials and structural investigations by synchrotron
   mu-computer tomography
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
DE bone substitution materials; microtomography; synchrotron radiation;
   calcium phosphate
ID MICROTOMOGRAPHY; IMPLANTS; BIOMATERIALS; RADIATION; PHOSPHATE; INGROWTH
AB The preparation of porous biomaterials for bone substitution is an important clinical issue in current biomedical technology because the ingrowth of bone can only occur if a suitable number of sufficiently large pores is available. Different procedures are compared here: The combined chemical-thermal treatment of bovine and human cancellous bone, the calcination of bovine cancellous bone, mechanical hole-drilling, and the extraction of porogens (in this case: salt crystals). The inner structure and the porosity of all samples were studied using high-resolution synchrotron mu-computer tomography.
C1 Univ Duisberg Essen, Inst Inorgan Chem, D-45117 Essen, Germany.
   GKSS Forschungszentrum Geesthacht GmbH, Mat Res Inst, D-21494 Geesthacht, Germany.
RP Epple, M (reprint author), Univ Duisberg Essen, Inst Inorgan Chem, D-45117 Essen, Germany.
EM matthias.epple@uni-essen.de
RI Beckmann, Felix/E-1940-2016
OI Beckmann, Felix/0000-0002-2266-9173
CR Beckmann F, 1999, P SOC PHOTO-OPT INS, V3772, P179, DOI 10.1117/12.363719
   BOHNER M, 2001, EUR SPINE J, V10, P114
   Bonse U, 1996, PROG BIOPHYS MOL BIO, V65, P133, DOI 10.1016/S0079-6107(96)00011-9
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Fajardo RJ, 2002, AM J PHYS ANTHROPOL, V118, P1, DOI 10.1002/ajpa.10086
   Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O
   Schnettler R, 2003, BIOMATERIALS, V24, P4603, DOI 10.1016/S0142-9612(03)00354-5
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   Tadic D, 2003, BIOMATERIALS, V24, P4565, DOI 10.1016/S0142-9612(03)00281-3
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   TADIC D, 2004, BIOMATERIALS, V24, P987
   Trentz OA, 2003, BIOMATERIALS, V24, P3417, DOI 10.1016/S0142-9612(03)00205-9
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
NR 18
TC 26
Z9 26
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD APR
PY 2004
VL 35
IS 4
BP 240
EP 244
DI 10.1002/mawe.200400730
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 815AQ
UT WOS:000221015600013
DA 2018-10-20
ER

PT J
AU Mirtaheri, P
   Grimnes, S
   Martinsen, OG
   Tonnessen, TI
AF Mirtaheri, P
   Grimnes, S
   Martinsen, OG
   Tonnessen, TI
TI A new biomedical sensor for measuring PCO2
SO PHYSIOLOGICAL MEASUREMENT
LA English
DT Article
DE biomedical sensor; ischemia; PCO2; gas measuring; conductivity
ID BIOLOGICAL-MATERIALS; ELECTRODES; ISCHEMIA; IMPEDANCE; CONDUCTIVITY;
   SURFACE
AB Measuring PCO2 (partial pressure of carbon dioxide) in an organ can enable early detection of ischemia. However, there are few clinical applicable solutions for measuring PCO2. Based upon the requirement for clinical applications, a conductivity based PCO2 sensor is proposed. A conductivity based PCO2 sensor measures conductance in an aqueous solution separated from the measured object by a gas-permeable membrane. A bridge design with two cavities is favored for such a sensor. A planar and a cylindrical macro prototype based upon the bridge design were studied. The design criteria were based on the contribution from the electrode polarization, stray capacitances, contact area with the sample and design ability to miniaturize the sensor. The cylindrical sensor is favored because of its large contact area and advantages for miniaturization. Further investigation has to be done to confirm the functionality of such a design in a miniaturized form and its clinical performance.
C1 Rikshosp Univ Hosp, Intervent Ctr, Oslo, Norway.
   Univ Oslo, Dept Phys, N-0316 Oslo, Norway.
   Rikshosp Univ Hosp, Dept Anesthesiol, Oslo, Norway.
   Rikshosp Univ Hosp, Dept Clin & Biomed Engn, Oslo, Norway.
RP Mirtaheri, P (reprint author), Rikshosp Univ Hosp, Intervent Ctr, Oslo, Norway.
RI Martinsen, Orjan/M-4459-2014
OI Martinsen, Orjan/0000-0003-1632-4352
CR Arquint P., 1994, INTEGRATED BLOOD GAS
   Baker JM, 1996, AGRON J, V88, P675, DOI 10.2134/agronj1996.00021962008800040029x
   BLACK J, 1999, BIOL PERFORMANCE MAT, P10
   Butler J., 1982, CARBON DIOXIDE EQUIL
   Cunningham R. E., 1980, DIFFUSION GASES PORO
   DETEMPLE P, 1998, MED DEVICE TECHNOL, V11, P18
   FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25
   GEDDES LA, 1971, MED BIOL ENG, V9, P511, DOI 10.1007/BF02474708
   Goldberg W., 1997, DESIGN SOLUTIONS USI
   Grimnes S, 2000, BIOIMPEDANCE BIOELEC
   Hoffman WE, 1999, SURG NEUROL, V51, P654, DOI 10.1016/S0090-3019(99)00011-7
   HONG XJ, 1996, BLOOD GAS NEWS, V5, P3
   JACOBS P, 1995, MED BIOL ENG COMPUT, V33, P802, DOI 10.1007/BF02523012
   KEMPEN LHJ, 1975, RESPIR PHYSL, V24, P89
   KORYTA J, 1993, PRINCIPLES ELECTROCH, P29
   Kvarstein G, 2004, CRIT CARE MED, V32, P232, DOI 10.1097/01.CCM.0000104948.41544.FC
   LIS K, 1979, PFLUG ARCH EUR J PHY, V381, P289, DOI 10.1007/BF00583262
   Niggemann M, 1999, MICROSYST TECHNOL, V6, P48, DOI 10.1007/s005420050174
   NUNN JF, 1993, NUNNS APPL RESP PHYS
   ONARAL B, 1982, MED BIOL ENG COMPUT, V20, P299, DOI 10.1007/BF02442796
   RAGHEB T, 1990, MED BIOL ENG COMPUT, V28, P182, DOI 10.1007/BF02441775
   Rolfe P, 1995, Acta Anaesthesiol Scand Suppl, V104, P61
   SCHWAN HP, 1968, REV SCI INSTRUM, V39, P481, DOI 10.1063/1.1683413
   SCHWAN HP, 1968, ANN NY ACAD SCI, V148, P191, DOI 10.1111/j.1749-6632.1968.tb20349.x
   SEVERINGHAUS JW, 1958, J APPL PHYSIOL, V13, P515
   SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P7, DOI 10.1111/j.1399-6576.1995.tb04250.x
   STOW RW, 1957, ARCH PHYS MED REHAB, V7, P646
   Tonnessen TI, 1996, ACTA ANAESTH SCAND, V40, P510, DOI 10.1111/j.1399-6576.1996.tb04481.x
   Tonnessen TI, 1997, ACTA ANAESTH SCAND, V41, P659
   VARLAN AR, 1997, SENSOR ACTUAT B-CHEM, V55, P309
NR 30
TC 12
Z9 12
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0967-3334
EI 1361-6579
J9 PHYSIOL MEAS
JI Physiol. Meas.
PD APR
PY 2004
VL 25
IS 2
BP 421
EP 436
AR PII S0967-3334(04)70867-9
DI 10.1088/0967-3334/25/2/002
PG 16
WC Biophysics; Engineering, Biomedical; Physiology
SC Biophysics; Engineering; Physiology
GA 815XM
UT WOS:000221075000004
PM 15132308
DA 2018-10-20
ER

PT J
AU Choi, HM
   Bide, M
   Phaneuf, M
   Quist, W
   Logerfo, F
AF Choi, HM
   Bide, M
   Phaneuf, M
   Quist, W
   Logerfo, F
TI Antibiotic treatment of silk to produce novel infection-resistant
   biomaterials
SO TEXTILE RESEARCH JOURNAL
LA English
DT Article
ID BOMBYX-MORI SILK; FIBROIN; TRANSITION; DACRON
AB Dye-like applications of antibiotics to silk produce infection-resistant materials for potential use in biomedical applications. Two antibiotics, doxycycline (doxy) and ciprofloxacin (cipro), are applied under a variety of conditions to silk and to silk that has previously been hydrolyzed at 40degreesC for 20, 40, and 60 minutes. FTIR spectroscopic analyses indicate that the drastically increased sorption of antibiotics by hydrolyzed silk is attributable to both chemical and conformational changes that occur with the hydrolysis. The high sorption of doxy by hydrolyzed silk does not necessarily yield a more infection-resistant material, as determined by a zone of inhibition test. Conversely, the same hydrolysis considerably increases both the sorption of cipro and the zone of inhibition of cipro-treated silk dyed at 65 and 85degreesC.
C1 Soongsil Univ, Sch Text, Seoul, South Korea.
   Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
   Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
RP Choi, HM (reprint author), Soongsil Univ, Sch Text, Seoul, South Korea.
EM hchoi@ssu.ac.kr
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ASAI M, 1955, J PHYS CHEM-US, V59, P322, DOI 10.1021/j150526a011
   Benavides S, 2002, ANN PHARMACOTHER, V36, P334
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   BIDE M, 2002, AATCC INT C EXH CHAR
   BIDE M, 2001, ACS SYM SER, V792, P125
   BOCKER R, 1980, J CHROMATOGR, V187, P439, DOI 10.1016/S0021-9673(00)80479-3
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Erra P, 1997, TEXT RES J, V67, P397, DOI 10.1177/004051759706700602
   Fawaz F, 1997, INT J PHARM, V154, P191, DOI 10.1016/S0378-5173(97)00138-5
   FOX CL, 1986, Patent No. 4563485
   GLASBY JS, 1992, ENCY ANTIBIOTICS, P243
   GRECO RS, 1985, ARCH SURG-CHICAGO, V120, P71
   Gu JW, 2002, MAT SCI ENG C-BIO S, V20, P199, DOI 10.1016/S0928-4931(02)00033-4
   HARVEY RA, 1984, AM J SURG, V147, P205, DOI 10.1016/0002-9610(84)90089-8
   HARVEY RA, 1982, SURGERY, V92, P504
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   MAGOSHI J, 1977, J APPL POLYM SCI, V21, P2405, DOI 10.1002/app.1977.070210909
   PETERS RH, 1963, TEXTILE CHEM, V1, P302
   Robson RM, 1999, INT J BIOL MACROMOL, V24, P145, DOI 10.1016/S0141-8130(98)00081-6
   Torniainen K, 1996, INT J PHARM, V132, P53, DOI 10.1016/0378-5173(95)04332-2
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Yuan CQ, 2001, AATCC REV, V1, P35
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 26
TC 11
Z9 11
U1 0
U2 1
PU TEXTILE RESEARCH INST
PI PRINCETON
PA PO BOX 625, PRINCETON, NJ 08540 USA
SN 0040-5175
J9 TEXT RES J
JI Text. Res. J.
PD APR
PY 2004
VL 74
IS 4
BP 333
EP 342
DI 10.1177/004051750407400409
PG 10
WC Materials Science, Textiles
SC Materials Science
GA 810WH
UT WOS:000220733900009
DA 2018-10-20
ER

PT J
AU Loir, AS
   Garrelie, F
   Donnet, C
   Belin, M
   Forest, B
   Rogemond, F
   Laporte, P
AF Loir, AS
   Garrelie, F
   Donnet, C
   Belin, M
   Forest, B
   Rogemond, F
   Laporte, P
TI Deposition of tetrahedral diamond-like carbon thin films by femtosecond
   laser ablation for applications of hip joints
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT EMRS 2003 Spring Conference
CY JUN 10-11, 2003
CL Strasbourg, FRANCE
DE diamond-like carbon (DLC); pulsed laser deposition (PLD); 316L stainless
   steel; Hip joints
ID AMORPHOUS-CARBON; NANOCRYSTALLINE DIAMOND; MECHANICAL-PROPERTIES;
   COATINGS; ADHESION
AB Tetrahedral diamond-like carbon films (ta-C) were deposited by femtosecond pulsed laser deposition (PLD) on various substrates, including 316L stainless steel and ultra high molecular weight polyethylene, in perspective to extend the wear resistance of materials used in hip joints. Usually films are deposited by plasma enhanced chemical vapor deposition or by PLD, principally performed with laser pulse duration in the nanosecond range. In the present study, DLC films were deposited by femtosecond laser ablation in high vacuum conditions at room temperature. The 800 nm, 150 fs laser pulses are generated by a mode-locked Ti:Sapphire laser, including an amplification stage. The fluence ranges from 1 to 6 J/cm(2). Sputter cleaning of the substrates in an argon atmosphere prior carbon deposition was widely investigated; the adhesion of the films onto the stainless steel substrates was then considerably enhanced by removing the contamination and oxidized top-coats. The adhesion properties of films deposited in various conditions on 316L stainless steel substrates were studied by tensile tests. The films exhibit high wear resistance (in the 10(-8) mm(3) N-1 m(-1) range) with moderate hardness (in the 20-30 GPa range), which may be favorable for the accommodation motion between contacting surfaces in a hip joint. The capacity of these films to satisfy the biomedical demand is discussed. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ St Etienne, CNRS, UMR 5516, Lab Traitement Signal & Instrumentat, F-42000 St Etienne, France.
   Ecole Cent Lyon, CNRS, UMR 5513, Lab Tirbol & Dynam Syst, F-69134 Ecully, France.
   Ecole Natl Super Mines, Dept Mecan Phys & Interfaces, CNRS, URA 84,Ctr Sci Mat & Struct, F-42023 St Etienne, France.
RP Loir, AS (reprint author), Univ St Etienne, CNRS, UMR 5516, Lab Traitement Signal & Instrumentat, 10 Rue Barrouis,Batiment F, F-42000 St Etienne, France.
EM anne.sophie.loir@univ-st-etienne.fr
RI LOIR, Anne-Sophie/J-4041-2012
OI LOIR, Anne-Sophie/0000-0001-9169-1545
CR Bonelli M, 2000, EUROPHYS LETT, V50, P501, DOI 10.1209/epl/i2000-00297-5
   Bulir J, 1997, THIN SOLID FILMS, V292, P318, DOI 10.1016/S0040-6090(96)08951-1
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Garrelie F, 2003, SURF COAT TECH, V163, P306, DOI 10.1016/S0257-8972(02)00481-4
   Garrelie F, 2002, PROC SPIE, V4760, P301, DOI 10.1117/12.482098
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Hou QR, 1999, APPL PHYS A-MATER, V68, P343, DOI 10.1007/s003390050900
   Loir AS, 2003, APPL SURF SCI, V208, P553, DOI 10.1016/S0169-4332(02)01380-6
   Matsuyama N, 2001, J APPL PHYS, V89, P1938, DOI 10.1063/1.1334640
   Morshed MM, 2003, SURF COAT TECH, V174, P579, DOI 10.1016/S0257-8972(03)00701-1
   Morshed MM, 2003, SURF COAT TECH, V163, P541, DOI 10.1016/S0257-8972(02)00619-9
   NEMANICH RJ, 1988, J VAC SCI TECHNOL A, V6, P1783, DOI 10.1116/1.575297
   PAPPAS DL, 1992, J APPL PHYS, V71, P5675, DOI 10.1063/1.350501
   Podgornik B, 2001, DIAM RELAT MATER, V10, P2232, DOI 10.1016/S0925-9635(01)00514-3
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Schwan J, 1996, J APPL PHYS, V79, P1416, DOI 10.1063/1.360979
   Sharda T, 2001, DIAM RELAT MATER, V10, P1592, DOI 10.1016/S0925-9635(01)00415-0
   Sharma AK, 2000, MAT SCI ENG B-SOLID, V77, P139, DOI 10.1016/S0921-5107(00)00434-7
   SHI X, 1997, PHILOS MAG B, V76, P351
   Shim KS, 2000, APPL SURF SCI, V154, P482, DOI 10.1016/S0169-4332(99)00401-8
   STAMBOULI V, 1990, SURF COAT TECH, V43-4, P137, DOI 10.1016/0257-8972(90)90068-N
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Tsui YY, 2000, SURF COAT TECH, V126, P96, DOI 10.1016/S0257-8972(99)00642-8
   Voevodin AA, 1996, SURF COAT TECH, V82, P199, DOI 10.1016/0257-8972(95)02734-3
   Wei Q, 2001, SURF COAT TECH, V146, P250, DOI 10.1016/S0257-8972(01)01394-9
NR 25
TC 22
Z9 24
U1 0
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD APR 1
PY 2004
VL 453
SI SI
BP 531
EP 536
DI 10.1016/j.tsf.2003.11.135
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 807ON
UT WOS:000220510900101
DA 2018-10-20
ER

PT J
AU Lewin, PA
AF Lewin, PA
TI Quo vadis medical ultrasound?
SO ULTRASONICS
LA English
DT Article; Proceedings Paper
CT Ultrasonics International 2003 Meetng
CY JUN 30-JUL 03, 2003
CL Granada, SPAIN
DE ultrasound imaging; diagnostic and therapeutic ultrasound; biomedical
   ultrasonics; ultrasound imaging transducers
ID FOCUSED ULTRASOUND; RADIATION FORCE; FLOW; ELASTOGRAPHY
AB The last three decades of development in diagnostic ultrasound imaging and technology are briefly reviewed and the impact of the crucial link between the two apparently independent research efforts, which eventually facilitated implementation of harmonic imaging modality is explored. These two efforts included the experiments with piezoelectric PVDF polymer material and studies of the interaction between ultrasound energy and biological tissue. Harmonic imaging and its subsequent improvements revolutionized the diagnostic power of clinical ultrasound and brought along images of unparalleled resolution, close to that of magnetic resonance imaging (MRI) quality. The nonlinear propagation effects and their implications for both diagnostic and therapeutic applications of ultrasound are also briefly addressed. In diagnostic applications, the impact of these effects on image resolution and tissue characterization is reviewed; in therapeutic applications, the influence of nonlinear propagation effects on highly localized tissue ablation and cauterization is examined. Next, the most likely developments and future trends in clinical ultrasound technology, including 3D and 4D imaging, distant palpation, image enhancement using contrast agents, monitoring, and merger of diagnostic and therapeutic applications by e.g. introducing ultrasonically controlled targeted drug delivery are reviewed. Finally, a possible competition from other imaging modalities is discussed. (C) 2004 Elsevier B.V. All rights reserved.
C1 Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, Philadelphia, PA 19104 USA.
   Drexel Univ, Sch Biomed Engn, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA.
RP Lewin, PA (reprint author), Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, 3141 Chestnut St,MS Biomed 7-727, Philadelphia, PA 19104 USA.
EM lewin@ece.drexel.edu
CR Bao SP, 1998, CANCER RES, V58, P219
   Behar V, 2003, ULTRASONICS, V41, P377, DOI [10.1016/S0041-624X(03)00105-7, 10.1016/S0041-642X(03)00105-7]
   Behar V, 2003, ULTRASONICS, V41, P385, DOI 10.1016/S0041-642X(03)00106-9
   BIBIBRA H, 1999, ECHOCARDIOGR-J CARD, V16, P733
   Cherin E, 1998, ULTRASOUND MED BIOL, V24, P341, DOI 10.1016/S0301-5629(97)00289-5
   ENTREKIN R, 1999, MEDICA MUNDI, V43
   Fatemi M, 1999, ULTRASONIC IMAGING, V21, P147, DOI 10.1177/016173469902100205
   Fenster A, 1996, IEEE ENG MED BIOL, V15, P41, DOI 10.1109/51.544511
   Fleischer AC, 2000, J ULTRAS MED, V19, P55, DOI 10.7863/jum.2000.19.1.55
   Forsberg F, 2000, ULTRASONICS, V38, P110, DOI 10.1016/S0041-624X(99)00149-3
   FORSBERG F, 1996, ULTRASONOGRAPHY
   Foster FS, 2000, IEEE T ULTRASON FERR, V47, P1363, DOI 10.1109/58.883525
   FOWLES JB, 2000, CATEGORICAL COURSE D
   Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3
   Haider B, 1998, IEEE T ULTRASON FERR, V45, P98, DOI 10.1109/58.646915
   Jensen JA, 1998, IEEE T ULTRASON FERR, V45, P837, DOI 10.1109/58.677749
   Jin XC, 2001, IEEE T ULTRASON FERR, V48, P750, DOI 10.1109/58.920706
   Jordan WD, 1999, CARDIOVASC SURG, V7, P33, DOI 10.1016/S0967-2109(98)00097-0
   Knapik DA, 2000, IEEE T ULTRASON FERR, V47, P1540, DOI 10.1109/58.883543
   Konofagou E, 2001, PHYS MED BIOL, V46, P2967, DOI 10.1088/0031-9155/46/11/314
   Kruse D, 2000, ULTRASOUND MED BIOL, V26, pS16, DOI 10.1016/S0301-5629(00)00154-X
   Nelson TR, 1998, ULTRASOUND MED BIOL, V24, P1243, DOI 10.1016/S0301-5629(98)00043-X
   Nightingale KR, 2001, J ACOUST SOC AM, V110, P625, DOI 10.1121/1.1378344
   ODONNELL M, 1992, IEEE T ULTRASON FERR, V39, P341, DOI 10.1109/58.143168
   Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933
   Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0
   Silverman RH, 2001, J ULTRAS MED, V20, P979
   ter Haar G, 2000, ULTRASOUND MED BIOL, V26, pS51, DOI 10.1016/S0301-5629(00)00164-2
   Varghese T, 1998, IEEE T ULTRASON FERR, V45, P65, DOI 10.1109/58.646912
   VILKOMMERSON DL, 1999, IEEE ULTRASONICS S E, V1459, P1464
   Wei K, 2001, J AM COLL CARDIOL, V37, P1135, DOI 10.1016/S0735-1097(00)01210-9
   NEWS MAGAZINES MEDIC
   NEWS MAGAZINES
   2000, ULTRASOUND MED BIOL, V26, pS1
NR 34
TC 21
Z9 22
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0041-624X
J9 ULTRASONICS
JI Ultrasonics
PD APR
PY 2004
VL 42
IS 1-9
BP 1
EP 7
DI 10.1016/j.ultras.2004.01.077
PG 7
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA 812DP
UT WOS:000220820500002
PM 15047254
DA 2018-10-20
ER

PT J
AU van Nostrum, CF
   Veldhuis, TFJ
   Bos, GW
   Hennink, WE
AF van Nostrum, CF
   Veldhuis, TFJ
   Bos, GW
   Hennink, WE
TI Tuning the degradation rate of poly(2-hydroxypropyl
   methacrylamide)-graft-oligo(lactic acid) stereocomplex hydrogels
SO MACROMOLECULES
LA English
DT Article
ID GRAFT-COPOLYMERS; BIOMEDICAL APPLICATIONS; RADICAL POLYMERIZATION;
   TRIBLOCK-COPOLYMERS; STEREO-COMPLEXATION; STRUCTURAL CONTROL; DEXTRAN
   HYDROGELS; POLY(L-LACTIDE); OLIGOMERS; DESIGN
AB The degradation time of stereocomplex hydrogels based on poly(2-hydroxypropyl methacrylamide) (pHPMAm) with oligo(lactic acid) side chains of opposite chirality can be tailored from approximately 1 week to almost 3 months under physiological conditions by adjusting the grafting density and the side chain terminus. The polymers were prepared by free radical copolymerization of HPDAAmoligo(lactic acid) macromonomers and HPMAm. The viscoelasticity and degradation time of hydrogels formed by mixing aqueous solutions of two polymers containing side chains of opposite chirality increased with increasing grafting density. Gels based on polymers with side chains having acetyl chain ends degraded slower than those containing hydroxyl-terminating side chains, because of a change in the hydrolysis mechanism from slow random chain scission to more rapid chain end scission (backbiting), respectively. The ease of preparation and the possibility of tuning the degradation rate over a wide range make these pHPMAm-based hydrogels ideal materials for the controlled release of, e.g., therapeutic proteins.
C1 Univ Utrecht, Dept Pharmaceut, Utreat Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands.
RP van Nostrum, CF (reprint author), Univ Utrecht, Dept Pharmaceut, Utreat Inst Pharmaceut Sci, POB 80082, NL-3508 TB Utrecht, Netherlands.
EM C.F.vanNostrum@pharm.uu.nl
RI van Nostrum, Cornelus/I-9445-2016
CR de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   de Jong SJ, 2002, J APPL POLYM SCI, V86, P289, DOI 10.1002/app.10954
   de Jong SJ, 2001, POLYMER, V42, P2795, DOI 10.1016/S0032-3861(00)00646-7
   de Jong SJ, 2001, J CONTROL RELEASE, V71, P261, DOI 10.1016/S0168-3659(01)00228-0
   de Jong SJ, 1998, MACROMOLECULES, V31, P6397, DOI 10.1021/ma980553i
   Eguiburu JL, 1996, POLYMER, V37, P3615, DOI 10.1016/0032-3861(96)00184-X
   Fujiwara T, 2001, MACROMOL BIOSCI, V1, P204, DOI 10.1002/1616-5195(20010701)1:5<204::AID-MABI204>3.3.CO;2-8
   Grijpma DW, 2001, J CONTROL RELEASE, V72, P247
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034
   Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lim DW, 2000, J APPL POLYM SCI, V75, P1615, DOI 10.1002/(SICI)1097-4628(20000328)75:13<1615::AID-APP7>3.0.CO;2-L
   Lim DW, 2000, MACROMOL RAPID COMM, V21, P464, DOI 10.1002/(SICI)1521-3927(20000501)21:8<464::AID-MARC464>3.0.CO;2-#
   Neradovic D, 2001, MACROMOLECULES, V34, P7589, DOI 10.1021/ma011198q
   OKIHARA T, 1991, J MACROMOL SCI PHYS, VB30, P119, DOI 10.1080/00222349108245788
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Shinoda H, 2001, MACROMOLECULES, V34, P6243, DOI 10.1021/ma0105791
   Shinoda H, 2001, MACROMOLECULES, V34, P3186, DOI 10.1021/ma001943j
   Slager J, 2003, ADV DRUG DELIVER REV, V55, P549, DOI 10.1016/S0169-409X(03)00042-5
   VANNOSTRUM CF, UNPUB
   VANNOSTRUM CF, 2003, ACS S SERIES, V846
NR 23
TC 19
Z9 19
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD MAR 23
PY 2004
VL 37
IS 6
BP 2113
EP 2118
DI 10.1021/ma035534+
PG 6
WC Polymer Science
SC Polymer Science
GA 804GY
UT WOS:000220288400019
DA 2018-10-20
ER

PT J
AU van der Walt, TN
   Vermeulen, C
AF van der Walt, TN
   Vermeulen, C
TI Thick targets for the production of some radionuclides and the chemical
   processing of these targets at iThemba LABS
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 21st World Conference of the
   International-Nuclear-Target-Development-Society
CY NOV 04-08, 2002
CL Argonne, IL
SP Int Nuclear Target Dev Soc
DE cyclotron; radionuclides; ion exchange chromatography; PET;
   radiopharmaceuticals
AB iThemba Laboratory for Accelerated Based Sciences is a multi-disciplinary research centre, operated by the National Research Foundation. It provides national accelerator and ancillary facilities for research and training in physical, biomedical, chemical and material sciences, research in, and the treatment of, cancer with energetic neutrons and protons. Radionuclides are produced for use in research and industry, and to prepare various radiopharmaceuticals for diagnostic imaging at nuclear medicine centers. (C) 2004 Elsevier B.V. All rights reserved.
C1 IThemba LABS, ZA-71290 Somerset W, South Africa.
RP van der Walt, TN (reprint author), IThemba LABS, POB 722, ZA-71290 Somerset W, South Africa.
EM nico@tlabs.ac.za; etienne@tlabs.ac.za
RI Vermeulen, Christiaan/C-5059-2013
OI Vermeulen, Christiaan/0000-0002-6723-8983
CR du Raan H, 2000, MED PHYS, V27, P1523, DOI 10.1118/1.599018
   Fassbender M, 1999, RADIOCHIM ACTA, V87, P87
   HAASBROEK FJ, 1991, SYNTHESIS APPL ISOTO
   Kastleiner S, 2002, APPL RADIAT ISOTOPES, V56, P685, DOI 10.1016/S0969-8043(01)00267-6
   NAIDOO C, 2002, J RADIOANAL CHEM, V2, P221
   NAIDOO C, 2001, APPL RADIAT ISOTOPES, P1
   NORTIER FM, 1991, SYNTHESIS APPL ISOTO
   Phillips DR, 2000, RADIOCHIM ACTA, V88, P149, DOI 10.1524/ract.2000.88.3-4.149
   STEYN GF, 1992, NUCL INSTRUM METH A, V316, P128, DOI 10.1016/0168-9002(92)90894-A
   VANDERWALT TN, 1994, SYNTHESIS APPL ISOTO
NR 10
TC 8
Z9 8
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD MAR 21
PY 2004
VL 521
IS 1
BP 171
EP 175
DI 10.1016/j.nima.2003.11.410
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 808UG
UT WOS:000220593400022
DA 2018-10-20
ER

PT J
AU Tanaka, M
   Mochizuki, A
AF Tanaka, M
   Mochizuki, A
TI Effect of water structure on blood compatibility - thermal analysis of
   water in poly(meth)acrylate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE blood compatible materials; poly(2-methoxyethyl acrylate); water
   structure; freezing bound water; cold crystallization
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; CARDIOPULMONARY BYPASS;
   POLY(2-METHOXYETHYLACRYLATE) PMEA; BIOMEDICAL APPLICATIONS; IR
   SPECTROSCOPY; POLYMER; SURFACE; RESISTANCE; SOLVATION
AB The purpose of this study is to clarify the main factor causing excellent blood compatibility of poly(2-methoxyethyl acrylate)(PMEA) by the comparison between PMEA and seven PMEA analogous polymers. The polymers have a typical functional group as ester side chains such as methoxyethyl, hydroxyethyl, phenoxyethyl, and alkyl groups. The properties of the polymers relating to water were investigated in terms of contact angle, equilibrium water content (EWC), and thermal analysis by differential scanning calorimetry. The water in PMEA could be classified into three types: nonfreezing water, freezing bound water, and free water while the water in the analogous polymers was classified into just two types: free and nonfreezing waters, regardless of the chemical structure of the side chain. The surface property represented by the contact angle of water corresponded to the content of the bound water (nonfreezing water + freezing bound water). The platelet compatibility in vitro did not depend on the contents of these waters, or on the contact angle. On the basis of the results of this work and the previous work on the platelet compatibility of poly(MEA-co-HEMA) (Tanaka et al. Biomacromolecules 2002;3;36-41), the main factor causing the excellent compatibility of PMEA is discussed. (C) 2004 Wiley Periodicals, Inc.
C1 Hokkaido Univ, Res Inst Elect Sci, Mol Device Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan.
   JST, PRESTO, Sapporo, Hokkaido 0600812, Japan.
   Terumo Co Ltd, Kofu Factory, Yamanashi 4093853, Japan.
RP Tanaka, M (reprint author), Hokkaido Univ, Res Inst Elect Sci, Mol Device Lab, Kita Ku, N12W6, Sapporo, Hokkaido 0600812, Japan.
EM tanaka@poly.es.hokudai.ac.jp
OI Mochizuki, Akira/0000-0001-8104-7764; Tanaka, Masaru/0000-0002-1115-2080
CR ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   Anzai T., 2000, JPN J ARTIF ORGANS, V29, P73
   Bajpai AK, 2002, J BIOMAT SCI-POLYM E, V13, P237, DOI 10.1163/156856202320176501
   BAYKUT D, 2001, EUR J MED RES, V30, P297
   BRUCK SD, 1973, J BIOMED MATER RES, V7, P387, DOI 10.1002/jbm.820070503
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Gracia C, 1980, T AM SOC INTERN ORGA, V26, P294
   Greenfield Benjamin L, 2002, J Extra Corpor Technol, V34, P267
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   HAZLEWOO.CF, 1969, NATURE, V222, P747, DOI 10.1038/222747a0
   HORBETT TA, 1995, ACS S SERIES, V302
   Ichikawa K, 2001, J POLYM SCI POL PHYS, V39, P2175, DOI 10.1002/polb.1191
   Ide M, 2003, LANGMUIR, V19, P429, DOI 10.1021/1a020617p
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Iwasaki Y, 2000, J BIOMED MATER RES, V52, P701, DOI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
   Kataoka K, 1998, J BIOMAT SCI-POLYM E, V9, P111, DOI 10.1163/156856298X00460
   Kitano H, 2001, J COLLOID INTERF SCI, V242, P133, DOI 10.1006/jcis.2001.7785
   KUNTZ ID, 1969, SCIENCE, V163, P1329, DOI 10.1126/science.163.3873.1329
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LINDON JN, 1986, BLOOD, V68, P355
   LING GN, 1983, PHYSIOL CHEM PHYS M, V15, P407
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Morra M, 2001, WATER BIOMATERIAL SU
   Mueller XM, 2002, INT J ARTIF ORGANS, V25, P223
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   Pal SK, 2002, P NATL ACAD SCI USA, V99, P1763, DOI 10.1073/pnas.042697899
   PEPPAS NA, 1987, HYDROGEL MED PHARM, V2
   RATHNER BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Rubens FD, 2002, J BIOMAT SCI-POLYM E, V13, P485, DOI 10.1163/156856202320253974
   Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x
   Schwendel D, 2001, LANGMUIR, V17, P5717, DOI 10.1021/la010576h
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   Severian D., 2002, POLYM BIOMATERIALS
   Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M., 2000, Japanese Journal of Artificial Organs, V29, P209
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tanaka M, 2002, COLLOID SURFACE A, V203, P195, DOI 10.1016/S0927-7757(01)01100-1
   Tanaka M, 2001, COLLOID SURFACE A, V193, P145, DOI 10.1016/S0927-7757(01)00682-3
   Tsuruta T, 1996, ADV POLYM SCI, V126, P1
   UEDAIRA H, 1980, WATER METAL CATIONS, P47
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Wolfgang G. G., 1992, ACS S SERIES, V489
   YAMADANOSAKA A, 1990, J APPL POLYM SCI, V39, P2443, DOI 10.1002/app.1990.070391117
NR 50
TC 109
Z9 109
U1 2
U2 32
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2004
VL 68A
IS 4
BP 684
EP 695
DI 10.1002/jbm.a.20088
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 779CG
UT WOS:000189277600009
PM 14986323
DA 2018-10-20
ER

PT J
AU Ding, B
   Kimura, E
   Sato, T
   Fujita, S
   Shiratori, S
AF Ding, B
   Kimura, E
   Sato, T
   Fujita, S
   Shiratori, S
TI Fabrication of blend biodegradable nanofibrous nonwoven mats via
   multi-jet electrospinning
SO POLYMER
LA English
DT Article
DE multi-jet electrospinning; blend nanofibrous mats; dispersibility
ID CELLULOSE-ACETATE; BENDING INSTABILITY; POLYMER NANOFIBERS; FIBER MATS;
   MORPHOLOGY; MEMBRANES; BEHAVIOR
AB A series of blend biodegradable nanofibrous mats comprising poly(vinyl alcohol) (PVA) and cellulose acetate (CA) were prepared via multi-jet electrospinning. A relative high voltage (20 kV) was used to supply the power for multi-jet electrospinning. The weight ratio of PVA/CA in blend nanofibrous mats can be controlled by changing the number ratio of jets of PVA/CA. Moreover, the real composition of PVA and CA in blend nanofibrous mats was determined by immersing the blend nanofibrous mats into water to remove the PVA component. Morphology, dispersibility, and mechanical properties of blend nanofibrous mats were examined by field emission scanning electron microscopy (FE-SEM), Fourier transform infrared (FT-IR) spectroscopy, wide-angle X-ray diffraction (WAXD), and tensile test. The results showed that the blend nanofibrous mats have good dispersibility. Additionally, the mechanical properties of blend nanofibrous mats were largely influenced by the weight ratio of PVA/CA in blends. Potential applications of the blend nanofibrous mats include filters and biomedical materials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan.
   Shiratori Nanotechnol Co Ltd, Kawasaki, Kanagawa 2120054, Japan.
RP Shiratori, S (reprint author), Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan.
EM binding@appi.keio.ac.jp; shiratori@appi.keio.ac.jp
RI Shiratori, Seimei/B-7882-2015
CR Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Ding B, 2002, J POLYM SCI POL PHYS, V40, P1261, DOI 10.1002/polb.10191
   Ding B, 2003, NANOTECHNOLOGY, V14, P532, DOI 10.1088/0957-4484/14/5/309
   Dror Y, 2003, LANGMUIR, V19, P7012, DOI 10.1021/la034234i
   Gupta P, 2003, POLYMER, V44, P6353, DOI 10.1016/S0032-3861(03)00616-5
   HE CH, 2003, J POLYM DEGRAD STAB, V81, P117
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Ko F, 2003, ADV MATER, V15, P1161, DOI 10.1002/adma.200304955
   Lee KH, 2003, J POLYM SCI POL PHYS, V41, P1256, DOI 10.1002/polb.10482
   Liu HQ, 2002, J POLYM SCI POL PHYS, V40, P2119, DOI 10.1002/polb.10261
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Norris ID, 2000, SYNTHETIC MET, V114, P109, DOI 10.1016/S0379-6779(00)00217-4
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Ryu JH, 2001, CHEM-EUR J, V7, P1525, DOI 10.1002/1521-3765(20010401)7:7<1525::AID-CHEM1525>3.0.CO;2-U
   Schreuder-Gibson H, 2002, J ADV MATER-COVINA, V34, P44
   Shao CL, 2003, MATER LETT, V57, P1579, DOI 10.1016/S0167-577X(02)01036-4
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Tsai PP, 2002, J ELECTROSTAT, V54, P333, DOI 10.1016/S0304-3886(01)00160-7
   Wang XY, 2002, NANO LETT, V2, P1273, DOI 10.1021/nl020216u
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Yu YH, 2003, POLYMER, V44, P3553, DOI 10.1016/S0032-3861(03)00062-4
   Zhou Q, 2003, POLYMER, V44, P1733, DOI 10.1016/S0032-3861(02)00748-6
NR 25
TC 263
Z9 275
U1 9
U2 142
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD MAR 15
PY 2004
VL 45
IS 6
BP 1895
EP 1902
DI 10.1016/j.polymer.2004.01.026
PG 8
WC Polymer Science
SC Polymer Science
GA 777ZQ
UT WOS:000189214700019
DA 2018-10-20
ER

PT J
AU Chatterjee, J
   Haik, Y
   Chen, CJ
AF Chatterjee, J
   Haik, Y
   Chen, CJ
TI pH-reversible magnetic gel with a biodegradable polymer
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE magnetic polymers; gels; biodegradable; nanocomposites
ID DRUG DELIVERY
AB Polymer gels that react to external stimuli, such as pH, temperature, and electromagnetic fields, are an important class of materials. Such materials have pharmaceutical, industrial, and biomedical applications. Our intention in this study was to synthesize a stimuli-responsive polymer gel with a biodegradable polymer. However, the chemical crosslinker, divinyl sulfone, which is most widely used for the crosslinking of this type of material, is highly toxic in nature. To overcome this problem, a reversible magnetic gel was synthesized with hydroxy propyl cellulose (HPC) and maghemite at pH 13 without with a chemical crosslinker. With a decrease in pH from 13 to 9, the gel formed a homogeneous dispersion of HPC particles with maghemite in it. This process was a reversible physical gelation where the crosslinks of the network had a physical origin (in this case, hydrogen bonding) and, therefore, were sensitive to variations in pH. When this physically prepared gel was compared with the chemically crosslinked one, no significant differences in structural properties were noted. At higher pH values, the gel was formed due to weak intermolecular hydrogen bonding, as observed by the broadening of the IR band in both the magnetic and nonmagnetic gels. Transmission electron micrographs also showed no significant difference in the gel morphology. Differential scanning calorimetry showed an increase in melting temperature for the gel sample compared to that of pure HPC. (C) 2004 Wiley Periodicals, Inc.
C1 Florida A&M Univ Florida State Univ Coll Engn, Biomagnet Engn Lab, Tallahassee, FL 32310 USA.
RP Haik, Y (reprint author), Florida A&M Univ Florida State Univ Coll Engn, Biomagnet Engn Lab, 2525 Pottsdamer St, Tallahassee, FL 32310 USA.
EM haik@eng.fsu.edu
CR BRONSTED H, 1992, ACS SYM SER, P285
   CHATTERJEE J, IN PRESS J MAG MAGN
   CHATTERJEE J, 2002, INT C PART ORL FL AP
   DONG LC, 1990, J CONTROL RELEASE, V13, P21, DOI 10.1016/0168-3659(90)90071-Z
   DONG LC, 1991, J CONTROL RELEASE, V15, P141, DOI 10.1016/0168-3659(91)90072-L
   GUTOWSKA A, 1994, MACROMOLECULES, V27, P4167, DOI 10.1021/ma00093a018
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   Holtz JH, 1997, NATURE, V389, P829
   KISHI R, 1991, POLYMER GELS, P205
   OKANO T, 1991, POLYMER GELS, P299
   Roland B., 1991, CARBOHYD POLYM, V16, P399
   Sebti I, 2002, CARBOHYD POLYM, V49, P139, DOI 10.1016/S0144-8617(01)00315-0
   Shojaei A H, 1998, J Pharm Pharm Sci, V1, P15
   SOCRATES G, 1980, INFRARED CHARACTERIS, P46
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   Zrinyi M, 1997, POLYM GELS NETW, V5, P415, DOI 10.1016/S0966-7822(97)00010-5
NR 16
TC 14
Z9 16
U1 0
U2 16
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 5
PY 2004
VL 91
IS 5
BP 3337
EP 3341
DI 10.1002/app.13545
PG 5
WC Polymer Science
SC Polymer Science
GA 770DR
UT WOS:000188708400073
DA 2018-10-20
ER

PT J
AU DeLongchamp, DM
   Hammond, PT
AF DeLongchamp, DM
   Hammond, PT
TI High-contrast electrochromism and controllable dissolution of assembled
   Prussian blue/polymer nanocomposites
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID MIXED-VALENCE HEXACYANIDES; LAYER POLYMER-FILMS; THIN-FILMS; METAL
   HEXACYANOFERRATE; MULTILAYER CAPSULES; MODIFIED ELECTRODES; BLUE;
   OXIDATION; POLYANILINE; REDUCTION
AB To maintain the momentum and impact of the field, assembled materials systems must increasingly incorporate broad functionality ality to meet real-world applications. Here we describe nanocomposite films of specially synthesized inorganic Prussian blue (PB) (PB) nanoparticles and linear poly(ethylene imine) (LPEI) that possess the unusual functional combination of high-performance electrochromism for displays and controllable dissolution for drug delivery. Fabrication using layer-by-layer (LBL) assembly was followed by spectroelectrochemical characterization, allowing a full composition determination rarely achieved for LBL films. The electrochromic performance of thick LPEI/PB nanocomposites most relevant to applications surpassed that or inorganic PB films with competitive switching speed and superior contrast. Oxidation beyond the primary electrochromic transition removes nanoparticle ionization and can controllably dissolve the films. Because PB is non-toxic we suggest this mechanism for controlled in-vivo drug delivery. The performance and multifunctional quality of these nanocomposites promise a strong impact on flexible displays, electrochromic windows, and even biomedical devices.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   NIST, Elect Mat Grp, Div Polymers, Gaithersburg, MD 20899 USA.
RP DeLongchamp, DM (reprint author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM hammond@mit.edu
CR Antipov AA, 2001, J PHYS CHEM B, V105, P2281, DOI 10.1021/jp002184+
   Bharathi S, 2001, LANGMUIR, V17, P7468, DOI 10.1021/la011053c
   BUSER HJ, 1977, INORG CHEM, V16, P2704, DOI 10.1021/ic50177a008
   CARPENTER MK, 1990, J ELECTROCHEM SOC, V137, P2464, DOI 10.1149/1.2086962
   Caruso F, 2000, LANGMUIR, V16, P1485, DOI 10.1021/la991161n
   Chen SM, 2002, J ELECTROANAL CHEM, V521, P29, DOI 10.1016/S0022-0728(02)00677-0
   Cho J, 2003, MACROMOLECULES, V36, P2845, DOI 10.1021/ma021049n
   Dagani R, 2003, CHEM ENG NEWS, V81, P25, DOI 10.1021/cen-v081n001.p025
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DeLongchamp D, 2001, ADV MATER, V13, P1455, DOI 10.1002/1521-4095(200110)13:19<1455::AID-ADMA1455>3.0.CO;2-7
   DeLongchamp DM, 2003, CHEM MATER, V15, P1165, DOI 10.1021/cm020945a
   DeLongchamp DM, 2003, CHEM MATER, V15, P1575, DOI 10.1021/cm021045x
   DELONGCHAMP DM, 2003, POLYM PREPR AM CHEM, V44, P649
   Dubas ST, 2001, J AM CHEM SOC, V123, P5368, DOI 10.1021/ja015774+
   DUEK EAR, 1993, ADV MATER, V5, P650, DOI 10.1002/adma.19930050912
   ELLIS D, 1981, J PHYS CHEM-US, V85, P1225, DOI 10.1021/j150609a026
   FERLAY S, 1995, NATURE, V378, P701, DOI 10.1038/378701a0
   Garjonyte R, 2000, BIOSENS BIOELECTRON, V15, P445, DOI 10.1016/S0956-5663(00)00101-9
   HABIB MA, 1992, J ELECTROCHEM SOC, V139, P2155, DOI 10.1149/1.2221194
   HABIB MA, 1991, J APPL ELECTROCHEM, V21, P203, DOI 10.1007/BF01052571
   ITAYA K, 1982, J APPL PHYS, V53, P804, DOI 10.1063/1.329997
   Jaiswal A, 2003, J COLLOID INTERF SCI, V261, P330, DOI 10.1016/S0021-9797(03)00054-7
   JELLE BP, 1993, ELECTROCHIM ACTA, V38, P1497, DOI 10.1016/0013-4686(93)80281-4
   Kulesza PJ, 2001, ELECTROCHIM ACTA, V46, P4065, DOI 10.1016/S0013-4686(01)00687-9
   Li JP, 2002, CHINESE J CHEM, V20, P1038
   LIN C, 1991, J ELECTROANAL CHEM, V300, P325, DOI 10.1016/0022-0728(91)85403-C
   Millward RC, 2001, CHEM COMMUN, P1994, DOI 10.1039/b106616c
   Monk P.M.S., 1995, ELECTROCHROMISM FUND
   Moriguchi I, 2002, CHEM LETT, P310, DOI 10.1246/cl.2002.310
   Mortimer RJ, 1997, CHEM SOC REV, V26, P147, DOI 10.1039/cs9972600147
   NEFF VD, 1978, J ELECTROCHEM SOC, V125, P886, DOI 10.1149/1.2131575
   PEARCE J, 1994, FOOD CHEM TOXICOL, V32, P577, DOI 10.1016/0278-6915(94)90116-3
   PEERCE PJ, 1980, J ELECTROANAL CHEM, V114, P89, DOI 10.1016/S0022-0728(80)80438-4
   Pyrasch M, 2001, LANGMUIR, V17, P7706, DOI 10.1021/la0104424
   RAJAN KP, 1982, J PHYS CHEM-US, V86, P4361, DOI 10.1021/j100219a017
   Ravaine S, 1998, LANGMUIR, V14, P6347, DOI 10.1021/la9808014
   ROBIN MB, 1962, INORG CHEM, V1, P337, DOI 10.1021/ic50002a028
   Santini JT, 1999, NATURE, V397, P335
   Sato O, 1996, SCIENCE, V271, P49, DOI 10.1126/science.271.5245.49
   Somani PR, 2003, MATER CHEM PHYS, V77, P117, DOI 10.1016/S0254-0584(01)00575-2
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Vittal R, 1999, J ELECTROCHEM SOC, V146, P786, DOI 10.1149/1.1391682
   Zhou DM, 1996, J ELECTROANAL CHEM, V408, P219, DOI 10.1016/0022-0728(95)04522-8
NR 44
TC 254
Z9 257
U1 21
U2 184
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAR
PY 2004
VL 14
IS 3
BP 224
EP 232
DI 10.1002/adfm.200304507
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 807KS
UT WOS:000220501000003
DA 2018-10-20
ER

PT J
AU Adar, E
AF Adar, E
TI SaRAD: a simple and robust abbreviation dictionary
SO BIOINFORMATICS
LA English
DT Article
ID ARTICLES; GENE
AB Motivation: Due to recent interest in the use of textual material to augment traditional experiments it has become necessary to automatically cluster, classify and filter natural language information.
   Results: The Simple and Robust Abbreviation Dictionary (SaRAD) provides an easy to implement, high performance tool for the construction of a biomedical symbol dictionary. The algorithms, applied to the MEDLINE document set, result in a high quality dictionary and toolset to disambiguate abbreviation symbols automatically.
C1 HP Labs, Palo Alto, CA 94304 USA.
RP Adar, E (reprint author), HP Labs, 1501 Page Mill Rd, Palo Alto, CA 94304 USA.
EM eytan@hpl.hp.com
CR Adamic LA, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P109, DOI 10.1109/CSB.2002.1039334
   BAEZAYATES R, 1999, MODERN INFORMATION R
   Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60
   BOWDEN PR, COMPUTERM 98, P43
   BOWDEN PR, 1999, AUTOMATIC GLOSSARY C
   BOWDEN PR, 2000, 17 INT C ENGL LANG R
   CHANG JS, 2001, P 3 INT S NONTH PLAS, P274
   Chang JT, 2002, J AM MED INFORM ASSN, V9, P612, DOI 10.1197/jamia.M1139
   CHANG JT, NLP BIOINFORMATICS
   Fuchs P, 2002, AUDIOL NEURO-OTOL, V7, P40, DOI 10.1159/000046862
   GUSFIELD D, 1997, ALGORITHMS STRINGS T, P227
   Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213
   Krauthammer M, 2000, GENE, V259, P245, DOI 10.1016/S0378-1119(00)00431-5
   LARKEY LS, 2000, P 5 ACM INT C DIG LI, P205
   LIU H, 2002, P AM MED INF ASS S 2
   PARK Y, 2001, P 2001 C EMP METH NA
   PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814
   Pustejovsky J, 2001, MEDINFO, V10, P371
   SCHWARTZ AS, 2003, P 2003 PAC S BIOC
   TAGHVA K, 1995, 9503 TR U NEV
   Yandell MD, 2002, NAT REV GENET, V3, P601, DOI 10.1038/nrg861
   YEATES S, 2000, DAT COMPR C, P582
   YEATES S, 1999, P 3 NZ COMP SCI RES, P117
   Yoshida M, 2000, BIOINFORMATICS, V16, P169, DOI 10.1093/bioinformatics/16.2.169
   Yu H, 2002, J AM MED INFORM ASSN, V9, P262, DOI 10.1197/jamia.M0913
NR 25
TC 25
Z9 28
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD MAR 1
PY 2004
VL 20
IS 4
BP 527
EP 533
DI 10.1093/bioinformatics/btg439
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 800WQ
UT WOS:000220058800011
PM 14990448
OA Bronze
DA 2018-10-20
ER

PT J
AU Juhasz, JA
   Best, SM
   Brooks, R
   Kawashita, M
   Miyata, N
   Kokubo, T
   Nakamura, T
   Bonfield, W
AF Juhasz, JA
   Best, SM
   Brooks, R
   Kawashita, M
   Miyata, N
   Kokubo, T
   Nakamura, T
   Bonfield, W
TI Mechanical properties of glass-ceramic A-W-polyethylene composites:
   effect of filler content and particle size
SO BIOMATERIALS
LA English
DT Article
DE composite; polyethylene; glass-ceramic; mechanical properties
ID HYDROXYAPATITE REINFORCED POLYETHYLENE; APATITE
AB Composites which comprise a bioactive filler and ductile polymer matrix are desirable as implant materials since both their biological and mechanical properties can be tailored for a given application. In the present study three-point bending was used to characterise biomedical materials composed of glass-ceramic apatite-wollastonite (A-W) particulate reinforced polyethylene (PE) (denoted as AWPEX). The effects of filler volume fraction, varied from 10 to 50 vol%, and average particle size, 4.4 and 6.7 mum, on the bending strength, yield strength, mode of fracture, Young's modulus and strain to failure were investigated. HAPEX(TM), a commercially used composite of hydroxyapatite and polyethylene, with a 40 vol% filler content, was used for comparison. Increasing the filler content caused an increase in Young's modulus, yield strength and bending strength, and a decreased strain to failure. When filler particle size was increased, the Young's modulus, yield and bending strengths were found to be slightly reduced. A transition in fracture behaviour from ductile to brittle behaviour was observed in samples containing between 30 and 40 vol% filler. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
   Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068501, Japan.
RP Juhasz, JA (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
RI Kawashita, Masakazu/E-6632-2016
OI Kawashita, Masakazu/0000-0002-4329-9001
CR Altman DG, 1991, PRACTICAL STAT MED R
   Bonfield W, 1988, Ann N Y Acad Sci, V523, P173, DOI 10.1111/j.1749-6632.1988.tb38510.x
   BONFIELD W, 1988, COMPSITES MED APPL E, P17
   BONFIELD W, 1984, Patent No. 2085461
   BONFIELD W, 1986, BIOL BIOMECHANICAL P, P153
   Bonfield W., 1991, US Patent, Patent No. 5017627
   Dowling N. E., 1993, MECH BEHAV MAT ENG M, P570
   FRIEDRICH K, 1981, J MATER SCI, V16, P2167, DOI 10.1007/BF00542377
   HENCH LL, 1982, BIOMATERIALS INTER 4, P62
   HUANG YL, 1988, J MATER SCI, V23, P2348
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   LIU DM, 1994, J MATER SCI-MATER M, V5, P7, DOI 10.1007/BF00121146
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nazhat SN, 2000, J MATER SCI-MATER M, V11, P621, DOI 10.1023/A:1008957729512
   Okuno K., 1974, J CELL PLAST, V10, P237
   Ravaglioli A, 1989, BIOCERAMICS, V1, P13
   TANNER KE, 1994, BRIT CERAM T, V93, P104
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M., 1996, BIOCERAMICS, V9, P387
   WANG M, 1997, BIOCERAMICS, V10, P15
   YAMAMURO T, 1995, BIOCERAMICS, V8, P123
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1, P335
   YAMAMURO T, 1993, INTRO BIOCERAMICS, P89
NR 27
TC 80
Z9 84
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2004
VL 25
IS 6
BP 949
EP 955
DI 10.1016/j.biomaterials.2003.07.005
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GF
UT WOS:000186853600001
PM 14615158
DA 2018-10-20
ER

PT J
AU Jones, DS
   Garvin, CP
   Gorman, SP
AF Jones, DS
   Garvin, CP
   Gorman, SP
TI Relationship between biomedical catheter surface properties and
   lubricity as determined using textural analysis and multiple regression
   analysis
SO BIOMATERIALS
LA English
DT Article
DE lubricity; catheters; dynamic contact angle analysis; microrugosity;
   textural analysis; agar; multiple regression
ID IN-VITRO; FRICTION; ADHESION; DEVICES; ENERGY
AB In this study, the surface properties of and work required to remove 12 commercially available and developmental catheters from a model biological medium (agar), a measure of catheter lubricity, were characterised and the relationships between these properties were examined using multiple regression and correlation analysis. The work required for removal of catheter sections (7 cm) from a model biological medium (1% w/w agar) were examined using tensile analysis. The water wettability of the catheters were characterised using dynamic contact angle analysis, whereas surface roughness was determined using atomic force microscopy. Significant differences in the ease of removal were observed between the various catheters, with the silicone-based materials generally exhibiting the greatest ease of removal. Similarly, the catheters exhibited a range of advancing and receding contact angles that were dependent on the chemical nature of each catheter. Finally, whilst the microrugosities of the various catheters differed, no specific relationship to the chemical nature of the biomaterial was apparent. Using multiple regression analysis, the relationship between ease of removal, receding contact angle and surface roughness was defined as: Work done (N mm) 17.18 + 0.055 Rugosity (nm)-0.52 Receding contact angle (degrees) (r = 0.49). Interestingly, whilst the relationship between ease of removal and surface roughness was significant (r = 0.48, p = 0.0005), in which catheter lubricity increased as the surface roughness decreased, this was not the case with the relationship between ease of removal and receding contact angle (r = -0.18, p > 0.05). This study has therefore uniquely defined the contributions of each of these surface properties to catheter lubricity. Accordingly, in the design of urethral catheters. it is recommended that due consideration should be directed towards biomaterial surface roughness to ensure maximal ease of catheter removal. Furthermore, using the method described in this study, differences in the lubricity of the various catheters were observed that may be apparent in their clinical use. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Unit, Belfast BT9 7BL, Antrim, North Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Unit, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
CR AKADA Y, 1993, LUBRICATING POLYM SU
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   COX AJ, 1987, BIOMATERIALS, V8, P500, DOI 10.1016/0142-9612(87)90089-5
   FERREIROS CM, 1989, FEMS MICROBIOL LETT, V60, P89, DOI 10.1016/0378-1097(89)90083-9
   GOLD P, 1985, Patent No. 4534363
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   GORMAN SP, 1993, J MED MICROBIOL, V38, P411, DOI 10.1099/00222615-38-6-411
   Gorman SP, 2003, MED IMPLICATIONS BIO, P136
   GROSCH KA, 1963, PROC R SOC LON SER-A, V274, P21, DOI 10.1098/rspa.1963.0112
   HEILMAN MS, 1978, Patent No. 4080706
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 1997, PHARMACEUT RES, V14, P450, DOI 10.1023/A:1012091231023
   Jones DS, 2001, J MATER SCI-MATER M, V12, P15, DOI 10.1023/A:1026744732504
   KiremitciGumusderelioglu M, 1996, BIOMATERIALS, V17, P443, DOI 10.1016/0142-9612(96)89662-1
   LAPORTE RJ, 1997, HYDROPHILLIC POLYM C
   Marmieri G, 1996, J BIOMED MATER RES, V33, P29, DOI 10.1002/(SICI)1097-4636(199621)33:1<29::AID-JBM5>3.3.CO;2-M
   McGovern JG, 1997, INT J PHARM, V149, P251, DOI 10.1016/S0378-5173(97)04883-7
   NAGAOKA S, 1990, BIOMATERIALS, V11, P419, DOI 10.1016/0142-9612(90)90098-B
   Polderman KH, 2002, INTENS CARE MED, V28, P1, DOI 10.1007/s00134-001-1154-9
   Pomfret I J, 1996, Br J Nurs, V5, P245
   RAMSAY JWA, 1986, BRIT J UROL, V58, P70, DOI 10.1111/j.1464-410X.1986.tb05431.x
   Rosen M, 1992, HDB PERCUTANEOUS CEN
   Tunney MM, 1999, METHOD ENZYMOL, V310, P558
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
NR 25
TC 24
Z9 26
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR-APR
PY 2004
VL 25
IS 7-8
BP 1421
EP 1428
DI 10.1016/j.biomaterials.2003.08.01
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 753PJ
UT WOS:000187239500031
PM 14643617
DA 2018-10-20
ER

PT J
AU Coyle, F
AF Coyle, F
TI 'Safe space' as counter-space: women, environmental illness and
   'corporeal chaos'
SO CANADIAN GEOGRAPHER-GEOGRAPHE CANADIEN
LA English
DT Review
ID MULTIPLE CHEMICAL SENSITIVITIES; MEDICAL GEOGRAPHY; THERAPEUTIC
   LANDSCAPES; CASE-DEFINITION; PLACE; BODY; HEALTH; FEAR; POLITICS;
   INVITATION
AB Women constitute a disproportionate 80 percent of people diagnosed with environmental illness (El), a contentious condition in which patients react adversely to everyday chemicals in the environment at levels politically conceived to be 'safe'. Whilst the diverse range of somatic symptoms constitutes a biomedical anomaly, in this paper I present an alternative means of conceiving environmentally ill bodies. Women (and environmental health practitioners at the Environmental Health Centre, Nova Scotia) have begun to view their bodies as complex systems that have been nudged into a state of 'corporeal chaos, in which minute quantities of chemicals trigger disproportionate somatic symptoms. This chaos extends into 'corporeal space' [Moss and Dyck (1999a)] as the diagnosis of environmental illness is experienced simultaneously through both material and discursive bodies. This diagnosis also carries with it a means to mitigate corporeal chaos through a series of body- and environment-based modifications that replace risky bodies with 'safe space'. As a discursive construct, safe space is associated with an absence of chemicals, and in order to mitigate chaos, should ideally be stable, predictable, controllable and communicative. I finalise this paper with some examples of body modifications and illustrate how safe space materialises in the home environment.
C1 Lincoln Univ, Agribusiness & Econ Res Unit, Canterbury, New Zealand.
RP Coyle, F (reprint author), Lincoln Univ, Agribusiness & Econ Res Unit, POB 84, Canterbury, New Zealand.
EM leadora2000@yahoo.com
OI Coyle, Fiona/0000-0002-8000-3636
CR APRR H, 1995, MAPPING SUBJECT GEOG, P199
   ASHFORD NA, 1992, NATL RES COUNCIL MUL
   Bankey R., 2001, GENDER PLACE CULT, V8, P37
   Baxter J., 1999, GEOGR ANN B, V81, P91, DOI DOI 10.1111/J.0435-3684.1999.00051.X
   BELL IR, 1992, BIOL PSYCHIAT, V32, P218, DOI 10.1016/0006-3223(92)90105-9
   Bondi L, 2003, ENVIRON PLANN A, V35, P853, DOI 10.1068/a35135
   BRIGGS J, 1989, TURBULENT MIRROR
   BUCHWALD D, 1994, ARCH INTERN MED, V154, P2049, DOI 10.1001/archinte.154.18.2049
   BUTLER R, 1999, MIND BODY SPACES GEO
   Chouinard V, 1999, EMBODIED GEOGRAPHIES, P142
   Coveney P., 1995, FRONTIERS COMPLEXITY
   Cox J. Charles, 1911, SANCTUARIES SANCTUAR
   COYLE FJ, 2002, THESIS CARLETON U OT
   Crawford C., 1994, NO SAFE PLACE LEGACY
   CULLEN MR, 1992, TOXICOL IND HEALTH, V8, P15
   CULLEN MR, 1987, OCCUPATIONAL MED STA, V2, P656
   CULLEN MR, 1992, PUBLIC HLTH PREVENTI, P459
   Davidson J, 2000, AREA, V32, P31, DOI 10.1111/j.1475-4762.2000.tb00112.x
   Davidson J, 2000, SOCIOL HEALTH ILL, V22, P640, DOI 10.1111/1467-9566.00224
   Davidson J, 2001, GENDER PLACE CULT, V8, P283, DOI 10.1080/09663690120067357
   DORN M, 1994, PROF GEOGR, V46, P106, DOI 10.1111/j.0033-0124.1994.00106.x
   DOUGLAS M, 1965, PURITY DANGER
   DUNN C, 1996, SOC SCI MED, V40, P307
   DYCK I, 1995, SOC SCI MED, V40, P307, DOI 10.1016/0277-9536(94)E0091-6
   DYCK I, 1998, PUTTING HLTH PLACE L
   Dyck I, 1999, MIND BODY SPACES GEO, P119
   ECALMER P, 1997, MISTREATMENT ELDERLY
   EYLES J, 1993, HEALTH PLACE, V1, P5
   Eyles J, 1997, HEALTH PLACE, V3, P1, DOI 10.1016/S1353-8292(96)00031-7
   Galey K., 1995, INT REV VICTIMOLOGY, V4, P63
   Garvin T, 2001, SOC SCI MED, V53, P1175, DOI 10.1016/S0277-9536(00)00418-4
   Gesler W. M., 1998, PUTTING HLTH PLACE L, P17
   GESLER WM, 1992, SOC SCI MED, V34, P735, DOI 10.1016/0277-9536(92)90360-3
   GESLER WM, 1993, ENVIRON PLANN D, V11, P171, DOI 10.1068/d110171
   GIBSON P, 1993, WOMEN THER, V14, P171
   Gibson PR, 1998, RES NURS HEALTH, V21, P103, DOI 10.1002/(SICI)1098-240X(199804)21:2<103::AID-NUR2>3.0.CO;2-N
   Gibson PR, 1997, FEM PSYCHOL, V7, P475, DOI 10.1177/0959353597074003
   Giddens A, 1990, CONSEQUENCES MODERNI
   GOLD SJ, 1991, VISUAL SOCIOLOGY, V6, P9
   Grosz Elizabeth, 1995, SPACE TIME PERVERSIO
   GUBERMAN C, 1985, NO SAFE PLACE VIOLEN
   Harper D, 1988, AM SOCIOL, V19, P54, DOI DOI 10.1007/BF02692374
   Havens L. L, 1989, SAFE PLACE LAYING GR
   Hayles N. Katherine, 1991, CHAOS ORDER COMPLEX
   Hayles N. Katherine, 1990, CHAOS BOUND
   HEUSER C, 1992, MULTIPLE CHEM SENSIT
   Kearns G., 1998, PUTTING HLTH PLACE L, P36
   KEARNS RA, 1994, PROF GEOGR, V46, P111, DOI 10.1111/j.0033-0124.1994.00111.x
   KEARNS RA, 1993, SOC SCI MED, V37, P711, DOI 10.1016/0277-9536(93)90364-A
   KEARNS RA, 1995, PROG HUM GEOG, V19, P251, DOI 10.1177/030913259501900206
   KEARNS RA, 1993, PROF GEOGR, V45, P139, DOI 10.1111/j.0033-0124.1993.00139.x
   KIPEN H, 1992, TOXICOL IND HEALTH, V8, P125
   Koskela H, 2000, GEOFORUM, V31, P269, DOI 10.1016/S0016-7185(99)00033-0
   Kroll-Smith S., 1997, BODIES PROTEST ENV I
   KROLLSMITH S, 1993, SOCIOL SPECTRUM, V13, P7, DOI 10.1080/02732173.1993.9982015
   Lyon M, 1997, BODY SOC, V3, P83, DOI [10.1177/1357034X97003001006, DOI 10.1177/1357034X97003001006]
   MACLEOD L, 1989, CITY WOMEN NO SAFE P
   MARTIN E, 1990, MED ANTHROPOL Q, V4, P410, DOI 10.1525/maq.1990.4.4.02a00030
   MARTIN E, 1999, REVISIONING WOMEN HL
   Martin E, 1994, FLEXIBLE BODIES TRAC
   MARTIN E, 1998, MAKING REALITY NATUR
   MEGGS WJ, 1993, ENVIRON HEALTH PERSP, V101, P234, DOI 10.2307/3431548
   MEISSNER SJ, 1998, PSYCHOANALYSIS CONT, V21, P113
   MILNE C, 1999, GLOBE MAIL HLTH S
   Moeller D., 1992, ENV HLTH
   MORROW L, 1993, STREETCAR NAMED DESI
   Moss P, 1996, ENVIRON PLANN D, V14, P737, DOI 10.1068/d140737
   Moss P, 1997, SOC SCI MED, V45, P23, DOI 10.1016/S0277-9536(96)00305-X
   Moss P., 1999, ANTIPODE, V31, P372, DOI DOI 10.1111/1467-8330.00110
   MOSS P, 1999, EMBODIED GEOGRAPHIES, P157
   Murphy M, 2000, CONFIGURATIONS, V8, P87
   NETHERCOTT JR, 1993, ARCH ENVIRON HEALTH, V48, P19, DOI 10.1080/00039896.1993.9938389
   Norman Jr W. R., 1991, VISUAL ANTHR, V4, P193
   *NRC, 1992, MULT CHEM SENS ADD B, V6
   Pain R, 2002, GEOFORUM, V33, P105, DOI 10.1016/S0016-7185(01)00025-2
   Pain R, 2000, PROG HUM GEOG, V24, P365, DOI 10.1191/030913200701540474
   Pain R. H., 1995, NO EC REV, V24, P96
   Pain RH, 1997, T I BRIT GEOGR, V22, P231
   Parr H, 1998, AREA, V30, P28, DOI 10.1111/j.1475-4762.1998.tb00045.x
   Parr H, 1999, ENVIRON PLANN D, V17, P673, DOI 10.1068/d170673
   PARR H, 1999, MIND BODY SPACES GEO
   PAULSEN M, 1993, UTNE READER, P81
   PROSSER J, 1998, IMAGE BASED RES SOUR, P60
   Prosser Jon, 1996, VISUAL SOCIOLOGY, V11, P25, DOI DOI 10.1080/14725869608583763
   RANDOLPH TG, 1965, ANN ALLERGY, V23, P11
   Randolph TG, 1962, HUMAN ECOLOGY SUSCEP, p148pp
   REA WJ, 1992, CHEM SENSITIVITY, V1
   ROGERS SA, 1990, TIRED TOXIC BLUEPRIN
   Shriver TE, 1998, SOCIOL INQ, V68, P458, DOI 10.1111/j.1475-682X.1998.tb00480.x
   Sibley D., 1995, GEOGRAPHIES EXCLUSIO
   Snyder E. E., 1990, Journal of Sport Management, V4, P21
   SPARKS PJ, 1994, J OCCUP ENVIRON MED, V36, P718
   Thrift N, 1999, THEOR CULT SOC, V16, P31, DOI 10.1177/02632769922050610
   TOMOKO K, 1998, CREATING SAFE SPACE
   Valentine G, 1997, J RURAL STUD, V13, P137, DOI 10.1016/S0743-0167(97)83094-X
   Valentine Gill, 1995, MAPPING DESIRE GEOGR
   VANLOON J, 1998, APOCALYPSE SPACE CUL, V2, P127
   Wakefield S, 2000, SOC SCI MED, V50, P1139, DOI 10.1016/S0277-9536(99)00361-5
   Wakefield SEL, 2001, HEALTH PLACE, V7, P163, DOI 10.1016/S1353-8292(01)00006-5
   WIELANDBURSTON J, 1992, CHAOS ORDER WORLD PY
   Williams A, 1998, SOC SCI MED, V46, P1193, DOI 10.1016/S0277-9536(97)10048-X
   Winnicott D., 1971, PLAYING REALITY
NR 102
TC 11
Z9 11
U1 0
U2 7
PU CANADIAN ASSN GEOGRAPHERS
PI MONTREAL
PA MCGILL UNIV, BURNSIDE HALL, 805 SHERBROKKE ST., WEST, MONTREAL, QUEBEC
   H3A 2K6, CANADA
SN 0008-3658
J9 CAN GEOGR-GEOGR CAN
JI Can. Geogr.-Geogr. Can.
PD SPR
PY 2004
VL 48
IS 1
BP 62
EP 75
DI 10.1111/j.1085-9489.2004.01e08.x
PG 14
WC Geography
SC Geography
GA 779VN
UT WOS:000189322400006
DA 2018-10-20
ER

PT J
AU Vlad, S
AF Vlad, S
TI Hydrolytic stability of some thermoplastic poly(ether-urethane-urea)s
SO HIGH PERFORMANCE POLYMERS
LA English
DT Article
DE thermoplastic poly(ether-urethane-urea); hydrolytic stability;
   biomedical application
ID POLYURETHANE BLOCK COPOLYMERS; SEPARATION KINETICS; HEART-VALVE;
   ELASTOMERS; URETHANES; SERIES
AB Two thermoplastic poly(ether-urethane-urea)s were synthesized from isophorone diisocyanate, hexamethylene diamine, and polyethylene glycol as macrodiol. The molecular weight of the macrodiol was 2000 g mol(-1). The polymers have been characterized by means of transmission electron microscopy, H-1-NMR, infrared spectroscopy, and other techniques. The hydrolytic stability of these materials was investigated under in vitro condition using Ringer's solution and phosphate-buffered saline. The stability of these series was compared with a poly(ether-urethane) prepared from isophorone diisocyanate, polyethylene glycol and 1,4-butanediol. The in vitro study revealed possible use of poly(ether-urethane-urea)s for long-terrn biomedical applications.
C1 Inst Macromol Chem, Iasi 6600, Romania.
RP Vlad, S (reprint author), Inst Macromol Chem, Aleea Grigore Ghica Voda 41-A, Iasi 6600, Romania.
EM vladus@icmpp.tuiasi.ro
RI Vlad, Stelian/C-3430-2011
OI Vlad, Stelian/0000-0002-5895-438X
CR BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   Bernacca GM, 1996, J HEART VALVE DIS, V5, P538
   CHANG YJP, 1975, J POLYM SCI POL PHYS, V13, P455, DOI 10.1002/pol.1975.180130302
   CHU B, 1992, MACROMOLECULES, V25, P5724, DOI 10.1021/ma00047a025
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   FERGUSON J, 1987, EUR POLYM J, V8, P385
   HUN SL, 1989, MACROMOLECULES, V22, P1100
   KAZMIERCZAK ME, 1989, J POLYM SCI POL PHYS, V27, P2189, DOI 10.1002/polb.1989.090271103
   KAZMIERCZAK ME, 1989, J POLYM SCI POL PHYS, V27, P2173, DOI 10.1002/polb.1989.090271102
   KIM BK, 1992, COLLOID POLYM SCI, V270, P956, DOI 10.1007/BF00655964
   KOBERSTEIN JT, 1992, MACROMOLECULES, V25, P6205, DOI 10.1021/ma00049a018
   KOBERSTEIN JT, 1986, J POLYM SCI POL PHYS, V24, P2487, DOI 10.1002/polb.1986.090241107
   KOLFF WJ, 1989, ANN THORAC SURG, V48, P598
   Lelah M. D., 1986, POLYURETHANES MED, P23
   LI YJ, 1992, MACROMOLECULES, V25, P1737, DOI 10.1021/ma00032a018
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   MARCONI W, 1994, MACROMOL CHEM PHYS, V195, P875, DOI 10.1002/macp.1994.021950306
   Mark HF, 1996, ENCY POLYM SCI TECHN, V4, P331
   PETROVIC ZS, 1991, PROG POLYM SCI, V16, P695, DOI 10.1016/0079-6700(91)90011-9
   PLANK H, 1987, POLYURETHANE BIOMEDI, P197
   Schollenberger C. S., 1971, J ELASTOPLAST, V3, P28, DOI DOI 10.1177/009524437100300103
   SREENIVASAN K, 1991, EUR POLYM J, V27, P811, DOI 10.1016/0014-3057(91)90014-F
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STRIZINAR I, 1992, J BIOMED MATER RES, V26, P577
   TAKAHARA A, 1988, ARTIFICIAL HEART, V2, P1095
   VANBOGART JWC, 1981, POLYMER, V22, P1428, DOI 10.1016/0032-3861(81)90250-0
   WILKES GL, 1975, J POLYM SCI POL LETT, V13, P321, DOI 10.1002/pol.1975.130130601
NR 30
TC 4
Z9 4
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-0083
J9 HIGH PERFORM POLYM
JI High Perform. Polym.
PD MAR
PY 2004
VL 16
IS 1
BP 81
EP 88
DI 10.1177/0954008304038963
PG 8
WC Polymer Science
SC Polymer Science
GA 802QV
UT WOS:000220178900006
DA 2018-10-20
ER

PT J
AU Gupta, AK
   Wells, S
AF Gupta, AK
   Wells, S
TI Surface-modified superparamagnetic nanoparticles for drug delivery:
   Preparation, characterization, and cytotoxicity studies
SO IEEE TRANSACTIONS ON NANOBIOSCIENCE
LA English
DT Article
DE biological cells; drug delivery systems; magnetic materials;
   nanotechnology
ID MAGNETITE NANOPARTICLES; IRON-OXIDES; SIZE; SYSTEM; AGENT
AB Superparamagnetic iron oxide nanoparticles have been used for many years as magnetic resonance imaging (MRI) contrast agents or in drug delivery applications. In this study, a novel approach to prepare magnetic polymeric nanoparticles with magnetic core and polymeric shell using inverse microemulsion polymerization process is reported. Poly (ethyleneglycol) (PEG)-modified superparamagnetic iron oxide nanoparticles with specific shape and size have been prepared inside the aqueous cores of AOT/n-Hexane reverse micelles and characterized by various pbysicochemical means such as transmission electron microscopy (TEM), infrared spectroscopy, atomic force microscopy (AFM), vibrating sample magnetometry (VSM), and ultraviolet/visible spectroscopy. The inverse microemulsion polymerization of a polymerizable derivative of PEG and a cross-linking agent resulted in a stable hydrophilic polymeric shell of the nanoparticles. The results taken together from TEM and AFM studies showed that the particles are spherical in shape with core-shell structure. The average size of the PEG-modified nanoparticles was found to be around 40-50 nm with narrow size distribution. The magnetic measurement studies revealed the superparamagnetic behavior of the nanoparticles with saturation magnetization values between 45-50 electromagnetic units per gram. The cytotoxicity profile of the nanoparticles on human dermal fibroblasts as measured by standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that the particles are nontoxic and may be useful for various in vivo and in vitro biomedical applications.
C1 Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Gupta, AK (reprint author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
EM akgupta25@hotmail.com
CR AMIMJI M, 1992, BIOMATERIALS, V13, P682
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   Dresco PA, 1999, LANGMUIR, V15, P1945, DOI 10.1021/la980971g
   DUNN J, 1994, PROF ENG, V7, P10
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   GRANQVIST CG, 1976, J APPL PHYS, V47, P2200, DOI 10.1063/1.322870
   GUPTA PK, 1989, LIFE SCI, V44, P175, DOI 10.1016/0024-3205(89)90593-6
   HOU MJ, 1988, J COLLOID INTERF SCI, V123, P398, DOI 10.1016/0021-9797(88)90261-5
   KENT TA, 1990, MAGNET RESON MED, V13, P434, DOI 10.1002/mrm.1910130310
   Kim DK, 2001, J MAGN MAGN MATER, V225, P30, DOI 10.1016/S0304-8853(00)01224-5
   MOBE G, 1983, J COLLOID INTERF SCI, V93, P293
   Mosmann T, 1993, J IMMUNOL METHODS, V95, P55
   Munshi N, 1997, J COLLOID INTERF SCI, V190, P387, DOI 10.1006/jcis.1997.4889
   Reimer P, 1996, RADIOLOGE, V36, P153, DOI 10.1007/s001170050053
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   WEISSLEDER R, 1994, RADIOLOGY, V191, P225, DOI 10.1148/radiology.191.1.8134576
   WEISSLEDER R, 1994, RADIOLOGY, V193, P593, DOI 10.1148/radiology.193.3.7972790
   WEISSLEDER R, 1992, RADIOLOGY, V182, P381, DOI 10.1148/radiology.182.2.1732953
   WEISSLEDER R, 1995, ADV DRUG DELIVER REV, V16, P321, DOI 10.1016/0169-409X(95)00033-4
   Zaitsev VS, 1999, J COLLOID INTERF SCI, V212, P49, DOI 10.1006/jcis.1998.5993
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
NR 23
TC 387
Z9 410
U1 8
U2 182
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1536-1241
J9 IEEE T NANOBIOSCI
JI IEEE Trans. Nanobiosci.
PD MAR
PY 2004
VL 3
IS 1
BP 66
EP 73
DI 10.1109/TNB.2003.820277
PG 8
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA 808ST
UT WOS:000220589500013
PM 15382647
DA 2018-10-20
ER

PT J
AU Esudero, ML
   Munoz-Morris, MA
   Garcia-Alonso, MC
   Fernandez-Escalante, E
AF Esudero, ML
   Munoz-Morris, MA
   Garcia-Alonso, MC
   Fernandez-Escalante, E
TI In vitro evaluation of a gamma-TiAl intermetallic for potential
   endoprothesic applications
SO INTERMETALLICS
LA English
DT Article
DE titanium aluminides; based on TiAl; corrosion; trace element analysis;
   electron microscopy, scanning; biomedical applications
ID CATHODIC STRIPPING VOLTAMMETRY; TITANIUM ALUMINIDES; ALLOYS; CORROSION;
   WATER; PROTECTION; RESISTANCE; OXIDATION; BEHAVIOR; METAL
AB In vitro properties of a new gamma-based TiAl intermetallic have been evaluated in the as-received state and after carrying out surface modifications by oxidation under two different heat treatments, namely 700 degreesC, 24 It and 1000 degreesC, I h. Cathodic stripping voltammetry was used to determine the concentration of Ti and Al elements released into a solution simulating the body fluids (Ringer's solution) after six months immersion. Electrochemical techniques were used to measure the corrosion resistance and the susceptibility to pitting corrosion. The results confirmed that the best material is the TiAl intermetallic pre-oxidised at 700 degreesC, since it produces a much lower concentration of Al and Ti ions and also exhibits the lowest passive current densities. The latter are one order of magnitude lower than those of the as-received intermetallic alloy and after pre-oxidation at 1000 degreesC and two orders of magnitude lower than that obtained from a conventional Ti6Al4V currently used as biomaterial. (C) 2004 Elsevier Ltd. All rights reserved.
C1 CSIC, CENIM, Dept Met Phys, E-28040 Madrid, Spain.
   CSIC, CENIM, Dept Mat Engn Degradat & Durabil, E-28040 Madrid, Spain.
RP Munoz-Morris, MA (reprint author), CSIC, CENIM, Dept Met Phys, Avenida Gregorio Amo 8, E-28040 Madrid, Spain.
EM mmunoz@cenim.csic.es
RI Garcia-Alonso, Maria Cristina/K-3779-2014
OI Garcia-Alonso, Maria Cristina/0000-0003-0275-4626; Munoz, Maria
   Antonia/0000-0002-9410-098X
CR Bloyce A, 1998, SURF COAT TECH, V107, P125, DOI 10.1016/S0257-8972(98)00580-5
   Brady MP, 1996, JOM-J MIN MET MAT S, V48, P46, DOI 10.1007/BF03223244
   Dimiduk DM, 1999, MAT SCI ENG A-STRUCT, V263, P281, DOI 10.1016/S0921-5093(98)01158-7
   Doorn PF, 1998, J BIOMED MATER RES, V42, P103, DOI 10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M
   Escudero ML, 2003, SCRIPTA MATER, V48, P1549, DOI 10.1016/S1359-6462(03)00090-3
   Gil I, 2001, INTERMETALLICS, V9, P373, DOI 10.1016/S0966-9795(01)00014-0
   Gurappa I, 2003, INTERMETALLICS, V11, P867, DOI 10.1016/S0966-9795(03)00094-3
   Hallab NJ, 2000, J BIOMED MATER RES, V49, P353, DOI 10.1002/(SICI)1097-4636(20000305)49:3<353::AID-JBM8>3.0.CO;2-T
   KIM YW, 1994, JOM-J MIN MET MAT S, V46, P30
   KIM YW, 1992, ACTA METALL MATER, V40, P1121, DOI 10.1016/0956-7151(92)90411-7
   Lang FQ, 2003, INTERMETALLICS, V11, P129, DOI 10.1016/S0966-9795(02)00192-9
   LI H, 1989, ANAL CHIM ACTA, V221, P269, DOI 10.1016/S0003-2670(00)81963-7
   MORRIS MA, 1994, SCRIPTA METALL MATER, V31, P449, DOI 10.1016/0956-716X(94)90017-5
   MUNOZMORRIS MA, 1997, MATER SCI ENG, V124, P1
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Schmitz-Niederau M, 1999, OXID MET, V52, P225, DOI 10.1023/A:1018839511102
   VAN DEN BERG CMG, 1986, ANAL CHIM ACTA, V188, P177, DOI 10.1016/S0003-2670(00)86041-9
   YOKOI K, 1991, ANAL CHIM ACTA, V245, P167, DOI 10.1016/S0003-2670(00)80217-2
NR 18
TC 20
Z9 20
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-9795
J9 INTERMETALLICS
JI Intermetallics
PD MAR
PY 2004
VL 12
IS 3
BP 253
EP 260
DI 10.1016/j.intermet.2003.10.004
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 778FR
UT WOS:000189229300002
DA 2018-10-20
ER

PT J
AU Naitoh, M
   Katsumata, A
   Mitsuya, S
   Kamemoto, H
   Ariji, E
AF Naitoh, M
   Katsumata, A
   Mitsuya, S
   Kamemoto, H
   Ariji, E
TI Measurement of mandibles with microfocus X-ray computerized tomography
   and compact computerized tomography for dental use
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE biomedical technology assessment; compact computerized tomography;
   dental radiography; microfocus x-ray computerized tomography; trabecular
   bone patterns
ID MICROCOMPUTED TOMOGRAPHY; IMPLANTS
AB Purpose; The trabecular bone patterns in jaws and tooth structure were analyzed using microfocus x-ray computerized tomography (micro-CT), and the usefulness of this method was reported. This study was performed to clarify the accuracy of micro-CT and to determine whether micro-CT could replace bone slice segments as a means for assessment of the accuracy of medical radiography units. In addition, the accuracy of compact CT for dental use (compact CT) was evaluated using the same method. Materials and Methods: Three dried hemimandibles were used in this study. Images of mandibular interdental alveolar bone in the premolar and molar regions were obtained using micro-CT and compact CT Measurement of the mandibular shape at 6 sites using micro-CT images and at 4 sites using compact CT images was performed, and then the values of the micro-CT and compact CT were compared with those of bone slice segments. Results: The accuracy of mandibular measurement and the ratios of agreement for micro-CT were significantly higher than those for compact CT Moreover, the coefficient of correlation of the rate of trabecular bone between compact CT images and bone slice segment images was 0.916. Discussion: The significant difference in mandibular measurement betwen micro-CT and compact CT was considered to be related to pixel size. Conclusion: Micro-CT can replace bone slice segments for assessment of the accuracy of medical radiography units. In addition, compact CT can be used for imaging diagnosis in dental implant treatment. It is suggested that the ratio of trabecular bone could be used to evaluate the bone density.
C1 Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chikusa Ku, Nagoya, Aichi 4648651, Japan.
   Asahi Univ, Sch Dent, Dept Oral Radiol, Gifu, Japan.
   Asahi Univ, Sch Dent, Dept Oral Radiol, Gifu, Japan.
   Aichi Gakuin Univ, Dent Hosp, Oral Implant Clin, Nagoya, Aichi 464, Japan.
RP Naitoh, M (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chikusa Ku, 2-11 Suemori Dori, Nagoya, Aichi 4648651, Japan.
EM mune@dpc.aichi-gakuin.ac.jp
OI Katsumata, Akitoshi/0000-0001-5281-5234; Ariji,
   Eiichiro/0000-0002-5245-5395
CR Bou Serhal C, 2001, Clin Oral Implants Res, V12, P230
   Bou Serhal C, 2000, Clin Oral Implants Res, V11, P242
   Dowker SEP, 1997, ORAL SURG ORAL MED O, V83, P510, DOI 10.1016/S1079-2104(97)90155-4
   Ekestubbe A, 1997, DENTOMAXILLOFAC RAD, V26, P206, DOI 10.1038/sj.dmfr.4600249
   HOLLENDER L, 1992, ADV OSSEOINTEGRATION, P80
   Ide Yoshinobu, 2000, Acta Anatomica Nipponica, V75, P357
   Ito K, 2001, CLIN ORAL IMPLAN RES, V12, P539, DOI 10.1034/j.1600-0501.2001.120516.x
   Ito M, 1998, BONE, V23, P163, DOI 10.1016/S8756-3282(98)00083-0
   KLINGE B, 1989, International Journal of Oral and Maxillofacial Implants, V4, P327
   KOBAYASHI K, 2001, 5 WORLD C OR IMPL JA
   MONOV G, 2002, CLIN ORAL IMPLAN RES, V13, P28
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   NAITOH M, 1999, J JAP SOC ORAL IMPLA, V12, P246
   PETRIKOWSKI CG, 1989, J PROSTHET DENT, V61, P59, DOI 10.1016/0022-3913(89)90110-8
   Potter BJ, 1997, ORAL SURG ORAL MED O, V84, P436, DOI 10.1016/S1079-2104(97)90045-7
   Sennerby L, 2001, CLIN ORAL IMPLAN RES, V12, P91, DOI 10.1034/j.1600-0501.2001.012001091.x
   Shibata Takashi, 1999, Acta Anatomica Nipponica, V74, P545
   Sonic M, 1994, INT J ORAL MAXILLOF, V9, P455
   TODD AD, 1993, J PERIODONTOL, V64, P1243, DOI 10.1902/jop.1993.64.12.1243
   Uchiyama T, 1997, CALCIFIED TISSUE INT, V61, P493, DOI 10.1007/s002239900373
   Wyatt CCL, 1998, INT J PROSTHODONT, V11, P442
NR 21
TC 42
Z9 46
U1 0
U2 6
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2004
VL 19
IS 2
BP 239
EP 246
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 810VR
UT WOS:000220732300011
PM 15101596
DA 2018-10-20
ER

PT J
AU Rossomacha, E
   Hoemann, CD
   Shive, MS
AF Rossomacha, E
   Hoemann, CD
   Shive, MS
TI Simple methods for staining chitosan in biotechnological applications
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE chitin; Fast Green; Safranin-O; cibacron brilliant Red-3BA; tissue
   repair; drug delivery; blood clots
AB Chitosan is a naturally abundant cationic polysaccharide with unique physicochemical properties resulting in its use in a vast array of biomedical applications, including wound repair, drug delivery, and tissue engineering. However, despite numerous and diverse studies investigating its use, there have been no detailed reports describing specific staining methods for cell culture and histopathological studies using chitosan based materials. Here, we describe methods for staining chitosan in both cell culture and within paraffin sections. Procedural models used included identifying chitosan within in vitro whole blood clots, and culture wells, and in vivo chitosan hydrogel implants in multiple anatomical sites. First, a staining process for identifying chitosan was optimized using 0.03% Cibacron Brilliant Red-3BA. A second sensitive and versatile method using 0.01% Fast Green in conjunction with the known Safranin-O Method was demonstrated and may prove to be a key advancement in the histological study of chitosan-based biotechnological products. The method described here is broadly applicable to histological in situ detection of chitosan scaffolds of multiple deacetylation level and of variable fabrication.
C1 Biosyntech Canada Inc, Laval, PQ, Canada.
   Ecole Polytech, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada.
RP Rossomacha, E (reprint author), 475 Armand Frappier Blvd, Laval, PQ H7V 4B3, Canada.
OI Hoemann, Caroline/0000-0003-3750-7879
CR Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHENITE A, Patent No. 6344488
   GOROVSKY MA, 1970, ANAL BIOCHEM, V35, P359, DOI 10.1016/0003-2697(70)90196-X
   Hoekstra A, 1998, BIOMATERIALS, V19, P1467, DOI 10.1016/S0142-9612(98)00060-X
   HOEMANN CD, 2003, 3 ANN ENG TISS GROWT
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   LILLIE RD, 1976, HISTOPATHOLOGIC TECH
   Mattioli-Belmonte M, 1999, CARBOHYD POLYM, V40, P23, DOI 10.1016/S0144-8617(99)00028-4
   Muzzarelli R. A. A., 1993, CHITIN ENZYMOLOGY
   Muzzarelli RAA, 1998, ANAL BIOCHEM, V260, P255, DOI 10.1006/abio.1998.2705
   Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
NR 16
TC 16
Z9 17
U1 1
U2 7
PU NATL SOC HISTOTECHNOLOGY
PI BOWIE
PA 4201 NORTHVIEW DR, STE 502, BOWIE, MD 20716-1073 USA
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD MAR
PY 2004
VL 27
IS 1
BP 31
EP 36
DI 10.1179/his.2004.27.1.31
PG 6
WC Cell Biology
SC Cell Biology
GA 809HT
UT WOS:000220628500004
DA 2018-10-20
ER

PT J
AU Sproule, TL
   Lee, JA
   Li, HB
   Lannutti, JJ
   Tomasko, DL
AF Sproule, TL
   Lee, JA
   Li, HB
   Lannutti, JJ
   Tomasko, DL
TI Bioactive polymer surfaces via supercritical fluids
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE supercritical carbon dioxide; polymethylmethacrylate; swelling;
   impregnation; biomaterials; fluorescent protein
ID CARBON-DIOXIDE; INACTIVATION; MIXTURES
AB Supercritical CO2 (scCO(2)) can reversibly swell thermoplastic polymers. We use this phenomenon to enhance the impregnation of a fluorescently-labeled protein into a polymethylmethacrylate (PMMA) matrix. Exposure to scCO(2) provides simultaneous sterilization and foamed morphologies similar to those found in both hard and soft tissues in vivo. This combination of enhanced diffusion, foaming, and sterilization can conceivably be exploited to produce or modify a variety of biomedical materials. In the current study, efforts were made to control the scCO(2)-induced foaming in PMMA. Fundamental information regarding solid state swelling (via laser dilatometry) and foaming (via microfocus X-ray computed tomography) were used to explore the interactions between process variables. This is the first application of laser dilatometry to measure scCO(2) swelling of and desorption from a polymer in situ. scCO(2) at 40degreesC was also used to impregnate PMMA with a fluorescently-labeled protein, a rhodamine-labeled antibody to immunoglobin. Protein impregnation was verified using confocal microscopy. (C) 2003 Elsevier B.V All rights reserved.
C1 Ohio State Univ, Dept Chem Engn, Koffolt Lab 125, Columbus, OH 43210 USA.
   Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
RP Tomasko, DL (reprint author), Ohio State Univ, Dept Chem Engn, Koffolt Lab 125, 140 W 19th Ave, Columbus, OH 43210 USA.
EM tomasko.1@osu.edu
CR BERENS AR, 1992, J APPL POLYM SCI, V46, P231, DOI 10.1002/app.1992.070460204
   CASTOR TP, 1999, Patent No. 5877005
   Chang SH, 1998, J SUPERCRIT FLUID, V13, P113, DOI 10.1016/S0896-8446(98)00042-4
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   COOPER AI, 2001, ADV MATER, V13, P1114
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   DURRILL PL, 1966, AICHE J, V12, P1147, DOI 10.1002/aic.690120619
   Fages J, 1998, ASAIO J, V44, P289
   KAMIYA Y, 1998, MACROMOLECULES, V31, P477
   Kazarian S. G., 2000, POLYM SCI SER C, V42, P78, DOI DOI 10.1080/03602549909351647
   Kazarian SG, 2002, INT J PHARM, V232, P81, DOI 10.1016/S0378-5173(01)00905-X
   Kazarian SG, 1999, CHEMTECH, V29, P36
   Kazarian SG, 1996, J AM CHEM SOC, V118, P1729, DOI 10.1021/ja950416q
   KISZKA MB, 1988, J APPL POLYM SCI, V36, P583, DOI 10.1002/app.1988.070360311
   LIAU IS, 1985, SUPERCRITICAL FLUID, P415
   Lu PZK, 2000, J AM CERAM SOC, V83, P2536
   Ratner B. D., 1996, BIOMATERIALS SCI, P165
   SAIDGALIYEV E, 2000, IND ENG CHEM RES, V39, P4896
   von Schnitzler J, 1999, J SUPERCRIT FLUID, V16, P81, DOI 10.1016/S0896-8446(99)00020-0
   WANG Y, 2001, IND ENG CHEM RES, V41, P1780
   West BL, 1998, J APPL POLYM SCI, V69, P911, DOI 10.1002/(SICI)1097-4628(19980801)69:5<911::AID-APP10>3.0.CO;2-R
   WISSINGER RG, 1987, J POLYM SCI POL PHYS, V25, P2497, DOI 10.1002/polb.1987.090251206
NR 22
TC 46
Z9 50
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD MAR
PY 2004
VL 28
IS 2-3
BP 241
EP 248
DI 10.1016/S0896-8446(03)00044-5
PG 8
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 801ES
UT WOS:000220079800008
DA 2018-10-20
ER

PT J
AU Mandel, NS
   Henderson, JD
   Hung, LY
   Wille, DF
   Wiessner, JH
AF Mandel, NS
   Henderson, JD
   Hung, LY
   Wille, DF
   Wiessner, JH
TI A porcine model of calcium oxalate kidney stone disease
SO JOURNAL OF UROLOGY
LA English
DT Article
DE kidney; kidney calculi; swine; calcium oxalate; diet
ID RENAL EPITHELIAL-CELLS; PIG
AB Purpose: The pig has been extensively used in biomedical research because of the similarities in organ structure and function to humans. It is desirable to have an animal model of oxaluria and urolithiasis with physiological, anatomical and nutritional characteristics that more closely resemble those of man. In this study we determined if feeding pigs trans-4-hydroxy-L-proline (HP) increased urine oxalate levels and if it would serve as a model for human hyperoxaluria and stone disease.
   Materials and Methods: Male Yorkshire-Durox cross-bred pigs were fed HP for up to 20 days. Urine was periodically collected and analyzed for oxalate levels and the presence of crystalluria. After 20 days of feeding the kidneys were removed and examined grossly and microscopically for indications of injury, crystal deposition and stone formation.
   Results: Feeding pigs 10% HP (weight per weight HP/food) produced hyperoxaluria, which reached a maximum and leveled off by day 6. Urine oxalate remained near this level until the study ended at 20 days regardless of the further increase in HP to 20% of the weight of the food. When the kidneys were removed and grossly examined, calcium oxalate encrustations were observed on multiple papillary tips. Histopathological observation of the papillary tissue showed tissue injury and crystal deposition.
   Conclusions: Pigs fed HP have hyperoxaluria and calcium oxalate crystalluria, and calcium oxalate papillary deposits form that may be precursors of kidney stones. The use of the pig as a model of human hyperoxaluria and stone formation should prove ideal for studies of these human diseases.
C1 Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA.
   Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA.
   Zablocki Vet Affairs Med Ctr, Dept Vet Affairs, Milwaukee, WI USA.
RP Mandel, NS (reprint author), Vet Affairs Med Ctr, Res Serv 151, 5000 W Natl Ave, Milwaukee, WI 53295 USA.
FU NIDDK NIH HHS [R21-DK062739-01]; PHS HHS [R01-30579]
CR ASSIMOS DG, 1986, SWINE BIOL RES, V1, P399
   BORDEN T. A., 1966, INVEST UROL, V4, P125
   Bushinsky DA, 2002, KIDNEY INT, V61, P975, DOI 10.1046/j.1523-1755.2002.00190.x
   Jonassen JA, 1999, J AM SOC NEPHROL, V10, pS446
   KHAN SR, 1985, SCAN ELECTRON MICROS, P759
   KHAN SR, 1989, UROLITHIASIS, P117
   Paterson RF, 2002, J ENDOUROL, V16, P543, DOI 10.1089/089277902320913215
   SACHS DH, 1994, VET IMMUNOL IMMUNOP, V43, P185, DOI 10.1016/0165-2427(94)90135-X
   TERRIS JM, 1986, SWINE BIOL RES, V1, P1673
   Wiessner JH, 1999, J AM SOC NEPHROL, V10, pS441
NR 10
TC 27
Z9 29
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAR
PY 2004
VL 171
IS 3
BP 1301
EP 1303
DI 10.1097/01.ju.0000110101.41653.bb
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 774DU
UT WOS:000188965100084
PM 14767337
DA 2018-10-20
ER

PT J
AU Lukaszczyk, J
   Benecki, L
   Jaszcz, K
   Smiga, M
AF Lukaszczyk, J
   Benecki, L
   Jaszcz, K
   Smiga, M
TI Versatility of potential biomedical use of functional polysuccinates
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 2nd International Symposium on React 2003
CY SEP 28-OCT 01, 2003
CL Dresden, GERMANY
SP Deutsch Forsch Geminsch, Sachsisches Staatsminister Wissensch & Kunst, Deutsch Akad Austauschdienst, Tech Univ Dresden, Parr Instrument Deutschland Gmbh, DSM, Geleen, Buchi Autoklaven & Reaktorsyst GmbH
DE biodegradable biomaterials; drug carriers; functional polysuccinates
ID POLYESTER RESINS; GLUTARIC ANHYDRIDE; ALLYL ETHERS
AB Polysuccinates with pendant allyl groups (PSAGE) were synthesized by melt copolymerization of succinic anhydride with allyl glycidyl ether and eventually other glycidyl ethers. It was found that PSAGE could be crosslinked by radical copolymerization with methyl methacrylate. Oxidized PSAGE considered as multifunctional epoxy resin was cured with use of glutaric anhydride to form solid material susceptible to hydrolytic degradation to water-soluble non-toxic products. Comb-like amphiphilic polysuccinates containing both pendant poly(oxyethylene) chains and epoxy groups have been synthesized as well and checked for their solubility in water. Properties of PSAGE-type polymers suggests their potential use as biomaterials and polymeric drug carries.
C1 Silesian Tech Univ, Dept Phys Chem & Technol Polymers, PL-44100 Gliwice, Poland.
RP Lukaszczyk, J (reprint author), Silesian Tech Univ, Dept Phys Chem & Technol Polymers, Ul M Strzody 9, PL-44100 Gliwice, Poland.
RI Smiga-Matuszowicz, Monika/R-9838-2018
OI Smiga-Matuszowicz, Monika/0000-0003-4651-5619; Jaszcz,
   Katarzyna/0000-0003-4883-8278
CR [Anonymous], 58332001 ISOFDIS
   BENDIX D, 1998, POLYM DEGRAD STABIL, V59, P12
   Bevington JC, 2001, J MACROMOL SCI PURE, V38, P981, DOI 10.1081/MA-100105960
   CHUNG H, 2003, EUR POLYM J, V39, P1817
   FURUKAWA S, 1980, FEBS LETT, V121, P239, DOI 10.1016/0014-5793(80)80351-6
   KOHN DH, 1992, MAT SCI TECHNOLOGY, V14
   Lukaszczyk J, 2002, MACROMOL CHEM PHYSIC, V203, P301, DOI 10.1002/1521-3935(20020101)203:2<301::AID-MACP301>3.0.CO;2-6
   Lukaszczyk J, 2002, POLYM ADVAN TECHNOL, V13, P871, DOI 10.1002/pat.281
   Lukaszczyk J, 2000, REACT FUNCT POLYM, V43, P25, DOI 10.1016/S1381-5148(98)00090-X
   ODIAN G, 1981, PRINCIPLES POLYM, P251
   Rokicki G, 1998, J APPL POLYM SCI, V70, P2031, DOI 10.1002/(SICI)1097-4628(19981205)70:10<2031::AID-APP19>3.3.CO;2-W
   ROSE S, 1991, CHEM LIFE
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   TIMMER MD, 2000, BIOMATERIALS, V21, P2395
   TRAENCKENER HJ, 1982, ANGEW MAKROMOL CHEM, V108, P619
   Uyama H, 2003, BIOMACROMOLECULES, V4, P211, DOI 10.1021/bm0256092
NR 16
TC 4
Z9 4
U1 0
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD MAR
PY 2004
VL 210
BP 457
EP 464
DI 10.1002/masy.200450651
PG 8
WC Polymer Science
SC Polymer Science
GA 821DC
UT WOS:000221439100052
DA 2018-10-20
ER

PT J
AU Laptev, A
   Bram, M
   Buchkremer, HP
   Stover, D
AF Laptev, A
   Bram, M
   Buchkremer, HP
   Stover, D
TI Study of production route for titanium parts combining very high
   porosity and complex shape
SO POWDER METALLURGY
LA English
DT Article
DE porous titanium; metal foam; pore forming; near net shape
ID MECHANICAL-PROPERTIES; STAINLESS-STEEL
AB The production of highly porous titanium parts of complex shape by powder metallurgical technology is described. Well defined porosity and pore sizes were achieved using a pore forming additive. This additive also enhances the strength of unsintered compacts, allowing machining in the green state. The requirements of the initial powders and pecularities of each production step are discussed in detail. The microstructure of porous materials and examples of net shape parts are given, aiming preferentially at biomedical applications. The impurities of the obtained titanium parts are compared with the requirements of the ISO standard for titanium implants.
C1 Forschoungzentrum Julich GmbH, Inst Werkstoffe & Verfahren Energietech, D-52425 Julich, Germany.
   Donbass State Engn Acad, UA-84313 Kramatorsk, Ukraine.
RP Laptev, A (reprint author), Forschoungzentrum Julich GmbH, Inst Werkstoffe & Verfahren Energietech, D-52425 Julich, Germany.
EM m.bram@fz-juelich.de
OI Laptev, Alexander/0000-0001-9077-5747
CR Azevedo CRF, 2003, J ALLOY COMPD, V353, P217, DOI 10.1016/S0925-8388(02)01297-5
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Bram M, 2000, MATERIALWISS WERKST, V31, P497, DOI 10.1002/1521-4052(200006)31:6<497::AID-MAWE497>3.3.CO;2-O
   BRAM M, 2001, CELLULAR METALS MATA, P215
   BRAM M, 2000, PM2000 WORLD C POWD, P1131
   BREME J, 1996, ITTAN TITANLEGIERUNG, P205
   BUCHKREMER HP, 1998, Patent No. 19726961
   Davis NG, 2001, J MATER RES, V16, P1508, DOI 10.1557/JMR.2001.0210
   GERMAN RM, 1996, SINTERING THEORY PRA, P550
   Hausner H. H., 1982, HDB POWDER METALLURG
   ILYUSCHENKO A, 2001, P 15 INT PLANS SEM, V3, P248
   *ISO, 58322 ISO
   LIDE DR, 1994, CRC HDB CHEM PHYS, P37
   Rausch G, 2000, MATERIALWISS WERKST, V31, P412, DOI 10.1002/1521-4052(200006)31:6<412::AID-MAWE412>3.3.CO;2-2
   SCHATT W, 1997, POWEDER METALLURGY P, P353
   Wen CE, 2002, J MATER SCI-MATER M, V13, P397, DOI 10.1023/A:1014344819558
   WHEELER KR, 1974, Patent No. 3852045
   WINTERMANTEL E, 1996, BIOKOMPATIBLE WERKST, V159, P162
NR 18
TC 72
Z9 74
U1 3
U2 11
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0032-5899
J9 POWDER METALL
JI Powder Metall.
PD MAR
PY 2004
VL 47
IS 1
BP 85
EP 92
DI 10.1179/003258904225015536
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 813IN
UT WOS:000220900900026
DA 2018-10-20
ER

PT J
AU Dabhade, RV
   Bodas, DS
   Gangal, SA
AF Dabhade, RV
   Bodas, DS
   Gangal, SA
TI Plasma-treated polymer as humidity sensing material - a feasibility
   study
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE PMMA; humidity sensing; plasma treatment
ID THIN-FILMS; SENSOR; PMMA
AB Plasma treatment of polymers (surface modification) has been carried out for a long time namely for adhesion improvement and biomedical applications, as it is known to improve the wettability (increase in hydrophilicity) of the polymer surface. It was noted that although extensive work in this area has been carried out, no literature is available on the possible use of plasma-treated/modified polymers for use as humidity sensors. With this in mind, work has been carried out to study the possible use of plasma surface treatment of polymers for humidity sensing. In this communication, we report to the best of our knowledge for the first time humidity sensing by argon plasma-treated polymer namely PMMA with encouraging results. The argon plasma-treated PMMA was characterized by FTIR, XPS, SEM, and contact angle measurements. A capacitive RH sensor was fabricated using the argon plasma-treated PMMA as the dielectric for relative humidity sensing. The sensors fabricated from argon plasma-treated PMMA showed improvement in their sensitivity in 0-40% RH range. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Poona, Dept Elect Sci, Pune 411007, Maharashtra, India.
RP Gangal, SA (reprint author), Univ Poona, Dept Elect Sci, Pune 411007, Maharashtra, India.
EM sag@electronics.unipune.ernet.in
CR Anchisini R, 1996, SENSOR ACTUAT B-CHEM, V35, P99, DOI 10.1016/S0925-4005(97)80037-8
   France RM, 1997, J CHEM SOC FARADAY T, V93, P3173, DOI 10.1039/a702311a
   LISTON EM, 1994, PLASMA SURFACE MODIF
   Maddanimath T, 2002, SENSOR ACTUAT B-CHEM, V81, P141, DOI 10.1016/S0925-4005(01)00944-3
   Matsuguchi M, 1998, SENSOR ACTUAT B-CHEM, V49, P179, DOI 10.1016/S0925-4005(98)00117-8
   MATSUGUCHI M, 1991, J ELECTROCHEM SOC, V138, P1862, DOI 10.1149/1.2085886
   Perez JMM, 1997, SENSOR ACTUAT B-CHEM, V42, P27, DOI 10.1016/S0925-4005(97)80308-5
   RALSTON ARK, 1994, SENSOR ACTUAT B-CHEM, V22, P139, DOI 10.1016/0925-4005(94)87013-6
   SAKAI Y, 1993, SENSOR ACTUAT B-CHEM, V13, P82, DOI 10.1016/0925-4005(93)85329-9
   Sakai Y, 1996, SENSOR ACTUAT B-CHEM, V35, P85, DOI 10.1016/S0925-4005(96)02019-9
   Schroth A, 1996, SENSOR ACTUAT B-CHEM, V34, P301, DOI 10.1016/S0925-4005(96)01936-3
   Schulz U, 2001, SURF COAT TECH, V142, P507, DOI 10.1016/S0257-8972(01)01202-6
   SILVERSTEEN RM, 2002, SPECTROSCOPIC IDENTI
   VARGO TG, 1989, J POLYM SCI POL CHEM, V27, P1267, DOI 10.1002/pola.1989.080270413
   WEXLER A, 1965, HUMIDITY MOISTURE ME, V1, P219
NR 15
TC 31
Z9 31
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD MAR 1
PY 2004
VL 98
IS 1
BP 37
EP 40
DI 10.1016/j.snb.2003.08.020
PG 4
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 801ZB
UT WOS:000220132700006
DA 2018-10-20
ER

PT J
AU Salgado, AJ
   Coutinho, OP
   Reis, RL
AF Salgado, AJ
   Coutinho, OP
   Reis, RL
TI Novel starch-based scaffolds for bone tissue engineering: Cytotoxicity,
   cell culture, and protein expression
SO TISSUE ENGINEERING
LA English
DT Article
ID BIODEGRADABLE POLYMER SCAFFOLDS; MORPHOLOGY; LINE; DIFFERENTIATION;
   PROLIFERATION; DEXAMETHASONE; REGENERATION; DEGRADATION; TECHNOLOGY;
   DESIGN
AB Starch-based biomaterials and scaffolds have been proposed for several biomedical applications. In the present work new scaffolds based on a 50150 (wt%) blend of corn starch/ethylene-vinyl alcohol (SEVA-C) were studied. These scaffolds were processed by a melt-based technology, which has been used before with other starch-based materials but never with SEVA-C. Scanning electron microscopy (SEM) observation showed that the developed porous structures were 60% porous with pore size between 200 and 900 mum and a reasonable degree of interconnectivity. Moreover, scaffolds presented a compressive modulus of 117.50 +/- 3.7 MPa and a compressive strength of 20.8 +/- 2.4 MPa. Cytotoxicity evaluation was performed according to ISO/EN 10993 part 5 guidelines, and revealed that the developed scaffolds were nontoxic and did not inhibit cell growth. Direct contact assays were also carried out by use of a cell line of human osteoblast-like cells (SaOS-2). Cells were seeded (3 X 101 per scaffold) and allowed to grow for 4 weeks at 37degreesC, in a humidified atmosphere containing 5% CO2. Total protein assay showed that the cells were able to grow for the 4 weeks of the experiment. These data were further confirmed by SEM. Moreover, a cell viability assay (NITS test) demonstrated that cells were perfectly viable after the 4 weeks of culture, showing the adequacy of the developed structure in supporting them. Finally, Western blot analysis revealed that osteopontin was being actively expressed by the cells, which, in association with collagen deposition observed by SEM, seems to indicate that bone extracellular matrix was being deposited. Consequently it is believed that starch-based scaffolds should be considered as an alternative for bone tissue-engineering applications in the near future.
C1 Univ Minho, Res Grp Biomat Biodegradables Biomimet B3, P-4710057 Braga, Portugal.
   Univ Minho, Dept Biol, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, Guimareaes, Portugal.
RP Salgado, AJ (reprint author), Univ Minho, Res Grp Biomat Biodegradables Biomimet B3, Campus Gualtar, P-4710057 Braga, Portugal.
EM asalgado@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Coutinho, Olga/K-7155-2013; Salgado,
   Antonio/J-4129-2013; Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Salgado, Antonio/0000-0003-3806-9823;
   Group, 3Bs/0000-0002-5195-3456; Coutinho, Olga/0000-0002-0647-080X
CR [Anonymous], 1992, 10993 ISO
   CORY AH, 1991, CANCER COMMUN, V3, P207
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Horbett TA, 1998, J BIOMAT SCI-POLYM E, V9, P1071, DOI 10.1163/156856298X00334
   Hulley PA, 1998, ENDOCRINOLOGY, V139, P2423, DOI 10.1210/en.139.5.2423
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Melican MC, 2001, J BIOMED MATER RES, V55, P194, DOI 10.1002/1097-4636(200105)55:2<194::AID-JBM1006>3.0.CO;2-K
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   Ogston N, 2002, STEROIDS, V67, P895, DOI 10.1016/S0039-128X(02)00054-5
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   REIS RL, 1998, J APPL MED POLYM, V2, P49
   REIS RL, 2001, BIOL BIOMIMETIC MAT, P8810
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Salih V, 2000, J MATER SCI-MATER M, V11, P615, DOI 10.1023/A:1008901612674
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   STEELE JG, 1999, BONE ENG, P225
   Temenoff J.S., 1999, BONE ENG, P454
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Washburn NR, 2002, J BIOMED MATER RES, V60, P20, DOI 10.1002/jbm.10049
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 36
TC 88
Z9 88
U1 0
U2 13
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAR-APR
PY 2004
VL 10
IS 3-4
BP 465
EP 474
DI 10.1089/107632704323061825
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 816JA
UT WOS:000221105000016
PM 15165463
DA 2018-10-20
ER

PT J
AU Friedman, M
AF Friedman, M
TI Applications of the ninhydrin reaction for analysis of amino acids,
   peptides, and proteins to agricultural and biomedical sciences
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Review
DE ninhydrin; Ruhemann's purple; amino acids; peptides; proteins; analysis;
   food chemistry; protein chemistry; clinical chemistry; histochemistry;
   fo; rensic science; microbiology; medicine; nutrition; pharmacology;
   plant science; toxicology; proteolysis; cereal proteins; keratin
   proteins; milk proteins; soy proteins; whey proteins; protein-tannin
   complexes; cheeses; fruits; vegetables
ID ION-EXCHANGE CHROMATOGRAPHY; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   BETA-UNSATURATED COMPOUNDS; THIN-LAYER CHROMATOGRAPHY; QUANTITATIVE
   COLORIMETRIC ASSAY; FLUORESCENT TERNARY PRODUCTS; TRIKETOHYDRINDENE
   HYDRATE; LATENT FINGERPRINTS; FOOD PROTEINS; SPECTROPHOTOMETRIC
   DETERMINATION
AB The reaction of ninhydrin with primary amino groups to form the purple dye now called Ruhemann's purple (RIP) was discovered by Siegfried Ruhemann in 1910. In addition, imines such as pipecolic acid and proline, the guanidino group of arginine, the amide groups of asparagine, the indole ring of tryptophan, the sulfhydryl group of cysteine, amino groups of cytosine and guanine, and cyanide ions also react with ninhydrin to form various chromophores of analytical interest. Since its discovery, extensive efforts have been made to apply manual and automated ninhydrin reactions as well as ninhydrin spray reagents to the detection, isolation, and analysis of numerous compounds of interest across a broad spectrum of disciplines. These include agricultural, biochemical, clinical, environmental, food, forensic, histochemical, microbiological, medical, nutritional, plant, and protein sciences. This reaction is unique among chromogenic reactions in that at pH 5.5 it results in the formation of the same soluble chromophore by all primary amines which react, be they amines, amino acids, peptides, proteins, and even ammonia. Because the chromophore is not chemically bound to the protein or other insoluble material, it is not lost when the insoluble substrate is removed by centrifugation or filtration after the reaction is completed. The visible color of the chromophore is distinctive and is generally not affected by the yellow colors present in many food, plant, and tissue extracts. Adaptations of the classical ninhydrin reaction to specialized needs; in analytical chemistry and biochemistry include the use of acid, alkaline, and fluorogenic ninhydrin reagents. To cross-fertilize information among several disciplines wherein an interest in the ninhydrin reaction has developed, and to enhance its utility, this review attempts to integrate and correlate the widely scattered literature on ninhydrin reactions of a variety of structurally different compounds. Specifically covered are the following aspects: historical perspective, chemistry and mechanisms, applications, and research needs. A better understanding of these multifaceted ninhydrin, reactions provide a scientific basis for further improvements of this important analytical technique.
C1 USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA.
RP Friedman, M (reprint author), USDA ARS, Western Reg Res Ctr, 800 Buchanan St, Albany, CA 94710 USA.
EM mfried@pw.usda.gov
OI Friedman, Mendel/0000-0003-2582-7517
CR Abdellatef HE, 2003, J PHARMACEUT BIOMED, V31, P209, DOI 10.1016/S0731-7085(02)00572-1
   ABDERHALDEN E, 1911, Z PHYSL CHEM, V72, P37
   ABDERHALDEN E, 1913, Z PHYSL CH, V85, P143
   AHOKAS H, 1989, CEREAL CHEM, V66, P135
   Al-Shabanah OA, 2000, LIFE SCI, V67, P559, DOI 10.1016/S0024-3205(00)00645-7
   BECKWITH AC, 1975, J AGR FOOD CHEM, V23, P194, DOI 10.1021/jf60198a015
   Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w
   BENSON JV, 1972, ANAL BIOCHEM, V50, P477, DOI 10.1016/0003-2697(72)90057-7
   BOPPANA VK, 1990, J CHROMATOGR, V507, P79, DOI 10.1016/S0021-9673(01)84183-2
   Boschin G, 2003, J DAIRY SCI, V86, P2283, DOI 10.3168/jds.S0022-0302(03)73820-X
   BOTTOM CB, 1979, BIOCHEM EDUC, V6, P4
   Briddon A, 1998, AMINO ACIDS, V15, P235, DOI 10.1007/BF01318862
   BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8
   BRODERICK GA, 1975, PROTEIN NUTRITIONA 2, P211
   CANDIANO G, 1989, PREP BIOCHEM, V19, P193, DOI 10.1080/10826068908544909
   CARRASCO P, 1988, PHYSIOL PLANTARUM, V72, P610, DOI 10.1111/j.1399-3054.1988.tb09171.x
   CASHMAN PJ, 1979, J FORENSIC SCI SOC, V19, P137, DOI 10.1016/S0015-7368(79)71264-3
   CAVINS JF, 1967, BIOCHEMISTRY-US, V6, P3766, DOI 10.1021/bi00864a021
   CAVINS JF, 1970, ANAL BIOCHEM, V35, P489, DOI 10.1016/0003-2697(70)90211-3
   CAVINS JF, 1968, CEREAL CHEM, V45, P172
   CHAPLIN MF, 1976, BIOCHEM J, V155, P457, DOI 10.1042/bj1550457
   Chauffe L, 1977, Adv Exp Med Biol, V86A, P415
   CHEN G, 1987, J DAIRY SCI, V70, P1211, DOI 10.3168/jds.S0022-0302(87)80133-9
   CHEN GJ, 1991, J ANIM SCI, V69, P2196
   CHINARD FP, 1952, J BIOL CHEM, V199, P91
   CONCON JM, 1975, PROTEIN NUTRITION QU, P311
   CONGER KA, 1978, J HISTOCHEM CYTOCHEM, V26, P423, DOI 10.1177/26.6.78939
   COOPER C, 2001, METHOD MOL BIOL, P265
   DAVIES RL, 1972, J CHROMATOGR, V71, P564
   de Jonge R, 2003, J APPL MICROBIOL, V94, P625
   DENT CE, 1948, BIOCHEM J, V43, P169, DOI 10.1042/bj0430169
   DHOOGE R, 1992, J NEUROL SCI, V112, P96, DOI 10.1016/0022-510X(92)90138-B
   DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5
   DORLAND L, 1990, CLIN CHIM ACTA, V188, P221, DOI 10.1016/0009-8981(90)90203-5
   EGGUM BO, 1989, ABSORPTION UTILIZATI, V3, P265
   EVERSE KE, 1986, J FORENSIC SCI, V31, P446
   Exline DL, 2003, J FORENSIC SCI, V48, P1047
   Ezeagu IE, 2002, FOOD CHEM, V78, P105, DOI 10.1016/S0308-8146(02)00105-X
   FELDHOFF RC, 1984, J CHROMATOGR, V311, P267, DOI 10.1016/S0378-4347(00)84720-9
   Finley J W, 1977, Adv Exp Med Biol, V86B, P123
   FINLEY JW, 1973, CEREAL CHEM, V50, P101
   FOLKERTSMA B, 1992, J DAIRY RES, V59, P217, DOI 10.1017/S0022029900030466
   Folkertsma B, 1996, INT DAIRY J, V6, P1117, DOI 10.1016/0958-6946(95)00066-6
   Fontaine J, 2000, J AOAC INT, V83, P771
   Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r
   Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+
   FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868
   FRIEDMAN M, 1980, ANAL BIOCHEM, V106, P27, DOI 10.1016/0003-2697(80)90114-1
   FRIEDMAN M, 1970, BIOCHIM BIOPHYS ACTA, V207, P361, DOI 10.1016/0005-2795(70)90028-0
   FRIEDMAN M, 1974, BIOORG CHEM, V3, P267, DOI 10.1016/0045-2068(74)90017-0
   Friedman M, 1999, J AGR FOOD CHEM, V47, P3457, DOI 10.1021/jf990080u
   FRIEDMAN M, 1984, J FOOD SCI, V49, P1282, DOI 10.1111/j.1365-2621.1984.tb14970.x
   FRIEDMAN M, 1980, ENVIRON SCI TECHNOL, V14, P1145, DOI 10.1021/es60169a003
   FRIEDMAN M, 1967, CAN J CHEMISTRY, V45, P2271, DOI 10.1139/v67-369
   FRIEDMAN M, 1971, MICROCHEM J, V16, P204, DOI 10.1016/0026-265X(71)90110-X
   FRIEDMAN M, 1981, J CHROMATOGR, V219, P343, DOI 10.1016/S0021-9673(00)87949-2
   FRIEDMAN M, 1973, ANAL BIOCHEM, V54, P333, DOI 10.1016/0003-2697(73)90361-8
   FRIEDMAN M, 1971, J AGR FOOD CHEM, V19, P626, DOI 10.1021/jf60176a010
   FRIEDMAN M, 1979, NUTR REP INT, V19, P437
   FRIEDMAN M, 1979, J AGR FOOD CHEM, V27, P331, DOI 10.1021/jf60222a001
   Friedman M, 1996, J AGR FOOD CHEM, V44, P6, DOI 10.1021/jf9400167
   FRIEDMAN M, 1966, J ORG CHEM, V31, P2888, DOI 10.1021/jo01347a036
   FRIEDMAN M, 1965, J AM CHEM SOC, V87, P3672, DOI 10.1021/ja01094a025
   FRIEDMAN M, 1995, J AGR FOOD CHEM, V43, P69, DOI 10.1021/jf00049a014
   Friedman M, 1978, Adv Exp Med Biol, V105, P131
   Friedman M., 1982, Diabetes, V31, P5
   FRIEDMAN M, 1984, J FOOD SCI, V49, P10, DOI 10.1111/j.1365-2621.1984.tb13656.x
   FRIEDMAN M, 1988, J AGR FOOD CHEM, V36, P1079, DOI 10.1021/jf00083a042
   FRIEDMAN M, 1968, J ORG CHEM, V33, P154, DOI 10.1021/jo01265a028
   FRIEDMAN M, 1986, J AGR FOOD CHEM, V34, P497, DOI 10.1021/jf00069a032
   FRIEDMAN M, 1973, ANAL BIOCHEM, V51, P280, DOI 10.1016/0003-2697(73)90476-4
   FRIEDMAN M, 1973, P485
   FRIEDMAN M, 1990, J AGR FOOD CHEM, V38, P2011, DOI 10.1021/jf00101a005
   FRIEDMAN M, 1970, TEXT RES J, V40, P1073, DOI 10.1177/004051757004001205
   FRIEDMAN M, 1974, INT J PEPT PROT RES, V6, P183
   FRIEDMAN M, 1979, ANAL BIOCHEM, V98, P293, DOI 10.1016/0003-2697(79)90144-1
   FRIEDMAN M, 1967, J AM CHEM SOC, V89, P4709, DOI 10.1021/ja00994a025
   FRIEDMAN M, 1982, J AGR FOOD CHEM, V30, P72, DOI 10.1021/jf00109a015
   Friedman M, 2001, J PROTEIN CHEM, V20, P431, DOI 10.1023/A:1012558530359
   Friedman M, 2001, J AGR FOOD CHEM, V49, P1069, DOI 10.1021/jf0009246
   Friedman M, 1999, J AGR FOOD CHEM, V47, P1295, DOI 10.1021/jf981000+
   FRIEDMAN M, 1964, J AM CHEM SOC, V86, P3735, DOI 10.1021/ja01072a025
   FRIEDMAN M, 1966, BIOCHEMISTRY-US, V5, P478, DOI 10.1021/bi00866a012
   Friedman M, 1984, PROGR TRYPTOPHAN SER, P119
   FRIEDMAN M, 1975, PROTEIN NUTRITIONA 1, P521
   FRIEDMAN M, 1977, PROTEIN CROSSLINKING, V86, P1
   FRIEDMAN M, 1978, NUTR IMPROVEMENT FOO, P882
   FRIEDMAN M, 1977, FOOD PROTEINS, P465
   FRIEDMAN M, 1990, UNPUB REACTIONS FRUI
   FRIEDMAN M, 1970, PROTEIN CROSS LINKIN, P545
   FRIEDMAN M, 1980, P 6 INT WOOL TEXT RE, V5, P323
   FRIEDMAN M, 1971, J APPL POLYM SCI, V18, P297
   FRIEDMAN M, 1978, FLAME RETARDANT POLY, P229
   Frutos P, 2000, J PHARMACEUT BIOMED, V21, P1149, DOI 10.1016/S0731-7085(99)00192-2
   FUKUDA M, 1979, HISTOCHEMISTRY, V63, P35, DOI 10.1007/BF00508010
   Fukuda S, 1996, CIENC TECNOL ALIMENT, V16, P52
   GAITONDE MK, 1970, BIOCHEM J, V117, P907, DOI 10.1042/bj1170907
   GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627
   GARCIABUSTOS JF, 1984, BIOCHEM BIOPH RES CO, V119, P779, DOI 10.1016/S0006-291X(84)80318-6
   GARDNER MLG, 1984, ANAL BIOCHEM, V141, P429, DOI 10.1016/0003-2697(84)90066-6
   GOLDMAN WE, 1982, INFECT IMMUN, V36, P782
   Grangeasse C, 1999, BIOTECHNIQUES, V27, P62, DOI 10.2144/99271bm12
   GRASSMANN W, 1934, ANAL CHEM, V6, P288
   GRIFFIN M, 1984, MOL CELL BIOCHEM, V58, P37, DOI 10.1007/BF00240603
   Griswold KE, 1997, J DAIRY SCI, V80, P167, DOI 10.3168/jds.S0022-0302(97)75924-1
   HAAGSMA N, 1979, J CHROMATOGR, V168, P550, DOI 10.1016/0021-9673(79)80032-1
   Harding VJ, 1916, J BIOL CHEM, V25, P319
   Harding VJ, 1916, J BIOL CHEM, V25, P337
   Heesing A, 1970, Justus Liebigs Ann Chem, V735, P72, DOI 10.1002/jlac.19707350112
   HIRS CHW, 1954, J BIOL CHEM, V211, P941
   HOLMES EJ, 1968, J HISTOCHEM CYTOCHEM, V16, P428, DOI 10.1177/16.6.428
   HSIEH CL, 1995, ANAL BIOCHEM, V224, P187, DOI 10.1006/abio.1995.1027
   HUAIGONG W, 1988, CHEM J CLIN U, V9, P732
   HURST PL, 1995, FOOD CHEM, V53, P467, DOI 10.1016/0308-8146(95)99843-O
   Hurst PL, 1998, FOOD CHEM, V61, P381, DOI 10.1016/S0308-8146(97)00031-9
   HUTZLER J, 1983, CLIN CHIM ACTA, V128, P75, DOI 10.1016/0009-8981(83)90057-8
   IWASE H, 1995, J CHROMATOGR B, V663, P15, DOI 10.1016/0378-4347(94)00439-C
   Jeannotte ME, 2003, INFECT IMMUN, V71, P4657, DOI 10.1128/IAI.71.8.4657-4663.2003
   JOOSTEN HMLJ, 1986, J CHROMATOGR, V356, P311, DOI 10.1016/S0021-9673(00)91491-2
   Jorns A, 1997, J ENDOCRINOL, V155, P283, DOI 10.1677/joe.0.1550283
   JOULLIE MM, 1991, TETRAHEDRON, V47, P8791, DOI 10.1016/S0040-4020(01)80997-2
   KABIRUD D, 2000, J CHEM A, V39, P1019
   KABIRUDDIN JKJ, 1999, J COLLOID INTERF SCI, V215, P9
   KALAN EB, 1965, ANAL BIOCHEM, V12, P488, DOI 10.1016/0003-2697(65)90215-0
   KANG SM, 1989, PLANT PHYSIOL, V91, P1232, DOI 10.1104/pp.91.3.1232
   KAS J, 1982, SB VYS SK CHEM TECHN, VE53, P67
   KATO T, 1986, J JPN SOC HORTIC SCI, V55, P169
   Kaupp G, 2002, CHEM-EUR J, V8, P594, DOI 10.1002/1521-3765(20020201)8:3<594::AID-CHEM594>3.0.CO;2-5
   Khramov V A, 2002, Stomatologiia (Mosk), V81, P10
   Kim MS, 2002, TOXICOL APPL PHARM, V183, P55, DOI 10.1006/taap.2002.9456
   Kleinman MH, 2003, PHOTOCHEM PHOTOBIOL, V77, P10, DOI 10.1562/0031-8655(2003)077<0010:TSON>2.0.CO;2
   KLOTZ AV, 1991, ARCH BIOCHEM BIOPHYS, V291, P113, DOI 10.1016/0003-9861(91)90112-V
   KOKKINI G, 1980, BLOOD, V56, P701
   KREMPF M, 1990, SCI ALIMENT, V10, P671
   Krzek J, 2001, J PHARMACEUT BIOMED, V24, P629, DOI 10.1016/S0731-7085(00)00438-6
   KUBO H, 1987, ANAL BIOCHEM, V162, P219, DOI 10.1016/0003-2697(87)90030-3
   KUBO H, 1989, BUNSEKI KAGAKU, V38, P215
   KUHN R, 1951, CHEM BER-RECL, V84, P91, DOI 10.1002/cber.19510840115
   LABER B, 1989, ANAL BIOCHEM, V181, P297, DOI 10.1016/0003-2697(89)90246-7
   LAMOTHE PJ, 1973, ANAL CHEM, V45, P1906, DOI 10.1021/ac60333a021
   LAMOTHE PJ, 1972, ANAL CHEM, V44, P821, DOI 10.1021/ac60312a003
   LANGNER HJ, 1969, J CHROMATOGR, V45, P142, DOI 10.1016/S0021-9673(01)86194-X
   LaPorte GM, 2003, J FORENSIC SCI, V48, P658
   Laskar S, 2001, AMINO ACIDS, V21, P201, DOI 10.1007/s007260170027
   LeBoucher J, 1997, CLIN CHEM, V43, P1421
   LENZEN S, 1992, N-S ARCH PHARMACOL, V346, P532
   LIARDON R, 1987, J AGR FOOD CHEM, V35, P661, DOI 10.1021/jf00077a007
   Ma ZW, 2003, J BIOMED MATER RES B, V67B, P610, DOI 10.1002/jbm.b.10049
   Macchi FD, 2000, METH MOL B, V159, P9
   MACFADYEN DA, 1950, J BIOL CHEM, V186, P13
   MACFADYEN DA, 1950, J BIOL CHEM, V186, P1
   MACGREGOR JT, 1980, ENVIRON MUTAGEN, V2, P405, DOI 10.1002/em.2860020311
   MAGNE C, 1992, ANAL BIOCHEM, V200, P115, DOI 10.1016/0003-2697(92)90285-F
   MAKKAR HPS, 1987, ANAL BIOCHEM, V166, P435, DOI 10.1016/0003-2697(87)90596-3
   MALININ GI, 1991, J HISTOCHEM CYTOCHEM, V39, P707, DOI 10.1177/39.5.2016517
   Markandeya N, 2002, INT J LEPROSY, V70, P125
   MARKS D, 1987, J SCI FOOD AGR, V38, P255, DOI 10.1002/jsfa.2740380309
   MARKS DL, 1985, ANAL BIOCHEM, V147, P136, DOI 10.1016/0003-2697(85)90019-3
   Martinez LG, 2002, J PHARMACEUT BIOMED, V29, P405
   MASON V C, 1976, Zeitschrift fuer Tierphysiologie Tierernaehrung und Futtermittelkunde, V36, P221
   MCCALDIN DJ, 1960, CHEM REV, V60, P39, DOI 10.1021/cr60203a004
   MCGRATH R, 1972, ANAL BIOCHEM, V49, P95, DOI 10.1016/0003-2697(72)90245-X
   MENCKE AJ, 1987, METHOD ENZYMOL, V138, P409
   MENEFEE E, 1985, J PROTEIN CHEM, V4, P333, DOI 10.1007/BF01025498
   MERTZ ET, 1974, CEREAL CHEM, V51, P304
   MOLNARPERL I, 1989, ANAL BIOCHEM, V177, P16, DOI 10.1016/0003-2697(89)90005-5
   Mondini C, 2003, J ENVIRON QUAL, V32, P2379, DOI 10.2134/jeq2003.2379
   MOORE S, 1954, J BIOL CHEM, V211, P907
   MOORE S, 1948, J BIOL CHEM, V176, P367
   MOORE S, 1968, J BIOL CHEM, V243, P6281
   MORRELL RS, 1944, J CHEM SOC, P46
   MORRIS GK, 1985, J CLIN MICROBIOL, V22, P714
   Moulin M, 2002, ANAL BIOCHEM, V308, P320, DOI 10.1016/S0003-2697(02)00202-6
   Nagaraja P, 2002, ANAL SCI, V18, P1027, DOI 10.2116/analsci.18.1027
   NAKAGAWA M, 1979, CHAGYO KENKYU HOKOKU, P56
   NIKA H, 1984, J CHROMATOGR, V297, P261, DOI 10.1016/S0021-9673(01)89047-6
   OKA Y, 1984, J NUTR SCI VITAMINOL, V30, P27
   OSTE RE, 1991, ADV EXP MED BIOL, V289, P371
   PAPAZOVA P, 1977, PHARMAZIE, V32, P486
   Paul RG, 1998, BIOCHEM J, V330, P1241, DOI 10.1042/bj3301241
   Pavia M, 2000, J DAIRY SCI, V83, P1441, DOI 10.3168/jds.S0022-0302(00)75014-4
   PEARCE KN, 1988, J FOOD SCI, V53, P432, DOI 10.1111/j.1365-2621.1988.tb07723.x
   Perrone P, 1998, PHYTOCHEMISTRY, V49, P1879, DOI 10.1016/S0031-9422(98)00370-7
   Picton SF, 2002, DIABETES METAB, V28, pS70
   PIEZ KA, 1960, ANAL BIOCHEM, V1, P187, DOI 10.1016/0003-2697(60)90045-2
   PINTERSZAKACS M, 1990, J AGR FOOD CHEM, V38, P720, DOI 10.1021/jf00093a028
   PROTA G, 1973, TETRAHEDRON, V29, P4271, DOI 10.1016/0040-4020(73)80269-8
   Quilliam Michael A., 1998, Natural Toxins, V6, P147, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<147::AID-NT8>3.0.CO;2-#
   QUINN JR, 1974, ANAL BIOCHEM, V58, P609, DOI 10.1016/0003-2697(74)90230-9
   Qureshi S, 2000, INVEST NEW DRUG, V18, P221, DOI 10.1023/A:1006465504723
   Rahman Nafisur, 2003, Farmaco (Lausanne), V58, P1045, DOI 10.1016/S0014-827X(03)00184-8
   Ramminger U, 2001, J FORENSIC SCI, V46, P288
   RERAT A, 1987, REPROD NUTR DEV, V27, P955, DOI 10.1051/rnd:19870708
   RHODES AP, 1979, J AGR FOOD CHEM, V27, P1266, DOI 10.1021/jf60226a034
   RODRIGUEZ GP, 1984, J CHROMATOGR, V308, P65, DOI 10.1016/0378-4347(84)80196-6
   ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2
   RUBIN MB, 1975, CHEM REV, V75, P177, DOI 10.1021/cr60294a002
   Ruhemann S, 1910, J CHEM SOC, V97, P1438, DOI 10.1039/ct9109701438
   Ruhemann S, 1911, J CHEM SOC, V99, P1306, DOI 10.1039/ct9119901306
   Ruhemann S, 1911, J CHEM SOC, V99, P1486, DOI 10.1039/ct9119901486
   Ruhemann S, 1910, J CHEM SOC, V97, P2025, DOI 10.1039/ct9109702025
   RYAN EA, 1980, J CHROMATOGR, V195, P127, DOI 10.1016/S0021-9673(00)81550-2
   SAMEJIMA K, 1971, ANAL BIOCHEM, V42, P237, DOI 10.1016/0003-2697(71)90031-5
   SAMEJIMA K, 1971, ANAL BIOCHEM, V42, P222, DOI 10.1016/0003-2697(71)90030-3
   SARWAR G, 1985, J ASSOC OFF ANA CHEM, V68, P52
   SARWAR G, 1983, J FOOD SCI, V48, P526, DOI 10.1111/j.1365-2621.1983.tb10781.x
   Schertz TD, 2001, J ORG CHEM, V66, P7596, DOI 10.1021/jo0102720
   SCHILLING ED, 1963, ANAL BIOCHEM, V5, P1, DOI 10.1016/0003-2697(63)90051-4
   SCHONBERG A, 1978, TETRAHEDRON, V34, P1285
   SCHRAM E, 1953, ANAL CHIM ACTA, V9, P149, DOI 10.1016/S0003-2670(01)80747-9
   Schwarz L, 2002, J FORENSIC SCI, V47, P1274
   Schwimmer S., 1972, Flavour Industry, V3, P137
   SCHWIMMER S, 1981, SOURCE BOOK FOOD ENZ, P967
   SCOTT DB, 1987, J BACTERIOL, V169, P278, DOI 10.1128/jb.169.1.278-282.1987
   SEKKAT M, 1989, J PHARMACEUT BIOMED, V7, P883, DOI 10.1016/0731-7085(89)80010-X
   SHAPIRO R, 1968, J AM CHEM SOC, V90, P474, DOI 10.1021/ja01004a045
   SHAPIRO R, 1966, BIOCHEMISTRY-US, V5, P2799, DOI 10.1021/bi00873a004
   SHENG SJ, 1993, ANAL BIOCHEM, V211, P242, DOI 10.1006/abio.1993.1264
   SHUKLA Y, 1994, FOOD CHEM TOXICOL, V32, P651, DOI 10.1016/0278-6915(94)90009-4
   SLOBODIAN E, 1962, SCIENCE, V135, P441, DOI 10.1126/science.135.3502.441
   SMITH GA, 1984, J FOOD SCI, V49, P817, DOI 10.1111/j.1365-2621.1984.tb13219.x
   SNOW JT, 1975, BIOCHEM BIOPH RES CO, V64, P441, DOI 10.1016/0006-291X(75)90272-7
   SODEK L, 1975, J AGR FOOD CHEM, V23, P1147, DOI 10.1021/jf60202a024
   SREEKRISHNA K, 1980, ANAL BIOCHEM, V103, P55, DOI 10.1016/0003-2697(80)90235-3
   Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050
   STOILOVIC M, 1986, J FORENSIC SCI, V31, P432
   Taha EA, 2003, CHEM PHARM BULL, V51, P1444, DOI 10.1248/cpb.51.1444
   TAKAHASHI K, 1976, J BIOCHEM, V80, P1173, DOI 10.1093/oxfordjournals.jbchem.a131373
   TAYLOR IEP, 1970, J CHROMATOGR, V50, P331, DOI 10.1016/S0021-9673(00)97955-X
   THOMPSON J, 1988, J BIOL CHEM, V263, P2064
   THOMPSON JF, 1959, ANAL CHEM, V31, P1031, DOI 10.1021/ac60150a023
   Tiedge M, 1997, BBA-PROTEIN STRUCT M, V1337, P175, DOI 10.1016/S0167-4838(96)00162-8
   TROLL W, 1953, J BIOL CHEM, V200, P803
   Tschen J S, 1989, Proc Natl Sci Counc Repub China B, V13, P258
   van den Bosch E, 2003, INT J BIOL MACROMOL, V32, P129, DOI 10.1016/S0141-8130(03)00046-1
   Van Slyke DD, 1943, J BIOL CHEM, V150, P471
   VANDALEN JP, 1971, HISTOCHEMISTRY, V26, P183
   VISSER S, 1986, ANAL BIOCHEM, V153, P235, DOI 10.1016/0003-2697(86)90087-4
   WARD LC, 1978, ANAL BIOCHEM, V88, P598, DOI 10.1016/0003-2697(78)90461-X
   WEST R, 1965, J CHEM EDUC, V42, P386, DOI 10.1021/ed042p386
   WHITFIELD RE, 1972, TEXT RES J, V42, P344, DOI 10.1177/004051757204200608
   Wiesner S, 2001, J FORENSIC SCI, V46, P1082
   Wimalasena R, 2003, BIOMED CHROMATOGR, V17, P165, DOI 10.1002/bmc.234
   WORK E, 1957, BIOCHEM J, V67, P416, DOI 10.1042/bj0670416
   YAMADA H, 1991, ANAL BIOCHEM, V198, P1, DOI 10.1016/0003-2697(91)90496-G
   YAMADA K, 1990, J HISTOCHEM CYTOCHEM, V38, P985, DOI 10.1177/38.7.2355178
   YAO K, 1992, J CHROMATOGR-BIOMED, V581, P11, DOI 10.1016/0378-4347(92)80442-S
   YAO K, 1990, ACTA MED OKAYAMA, V44, P65
   YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209
   YUFEROV VP, 1970, BIOCHIM BIOPHYS ACTA, V200, P160, DOI 10.1016/0005-2795(70)90054-1
   YUFEROV VP, 1968, BIOFIZIKA, V13, P1119
   YUFEROV VP, 1971, USP BIOL KHIM, V12, P62
   ZACHARIUS RM, 1962, J CHROMATOGR, V7, P51, DOI 10.1016/S0021-9673(01)86378-0
   ZACHARIUS RM, 1976, J CHROMATOGR, V125, P421, DOI 10.1016/S0021-9673(00)83373-7
   ZAHNLEY JC, 1973, BIOCHEM J, V135, P59, DOI 10.1042/bj1350059
   Zdebska E, 1999, ANAL BIOCHEM, V275, P171, DOI 10.1006/abio.1999.4294
   Zhan CG, 2002, J AM CHEM SOC, V124, P2744, DOI 10.1021/ja0113394
   ZORRILLA HL, 1979, CROP SCI, V19, P659
NR 258
TC 214
Z9 220
U1 17
U2 304
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD FEB 11
PY 2004
VL 52
IS 3
BP 385
EP 406
DI 10.1021/jf030490p
PG 22
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 772FH
UT WOS:000188830300001
PM 14759124
DA 2018-10-20
ER

PT J
AU Leoni, L
   Desai, TA
AF Leoni, L
   Desai, TA
TI Micromachined biocapsules for cell-based sensing and delivery
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE nanotechnology; microfabrication; silicon; immunoisolation; cell-based
   delivery
ID SINGLE-FILE DIFFUSION; PC12 CELLS; IMMUNOISOLATION; SILICON; TRANSPORT;
   MEMBRANES; ISLETS
AB In recent years, rapid advancements have been made in the biomedical applications of micro- and nanotechnology. While the focus of such technology has primarily been on in vitro analytical and diagnostic tools, more recently, in vivo therapeutic and sensing applications have gained attention. The long-term integration of cells with inorganic materials provides the basis for novel delivery and sensing platforms. Our recent work has focused on the ability to maintain cells long term in nanoporous silicon-based microenvironments. This paper describes the creation of monodisperse, nanoporous, biocompatible, silicon membranes as a platform for the delivery of cells. Studies described herein focus on the interaction of silicon-based substrates with cells of interest in terms of viability, proliferation, and functionality. Such microfabricated nanoporous membranes can be used both in vitro for cell-based assays and in vivo for immunoisolation and drug delivery applications. (C) 2003 Elsevier B.V. All rights reserved.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
RP Desai, TA (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
EM tdesai@bu.edu
CR AEBISCHER P, 1994, EXP NEUROL, V126, P151, DOI 10.1006/exnr.1994.1053
   AITYAN SK, 1986, GEN PHYSIOL BIOPHYS, V5, P351
   AITYAN SK, 1988, GEN PHYSIOL BIOPHYS, V7, P591
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   Chu W., 1996, SPIE P MICRO NANOFAB, V2978, P111
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   COLTON CK, 1991, T ASME, V113, P152
   DESAI T, 1998, THESIS U CALIFORNIA
   Desai TA, 2000, BIOMOL ENG, V17, P23, DOI 10.1016/S1389-0344(00)00063-0
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9
   DESAI TA, 1999, J BIOMED MICRODEVICE, V1, P131
   Ferrari M, 1996, MATER RES SOC SYMP P, V414, P101
   Hahn K, 1996, PHYS REV LETT, V76, P2762, DOI 10.1103/PhysRevLett.76.2762
   HANSFORD DJ, 1999, THESIS U CALIFORNIA
   HERNANDEZ JA, 1994, BIOPHYS J, V67, P996, DOI 10.1016/S0006-3495(94)80565-X
   Iwata H, 1995, TRANSPLANT P, V27, P3224
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   Kovacs GTA, 1998, P IEEE, V86, P1536, DOI 10.1109/5.704259
   Lanza RP, 1996, NAT BIOTECHNOL, V14, P1107, DOI 10.1038/nbt0996-1107
   Leoni L, 2002, BIOMED MICRODEVICES, V4, P131, DOI 10.1023/A:1014639332543
   LEONI L, 2001, IEEE T BIOMED ENG, V48, P11
   LEONI L, 2003, THESIS U ILLINOIS
   Polla DL, 2000, ANNU REV BIOMED ENG, V2, P551, DOI 10.1146/annurev.bioeng.2.1.551
   Roberts T, 1996, BIOMATERIALS, V17, P267, DOI 10.1016/0142-9612(96)85564-5
   SAGEN J, 1993, J NEUROSCI, V13, P2415
   Storrs R, 2001, ANN NY ACAD SCI, V944, P252
   Suzuki K, 1998, CELL TRANSPLANT, V7, P47, DOI 10.1016/S0963-6897(97)00114-0
   SZE M, 1994, SEMICONDUCTOR SENSOR
   Wei QH, 2000, SCIENCE, V287, P625, DOI 10.1126/science.287.5453.625
   WINN SR, 1994, P NATL ACAD SCI USA, V91, P2324, DOI 10.1073/pnas.91.6.2324
NR 31
TC 57
Z9 63
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD FEB 10
PY 2004
VL 56
IS 2
BP 211
EP 229
DI 10.1016/j.addr.2003.08.014
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 771GU
UT WOS:000188777900007
PM 14741117
DA 2018-10-20
ER

PT J
AU Cui, YJ
   Zhao, M
   Tang, XZ
   Luo, YP
AF Cui, YJ
   Zhao, M
   Tang, XZ
   Luo, YP
TI Novel micro-crosslinked poly(organophosphazenes) with improved
   mechanical properties and controllable degradation rate as potential
   biodegradable matrix
SO BIOMATERIALS
LA English
DT Article
DE polyphosphazenes; biodegradation; mechanical properties; crosslinked
ID POLY<(AMINO ACID ESTER)PHOSPHAZENES>; SKELETAL TISSUE REGENERATION;
   BIOMEDICAL APPLICATIONS; CONTROLLED-RELEASE; SIDE-GROUPS;
   POLYPHOSPHAZENES; BLENDS; POLYMERS
AB As biodegradable materials, linear polyphosphazenes undergo rapid hydrolysis degradation but exhibit poor mechanical properties. Blending with biodegradable polyesters or inorganic particles strengthen their mechanical properties but give rise to slower degradation rate. To balance the mechanical properties and the degradation rate, micro-crosslinked polyphosphazenes were synthesized in this study. Their glass transition temperatures, mechanical properties, and in vitro degradation behavior were investigated. 2-Hydroxyethyl methacrylate (HEMA) was firstly attached to the side chain along with glycine ethyl ester to prepare co-substituted poly(organophosphazene) with pendant ethenyl substituents. The co-substituted poly(organophosphazene) was blended with HEMA or acrylic acid (AA) followed by a free radical polymerization to prepare micro-crosslinked poly(organophosphazenes). The resulting crosslinked polymers showed two separate glass transition temperatures depending on the HEMA or AA feed. Incorporation of crosslinking affected the mechanical properties positively. Crosslinked poly(organophosphazenes) showed an approximately 11-17 fold increase in terms of modulus of elasticity when compared to the linear counterpart. In vitro degradation tests indicated that HEMA-crosslinked polymers hydrolyzed at a retarded rate while AA-crosslinked polymers hydrolyzed at a moderate rate compared to linear polymers. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
RP Tang, XZ (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
CR Aldini NN, 2000, INT ORTHOP, V24, P121
   ALEXANDER KA, 1998, BIOMATERIALS, V19, P109
   ALLCOCK HR, 1994, MACROMOLECULES, V27, P1, DOI 10.1021/ma00079a001
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   ALLCOCK HR, 1994, BIOMATERIALS, V15, P563, DOI 10.1016/0142-9612(94)90205-4
   ALLCOCK HR, 1977, ANGEW CHEM INT EDIT, V16, P147, DOI 10.1002/anie.197701471
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   Allcock HR, 1996, MACROMOLECULES, V29, P2721, DOI 10.1021/ma9501398
   ALLCOCK HR, 1994, MACROMOLECULES, V27, P1071, DOI 10.1021/ma00083a001
   ALLCOCK HR, 1992, CHEM MATER, V4, P1182, DOI 10.1021/cm00024a015
   ALLCOCK HR, 1992, SCIENCE, V255, P1106, DOI 10.1126/science.255.5048.1106
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   CROMMEN J, 1993, J CONTROL RELEASE, V24, P167, DOI 10.1016/0168-3659(93)90176-6
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Ibim SEM, 1997, BIOMATERIALS, V18, P1565, DOI 10.1016/S0142-9612(97)00099-9
   Ibim SM, 1996, J CONTROL RELEASE, V40, P31, DOI 10.1016/0168-3659(95)00136-0
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   Lemmouchi Y, 1998, J BIOACT COMPAT POL, V13, P4, DOI 10.1177/088391159801300102
   NEILSON RH, 1988, CHEM REV, V88, P541, DOI 10.1021/cr00085a005
   Qiu LY, 2000, POLYM INT, V49, P1283, DOI 10.1002/1097-0126(200011)49:11<1283::AID-PI471>3.0.CO;2-D
   Reed CS, 1996, CHEM MATER, V8, P440, DOI 10.1021/cm9503644
   Schacht E, 1996, BIOTECHNOL BIOENG, V52, P102, DOI 10.1002/(SICI)1097-0290(19961005)52:1<102::AID-BIT10>3.3.CO;2-B
   SMETANA K, 1987, J BIOMED MATER RES, V21, P1247, DOI 10.1002/jbm.820211007
NR 26
TC 23
Z9 27
U1 4
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 3
BP 451
EP 457
DI 10.1016/S0142-9612(03)00532-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 746CA
UT WOS:000186727900009
PM 14585693
DA 2018-10-20
ER

PT J
AU Sionkowska, A
   Wisniewski, M
   Skopinska, J
   Kennedy, CJ
   Wess, TJ
AF Sionkowska, A
   Wisniewski, M
   Skopinska, J
   Kennedy, CJ
   Wess, TJ
TI Molecular interactions in collagen and chitosan blends
SO BIOMATERIALS
LA English
DT Article
DE collagen; chitosan; FTIR; XRD; structure; viscometry; gelatin
ID BIOARTIFICIAL POLYMERIC MATERIALS; PRINCIPAL COMPONENTS-ANALYSIS;
   PHYSICOCHEMICAL CHARACTERISTICS; PROPRANOLOL HYDROCHLORIDE;
   MECHANICAL-PROPERTIES; COMPOSITE MEMBRANES; TISSUE; BIOMATERIALS;
   SCAFFOLDS; SAMPLES
AB Molecular interactions between collagen and chitosan (CC) have the potential to produce biocomposites with novel properties. We have characterised the molecular interactions in CC complexes by viscometry, wide angle X-ray scattering and Fourier transform infrared spectroscopy. It was found that CC are miscible at the molecular level and exhibit interactions between the components;, X-ray diffraction of CC blends indicate that the collagen helix structure is lost in CC films with increasing chitosan content. Non-linear viscometic behaviour with decreasing chitosan content is interpreted as evidence of a third structural phase formed as a complex of CC. The blending of collagen with chitosan gives the possibility of producing new bespoke materials for potential biomedical applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Nicholas Copernicus Univ, Fac Chem, PL-87100 Torun, Poland.
   Univ Stirling, Dept Biol Sci, Ctr Extracellular Matrix Biol, Stirling FK9 4LA, Scotland.
RP Wess, TJ (reprint author), Cardiff Univ, Dept Opt & Vis Sci, Redwood Bldg,King Edward 7 Ave,Cathays Pk, Cardiff CF10 3NB, S Glam, Wales.
EM tjw3@stir.ac.uk
RI Kennedy, Craig/H-8826-2012; Skopinska-Wisniewska, Joanna/O-6445-2015;
   Sionkowska, Alina/I-5599-2014
OI Kennedy, Craig/0000-0001-7788-5095
CR Basilevsky A., 1994, STAT FACTOR ANAL REL
   Boik RJ, 1998, J MULTIVARIATE ANAL, V67, P244, DOI 10.1006/jmva.1998.1766
   Brodsky-Doyle B, 1975, BIOPOLYMERS, V14, P937
   Candel MJJM, 2001, QUAL QUANT, V35, P91, DOI 10.1023/A:1004873031561
   Cascone MG, 1997, POLYM INT, V43, P55
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Everitt B S, 1992, APPL MULTIVARIATE DA
   GARP T, 1999, HDB MICROANALYSIS PA, P211
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   Kalukin AR, 2000, IEEE T NUCL SCI, V47, P1729, DOI 10.1109/23.890998
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Leffler CC, 2000, INT J PHARM, V194, P229, DOI 10.1016/S0378-5173(99)00383-X
   Machado AAS, 2002, J THERM ANAL CALORIM, V67, P491
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   OGAWA K, 1991, AGR BIOL CHEM TOKYO, V55, P2375, DOI 10.1080/00021369.1991.10870939
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720
   PINGPING Z, 1997, EUR POLYM J, V33, P411
   RENUGOPALAKRISHNAN V, 1989, MACROMOLECULES, V22, P4121, DOI 10.1021/ma00200a054
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Silverman BW, 1996, ANN STAT, V24, P1
   Struszczyk MH, 2002, POLIMERY-W, V47, P396
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   SUSI H, 1971, J AM LEATHER CHEM AS, V66, P508
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   THACHARODI D, 1995, INT J PHARM, V120, P115, DOI 10.1016/0378-5173(94)00423-3
   Thacharodi D, 1996, INT J PHARM, V134, P239, DOI 10.1016/0378-5173(96)04453-5
   WARREN JR, 1969, J AM CHEM ASS, V64, P4
   WEINER S, 1980, NATURE, V287, P820, DOI 10.1038/287820a0
   Wess TJ, 2001, ARCHAEOMETRY, V43, P117, DOI 10.1111/1475-4754.00007
NR 37
TC 280
Z9 297
U1 3
U2 87
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 5
BP 795
EP 801
DI 10.1016/S0142-9612(03)00595-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GD
UT WOS:000186853400005
PM 14609668
DA 2018-10-20
ER

PT J
AU Bujan, J
   Garcia-Honduvilla, N
   Bellon, JM
AF Bujan, J
   Garcia-Honduvilla, N
   Bellon, JM
TI Engineering conduits to resemble natural vascular tissue
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Review
DE endothelial-cell seeding; expanded polytetrafluoroethylene (ePTFE);
   scaffold; tissue engineering; vascular prostheses
ID IN-VITRO ENDOTHELIALIZATION; DACRON ARTERIAL GRAFTS; MARROW STROMAL
   CELLS; EXPANDED POLYTETRAFLUOROETHYLENE; INTIMAL HYPERPLASIA; PROSTHETIC
   GRAFTS; PULMONARY-ARTERY; EPTFE GRAFTS; PLATELET-AGGREGATION;
   CLINICAL-EXPERIENCE
AB Research on the use of biomaterials as vascular substitutes has been dominated in the past by studies focusing on the properties of the materials used. These need to be resistant to protein absorption and should allow cell colonization and integration of the biomaterial within recipient tissue. Despite promising perspectives related both to the appearance of new synthetic materials with biomedical applications and to developments in arterial replacement techniques, there are still many unresolved problems. These include the appearance of occlusive phenomena when using medium- or small-calibre arterial substitutes, and the lack of growth and adaptability of the biomaterial to changes in the host. Notwithstanding, the tissue-engineering techniques developed in recent decades have vastly improved prosthetic behaviour at the blood/ biomaterial interface. There is also no doubt that developments in engineered arterial grafts made of natural biomaterials colonized with cells harvested from the recipient patient are drawing us closer and closer to achieving the living graft.
C1 Univ Alcala de Henares, Fac Med, Dept Med Specialties, Madrid, Spain.
   Univ Alcala de Henares, Fac Med, Dept Surg, Madrid, Spain.
RP Bujan, J (reprint author), Univ Alcala de Henares, Fac Med, Dept Med Specialties, Madrid, Spain.
EM mjulia.bujan@uah.es
OI BELLON, JUAN M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476;
   Garcia Honduvilla, Natalio/0000-0003-0904-6198
CR AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   ALLEN BT, 1984, J VASC SURG, V1, P224, DOI 10.1067/mva.1984.avs0010224
   Almeida JI, 1998, J VASC SURG, V27, P896, DOI 10.1016/S0741-5214(98)70270-8
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Arts CHP, 2002, EUR J VASC ENDOVASC, V23, P29, DOI 10.1053/ejvs.2001.1532
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Bader A, 2000, TRANSPLANTATION, V70, P7
   BADYLAK SF, 1998, BIOMATER SCI POLYM E, V8, P863
   BARRENA EG, 2000, BIOMATERIALS AQUI AH, P31
   Bellon J M, 1993, Ann Vasc Surg, V7, P549, DOI 10.1007/BF02000149
   Bellon JM, 1997, EUR J VASC ENDOVASC, V13, P142, DOI 10.1016/S1078-5884(97)80010-X
   BELLON JM, 1992, CIR ESPAN, V51, P25
   BENGTSSON LA, 1995, ANN THORAC SURG, V60, pS365, DOI 10.1016/0003-4975(95)00316-D
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Bos GW, 1999, THROMB HAEMOSTASIS, V82, P1757
   Brockbank KGM, 2000, TRANSPLANT P, V32, P3, DOI 10.1016/S0041-1345(99)00851-9
   Bujan J, 1998, J BIOMED MATER RES, V39, P32, DOI 10.1002/(SICI)1097-4636(199801)39:1<32::AID-JBM5>3.0.CO;2-J
   BUJAN J, 1999, PATOL VASC, V5, P9
   BUJAN J, 1997, ANGIOLOGIA, V3, P111
   CAMPBELL LB, 1988, EUR J VASCULAR SURG, V2, P365
   Chakfe N, 2003, EUR J VASC ENDOVASC, V25, P360, DOI 10.1053/ejvs.2002.1790
   CIMA LG, 1993, CHEM ENG PROG    JUN, P46
   Clarke DR, 2001, ANN THORAC SURG, V71, pS433, DOI 10.1016/S0003-4975(01)02556-5
   Coito A J, 1996, Ann Transplant, V1, P14
   Coito A J, 2000, Dev Immunol, V7, P239, DOI 10.1155/2000/98187
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   COURTMAN DW, 1999, P SOC BIOM 25 ANN M
   Curtil A, 1997, J HEART VALVE DIS, V6, P296
   CURTIS ASG, 1984, J CELLS CI, V86, P9
   DAHM M, 1990, J THORAC CARDIOV SUR, V99, P1082
   Dardik H, 1999, Semin Vasc Surg, V12, P1
   DEBAKEY ME, 1964, ARCH SURG-CHICAGO, V89, P757
   Falkenback D, 2000, EUR J VASC ENDOVASC, V19, P468, DOI 10.1053/ejvs.1999.1075
   Fauza DO, 2001, J PEDIATR SURG, V36, P146, DOI 10.1053/jpsu.2001.20034
   FLETCHER JP, 1990, AUST NZ J SURG, V60, P801, DOI 10.1111/j.1445-2197.1990.tb07477.x
   GALLARDO A, 2000, BIOMATERIALS AQUI AH, P45
   GARCIAHONDUVILL.N, 2002, ANGIOLOGIA, V54, P270
   GARCIAHONDUVILL.N, 1995, ARTIF ORGANS, V19, P144
   GARCIAHONDUVILL.N, 2000, PATOL VASC, V6, P203
   GIMBRONE MA, 1976, PROG HEMOST THROMB, V31, P1
   Goissis G, 2000, ARTIF ORGANS, V24, P217, DOI 10.1046/j.1525-1594.2000.06537.x
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   GRAHAM L, 1987, ENDOTHELIALISATION V, P57
   GRAHAM LM, 1991, J BIOMED MATER RES, V25, P525, DOI 10.1002/jbm.820250409
   GRAHAM LM, 1982, SURGERY, V91, P550
   GREISLER HP, 1990, ARCH SURG-CHICAGO, V125, P1622
   HARRISON JH, 1958, AM J SURG, V95, P3, DOI 10.1016/0002-9610(58)90735-9
   Hazama K, 1999, J SURG RES, V81, P174, DOI 10.1006/jsre.1998.5497
   Hernandez D.J., 1994, SOCIAL POLICY REPORT, V8, P1
   HERNANDO A, 1995, EUR J VASC ENDOVASC, V10, P387, DOI 10.1016/S1078-5884(05)80077-2
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1994, J VASC SURG, V20, P650, DOI 10.1016/0741-5214(94)90291-7
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUBBELL JA, 1995, CHEM ENG NEWS   0313, P42
   HUSSAIN S, 1989, J VASC SURG, V9, P656, DOI 10.1067/mva.1989.vs0090656
   IMANISHI Y, 1988, J MACROMOL SCI CHEM, VA25, P555, DOI 10.1080/00222338808053384
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kadner A, 2002, EUR J CARDIO-THORAC, V21, P1055, DOI 10.1016/S1010-7940(02)00079-9
   Kao WYJ, 2000, BIOMATERIALS, V21, P2295, DOI 10.1016/S0142-9612(00)00156-3
   KATZ MH, 1991, J AM ACAD DERMATOL, V25, P1054, DOI 10.1016/0190-9622(91)70306-M
   Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945
   Kaviani A, 2002, J PEDIATR SURG, V37, P995, DOI 10.1053/jpsu.2002.33828
   KEMPCZINSKI RF, 1985, J VASC SURG, V2, P424, DOI 10.1067/mva.1985.avs0020424
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KIRKPATRICK CJ, 1990, PATHOBIOLOGY, V58, P221
   KRIJGSMAN B, 1995, EUR J VASC ENDOVASC, V10, P387, DOI 10.1016/S1078-5884(05)80076-0
   LALKA SG, 1989, ANN VASC SURG, V3, P187
   Lamm P, 1999, J THORAC CARDIOV SUR, V117, P1217, DOI 10.1016/S0022-5223(99)70264-3
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   Lemson MS, 2000, EUR J VASC ENDOVASC, V19, P336, DOI 10.1053/ejvs.1999.1040
   Liechty KW, 2000, NAT MED, V6, P1282
   LIVESEY S, 1999, MAT RES SOC S P SER, V530
   LOGERFO FW, 1983, ANN SURG, V197, P479, DOI 10.1097/00000658-198304000-00018
   MACKENZIE DC, 1960, BRIT J SURG, V48, P212, DOI 10.1002/bjs.18004820827
   Madden R, 2002, AM J KIDNEY DIS, V40, P1240, DOI 10.1053/ajkd.2002.36892
   MALONE JM, 1984, J VASC SURG, V1, P181, DOI 10.1067/mva.1984.avs0010181
   MANSFIELD P B, 1970, Review of Surgery, V27, P291
   Marois Y, 1999, ASAIO J, V45, P272, DOI 10.1097/00002480-199907000-00005
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mikucki S A, 1999, Semin Vasc Surg, V12, P18
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niu S, 1991, ASAIO Trans, V37, pM441
   Noishiki Y, 1989, ASAIO Trans, V35, P267, DOI 10.1097/00002480-198907000-00030
   NUWAYSER ES, 1973, ASAIO T, V19, P168
   OBLATH RW, 1978, SURGERY, V84, P37
   PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0
   Park JC, 2001, YONSEI MED J, V42, P304, DOI 10.3349/ymj.2001.42.3.304
   PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242
   Pascual G, 2002, EUR J VASC ENDOVASC, V24, P23, DOI 10.1053/ejvs.2002.1663
   Patterson R B, 1989, Ann Vasc Surg, V3, P160, DOI 10.1016/S0890-5096(06)62010-4
   Phaneuf MD, 2001, BIOMATERIALS, V22, P463, DOI 10.1016/S0142-9612(00)00202-7
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PREVEL CD, 1994, MICROSURG, V15, P586, DOI 10.1002/micr.1920150812
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   RAMALANJAONA GR, 1986, J SURG RES, V41, P479, DOI 10.1016/0022-4804(86)90165-4
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   ROSENMAN JE, 1985, J VASC SURG, V2, P778, DOI 10.1067/mva.1985.avs0020778
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SanRoman J, 1996, J BIOMED MATER RES, V32, P19, DOI 10.1002/(SICI)1097-4636(199609)32:1<19::AID-JBM3>3.0.CO;2-S
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCHMITZRIXEN T, 1988, J VASC SURG, V7, P82, DOI 10.1067/mva.1988.avs0070082
   SCHNEIDER PA, 1989, J VASC SURG, V23, P183
   SEEGER JM, 1988, J VASC SURG, V8, P476
   SHAREFKIN JB, 1982, SURGERY, V92, P385
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Siegel G, 2001, BIOSENS BIOELECTRON, V16, P895, DOI 10.1016/S0956-5663(01)00235-4
   SOYER T, 1972, SURGERY, V72, P864
   Sparks SR, 2002, ANN VASC SURG, V16, P73, DOI 10.1007/s10016-001-0133-5
   STANSBY G, 1994, CARDIOVASC SURG, V2, P254
   STERPETTI AV, 1988, J VASC SURG, V7, P677, DOI 10.1067/mva.1988.avs0070677
   Stock UA, 2000, J THORAC CARDIOV SUR, V120, P1158, DOI 10.1067/mtc.2000.109539
   SZILAGYI DE, 1982, J CARDIOVASC SURG, V23, P183
   Takasaki K., 1989, REV MATH PHYS, V1, P1
   Teebken OE, 2000, EUR J VASC ENDOVASC, V19, P381, DOI 10.1053/ejvs.1999.1004
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Thomson JJ, 1900, PHYS Z, V1, P20
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Tsukagoshi T, 1999, J RECONSTR MICROSURG, V15, P127, DOI 10.1055/s-2007-1000083
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   VANDERLEI B, 1991, INT ANGIOL, V10, P202
   VANHINSBERGH VWM, 1990, BLOOD, V75, P1490
   Vinard E, 1999, ANN VASC SURG, V13, P141, DOI 10.1007/s100169900232
   Vohra R K, 1990, Eur J Vasc Surg, V4, P33, DOI 10.1016/S0950-821X(05)80036-2
   VOHRA RK, 1990, ARTIF ORGANS, V14, P41
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   Walles T, 2003, INT J ARTIF ORGANS, V26, P225
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   WILLIAMS SK, 1991, J ELECTRON MICR TECH, V19, P439, DOI 10.1002/jemt.1060190406
   Wilson G J, 1993, ASAIO J, V39, pM526
   WILSON GJ, 1995, ANN THORAC SURG, V60, pS353, DOI 10.1016/0003-4975(95)98967-Y
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   Zdrahala RJ, 1996, J BIOMATER APPL, V10, P309, DOI 10.1177/088532829601000402
NR 143
TC 25
Z9 26
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD FEB
PY 2004
VL 39
BP 17
EP 27
DI 10.1042/BA20030111
PN 1
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 773MH
UT WOS:000188927200003
PM 14535843
DA 2018-10-20
ER

PT J
AU Laymon, CM
   Harrison, RL
   Kohlmyer, SG
   Miyaoka, RS
   Lewellen, TK
AF Laymon, CM
   Harrison, RL
   Kohlmyer, SG
   Miyaoka, RS
   Lewellen, TK
TI Charicterization of single and multiple scatter from matter and activity
   distributions outside the FOV in 3-D PET
SO IEEE TRANSACTIONS ON NUCLEAR SCIENCE
LA English
DT Article
DE biomedical image processing; biomedical imaging; positron emission
   tomography (PET); scattering
ID FIELD-OF-VIEW; ENERGY THRESHOLD; 3D PET
AB Operation of PET in 3-D mode, without internal septa results in increased sensitivity but at the cost of increased scatter fraction. Significant amounts of scattered events in 3-D PET either originate from activity outside the FOV (OFOV) or scatter from matter outside the FOV, complicating scatter correction methods. We performed 3-D PET simulations with scanner geometry based on the GE Advance with several phantom geometries designed to characterize all scatter with particular attention to that from outside the FOV. Scatter from OFOV matter was deduced by performing simulations with matter and activity within the FOV only (short phantom). Studies were repeated with phantoms with identical characteristics inside the FOV but with additional OFOV material (long phantom) but no activity outside the FOV. The incremental effect of OFOV activity was then determined by repeating the long phantom studies with additional activity. Scatter was also classified as single or multiple. In summary, the data allow extraction of yields from unscattered and all types of scattered events. The effect of source position, both within and external to the FOV, on scatter was determined by performing a series of simulations with point sources and techniques similar to those described above. The effect of energy,discriminator setting (with BGO detectors) was also studied and data sets were generated for five settings from 300 to 425 keV. Using a Zubal phantom with the lungs and heart in the FOV and the abdomen outside the FOV and with a 300 keV discriminator, we find a total scatter fraction of 57%. Of the total scatter, 7.4% comes from OFOV matter, and 24% from OFOV activity. If the discriminator is increased to 425 keV the scatter fraction drops to 36%. OFOV scatter, particularly from OFOV activity, becomes relatively less important with the OFOV matter contribution dropping to 5.3% and OFOV activity contribution to 17%. Additionally, the spatial distributions of scatter from external matter and external activity were found to be different.
C1 Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15213 USA.
   Univ Washington, Seattle, WA 98195 USA.
   GE Med Syst, Waukesha, WI 53188 USA.
RP Laymon, CM (reprint author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15213 USA.
EM CML14@pitt.edu
CR Adam LE, 1999, PHYS MED BIOL, V44, P2879, DOI 10.1088/0031-9155/44/12/302
   BENTOURKIA M, 1999, P 1999 MED IM C SEAT, V2, P958
   DAUBEWITHERSPOO.ME, 1998, P IEEE NUCL SCI S ME, V2, P1237
   Kohlmyer SG, 1999, IEEE T NUCL SCI, V46, P2141, DOI 10.1109/23.819296
   Lewellen TK, 1999, IEEE T NUCL SCI, V46, P1129, DOI 10.1109/23.790846
   Lewellen TK, 1998, MED SCI SER, P77
   Ollinger JM, 1996, PHYS MED BIOL, V41, P153, DOI 10.1088/0031-9155/41/1/012
   SOSSI V, 1995, IEEE T NUCL SCI, V42, P1157, DOI 10.1109/23.467733
   Spinks TJ, 1998, PHYS MED BIOL, V43, P895, DOI 10.1088/0031-9155/43/4/017
   Watson CC, 1997, IEEE T NUCL SCI, V44, P90, DOI 10.1109/23.554831
   ZUBAL IG, 1994, MED PHYS, V21, P299, DOI 10.1118/1.597290
NR 11
TC 5
Z9 5
U1 0
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9499
J9 IEEE T NUCL SCI
JI IEEE Trans. Nucl. Sci.
PD FEB
PY 2004
VL 51
IS 1
BP 10
EP 15
DI 10.1109/TNS.2004.823340
PN 1
PG 6
WC Engineering, Electrical & Electronic; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA 813BR
UT WOS:000220883100002
DA 2018-10-20
ER

PT J
AU Altpeter, H
   Bevis, MJ
   Grijpma, DW
   Feijen, J
AF Altpeter, H
   Bevis, MJ
   Grijpma, DW
   Feijen, J
TI Non-conventional injection molding of poly(lactide) and
   poly(epsilon-caprolactone) intended for orthopedic applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID EPSILON-CAPROLACTONE; ENHANCEMENT
AB Biodegradable polymers such as poly(lactide) (PLA) and poly(epsilon-caprolactone) (PCL) are increasingly used in biomedical applications as temporary implants. However, melt processing of these materials in particular of PLA is difficult due to the temperature sensitivity. Within this study, PLA and PCL were injection molded conventionally and by using the process shear controled orientation in injection molding (SCORIM) in order to investigate the effect of processing parameters on the physical properties of the moldings. Therefore, flexural testing, differential scanning calorimetry (DSC), wide-angle X-ray diffraction (WAXD), molecular weight (MW) and orientation measurements were performed.
   PLA showed high sensitivity to melt temperature. In the case of amorphous poly(DL-lactide), the molecular weight and subsequently the ductility is substantially reduced by processing at higher melt temperatures. In the case of crystallizable poly(L-lactide), higher melt temperatures and shear induced by the SCORIM process resulted in enhanced crystallinity, which compromised the mechanical properties. Generally, SCORIM processing improved the mechanical properties, in particular the ductility, by orientating the molecular structure. PCL was shown to be less sensitive to shear and temperature than PLA. Stress at yield and stiffness are more improved by SCORIM processing. However, the processing temperature in combination with the grade used proved to be influential for the mechanical properties of resulting moldings. (C) 2004 Kluwer Academic Publishers.
C1 Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
   Univ Twente, Fac Chem Technol, Dept Polymer Chem & Biomat, NL-7500 AE Enschede, Netherlands.
RP Altpeter, H (reprint author), Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
CR ALLAN PS, 1987, PLAST RUB PROC APPL, V7, P3
   ALLAN PS, Patent No. 2170140
   ANDREOPOULOS AG, 1994, J ELASTOM PLAST, V26, P308, DOI 10.1177/009524439402600401
   BERGSMA JE, 1998, J CRANIO MAXILLOFAC, V26, P17
   Corden TJ, 2000, BIOMATERIALS, V21, P713, DOI 10.1016/S0142-9612(99)00236-7
   GURAV N, 1994, J MATER SCI-MATER M, V3, P784
   Ikada Y, 1996, J BIOMED MATER RES, V30, P553
   Kalay G, 1999, J APPL POLYM SCI, V73, P2473, DOI 10.1002/(SICI)1097-4628(19990919)73:12<2473::AID-APP16>3.3.CO;2-F
   Kalay G, 1997, KUNSTST-PLAST EUR, V87, P768
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   Nakamura T, 1998, J BIOMED MATER RES, V42, P475, DOI 10.1002/(SICI)1097-4636(19981215)42:4<475::AID-JBM1>3.0.CO;2-B
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.3.CO;2-9
   ROSS PJ, 1988, TAGUSHI TECHNIQUES Q
   Sinclair RG, 1996, J MACROMOL SCI PURE, VA33, P585, DOI 10.1080/10601329608010880
   SOUSA RA, 2000, J APPL POLYM SCI, V77, P1300
   Tormala P, 1998, P I MECH ENG H, V212, P101, DOI 10.1243/0954411981533872
   VERT M, 1995, J MACROMOL SCI PURE, V32, P4
   von Oepen R, 1992, Clin Mater, V10, P21, DOI 10.1016/0267-6605(92)90080-D
NR 18
TC 18
Z9 19
U1 0
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2004
VL 15
IS 2
BP 175
EP 184
DI 10.1023/B:JMSM.0000011820.64572.a5
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 762XA
UT WOS:000188006700012
PM 15330053
DA 2018-10-20
ER

PT J
AU Trouet, C
AF Trouet, C
TI New European guidelines for the use of stored human biological materials
   in biomedical research
SO JOURNAL OF MEDICAL ETHICS
LA English
DT Article
AB The increasing possibilities for using tissue for research and development in genetics and biotechnology have made stored human biological materials more important than ever. Using stored human biological materials raises many legal and ethical questions. On an international level however, the use of these materials has not been regulated in a detailed manner so far. The Council of Europe recently declassified the text of the proposal for an instrument on the use of archived human biological materials in biomedical research for public consultation. The purpose of this paper is to comment on this document regarding its primary goal, which is to protect the rights and fundamental freedoms of the individual whose biological materials could be included in a research project. The guidelines offer good basic protection for sources of identifiable human biological materials but, surprisingly, offer no protection to sources of anonymous or anonymised materials.
RP Trouet, C (reprint author), Kapucijnenvoer 35, B-3000 Leuven, Belgium.
EM Caroline.Trouet@med.kuleuven.ac.be
CR ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2347
   BOEL E, 1997, HUMAN BIO BANKS ETHI, P107
   CLAYTON EW, 1997, HUMAN DNA LAW POLICY, P294
   CLAYTON EW, 1997, HUMAN DNA LAW POLICY, P298
   *COUNC EUR, 1998, ETH REV BIOM RES EUR
   DANIELS LB, 1990, CALIFORNIA W SCH LAW, P210
   DEHERT P, 1998, ARTIKEL 8 EVRM BELGI, P75
   GASSNER UM, 2001, MEDIZINRECHT, V19, P553
   GULWIRTH S, 1993, WAARHEIDSAANSPRAKEN, P23
   HARRIS DJ, 1995, LAW EUROPEAN CONVENT, P306
   HERMITTE MA, 1993, BIOETHIQUE DROITS HO, P50
   JONSSON L, 2001, USE HUMAN BIO BANKS, P4
   Knoppers B, 1999, COMMERCIALIZATION GE, P1
   LABRUSSERIOU C, 1997, PRODUIRE HOMME QUEL, P196
   LAWRENCE SC, 1998, STORED TISSUE SAMPLE, P113
   LEENEN HJJ, 2000, HDB GEZONDHEIDSRECHT, V1, P36
   LOUCAIDES LG, 1991, BRIT YB INT LAW 1990, P178
   LOUCAIDES LG, 1991, BRIT YB INT LAW 1990, P176
   *MRC UK, 2001, HUM TISS BIOL SAMPL
   *OFF PARL EV CHOIX, 1994, 94654 OFF PARL EV CH, P34
   PHILLIPS JA, 1995, AM J HUM GENET, V57, P1499
   *ROYAL COLL PATH, 2001, TRANS GUID FAC CHANG
   *STEER COMM BIOETH, 2002, PROP INSTR US ARCH H
   WARBRICK C, 1998, EUROPEAN HUMAN RIGHT, P33
   Wertz D C, 1999, Community Genet, V2, P51, DOI 10.1159/000016187
   WINICKOFF D, 2000, J BIOLAW BUS, V4, P11
   ZIEMELE I, 2002, BALTIC YB INT LAW, V2, P11
NR 27
TC 26
Z9 26
U1 0
U2 0
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-6800
J9 J MED ETHICS
JI J. Med. Ethics
PD FEB 1
PY 2004
VL 30
IS 1
BP 99
EP 103
DI 10.1136/jme.2003.003467
PG 5
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA 772TG
UT WOS:000188856900021
PM 14872085
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Shih, IL
   Van, YT
   Shen, MH
AF Shih, IL
   Van, YT
   Shen, MH
TI Biomedical applications of chemically and microbiologically synthesized
   poly(glutamic acid) and poly(lysine)
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE poly-alpha-glutamic acid; poly-alpha-lysine; poly-gamma-glutamic acid;
   poly-epsilon-lysine; biosynthesis; biomedical applications
ID POLY-L-LYSINE; POLYRIBOINOSINIC-POLYRIBOCYTIDYLIC ACID;
   INTERMEDIATE-DRUG CARRIER; BACILLUS-SUBTILIS NATTO; GAMMA-POLYGLUTAMIC
   ACID; GLUTAMIC-ACID; POLY(GAMMA-GLUTAMIC ACID); GENE-THERAPY;
   POLY(L-GLUTAMIC ACID); STREPTOMYCES-ALBULUS
AB This review article deals with the synthesis, physiochemical properties, and potential biomedical applications of two homo-poly amino acids. Poly-alpha-glutamic acid (alpha-PGA) and poly-alpha-lysine (alpha-PL) were synthesized by chemical synthesis, poly-gamma-glutamic acid (gamma-PGA) and poly-epsilon-lysine (epsilon-PL) were naturally occurring bio-materials that were produced by microbial fermentation. Poly(glutamic acid) (PGA) and poly(lysine) (PL) are water soluble, biodegradable, edible and nontoxic toward humans and the environment. As a result, they are suitable for various applications and have recently attracted considerable interest of the chemical industry. The distinguished features of PGA and PL also make them promising candidates for biomedical applications. The applications of PGA and PL in the areas of biomedical materials. drug delivery carriers and biological adhesives have been studied extensively and will be discussed in this review.
C1 Da Yeh Univ, Dept Environm Engn, Da Tsuen 51505, Chang Hwa, Taiwan.
RP Shih, IL (reprint author), Da Yeh Univ, Dept Environm Engn, 112,Shan Jiau Rd, Da Tsuen 51505, Chang Hwa, Taiwan.
EM ils@mail.dyu.edu.tw
CR Asayama S, 1998, BIOCONJUGATE CHEM, V9, P476, DOI 10.1021/bc970213m
   Ashiuchi M, 2001, APPL MICROBIOL BIOT, V57, P764, DOI 10.1007/s00253-001-0848-9
   Avichezer D, 1998, REACT FUNCT POLYM, V36, P59, DOI 10.1016/S1381-5148(97)00121-1
   BATZ HG, 1974, MAKROMOL CHEM, V175, P2229
   BECKER RR, 1952, J AM CHEM SOC, V74, P38, DOI 10.1021/ja01121a010
   BEHR JP, 1993, ACCOUNTS CHEM RES, V26, P274, DOI 10.1021/ar00029a008
   BENISHAI D, 1952, J ORG CHEM, V17, P1564, DOI 10.1021/jo50012a002
   BLOCK L, 1983, POLY GAMA BENZYL L G
   Bogdanov AA, 1996, BIOCONJUGATE CHEM, V7, P144, DOI 10.1021/bc950089b
   BORST HG, 1982, J THORAC CARDIOV SUR, V84, P548
   Bovarnick M, 1942, J BIOL CHEM, V145, P415
   CALBRESI P, 1975, PHARMACOL BASIS THER, P1268
   CHAMPNEY K, 1976, CLIN RES, V24, P451
   CHENG C, 1989, AGR BIOL CHEM TOKYO, V53, P2369, DOI 10.1080/00021369.1989.10869686
   CHIO JS, 2000, NUCLEIC ACIDS RES, V122, P474
   CHIOU HC, 1994, NUCLEIC ACIDS RES, V22, P5439, DOI 10.1093/nar/22.24.5439
   Choi JS, 2000, J AM CHEM SOC, V122, P474, DOI 10.1021/ja9931473
   Choi YH, 1998, BIOCONJUGATE CHEM, V9, P708, DOI 10.1021/bc980017v
   Cromwick AM, 1996, BIOTECHNOL BIOENG, V50, P222, DOI 10.1002/(SICI)1097-0290(19960420)50:2<222::AID-BIT10>3.0.CO;2-P
   CROMWICK AM, 1995, INT J BIOL MACROMOL, V16, P265
   Dekie L, 2000, J CONTROL RELEASE, V65, P187, DOI 10.1016/S0168-3659(99)00235-7
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   DEVITA V, 1970, P AM ASSOC CANC RES, V11, P21
   DORUDI S, 1993, BRIT J SURG, V80, P566, DOI 10.1002/bjs.1800800507
   EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194
   EWEL CH, 1992, CANCER RES, V52, P3005
   FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004
   Frankel M, 1944, J AM CHEM SOC, V66, P763, DOI 10.1021/ja01233a031
   FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949
   FUJII H, 1963, J AGR CHEM SOC JPN, V37, P407
   FULLER WD, 1976, BIOPOLYMERS, V15, P1869, DOI 10.1002/bip.1976.360150922
   GALUN E, 1990, HEPATOLOGY, V11, P578, DOI 10.1002/hep.1840110409
   GILBOA E, 1986, BIOTECHNIQUES, V4, P504
   GILBOIN H, 1970, SCIENCE, V107, P205
   GIOVANELLA BC, 1989, SCIENCE, V246, P1046, DOI 10.1126/science.2555920
   GIOVANELLA BC, 1991, CANCER RES, V51, P3052
   GOFF BA, 1991, CANCER RES, V51, P4761
   GOTO A, 1992, BIOSCI BIOTECH BIOCH, V56, P1031, DOI 10.1271/bbb.56.1031
   GREENFIELD RS, 1989, ANTIBODY IMMUNOCONJ, V2, P201
   HANANIA EG, 1995, AM J MED, V99, P537, DOI 10.1016/S0002-9343(99)80232-0
   HARA T, 1982, AGR BIOL CHEM TOKYO, V46, P2275, DOI 10.1080/00021369.1982.10865430
   Hashida M, 1998, J CONTROL RELEASE, V53, P301, DOI 10.1016/S0168-3659(97)00263-0
   Hiraki J, 1998, SEIBUTSU-KOGAKU KAIS, V76, P487
   Hirayama C, 1999, J CHROMATOGR B, V721, P187, DOI 10.1016/S0378-4347(98)00479-4
   HOES CJT, 1993, J CONTROL RELEASE, V23, P37, DOI 10.1016/0168-3659(93)90069-H
   HOLMES FA, 1995, TAXANE ANTICANCER AG, P31
   HOUSEWRIGHT RD, 1962, BACTERIA, V3, P389
   Hurwitz E., 1980, J APPL BIOCHEM, V2, P25
   IDELSON M, 1958, J AM CHEM SOC, V80, P4631, DOI 10.1021/ja01550a056
   Ito Y, 1996, BIOSCI BIOTECH BIOCH, V60, P1239, DOI 10.1271/bbb.60.1239
   IVAOVICS G, 1937, ZIMMUNITATSFORSCH, V90, P304
   JIANG XT, 1996, ACTA PHARMACOL SINIC, V31, P632
   KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002
   Kahar P, 2002, J BIOSCI BIOENG, V93, P274, DOI 10.1263/jbb.93.274
   Kahar P, 2001, J BIOSCI BIOENG, V91, P190, DOI 10.1263/jbb.91.190
   KALCHALSKI E, 1958, ADV PROTEIN CHEM, V13, P243
   Kambourova M, 2001, APPL ENVIRON MICROB, V67, P1004, DOI 10.1128/AEM.67.2.1004-1007.2001
   KATAKAI R, 1985, J ORG CHEM, V50, P715, DOI 10.1021/jo00205a039
   KATO Y, 1984, J MED CHEM, V27, P1602, DOI 10.1021/jm00378a013
   KATO Y, 1984, CANCER RES, V44, P25
   Ko YH, 1998, BIOTECHNOL BIOENG, V57, P430, DOI 10.1002/(SICI)1097-0290(19980220)57:4<430::AID-BIT6>3.0.CO;2-N
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   Kunioka M, 1997, APPL MICROBIOL BIOT, V47, P469, DOI 10.1007/s002530050958
   LAEMMLI UK, 1975, P NATL ACAD SCI USA, V72, P4288, DOI 10.1073/pnas.72.11.4288
   LAMPKIN BC, 1985, CANCER RES, V45, P5904
   LEDLEY FD, 1995, HUM GENE THER, V6, P1129, DOI 10.1089/hum.1995.6.9-1129
   LEONARD CG, 1958, J BACTERIOL, V76, P499
   LEVY HB, 1985, J BIOL RESP MODIF, V4, P475
   LEVY HB, 1975, J INFECT DIS, V132, P434, DOI 10.1093/infdis/132.4.434
   LEVY HB, 1969, P NATL ACAD SCI USA, V62, P357, DOI 10.1073/pnas.62.2.357
   Li C, 1998, CANCER RES, V58, P2404
   Li C, 2002, ADV DRUG DELIVER REV, V54, P695, DOI 10.1016/S0169-409X(02)00045-5
   Li C, 1999, CLIN CANCER RES, V5, P891
   Machluf M, 2000, WORLD J UROL, V18, P80, DOI 10.1007/s003450050014
   MACHULUF M, 1999, P ANN M AM UR ASS DA
   Markland P, 1999, INT J PHARM, V178, P183, DOI 10.1016/S0378-5173(98)00373-1
   Maruyama A, 1997, BIOCONJUGATE CHEM, V8, P735, DOI 10.1021/bc9701048
   Moromoto Y, 1984, J PHARMACOBIO-DYNAM, V7, P688
   MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530
   Murao S, 1969, KOBUNSHI, V16, P1204
   NITCCKI DE, 1971, CHEM BIOCH AMINO ACI, V1, P87
   Ogawa Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1684, DOI 10.1271/bbb.61.1684
   Okada N, 1997, BIOCHEM BIOPH RES CO, V230, P524, DOI 10.1006/bbrc.1996.5996
   Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1998, BIOMATERIALS, V19, P2167, DOI 10.1016/S0142-9612(98)00123-9
   PALACIOS P, 1991, J BIOCHEM BIOPH METH, V23, P67, DOI 10.1016/0165-022X(91)90051-W
   Perez-Camero G, 1999, BIOTECHNOL BIOENG, V63, P110, DOI 10.1002/(SICI)1097-0290(19990405)63:1<110::AID-BIT11>3.0.CO;2-T
   ROOS CF, 1984, INT J PHARM, V22, P75, DOI 10.1016/0378-5173(84)90047-4
   ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680
   ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507
   ROWLAND GF, 1975, NATURE, V255, P487, DOI 10.1038/255487a0
   RYSER HJP, 1978, P NATL ACAD SCI USA, V75, P3867, DOI 10.1073/pnas.75.8.3867
   RYSER HJP, 1980, CANCER, V45, P1207, DOI 10.1002/1097-0142(19800315)45:5+<1207::AID-CNCR2820451327>3.0.CO;2-M
   SEKINE T, 2000, J BIOMED MATER RES, V35, P305
   SHEN C, 1981, P FED AM SOC EXP BIO, V49, P642
   SHEN WC, 1981, LIFE SCI, V28, P1209, DOI 10.1016/0024-3205(81)90445-8
   SHEN WC, 1978, P NATL ACAD SCI USA, V75, P1872, DOI 10.1073/pnas.75.4.1872
   SHEN WC, 1979, MOL PHARMACOL, V16, P614
   Shih IL, 2002, ENZYME MICROB TECH, V31, P213, DOI 10.1016/S0141-0229(02)00103-5
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   SHIMA S, 1981, AGR BIOL CHEM TOKYO, V45, P2497, DOI 10.1080/00021369.1981.10864929
   SHIMA S, 1977, AGR BIOL CHEM TOKYO, V41, P1807, DOI 10.1080/00021369.1977.10862764
   SHIMA S, 1984, J ANTIBIOT, V37, P1449, DOI 10.7164/antibiotics.37.1449
   SHIMA S, 1981, AGR BIOL CHEM TOKYO, V45, P2503, DOI 10.1080/00021369.1981.10864930
   SHIMA S, 1983, J AGR CHEM SOC JPN, V57, P221, DOI 10.1271/nogeikagaku1924.57.221
   Singer JW, 2000, ANN NY ACAD SCI, V922, P136
   Singer JW, 2001, J CONTROL RELEASE, V74, P243, DOI 10.1016/S0168-3659(01)00323-6
   Spotnitz W. D., 1996, SURG ADHESIVES SEALA, P3
   Suye S, 1998, BIOTECHNOL APPL BIOC, V27, P245
   TEMIN HM, 1990, HUM GENE THER, V10, P4329
   THORNE CB, 1954, J BACTERIOL, V68, P307
   TORIUMI D, 1996, SURG ADHESIVES SEALA, P61
   TROY FA, 1973, J BIOL CHEM, V248, P305
   TROY FA, 1982, PEPTIDES ANTIBIOTICS
   TSUKADA Y, 1984, JNCI-J NATL CANCER I, V73, P721
   Van Heeswijk WAR, 1985, J CONTROL RELEASE, V1, P301
   VEGA J, 2002, 5 INT S POL THER LAB, P63
   WOLFERT MA, 1996, HUM GENE THER, V7, P213
   WONG JP, 1995, ANTIMICROB AGENTS CH, V39, P2574, DOI 10.1128/AAC.39.11.2574
   WORTHINGTON M, 1973, P SOC EXP BIOL MED, V143, P638
   Yoon SH, 2000, BIOTECHNOL LETT, V22, P585, DOI 10.1023/A:1005625026623
   YOUNG CW, 1971, MED CLIN N AM, V55, P721, DOI 10.1016/S0025-7125(16)32513-5
   Zauner W, 1998, ADV DRUG DELIVER REV, V30, P97, DOI 10.1016/S0169-409X(97)00110-5
   Zou YY, 2001, INT J ONCOL, V18, P331
   ZUNINO F, 1989, J CONTROL RELEASE, V10, P65, DOI 10.1016/0168-3659(89)90018-7
NR 126
TC 76
Z9 85
U1 4
U2 51
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PD FEB
PY 2004
VL 4
IS 2
BP 179
EP 188
DI 10.2174/1389557043487420
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 890BL
UT WOS:000226486600005
PM 14965290
DA 2018-10-20
ER

PT B
AU Dong, HS
AF Dong, HS
BE Xu, Y
   Shao, Z
   Gao, N
TI Towards long-life replacement joint prostheses - A surface engineering
   approach
SO 14TH CONGRESS OF INTERNATIONAL FEDERATION FOR HEAT TREATMENT AND SURFACE
   ENGINEERING, VOLS 1 and 2, PROCEEDINGS
LA English
DT Proceedings Paper
CT 14th Congress of the
   International-Federation-for-Heat-Treatment-and-Surface-Engineering
CY OCT 26-28, 2004
CL Shanghai, PEOPLES R CHINA
SP Int Federat Heat Treatmant & Surface Engn, Chinese Mech Engn Soc, Chinese Heat Treatment Soc, Shanghai Jiao Tong Univ, Shanghai Elect Grp Corp
DE joint prostheses; surface engineering; biomaterials; plasma surface
   alloying; ion beam; ceramic conversion
ID WEAR; RESISTANCE
AB How to improve the wear resistance of bearing surfaces, hereby achieving long life of orthopaedic joint prostheses has long been a technical challenge with much fundamental interest and social and economic impacts. Surface engineering has been emerging as one of the most promising technologies to improve the tribological properties of biomedical materials. A current area of research within the Birmingham Surface Engineering Group has been directed at developing novel surface engineering technologies for biomedical materials towards long-life joint prostheses. Following a brief introduction, the author reports their recent progress in the surface engineering of biomedical materials particular for joint prosthesis. The potential of these innovative surface engineering technologies in enhancing the performance of oral and maxillofacial implants and surgical devices is also discussed.
C1 Univ Birmingham, Dept Met & Mat, Birmingham B15 2TT, W Midlands, England.
RP Dong, HS (reprint author), Univ Birmingham, Dept Met & Mat, Birmingham B15 2TT, W Midlands, England.
CR Dong H, 2000, WEAR, V238, P131, DOI 10.1016/S0043-1648(99)00359-2
   DONG H, 2001, Patent No. 6210807
   Fisher J, 2004, J MATER SCI-MATER M, V15, P225, DOI 10.1023/B:JMSM.0000015482.24542.76
   JONES AHS, 2000, C FRICT LUBR WEAR AR
   LACOMBE P, 1982, TITANIUM TITANIUM AL, V2, P874
   Li XY, 2001, WEAR, V250, P553, DOI 10.1016/S0043-1648(01)00637-8
   MALCHAU H, 1996, P 63 ANN M AM AC ORT
   Raimondi MT, 2000, BIOMATERIALS, V21, P907
   Shi W, 2004, J MATER SCI, V39, P3183, DOI 10.1023/B:JMSC.0000025854.49913.4a
   Sun Y, 1999, SURF ENG, V15, P49, DOI 10.1179/026708499322911647
   Thaiwatthana S, 2003, SURF ENG, V19, P211, DOI 10.1179/026708403225006203
   Zhang Z.L., 1985, SURF ENG, V1, P131, DOI DOI 10.1179/SUR.1985.1.2.131
NR 12
TC 1
Z9 1
U1 0
U2 2
PU TRANSACTIONS MATERIALS & HEAT TREATMENT
PI BEIJING
PA NO 18 XUEQING RD, BEIJING, 100083, PEOPLES R CHINA
PY 2004
BP 1287
EP 1290
PG 4
WC Engineering, Mechanical; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Engineering; Materials Science; Metallurgy & Metallurgical Engineering
GA BCC83
UT WOS:000228664200300
DA 2018-10-20
ER

PT B
AU Krishnaswamy, A
   Baranoski, GVG
AF Krishnaswamy, A
   Baranoski, GVG
BE Gaudiot, JL
   Pilla, ML
   Navaux, POA
   Song, SW
TI Combining a shared-memory high performance computer and a heterogeneous
   cluster for the simulation of light interaction with human skin
SO 16TH SYMPOSIUM ON COMPUTER ARCHITECTURE AND HIGH PERFORMANCE COMPUTING,
   PROCEEDINGS
LA English
DT Proceedings Paper
CT 16th Symposium on Computer Architecture and High Performance Computing
CY OCT 27-29, 2004
CL Iguassu Falls, BRAZIL
SP Brazilian Comp Soc, IEEE Comp Soc, Int Federat Informat Proc, Fed Univ Rio Grande do Sul, Univ Sao Paulo
AB When light interacts with human skin, a complex and involved process begins as the light is absorbed and propagated by cells, fibers and other microscopic materials. This interaction happens countless times each day and its accurate simulation is essential to biomedical and computer graphics applications. Simulating this interaction is computationally intensive, yet highly suitable to parallelization. This paper describes the use of both a shared-memory high performance computer and a heterogeneous cluster to accelerate these simulations. With a description of the parallel software used, we present results to show the performance gains from using such a hybrid approach.
C1 Univ Waterloo, Sch Comp Sci, Nat Phenomena Simulat Grp, Waterloo, ON N2L 3G1, Canada.
RP Krishnaswamy, A (reprint author), Univ Waterloo, Sch Comp Sci, Nat Phenomena Simulat Grp, Waterloo, ON N2L 3G1, Canada.
CR ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191
   BARANOSKI GVG, 2003, CS200345 U WAT SCH C
   BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P231, DOI 10.1111/j.1751-1097.1984.tb04581.x
   GLASSNER A, 1995, PRINCIPLES DIGITAL I
   Gropp W., 1999, USING MPI PORTABLE P
   Jacques S. L., 1996, OSA TOPS ADV OPTICAL, V2, P364
   KRISHNASWAMY A, 2004, IN PRDESS COMPUTER G
   REINHARD E, 1999, THESIS U BRISTOL BRI
   Shirley P., 2000, REALISTIC RAY TRACIN
   Su YX, 2002, P SOC PHOTO-OPT INS, V4916, P299, DOI 10.1117/12.482974
   TUCHIN V, 1997, PHYSICS USPEKHI, V40
   Tuchin V, 2000, TISSUE OPTICS LIGHT
   Wang C., 1999, Journal of Graphics Tools, V4, P39
NR 13
TC 2
Z9 2
U1 0
U2 0
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
BN 0-7695-2240-8
PY 2004
BP 166
EP 171
DI 10.1109/SBAC-PAD.2004.13
PG 6
WC Computer Science, Hardware & Architecture; Computer Science, Theory &
   Methods
SC Computer Science
GA BBF41
UT WOS:000225222600021
DA 2018-10-20
ER

PT B
AU Wechsler, D
AF Wechsler, D
GP IEEE
TI Nanobiotechnology meets medical technology: Prospects and demands
SO 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY
LA English
DT Proceedings Paper
CT 4th IEEE Conference on Nanotechnology
CY AUG 16-19, 2004
CL Munich, GERMANY
SP IEEE
DE anotechnology; biomedical materials; membranes; drug delivery systems;
   control systems
ID NANOPARTICLES
AB Nanobiotechnology bridges the technological gaps between physics, chemistry and biology on the nanoscale. This leads to many innovative approaches which will result in new methods and products for both, technological and medical-pharmaceutical applications. This report discusses the following question how can nanobiotechnology contribute to and combined with medical technology
   inactive, biocompatible and functionalised surfaces are important for the further development of many applied medical systems like bone implants, stents and also membranes for apheresis. Furthermore nanoparticles are good candidates for establishing new therapeutic applications. They are considered and some are already applied as drug delivery systems and contrast agents. It is argued that coated nanoparticles functionalised with target molecules and interacting with a ternal devices offer real perspectives for medical applications which come close to the more or less realistic visions connected with nanobots.
C1 VDI Technol Zentrum GmbH, D-40239 Dusseldorf, Germany.
RP Wechsler, D (reprint author), VDI Technol Zentrum GmbH, Graf Recke Str 84, D-40239 Dusseldorf, Germany.
CR Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   CATLEDGE SA, 2002, ANOSCI ANOTECH, V2, P1
   GOULD P, 2004, MAT TODAY        FEB, P36
   O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004
   Steiniger SCJ, 2004, INT J CANCER, V109, P759, DOI 10.1002/ijc.20048
   WAGNER V, 2004, VDI TECHNOLOGIEZENTR
NR 6
TC 0
Z9 0
U1 0
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8536-5
PY 2004
BP 230
EP 232
PG 3
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BBL92
UT WOS:000226085100076
DA 2018-10-20
ER

PT B
AU De Santo, MP
   Lombardo, M
   Serrao, S
   Lombardo, G
   Barberi, R
AF De Santo, MP
   Lombardo, M
   Serrao, S
   Lombardo, G
   Barberi, R
GP IEEE
TI Atomic force microscopy in ophthalmic surgery
SO 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY
LA English
DT Proceedings Paper
CT 4th IEEE Conference on Nanotechnology
CY AUG 16-19, 2004
CL Munich, GERMANY
SP IEEE
DE Atomic force microscopy; biomedical materials; excimer lasers; laser
   biomedical applications; surgery
AB Refractive errors are some of the most common ophthalmic abnormalities. The introduction of excimer laser technology in refractive corneal surgery aims to eliminate all or the major part of the first corneal surface optical aberrations through the modelling of the corneal surface. Among the main causes of post-operative aberrations are the new corneal profile created by laser and the roughness of the treated surface. It is mandatory for an optimal surgical outcome that the treated surface be as similar as possible to the natural architecture of the cornea. The aim of this study is to evaluate the corneal topography before and after the laser treatment by means of Atomic Force Microscopy.
C1 Univ Calabria, Dept Phys, LICRYL, I-87036 Arcavacata Di Rende, Italy.
RP De Santo, MP (reprint author), Univ Calabria, Dept Phys, LICRYL, I-87036 Arcavacata Di Rende, Italy.
RI Lombardo, Giuseppe/B-2656-2012; Barberi, Riccardo/D-9219-2012
OI Lombardo, Giuseppe/0000-0002-9416-967X; Barberi,
   Riccardo/0000-0001-9713-1696; De Santo, Maria
   Penelope/0000-0001-6556-3611
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   SERRAO S, IN PRESS J REFRACT S
   YU YW, 1999, CMAJ, V160, P1329
NR 3
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8536-5
PY 2004
BP 252
EP 254
PG 3
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BBL92
UT WOS:000226085100083
DA 2018-10-20
ER

PT B
AU Singh, K
AF Singh, K
GP IEEE
TI A biomedical bone nano-transducer
SO 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY
LA English
DT Proceedings Paper
CT 4th IEEE Conference on Nanotechnology
CY AUG 16-19, 2004
CL Munich, GERMANY
SP IEEE
DE piezo-electricity; bone; sensors; diagnostic probe; microphone pick-up;
   vibration sensor
AB Bones are now considered as a well accepted series of piezoelectric materials. Several researchers have used the bone material to develop piezoelectric sensors for the measurement of pressure, force, acceleration and other such parameters. However, with the advancement of technology in sensor systems, micro and nano-scale devices are now being developed by using semiconductor or biological materials, all over the world. Bio-chips based on DNA; and Bio-MEMS, etc are some of the examples. In the present research, new bone chips have been developed for various sensor applications, mainly micro or nanoscale systems. Design and fabrication aspects of the bone sensor chips for nano-transducers are discussed in detail here. Possible biomedical applications of these chips are also given in brief.
C1 Indian Inst Technol, CBME, New Delhi 110016, India.
RP Singh, K (reprint author), 7-9 MS Bldg,NPL Colony, New Delhi 110060, India.
CR ANDREW MA, 1975, NATURE, V253, P627
   Fukuda E., 1957, J PHYS SOC JPN, V12, P1158
   FUKUDA E, 1964, JPN J APPL PHYS, V3, P117
   MARINO AA, 1970, NATURE, V228, P473, DOI 10.1038/228473a0
   SINGH VR, 1988, J INSTN ENG, V68, P43
   SINGH VR, 1988, P 10 ANN INT IEEE C
   YADAV S, 1990, INNOV TECH BIOL MED, V11, P89
NR 7
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8536-5
PY 2004
BP 438
EP 439
PG 2
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BBL92
UT WOS:000226085100145
DA 2018-10-20
ER

PT B
AU De Santo, MP
   Lombardo, M
   Serrao, S
   Lombardo, G
   Barberi, R
AF De Santo, MP
   Lombardo, M
   Serrao, S
   Lombardo, G
   Barberi, R
GP IEEE
TI Atomic force microscopy in ophthalmic surgery
SO 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY
LA English
DT Proceedings Paper
CT 4th IEEE Conference on Nanotechnology
CY AUG 16-19, 2004
CL Munich, GERMANY
SP IEEE
DE atomic force microscopy; biomedical materials; excimer lasers; laser
   biomedical applications; Surgery
AB Refractive errors are some of the most common ophthalmic abnormalities. The introduction of excimer laser technology in refractive corneal surgery aims to eliminate all or the major part of the first corneal surface optical aberrations through the modelling of the corneal surface. Among the main causes of post-operative aberrations are the new corneal profile created by laser and the roughness of the treated surface. It is mandatory for an optimal surgical outcome that the treated surface be as similar as possible to the natural architecture of the cornea. The aim of this study is to evaluate the corneal topography before and after the laser treatment by means of Atomic Force Microscopy.
C1 Univ Calabria, Dept Phys, LICRYL, I-87036 Arcavacata Di Rende, Italy.
RP De Santo, MP (reprint author), Univ Calabria, Dept Phys, LICRYL, I-87036 Arcavacata Di Rende, Italy.
OI Lombardo, Marco/0000-0001-8842-7102; De Santo, Maria
   Penelope/0000-0001-6556-3611; BARBERI, Riccardo
   Cristoforo/0000-0001-9713-1696
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   SERRAO S, IN PRESS J REFRACT S
   YU YW, 1999, CMAJ, V160, P1329
NR 3
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8536-5
PY 2004
BP 562
EP 564
PG 3
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BBL92
UT WOS:000226085100188
DA 2018-10-20
ER

PT B
AU Soumetz, FC
   Giacomini, M
   Phillips, JB
   Brown, RA
   Ruggiero, C
AF Soumetz, FC
   Giacomini, M
   Phillips, JB
   Brown, RA
   Ruggiero, C
GP IEEE
TI A drug delivery system for the treatment of peripheral nervous system
   injuries
SO 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY
LA English
DT Proceedings Paper
CT 4th IEEE Conference on Nanotechnology
CY AUG 16-19, 2004
CL Munich, GERMANY
SP IEEE
DE drug delivery systems; fluorescence spectroscopy; materials science and
   technology; materials testing; nanotechnology; nervous system; repair
ID ULTRATHIN FIBRONECTIN FIBERS; HYALURONIC-ACID; MIGRATION; ADHESIONS;
   CELLS; MATS
AB Recent results in biomedical engineering and materials science and technology have brought about the development of novel bioactive materials by which the repair of peripheral nervous system injuries can be improved. The formation of scarring tissue, which represents a physical barrier to axon elongation, and the not oriented outgrowth of neurites are the two major obstacles for a complete recovery of physiological nerve function. This study mainly focuses on the analysis of biocompatible constructs for the controlled release of anti-scarring antibodies by means of fluorescence spectroscopy techniques.
C1 Univ Genoa, DIST, I-16145 Genoa, Italy.
RP Soumetz, FC (reprint author), Univ Genoa, DIST, Via Opera Pia 13, I-16145 Genoa, Italy.
RI Phillips, James/G-7926-2014; Ruggiero, Carmelina/B-6038-2015
OI Ruggiero, Carmelina/0000-0002-5275-2074; Giacomini,
   Mauro/0000-0001-5646-2034; Phillips, James/0000-0001-8117-3074
CR Ahmed Z, 1999, CELL MOTIL CYTOSKEL, V42, P331
   ANDREASSI L, 1991, WOUNDS, V3, P116
   BENEDETTI L, 1994, MED DEVICE TECHNOL, V5, P32
   BRONZINO J, 1995, BIOMEDICAL ENG HDB
   BROWN RA, 1994, BIOMATERIALS, V15, P475
   Brown Robert A., 1997, Wound Repair and Regeneration, V5, P212, DOI 10.1046/j.1524-475X.1997.50304.x
   Creange A, 1998, REV NEUROL, V154, P208
   Curtis A., 1995, Journal of Cellular Engineering Incorporating Molecular Engineering, V1, P35
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Davison SP, 1999, LARYNGOSCOPE, V109, P631, DOI 10.1097/00005537-199904000-00021
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   GIACOMINI M, 2002, EUROPEAN CELLS MAT, V4, P113
   GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206
   KING VR, 1998, SOC NEUROSCI ABS, V24
   KNUDSON CB, 1993, FASEB J, V7, P1233
   LOFBERG J, 1980, DEV BIOL, V75, P148, DOI 10.1016/0012-1606(80)90151-7
   Nath RK, 1998, PLAST RECONSTR SURG, V102, P1100, DOI 10.1097/00006534-199809040-00027
   NIES S, 1997, ANNU REV BIOPH BIOM, V26, P567
   *PERK INC, 2000, INTRO FLUOR SPECTR
   Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856
   SHUSHAN A, 1994, J REPROD MED, V39, P398
   WHITWORTH IH, 1995, J HAND SURG-BRIT EUR, V20B, P429, DOI 10.1016/S0266-7681(05)80148-2
   WHIWORTH IH, 1995, EUROPEAN J NEUROSCIE, V7, P2220
   WojciakStothard B, 1997, IN VITRO CELL DEV-AN, V33, P110
NR 27
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8536-5
PY 2004
BP 571
EP 573
PG 3
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BBL92
UT WOS:000226085100191
DA 2018-10-20
ER

PT B
AU Chu, PK
AF Chu, PK
BE Huang, R
   Yu, M
   Liou, JJ
   Hiramoto, T
   Claeys, C
TI Recent advances and applications of plasma immersion ion implantation
SO 2004: 7TH INTERNATIONAL CONFERENCE ON SOLID-STATE AND INTEGRATED
   CIRCUITS TECHNOLOGY, VOLS 1- 3, PROCEEDINGS
LA English
DT Proceedings Paper
CT 7th International Conference on Solid-State and Integrated Circuits
   Technology
CY OCT 18-21, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Inst Elect, IEEE Beijing Sect, IEEE Elect Devices Soc, IEEE EDS Beijing Chapter, IEEE Solid-State Circuits Soc, IEEE SSCS Beijing Chapter, Japan Soc Appl Phys, IEE Elect Div, URSI Commiss D, Inst Elect Engineers Korea, Natl Nat Sci Fdn China, Beijing Municipal Bureau Ind Dev, Peking Univ
ID INSULATOR MATERIAL TECHNOLOGY; SILICON; HYDROGEN; PHOTOLUMINESCENCE
AB Many new applications of plasma immersion ion implantation (PIII) have recently emerged. In addition to the surface modification and fabrication of conventional metallurgical and semiconductor materials and structures by PIII, new areas such as biomedical materials engineering and plasma treatment of insulating materials have attracted much attention. In this paper, the progress of our recent research work of PIII on microelectronics, namely optical characteristics of hydrogen plasma implanted silicon and fabrication of novel silicon-on-insulator materials, are described.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR Bruel M, 1996, NUCL INSTRUM METH B, V108, P313, DOI 10.1016/0168-583X(95)01056-4
   BRUEL M, 1995, ELECTRON LETT, V31, P1201, DOI 10.1049/el:19950805
   Cerofolini GF, 1996, MAT SCI ENG B-SOLID, V36, P108, DOI 10.1016/0921-5107(95)01267-2
   Chu PK, 1997, REV SCI INSTRUM, V68, P1866, DOI 10.1063/1.1147959
   Chu PK, 2002, SURF COAT TECH, V156, P244, DOI 10.1016/S0257-8972(02)00100-7
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   COLLINGE JP, 1998, MAT RES B, V33, P16
   GULYASHIN A, 2001, MAT SCI SEMICON PROC, V4, P297
   Hirschman KD, 1996, NATURE, V384, P338, DOI 10.1038/384338a0
   LONI A, 1995, J APPL PHYS, V77, P3557, DOI 10.1063/1.358587
   Mudryi AV, 2001, PHYSICA B, V308, P181, DOI 10.1016/S0921-4526(01)00687-1
   PAVESI L, 1994, APPL PHYS LETT, V65, P454, DOI 10.1063/1.112331
   PEARTON SJ, 1991, HYDROGEN CRYSTALLINE
   REDMANWHITE W, 1993, ELECTRON LETT, V29, P1180, DOI 10.1049/el:19930789
   Song ZR, 2002, APPL PHYS LETT, V80, P743, DOI 10.1063/1.1445472
   VINH NQ, 2003, PHYS REV LETT, V90, P66401
   Yushin GN, 2002, APPL PHYS LETT, V81, P3275, DOI 10.1063/1.1516636
   Zhu M, 1997, APPL PHYS A-MATER, V65, P195, DOI 10.1007/s003390050565
NR 18
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8511-X
PY 2004
BP 2172
EP 2177
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA BBR18
UT WOS:000227342202141
DA 2018-10-20
ER

PT S
AU Yesin, KB
   Vollmers, K
   Nelson, BJ
AF Yesin, KB
   Vollmers, K
   Nelson, BJ
GP IEEE
TI Analysis and design of wireless magnetically guided microrobots in body
   fluids
SO 2004 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-
   5, PROCEEDINGS
SE IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION
LA English
DT Proceedings Paper
CT IEEE International Conference on Robotics and Automation
CY APR 26-MAY 01, 2004
CL New Orleans, LA
SP IEEE Robot & Automat Soc, IEEE
ID MAGNETS; LEVITATION; SYSTEMS; RELAYS
AB The active guidance of magnetic particles inside biological organisms for drug delivery, cell separation, and protein manipulation has been actively pursued in biomedical research for many years. Recent advances in the integration of magnetic materials in MEMS are enabling the convergence of these two technologies towards the realization of wireless magnetically guided biomedical microrobots. This paper discusses some of the fundamental design issues for a biomedical microrobot that is actively steered in body fluids using magnetic fields. The effects of miniaturization on magnetic, fluid drag, and gravity/buoyancy forces and on control stability are analyzed. The advantages of using hard magnetic materials and the state of the art in the integration of hard magnetic materials into MEMS devices are discussed. The analysis indicates that untethered microrobots capable of being navigated under external control within biological organisms including the human body is a realistic goal.
C1 Swiss Fed Inst Technol, ETH, Inst Robot & Intelligent Syst, Zurich, Switzerland.
RP Yesin, KB (reprint author), Swiss Fed Inst Technol, ETH, Inst Robot & Intelligent Syst, Zurich, Switzerland.
RI Nelson, Bradley/B-7761-2013
OI Nelson, Bradley/0000-0001-9070-6987
CR Amblard F, 1996, REV SCI INSTRUM, V67, P818, DOI 10.1063/1.1146816
   Berry M. V., 1997, European Journal of Physics, V18, P307, DOI 10.1088/0143-0807/18/4/012
   Cho H. J., 2000, Proceedings IEEE Thirteenth Annual International Conference on Micro Electro Mechanical Systems (Cat. No.00CH36308), P686, DOI 10.1109/MEMSYS.2000.838601
   Cho HJ, 2003, J APPL PHYS, V93, P8674, DOI 10.1063/1.1558591
   Dutoit BM, 1999, SENSOR ACTUAT A-PHYS, V77, P178, DOI 10.1016/S0924-4247(99)00193-4
   Furlani E., 2001, PERMANENT MAGNET ELE
   GAY WR, 1991, COLOR ATLAS PHYSL, P156
   GUAN S, 2003, 203 ECS M FRANC
   Haber C, 2000, REV SCI INSTRUM, V71, P4561, DOI 10.1063/1.1326056
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   Helin P., 2000, Proceedings IEEE Thirteenth Annual International Conference on Micro Electro Mechanical Systems (Cat. No.00CH36308), P467, DOI 10.1109/MEMSYS.2000.838562
   HOLLIGAN DL, 2003, IOP NANOTECHNOLOGY, V14, P661
   Jin J., 1999, ELECTROMAGNETIC ANAL
   Judy JW, 1997, J MICROELECTROMECH S, V6, P249, DOI 10.1109/84.623114
   Khamesee MB, 2002, IEEE-ASME T MECH, V7, P1, DOI 10.1109/3516.990882
   Lagorce LK, 1997, J MICROELECTROMECH S, V6, P307, DOI 10.1109/84.650127
   Lagorce LK, 1999, J MICROELECTROMECH S, V8, P2, DOI 10.1109/84.749396
   MATHIEU J, 2003, IEEE CCECE C EL COMP, P835
   PEPIN JG, 2002, P POL BOND MAGN C CH
   Ruan M, 2001, SENSOR ACTUAT A-PHYS, V91, P346, DOI 10.1016/S0924-4247(01)00606-9
   Sendoh M., 2000, P 2000 INT S MICR HU, P65
   Simon MD, 2001, AM J PHYS, V69, P702, DOI 10.1119/1.1375157
   Taylor WP, 1998, J MICROELECTROMECH S, V7, P181, DOI 10.1109/84.679353
   VICCI L, 2001, TR01031 UNC CHAP HIL
   Vikramaditya B., 2001, Journal of Micromechatronics, V1, P99, DOI 10.1163/156856301753398136
   Vollmers K, 2003, PROC IEEE MICR ELECT, P60
   Wagner B., 1991, Proceedings. IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (Cat. No.91CH2957-9), P27, DOI 10.1109/MEMSYS.1991.114764
   Zborowski M, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P205
NR 28
TC 7
Z9 7
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1050-4729
BN 0-7803-8232-3
J9 IEEE INT CONF ROBOT
PY 2004
BP 1333
EP 1338
DI 10.1109/ROBOT.2004.1308009
PG 6
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Robotics
SC Automation & Control Systems; Computer Science; Robotics
GA BAE24
UT WOS:000221794800215
DA 2018-10-20
ER

PT B
AU Bin Aris, MA
   Ghodgaonkar, DK
AF Bin Aris, MA
   Ghodgaonkar, DK
BE Ghodgaonkar, DK
   Esa, M
   Lin, A
   Awang, Z
   Habash, RW
TI Nondestructive and noncontact dielectric measurement method for
   high-loss liquids using free space microwave measurement system in
   8-12.5 GHz frequency range
SO 2004 RF and Microwave Conference, RFM 2004, Proceedings
LA English
DT Proceedings Paper
CT RF and Microwave Conference 2004
CY OCT 05-06, 2004
CL Selangor, MALAYSIA
SP Microwave Technol Ctr, Univ Teknol MARA, Ctr Elect Compatibil, Kolej Univ Teknol Tun Hussein Onn, Dept Radio Commun Engn, Fac Elect Engn, Univ Teknol Malaysia, IEEE Antennas & Propagat, Microwave Theory & Tech & Electromagnet Compatibil, Joint Chapter Malaysia Sect
ID COMPLEX PERMITTIVITY
AB Nondestructive, noncontact and real time evaluation of dielectric properties of liquids is important for applications such as biomedical, remote sensing and design of radar absorbing material. Free-space methods (which are nondestructive and noncontact) were developed for accurate measurement of dielectric properties of high-loss liquids at microwave frequencies. Free space microwave measurement system (FSMM) consists of spot focusing horn lens antennas, mode transitions, coaxial cables and vector network analyzer (VNA). For high-loss liquids, namely, methanol, ethanol, ethylene glycol and N-Propyl Alcohol, dielectric constants and loss factors were measured using reflection-transmission method. It is observed that the reflection-transmission method is suitable for accurate measurement of dielectric properties of high-loss liquids.
C1 Univ Teknol MARA, Fac Elect Engn, Microwave Technol Ctr, Shah Alam 40450, Malaysia.
RP Bin Aris, MA (reprint author), Univ Teknol MARA, Fac Elect Engn, Microwave Technol Ctr, Shah Alam 40450, Malaysia.
CR Ghodgaonkar Deepak Kumar, 2000, 15 WORLD C NOND TEST
   GHODGAONKAR DK, 1990, IEEE T INSTRUM MEAS, V39, P387, DOI 10.1109/19.52520
   GREGORY AP, 76 WEPNPL
   Hippel AR. von, 1995, DIELECTRIC MAT APPL, P18
   JORDAN BP, 1978, J PHYS D APPL PHYS, V11, P695, DOI 10.1088/0022-3727/11/5/013
   Jose KA, 2001, MICROW OPT TECHN LET, V30, P75, DOI 10.1002/mop.1225
   Wang Y., 2003, PROGR ELECTROMAGNETI, V42, P131
NR 7
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8671-X
PY 2004
BP 169
EP 176
DI 10.1109/RFM.2004.1411102
PG 8
WC Engineering, Electrical & Electronic
SC Engineering
GA BCK46
UT WOS:000229741500041
DA 2018-10-20
ER

PT B
AU Bin Aris, MA
   Ghodgaonkar, DK
   Khadri, N
AF Bin Aris, MA
   Ghodgaonkar, DK
   Khadri, N
BE Ghodgaonkar, DK
   Esa, M
   Lin, A
   Awang, Z
   Habash, RW
TI Nondestructive and noncontact dielectric measurement methods for
   low-loss liquids using free space microwave measurement system in 8-12.5
   GHz frequency range
SO 2004 RF and Microwave Conference, RFM 2004, Proceedings
LA English
DT Proceedings Paper
CT RF and Microwave Conference 2004
CY OCT 05-06, 2004
CL Selangor, MALAYSIA
SP Microwave Technol Ctr, Univ Teknol MARA, Ctr Elect Compatibil, Kolej Univ Teknol Tun Hussein Onn, Dept Radio Commun Engn, Fac Elect Engn, Univ Teknol Malaysia, IEEE Antennas & Propagat, Microwave Theory & Tech & Electromagnet Compatibil, Joint Chapter Malaysia Sect
ID COMPLEX PERMITTIVITY
AB Nondestructive, noncontact and real time evaluation of dielectric properties of low-loss liquids is important for applications such as service-aged transformer oil, biomedical, remote sensing and design of radar absorbing material. Free-space methods (which are nondestructive and noncontact) were developed for accurate measurement of dielectric properties of low-loss liquids at microwave frequencies. Two methods, namely, transmissions only method and metal-back method are developed for measurements using free space microwave measurement system (FSMM). FSMM system. consists of spot focusing horn lens antennas, mode transitions, coaxial cables and vector network analyzer (VNA), Dielectric constants and loss factors were measured for low-loss liquids such as dioxane, benzene and new transformer oil. It is observed that both transmissions only method and metal-back method is suitable for dielectric measurement of low-loss liquids.
C1 Univ Teknol MARA, Fac Elect Engn, Microwave Technol Ctr, Shah Alam 40450, Selangor, Malaysia.
RP Bin Aris, MA (reprint author), Univ Teknol MARA, Fac Elect Engn, Microwave Technol Ctr, Shah Alam 40450, Selangor, Malaysia.
CR Duhamel F, 1997, IEEE MTT-S, P107, DOI 10.1109/MWSYM.1997.604532
   GHODGAONKAR D, 1989, IEEE T INSTRUM MEAS, V37, P789
   GHODGAONKAR DK, 1990, IEEE T INSTRUM MEAS, V39, P387, DOI 10.1109/19.52520
   Jose KA, 2001, MICROW OPT TECHN LET, V30, P75, DOI 10.1002/mop.1225
   KUDO Y, RELATIVE DIELECTRIC, P329
   LIDE DR, 2003, CRC HDB CHEM PHYSICS
   MISRA D, 1990, IEEE T MICROW THEORY, V38, P8, DOI 10.1109/22.44150
   Muller D.E., 1965, MATHEMATIC TABLES OT, V10, P208, DOI DOI 10.1090/S0025-5718-1956-0083822-0
   MUSIL J, 1986, MICROWAVE MEASUREMEN, P20
   RAJ A, 2001, IEEE T INSTRUMENTATI, V50
   VASUNDARA VV, 1991, IEEE T INSTRU MEAS, V40, P842
   Von Hippel A. R., 1995, DIELECTRIC MAT APPL
   WADHWA CL, 1994, HIGH VOLTAGE ENG, P20
   Wang Y., 2003, PROGR ELECTROMAGNETI, V42, P131
NR 14
TC 3
Z9 3
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8671-X
PY 2004
BP 182
EP 189
DI 10.1109/RFM.2004.1411104
PG 8
WC Engineering, Electrical & Electronic
SC Engineering
GA BCK46
UT WOS:000229741500043
DA 2018-10-20
ER

PT B
AU Contarino, MV
   Petrosyuk, IM
AF Contarino, MV
   Petrosyuk, IM
BE Callaos, N
   Lesso, W
   Ahmad, A
TI Hyperspectral and multispectral optical systems. Rewiew
SO 8TH WORLD MULTI-CONFERENCE ON SYSTEMICS, CYBERNETICS AND INFORMATICS,
   VOL VI, PROCEEDINGS: IMAGE, ACOUSTIC, SIGNAL PROCESSING AND OPTICAL
   SYSTEMS, TECHNOLOGIES AND APPLICATIONS
LA English
DT Proceedings Paper
CT 8th World Multi-Conference on Systemics, Cybernetics and Informatics
CY JUL 18-21, 2004
CL Orlando, FL
SP Int Inst Informat & System, Amer Soc Cybernet, Acad Non Linear Sci, Univ Las Palmas Gran Canaria, Telemat Engn Dept, Concurrency & Architecture Grp, CUST, Blaise Pascal Univ, Engn Sci Inst, Cybernet & Human Knowing, Int Federat Syst Res, Int Syst Inst, Int Soc Syst Sci, Italian Soc System, Univ Nacl San Luis, Lab Res Computac Intelligence, Dept Informat, Polish Syst Soc, Slovenian Artificial Intelligence Soc, Soc Appl Syst Res, Syst Soc Poland, Ctr Syst Studies, Tunisian Sci Soc, World Org System & Cybernet, IEEE Comp Soc, Venezuela Chapter, IEEE, Venezuela Chapter, Natl Res Council Canada, Steacie Inst Mol Sci
DE hyperspectral; multispectral; system; technology; spectral imaging;
   spectral; spatial; analysis
AB Hyperspectral and multispectral optical technologies are creative techniques that combine and integrate spectral with spatial methods. With the increase in performance of new technology for these optical systems there is a corresponding extension in the application to new areas. This includes geologic, atmospheric, underwater, space, biomedical, and material applications.
   The image processing can be combined as the best of two worlds: spatial and spectral analysis while and the spectral generation can be divided into four parts: image acquisition, spectral analysis, image fusion, and spectral reconstruction. The combined analysis is considered as data fusion.
C1 USN, Air Syst Command Red & Engn Grp, Patuxent River, MD 20670 USA.
RP Contarino, MV (reprint author), USN, Air Syst Command Red & Engn Grp, Patuxent River, MD 20670 USA.
CR DU HT, BAND SELECTION USING
   FITZGERALD GJ, HYPERSPECTRAL REMOTE
   GOMEZ RB, WAVELET BASED HYPERS
   *STI, STI GOVT SYST SPECTR
   HYPER SPECTRAL IMAGI
NR 5
TC 0
Z9 0
U1 0
U2 1
PU INT INST INFORMATICS & SYSTEMICS
PI ORLANDO
PA 14269 LORD BARCLAY DR, ORLANDO, FL 32837 USA
BN 980-6560-13-2
PY 2004
BP 41
EP 44
PG 4
WC Acoustics; Engineering, Electrical & Electronic; Optics; Imaging Science
   & Photographic Technology
SC Acoustics; Engineering; Optics; Imaging Science & Photographic
   Technology
GA BBT30
UT WOS:000227681100008
DA 2018-10-20
ER

PT B
AU Manolova, N
   Stoilova, O
   Paneva, D
   Rashkov, I
AF Manolova, N
   Stoilova, O
   Paneva, D
   Rashkov, I
BE Thomas, DW
TI Novel materials and systems based on synthetic and natural polymers
   targeted for use in the biomedical field
SO Advanced Biomaterials for Medical Applications
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Approaches to Advanced Biomaterials
   Engineering Systems
CY NOV 10-12, 2003
CL Sofia, BULGARIA
SP NATO
ID PLA/PEO/PLA TRIBLOCK COPOLYMERS; RING-OPENING POLYMERIZATION;
   DRUG-RELEASE; HYDROLYTIC DEGRADATION; END-GROUPS; FULLERENE; CHITOSAN;
   COMPLEX; ACID); PROTEINS
C1 Bulgarian Acad Sci, Inst Polymer, Lab Bioact Polymers, BU-1113 Sofia, Bulgaria.
RP Manolova, N (reprint author), Bulgarian Acad Sci, Inst Polymer, Lab Bioact Polymers, BU-1113 Sofia, Bulgaria.
RI Rashkov, Iliya/L-1460-2016; Paneva, Dilyana/K-9334-2016; stoilova,
   olya/L-1123-2016; Manolova, Nevena/L-1464-2016
OI stoilova, olya/0000-0001-6903-0396; 
CR Angelova N, 1995, J BIOACT COMPAT POL, V10, P285, DOI 10.1177/088391159501000401
   Angelova N, 1996, J BIOACT COMPAT POL, V11, P28, DOI 10.1177/088391159601100103
   CHAVASIT V, 1988, POLYM BULL, V19, P223
   Delpeux S, 1998, EUR POLYM J, V34, P905, DOI 10.1016/S0014-3057(97)00225-5
   DELPEUX S, 1999, EUR POLYM J, V39, P1619
   Dumitriu S, 1998, ADV DRUG DELIVER REV, V31, P223, DOI 10.1016/S0169-409X(97)00120-8
   Espartero JL, 1996, MACROMOLECULES, V29, P3535, DOI 10.1021/ma950529u
   *EUR POL FED, 2001, AIM MAGAZINE S, V35
   GRUBER P, 2002, BIOPOLYMERS, V4, pCH8
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Hirayama J, 1999, BIOL PHARM BULL, V22, P1106
   HIRSCH A, 1991, ANGEW CHEM INT EDIT, V30, P1309, DOI 10.1002/anie.199113091
   Kissel T, 2002, ADV DRUG DELIVER REV, V54, P99, DOI 10.1016/S0169-409X(01)00244-7
   Koseva N, 2001, J BIOACT COMPAT POL, V16, P3
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   Manolova N, 1998, EUR POLYM J, V34, P1133, DOI 10.1016/S0014-3057(97)00233-4
   Manolova N, 1997, J BIOACT COMPAT POL, V12, P221, DOI 10.1177/088391159701200305
   MANOLOVA N, 1993, J CHEM SOC CHEM COMM, P1725, DOI 10.1039/c39930001725
   Mladenova R, 2001, J BIOACT COMPAT POL, V16, P259, DOI 10.1106/AD9E-DQYK-579V-HT7A
   Paneva D., 2003, E POLYM, V052
   Patel N, 1998, FASEB J, V12, P1447
   PROCOP A, 1998, ADV POLYM SCI, V136, P1
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   SORM M, 1979, J POLYM SCI POLYM S, V66, P349
   Stoilova O, 1999, POLYM BULL, V43, P67, DOI 10.1007/s002890050534
   Tabata Y, 1997, JPN J CANCER RES, V88, P1108, DOI 10.1111/j.1349-7006.1997.tb00336.x
   VERT M, 1997, Patent No. 9719973
   Zhong ZY, 2001, POLYM BULL, V46, P51, DOI 10.1007/s002890170088
   Zhong ZY, 2001, MACROMOLECULES, V34, P3863, DOI 10.1021/ma0019510
NR 30
TC 1
Z9 1
U1 1
U2 3
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-2906-3
J9 NATO SCI SER II MATH
PY 2004
VL 180
BP 127
EP 142
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA BCM98
UT WOS:000230107000010
DA 2018-10-20
ER

PT S
AU Avrit, BK
   Maxwell, EW
   Huynh, LM
   Capsuto, E
AF Avrit, BK
   Maxwell, EW
   Huynh, LM
   Capsuto, E
BE Sturtevant, JL
TI Characterization of an ultra-thick positive photoresist for
   electroplating applications
SO ADVANCES IN RESIST TECHNOLOGY AND PROCESSING XXI, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Advances in Resist Technology and Processing XXI
CY FEB 23-24, 2004
CL Santa Clara, CA
SP SPIE
DE advanced packaging; MEMS; thick resist; electroplating; process
   optimization; Cu bump; single coat 100 micron resist film
ID FILMS
AB The performance requirements for ultra-thick photoresists are rapidly increasing with the dramatic growth in new lithographic applications that require electroplating processes. Two of the main applications for ultra-thick photoresists are nanotechnology (MEMS) and advanced packaging. Flipchip packaging has become widely adopted to address electrical device performance and chip form factor considerations. The growth in the nanotechnology market is driven by a wide range of products, which include accelerometers, inkjet print heads, biomedical sensors and optical switches.
   Electroplating levels for these applications require a photosensitive polymer material capable of coating, exposing and plating with conventional semiconductor equipment and standard ancillary process chemicals. A single coat step to achieve the final photoresist thickness is critical to minimize the number of process steps and cycle time. For this thick layer the sidewall profile, aspect ratio, el ectroplating durability and subsequent stripability are all important. This study characterized a novel positive photoresist (Shin-Etsu SIPe) for use in a 100 micron thick coat for electroplating on copper.
   The lithographic performance of the ultra-thick positive photoresist was optimized using a broad band, 1X KARL SUSS MA150 aligner used in the proximity mode. All proximity gaps were hard set at 100 microns. Cross sectional SEM analysis, process linearity, and optimized proximity gaps were used to establish the lithographic capabilities. High aspect ratio structures were then electroplated using the optimized photoresist process to demonstrate photoresist durability and stripability. A recommended process flow is described for this photoresist and exposure tool.
C1 TriQuint Semicond, Hillsboro, OR 97124 USA.
RP Avrit, BK (reprint author), TriQuint Semicond, Hillsboro, OR 97124 USA.
CR Flack WW, 1999, P SOC PHOTO-OPT INS, V3678, P474, DOI 10.1117/12.350230
   Flack WW, 1998, P SOC PHOTO-OPT INS, V3333, P1288, DOI 10.1117/12.312452
   Flack WW, 1998, P SOC PHOTO-OPT INS, V3512, P296, DOI 10.1117/12.324073
   FLORES, 1993, SPIE, V1927
   LAU, 1996, 4L EL COMP TECHN C
   Mansfield SM, 2000, P SOC PHOTO-OPT INS, V4000, P63, DOI 10.1117/12.389061
   PATTERSON D, 2001, ADV PACKAGING    JUL
   RANJAN M, 2002, SEM CHIN TECHN SEM M
   TONG L, 1999, SPIE, V3677, P3677
NR 9
TC 1
Z9 1
U1 0
U2 8
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5289-0
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5376
BP 929
EP 938
DI 10.1117/12.537120
PN 1&2
PG 10
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA BAI78
UT WOS:000222468500104
DA 2018-10-20
ER

PT S
AU Flack, WW
   Nguyen, HA
   Buchanan, J
   Capsuto, E
   Marks, A
AF Flack, WW
   Nguyen, HA
   Buchanan, J
   Capsuto, E
   Marks, A
BE Sturtevant, JL
TI Contrast enhancement materials for thick photoresist applications
SO ADVANCES IN RESIST TECHNOLOGY AND PROCESSING XXI, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Advances in Resist Technology and Processing XXI
CY FEB 23-24, 2004
CL Santa Clara, CA
SP SPIE
DE contrast enhancement material; CEM; thick photoresist; advanced
   packaging; flipchip; MEMS; aspect ratios; BCB
AB The performance requirements for ultra-thick photoresists; are rapidly increasing due to the dramatic growth of applications such as nanotechnology (MEMS) and advanced packaging. Commercial products such as accelerometers, ink jet print heads, biomedical sensors and optical switches are driving growth in the nanotechnology market. Advanced packaging techniques such as flip chip in package, flip chip in board and wafer level chip scale packaging have become widely adopted to address electrical device performance and chip form factor considerations.
   The common lithography requirement for these applications is formation of high aspect ratio structures with sufficient process latitude to allow devices to be manufactured in production volumes. The use of a contrast enhancement material (CEM) has been shown to be effective in improving lithographic performance and process latitude for thin photoresist applications. However, CEM technology can also be used for the thick photoresist materials in MEMS and advanced packaging applications.
   The lithographic performance of three representative thick photoresists was characterized with and without a top CEM. The first two materials are ultra-thick positive photoresists that are widely used for electroplated bump bonding structures. The third material is a thick negative photoresist widely used for electrical redistribution levels. All lithography was performed using a low numerical aperture, 1X stepper to control critical dimensions (CD), sidewall angles and aspect ratios. Cross sectional SEM analysis was used to establish the lithographic capabilities of the three photoresists with and without top CEM. The recommended process flow for each photoresist with top CEM is described. The advantages and disadvantages of using CEM for thick photoresist applications are also discussed.
C1 Ultratech Inc, San Jose, CA 95134 USA.
RP Flack, WW (reprint author), Ultratech Inc, San Jose, CA 95134 USA.
CR FLACK W, 1998, SPIE, V3512
   FLACK W, 1999, SPIE, V3678
   FLACK W, 2001, SPIE, V4326
   FLACK W, 2003, SPIE, V5039
   FLACK W, 1998, SPIE, V3333
   FLORES G, 1993, SPIE, V1927
   GEARY S, 2002, SPIE, V4690
   KNUTTI J, 1998, SPIE, V3511
   Levinson H. J., 2001, PRINCIPLES LITHOGRAP
   MANSFIELD S, 2000, SPIE, V4000
   RANJAN M, 2002, ADV PACKAGING    AUG
   TODD B, 1999, SPIE, V3874
NR 12
TC 1
Z9 1
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5289-0
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5376
BP 1190
EP 1205
DI 10.1117/12.556842
PN 1&2
PG 16
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA BAI78
UT WOS:000222468500133
DA 2018-10-20
ER

PT B
AU Pang, X
   Zhitomirsky, I
AF Pang, X
   Zhitomirsky, I
BE Patnaik, PC
TI Cathodic electrodeposition of protective zirconia coatings
SO Aerospace Materials and Manufacturing: Development, Testing, and Life
   Cycle Issues - Honoring William Wallace
LA English
DT Proceedings Paper
CT 2nd International Symposium on Aerospace Materials and Manufacturing
   held at the 43rd Annual Conference of Metallurgists of CIM
CY AUG 22-25, 2004
CL Hamilton, CANADA
SP Canadian Inst Min, Met & Petr, Mat Performance & Integr Sect
ID ELECTROLYTIC DEPOSITION; ELECTROPHORETIC DEPOSITION; POLYELECTROLYTE
   ADSORPTION; FILMS; ZRO2; COMPOSITES; OXIDES; ELECTROSYNTHESIS;
   MECHANISM; GROWTH
AB The outstanding thermal and chemical stability, excellent mechanical properties and biocompatibility of zirconia have made this material an important candidate for fabrication of advanced protective coatings on metals, graphite, carbon fibers and biomedical implants. Nanostructured polymer-ceramic composite films containing zirconia were synthesized on metallic substrates by combining cathodic electrosynthesis of inorganic particles with electrophoretic deposition of cationic polyelectrolytes. Thick crack-free oxide and composite coatings were obtained using this newly developed technique. The deposits were studied by thermogravimetric analysis, X-ray diffraction analysis, scanning electron microscopy and atomic force microscopy. The mechanisms of deposition are discussed.
C1 McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON L8S 4L7, Canada.
RP Pang, X (reprint author), McMaster Univ, Dept Mat Sci & Engn, 1280 Main St W, Hamilton, ON L8S 4L7, Canada.
CR Baklouti S, 1997, J EUR CERAM SOC, V17, P1387, DOI 10.1016/S0955-2219(97)00010-1
   Boccaccini AR, 1998, J MATER SCI, V33, P933, DOI 10.1023/A:1004351525920
   CHAIM R, 1994, J MATER SCI, V29, P6241, DOI 10.1007/BF00354566
   CHAIM R, 1991, J ELECTROCHEM SOC, V138, P1942, DOI 10.1149/1.2085905
   CLEARFIELD A, 1990, J MATER RES, V5, P161, DOI 10.1557/JMR.1990.0161
   der Biest O. O. V., 1999, ANNU REV MATER SCI, V29, P327
   Espitia I., 2003, MATER LETT, V58, P191, DOI DOI 10.1016/S0167-577X(03)00443-9
   Fang MM, 1999, CHEM MATER, V11, P1526, DOI 10.1021/cm981066k
   Hoogeveen NG, 1996, J COLLOID INTERF SCI, V182, P146, DOI 10.1006/jcis.1996.0445
   Hoogeveen NG, 1996, J COLLOID INTERF SCI, V182, P133, DOI 10.1006/jcis.1996.0444
   Kaya C, 1999, J EUR CERAM SOC, V19, P2859, DOI 10.1016/S0955-2219(99)00085-0
   Limmer SJ, 2002, ADV FUNCT MATER, V12, P59, DOI 10.1002/1616-3028(20020101)12:1<59::AID-ADFM59>3.0.CO;2-B
   Moreno R, 2000, AM CERAM SOC BULL, V79, P44
   Mukherjee A, 2001, ELECTROCHEM SOLID ST, V4, pD5, DOI 10.1149/1.1391075
   Nakajima K, 1996, J MATER CHEM, V6, P1795, DOI 10.1039/jm9960601795
   PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002
   Sasaki T, 2001, CHEM MATER, V13, P4661, DOI 10.1021/cm010478h
   Shchukin DG, 2003, J PHYS CHEM B, V107, P86, DOI 10.1021/jp0265236
   Tyan HL, 1999, CHEM MATER, V11, P1942, DOI 10.1021/cm990187x
   Yen SK, 1999, J ELECTROCHEM SOC, V146, P1392, DOI 10.1149/1.1391776
   Yen SK, 2000, MATER CHEM PHYS, V63, P256, DOI 10.1016/S0254-0584(99)00232-1
   Zhitomirsky I, 2000, MATER LETT, V46, P1, DOI 10.1016/S0167-577X(00)00133-6
   Zhitomirsky I, 2000, J MATER CHEM, V10, P1215, DOI 10.1039/b000311p
   Zhitomirsky I, 2004, J APPL ELECTROCHEM, V34, P235, DOI 10.1023/B:JACH.0000009965.74890.d9
   Zhitomirsky I, 2003, MATER LETT, V57, P1045, DOI 10.1016/S0167-577X(02)00922-9
   Zhitomirsky I, 2000, MATER LETT, V42, P273, DOI 10.1016/S0167-577X(99)00193-7
   Zhitomirsky I, 1998, J EUR CERAM SOC, V18, P849, DOI 10.1016/S0955-2219(97)00213-6
   Zhitomirsky I, 2001, MATER LETT, V50, P189, DOI 10.1016/S0167-577X(01)00223-3
   Zhitomirsky I, 2000, MAT SCI ENG B-SOLID, V78, P125, DOI 10.1016/S0921-5107(00)00535-3
   Zhitomirsky I., 2002, ADV COLLOID INTERFAC, V97, P297
   Zhu XW, 2003, J AM CERAM SOC, V86, P189, DOI 10.1111/j.1151-2916.2003.tb03302.x
NR 31
TC 0
Z9 0
U1 0
U2 6
PU CANADIAN INST MINING, METALLURGY AND PETROLEUM
PI MONTREAL
PA XEROX TOWER, 1 PLACE ALEXIS NIHON, 1210-3400 DE MAISONNEUVE BLVD,
   MONTREAL, PQ H3Z 3B8, CANADA
BN 1-894475-48-8
PY 2004
BP 109
EP 122
PG 14
WC Engineering, Aerospace; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BBZ32
UT WOS:000228356300009
DA 2018-10-20
ER

PT J
AU Thompson, M
AF Thompson, M
TI Nanomedicine - A tremendous research opportunity for analytical chemists
SO ANALYST
LA English
DT Editorial Material
AB Michael Thompson in consultation with Professor Chris Yip from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto considers the segments that comprise the field of nanomedicine (biopharmaceutics, implantable materials and devices, surgical aids, diagnostic tools) and how the analytical chemist can contribute in this exciting arena.
C1 Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
CR GORDON N, 2003, NANOMEDICINE TAXONOM
NR 1
TC 7
Z9 7
U1 0
U2 4
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
J9 ANALYST
JI Analyst
PY 2004
VL 129
IS 8
BP 671
EP 671
DI 10.1039/b409906k
PG 1
WC Chemistry, Analytical
SC Chemistry
GA 842IN
UT WOS:000222997200001
PM 15284906
DA 2018-10-20
ER

PT J
AU Senna, M
   Legrand, AP
AF Senna, M
   Legrand, AP
TI Inorganic/organic composites for biological, pharmaceutical and medical
   applications: Why?
SO ANNALES DE CHIMIE-SCIENCE DES MATERIAUX
LA English
DT Article
ID NMR-SPECTROSCOPY; BONE SUBSTITUTES
AB The term "composite material" is largely used to designate many compounds for practical applications. This type of materials has existed, more or less sophisticated, for millennia, as in ancient, civilisations for the preparation of pottery or of plant-mineral mixtures for their pharmaceutical properties. Nothing is more significant, however, than those in the biomedical field, since there are so many living examples of nano bio-composites in our own bodies. It is of particular importance to review the composites in these areas from the advanced viewpoints of the 21st century.
C1 Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
   Ecole Super Phys & Chim Ind Ville Paris, Lab Phys Quant, Paris, France.
RP Senna, M (reprint author), Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
CR *AFNOR, 1993, S94066 AFNOR
   BOHIC S, 2000, BONE, V2, P341
   Bohner M, 1996, J MATER SCI-MATER M, V7, P457, DOI 10.1007/BF00122016
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Collis N, 2000, PLAST RECONSTR SURG, V105, P1979, DOI 10.1097/00006534-200005000-00010
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   Daculsi G, 1999, BONE, V25, P59
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   GAUTHIER O, 1999, BONE, V25, P71
   GOUIN F, 1995, REV CHIR ORTHOP REPA, V81, P65
   ISHIKAWA K, 1993, J MATER SCI-MATER M, V4, P168
   Legrand AP, 2002, J BIOMED MATER RES, V63, P390, DOI 10.1002/jbm.10255
   Legrand AP, 1999, BONE, V25, p103S
   MARCHANDISE X, 1992, MAGNET RESON MED, V28, P1, DOI 10.1002/mrm.1910280102
   MIQUEL J L, 1990, Clinical Materials, V5, P115, DOI 10.1016/0267-6605(90)90011-J
   Ransford AO, 1998, J BONE JOINT SURG BR, V80B, P13, DOI 10.1302/0301-620X.80B1.7276
   REY C, 1995, BONE, V16, P583, DOI 10.1016/8756-3282(95)00101-I
   TOTH JM, 1991, J APPL BIOMATER, V2, P40
   WEISS P, 1999, BONE, V25, P67
NR 19
TC 2
Z9 2
U1 0
U2 1
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0151-9107
J9 ANN CHIM-SCI MAT
JI Ann. Chim.-Sci. Mat.
PD JAN-FEB
PY 2004
VL 29
IS 1
BP 1
EP 5
DI 10.3166/acsm.29.1-5
PG 5
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 839MP
UT WOS:000222789500001
DA 2018-10-20
ER

PT J
AU Redondo, A
   LeSar, R
AF Redondo, A
   LeSar, R
TI Modeling and simulation of biomaterials
SO ANNUAL REVIEW OF MATERIALS RESEARCH
LA English
DT Review
DE biology; soft matter; theory
ID MOLECULAR-DYNAMICS SIMULATIONS; FINITE-ELEMENT APPROACH; BONE REMODELING
   THEORY; TUMOR GROWTH DYNAMICS; GRAMICIDIN-A CHANNEL; NERNST-PLANCK
   THEORY; FLUID MOSAIC MODEL; COMPUTER-SIMULATION; TRABECULAR BONE; ION
   CHANNELS
AB Modeling and simulation are becoming increasingly accepted components of materials research. In this review we discuss application of modeling and simulation in the developing field of biomaterials. To restrict the discussion somewhat, we focus primarily on the structure and properties of biomaterials and do not discuss biochemical or biomedical applications. We start with a discussion of how atomistic-level simulation can be used to study molecules and collections of molecules. We then focus on mesoscale simulations of structure and properties, followed by a brief review of continuum-scale approaches. We end with some thoughts on the future of modeling and simulation in biomaterials applications.
C1 Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.
RP Redondo, A (reprint author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.
EM redondo@lanl.gov; lesar@lanl.gov
RI LeSar, Richard/G-1609-2012
OI LeSar, Richard/0000-0002-8780-935X
CR Adachi T, 2001, J BIOMECH ENG-T ASME, V123, P403, DOI 10.1115/1.1392315
   Alber MS, 2003, IMA VOL MATH APPL, V134, P1
   Alber MS, 2001, J PHYS A-MATH GEN, V34, P10707, DOI 10.1088/0305-4470/34/48/332
   ALBER MS, 2004, UNPUB PHYS REV LETT
   Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8
   Alberts B, 2002, MOL BIOL CELL
   Albinet G, 1996, EUROPHYS LETT, V33, P569, DOI 10.1209/epl/i1996-00380-5
   ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376
   ALLEN MP, 1987, COMPUTER SIMULATION
   Allen TW, 2003, BIOPHYS J, V84, P2159, DOI 10.1016/S0006-3495(03)75022-X
   ANDERSON MP, 1984, ACTA METALL MATER, V32, P783, DOI 10.1016/0001-6160(84)90151-2
   ARAKAWA T, 1985, METHOD ENZYMOL, V114, P49
   Arbib M. A., 1998, NEURAL ORG STRUCTURE
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   Ben-Shaul A., 1987, PHYSICS AMPHIPHILIC, P2
   Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7
   Berry JL, 2002, J VASC INTERV RADIOL, V13, P97, DOI 10.1016/S1051-0443(07)60015-3
   Bicerano J, 1992, COMPUTATIONAL MODELI
   Biggin PC, 2000, CURR OPIN STRUC BIOL, V10, P456, DOI 10.1016/S0959-440X(00)00114-7
   Binder K, 1995, MONTE CARLO MOL DYNA
   Blaxter K, 1989, ENERGY METABOLISM AN
   Boal D., 2002, MECH CELL
   Bodig J., 1982, MECH WOOD WOOD COMPO
   BORM, 2001, COMPUTATIONAL MODELI, P189
   BOWER JM, 2001, COMPUTATIONAL MODELI
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Bragg W.L., 1934, Proceedings of the Royal Society of London, V145, P699, DOI 10.1098/rspa.1934.0132
   Branden C., 1999, INTRO PROTEIN STRUCT
   Breuls RGM, 2002, J BIOMECH ENG-T ASME, V124, P198, DOI 10.1115/1.1449492
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Burykin A, 2002, PROTEINS, V47, P265, DOI 10.1002/prot.10106
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   Cahn R. W., 2001, COMING MAT SCI
   CANTOR CR, 1980, BIOPHYS CHEM 3
   Cardenas AE, 2000, BIOPHYS J, V79, P80, DOI 10.1016/S0006-3495(00)76275-8
   CEVC G, 1987, PHOSPHOLIPID BILAYER
   CHAIKIN PMT, 1995, PRINCIPLES CONDENSED
   Chang I, 2003, MICROBIOL-SGM, V149, P2859, DOI 10.1099/mic.0.26211-0
   CHAO SD, 2004, IN PRESS J CHEM PHYS, V120
   Chapman D., 1984, BIOL MEMBRANES, V5
   Chiu SW, 1999, BIOPHYS J, V76, P1929, DOI 10.1016/S0006-3495(99)77352-2
   CHOPARD B, 1998, CELL AUTOMATA MODELI
   Chou SK, 2003, IND ENG CHEM RES, V42, P4939, DOI 10.1021/ie0301536
   Chua KJ, 2003, BIORESOURCE TECHNOL, V90, P285, DOI 10.1016/S0960-8524(03)00133-0
   Chung SH, 2002, EUR BIOPHYS J BIOPHY, V31, P283, DOI 10.1007/s00249-002-0216-4
   Chung SH, 2002, BBA-BIOMEMBRANES, V1565, P267, DOI 10.1016/S0005-2736(02)00574-6
   Chung SH, 2002, BIOPHYS J, V83, P263, DOI 10.1016/S0006-3495(02)75167-9
   Cimrman R, 2003, ADV COMP BIOENG, V7, P25
   Cordes JA, 1998, COMPOS PART A-APPL S, V29, P1475, DOI 10.1016/S1359-835X(98)00107-9
   COREY DP, 1983, J NEUROSCI, V3, P942
   Corry B, 2003, BIOPHYS J, V84, P3594, DOI 10.1016/S0006-3495(03)75091-7
   Corry B, 2002, BIOPHYS J, V82, P1975, DOI 10.1016/S0006-3495(02)75546-X
   Creighton T. E., 1993, PROTEINS STRUCTURES
   Creighton TE, 1991, CURR OPIN STRUC BIOL, V1, P5, DOI 10.1016/0959-440X(91)90004-D
   CURREY J, 1984, MECH ADAPTATIONS BON
   DAOUD M, 1995, SOFT MATTER PHYS
   de Groot BL, 2002, BIOPHYS J, V82, P2934, DOI 10.1016/S0006-3495(02)75634-8
   DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81, DOI 10.1017/S0033583500002080
   Derjaguin B, 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L
   DERJAGUIN BV, 1949, THEORY STABILITY COL
   Dewitt N, 2003, NATURE, V423, P315, DOI 10.1038/423315a
   Dinwoodie J. M., 1981, TIMBER ITS NATURE BE
   dos Reis AN, 2003, PHYSICA A, V322, P546, DOI 10.1016/S0378-4371(02)01821-6
   Dossel O, 2002, BIOMED TECH, V47, P250
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   DREXLER KE, 1992, NANOSYSTEMS MOL MACH
   Drozdov A. D., 1998, MECH VISCOELASTIC SO
   Duysak A, 2003, INT CONGR SER, V1256, P337, DOI 10.1016/S0531-5131(03)00423-0
   Edwards S, 2002, BIOPHYS J, V83, P1348, DOI 10.1016/S0006-3495(02)73905-2
   Elbaum M, 1996, PHYS REV LETT, V76, P4078, DOI 10.1103/PhysRevLett.76.4078
   Elliott GF, 2000, INT J BIOL MACROMOL, V27, P327, DOI 10.1016/S0141-8130(00)00132-X
   ERIKSEN EF, 1986, ENDOCR REV, V7, P379, DOI 10.1210/edrv-7-4-379
   ERMENTROUT B, 1986, VELIGER, V28, P369
   Evans DF, 1999, COLLOIDAL DOMAIN
   Eyring H., 1963, MODERN CHEM KINETICS
   Felgner H, 1996, J CELL SCI, V109, P509
   FENDLER JH, 1987, MEMBRANE MIMETIC CHE
   Ferreira CP, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041903
   Finkelstein AV, 1997, CURR OPIN STRUC BIOL, V7, P60, DOI 10.1016/S0959-440X(97)80008-5
   FLEER GJ, 1993, POLYM INTERFACES
   FLORY PJ, 1969, STAT MECH CHAIN MOL
   FRANKS F, 1995, ADV PROTEIN CHEM, V46, P105, DOI 10.1016/S0065-3233(08)60333-2
   Fredrickson GH, 2002, MACROMOLECULES, V35, P16, DOI 10.1021/ma011515t
   FRENKLER D, 2002, UNDERSTANDING MOL SI
   FRISCH U, 1986, PHYS REV LETT, V56, P1505, DOI 10.1103/PhysRevLett.56.1505
   FROST HM, 1985, CLIN ORTHOP RELAT R, P198
   Galam S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051907
   GAN CK, 2004, IN PRESS PHYS REV B
   Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687
   GEISSLER PS, 1981, ACS SYM SER, V150, P265
   GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P25, DOI 10.1098/rspa.1982.0087
   GIBSON LJ, 1997, CELL SOLIDS STRUCTUR
   GILBERT EN, 1962, ANN MATH STAT, V33, P958, DOI 10.1214/aoms/1177704464
   Gittes F, 1996, BIOPHYS J, V70, P418, DOI 10.1016/S0006-3495(96)79585-1
   GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923
   Goetz R, 1999, PHYS REV LETT, V82, P221, DOI 10.1103/PhysRevLett.82.221
   Goetz R, 1998, J CHEM PHYS, V108, P7397, DOI 10.1063/1.476160
   GOMPPER G, 1995, PHYS REV E, V51, P514, DOI 10.1103/PhysRevE.51.514
   Gompper G, 1997, PHYS REV LETT, V78, P2859, DOI 10.1103/PhysRevLett.78.2859
   GREENSPAN D, 1997, PARTICLE MODELING
   GULDBRAND L, 1984, J CHEM PHYS, V80, P2221, DOI 10.1063/1.446912
   Haile J M, 1992, MOL DYNAMICS SIMULAT
   Hamaker HC, 1937, PHYSICA, V4, P1058, DOI 10.1016/S0031-8914(37)80203-7
   Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1
   Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660
   HAYNIE DT, 2001, BIOL THERMODYNAMICS
   Hazelwood SJ, 2001, J BIOMECH, V34, P299, DOI 10.1016/S0021-9290(00)00221-9
   HELFRICH W, 1978, Z NATURFORSCH A, V33, P305
   Helms JA, 2003, NATURE, V423, P326, DOI 10.1038/nature01656
   HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807
   Hill AV, 1922, J PHYSIOL-LONDON, V56, P19
   Hill T, 1963, THERMODYNAMICS SMALL
   Hockney R. W., 1988, COMPUTER SIMULATION
   HOLM EA, 1991, PHYS REV A, V43, P2662, DOI 10.1103/PhysRevA.43.2662
   Horgan CO, 2003, BIOMECH MODEL MECHAN, V1, P251, DOI 10.1007/s10237-002-0022-z
   HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99
   Howard J., 2001, MECH MOTOR PROTEINS
   HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5
   HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8
   Im W, 2000, BIOPHYS J, V79, P788, DOI 10.1016/S0006-3495(00)76336-3
   Irons B, 1983, FINITE ELEMENT PRIME
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   Jacobs CR, 2000, J REHABIL RES DEV, V37, P209
   JACOBS CR, 1995, J BIOMECH, V28, P449, DOI 10.1016/0021-9290(94)00087-K
   JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769
   Janeway C., 2001, IMMUNOBIOLOGY
   JERONIMIDIS G, 2000, STRUCTURAL BIOL MAT
   Jiang Y, 1998, BIOPHYS J, V75, P2615, DOI 10.1016/S0006-3495(98)77707-0
   Johansson T, 2000, J THEOR BIOL, V206, P131, DOI 10.1006/jtbi.2000.2109
   Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000
   Kansal AR, 2000, BIOSYSTEMS, V55, P119, DOI 10.1016/S0303-2647(99)00089-1
   Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654
   Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   KETCHEM RR, 1993, SCIENCE, V261, P1457, DOI 10.1126/science.7690158
   KOEPPE RE, 1994, BIOPHYS J, V66, P14, DOI 10.1016/S0006-3495(94)80748-9
   Kong YY, 2000, EXP GERONTOL, V35, P947, DOI 10.1016/S0531-5565(00)00178-9
   Koontz JT, 2001, J BIOMECH ENG-T ASME, V123, P607, DOI 10.1115/1.1406951
   Kowalczyk P, 2003, J BIOMECH, V36, P961, DOI 10.1016/S0021-9290(03)00065-4
   Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2
   KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106
   KRAYNIK AM, 1991, J RHEOL, V35, P1235, DOI 10.1122/1.550173
   Kreis T., 1999, GUIDEBOOK CYTOSKELET
   Kubik T, 2002, PHYS MED BIOL, V47, P1543, DOI 10.1088/0031-9155/47/9/309
   Kurnikova MG, 1999, BIOPHYS J, V76, P642, DOI 10.1016/S0006-3495(99)77232-2
   KURZ JC, 1995, BIOCHEMISTRY-US, V34, P13374, DOI 10.1021/bi00041a014
   Kuyucak S, 2001, REP PROG PHYS, V64, P1427, DOI 10.1088/0034-4885/64/11/202
   Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0
   LAKES R, 1991, J MATER SCI, V26, P2287, DOI 10.1007/BF01130170
   LANDAU L, 1986, THEORY ELASTICITY
   Landau L. D., 1965, COLLECTED PAPERS LD
   Langton CM, 1998, BONE, V22, P375, DOI 10.1016/S8756-3282(97)00290-1
   Latour RA, 2002, BIOMATERIALS, V23, P4633, DOI 10.1016/S0142-9612(02)00213-2
   Latour RA, 1999, CURR OPIN SOLID ST M, V4, P413, DOI 10.1016/S1359-0286(99)00022-4
   LEIBLER S, 1993, J CELL BIOL, V121, P1357, DOI 10.1083/jcb.121.6.1357
   Leibler S, 1989, STATISTICAL MECHANIC, P45
   Leitner DM, 2000, BIOPHYS J, V78, P125, DOI 10.1016/S0006-3495(00)76579-9
   LEONDES CT, 2003, COMPUTATIONAL METHOD, V2
   Lerner AL, 1998, J BIOMECH, V31, P327, DOI 10.1016/S0021-9290(98)00015-3
   LESAR R, 2002, ANN REV MAT RES, V32
   Levine H, 1998, PHYSICA A, V249, P53, DOI 10.1016/S0378-4371(97)00431-7
   LIFSHITZ EM, 1956, SOV PHYS JETP-USSR, V2, P73
   Lipowsky R., 1995, P521
   LSAR R, 2004, UNPUB BONE
   Luebeck EG, 2001, MATH COMPUT MODEL, V33, P1387
   Luzzati V., 1968, BIOLOGICAL MEMBRANES, V1, P71
   Mackerle J, 2000, ENG COMPUTATION, V17, P813, DOI 10.1108/02644400010352270
   MACKERLE J, 1998, APPL MECH REV, V51, P587
   MAGGELAKIS AA, 2003, COMPUTATIONAL METHOD, V2, P89
   MAMONOV A, 2003, BIOPHYS J, V84, P1
   Mansury Y, 2002, J THEOR BIOL, V219, P343, DOI 10.1006/yjtbi.3131
   Maree AFM, 2002, B MATH BIOL, V64, P327, DOI 10.1006/bulm.2001.0277
   Marsh D., 1990, CRC HDB LIPID BILAYE
   Martin RB, 2000, BONE, V26, P1, DOI 10.1016/S8756-3282(99)00241-0
   Martin RB, 2003, J THEOR BIOL, V220, P271, DOI 10.1006/jtbi.2003.3148
   Martin RB, 2002, BONE, V30, P8, DOI 10.1016/S8756-3282(01)00620-2
   MCCAMMON JA, 1976, NATURE, V262, P325, DOI 10.1038/262325a0
   MCCAMMON JA, 1987, DYNAMICS PROTEINS NU
   Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1
   MEINHARDT H, 1987, J THEOR BIOL, V126, P63, DOI 10.1016/S0022-5193(87)80101-7
   Meinhardt H., 1982, MODELS BIOL PATTERN
   MENDELSON RA, 1973, BIOCHEMISTRY-US, V12, P2250, DOI 10.1021/bi00736a011
   MERZ BR, 2003, COMPUTATIONAL METHOD, V2, P1
   METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114
   Meunier J., 1987, PHYS AMPHIPHILIC LAY
   MILIK M, 1993, PROTEINS, V15, P10, DOI 10.1002/prot.340150104
   MOHANTY J, 1976, DISPERSION FORCES
   MULLERBORER BJ, 1994, IEEE T BIO-MED ENG, V41, P445, DOI 10.1109/10.293219
   MURRAY JD, 1993, MATH BIOL
   Nabhani F, 2002, J MATER PROCESS TECH, V127, P40, DOI 10.1016/S0924-0136(02)00195-4
   NAGLE JF, 1985, MACROMOLECULES, V18, P2643, DOI 10.1021/ma00154a047
   Nelson D. R., 2002, DEFECTS GEOMETRY CON
   Ni H, 1999, INT J HEAT MASS TRAN, V42, P1501, DOI 10.1016/S0017-9310(98)00123-9
   OSBORN M, 1978, J CELL BIOL, V77, pR27, DOI 10.1083/jcb.77.3.R27
   Ott SM., 2002, PRINCIPLES BONE BIOL, P303
   Ouchi NB, 2003, PHYSICA A, V329, P451, DOI 10.1016/S0378-4371(03)00574-0
   PAPKA SD, 1994, J MECH PHYS SOLIDS, V41, P571
   PARTENSKII MB, 1992, Q REV BIOPHYS, V25, P477, DOI 10.1017/S0033583500004388
   PASTOR RW, 1994, CURR OPIN STRUC BIOL, V4, P486, DOI 10.1016/S0959-440X(94)90209-7
   PELEG M, 1994, BIOTECHNOL PROGR, V10, P385, DOI 10.1021/bp00028a007
   PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X
   PETERSON MA, 1992, J PHYS II, V2, P1273
   Petrache HI, 1997, BIOPHYS J, V72, P2237, DOI 10.1016/S0006-3495(97)78867-2
   PLUM GE, 1995, CURR OPIN STRUC BIOL, V5, P682, DOI 10.1016/0959-440X(95)80062-X
   Pohorille A, 2001, CELL MOL BIOL LETT, V6, P369
   Poshusta AK, 2002, J BIOMAT SCI-POLYM E, V13, P797, DOI 10.1163/156856202760197429
   PRATT LR, 1999, AIP C P, V492
   PULLMAN A, 1987, Q REV BIOPHYS, V20, P173, DOI 10.1017/S0033583500004170
   QUINN PJ, 1992, STRUCTURAL DYNAMICS
   RAABE D, 1989, BIOCHIM BIOPHYS ACTA, V988, P53
   Ramtani S, 1999, MECH RES COMMUN, V26, P701, DOI 10.1016/S0093-6413(99)00081-6
   Ramtani S, 2001, J BIOMECH, V34, P471, DOI 10.1016/S0021-9290(00)00215-3
   RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5
   Rappaport DC, 1995, ART MOL DYNAMICS SIM
   REEVE J, 1986, CLIN ORTHOP RELAT R, P264
   Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482
   RIVIER N, 1982, J PHYS-PARIS, V43, P91, DOI 10.1051/jphyscol:1982917
   Roux B, 2002, ACCOUNTS CHEM RES, V35, P366, DOI 10.1021/ar010028v
   ROUX B, 1994, ANNU REV BIOPH BIOM, V23, P731, DOI 10.1146/annurev.bb.23.060194.003503
   ROUX B, 2002, BIOPHYS J, V82, P1677
   RUAN XG, 2002, P 4 WORLD C INT CONT, V1, P2266
   SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111
   SAFFMAN PG, 1976, J FLUID MECH, V73, P593, DOI 10.1017/S0022112076001511
   Safran S. A., 1994, STAT THERMODYNAMICS
   Salzberg S., 1998, COMPUTATIONAL METHOD
   Sander EA, 2003, BIOMECH MODEL MECHAN, V2, P97, DOI [10.1007/s10237-003-0031-6, 10.1007/S10237-003-0031-6]
   Sander LM, 2000, CONTEMP PHYS, V41, P203, DOI 10.1080/001075100409698
   Sansom MSP, 1998, CURR OPIN STRUC BIOL, V8, P237, DOI 10.1016/S0959-440X(98)80045-6
   SAVILLE N, 1997, J THEOR BIOL, V22, P437
   Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373
   SCHLIWA M, 1986, CYTOSKELETON INTRO S
   SCHOENBERG M, 1985, BIOPHYS J, V48, P467, DOI 10.1016/S0006-3495(85)83802-9
   SCHUMANDER S, 2002, BIOCHIM BIOPHYS ACTA, V988, P437
   Secrest D, 1996, J CHEM EDUC, V73, P998, DOI 10.1021/ed073p998
   Sedivy R, 2002, J PATHOL, V197, P163, DOI 10.1002/path.1118
   SERVUSS RM, 1989, J PHYS-PARIS, V50, P809, DOI 10.1051/jphys:01989005007080900
   SHI J, 2000, LEBENSM WISSEN TECHN, V36, P3
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720
   Skalak R, 1997, J MATH BIOL, V35, P869, DOI 10.1007/s002850050081
   SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819
   Spector AA, 2002, BIOMECH MODEL MECHAN, V1, P123, DOI 10.1007/s10237-002-0012-1
   SROLOVITZ DJ, 1983, SCRIPTA METALL MATER, V17, P241, DOI 10.1016/0036-9748(83)90106-0
   SROLOVITZ DJ, 1992, ATOMIC LEVEL PROPERT, P691
   Stamenovic D, 2002, BIOMECH MODEL MECHAN, V1, P95, DOI 10.1007/s10237-002-0009-9
   Stanley H. E., 1987, INTRO PHASE TRANSITI
   Steigenberger J, 2003, BIOMECH MODEL MECHAN, V2, P37, DOI 10.1007/S10237-003-0027-2
   Stein W. D., 1990, CHANNELS CARRIERS PU
   Stevens A, 2000, SIAM J APPL MATH, V61, P172, DOI 10.1137/S0036139998342053
   STEVENS M, 2003, MODELING SELF ASSEMB
   STOKKE BT, 1985, BIOCHIM BIOPHYS ACTA, V816, P102, DOI 10.1016/0005-2736(85)90398-0
   Stolken JS, 2003, BONE, V33, P494, DOI 10.1016/S875603282(03)00214-X
   Summers AP, 2002, COMP BIOCHEM PHYS A, V133, P1159, DOI 10.1016/S1095-6433(02)00241-6
   Tabor Z, 2002, BONE, V31, P413, DOI 10.1016/S8756-3282(02)00837-2
   TANFORD C, 1983, ANNU REV BIOCHEM, V52, P379, DOI 10.1146/annurev.bi.52.070183.002115
   TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5
   Tayyar S, 1999, BONE, V25, P733, DOI 10.1016/S8756-3282(99)00218-5
   Thomsen JS, 1996, BONE, V19, P505, DOI 10.1016/S8756-3282(96)00231-1
   THOMSEN JS, 1994, BONE, V15, P655, DOI 10.1016/8756-3282(94)90314-X
   Tieleman DP, 1999, BIOPHYS J, V76, P1757
   Tieleman DP, 2001, Q REV BIOPHYS, V34, P473, DOI 10.1017/S00335801003729
   Toledano P., 1998, PHASE TRANSITIONS CO
   Tschoegl NW, 1989, PHENOMENOLOGICAL THE
   Tsili MC, 2000, J BIOMECH, V33, P235, DOI 10.1016/S0021-9290(99)00145-1
   Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0
   Tsubota K, 2003, COMPUTATIONAL FLUID AND SOLID MECHANICS 2003, VOLS 1 AND 2, PROCEEDINGS, P1833
   TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012
   Turner S, 2002, J THEOR BIOL, V216, P85, DOI 10.1006/jtbi.2001.2522
   URRY DW, 1971, P NATL ACAD SCI USA, V68, P672, DOI 10.1073/pnas.68.3.672
   Vaidehi Nagarajan, 2001, P161
   Van der Linden JC, 2001, J BONE MINER RES, V16, P688, DOI 10.1359/jbmr.2001.16.4.688
   Vanderzande C., 1998, LATTICE MODELS POLYM
   VENABLE RM, 1993, SCIENCE, V262, P223, DOI 10.1126/science.8211140
   VENIER P, 1994, J BIOL CHEM, V269, P13353
   VERWEY EJW, 1948, THEORY STABILITY LYO
   Vincent J. F. V., 1990, STRUCTURAL BIOMECHAN
   Voter AF, 2002, ANNU REV MATER RES, V32, P321, DOI 10.1146/annurev.matsci.32.112601.141541
   WADDINGTON CH, 1969, J THEOR BIOL, V25, P219, DOI 10.1016/S0022-5193(69)80060-3
   Wang W, 2001, ANNU REV BIOPH BIOM, V30, P211, DOI 10.1146/annurev.biophys.30.1.211
   Wang XB, 2002, J BIOMECH, V35, P375, DOI 10.1016/S0021-9290(01)00191-9
   Ward JP, 2003, J MATH BIOL, V47, P23, DOI 10.1007/s00285-002-0190-6
   WARREN WE, 1988, J APPL MECH-T ASME, V55, P341, DOI 10.1115/1.3173680
   WARREN WE, 1987, MECH MATER, V6, P27, DOI 10.1016/0167-6636(87)90020-2
   WEAIRE D, 1984, CONTEMP PHYS, V25, P59, DOI 10.1080/00107518408210979
   Weerts AH, 2003, J FOOD SCI, V68, P937, DOI 10.1111/j.1365-2621.2003.tb08268.x
   Weinberger NM, 1998, TRENDS COGN SCI, V2, P271, DOI 10.1016/S1364-6613(98)01200-5
   Westmoreland P. R, 2002, APPL MOL MAT MODELIN
   WOLFRAM S, 1984, NATURE, V311, P419, DOI 10.1038/311419a0
   Yamakawa H., 1997, HELICAL WORMLIKE CHA
   YAMAKAWA H, 1971, MODERN THEORY POLYM
   YGUERABIDE J, 1970, J MOL BIOL, V51, P573, DOI 10.1016/0022-2836(70)90009-4
   Young TH, 2003, BIOMATERIALS, V24, P2251, DOI 10.1016/S0142-9612(03)00032-2
   Zannoni C, 1998, MED ENG PHYS, V20, P735
   Zhdanov VP, 2003, PHYS CHEM CHEM PHYS, V5, P1433, DOI 10.1039/b300087g
   Zidi M, 1999, J BIOMECH, V32, P743, DOI 10.1016/S0021-9290(99)00033-0
   Zienkiewicz O. C., 1991, FINITE ELEMENT METHO, VII
   Zienkiewicz O.C., 1994, FINITE ELEMENT METHO, V1
   ZILKER A, 1992, PHYS REV A, V46, P7998, DOI 10.1103/PhysRevA.46.7998
NR 299
TC 26
Z9 27
U1 3
U2 18
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1531-7331
J9 ANNU REV MATER RES
JI Ann. Rev. Mater. Res.
PY 2004
VL 34
BP 279
EP 314
DI 10.1146/annurev.matsci.34.070503.123908
PG 36
WC Materials Science, Multidisciplinary
SC Materials Science
GA 846MK
UT WOS:000223319600011
DA 2018-10-20
ER

PT S
AU Yu, SM
   Wang, YL
   Yun, CS
AF Yu, SM
   Wang, YL
   Yun, CS
BE Wong, JY
   Plant, AL
   Schmidt, CE
   Shea, L
   Coury, AJ
   Chen, CS
   Barron, AE
   Klok, HA
   Saltzman, WM
   Chilkoti,A
   Luo, D
   Uhrich, K
TI Exploitation of collagen mimetic peptide as a collagen adhesive
   biopolymer for novel biomaterials development
SO ARCHITECTURE AND APPLICATION OF BIOMATERIALS AND BIOMOLECULAR MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Architecture and Application of Biomaterials and
   Biomolecular Materials held at the 2003 MRS Fall Meeting
CY DEC 01-04, 2003
CL Boston, MA
AB Collagen, either alone or in combination with other component, is in important biomaterial that is used in a variety of medical applications ranging from hemostatic materials and biocompatible coatings to drug delivery and tissue engineering. Currently, there are manifest biomedical interests in modifying the structure of natural collagen to improve its biochemical and mechanical properties. As an alternative to the prevalent "chemical" modification method, we have developed a novel "physical" collagen modification technique that is based on collagen's native ability to fold into triple-helix molecular architecture. Here we present that synthetic collagen mimetic peptides exhibit specific affinity to natural collagen under controlled thermal conditions (heat or laser treatment). Such affinity can be explored as a new targeting method to attach therapeutic drugs to collagens in the living tissues and to biomaterials that incorporate natural collagens.
C1 Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA.
RP Yu, SM (reprint author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
RI Yu, Michael/A-3332-2010
CR Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
NR 4
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-745-8
J9 MATER RES SOC SYMP P
PY 2004
VL 1
BP 295
EP 299
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAB22
UT WOS:000221434200059
DA 2018-10-20
ER

PT J
AU Nottle, MB
   Boquest, AC
   Harrison, SJ
   Grupen, CG
   Faast, RA
   Ashman, RJ
   McIlfatrick, SM
AF Nottle, MB
   Boquest, AC
   Harrison, SJ
   Grupen, CG
   Faast, RA
   Ashman, RJ
   McIlfatrick, SM
TI Transgenic perspectives in livestock science: a review
SO AUSTRALIAN JOURNAL OF EXPERIMENTAL AGRICULTURE
LA English
DT Article
ID NUCLEAR TRANSFER; FETAL FIBROBLASTS; GENE-TRANSFER; PIGS; OOCYTES;
   CALVES; MOUSE; CELLS; MICE; MICROINJECTION
AB The limitations of existing transgenic technology, the potential of cloning technology to overcome these, as well as technologies which may be available in the future for inserting new genetic material are discussed. Currently, transgenic livestock are produced by injecting hundreds to thousands of copies of a particular transgene into the pronucleus of a fertilised egg. This method suffers from a number of inherent limitations that prevent the full potential of this technology from being explored. Most of these limitations stem from the fact that it is impossible to control the site at which the transgene becomes inserted. Transgenic technology holds considerable promise for the livestock industries as well as having important biomedical applications. However, before any of these possibilities can be realised, technology is required whereby a single copy of a particular transgene can be inserted or 'knocked in' at a site that does not interfere with expression, as well as having the capacity to 'knockout' existing genes. This is possible in mice using a combination of homologous recombination and embryonic stem cell technologies. However, despite considerable effort worldwide, embryonic stem cells are yet to be isolated from any of the livestock species. The ability to clone these now means that somatic cells most notably fetal fibroblasts, can used for gene targeting purposes instead of embryonic stem cells. However, this method is not without its limitations and it is possible that more efficient methods will be developed in the future. In particular, the use of mammalian artificial chromosomes will extend this technology to allow combinations of transgenes as well as chromosomal segments to be incorporated, allowing us to explore the full potential of transgenic technology for agricultural as well as biomedical applications.
C1 BresaGen Ltd, Reprod Biotechnol Div, Adelaide, SA 5000, Australia.
RP Nottle, MB (reprint author), Univ Adelaide, Dept Obstet & Gynaecol, Adelaide, SA 5005, Australia.
EM mark.nottle@adelaide.edu.au
CR APICE AJF, 2001, TRANSPLANT P, V33, P3053, DOI DOI 10.1016/S0041-1345(01)02305-O
   Chan AWS, 1998, P NATL ACAD SCI USA, V95, P14028, DOI 10.1073/pnas.95.24.14028
   Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256
   Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251
   Harrison SJ, 2002, TRANSGENIC RES, V11, P143, DOI 10.1023/A:1015262108526
   Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8
   Keefer CL, 2001, BIOL REPROD, V64, P849, DOI 10.1095/biolreprod64.3.849
   Kitamoto T, 1996, BIOCHEM BIOPH RES CO, V222, P742, DOI 10.1006/bbrc.1996.0814
   Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727
   Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228
   Lauth M, 2000, GENESIS, V27, P153, DOI 10.1002/1526-968X(200008)27:4<153::AID-GENE40>3.0.CO;2-B
   Lavitrano M, 2002, P NATL ACAD SCI USA, V99, P14230, DOI 10.1073/pnas.222550299
   LAVITRANO M, 1989, CELL, V57, P717, DOI 10.1016/0092-8674(89)90787-3
   Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111
   McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604
   Nottle MB, 2001, TRANSGENIC RES, V10, P523, DOI 10.1023/A:1013007329936
   NOTTLE MB, 1997, CONTROL PIG REPROD, P237
   Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188
   Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593
   Stein GS, 1984, HISTONE GENES STRUCT
   STEWART CL, 1985, EMBO J, V4, P3701, DOI 10.1002/j.1460-2075.1985.tb04138.x
   WIGLEY P, 1994, REPROD FERT DEVELOP, V6, P585, DOI 10.1071/RD9940585
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079
NR 24
TC 2
Z9 2
U1 0
U2 2
PU C S I R O PUBLISHING
PI COLLINGWOOD
PA 150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA
SN 0816-1089
J9 AUST J EXP AGR
JI Aust. J. Exp. Agric.
PY 2004
VL 44
IS 11
BP 1113
EP 1117
DI 10.1071/EA03237
PG 5
WC Agriculture, Multidisciplinary
SC Agriculture
GA 879BC
UT WOS:000225690400008
DA 2018-10-20
ER

PT J
AU Haris, PI
AF Haris, PI
TI Special Issue: 2nd International Conference on New Biomedical Materials,
   5-8 April 2003, Cardiff, Wales, UK
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Editorial Material
C1 De Montfort Univ, Fac Hlth & Life Sci, Leicester LE1 9BH, Leics, England.
RP Haris, PI (reprint author), De Montfort Univ, Fac Hlth & Life Sci, Leicester LE1 9BH, Leics, England.
CR Chapman D, 1996, BIOCHEM SOC T, V24, P329, DOI 10.1042/bst0240329
   CHAPMAN D, 1996, NEW BIOMEDICAL MAT B
   Haris PI, 2000, TRENDS BIOCHEM SCI, V25, P104, DOI 10.1016/S0968-0004(00)01548-6
NR 3
TC 0
Z9 0
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2004
VL 14
IS 4
BP 341
EP 342
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HX
UT WOS:000226003300001
DA 2018-10-20
ER

PT J
AU Saravanapavan, P
   Jones, JR
   Verrier, S
   Beilby, R
   Shirtliff, VJ
   Hench, LL
   Polak, JM
AF Saravanapavan, P
   Jones, JR
   Verrier, S
   Beilby, R
   Shirtliff, VJ
   Hench, LL
   Polak, JM
TI Binary CaO-SiO2 gel-glasses for biomedical applications
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
ID LOW-TEMPERATURE SYNTHESIS; BIOACTIVE GLASS; IN-VITRO; HUMAN OSTEOBLASTS;
   GENE-EXPRESSION; IONIC PRODUCTS; BONE; TISSUE; SYSTEM; SCAFFOLDS
AB Bioactive materials are routinely used in dental and orthopaedic applications. The concept was first introduced in 1971, with the discovery of 45S5 Bioglass(R), which is known to develop an interfacial bond between the implant and the host tissue. This glass is composed of SiO2, CaO, P2O5 and Na2O. Since then numerous glasses and glass ceramics with similar compositions have been extensively studied for clinical applications. Until 1990 it was accepted that P2O5 and Na2O were necessary components for the glass composition to be bioactive. However, calcium silicate glasses with high SiO2 content are impossible to produce using the traditional melt-quench method. This is due to the liquid-liquid immiscibility region that is present between 0.02 and 0.3 mole fraction of CaO and in terms of bioactivity, high CaO compositions were inferior to those quaternary bioactive glass compositions already in existence. In the last few years several studies have been reported regarding the production of CaO-SiO2 glasses via the sol-gel processing technique. This report summarises the findings of the past and the present and also outlines potential of these calcium silicate gel-glasses in the field of biomaterials.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, Tissue Engn & Regenerat Med Ctr, London SW7 2AZ, England.
   Univ London Imperial Coll Sci Technol & Med, Fac Med, Tissue Engn & Regenerat Med Ctr, London SW7 2AZ, England.
RP Saravanapavan, P (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Tissue Engn & Regenerat Med Ctr, Bessemer Bldg,S Kensington Campus,Exhibit Rd, London SW7 2AZ, England.
EM p.pavan@imperial.ac.uk
RI Jones, Julian/B-1007-2012
OI Jones, Julian/0000-0002-2647-8024
CR BANSAL NP, 1990, J AM CERAM SOC, V73, P2647, DOI 10.1111/j.1151-2916.1990.tb06741.x
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   BIELBY R, 2001, P 14 INT S CER MED P
   Catauro M, 1997, J SOL-GEL SCI TECHN, V10, P231, DOI 10.1023/A:1018368117448
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   DRUMHELLER P, 2000, BIOMEDICAL ENG HDB, V2
   Dufrane D, 2003, J MATER SCI-MATER M, V14, P33, DOI 10.1023/A:1021545302732
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Geyer G, 1999, HNO, V47, P25, DOI 10.1007/s001060050354
   GREENSPAN DC, 1998, BIOCERAMICS, V11, P354
   GREENSPAN DC, 1997, BIOCERAMICS, V10, P391
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   HAYASHI T, 1980, J MATER SCI, V15, P1971, DOI 10.1007/BF00550622
   Healy KE, 1999, CURR OPIN SOLID ST M, V4, P381, DOI 10.1016/S1359-0286(99)00038-8
   HENCH L, 1993, INTRO BIOCERAMICS
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1996, CLINICAL PERFORMANCE
   Hench LL., 2001, KEY ENG MATER, V192-195, P575
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HENCH LL, 1995, CERAMIC T, V48
   HENCH LL, 2001, J MAT RES INNOVATION, V3, P313
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Ishizaki K, 1998, POROUS MAT PROCESS T, P67
   ITO G, 1987, J BIOMED MATER RES, V21, P485, DOI 10.1002/jbm.820210408
   Izquierdo-Barba I, 1999, J BIOMED MATER RES, V47, P243, DOI 10.1002/(SICI)1097-4636(199911)47:2<243::AID-JBM15>3.0.CO;2-S
   KITSUGI T, 1989, J BONE JOINT SURG AM, V71A, P264, DOI 10.2106/00004623-198971020-00014
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P1255, DOI 10.1002/jbm.820211008
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   Lekmine F, 1999, MOL CELL ENDOCRINOL, V157, P181, DOI 10.1016/S0303-7207(99)00138-0
   Lenza RFS, 2002, J MATER SCI-MATER M, V13, P837, DOI 10.1023/A:1016592127407
   LENZA RFS, IN PRESS IN VITRO RE
   LENZA RFS, IN PRESS CONTROLLED
   LI RN, 1992, CHEMICAL PROCESSING OF ADVANCED MATERIALS, P627
   LIVAGE J, 1992, J NON-CRYST SOLIDS, V145, P11, DOI 10.1016/S0022-3093(05)80422-3
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mansur HS, 2000, J NON-CRYST SOLIDS, V273, P109, DOI 10.1016/S0022-3093(00)00150-2
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NICHOLL SB, 1997, BIOMATERIALS, V18, P853
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Pryce RS, 2003, KEY ENG MAT, V240-2, P205, DOI 10.4028/www.scientific.net/KEM.240-242.205
   Ratner BD, 1999, CURR OPIN SOLID ST M, V4, P395, DOI 10.1016/S1359-0286(99)00047-9
   Saravanapavan P, 2003, KEY ENG MAT, V240-2, P245, DOI 10.4028/www.scientific.net/KEM.240-242.245
   Saravanapavan P, 2003, KEY ENG MAT, V240-2, P233, DOI 10.4028/www.scientific.net/KEM.240-242.233
   Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P1, DOI 10.1016/S0022-3093(02)01864-1
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   SARAVANAPAVAN P, 2003, J NONCRYST SOLIDS, V318, P13
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   VISTICA DT, 1991, CANCER RES, V51, P2515
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
NR 62
TC 54
Z9 55
U1 0
U2 12
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2004
VL 14
IS 4
BP 467
EP 486
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HX
UT WOS:000226003300013
PM 15472395
DA 2018-10-20
ER

PT J
AU Towler, MR
   Kenny, S
   Boyd, D
   Pembroke, T
   Buggy, M
   Hill, RG
AF Towler, MR
   Kenny, S
   Boyd, D
   Pembroke, T
   Buggy, M
   Hill, RG
TI Zinc ion release from novel hard tissue biomaterials
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE glass polyalkenoate cements; ion release; modulus
ID GLASS-IONOMER CEMENTS; POLYALKENOATE CEMENTS; MECHANICAL-PROPERTIES;
   DENTAL CEMENTS; HYDROXYAPATITE; FLUORIDE; STRENGTH
AB Zinc polyalkenoate cements (ZPCs) and glass polyalkenoate cements (GPCs) are used routinely in dentistry, but have potential for orthopaedic applications as they set at body temperature without shrinkage or significant heat evolution. However, the materials have drawbacks; ZPCs are biocompatible in implant studies, but a fibrous collagen capsular layer forms adjacent to the cement. GPCs are bioactive in the bone environment as a result of the release of calcium, phosphate and fluoride ions, as well as the formation of a silicious gel phase, but research has shown that aluminum ions released result in defective bone mineralisation and as a consequence the ability of these cements to chemically bond to bone is lost. Two approaches have been developed to overcome these problems. The ZPC route considers a ZnO : hydroxyapatite (HA) : poly(acrylic acid) (PAA) mixture, the HA incorporated to improve bioactivity. The GPC route employs a calcium zinc silicate glass; the zinc taking the role that aluminum plays in conventional GPCs. This study has shown that cements can be formulated by an acid base reaction between PAA and both calcium zinc silicate glasses (GPCs) and a mixture of hydroxyapatite and zinc oxide (ZPCs). The moduli of these cements are comparable to both bone and conventional acrylic cements, highlighting their potential for biomedical applications. Unfortunately, both materials have previously been shown to be toxic by cell culture methods, as a result of high zinc ion release, and so it is necessary to study ion release profiles of the cements in order to determine the magnitude of this release. Considering the ZPCs, the modulus of the cement has an inversely proportional relationship to the zinc ion release. From the data presented it is clear that increases in polymer concentration results in lower amounts of zinc ions being released, whilst molar mass of the PAA has no influence. Therefore it would appear that polymer concentration has a significant influence over ion release. Generally, the amount of Zn2+ released decreases with increasing HA content and/or decreasing ZnO content. Considering the GPCs, the materials are all seen to release large amounts of the active ion, when compared to the commercial versions. The extent of this release increases with temperature and agitation. The release could be minimised by an increased P : L mixing ratio, and an increased PAA concentration, which would produce a more cross-linked cement matrix. Minimising the release of the active ion should improve the in vitro bioactivity of both materials. However, for a full understanding of the clinical benefits of such materials, an in vivo study would be required.
C1 Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
RP Towler, MR (reprint author), Univ Limerick, Mat & Surface Sci Inst, Natl Technol Pk, Limerick, Ireland.
EM mark.towler@ul.ie
RI Irish Centre for Composites, Research (ICOMP)/D-4887-2011
OI Pembroke, Tony/0000-0001-9340-7026
CR ASMUSSEN E, 1983, ACTA ODONTOL SCAND, V41, P155, DOI 10.3109/00016358309162317
   Blades MC, 1998, J MATER SCI-MATER M, V9, P701, DOI 10.1023/A:1008990516159
   CRISP S, 1974, J DENT RES, V53, P1408, DOI 10.1177/00220345740530061901
   DARLING M, 1994, BIOMATERIALS, V15, P299, DOI 10.1016/0142-9612(94)90055-8
   Flaten TP, 1996, J TOXICOL ENV HEALTH, V48, P527, DOI 10.1080/009841096161050
   FORSS H, 1993, J DENT RES, V72, P1257, DOI 10.1177/00220345930720081601
   Ishikawa K, 2002, BIOMATERIALS, V23, P423, DOI 10.1016/S0142-9612(01)00121-1
   *ISO, 9917E ISO
   Kenny S, 2000, J MATER SCI-MATER M, V11, P847, DOI 10.1023/A:1008969932746
   Kenny S, 2002, KEY ENG MAT, V218-2, P347, DOI 10.4028/www.scientific.net/KEM.218-220.347
   Kenny S, 2001, J MATER SCI-MATER M, V12, P901, DOI 10.1023/A:1012828209119
   LEE PWR, 1972, LANCET, V2, P1089
   MACMILLAN PW, 1979, GLASS CERAMICS
   MITRA SB, 1994, DENT MATER, V10, P78, DOI 10.1016/0109-5641(94)90044-2
   MITRA SB, 1991, J DENT RES, V70, P75, DOI 10.1177/00220345910700011301
   PEARSON GJ, 1991, BIOMATERIALS, V12, P658, DOI 10.1016/0142-9612(91)90113-O
   RAWSON H, 1967, INORGANIC GLASS FORM
   SAITO S, 1979, DENT DIAMOND, V4, P69
   Segnit E.R., 1954, J AM CERAM SOC, V37, P273
   Smith D C, 1968, Br Dent J, V124, P381
   TORTORA GJ, 1997, INTRO HUMAN ODY ESSE
   Towler MR, 2002, J MATER SCI LETT, V21, P1123, DOI 10.1023/A:1016570819402
   TOWLER MR, 1998, J DENT RES, V77
   Utley R, 1992, Ostomy Wound Manage, V38, P26
   WILLIAMS JA, 1991, J ORAL REHABIL, V18, P163, DOI 10.1111/j.1365-2842.1991.tb00044.x
   WILSON AD, 1978, CHEM SOC REV, V7, P265, DOI 10.1039/cs9780700265
   XAVIER SF, 1990, J MATER SCI, V25, P2411, DOI 10.1007/BF00638035
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
NR 28
TC 13
Z9 13
U1 0
U2 15
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2004
VL 14
IS 4
BP 565
EP 572
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HX
UT WOS:000226003300021
PM 15472403
DA 2018-10-20
ER

PT S
AU de Campos, M
   Muller, FA
   Bressiani, AHA
   Bressiani, JC
   Greil, P
AF de Campos, M
   Muller, FA
   Bressiani, AHA
   Bressiani, JC
   Greil, P
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Comparative study of sonochemical synthesized beta-TCP- and
   BCP-nanoparticles
SO BIOCERAMICS 16
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Oporto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE tricalcium phosphate; biphasic calcium phosphate; nanopowders;
   ultrasound; sonochemical synthesis
ID HYDROXYAPATITE
AB Hydroxyapatite (HA), beta tricalcium phosphate (beta-TCP) and biphasic calcium phosphate (BCP) are successfully used materials for biomedical applications due to their ability to promote bone integration. In this work calcium phosphate nanopowders were produced. Their morphology and crystalline phases were investigated in dependence of ultrasonic irradiation and addition of D-glucose and glycerol in the neutralization method. The results show that the neutralization method was effective to obtain beta-TCP and BCP with adjustable Ca:P ratios. The morphology and crystallinity of synthesized nanopowders are significantly affected by ultrasonic irradiation and additives. The grain size of the obtained nanopowders was decreased from 300 nm to 50 nm by assistance of ultrasound.
C1 Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91058 Erlangen, Germany.
   IPEN CNEN SP, DMC, Dept Mat Engn, BR-05508900 Sao Paulo, Brazil.
   Univ Mogi das Cruzes, Technol Res Ctr, BR-08780911 Mogi Das Cruzes, SP, Brazil.
RP de Campos, M (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, Martensstr 5, D-91058 Erlangen, Germany.
EM fmueller@ww.uni-erlangen.de
RI Bressiani, Ana/I-1402-2012; Bressiani, Jose/I-1426-2012
CR DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   de Campos M, 2002, KEY ENG MATER, V218-2, P171, DOI 10.4028/www.scientific.net/KEM.218-220.171
   DUNN D, 1976, ULTRASONIC BIOPHYS B, V7
   Entezari MH, 1996, ULTRASON SONOCHEM, V3, P19, DOI 10.1016/1350-4177(95)00037-2
   Hench L.L., 1993, INTRO BIOCERAMICS AD, V1
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   Kim W, 2001, ULTRASON SONOCHEM, V8, P85, DOI 10.1016/S1350-4177(00)00034-1
   Li B, 1999, ULTRASON SONOCHEM, V6, P217, DOI 10.1016/S1350-4177(99)00013-9
NR 8
TC 3
Z9 3
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MATER
PY 2004
VL 254-2
BP 923
EP 926
DI 10.4028/www.scientific.net/KEM.254-256.923
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000228
DA 2018-10-20
ER

PT S
AU Will, J
   Zuegner, S
   Haugen, H
   Hopfner, U
   Aigner, J
   Wintermantel, E
AF Will, J
   Zuegner, S
   Haugen, H
   Hopfner, U
   Aigner, J
   Wintermantel, E
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Manufacturing of biocompatible TiO2-surface-structures with a water
   based tape casting
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE TiO2; scaffold; porous ceramics
AB TiO2 a bioactive material, as it has been demonstrated in several studies. Tape casting is a well established method of high-quality ceramic sheet production. Little work has been done in the field of combining this method and TiO2 for biomedical applications. This paper shows a water-based manufacturing method for thin ceramic scaffolds with an adjustable micro- and macro surface structure (pore diameters 0.37-0.96 mum and 50-150 mum), which is needed for cell attachments.
C1 Tech Univ Munich, Cent Inst Med Engn ZIMT, D-8000 Munich, Germany.
RP Will, J (reprint author), Tech Univ Munich, Cent Inst Med Engn ZIMT, D-8000 Munich, Germany.
EM will@zimt.tum.de; haugen@zimt.tum.de
RI Haugen, Havard Jostein/H-3551-2014
OI Haugen, Havard Jostein/0000-0002-6690-7233
CR HELLEBRAND H, 1996, MAT SCI TECHNOLO A 1, V17
   Mistler R. E., 2000, TAPE CASTING THEORY
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   SHANEFIELD DJ, 1995, OGRANIC ADDITIVES CE
   Wintermantel E, 1999, CHIRURG, V70, P847, DOI 10.1007/s001040050734
   Wintermantel E., 1992, ANGIOGENESIS PRINCIP
NR 6
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 937
EP 940
DI 10.4028/www.scientific.net/KEM.254-256.937
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000231
DA 2018-10-20
ER

PT S
AU Gonzalez, P
   Borrajo, JP
   Serra, J
   Liste, S
   Chiussi, S
   Leon, B
   Semmelmann, K
   de Carlos, A
   Varela-Feria, FM
   Martinez-Fernandez, J
   de Arellano-Lopez, AR
AF Gonzalez, P
   Borrajo, JP
   Serra, J
   Liste, S
   Chiussi, S
   Leon, B
   Semmelmann, K
   de Carlos, A
   Varela-Feria, FM
   Martinez-Fernandez, J
   de Arellano-Lopez, AR
BE Barbosa, MA
   Monteiro, FJ
   Correia, R
   Leon, B
TI Extensive studies on biomorphic SiC ceramics properties for medical
   applications
SO BIOCERAMICS, VOL 16
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Ceramics in Medicine
CY NOV 06-09, 2003
CL Porto, PORTUGAL
SP Fund Ciencia & Tecnol, Cipan, Univ Porto, Fac Engenhar, Reitoria Univ Porto, INEB Inst Engenhar Biomed
DE silicon carbide; bioceramics; biomaterials; EDS; XPS; XRF
AB Biomorphic silicon carbide ceramics are light, tough and high-strength materials with interesting biomedical applications. The fabrication method of the biomorphic SiC is based in the infiltration of molten-Si in carbon preforms with open porosity. The final product is a biostructure formed by a tangle of SiC fibers. This innovative process allows the fabrication of complex shapes and the tailoring of SiC ceramics with optimised properties and controllable microstructures that will match the biomechanical requirements of the natural host tissue. An interdisciplinary approach of the biomorphic SiC fabricated from beech, sapelly and eucalyptus is presented. Their mechanical properties, microstructure and chemical composition were evaluated. The biocompatible behaviour of these materials has been tested in vitro.
C1 Univ Vigo, Dept Fis Aplicada, Vigo 36200, Spain.
   Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo 36200, Spain.
   Univ Sevilla, Dept Fis Mat Condensada, Seville 41080, Spain.
RP Gonzalez, P (reprint author), Univ Vigo, Dept Fis Aplicada, Vigo 36200, Spain.
EM pglez@uvigo.es
RI MARTINEZ FERNANDEZ, JULIAN/K-1826-2012; de Carlos,
   Alejandro/L-5819-2014; New Materials Group, FA3/D-6799-2014; Chiussi,
   Stefano/D-6218-2014
OI MARTINEZ FERNANDEZ, JULIAN/0000-0002-1199-6638; de Carlos,
   Alejandro/0000-0003-0138-4918; New Materials Group,
   FA3/0000-0003-4286-2015; Chiussi, Stefano/0000-0002-3933-8725; Serra,
   Julia/0000-0001-6187-4025; GONZALEZ, PIO/0000-0002-7353-712X; R. de
   Arellano Lopez, Antonio/0000-0002-7443-0244
CR Gibson L. J., 1988, CELLULAR SOLIDS
   GONZALEZ P, 2003, IN PRESS BIOMATERIAL
   KOKUBO T, 1993, BIOCERAMICS, V6, P327
   Lai W, 2002, BIOMATERIALS, V23, P213, DOI 10.1016/S0142-9612(01)00097-7
   Mangonon P.L., 1999, PRINCIPLES MAT SELEC
   Singh M., 2000, CERAM SCI ENG P, V21, P39
   Varela-Feria F. M., 2002, Ceramic Engineering and Science Proceedings, V23, P681
NR 7
TC 20
Z9 21
U1 2
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-932-6
J9 KEY ENG MAT
PY 2004
VL 254-2
BP 1029
EP 1032
DI 10.4028/www.scientific.net/KEM.254-256.1029
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BY58T
UT WOS:000189415000254
OA Green Published
DA 2018-10-20
ER

PT S
AU Xj, JZ
   Schmidt, JJ
   Montemagno, CD
AF Xj, JZ
   Schmidt, JJ
   Montemagno, CD
BE Aizenberg, J
   Landis, WJ
   Orme, C
   Wang, R
TI Development of self-assembled muscle-powered microdevices
SO BIOLOGICAL AND BIOINSPIRED MATERIALS AND DEVICES
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biological and Bioinspired Materials and Devices held at
   the 2004 MRS Spring Meeting
CY APR 13-16, 2004
CL San Francisco, CA
SP Mat Res Soc
ID CULTURED-CELLS; TEMPERATURE; MYOCYTES; SHEETS; SYSTEM
AB As microcomponents in engineered systems, biological muscles have unique advantages such as large force transduction, utilization of biochemical fuel, and self-assembly from single cells, over other inorganic actuators for biomedical engineering applications. Successful integration of muscles with inorganic fabricated structures and electronics promises the capability of precisely characterizing muscles' mechanical properties and fabricating self-assembled controllable autonomous structures powered by ubiquitous glucose. However, the use of extracted muscle tissue from animals on these devices is impractical and inefficient, as the tissues must be dissected and incorporated into each device by hand with crude interfaces between the biological tissue and inorganic materials. Integration of muscle with fabricated structures would be optimally achieved through self-assembling muscle cells on MEMS. The construction of self-assembled muscle-powered MEMS structures is complicated by the stringent requirements to spatially direct the cell growth, control the tight connection of these differentiated structures with MEMS structures, and enable the cells and the integrated hybrid freedom to move. Conventional and soft photolithography techniques have been extensively employed to pattern the growth of a variety of cell types and investigate their interaction with substrate in the micrometer level. However, all studies are only suitable for patterning static cells on an immobile surface, so a novel system of spatially patterning the contractible cells must be developed to enable the cells and the integrated hybrid devices to be free to move.
   We present a novel system of self-assembling myocytes on MEMS devices. This system has shown its capability of spatially and selectively directed growth and differentiation of myocytes into single muscle bundles, attachment of these functional bundles to MEMS structures, and the controlled partial release of the resultant hybrid devices. Two groups of self-assembled muscle-MEMS devices, force-measuring cantilevers and muscle-powered microrobots have been created. Here the further detailed studies of this system are discussed, especially the concept of the self-assembly and the material interfacial problems in this system.
C1 Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Xj, JZ (reprint author), Univ Calif Los Angeles, Dept Bioengn, 7523 Boelter Hall,420 Westwood Plaza, Los Angeles, CA 90095 USA.
CR BRADY AJ, 1991, PHYSIOL REV, V71, P413
   Chen GP, 1997, BIOTECHNOL BIOENG, V53, P339
   Fauver ME, 1998, IEEE T BIO-MED ENG, V45, P891, DOI 10.1109/10.686797
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Fromherz P, 2002, CHEMPHYSCHEM, V3, P276, DOI 10.1002/1439-7641(20020315)3:3<276::AID-CPHC276>3.0.CO;2-A
   Herzog W, 2000, SKELETAL MUSCLE MECH
   Hu ZB, 1998, NATURE, V393, P149, DOI 10.1038/30205
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Lin G, 2001, IEEE T BIO-MED ENG, V48, P996, DOI 10.1109/10.942589
   MCMAHON D, 1994, AM PHYSL SOC, V35, pC1795
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Ross RS, 1998, CIRC RES, V82, P1160, DOI 10.1161/01.RES.82.11.1160
   SEN A, 1988, J BIOL CHEM, V263, P19132
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   XI JZ, 2003, PREPARATION
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
NR 18
TC 0
Z9 0
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-773-3
J9 MATER RES SOC SYMP P
PY 2004
VL 823
BP 175
EP 180
PG 6
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BBA62
UT WOS:000224424400026
DA 2018-10-20
ER

PT J
AU Barbosa, MEM
   Cammas, S
   Appel, M
   Ponchel, G
AF Barbosa, MEM
   Cammas, S
   Appel, M
   Ponchel, G
TI Investigation of the degradation mechanisms of poly(malic acid) esters
   in vitro and their related cytotoxicities on J774 macrophages
SO BIOMACROMOLECULES
LA English
DT Article
ID POLY(BETA-MALIC ACID); DRUG-CARRIER; POLYESTERS; DESIGN; POLYMERS
AB Poly(beta-malic acid) hydrophobic derivatives are promising polymers for biomedical and pharmaceutical applications. The objectives of the present work were to study the in vitro degradation profile of three PMLA hydrophobic derivatives and to evaluate their cytotoxicity before and after degradation. For this purpose, nanoparticles from poly(benzyl-malate) (PMLABe), poly(hexyl-malate) (PMLAHe), and poly(malic acid-co-benzyl-malate) (PMLAH/He) were prepared for degradation studies on standardized materials. Size exclusion chromatography (SEC) and H-1 NMR indicated that degradation occurred by random hydrolysis of the polymer main chain for all three polymer derivatives. The presence of carboxyl groups on the side chain and their esterification with different alcohols varying hydrophilicities could affect the degradation rate. It was postulated that the degradation depended on the rate of diffusion of water into the core of the particles. The cytotoxicity of the polymer nanospheres as well as their degradation products were evaluated in vitro with J774 A1 murine macrophage-like cell line. The cytotoxicity depended on the degradation rate of the polymers and the amount of degradation products of low molecular weight produced.
C1 CNRS, Fac Pharm, UMR 8612, F-92290 Chatenay Malabry, France.
RP Ponchel, G (reprint author), CNRS, Fac Pharm, UMR 8612, 5 Rue JB Clement, F-92290 Chatenay Malabry, France.
EM gilles.ponchel@cep.u-psud.fr
CR Boudad H, 2001, STP PHARMA SCI, V11, P369
   BRAUD C, 1992, POLYM BULL, V29, P177, DOI 10.1007/BF00558054
   BRAUD C, 1985, POLYM BULL, V13, P293
   Breitenbach A, 2000, POLYMER, V41, P4781, DOI 10.1016/S0032-3861(99)00710-7
   Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2
   Cammas S, 1999, INT J BIOL MACROMOL, V25, P273, DOI 10.1016/S0141-8130(99)00042-2
   Cammas-Marion S, 2000, MACROMOL SYMP, V153, P167, DOI 10.1002/1521-3900(200003)153:1<167::AID-MASY167>3.0.CO;2-Q
   Cammas-Marion S, 2000, DES MONOMERS POLYM, V3, P77, DOI 10.1163/156855500750198744
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   FOURNIE P, 1992, J BIOACT COMPAT POL, V7, P113, DOI 10.1177/088391159200700201
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mosqueira VCF, 1999, J DRUG TARGET, V7, P65, DOI 10.3109/10611869909085493
   Steendam R, 2001, J CONTROL RELEASE, V70, P71, DOI 10.1016/S0168-3659(00)00342-4
   Thioune O, 1997, INT J PHARM, V146, P233, DOI 10.1016/S0378-5173(96)04830-2
   Torchilin VP, 2000, EUR J PHARM SCI, V11, pS81, DOI 10.1016/S0928-0987(00)00166-4
   *UPS, 1990, US PHARM NAT FORM, V22
   Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3
   Vert M, 1998, POLYM DEGRAD STABIL, V59, P169, DOI 10.1016/S0141-3910(97)00158-4
   Vert M., 1979, ACS POLYM PREPT, V20, P608
NR 19
TC 23
Z9 24
U1 1
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2004
VL 5
IS 1
BP 137
EP 143
DI 10.1021/bm0300608
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 777MY
UT WOS:000189183200020
DA 2018-10-20
ER

PT J
AU Oh, BK
   Meyerhoff, ME
AF Oh, BK
   Meyerhoff, ME
TI Catalytic generation of nitric oxide from nitrite at the interface of
   polymeric films doped with lipophilic Cu(Il)-complex: a potential route
   to the preparation of thromboresistant coatings
SO BIOMATERIALS
LA English
DT Article
DE nitric oxide; catalytic nitrite reduction; lipophilic Cu(II)-complex;
   nitrite ion pair; biocompatible polymers
ID IN-VIVO EVALUATION; ASCORBIC-ACID; REDUCTASE COMPONENTS; NO-SYNTHASE;
   RELEASE; SENSORS; OXYGEN; SYSTEM; TISSUE; CYCLE
AB A novel approach potentially useful for the development of more thromboresistant polymeric materials is examined. The method is based on the catalytic generation of nitric oxide (NO) via Cu(I) mediated reduction of nitrite ions. Preliminary solution phase studies demonstrate that ascorbate or thiolate anions can generate Cu(I) from Cu(II) with subsequent catalytic conversion of any nitrite ions present to NO by the unstable Cu(I) species. Incorporation of this same chemistry within a hydrophobic polymeric material requires immobilizing Cu(II) ions into a polymeric phase via use of a lipophilic Cu(II) chelating ligand (dibenzo [e,k]2,3,8,9-tetraphenyl-1,4,7,10-tetraaza-cyclododeca-1,3,7,9-tetraene (DTTCT)). It is shown that this complex can be reduced to its Cu(I) form by appropriate reducing equivalents present in the bathing solution. The resulting Cu(I) complex can then reduce nitrite to NO with the NO generation occurring at the polymer/solution interface at physiological pH. Data from chemiluminescence experiments indicate that the flux of NO at the polymer surface is comparable to that of endothelial cells (greater than or equal to 1 x 10(-10) mol/cm(2) min) when 0.5 mm nitrite/l mm ascorbate are present in the bathing solution. Potentially more useful NO generation can be achieved by doping the polymer film with the Cu(II) complex along with a lipophilic quaternary ammonium nitrite salt. In this case reducing equivalents within the aqueous phase enable the nitrite derived from the polymer to be converted into NO by the Cu(II/I) ligand complex. Films of this type are shown to generate NO for at least 6 h in PBS buffer with fluxes on the order of 1.5 x 10(-10) mol/cm(2) min. Physiologically relevant levels of NO release are also shown to exist at the polymer interface when films are soaked in fresh plasma as well as undiluted whole blood, indicating that endogenous reducing equivalents present in blood can efficiently reduce the Cu(II)-ligand within the polymer film. The prospects of using these new NO releasing films to devise more biocompatible polymeric coatings for biomedical applications are discussed. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
FU NIBIB NIH HHS [EB 00783]
CR ARCHER MC, 1975, J NATL CANCER I, V54, P1203, DOI 10.1093/jnci/54.5.1203
   BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0
   Bredt D.S., 1992, SCI AM, V266, P68
   Chandra S, 1998, INDIAN J CHEM A, V37, P1074
   Cutruzzola F, 1999, BBA-BIOENERGETICS, V1411, P231, DOI 10.1016/S0005-2728(99)00017-1
   DAHN H, 1960, HELV CHIM ACTA, V43, P320, DOI 10.1002/hlca.19600430143
   FELDMAN PL, 1993, CHEM ENG NEWS, V20, P26
   Frost MC, 2003, MICROCHEM J, V74, P277, DOI 10.1016/S0026-265X(03)00033-X
   Frost MC, 2002, ANAL CHEM, V74, P5942, DOI 10.1021/ac025944g
   GUTTERIDGE JMC, 1982, FEBS LETT, V137, P327, DOI 10.1016/0014-5793(82)80377-3
   HARRIS DC, 1999, QUANTITATIVE CHEM AN, P337
   HENRY JB, 1991, CLIN DIAGNOSIS MANAG, pT1368
   HUNSBERGER JF, 1980, CRC HDB CHEM PHYSICS, pD155
   Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0
   Keefer Larry K., 1995, Methods (Orlando), V7, P121, DOI 10.1006/meth.1995.1018
   Kelm M, 1999, BBA-BIOENERGETICS, V1411, P273, DOI 10.1016/S0005-2728(99)00020-1
   KELM M, 1996, METHODS NITRIC OXIDE, P47
   KHAN MMT, 1967, J AM CHEM SOC, V89, P4176, DOI 10.1021/ja00992a036
   KOBAYASHI M, 1995, J BIOL CHEM, V270, P4146, DOI 10.1074/jbc.270.8.4146
   MACALLISTER RJ, 1996, JIFCC, V8, P152
   May JM, 2000, FREE RADICAL BIO MED, V28, P1421, DOI 10.1016/S0891-5849(00)00269-0
   MIRVISH SS, 1972, SCIENCE, V177, P65, DOI 10.1126/science.177.4043.65
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   MORF WE, 1981, PRINCIPLES ION SELEC, P211
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   OH BK, 2000, PITTCON 2000 NEW ORL
   Pazuchowski PG, 2002, J AM CHEM SOC, V124, P12182
   RAGSDALE RO, 1965, INORG CHEM, V4, P420, DOI 10.1021/ic50025a038
   Ramamurthi A, 2000, ANN BIOMED ENG, V28, P174, DOI 10.1114/1.242
   Reutov VP, 1998, BIOCHEMISTRY-MOSCOW+, V63, P874
   Reutov VP, 1999, BIOCHEMISTRY-MOSCOW+, V64, P528
   Rucker AT, 1999, LANCET, V354, P1670
   Sarjeant JM, 2002, CARDIOVASC PATHOL, V11, P263, DOI 10.1016/S1054-8807(02)00125-4
   SCHMIDT HHH, 1996, METHODS NITRIC OXIDE, P491
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   SHIBUKI K, 1990, NEUROSCI RES, V9, P69, DOI 10.1016/0168-0102(90)90048-J
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Tsuji A, 1998, BIOCHEM BIOPH RES CO, V245, P11, DOI 10.1006/bbrc.1998.8368
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163
   Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8
   Yang F, 1997, CLIN CHEM, V43, P657
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 42
TC 50
Z9 54
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2004
VL 25
IS 2
BP 283
EP 293
DI 10.1016/S0142-9612(03)00530-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 746BZ
UT WOS:000186727700011
PM 14585716
DA 2018-10-20
ER

PT S
AU Silva, GA
   Costa, FJ
   Neves, NM
   Reis, RL
AF Silva, GA
   Costa, FJ
   Neves, NM
   Reis, RL
BE Hasirci, N
   Hasirci, V
TI Microparticulate release systems based on natural origin materials
SO BIOMATERIALS: FROM MOLECULES TO ENGINEERED TISSUES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 10th International Symposium on Biomedical Science and Technology
CY OCT 10-12, 2003
CL CYPRUS
ID DRUG-DELIVERY SYSTEMS; STARCH-BASED POLYMERS; IN-VITRO DEGRADATION; ORAL
   INSULIN DELIVERY; BIODEGRADABLE MICROSPHERES; MECHANICAL-PROPERTIES;
   CISPLATIN DELIVERY; AFFINITY-CHROMATOGRAPHY; BIOMEDICAL APPLICATIONS;
   COMPOSITE MICROSPHERES
C1 Univ Minho, 3Bs Res Grp Biomat Biodegradables Biomimet, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Silva, GA (reprint author), Univ Minho, 3Bs Res Grp Biomat Biodegradables Biomimet, P-4710057 Braga, Portugal.
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008; Neves,
   Nuno/B-4685-2008; silva, gabriela/F-4409-2012
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Neves,
   Nuno/0000-0003-3041-0687; silva, gabriela/0000-0001-5946-1918
CR Aiedeh K, 2001, EUR J PHARM SCI, V13, P159, DOI 10.1016/S0928-0987(00)00217-7
   An XN, 2003, J CHEM TECHNOL BIOT, V78, P596, DOI 10.1002/jctb.820
   Arica B, 2002, INT J PHARM, V242, P267, DOI 10.1016/S0378-5173(02)00172-2
   ARTURSSON P, 1984, J PHARM SCI, V73, P1507, DOI 10.1002/jps.2600731103
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   BAILLIE AJ, 1987, J PHARM PHARMACOL, V39, P832, DOI 10.1111/j.2042-7158.1987.tb05126.x
   Belmin J, 2003, DRUG AGING, V20, P303, DOI 10.2165/00002512-200320040-00006
   Boesel L. F., 2003, BIODEGRADABLE POLYM
   Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   BORISSOVA R, 1995, J PHARM SCI, V84, P249, DOI 10.1002/jps.2600840226
   Carino GP, 2000, J CONTROL RELEASE, V65, P261, DOI 10.1016/S0168-3659(99)00247-3
   Chellat F, 2000, J BIOMED MATER RES, V53, P592, DOI 10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO;2-P
   Chellat F, 2000, J BIOMED MATER RES, V51, P107, DOI 10.1002/(SICI)1097-4636(200007)51:1<107::AID-JBM14>3.0.CO;2-F
   Cui ZR, 2001, J CONTROL RELEASE, V75, P409, DOI 10.1016/S0168-3659(01)00407-2
   CZEJKA MJ, 1989, J CHROMATOGR-BIOMED, V497, P336, DOI 10.1016/0378-4347(89)80039-8
   DASILVA MA, 1991, MATER LETT, V11, P96, DOI 10.1016/0167-577X(91)90093-L
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Dhanaraju MD, 2003, INT J PHARM, V268, P23, DOI 10.1016/j.ijpharm.2003.08.011
   Ehrhart N, 1999, AM J VET RES, V60, P1347
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Erdogan S, 2003, J CONTROL RELEASE, V87, P238
   Filipovic-Grcic J, 2000, EUR J PHARM SCI, V9, P373, DOI 10.1016/S0928-0987(99)00078-0
   Genc O, 2002, HYDROMETALLURGY, V67, P53, DOI 10.1016/S0304-386X(02)00160-3
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Hata H, 2000, BIOMATERIALS, V21, P1779, DOI 10.1016/S0142-9612(00)00069-7
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P701, DOI 10.1002/jbm.10024
   IKE O, 1992, BIOMATERIALS, V13, P230, DOI 10.1016/0142-9612(92)90189-U
   Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2
   KOST J, 1994, J CONTROL RELEASE, V30, P77, DOI 10.1016/0168-3659(94)90046-9
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   LAAKSO T, 1987, ACTA PHARM SUEC, V24, P208
   LANGER R, 1991, MRS BULL, V16, P47
   Lee TH, 2002, J CONTROL RELEASE, V83, P437, DOI 10.1016/S0168-3659(02)00235-3
   Leonor IB, 2003, J MATER SCI-MATER M, V14, P435, DOI 10.1023/A:1023214918592
   Lim ST, 2000, J CONTROL RELEASE, V66, P281, DOI 10.1016/S0168-3659(99)00285-0
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   MAO QM, 1991, J CHROMATOGR, V548, P147, DOI 10.1016/S0021-9673(01)88598-8
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Mateo C, 2001, J CHROMATOGR A, V915, P97, DOI 10.1016/S0021-9673(01)00626-4
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Mi FL, 2003, BIOMATERIALS, V24, P5023, DOI 10.1016/S0142-9612(03)00413-7
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   Osth K, 2003, J DRUG TARGET, V11, P75, DOI 10.1080/1061186031000093254
   PAIVARINTA U, 1993, ARCH ORTHOP TRAUM SU, V112, P71, DOI 10.1007/BF00420258
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Pillai O, 2001, CURR OPIN CHEM BIOL, V5, P447, DOI 10.1016/S1367-5931(00)00227-1
   Pillai O, 2001, CURR OPIN CHEM BIOL, V5, P439, DOI 10.1016/S1367-5931(00)00226-X
   Qiu QQ, 2001, IN VITRO CELL DEV-AN, V37, P157
   Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5
   Qiu QQ, 2000, J BIOMED MATER RES, V52, P66, DOI 10.1002/1097-4636(200010)52:1<66::AID-JBM9>3.0.CO;2-2
   Qu QQ, 2002, ANN NY ACAD SCI, V974, P556, DOI 10.1111/j.1749-6632.2002.tb05930.x
   Ramadas M, 2000, J MICROENCAPSUL, V17, P405
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.3.CO;2-9
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   Reis RL, 1997, J MATER SCI-MATER M, V8, P897, DOI 10.1023/A:1018514107669
   Reis RL, 1999, MOD PLAST, V76, P73
   Rongved P, 1997, CARBOHYD RES, V297, P325, DOI 10.1016/S0008-6215(96)00286-8
   Safarikova M, 2003, J BIOTECHNOL, V105, P255, DOI 10.1016/j.jbiotec.2003.07.002
   Sahin S, 2002, J CONTROL RELEASE, V82, P345, DOI 10.1016/S0168-3659(02)00141-4
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P597
   Schepers E, 2001, J DENT RES, V80, P1215
   Schlapp M, 2003, J PHARM SCI-US, V92, P2145, DOI 10.1002/jps.10460
   Silva GA, 2003, J MATER SCI-MATER M, V14, P1055, DOI 10.1023/B:JMSM.0000004002.11278.30
   SILVA GA, 2004, UNPUB RESPONSE STARC
   SILVA GA, 2003, J BIOMEDICAL MAT R A
   SILVA GA, 2004, IN PRESS EVALUATION
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   SORIANO I, 1995, INT J PHARMACEUT, V125, P223, DOI 10.1016/0378-5173(95)00128-6
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   Sousa RA, 2000, J APPL POLYM SCI, V77, P1303, DOI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
   STANLEY HR, 1987, J PROSTHET DENT, V58, P607, DOI 10.1016/0022-3913(87)90393-3
   Sun YM, 1999, J DISPER SCI TECHNOL, V20, P907, DOI 10.1080/01932699908943827
   Takagi M, 1999, J BIOSCI BIOENG, V88, P693, DOI 10.1016/S1389-1723(00)87105-4
   Toth JM, 2002, ORTHOPEDICS, V25, pS1131
   Tuncel A, 1996, J APPL POLYM SCI, V62, P789, DOI 10.1002/(SICI)1097-4628(19961031)62:5<789::AID-APP11>3.3.CO;2-F
   Vaz CM, 2003, BIOMACROMOLECULES, V4, P1520, DOI 10.1021/bm034050i
   Vaz CM, 2003, POLYMER, V44, P5983, DOI 10.1016/S0032-3861(03)00549-4
   Vaz CM, 2003, J MATER SCI-MATER M, V14, P789, DOI 10.1023/A:1025040522513
   Vaz CM, 2003, POLYM DEGRAD STABIL, V81, P65, DOI 10.1016/S0141-3910(03)00063-6
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   Vaz CM, 2001, MATER RES INNOV, V4, P375, DOI 10.1007/s100190000112
   Victor SP, 2002, J BIOMATER APPL, V17, P125, DOI 10.1106/088532802028583
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   WILSON J, 1998, J APPL BIOMATERIALS, V22, P159
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Yapp DTT, 1998, ANTI-CANCER DRUG, V9, P791, DOI 10.1097/00001813-199810000-00008
   Yenice I, 2003, J MICROENCAPSUL, V20, P705, DOI 10.1080/0265204031000154179
NR 97
TC 4
Z9 4
U1 0
U2 4
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0065-2598
BN 0-306-48583-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2004
VL 553
BP 283
EP 300
PG 18
WC Engineering, Biomedical; Medicine, Research & Experimental; Materials
   Science, Biomaterials
SC Engineering; Research & Experimental Medicine; Materials Science
GA BAW84
UT WOS:000223979400022
PM 15503464
DA 2018-10-20
ER

PT S
AU Subramanian, A
   Sarkar, S
   Woollam, JA
   Nosal, WH
AF Subramanian, A
   Sarkar, S
   Woollam, JA
   Nosal, WH
GP ISA
TI Synthesis and characterization of albumin binding surfaces for
   implantable surfaces
SO BIOMEDICAL SCIENCES INSTRUMENTATION, VOL 40
SE TECHNICAL PAPERS OF ISA
LA English
DT Proceedings Paper
CT 41st Annual Rocky Mountain Bioengineering Symposium/41st International
   ISA Biomedical Sciences Instrumentation Symposium
CY APR 23-25, 2004
CL Ft Collins, CO
SP Instrumentat Syst & Automat Soc
DE albumin; synthetic peptides; ligands; biomaterials
ID PROTEIN ADSORPTION; AFFINITY
AB Implanted medical devices are of increasing importance in the practice of medicine and it is estimated that more than 3-million people in the United States have long-term implants like vascular grafts, pacemakers, catheters and joint replacements. Even though most biomedical polymers employed are relatively inert, unreactive, and non-toxic, most implant materials when contacted with blood invoke the activation of blood cells as well as the plasma proteolytic enzyme systems. In order to overcome aforementioned problems, attempts have been made to modify the surface chemistry of the blood-contacting biomaterials so that they become thromboresistant. One potential strategy to address the problem of the chaotic adsorption of proteins to medical devices and surfaces is to create a layer of albumin as a "barrier protein cover", as a thin layer of albumin has been reported to minimize adhesion and aggregation of platelets. By grafting peptides and synthetic ligands, that specifically bind human serum albumin, oil all epoxide functionalized surface, we have generated surfaces that exhibit enhanced albumin binding over other serum proteins. We have characterized the surface using infra-red ellipsiometry and quantified protein adsorption via specific ELISA assays and gel electrophoresis.
C1 Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA.
RP Subramanian, A (reprint author), Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   Goodman S L, 1991, J Biomater Sci Polym Ed, V2, P147, DOI 10.1163/156856291X00133
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   JAHANGIR R, 2003, BIOMATERIALS, V24, P123
   KEOGH RJ, 1996, CELLS MAT, V6, P209
   KIM SW, 1975, BIOMEDICAL APPL POLY
   LINDSAY RM, 1980, T AM SOC ART INT ORG, V26, P603
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   Sato AK, 2002, BIOTECHNOL PROGR, V18, P182, DOI 10.1021/bp010181o
   SUBRAMANIAN A, 2003, J CHROMATOGR, V790, P143
   VANOSS CJ, 1989, J COLLOID INTERF SCI, V128, P313, DOI 10.1016/0021-9797(89)90345-7
NR 15
TC 4
Z9 4
U1 0
U2 1
PU INSTRUMENT SOC AMER
PI RESEARCH TRIANGLE PARK
PA 67 ALEXANDER DR, PO BOX 12277, RESEARCH TRIANGLE PARK, NC 27709 USA
SN 1054-0032
J9 TECH PAPERS ISA
PY 2004
VL 449
BP 1
EP 6
PG 6
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BAE76
UT WOS:000221906600001
DA 2018-10-20
ER

PT S
AU Zhang, M
   James, SP
AF Zhang, M
   James, SP
GP ISA
TI Novel hyaluronan esters for biomedical applications
SO BIOMEDICAL SCIENCES INSTRUMENTATION, VOL 40
SE TECHNICAL PAPERS OF ISA
LA English
DT Proceedings Paper
CT 41st Annual Rocky Mountain Bioengineering Symposium/41st International
   ISA Biomedical Sciences Instrumentation Symposium
CY APR 23-25, 2004
CL Ft Collins, CO
SP Instrumentat Syst & Automat Soc
DE biomaterials; hyaluronan esters; esterification; biopolymer
   plasticization
ID DERIVATIVES
AB A series of novel hyaluronan (HA) esters with aliphatic chains of different length were Synthesized. A silylated complex of HA with cetyltrimethylammonium cations (silyl HA-CTA) was used as the starting material. The reactions were performed in xylenes or no solvent with acid chlorides as the acylation agents. The disappearance of all characteristic FT-IR vibration bands associated with the -OSi(CH3)(3) groups and the appearance of the strong ester carbonyl peak at 1753 cm(-1) demonstrated the success of esterification. Thermoplasticity was achieved with HA esters of high aliphatic acids. It was found that the longer the ester chain, the lower the melting points, so different melting temperatures can be obtained by adjusting the acid chloride chain length to meet various needs.
C1 Colorado State Univ, Biomed Engn Program, Dept Mech Engn, Ft Collins, CO 80523 USA.
RP Zhang, M (reprint author), Colorado State Univ, Biomed Engn Program, Dept Mech Engn, Ft Collins, CO 80523 USA.
CR BARBUCCI R, 1993, J BIOMAT SCI-POLYM E, V4, P245, DOI 10.1163/156856293X00555
   Della Valle F, 1989, U.S. Patent, Patent No. [4,851,521, 4851521, 4851521A]
   KLEMM D, 1998, COMPREHENSIVE CELLUL, V2, P182
   SHIRAISHI N, 1979, J APPL POLYM SCI, V24, P2361, DOI 10.1002/app.1979.070241204
   SHIRAISHI N, 1989, CELLULOSIC UTILIZATI, P97
   STEIN A, 1988, MAKROMOL CHEM-RAPID, V9, P569
   YUI N, 2002, Patent No. 20020143171
   ZHANG M, 2004, 41 ANN ROCK MOUNT BI, V40
NR 8
TC 0
Z9 0
U1 0
U2 1
PU INSTRUMENT SOC AMER
PI RESEARCH TRIANGLE PARK
PA 67 ALEXANDER DR, PO BOX 12277, RESEARCH TRIANGLE PARK, NC 27709 USA
SN 1054-0032
J9 TECH PAPERS ISA
PY 2004
VL 449
BP 238
EP 242
PG 5
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BAE76
UT WOS:000221906600039
DA 2018-10-20
ER

PT S
AU Mukdadi, O
   Shandas, R
AF Mukdadi, O
   Shandas, R
GP ISA
TI Ultrasound wave propagation in tissue and scattering from microbubbles
   for echo particle image velocimetry technique
SO BIOMEDICAL SCIENCES INSTRUMENTATION, VOL 40
SE TECHNICAL PAPERS OF ISA
LA English
DT Proceedings Paper
CT 41st Annual Rocky Mountain Bioengineering Symposium/41st International
   ISA Biomedical Sciences Instrumentation Symposium
CY APR 23-25, 2004
CL Ft Collins, CO
SP Instrumentat Syst & Automat Soc
DE contrast harmonic imaging; tissue imaging; echo particle image
   velocimetry; contrast agents; microbubbles
ID NONLINEAR ACOUSTICS; SOUND BEAMS; TIME-DOMAIN; PARAMETER
AB Nonlinear wave propagation in tissue call be employed for tissue harmonic imaging, ultrasound surgery and more effective tissue ablation for high intensity focused ultrasound (HIFU). Wave propagation in soft tissue and scattering from microbubbles (ultrasound contrast agents) are modeled to improve detectability, signal-to-noise ratio, and contrast harmonic imaging used for echo particle image velocimetry (Eclio-PIV) technique. The wave motion in nonlinear material (tissue) is studied using KZK-type parabolic evolution equation. This model considers ultrasound beam diffraction, attenuation, and tissue nonlinearity. Time-domain numerical model is based oil that originally developed by Lee and Hamilton [J. Acoust. Soc. Am 97:906-917 (1995)] for axi-synimetric acoustic field. The initial acoustic waveform emitted from the transducer is assumed to be a broadband wave modulated by Gaussian envelope. Scattering from microbubbles seeded in the blood stream is characterized. Hence., we compute the pressure field impinges the wall of a coated microbubble. the dynamics of oscillating microbubble can be modeled using Rayleigh-Plesset-type equation. Here, the continuity and the radial-momentum equation of encapsulated microbubbles are used to account for the lipid layer surrounding the microbubble. Numerical results show the effects of tissue and microbubble nonlinearities oil the propagating pressure wave field. These nonlinearities have a strong influence on the waveform distortion and harmonic generation of the propagating and scattering waves. Results also show that microbubbles have stronger nolinearity, than tissue. and thus improves S/N ratio. These theoretical predictions of wave phenomena provide further understanding of biomedical imaging technique and provide better system design.
C1 Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
RP Mukdadi, O (reprint author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
OI Shandas, Robin/0000-0002-9473-7542
CR ADLER L, 1962, J ACOUST SOC AM, V34, P410, DOI 10.1121/1.1918142
   BEYER RT, 1960, J ACOUST SOC AM, V32, P719, DOI 10.1121/1.1908195
   BJORNO L, 1986, ULTRASONICS, V24, P254, DOI 10.1016/0041-624X(86)90102-2
   Cahill MD, 1998, J ACOUST SOC AM, V104, P1274, DOI 10.1121/1.424336
   CHURCH CC, 1995, J ACOUST SOC AM, V97, P1510, DOI 10.1121/1.412091
   DEJONG N, 1994, ULTRASONICS, V32, P455, DOI 10.1016/0041-624X(94)90065-5
   Duck F., 1990, PHYS PROPERTIES TISS
   Duck FA, 2002, ULTRASOUND MED BIOL, V28, P1, DOI 10.1016/S0301-5629(01)00463-X
   DUNN F, 1981, P IEEE 1981 ULTR S N, V1, P527
   Feng ZC, 1997, ANNU REV FLUID MECH, V29, P201, DOI 10.1146/annurev.fluid.29.1.201
   FOX FE, 1954, J ACOUST SOC AM, V26, P994, DOI 10.1121/1.1907468
   Gol'dberg Z. A., 1961, SOV PHYS ACOUST, V6, P306
   Hamilton M F, 1998, NONLINEAR ACOUSTICS
   Humphrey VF, 2000, ULTRASONICS, V38, P267, DOI 10.1016/S0041-624X(99)00122-5
   Kim H. B., 2003, P ASME SUMM BIOENG C, P71
   KIM HB, 2003, IN PRESS EXPT FLUIDS
   KUZNETSOV VP, 1971, SOV PHYS ACOUST+, V16, P467
   LEE YS, 1995, J ACOUST SOC AM, V97, P906, DOI 10.1121/1.412135
   Leighton T., 1994, ACOUSTIC BUBBLE
   Li YD, 2000, IEEE T ULTRASON FERR, V47, P1259, DOI 10.1109/58.869075
   MUKDADI OM, 2003, IN PRESS ULTRASONICS
   Shandas R, 2003, BOSTON TRANSDUCERS'03: DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2, P919
   Strutt JW, 1917, PHILOS MAG, VXXXIV, P94
   Tavakkoli J, 1998, J ACOUST SOC AM, V104, P2061, DOI 10.1121/1.423720
   ZABOLOTSKAYA EA, 1969, SOV PHYS ACOUST+, V15, P35
NR 25
TC 0
Z9 0
U1 0
U2 1
PU INSTRUMENT SOC AMER
PI RESEARCH TRIANGLE PARK
PA 67 ALEXANDER DR, PO BOX 12277, RESEARCH TRIANGLE PARK, NC 27709 USA
SN 1054-0032
J9 TECH PAPERS ISA
PY 2004
VL 449
BP 364
EP 370
PG 7
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BAE76
UT WOS:000221906600060
DA 2018-10-20
ER

PT S
AU Parthasaradhi, S
   Derakhshani, R
   Hornak, L
   Schuckers, S
AF Parthasaradhi, S
   Derakhshani, R
   Hornak, L
   Schuckers, S
BE Jain, AK
   Ratha, NK
TI Improvement of an algorithm for recognition of liveness using
   perspiration in fingerprint devices
SO BIOMETRIC TECHNOLOGY FOR HUMAN IDENTIFICATION
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biometric Technology for Human Identification
CY APR 12-13, 2004
CL Orlando, FL
SP SPIE
DE biomedical measurements; biomedical image processing; identification of
   persons; pattern recognition; biometrics; fingerprint recognition;
   liveness
AB Previous work in our laboratory and others have demonstrated that spoof fingers made of a variety of materials including silicon, Play-Doh, clay, and gelatin (gummy finger) can be scanned and verified when compared to a live enrolled finger. Liveness, i.e. to determine whether the introduced biometric is coming from a live source, has been suggested as a means to circumvent attacks using spoof fingers. We developed a new liveness method based on perspiration changes in the fingerprint image. Recent results showed approximately 90% classification rate using different classification methods for various technologies including optical, electro-optical, and capacitive DC, a shorter time window and a diverse dataset. This paper focuses on improvement of the live classification rate by using a weight decay method during the training phase in order to improve the generalization and reduce the variance of the neural network based classifier. The dataset included fingerprint images from 33 live subjects, 33 spoofs created with dental impression material and Play-Doh, and fourteen cadaver fingers. 100% live classification was achieved with 81.8 to 100% spoof classification, depending on the device technology. The weight-decay method improves upon past reports by increasing the live and spoof classification rate.
C1 W Virginia Univ, Lane Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA.
RP Schuckers, S (reprint author), W Virginia Univ, Lane Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA.
RI Schuckers, Stephanie/F-6197-2017
OI Schuckers, Stephanie/0000-0002-9365-9642
CR DERAKSHANI R, 2003, PATTERN RECOGNITION, V36
   Kallo P., 2001, US Patent, Patent No. 617564
   KURT S, 2001, SECURITY PORTAL, V10
   Lapsley P.D., 1998, U.S. Patent, Patent No. [5,737,439, 5737439]
   Matsumoto T, 2002, P SPIE, V4677
   Osten D., 1998, US Patent, Patent No. 5719950
   PARTHASARADHI ST, 2003, THESIS W VIRGINIA U
   PUTTE T, 2000, SMART CARD RES ADV A, P289
   Schuckers S. A. C, 2002, INFORMATION SECURITY, V7, P56
   SCHUCKERS SAC, 2003, BIOM CONS C SEP
   Valencia V., 2003, BIOMETRICS
   LIVENESS DETECTION B
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5327-7
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5404
BP 270
EP 277
DI 10.1117/12.541805
PG 8
WC Computer Science, Artificial Intelligence; Imaging Science &
   Photographic Technology
SC Computer Science; Imaging Science & Photographic Technology
GA BAW59
UT WOS:000223908800028
DA 2018-10-20
ER

PT J
AU Kasai, S
   Ohga, Y
   Mochizuki, M
   Nishi, N
   Kadoya, Y
   Nomizu, M
AF Kasai, S
   Ohga, Y
   Mochizuki, M
   Nishi, N
   Kadoya, Y
   Nomizu, M
TI Multifunctional peptide fibrils for biomedical materials
SO BIOPOLYMERS
LA English
DT Article; Proceedings Paper
CT 3rd Peptide Engineering Meeting (PEM-III)
CY JUL 17-18, 2003
CL Boston, MA
SP Amer Peptide Soc, European Peptide Soc, Japan Peptide Soc
DE amyloid-like fibril; laminin; cell attachment; integrin; basement
   membrane
ID LAMININ ALPHA-1 CHAIN; TERMINAL GLOBULAR DOMAIN; CELL-BINDING SEQUENCES;
   A-CHAIN; SYNTHETIC PEPTIDES; IKVAV SEQUENCE; IDENTIFICATION; ATTACHMENT;
   SEGMENT; SITES
AB The Ile-Lys-Val-Ala-Val (IKVAV) containing peptide, A208 (AASIKVAVSADR, mouse laminin a] chain 2097-2108), was recently found to form amyloid-like fibrils. Fibril formation is critical for its biological activities, including promotion of cell adhesion and neurite outgrowth. In the present study, we designed multifunctional peptide, fibrils using the A208 peptide and an Arg-Gly-Asp (RGD)containing fibronectin active sequence for biomedical applications. The fibronectin active sequence GRGDS (FN) or a scrambled sequence RSGGD (SC) were conjugated to either A208 or to A208S (AASVVIAKSADR), a scrambled peptide of A208, with a glycine as a spacer. The FN-A208 and SC-A208 peptides formed a gel and were stained with Congo red similar to that of A208, but FN-A208S and SC-A208S did not form a gel. These results indicate that FN-A208 and SC-A208 form amyloid-like fibrils similar to A208. A208 and SC-A208 promoted cell attachment with filopodia formation, and this adhesion was inhibited by the IKVAV-containing peptide, but not by EDTA or a GRGDS peptide. FN-A208 promoted cell attachment with well-organized actin stress fibers, and this adhesion was partially inhibited by either EDTA, GRGDS, or IKVAV. These data suggest that A208 binds to only IKVAV receptor(s) while the FN-A208 interacts with both integrins and the IKVAV receptor(s). We conclude that multifunctional peptide fibrils can be designed by conjugation of active peptides on A208 and that this construct has potential to serve as a bioadhesive for tissue regeneration and engineering. (C) 2004 Wiley Periodicals, Inc.
C1 Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.
   Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2288555, Japan.
RP Nomizu, M (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.
CR Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   DESUNIBE DW, 1992, DEV BIOL, V149, P357
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   GUIMBINER BM, 1996, CELL, V84, P345
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   KANEMOTO T, 1990, P NATL ACAD SCI USA, V87, P2279, DOI 10.1073/pnas.87.6.2279
   KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633
   KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V
   Makino M, 2002, EXP CELL RES, V277, P95, DOI 10.1006/excr.2002.5540
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   NAIDET C, 1987, NATURE, V325, P348, DOI 10.1038/325348a0
   NOMIZU M, 1992, J BIOL CHEM, V267, P14118
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   Nomizu M, 1996, FEBS LETT, V396, P37, DOI 10.1016/0014-5793(96)01060-5
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   NOMIZU M, 2001, BIOCHEMISTRY-US, V20, P15310
   Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200
   RUOSLAHTI E, 1987, J BIOL CHEM, V25, P17294
   RUOSLAHTI E, 1987, J BIOL CHEM, V25, P262
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L
NR 27
TC 51
Z9 56
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD 04
PY 2004
VL 76
IS 1
BP 27
EP 33
DI 10.1002/bip.10565
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 800GE
UT WOS:000220016100005
PM 14997472
DA 2018-10-20
ER

PT J
AU Goel, M
AF Goel, M
TI Recent developments in electroceramics: MEMS applications for energy and
   environment
SO CERAMICS INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT 3rd Asian Meeting on Electroceramics (AMEC-3)
CY DEC 07-11, 2003
CL Singapore, SINGAPORE
SP Japanese Ceram Sco, Chinese Ceram Soc, Korean Ceram Soc, Amer Ceram Soc, Elect Div, IEEE UFFC, Lee Fdn, Tan Fdn, Singapore Def Sci Org Natl Labs, LMS Technologies Pte Ltd, Chief Up Int Co, Kanthal Electroheat Pte Ltd, Zogo Photon Pte Ltd
DE electroceramic materials; ferroelectric polymers; electric poling;
   polarization; MEMS applications
ID THIN-FILMS; TECHNOLOGY; CERAMICS; SENSORS
AB Thin films of ferroelectric materials such as polar polymers and polymer ceramic composites show unique properties for a wide range of applications in the field of microelectronics, communications, biomedical engineering, energy conservation, micro-electromechanical system (MEMS) and others. Interest in these materials for devices having high permittivity induced by electrostatic polarization, has been revived in the past few years. The work on development of acoustic transducers, vibration sensors and pyroelectric arrays with integration of MEMS structures by bulk micromachining has begun in number of organizations in India. In this paper, recent developments in ferroelectric materials, advancements in poling and characterization techniques as well as materials considerations for integration with microelectronics in MEMS structures are briefly discussed. A review of status of the ongoing research work and the future prospects for application of MEMS devices in energy and environment are presented. (C) 2004 Elsevier Ltd and Techna Group S.r.1. All rights reserved.
C1 Minist Sci & Technol, Dept Sci & Technol, New Delhi 110016, India.
RP Goel, M (reprint author), Minist Sci & Technol, Dept Sci & Technol, New Delhi 110016, India.
EM mlg@alpha.nic.in
CR Bauer F, 2000, IEEE T ULTRASON FERR, V47, P1448, DOI 10.1109/58.883534
   Bharadwaja SSN, 2001, J APPL PHYS, V89, P4541, DOI 10.1063/1.1331659
   Damjanovic D, 1998, REP PROG PHYS, V61, P1267, DOI 10.1088/0034-4885/61/9/002
   Goel M, 2003, CURR SCI INDIA, V85, P443
   GOEL M, IN PRESS INT J ELECT
   GOVINDAN A, 1997, ADV ELECTROCERAM NOV, P88
   Haertling GH, 1999, J AM CERAM SOC, V82, P797, DOI 10.1111/j.1151-2916.1999.tb01840.x
   HARRISON JS, 2001, NASACR2001211422, P1
   JAIN GC, 1983, INDIAN J PURE AP PHY, V21, P573
   Jain M, 2002, J MATER SCI, V37, P807, DOI 10.1023/A:1013852217310
   OHIGASHI H, 1999, P ISE 10, P615
   PRASAD CD, 1996, DEV PZT POLYM COMPOS, P159
   Ramesh R, 2001, MAT SCI ENG R, V32, P191, DOI 10.1016/S0927-796X(00)00032-2
   SETTER N, 2000, ACTA MAT, V48, P51
   Singh R, 2004, IEEE T DIELECT EL IN, V11, P264, DOI 10.1109/TDEI.2004.1285896
   WISNIEWSKI C, 1999, P 10 INT S EL DELF G, P627
   XU F, 2002, P 11 INT S EL, P386
NR 17
TC 22
Z9 23
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 2004
VL 30
IS 7
SI SI
BP 1147
EP 1154
DI 10.1016/j.ceramint.2003.12.012
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 858CR
UT WOS:000224168300014
DA 2018-10-20
ER

PT J
AU Yu, HZ
AF Yu, HZ
TI New chemistry on old CDs
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID GOLD ELECTRODES; RECORDABLE CDS; AMPEROMETRIC DETERMINATION; COMPACT
   DISCS; FABRICATION; PLATFORM; CELL
AB Old compact discs (CDs) have been found to be useful for modern chemical research. Their metal reflective film is suitable for the preparation of high-quality self-assembled monolayers (SAMs) and for electrochemical analysis; pre-grooved polycarbonate base is ideal for the "customized" fabrication of material micro/nanostructures; and the immobilization of biomolecules on CDs, in conjunction with a conventional CD drive, promises to be an inexpensive tool for point-of-care biomedical diagnosis and gene analysis.
C1 Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.
RP Yu, HZ (reprint author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.
EM hzyu@sfu.ca
CR Alexandre I, 2002, BIOTECHNIQUES, V33, P435, DOI 10.2144/02332pf01
   Angnes L, 2000, ANAL CHEM, V72, P5503, DOI 10.1021/ac000437p
   Banks JT, 2002, J PHYS CHEM B, V106, P3538, DOI 10.1021/jp013970x
   Birkett D, 2002, J CHEM EDUC, V79, P1081, DOI 10.1021/ed079p1081
   Daniel D, 2003, ELECTROCHEM COMMUN, V5, P782, DOI 10.1016/j.elecom.2003.07.004
   Daniel D, 2001, ELECTROANAL, V13, P681, DOI 10.1002/1521-4109(200105)13:8/9<681::AID-ELAN681>3.0.CO;2-F
   Hazarika P, 2003, LAB CHIP, V3, P128, DOI 10.1039/b302563m
   Helt JM, 2004, J AM CHEM SOC, V126, P628, DOI 10.1021/ja035142i
   Kido H, 2000, ANAL CHIM ACTA, V411, P1, DOI 10.1016/S0003-2670(00)00776-5
   La Clair JJ, 2003, ORG BIOMOL CHEM, V1, P3244, DOI 10.1039/b306391g
   Lai S, 2004, ANAL CHEM, V76, P1832, DOI 10.1021/ac0348322
   LENK JD, 1986, COMPLETE GUIDE COMPA
   Madou MJ, 2001, BIOMED MICRODEVICES, V3, P245, DOI 10.1023/A:1011419515576
   Munoz RAA, 2001, TALANTA, V55, P855, DOI 10.1016/S0039-9140(01)00515-X
   Richter EM, 2000, FRESEN J ANAL CHEM, V366, P444, DOI 10.1007/s002160050090
   Richter EM, 2003, QUIM NOVA, V26, P839, DOI 10.1590/S0100-40422003000600011
   Richter EM, 2001, ELECTROANAL, V13, P760, DOI 10.1002/1521-4109(200105)13:8/9<760::AID-ELAN760>3.0.CO;2-N
   Westbroek P, 2002, ANAL CHEM, V74, P915, DOI 10.1021/ac0104072
   Yu HZ, 2004, CHEMPHYSCHEM, V5, P1035, DOI 10.1002/cphc.200301042
   Yu HZ, 2002, ANAL CHEM, V74, P5742, DOI 10.1021/ac025686n
   Yu HZ, 2001, ANAL CHEM, V73, P4743, DOI 10.1021/ac015521z
NR 21
TC 31
Z9 32
U1 0
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
J9 CHEM COMMUN
JI Chem. Commun.
PY 2004
IS 23
BP 2633
EP 2636
DI 10.1039/b412784f
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 874VA
UT WOS:000225377100001
PM 15568049
DA 2018-10-20
ER

PT J
AU Mitsuishi, M
   Warisawa, S
   Sugita, N
AF Mitsuishi, M
   Warisawa, S
   Sugita, N
TI Determination of the machining characteristics of a biomaterial using a
   machine tool designed for total knee arthroplasty
SO CIRP ANNALS-MANUFACTURING TECHNOLOGY
LA English
DT Article
DE biomedical material cutting; machinability; cutting force analysis
ID FATIGUE DAMAGE; CORTICAL BONE
AB The authors have developed a prototype of a sophisticated 9-axis machine tool for bone cutting to reduce the machining error in cutting bone to accept artificial joint replacements and to improve the postoperative performance of the implants. It is necessary to determine the machining characteristics of the bone to optimize the cutting state. In this paper, model bones with mechanical characteristics similar to those of human bone and pig bone, were endmilled. The relationship between the cutting conditions and the cutting characteristics of cortical bone and cancellous tissue, of which bone is comprised, were evaluated.
C1 Univ Tokyo, Sch Engn, Dept Engn Synth, Tokyo, Japan.
RP Mitsuishi, M (reprint author), Univ Tokyo, Sch Engn, Dept Engn Synth, Tokyo, Japan.
CR BERNARD A, 2002, ANN CIRP, V51, P635
   BRAIDOTTI P, 1995, J BIOMECH, V28, P439, DOI 10.1016/0021-9290(94)00082-F
   Burger EH, 1999, FASEB J, V13, P101
   Burger T, 2001, CIRP ANN-MANUF TECHN, V50, P295, DOI 10.1016/S0007-8506(07)62125-8
   CARTER DR, 1977, J BIOMECH, V10, P325, DOI 10.1016/0021-9290(77)90005-7
   Gu P, 2002, CIRP ANN-MANUF TECHN, V51, P181, DOI 10.1016/S0007-8506(07)61495-4
   ITOH S, 1983, B JSME, V26, P2295
   Jacobs CR, 1997, J BIOMECH, V30, P603, DOI 10.1016/S0021-9290(96)00189-3
   MITSUISHI M, 2003, ANN CIRP, V52, P323
   MITSUISHI M, 1992, ANN CIRP, V41, P505
   Shaffler M, 1995, BONE, V17, P521
   Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8
   Wenzel TE, 1996, BONE, V19, P89, DOI 10.1016/8756-3282(96)88871-5
   Yeni YN, 2002, BONE, V30, P509, DOI 10.1016/S8756-3282(01)00696-2
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 15
TC 20
Z9 20
U1 0
U2 11
PU TECHNISCHE RUNDSCHAU EDITION COLIBRI LTD
PI BERN
PA NORDRING 4, CH-3001 BERN, SWITZERLAND
J9 CIRP ANN-MANUF TECHN
JI CIRP Ann-Manuf. Technol.
PY 2004
VL 53
IS 1
BP 107
EP 112
DI 10.1016/S0007-8506(07)60656-8
PG 6
WC Engineering, Industrial; Engineering, Manufacturing
SC Engineering
GA 835XV
UT WOS:000222519700026
DA 2018-10-20
ER

PT J
AU Kealey, SM
   Dodd, JD
   MacEneaney, PM
   Gibney, RG
   Malone, DE
AF Kealey, SM
   Dodd, JD
   MacEneaney, PM
   Gibney, RG
   Malone, DE
TI Minimal preparation computed tomography instead of barium
   enema/colonoscopy for suspected colon cancer in frail elderly patients:
   an outcome analysis study
SO CLINICAL RADIOLOGY
LA English
DT Article
DE colonography; computed tomography/methods; frail elderly; colonic
   neoplasms/radiography; follow-up studies; technology
   assessment/biomedical; evidence-based practice
ID STATISTICAL-ANALYSIS; CT; COLONOSCOPY; RADIOLOGY; CARCINOMA; ENEMA;
   EFFICACY
AB AIM: To evaluate the efficacy of minimal preparation computed tomography (MPCT) in diagnosing clinically significant colonic tumours in frail, elderly patients.
   MATERIALS AND METHODS: A prospective study was performed in a group of consecutively referred, frail, elderly patients with symptoms or signs of anaemia, pain, rectal bleeding or weight loss. The MPCT protocol consisted of 1.51 Gastrografin 1% diluted with sterile water administered during the 48 h before the procedure with no bowel preparation or administration of-intravenous contrast medium. Eight millimetre contiguous scans through the abdomen and pelvis were performed. The scans were double-reported by two gastrointestinal radiologists as showing definite (> 90% certain), probable (50-90% certain), possible (< 50% certain) neoplasm or normal. Where observers disagreed the more pessimistic of the two reports was accepted. The gold standard was clinical outcome at 1 year with positive end-points defined as (1) histological confirmation of CRC, (2) clinical presentation consistent with CRC without histological confirmation if the patient was too unwell for biopsy/surgery, and (3) death directly attributable to colorectal carcinoma (CRC) with/without post-mortern confirmation. Negative endpoints were defined as patients with no clinical, radiological or post-mortern findings of CRC. Patients were followed for 1 year or until one of the above end-points were met.
   RESULTS: Seventy-two patients were included (mean age 81; range 62-93). One-year follow-up was completed in 94.4% (n = 68). Mortality from all causes was 33% (n = 24). Five histologically proven tumours were diagnosed with CT and there were two probable false-negatives. Results were analysed twice: assuming all CT lesions test positive and considering "possible" lesions test negative [brackets] (95% confidence intervals): sensitivity 0.88 (0.47-1.0) [0.75 (0.35-0.97)], specificity 0.47 (0.34-0.6) [0.87 (0.750. 94)], positive predictive value 0.18 [0.43], negative predictive value 0.97 [0.96], positive likelihood ratio result 1.6 [5.63], negative likelihood ratio result 0.27 [0.29], kappa 0.31 [0.43]. Tumour prevalence was 12%. A graph of conditional probabilities was generated and analysed. A variety of unsuspected pathology was also found in this series of patients.
   CONCLUSIONS: MPCT should be double-reported, at least initially. "Possible" lesions should beignored. Analysis of the graph of conditional probability applied to a group of rail, elderly patients with a high mortality from all causes (33% in our study) suggests: (1) if MPCT suggests definite or probable carcinoma, regardless of the pre-test probability, the post-test probability is high enough to warrant further action, (2) frail, elderly patients with a lowpre-test probability for CRC anda negative MPCT should not have further investigation, (3)frail, elderly patients with a higher pre-test probability of CRC (such as those presenting with rectal bleeding) and a negative MPCT should have either double contrast barium enema (DCBE) or cotonoscopy as further investigations or be followed clinically for 3-6 months. MPCT was acceptable to patients and clinicians and may reveal significant extra-colonic pathology. (C) 2004 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
C1 St Vincents Hosp, Dept Radiol, Dublin 4, Ireland.
RP Malone, DE (reprint author), St Vincents Hosp, Dept Radiol, Dublin 4, Ireland.
EM d.malone@st-vincents.ie
CR BALTHAZAR EJ, 1988, AM J ROENTGENOL, V150, P301, DOI 10.2214/ajr.150.2.301
   Black WC, 2001, RADIOLOGY, V220, P566
   Daly L.E., 2000, INTERPRETATION USES, P407
   DAY JJ, 1993, CLIN RADIOL, V48, P48, DOI 10.1016/S0009-9260(05)80108-4
   Domjan J, 1998, CLIN RADIOL, V53, P894, DOI 10.1016/S0009-9260(98)80215-8
   ELSTER AD, 1994, AM J ROENTGENOL, V163, P711, DOI 10.2214/ajr.163.3.8079874
   FAGAN TJ, 1975, NEW ENGL J MED, V293, P257
   Fenlon HM, 1999, RADIOLOGY, V210, P423, DOI 10.1148/radiology.210.2.r99fe21423
   Fenlon HM, 1999, NEW ENGL J MED, V341, P1496, DOI 10.1056/NEJM199911113412003
   FINK M, 1994, BRIT MED J, V308, P1018, DOI 10.1136/bmj.308.6935.1018
   FITZGERALD R, 1994, BRIT MED J, V308, P1639
   FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203
   Goldin J, 1996, CLIN RADIOL, V51, P47, DOI 10.1016/S0009-9260(96)80219-4
   Hara AK, 2001, RADIOLOGY, V219, P461, DOI 10.1148/radiology.219.2.r01ma28461
   IRVINE EJ, 1988, GUT, V29, P1188, DOI 10.1136/gut.29.9.1188
   Maceneaney PM, 2000, CLIN RADIOL, V55, P227, DOI 10.1053/crad.1999.0444
   Ng CS, 2002, EUR RADIOL, V12, P2988, DOI 10.1007/s00330-002-1367-5
   Ng CS, 2002, CLIN RADIOL, V57, P359, DOI 10.1053/crad.2001.0841
   Parkin DM, 2001, EUR J CANCER, V37, pS4
   Robinson P, 2002, CLIN RADIOL, V57, P389, DOI 10.1053/crad.2001.0866
   Thornbury J R, 1999, Acad Radiol, V6 Suppl 1, pS58, DOI 10.1016/S1076-6332(99)80088-9
   THORNBURY JR, 1994, AM J ROENTGENOL, V162, P1
   TINETTI ME, 1989, ARCH INTERN MED, V149, P2014, DOI 10.1001/archinte.149.9.2014
NR 23
TC 28
Z9 32
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0009-9260
J9 CLIN RADIOL
JI Clin. Radiol.
PD JAN
PY 2004
VL 59
IS 1
BP 44
EP 52
DI 10.1016/j.crad.2003.08.001
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 761LZ
UT WOS:000187911400005
PM 14697374
DA 2018-10-20
ER

PT S
AU Smith, JR
   Knight, D
   Kohn, J
   Rasheed, K
   Weber, N
   Abramson, S
AF Smith, JR
   Knight, D
   Kohn, J
   Rasheed, K
   Weber, N
   Abramson, S
BE Potyrailo, RA
   Karim, A
   Wang, Q
   Chikyow, T
TI Using non-linear regression to predict bioresponse in a combinatorial
   library of biodegradable polymers
SO COMBINATORIAL AND ARTIFICIAL INTELLIGENCE METHODS IN MATERIALS SCIENCE
   II
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Combinatorial and Artificial Intelligence Methods in
   Materials Science II held at the 2003 MRS Fall Meeting
CY DEC 01-04, 2003
CL Boston, MA
SP Mat Res Soc, GE Global Res Ctr, Hysitron Inc, Natl Renewable Energy Lab, Natl Sci Fdn
ID DEGRADABLE BIOMATERIALS; DESIGN
AB We have developed an empirical method to model bioresponse to the surfaces of biodegradable polymers in a combinatorial library using Artificial Neural Networks (ANN) in conjunction with molecular modeling and machine learning methodology. We validated the procedure by modeling human fibrinogen adsorption to 22 structurally distinct polymers. Subsequently, the method was used to model the more complicated phenomena of rat lung fibroblast and normal human fetal foreskin fibroblast proliferation in the presence of 24 and 44 different polymers, respectively. In each case, the root mean square (rms) percent error of the prediction was substantially less than the experimental variation, showing that the models can distinguish high and low performing polymers based on structure/property information. Using this method to screen candidate materials in terms of specific bioresponse prior to extensive experimental testing will greatly facilitate materials development for biomedical applications.
C1 Rutgers State Univ, Dept Chem & Chem Biol, New Brunswick, NJ 08903 USA.
RP Smith, JR (reprint author), Rutgers State Univ, Dept Chem & Chem Biol, New Brunswick, NJ 08903 USA.
CR Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Burden FR, 1997, QUANT STRUCT-ACT REL, V16, P309, DOI 10.1002/qsar.19970160406
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i
   Hertz J, 1991, INTRO THEORY NEURAL, V1
   LABUTE P, UNPUB MOE LOGP OCTAN
   Mitchell T., 1997, MACHINE LEARNING
   Rasheed K, 1997, ARTIF INTELL ENG, V11, P295, DOI 10.1016/S0954-1810(96)00050-7
   WEBER N, 2003, IN PRESS J BIOMED MA
   Wiechert W, 2002, J BIOTECHNOL, V94, P37, DOI 10.1016/S0168-1656(01)00418-7
   Wildman SA, 1999, J CHEM INF COMP SCI, V39, P868, DOI 10.1021/ci990307l
NR 12
TC 4
Z9 4
U1 0
U2 5
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-742-3
J9 MATER RES SOC SYMP P
PY 2004
VL 804
BP 155
EP 161
PG 7
WC Computer Science, Artificial Intelligence; Instruments &
   Instrumentation; Materials Science, Multidisciplinary; Materials
   Science, Characterization & Testing
SC Computer Science; Instruments & Instrumentation; Materials Science
GA BY92J
UT WOS:000189496200023
DA 2018-10-20
ER

PT J
AU Ohki, T
   Ni, QQ
   Ohsako, N
   Iwamoto, M
AF Ohki, T
   Ni, QQ
   Ohsako, N
   Iwamoto, M
TI Mechanical and shape memory behavior of composites with shape memory
   polymer
SO COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING
LA English
DT Article
DE mechanical properties; shape memory polymer
ID POLYETHER-BASED POLYURETHANES; MOLECULAR-WEIGHT
AB Shape memory polymers (SMPs) are playing a prominent role for biomedical, self-repairing and smart materials. Among various SMPs, shape memory polyurethanes (PUs) are receiving much attention for their easy control of glass transition temperature (T.) around the room temperature and excellent shape memory effect even at the room temperature. In this paper, the glass fiber reinforced PUs were developed for the improvement of the mechanical weakness of PUs bulk and for wider practical engineering uses. The specimens with different fiber weight fractions were fabricated and their mechanical behavior and shape memory effect were investigated. As a result, the tensile strength and the resistance against mechanical and thermal mechanical cycle loading in the developed materials increased due to the role of reinforcement fiber. It was shown there is an optimum fiber weight fraction between 10 and 20 wt% to have an extremely low residual strain during cyclic loading. Although the shape memory effect of developed glass fiber reinforced shape memory PUs composites was affected by glass fiber weight fraction, it was confirmed that the shape memory effect was kept in the developed composite materials. 2004 Elsevier Ltd. All rights reserved.
C1 Kyoto Inst Technol, Div Adv Fibro Sci, Sakyo Ku, Kyoto 6068585, Japan.
RP Ni, QQ (reprint author), Kyoto Inst Technol, Div Adv Fibro Sci, Sakyo Ku, Kyoto 6068585, Japan.
EM nqq@ipc.kit.ac.jp
CR HIRAI T, 1992, J APPL POLYM SCI, V45, P1849, DOI 10.1002/app.1992.070451019
   HU WC, 1994, J POLYM SCI POL PHYS, V32, P437, DOI 10.1002/polb.1994.090320304
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lin JR, 1998, J APPL POLYM SCI, V69, P1563, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1563::AID-APP11>3.0.CO;2-W
   Lin JR, 1998, J APPL POLYM SCI, V69, P1575, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1575::AID-APP12>3.0.CO;2-U
   NI QQ, 2001, ICCM 13 ID, V1332, P1
   NI QQ, 2002, 10 EUR C COMP MAT CD, V283, P1
   Ni QQ, 2000, INT S SMART STRUCT M, P1
   NI QQ, 2000, JCOM JSMS COMPOSITES, V3, P293
   NI QQ, 2001, 7 INT SAMPE S JAP, V51, P54
   OHKI T, 2001, MATER SCI RES INT, V2, P115
   OTSUKA K, 1998, SHAPE MEMORY MAT, P203
   TOBUSHI H, 1992, JSME INT J I-SOLID M, V35, P296, DOI 10.1299/jsmea1988.35.3_296
   TOBUSHI H, 1991, T JAPAN SOC MECH E A, V57, P146
   TOBUSHI H, 1998, 76 JSME FALL ANN M, V1, P237
   TOBUSHI H, 1992, T JAPAN SOC MECH E A, V58, P139
   TOBUSHI H, 1998, T JAPAN SOC MECH E A, V64, P186
NR 18
TC 160
Z9 170
U1 6
U2 69
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-835X
J9 COMPOS PART A-APPL S
JI Compos. Pt. A-Appl. Sci. Manuf.
PY 2004
VL 35
IS 9
BP 1065
EP 1073
DI 10.1016/j.compositesa.2004.03.001
PG 9
WC Engineering, Manufacturing; Materials Science, Composites
SC Engineering; Materials Science
GA 845KX
UT WOS:000223242600008
DA 2018-10-20
ER

PT B
AU Dressel, M
   Gompf, B
   Mair, S
AF Dressel, M
   Gompf, B
   Mair, S
BE Thumm, M
   Wiesbeck, W
TI Near-field spectroscopy at THz frequencies - a new tool for solid state
   spectroscopy and biomedical imaging
SO CONFERENCE DIGEST OF THE 2004 JOINT 29TH INTERNATIONAL CONFERENCE ON
   INFRARED AND MILLIMETER WAVES AND 12TH INTERNATIONAL CONFERENCE ON
   TERAHERTZ ELECTRONICS
LA English
DT Proceedings Paper
CT Joint 29th International Conference on Infrared and Millimeter
   Waves/12th International Conference on Terahertz Electronics
CY SEP 17-OCT 01, 2004
CL Univ Karlsruhe, Karlsruhe, GERMANY
SP Karlsruhe Res Ctr, IEEE, IEEE MTT Soc, ITG Soc, VDE
HO Univ Karlsruhe
ID ZONE FIELDS; DIFFRACTION; APERTURE; THICK
AB We developed a novel technique to obtain spectroscopic information in the optical near-field of small pinholes (lambda/100-lambda/10). The spectrometer operates in the frequency range from 30 GHz to 1.5 THz using highly monochromatic and coherent radiation which can be continuously tuned. For an accurate, fast and contact-less control of the probe-sample distance a confocal microscope is employed. We experimentally tested the diffraction theory of electromagnetic waves on sub-wavelength pinholes. Based on our findings we formulate requirements for near-field spectroscopy at THz-frequencies. Besides the possibility to make images at discrete frequencies, a new near-field modulation technique allows us to detect absorption spectra from strongly absorbing materials, which cannot be measured with normal transmission or reflection spectroscopy.
C1 Univ Stuttgart, Inst Phys 1, D-70550 Stuttgart, Germany.
RP Dressel, M (reprint author), Univ Stuttgart, Inst Phys 1, Pfaffenwaldring 57, D-70550 Stuttgart, Germany.
RI Dressel, Martin/D-3244-2012
OI Dressel, Martin/0000-0003-1907-052X
CR Bethe HA, 1944, PHYS REV, V66, P163, DOI 10.1103/PhysRev.66.163
   BOUWKAMP CJ, 1950, PHILIPS RES REP, V5, P321
   Dressel M., 2002, ELECTRODYNAMICS SOLI
   HU BB, 1995, OPT LETT, V20, P1716, DOI 10.1364/OL.20.001716
   LEVIATAN Y, 1986, J APPL PHYS, V60, P1577, DOI 10.1063/1.337294
   Mair S, 2004, APPL PHYS LETT, V84, P1219, DOI 10.1063/1.1647707
   Mair S, 2002, PHYS MED BIOL, V47, P3719, DOI 10.1088/0031-9155/47/21/307
   MITTLEMAN DM, 2002, SENSING TERAHERTZ RA
   ROBERTS A, 1987, J OPT SOC AM A, V4, P1970, DOI 10.1364/JOSAA.4.001970
   ROBERTS A, 1989, J APPL PHYS, V65, P2896, DOI 10.1063/1.342735
   Tiziani HJ, 2000, OPT ENG, V39, P32, DOI 10.1117/1.602332
NR 11
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8490-3
PY 2004
BP 95
EP 96
PG 2
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BBN34
UT WOS:000226274600020
DA 2018-10-20
ER

PT S
AU Zhou, YL
   Niinomi, M
   Akahori, T
AF Zhou, YL
   Niinomi, M
   Akahori, T
BE Kang, SG
   Kobayashi, T
TI Mechanical properties of binary Ti-Ta alloys for biomedical applications
SO DESIGNING, PROCESSING AND PROPERTIES OF ADVANCED ENGINEERING MATERIALS,
   PTS 1 AND 2
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Designing, Processing and Properties of
   Advanced Engineering Materials
CY NOV 05-08, 2003
CL Jeju, SOUTH KOREA
SP Mat Res Soc Korea, Japan Soc Promot Sci, Adv Engn Mat Comm
DE Young's modulus; microstructure; Ti-Ta alloy; solution treatment;
   mechanical property; biomedical implant materials
ID MARTENSITIC TRANSFORMATIONS; TITANIUM-ALLOYS; MO ALLOYS
AB The effect of Ta content on the mechanical properties of the quenched binary Ti-Ta alloys with different mass percentage of Ta from 10 to 80% was investigated in order to find a Ta content that gives a good balance of low modulus and high strength for biomedical applications. The mechanical properties of binary Ti-Ta alloys depend strongly on the microstructures caused by Ta content. Among all the studied Ti-Ta alloys, Ti-30 mass % Ta alloy with martensite alpha" and Ti-70 mass % Ta alloy with metastable beta phase have the potential to be the new candidates for biomedical applications.
C1 Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
RP Zhou, YL (reprint author), Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR [Anonymous], 1951, P PHYS SOC B
   BAGARIATSKII IA, 1959, TECH PHYS, P1014
   BYWATER KA, 1972, PHILOS MAG, V25, P1249, DOI 10.1080/14786437208223852
   DAVIS R, 1979, J MATER SCI, V14, P712
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Fedotov S G, 1986, PHYS MET METALLOGR, V62, P109
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Lin DJ, 2002, BIOMATERIALS, V23, P1723, DOI 10.1016/S0142-9612(01)00233-2
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   PETCH NJ, 1955, J IRON STEEL I
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   ZHOU YL, 2003, INT C ADV TECHN EXPT
NR 13
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-939-3
J9 MATER SCI FORUM
PY 2004
VL 449-4
BP 1089
EP 1092
DI 10.4028/www.scientific.net/MSF.449-452.1089
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BY90Q
UT WOS:000189492000269
DA 2018-10-20
ER

PT S
AU Sasov, A
AF Sasov, A
BE Bonse, U
TI X-ray nanotomography
SO DEVELOPMENTS IN X-RAY TOMOGRAPHY IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 4th Conference on Developments in X-Ray Tomography
CY AUG 04-06, 2004
CL Denver, CO
SP SPIE
DE tomography; microtomography; microCT; nanotomography; nanoCT; volumetric
   reconstruction; noninvasive imaging; three-dimensional visualization
AB A compact laboratory x-ray "nano-CT" scanner has been created for 3D non-invasive imaging with 150-200 nanometers 3D spatial resolution, using advanced x-ray technologies and specific physical phenomena for signal detection. This spatial resolution in volume terms is 3 orders better than can be achieved in synchrotron tomography, 5 orders better then in existing laboratory micro-CT instruments and 10-12 orders better in comparison to clinical CT. The instrument employs an x-ray source with a 300-400nm x-ray spot size and uses small-angle scattering to attain a detail detectability of 150-200nm. An object manipulator allows positioning and rotation with an accuracy of 150nm. The x-ray detector is based on an intensified CCD with single-photon sensitivity. A typical acquisition cycle for 3D reconstruction of the full object volume takes from 10 to 60 minutes, with the collection of several hundred angular views. Subsequent volumetric reconstruction produces results as a set of cross sections with isotropic voxel size down to 140 x 140 x 140nm, or as a 3D-model, which can be virtually manipulated and measured. This unique spatial resolution in non-invasive investigations gives previously unattainable 3D images in several application areas, such as composite materials, paper and wood microstructure, biomedical applications and others.
C1 SkyScan, B-2630 Aartselaar, Belgium.
RP Sasov, A (reprint author), SkyScan, Vluchtenburgstr 3, B-2630 Aartselaar, Belgium.
CR Feldkamp L. A., 1984, J OPT SOC AM, V1
   SASOV A, 2001, SPIE, V4503, P282
   YADA K, 1994, HIGH RESOLUTION PROJ
NR 3
TC 16
Z9 16
U1 1
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5473-7
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5535
BP 201
EP 211
DI 10.1117/12.559009
PG 11
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BBI73
UT WOS:000225665000021
DA 2018-10-20
ER

PT S
AU Kumar, D
   Cong, WX
   Bohenkamp, F
   Kakaday, T
   Taft, P
   Wang, LV
   McLennan, G
   Hoffman, EA
   Wang, G
AF Kumar, D
   Cong, WX
   Bohenkamp, F
   Kakaday, T
   Taft, P
   Wang, LV
   McLennan, G
   Hoffman, EA
   Wang, G
BE Bonse, U
TI Development of lung tissue phantoms for bioluminescent imaging
SO DEVELOPMENTS IN X-RAY TOMOGRAPHY IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 4th Conference on Developments in X-Ray Tomography
CY AUG 04-06, 2004
CL Denver, CO
SP SPIE
DE bioluminescence tomography (BLT); tissue phantom; optic fiber; light
   transmission; perturbation analysis
ID DIFFUSION
AB White nylon material was chosen to make cylindrical tissue phantoms for development of bioluminescence tomography techniques. A low-level light source, delivered through a optic fiber of core diameter 200mum, was placed at different locations on one phantom surface. The light travels through the phantom, reaches the external surface, and is captured by a liquid nitrogen-cooled CCD camera. The scattering, absorption, and anisotropy parameters of the phantom are obtained by matching the measured light transmission profiles to the profiles generated by the TracePro software. The perturbation analysis, with the homogeneous phantoms, demonstrated that the imaging system is sufficiently sensitive to capture intensity change of higher than 0.5nW/cm(2) or a location shift of the light source of more than 200microns. It is observed that the system can distinguish two point light sources with separation of about 2mm. The perturbation analysis is also performed with the heterogeneous phantom. Based on our data, we conclude that there is inherent tomographic information in bioluminescent measures taken on the external surface of the mouse, which suggests the feasibility of bioluminescence tomography for biomedical research using the small animals, especially the mice.
C1 Univ Iowa, Bioluminescence Tomog Lab, Dept Radiol, Iowa City, IA 52242 USA.
RP Wang, G (reprint author), Univ Iowa, Bioluminescence Tomog Lab, Dept Radiol, Iowa City, IA 52242 USA.
OI Hoffman, Eric/0000-0001-8456-9437
CR Budinger TF, 1999, ANNU REV BIOMED ENG, V1, P611, DOI 10.1146/annurev.bioeng.1.1.611
   CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354
   Cherry S R, 2004, PHYS MED BIOL, V49, P13
   Cubeddu R, 1997, PHYS MED BIOL, V42, P1971, DOI 10.1088/0031-9155/42/10/011
   KEIJZER M, 1988, APPL OPTICS, V27, P1820, DOI 10.1364/AO.27.001820
   Kumar D, 2003, IEEE T BIO-MED ENG, V50, P1012, DOI 10.1109/TBME.2003.814533
   Marquez G, 1999, PHYS MED BIOL, V44, P309, DOI 10.1088/0031-9155/44/1/022
   PRITHA R, 2003, CANCER RES, V63, P1160
   Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210
   SCHMITT JM, 1990, J OPT SOC AM A, V7, P2141, DOI 10.1364/JOSAA.7.002141
   Srinivasan R, 2003, IEEE T BIO-MED ENG, V50, P724, DOI 10.1109/TBME.2003.812188
   Tuchin V, 2000, TISSUE OPTICS LIGHT
   Welch A. J., 1995, OPTICAL THERMAL RESP
NR 13
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5473-7
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5535
BP 687
EP 693
DI 10.1117/12.560530
PG 7
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BBI73
UT WOS:000225665000071
DA 2018-10-20
ER

PT S
AU Choubey, A
   Dorner-Reisel, A
   Basu, B
AF Choubey, A
   Dorner-Reisel, A
   Basu, B
BE Mandal, H
   Ovecoglu, L
TI Friction and wear behaviour of DLC coated biomaterials in simulated body
   fluid solution at fretting contacts
SO EURO CERAMICS VIII, PTS 1-3
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 8th Conference of the European-Ceramic-Society
CY JUN 29-JUL 03, 2003
CL Istanbul, TURKEY
SP Turkish Ceram Soc, European Ceram Soc
DE DLC; CoCrMo; CVD; biomaterial; friction and wear
AB Considering the significance of wear on the materials performance in biomedical applications, the present research is carried out to understand the tribological behavior of CVD-DLC coated CoCrMo alloys under fretting contacts. The fretting experiments were carried out on uncoated and coated CoCrMo alloys against bearing steel under varying load for different test duration on a fretting (low amplitude reciprocatory tangential sliding) wear tester. The wear tests were performed in Hank's balanced salt solution to assess the performance in simulated body fluid (physiological) solution. Based on the microstructural characterization of the worn surfaces, the underlying wear mechanisms of the investigated wear couples are elucidated. The obtained research results clearly indicate the superior tribological performance of DLC coatings as compared to uncoated CoCrMo alloys.
C1 Tech Univ Bergakad Freiberg, Inst Ceram Mat, D-09596 Freiberg, Germany.
   Indian Inst Technol, Ceram Lab, Dept Mat & Met Engn, Kanpur 208016, Uttar Pradesh, India.
RP Choubey, A (reprint author), Tech Univ Bergakad Freiberg, Inst Ceram Mat, Gustav Zeuner Str 3, D-09596 Freiberg, Germany.
RI BASU, BIKRAMJIT/A-9967-2013
CR DORNERREISEL A, 2003, WERKST K LEHRST VERB
   DORNERREISEL A, UNPUB DIAM RELAT MAT
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KUMAR P, 1991, J BIOMED MATER RES, V25, P813, DOI 10.1002/jbm.820250703
NR 4
TC 3
Z9 3
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-946-6
J9 KEY ENG MAT
PY 2004
VL 264-268
BP 2115
EP 2118
DI 10.4028/www.scientific.net/KEM.264-268.2115
PN 1-3
PG 4
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Materials Science
GA BAO19
UT WOS:000223059700508
DA 2018-10-20
ER

PT J
AU Cox, M
   Pacala, JT
   Vercellotti, GM
   Shea, JA
AF Cox, M
   Pacala, JT
   Vercellotti, GM
   Shea, JA
TI Health care economics, financing, organization, and delivery
SO FAMILY MEDICINE
LA English
DT Article
ID MANAGED CARE; MEDICAL-EDUCATION; INSURANCE COVERAGE; PHYSICIANS; SYSTEM;
   ENVIRONMENT; COMPETENCES; STUDENTS; FACULTY; QUALITY
AB Background: The US health care system is in a state of rapid evolution, with changing payment, organizational, and management structures. To learn how to function optimally in a system in which care is increasingly managed and competitive, today's medical students must understand the structural and economic underpinnings of the system within which they will practice. At the outset of the Undergraduate Medical Education for the 21st Century (UME-21) project, the great majority of medical school curricula were lacking in areas of health care financing and organizational structure. The institutions involved in the UME-21 project sought to address curricular deficiencies in two broad areas: (1) the structure and financing of the US health care system ("health policy") and (2) the manner in which this system is reflected in the organization and activities of health care providers ("care delivery"). This article discusses the development, implementation, and evaluation of the first of the two areas. Methods: Data were abstracted from written reports provided by each of the UME-21 schools to the project's Executive Committee and sponsor In selected cases, additional data were obtained by personal communications with project directors and evaluators. Local UME-21 project leaders verified all data presented. Results: Curricular philosophy and teaching methods varied widely, but health policy curricula were predominantly preclinical and didactic in nature. At the school level, much was achieved in terms of student knowledge, curricula were generally well received by students, attitudes toward managed care generally moved in a positive direction, and behavior may have been positively influenced as well. At the project level, many potentially interesting changes exist within the 18 schools and between the UME-21 and other schools, but it is not clear whether or what parts of the health policy curricula were responsible for these changes. Nonetheless, as measured by changes in health policy-related items on the Association of American Medical Colleges Graduation Questionnaire, it appears that UME-21 schools outperformed their non-UME-21 counterparts. All of the UME-21 schools were enthusiastic about their health policy innovations, and this extended across all key stakeholders. Most schools avoided focusing on managed care and instead adopted more neutral themes that introduced the same material. Integrating the new material in conjunction with the more traditional aspects of the curriculum was also an effective implementation strategy. Conclusions: Health policy should be incorporated into both the preclinical and clinical years. The former emphasizes health care economics as one of the foundations of medical practice, whereas the latter provides the opportunity for its use on a daily basis in clinical settings. However, like any new curriculum, to achieve equal status with the traditional biomedical curriculum, it must be presented in a scholarly, rigorous, and reasonably comprehensive fashion. Mounting a scholarly health policy curriculum requires a wide-ranging, interdisciplinary faculty. If it is to become a central component of the medical school curriculum, creative approaches to faculty recruitment and development will be needed. This will require both careful educational policy formulation and new investment.
C1 Univ Penn, Off Evaluat, Philadelphia, PA 19104 USA.
   Univ Minnesota, Dept Family Practice & Community Med, Minneapolis, MN 55455 USA.
RP Cox, M (reprint author), Harvard Univ, Sch Med, 103 Gordon Hall,25 Shattuck St, Boston, MA 02115 USA.
EM malcolm_cox@hms.harvard.edu
CR Blumenthal D, 1996, JAMA-J AM MED ASSOC, V276, P725
   Blumenthal D, 1999, NEW ENGL J MED, V340, P1916, DOI 10.1056/NEJM199906173402412
   Bodenheimer T, 1999, NEW ENGL J MED, V340, P488, DOI 10.1056/NEJM199902113400621
   Campbell EG, 1997, JAMA-J AM MED ASSOC, V278, P222, DOI 10.1001/jama.278.3.222
   *CO7UNC GRAD MED E, 1999, 13 US DEP HLTH HUM S
   Committee On Quality Of Health Care In America and Medicine Institute O, 2001, CROSS QUAL CHASM NEW
   Commonwealth Fund Task Force on Academic Health Centers, 2002, TRAIN TOM DOCT MED E
   *COUNC GRAD MED ED, 1995, 6 US DEP HLTH HUM SE
   Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579
   Friedman E, 1997, ACAD MED, V72, P325, DOI 10.1097/00001888-199705000-00008
   GREENLICK MR, 1992, JAMA-J AM MED ASSOC, V267, P1645, DOI 10.1001/jama.267.12.1645
   Halpern R, 2001, ACAD MED, V76, P606, DOI 10.1097/00001888-200106000-00009
   Heffler S, 2002, HEALTH AFFAIR, V21, P207, DOI 10.1377/hlthaff.21.2.207
   IGLEHART JK, 1992, NEW ENGL J MED, V327, P742, DOI 10.1056/NEJM199209033271029
   Iglehart JK, 1999, NEW ENGL J MED, V340, P70, DOI 10.1056/NEJM199901073400122
   Kohn L.T., 1999, ERR IS HUMAN BUILDIN
   Kuttner R, 1999, NEW ENGL J MED, V341, P1092, DOI 10.1056/NEJM199909303411421
   Kuttner R, 1999, NEW ENGL J MED, V340, P163, DOI 10.1056/NEJM199901143400226
   Ludmerer Km., 1999, TIME HEAL AM MED ED
   Lurie N, 1996, ACAD MED, V71, P1044, DOI 10.1097/00001888-199610000-00009
   *MED STAT GROUP, 1998, 1998 MED STAT QUAL C
   Meyer GS, 1997, ACAD MED, V72, P669, DOI 10.1097/00001888-199708000-00010
   Moore G T, 1986, Health Aff (Millwood), V5, P147, DOI 10.1377/hlthaff.5.1.147
   PHILLIPS J, 2004, FAM MED S, V36
   Rabinowitz HK, 2001, ACAD MED, V76, P587, DOI 10.1097/00001888-200106000-00007
   Rivo ML, 2004, FAM MED, V36, pS63
   Schroeder SA, 2001, NEW ENGL J MED, V344, P847, DOI 10.1056/NEJM200103153441113
   Shea JA, 2004, FAM MED, V36, pS133
   Simon SR, 1999, NEW ENGL J MED, V340, P928, DOI 10.1056/NEJM199903253401206
   Smedley BD, 2002, UNEQUAL TREATMENT CO
   Veloski JJ, 2004, FAM MED, V36, pS138
   Wood DL, 1998, ACAD MED, V73, P1280, DOI 10.1097/00001888-199812000-00018
   Yedidia MJ, 2000, JAMA-J AM MED ASSOC, V284, P1093, DOI 10.1001/jama.284.9.1093
NR 33
TC 13
Z9 13
U1 0
U2 0
PU SOC TEACHERS FAMILY MEDICINE
PI LEAWOOD
PA 11400 TOMAHAWK CREEK PARKWAY, STE 540, LEAWOOD, KS 66207 USA
SN 0742-3225
J9 FAM MED
JI Fam. Med.
PD JAN
PY 2004
VL 36
SU S
BP S20
EP S30
PG 11
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA 775TB
UT WOS:000189075800004
PM 14961399
DA 2018-10-20
ER

PT J
AU Wallace, VP
   Taday, PF
   Fitzgerald, AJ
   Woodward, RM
   Cluff, J
   Pye, RJ
   Arnone, DD
AF Wallace, VP
   Taday, PF
   Fitzgerald, AJ
   Woodward, RM
   Cluff, J
   Pye, RJ
   Arnone, DD
TI Terahertz pulsed imaging and spectroscopy for biomedical and
   pharmaceutical applications
SO FARADAY DISCUSSIONS
LA English
DT Article
ID TIME-DOMAIN SPECTROSCOPY; BASAL-CELL CARCINOMA; IN-VIVO; RANITIDINE
   HYDROCHLORIDE; MAGNETIC-RESONANCE; RELAXATION-TIMES; LIQUID WATER;
   TISSUE; SKIN; GUIDELINES
AB Terahertz (THz) radiation lies between the infrared and microwave regions of the electromagnetic spectrum. Advances in THz technology have opened up many opportunities in this scientifically and technologically important spectroscopic region. The THz frequency range excites large amplitude vibrational modes of molecules as well as probing the weak interactions between them. Here we describe two techniques that utilize THz radiation, terahertz pulsed imaging (TPI) and terahertz pulsed spectroscopy (TPS). Both have a variety of possible applications in biomedical imaging and pharmaceutical science. TPI, a non-invasive imaging technique, has been used to image epithelial cancer ex vivo and recently in vivo. The diseased tissue showed a change in absorption compared to normal tissue, which was confirmed by histology. To understand the origins of the differences seen between diseased and normal tissue we have developed a TPS system. TPS has also been used to study solids of interest in the pharmaceutical industry. One particularly interesting example is ranitidine hydrochloride, which is used in treatment of stomach ulcers. Crystalline ranitidine has two polymorphic forms known as form 1 and form 2. These polymorphs have the same chemical formula but different crystalline structure that give rise to different physiochemical properties of the material. Using TPS it is possible to rapidly distinguish between the two polymorphic forms.
C1 TeraView Ltd, Cambridge CB4 0WG, England.
RP Wallace, VP (reprint author), TeraView Ltd, 302-304 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England.
RI Wallace, Vincent/A-9320-2012
OI Wallace, Vincent/0000-0003-3814-5400
CR American Cancer Society, 2001, CANC FACTS FIG
   Arnone DD, 1999, P SOC PHOTO-OPT INS, V3828, P209, DOI 10.1117/12.361037
   Backman V, 2000, NATURE, V406, P35
   Bawazir SA, 1998, INT J CLIN PHARM TH, V36, P270
   Berry E, 2003, J LASER APPL, V15, P192, DOI 10.2351/1.1585079
   CHEN JH, 1992, RADIOLOGY, V184, P427, DOI 10.1148/radiology.184.2.1620841
   Clothier RH, 2003, J BIOL PHYS, V29, P179, DOI 10.1023/A:1024492725782
   Cole BE, 2001, P SOC PHOTO-OPT INS, V4276, P1, DOI 10.1117/12.448865
   CROOKES DL, 1982, CHEM ABS, V97, P332
   HALEBLIAN J, 1969, J PHARM SCI-US, V58, P911, DOI 10.1002/jps.2600580802
   HOHNJEC M, 1986, ANAL PROFILES DRUG S, V15, P534
   Holme SA, 2000, BRIT J DERMATOL, V143, P1224, DOI 10.1046/j.1365-2133.2000.03892.x
   MADAN T, 1994, DRUG DEV IND PHARM, V20, P1571, DOI 10.3109/03639049409050198
   ROFSTAD EK, 1994, INT J RADIAT BIOL, V65, P387, DOI 10.1080/09553009414550451
   Ronne C, 2002, J MOL LIQ, V101, P199, DOI 10.1016/S0167-7322(02)00093-4
   ROSS KFA, 1982, J MICROSC-OXFORD, V128, P7, DOI 10.1111/j.1365-2818.1982.tb00433.x
   Shen J., 1995, NZ PHARM, V15, P24
   Shen YC, 2003, APPL PHYS LETT, V82, P2350, DOI 10.1063/1.1565680
   Shriner DL, 1998, J AM ACAD DERMATOL, V39, P79, DOI 10.1016/S0190-9622(98)70405-0
   Smye SW, 2001, PHYS MED BIOL, V46, pR101, DOI 10.1088/0031-9155/46/9/201
   Taday PF, 2003, J PHARM SCI, V92, P831, DOI 10.1002/jps.10358
   Telfer NR, 1999, BRIT J DERMATOL, V141, P415
   THRANE L, 1995, CHEM PHYS LETT, V240, P330, DOI 10.1016/0009-2614(95)00543-D
   VANEXTER M, 1990, IEEE T MICROW THEORY, V38, P1684, DOI 10.1109/22.60016
   Walther M, 2002, BIOPOLYMERS, V67, P310, DOI 10.1002/bip.10106
   WOLF DJ, 1987, ARCH DERMATOL, V123, P340, DOI 10.1001/archderm.123.3.340
   Woodward RM, 2002, P SOC PHOTO-OPT INS, V4625, P160, DOI 10.1117/12.469785
   Wu Q, 1997, APPL PHYS LETT, V71, P1285, DOI 10.1063/1.119873
   ZELSMANN HR, 1995, J MOL STRUCT, V350, P95, DOI 10.1016/0022-2860(94)08471-S
NR 29
TC 104
Z9 106
U1 2
U2 46
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1364-5498
J9 FARADAY DISCUSS
JI Faraday Discuss.
PY 2004
VL 126
BP 255
EP 263
DI 10.1039/b309357n
PG 9
WC Chemistry, Physical
SC Chemistry
GA 755HN
UT WOS:000187397600019
PM 14992411
DA 2018-10-20
ER

PT S
AU Holton, C
   Meissner, K
   Herz, E
   Kominsky, D
   Pickrell, G
AF Holton, C
   Meissner, K
   Herz, E
   Kominsky, D
   Pickrell, G
BE Durvasula, LN
TI Colloidal quantum dots entrained in micro-structured optical fibers
SO FIBER LASERS: TECHNOLOGY, SYSTEMS, AND APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Fiber Lasers
CY JAN 26-28, 2004
CL San Jose, CA
SP SPIE
DE fiber optics; quantum dots; photonic crystals; holey optical fibers;
   random hole optical fibers
ID NANOCRYSTALS; GROWTH; CDSE
AB We present the initial results of entraining colloidal quantum dots emitting at wavelengths from 0.5um through 1.2um, in various micro-structured optical fibers. Conventional and non-conventional, micro-structured optical fibers fabricated at Virginia Tech's Fiber & ElectroOptics Research Center (FEORC) have been combined with semiconductor, colloidal quantum dots fabricated by the VT Advanced Biomedical Center (VTabc). The results are presented primarily in the form of visual verification and analysis of entrainment phenomena, for a cross-section of colloidal dot and microstructured fiber forms. Unique optical, electro-optical and material properties resulting from the combinations are visibly suggested in the results. Core/clad/free space propagation properties and effects of emitted and absorbed light fields are observed to be dependent on the structure, aspect ratio and materials of the fibers as well as the properties of the colloidal quantum dots. Basic spectral data on representative free-space materials will be presented in the current paper. The presentation will explore in passing, the research options available to such quantum dot-fiber combinations, including advanced sensors, sources and filters.
C1 Virginia Tech, Fiber & Electroopt Res Ctr, Blacksburg, VA 24061 USA.
RP Holton, C (reprint author), Virginia Tech, Fiber & Electroopt Res Ctr, Blacksburg, VA 24061 USA.
CR BOL AAM, 2001, MATER RES SOC S P, V667, pG471
   BURT MG, 1999, Patent No. 5881200
   BWENDI MG, ADV MAT 2000, V12
   Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562
   JENSEN JB, CLEOS 2003
   KLIMOV VI, OPTICAL GAIN STIMULA
   KOMINSKY D, OPTICS LETT, V28, P1409
   Kubo T, 2002, J LUMIN, V99, P39, DOI 10.1016/S0022-2313(02)00296-X
   MI I, 1997, J PHYS CHEM B, V101, P4904
   MOTT A, OSA CLEOS BALTIMORE
   Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425
   Peng XG, 1997, J AM CHEM SOC, V119, P7019, DOI 10.1021/ja970754m
   Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m
   POITRAS CB, OSA CLEOS BALTIMORE
   Qu L., 2001, NANO LETT, V1
   SIEGEL RW, 1996, SCI AM           DEC, P74
   SPECKMAN DM, 2002, SPIE P, V4745
   TOWNSEND JE, 1987, ELECTRON LETT, V23, P329, DOI 10.1049/el:19870244
   TUOMOILLO T, 2003, PHOTON SPECTRA, P100
   WANY YS, 2003, APPL PHYS LETT, V82
   WISE F, 2002, SPIE NEWSROOM OEMAGA, P24
   Yoffe AD, 2001, ADV PHYS, V50, P1, DOI 10.1080/00018730010006608
NR 22
TC 4
Z9 4
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5243-2
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5335
BP 258
EP 265
DI 10.1117/12.538791
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA BAO16
UT WOS:000223058400032
DA 2018-10-20
ER

PT J
AU Rogers, J
AF Rogers, J.
TI The potential impact of increased access to primate genetic and genomic
   resources on evolutionary primatology and biomedical research
SO FOLIA PRIMATOLOGICA
LA English
DT Meeting Abstract
DE genetic resources; biological materials
C1 [Rogers, J.] SW Natl Primate Res Ctr, San Antonio, TX USA.
EM jrogers@darwin.sfbr.org
NR 0
TC 0
Z9 0
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0015-5713
J9 FOLIA PRIMATOL
JI Folia Primatol.
PY 2004
VL 75
SU 1
MA 295
BP 168
EP 169
PG 2
WC Zoology
SC Zoology
GA V50KS
UT WOS:000203407800294
DA 2018-10-20
ER

PT J
AU Corti, CW
   Holliday, RJ
AF Corti, CW
   Holliday, RJ
TI Commercial aspects of gold applications: From materials science to
   chemical science
SO GOLD BULLETIN
LA English
DT Article; Proceedings Paper
CT Gold 2003 Conference
CY SEP 28-OCT 01, 2003
CL Vancouver, CANADA
AB A major aim of the GOLD 2003 conference is to promote new gold related science and technology with a view to developing new useful industrial applications for gold. Current industrial uses have provided a steady annual demand for gold of around 350-400 tonnes in recent years, the bulk of which is centred on electronics applications, with dental uses constituting the second largest application. However, there is good reason to believe that whilst gold will continue to play a major role in these sectors in the future, substantial growth of demand is not anticipated. Increased industrial demand for gold is only likely to come through the emergence of new applications, probably most significantly in five broad market sectors:
   * Pollution and emission control technologies, including fuel cells.
   * New uses for gold in advanced electronics, electrical systems and devices.
   * Chemical processing of a range of bulk and speciality chemicals, using gold based catalysts.
   * Advanced coatings exploiting the novel properties of gold, particularly in nanoparticulate form.
   *New biomedical uses for gold including medical treatments, drugs, implants, sensors and devices.
   There is cause for optimism that many new applications for gold could emerge in these sectors over the next decade and that this will lead to a substantial growth in demand for gold. It is clear that many of these new opportunities will be based on a chemical approach to synthesis of useful products rather than what has historically been a materials or mechanical approach. To turn this expectation into reality requires sustained support of R & D and a determination to exploit this new science and technology into viable commercial applications.
C1 World Gold Council, London, England.
RP Corti, CW (reprint author), World Gold Council, London, England.
CR ANGLO AM, 1999, Patent No. 5895772
   [Anonymous], 2000, EP 1 043 059, Patent No. 1043059
   [Anonymous], 2001, US Patent, Patent No. 2001020105
   BAYER AG, 2001, Patent No. 200158887
   Cameron D, 2003, J POWER SOURCES, V118, P298, DOI 10.1016/S0378-7753(03)00074-0
   Goodman P, 2002, GOLD BULL, V35, P21, DOI 10.1007/BF03214833
   GRUNWALDT J, 2002, Patent No. 1209121
   Hao ZP, 2001, APPL CATAL B-ENVIRON, V33, P217, DOI 10.1016/S0926-3373(01)00172-2
   *I APPL CAT UK, LOC IN SIT GEN HYDR
   JONES A, 2002, Patent No. 02064500
   Kajikawa O., 1999, ORGANOHALOGEN COMPOU, V40, P581
   KNOSP H, 2003, GOLD BULL, V36, P59
   KOBAYASHI T, 2002, COMMUNICATION
   Konova P., 2002, BULG CHEM COMMUN, V34, P437
   Landon P, 2002, CHEM COMMUN, P2058, DOI 10.1039/b205248m
   MATSUSHITA ELECT IND, 2002, Patent No. 305001
   MITS HEAVY IND, 1990, Patent No. 2153801
   OMG AG, 2002, Patent No. 20030012719
   Thompson D., 2003, COMMUNICATION
   THOMPSON DT, 2002, 35 ANN IICIT CONN IN
   THOMPSON DT, 2002, AUT TRANSP TECHN C P
   2000, Patent No. 6086835
   2003, RE GEN MAGAZINE  APR
NR 23
TC 47
Z9 50
U1 0
U2 11
PU WORLD GOLD COUNCIL
PI LONDON
PA 55 OLD BROAD STREET, LONDON EC2M 1RX, ENGLAND
SN 0017-1557
J9 GOLD BULL
JI Gold Bull.
PY 2004
VL 37
IS 1-2
BP 20
EP 26
DI 10.1007/BF03215513
PG 7
WC Chemistry, Inorganic & Nuclear; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 863PE
UT WOS:000224573200004
OA Bronze
DA 2018-10-20
ER

PT S
AU Lichtenstein, N
   Schmidt, B
   Fily, A
   Weiss, S
   Arlt, S
   Pawlik, S
   Sverdlov, B
   Muller, J
   Harder, C
AF Lichtenstein, N
   Schmidt, B
   Fily, A
   Weiss, S
   Arlt, S
   Pawlik, S
   Sverdlov, B
   Muller, J
   Harder, C
BE Zadiker, MS
TI DPSSL and FL pumps based on 980nm-telecom pump laser technology:
   Changing the industry
SO HIGH-POWER DIODE LASER TECHNOLOGY AND APPLICATIONS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on High-Power Diode Laser Technology and Applications II
CY JAN 26-27, 2004
CL San Jose, CA
SP SPIE
DE semiconductor laser diodes; broad-area laser; laser bar; high-power;
   reliability; brightness; AuSn solder
AB Diode-pumped solid state laser (DPSSL) and fiber laser (FL) are believed to become the dominant systems of very high power lasers in the industrial environment. Today, ranging from 100 W to 5 - 10 kW in fight output power, their field of applications spread from biomedical and sensoring to material processing. Key driver for the wide spread of such systems is a competitive ratio of cost, performance and reliability. Enabling high power, highly reliable broad-area laser diodes and laser diode bars with excellent performance at the relevant wavelengths can further optimize this ratio. In this communication we present, that this can be achieved by leveraging the tremendous improvements in reliability and performance together with the high volume, low cost manufacturing areas established during the "telecom-bubble". From today's generations of 980-nm narrow-stripe laser diodes 1.8 W of maximum CW output power can be obtained fulfilling the stringent telecom reliability at operating condition. Single-emitter broad-area lasers deliver in excess of I I W CW while from similar 940-nm laser bars more than 160 W output power (CW) can be obtained at 200 A. In addition, introducing telecom-grade AuSn-solder mounting technology on expansion matched subassemblies enables excellent reliability performance. Degradation rates of less than 1% over 1000 h at 60 A are observed for both 808-nm and 940-nm laser bars even under harsh intermittent operation conditions.
C1 Bookham Switzerland AG, CH-8045 Zurich, Switzerland.
RP Lichtenstein, N (reprint author), Bookham Switzerland AG, Binzstr 17, CH-8045 Zurich, Switzerland.
CR LICHTENSTEIN N, 2003, OSA TRENDS OPTICS PH, V86, P396
   OOSENBRUG A, 1998, P SPIE SAN JOS CAL, P20
   Schmidt B, 2003, P SOC PHOTO-OPT INS, V5248, P42, DOI 10.1117/12.513292
   SCHMIDT B, 2002, OPTICAL FIBER TELECO
   SCHMIDT B, 2002, IEEE 2002 SEM LAS C, P159
NR 5
TC 16
Z9 16
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5244-0
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5336
BP 77
EP 83
DI 10.1117/12.558737
PG 7
WC Optics; Physics, Applied
SC Optics; Physics
GA BAJ83
UT WOS:000222604000012
DA 2018-10-20
ER

PT J
AU Vettel, EJ
AF Vettel, EJ
TI The protean nature of Stanford University's biological sciences,
   1946-1972
SO HISTORICAL STUDIES IN THE PHYSICAL AND BIOLOGICAL SCIENCES
LA English
DT Article
ID MOLECULAR-BIOLOGY; POLICY; FOUNDATION
AB Academic literature has paid scant attention to the biological sciences at Stanford University, an omission all the more conspicuous considering their productivity since World War II. This article draws on previously unused archival material to establish a starting point for further study of the biological sciences at Stanford. It traces the evolution of Stanford's biological sciences through three experimental fields: self-directed developmental and evolutionary studies; fundamental research at the molecular level; and biomedical applications of fundamental knowledge. Taken together, a history of Stanford's biological sciences offers a remarkably fertile example of organizational flexibility in historical context. This essay ends by suggesting that a fourth phase of biological research at Stanford will be governed by commercial interest in biology.
EM evettel@lib.berkeley.edu
CR ABIRAM P, 1982, SOC STUD SCI, V12, P341, DOI 10.1177/030631282012003001
   ALWAY D, 1961, JME, V36, P686
   [Anonymous], 1967, SAN JOSE MERCUR 0922
   APPEL T, 2000, SHAPING BIOL, P31
   BELANGER D, 1998, ENABLING AM INNOVATI, P47
   BONINE, 1963, STANFORD DAILY  0926
   BONINE, 1964, STANFORD DAILY  1204, P1
   BRONK DW, 1980, TECHNOL SOC, V2, P245, DOI 10.1016/0160-791X(80)90040-8
   Bud Robert, 1993, USES LIFE HIST BIOTE
   CAMPAIGNE D, 1997, THESIS INDIANA U
   CASSEDY JH, 1964, SCIENCE, V145, P897, DOI 10.1126/science.145.3635.897
   COMROE J, 1976, SCIENCE, V9, P105
   COMROE J, 1962, JME, V37, P381
   CRAIN R, 1969, POLITICS COMMUNAL CO
   Crenson Matthew A., 1987, NEW AM STAT BUREAUCR, P147
   DREW E, 1967, ATLANTIC, P81
   FUERST JA, 1984, SOC STUD SCI, V14, P225, DOI 10.1177/030631284014002003
   Greenberg Daniel S, 1999, POLITICS PURE SCI
   GROBSTEIN C, 1964, STANFORD DAILY  1116
   GROBSTEIN C, 1964, STANFORD DAILY  1114
   Hall S. S., 1987, INVISIBLE FRONTIERS
   HARDEN VA, 1986, INVENTING NIH
   HUGHES S, 1997, A KOMBERG BIOCH STAN, P18
   HUNTER, 1963, STANFORD DAILY  0416, P2
   JUDSON H, 1979, 8 DAY CREATION, P271
   KAY L, 1993, MOL VISIONS LIFE CAL, P206
   KORNBERG A, 1960, SCIENCE, V131, P1503, DOI 10.1126/science.131.3412.1503
   Kornberg A., 1989, LOVE ENZYMES
   LEDERBERG J, 1986, NATURE, V324, P627, DOI 10.1038/324627a0
   LEDERBERG J, 1967, SCIENCE, V20, P313
   Leslie Stuart W., 1993, COLD WAR AM SCI
   Lowen R., 1997, CREATING COLD WAR U
   MASKALL M, 1963, STANFORD DAILY  0531
   MORANGE M, 1998, HIST MOL BIOL, P231
   PATTERSON J, 1987, DREAD DIS CANC MODER, P201
   PHILLIPS D, 1985, STUDENT PROTEST, P166
   ROSSITER MW, 1985, OSIRIS, V1, P273, DOI 10.1086/368649
   SAXENIAN A, 1996, REGIONAL ADVANTAGE, P22
   SLOAN R, 2000, CONTROLLING OUR DEST, P19
   STRICKLAND S, 1972, STORY NIH GRANTS PRO, P2
   SWAIN DC, 1962, SCIENCE, V138, P1233, DOI 10.1126/science.138.3546.1233
   WERTZ B, 1965, STANFORD DAILY  1102, P1
   WERTZ B, 1965, STANFORD DAILY  1101
   WRIGHT S, 1986, OSIRIS, V2, P303, DOI 10.1086/368659
   1953, STANFORD DAILY  0703
   1958, STANFORD DAILY  0107
   1968, PENINSULA OBSER 1028, P10
   1964, STANFORD DAILY  0524, P1
   1958, STANFORD DAILY  1015
   1970, SAN JOSE MERCUR 1112
   1967, SAN FRANCISCO C 0504
   1964, STANFORD DAILY  1114, P1
   1959, STANFORD DAILY  1105
   1964, STANFORD DAILY  1114
   1967, STANFORD DAILY  0922
   1959, STANFORD DAILY  0402
   1960, STANFORD DAILY  0115
   1959, STANFORD DAILY  1029
   1964, STANFORD DAILY  0525, P4
   1959, STANFORD DAILY  1013
   1960, STANFORD DAILY  0406
   1963, STANFORD DAILY  0923
NR 62
TC 6
Z9 6
U1 0
U2 0
PU UNIV CALIF PRESS
PI BERKELEY
PA C/O JOURNALS DIVISION, 2000 CENTER ST, STE 303, BERKELEY, CA 94704-1223
   USA
SN 0890-9997
J9 HIST STUD PHYS BIOL
JI Hist. Stud. Phys. Biol. Sci.
PY 2004
VL 35
BP 95
EP 113
DI 10.1525/hsps.2004.35.1.95
PN 1
PG 19
WC History & Philosophy Of Science
SC History & Philosophy of Science
GA 892UV
UT WOS:000226676400004
DA 2018-10-20
ER

PT S
AU Yoon, YH
   Jung, ES
   Kang, HK
   Kim, MK
   Song, BS
   Cho, JH
AF Yoon, Young-Ho
   Jung, Eui-Sung
   Kang, Ho-Kyung
   Kim, Min-Kyu
   Song, Byung-Seop
   Cho, Jin-Ho
GP IEEE
TI Design of Implantable Wireless Biomedical Signals Telemetry System
SO IECON 2004: 30TH ANNUAL CONFERENCE OF IEEE INDUSTRIAL ELECTRONICS
   SOCIETY, VOL 3
SE IEEE Industrial Electronics Society
LA English
DT Proceedings Paper
CT 30th Annual Conference of the IEEE-Industrial-Electronics-Society
   (IECON)
CY NOV 02-06, 2004
CL Busan, SOUTH KOREA
SP IEEE Ind Elect Soc, IEEE
AB For the measurement of biomedical signals in the under body, a miniaturized implantable wireless telemetry system is implemented. This overall system consists of a charging system, an IR receiver, a multi-channel signal processor and a FM transmitter. All the parts are packed in the titanium case of which size is SO(L) x 27(W) x 7(H) mm. To control the implanted device at the external body and utilize the advantages of the simplification of circuit structure and the reduction of power consumption, an infrared wireless communication method has been adopted. The implements system uses a unique data protocol to prevent the interferences from other infrared remote control of the household appliances. The surface of the implanted device has been coated by biocompatible material to be implanted in the body. This system can be applied to measurements system of various kinds of bio-signals such as bio-electrical, bio-chemical and bio-mechanical signals, including EMG, ECG, insulin level, blood pressure signal etc..
C1 [Yoon, Young-Ho; Song, Byung-Seop; Cho, Jin-Ho] Kyungpook Natl Univ, Adv Res Ctr Recovery Human Sensibil, Taegu, South Korea.
RP Yoon, YH (reprint author), Kyungpook Natl Univ, Adv Res Ctr Recovery Human Sensibil, Taegu, South Korea.
EM uhii@palgong.knu.ac.kr; jhcho@ee.knu.ac.kr
CR Al-Imari A.A., 2003, SYST ON CHIP REAL TI, P352
   Beach RD, 1999, IEEE T INSTRUM MEAS, V48, P1239, DOI 10.1109/19.816143
   Cerussi AE, 2001, ACAD RADIOL, V8, P211, DOI 10.1016/S1076-6332(03)80529-9
   D Beach R, 1999, BIOENG C 1999 P IEEE, P115
   ISHIMARU A, 1978, WAVE PROPAGATION SCA, V1, P1
   Lim W. S., 2002, 2002 IEEE 33 ANN, V2, P579
   WELCH AJ, 1984, IEEE J QUANTUM ELECT, V20, P1471, DOI 10.1109/JQE.1984.1072339
NR 7
TC 2
Z9 3
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1553-572X
BN 978-0-7803-8730-0
J9 IEEE IND ELEC
PY 2004
BP 2982
EP 2986
PG 5
WC Engineering, Industrial
SC Engineering
GA BYK52
UT WOS:000299171300188
DA 2018-10-20
ER

PT B
AU Wu, X
   Ramahi, OM
AF Wu, X
   Ramahi, OM
GP IEEE
TI Near-field scanning microwave microscopy for detection of subsurface
   biological anomalies
SO IEEE ANTENNAS AND PROPAGATION SOCIETY SYMPOSIUM, VOLS 1-4 2004, DIGEST
LA English
DT Proceedings Paper
CT IEEE Antennas-and-Propagation-Society International Symposium
CY JUN 20-26, 2004
CL Monterey, CA
SP IEEE Antennas & Propatat Soc, Univ Calif, Lawrence Livermore Natl Lab, Northrop Grumman, ITT Ind, ANSOFT
AB In this paper, near-field non-destructive detection technique is proposed for biomedical applications. By using open-end microwave resonator, buried objects under skin, such as breast tumors, can be detected by measuring the resonant frequency shift, which results from the interaction of evanescent electromagnetic energy and buried objects. High spatial resolution can be reached since the technique is based on the near-field wave-material interaction, which is not limited by the diffraction limit of the far-field imaging.
C1 Univ Maryland, A James Clark Sch Engn, Dept Mech Engn, Dept Elect & Comp Engn, College Pk, MD 20742 USA.
RP Wu, X (reprint author), Univ Maryland, A James Clark Sch Engn, Dept Mech Engn, Dept Elect & Comp Engn, College Pk, MD 20742 USA.
CR Duewer F, 1999, APPL PHYS LETT, V74, P2696, DOI 10.1063/1.123940
   Gao C, 1997, APPL PHYS LETT, V71, P1872, DOI 10.1063/1.120444
   HALL FM, 1988, RADIOLOGY, V167, P353, DOI 10.1148/radiology.167.2.3282256
   Hong S, 2002, APPL PHYS LETT, V80, P524, DOI 10.1063/1.1435068
   Lann AF, 1998, APPL PHYS LETT, V73, P2832, DOI 10.1063/1.122605
   Pozar D. M., 1990, MICROWAVE ENG
   Sihvola A. H., 1999, ELECTROMAGNETIC MIXI
   Wang YG, 2001, APPL PHYS LETT, V78, P3872, DOI 10.1063/1.1377628
   Wei T, 1996, APPL PHYS LETT, V68, P3506, DOI 10.1063/1.115773
NR 9
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8302-8
PY 2004
BP 2444
EP 2447
DI 10.1109/APS.2004.1331867
PG 4
WC Telecommunications
SC Telecommunications
GA BAO41
UT WOS:000223066400615
DA 2018-10-20
ER

PT B
AU Hamsakutty, V
   Lonappan, A
   Jacob, J
   Bindu, G
   Thomas, V
   Kumar, AVP
   Mathew, KT
AF Hamsakutty, V
   Lonappan, A
   Jacob, J
   Bindu, G
   Thomas, V
   Kumar, AVP
   Mathew, KT
GP IEEE
TI Biomedical applications of sodium meta silicate gel as coupling medium
   for microwave medical imaging.
SO IEEE ANTENNAS AND PROPAGATION SOCIETY SYMPOSIUM, VOLS 1-4 2004, DIGEST
LA English
DT Proceedings Paper
CT IEEE Antennas-and-Propagation-Society International Symposium
CY JUN 20-26, 2004
CL Monterey, CA
SP IEEE Antennas & Propatat Soc, Univ Calif, Lawrence Livermore Natl Lab, Northrop Grumman, ITT Ind, ANSOFT
ID DIELECTRIC-PROPERTIES
AB A study on the dielectric properties of sodium meta silicate (SMS) gel at the S band of microwave frequencies is carried out using cavity perturbation technique. Dielectric parameters such as dielectric constant, dielectric loss and absorption coefficient of various SMS gel samples with different relative density (RD) and pH combinations are determined. It is observed that the dielectric constants between 8 and 20, which matches well with that of various biological tissues can be achieved. Dielectric loss and absorption coefficient are found to be less than the corresponding values for the conventional coupling media viz. water and saline. This material can find application as an efficient coupling medium and phantom model in microwave medical imaging.
C1 Cochin Univ Sci & Technol, Dept Elect, MTMR Lab, Cochin 682022, Kerala, India.
RP Hamsakutty, V (reprint author), Cochin Univ Sci & Technol, Dept Elect, MTMR Lab, Cochin 682022, Kerala, India.
CR Fear EC, 2002, IEEE MICROW MAG, V3, P48, DOI 10.1109/6668.990683
   Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002
   John A, 2002, B MATER SCI, V25, P141, DOI 10.1007/BF02706235
   KUMAR SB, 2001, J MICROWAVE POWER EE, V39, P67
   LEVENTON W, 2002, IEEE SPECTRUM   1228
   MATHEW KT, 2002, MATER CHEM PHYS, V79, P187
   Meaney PM, 2000, IEEE T MICROW THEORY, V48, P1841, DOI 10.1109/22.883861
   Paul I, 2002, MICROW OPT TECHN LET, V35, P297, DOI 10.1002/mop.10588
   Semenov SY, 2000, IEEE T MICROW THEORY, V48, P1071, DOI 10.1109/22.904748
   Sinha A, 2001, B MATER SCI, V24, P653, DOI 10.1007/BF02704016
NR 10
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8302-8
PY 2004
BP 2448
EP 2451
DI 10.1109/APS.2004.1331868
PG 4
WC Telecommunications
SC Telecommunications
GA BAO41
UT WOS:000223066400616
DA 2018-10-20
ER

PT J
AU Tang, SM
   Cheang, P
   AbuBakar, MS
   Khor, KA
   Liao, K
AF Tang, SM
   Cheang, P
   AbuBakar, MS
   Khor, KA
   Liao, K
TI Tension-tension fatigue behavior of hydroxyapatite reinforced
   polyetheretherketone composites
SO INTERNATIONAL JOURNAL OF FATIGUE
LA English
DT Article
DE hydroxyapatite; polyetheretherketone; tension-tension fatigue;
   filler-matrix debonding; matrix cracking
ID POLYETHYLENE COMPOSITE
AB Hydroxyapatite (HA) particle reinforced polyetheretherketone (PEEK) composites with 5, 10, 20, 30, and 40% (by volume) HA content were subjected to tension-tension fatigue under load-controlled mode. Results of quasi-static tensile tests indicated that the tensile stiffness of the HA/PEEK composites increases while their tensile strength decreases, with an increase in HA content, up to 40% (by volume). Stress-life (SN) and stiffness degradation data were obtained. The fact that all of the specimens survived cyclic load at 50% ultimate tensile strength (and below) and the high estimated fatigue strength at I million cycles suggest that HA/PEEK composite is a promising fatigue-resistant material for biomedical applications. Microscopic examination of cyclically loaded specimens revealed evidence of interfacial failure between the filler and the PEEK matrix, and subsequent initiation and propagation of micro cracks in the matrix that cause fatigue failure. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, Biomed Engn Res Ctr, Singapore 639798, Singapore.
RP Liao, K (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Liao, Kin/A-7915-2014; Khor, Khiam Aik
   (Michael)/B-6929-2009
OI Liao, Kin/0000-0001-6352-2349; KHOR, Khiam/0000-0003-1954-8423
CR Abu Bakar MS, 1999, J MATER PROCESS TECH, V90, P462
   Corvelli AA, 1999, J MATER SCI, V34, P2421, DOI 10.1023/A:1004562732460
   ECHTERMEYER AT, 1995, COMPOSITES, V26, P10
   Knepper M, 1997, BIOMATERIALS, V18, P1523, DOI 10.1016/S0142-9612(97)00066-5
   Liao K, 1999, INT J FATIGUE, V21, P485, DOI 10.1016/S0142-1123(98)00088-7
   LIAO K, 1993, ASTM STP, P42
   Reifsnider KL, 1991, FATIGUE COMPOSITE MA
   SARASUA JR, 1995, J MATER SCI, V30, P3501, DOI 10.1007/BF00349901
   Sim CP, 1997, J MATER PROCESS TECH, V69, P75, DOI 10.1016/S0924-0136(96)00044-1
   Tai NH, 1999, COMPOS PART B-ENG, V30, P849, DOI 10.1016/S1359-8368(99)00048-7
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   That PTT, 2000, J BIOMED MATER RES, V51, P453
   That PTT, 2000, J BIOMED MATER RES, V51, P461
   Ural E, 2000, BIOMATERIALS, V21, P2147, DOI 10.1016/S0142-9612(00)00098-3
NR 14
TC 52
Z9 53
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-1123
J9 INT J FATIGUE
JI Int. J. Fatigue
PD JAN
PY 2004
VL 26
IS 1
BP 49
EP 57
DI 10.1016/S0142-1123(03)00080-X
PG 9
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 747YX
UT WOS:000186835100005
DA 2018-10-20
ER

PT J
AU Fisher, A
   Goodall, P
   Hinds, MW
   Nelms, SN
   Penny, DM
AF Fisher, A
   Goodall, P
   Hinds, MW
   Nelms, SN
   Penny, DM
TI Atomic spectrometry update. Industrial analysis: metals, chemicals and
   advanced materials
SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
LA English
DT Review
ID PLASMA-MASS SPECTROMETRY; X-RAY-FLUORESCENCE; LASER-INDUCED BREAKDOWN;
   OPTICAL-EMISSION-SPECTROMETRY; CLOUD POINT EXTRACTION; LOW Z-ELEMENTS;
   HPLC-ICP-MS; POLYACRYLAMIDE-GEL ELECTROPHORESIS; SUPERCRITICAL
   CARBON-DIOXIDE; SELENIUM-CONTAINING PROTEINS
AB This atomic spectrometry update is the latest in an annual series under the title 'Industrial Analysis'. Again, the writing team has remained unchanged this year. Solid sampling techniques are still proving extremely popular for the industrial type samples because many of them are hard to dissolve/digest. As well as perennial favourites such as the X-ray techniques that, in general, are regarded as being non-sample destructive, laser ablation and glow discharge, which cause minimal sample loss, are also gaining ground. The use of LIBS is growing rapidly and it is appearing in application sectors where it had not previously. There has been a large increase of interest in the biomedical subject areas. Proteomics has had several applications featured, as has the detection of several drug/drug metabolites. Similarly, the interaction of drugs with compounds that are present naturally has also been studied. Even biocompatible ceramics for use in orthopaedic applications have been studied in this review period. The nuclear section is still dominated by the determination of depleted uranium. This topic looks as if it could run for a few years yet. As always, the glass section is split largely between archaeological determinations and forensic applications, although some new XRF instrumentation was also reported. In the semiconductor and conducting materials section, there has been an increase in the development and characterisation of solar cells.
C1 Univ Plymouth, Sch Earth Ocean & Environm Sci, Plymouth PL4 8AA, Devon, England.
   BNFL, Seascale CA20 1PG, Cumbria, England.
   Royal Canadian Mint, Ottawa, ON K1A 0G8, Canada.
   Thermo Elemental, Winsford CW7 3BX, Cheshire, England.
   Shell Res & Technol Ctr, Chester CH1 3SH, Cheshire, England.
RP Fisher, A (reprint author), Univ Plymouth, Sch Earth Ocean & Environm Sci, Drake Circus, Plymouth PL4 8AA, Devon, England.
OI Fisher, Andrew/0000-0003-4373-4904
CR Adebajo MO, 2004, SPECTROCHIM ACTA A, V60, P791, DOI 10.1016/S1386-1425(03)00302-0
   Aeschliman DB, 2003, J ANAL ATOM SPECTROM, V18, P872, DOI 10.1039/b205683f
   Aguera A, 2004, INT J ENVIRON AN CH, V84, P149, DOI 10.1080/03067310310001593729
   Altwaiq AM, 2003, ANAL CHIM ACTA, V491, P111, DOI 10.1016/S0003-2670(03)00785-2
   Amaro JAD, 2004, J ANAL ATOM SPECTROM, V19, P246, DOI 10.1039/b312168b
   An X, 2003, SPECTROCHIM ACTA B, V58, P689, DOI 10.1016/S0584-8547(02)00277-X
   Anderson DL, 2003, J AOAC INT, V86, P583
   Anthemidis AN, 2004, TALANTA, V62, P437, DOI 10.1016/j.talanta.2003.07.019
   Arai Y, 2003, ENVIRON SCI TECHNOL, V37, P4083, DOI 10.1021/es0340580
   Araujo MF, 2003, J PHYS IV, V104, P523, DOI 10.1051/jp4:20030137
   Asami K, 2003, CORROS SCI, V45, P2263, DOI 10.1016/S0010-938X(03)00047-7
   Balzano L, 2003, J MOL CATAL A-CHEM, V204, P737, DOI 10.1016/S1381-1169(03)00359-5
   Bancon-Montigny C, 2004, APPL ORGANOMET CHEM, V18, P57, DOI 10.1002/aoc.572
   Barba MF, 2003, J EUR CERAM SOC, V23, P2893, DOI 10.1016/S0955-2219(03)00300-5
   Barbotteau Y, 2004, NUCL INSTRUM METH B, V215, P214, DOI 10.1016/S0168-583X(03)01785-3
   Barbotteau Y, 2003, SURF INTERFACE ANAL, V35, P450, DOI 10.1002/sia.1559
   Barison S, 2004, RAPID COMMUN MASS SP, V18, P278, DOI [10.1002/rcm.1326, 10.1022/rcm.1326]
   Barison S, 2003, RAPID COMMUN MASS SP, V17, P996, DOI 10.1002/rcm.1014
   Barone G, 2003, J MOL STRUCT, V651, P449, DOI 10.1016/S0022-2860(02)00665-8
   Becker JS, 2004, J ANAL ATOM SPECTROM, V19, P149, DOI 10.1039/b311274h
   Becker JS, 2003, INT J MASS SPECTROM, V228, P127, DOI 10.1016/S1387-3806(03)00270-7
   Becker JS, 2003, SPECTROCHIM ACTA B, V58, P1757, DOI 10.1016/S0584-8547(03)00156-3
   Beckhoff B, 2003, SOL ST PHEN, V92, P165, DOI 10.4028/www.scientific.net/SSP.92.165
   BECKHOFF B, 2003, ULTRACLEAN PROCESSIN, V92, P89
   Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   Bendahl L, 2004, J ANAL ATOM SPECTROM, V19, P143, DOI 10.1039/b307474a
   Bengtson A, 2003, J ANAL ATOM SPECTROM, V18, P1066, DOI 10.1039/b302606j
   Berger G, 2003, KEY ENG MAT, V240-2, P607, DOI 10.4028/www.scientific.net/KEM.240-242.607
   Bernas A, 2003, APPL CATAL A-GEN, V245, P257, DOI 10.1016/S0926-860X(02)00646-4
   Bhat NV, 2004, TEXT RES J, V74, P155, DOI 10.1177/004051750407400212
   Binet MRB, 2003, ANAL BIOCHEM, V318, P30, DOI 10.1016/S0003-2697(03)00190-8
   Biron I, 2003, MEAS SCI TECHNOL, V14, P1564, DOI 10.1088/0957-0233/14/9/308
   Bjorn E, 2003, ANAL BIOANAL CHEM, V376, P274, DOI 10.1007/s00216-003-1874-5
   Bleiner D, 2003, J ANAL ATOM SPECTROM, V18, P1146, DOI 10.1039/b301907a
   Boehm E, 2003, SOLID STATE SCI, V5, P973, DOI 10.1016/S1293-2558(03)00091-8
   Boeykens S, 2003, SPECTROCHIM ACTA B, V58, P2169, DOI 10.1016/j.sab.2003.07.005
   Boeykens SP, 2004, CARBOHYD POLYM, V55, P129, DOI 10.1016/jcarbpol.2003.08.019
   Boman C, 2004, ENERG FUEL, V18, P338, DOI 10.1021/ef034028i
   Bormashenko E, 2003, SYNTHETIC MET, V139, P321, DOI 10.1016/S0379-6779(03)00182-6
   Boulyga SF, 2004, ANAL BIOANAL CHEM, V378, P342, DOI 10.1007/s00216-003-2193-6
   Bouvier-Capely C, 2003, HEALTH PHYS, V85, P216, DOI 10.1097/00004032-200308000-00011
   Bu XD, 2003, J ANAL ATOM SPECTROM, V18, P1443, DOI 10.1039/b306570g
   Bungener R, 2003, MAT SCI SEMICON PROC, V6, P43, DOI 10.1016/S1369-8001(03)00070-2
   Buonassisi T, 2003, PHYSICA B, V340, P1137, DOI 10.1016/j.physb.2003.09.099
   Camerani MC, 2004, ANAL CHEM, V76, P1586, DOI 10.1021/ac030282w
   Capelo JL, 2004, ANAL CHEM, V76, P233, DOI 10.1021/ac034871d
   Casellato U, 2003, J CULT HERIT, V4, P337, DOI 10.1016/j.culher.2003.06.003
   Cesareo R, 2004, NUCL INSTRUM METH B, V213, P703, DOI 10.1016/S0168-583X(03)01758-0
   Chang MJ, 2003, SPECTROCHIM ACTA B, V58, P1979, DOI 10.1016/j.sab.2003.09.001
   Chassaigne H, 2004, J ANAL ATOM SPECTROM, V19, P85, DOI 10.1039/b30703111
   Chen CW, 2003, STUD SURF SCI CATAL, V146, P617
   Chen SY, 2003, SPECTROSC SPECT ANAL, V23, P1185
   Chery CC, 2003, ELECTROPHORESIS, V24, P3305, DOI 10.1002/elps.200305590
   Cleere CP, 2004, KEY ENG MAT, V254-2, P585, DOI 10.4028/www.scientific.net/KEM.254-256.585
   Colomban P, 2004, ARCHAEOMETRY, V46, P125, DOI 10.1111/j.1475-4754.2004.00148.x
   Coustures MP, 2003, ARCHAEOMETRY, V45, P599, DOI 10.1046/j.1475-4754.2003.00131.x
   Cravetchi IV, 2003, APPL OPTICS, V42, P6138, DOI 10.1364/AO.42.006138
   D'Santhoshini BA, 2003, J PHYS-CONDENS MAT, V15, P4903, DOI 10.1088/0953-8984/15/29/302
   DAMM CJ, 2003, P COMBUST INST, V29, P2767
   Daolio S, 2004, APPL SURF SCI, V222, P166, DOI 10.1016/j.apsusc.2003-08.005
   Datta A, 2003, ORGANOMETALLICS, V22, P4685, DOI 10.1021/om0303754
   Davis WC, 2003, ANAL CHEM, V75, P2243, DOI 10.1021/ac020673v
   De Clercq B, 2003, APPL CATAL A-GEN, V247, P345, DOI 10.1016/S0926-860X(03)00126-1
   Deschamps P, 2003, CHEM GEOL, V201, P141, DOI 10.1016/S0009-2541(03)00226-2
   Dietz C, 2004, J ANAL ATOM SPECTROM, V19, P260, DOI 10.1039/b308544a
   Dogan O, 2003, X-RAY SPECTROM, V32, P363, DOI 10.1002/xrs.652
   Encinar JR, 2003, ANAL CHEM, V75, P3765, DOI 10.1021/ac034103m
   Epov VN, 2003, J RADIOANAL NUCL CH, V258, P473, DOI 10.1023/B:JRNC.0000011740.95950.d9
   Escoda L, 2003, BOL SOC ESP CERAM V, V42, P85, DOI 10.3989/cyv.2003.v42.i2.645
   Falcone R, 2002, ARCHAEOMETRY, V44, P531, DOI 10.1111/1475-4754.00084
   Farmer DE, 2003, HEALTH PHYS, V85, P457, DOI 10.1097/00004032-200310000-00009
   Fehr MA, 2004, INT J MASS SPECTROM, V232, P83, DOI 10.1016/j.ijms.2003.11.006
   Feliu MJ, 2004, ANAL CHIM ACTA, V502, P241, DOI 10.1016/j.aca.2003.10.023
   Feo JC, 2003, ANAL SCI, V19, P1631, DOI 10.2116/analsci.19.1631
   Ferrero JL, 2004, NUCL INSTRUM METH B, V213, P729, DOI 10.1016/S0168-583X(03)01694-X
   Funke HH, 2003, REV SCI INSTRUM, V74, P3909, DOI 10.1063/1.1597939
   Gaber AAA, 2003, ANAL LETT, V36, P2585
   Gammer K, 2003, ANAL BIOANAL CHEM, V376, P255, DOI 10.1007/s00216-003-1851-z
   Gao YX, 2003, ANAL CHIM ACTA, V485, P131, DOI 10.1016/S0003-2670(03)00347-7
   Garcia CC, 2003, J ANAL ATOM SPECTROM, V18, P779, DOI 10.1039/b300347g
   Garrigos JBI, 2003, ARCHAEOMETRY, V45, P1
   Gawdzik B, 2003, APPL SURF SCI, V214, P52, DOI 10.1016/S0169-4332(03)00353-2
   Geckeis H, 2003, COLLOID SURFACE A, V217, P101, DOI 10.1016/S0927-7757(02)00564-2
   Gikunju CM, 2004, TALANTA, V62, P741, DOI 10.1016/j.talanta.2003.09.012
   Giokas DL, 2004, ANAL CHIM ACTA, V505, P51, DOI 10.1016/S0003-2670(03)00175-2
   GODLEWSKAZYLKIEWIC, 2003, MICROCHIM ACTA, V143, P13
   Goetheer ELV, 2003, J CATAL, V219, P126, DOI 10.1016/S0021-9517(03)00155-6
   Goltz D, 2003, SPECTROCHIM ACTA B, V58, P1325, DOI 10.1016/S0584-8547(03)00070-3
   Gonzalez RF, 2004, BUILD ENVIRON, V39, P357, DOI 10.1016/j.buildenv.2003.09.012
   Gopikrishna P, 2004, MICROCHIM ACTA, V144, P285, DOI 10.1007/s00604-003-0105-2
   Gornushkin IB, 2003, APPL SPECTROSC, V57, P197, DOI 10.1366/000370203321535123
   Govaert F, 2004, FORENSIC SCI INT, V140, P61, DOI 10.1016/j.forsciint.2003.11.015
   Graham MJ, 2003, CORROSION, V59, P475, DOI 10.5006/1.3277578
   Grams J, 2004, SURF SCI, V549, pL21, DOI 10.1016/j.susc.2003.10.043
   Grotti M, 2003, J ANAL ATOM SPECTROM, V18, P1192, DOI 10.1039/b304215d
   Guchardi R, 2004, ANALYST, V129, P347, DOI 10.1039/b315773c
   Gunther-Leopold I, 2004, ANAL BIOANAL CHEM, V378, P241, DOI 10.1007/s00216-003-2226-1
   Gwiazda RH, 2004, HEALTH PHYS, V86, P12, DOI 10.1097/00004032-200401000-00004
   Haberecht J, 2004, CHEM MATER, V16, P418, DOI 10.1021/cm034832i
   Hagrman D, 2004, J PHARMACOL EXP THER, V308, P658, DOI 10.1124/jpet.103.059410
   Hagrman D, 2003, DRUG METAB DISPOS, V31, P916, DOI 10.1124/dmd.31.7.916
   Hall GS, 2003, J ANAL ATOM SPECTROM, V18, P775, DOI 10.1039/b300597f
   Haneda H, 2003, J CERAM SOC JPN, V111, P439, DOI 10.2109/jcersj.111.439
   Hankare PP, 2004, SEMICOND SCI TECH, V19, P277, DOI 10.1088/0268-1242/19/2/027
   Hankare PP, 2003, MATER CHEM PHYS, V82, P711, DOI 10.1016/S0254-0584(03)00365-1
   Hann S, 2004, J ANAL ATOM SPECTROM, V19, P74, DOI 10.1039/b310650k
   Hann S, 2003, J ANAL ATOM SPECTROM, V18, P1391, DOI 10.1039/b309028k
   Haraguchi H, 2004, J ANAL ATOM SPECTROM, V19, P5, DOI 10.1039/b308213j
   Herz K, 2003, THIN SOLID FILMS, V431, P392, DOI 10.1016/S0040-6090(03)00259-1
   Hobbs AL, 2003, ANAL BIOANAL CHEM, V376, P1265, DOI 10.1007/s00216-003-1918-x
   Hochleitner B, 2003, SPECTROCHIM ACTA B, V58, P641, DOI 10.1016/S0584-8547(02)00280-X
   Hofmann S, 2004, PHILOS T R SOC A, V362, P55, DOI 10.1098/rsta.2003.1304
   Hosseini SH, 2003, J APPL POLYM SCI, V90, P40, DOI 10.1002/app.12483
   Hosseini SH, 2003, J APPL POLYM SCI, V90, P49, DOI [10.1002/app.12492, 10.1002/app/.12492]
   Hou YL, 2004, EUR J INORG CHEM, P1169, DOI 10.1002/ejic.200300779
   Hu J, 2003, J APPL POLYM SCI, V89, P1124, DOI 10.1002/app.12298
   Hurtgen C, 2003, RADIAT PROT DOSIM, V105, P375, DOI 10.1093/oxfordjournals.rpd.a006261
   Infante HG, 2003, ANALYST, V128, P651, DOI 10.1039/b212889f
   Itoh Y, 2003, J CERAM SOC JPN, V111, P815, DOI 10.2109/jcersj.111.815
   Iwasa N, 2003, TOP CATAL, V22, P215, DOI 10.1023/A:1023571819211
   Izmer AV, 2003, J ANAL ATOM SPECTROM, V18, P1339, DOI 10.1039/b306446h
   Jakubowski N, 2004, J ANAL ATOM SPECTROM, V19, P1, DOI 10.1039/b313299b
   Jensen BP, 2004, RAPID COMMUN MASS SP, V18, P181, DOI 10.1002/rcm.1312
   Jensen BP, 2003, J ANAL ATOM SPECTROM, V18, P891, DOI 10.1039/b304651f
   Jiang CJ, 2003, APPL CATAL A-GEN, V256, P203, DOI 10.1016/S0926-860X(03)00400-9
   Jiang CJ, 2004, MATER RES BULL, V39, P251, DOI 10.1016/j.materresbull.2003.09.033
   Jiang LY, 2004, J APPL POLYM SCI, V92, P1422, DOI 10.1002/app.13676
   Jiricka A, 2003, GLASS SCI TECHNOL, V76, P298
   Jones JM, 2003, CATAL TODAY, V81, P589, DOI 10.1016/S0920-5861(03)00157-3
   Junk SA, 2003, ARCHAEOMETRY, V45, P313, DOI 10.1111/1475-4754.00110
   Jurado-Lopez A, 2003, SPECTROCHIM ACTA B, V58, P1291, DOI 10.1016/S0584-8547(03)00052-1
   Kahen K, 2003, SPECTROCHIM ACTA B, V58, P397, DOI 10.1016/S0584-8547(02)00261-6
   Kannamkumarath SS, 2004, J ANAL ATOM SPECTROM, V19, P107, DOI 10.1039/b307970h
   Karami H, 2004, ANAL CHIM ACTA, V509, P89, DOI 10.1016/j.aca.2003.12.022
   Karasev AV, 2004, ISIJ INT, V44, P356, DOI 10.2355/isijinternational.44.356
   Karasev AV, 2004, ISIJ INT, V44, P364, DOI 10.2355/isijinternational.44.364
   Kasik M, 2003, J ANAL ATOM SPECTROM, V18, P603, DOI 10.1039/b300025g
   Kawabata K, 2003, ATOM SPECTROSC, V24, P66
   Kelly WR, 2003, ANAL BIOANAL CHEM, V376, P753, DOI 10.1007/s00216-003-1952-8
   Kennett DJ, 2004, ARCHAEOMETRY, V46, P35, DOI 10.1111/j.1475-4754.2004.00142.x
   Ketterer ME, 2003, J ENVIRON RADIOACTIV, V67, P191, DOI 10.1016/S0265-931X(02)00186-8
   Khalil MS, 2003, MAT SCI ENG A-STRUCT, V352, P64, DOI 10.1016/S0921-5093(02)00557-9
   Khan AA, 2004, ANAL CHIM ACTA, V504, P253, DOI 10.1016/j.aca.2003.10.054
   Kilo M, 2003, J APPL PHYS, V94, P7547, DOI 10.1063/1.1628379
   Kladis C, 2003, J MOL CATAL A-CHEM, V203, P193, DOI 10.1016/S1381-1169(03)00262-0
   Koch J, 2004, SPECTROCHIM ACTA B, V59, P199, DOI 10.1016/j.sab.2003.12.005
   Koklic B, 2003, ACCREDIT QUAL ASSUR, V8, P146, DOI 10.1007/s00769-003-0584-1
   Kondo H, 2003, TETSU TO HAGANE, V89, P1000, DOI 10.2355/tetsutohagane1955.89.9_1000
   Kralj P, 2003, ACTA CHIM SLOV, V50, P633
   Kraushaar M, 2003, APPL SPECTROSC, V57, P1282, DOI 10.1366/000370203769699171
   Krupp EM, 2004, ANAL BIOANAL CHEM, V378, P250, DOI 10.1007/s00216-003-2328-9
   Kuczewski B, 2003, ANAL CHEM, V75, P6769, DOI 10.1021/ac0347213
   Kumar A, 2003, TRANSIT METAL CHEM, V28, P913, DOI 10.1023/A:1026334921387
   Kuzuya M, 2003, SPECTROCHIM ACTA B, V58, P957, DOI 10.1016/S0584-8547(03)00011-9
   Lantz L, 2003, IEEE T COMPON PACK T, V26, P199, DOI 10.1109/TCAPT.2002.806183
   Lebiedz D, 2003, J ALLOY COMPD, V356, P679, DOI 10.1016/S0925-8388(03)00288-3
   Lee KS, 2004, ENVIRON ENG SCI, V21, P11, DOI 10.1089/109287504322746703
   Leung PL, 2003, SCI CHINA SER B, V46, P465
   Li BP, 2003, CHINESE SCI BULL, V48, P1219, DOI 10.1360/02wb0121
   Li BT, 2003, ENERG FUEL, V17, P810, DOI 10.1021/ef0202440
   Li J, 2003, ATOM SPECTROSC, V24, P169
   Li J, 2003, SEMICOND SCI TECH, V18, P611, DOI 10.1088/0268-1242/18/7/302
   Li L, 2003, ANAL CHEM, V75, P3953, DOI 10.1021/ac034567k
   Li QC, 2003, MICROPOR MESOPOR MAT, V59, P105, DOI 10.1016/S1387-1811(03)00290-7
   Li SX, 2003, J PHARMACEUT BIOMED, V32, P51, DOI 10.1016/S0731-7085(03)00024-4
   Li WD, 2003, CERAM INT, V29, P933, DOI 10.1016/S0272-8842(03)00048-8
   Liang L, 2003, J ANAL ATOM SPECTROM, V18, P1383, DOI 10.1039/b306603g
   Lima MV, 2003, J PHYS IV, V107, P777, DOI 10.1051/jp4:20030416
   Link DD, 2003, ENERG FUEL, V17, P1292, DOI 10.1021/ef0300747
   Linke R, 2003, X-RAY SPECTROM, V32, P373, DOI 10.1002/xrs.654
   Liou TH, 2003, J HAZARD MATER, V103, P107, DOI 10.1016/S0304-3894(03)00244-9
   Liu R, 2004, SURF INTERFACE ANAL, V36, P172, DOI 10.1002/sia.1668
   Loebe K, 2003, APPL OPTICS, V42, P6166, DOI 10.1364/AO.42.006166
   Lombaert K, 2004, PLASMA CHEM PLASMA P, V24, P41, DOI 10.1023/B:PCPP.0000004881.17458.0d
   Lu LM, 2003, ISIJ INT, V43, P1940, DOI 10.2355/isijinternational.43.1940
   Maichin B, 2003, ANAL BIOANAL CHEM, V376, P715, DOI 10.1007/s00216-003-1962-6
   Mandal R, 2003, APPL ORGANOMET CHEM, V17, P675, DOI 10.1002/aoc.502
   Mandal R, 2003, ANALYST, V128, P629, DOI 10.1039/b212797k
   Mantler M, 2004, POWDER DIFFR, V19, P16, DOI 10.1154/1.1649962
   Manzoori JL, 2003, ANAL CHIM ACTA, V484, P155, DOI 10.1016/S0003-2670(03)00343-X
   Marcon J, 2003, J CRYST GROWTH, V253, P174, DOI 10.1016/S0022-0248(03)01096-0
   Maret W, 2004, J ANAL ATOM SPECTROM, V19, P15, DOI 10.1039/b307540k
   Margetic V, 2003, ANAL CHEM, V75, P3435, DOI 10.1021/ac020791i
   Mastalir A, 2003, J CATAL, V220, P372, DOI 10.1016/S0021-9517(03)00269-0
   Mateo MP, 2003, APPL SPECTROSC, V57, P1461, DOI 10.1366/000370203322640080
   Matusiewicz H, 2003, J ANAL ATOM SPECTROM, V18, P1415, DOI 10.1039/b309359j
   Matzui LY, 2003, INORG MATER+, V39, P1147, DOI 10.1023/A:1027345408360
   Mbhele ZH, 2003, CHEM MATER, V15, P5019, DOI 10.1021/cm034505a
   Menut D, 2003, APPL OPTICS, V42, P6063, DOI 10.1364/AO.42.006063
   Merabet A, 2003, MAT SCI ENG B-SOLID, V102, P257, DOI 10.1016/S0921-5107(02)00742-0
   Milazzo M, 2004, NUCL INSTRUM METH B, V213, P683, DOI 10.1016/S0168-583X(03)01686-0
   MILL T, 1980, COMPREHENSIVE CHEM K, V1, P1
   Min BK, 2003, CATAL TODAY, V85, P113, DOI 10.1016/S0920-5861(03)00380-8
   Minami H, 2004, ANAL SCI, V20, P455, DOI 10.2116/analsci.20.455
   Montero S, 2003, J FORENSIC SCI, V48, P1101
   Morales R, 2003, J MOL CATAL A-CHEM, V203, P277, DOI 10.1016/S1381-1169(03)00367-4
   Mori Y, 2003, SPECTROCHIM ACTA B, V58, P2085, DOI 10.1016/S0584-8547(03)00212-X
   Mosbaek H, 2003, J ANAL ATOM SPECTROM, V18, P1489, DOI 10.1039/b310142h
   Mosca R, 2003, J APPL PHYS, V93, P9709, DOI 10.1063/1.1572192
   Muller K, 2003, ARCHAEOMETRY, V45, P421, DOI 10.1111/1475-4754.00119
   Nakamoto Y, 2003, BUNSEKI KAGAKU, V52, P513, DOI 10.2116/bunsekikagaku.52.513
   Nakano K, 2003, X-RAY SPECTROM, V32, P452, DOI 10.1002/xrs.675
   Nan J, 2003, J ANAL ATOM SPECTROM, V18, P946, DOI 10.1039/b304552h
   Nerin C, 2003, FOOD ADDIT CONTAM, V20, P668, DOI 10.1080/0265203031000109503
   Nieminen V, 2003, MICROPOR MESOPOR MAT, V60, P159, DOI 10.1016/S1387-1811(03)00337-8
   Nishiwaki S, 2003, THIN SOLID FILMS, V431, P296, DOI 10.1016/S0040-6090(03)00147-0
   Niwa T, 2003, IEEE T APPL SUPERCON, V13, P2747, DOI 10.1109/TASC.2003.811987
   Nygren U, 2003, J ANAL ATOM SPECTROM, V18, P1426, DOI 10.1039/b306357g
   Oriani MRD, 2003, WORLD J MICROB BIOT, V19, P625, DOI 10.1023/A:1025119902239
   Ostermann M, 2003, ANAL BIOANAL CHEM, V377, P779, DOI 10.1007/s00216-003-2127-3
   Otero-Rey JR, 2003, ENVIRON SCI TECHNOL, V37, P5262, DOI 10.1021/es020949g
   Padeletti G, 2003, APPL PHYS A-MATER, V77, P125, DOI 10.1007/s00339-002-2048-6
   Padovani S, 2003, J APPL PHYS, V93, P10058, DOI 10.1063/1.1571965
   Pahlke S, 2003, SPECTROCHIM ACTA B, V58, P2025, DOI 10.1016/S0584-8547(03)00193-9
   Palanco S, 2003, J ANAL ATOM SPECTROM, V18, P933, DOI 10.1039/b303248e
   Papadopoulou DN, 2004, ANAL CHIM ACTA, V505, P173, DOI 10.1016/S0003-2670(03)00357-X
   Pappalardo L, 2003, ARCHAEOMETRY, V45, P333, DOI 10.1111/1475-4754.00111
   Pappas RS, 2003, J ANAL ATOM SPECTROM, V18, P1289, DOI 10.1039/b305515a
   Park DP, 2003, MATER RES INNOV, V7, P161, DOI 10.1007/s10019-003-0242-6
   Paryjczak T, 2003, PRZEM CHEM, V82, P199
   Paunesku T, 2003, J PHYS IV, V104, P317, DOI 10.1051/jp4:200300089
   Pelaez MV, 2003, J ANAL ATOM SPECTROM, V18, P864, DOI 10.1039/b305070j
   Pergher SBC, 2004, J MOL CATAL A-CHEM, V209, P107, DOI 10.1016/j.molcata.2003.08.005
   Peter L, 2003, APPL OPTICS, V42, P6199, DOI 10.1364/AO.42.006199
   Phillips DN, 2003, BRIT CERAM T, V102, P257, DOI 10.1179/096797803225005025
   Pibida L, 2004, APPL RADIAT ISOTOPES, V60, P567, DOI 10.1016/j.apradiso.2003.11.082
   Pintar A, 2004, APPL CATAL B-ENVIRON, V47, P143, DOI 10.1016/j.apcatb.2003.08.005
   Piticescu RM, 2004, J EUR CERAM SOC, V24, P931, DOI 10.1016/S0955-2219(03)00545-4
   Polatajko A, 2004, J ANAL ATOM SPECTROM, V19, P114, DOI 10.1039/b308756p
   Ponting M, 2003, ARCHAEOMETRY, V45, P591, DOI 10.1046/j.1475-4754.2003.00130.x
   Potgieter SS, 2003, CEMENT CONCRETE RES, V33, P1589, DOI 10.1016/S0008-8846(03)00132-7
   Premaratne K, 2004, RENEW ENERG, V29, P549, DOI 10.1016/j.renene.2003.08.002
   Profrock D, 2003, ANAL BIOANAL CHEM, V377, P132, DOI 10.1007/s00216-003-2041-8
   Profrock D, 2003, SPECTROCHIM ACTA B, V58, P1403, DOI 10.1016/S0584-8547(03)00088-0
   Qi HP, 2003, CHEM GEOL, V199, P183, DOI 10.1016/S0009-2541(03)00075-5
   Qiu Y, 2003, J AM CERAM SOC, V86, P1214, DOI 10.1111/j.1151-2916.2003.tb03452.x
   Radivojevic I, 2004, ANAL CHEM, V76, P1648, DOI 10.1021/ac0351365
   Rathossi C, 2004, APPL CLAY SCI, V24, P313, DOI 10.1016/j.clay.2003.07.008
   Resano M, 2003, J ANAL ATOM SPECTROM, V18, P1238, DOI 10.1039/b303462n
   Resano M, 2003, J ANAL ATOM SPECTROM, V18, P1477, DOI 10.1039/b308958d
   Richter S, 2003, INT J MASS SPECTROM, V229, P181, DOI [10.1016/S1387-3806(03)00338-5, 10.1016/S1387-3806(03)000338-5]
   Rindby A, 2003, X-RAY SPECTROM, V32, P248, DOI 10.1002/xrs.647
   Roldan C, 2004, X-RAY SPECTROM, V33, P28, DOI 10.1002/xrs.673
   Ryshchenko MI, 2003, GLASS CERAM+, V60, P168, DOI 10.1023/A:1025769102945
   Sakae T, 2003, KEY ENG MAT, V240-2, P395, DOI 10.4028/www.scientific.net/KEM.240-242.395
   Scheidegger AM, 2003, J PHYS IV, V104, P417, DOI 10.1051/jp4:20030112
   Schreiner M, 2004, POWDER DIFFR, V19, P3, DOI 10.1154/1.1649963
   Schubert US, 2003, MACROMOL MATER ENG, V288, P852, DOI 10.1002/mame.200300140
   Seah MP, 2003, SURF INTERFACE ANAL, V35, P906, DOI 10.1002/sia.1618
   Seby F, 2003, ANAL BIOANAL CHEM, V377, P685, DOI 10.1007/s00216-003-2133-5
   Sellner H, 2003, J CATAL, V215, P87, DOI 10.1016/S0021-9517(02)00147-1
   Seltzer MD, 2003, APPL SPECTROSC, V57, P1173, DOI 10.1366/00037020360696053
   SEWING A, 2004, BIOCERAMICS, V254, P419
   Shabani MB, 2003, MAT SCI ENG B-SOLID, V102, P238, DOI 10.1016/S0921-5107(02)00739-0
   Shen JJS, 2003, ANAL CHEM, V75, P1972, DOI 10.1021/ac020589f
   Shi X, 2003, CORROS SCI, V45, P2577, DOI 10.1016/S0010-938X(03)00079-9
   Shimizu K, 2003, SPECTROCHIM ACTA B, V58, P1573, DOI 10.1016/S0584-8547(03)00133-2
   Shortland AJ, 2002, ARCHAEOMETRY, V44, P517, DOI 10.1111/1475-4754.00083
   Sitko R, 2004, MICROCHIM ACTA, V144, P9, DOI 10.1007/s00604-003-0093-2
   Skrzydlewska E, 2004, TALANTA, V62, P937, DOI 10.1016/j.talanta.2003.10.018
   Skrzydlewska E, 2003, CHEM ANAL-WARSAW, V48, P909
   Smit Z, 2004, NUCL INSTRUM METH B, V213, P717, DOI [10.1016/S0168-583X(03)01691-4, 10.1016/S0168-583X903)01691-4]
   Song JS, 2004, J CRYST GROWTH, V264, P98, DOI [10.1016/j.jcrysgro.2003.12.063, 10.1016/j.jcrysgro.2003.10.063]
   Soylak M, 2003, J TRACE MICROPROBE T, V21, P455, DOI 10.1081/TMA-120023062
   Sridhar TM, 2003, T INDIAN I METALS, V56, P221
   Stepputat M, 2003, APPL OPTICS, V42, P6210, DOI 10.1364/AO.42.006210
   Streli C, 2003, SPECTROCHIM ACTA B, V58, P2113, DOI 10.1016/j.sab.2003.05.008
   Streli C, 2003, SPECTROCHIM ACTA B, V58, P2105, DOI 10.1016/S0584-8547(03)00218-0
   Stripeikis J, 2004, ANAL CHIM ACTA, V502, P99, DOI 10.1016/j.aca.2003.09.022
   Sun HW, 2004, ANAL CHIM ACTA, V505, P255, DOI 10.1016/j.aca.2003.10.071
   Suzuki Y, 2003, BUNSEKI KAGAKU, V52, P469, DOI 10.2116/bunsekikagaku.52.469
   Tadic D, 2003, MATERIALWISS WERKST, V34, P1048, DOI 10.1002/mawe.200300702
   Taher MA, 2003, CROAT CHEM ACTA, V76, P273
   Taher MA, 2003, B KOR CHEM SOC, V24, P1177
   TAHER MA, 2003, ASIAN J CHEM, V15, P1331
   Trejos T, 2004, ANAL CHEM, V76, P1236, DOI 10.1021/ac0349330
   Trejos T, 2003, ANAL BIOANAL CHEM, V376, P1255, DOI 10.1007/s00216-003-1968-0
   Truica-Marasescu F, 2004, J APPL POLYM SCI, V91, P3886, DOI 10.1002/app.13589
   Tsukui S, 2003, PHYSICA C, V392, P841, DOI 10.1016/S0921-4534(03)01132-8
   Vacchina V, 2003, J ANAL ATOM SPECTROM, V18, P884, DOI 10.1039/b302241b
   Valley J, 2004, SPECTROSCOPY, P13
   van Stee LLR, 2003, J CHROMATOGR A, V1019, P89, DOI 10.1016/S0021-9673(03)01301-3
   Vannier RN, 2003, SOLID STATE IONICS, V160, P85, DOI 10.1016/S0167-2738(03)00142-5
   Vittiglio G, 2004, NUCL INSTRUM METH B, V213, P693, DOI 10.1016/S0168-583X(03)01687-2
   Wang CJ, 2003, APPL SPECTROSC, V57, P1167, DOI 10.1366/00037020360696044
   WANG E, 1989, ELECTROANAL, V1, P75, DOI 10.1002/elan.1140010112
   Wang HX, 2003, J PHYS CHEM B, V107, P12964, DOI 10.1021/jp0225931
   Wang JW, 2004, J MATER SCI-MATER M, V15, P129, DOI 10.1023/B:JMSM.0000011813.45822.0b
   Wang TB, 2003, J PHARMACEUT BIOMED, V33, P639, DOI 10.1016/S0731-7085(03)00357-1
   Weber G, 2003, ANAL BIOANAL CHEM, V375, P1067, DOI 10.1007/s00216-002-1706-z
   Wehrmeyer JA, 2003, APPL SPECTROSC, V57, P1020, DOI 10.1366/000370203322258995
   Weiss Z, 2003, J ANAL ATOM SPECTROM, V18, P584, DOI 10.1039/b300838j
   Weseloh G, 2004, J RADIOANAL NUCL CH, V259, P473, DOI 10.1023/B:JRNC.0000020921.66046.1c
   White C, 2003, POLYM ENG SCI, V43, P1241, DOI 10.1002/pen.10105
   Wind M, 2003, ELECTROPHORESIS, V24, P1276, DOI 10.1002/elps.200390164
   Wind M, 2003, ANAL BIOCHEM, V317, P26, DOI 10.1016/S0003-2697(03)00083-6
   Wlodarczyk M, 2003, SPECTROCHIM ACTA B, V58, P511, DOI 10.1016/S0584-8547(03)00005-3
   Wu WD, 2004, J FIRE SCI, V22, P11, DOI 10.1177/0734904104035253
   Wu WD, 2003, J APPL POLYM SCI, V90, P1885, DOI 10.1002/app.12861
   Wuilloud RG, 2003, J ANAL ATOM SPECTROM, V18, P1119, DOI 10.1039/b300911b
   Xhoffer C, 2003, J ANAL ATOM SPECTROM, V18, P576, DOI 10.1039/b212750b
   Xi HG, 2003, MATER LETT, V57, P2657, DOI 10.1016/S0167-577X(02)01346-0
   Xing XM, 2003, SPECTROSC SPECT ANAL, V23, P995
   Yamagami M, 2003, SPECTROCHIM ACTA B, V58, P2079, DOI 10.1016/S0584-8547(03)00227-1
   Yang HQ, 2004, J MOL CATAL A-CHEM, V210, P143, DOI 10.1016/j.molcata.2003.09.009
   Yang Y, 2003, J MATER CHEM, V13, P1686, DOI 10.1039/b212868c
   Yeh CF, 2004, J CHROMATOGR A, V1029, P255, DOI 10.1016/j.chroma.2003.12.070
   Yeh CF, 2004, ANAL CHIM ACTA, V502, P57, DOI 10.1016/j.aca.2003.09.051
   Yu DG, 2003, J MEMBRANE SCI, V225, P115, DOI 10.1016/j.memsci.2003.08.010
   Zaumseil P, 2004, SOLID STATE PHENOMEN, V95-96, P473, DOI 10.4028/www.scientific.net/SSP.95-96.473
   Zhang JL, 2003, LANGMUIR, V19, P7616, DOI 10.1021/la034480u
   Zhang PQ, 2004, CATAL LETT, V92, P63
   Zhou WQ, 2004, APPL CATAL A-GEN, V260, P19, DOI 10.1016/j.apcata.2003.10.024
   Zou LM, 2003, NEW CARBON MATER, V18, P214
NR 314
TC 10
Z9 12
U1 1
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0267-9477
J9 J ANAL ATOM SPECTROM
JI J. Anal. At. Spectrom.
PY 2004
VL 19
IS 12
BP 1567
EP 1595
DI 10.1039/b416929h
PG 29
WC Chemistry, Analytical; Spectroscopy
SC Chemistry; Spectroscopy
GA 874WR
UT WOS:000225381800010
DA 2018-10-20
ER

PT J
AU Manso, M
   Rossini, P
   Malerba, I
   Valsesia, A
   Gribaldo, L
   Ceccone, G
   Rossi, F
AF Manso, M
   Rossini, P
   Malerba, I
   Valsesia, A
   Gribaldo, L
   Ceccone, G
   Rossi, F
TI Combination of ion beam stabilisation, plasma etching and plasma
   deposition for the development of tissue engineering micropatterned
   supports
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE poly(ethylene glycol); acrylic acid; ion-beam stabilisation;
   plasma-enhanced chemical vapour deposition; X-ray photoelectron
   spectroscopy; endothelial cells
ID CELLS; FILMS
AB The performance of biomedical assays at both molecular and cellular level depends greatly on the ability to design new polymer surfaces. Patterns can be created by using materials with contrasted surface properties. In this work we describe in detail the preparation of micropatterned surfaces to be used as tissue engineering supports. Poly(ethylene glycol) (PEG) was used as the 'anti-fouling' polymer in opposition to functional regions covered by acrylic acid (AAc). Since spin-casted PEG films are unstable, ion beam stabilization (IBS) treatment was applied in order to render it insoluble. On the other hand, AAc films were deposited by low-power plasma chemical vapour deposition. Chemical properties of both polymers were monitored by Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy while topographic features were followed by atomic force microscopy. Finally, a micropattern was produced by using a mask, which isolated the IBS-PEG from the AAc-deposited regions. Endothelial cells cultured on the surface were observed to follow the micropatterns. In fact, for a certain surface density it was observed that the cells present tensile or compressive stresses when forced to remain in the anti-fouling or the functionalised regions, respectively.
C1 Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, VA, Italy.
RP Manso, M (reprint author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, TP-203,Via Enrico Fermi, I-21020 Ispra, VA, Italy.
EM miguel.manso@jrc.it
RI Manso Silvan, Miguel/B-4947-2010
OI Manso Silvan, Miguel/0000-0002-5063-1607; Rossi,
   Francois/0000-0003-3090-1398
CR BALWAS AS, 1998, BIOMATERIALS, V19, P595
   BEAMSON G, 1992, HIGH RESOLUTION XPS, P84
   Briggs D., 1994, PRACTICAL SURFACE AN, V1, P635
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   DACOSTA VM, 1994, J CHEM PHYS, V101, P2746, DOI 10.1063/1.467657
   FAVIA P, 1998, PLASMAS POLYM, V3, P77, DOI DOI 10.1023/B:PAPO.0000005940.30092.58
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   LU VA, 2002, J BIOMED MATER RES, V60, P126
   MERRILL EW, 1986, PROGR ARTIFICIAL ORG, P909
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   Papra A, 2001, LANGMUIR, V17, P1457, DOI 10.1021/la000609d
   ROSSINI P, 2003, MAT SCI ENG C-BIO S, V1050, P1
   SETHI RS, 1994, BIOSENS BIOELECTRON, V9, P243, DOI 10.1016/0956-5663(94)80127-4
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
NR 18
TC 10
Z9 10
U1 0
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 2
BP 161
EP 172
DI 10.1163/156856204322793557
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 811IQ
UT WOS:000220766000003
PM 15109095
DA 2018-10-20
ER

PT J
AU Vince, V
   Thil, MA
   Veraart, C
   Colin, IM
   Delbeke, J
AF Vince, V
   Thil, MA
   Veraart, C
   Colin, IM
   Delbeke, J
TI Biocompatibility of platinum-metallized silicone rubber: in vivo and in
   vitro evaluation
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE spiral nerve cuff electrode; neural prosthesis; surface modification;
   neutral red assay; laser ablation
ID PERIPHERAL-NERVE; PROLIFERATION RATES; CUFF ELECTRODE; STIMULATION;
   EXPRESSION; ALLOYS; TISSUE
AB Silicone rubber is commonly used for biomedical applications, including implanted cuff electrodes for both recording and stimulation of peripheral nerves. This study was undertaken to evaluate the consequences of a new platinum metallization method on the biocompatibility of silicone rubber cuff electrodes. This method was introduced in order to allow the manufacture of spiral nerve cuff electrodes with a large number of contacts. The metallization process, implying silicone coating with poly(methyl methacrylate) (PMMA), its activation by an excimer laser and subsequent electroless metal deposition, led to a new surface microtexture. The neutral red cytotoxicity assay procedure was first applied in vitro on BALB/c 3T3 fibroblasts in order to analyze the cellular response elicited by the studied material. An in vivo assay was then performed to investigate the tissue reaction after chronic subcutaneous implantation of the metallized material. Results demonstrate that silicone rubber biocompatibility is not altered by the new platinum metallization method.
C1 Univ Catholique Louvain, Fac Med, Dept Physiol & Pharmacol, Neural Rehabil Engn Lab, B-1200 Brussels, Belgium.
   Univ Catholique Louvain, Fac Med, Histol Lab, B-1200 Brussels, Belgium.
RP Delbeke, J (reprint author), Univ Catholique Louvain, Fac Med, Dept Physiol & Pharmacol, Neural Rehabil Engn Lab, Ave Hippocrate 54, B-1200 Brussels, Belgium.
EM delbeke@gren.ucl.ac.be
CR Agnew WF, 1999, MUSCLE NERVE, V22, P1393, DOI 10.1002/(SICI)1097-4598(199910)22:10<1393::AID-MUS9>3.0.CO;2-E
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3
   DICARA C, 2002, ADV LASER TECHNOLOGI
   Granchi D, 1998, BIOMATERIALS, V19, P93, DOI 10.1016/S0142-9612(97)00161-0
   Grill V, 2000, QUINTESSENCE INT, V31, P741
   Grill V, 2000, J BIOMED MATER RES, V52, P479, DOI 10.1002/1097-4636(20001205)52:3<479::AID-JBM5>3.0.CO;2-X
   GRILL WM, 1994, ANN BIOMED ENG, V22, P23, DOI 10.1007/BF02368219
   Heijke GCM, 2001, MICROSURG, V21, P306, DOI 10.1002/micr.1057
   Hoffer JA, 1996, J REHABIL RES DEV, V33, P145
   JANSEN JA, 1995, BIOMATERIALS, V16, P819, DOI 10.1016/0142-9612(95)94142-8
   Kristensen BW, 2001, BRAIN RES, V896, P1, DOI 10.1016/S0006-8993(00)03304-7
   Laude L D, 1997, US Patent No, Patent No. 5599592
   LEFURGE T, 1991, ANN BIOMED ENG, V19, P197, DOI 10.1007/BF02368469
   Loeb GE, 1996, J NEUROSCI METH, V64, P95, DOI 10.1016/0165-0270(95)00123-9
   McCreery DB, 1997, IEEE T BIO-MED ENG, V44, P931, DOI 10.1109/10.634645
   MORTIMER JT, 1995, IEEE T REHABIL ENG, V3, P145
   NAPLES GG, 1988, IEEE T BIO-MED ENG, V35, P905, DOI 10.1109/10.8670
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   RICH A, 1981, J CELL SCI, V50, P1
   Romero E, 2001, MED BIOL ENG COMPUT, V39, P90, DOI 10.1007/BF02345271
   Strange K D, 1999, IEEE Trans Rehabil Eng, V7, P289, DOI 10.1109/86.788466
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   Vale FM, 1997, BIOMATERIALS, V18, P1133, DOI 10.1016/S0142-9612(97)00043-4
   VANDERPUIJE PD, 1993, P 19 CAN MED BIOL EN, P186
   Veraart C, 1998, BRAIN RES, V813, P181, DOI 10.1016/S0006-8993(98)00977-9
   VINCE V, 2002, P 7 ANN C INT FUNCT, P234
   WOOD RC, 1995, BIOMATERIALS, V16, P957, DOI 10.1016/0142-9612(95)93122-T
NR 28
TC 13
Z9 13
U1 1
U2 11
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 2
BP 173
EP 188
DI 10.1163/156856204322793566
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 811IQ
UT WOS:000220766000004
PM 15109096
DA 2018-10-20
ER

PT J
AU Koffas, TS
   Amitay-Sadovsky, E
   Kim, J
   Somorjai, GA
AF Koffas, TS
   Amitay-Sadovsky, E
   Kim, J
   Somorjai, GA
TI Molecular composition and mechanical properties of biopolymer interfaces
   studied by sum frequency generation vibrational spectroscopy and atomic
   force microscopy
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE sum frequency generation (SFG) vibrational spectroscopy; atomic force
   microscopy; contact lens; protein adsorption; surface mechanics;
   polyurethane; molecular ordering
ID SELF-DIFFUSION COEFFICIENT; CONTACT-ANGLE GONIOMETRY; SILICA-WATER
   INTERFACE; NEUTRON REFLECTION; POLYMER SURFACES; BIOMEDICAL
   APPLICATIONS; MODIFIED POLYURETHANES; CONFORMATIONAL-CHANGES;
   HYDROPHOBIC SURFACES; POLYSTYRENE SURFACE
AB Sum frequency generation (SFG) vibrational spectroscopy and atomic force microscopy (AFM) have been used to study the surface structure and surface mechanical behavior of biologically-relevant polymer systems. These techniques have emerged as powerful surface analytical tools to deduce structure/property relationships in situ, at both air/solid and air/liquid interfaces. SFG and AFM studies have been performed to understand how the surface properties of polymers are linked to polymer bulk compositions, changes in the ambient environment, or the degree of mechanical strain. Specifically, this review discusses (1) the macroscopic- and molecular-level tracking of small end groups attached to polyurethane blends, engineered to reduce blood clotting; (2) the role of ambient humidity on the surface mechanics of soft contact lenses possessing different water content in the bulk; (3) the affect of cyclic stretch on the molecular surface structure of polyurethane films, designed to mimic the mechanical deformation caused by heartbeat; and (4) the molecular ordering of functional groups at the polystyrene-protein interface. The correlation of spectroscopic and mechanical data by SFG and AFM is a powerful methodology to study and design materials with tailored surface properties.
C1 Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   Lawrence Berkeley Natl Lab, Div Sci Mat, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.
RP Somorjai, GA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
EM somorjai@socrates.berkeley.edu
CR Amitay-Sadovsky E, 2003, APPL PHYS LETT, V83, P3066, DOI 10.1063/1.1610249
   Amitay-Sadovsky E, 2003, J PHYS CHEM B, V107, P6377, DOI 10.1021/jp030169+
   Amitay-Sadovsky E, 2002, APPL PHYS LETT, V80, P1829, DOI 10.1063/1.1458526
   Amitay-Sadovsky E, 2002, J APPL PHYS, V91, P375, DOI 10.1063/1.1417990
   Aoike T, 2001, LANGMUIR, V17, P2153, DOI 10.1021/la001326o
   ARCIOLA CR, 1995, BIOMATERIALS, V16, P685, DOI 10.1016/0142-9612(95)99695-I
   *ASTM, 1997, 1997 ANN BOOK AM SOC
   Barbieri R, 1998, POLYMER, V39, P1059, DOI 10.1016/S0032-3861(97)00403-5
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   BERG OG, 2002, INTERFACIAL ENZYME K
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bonanno JA, 2002, INVEST OPHTH VIS SCI, V43, P371
   Briggman KA, 2001, J PHYS CHEM B, V105, P2785, DOI 10.1021/jp0037495
   BRIGGS D, 1989, BRIT POLYM J, V21, P3, DOI 10.1002/pi.4980210103
   BROWN A, 1986, SURF INTERFACE ANAL, V8, P75, DOI 10.1002/sia.740080207
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   CASTNER DG, 1990, SURF INTERFACE ANAL, V15, P479, DOI 10.1002/sia.740150807
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chatelier RC, 1996, BIOPHYS J, V71, P2367, DOI 10.1016/S0006-3495(96)79430-4
   Chen C, 2002, LANGMUIR, V18, P1302, DOI 10.1021/la0107805
   Chen CY, 2002, MACROMOLECULES, V35, P9130, DOI 10.1021/ma020614j
   CHEN J, 1982, J COLLOID INTERF SCI, V89, P577, DOI 10.1016/0021-9797(82)90212-0
   Chen Q, 1999, J AM CHEM SOC, V121, P446, DOI 10.1021/ja9831453
   Chen Z, 2000, J AM CHEM SOC, V122, P10615, DOI 10.1021/ja000808j
   Chen Z, 1999, J PHYS CHEM B, V103, P2935, DOI 10.1021/jp984502z
   Chen Z, 1999, APPL PHYS B-LASERS O, V68, P549, DOI 10.1007/s003400050664
   Chen Z, 2002, J BIOMED MATER RES, V62, P254, DOI 10.1002/jbm.10075
   CHU B, 1992, MACROMOLECULES, V25, P5724, DOI 10.1021/ma00047a025
   COHEN SH, 1999, ATOMIC FORCE MICROSC
   COLE KC, 1994, APPL SPECTROSC, V48, P1513, DOI 10.1366/0003702944027877
   Cuppett CM, 2000, LANGMUIR, V16, P7279, DOI 10.1021/la9915419
   DABROWSKI A, 2001, ADV COLLOID INTERFAC, V135, P93
   deGennes PG, 1979, SCALING CONCEPTS POL
   Eisenthal KB, 1996, CHEM REV, V96, P1343, DOI 10.1021/cr9502211
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   FOWKES FM, 1964, AM CHEM SOC ADV CHEM, V43
   Gautam KS, 2000, PHYS REV LETT, V85, P3854, DOI 10.1103/PhysRevLett.85.3854
   Goodwin J. W., 1995, COLLOIDAL POLYM PART
   Gracias DH, 1999, CHEM PHYS, V245, P277, DOI 10.1016/S0301-0104(99)00043-9
   Gragson DE, 1997, J AM CHEM SOC, V119, P6144, DOI 10.1021/ja962277y
   Gragson DE, 1998, J PHYS CHEM B, V102, P3847, DOI 10.1021/jp9806011
   Grobe GL, 1996, J BIOMED MATER RES, V32, P45, DOI 10.1002/(SICI)1097-4636(199609)32:1<45::AID-JBM6>3.0.CO;2-P
   HAEBERLI A, 1998, HUMAN PROTEIN DATA
   HAN CD, 1984, ADV CHEM SERIES, V206
   HARRIS MG, 1973, AM J OPTOM PHYS OPT, V50, P747
   Himmelhaus M, 2000, J PHYS CHEM B, V104, P576, DOI 10.1021/jp992073e
   HORSLEY D, 1986, PROTEINS INTERFACES, P290
   ISRAELACHVILI J, 1992, J VAC SCI TECHNOL A, V10, P2961, DOI 10.1116/1.577894
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JHON MS, 1976, HYDROGELS MED RELATE, P37
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kawaguchi H, 2000, PROG POLYM SCI, V25, P1171, DOI 10.1016/S0079-6700(00)00024-1
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   Kim SH, 2002, BIOMATERIALS, V23, P1657, DOI 10.1016/S0142-9612(01)00292-7
   Kim SH, 2001, BIOMATERIALS, V22, P3285, DOI 10.1016/S0142-9612(01)00175-2
   KIP BJ, 1991, J POLYM SCI POL PHYS, V29, P99, DOI 10.1002/polb.1991.090290113
   Koffas TS, 2003, LANGMUIR, V19, P3563, DOI 10.1021/la027041o
   Koffas TS, 2003, LANGMUIR, V19, P3453, DOI 10.1021/la026719x
   KOHLER JA, 1985, ICLC, V12, P152
   Lelah M. D., 1986, POLYURETHANES MED
   Liang BR, 1997, J APPL POLYM SCI, V66, P217, DOI 10.1002/(SICI)1097-4628(19971010)66:2<217::AID-APP2>3.0.CO;2-Z
   LINDSAY SM, 1989, J BIOMOL STRUCT DYN, V7, P279, DOI 10.1080/07391102.1989.10507771
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu JR, 1998, J COLLOID INTERF SCI, V206, P212, DOI 10.1006/jcis.1998.5680
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   McConville P, 2000, POLYMER, V41, P9081, DOI 10.1016/S0032-3861(00)00295-0
   MCPHERSON TB, 1995, PROTEINS INTERFACES, V2, P395
   Miyamae T, 2003, SURF SCI, V532, P1045, DOI 10.1016/S0039-6028(03)00174-2
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   NORDE W, 1992, COLLOID SURFACE, V64, P87, DOI 10.1016/0166-6622(92)80164-W
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   Norde W, 1999, MACROMOL SYMP, V145, P125, DOI 10.1002/masy.19991450114
   Opdahl A, 2003, J BIOMED MATER RES A, V67A, P350, DOI 10.1002/jbm.a.10054
   Opdahl A, 2002, J PHYS CHEM B, V106, P5212, DOI 10.1021/jp013741a
   Opdahl A, 2001, J POLYM SCI POL PHYS, V39, P2263, DOI 10.1002/polb.1200
   OPDAHL A, 2004, IN PRESS J PHYS COND
   Osserman EF, 1974, LYSOZYME
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Otsuka H, 2001, CURR OPIN COLLOID IN, V6, P3, DOI 10.1016/S1359-0294(00)00082-0
   PARK JB, 1992, BIOMATERIALS INTRO
   Peters T., 1996, ALL ALBUMIN BIOCH GE
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ratner B.D., 1976, HYDROGELS MED RELATE, p[1, 1]
   RATNER BD, 1996, SURFACE SURFACE MODI
   Rechavia E, 1998, CATHETER CARDIO DIAG, V45, P202, DOI 10.1002/(SICI)1097-0304(199810)45:2<202::AID-CCD20>3.0.CO;2-L
   Recum A. F., 1986, HDB BIOMATERIALS EVA
   Rider KB, 2001, PHYS REV LETT, V86, P4330, DOI 10.1103/PhysRevLett.86.4330
   Rottler J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.195501
   Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997
   Salmeron M, 2001, TRIBOL LETT, V10, P69, DOI 10.1023/A:1009026312732
   SCHAAF P, 1987, LANGMUIR, V3, P1131, DOI 10.1021/la00078a045
   Shen Y. R., 1984, PRINCIPLE NONLINEAR
   SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Somorjai G. A., 1994, INTRO SURFACE CHEM C
   Su TJ, 1998, J COLLOID INTERF SCI, V203, P419, DOI 10.1006/jcis.1998.5545
   Su TJ, 1998, LANGMUIR, V14, P438, DOI 10.1021/la970623z
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Wang J, 2002, J PHYS CHEM B, V106, P11666, DOI 10.1021/jp021363j
   WARD RS, Patent No. 5589563
   Wei X, 2000, PHYS REV E, V62, P5160, DOI 10.1103/PhysRevE.62.5160
   Wen JM, 1997, MACROMOLECULES, V30, P7206, DOI 10.1021/ma961442r
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wicks Z. W., 1992, ORGANIC COATINGS SCI
   Woodruff DP, 1986, MODERN TECHNIQUES SU
   Wu T, 2001, MACROMOLECULES, V34, P684, DOI 10.1021/ma001750w
   YAN G, 1995, PROTEINS INTERFACES, V2, P256
   Ye S, 2003, LANGMUIR, V19, P2238, DOI 10.1021/la0266233
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   YUI N, 1995, POLYM J, V27, P614, DOI 10.1295/polymj.27.614
   Zhang D, 2000, LANGMUIR, V16, P4528, DOI 10.1021/1a991353i
   Zhang D, 1997, J PHYS CHEM B, V101, P9060, DOI 10.1021/jp9718358
   Zhang D, 1998, J PHYS CHEM B, V102, P6225, DOI 10.1021/jp981550a
NR 115
TC 10
Z9 10
U1 0
U2 19
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 4
BP 475
EP 509
DI 10.1163/156856204323005325
PG 35
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 826ID
UT WOS:000221821900010
PM 15212330
DA 2018-10-20
ER

PT J
AU Abayasinghe, NK
   Perera, KPU
   Thomas, C
   Daly, A
   Suresh, S
   Burg, K
   Harrison, GM
   Smith, DW
AF Abayasinghe, NK
   Perera, KPU
   Thomas, C
   Daly, A
   Suresh, S
   Burg, K
   Harrison, GM
   Smith, DW
TI Amido-modified polylactide for potential tissue engineering applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Gels, Genes, Grafts and Giants held in Celebration of the
   70th Birthday of Allan Hoffman
CY DEC, 2002
CL Maui, HI
SP Univ Washington Engineered Biomat NSF Engn Res Ctr
DE polylactide; depsipeptide; poly(ester amide); morpholinedione; tissue
   engineering
ID POLYMERS; POLYMERIZATION; LACTIDE; L,L-DILACTIDE; FILMS
AB Poly(ester amide) copolymers based on L-lactide (2) and a new depsipeptide (1) were prepared by ring opening polymerization in the presence of Sn(Oct)(2) as the catalyst. Variable monomer feed ratios up to 2.3 mol% 1 afforded copolymers containing ester and amido functional groups in the backbone. Lower glass transition temperatures and reduced crystallization kinetics and crystallinity compared to homo-polylactide (PLA) was achieved with low levels of amido incorporation. A reactivity comparison between enchainment of 2 and 1 was determined using in situ infrared spectroscopy. An increase in shear viscosity was observed with the increase of 1 content as determined by theology studies. Cellular compatibility of the co-polymers was investigated by seeding D1 mouse stem cells onto films and characterizing cell morphology by optical microscopy. Preliminary results indicate that these novel materials exhibit reduced cell attachment compared to PLA and, pending further exploration, may have potential use in biomedical applications.
C1 Clemson Univ, Dept Chem, Clemson, SC 29634 USA.
   Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   Clemson Univ, Ctr Adv Engn Fibers & Films, Clemson, SC 29634 USA.
RP Smith, DW (reprint author), Clemson Univ, Dept Chem, Clemson, SC 29634 USA.
EM dwsmith@clemson.edu
CR ABAYASINGHE NK, 2003, POLYM PREPR, V44, P847
   ALBERTSSON AC, 1995, ACTA POLYM, V46, P114, DOI 10.1002/actp.1995.010460203
   Aubrecht KB, 2002, MACROMOLECULES, V35, P644, DOI 10.1021/ma011873w
   Burg KJL, 1997, J BIOMAT SCI-POLYM E, V9, P15
   Burg KJL, 1997, ANN NY ACAD SCI, V831, P217
   Burg KJL, 1999, J BIOMAT SCI-POLYM E, V10, P147, DOI 10.1163/156856299X00108
   CHASIN M, 1990, BIODEGRADABLE POLYM, P1
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   FELDER J, 1986, MAKROMOL CHEM-RAPID, V7, P193
   INTVELD PJA, 1992, MAKROMOL CHEM, V193, P1927
   KOBAYASHI H, 1991, J BIOMED MATER RES, V25, P1481, DOI 10.1002/jbm.820251206
   Kowalski A, 2000, MACROMOLECULES, V33, P7359, DOI 10.1021/ma000125o
   KRICHELDORF HR, 1987, MAKROMOL CHEM, V188, P1861
   Kricheldorf HR, 2000, MACROMOLECULES, V33, P702, DOI 10.1021/ma991181w
   KRICHELDORF HR, 1992, POLYMER, V33, P2817, DOI 10.1016/0032-3861(92)90459-A
   Kumar G. S., 1987, BIODEGRADABLE POLYM, P3
   LANGER R, 1983, J MACROMOL SCI R M C, VC23, P61, DOI 10.1080/07366578308079439
   Lunt J, 1998, POLYM DEGRAD STABIL, V59, P145, DOI 10.1016/S0141-3910(97)00148-1
   OTEY FH, 1980, IND ENG CHEM PROD RD, V19, P502
   Schnabel W., 1981, POLYM DEGRADATION PR, P154
   Vink ETH, 2003, POLYM DEGRAD STABIL, V80, P403, DOI 10.1016/S0141-3910(02)00372-5
   Westervelt R, 2000, CHEM WEEK, V162, P9
   Williams CK, 2002, CHEM COMMUN, P2132, DOI 10.1039/b206437e
NR 24
TC 18
Z9 20
U1 0
U2 4
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 5
BP 595
EP 606
DI 10.1163/156856204323046861
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 832QA
UT WOS:000222280800004
PM 15264661
DA 2018-10-20
ER

PT J
AU Htay, AS
   Teoh, SH
   Hutmacher, DW
AF Htay, AS
   Teoh, SH
   Hutmacher, DW
TI Development of perforated microthin poly(epsilon-caprolactone) films as
   matrices for membrane tissue engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Gels, Genes, Grafts and Giants held in Celebration of the
   70th Birthday of Allan Hoffman
CY DEC, 2002
CL Maui, HI
SP Univ Washington Engineered Biomat NSF Engn Res Ctr
DE poly(epsilon-caprolactone); biaxial stretching; water vapour
   transmission; tissue engineering; perforated film; accelerated
   degradation; sodium hydroxide
ID POLY-EPSILON-CAPROLACTONE; IN-VITRO DEGRADATION; HYDROLYTIC DEGRADATION;
   ALIPHATIC POLYESTERS; SKIN; POLY(CAPROLACTONE); MECHANISMS; COPOLYMER;
   RELEASE; DEVICES
AB The design and fabrication of thin films based on bioresorbable polymers such as poly(epsilon-caprolactone) (PCL) has been the focus of a part of current biomedical research, especially as matrices for membrane tissue engineering. We have successfully developed perforated microthin PCL membrane for this purpose. Two critical issues are the control of moisture permeability and understanding the degradation of PCL microthin film. In order to increase the moisture permeability, PCL films were biaxially stretched to a thickness of 10 +/- 3 mum and perforated with uniform array of holes (180-275 mum) using a Sony Robotic system. After perforation, the water vapour transmission rate was increased by 50% to a value of 47.6 +/- 2.7 g/h per m(2). Accelerated hydrolytic degradations were performed in 5 M NaOH. The degraded samples were characterised for changes in weight, surface morphology, mechanical properties, crystallinity and molecular weight. Hydrolytic degradation commenced with random chain scission of backbone ester bonds on the film surface and followed by loss of material due to surface erosion. In general, the perforated films degraded faster than the unperforated microthin films. Scanning electron microscopic images showed that surface erosion led to extensive formation of micropores, microcracks and increased in surface roughness.
C1 Natl Univ Singapore, Div Bioengn, Dept Mech Engn, Singapore, Singapore.
   Natl Univ Singapore, Dept Orthopaed Surg, Singapore, Singapore.
RP Teoh, SH (reprint author), Natl Univ Singapore, Div Bioengn, Dept Mech Engn, Singapore, Singapore.
EM mpetsh@nus.edu.sg
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   Gan ZH, 1997, POLYM DEGRAD STABIL, V56, P209, DOI 10.1016/S0141-3910(96)00208-X
   GERRITS NSJA, 1991, POLYMER, V32, P1770, DOI 10.1016/0032-3861(91)90361-L
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GOPFERICH A, 1995, EUR J PHARM BIOPHARM, V41, P81
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Hollander DA, 2001, J TRAUMA, V50, P1125, DOI 10.1097/00005373-200106000-00024
   HTAY AS, 2004, THESIS NATL U SINGAP
   Hutmacher DW, 2002, DRUGS TODAY, V38, P113, DOI 10.1358/dot.2002.38.2.820107
   JARRETT P, 1981, POLYM PREPR, V22, P351
   Khor HL, 2003, J MATER SCI-MATER M, V14, P113, DOI 10.1023/A:1022059511261
   LAM PK, 1999, J TRAUMA, V11, P47
   LANIR Y, 1987, HDB BIOENGINEERING
   Li S, 1995, DEGRADABLE POLYM PRI, P43
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Li SM, 1996, J BIOMAT SCI-POLYM E, V8, P165, DOI 10.1163/156856296X00237
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Maeda M, 2001, J CONTROL RELEASE, V77, P261, DOI 10.1016/S0168-3659(01)00512-0
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   McMurry J., 1996, ORGANIC CHEM
   Mochizuki M, 1997, POLYM ADVAN TECHNOL, V8, P203
   Ng CS, 2000, POLYMER, V41, P5855, DOI 10.1016/S0032-3861(99)00760-0
   Ng Kee Woei, 2001, Tissue Engineering, V7, P441, DOI 10.1089/10763270152436490
   NG KW, 2002, P 11 INT C BIOM ENG
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Rennekampff HO, 1996, J SURG RES, V62, P288, DOI 10.1006/jsre.1996.0210
   Skin Widra A., 1989, ENCY POLYM SCI ENG, V15, P335
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   Teumer J., 1998, FRONTIERS TISSUE ENG, P664
   Tilstra L., 1993, J ENVIRON POLYM DEGR, V1, P257
   Trent JF, 1998, INT J CLIN PRACT, V52, P408
   TSUJI H, 2001, J APPL POLYM SCI, V80, P281
   Ye WP, 1997, REACT FUNCT POLYM, V32, P161, DOI 10.1016/S1381-5148(96)00081-8
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 37
TC 27
Z9 27
U1 0
U2 15
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 5
BP 683
EP 700
DI 10.1163/156856204323046933
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 832QA
UT WOS:000222280800011
PM 15264668
DA 2018-10-20
ER

PT J
AU Goessl, A
   Tirelli, N
   Hubbell, JA
AF Goessl, A
   Tirelli, N
   Hubbell, JA
TI A hydrogel system for stimulus-responsive, oxygen-sensitive in situ
   gelation
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Gels, Genes, Grafts and Giants held in Celebration of the
   70th Birthday of Allan Hoffman
CY DEC, 2002
CL Maui, HI
SP Univ Washington Engineered Biomat NSF Engn Res Ctr
DE hydrogel; stimulus-responsive; thiol; disulfide; in situ polymerization
ID POLY(ETHYLENE GLYCOL); FENTON CHEMISTRY; GOLD; COPOLYMERS; TOXICITY;
   SURFACES; POLYMER; ISLETS
AB A hydrogel system that is designed to gel due to oxidation by molecular oxygen is described. This is achieved by the use of a branched poly(ethylene glycol) modified with thiol end groups. A stable precursor molecule, starPEG thioacetate, was synthesized by radical addition of thioacetic acid to an intermediate starPEG allyl ether. Rapid deprotection of the thiol can be achieved using a base, e.g. sodium hydroxide, quantitatively liberating a thiol group and a non-toxic acetate ion. This step can be carried out under anaerobic conditions, yielding a solution with known thiol content that can be stored. The reaction with oxygen is accelerated by the use of a catalyst based on Fenton chemistry, which makes the material useful for biomedical applications where in situ polymerization of an injectable material is beneficial. This gelation takes place under near physiological conditions without the need for a cross-linking agent.
C1 Swiss Fed Inst Technol, ETH, Dept Mat, Inst Biomed Engn, Zurich, Switzerland.
   Baxter Biosci, A-1220 Vienna, Austria.
   Univ Manchester, Sch Pharm, Manchester M13 9PL, Lancs, England.
   Univ Manchester, Mat Mol Ctr, Manchester M13 9PL, Lancs, England.
   Swiss Fed Inst Technol Lausanne, EPFL, Inst Biol & Chem Engn, Ecublens, Switzerland.
RP Goessl, A (reprint author), Swiss Fed Inst Technol, ETH, Dept Mat, Inst Biomed Engn, Zurich, Switzerland.
EM andreas_goessl@baxter.com
RI Hubbell, Jeffrey/A-9266-2008; Tirelli, Nicola/P-3604-2018; Tirelli,
   Nicola/P-7210-2014
OI Hubbell, Jeffrey/0000-0003-0276-5456; Tirelli,
   Nicola/0000-0002-4879-3949; Tirelli, Nicola/0000-0002-4879-3949
CR Boal AK, 2000, NATURE, V404, P746
   Capozzi G., 1974, CHEM THIOL GROUP, V2, P785
   DEAN JA, 1992, LANGE HDB CHEM
   Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308
   Held KD, 1996, RADIAT RES, V145, P542, DOI 10.2307/3579272
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   Hisano N, 1998, J BIOMED MATER RES, V40, P115, DOI 10.1002/(SICI)1097-4636(199804)40:1<115::AID-JBM13>3.0.CO;2-N
   Hoffman AS, 2001, ANN NY ACAD SCI, V944, P62
   Jorns A, 1999, FREE RADICAL BIO MED, V26, P1300, DOI 10.1016/S0891-5849(98)00325-6
   Laschewsky A, 2001, MACROMOL SYMP, V164, P323, DOI 10.1002/1521-3900(200102)164:1<323::AID-MASY323>3.0.CO;2-9
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Nakayama Y, 1998, LANGMUIR, V14, P3909, DOI 10.1021/la971390e
   Napoli A, 2001, MACROMOLECULES, V34, P8913, DOI 10.1021/ma0108057
   Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270
   WOGHIREN C, 1993, BIOCONJUGATE CHEM, V4, P314, DOI 10.1021/bc00023a002
   YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432
   Yang EY, 2000, REDOX REP, V5, P371, DOI 10.1179/135100000101535942
   Zhang F, 2001, J BIOMAT SCI-POLYM E, V12, P515, DOI 10.1163/156856201300194252
NR 19
TC 29
Z9 32
U1 2
U2 26
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 7
BP 895
EP 904
DI 10.1163/1568562041271039
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 854CQ
UT WOS:000223878300007
PM 15318799
DA 2018-10-20
ER

PT J
AU Zhong, ZY
   Dijkstra, PJ
   Feijen, J
AF Zhong, ZY
   Dijkstra, PJ
   Feijen, J
TI Controlled synthesis of biodegradable lactide polymers and copolymers
   using novel in situ generated or single-site stereoselective
   polymerization initiators
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Gels, Genes, Grafts and Giants held in Celebration of the
   70th Birthday of Allan Hoffman
CY DEC, 2002
CL Maui, HI
SP Univ Washington Engineered Biomat NSF Engn Res Ctr
DE polylactide; ring-opening polymerization; in situ polymerization;
   stereoselective polymerization; living polymerization; biodegradable
   polymers
ID RING-OPENING POLYMERIZATION; DIRECT CONDENSATION POLYMERIZATION;
   POLY(LACTIC ACID); CYCLIC ESTERS; EPSILON-CAPROLACTONE; STEREOCOMPLEX
   FORMATION; ASYMMETRIC CATALYSIS; ALKOXIDE INITIATOR; YTTRIUM ALKOXIDES;
   BASIC PROPERTIES
AB Polylactides and their copolymers are key biodegradable polymers used widely in biomedical, pharmaceutical and ecological applications. The development of synthetic pathways and catalyst/initiator systems to produce pre-designed polylactides, as well as the fundamental understanding of the polymerization reactions, has continuously been an important topic. Here, we will address the recent advances in the ring-opening polymerization of lactides, with an emphasis on the highly versatile in situ generated initiator systems and single-site stereoselective initiators. The in situ generated initiators including in situ formed yttrium, calcium and zinc alkoxides all have been shown to bring about a rapid and living polymerization of lactides under mild conditions, which facilitated the preparation of a variety of advanced lactide-based biomaterials. For example, well-defined di- and tri-block copolymers consisting of hydrophilic poly(ethylene glycol) blocks and hydrophobic polyester blocks, which form novel biodegradable polymersomes or biodegradable thermosensitive hydrogels, have been prepared. In the past few years, significant progress has also been made in the area of stereoselective polymerization of lactides. This new generation of initiators has enabled the production of polylactide materials with novel microstructures and/or properties, such as heterotactic (-RRSSRRSSRRSS-) polylactide, crystalline syndiotactic (-RSRSRSRSRSRS-) polylactide and isotactic stereoblock (-R(n)S(n)R(n)S(n)-) polylactide, exhibiting a high melting temperature. The recently developed polymerizations using in situ generated initiators and stereoselective polymerizations have no doubt opened a brand-new avenue for the design and exploration of polylactides and their copolymers.
C1 Univ Twente, Fac Sci & Technol, Dept Polymer Chem & Biomat, NL-7500 AE Enschede, Netherlands.
   Univ Twente, Fac Sci & Technol, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
RP Feijen, J (reprint author), Univ Twente, Fac Sci & Technol, Dept Polymer Chem & Biomat, POB 217, NL-7500 AE Enschede, Netherlands.
EM j.feijen@ct.utwente.nl
RI Dijkstra, Pieter/N-9328-2013; Zhong, Zhiyuan/D-8508-2011
OI Zhong, Zhiyuan/0000-0003-4175-4741
CR AJIOKA M, 1995, J ENVIRON POLYM DEGR, V3, P225, DOI 10.1007/BF02068677
   AJIOKA M, 1995, B CHEM SOC JPN, V68, P2125, DOI 10.1246/bcsj.68.2125
   ATALA A, 1997, TISSUE ENG, P258
   BARAKAT I, 1993, J POLYM SCI POL CHEM, V31, P505, DOI 10.1002/pola.1993.080310222
   Bhaw-Luximon A, 2000, POLYM BULL, V44, P31, DOI 10.1007/s002890050570
   Cameron PA, 1999, MACROMOL RAPID COMM, V20, P616, DOI 10.1002/(SICI)1521-3927(19991201)20:12<616::AID-MARC616>3.0.CO;2-Z
   Chamberlain BM, 2001, J AM CHEM SOC, V123, P3229, DOI 10.1021/ja003851f
   Cheng M, 1999, J AM CHEM SOC, V121, P11583, DOI 10.1021/ja992678o
   Coates GW, 2002, J CHEM SOC DALTON, P467, DOI 10.1039/b111226k
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034
   Jacobsen EN, 2000, ACCOUNTS CHEM RES, V33, P421, DOI 10.1021/ar960061v
   Jhurry D, 2001, MACROMOL SYMP, V175, P67, DOI 10.1002/1521-3900(200110)175:1<67::AID-MASY67>3.0.CO;2-6
   Joukainen A, 2000, J BIOMAT SCI-POLYM E, V11, P1411, DOI 10.1163/156856200744318
   Kaab MJ, 2002, INJURY, V33, P37, DOI 10.1016/S0020-1383(02)00131-6
   Ko BT, 2001, J AM CHEM SOC, V123, P7973, DOI 10.1021/ja010604i
   Kowalski A, 2000, MACROMOLECULES, V33, P7359, DOI 10.1021/ma000125o
   Kricheldorf HR, 1997, MACROMOL CHEM PHYSIC, V198, P1753, DOI 10.1002/macp.1997.021980605
   Kricheldorf HR, 2000, MACROMOLECULES, V33, P702, DOI 10.1021/ma991181w
   Lanza R, 2000, PRINCIPLES TISSUE EN
   LEBORGNE A, 1993, MAKROMOL CHEM-M SYMP, V73, P37, DOI 10.1002/masy.19930730106
   LEBORGNE A, 1995, PAP AM CHEM SOC, V210, P81
   LOFGREN A, 1995, J MACROMOL SCI R M C, VC35, P379
   Martin E, 2000, MACROMOLECULES, V33, P1530, DOI 10.1021/ma991045r
   Mecerreyes D, 1999, MACROMOL CHEM PHYSIC, V200, P2581, DOI 10.1002/(SICI)1521-3935(19991201)200:12<2581::AID-MACP2581>3.0.CO;2-P
   MENG FH, 2003, ARTIFICIAL CELLS BAS, P105
   Montaudo G, 1996, MACROMOLECULES, V29, P6461, DOI 10.1021/ma960538i
   MWNF FH, 2003, MACROMOLECULES, V36, P3004
   Nomura N, 2002, J AM CHEM SOC, V124, P5938, DOI 10.1021/ja0175789
   O'Keefe BJ, 2001, J CHEM SOC DALTON, P2215, DOI 10.1039/b104197p
   Ovitt TM, 2002, J AM CHEM SOC, V124, P1316, DOI 10.1021/ja012052+
   Ovitt TM, 1999, J AM CHEM SOC, V121, P4072, DOI 10.1021/ja990088k
   Ovitt TM, 2000, J POLYM SCI POL CHEM, V38, P4686, DOI 10.1002/1099-0518(200012)38:1+<4686::AID-POLA80>3.0.CO;2-0
   PONCELET O, 1989, INORG CHEM, V28, P263, DOI 10.1021/ic00301a021
   Radano CP, 2000, J AM CHEM SOC, V122, P1552, DOI 10.1021/ja9930519
   REEVE MS, 1994, MACROMOLECULES, V27, P825, DOI 10.1021/ma00081a030
   ROPSON N, 1993, MACROMOLECULES, V26, P6378, DOI 10.1021/ma00076a012
   Sarasua JR, 1998, MACROMOLECULES, V31, P3895, DOI 10.1021/ma971545p
   Schwach G, 1998, POLYM INT, V46, P177, DOI 10.1002/(SICI)1097-0126(199807)46:3<177::AID-PI937>3.0.CO;2-S
   SHINER VJ, 1963, J AM CHEM SOC, V85, P2318, DOI 10.1021/ja00898a028
   Spassky N, 1996, MACROMOL CHEM PHYSIC, V197, P2627, DOI 10.1002/macp.1996.021970902
   Stevels WM, 1996, MACROMOLECULES, V29, P6132, DOI 10.1021/ma9605311
   Stevels WM, 1996, MACROMOLECULES, V29, P3332, DOI 10.1021/ma951813o
   Stevels WM, 1997, TRENDS POLYM SCI, V5, P300
   Tokunaga M, 1997, SCIENCE, V277, P936, DOI 10.1126/science.277.5328.936
   Tortosa K, 2001, MACROMOL CHEM PHYSIC, V202, P1156, DOI 10.1002/1521-3935(20010401)202:7<1156::AID-MACP1156>3.0.CO;2-9
   Toth JM, 2002, ORTHOPEDICS, V25, pS1131
   Tsuji H, 1999, POLYMER, V40, P6699, DOI 10.1016/S0032-3861(99)00004-X
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Westerhausen M, 2003, EUR J INORG CHEM, P3432, DOI 10.1002/ejic.200300286
   Wisniewski M, 1997, MACROMOL CHEM PHYSIC, V198, P1227, DOI 10.1002/macp.1997.021980424
   YUI N, 1990, MAKROMOL CHEM, V191, P481
   Zhong Z, 2002, ANGEW CHEM, V114, P4692, DOI [DOI 10.1002/1521-3757(20021202)114:23<4692::AID-ANGE4692>3.0.CO;2-5, 10.1002/1521-3757(20021202)114:23<lessthan>4692::AID-ANGE4692<greaterthan>3.0.CO;2-5]
   Zhong ZY, 2003, POLYM BULL, V51, P175, DOI 10.1007/s00289-003-0211-7
   Zhong ZY, 2003, MACROMOLECULES, V36, P8198, DOI 10.1021/ma034482l
   Zhong ZY, 2003, J AM CHEM SOC, V125, P11291, DOI 10.1021/ja0347585
   Zhong ZY, 2002, ANGEW CHEM INT EDIT, V41, P4510, DOI 10.1002/1521-3773(20021202)41:23<4510::AID-ANIE4510>3.0.CO;2-L
   Zhong ZY, 2001, J POLYM ENVIRON, V9, P31, DOI 10.1023/A:1016092420618
   Zhong ZY, 2002, MACROMOL CHEM PHYS, V203, P1797, DOI 10.1002/1521-3935(200208)203:12<1797::AID-MACP1797>3.0.CO;2-A
   Zhong ZY, 2001, POLYM BULL, V46, P51, DOI 10.1007/s002890170088
   Zhong ZY, 2001, MACROMOLECULES, V34, P3863, DOI 10.1021/ma0019510
   ZHONG ZY, 2002, NOVEL CALCIUM ALUMIN, P121
NR 65
TC 26
Z9 26
U1 2
U2 17
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 7
BP 929
EP 946
DI 10.1163/1568562041271066
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 854CQ
UT WOS:000223878300010
PM 15318802
DA 2018-10-20
ER

PT J
AU Lee, JW
   Jung, MC
   Park, HD
   Park, KD
   Ryu, GH
AF Lee, JW
   Jung, MC
   Park, HD
   Park, KD
   Ryu, GH
TI Synthesis and characterization of thermosensitive chitosan copolymer as
   a novel biomaterial
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE chitosan; hydrogel; thermally-responsive material; N-isopropyl
   acrylamide (NIPAAm); cell viability
ID DRUG-DELIVERY SYSTEMS; N-ISOPROPYLACRYLAMIDE; GRAFT-POLYMERIZATION;
   ACRYLIC-MONOMERS; BLOCK-COPOLYMERS; IN-VITRO; GELS; HYDROGELS; POLYMERS
AB Novel water-soluble thermosensitive chitosan copolymers were prepared by graft polymerization of N-isopropylacrylamide (NIPAAm) onto chitosan using cerium ammonium nitrate (CAN) as an initiator. The physicochemical properties of the resulting chitosan-g-NIPAAm copolymers were characterized by Fourier transform infrared (FT-IR) spectroscopy, 1 H-nuclear magnetic resonance, X-ray diffraction measurement, thermogravimetric analysis (TGA) and solubility test. Sol-gel transition behavior was investigated by the cloud point measurement of the chitosan-g-NIPAAm aqueous solution. The gelling temperature was examined using the vial inversion method. The percentage of grafting (%) and efficiency of grafting (%) were investigated according to concentrations of monomer and initiator. The maximum grafted chitosan copolymer was obtained with 0.4 M NIPAAm and 6 x 10(-3) M CAN. Water-soluble chitosan-g-NIPAAm copolymers were prepared successfully and they formed thermally reversible hydrogel, which exhibits a lower critical solution temperature (LCST) around 32degreesC in aqueous solutions. A preliminary in vitro cell study showed nontoxic and biocompatible properties. These results suggest that chitosan-g-NIPAAm copolymer could be very useful in biomedical and pharmaceutical applications as an injectable material for cell and drug delivery.
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea.
   Korea Inst Sci & Technol Informat, Dept Mat & Component Informat Anal, Seoul 130742, South Korea.
   Korea Food & Drug Adm, Dept Med Devices & Radiat, Seoul 122704, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea.
EM kdp@ajou.ac.kr
RI Park, Hee-Deung/D-2596-2013; Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771; Jung, Myung-Chul/0000-0002-7348-3272
CR Ahn Y., 2001, US patent, Patent No. [US 6103528, 6103528]
   Bae YH, 1997, CONTROLLED DRUG DELI, P147
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   CERRAI P, 1996, MACROMOL CHEM PHYS, V197, P3367
   Chellat F, 2000, J BIOMED MATER RES, V51, P107, DOI 10.1002/(SICI)1097-4636(200007)51:1<107::AID-JBM14>3.0.CO;2-F
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028
   DONG LC, 1991, J CONTROL RELEASE, V15, P141, DOI 10.1016/0168-3659(91)90072-L
   Ebara M, 2000, MACROMOLECULES, V33, P8312, DOI 10.1021/ma000121j
   Felt O, 1999, INT J PHARM, V180, P185, DOI 10.1016/S0378-5173(99)00003-4
   Ganorkar CR, 1999, J CONTROL RELEASE, V59, P287
   GONI I, 1983, J POLYM SCI POL CHEM, V21, P2573, DOI 10.1002/pol.1983.170210837
   GURRUCHAGA M, 1989, J POLYM SCI POL LETT, V27, P149, DOI 10.1002/pol.1989.140270501
   Han CK, 1998, POLYMER, V39, P2809, DOI 10.1016/S0032-3861(97)00612-5
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Nonaka T, 1997, J APPL POLYM SCI, V66, P209, DOI 10.1002/(SICI)1097-4628(19971010)66:2<209::AID-APP1>3.3.CO;2-#
   Park K, 1997, CONTROLLED DRUG DELI, P485
   ROBERTS GAF, 1992, CHITIN CHEM, P77
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Topp MDC, 1997, MACROMOLECULES, V30, P8518, DOI 10.1021/ma9710803
   Vernon B, 1999, J BIOMAT SCI-POLYM E, V10, P183, DOI 10.1163/156856299X00126
NR 27
TC 38
Z9 40
U1 4
U2 25
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2004
VL 15
IS 8
BP 1065
EP 1079
DI 10.1163/1568562041526496
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 868RR
UT WOS:000224931200008
PM 15461190
DA 2018-10-20
ER

PT J
AU Murayama, Y
   Constantinou, CE
   Omata, S
AF Murayama, Y
   Constantinou, CE
   Omata, S
TI Micro-mechanical sensing platform for the characterization of the
   elastic properties of the ovum via uniaxial measurement
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Young's modulus; Micro Tactile Sensor; zona pellucida
ID ZONA-PELLUCIDA; FERTILIZATION; FORCE
AB Stiffness is an important parameter in determining the physical properties of living tissue. Recently, considerable biomedical attention has centered on the mechanical properties of living tissues at the single cell level. In the present paper, the Young's modulus of zona pellucida of bovine ovum was calculated using Micro Tactile Sensor (MTS) fabricated using piezoelectric (PZT) material. The sensor consists of a needle-shaped 20-mum transduction point made using a micro-electrode puller and mounted on a micro-manipulator platform. Measurements were made under microscopic control, using a suction pipette to support the ovum in the same horizontal axis as the MTS. Young's modulus of ovum was found to be 25.3 +/- 7.94 kPa (n = 28). This value was indirectly determined based on calibration curves relating change in resonance frequency (Deltaf(0)) of the sensor with tip displacement for gelatin at concentrations of 4%, 6%, and 8%. The regression equation between the rate of change in resonance frequency (versus sensor tip displacement), Deltaf(0)/x and Young's modulus is Deltaf(0)/x (Hz/mum) = 0.2992 x Young's modulus (kPa) - 1.0363. It is concluded that a reason that the stiffness of ovum measured in the present study is approximately six times larger than previously reported, may be due to the absence of large deformation present in of existing methodologies. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Nihon Univ, Coll Engn, Koriyama, Fukushima 9638642, Japan.
   Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.
RP Murayama, Y (reprint author), Nihon Univ, Coll Engn, Koriyama, Fukushima 9638642, Japan.
EM murayama@ee.ce.nihon-u.ac.jp; ceconst@leland.stanford.edu;
   omata@ee.ce.nihon-u.ac.jp
CR BRADEN AWH, 1954, AUST J BIOL SCI, V7, P391, DOI 10.1071/BI9540391
   Constans J, 1996, INT ANGIOL, V15, P1
   DROBNIS EZ, 1988, J EXP ZOOL, V245, P206, DOI 10.1002/jez.1402450210
   GREEN DPL, 1987, EXP CELL RES, V169, P31, DOI 10.1016/0014-4827(87)90221-7
   Gregson CM, 1999, CARBOHYD POLYM, V38, P255, DOI 10.1016/S0144-8617(98)00113-1
   Hall TJ, 1997, IEEE T ULTRASON FERR, V44, P1355, DOI 10.1109/58.656639
   HATANAKA Y, 1992, J REPROD FERTIL, V95, P431
   Hatzichristou D G, 1995, Int J Impot Res, V7, P221
   HIRAMOTO Y, 1970, Biorheology, V6, P201
   Iwamoto K, 1999, J REPROD FERTIL, V117, P395, DOI 10.1530/jrf.0.1170395
   KAYADA K, 1994, NEUROL URODYN, V13, P407
   KLEESATTEL C, 1968, ULTRASONICS      JUL, P175
   Lee DW, 1998, ORGANOMETALLICS, V17, P1, DOI 10.1021/om9707679
   Lindahl OA, 1998, J MED ENG TECHNOL, V22, P147, DOI 10.3109/03091909809032532
   Magonov SN, 1997, SURF SCI, V375, P385
   OMATA S, 1992, SENSOR ACTUAT A-PHYS, V3, P9
   Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5
   Schmell E. D., 1983, MECH CONTROL ANIMAL, P356
   Timoshenko S, 1959, THEORY PLATES SHELLS
   Watanabe T, 1997, NEUROUROL URODYNAM, V16, P567, DOI 10.1002/(SICI)1520-6777(1997)16:6<567::AID-NAU7>3.0.CO;2-C
NR 20
TC 63
Z9 67
U1 2
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
J9 J BIOMECH
JI J. Biomech.
PD JAN
PY 2004
VL 37
IS 1
BP 67
EP 72
DI 10.1016/S0021-9290(03)00242-2
PG 6
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 763PE
UT WOS:000188094100007
PM 14672569
DA 2018-10-20
ER

PT J
AU Druecke, D
   Langer, S
   Lamme, E
   Pieper, J
   Ugarkovic, M
   Steinau, HU
   Homann, HH
AF Druecke, D
   Langer, S
   Lamme, E
   Pieper, J
   Ugarkovic, M
   Steinau, HU
   Homann, HH
TI Neovascularization of poly(ether ester) block-copolymer scaffolds in
   vivo: Long-term investigations using intravital fluorescent microscopy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; block-copolymer scaffolds; intravital microscopy;
   microcirculation; mouse skinfold chamber; neovascularization; tissue
   engineering
ID DORSAL SKINFOLD CHAMBER; ISCHEMIA-REPERFUSION; STRIATED-MUSCLE; TISSUE;
   ANGIOGENESIS; GROWTH; MICROVESSELS; REPLACEMENT; SUBSTRATE; HAMSTERS
AB Poly(ether ester) block-copolymer scaffolds of different pore size were implanted into the dorsal skinfold chamber of balb / c mice. Using intravital fluorescent microscopy, the temporal course of neovascularization into these scaffolds was quantitatively analyzed. Three scaffold groups (diameter, 5 mm; 220-260 thickness, mum; n = 30) were implanted. Different pore sizes were evaluated: small (20-75 mum), medium (75-212 mum) and large pores (250-300 mum). Measurements were performed on days 8, 12, 16, and 20 in the surrounding normal tissue, in the border zone, and in the center of the scaffold. Standard microcirculatory parameters were assessed (plasma leakage, vessel diameter, red blood cell velocity, and functional vessel density). The large-pored scaffolds showed significantly higher functional vessel density in the border zone and in the center (days 8 and 12) compared with the scaffold with the small and medium-sized pores. These data correlated with a larger vessel diameter and a higher red blood cell velocity in the large-pored scaffold group. Interestingly, during the evaluation period the microcirculatory parameters on the edge of the scaffolds returned to values similar to those found in the surrounding tissue. In the center of the scaffold, however, neovascularization was still active 20 days after implantation. Plasma leakage and vessel diameter were higher in the center of the scaffold. Red blood cell velocity and functional vessel density were 50% lower than in the surrounding tissue. In conclusion, the dorsal skinfold chamber model in mice allows long-term study of blood vessel growth and remodeling in porous biomedical materials. The rate of vessel ingrowth into poly(ether ester) block-copolymer scaffolds is influenced by pore size and was highest in the scaffold with the largest pores. The data generated with this model contribute to knowledge about the development of functional vessels and tissue ingrowth into biomaterials. (C) 2003 Wiley Periodicals, Inc.
C1 Ruhr Univ Bochum, Burn Ctr, Dept Plast & Hand Surg, D-44789 Bochum, Germany.
   ISOTIS NV, Bilthoven, Netherlands.
RP Langer, S (reprint author), Ruhr Univ Bochum, Burn Ctr, Dept Plast & Hand Surg, Buerkle Camp Platz 1, D-44789 Bochum, Germany.
CR Beumer G. J., 1993, Clinical Materials, V14, P21, DOI 10.1016/0267-6605(93)90043-7
   BEUMER GJ, 1994, BIOMATERIALS, V15, P551, DOI 10.1016/0142-9612(94)90022-1
   Brey EM, 2002, MICROVASC RES, V63, P279, DOI 10.1006/mvre.2002.2395
   Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Deodato B, 2002, GENE THER, V9, P777, DOI 10.1038/sj/gt/3301697
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   Harris AG, 1996, AM J PHYSIOL-HEART C, V271, pH2388
   Harris AG, 1997, AM J PHYSIOL-HEART C, V273, pH989
   Jamell GA, 1996, OPHTHALMIC PLAST REC, V12, P127, DOI 10.1097/00002341-199606000-00007
   Klyscz T, 1997, BIOMED TECH, V42, P168, DOI 10.1515/bmte.1997.42.6.168
   Langer S, 1999, J INVEST DERMATOL, V112, P723, DOI 10.1046/j.1523-1747.1999.00579.x
   Langer S, 2002, ANN PLAS SURG, V48, P646, DOI 10.1097/00000637-200206000-00014
   Langer S, 2001, MICROSURG, V21, P317, DOI 10.1002/micr.1058
   Langer S, 2002, ANN PLAS SURG, V48, P53, DOI 10.1097/00000637-200201000-00008
   Lee H, 2002, TRANSPLANTATION, V73, P1589, DOI 10.1097/00007890-200205270-00011
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   MENGER MD, 1994, J CLIN INVEST, V93, P2280, DOI 10.1172/JCI117228
   MENGER MD, 1992, AM J PHYSIOL, V263, pH1901
   MENGER MD, 1990, THORAC CARDIOV SURG, V38, P139, DOI 10.1055/s-2007-1014008
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   Nolte D, 1995, INT J MICROCIRC, V15, P244, DOI 10.1159/000179025
   Nolte D, 1995, INT J MICROCIRC, V15, P9, DOI 10.1159/000179088
   Nor JE, 2001, LAB INVEST, V81, P453
   Papadaki M, 2001, J BIOMED MATER RES, V54, P47, DOI 10.1002/1097-4636(200101)54:1<47::AID-JBM6>3.0.CO;2-3
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Radder AM, 1996, J BIOMED MATER RES, V30, P341
   Sakai H, 2000, MICROVASC RES, V60, P21, DOI 10.1006/mvre.2000.2240
   Soker S, 2000, WORLD J UROL, V18, P10, DOI 10.1007/PL00007070
   van Dorp AGM, 1999, J BIOMED MATER RES, V47, P292, DOI 10.1002/(SICI)1097-4636(19991205)47:3<292::AID-JBM2>3.0.CO;2-B
   VANDORP AGM, 1998, J WOUND REP REG, V6, P556
   VANLOON JA, 1994, 20 ANN M SOC BIOM, P370
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Xiao YL, 1999, J MATER SCI-MATER M, V10, P773, DOI 10.1023/A:1008946832443
   Yang CF, 2000, OPHTHALMIC RES, V32, P19, DOI 10.1159/000055582
NR 37
TC 97
Z9 102
U1 1
U2 22
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN 1
PY 2004
VL 68A
IS 1
BP 10
EP 18
DI 10.1002/jbm.a..20016
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 758TN
UT WOS:000187666400002
PM 14661244
DA 2018-10-20
ER

PT J
AU Porter, AE
   Best, SM
   Bonfield, W
AF Porter, AE
   Best, SM
   Bonfield, W
TI Ultrastructural comparison of hydroxyapatite and silicon-substituted
   hydroxyapatite for biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydroxyapatite; silicon; TEM (transmission electron microscopy);
   bioactivity; defects
ID RESOLUTION ELECTRON-MICROSCOPY; DISSOLUTION; BONE; APATITES; INTERFACE;
   DISLOCATIONS; CERAMICS
AB Silicon-substituted hydroxyapatite (Si-HA) has been shown to lead to significantly increased rates of bone apposition when compared with phase-pure hydroxyapatite (HA) bioceramic implants (Patel N, et al. J Mater Sci Mater Med 2002;13:1199-1206). However, uncertainty remains about the mechanism by which Si increases the in vivo bioactivity. In this study, defect structures in Si-HA were observed and characterized for the first time using high-resolution transmission electron microscopy. Using tilting experiments and the g (.) b = 0 criterion for invisibility, the Burgers vectors of dislocations in phase-pure HA and 0.8 wt % Si-HA were characterized to be screw and mixed in character. Dislocations were observed in both pure HA and 0.8 wt % Si-HA with no significant difference in dislocation density between HA and Si-HA. However, our findings suggest that an increased number of triple junctions in Si-HA may have a significant role in increasing the solubility of the material and the subsequent rate at which bone apposes Si-HA ceramics. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Porter, AE (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   ARENDS J, 1977, CARIES RES, V11, P186, DOI 10.1159/000260266
   BACON HD, 1984, INTRO DISLOCATIONS
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   DACULSI G, 1977, J BIOL BUCCALE, V5, P203
   DACULSI G, 1989, CALCIFIED TISSUE INT, V45, P95, DOI 10.1007/BF02561408
   DALCULSI G, 1989, J BIOMED MATER RES, V23, P883
   Gibson I, 1999, BIOCERAMICS, V12, P191
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   HOLAND W, 1985, J BIOMED MATER RES, V19, P303, DOI 10.1002/jbm.820190311
   *ICDD, 9432 PDF
   Keblinski P, 1997, PHIL MAG LETT, V76, P143, DOI 10.1080/095008397179093
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Layani JD, 2000, J BIOMED MATER RES, V50, P199, DOI 10.1002/(SICI)1097-4636(200005)50:2<199::AID-JBM15>3.0.CO;2-Q
   NELSON DGA, 1983, J ULTRA MOL STRUCT R, V84, P1, DOI 10.1016/S0022-5320(83)90081-3
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6
   POSNER AS, 1969, PHYSIOL REV, V49, P760
   Ruys AJ, 1993, J AUST CERAM SOC, V29, P71
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   TORNITA K, 1996, J MINER PETROL EC GE, V91, P11
   VOEGEL JC, 1977, CALC TISS RES, V24, P19, DOI 10.1007/BF02223292
   Wen SL, 1998, MICROSC RES TECHNIQ, V40, P177, DOI 10.1002/(SICI)1097-0029(19980201)40:3<177::AID-JEMT2>3.0.CO;2-S
NR 24
TC 68
Z9 69
U1 0
U2 25
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN 1
PY 2004
VL 68A
IS 1
BP 133
EP 141
DI 10.1002/jbm.a.20064
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 758TN
UT WOS:000187666400016
PM 14661258
OA Bronze
DA 2018-10-20
ER

PT J
AU Laity, PR
   Taylor, JE
   Wong, SS
   Khunkamchoo, P
   Norris, K
   Cable, M
   Chohan, V
   Andrews, GT
   Johnson, AF
   Cameron, RE
AF Laity, PR
   Taylor, JE
   Wong, SS
   Khunkamchoo, P
   Norris, K
   Cable, M
   Chohan, V
   Andrews, GT
   Johnson, AF
   Cameron, RE
TI Mechanical deformation of polyurethanes
SO JOURNAL OF MACROMOLECULAR SCIENCE-PHYSICS
LA English
DT Article; Proceedings Paper
CT Conference on Synchrotron Radiation in Polymer Science II
CY SEP 04-06, 2002
CL sheffield, ENGLAND
SP European Phys Soc Macromol
DE polyurethane; deformation; 2-dimensional small-angle x-ray scattering;
   transmission electron microscopy
ID X-RAY-SCATTERING; SIMULTANEOUS SMALL-ANGLE; SOFT SEGMENT LENGTH;
   HARD-SEGMENT; BLOCK-COPOLYMERS; ELECTRON-MICROSCOPY; POLYETHYLENE
   DEFORMATION; BIOMEDICAL POLYURETHANES; TENSILE DEFORMATION; LAMELLAR
   STRUCTURES
AB The mechanical properties of thermoplastic polyurethanes (TPU) depend upon their composition and the complex two-phase morphologies, which originate from microphase separation of chains segments. In the present work, poly(ether-urethanes) were prepared with hard segment contents from 36% to 71% by weight, by systematically varying the length of the soft-segment macrodiol. Samples were prepared by hot pressing or solvent casting, and the resulting hard- and soft-segment morphologies were characterized by using small-angle x-ray scattering (SAXS) and transmission electron microscopy (TEM). Environmental scanning electron microscopy (ESEM) was used to study the fracture surfaces of TPU samples. The deformation behavior of the morphology was studied in real time, by using 2-dimensional SAXS (2D-SAXS) at the Daresbury synchrotron radiation source. Two distinct mechanisms were identified, with the dominant mechanism in a given material dependent on the copolymer composition and the extent of microphase separation, which developed during processing.
C1 Univ Leeds, Sch Chem, IRC Polymer Sci & Technol, Leeds LS2 9JT, W Yorkshire, England.
   Univ Cambridge, Cambridge, England.
   Ranier Technol Ltd, Greenhouse Pk Innovat Ctr, Cambridge, England.
RP Johnson, AF (reprint author), Univ Leeds, Sch Chem, IRC Polymer Sci & Technol, Leeds LS2 9JT, W Yorkshire, England.
EM a.f.johnson@chemistry.leeds.ac.uk
OI Cameron, Ruth/0000-0003-1573-4923; Laity, Peter/0000-0001-8608-875X
CR Blundell DJ, 2002, POLYMER, V43, P5197, DOI 10.1016/S0032-3861(02)00386-5
   BROWN HR, 1981, J MACROMOL SCI PHYS, VB19, P487, DOI 10.1080/00222348108015315
   BUTLER MF, 1995, MACROMOLECULES, V28, P6383, DOI 10.1021/ma00123a001
   Butler MF, 1997, POLYMER, V38, P5521, DOI 10.1016/S0032-3861(97)00111-0
   Chen TK, 1997, MACROMOLECULES, V30, P5068, DOI 10.1021/ma9618639
   Chen TK, 1998, MACROMOLECULES, V31, P1312, DOI 10.1021/ma970913m
   Chen ZR, 1997, MACROMOLECULES, V30, P7096, DOI 10.1021/ma9706743
   CHENTSAI CHY, 1986, POLYMER, V27, P659, DOI 10.1016/0032-3861(86)90121-7
   COATES PD, 1994, P ANTEC, P1654
   Cohen Y, 2000, MACROMOLECULES, V33, P6502, DOI 10.1021/ma000513q
   DESPER CR, 1985, MACROMOLECULES, V18, P2755, DOI 10.1021/ma00154a067
   Fambri L, 2001, J APPL POLYM SCI, V81, P1216, DOI 10.1002/app.1544
   GALAMBOS AF, 1989, POLYM MATER SCI ENG, V61, P359
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Garrett JT, 2000, MACROMOLECULES, V33, P6353, DOI 10.1021/ma000600i
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   Hamley I. W, 1998, PHYS BLOCK COPOLYMER
   HAMLEY IW, 2000, ITNRO SOFT MATTER, P109
   Hatakeyama T., 1999, THERMAL ANAL FUNDAME, P90
   Hentschel T, 2001, POLYMER, V42, P3195, DOI 10.1016/S0032-3861(00)00489-4
   Hepburn C., 1992, POLYURETHANE ELASTOM
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HU WC, 1994, J POLYM SCI POL PHYS, V32, P437, DOI 10.1002/polb.1994.090320304
   Kaushiva BD, 2000, POLYMER, V41, P6987, DOI 10.1016/S0032-3861(99)00860-5
   KOBERSTEIN JT, 1983, J POLYM SCI POL PHYS, V21, P1439, DOI 10.1002/pol.1983.180210814
   KOBERSTEIN JT, 1986, MACROMOLECULES, V19, P714, DOI 10.1021/ma00157a039
   KOBERSTEIN JT, 1992, MACROMOLECULES, V25, P5618, DOI 10.1021/ma00047a010
   Krakovsky I, 1997, POLYMER, V38, P3637, DOI 10.1016/S0032-3861(96)00897-X
   Lee DK, 2000, J APPL POLYM SCI, V75, P167, DOI 10.1002/(SICI)1097-4628(20000103)75:1<167::AID-APP19>3.0.CO;2-N
   LEE HS, 1994, J POLYM SCI POL PHYS, V32, P2085, DOI 10.1002/polb.1994.090321215
   Lee HS, 1999, J POLYM SCI POL PHYS, V37, P3233
   LI C, 1990, POLYMER, V31, P3, DOI 10.1016/0032-3861(90)90339-Z
   LIN SB, 1985, COLLOID POLYM SCI, V263, P128, DOI 10.1007/BF01412787
   MACOSKO CW, 1989, REACTION INJECTION M
   Martin DJ, 1996, J APPL POLYM SCI, V62, P1377
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   Martin DJ, 1999, J APPL POLYM SCI, V71, P937
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   Murthy NS, 2002, J POLYM SCI POL PHYS, V40, P691, DOI 10.1002/polb.10128
   Pegoretti A, 1998, J APPL POLYM SCI, V70, P577, DOI 10.1002/(SICI)1097-4628(19981017)70:3<577::AID-APP20>3.0.CO;2-X
   REYNOLDS N, 1994, MACROMOL CHEM PHYSIC, V195, P2855, DOI 10.1002/macp.1994.021950816
   Roe R.-J., 2000, METHODS XRAY NEUTRON
   RYAN AJ, 1992, MACROMOLECULES, V25, P6277, DOI 10.1021/ma00049a026
   RYAN AJ, 1993, J THERM ANAL, V40, P887, DOI 10.1007/BF02546847
   RYAN AJ, 1993, POLYMER, V34, P4020, DOI 10.1016/0032-3861(93)90662-T
   Saiani A, 2001, MACROMOLECULES, V34, P9059, DOI 10.1021/ma0105993
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   SASANUMA Y, 1993, J POLYM SCI POL PHYS, V31, P1179, DOI 10.1002/polb.1993.090310912
   SERRANO M, 1987, POLYMER, V28, P1667, DOI 10.1016/0032-3861(87)90009-7
   Servay T, 2000, POLYMER, V41, P5247, DOI 10.1016/S0032-3861(99)00743-0
   Shieh YT, 1999, J POLYM SCI POL CHEM, V37, P4126
   Shirasaka H, 2000, MACROMOLECULES, V33, P2776, DOI 10.1021/ma9917904
   Stribeck N, 1999, MACROMOLECULES, V32, P3368, DOI 10.1021/ma9818477
   Stribeck N, 2001, MACROMOLECULES, V34, P7758, DOI 10.1021/ma010603a
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   VICKERS ME, 1995, POLYMER, V36, P2667, DOI 10.1016/0032-3861(95)91216-T
   Wang H, 1997, MACROMOLECULES, V30, P982, DOI 10.1021/ma961269z
   Zhang XC, 2000, POLYMER, V41, P3797, DOI 10.1016/S0032-3861(99)00594-7
NR 59
TC 21
Z9 21
U1 1
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0022-2348
J9 J MACROMOL SCI PHYS
JI J. Macromol. Sci.-Phys.
PY 2004
VL B43
IS 1
BP 95
EP 124
DI 10.1081/MB-120027753
PG 30
WC Polymer Science
SC Polymer Science
GA 801IS
UT WOS:000220090200007
DA 2018-10-20
ER

PT J
AU Woods, HM
   Silva, MMCG
   Nouvel, C
   Shakesheff, KM
   Howdle, SM
AF Woods, HM
   Silva, MMCG
   Nouvel, C
   Shakesheff, KM
   Howdle, SM
TI Materials processing in supercritical carbon dioxide: surfactants,
   polymers and biomaterials
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Review
ID GROWTH-FACTOR DELIVERY; MOLECULAR-WEIGHT POLYETHYLENE; FREE-RADICAL
   POLYMERIZATION; PSEUDO-GRAFT STABILIZER; IN-SITU POLYMERIZATION; VIVO
   BONE-FORMATION; DISPERSION POLYMERIZATION; METHYL-METHACRYLATE;
   WATER-IN-CO2 MICROEMULSIONS; SWELLING AGENT
AB Supercritical carbon dioxide (scCO(2)) is a unique solvent with a wide range of interesting properties. This review focuses upon recent advances in the use of scCO(2) in materials synthesis and materials processing. In particular, we consider the advances made in three major areas. First the design and application of new surfactants for use in scCO(2), which enable the production of metal nanoparticles, porous polymers and polymers of high molecular weight with excellent morphology. Second the development of new polymer processing and polymer blend technologies in scCO2, which enable the synthesis of some very complex polymer composites and blends. Finally, the application of scCO(2) in the preparation of novel biomedical materials, for example biodegradable polymer particles and scaffolds. The examples described here highlight that scCO(2) allows facile synthesis and processing of materials, leading to new products with properties that would otherwise be very difficult to achieve.
C1 Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.
   Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Howdle, SM (reprint author), Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England.
EM steve.howdle@nottingham.ac.uk
RI Nouvel, Cecile/B-6942-2012; Howdle, Steven/A-2954-2010; Shakesheff,
   Kevin/O-6371-2018
OI Nouvel, Cecile/0000-0002-4154-187X; Howdle, Steven/0000-0001-5901-8342;
   Shakesheff, Kevin/0000-0003-3236-2439
CR Abbett KF, 2003, MACROMOLECULES, V36, P3015, DOI 10.1021/ma021151
   Andersson MR, 1999, J MATER CHEM, V9, P1933, DOI 10.1039/a902859e
   Arora KA, 1999, MACROMOLECULES, V32, P2562, DOI 10.1021/ma981794t
   Arora KA, 1998, MACROMOLECULES, V31, P4614, DOI 10.1021/ma971811z
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   BARRY JJA, 2004, UNPUB
   Beecroft LL, 1997, CHEM MATER, V9, P1302, DOI 10.1021/cm960441a
   Boggess RK, 1997, J APPL POLYM SCI, V64, P1309, DOI 10.1002/(SICI)1097-4628(19970516)64:7<1309::AID-APP10>3.0.CO;2-S
   BOTT DC, 1986, HDB CONDUCTING POLYM
   Bratton D, 2003, MACROMOLECULES, V36, P5908, DOI 10.1021/ma034453a
   BRATTON D, 2003, UNPUB
   Busby AJ, 2003, J MATER CHEM, V13, P2838, DOI 10.1039/b304082h
   Butler R, 2001, ADV MATER, V13, P1459, DOI 10.1002/1521-4095(200110)13:19<1459::AID-ADMA1459>3.0.CO;2-K
   Butler R, 2003, J AM CHEM SOC, V125, P14473, DOI 10.1021/ja037570u
   Campbell ML, 2001, LANGMUIR, V17, P5458, DOI 10.1021/la0104166
   Canelas DA, 1997, MACROMOLECULES, V30, P5673, DOI 10.1021/ma970579u
   Caskey TC, 2003, J APPL POLYM SCI, V88, P1600, DOI 10.1002/app.11837
   Castro C, 2000, CHEM MATER, V12, P3681, DOI 10.1021/cm0011561
   Chattopadhyay P, 2002, IND ENG CHEM RES, V41, P6049, DOI 10.1021/ie020205b
   Chattopadhyay P, 2003, IND ENG CHEM RES, V42, P465, DOI 10.1021/ie020261c
   Chattopadhyay P, 2000, IND ENG CHEM RES, V39, P2281, DOI 10.1021/ie990729k
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Christian P, 2000, MACROMOLECULES, V33, P237, DOI 10.1021/ma991268h
   Christian P, 2000, MACROMOLECULES, V33, P9222, DOI 10.1021/ma0008948
   Clarke MJ, 1997, J AM CHEM SOC, V119, P6399, DOI 10.1021/ja9639527
   Cooper AI, 2003, ADV MATER, V15, P1049, DOI 10.1002/adma.200300380
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   Cooper AI, 2001, ADV MATER, V13, P1111, DOI 10.1002/1521-4095(200107)13:14<1111::AID-ADMA1111>3.0.CO;2-L
   da Rocha SRP, 2000, LANGMUIR, V16, P3690, DOI 10.1021/la9912601
   da Rocha SRP, 2003, LANGMUIR, V19, P3114, DOI 10.1021/la026608y
   da Rocha SRP, 1999, LANGMUIR, V15, P419, DOI 10.1021/la980844k
   da Rocha SRP, 2002, J PHYS CHEM B, V106, P13250, DOI 10.1021/jp021485b
   da Rocha SRP, 2001, J COLLOID INTERF SCI, V239, P241, DOI 10.1006/jcis.2001.7544
   Dai XH, 2002, MACROMOL RAPID COMM, V23, P626, DOI 10.1002/1521-3927(20020701)23:10/11<626::AID-MARC626>3.0.CO;2-Q
   DeSimone JM, 2001, CURR OPIN SOLID ST M, V5, P333, DOI 10.1016/S1359-0286(00)00041-3
   Ding LH, 2003, MACROMOLECULES, V36, P4779, DOI 10.1021/ma026015u
   Dos Santos IR, 2002, INT J PHARM, V242, P69
   Eastoe J, 2003, J COLLOID INTERF SCI, V258, P367, DOI 10.1016/S0021-9797(02)00104-2
   Eastoe J, 2002, LANGMUIR, V18, P3014, DOI 10.1021/la015576w
   Eastoe J, 2001, J AM CHEM SOC, V123, P988, DOI 10.1021/ja005795o
   Fu YP, 1997, MACROMOLECULES, V30, P7611, DOI 10.1021/ma9710747
   FURNO F, 2004, UNPUB
   Galia A, 2003, IND ENG CHEM RES, V42, P448, DOI 10.1021/ie020382c
   Giles MR, 2003, EUR POLYM J, V39, P1785, DOI 10.1016/S0014-3057(03)00102-2
   Giles MR, 2001, MACROMOLECULES, V34, P20, DOI 10.1021/ma001369b
   Giles MR, 2001, EUR POLYM J, V37, P1347, DOI 10.1016/S0014-3057(00)00258-5
   Giles MR, 2000, MACROMOLECULES, V33, P1996, DOI 10.1021/ma991650u
   Giles MR, 2000, POLYMER, V41, P6715, DOI 10.1016/S0032-3861(00)00009-4
   Giles MR, 2000, MACROMOL RAPID COMM, V21, P1019, DOI 10.1002/1521-3927(20001001)21:15<1019::AID-MARC1019>3.3.CO;2-D
   Green JW, 2000, POLYM ADVAN TECHNOL, V11, P820, DOI 10.1002/1099-1581(200008/12)11:8/12<820::AID-PAT31>3.0.CO;2-O
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hanrahan JP, 2003, LANGMUIR, V19, P3145, DOI 10.1021/la026438p
   HAO J, 2004, IN PRESS J PHARM SCI
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hems WP, 1999, J MATER CHEM, V9, P1403, DOI 10.1039/a901105f
   Hentze H. P., 2002, REV MOL BIOTECHNOL, V90, P27, DOI [DOI 10.1016/S1389-0352(01)00046-0, 10.1016/S1389-0352(01)00046-0]
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Hile DD, 2001, J POLYM SCI POL CHEM, V39, P562, DOI 10.1002/1099-0518(20010215)39:4<562::AID-POLA1027>3.0.CO;2-L
   Holmes JD, 1999, LANGMUIR, V15, P6613, DOI 10.1021/la990510a
   Holmes JD, 1998, LANGMUIR, V14, P6371, DOI 10.1021/la9806956
   Howard D, 2002, BIOCHEM BIOPH RES CO, V299, P208, DOI 10.1016/S0006-291X(02)02561-5
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   HOWDLE SM, 2003, MAT NEW CHEM    0331
   HOWDLE SM, 1998, BIOFUNCTIONAL POLYM
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jacobson GB, 1999, J ORG CHEM, V64, P1201, DOI 10.1021/jo981825i
   Ji M, 1999, J AM CHEM SOC, V121, P2631, DOI 10.1021/ja9840403
   Jia XQ, 2002, LANGMUIR, V18, P683, DOI 10.1021/la010768c
   Johnston KP, 1996, SCIENCE, V271, P624, DOI 10.1126/science.271.5249.624
   Johnston KP, 2001, LANGMUIR, V17, P7191, DOI 10.1021/la0110388
   Johnston KP, 2000, CURR OPIN COLLOID IN, V5, P351
   Jung J, 2001, J SUPERCRIT FLUID, V20, P179, DOI 10.1016/S0896-8446(01)00064-X
   Kameo A, 2003, COLLOID SURFACE A, V215, P181, DOI 10.1016/S0927-7757(02)00439-9
   Kazarian S. G., 2000, POLYM SCI SER C, V42, P78, DOI DOI 10.1080/03602549909351647
   Keiper JS, 2002, J AM CHEM SOC, V124, P1834, DOI 10.1021/ja0122142
   Kendall JL, 1999, CHEM REV, V99, P543, DOI 10.1021/cr9700336
   Kerc J, 1999, INT J PHARM, V182, P33, DOI 10.1016/S0378-5173(99)00063-0
   Kikic I, 2003, IND ENG CHEM RES, V42, P3022, DOI 10.1021/ie020961h
   KIRBY CF, 1999, CHEM REV, P99
   KOKTURK G, 2001, 7 INT WORKSH POL REA, P79
   Kung E, 2000, MACROMOLECULES, V33, P8192, DOI 10.1021/ma000695o
   Kung E, 1998, MACROMOLECULES, V31, P4160, DOI 10.1021/ma980140h
   Kyung-Nam L., 2000, POLYM INT, V49, P712
   Lardini E., 1991, USE SUPERCRITICAL FL
   Lee CT, 2000, J PHYS CHEM B, V104, P11094
   Lee CT, 2003, J AM CHEM SOC, V125, P3181, DOI 10.1021/ja025735d
   Lee JY, 2002, J NANOPART RES, V4, P53, DOI 10.1023/A:1020107522135
   Levesque I, 1997, MACROMOLECULES, V30, P4347, DOI 10.1021/ma961892j
   Li D, 2000, MACROMOLECULES, V33, P4555, DOI 10.1021/ma991745w
   Li D, 2002, POLYMER, V43, P5363, DOI 10.1016/S0032-3861(02)00374-9
   Li D, 2001, POLYMER, V42, P2331, DOI 10.1016/S0032-3861(00)00601-7
   Li D, 2000, IND ENG CHEM RES, V39, P4506, DOI 10.1021/ie000228v
   Li G, 2000, MACROMOLECULES, V33, P4008, DOI 10.1021/ma9921504
   Licence P, 2003, GREEN CHEM, V5, P99, DOI 10.1039/b212220k
   Liu HW, 2003, LANGMUIR, V19, P1106, DOI 10.1021/la026614u
   Liu JC, 2002, LANGMUIR, V18, P3086, DOI 10.1021/la011721u
   Liu JC, 2002, CHEM-EUR J, V8, P1356, DOI 10.1002/1521-3765(20020315)8:6<1356::AID-CHEM1356>3.0.CO;2-N
   Liu ZM, 2002, CHEM MATER, V14, P4619, DOI 10.1021/cm0203215
   Liu ZT, 2001, LANGMUIR, V17, P274, DOI 10.1021/la000947e
   Loeker F, 2003, COLLOID SURFACE A, V214, P143, DOI 10.1016/S0927-7757(02)00407-7
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   MCCOY M, 1999, CHEM ENG NEWS   0426, P10
   McLeod MC, 2003, J PHYS CHEM B, V107, P2693, DOI 10.1021/jp0218645
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   MOONEY DJ, 1996, BIOMATERIALS, V17, P1471
   Morley KS, 2004, J MATER CHEM, V14, P1212, DOI 10.1039/b311065f
   Morley KS, 2002, J MATER CHEM, V12, P1898, DOI 10.1039/b111111f
   Moshashaee S, 2003, J PHARM PHARMACOL, V55, P185, DOI 10.1211/002235702504
   Muth O, 2000, J SUPERCRIT FLUID, V17, P65, DOI 10.1016/S0896-8446(99)00042-X
   Nazem N, 2002, J SUPERCRIT FLUID, V23, P43, DOI 10.1016/S0896-8446(01)00130-9
   O'Neil AS, 2002, J AM CHEM SOC, V124, P10636, DOI 10.1021/ja026111a
   Ohde H, 2002, NANO LETT, V2, P721, DOI 10.1021/nl010084p
   Ohde H, 2002, J AM CHEM SOC, V124, P4540, DOI 10.1021/ja012232j
   Ohde H, 2001, CHEM MATER, V13, P4130, DOI 10.1021/cm010030g
   OHDE H, 2000, NANO LETT, P2353
   Partridge K, 2002, BIOCHEM BIOPH RES CO, V292, P144, DOI 10.1006/bbrc.2002.6623
   Potluri VK, 2002, ORG LETT, V4, P2333, DOI 10.1021/ol026007y
   Psathas PA, 2000, IND ENG CHEM RES, V39, P2655, DOI 10.1021/ie990779p
   Rajagopalan P, 1998, MACROMOLECULES, V31, P4791, DOI 10.1021/ma9718816
   Ramos J, 2000, POLYMER, V41, P8461, DOI 10.1016/S0032-3861(00)00272-X
   Raveendran P, 2002, J AM CHEM SOC, V124, P7274, DOI 10.1021/ja025508b
   Rehman M, 2001, J PHARM SCI-US, V90, P1570, DOI 10.1002/jps.1107
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Ryoo W, 2003, IND ENG CHEM RES, V42, P6348, DOI 10.1021/ie0300427
   Salaniwal S, 2001, LANGMUIR, V17, P1773, DOI 10.1021/la000554f
   Salaniwal S, 2001, LANGMUIR, V17, P1784, DOI 10.1021/la0005558
   Sarbu T, 2000, NATURE, V405, P165, DOI 10.1038/35012040
   SencarBozic P, 1997, INT J PHARM, V148, P123, DOI 10.1016/S0378-5173(96)04838-7
   Shakesheff K, 2003, CHEM BRIT, V39, P30
   Shen Z, 2003, POLYMER, V44, P1491, DOI 10.1016/S0032-3861(03)00020-X
   Shenoy SL, 2001, SYNTHETIC MET, V123, P509, DOI 10.1016/S0379-6779(01)00367-8
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shieh YT, 1996, J APPL POLYM SCI, V59, P707, DOI 10.1002/(SICI)1097-4628(19960124)59:4<707::AID-APP16>3.3.CO;2-D
   Shieh YT, 1996, J APPL POLYM SCI, V59, P695, DOI 10.1002/(SICI)1097-4628(19960124)59:4<695::AID-APP15>3.0.CO;2-P
   Shiho H, 2000, J POLYM SCI POL CHEM, V38, P3783, DOI 10.1002/1099-0518(20001015)38:20<3783::AID-POLA90>3.0.CO;2-X
   Shiho H, 2001, MACROMOLECULES, V34, P1198, DOI 10.1021/ma0010074
   Shiho H, 2000, J POLYM SCI POL CHEM, V38, P1146, DOI 10.1002/(SICI)1099-0518(20000401)38:7<1146::AID-POLA13>3.0.CO;2-8
   Stakheev AY, 1999, APPL CATAL A-GEN, V188, P3, DOI 10.1016/S0926-860X(99)00232-X
   Stanton LA, 2002, AUST J CHEM, V55, P443, DOI 10.1071/CH02058
   Steytler DC, 2001, LANGMUIR, V17, P7948, DOI 10.1021/la010758b
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tang M, 2003, EUR POLYM J, V39, P151, DOI 10.1016/S0014-3057(02)00168-4
   Tang M, 2003, EUR POLYM J, V39, P143, DOI 10.1016/S0014-3057(02)00167-2
   Taylor DK, 2002, IND ENG CHEM RES, V41, P4451, DOI 10.1021/ie010715q
   Thiering R, 2001, J SUPERCRIT FLUID, V21, P159, DOI 10.1016/S0896-8446(01)00090-0
   TOM JW, 1994, J SUPERCRIT FLUID, V7, P9, DOI 10.1016/0896-8446(94)90003-5
   TOM JW, 1993, ACS SYM SER, V514, P238
   TOM JW, 1991, J AEROSOL SCI, V22, P555, DOI 10.1016/0021-8502(91)90013-8
   TOMASKO DL, 2003, IND ENG CHEM RES
   Tominaga Y, 2003, MACROMOLECULES, V36, P8766, DOI 10.1021/ma030207n
   Vaia RA, 1997, J POLYM SCI POL PHYS, V35, P59
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Wang WX, 2002, POLYMER, V43, P6653, DOI 10.1016/S0032-3861(02)00579-7
   Wang WX, 2003, EUR POLYM J, V39, P423, DOI 10.1016/S0014-3057(02)00249-5
   Wang WX, 2003, MACROMOLECULES, V36, P5424, DOI 10.1021/ma0259923
   Wang WX, 2003, POLYMER, V44, P3803, DOI 10.1016/S0032-3861(03)00310-0
   WATKINS JJ, 1995, CHEM MATER, V7, P1991, DOI 10.1021/cm00059a001
   Watkins JJ, 1999, CHEM MATER, V11, P213, DOI 10.1021/cm981016f
   WATKINS JJ, 1994, MACROMOLECULES, V27, P4845, DOI 10.1021/ma00095a031
   Watson MS, 2002, ADV MATER, V14, P1802, DOI 10.1002/adma.200290003
   Webb PB, 2000, PURE APPL CHEM, V72, P1347, DOI 10.1351/pac200072071347
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Wood CD, 2001, MACROMOLECULES, V34, P5, DOI 10.1021/ma001514l
   Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764
   Wyre RM, 2000, BIOMATERIALS, V21, P335, DOI 10.1016/S0142-9612(99)00185-4
   Yang XB, 2003, J BONE MINER RES, V18, P1366
   Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Ye WJ, 2000, IND ENG CHEM RES, V39, P4564, DOI 10.1021/ie000184q
   Ye XG, 2003, J CHEM EDUC, V80, P198, DOI 10.1021/ed080p198
   Yeo SY, 2003, J MATER SCI, V38, P2143, DOI 10.1023/A:1023767828656
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Yu KMK, 2003, J MATER CHEM, V13, P130, DOI 10.1039/b207064b
   Zerda AS, 2003, MACROMOLECULES, V36, P1603, DOI 10.1021/ma0213450
   Zhang JX, 2002, MACROMOLECULES, V35, P8869, DOI 10.1021/ma012258v
   Zhu J, 2003, CATAL TODAY, V81, P673, DOI 10.1016/S0920-5861(03)00165-2
   Zhu J, 2002, CHEM COMMUN, P2044, DOI 10.1039/b205673a
   UNIQEMA
NR 180
TC 214
Z9 217
U1 5
U2 97
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2004
VL 14
IS 11
BP 1663
EP 1678
DI 10.1039/b315262f
PG 16
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 823SW
UT WOS:000221634500001
DA 2018-10-20
ER

PT J
AU Vakiparta, M
   Koskinen, MK
   Vallittu, P
   Narhi, T
   Yli-Urpo, A
AF Vakiparta, M
   Koskinen, MK
   Vallittu, P
   Narhi, T
   Yli-Urpo, A
TI In vitro cytotoxicity of E-glass fiber weave preimpregnated with novel
   biopolymer
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ACRYLIC BONE-CEMENT; MECHANICAL-PROPERTIES
AB The aim of this study was to investigate cytotoxicity of composition of E-glass fibers and novel biopolymer of poly(hydroxyproline). Growth and proliferation of the human gingival fibroblast cells on the surface of the materials was evaluated. The number of cells grown and proliferated on cell culture plastic was used as a control. Bi-directional fiber weaves were preimpregnated with poly(hydroxyproline). Cytotoxicities of the preimpregnated and non-impregnated materials were evaluated by the release of lactate dehydrogenase from the cells during the culture period of 24 h. The values of the lactate dehydrogenase activity of the materials' extracts showed non-toxicity for poly(hydroxyproline) preimpregnated E-glass fiber weaves. The growth of fibroblasts on the surface of the materials appeared normal after 11 days culture period; they looked healthy and normal in size and shape. The results of this study suggest that based on its' non-cytotoxicity the composition of E-glass fibers and poly(hydroxyproline) can further be evaluated as a material that is suitable for biomedical use. (C) 2004 Kluwer Academic Publishers.
C1 Univ Turku, Inst Dent, Turku Ctr Biomat, FIN-20520 Turku, Finland.
   Univ Turku, Inst Dent, Dept Prosthet Dent & Biomat Res, FIN-20520 Turku, Finland.
RP Vakiparta, M (reprint author), Univ Turku, Inst Dent, Turku Ctr Biomat, Itainen Pitkakatu 4B, FIN-20520 Turku, Finland.
CR KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6
   LARJAVA H, 1988, BIOCHEM J, V256, P35, DOI 10.1042/bj2560035
   Lim YB, 1999, J AM CHEM SOC, V121, P5633, DOI 10.1021/ja984012k
   Muh E, 2002, BIOMATERIALS, V23, P2849, DOI 10.1016/S0142-9612(01)00411-2
   PETTY W, 1980, J BIOMED MATER RES, V14, P427, DOI 10.1002/jbm.820140409
   Puska MA, 2003, BIOMATERIALS, V24, P417, DOI 10.1016/S0142-9612(02)00354-X
   PUSKA MA, 2000, POLYM PREPRINTS, V41, P1050
   SAHA S, 1984, J BIOMECH, V17, P467, DOI 10.1016/0021-9290(84)90015-0
   Sperling L.H., 1994, ADV CHEM SER, V239, P4
   VAKIPARTA M, UNPUB J MAT SCI MAT
   Vallittu P K, 1997, Quintessence Int, V28, P39
   Vallittu PK, 1999, J ORAL REHABIL, V26, P666, DOI 10.1046/j.1365-2842.1999.00431.x
NR 12
TC 11
Z9 11
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2004
VL 15
IS 1
BP 69
EP 72
DI 10.1023/B:JMSM.0000010099.58361.1b
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 757EF
UT WOS:000187535300010
PM 15338593
DA 2018-10-20
ER

PT J
AU Nguyen, NT
   Truong, TQ
   Wong, KK
   Ho, SS
   Low, CLN
AF Nguyen, NT
   Truong, TQ
   Wong, KK
   Ho, SS
   Low, CLN
TI Micro check valves for integration into polymeric microfluidic devices
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
ID SIMULATION; SYSTEMS; MEMS
AB In this paper we describe the design, simulation, fabrication and characterization of micro check valves suitable for integration into polymeric microfluidic devices such as micropumps or test cartridges for biomedical analysis. The valves are fabricated by a polymeric surface micromachining process,which utilizes SU-8 as the functional material. The devices are assembled with the lamination technique. A micro check valve consists of three layers: an inlet layer, a valve layer and an outlet layer. The valve is a disc with a diameter of 1 mm. The disc is suspended on folded beams, which act as valve springs. Both valve disc and springs are fabricated in a 100 mum SU-8 layer. The valves prove a clear flow rectification function. Relatively low pressure is required for opening the valve. The valves were tested and characterized with water. One of the valves is successfully integrated into a polymeric micropump. These valves prove the facile and reliable lamination technology for the fabrication of complex polymeric microfluidic devices for biomedical analysis.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
   Singapore Polytech, Sch Elect & Elect Engn, Singapore 139651, Singapore.
RP Nguyen, NT (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mntnguyen@ntu.edu.sg
RI Nguyen, Nam-Trung/A-4180-2008; NTU, S'gapore/F-4683-2012
OI Nguyen, Nam-Trung/0000-0003-3626-5361; 
CR Anderson RC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e60
   BOEHM S, 1999, SENSOR ACTUAT A-PHYS, V77, P223
   Grover WH, 2003, SENSOR ACTUAT B-CHEM, V89, P315, DOI 10.1016/S0925-4005(02)00468-9
   Howell LL, 2001, COMPLIANT MECH
   KOCH M, 1995, P MICR EUR COP, P160
   Krulevitch P, 2002, BIOMED MICRODEVICES, V4, P301, DOI 10.1023/A:1020958323891
   Linder V, 2002, ELECTROPHORESIS, V23, P740, DOI 10.1002/1522-2683(200203)23:5<740::AID-ELPS740>3.0.CO;2-7
   Lorenz H, 1997, J MICROMECH MICROENG, V7, P121, DOI 10.1088/0960-1317/7/3/010
   Medintz I, 2001, GENOME RES, V11, P413, DOI 10.1101/gr.164701
   Nguyen N.-T, 2002, FUNDAMENTALS APPL MI
   Nguyen NT, 2002, J FLUID ENG-T ASME, V124, P384, DOI 10.1115/1.1459075
   NGUYEN NT, 2003, IN PRESS SENSORS A B
   PAEGEL BM, 2002, P NATL ACAD SCI USA, V99, P254
   Parise JJ, 2001, MECH MACH THEORY, V36, P1281, DOI 10.1016/S0094-114X(01)00051-9
   RAPP R, 1994, SENSOR ACTUAT A-PHYS, V40, P57, DOI 10.1016/0924-4247(94)85030-5
   SCHOMBURG WK, 1994, J MICROMECH MICROENG, V4, P186, DOI 10.1088/0960-1317/4/4/003
   SHOJI S, 1994, J MICROMECH MICROENG, V4, P157, DOI 10.1088/0960-1317/4/4/001
   Tamanaha CR, 2002, J MICROMECH MICROENG, V12, pN7, DOI 10.1088/0960-1317/12/2/401
   Taylor MT, 2003, J MICROMECH MICROENG, V13, P201, DOI 10.1088/0960-1317/13/2/306
   Ulrich J, 1996, SENSOR ACTUAT A-PHYS, V53, P379, DOI 10.1016/0924-4247(96)80162-2
NR 20
TC 68
Z9 71
U1 3
U2 13
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD JAN
PY 2004
VL 14
IS 1
BP 69
EP 75
AR PII S0960-1317(04)63312-2
DI 10.1088/0960-1317/14/1/309
PG 7
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 771PZ
UT WOS:000188796400009
DA 2018-10-20
ER

PT J
AU Altaf, WJ
   Akanle, OA
   Admans, LL
   Beasley, D
   Butler, C
   Spyrou, NM
AF Altaf, WJ
   Akanle, OA
   Admans, LL
   Beasley, D
   Butler, C
   Spyrou, NM
TI The University of Surrey database of elemental composition of human hair
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Article
ID NIGERIAN SUBJECTS; HEAD HAIR
AB The elemental composition of human hair obtained from different studies at Surrey University over a period of 25 years has been recorded and forms part of a database, for biological and environmental samples, which is being developed. Instrumental neutron activation analysis (INAA), using reactor neutrons, was the principal method employed and from which reported data are presented. Elemental concentrations of Br, Ca, Ce, Cl, Co, Cr, Cs, F, Fe, Hf, K, Mg, Mn, Na, Rb, Sb, Sc, Se, V and Zn were obtained and recorded in the database. Chronological variations in two sets of subjects separated by a period of time of 16 years are also given. Variations in the concentration values of some elements related to the state of health and disease were reported for hair samples collected from subjects suffering from manic depression, senile dementia and breast cancer. Concentration values of some elements with relation to the nationality of subjects from Bulgaria, England, Kenya, Nigeria and Wales are presented and compared. This study is part of on-going research in the analysis of biomedical and bioenvironmental materials. The database is still in its infancy.
C1 Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England.
   Univ Umm Al Qura, Dept Phys, Mecca, Saudi Arabia.
RP Altaf, WJ (reprint author), Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England.
EM w.altaf@surrey.ac.uk
RI Beasley, Daniel/J-6811-2013
OI Beasley, Daniel/0000-0003-1433-9016
CR AKANLE OA, 1987, J RADIOAN NUCL CH AR, V113, P405, DOI 10.1007/BF02050514
   BENSON CA, 1969, CLIN CHEM ABS, P23
   IYENGAR GV, 1987, ELEMENTAL COMPOSITIO
   OJO JO, 1994, BIOL TRACE ELEM RES, V43-5, P453, DOI 10.1007/BF02917347
   OLUWOLE AF, 1994, BIOL TRACE ELEM RES, V43-5, P443, DOI 10.1007/BF02917346
   OTHMAN I, 1980, SCI TOTAL ENVIRON, V16, P267, DOI 10.1016/0048-9697(80)90111-4
   SANDERS JM, 1982, MINERAL ELEMENTS, V2, P475
   WARD NI, 1987, J RADIOAN NUCL CH AR, V114, P125, DOI 10.1007/BF02048883
NR 8
TC 5
Z9 5
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0236-5731
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PY 2004
VL 259
IS 3
BP 493
EP 498
DI 10.1023/B:JRNC.0000020925.61388.d8
PG 6
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA 805XU
UT WOS:000220399800025
DA 2018-10-20
ER

PT J
AU O'Connor, A
   Riga, A
   Turner, JF
AF O'Connor, A
   Riga, A
   Turner, JF
TI Determination of crystalline content gradients in cold-drawn
   poly-L-lactic acid films by DSC
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE crystallinity; DSC; osteogenesis; PLLA; scaffold; XRD
ID IN-VITRO HYDROLYSIS; MOLECULAR-WEIGHT; ENANTIOMERIC POLY(LACTIDE)S;
   POLY(L-LACTIC ACID); DEGRADATION; IMPROVEMENT; MONOLAYERS; SCAFFOLDS;
   BLENDS
AB Poly-L-lactic acid (PLLA) is a semi-crystalline, optically active, biodegradable, and biocompatible polymer that has been utilized extensively in biomedical applications as an implantable artificial cell scaffold material. In its crystalline form, PLLA is piezoelectric and it has been implicated in the enhancement of electromechanically induced osteogenesis in vivo. In its amorphous state, however, PLLA does not exhibit piezoelectricity. By uniaxially cold-drawing the polymer, PLLA can be endowed with varying degrees of piezoelectricity. It is important to understand the crystalline architecture of drawn PLLA so that the osteogenic potential imparted by piezoelectricity, if any, can be differentiated from the effects of sample crystallinity. In our work we investigate the induced crystallinity for samples of drawn PLLA at draw ratios between 1.0 and 5.5 by differential scanning calorimetry (DSC). As long-range molecular ordering occurs along the draw axis, we observe an increase in the average percent crystallinity up to a draw ratio of 5.0 and a slight decrease at a draw ratio of 5.5. More importantly, we observe significant heterogeneity in the crystalline content along the draw axis of standard dumbbells cut from PLLA and cold-drawn to representative draw ratios of 2.5 and 4.0. On average, the highest percent crystallinity occurs nearest the dumbbell center, but the maximum crystallinity is independent of draw ratio. Therefore, the draw ratio should not be considered a semi-quantitative estimate of localized PLLA crystallinity and point-to-point analysis of crystallinity in PLLA samples is required for constructing scaffolds with enhanced cell growth properties.
C1 Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA.
RP Turner, JF (reprint author), Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA.
EM j.f.turner@csuohio.edu
CR ALEXANDER LE, 1969, XRAY DIFFRACTION MET, P335
   Altpeter H, 2004, J MATER SCI-MATER M, V15, P175, DOI 10.1023/B:JMSM.0000011820.64572.a5
   BILLMEYER FW, 1984, TXB POLYM SCI, P280
   Borden M, 2002, J BIOMED MATER RES, V61, P421, DOI 10.1002/jbm.10201
   CAM D, 1995, BIOMATERIALS, V16, P833, DOI 10.1016/0142-9612(95)94144-A
   Fukada E, 1995, BIORHEOLOGY, V32, P593, DOI 10.1016/0006-355X(95)00039-C
   Fukada E, 1998, JPN J APPL PHYS 1, V37, P2775, DOI 10.1143/JJAP.37.2775
   Giordano GG, 1997, J BIOMED MATER RES, V34, P87, DOI 10.1002/(SICI)1097-4636(199701)34:1<87::AID-JBM12>3.0.CO;2-M
   Gombas A, 2002, J THERM ANAL CALORIM, V68, P503, DOI 10.1023/A:1016039819247
   Grijpma DW, 2002, POLYM INT, V51, P845, DOI 10.1002/pi.988
   Hadlock T, 1999, TISSUE ENG, V5, P187, DOI 10.1089/ten.1999.5.187
   Ikada Y, 1996, J BIOMED MATER RES, V30, P553
   JONG LK, 2001, EURO POLY J, V37, P907
   Kuhn W, 1934, KOLLOID Z, V68, P2, DOI 10.1007/BF01451681
   Lee JK, 2004, MAT SCI ENG C-BIO S, V24, P23, DOI 10.1016/j.msec.2003.09.032
   Leonov AI, 2002, INT J SOLIDS STRUCT, V39, P5913, DOI 10.1016/S0020-7683(02)00478-X
   Lim JY, 2003, MACROMOL MATER ENG, V288, P50, DOI 10.1002/mame.200290033
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Maeda Y, 2002, J THERM ANAL CALORIM, V70, P669, DOI 10.1023/A:1022279414256
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Ochiai T, 1998, JPN J APPL PHYS 1, V37, P3374, DOI 10.1143/JJAP.37.3374
   Ouchi T, 2004, J POLYM SCI POL CHEM, V42, P453, DOI 10.1002/pola.10848
   RIGA A, 2000, ENCY ANAL CHEM, P13147
   Tsuji F, 2002, POLYMER, V43, P1789
   Tsuji H, 2003, BIOMATERIALS, V24, P537, DOI 10.1016/S0142-9612(02)00365-4
   Tsuji H, 2003, BIOMACROMOLECULES, V4, P7, DOI 10.1021/bm020090v
   Turner JF, 2004, J THERM ANAL CALORIM, V75, P257, DOI 10.1023/B:JTAN.0000017347.08469.b1
   Yang XZ, 2002, J POLYM SCI POL PHYS, V40, P2646, DOI 10.1002/polb.10325
   Yasuniwa M, 2004, J POLYM SCI POL PHYS, V42, P25, DOI 10.1002/polb.10674
   Yu HX, 2003, J APPL POLYM SCI, V88, P2557, DOI 10.1002/app.12093
   Zhou SB, 2004, J APPL POLYM SCI, V91, P1848, DOI 10.1002/app.13385
NR 32
TC 6
Z9 6
U1 1
U2 13
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PY 2004
VL 76
IS 2
BP 455
EP 470
PG 16
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 821LA
UT WOS:000221460800010
DA 2018-10-20
ER

PT S
AU Han, W
   Pryputniewicz, RJ
AF Han, W
   Pryputniewicz, RJ
BE Dickey, FM
   Shealy, DL
TI Investigations of laser percussion drilling of small holes on thin sheet
   metals
SO LASER BEAM SHAPING V
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Laser Beam Shaping V
CY AUG   05, 2004
CL Denver, CO
SP SPIE
DE laser percussion drilling; small holes; laser parameters; heat affected
   zone; hole geometry
AB Laser drilling is increasingly being used in fabrication of small components for electronics, aerospace, biomedical, and MEMS applications because it provides rapid, precise, clean, flexible, and efficient process. For laser percussion drilling, the workpiece is subjected to a series of laser pulses at the same spot at a specified laser parameter setting. Large temperature gradient is introduced, which results in a minimal heat affected zone (HAZ) and low heat distortion. In laser percussion drilling of small holes, profile of the HAZ and the geometry of the holes strongly depend on settings of the laser parameters such as peak power, pulse length, pulse repetition rate, focal condition, number of pulses, etc. In addition, the processing results are strongly influenced by geometrical and material properties of the workpiece. This paper presents a study of laser process for percussion drilling of micrometer size holes on thin sheet metals using a pulsed Nd:YAG laser. Experimental investigations are performed to characterize the geometry of the hole and surface topography in their vicinity. Analytical and computational modeling of the temperature distribution is also performed and used to determine profiles of the HAZs. The effects of different combinations of laser parameters and workpiece properties on the hole geometry are summarized and a procedure for laser percussion drilling of small holes on sheet metals is outlined.
C1 Worcester Polytech Inst, Ctr Holograph Studies & Laser Micromechatron, Dept Mech Engn, Worcester, MA 01609 USA.
RP Han, W (reprint author), Worcester Polytech Inst, Ctr Holograph Studies & Laser Micromechatron, Dept Mech Engn, 100 Inst Rd, Worcester, MA 01609 USA.
CR CARSLAW HS, 1969, CONDUCTION HEAT SOLI
   Chryssolouris G., 1991, LASER MACHINING THEO
   Dowden J.M., 2001, MATH THERMAL MODELIN
   Duley W. W., 1999, LASER WELDING
   Guan YH, 1998, P SOC PHOTO-OPT INS, V3550, P223, DOI 10.1117/12.317898
   HAN W, 1999, COMPUTATIONAL EXPT I
   Jackson MJ, 2003, J MATER PROCESS TECH, V142, P517, DOI 10.1016/S0924-0136(03)00651-4
   ORDAL MA, 1985, APPL OPTICS, V24, P4493, DOI 10.1364/AO.24.004493
   Pryputniewicz RJ, 2001, INTEGRATED THERMOMEC
   PTC, 2003, THERMAL ANAL SYSTEM
   Semak V, 1997, J PHYS D APPL PHYS, V30, P2541, DOI 10.1088/0022-3727/30/18/008
   Semak V., 1997, P LAS MAT PROC C ICA, P81
   Steen W., 1998, LASER MAT PROCESSING
   Treusch H.-G., 1986, Proceedings of the SPIE - The International Society for Optical Engineering, V650, P220
   Voisey KT, 2003, MAT SCI ENG A-STRUCT, V356, P414, DOI 10.1016/S0921-5093(03)00155-2
   Webb R., 1986, Proceedings of the SPIE - The International Society for Optical Engineering, V668, P112
   Xu X, 1999, INT J HEAT MASS TRAN, V42, P1371, DOI 10.1016/S0017-9310(98)00272-5
   Yilbas BS, 1997, J MATER PROCESS TECH, V70, P264, DOI 10.1016/S0924-0136(97)00076-9
   Zhang YW, 1999, INT J HEAT MASS TRAN, V42, P1775, DOI 10.1016/S0017-9310(98)00268-3
NR 19
TC 1
Z9 1
U1 1
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5463-X
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5525
BP 31
EP 40
DI 10.1117/12.560253
PG 10
WC Optics
SC Optics
GA BBB42
UT WOS:000224540600003
DA 2018-10-20
ER

PT J
AU Vesselov, LM
   Whittington, W
   Lilge, L
AF Vesselov, LM
   Whittington, W
   Lilge, L
TI Performance evaluation of cylindrical fiber optic light diffusers for
   biomedical applications
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE light delivery; optical radiation measurement; photodynamic therapy;
   interstitial laser hyperthermia; interstitial photocoagulation
ID PHOTODYNAMIC THERAPY; 5-AMINOLEVULINIC ACID; IN-VIVO; DOSIMETRY; CANCER;
   PENETRATION; ESOPHAGUS
AB Background and Objectives: Dosimetry for intracavity and interstitial light delivery requires next to the knowledge of tissue optical properties and models describing light propagation in tissue also exact knowledge of the spatial light source emission characteristics. However, the emission characteristics of cylindrical diffusers are often ill defined by the manufacturer, and not regularly determined by the end user, thus limiting the attainable dosimetry accuracy.
   Study Design/Materials and Methods: Commercial cylindrical diffusers, with active diffusive lengths of 12 cm and outer diameters of less than or equal to1 mm, were evaluated regarding their photometric emission characteristics. In addition to traditional tests of homogeneity such as light intensity emitted along the diffuser length and around its circumference (polar angle), azimuth emission was also measured.
   Results: It was demonstrated that the light emission distribution is specific to the diffuser manufacturer, and while good polar isotropy is often attained, azimuth isotropy can vary by more than a factor of 5. In hollow organs the latter can result in over treatment of tissue distal to the actual placement of the cylindrical diffusers.
   Conclusions: To enable light dosimetry and treatment planning for applications such as photodynamic therapy or interstitial laser hyperthermia or photocoagulation, standardization of emission properties reporting for optical fiber diffusers is required. (C) 2004 Wiley-Liss, Inc.
C1 Univ Hlth Network, Toronto, ON M5G 2M9, Canada.
   Walsh Med Devices Inc, Oakville, ON L6L 5T7, Canada.
   Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.
RP Lilge, L (reprint author), Univ Hlth Network, 610 Univ Ave Room 7-416, Toronto, ON M5G 2M9, Canada.
EM llilge@uhnres.utoronto.ca
RI Lilge, lothar/J-6434-2013
OI lilge, lothar/0000-0001-5533-0005
FU NCI NIH HHS [R01-CA90524-02]
CR Boere IA, 2003, PHOTOCHEM PHOTOBIOL, V78, P271, DOI 10.1562/0031-8655(2003)078<0271:MISDAP>2.0.CO;2
   Dimofte A, 2002, LASER SURG MED, V31, P305, DOI 10.1002/lsm.10115
   GRANJON Y, 1994, MED BIOL ENG COMPUT, V32, P323, DOI 10.1007/BF02512530
   Jankun J, 2000, PROC SPIE, V3907, P222, DOI 10.1117/12.386260
   KOZODOY RL, 1994, APPL OPTICS, V33, P6674, DOI 10.1364/AO.33.006674
   Lilge L, 1996, BRIT J CANCER, V73, P332, DOI 10.1038/bjc.1996.58
   Mizeret JC, 1996, LASER SURG MED, V19, P159, DOI 10.1002/(SICI)1096-9101(1996)19:2<159::AID-LSM6>3.0.CO;2-R
   MULLER P, 1991, P SOC PHOTO-OPT INS, V1426, P254, DOI 10.1117/12.44064
   MULLER PJ, 1993, PHOTODYNAMIC THERAPY, P201
   PANTELIDES ML, 1990, J UROLOGY, V143, P398, DOI 10.1016/S0022-5347(17)39973-1
   POTTER WR, 1990, P SOC PHOTO-OPT INS, V1201, P292, DOI 10.1117/12.17548
   SHENG C, 2003, P SOC PHOTO-OPT INS, V4753, P39
   Stewart F, 1998, RADIOTHER ONCOL, V48, P233, DOI 10.1016/S0167-8140(98)00063-2
   Tromberg BJ, 1996, PHYS MED BIOL, V41, P223, DOI 10.1088/0031-9155/41/2/002
   van den Bergh H, 1998, ENDOSCOPY, V30, P392, DOI 10.1055/s-2007-1001289
   van Veen RLP, 2002, LASER SURG MED, V31, P299, DOI 10.1002/lsm.10129
   vanStaveren HJ, 1996, PHYS MED BIOL, V41, P579, DOI 10.1088/0031-9155/41/4/001
   Welch J. A., 1995, OPTICAL THERMAL RESP, P15
   Whelan WM, 1999, LASER SURG MED, V24, P202, DOI 10.1002/(SICI)1096-9101(1999)24:3<202::AID-LSM5>3.0.CO;2-8
   WHELAN WM, 1995, MED PHYS, V22, P105, DOI 10.1118/1.597598
NR 20
TC 34
Z9 35
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 2004
VL 34
IS 4
BP 348
EP 351
DI 10.1002/lsm.20031
PG 4
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 813MF
UT WOS:000220910500009
PM 15083496
DA 2018-10-20
ER

PT B
AU Calvert, P
   Yoshioka, Y
   Jabbour, G
AF Calvert, P
   Yoshioka, Y
   Jabbour, G
BE Reis, RL
   Weiner, S
TI Inkjet printing for biomimetic and biomedical materials
SO LEARNING FROM NATURE HOW TO DESIGN NEW IMPLANTABLE BIOMATERIALS: FROM
   BIOMINERALIZATION FUNDAMENTALS TO BIOMIMETIC MATERIALS AND PROCESSING
   ROUTES
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Learning from Nature
   How to Design New Implantable Biomaterials
CY OCT 13-24, 2003
CL Alvor, PORTUGAL
ID DROPS
AB Growth of biological tissues often occurs by a layer of cells building new tissue layer-by-layer. Each new layer is the result of the reaction between a series of reagents and catalysts expressed by the cell layer. The nozzles of inkjet printheads have dimensions similar to those of cells and so it is possible to imagine a versatile inkjet printer also building tissues by depositing a series of drops of various reagents. This paper describes preliminary tests of this approach, the use of inkjet printing to form lines and layers of polymers, reaction between successive drops to produce layers of gels about 100nm thick, addition of enzymes into these gels and there use to produce mineralized structures.
C1 Univ Arizona, Tucson, AZ 85721 USA.
RP Calvert, P (reprint author), Univ Arizona, Tucson, AZ 85721 USA.
RI Group, 3Bs/E-4374-2012
OI Group, 3Bs/0000-0002-5195-3456
CR Bianco Paolo, 1992, CALCIFICATION BIOL S
   Calvert P, 2001, CHEM MATER, V13, P3299, DOI 10.1021/cm0101632
   Calvert P, 1998, ACTA MATER, V46, P2565, DOI 10.1016/S1359-6454(98)80041-4
   Creagh LT, 2003, MRS BULL, V28, P807, DOI 10.1557/mrs2003.229
   Deegan RD, 2000, PHYS REV E, V61, P475, DOI 10.1103/PhysRevE.61.475
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Derby B, 2003, MRS BULL, V28, P815, DOI 10.1557/mrs2003.230
   Diekwisch TGH, 2002, MICROSC RES TECHNIQ, V59, P373, DOI 10.1002/jemt.10218
   Fischer BJ, 2002, LANGMUIR, V18, P60, DOI 10.1021/la015518a
   Landis WJ, 2002, COMP BIOCHEM PHYS A, V133, P1135, DOI 10.1016/S1095-6433(02)00248-9
   Shimoda T, 2003, MRS BULL, V28, P821, DOI 10.1557/mrs2003.231
   Shmuylovich L, 2002, LANGMUIR, V18, P3441, DOI 10.1021/la011484v
NR 12
TC 5
Z9 5
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-2644-7
J9 NATO SCI SER II MATH
PY 2004
VL 171
BP 169
EP 180
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA BBH09
UT WOS:000225478500010
DA 2018-10-20
ER

PT S
AU Calderon, A
   Rodriguez, GP
   Hernandez, RAM
   Gongora, JAID
   Barradas, CMM
AF Calderon, A
   Rodriguez, GP
   Hernandez, RAM
   Gongora, JAID
   Barradas, CMM
BE VargasLuna, M
   GutierrezJuarez, G
   HuertaFranco, R
   MarquezGamino, S
TI Thermal diffusivity in bone and hydroxyapatite
SO MEDICAL PHYSICS
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 8th Mexican Symposium on Medical Physics
CY MAR 17-19, 2004
CL Univ Guanajuato, Guanajuato, MEXICO
SP Soc Mexicana Fis, CONACyT, CONCyTEG, UNESCO ICTP, GBC Mexicana SA CV, Ctr Estatal Transfus Sanguinea, Ctr Latinoamericano Fis, Brazil, Ctr Latinoamericano Fis, Mexico, Ctr Investigac & Estudios Avanzados, Univ Nacl Autonoma Mexico
HO Univ Guanajuato
ID TISSUE
AB We report thermal diffusivity measurements in bull bone and commercial hydroxyapatite (HA), both in powder form, in order to determinate the thermal compatibility between these materials. Besides this, we report a comparison between these measured values and those of metallic samples frequently used in implants, as high purity titanium and stainless steel. Our results show a good thermal compatibility (74%) between HA and bone, both in powder form. Finally, it was obtained a one order of magnitude difference between the thermal diffusivity values of metallic samples and those corresponding values to bone and HA being this difference greater in titanium than in stainless steel, which is important to consider in some biomedical and dental applications.
C1 CICATA, IPN, Mexico City, DF, Mexico.
RP Calderon, A (reprint author), CICATA, IPN, Legaria 694,Colonia Irrigac, Mexico City, DF, Mexico.
CR Alberts B, 2002, MOL BIOL CELL
   Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   Calderon A, 1997, PHYS REV LETT, V79, P5022, DOI 10.1103/PhysRevLett.79.5022
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   Joiner A, 2004, J DENT, V32, P19, DOI 10.1016/j.jdent.2003.10.007
   MASSIN P, 2004, J BIOMED MATER RES, V15, P140
   MOTTANA A, 1977, MINERALI ROCCE
   NAGAI M, 1991, J MATER SCI, V26, P2949, DOI 10.1007/BF01124826
   Sutter B, 2003, SOIL SCI SOC AM J, V67, P1935, DOI 10.2136/sssaj2003.1935
   Touloukian Y. S., 1970, THERMOPHYSICAL PROPE, V10
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Yamada K, 2001, BIOMATERIALS, V22, P2207, DOI 10.1016/S0142-9612(00)00402-6
NR 12
TC 0
Z9 1
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0205-1
J9 AIP CONF PROC
PY 2004
VL 724
BP 278
EP 281
PG 4
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA BBC14
UT WOS:000224701300057
DA 2018-10-20
ER

PT S
AU Bertsch, A
   Jiguet, S
   Hofmann, H
   Renaud, P
AF Bertsch, A
   Jiguet, S
   Hofmann, H
   Renaud, P
GP IEEE
TI Ceramic microcomponents by microstereolithography
SO MEMS 2004: 17TH IEEE INTERNATIONAL CONFERENCE ON MICRO ELECTRO
   MECHANICAL SYSTEMS, TECHNICAL DIGEST
SE Proceedings IEEE Micro Electro Mechanical Systems
LA English
DT Proceedings Paper
CT 17th IEEE International Conference on Micro Electro Mechanical Systems
CY JAN 25-29, 2004
CL Maastricht, NETHERLANDS
SP IEEE Robot & Automat Soc
AB This paper describes new polymer/ceramic photosensitive resins that can be used in the microstereolithography process for manufacturing complex 3D components in composite material. These new resins contain high loads (up to 80 wt.%) of alumina nanoparticles, used as fillers in a photosensitive acrylate-based resin of low viscosity. With the nanopowder-filled resin we developed, various small polymer/alumina composite components having a real geometric complexity were produced with small manufacturing times. When using a reactive medium containing a high enough percentage of ceramic nanoparticles, no deformation or cracks are observed after debinding and sintering, even if some shrinkage occurs during these steps. This process makes it possible to manufacture a new set of micro-components in ceramic material that could be of interest for high-temperature micro-reaction technologies, or for the production of new components in the biomedical domain.
C1 Swiss Fed Inst Technol, EPFL, STI, IMM,LMIS4, CH-1015 Lausanne, Switzerland.
RP Bertsch, A (reprint author), Swiss Fed Inst Technol, EPFL, STI, IMM,LMIS4, CH-1015 Lausanne, Switzerland.
EM amaud.bertsch@epfl.ch
RI Renaud, P/A-6994-2011; Bertsch, Arnaud/U-5753-2017
OI Renaud, P/0000-0001-5199-1252; Bertsch, Arnaud/0000-0002-1044-0478
CR BALLANDRAS S, 1999, IEEE ULTR S P IEEE N, P1159
   Bauer W, 2002, MICROSYST TECHNOL, V9, P81, DOI 10.1007/s00542-002-0200-z
   Bertsch A., 2001, 8 IEEE INT C EM TECH, V2, P289
   Bertsch A, 2000, RAPID PROTOTYPING J, V6, P259, DOI 10.1108/13552540010373362
   Chartier T, 2002, KEY ENG MAT, V206-2, P293, DOI 10.4028/www.scientific.net/KEM.206-213.293
   Filser F, 1998, MAT MED, P165
   Gautam N, 1998, INT J MACH TOOL MANU, V38, P15, DOI 10.1016/S0890-6955(98)00034-0
   Griffith ML, 1996, J AM CERAM SOC, V79, P2601
   Groza JR, 1999, NANOSTRUCT MATER, V12, P987, DOI 10.1016/S0965-9773(99)00284-6
   Heitz J, 1997, APPL PHYS A-MATER, V65, P259, DOI 10.1007/s003390050575
   IKUTA K, 1993, 6 IEEE WORKSH MICR E, P42
   Kohler M., 1999, ETCHING MICROSYSTEM
   LUBITZ K, 1993, ULTRASON, P515, DOI 10.1109/ULTSYM.1993.339556
   SAYAH A, 2002, IEEE ULTR S, P1115
NR 14
TC 9
Z9 9
U1 1
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1084-6999
BN 0-7803-8265-X
J9 PROC IEEE MICR ELECT
PY 2004
BP 725
EP 728
DI 10.1109/MEMS.2004.1290687
PG 4
WC Engineering, Electrical & Electronic; Engineering, Mechanical;
   Instruments & Instrumentation; Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BY67D
UT WOS:000189435200180
DA 2018-10-20
ER

PT J
AU Maojo, V
   Martin-Sanchez, F
AF Maojo, V
   Martin-Sanchez, F
TI Bioinformatics: Towards new directions for public health
SO METHODS OF INFORMATION IN MEDICINE
LA English
DT Article
DE public health; bioinformatics; epidemiology; genomics; medical
   informatics
ID MEDICAL INFORMATICS; MOLECULAR EPIDEMIOLOGY; INTEGRATING GENOMICS;
   GENETIC EPIDEMIOLOGY; INFECTIOUS-DISEASES; FUTURE; ONTOLOGY; TOOL;
   CHALLENGES; DATABASES
AB Objectives: Epidemiologists are reformulating their classical approaches to diseases by considering various issues associated to "omics" areas and technologies. Traditional differences between epidemiology and genetics include background, training, terminologies, study designs and others. Public health and epidemiology are increasingly looking forward to using methodologies and informatics tools, facilitated by the Bioinformatics community, for managing genomic information. Our aim is to describe which are the most important implications related with the increasing use of genomic information for public health practice, research and education. To review the contribution of bioinformatics to these issues, in terms of providing the methods and tools needed for processing genetic information from pathogens and patients. To analyze the research challenges in biomedical informatics related with the need of integration of clinical, environmental and genetic data and the new scenarios arisen in public health.
   Methods: Review of the literature, Internet resources and material and reports generated by internal and external research projects.
   Results: New developments are needed to advance in the study of the interactions between environmental agents and genetic factors involved in the development of diseases. The use of biomarkers, biobanks, and integrated genomic/clinical databases poses serious challenges for informaticians in order to extract useful information and knowledge for public health, biomedical research and healthcare.
   Conclusions: From an informatics perspective, integrated medical/biological ontologies and new semantic-based models for managing information provide new challenges for research in areas such as genetic epidemiology and the "omics" disciplines, among others. In this regard, there are various ethical, privacy, informed consent and social implications, that should be carefully addressed by researchers, practitioners and policy makers.
C1 Univ Politecn Madrid, Artificial Intelligence Lab, Biomed Informat Grp, E-28660 Madrid, Spain.
   Inst Hlth Carlos III, Med Bioinformat Dept, Madrid, Spain.
RP Maojo, V (reprint author), Univ Politecn Madrid, Artificial Intelligence Lab, Biomed Informat Grp, Boadilla Monte, E-28660 Madrid, Spain.
EM vmaojo@infomed.dia.fi.upm.es
OI Martin-Sanchez, Fernando/0000-0002-7312-5707
CR Altman RB, 2000, J AM MED INFORM ASSN, V7, P439, DOI 10.1136/jamia.2000.0070439
   Annas GJ, 2000, NEW ENGL J MED, V342, P1830, DOI 10.1056/NEJM200006153422412
   [Anonymous], 2000, NATURE GENETICS, V25, P25
   Austin MA, 2002, AM J EPIDEMIOL, V155, P585, DOI 10.1093/aje/155.7.585
   Bairoch A, 2000, BIOINFORMATICS, V16, P48, DOI 10.1093/bioinformatics/16.1.48
   Benton D, 1996, TRENDS BIOTECHNOL, V14, P261, DOI 10.1016/0167-7799(96)10037-8
   Bertone P, 2001, IEEE ENG MED BIOL, V20, P33, DOI 10.1109/51.940042
   Beskow L.M., 2001, Community Genet, V4, P2, DOI 10.1159/000051150
   Broder S, 2002, EMBO REP, V3, P806, DOI 10.1093/embo-reports/kvf187
   Butler D, 2001, NATURE, V414, P139, DOI 10.1038/35102713
   Cambon-Thomsen A, 2003, NAT GENET, V34, P25, DOI 10.1038/ng0503-25b
   Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540
   Collins FS, 2001, JAMA-J AM MED ASSOC, V286, P2322, DOI 10.1001/jama.286.18.2322
   Dalma-Weiszhausz DD, 2002, GENET EPIDEMIOL, V23, P4, DOI 10.1002/gepi.0216
   Ellsworth DL, 1999, ANN EPIDEMIOL, V9, P207, DOI 10.1016/S1047-2797(99)00007-1
   Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235
   Foxman B, 2001, AM J EPIDEMIOL, V153, P1135, DOI 10.1093/aje/153.12.1135
   Furberg AH, 2001, TRENDS MOL MED, V7, P517, DOI 10.1016/S1471-4914(01)02162-1
   GARCIAREMESAL M, 2004, IN PRESS P IEEE 4 S
   Genkin A, 2002, J INTELL FUZZY SYST, V12, P5
   Gilbert GL, 2002, TRENDS MOL MED, V8, P280, DOI 10.1016/S1471-4914(02)02349-3
   Goldie SJ, 2001, JAMA-J AM MED ASSOC, V286, P1637, DOI 10.1001/jama.286.13.1637
   GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008
   Henry CJ, 2002, ENVIRON HEALTH PERSP, V110, P1047, DOI 10.1289/ehp.021101047
   Hoffman SL, 2000, SCIENCE, V290, P1509, DOI 10.1126/science.290.5496.1509
   Institute of Medicine, 1988, FUT PUBL HLTH
   Kaiser J, 2002, SCIENCE, V298, P1158, DOI 10.1126/science.298.5596.1158
   Khoury MJ, 2004, HUMAN GENOME EPIDEMI
   Kohane I, 2000, J AM MED INFORM ASSN, V7, P439
   Kohler J, 2003, BIOINFORMATICS, V19, P2420, DOI 10.1093/bioinformatics/btg340
   KULIKOWSKI C, 2001, METHOD INFORM MED, V41, P20
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   LILIENFELD AM, 1980, INT J EPIDEMIOL, V9, P199, DOI 10.1093/ije/9.3.199
   Maojo V, 2003, METHOD INFORM MED, V42, P121
   Maojo V, 2002, J INTELL FUZZY SYST, V12, P1
   Maojo V, 2001, J BIOMED INFORM, V34, P423, DOI 10.1006/jbin.2002.1042
   MAOJO V, 2003, IN PRESS JAMIA
   Martin-Sanchez F, 2004, J BIOMED INFORM, V37, P30, DOI 10.1016/j.jbi.2003.09.003
   Martin-Sanchez F, 2002, METHOD INFORM MED, V41, P25
   Miller PL, 2000, J AM MED INFORM ASSN, V7, P431, DOI 10.1136/jamia.2000.0070431
   Millikan R, 2002, EPIDEMIOLOGY, V13, P472, DOI 10.1097/01.EDE.0000016862.96948.6E
   Mostowy Serge, 2002, Am J Pharmacogenomics, V2, P189, DOI 10.2165/00129785-200202030-00004
   MOUNT DW, 2001, BIOINFORMATICS SEQUE
   Musen MA, 2002, METHOD INFORM MED, V41, P1
   Noonan AS, 2002, GENET MED, V4, p68S, DOI 10.1097/01.GIM.0000043818.54200.4F
   Ohno-Machado L, 2002, J INTELL FUZZY SYST, V12, P19
   Olden K, 2000, NAT REV GENET, V1, P149, DOI 10.1038/35038586
   Pang T, 2002, AM J PUBLIC HEALTH, V92, P1077, DOI 10.2105/AJPH.92.7.1077
   Perera FP, 2000, CARCINOGENESIS, V21, P517, DOI 10.1093/carcin/21.3.517
   PEREZREY D, 2004, IN PRESS P IEEE 4 S
   Potter JD, 2001, NAT REV GENET, V2, P142, DOI 10.1038/35052575
   Roberts RJ, 2000, BIOINFORMATICS, V16, P2, DOI 10.1093/bioinformatics/16.1.2
   Schork NJ, 2000, CLIN GENET, V58, P250, DOI 10.1034/j.1399-0004.2000.580402.x
   SILVESCU A, 2001, P IJCAI2001 WORKSH K
   Steinberg KK, 2001, JAMA-J AM MED ASSOC, V286, P1635, DOI 10.1001/jama.286.13.1635
   van Belkum A, 2001, CLIN MICROBIOL REV, V14, P547, DOI 10.1128/CMR.14.3.547-560.2001
   WEATHERALL D, 1995, SCI QUIET ART MED RE
   2001, NATURE, V414, P133
NR 58
TC 27
Z9 27
U1 1
U2 12
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0026-1270
J9 METHOD INFORM MED
JI Methods Inf. Med.
PY 2004
VL 43
IS 3
BP 208
EP 214
PG 7
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 838CH
UT WOS:000222690200002
PM 15227550
DA 2018-10-20
ER

PT S
AU Han, W
   Pryputniewicz, RJ
AF Han, W
   Pryputniewicz, RJ
BE LaVan, DA
   Ayon, AA
   Madou, MJ
   McNie, ME
   Prasad, SV
TI Mechanical characterizations of laser microwelds for MEMS packaging
SO MICRO- AND NANOSYSTEMS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Micro- and Nanosystems held at the 2003 MRS Fall Meeting
CY DEC 01-03, 2003
CL Boston, MA
SP Mat Res Soc
AB Laser micromachining has proven to be a very powerful and successful tool for precision machining and microfabrication with applications in electronics, MEMS, medical, and biomedical fields. For MEMS fabrication and packaging, several approaches based on localized heating and bonding have been proposed such as localized eutectic bonding, fusion bonding, solder bonding, and chemical vapor deposition (CVD) bonding. However, these approaches are based on resistive heating which requires intimate contact at the electrodes, and this is not preferred for MEMS packaging applications. As a good alternative, laser microwelding has advantages of non contact, low heat distortion, high speed, high precision, and consistent weld integrity. Therefore, it is finding increasing use in MEMS fabrication and packaging applications. In laser microwelding, the material in the HAZ of the workpiece experiences heating, melting, and re-solidifying stages, and the final characterizations of the laser microwelds can be influenced by various factors such as the laser beam properties, the system cooling condition, and the surface roughness/reflectivity of the component. This paper presents characterization of laser microwelds, with emphasis on study of deformation and strength of the microwelds made by a Nd:YAG pulsed laser. Optical interferometry is used to nondestructively record fringe patterns of the shape and deformation of the laser microwelded workpiece before, during, and after the microwelding process, and tensile tests are performed to study strength of the laser microwelds as a function of different welding parameters. Results indicate that quality of the laser microwelds depends on selection of an appropriate set of parameters controlling the microwelding process.
C1 Worcester Polytech Inst, Dept Mech Engn, NEST, CHSLT, Worcester, MA 01609 USA.
RP Han, W (reprint author), Worcester Polytech Inst, Dept Mech Engn, NEST, CHSLT, Worcester, MA 01609 USA.
CR CARSLAW HS, 1969, CONDUCTION HEAT SOLI
   Dowden J.M., 2001, MATH THERMAL MODELIN
   *INSTR CORP, 2000, INSTR INSTR 550 UN M
   Lu G., 1999, J MATER PROCESS TECH, V89, P298
   PRYPUTNIEWICZ RJ, 2001, P INT C EXP APPL MEC, P826
   PTC, 2003, THERMAL ANAL SYSTEM
   Steen W., 1998, LASER MAT PROCESSING
   WEETER LA, 1986, WELD J, V65, P51
   Xie J., 1999, WELD J, V78, P343
   Yilbas BS, 2000, OPT LASER ENG, V33, P65, DOI 10.1016/S0143-8166(00)00016-6
NR 10
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-720-2
J9 MATER RES SOC SYMP P
PY 2004
VL 782
BP 343
EP 348
PG 6
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BAH04
UT WOS:000222177500052
DA 2018-10-20
ER

PT J
AU Ben-Nissan, B
AF Ben-Nissan, B
TI Nanoceramics in biomechanical applications
SO MRS BULLETIN
LA English
DT Article
DE bioceramics; biomaterials; implants; nanoceramics; nanostructure
AB An improved understanding of the interactions at the nanoscale level between the bioceramics in medical implants and the hard or soft tissues in the human body could contribute significantly to the design of new-generation prostheses and postoperative patient management strategies. Overall, the benefits of advanced ceramic materials in biomedical applications have been universally accepted, specifically in terms of their strength, biocompatibility, hydrophilicity, and wear resistance in articulating joints. The continuous development of new-generation implants utilizing nanocoatings with novel nanosensors and devices is leading to better compatibility with human tissue and improved well-being and longevity for patients. This article gives a short overview of bioceramics and reexamines key issues of concern for processing and applying nanoceramics as biomaterials.
C1 Univ Technol Sydney, Dept Chem Mat & Forens Sci, Sydney, NSW 2007, Australia.
RP Ben-Nissan, B (reprint author), Univ Technol Sydney, Dept Chem Mat & Forens Sci, Sydney, NSW 2007, Australia.
CR Ben-Nissan B, 2001, J SOL-GEL SCI TECHN, V21, P27, DOI 10.1023/A:1011281826850
   BENNISSAN B, 2002, Patent No. 0240398
   DEGROOT K, 1987, CERAMICS CLIN APPL, P381
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   EHRHARDT GJ, 1987, NUCL MED BIOL, V14, P233
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   IKENAGA M, 1993, J ORTHOP RES, V11, P849, DOI 10.1002/jor.1100110611
   Kawashita M., 2002, BIOCERAMICS, P645
   KOKUBO T, 2003, BIOCERAMICS, V15, P523
   KOKUBO T, 1989, BIOCERAMICS, V1, P157
   Kokubo T., 2000, J AUST CERAM SOC, V36, P37
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   OONISHI H, 2003, BIOCERAMICS, V15, P735
   Paunesku T, 2003, NAT MATER, V2, P343, DOI 10.1038/nmat875
   YOSHIKAWA T, 2003, BIOCERAMICS, V15, P383
   2002, WORLD ORTHOPAEDIC MA
NR 16
TC 28
Z9 32
U1 1
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2004
VL 29
IS 1
BP 28
EP 32
DI 10.1557/mrs2004.13
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 777DH
UT WOS:000189159400018
DA 2018-10-20
ER

PT J
AU Kriven, WM
   Kwak, SY
   Wallig, MA
   Choy, JH
AF Kriven, WM
   Kwak, SY
   Wallig, MA
   Choy, JH
TI Bio-resorbable nanoceramics for gene and drug delivery
SO MRS BULLETIN
LA English
DT Article
DE biomedical materials; ceramics; drug delivery; intercalation; nonviral
   vectors; safety studies; scanning electronmicroscopy (SEM); transmission
   electron microscopy (TEM)
ID LAYERED DOUBLE HYDROXIDES; PROMYELOCYTIC LEUKEMIA; DNA; INTERCALATION;
   THERAPY; NANOTECHNOLOGY; NANOHYBRIDS; MOLECULES; RELEASE; SALTS
AB Nanoscale ceramic particles, such as layered double hydroxides (LDHs'), have been developed to deliver drugs or genes into biological cells. In this article, we describe the controlled-release properties of LDHs as drug delivery carriers, the formation of bio-LDH nanohybrids, their in vivo and in vitro cytotoxicity tests, and their potential as anticancer gene delivery carriers. Unstable biomolecules can be intercalated into LDHs, displacing the interlayer anions; the drug or gene's negative charge is thus shielded, enabling penetration into the cell. In the slightly acidic environment of the cell, ceramic nanoplatelets of similar to100 nm diameter dissolve, thus releasing the intercalates in a controlled manner.
C1 Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   Univ Illinois, Dept Vet Pathobiol, Urbana, IL 61801 USA.
   Seoul Natl Univ, Sch Chem & Mol Engn, Seoul, South Korea.
RP Kriven, WM (reprint author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.
OI Choy, Jin-Ho/0000-0002-4149-7100
CR Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   BEZANILLA M, 1995, LANGMUIR, V11, P655, DOI 10.1021/la00002a050
   Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K
   Choy JH, 1999, J AM CHEM SOC, V121, P1399, DOI 10.1021/ja981823f
   Choy JH, 2001, J MATER CHEM, V11, P1671, DOI 10.1039/b008680k
   Choy JH, 2000, MOL CRYST LIQ CRYST, V341, P1229
   CHOY JH, 2000, ANGEW CHEM, V112, P4208
   COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458
   CONSTANTINO VRL, 1995, INORG CHEM, V34, P883, DOI 10.1021/ic00108a020
   Davis SS, 1997, TRENDS BIOTECHNOL, V15, P217, DOI 10.1016/S0167-7799(97)01036-6
   GALLAGHER R, 1979, BLOOD, V54, P713
   Hwang SH, 2001, B KOR CHEM SOC, V22, P1019
   Khan AI, 2001, CHEM COMMUN, P2342, DOI 10.1039/b106465g
   Kwak SY, 2002, SOLID STATE IONICS, V151, P229, DOI 10.1016/S0167-2738(02)00714-2
   KWAK SY, 2004, IN PRESS BIOMATER
   LEE RJ, 1994, J BIOL CHEM, V269, P3198
   Lee ZW, 1998, J BIOL CHEM, V273, P12710, DOI 10.1074/jbc.273.21.12710
   Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C
   MEYN M, 1993, INORG CHEM, V32, P1209, DOI 10.1021/ic00059a030
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Niemeyer CM, 1997, ANGEW CHEM INT EDIT, V36, P585, DOI 10.1002/anie.199705851
   Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810
   Sinden R.R., 1994, DNA STRUCTURE FUNCTI
   TUNISSCHNEIDER MJ, 1970, J MOL BIOL, V52, P521, DOI 10.1016/0022-2836(70)90417-1
   VARMUS HE, 1987, MOL BASIS BLOOD DISE, P271
   Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410
   Vogel K, 1996, J AM CHEM SOC, V118, P1581, DOI 10.1021/ja952725m
   WICKSTROM EL, 1988, P NATL ACAD SCI USA, V85, P1028, DOI 10.1073/pnas.85.4.1028
   ZIMMERMAN SB, 1980, J MOL BIOL, V142, P315, DOI 10.1016/0022-2836(80)90275-2
NR 29
TC 50
Z9 55
U1 7
U2 17
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2004
VL 29
IS 1
BP 33
EP 37
DI 10.1557/mrs2004.14
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 777DH
UT WOS:000189159400019
DA 2018-10-20
ER

PT S
AU Meyer, J
   Pahwa, A
AF Meyer, J
   Pahwa, A
BE Chen, CW
   Kuo, CCJ
   Vetro, A
TI A novel method for efficient archiving and retrieval of biomedical
   images using MPEG-7
SO MULTIMEDIA SYSTEMS AND APPLICATIONS VII
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Multimedia Systems and Applications VII
CY OCT 25-27, 2004
CL Philadelphia, PA
SP SPIE, IEICE Commun Soc, IEICEElect Soc
DE MPEG-7; biomedical imaging; image archival; image search; image
   retrieval
AB Digital archiving and efficient retrieval of radiological scans have become critical steps in contemporary medical diagnostics. Since more and more images and image sequences (single scans or video) from various modalities (CT/MRI/PET/digital X-ray) are now available in digital formats (e.g., DICOM-3), hospitals and radiology clinics need to implement efficient protocols capable of managing the enormous amounts of data generated daily in a typical clinical routine.
   We present a method that appears to be a viable way to eliminate the tedious step of manually annotating image and video material for database indexing. MPEG-7 is a new framework that standardizes the way images are characterized in terms of color, shape, and other abstract, content-related criteria. A set of standardized descriptors that are automatically generated from an image is used to compare an image to other images in a database, and to compute the distance between two images for a given application domain.
   Text-based database queries can be replaced with image-based queries using MPEG-7. Consequently, image queries can be conducted without any prior knowledge of the keys that were used as indices in the database. Since the decoding and matching steps are not part of the MPEG-7 standard, this method also enables searches that were not planned by the time the keys were generated.
C1 Univ Calif Irvine, Calif Inst Telecommun & Informat Technol, Irvine, CA 92697 USA.
RP Meyer, J (reprint author), Univ Calif Irvine, Calif Inst Telecommun & Informat Technol, 644 E Engn Tower, Irvine, CA 92697 USA.
CR MANJUNATH BS, 2002, INTRO MPEG 7 MULT CO
NR 1
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5553-9
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5600
BP 211
EP 219
DI 10.1117/12.571469
PG 9
WC Imaging Science & Photographic Technology; Telecommunications
SC Imaging Science & Photographic Technology; Telecommunications
GA BBK83
UT WOS:000225926200022
DA 2018-10-20
ER

PT S
AU Xi, JZ
   Schmidt, JJ
   Montemagno, CD
AF Xi, JZ
   Schmidt, JJ
   Montemagno, CD
BE Taylor, DP
   Liu, J
   McIlroy, D
   Merhari, L
   Pendry, JB
   Borenstein, JT
   Grodzinski, P
   Lee, LP
   Wang, ZL
TI Development of self-assembled muscle-powered microdevices
SO NANOENGINEERED ASSEMBLIES AND ADVANCED MICRO/NANOSYSTEMS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoengineered Assemblies and Advanced Micro/Nanosystems
   held at the 2004 MRS Spring Meeting
CY APR 13-16, 2004
CL San Francisco, CA
SP Mat Res Soc
ID CULTURED-CELLS; TEMPERATURE; MYOCYTES; SHEETS; SYSTEM
AB As microcomponents in engineered systems, biological muscles have unique advantages such as large force transduction, utilization of biochemical fuel, and self-assembly from single cells, over other inorganic actuators for biomedical engineering applications. Successful integration of muscles with inorganic fabricated structures and electronics promises the capability of precisely characterizing muscles' mechanical properties and fabricating self-assembled controllable autonomous structures powered by ubiquitous glucose. However, the use of extracted muscle tissue from animals on these devices is impractical and inefficient, as the tissues must be dissected and incorporated into each device by hand with crude interfaces between the biological tissue and inorganic materials. Integration of muscle with fabricated structures would be optimally achieved through self-assembling muscle cells on MEMS. The construction of self-assembled muscle-powered MEMS structures is complicated by the stringent requirements to spatially direct the cell growth, control the tight connection of these differentiated structures with MEMS structures, and enable the cells and the integrated hybrid freedom to move. Conventional and soft photolithography techniques have been extensively employed to pattern the growth of a variety of cell types and investigate their interaction with substrate in the micrometer level. However, all studies are only suitable for patterning static cells on an immobile surface, so a novel system of spatially patterning the contractible cells must be developed to enable the cells and the integrated hybrid devices to be free to move.
   We present a novel system of self-assembling myocytes on MEMS devices. This system has shown its capability of spatially and selectively directed growth and differentiation of myocytes into single muscle bundles, attachment of these functional bundles to MEMS structures, and the controlled partial release of the resultant hybrid devices. Two groups of self-assembled muscle-MEMS devices, force-measuring cantilevers and muscle-powered microrobots have been created. Here the further detailed studies of this system are discussed, especially the concept of the self-assembly and the material interfacial problems in this system.
C1 Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Xi, JZ (reprint author), Univ Calif Los Angeles, Dept Bioengn, 7523 Boelter Hall,420 Westwood Plaza, Los Angeles, CA 90095 USA.
RI Xi, Jianzhong/J-1420-2014
CR BRADY AJ, 1991, PHYSIOL REV, V71, P413
   Chen GP, 1997, BIOTECHNOL BIOENG, V53, P339
   Fauver ME, 1998, IEEE T BIO-MED ENG, V45, P891, DOI 10.1109/10.686797
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Fromherz P, 2002, CHEMPHYSCHEM, V3, P276, DOI 10.1002/1439-7641(20020315)3:3<276::AID-CPHC276>3.0.CO;2-A
   Herzog W, 2000, SKELETAL MUSCLE MECH
   Hu ZB, 1998, NATURE, V393, P149, DOI 10.1038/30205
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Lin G, 2001, IEEE T BIO-MED ENG, V48, P996, DOI 10.1109/10.942589
   MCMAHON D, 1994, AM PHYSL SOC, V35, pC1795
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Ross RS, 1998, CIRC RES, V82, P1160, DOI 10.1161/01.RES.82.11.1160
   SEN A, 1988, J BIOL CHEM, V263, P19132
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   XI JZ, 2003, UNPUB
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
NR 18
TC 0
Z9 0
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-770-9
J9 MATER RES SOC SYMP P
PY 2004
VL 820
BP 139
EP 144
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBA61
UT WOS:000224423500018
DA 2018-10-20
ER

PT S
AU Huang, C
   Bai, B
   Chu, BJ
   Ding, J
   Zhang, QM
AF Huang, C
   Bai, B
   Chu, BJ
   Ding, J
   Zhang, QM
BE Taylor, DP
   Liu, J
   McIlroy, D
   Merhari, L
   Pendry, JB
   Borenstein, JT
   Grodzinski, P
   Lee, LP
   Wang, ZL
TI Electroactive polymer deformable micromirrors (EAPDM) for biomedical
   optics
SO NANOENGINEERED ASSEMBLIES AND ADVANCED MICRO/NANOSYSTEMS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoengineered Assemblies and Advanced Micro/Nanosystems
   held at the 2004 MRS Spring Meeting
CY APR 13-16, 2004
CL San Francisco, CA
SP Mat Res Soc
ID SPATIAL LIGHT-MODULATOR
AB Electroactive polymers (EAPs) are capable of converting energy in the form of electric charge and voltage to mechanical force and movement and vice versa. Several electroactive polymer actuator materials whose responses are controlled by external electric fields, e.g. poly(vinylidene fluoride-trifluoroethylene) based fluoroterpolymers, have generated considerable interest for use in applications such as artificial muscles, sensors, parasitic energy capture, integrated bio-microelectromechanical systems (BioMEMS) and microfluidic devices due to their high electric-field induced strain, high elastic modulus, high electromechanical coupling and high frequency operation, etc. Scaling the EAP down into microsystems is one of the promising trends of EAP actuators and sensors especially for biomedical engineering. The combination of micro-optics and integrated BioMEMS, referred to as bio-micro-opto-electromechanical systems (BioMOEMS), makes a new opportunity for innovation in the EAP field. We present an approach to the fabrication of low-cost, large-stroke deformable micromirrors based on high performance electroactive polymer film microactuator arrays. Integrated Optic-BioMEMS based on electroactive polymer deformable micromirror (EAPDM) technology provide potential applications in biomedical optics such as ophthalmology (retinal imaging and vision care) and cancer detection and treatment.
C1 Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
RP Huang, C (reprint author), Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
RI Chu, Baojin/A-7623-2009
CR Ashley S, 2003, SCI AM, V289, P52, DOI 10.1038/scientificamerican1003-52
   BARCOHEN Y, 2004, ELECTROACTIVE POLMER
   FURLANI EP, 1998, TECHNICAL P INT C MO, P614
   Galletti PM, 1988, MED APPL PIEZOELECTR
   GEHNER A, 2003, P SOC PHOTO-OPT INS, V4985, P180
   GERHARDMULTHAUPT R, 1989, PROG COLL POL SCI S, V80, P63
   GERHARDMULTHAUPT R, 1991, DISPLAYS, V12, P115, DOI 10.1016/0141-9382(91)90032-9
   Hornbeck L., 1998, TI TECHNICAL J   JUL, P7
   HUANG C, 2004, IN PRESS P SPIE, V5389
   HUANG C, 2004, CHENG IEEE T DIEL EL, V11, P299
   HUANG C, 2004, IN PRESS APPL PHYS L
   Kuck H, 1996, SENSOR ACTUAT A-PHYS, V54, P536, DOI 10.1016/S0924-4247(95)01198-6
   LIU C, 1999, P SOC PHOTO-OPT INS, V3669, P69
   OCONNOR L, 2003, SPIES MAGANZINE, P24
   Sakarya S, 2003, P SOC PHOTO-OPT INS, V4985, P279
   TEPE R, 1987, J OPT SOC AM A, V4, P1273, DOI 10.1364/JOSAA.4.001273
   TEPE R, 1989, APPL OPTICS, V28, P4826, DOI 10.1364/AO.28.004826
   WALKER J, 2004, VISION CORRECTION 21, P42
   XIA F, 2003, ZHANG ACS POLYM PREP, P187
   Xu TB, 2002, APPL PHYS LETT, V80, P1082, DOI 10.1063/1.1448661
   Zhang QM, 2002, NATURE, V419, P284, DOI 10.1038/nature01021
NR 21
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-770-9
J9 MATER RES SOC SYMP P
PY 2004
VL 820
BP 207
EP 214
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBA61
UT WOS:000224423500028
DA 2018-10-20
ER

PT S
AU Milner, KR
   Balmer, M
   Donahue, HJ
   Snyder, AJ
   Siedlecki, CA
AF Milner, KR
   Balmer, M
   Donahue, HJ
   Snyder, AJ
   Siedlecki, CA
BE Taylor, DP
   Liu, J
   McIlroy, D
   Merhari, L
   Pendry, JB
   Borenstein, JT
   Grodzinski, P
   Lee, LP
   Wang, ZL
TI Fabrication of ordered sub-micron topographies on large-area
   poly(urethane urea) by two-stage replication molding
SO NANOENGINEERED ASSEMBLIES AND ADVANCED MICRO/NANOSYSTEMS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoengineered Assemblies and Advanced Micro/Nanosystems
   held at the 2004 MRS Spring Meeting
CY APR 13-16, 2004
CL San Francisco, CA
SP Mat Res Soc
ID SOFT LITHOGRAPHY; PLATELET-ADHESION; CELL BEHAVIOR; FIBROBLASTS;
   ATTACHMENT; PROLIFERATION; POLYURETHANES; SUBSTRATA; POLYMERS; GUIDANCE
AB It has been established that material surface topography can have a significant effect on biological cell adhesion, in the absence of changes in surface chemistry. Such investigations were typically performed using surface features with size on the order of microns, comparable to the dimensions of the cells. It has been demonstrated that sub-Micron sized topographies that cannot be created via contact lithography also influence cell behavior. The ability to affect cell adhesion is a prime consideration in the development of novel biomaterials. This study reports a two-stage replication molding process for fabricating ordered sub-micron sized features over a large area of biomedical polyether(urethane urea). Such a technique has great applicability in the area of long-term implantable materials as a method for influencing cell-material interactions.
C1 Penn State Univ, Coll Med, Dept Bioengn, Hershey, PA 17033 USA.
RP Milner, KR (reprint author), Penn State Univ, Coll Med, Dept Bioengn, Hershey, PA 17033 USA.
CR CLARK P, 1991, J CELL SCI, V99, P73
   Curtain WA, 2001, ADV ENG MATER, V3, P275
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Odom TW, 2002, LANGMUIR, V18, P5314, DOI 10.1021/la020169l
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Schmid H, 2000, MACROMOLECULES, V33, P3042, DOI 10.1021/ma982034l
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Turner S, 1997, J VAC SCI TECHNOL B, V15, P2848, DOI 10.1116/1.589742
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   Xia YN, 1997, ADV MATER, V9, P147, DOI 10.1002/adma.19970090211
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 19
TC 0
Z9 0
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-770-9
J9 MATER RES SOC SYMP P
PY 2004
VL 820
BP 339
EP 344
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBA61
UT WOS:000224423500044
DA 2018-10-20
ER

PT B
AU Laurencin, CT
   Nair, LS
AF Laurencin, CT
   Nair, LS
BE Guceri, S
   Gogotsi, YG
   Kuznetsov, V
TI Polyphosphazene nanofibers for biomedical applications: Preliminary
   studies
SO NANOENGINEERED NANOFIBROUS MATERIALS
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Nanoengineered
   Nanofibrous Materials
CY SEP 01-12, 2003
CL Belek-Antalya, TURKEY
SP NATO Adv Study Inst
DE polyphosphazene; nanofibers; biodegradable
ID LIVING CATIONIC POLYMERIZATION; SKELETAL TISSUE REGENERATION; POLYMERS;
   POLY(ORGANOPHOSPHAZENES); PHOSPHORANIMINES; SURFACES; MATRIX; CHEMISTRY;
   SCAFFOLD; RELEASE
AB Polyphosphazenes form novel class of inorganic polymers having backbone composed of phosphorous and nitrogen atoms with each phosphorous atom bearing two organic or organometallic groups. The side groups on phosphorous atoms play a crucial role in determining the properties of corresponding polyphosphazenes. Thus, polymers with unusual thermal, electrical, optical, electrolytic conductivity, electroactivity, oxidative stability, biocompatibility and biodegradability have been synthesized by the incorporation of appropriate side groups. Many of these polymers have been identified as excellent candidates for biomedical and high technological applications. Polymeric nanofibers due to their very high surface area, remarkable surface properties and superior mechanical properties are assuming great interest lately. We have demonstrated that nanofibers of polyphosphazenes can be prepared by clectrospinning wherein submicron sized fibers are produced from an electrostatically driven jet of polymer solution. The diameter as well as the morphology of the resulting fibers can be efficiently tuned by varying process parameters such as viscosity of the solution and potential gradient. By combining the advantages of nanoscale fibers with the unusual property profile available with polyphosphazenes, novel materials with excellent properties can be developed.
C1 Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.
RP Laurencin, CT (reprint author), Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.
CR ABDELGHANI MS, 1985, CHEM ENG SCI, V40, P117, DOI 10.1016/0009-2509(85)85052-1
   Aldini NN, 1997, J BIOACT COMPAT POL, V12, P3, DOI 10.1177/088391159701200101
   Allcock H. R., 2002, CHEM APPL POLYPHOSPH
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P4179, DOI 10.1021/ma00201a008
   Allcock HR, 1997, MACROMOLECULES, V30, P2213, DOI 10.1021/ma961639j
   ALLCOCK HR, 1966, INORG CHEM, V5, P1709, DOI 10.1021/ic50044a016
   ALLCOCK HR, 1977, ANGEW CHEM INT EDIT, V16, P147, DOI 10.1002/anie.197701471
   Allcock HR, 1997, MACROMOLECULES, V30, P50, DOI 10.1021/ma961215p
   Allcock HR, 1996, MACROMOLECULES, V29, P7740, DOI 10.1021/ma960876j
   Allcock HR, 1996, CHEM MATER, V8, P2730, DOI 10.1021/cm9602050
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1985, CHEM ENG NEWS, V63, P22, DOI 10.1021/cen-v063n011.p022
   ALLCOCK HR, 1980, SCI PROG, V66, P355
   ALLCOCK HR, 1988, MACROMOLECULES, V21, P323, DOI 10.1021/ma00180a008
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   ALLCOCK HR, 1982, MACROMOLECULES, V15, P693, DOI 10.1021/ma00231a002
   ALLCOCK HR, 1987, DESIGN NEW MAT
   Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0
   Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534
   LAKSHMI S, 2002, ADV DRUG DELIVERY RE, V55, P467
   Laurencin C. T., 1998, 24 ANN M CONJ 30 INT
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   LAURENCIN CT, 1999, ANN REV BIOMEDICAL E
   LAURENCIN CT, 1992, POLYM ADVAN TECHNOL, V3, P359
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   MacDiarmid AG, 2001, SYNTHETIC MET, V119, P27, DOI 10.1016/S0379-6779(00)00597-X
   Martin CR, 1996, CHEM MATER, V8, P1739, DOI 10.1021/cm960166s
   Martin G.E., 1977, U.S. Patent, Patent No. [4,044,404, 4044404]
   Mathiowitz E., 1999, ENCY CONTROLLED DRUG
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Nalwa H. S., 2000, HDB NANOSTRUCTURED M
   NEENAN TX, 1982, BIOMATERIALS, V3, P78, DOI 10.1016/0142-9612(82)90037-0
   Ondarcuhu T, 1998, EUROPHYS LETT, V42, P215, DOI 10.1209/epl/i1998-00233-9
   Smith D., 2001, [No title captured], Patent No. [0027737, PCT/US, 00/27737]
   TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Tsai PP, 2002, J ELECTROSTAT, V54, P333, DOI 10.1016/S0304-3886(01)00160-7
   Veronese FM, 1998, J CONTROL RELEASE, V52, P227, DOI 10.1016/S0168-3659(97)00098-9
   WADE CWR, 1978, ORGANOMTEALLIC POLYM
   WELLE A, 2000, J APPL MED POLYM, V4, P6
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 50
TC 4
Z9 4
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-2548-3
J9 NATO SCI SER II MATH
PY 2004
VL 169
BP 283
EP 302
PG 20
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBH08
UT WOS:000225477500031
DA 2018-10-20
ER

PT S
AU Seeman, NC
   Ding, BQ
   Liao, SP
   Wang, T
   Sherman, WB
   Constantinou, PE
   Kopatsch, J
   Mao, CD
   Sha, RJ
   Liu, FR
   Yan, H
   Lukeman, PS
AF Seeman, NC
   Ding, BQ
   Liao, SP
   Wang, T
   Sherman, WB
   Constantinou, PE
   Kopatsch, J
   Mao, CD
   Sha, RJ
   Liu, FR
   Yan, H
   Lukeman, PS
BE Lai, WYC
   Pau, S
   Lopez, OD
TI Experiments in structural DNA nanotechnology: Arrays and devices
SO NANOFABRICATION: TECHNOLOGIES, DEVICES AND APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1st International Conference on Nanofabrication
CY OCT 25-28, 2004
CL Philadelphia, PA
SP SPIE, New Jersey Nanotechnol Consortium, JEOL, Quantachrome Instruments, IEICE, Commun Soc, IEICE, Elect Soc
DE DNA structure; periodic designed DNA arrays; DNA nanomechanical devices;
   2D DNA crystals; 3D DNA crystals; control of structure; branched DNA
   motifs
ID SINGLE-STRANDED-DNA; DOUBLE-CROSSOVER MOLECULES; ATOMIC-FORCE
   MICROSCOPY; NUCLEIC-ACID JUNCTIONS; DESIGN; CONSTRUCTION; FLEXIBILITY;
   OCTAHEDRON; LIGATION; CRYSTALS
AB In recent years, the chemistry of DNA has expanded from biological systems to nanotechnology. The generalization of the biological processes of reciprocal exchange leads to stable branched motifs that can be used for the construction of DNA-based geometrical and topological objects, arrays and nanomechanical devices. The information in DNA is the, basis of life, but it can also be used to control the physical states of a variety of systems, leading ultimately to nanorobotics; these devices include shape-changing, walking and translating machines. We expect ultimately to be able to use the dynamic information-based architectural properties of nucleic acids to be the basis for advanced materials with applications from nanoelectronics to biomedical devices on the nanometer scale.
C1 NYU, Dept Chem, New York, NY 10003 USA.
RP Seeman, NC (reprint author), NYU, Dept Chem, 4 Washington Pl, New York, NY 10003 USA.
FU NIGMS NIH HHS [R37 GM029554, R01 GM029554]
CR CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0
   Ding BQ, 2004, J AM CHEM SOC, V126, P10230, DOI 10.1021/ja047486u
   DU SM, 1995, J AM CHEM SOC, V117, P1194, DOI 10.1021/ja00109a002
   FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003
   HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265
   HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233
   KALLENBACH NR, 1983, NATURE, V305, P829, DOI 10.1038/305829a0
   LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e
   LIAO S, 2004, IN PRESS SCIENCE
   Lukeman PS, 2004, CHEM COMMUN, P1694, DOI 10.1039/b401103a
   MA RI, 1986, NUCLEIC ACIDS RES, V14, P9745, DOI 10.1093/nar/14.24.9745
   Mao CD, 1999, NATURE, V397, P144
   Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398
   Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0
   MUELLER JE, 1991, J AM CHEM SOC, V113, P6306, DOI 10.1021/ja00016a077
   PETRILLO ML, 1988, BIOPOLYMERS, V27, P1337, DOI 10.1002/bip.360270902
   Qiu HX, 1997, J MOL BIOL, V267, P881, DOI 10.1006/jmbi.1997.0918
   RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043
   ROBINSON BH, 1987, PROTEIN ENG, V1, P295, DOI 10.1093/protein/1.4.295
   Sa-Ardyen P, 2003, BIOPHYS J, V84, P3829, DOI 10.1016/S0006-3495(03)75110-8
   SEEMAN NC, 1991, DNA CELL BIOL, V10, P475, DOI 10.1089/dna.1991.10.475
   SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9
   SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829
   Seeman NC, 2001, NANO LETT, V1, P22, DOI 10.1021/nl000182v
   Sha RJ, 2000, CHEM BIOL, V7, P743, DOI 10.1016/S1074-5521(00)00024-7
   Sha RJ, 2002, BIOCHEMISTRY-US, V41, P5950, DOI 10.1021/bi020001z
   Shen ZY, 2004, J AM CHEM SOC, V126, P1666, DOI 10.1021/ja038381e
   Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q
   Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307
   WANG YL, 1991, BIOCHEMISTRY-US, V30, P5667, DOI 10.1021/bi00237a005
   Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998
   Xiao SJ, 2002, J NANOPART RES, V4, P313, DOI 10.1023/A:1021145208328
   Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a
   Yang XP, 1998, BIOPOLYMERS, V45, P69, DOI 10.1002/(SICI)1097-0282(199801)45:1<69::AID-BIP6>3.3.CO;2-W
   Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524
   ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006
   Zhu L, 2003, J AM CHEM SOC, V125, P10178, DOI 10.1021/ja035186r
NR 37
TC 1
Z9 1
U1 1
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5545-8
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5592
BP 71
EP 81
DI 10.1117/12.578118
PG 11
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BBR38
UT WOS:000227355700008
PM 24386524
OA Green Accepted
DA 2018-10-20
ER

PT S
AU Jayatissa, AH
AF Jayatissa, AH
BE Lai, WYC
   Pau, S
   Lopez, OD
TI Electrophoresis coating of titanium dioxide nanoparticles in anodic
   nanotemplate
SO NANOFABRICATION: TECHNOLOGIES, DEVICES AND APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1st International Conference on Nanofabrication
CY OCT 25-28, 2004
CL Philadelphia, PA
SP SPIE, New Jersey Nanotechnol Consortium, JEOL, Quantachrome Instruments, IEICE, Commun Soc, IEICE, Elect Soc
DE porous alumina; nanotemplate; electrophoresis; coating; nanocrstalline;
   titanium dioxide
AB Self-assembling is a widely accepted for manufacturing of nanostructured materials and nanometer-scale devices. In this paper, coating of titanium oxide nanoparticles into a porous alumina template by electrophoresis technique was investigated. Aluminum template was in de by anodization of aluminum plate in an oxalic acid solution. The diameter of porous aluminum was in the range of 35-45 nm. The electrophoresis deposition of nanoparticles of titanium oxide was carried put using a colloidal titanium oxide complex. The structural and composition of these films were investigated using X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM) measurements. It was found that the titanium particles were loaded into the porous cavity of nanotemplate under bias conditions. Self-assembled titanium dioxide nanoparticles can be used in different applications including catalysts, sensors, photonics and biomedical devices. In this paper, results of our preliminary experiments are reported.
C1 Univ Toledo, Dept Mech Ind & Mfg Engn, Toledo, OH 43606 USA.
RP Jayatissa, AH (reprint author), Univ Toledo, Dept Mech Ind & Mfg Engn, 2801 W Bancroft St, Toledo, OH 43606 USA.
CR Kim SJ, 1998, J MATER SCI LETT, V17, P141
   Li J, 1999, APPL PHYS LETT, V75, P367, DOI 10.1063/1.124377
   SHOSO S, 2003, J NANOPART RES, V5, P17
   Ulrike D., 1996, SURFACE SCI SPECTRA, V4, P227
NR 4
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5545-8
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5592
BP 400
EP 405
DI 10.1117/12.571944
PG 6
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BBR38
UT WOS:000227355700042
DA 2018-10-20
ER

PT B
AU Elinson, VM
   Sletsov, VV
   Potraysay, VV
   Laymin, AN
AF Elinson, VM
   Sletsov, VV
   Potraysay, VV
   Laymin, AN
BE Voevodin, AA
   Shtansky, DV
   Levashov, EA
   Moore, JJ
TI Biomedical properties of nanostructured surfaces formed by ion-plasma
   methods
SO NANOSTRUCTURED THIN FILMS AND NANODISPERSION STRENGTHENED COATINGS
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT NATO-Russia Advanced Research Workshop on Nanostructured Thin Films and
   Nanodispersion Strengthened Coatings
CY DEC 08-10, 2003
CL Technol Univ, Moscow State Inst Steel & Alloys, Moscow, RUSSIA
SP NATO, Brussels, Public Diplomacy Div, Collaborat Programmers Sect
HO Technol Univ, Moscow State Inst Steel & Alloys
DE nanostructured surfaces; polymers; surface properties; carbon films;
   superporous films; surface topography; surface charge; antimicrobial
   activity
AB In the present paper the fields of application for materials with nanostructured surfaces (NSS) in biology, medicine and the food industry are discussed. Investigations of processes for manufacturing NSS on polymers: polyethyleneterephtalate (PET) and polytetrafluorethylene (PTFE) are discribed, a study of their surface characteristics and possibilities for using them, as well as a study of their biomedical characteristics, in particular, antimicrobial activity, are presented.
C1 Russian State Technol Univ, MATI, Moscow 121552, Russia.
RP Elinson, VM (reprint author), Russian State Technol Univ, MATI, 3 Orshanskaya Str, Moscow 121552, Russia.
CR AFINOGENOV GE, 1993, ANTIMICROBIOL POLYM
   DRACHEV AI, 2004, IN PRESS CHEM HIGH E
   ELINSON VM, 2002, P C VAC SCI TECHN, P384
   ELINSON VM, 2001, MICROELECTRONICS, V4, P279
   ELINSON VM, 1998, DIAM RELAT MATER, V8, P2103
   ELINSON VM, 1998, TECHNOLOGICAL EXPT M, V2, P42
   GILMAN AB, 1997, KHIM VYS ENERG, V31, P393
   GRINCHENKO VT, 1988, P RUSS SCI TECHN C N, P261
   KEMENOV VN, 2002, P C VACC SCI TECHN, P153
   NESTEROV SB, 2004, IN PRESS VACUUM TECH
   Roco M. C., 2000, NANOTECHNOLOGY RES D
   SERGEEVA NS, 1995, J EXP CLIN CANC RES, V14, P81
   Sevast'yanov V. I., 1999, BIOCOMPATIBILITY
   SHTILMAN M, 2002, ECOLOGY BIOTECHNOLOG, V3, P4
   Sleptsov VV, 1996, DIAM RELAT MATER, V5, P483, DOI 10.1016/0925-9635(96)80064-1
   SUMM BD, 1976, M CHEM, P231
   ZIMAN AD, 1974, M CHEM, P413
   2003, P 11 MOSC INT C BIOT
NR 18
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-2221-2
J9 NATO SCI SER II MATH
PY 2004
VL 155
BP 307
EP 319
DI 10.1007/1-4020-2222-0_31
PG 13
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA BAY50
UT WOS:000224223400031
DA 2018-10-20
ER

PT S
AU Engel, A
   Haspel, R
   Rupertus, V
AF Engel, A
   Haspel, R
   Rupertus, V
BE Osten, W
   Takeda, M
TI Fluorescence metrology used for analysis of high quality optical
   materials
SO OPTICAL METROLOGY IN PRODUCTION ENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical Metrology in Production Engineering
CY APR 27-30, 2004
CL Strasbourg, FRANCE
SP SPIE, European Opt Soc, Soc Francaise Opt, Soc Italiana Ottica Foton, Deutsch Gesell Angewandte Opt, IEE, Photon Clusters, Oemagazine
ID CAF2
AB Optical glass ceramics and crystals are used for various specialized applications in telecommunication, biomedical, optical, and micro lithography technology.
   In order to qualify and control the material quality during research and production processes several specialized ultra trace analysis methods have to be applied.
   One focus of the activities is the determination of impurities in the sub ppb-regime, because such kind of impurity level is required e.g. for pure materials used for microlithography. Common analytical techniques for these impurity levels are LA ICP-MS or Neutron Activation Analysis.
   Nevertheless direct and non-destructive optical analysis becomes attractive because it visualizes the requirement of the optical applications additionally. Typical examples are absorption and laser resistivity measurements of optical material with optical methods like precision spectral photometers or in-situ transmission measurements by means of lamps or UV lasers. Both methods are time consuming and rather expensive, whereas the sensitivity for the absorption method will not be sufficient to characterize the future needs (coefficient much below 10(-3) cm(-1)).
   For a non-destructive qualification for them current and future quality requirements fluorescence spectrometry is employed to enable fast and precise qualification and analysis. The main advantage of this setup is the combination of highest sensitivity (more than one order of magnitude higher than state of the art UV absorption spectroscopy), fast measurement and evaluation cycles (several minutes compared to several hours necessary for chemical analysis).
   An overview is given for spectral characteristics using specified standards, which are necessary to establish the analytical system. The elementary fluorescence and absorption of rare earth element impurities as well as crystal defects induced luminescence originated by impurities was investigated. Quantitative numbers are given for the relative quantum yield as well as for the excitation cross section for doped glass and calcium fluoride.
C1 SCHOTT GLAS, D-55014 Mainz, Germany.
RP Engel, A (reprint author), SCHOTT GLAS, Hattenbergstr 10, D-55014 Mainz, Germany.
CR Basiev W., 1997, APPL OPTICS, V36, P2512
   DEROSE P, 2003, FLUOR WORKSH BAM BER
   EHRT D, 2001, P INT C GLASS ED SCO, V1, P84
   ENGEL A, 2000, 1 157 NM S DAN POINT, P391
   ENGEL A, 2001, HIGH QUALITY CAF2 US, P177
   ENGEL A, 2003, SPIE P, P182
   GEFFKEN W, 1962, GLASTECHN BERICHTE, V35, P27
   GELLERMANN W, 1989, J CHEM SOLIDS, V52, P249
   *JOGIS, 031975 JOGIS
   Mizuguchi M, 1999, J OPT SOC AM B, V16, P1153, DOI 10.1364/JOSAB.16.001153
   MUHLIG C, 2003, CAF2 ARF LITHOGRAPHY, P257
   PACK DW, 1989, PHYS REV B, V40, P9930, DOI 10.1103/PhysRevB.40.9930
   Pick H., 1972, Optical properties of solids, P653
   RAVI BG, 1992, INT J MOD PHYS B, V6, P2809, DOI 10.1142/S0217979292002255
   Stroud J. S., 1971, J AM CERAM SOC, V54, P8
NR 15
TC 0
Z9 0
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5379-X
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5457
BP 65
EP 73
DI 10.1117/12.547448
PG 9
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BBA73
UT WOS:000224432300009
DA 2018-10-20
ER

PT S
AU Soskin, MS
   Denisenko, VG
   Egorov, RI
AF Soskin, MS
   Denisenko, VG
   Egorov, RI
BE Gorecki, C
   Asundi, AK
TI Singular Stokes-polarimetry as new technique for metrology and
   inspection of polarized speckle fields
SO OPTICAL MICRO- AND NANOMETROLOGY IN MANUFACTURING TECHNOLOGY
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical Micr-and Nanometrology in Manufacturing Technology
CY APR 29-30, 2004
CL Strasbourg, FRANCE
SP SPIE, European Opt Soc, Soc Francaise Opt, Soc Italiana Ottica Foton, Deutsch Gesell Angewandte Opt, Inst Elect Engineers, Photon Clusters, Oemagazine, Network Excellence Micro-Opt, Reg Alsace, Commun Urbaine Strasbourg, Conseil Gen Bas-Rhin, Alsace Dev Agcy, European Off Aerosp Res & Dev, USAF Off Sci Res
DE elliptic polarimetry; singular Stokes-polarimetry; polarization
   singularities; speckle
ID ELLIPTIC CRITICAL-POINTS; WAVE-FIELDS; LINES
AB Polarimetry is effective technique for polarized light fields characterization. It was shown recently that most full "finger-print" of light fields with arbitrary complexity is network of polarization singularities: C points with circular polarization and L lines with variable azimuth. The new singular Stokes-polarimetry was elaborated for such measurements. It allows define azimuth, eccentricity and handedness of elliptical vibrations in each pixel of receiving CCD camera in the range of mega-pixels. It is based on precise measurement of full set of Stokes parameters by the help of high quality analyzers and quarter-wave plates with lambda/500 preciseness and 4' adjustment. The matrices of obtained data are processed in PC by special programs to find positions of polarization singularities and other needed topological features. The developed SSP technique was proved successfully by measurements of topology of polarized speckle-fields produced by multimode "photonic-crystal" fibers, double side rubbed polymer films, biomedical samples. Each singularity is localized with preciseness up to 1 pixel in comparison with 500 pixels dimensions of typical speckle. It was confirmed that network of topological features appeared in polarized light field after its interaction with specimen under inspection is exact individual "passport" for its characterization. Therefore, SSP can be used for smart materials characterization.
   The presented data show that SSP technique is promising for local analysis of properties and defects of thin films, liquid crystal cells, optical elements, biological samples, etc. It is able discover heterogeneities and defects, which define essentially merits of specimens under inspection and can't be checked by usual polarimetry methods. The detected extra high sensitivity of polarization singularities position and network to any changes of samples position and deformation opens quite new possibilities for sensing of deformations and displacement of checked elements in the submicron range.
C1 Natl Acad Sci Ukraine, Inst Phys, UA-03680 Kiev, Ukraine.
RP Soskin, MS (reprint author), Natl Acad Sci Ukraine, Inst Phys, 46 Prospect Nauki, UA-03680 Kiev, Ukraine.
RI Егоров, Роман/P-8611-2015
OI Егоров, Роман/0000-0002-3837-2382; Soskin, Marat/0000-0003-3401-274X
CR Angelsky O, 2002, OPT COMMUN, V207, P57, DOI 10.1016/S0030-4018(02)01479-7
   Angelsky OV, 2002, PHYS REV E, V65, DOI [10.1103/PhysRevE.65.036602, 10.1103/PhysRevE.036602]
   Berry M. V., 1980, Progress in optics. Vol.XVIII, P257, DOI 10.1016/S0079-6638(08)70215-4
   Berry MV, 2001, P ROY SOC A-MATH PHY, V457, P141, DOI 10.1098/rspa.2000.0660
   BERRY MV, 2003, P ROY SOC LOND A MAT, V459, P1
   Born M., 1959, PRINCIPLES OPTICS
   DENISENKO V, 2004, UNPUB J OPT A
   Dennis MR, 2002, OPT COMMUN, V213, P201, DOI 10.1016/S0030-4018(02)02088-6
   Freund I, 2002, OPT COMMUN, V208, P223, DOI 10.1016/S0030-4018(02)01585-7
   Freund I, 2002, OPT LETT, V27, P545, DOI 10.1364/OL.27.000545
   Freund I, 1998, WAVE RANDOM MEDIA, V8, P119, DOI 10.1088/0959-7174/8/1/012
   FREUND I, 1995, PHYS REV E, V52, P2348, DOI 10.1103/PhysRevE.52.2348
   HAJNAL JV, 1987, P ROY SOC LOND A MAT, V414, P447, DOI 10.1098/rspa.1987.0154
   Mokhun AI, 2002, OPT LETT, V27, P995, DOI 10.1364/OL.27.000995
   Nye J. F., 1999, NATURAL FOCUSING FIN
   NYE JF, 1983, PROC R SOC LON SER-A, V389, P279, DOI 10.1098/rspa.1983.0109
   NYE JF, 1974, P ROY SOC LOND A MAT, V336, P90
   Soskin MS, 2001, PROG OPTICS, V42, P219, DOI 10.1016/S0079-6638(01)80018-4
   Soskin MS, 2003, OPT LETT, V28, P1475, DOI 10.1364/OL.28.001475
   ZELDOVICH B, 1985, WAVE FRONT CONJUGATI
NR 20
TC 19
Z9 19
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5380-3
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5458
BP 79
EP 85
DI 10.1117/12.544681
PG 7
WC Engineering, Manufacturing; Instruments & Instrumentation; Materials
   Science, Characterization & Testing; Optics
SC Engineering; Instruments & Instrumentation; Materials Science; Optics
GA BAW71
UT WOS:000223942100010
DA 2018-10-20
ER

PT S
AU Ikuta, K
   Maruo, S
   Hasegawa, T
   Itho, S
   Korogi, H
   Takahashi, A
AF Ikuta, K
   Maruo, S
   Hasegawa, T
   Itho, S
   Korogi, H
   Takahashi, A
BE Katagiri, Y
TI Light-drive biomedical micro tools and biochemical IC chips fabricated
   by 3D micro/nano stereolithography
SO OPTOMECHATRONIC MICRO/NANO COMPONENTS, DEVICES, AND SYSTEMS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Optomechatronic Micro/Nano Components, Devices and Systems
CY OCT 27-28, 2004
CL Philadelphia, PA
SP SPIE, IEICE Commun Soc, IEICE Elect Soc
DE optical drive; light drive; micro stereolithography; biochemical IC;
   nano manipulator
ID 3-DIMENSIONAL MICROFABRICATION; POLYMERIZATION; MICROMACHINES;
   MICROSTEREOLITHOGRAPHY; PHOTOPOLYMERIZATION; MEMS
AB New concept of micro/nano tools working in water solutuon has been proposed by the author. A real three dimensional micro fabrication process using photo curable polymer named "micro/nano stereolithography "has been also developed by the author's group. The latest version of this process achieved 100 nm in 3D resolution and freely movable micro/nano mechanism are easily fabricated within 20 min. Nano tweezers and nano needle with two degrees of freedom were successfully fabricated without any assembly process. Cell and delicate biological materials can be remotely handled with neither any micro actuators nor lead wire. It was verified that this light-driven micro tool has precise force control with 10 FtN. These light-driven micro tools contribute to cellular biology as well as medical tools.
   The second application of microstereolithography is the biochemical IC chips for both micro chemical analysis and synthesis. Unlike conventional "lab. on a chip" and "micro total analysis system (micro-TAS), our biochemical IC has micro pumps and active valves in one chip. Users can construct their own micro chemical device by themselves. The advanced biochemical IC chip-set for "on chip cell-free protein synthesis" has been prototyped and verified experimentally. A luminous enzyme of fire fly so called "Luciferase" and useful bio-marker protein "GFP" were synthesized successfully. According to above results, the biomchemical IC chips will be useful to " Order-made medicine" in near future.
C1 Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.
RP Ikuta, K (reprint author), Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.
OI maruo, shoji/0000-0002-6589-1225
CR Bertsch A, 1997, MICROSYST TECHNOL, V3, P42, DOI 10.1007/s005420050053
   Cumpston BH, 1999, NATURE, V398, P51
   Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258
   HASEGAWA T, 2001, P MUTAS 2001, P377
   HASEGAWA T, 2002, P MUTAS 2002, P694
   Ikuta K, 1999, PROC IEEE MICR ELECT, P376, DOI 10.1109/MEMSYS.1999.746858
   Ikuta K., 1993, Proceedings. IEEE. Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Systems (Cat. No.93CH3265-6), P42, DOI 10.1109/MEMSYS.1993.296949
   Ikuta K, 2001, PROC IEEE MICR ELECT, P455, DOI 10.1109/MEMSYS.2001.906576
   Ikuta K., 2000, Proceedings IEEE Thirteenth Annual International Conference on Micro Electro Mechanical Systems (Cat. No.00CH36308), P739, DOI 10.1109/MEMSYS.2000.838610
   IKUTA K, 1998, P MEMS, V98, P290
   IKUTA K, 2001, P TRANSD 01, V1, P916
   IKUTA K, 1996, P 5 INT C ART LIF LI, V5, P17
   Ikuta K., 1998, P MEMS 98, V98, P131
   IKUTA K, 2002, P MUTAS 2002, P745
   IKUTA K, 2002, P MUTAS 2002, P37
   Ikuta K., 1996, P MEMS 96, V96, P301
   IUTA K, 1994, P MEMS, V94, P1
   Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130
   Maruo S, 1997, OPT LETT, V22, P132, DOI 10.1364/OL.22.000132
   Maruo S, 2003, J MICROELECTROMECH S, V12, P533, DOI 10.1109/JMEMS.2003.817894
   Maruo S, 1998, J MICROELECTROMECH S, V7, P411, DOI 10.1109/84.735349
   Maruo S, 2000, APPL PHYS LETT, V76, P2656, DOI 10.1063/1.126742
   Maruo S, 2001, PROCEEDINGS OF THE 2001 1ST IEEE CONFERENCE ON NANOTECHNOLOGY, P507, DOI 10.1109/NANO.2001.966475
   Maruo S, 2002, SENSOR ACTUAT A-PHYS, V100, P70, DOI 10.1016/S0924-4247(02)00043-2
   Maruo S, 2001, PROC IEEE MICR ELECT, P594, DOI 10.1109/MEMSYS.2001.906611
   Maruo S, 2001, PROC IEEE MICR ELECT, P151, DOI 10.1109/MEMSYS.2001.906501
   Maruo S, 2000, PROC SPIE, V3937, P106, DOI 10.1117/12.382800
   MARUO S, 1999, P 10 INT C SOL STAT, P1232
   MARUO S, 2002, P MICR TOT AN SYST 2, P937
   TAKAGI T, 1993, P MEMS, V93, P173
   WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192
NR 31
TC 2
Z9 2
U1 1
U2 7
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5557-1
J9 PROC SPIE
PY 2004
VL 5604
BP 52
EP 66
DI 10.1117/12.581900
PG 15
WC Engineering, Mechanical; Optics
SC Engineering; Optics
GA BBK00
UT WOS:000225835400007
DA 2018-10-20
ER

PT S
AU Bauer, I
   Russek, UA
   Herfurth, HJ
   Witte, R
   Heinemann, S
   Newaz, G
   Mian, A
   Georgiev, D
   Auner, G
AF Bauer, I
   Russek, UA
   Herfurth, HJ
   Witte, R
   Heinemann, S
   Newaz, G
   Mian, A
   Georgiev, D
   Auner, G
BE Herman, PR
   Fieret, J
   Pique, A
   Okada, T
   Bachmann, FG
   Hoving, W
   Washio, K
   Xu, X
   Dubowski, JJ
   Geohegan, DB
   Trager, F
TI Laser micro-joining of dissimilar and biocompatible materials
SO PHOTON PROCESSING IN MICROELECTRONICS AND PHOTONICS III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Photon Processing in Microelectronics and Photonics III
CY JAN 26-29, 2004
CL San Jose, CA
SP SPIE
DE dissimilar materials; laser beam joining; hermetic sealing;
   biocompatibility; biomedical application
AB Micro-joining and hermetic sealing of dissimilar and biocompatible materials is a critical issue for a broad spectrum of products such as micro-electronics, micro-optical and biomedical products and devices. Today, biocompatible titanium is widely applied as a material for orthopedic implants as well as for the encapsulation of implantable devices such as pacemakers, defibrillators, and neural stimulator devices.
   Laser joining is the process of choice to hermetically seal such devices. Laser joining is a contact-free process therefore minimizing mechanical load on the parts to be joined and the controlled heat input decreases the potential for thermal damage to the highly sensitive components. Laser joining also offers flexibility, shorter processing time and higher quality. However. novel biomedical products, in particular implantable microsystems currently under development, pose new challenges to the assembly and packaging process based on the higher level of integration, the small size of the device's features, and the type of materials and material combinations. In addition to metals, devices will also include glass, ceramic and polymers as biocompatible building materials that must be reliably joined in similar and dissimilar combinations. Since adhesives often lack long-term stability or do not meet biocompatibility requirements, new joining techniques are needed to address these joining challenges. Localized laser joining provides promising developments in this area. This paper describes the latest achievements in micro-joining of metallic and non-metallic materials with laser radiation. The focus is on material combinations of metal-polymer, polymer-glass, metal-glass and metal-ceramic using CO2, Nd:YAG and diode laser radiation. The potential for applications in the biomedical sector will be demonstrated.
C1 Fraunhofer Inst Laser Technol ILT, D-52074 Aachen, Germany.
RP Bauer, I (reprint author), Fraunhofer Inst Laser Technol ILT, Steinbachstr 15, D-52074 Aachen, Germany.
OI Mian, Ahsan/0000-0002-2033-6738
CR Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   CHU CC, 1990, CONCISE ENCY MED DEN, P261
   CURTIS H, WTEC MCC WORKSH MICR
   de Haro C, 2002, BIOMATERIALS, V23, P4515, DOI 10.1016/S0142-9612(02)00195-3
   DEVRIES E, 2001, STATE TECHNOLOGY MEC
   *FRAUNH I SIL, 2003, LAFICENT
   Gjuric M, 1998, AM J OTOL, V19, P273
   HAFERKAMP H, 1998, HIGH TEMPERATURE BRA
   JAKOBSEN H, 200 M EL SOC INC 52
   Kazakov N. F., 1981, DIFFUSION BONDING MA
   LAHL N, 1999, THESIS U WERKSTOFFE
   LUGSCHEIDER E, 2002, BRAZING METALS CERAM
   LUGSCHEIDER E, 1998, HIGH TEMPERATURE BRA, V192
   MAILLEFER D, 2001, IEEE, P413
   MULLER H, 1997, THESIS U SAARBRUCKEN
   *NAT PHYS LAB, 2003, SENS FUNCT MAT MEMS
   Niebauer MJ, 1997, CIRCULATION, V96, P3732
   SANTINI JT, 2002, BIOMEMS 2002
   STIEGLITZ T, WORLD MARKET SERIES
   Tong Q.-Y, 1999, SEMICONDUCTOR WAFER
   WIEMER M, 2002, MONTAGE KONTAKTIERUN, P266
   Wild MJ, 2001, SENSOR ACTUAT A-PHYS, V93, P63, DOI 10.1016/S0924-4247(01)00622-7
   WILD MJ, 2002, THESIS FRAUNHOFER IL
   Wintermantel E, 2002, MEDIZINTECHNIK BIOKO
NR 24
TC 21
Z9 21
U1 2
U2 8
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5247-5
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5339
BP 454
EP 464
DI 10.1117/12.530239
PG 11
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BAR96
UT WOS:000223331300050
DA 2018-10-20
ER

PT S
AU Jeetender, A
   Stiharu, I
   Packirisamy, M
   Balagopal, G
   Li, X
AF Jeetender, A
   Stiharu, I
   Packirisamy, M
   Balagopal, G
   Li, X
BE Armitage, JC
   Lessard, RA
   Lampropoulos, GA
TI MOEMS based cardiac enzymes detector for acute myocardial infarction
SO PHOTONICS NORTH: APPLICATIONS OF PHOTONIC TECHNOLOGY 7B, PTS 1 AND 2:
   CLOSING THE GAP BETWEEN THEORY, DEVELOPMENT, AND APPLICATION - PHOTONIC
   APPLICATIONS IN ASTRONOMY, BIOMEDICINE, IMAGING, MATERIALS PROCESSING,
   AND EDUCATION
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Conference on Applications of Photonics Technology
CY SEP 26-29, 2004
CL Ottawa, CANADA
SP SPIE, Canadian Photon Consortium, Ottawa Photon Cluster, Agilent Technol Canada Inc, Canadian Inst Photon Innovat, Invest Germany, OCRI Ottawa Global Marketing, Ontario Exports Inc, OPETA, OZ Opt Ltd, Univc Arizona Sci & Technol Park, Univ Ottawa
DE micro opto electro mechanical systems (MOEMS); cardiac enzymes; acute
   myocardial infarction (AMI); electrocardiographic; glass spectrums and
   horseradish peroxidase (HRP)
ID HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; GLASS; FORM
AB Biomedical applications of MOEMS are limited only by the mankind imagination. Precision measurements on minute amounts of biological material could be performed by optical means with a remarkable accuracy. Although available in medical laboratories for general purposes, such analyzers are making their way directly to the users in the form of dedicated equipment. Such an example is a test kit to detect the existence of cardiac enzymes in the blood stream. Apart from the direct users, the medical personnel will make use of such tools given the practicality of the kit. In a large proportion of patients admitted to the hospital suspected of Acute Myocardial Infarction (AMI), the symptoms and electrocardiographic changes are inconclusive. This necessitates the use of biochemical markers of myocardial damage for correct exclusion or conformation of AMI. In this study the concept of MOEMS is applied for the detection of enzyme reaction, in which glass spectrums are scanned optically when enzyme molecules adsorb on their surface. This paper presents the optical behavior of glass spectrums under Horseradish Peroxide (HRP) enzyme reaction. The reported experimental results provide valuable information that will be useful in the development of biosensors for enzymatic detection. This paper also reports the dynamic behavior of different glass spectrums.
C1 Concordia Univ, CONCAVE Res Ctr, Micromechatron Lab, Montreal, PQ H3G 1M8, Canada.
RP Jeetender, A (reprint author), Concordia Univ, CONCAVE Res Ctr, Micromechatron Lab, 1455 Maisonneuve Bld, Montreal, PQ H3G 1M8, Canada.
CR ADEDIRAN SA, 1989, EUR J BIOCHEM, V186, P571, DOI 10.1111/j.1432-1033.1989.tb15246.x
   BARNES JR, 1994, REV SCI INSTRUM, V65, P3793, DOI 10.1063/1.1144509
   Cho YW, 1999, B KOR CHEM SOC, V20, P1363
   Colonna S, 1999, TRENDS BIOTECHNOL, V17, P163, DOI 10.1016/S0167-7799(98)01288-8
   DOLMAN D, 1975, CAN J BIOCHEM CELL B, V53, P495, DOI 10.1139/o75-069
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Janata J, 1989, PRINCIPLES CHEM SENS
   Liu X, 2003, ANAL BIOCHEM, V314, P301, DOI 10.1016/S0003-2697(02)00696-6
   *MEMS, 2004, 545513 P SPIE
   PIRES MJ, 1993, BIOTECHNOL PROGR, V9, P647, DOI 10.1021/bp00024a012
   RALSTON IM, 1981, BIOPHYS J, V36, P311, DOI 10.1016/S0006-3495(81)84731-5
   ROBERT K, 1997, J BIOL CHEM, V256, P6903
   RYAN G, 2001, CRIT CARE NURS, V24, P54
   Subramanian A, 1999, ENZYME MICROB TECH, V24, P26, DOI 10.1016/S0141-0229(98)00084-2
   Trivedi B, 1999, NAT BIOTECHNOL, V17, P339, DOI 10.1038/7892
   WU SG, 1994, APPL BIOCHEM BIOTECH, V47, P11, DOI 10.1007/BF02788671
NR 16
TC 4
Z9 4
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5527-X
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5578
BP 91
EP 98
DI 10.1117/12.567678
PN 1-2
PG 8
WC Optics
SC Optics
GA BBN39
UT WOS:000226279900011
DA 2018-10-20
ER

PT S
AU Li, GP
AF Li, GP
GP IEEE
TI Micro/nano technology: A solution for next generation multi-function
   integrated systems
SO PROCEEDING OF THE 2004 BIPOLAR/BICMOS CIRCUITS AND TECHNOLOGY MEETING
SE BCTM PROCEEDINGS
LA English
DT Proceedings Paper
CT BIPOLAR/BiCMOS Circuits and Technology Meeting
CY SEP 13-14, 2004
CL Montreal, CANADA
SP IEEE, Elect Dev Soc, IEEE Solid State Circuits Soc
AB The unprecedented technology advancements in miniaturizing integrated circuits, and the resulting plethora of sophisticated, low cost electronic devices demonstrate the impact that micro/nano scale engineering can have when applied only to the area of electrical and computer engineering. Current research efforts in micro/nano fabrication technology for implementing integrated systems hope to yield similar revolutions in engineering fields of biomedical, mechanical, chemical, optical, fluidic, civil and environmental. The integrated system technology requires the integration of multiple materials, phenomena, technologies, and functions at micro/nano scales. By cross linking the individual engineering fields through micro/nano technology, various miniaturized system components have been developed at UCI that will have future impacts in the application markets such as medicine, healthcare, and telecommunications.
C1 Univ Calif Irvine, Dept Elect & Comp Engn, Integrated Nanosyst Res Facil, Irvine, CA 92697 USA.
RP Li, GP (reprint author), Univ Calif Irvine, Dept Elect & Comp Engn, Integrated Nanosyst Res Facil, Irvine, CA 92697 USA.
RI Li, Guann-Pyng/B-8466-2009
CR Bousse L, 2000, ANNU REV BIOPH BIOM, V29, P155, DOI 10.1146/annurev.biophys.29.1.155
   Cetiner BA, 2003, IEEE T MICROW THEORY, V51, P332, DOI 10.1109/TMTT.2002.806521
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   Polson NA, 2001, ANAL CHEM, V73, p312A, DOI 10.1021/ac0124585
   TAN YC, 2004, DESIGN MICROFLUI 1 2
   XU T, 2004, IN PRESS SENSORS A A
NR 6
TC 5
Z9 5
U1 1
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1088-9299
BN 0-7803-8618-3
J9 BCTM PROC
PY 2004
BP 201
EP 208
DI 10.1109/BIPOL.2004.1365781
PG 8
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA BBC61
UT WOS:000224835800044
DA 2018-10-20
ER

PT S
AU Ressler, J
   Grothe, H
   Motrescu, ER
   Wolf, B
AF Ressler, J
   Grothe, H
   Motrescu, ER
   Wolf, B
GP ieee
TI New concepts for chip-supported multi-well-plates: Realization of a
   24-wellplate with integrated impedance-sensors for functional cellular
   screening applications and automated microscope aided cell-based assays
SO PROCEEDINGS OF THE 26TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 26th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 01-05, 2004
CL San Francisco, CA
SP IEEE Engn Med & Biol Soc, Whitaker Fdn, Cyberonics, NIH, NIBIB, NIDOCD, NINDS
DE cell-based biosensor; multiwellplate; cell monitoring; drug-screening
AB Based on the experience with multiparametric bioelectronic sensor chips for the monitoring of living cells, we have combined the established multi-well-format with the advantages of microelectronic sensors. The result is a 24-well-plate where the bottom of the wells is replaced by glass-based chips with integrated IDES (interdigital electrode structure). By using IDES it is possible to detect adhesion and morphological changes of adherent growing cell cultures. Up to now these measurements were inaccessible in conjunction with multi-well-plates, especially in high throughput applications.
   If microscopic monitoring of the cell culture is required, the IDES can be fabricated using transparent conductor materials like ITO (indium tin oxide). Both the transparent material for the sensors and the sensor-carrier make the multi-well-plate also applicable for all kinds of fluorescence and luminescence biological tests. In addition to the impedance-sensors optical read-out sensor layers for pH and pO(2) can be integrated. For this reason there are many possible fields of application in biological and biomedical areas such as drug screening, chemosensitive testing and environmental toxicology as well as in biosensing for biological and chemical warfare. Especially the possibility of using this multi-well-plate together with automated imaging-systems has the great advantage of combining optical and sensory monitoring accessible to high-throughput-applications.
C1 Tech Univ Munich, Heinz Nixdorf Chair Med Elect, D-8000 Munich, Germany.
RP Ressler, J (reprint author), Tech Univ Munich, Heinz Nixdorf Chair Med Elect, D-8000 Munich, Germany.
CR Bard AJ, 2001, ELECTROCHEMICAL METH, P376
   Brischwein M, 2003, LAB CHIP, V3, P234, DOI 10.1039/b308888j
   Ehret R, 1997, BIOSENS BIOELECTRON, V12, P29, DOI 10.1016/0956-5663(96)89087-7
   Ehret R, 2001, FRESEN J ANAL CHEM, V369, P30, DOI 10.1007/s002160000628
   GROTHE H, 2003, TAGUNGSBAND SENSORS, P38
   Motrescu ER, 2004, EUR J CELL BIOL, V83, P90
   Terasaki M., 1995, P327
NR 7
TC 4
Z9 4
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8439-3
J9 P ANN INT IEEE EMBS
PY 2004
VL 26
BP 2074
EP 2077
PN 1-7
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Engineering, Biomedical; Medicine, Research &
   Experimental; Neurosciences; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Research & Experimental Medicine;
   Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA BBG76
UT WOS:000225461800535
PM 17272129
DA 2018-10-20
ER

PT S
AU Singh, K
AF Singh, K
GP ieee
TI A bone- material-based sensor
SO PROCEEDINGS OF THE 26TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 26th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 01-05, 2004
CL San Francisco, CA
SP IEEE Engn Med & Biol Soc, Whitaker Fdn, Cyberonics, NIH, NIBIB, NIDOCD, NINDS
DE piezo-electricity; bone; sensors; diagnostic probe; microphone pick-up;
   vibration sensor
AB Bones are now considered as a well accepted series of piezoelectric materials. Several researchers have used the bone material to develop piezoelectric sensors for the measurement of pressure, force, acceleration and other such parameters. However, with the advancement of technology in sensor systems, micro and nano-scale devices are now being developed by using semiconductor or biological materials, all over the world. Bio-chips based on DNA, and Bio-MEMS, etc are some of the examples. In the present research, new bone chips have been developed for various sensor applications, mainly micro or nanoscale systems. Design and fabrication aspects of the bone sensor chips for nano-transducers are discussed in detail here. Possible biomedical applications of these chips are also given in brief.
C1 Indian Inst Technol, CBME, New Delhi 110016, India.
RP Singh, K (reprint author), Indian Inst Technol, CBME, New Delhi 110016, India.
CR ANDREW MA, 1975, NATURE, V253, P627
   Fukuda E., 1957, J PHYS SOC JPN, V12, P1158
   FUKUDA E, 1964, JPN J APPL PHYS, V3, P117
   MARINO AA, 1970, NATURE, V228, P473, DOI 10.1038/228473a0
   SINGH VR, 1988, J INSTN ENG, V68, P43
   SINGH VR, 1988, P 10 ANN INT IEEE C
   YADAV S, 1990, INNOV TECH BIOL MED, V11, P89
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8439-3
J9 P ANN INT IEEE EMBS
PY 2004
VL 26
BP 2078
EP 2079
PN 1-7
PG 2
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Engineering, Biomedical; Medicine, Research &
   Experimental; Neurosciences; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Research & Experimental Medicine;
   Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA BBG76
UT WOS:000225461800536
DA 2018-10-20
ER

PT S
AU Soumetz, FC
   Giacomini, M
   Phillips, JB
   Brown, RA
   Ruggiero, C
AF Soumetz, FC
   Giacomini, M
   Phillips, JB
   Brown, RA
   Ruggiero, C
GP ieee
TI A drug delivery system for the treatment of peripheral nervous system
   injuries
SO PROCEEDINGS OF THE 26TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 26th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 01-05, 2004
CL San Francisco, CA
SP IEEE Engn Med & Biol Soc, Whitaker Fdn, Cyberonics, NIH, NIBIB, NIDOCD, NINDS
DE drug delivery systems; fluorescence spectroscopy; materials science and
   technology; materials testing; nanotechnology; nervous system; repair
ID ULTRATHIN FIBRONECTIN FIBERS; HYALURONIC-ACID; MIGRATION; ADHESIONS;
   CELLS; MATS
AB Recent results in biomedical engineering and materials science and technology have brought about the development of novel bioactive materials by which the repair of peripheral nervous system injuries can be improved. The formation of scarring tissue, which represents a physical barrier to axon elongation, and the not oriented outgrowth of neurites are the two major obstacles for a complete recovery of physiological nerve function. This study mainly focuses on the analysis of biocompatible constructs for the controlled release of anti-scarring antibodies by means of fluorescence spectroscopy techniques.
C1 Univ Genoa, DIST, I-16145 Genoa, Italy.
RP Soumetz, FC (reprint author), Univ Genoa, DIST, Via Opera Pia 13, I-16145 Genoa, Italy.
RI Giacomini, Mauro/D-3194-2013; Phillips, James/G-7926-2014
OI Giacomini, Mauro/0000-0001-5646-2034; Ruggiero,
   Carmelina/0000-0002-5275-2074
CR Ahmed Z, 1999, CELL MOTIL CYTOSKEL, V42, P331
   ANDREASSI L, 1991, WOUNDS, V3, P116
   [Anonymous], 2000, INTR FLUOR SPECTR
   BENEDETTI L, 1994, MED DEVICE TECHNOL, V5, P32
   BROWN RA, 1994, BIOMATERIALS, V15, P475
   Brown Robert A., 1997, Wound Repair and Regeneration, V5, P212, DOI 10.1046/j.1524-475X.1997.50304.x
   Creange A, 1998, REV NEUROL, V154, P208
   Curtis A., 1995, Journal of Cellular Engineering Incorporating Molecular Engineering, V1, P35
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Davison SP, 1999, LARYNGOSCOPE, V109, P631, DOI 10.1097/00005537-199904000-00021
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   GIACOMINI M, 2002, EUROPEAN CELLS MAT, V4, P113
   GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206
   KING VR, 1998, SOC NEUR ABS, V24, P3, DOI UNSP 23.3
   KNUDSON CB, 1993, FASEB J, V7, P1233
   LOFBERG J, 1980, DEV BIOL, V75, P148, DOI 10.1016/0012-1606(80)90151-7
   Nath RK, 1998, PLAST RECONSTR SURG, V102, P1100, DOI 10.1097/00006534-199809040-00027
   NIES S, 1997, ANNU REV BIOPH BIOM, V26, P567
   Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856
   SHUSHAN A, 1994, J REPROD MED, V39, P398
   Valentini R. F., 1995, BIOMEDICAL ENG HDB, P1985
   WHITWORTH IH, 1995, J HAND SURG-BRIT EUR, V20B, P429, DOI 10.1016/S0266-7681(05)80148-2
   WHIWORTH IH, 1995, EUROPEAN J NEUROSCIE, V7, P2220
   WojciakStothard B, 1997, IN VITRO CELL DEV-AN, V33, P110
NR 27
TC 0
Z9 0
U1 1
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8439-3
J9 P ANN INT IEEE EMBS
PY 2004
VL 26
BP 5047
EP 5049
PN 1-7
PG 3
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Engineering, Biomedical; Medicine, Research &
   Experimental; Neurosciences; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Research & Experimental Medicine;
   Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA BBG76
UT WOS:000225461801321
PM 17271451
DA 2018-10-20
ER

PT J
AU Grayson, ACR
   Shawgo, RS
   Johnson, AM
   Flynn, NT
   Li, YW
   Cima, MJ
   Langer, R
AF Grayson, ACR
   Shawgo, RS
   Johnson, AM
   Flynn, NT
   Li, YW
   Cima, MJ
   Langer, R
TI A BioMEMS review: MEMS technology for physiologically integrated devices
SO PROCEEDINGS OF THE IEEE
LA English
DT Review
DE biomedical engineering; biomedical materials; biomedical transducers;
   drug delivery systems; microelectrome-chanical devices; micromachining;
   microneedles; microparticles; cardiac pacemakers; surface modification;
   tissue engineering
ID DRUG-DELIVERY SYSTEMS; RETINA IMPLANT SYSTEM; PROTEIN ADSORPTION;
   CONTROLLED-RELEASE; MICROFABRICATED MICRONEEDLES; LONG-TERM; IN-VITRO;
   NEOINTIMAL HYPERPLASIA; SENSITIVE HYDROGELS; POLYMERIC MICELLES
AB MEMS devices are manufactured using similar microfabrication techniques as those used to create integrated circuits. They often, however have moving components that allow physical or analytical functions to be performed by the device. Although MEMS can be aseptically fabricated and hermetically sealed, biocompatibility of the component materials is a key issue for MEMS used in vivo. Interest in MEMS for biological applications (BioMEMS) is growing rapidly, with opportunities in areas such as biosensors, pacemakers, immunoisolation capsules, and drug delivery. The key to many of these applications lies in the lever-aging of features unique to MEMS (for example, analyte sensitivity, electrical responsiveness, temporal control, and feature sizes similar to cells and organelles) for maximum impact. In this paper we focus on how the biological integration of MEMS and other implantable devices can be improved through the application of microfabrication technology and concepts. Innovative approaches for improved physical and chemical integration of systems with the body are reviewed. An untapped potential for MEMS may lie in the area of nervous and endocrine system actuation , whereby the ability of MEMS to deliver potent drugs or hormones, combined with their precise temporal control, may provide new treatments for disorders of these systems.
C1 Cornell Univ, Biomed Engn Program, Ithaca, NY 14853 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   Wellesley Coll, Dept Chem, Wellesley, MA 02481 USA.
RP Grayson, ACR (reprint author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
EM acg37@cornell.edu; shawgo@mit.edu; cameo@mit.edu; nflynn@mit.edu;
   ywli@mit.edu; mjcima@mit.edu; rlanger@mit.edu
CR Abel PU, 2002, BIOSENS BIOELECTRON, V17, P1059, DOI 10.1016/S0956-5663(02)00099-4
   Ahmed A, 2002, J CONTROL RELEASE, V81, P291, DOI 10.1016/S0168-3659(02)00074-3
   Ahmed A, 2001, BIOMED MICRODEVICES, V3, P89, DOI 10.1023/A:1011489907820
   Alt E, 1998, PACE, V21, P1862, DOI 10.1111/j.1540-8159.1998.tb00003.x
   Armani DK, 2000, J MICROMECH MICROENG, V10, P80, DOI 10.1088/0960-1317/10/1/311
   BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481
   BAE YH, 1994, ACS SYM SER, V545, P98
   Bassetti MJ, 2002, ENG MED BIOL SOC ANN, P410, DOI 10.1109/MMB.2002.1002358
   Bearinger JP, 1997, LANGMUIR, V13, P5175, DOI 10.1021/la970101j
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Boateng S, 2002, ADV MATER, V14, P461, DOI 10.1002/1521-4095(20020318)14:6<461::AID-ADMA461>3.0.CO;2-S
   Borenstein JT, 2002, BIOMED MICRODEVICES, V4, P167, DOI 10.1023/A:1016040212127
   Brainard GC, 2001, J NEUROSCI, V21, P6405
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   Bustillo JM, 1998, P IEEE, V86, P1552, DOI 10.1109/5.704260
   Canham LT, 1996, ADV MATER, V8, P850, DOI 10.1002/adma.19960081020
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Canham LT, 1999, ADV MATER, V11, P1505, DOI 10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.3.CO;2-3
   Cao X, 2001, BIOMED MICRODEVICES, V3, P109, DOI 10.1023/A:1011494008729
   CHRISTINI DJ, 1999, P 1 JOINT BMES EMBS, V1, P319
   Chung JE, 1999, J CONTROL RELEASE, V62, P115, DOI 10.1016/S0168-3659(99)00029-2
   CIMA MJ, 2002, ACS PROSP FUT DIR DR
   *CON MEDS, 2002, COR STENT PLATF
   Cox JD, 2002, BIOMATERIALS, V23, P929, DOI 10.1016/S0142-9612(01)00205-8
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   De SK, 2002, J MICROELECTROMECH S, V11, P544, DOI 10.1109/JMEMS.2002.803281
   Degertekin M, 2002, CIRCULATION, V106, P1610, DOI 10.1161/01.CIR.0000034447.02535.D5
   Desai TA, 1997, P SOC PHOTO-OPT INS, V2978, P216, DOI 10.1117/12.269972
   Desai TA, 1998, PROG BIOM O, V3258, P40, DOI 10.1117/12.304387
   Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9
   DESAI TA, 1999, J BIOMED MICRODEVICE, V1, P131
   Desai TA, 1999, BIOMED MICRODEVICES, V2, P11, DOI 10.1023/A:1009903215959
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   DONG LC, 1992, J CONTROL RELEASE, V19, P171
   DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253
   Duncan AC, 2002, BIOSENS BIOELECTRON, V17, P413, DOI 10.1016/S0956-5663(01)00281-0
   Eddington DT, 2001, LAB CHIP, V1, P96, DOI 10.1039/b108078d
   EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202
   EDELMAN ER, 1985, J BIOMED MATER RES, V19, P67, DOI 10.1002/jbm.820190107
   FEARNOT N E, 1989, Journal of Clinical Engineering, V14, P225
   Folch A, 2000, BIOMED MICRODEVICES, V2, P207, DOI 10.1023/A:1009932530375
   Gerasimov OV, 1999, ADV DRUG DELIVER REV, V38, P317, DOI 10.1016/S0169-409X(99)00035-6
   Glikson M, 2001, MED CLIN N AM, V85, P369, DOI 10.1016/S0025-7125(05)70320-5
   GLIKSON M, 1994, CURR OPIN CARDIOL, V9, P65, DOI 10.1097/00001573-199401000-00008
   GOUGH DA, 1988, HORM METAB RES, V20, P30
   GOUGH DA, 1995, DIABETES, V44, P1005, DOI 10.2337/diab.44.9.1005
   Grant SA, 1997, P SOC PHOTO-OPT INS, V2976, P64, DOI 10.1117/12.275514
   Grant SA, 2001, SENSOR ACTUAT B-CHEM, V72, P174, DOI 10.1016/S0925-4005(00)00650-X
   Grimes CA, 1999, BIOMED MICRODEVICES, V2, P51, DOI 10.1023/A:1009907316867
   Grube E, 2001, J AM COLL CARDIOL, V37, p74A
   GU Y, 2002, P 2 ANN INT IEEE EMB, P406
   Han IS, 2002, BIOMACROMOLECULES, V3, P1271, DOI 10.1021/bm0255894
   Hanein Y, 2001, SENSOR ACTUAT B-CHEM, V81, P49, DOI 10.1016/S0925-4005(01)00925-X
   Hayes DL, 1999, AM J CARDIOL, V83, p161D
   HAYES DL, 1992, MAYO CLIN PROC, V67, P379, DOI 10.1016/S0025-6196(12)61556-0
   Heldman AW, 2001, CIRCULATION, V103, P2289
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   Hernandez PR, 1998, SENSOR ACTUAT B-CHEM, V46, P133, DOI 10.1016/S0925-4005(98)00099-9
   Hiatt BL, 2002, CATHETER CARDIO INTE, V55, P409, DOI 10.1002/ccd.10161
   Hill SM, 2000, FASEB J, V14, pA268
   Ho JJ, 2000, INT J ELECTRON, V87, P757, DOI 10.1080/002072100131940
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   Holmstrom N, 1998, BIOSENS BIOELECTRON, V13, P1287, DOI 10.1016/S0956-5663(98)00091-8
   Hsieh MC, 2001, J MICROELECTROMECH S, V10, P121, DOI 10.1109/84.911100
   Jackman RJ, 1998, ANAL CHEM, V70, P2280, DOI 10.1021/ac971295a
   Jauniaux E, 1999, HUM REPROD, V14, P2901, DOI 10.1093/humrep/14.11.2901
   JAWORSKI Z, 2000, P 1 ANN INT IEEE EMB, P475
   Jones BR, 1999, AM J CARDIOL, V83, p192D
   Kagatani S, 1997, J PHARM SCI, V86, P1273, DOI 10.1021/js9700762
   Kancharla VV, 2002, BIOMED MICRODEVICES, V4, P105, DOI 10.1023/A:1014679013888
   Kapur R, 1999, J BIOMECH ENG-T ASME, V121, P65, DOI 10.1115/1.2798044
   Kataoka K, 1998, J AM CHEM SOC, V120, P12694, DOI 10.1021/ja982975d
   KATAOKA K, 1995, MACROMOLECULES, V28, P3336, DOI 10.1021/ma00113a038
   Kaushik S, 2001, ANESTH ANALG, V92, P502, DOI 10.1213/00000539-200102000-00041
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   KIM HL, 1994, POLYM MAT SCI ENG, V70, P133
   Kim K, 2001, LANGMUIR, V17, P5066, DOI 10.1021/la0102096
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   KOST J, 1987, J BIOMED MATER RES, V21, P1367, DOI 10.1002/jbm.820211202
   KOST J, 1989, P NATL ACAD SCI USA, V86, P7663, DOI 10.1073/pnas.86.20.7663
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Kovacs GTA, 1998, P IEEE, V86, P1536, DOI 10.1109/5.704259
   Koyama H, 2002, J BONE MINER RES, V17, P1219, DOI 10.1359/jbmr.2002.17.7.1219
   KRAEGEN EW, 1988, HORM METAB RES, V20, P1
   Kristensen BW, 2001, BRAIN RES, V896, P1, DOI 10.1016/S0006-8993(00)03304-7
   Kulczykowska E, 2002, REV FISH BIOL FISHER, V11, P321
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   Lawrence VJ, 2000, HORM METAB RES, V32, P453, DOI 10.1055/s-2007-978671
   Lee YM, 1996, J APPL POLYM SCI, V62, P301, DOI 10.1002/(SICI)1097-4628(19961010)62:2<301::AID-APP5>3.0.CO;2-0
   Leoni L, 2002, BIOMED MICRODEVICES, V4, P131, DOI 10.1023/A:1014639332543
   LI Y, 2002 FALL MAT RES SO
   LI Y, 2002, P 2 ANN INT IEEE EMB, P390
   Lin WQ, 2001, PHARMACEUT RES, V18, P1789, DOI 10.1023/A:1013395102049
   Liu RH, 2002, J MICROELECTROMECH S, V11, P45, DOI 10.1109/84.982862
   Loeb GE, 2001, MED ENG PHYS, V23, P9, DOI 10.1016/S1350-4533(01)00011-X
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Madou M. J., 2002, FUNDAMENTALS MICROFA
   Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014
   Martin FJ, 2001, BIOMED MICRODEVICES, V3, P97, DOI 10.1023/A:1011442024658
   Matriano JA, 2002, PHARMACEUT RES, V19, P63, DOI 10.1023/A:1013607400040
   McAllister DV, 2000, ANNU REV BIOMED ENG, V2, P289, DOI 10.1146/annurev.bioeng.2.1.289
   McNichols RJ, 2000, J BIOMED OPT, V5, P5, DOI 10.1117/1.429962
   MEYER JM, 1995, J MATER SCI-MATER M, V6, P534, DOI 10.1007/BF00151035
   MEYERHOFF ME, 1993, TRAC-TREND ANAL CHEM, V12, P257, DOI 10.1016/0165-9936(93)87065-6
   MILHEISER TA, 1998, IDENTIFICATION SYSTE
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
   Nakayama Y, 2001, J BIOMED MATER RES, V57, P559, DOI 10.1002/1097-4636(20011215)57:4<559::AID-JBM1202>3.0.CO;2-H
   Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2
   NORWAK B, 1999, AM J CARDIOL, V83, pD172
   Oberhoff M, 2002, CATHETER CARDIO INTE, V55, P404, DOI 10.1002/ccd.10034
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Papra A, 2001, LANGMUIR, V17, P4090, DOI 10.1021/la0016930
   Pistorius A, 2002, EUR J MED RES, V7, P81
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   Prausnitz M R, 2001, Diabetes Technol Ther, V3, P233, DOI 10.1089/152091501300209606
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Reed ML, 1998, J PHARM SCI-US, V87, P1387, DOI 10.1021/js980085q
   Rogers JA, 1997, APPL PHYS LETT, V70, P2658, DOI 10.1063/1.118988
   Rosengren A, 2002, IEEE T BIO-MED ENG, V49, P392, DOI 10.1109/10.991167
   Sanders RS, 1996, P IEEE, V84, P480, DOI 10.1109/5.486749
   Santini JT, 1999, NATURE, V397, P335
   Santini JT, 2000, ANGEW CHEM INT EDIT, V39, P2397
   Saoudi N, 1999, AM J CARDIOL, V83, p180D
   SAWAHATA K, 1990, J CONTROL RELEASE, V14, P253, DOI 10.1016/0168-3659(90)90165-P
   Schaldach M., 1996, P 18 ANN INT C IEEE, V5, P1955
   SCHEIDT RA, 2000, P 1 ANN INT IEEE EMB, P483
   Schmidt MA, 1998, P IEEE, V86, P1575, DOI 10.1109/5.704262
   Schoenfisch MH, 2000, J BIOMED MATER RES, V51, P209, DOI 10.1002/(SICI)1097-4636(200008)51:2<209::AID-JBM9>3.0.CO;2-5
   Schwarz M, 1999, IEEE T CIRCUITS-II, V46, P870, DOI 10.1109/82.775382
   Schwarz M, 2000, SENSOR ACTUAT A-PHYS, V83, P40, DOI 10.1016/S0924-4247(00)00290-9
   Service RF, 2002, SCIENCE, V297, P962, DOI 10.1126/science.297.5583.962
   Sharma S, 2002, LANGMUIR, V18, P8728, DOI 10.1021/la026097f
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Snellings GMBF, 2000, ADV MATER, V12, P1959, DOI 10.1002/1521-4095(200012)12:24<1959::AID-ADMA1959>3.3.CO;2-M
   Stangel K, 2001, IEEE J SOLID-ST CIRC, V36, P1094, DOI 10.1109/4.933466
   Strong ZA, 2002, BIOMED MICRODEVICES, V4, P97, DOI 10.1023/A:1014627029818
   SUTINEN R, 1995, J CONTROL RELEASE, V33, P163, DOI 10.1016/0168-3659(94)00080-E
   Taillefer J, 2000, J PHARM SCI, V89, P52, DOI 10.1002/(SICI)1520-6017(200001)89:1<52::AID-JPS6>3.0.CO;2-D
   TIERNEY MJ, 1990, J ELECTROCHEM SOC, V137, P3789, DOI 10.1149/1.2086302
   Troyk PR, 1999, ANNU REV BIOMED ENG, V1, P177, DOI 10.1146/annurev.bioeng.1.1.177
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Vaidya R, 1998, BIOTECHNOL PROGR, V14, P371, DOI 10.1021/bp980039w
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   VOSKERICIAN G, IN PRESS IEEE T BIOM
   Wang L, 2002, IEEE T BIO-MED ENG, V49, P1340, DOI 10.1109/TBME.2002.804586
   Ward WK, 2002, BIOSENS BIOELECTRON, V17, P181, DOI 10.1016/S0956-5663(01)00268-8
   Werner J, 2000, T I MEAS CONTROL, V22, P289, DOI 10.1177/014233120002200402
   Wheatley MA, 1999, MATER RES SOC SYMP P, V550, P113
   Widu F, 1999, J MATER SCI-MATER M, V10, P275, DOI 10.1023/A:1008953412622
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Windecker S, 2001, CIRCULATION, V104, P928, DOI 10.1161/hc3401.093146
   Wirthlin DJ, 2002, J SURG RES, V108, P14, DOI 10.1006/jsre.2002.6509
   Yu Q, 2001, APPL PHYS LETT, V78, P2589, DOI 10.1063/1.1367010
   YU Q, 2000, P 1 ANN INT IEEE EMB, P336
   YUK SH, 1992, PHARMACEUT RES, V9, P955, DOI 10.1023/A:1015821504229
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   Zhao B, 2001, LANGMUIR, V17, P4758, DOI 10.1021/la001709m
   Ziaie B, 1997, IEEE T BIO-MED ENG, V44, P909, DOI 10.1109/10.634643
   Ziaie B, 2001, BIOMED MICRODEVICES, V3, P285, DOI 10.1023/A:1012452613720
NR 164
TC 282
Z9 290
U1 7
U2 176
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9219
EI 1558-2256
J9 P IEEE
JI Proc. IEEE
PD JAN
PY 2004
VL 92
IS 1
BP 6
EP 21
DI 10.1109/JPROC.2003.820534
PG 16
WC Engineering, Electrical & Electronic
SC Engineering
GA 762TX
UT WOS:000187999200002
OA Green Published
DA 2018-10-20
ER

PT S
AU Filippini, D
   Asberg, P
   Nilsson, P
   Inganas, O
   Lundstrom, I
AF Filippini, D
   Asberg, P
   Nilsson, P
   Inganas, O
   Lundstrom, I
BE Rocha, D
   Sarro, PM
   Vellekoop, MJ
TI Computer screen photo-assisted spectral fingerprinting of luminescent
   polythiophene pH reporter
SO PROCEEDINGS OF THE IEEE SENSORS 2004, VOLS 1-3
SE IEEE Sensors
LA English
DT Proceedings Paper
CT IEEE Sensors 2004 Conference
CY OCT 24-27, 2004
CL Vienna Univ Technol, Vienna, AUSTRIA
SP IEEE
HO Vienna Univ Technol
DE computer screen illumination; fluorescent assays; spectral
   fingerprinting
AB The capability of the computer screen photo-assisted technique (CSPT)for the spectral fingerprinting of a photoactive polythiophene derivative (POWT) used as pH reporter is demonstrated. POWT is part of a family of industrial scalable materials, well established for organic electronics and biomedical applications, which is used here to demonstrate the capability of CSPT for tracing key spectral features.
   The ability of CSPTfor substance classification, corroborated by principal component analysis (PCA), successfully compares to standard spectroscopy, especially considering the involved equipments: CSPT is only a computer set and a web camera.
C1 Linkoping Univ, IFM, SE-58183 Linkoping, Sweden.
RP Filippini, D (reprint author), Linkoping Univ, IFM, SE-58183 Linkoping, Sweden.
EM danfi@ifm.liu.se
OI Inganas, Olle/0000-0002-6243-1450
CR ANDERSSON M, 1991, POLYM COMMUN, V32, P546
   Filippini D, 2004, ANAL CHIM ACTA, V521, P237, DOI 10.1016/j.aca.2004.05.081
   Filippini D, 2003, BIOSENS BIOELECTRON, V19, P35, DOI 10.1016/S0956-5663(03)00132-5
   FILIPPINI D, 2004, IN PRESS SENSORS A B
   Filippini D., 2003, CHEM COMMUN, V9, P240
   NILSSON K, 2003, NATURE MAT, V2
NR 6
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1930-0395
BN 0-7803-8692-2
J9 IEEE SENSOR
PY 2004
BP 1377
EP 1380
DI 10.1109/ICSENS.2004.1426440
PG 4
WC Engineering, Multidisciplinary; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BCH15
UT WOS:000229268100357
DA 2018-10-20
ER

PT B
AU Scherer, KP
   Guth, H
   Quinte, A
   Stiller, P
AF Scherer, KP
   Guth, H
   Quinte, A
   Stiller, P
BE Tilg, B
TI Biomedical modelling of human eyes for surgical interventions
SO Proceedings of the Second IASTED International Conference on Biomedical
   Engineering
LA English
DT Proceedings Paper
CT 2nd IASTED International Conference on Biomedical Engineering
CY FEB 16-18, 2004
CL Innsbruck, AUSTRIA
SP Int Assoc Sci & Technol Dev, Univ Hlth Informat & Technol, Biomed Engn Soc, Amer Inst Med & Biol Engn, European Soc Engn & Med, Int Federat Med & Biol Engn, Austrian Soc Biomed Engn, Biomat Network
DE biomedical behaviour; biological tissue deformation; comeal
   biomechanics; surgical planning; FEM simulation; lens system; human eye
   components
AB Concerning surgical and therapy planning for interventions at human eyes, especially at cornea and lens, computer based simulations are needed to predict the postoperative behaviour of the eye (vision) before surgical acts at the patients. In the Institute of computer science in the Research Center Karlsruhe a simulation system is developed for the refractive surgery methods. Biomechanical simulations are performed with the commercial tool ANSYS, where morphometric and material data of the human eye are very important. The deformation of the cornea after interventions is the input for further optical simulations to give answer concerning the quality of vision.
C1 Forschungszentrum Karlsruhe GmbH, Inst Angew Informat, D-76021 Karlsruhe, Germany.
RP Scherer, KP (reprint author), Forschungszentrum Karlsruhe GmbH, Inst Angew Informat, POB 3640, D-76021 Karlsruhe, Germany.
CR JUE B, 1986, J BIOMECHANICS
   Maurice D.M., 1988, CORNEA, V8, P187
   Orssengo GJ, 1999, B MATH BIOL, V61, P551, DOI 10.1006/bulm.1999.0102
   SCHERER KP, 2001, INT C APPL SIM MOD M, P188
   SCHERER KP, 2001, 13 INT C SOC MED INN
   Seiler T., 2000, REFRAKTIVE CHIRURG H
   SPOERL E, 1995, INVESTIGATE OPHTHALM, V36
   VITO RP, 1992, REFRACTIVE KERATOTOM, P1017
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ACTA PRESS
PI CALGARY
PA B6, STE 101, 2509 DIEPPE AVE SW, CALGARY, ALBERTA T3E 7J9, CANADA
BN 0-88986-408-X
PY 2004
BP 492
EP 496
PG 5
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA BCA43
UT WOS:000228456600107
DA 2018-10-20
ER

PT B
AU Wei, QF
   Wang, XQ
   Mather, RR
   Fotheringham, AF
AF Wei, QF
   Wang, XQ
   Mather, RR
   Fotheringham, AF
GP college of textiles
TI Dynamic characterisation of biopolymer fibres using an environmental
   scanning electron microscope
SO QUALITY TEXTILES FOR QUALITY LIFE, VOLS 1-4
LA English
DT Proceedings Paper
CT 83rd Textile-Institute World Conference
CY MAY 23-27, 2004
CL Shanghai, PEOPLES R CHINA
SP Textile Inst, Donghua Univ, Textile & Garment Champer Commerce, Shanghai Textile Holding Grp Corp, Marzoli Textile Machinery Comp Ltd, Quanzhou Haitian Textile Co Ltd
AB Biopolymer fibres are generally recognised to be one of the most dynamic and promising materials for biomedical and other applications. The use of new tools is vital in the fundamental and practical research of these versatile fibres. Environmental Scanning Electron Microscope (ESEM) is a low vacuum analytical technique, which allows for dynamic experiments at a range of pressures, temperatures and under a variety of gases/fluids. In this study, a Phillips XL-30 FEG-ESEM was used to characterise the biopolymer fibres of poly( L-lactic acid) and alginate under dynamic conditions. Dynamic wetting and absorption of the fibres were examined in situ by providing conditions in favour of condensation or evaporation of water. A full energy dispersive x-ray analysis (EDX) mounted on the ESEM was also used to detect the ion exchange behaviour of the alginate fibres. A mechanical testing stage was placed in the ESEM chamber to examine the dynamic tensile properties of the biopolymer fibres. The ability of ESEM to follow dynamic events has given new insight into the kinetics of structure rearrangement and breakdown of the biopolymer fibres under dynamic conditions. The study has also revealed that the ESEM is a promising tool in the dynamic studies of textile materials.
C1 Anhui Univ Technol & Sci, Wuhu 241000, Peoples R China.
RP Wei, QF (reprint author), Anhui Univ Technol & Sci, Wuhu 241000, Peoples R China.
CR Combes R, 1998, J PETROL SCI ENG, V20, P133, DOI 10.1016/S0920-4105(98)00012-6
   HAGEGE R, 1989, J MICROSC SPECTROSC, V14, P14
   MATSUNAGA T, 1994, TEXTILE ASIA, V25, P25
   Wei QF, 2003, TEXT RES J, V73, P557, DOI 10.1177/004051750307300615
   WEI QF, 2002, TECHNICAL TEXTILE IN, P19
NR 5
TC 0
Z9 0
U1 0
U2 1
PU TEXTILE INST
PI MANCHESTER
PA 10 BLACKFRIARS ST, MANCHESTER M3 5DR, ENGLAND
BN 1-8703-7261-1
PY 2004
BP 465
EP 470
PG 6
WC Materials Science, Textiles
SC Materials Science
GA BAK83
UT WOS:000222655600109
DA 2018-10-20
ER

PT J
AU Beyer, GJ
   Zeisler, SK
   Becker, DW
AF Beyer, GJ
   Zeisler, SK
   Becker, DW
TI The Auger-electron emitter Er-165: excitation function of the Ho-165(p,
   n)Er-165 process
SO RADIOCHIMICA ACTA
LA English
DT Article
DE radio-lanthanides; erbium-165; Auger therapy; cross section; cyclotron
AB The lanthanide isotope Er-165 decays by electron capture without any accompanying gamma radiation, which makes it an ideal radionuclide for Auger electron therapy. The chemical properties of erbium with regard to labelling of bioconjugates are virtually identical to those of radio-yttrium. We measured the excitation function of the Ho-165(p, n)Er-165 reaction and obtained a maximum cross section of 166 +/- 20mb at 11.1 +/- 0.5 MeV proton energy. Our findings indicate that Er-165 can be produced at any small-sized cyclotron in quantities suitable for biomedical applications. The thick target yield at E-p = 15 MeV is 55 MBq/muAh. A mass separated sample of the nuclide pair Er-160/Ho-160 was used as model to demonstrate that the separation of the Er-165 from the target matrix material Ho can be achieved by cation-exchange chromatography using Aminex A5 resin and alpha-HIBA as eluent in about 1 hour.
C1 Univ Hosp Geneva, Cyclotron Unit, CH-1211 Geneva, Switzerland.
   TRIUMF, Appl Technol Grp, Vancouver, BC V6T 2A3, Canada.
   ARGOS Cyclotron Betriebs GmbH, LKH, Klagenfurt, Austria.
RP Beyer, GJ (reprint author), Univ Hosp Geneva, Cyclotron Unit, CH-1211 Geneva, Switzerland.
EM gerd.beyer@hcuge.ch
CR Allen BJ, 1996, NUCL MED COMMUN, V17, P40, DOI 10.1097/00006231-199601000-00008
   BEYER GJ, 1981, KERNENERGIE, V24, P388
   Beyer GJ, 2002, RADIOCHIM ACTA, V90, P247, DOI 10.1524/ract.2002.90.5_2002.247
   Chu S. Y. F., LUND LBNL NUCL DATA
   Stocklin G, 1995, RADIOCHIM ACTA, V70-1, P249
   Sudar S, 2002, APPL RADIAT ISOTOPES, V56, P821, DOI 10.1016/S0969-8043(02)00054-4
   VYLOV T, 2001, E6200135
   Zeisler S. K., 1999, Journal of Labelled Compounds and Radiopharmaceuticals, V42, pS921
   ZIEGLER JF, 1998, TRIM PROGRAM DOS VER
NR 9
TC 10
Z9 10
U1 1
U2 5
PU R OLDENBOURG VERLAG
PI MUNICH
PA LEKTORAT MINT, POSTFACH 80 13 60, D-81613 MUNICH, GERMANY
SN 0033-8230
J9 RADIOCHIM ACTA
JI Radiochim. Acta
PY 2004
VL 92
IS 4-6
BP 219
EP 222
DI 10.1524/ract.92.4.219.35608
PG 4
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology
SC Chemistry; Nuclear Science & Technology
GA 838ZT
UT WOS:000222753800007
DA 2018-10-20
ER

PT S
AU Mudarri, TC
   Leo, DJ
   Wood, BC
   Shires, PK
AF Mudarri, TC
   Leo, DJ
   Wood, BC
   Shires, PK
BE BarCohen, Y
TI Developing a polymeric sensor to monitor intracellular conditions
SO SMART STRUCTURES AND MATERIALS 2004: ELECTROACTIVE POLYMER ACTUATORS AND
   DEVICES (EAPAD)
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2004 Conference
CY MAR 15-18, 2004
CL San Diego, CA
SP SPIE, Amer Inst Aeronaut & Astronaut, Amer Soc Mech Engineers, Soc Expt Mech, Boeing Co, Journal Intelligent Mat Syst & Struct, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada
DE ion sensing; electrochemical biosensor; ionic polymer; electroactive
   polymer; bone healing
ID MEMBRANES
AB Ionic electroactive polymers have been developed as mechanical sensors or actuators, taking advantage of the electromechanical coupling of the materials. This research attempts to take advantage of the chemomechanical and chemoelectrical coupling by characterizing the transient response as the polymer undergoes an ion exchange, thus using the polymer for ionic sensing. Nafion(TM) is a biocompatible material, and an implantable polymeric ion sensor which has applications in the biomedical field for bone healing research. An ion sensor and a strain gauge could determine the effects of motion allowed at the fracture site, thus improving rehabilitation procedures for bone fractures.
   The charge sensitivity of the material and the capacitance of the material were analyzed to determine the transient response. Both measures indicate a change when immersed in ionic salt solutions. It is demonstrated that measuring the capacitance is the best indicator of an ion exchange. Relative to a flat response in deionized water (+/-2%), the capacitance of the polymer exhibits an exponential decay of similar to25% of its peak when placed in a salt solution. A linear correlation between the time constant of the decay and the ionic size of the exchanging ion was developed that could reasonably predict a diffusing ion. Tests using an energy dispersive spectrometer (EDS) indicate that 90% of the exchange occurs in the first 20 minutes, shown by both capacitance decay and an atomic level scan. The diffusion rate time constant was found to within 0.3% of the capacitance time constant, confirming the ability of capacitance to measure ion exchange.
C1 Virginia Polytech Inst & State Univ, Ctr Intelligent Mat & Struct, Blacksburg, VA 24061 USA.
RP Mudarri, TC (reprint author), Virginia Polytech Inst & State Univ, Ctr Intelligent Mat & Struct, 310 Durham Hall, Blacksburg, VA 24061 USA.
CR BENNET M, 2002, THESIS VIRGINIA POLY
   Bennett MD, 2003, SMART MATER STRUCT, V12, P424, DOI 10.1088/0964-1726/12/3/314
   BKER A, 1994, DESIGN NEWS, V49, P100
   DUPONT, NAF MEMBR NE 112 NE
   FARINHOLT KM, 2002, P 1 WORLD C BIOM ART
   FARINHOLT KM, 2003, 2003 SPIE SMART MAT
   GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650
   Grodzinsky A, 1974, P 27 ANN C ENG MED B, V16, P485
   Hisamoto H, 2001, ANAL CHEM, V73, P5551, DOI 10.1021/ac0107150
   MILLET P, 1995, J APPL ELECTROCHEM, V25, P227
   MILLET P, 1993, J ELECTROCHEM SOC, V140, P1373, DOI 10.1149/1.2221563
   MUDARRI T, 2003, THESIS VIRGINIA POLY
   Newbury K.M., 2002, THESIS VIRGINIA POLY
   Newbury KM, 2002, J INTEL MAT SYST STR, V13, P51, DOI 10.1106/104538902027978
   OGURO K, 1992, J MICROMACHINE SOC, V5, P27
   POLLACK SR, 2001, BONE MECH HDB
   Prendergast P., 2001, BONE MECH HDB
   SEGALMAN D, 1992, SMART MATER STRUCT, V1, P44
   Thevenot DR, 2001, BIOSENS BIOELECTRON, V16, P121, DOI 10.1016/S0956-5663(01)00115-4
   TURNER RFB, 1991, BIOMATERIALS, V12, P361, DOI 10.1016/0142-9612(91)90003-S
   YEAGER HL, 1981, J ELECTROCHEM SOC, V128, P1880, DOI 10.1149/1.2127757
NR 21
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5302-1
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5385
BP 326
EP 337
DI 10.1117/12.540196
PG 12
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Polymer Science
SC Engineering; Instruments & Instrumentation; Polymer Science
GA BAS49
UT WOS:000223368700038
DA 2018-10-20
ER

PT B
AU Imbeni, V
   Mehta, A
   Robertson, SW
   Duerig, TW
   Pelton, AR
   Ritchie, RO
AF Imbeni, V
   Mehta, A
   Robertson, SW
   Duerig, TW
   Pelton, AR
   Ritchie, RO
BE Pelton, AR
   Duerig, T
TI On the mechanical behavior of Nitinol under multiaxial loading
   conditions and in situ synchrotron x-ray
SO SMST-2003: Proceedings of the International Conference on Shape Memory
   and Superelastic Technologies
LA English
DT Proceedings Paper
CT International Conference on Shape Memory and Superelastic Technologies
   (SMST-2003)
CY MAY 05-08, 2003
CL Pacific Grove, CA
SP Boston Sci, Ft Wayne Met, Johnson Matthey, Shape Mem Applicat, MeKo, Minitubes, Special Met, TiNi Alloy Co, UTI
DE Nitinol; multiaxial; torsion; x-ray; synchrotron; Luders bands; R-phase;
   in situ
ID SHAPE-MEMORY; TRANSFORMATION; TENSION; ALLOYS
AB Although the use of Nitinol in the biomedical industry has been very successful, it has been difficult to accurately compute stresses via Finite Element Analysis (FEA) due to the presence of complex in vivo loading patterns. Constitutive laws for shape memory alloys (SMA) subjected to multiaxial loading, which are based on direct experimental observations, are generally not available in the literature, and thus FEA models are generally based on uniaxial data. Accordingly, in the present work, tension-torsion tests are conducted on Nitinol thin walled tubes (thickness/radius ratio of 1:10) using various loading/unloading paths under isothermal conditions. The experimental results showed significant variations in the mechanical response along the two loading axes. To fully understand the macroscopic and microscopic aspects of the transformation, in situ multiaxial (tension-torsion) loading experiments were also performed at the Stanford Synchrotron Radiation Laboratory (SSRL) in order to monitor the material's state of transformation and identify the nature, volume fraction of phases present, and the elastic strain in them as a function of stress and stress state.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Div Sci Mat, Berkeley, CA 94720 USA.
RP Imbeni, V (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Sci Mat, Berkeley, CA 94720 USA.
RI Ritchie, Robert/A-8066-2008
OI Ritchie, Robert/0000-0002-0501-6998
CR Gall K, 1999, ACTA MATER, V47, P1203, DOI 10.1016/S1359-6454(98)00432-7
   HELM D, 2001, SPIE, V4333, P302
   JUNG Y, 2003, IN PRESS INT J NUMER
   Lim TJ, 1995, J INTEL MAT SYST STR, V6, P817
   LIM TJ, ASME, V121, P9
   LING HC, 1981, METALL TRANS A, V12, P2101, DOI 10.1007/BF02644180
   MCNANEY JH, 2003, IN PRESS MECH MAT
   MIYAZAKI S, 1989, ACTA METALL MATER, V37, P1873, DOI 10.1016/0001-6160(89)90072-2
   Sun QP, 2002, INT J SOLIDS STRUCT, V39, P3797, DOI 10.1016/S0020-7683(02)00182-8
NR 9
TC 1
Z9 1
U1 0
U2 8
PU SMST SOC INC
PI MENLO PARK
PA C/O SRI M/S AA287, 333 RAVENSWOOD AVENUE, MENLO PARK, CA 94025 USA
BN 0-9660508-3-5
PY 2004
BP 267
EP 276
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BCC80
UT WOS:000228663400031
DA 2018-10-20
ER

PT B
AU Robertson, SW
   Imbeni, V
   Notkina, E
   Wenk, HR
   Ritchie, RO
AF Robertson, SW
   Imbeni, V
   Notkina, E
   Wenk, HR
   Ritchie, RO
BE Pelton, AR
   Duerig, T
TI Texture in tubes and plates of Nitinol
SO SMST-2003: Proceedings of the International Conference on Shape Memory
   and Superelastic Technologies
LA English
DT Proceedings Paper
CT International Conference on Shape Memory and Superelastic Technologies
   (SMST-2003)
CY MAY 05-08, 2003
CL Pacific Grove, CA
SP Boston Sci, Ft Wayne Met, Johnson Matthey, Shape Mem Applicat, MeKo, Minitubes, Special Met, TiNi Alloy Co, UTI
DE Nitinol; texture; x-ray diffraction; pole figures
ID TENSION; STRAIN
AB The superelastic/shape memory material, Nitinol, a roughly equiatomic alloy of Ni and Ti, rapidly is becoming one of the most important metallic implant materials in the biomedical industry, in particular for the manufacture of endovascular stents. As such stents invariably are laser machined from Nitinol tubes (or sheets rolled into tubes), it is important to understand fully the physical phenomena that may affect the mechanical behavior of this material. With tubing and sheet, one major issue is crystallographic texture, which can play a key role in influencing the mechanical properties of Nitinol. In this paper, we present a preliminary study on how geometry and heat treatment can affect the texture of Nitinol.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RP Robertson, SW (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RI Ritchie, Robert/A-8066-2008
OI Ritchie, Robert/0000-0002-0501-6998
CR Gall K, 1999, INT J PLASTICITY, V15, P69, DOI 10.1016/S0749-6419(98)00060-6
   Hornbogen E, 2002, Z METALLKD, V93, P3, DOI 10.3139/146.020003
   Inoue H, 1996, ACTA MATER, V44, P4825, DOI 10.1016/S1359-6454(96)00120-6
   JUNG Y, 2003, UNPUB CONSTITUTIVE M
   KITAMURA K, SMST97 P 2 INT C SHA, P47
   Kocks U. F., 1998, TEXTURE ANISOTROPY, P195
   LI DY, 1990, ACTA METALL MATER, V38, P19, DOI 10.1016/0956-7151(90)90130-9
   Li ZQ, 2002, INT J PLASTICITY, V18, P1481, DOI 10.1016/S0749-6419(02)00026-8
   MONASEVICH LA, 1979, MET SCI HEAT TREAT+, V21, P735, DOI 10.1007/BF00708647
   MULDER JH, 1993, Z METALLKD, V84, P501
   Shu YC, 1998, ACTA MATER, V46, P5457, DOI 10.1016/S1359-6454(98)00184-0
   Vaidyanathan R, 2001, METALL MATER TRANS A, V32, P777
   Wenk HR, 1998, J APPL CRYSTALLOGR, V31, P262, DOI 10.1107/S002188989700811X
NR 13
TC 1
Z9 1
U1 0
U2 0
PU SMST SOC INC
PI MENLO PARK
PA C/O SRI M/S AA287, 333 RAVENSWOOD AVENUE, MENLO PARK, CA 94025 USA
BN 0-9660508-3-5
PY 2004
BP 341
EP 347
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BCC80
UT WOS:000228663400039
DA 2018-10-20
ER

PT B
AU Lendlein, A
   Canisius, J
   Schulte, J
   Kratz, K
AF Lendlein, A
   Canisius, J
   Schulte, J
   Kratz, K
BE Pelton, AR
   Duerig, T
TI Shape memory polymers as stimuli-sensitive implant materials for medical
   applications
SO SMST-2003: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SHAPE MEMORY
   AND SUPERELASTIC TECHNOLOGIES
LA English
DT Proceedings Paper
CT International Conference on Shape Memory and Superelastic Technologies
   (SMST-2003)
CY MAY 05-08, 2003
CL Pacific Grove, CA
SP Boston Sci, Ft Wayne Met, Johnson Matthey, Shape Mem Applicat, MeKo, Minitubes, Special Met, TiNi Alloy Co, UTI
DE block copolymers; elastomers; polymer networks; shape memory polymers;
   biocompatibility; biodegradation; resorbable implants
ID BIOMEDICAL APPLICATIONS; ANGIOGENESIS; NETWORKS
AB Shape memory materials are smart materials that can recover substantial programmed deformation after being exposed to an external stimulus. They can sense a stimulus, process information, and then respond in a predetermined way to restore the undisturbed state. Self-shaping, self-repairing, and dimensionally accurate material systems are likely to play a key role in the technological progress of this millennium [1]. This concept has found growing interest in recent years due to the rise of a new class of polymers. Upon the application of an external stimulus (e.g., an increase in temperature), such a polymer can return to its previously memorized shape. Due to their manufacturability using conventional methods (e.g., injection molding), these materials can represent an efficient alternative to metallic shape memory alloys (SMA). The shape memory effect in polymers (e.g., heat shrinkable films) is not a specific bulk property, but results from the polymer's structure and morphology in combination with a processing and programming technology. The effect is persistent in many polymers, which differ significantly in chemical composition. To date, however, only a few shape memory polymer systems have been described in the literature [2]. Structural concepts will be introduced for biocompatible and degradable polymer systems (thermoplastic elastomers as well as covalently cross-linked polymers) showing shape memory properties. Their thermal and shape memory properties and their degradation behavior will be discussed.
C1 MnemoSci GmbH, D-52074 Aachen, Germany.
RP Lendlein, A (reprint author), MnemoSci GmbH, Pauwelsstr 19, D-52074 Aachen, Germany.
RI Kratz, Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013
OI Kratz, Karl/0000-0002-9229-4266; Lendlein, Andreas/0000-0003-4126-4670
CR Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   LENDLEIN A, 2002, ENCY POLYM SCI TECHN, V4, P125
   LENDLEIN A, 2002, KIRKOTHMER ENCY CHEM
   LIPSCOMB P, 1996, APPL SHAPE MEMORY AL
   MANTOVANI D, 2000, JOM, V10, P36
   Otsuka K., 1998, SHAPE MEMORY MAT
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   1997, LIFE MAGAZINES S FAL, P168
NR 12
TC 3
Z9 3
U1 1
U2 7
PU SMST SOC INC
PI MENLO PARK
PA C/O SRI M/S AA287, 333 RAVENSWOOD AVENUE, MENLO PARK, CA 94025 USA
BN 0-9660508-3-5
PY 2004
BP 563
EP 572
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BCC80
UT WOS:000228663400063
DA 2018-10-20
ER

PT B
AU McCann, PJ
AF McCann, PJ
BE Buckley, DN
   Chang, PC
   Fox, PD
   Chan, WK
   Shiojima, K
TI IV-VI semiconductor materials, devices, and applications
SO STATE-OF-THE-ART PROGRAM ON COMPOUND SEMICONDUCTORS XL (SOTAPOCS XL) AND
   NARROW BANDGAP OPTOELECTRONIC MATERIALS AND DEVICES II
SE ELECTROCHEMICAL SOCIETY SERIES
LA English
DT Proceedings Paper
CT 40th State-of-the-Art Program on Compound Semiconductors (SOTAPOCS
   XL)/2nd Narrow Bandgap Optoelectronic Materials and Devices Symposium
CY MAY 09-14, 2004
CL San Antonio, TX
SP Electrochem Soc, Electron Div
ID QUANTUM-WELL STRUCTURES; MOLECULAR-BEAM EPITAXY; ROOM-TEMPERATURE;
   MIDINFRARED PHOTOLUMINESCENCE; BREATH BIOMARKERS; DIODE-LASERS;
   NITRIC-OXIDE; PBSE; SI(111); GROWTH
AB IV-VI semiconductor technology has a long history beginning with Ferdinand Braun's 1874 report of the first observation of electrical rectification using galena (PbS) crystals. Progress continues to take place today with the scientific understanding and technological development of IV-VI semiconductor materials. This paper reviews some recent developments including the ability to grow epitaxial layer structures on silicon substrates, the elucidation of electronic sub-band energy levels in (111)-oriented quantum wells, the demonstration of novel laser fabrication methods involving growth substrate removal techniques, and the use of IV-VI semiconductor tunable diode lasers in some emerging biomedical applications. It is argued that much progress is still possible with IV-VI semiconductor materials technology and that continued research and development efforts in this area will lead to breakthroughs in new materials and device applications.
C1 Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA.
RP McCann, PJ (reprint author), Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA.
CR Alchalabi K, 2001, IEEE ELECTR DEVICE L, V22, P110, DOI 10.1109/55.910611
   Beck M, 2002, SCIENCE, V295, P301, DOI 10.1126/science.1066408
   Beyer H, 2002, APPL PHYS LETT, V80, P1216, DOI 10.1063/1.1448388
   BUTLER JF, 1964, APPL PHYS LETT, V5, P75, DOI 10.1063/1.1754062
   Ebeler SE, 1997, J CHROMATOGR B, V702, P211, DOI 10.1016/S0378-4347(97)00369-1
   Fang XM, 1997, MATER RES SOC SYMP P, V450, P457
   Fang XM, 2000, J VAC SCI TECHNOL B, V18, P1720, DOI 10.1116/1.591460
   Feit Z, 1996, APPL PHYS LETT, V68, P738, DOI 10.1063/1.116726
   Khodr MF, 1996, IEEE J QUANTUM ELECT, V32, P236, DOI 10.1109/3.481871
   Kinsler P, 1999, J APPL PHYS, V85, P23, DOI 10.1063/1.369435
   Kittel C, 1976, INTRO SOLID STATE PH
   Lewelling KR, 1997, IEEE PHOTONIC TECH L, V9, P297, DOI 10.1109/68.556052
   McAlister DW, 2000, IEEE PHOTONIC TECH L, V12, P22, DOI 10.1109/68.817456
   McAlister DW, 2001, J APPL PHYS, V89, P3514, DOI 10.1063/1.1347950
   McCann PJ, 1997, J CRYST GROWTH, V175, P1057, DOI 10.1016/S0022-0248(96)00913-X
   McCann PJ, 1999, APPL PHYS LETT, V75, P3608, DOI 10.1063/1.125403
   Muller P, 1997, PHYS REV LETT, V78, P3007, DOI 10.1103/PhysRevLett.78.3007
   Muller P, 1996, J APPL PHYS, V79, P1911, DOI 10.1063/1.361076
   Narasimhan LR, 2001, P NATL ACAD SCI USA, V98, P4617, DOI 10.1073/pnas.071057598
   PHILLIPS M, 1995, J CLIN PATHOL, V48, P466, DOI 10.1136/jcp.48.5.466
   Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x
   QUIST TM, 1962, APPL PHYS LETT, V1, P91, DOI 10.1063/1.1753710
   Rappl PHO, 2003, IEEE PHOTONIC TECH L, V15, P374, DOI 10.1109/LPT.2002.807910
   Roller C, 2002, OPT LETT, V27, P107, DOI 10.1364/OL.27.000107
   Roller C, 2002, APPL OPTICS, V41, P6018, DOI 10.1364/AO.41.006018
   Sehnert SS, 2002, BIOMARKERS, V7, P174, DOI 10.1080/13547500110118184
   SELROOS O, 1995, CHEST, V108, P1228, DOI 10.1378/chest.108.5.1228
   Shen WZ, 2002, J APPL PHYS, V91, P192, DOI 10.1063/1.1421634
   Strecker BN, 1997, J ELECTRON MATER, V26, P444, DOI 10.1007/s11664-997-0117-5
   Studer SM, 2001, J HEART LUNG TRANSPL, V20, P1158, DOI 10.1016/S1053-2498(01)00343-6
   Wu HZ, 1999, J VAC SCI TECHNOL B, V17, P1263, DOI 10.1116/1.590736
   Wu HZ, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045303
   Wu HZ, 2001, J VAC SCI TECHNOL B, V19, P1447, DOI 10.1116/1.1385915
   Wu HZ, 2001, APPL PHYS LETT, V78, P2199, DOI 10.1063/1.1361104
   Yang AL, 2000, CHINESE PHYS LETT, V17, P606
   Yates DH, 2001, IMMUNOL CELL BIOL, V79, P178, DOI 10.1046/j.1440-1711.2001.00990.x
   YUAN S, 1993, APPL PHYS LETT, V62, P885, DOI 10.1063/1.108555
   Zhao F, 2002, APPL PHYS LETT, V80, P1129, DOI 10.1063/1.1449540
   Zogg H, 1995, INST PHYS CONF SER, P160
NR 39
TC 0
Z9 0
U1 0
U2 3
PU ELECTROCHEMICAL SOCIETY INC
PI PENNINGTON
PA 65 S MAIN ST, PENNINGTON, NJ 08534-2839 USA
BN 1-56677-407-1
J9 ELEC SOC S
PY 2004
VL 2004
IS 2
BP 218
EP 233
PG 16
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Optics; Physics, Condensed Matter
SC Engineering; Materials Science; Optics; Physics
GA BAH42
UT WOS:000222222800030
DA 2018-10-20
ER

PT S
AU Burkes, DE
   Gottoli, G
   Moore, JJ
   Yi, HC
   Ayers, RA
AF Burkes, DE
   Gottoli, G
   Moore, JJ
   Yi, HC
   Ayers, RA
BE Armstrong, R
   Thadhani, N
   Wilson, W
   Gilman, J
   Simpson, R
TI Combustion synthesis of NiTi-TiCcomposites with controlled porosity for
   biomedical applications
SO SYNTHESIS, CHARACTERIZATION AND PROPERTIES OF ENERGETIC/REACTIVE
   NANOMATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Synthesis, Characterization and Properties of
   Energetic/Reactive Nanomaterials held at the 2003 MRS Fall Meeting
CY DEC 01-05, 2003
CL Boston, MA
SP Mat Res Soc
ID SHAPE-MEMORY; TIC COMPOSITES; TEMPERATURE; ALLOYS
AB Combustion synthesis, or Self-propagating High-temperature Synthesis (SHS), is currently being used by the Center for Commercial Applications of Combustion in Space (CCACS) at the Colorado School of Mines to produce advanced porous materials for several important applications. These materials include ceramic, inter-metallic, and metal-matrix composites that can be used for orthopedic implants, heat exchanger and damping systems and micro-and macro-filter applications. Functionally graded materials, both in porosity and composition, can be produced using a range of combustion synthesis reactions systems. There are multiple factors that contribute to the final SHS product, e.g. reactant stoichiometry, initial relative density and pre-heat. The synthesis of nickel-titanium (NiTi) intermetallic compounds and composites is of considerable interest due to the ability to create a porous, shape memory and super-elastic alloy with high corrosion resistance. The synthesis effects of adding a carbon reactant so as to modify the reaction products and reaction exothermicity have been studied through the use of two different reaction stoichiometries involving elemental nickel, titanium and carbon., This paper outlines the synthesis of NiTi intermetallic composites based on the following SHS chemical reaction:
   xNi + (Y + y)Ti + yC = xNiTi + yTiC
   The effect of the carbon reactant and the initial sample green density on the apparent porosity, bulk density, pore size and pore distribution of the final materials has been studied and is presented within this paper. A NiTi - TiC intermetallic ceramic composite has been synthesized that is functionally graded in both composition and porosity: the latter grading being due to buoyancy and gas evolution effects. Proposed kinetic mechanisms that drive this synthesis process and control the graded structure are discussed in detail.
C1 Colorado Sch Mines, Met & Mat Engn Dept, Golden, CO 80401 USA.
RP Burkes, DE (reprint author), Colorado Sch Mines, Met & Mat Engn Dept, Golden, CO 80401 USA.
RI Ayers, Reed/E-5558-2011
CR *ASTM, 1992, 209257C ASTM
   Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   FukamiUshiro KL, 1996, METALL MATER TRANS A, V27, P193, DOI 10.1007/BF02647759
   FukamiUshiro KL, 1996, METALL MATER TRANS A, V27, P183, DOI 10.1007/BF02647758
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HIEMENZ PC, 1986, PRINCIPLES COLLOID S, P62
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Ishikawa T, 2003, J CHEM PHYS, V118, P7912, DOI 10.1063/1.1564050
   KNYAZIK VA, 1985, COMBUST EXPLO SHOCK+, V21, P333, DOI 10.1007/BF01463853
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li YH, 2002, J ALLOY COMPD, V345, P271, DOI 10.1016/S0925-8388(02)00412-7
   LIDE DR, 2002, CRC HDB CHEM PHYSICS
   MOORE JJ, 2001, 6 INT MICR COMB WORK, P273
   MOORE JJ, 1994, PROCESSING FABRICATI, V3, P817
   Munir Z.A., 1989, MATER SCI REP, V3, P227
   MUNIR ZA, 1988, AM CERAM SOC BULL, V67, P342
   Munir ZA, 1996, METALL MATER TRANS A, V27, P2080, DOI 10.1007/BF02651861
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   VANEEDEN SP, 1994, PLAST RECONSTR SURG, V93, P959, DOI 10.1097/00006534-199404001-00010
   VAUGHAN JG, 1982, J VAC SCI TECHNOL, V20, P383, DOI 10.1116/1.571472
   Yamada O, 1986, J MATER RES, V1, P275, DOI 10.1557/JMR.1986.0275
   1995, NIH HLTH WORKSH SUMM
NR 22
TC 0
Z9 0
U1 1
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-738-5
J9 MATER RES SOC SYMP P
PY 2004
VL 800
BP 125
EP 136
PG 12
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BY95X
UT WOS:000189504700014
DA 2018-10-20
ER

PT S
AU DeAngelis, PL
AF DeAngelis, PL
BE Wang, PG
   Ichikawa, Y
TI Sugar engineering with glycosaminoglycan synthases
SO SYNTHESIS OF CARBOHYDRATES THROUGH BIOTECHNOLOGY
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Conference on Synthesis of Carbohydrates through Biotechnology held at
   the 224th Meeting of the American-Chemical-Society
CY 2002
CL Boston, MA
SP Amer Chem Soc, Div Carbohydrate Chem, Kyowa Hakko Kogyo Co Ltd, Neose Technologies Inc, Amer Chem Soc Corp Associates
ID MULTOCIDA HYALURONAN SYNTHASE; PASTEURELLA-MULTOCIDA; MOLECULAR-CLONING;
   IDENTIFICATION
AB The chemoenzymatic synthesis of natural and artificial glycosaminoglycans [GAGs] is now possible with the advent of three cloned, recombinant Pasteurella GAG synthases. Depending on the choice of the catalyst, the acceptor molecule and the UDP-sugar precursors, a wide variety of potentially useful materials based on the GAGs hyaluronan, chondroitin, and/or N-acetylheparosan may be created. We present the syntheses of (a) short monodisperse oligosaccharides, (b) hybrid polymers composed of two disparate GAGs, (c) GAGs immobilized on surfaces, (d) libraries of GAG oligosaccharides, and (e) novel GAGs containing unnatural functionalities. These materials should have many future biomedical applications due to the prevalence and the importance of GAGs in the mammalian body. (C) 2004 American Chemical Society.
C1 Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA.
RP DeAngelis, PL (reprint author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, 940 S L Young Blvd, Oklahoma City, OK 73104 USA.
CR DeAngelis PL, 2000, J BIOL CHEM, V275, P24124, DOI 10.1074/jbc.M003385200
   DeAngelis PL, 1998, J BIOL CHEM, V273, P8454, DOI 10.1074/jbc.273.14.8454
   DeAngelis PL, 1999, J BIOL CHEM, V274, P26557, DOI 10.1074/jbc.274.37.26557
   DeAngelis PL, 2002, GLYCOBIOLOGY, V12, p9R, DOI 10.1093/glycob/12.1.9R
   DeAngelis PL, 2002, J BIOL CHEM, V277, P7209, DOI 10.1074/jbc.M112130200
   DEANGELIS PL, 2002, Patent No. 6444447
   DEANGELIS PL, UNPUB
   Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883
   JING W, UNPUB
   Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285
NR 10
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3865-0
J9 ACS SYM SER
PY 2004
VL 873
BP 125
EP 137
PG 13
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry
GA BY76L
UT WOS:000189457500009
DA 2018-10-20
ER

PT S
AU Kim, MK
AF Kim, MK
BE Conchello, JA
   Cogswell, CH
   Wilson, T
TI Microscopic tomography by digital interference holography
SO THREE-DIMENSIONAL AND MULTIDIMENSIONAL MICROSCOPY: IMAGE ACQUISITION AND
   PROCESSING XI
SE PROGRESS IN BIOMEDICAL OPTICS AND IMAGING
LA English
DT Proceedings Paper
CT Conference on 3-Dimensional and Multidimensional Microscopy - Image
   Acquisition and Processing XI
CY JAN 27-29, 2004
CL San Jose, CA
SP SPIE
DE digital holography; tomography; microscopy; multi-wavelength imaging
ID OPTICAL COHERENCE TOMOGRAPHY; RECONSTRUCTION; WAVELENGTH
AB We are developing the digital interference holography (DIH) as a novel method of microscopic tomographic imaging by numerical superposition of a number of holographic fields taken with varying wavelengths. The digital interference holography does not involve pixel-by-pixel mechanical scanning of three-dimensional volume and yet achieves high lateral and longitudinal resolutions. The holographic interference pattern of an ob ect is generated optically and recorded digitally using a CCD camera. The hologrpahic image field is numerically calculated using basic diffraction formulas and the process is repeated for a range of varying wavelengths at regular intervals. Numerical superposition, or digital interference, of the holographic image fields yields the desired three-dimensional representation of the object. Experiments have demonstrated a few-micron lateral and axial resolutions. Furthermore, since the DIH is a coherent imaging system, one can form true tomographic images of sub-surface structures, in the presence of diffuse scattering from overlying layers. By being able to generate true tomographic images of subsurface structures, without the need for three-dimensional mechanical scannig, the DIH method can provide a very efficient and versatile imaging modality for a wide range of applications in materials science and biomedical imaging.
C1 Univ S Florida, Dept Phys, Tampa, FL 33620 USA.
RP Kim, MK (reprint author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.
CR ABRAMSON NH, 1989, APPL OPTICS, V28, P1834, DOI 10.1364/AO.28.001834
   Ansari Z, 2002, APPL PHYS LETT, V81, P2148, DOI 10.1063/1.1507354
   Dakoff A, 2003, J ELECTRON IMAGING, V12, P643, DOI 10.1117/1.1604784
   De Nicola S, 2001, OPT LETT, V26, P974, DOI 10.1364/OL.26.000974
   Gass J, 2003, OPT LETT, V28, P1141, DOI 10.1364/OL.28.001141
   Goodman J. W, 1996, INTRO FOURIER OPTICS
   Harihan P., 1996, OPTICAL HOLOGRAPHY P
   He ZY, 1999, OPT LETT, V24, P1502, DOI 10.1364/OL.24.001502
   Herman B, 1993, OPTICAL MICROSCOPY E
   HILDEBRAND BP, 1967, J OPT SOC AM, V57, P155, DOI 10.1364/JOSA.57.000155
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Kim MK, 2000, OPT EXPRESS, V7, P305, DOI 10.1364/OE.7.000305
   Lagerholm BC, 2000, BIOCHEMISTRY-US, V39, P2042, DOI 10.1021/bi9917434
   MARRON JC, 1992, OPT LETT, V17, P285, DOI 10.1364/OL.17.000285
   PARSHALL D, 2003, OPTICS SE
   Poon TC, 2003, ADV IMAG ELECT PHYS, V126, P329, DOI 10.1016/S1076-5670(03)80018-6
   Schnars U, 1996, OPT ENG, V35, P977, DOI 10.1117/1.600706
   SHEPPARD CJR, 1997, CONFOCAL LASER SCANN
   Zhang T, 1998, OPT LETT, V23, P1221, DOI 10.1364/OL.23.001221
NR 19
TC 2
Z9 2
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1605-7422
BN 0-8194-5232-7
J9 PRO BIOMED OPT IMAG
PY 2004
VL 5
IS 13
BP 102
EP 111
DI 10.1117/12.524864
PG 10
WC Microscopy; Imaging Science & Photographic Technology
SC Microscopy; Imaging Science & Photographic Technology
GA BAR80
UT WOS:000223297800012
DA 2018-10-20
ER

PT S
AU Beer, S
   Zeller, P
   Blanc, N
   Lustenberger, F
   Seitz, P
AF Beer, S
   Zeller, P
   Blanc, N
   Lustenberger, F
   Seitz, P
BE Corner, BD
   Li, P
   Pargas, RP
TI Smart pixels for real-time optical coherence tomography
SO THREE-DIMENSIONAL IMAGE CAPTURE AND APPLICATIONS VI
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Three-Dimensional Image Capture and Applications VI
CY JAN 19-20, 2004
CL San Jose, CA
SP Soc Imaging Sci & Technol, SPIE
DE optical coherence tomography; parallel detection; smart sensor;
   demodulation; low-power signal processing
AB Optical Coherence Tomography (OCT) is an optical imaging technique allowing the acquisition of three-dimensional images with micrometer resolution. It is very well suited to cross-sectional imaging of highly scattering materials, such as most biomedical tissues. A novel custom image sensor based on smart pixels dedicated to parallel OCT (pOCT) is presented. Massively parallel detection and signal processing enables a significant increase in the 3D frame rate and a reduction of the mechanical complexity of the complete setup compared to conventional point-scanning OCT. This renders the parallel OCT technique particularly advantageous for high-speed applications in industrial and biomedical domains while also reducing overall system costs. The sensor architecture presented in this article overcomes the main challenges for OCT Using parallel detection such as data rate, power consumption, circuit size, and optical sensitivity. Each pixel of the pOCT sensor contains a low-power signal demodulation circuit allowing the simultaneous detection of the envelope and the phase information of the optical interferometry signal. An automatic photocurrent off-set-compensation circuit, a synchronous sampling stage, programmable time averaging, and random pixel accessing are also incorporated at the pixel level. The low-power demodulation principle chosen as well as alternative implementations are discussed. The characterization results of the sensor exhibit a sensitivity of at least 74 dB, which is within 4dB of the theoretical limit, of a shot-noise limited OCT system. Real-time high-resolution three-dimensional tomographic imaging is demonstrated along with corresponding performance measurements.
C1 CSEM SA, CH-8048 Zurich, Switzerland.
RP Beer, S (reprint author), CSEM SA, Badenerstr 569, CH-8048 Zurich, Switzerland.
CR BEER S, 2003, SPIE, V5140, P69
   Bouma BE, 2002, HDB OPTICAL COHERENC
   DUBOIS A, 2003, SPIE, V5140, P43
   Park BH, 2003, OPT EXPRESS, V11, P782, DOI 10.1364/OE.11.000782
   POVAZAY B, 2003, SPIE, V5140, P51
   Saleh B. E. A.., 1991, FUNDAMENTALS PHOTONI, P673
   Szydlo J, 1998, OPT COMMUN, V154, P1, DOI 10.1016/S0030-4018(98)00303-4
NR 7
TC 14
Z9 14
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5205-X
J9 P SOC PHOTO-OPT INS
PY 2004
VL 5302
BP 21
EP 32
DI 10.1117/12.525698
PG 12
WC Imaging Science & Photographic Technology
SC Imaging Science & Photographic Technology
GA BAE16
UT WOS:000221774600003
DA 2018-10-20
ER

PT S
AU Tesk, JA
   Karam, LR
AF Tesk, JA
   Karam, LR
BE Schutte, E
   Picciolo, GL
   Kaplan, D
TI NIST and standards for tissue engineered medical products
SO TISSUE ENGINEERED MEDICAL PRODUCTS (TEMPS)
SE AMERICAN SOCIETY FOR TESTING AND MATERIALS SPECIAL TECHNICAL PUBLICATION
LA English
DT Proceedings Paper
CT Symposium on Tissue Engineered Medical Products
CY NOV 04-05, 2002
CL Miami Beach, FL
SP Amer Soc Testing & Mat, Int Comm F4
DE standards for tissue engineering; TEMPs; test methods for tissue
   engineering; measurements for tissue engineering; scaffolds;
   cell-material interactions; measurement technologies; characterization
   of surfaces; characterization of materials; characterization of cells;
   NIST; standard reference materials; SRM; DNA; bioinformatics
AB On June 13-14, 2001, the National Institute of Standards and Technology (NIST) convened a workshop of high level representatives from industry, federal agencies, and standards organizations to identify standards-related needs of the biomedical materials and devices industry. There were individual breakout sessions on standards for: Biomaterials, Therapeutic and Drug Delivery Devices, Auditory Diagnostic and Prosthetic Devices, Manufacturing of Prostheses, and Tissue Engineered Medical Products (TEMPs). Cross-cutting issues of Harmonization of Standards, Data, and Sterilization were also addressed. The session on Standards for TEMPs placed its most significant needs on the development of test methods and materials characterization. Action items for NIST to consider were separated into those relative to the Food and Drug Administration (FDA) approval process and those relative to industry needs not directly related to the FDA approval process. This paper summarizes the needs identified for TEMPs and the status of NIST-related activities.
C1 Natl Inst Stand & Technol, Ind Liaison Off, Directors Off, Gaithersburg, MD 20899 USA.
RP Tesk, JA (reprint author), Natl Inst Stand & Technol, Ind Liaison Off, Directors Off, Gaithersburg, MD 20899 USA.
CR BARKER PE, 2002, BIOM FORUM, V24, P16
   CHAPEKAR M, 2001, WORKSH STAND BIOM MA, P22
   HANCOCK DK, 2002, IN PRESS CLIN CHEM
   Levin BC, 2001, FRESEN J ANAL CHEM, V370, P213, DOI 10.1007/s002160100792
   Levin BC, 1999, GENOMICS, V55, P135, DOI 10.1006/geno.1998.5513
   RODRIGUEZ H, 2002, BIOM FORUM, V24, P12
   TESK JA, 2001, APPL BIOMATERIALS, V58, P463
NR 7
TC 0
Z9 0
U1 0
U2 0
PU AMERICAN SOCIETY TESTING AND MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, W CONSHOHOCKEN, PA 19428-2959 USA
SN 1040-1695
BN 0-8031-3471-1
J9 AM SOC TEST MATER
PY 2004
VL 1452
BP 40
EP 46
DI 10.1520/STP11632S
PG 7
WC Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials
SC Cell Biology; Engineering; Materials Science
GA BAH88
UT WOS:000222328400004
DA 2018-10-20
ER

PT S
AU Svanberg, S
AF Svanberg, S
BE Krausz, F
   Korn, G
   Corkum, P
   Walmsley, IA
TI Some medical and biological applications of ultrafast lasers
SO ULTRAFAST OPTICS IV
SE Springer Series in Optical Sciences
LA English
DT Proceedings Paper
CT 4th International Conference on Ultrafast Optics
CY JUN, 2003
CL Vienna, AUSTRIA
ID X-RAY SOURCE; PHOTODYNAMIC THERAPY; MALIGNANT-TUMORS; ENDOGENOUS
   PROTOPORPHYRIN; SCATTERING MEDIA; FLUORESCENCE; PLASMA; SPECTROSCOPY;
   LIGHT; TRANSILLUMINATION
AB Ultrafast lasers are finding many applications in medicine and biology. Pulses from such systems can be used directly or after non-linear modification. Direct utilisation includes time-resolved fluorescence spectroscopy and imaging. Such studies can be performed for tissue diagnosis in the field of malignant diseases as well as in the cardiovascular sector. Two-photon induced fluorescence provides a basis for high-quality optical microscopy, and optical coherence tomography with ultra-short and thus broadband pulses allow a radar-like depth-ranging into tissue. Photon propagation in scattering media also has important applications in optical mammography, dosimetry for photodynamic therapy and species concentration assessment. Intense continua of electromagnetic radiation of very brief duration are formed in the interaction of focused ultra-short and intense laser pulses with matter. Focusing into water, or better, a photonic band-gap fibre, leads to the generation of a light continuum through self-phase modulation. The propagation of white light through tissue was studied addressing questions related to tissue chromophore concentration measurements employing their absorptive imprint in the light. Even free gas enclosures in solids and liquids give rise to an absorptive signature, which, however, is typically 10(4) times narrower than spectral structures in the matrix material. Such sharp features are best detected by wavelength modulation of a single-mode laser; and many new applications of gas-in-scattering-media absorption spectroscopy (GASMAS) are developing. When terawatt laser pulses are focused onto a solid target with high nuclear charge Z, intense X-ray radiation of few ps duration and with energies exceeding hundreds of keV is emitted. Biomedical applications of this radiation are described, including differential absorption and gated-viewing imaging.
C1 Lund Inst Technol, Dept Phys, S-22100 Lund, Sweden.
RP Svanberg, S (reprint author), Lund Inst Technol, Dept Phys, POB 118, S-22100 Lund, Sweden.
CR ALNIS J, 2003, IN PRESS APPL PHYS B
   Anderman EM, 2001, CONTEMP EDUC PSYCHOL, V26, P76, DOI 10.1006/ceps.1999.1043
   Andersson-Engels S., 1992, Lasers in the Life Sciences, V5, P1
   ANDERSSON-ENGELS S, 1991, Lasers in Medical Science, V6, P415, DOI 10.1007/BF02042464
   ANDERSSONENGELS S, 1994, APPL OPTICS, V33, P8022, DOI 10.1364/AO.33.008022
   ANDERSSONENGELS S, 1990, J PHOTOCH PHOTOBIO B, V4, P363, DOI 10.1016/1011-1344(90)85015-O
   ANDERSSONENGELS S, 1990, SPECTROCHIM ACTA A, V46, P1203, DOI 10.1016/0584-8539(90)80196-6
   ANDERSSONENGELS S, 1993, OPT LETT, V18, P1697, DOI 10.1364/OL.18.001697
   ANDERSSONENGELS S, 1990, OPT LETT, V15, P1179, DOI 10.1364/OL.15.001179
   ANDERSSONENGLES S, IN PRESS LASERS MED
   BERG R, 1993, APPL OPTICS, V32, P574, DOI 10.1364/AO.32.000574
   CHANCE B, 1988, P NATL ACAD SCI USA, V85, P4971, DOI 10.1073/pnas.85.14.4971
   Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889
   DREXLER W, 2000, ARCH OPHTHALMOL-CHIC, V121, P695
   FUJIMOTO JG, 1986, OPT LETT, V11, P1250
   GORDON CL, 1995, OPT LETT, V20, P1056, DOI 10.1364/OL.20.001056
   Gratz M, 1996, IEEE J SEL TOP QUANT, V2, P1041, DOI 10.1109/2944.577334
   Gratz M, 1998, APPL PHYS LETT, V73, P2899, DOI 10.1063/1.122623
   GROSSWEINER LI, 1994, SCI PHOTOTHERAPY
   Gustafsson U, 2000, REV SCI INSTRUM, V71, P3004, DOI 10.1063/1.1305814
   GUSTAFSSON U, 2003, SPIE, V4959, P12
   HERRLIN K, 1993, RADIOLOGY, V189, P65, DOI 10.1148/radiology.189.1.8372221
   Johansson J, 2002, APPL SPECTROSC, V56, P725, DOI 10.1366/000370202760077676
   Johansson J, 1999, PHOTOCHEM PHOTOBIOL, V69, P242, DOI 10.1111/j.1751-1097.1999.tb03281.x
   KENNEDY JC, 1992, J PHOTOCH PHOTOBIO B, V14, P275, DOI 10.1016/1011-1344(92)85108-7
   KENNEDY JC, 1990, J PHOTOCH PHOTOBIO B, V6, P143, DOI 10.1016/1011-1344(90)85083-9
   KLINTEBERG C, UNPUB REV SCI INSTRU
   KLINTEBERG CA, 1995, SPIE, V2629, P149
   KLINTEBERG CA, IN PRESS INV VIVO AB
   KMETEC JD, 1992, PHYS REV LETT, V68, P1527, DOI 10.1103/PhysRevLett.68.1527
   Ledingham KWD, 1999, CONTEMP PHYS, V40, P367, DOI 10.1080/001075199181288
   MARCUS SL, 1990, FUTURE DIRECTIONS IS, V6, P5
   MULLER G, 1993, SPIE I SER, V11
   Sjogren A, 2003, REV SCI INSTRUM, V74, P2300, DOI 10.1063/1.1544054
   Sjoholm M, 2001, OPT LETT, V26, P16, DOI 10.1364/OL.26.000016
   Somesfalean G, 2002, APPL OPTICS, V41, P3538, DOI 10.1364/AO.41.003538
   SVANBERG K, 1994, BRIT J DERMATOL, V130, P743, DOI 10.1111/j.1365-2133.1994.tb03412.x
   Svanberg K, 1998, ACTA RADIOL, V39, P2
   Svanberg S, 2002, LASERS IN MEDICINE, P135
   Svanberg S, 2001, MEAS SCI TECHNOL, V12, P1777, DOI 10.1088/0957-0233/12/11/304
   Svanberg S, 1997, PHYS SCRIPTA, VT72, P69, DOI 10.1088/0031-8949/1997/T72/009
   SWANSON EA, 1993, OPT LETT, V18, P1864, DOI 10.1364/OL.18.001864
   TILLMAN C, 1995, APPL PHYS B-LASERS O, V61, P333, DOI 10.1007/BF01081532
   Tillman C, 1999, RADIOLOGY, V213, P860, DOI 10.1148/radiology.213.3.r99dc13860
   Tillman C, 1996, J OPT SOC AM B, V13, P209, DOI 10.1364/JOSAB.13.000209
   Wang I, 2001, BRIT J DERMATOL, V144, P832, DOI 10.1046/j.1365-2133.2001.04141.x
   Wang I, 1999, ACTA OPHTHALMOL SCAN, V77, P182, DOI 10.1034/j.1600-0420.1999.770213.x
   Welch A. J., 1995, OPTICAL THERMAL RESP
NR 48
TC 1
Z9 1
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0342-4111
BN 0-387-40091-5
J9 SPRINGER SER OPT SCI
PY 2004
VL 95
BP 437
EP 448
PG 12
WC Optics; Physics, Applied
SC Optics; Physics
GA BAG72
UT WOS:000222127000055
DA 2018-10-20
ER

PT S
AU Baha, E
   Crittenden, PE
AF Baha, E
   Crittenden, PE
BE VoDinh, T
   Gauglitz, G
   Lieberman, RA
   Schafer, KP
   Killinger, DK
TI Near field and far field characterization of stratified chiral
   structures
SO ENVIRONMENTAL MONITORING AND REMEDIATION III
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Environmental Monitoring and Remediation III
CY OCT 28-30, 2003
CL Providence, RI
SP SPIE
DE chiral media; generalized telegraphists equations; biosecurity
ID GENERALIZED TELEGRAPHISTS EQUATIONS; MEDIA
AB Full wave expression for the electromagnetic fields scattered by a rough interface between two chiral materials with laterally varying electromagnetic properties are obtained from generalized telegraphists equation for irregular media. The telegraphists equation are a set of coupled differential equations for the forward and backward wave amplitudes of the transverse components of the magnetic field and the electric field. They can be used to determine the electromagnetic near and far fields scattered above and below the interface. This has direct applications to the detection of chiral materials, the discrimination between different chiral media and the optimization of desired electromagnetic characteristics of artificial chiral materials.
   To derive the generalized telegraphists equations, no simplifying assumptions are made about the characteristics of the rough interface, the frequency of the source, or the locations of the source and observation points. Therefore, they provide advantageous starting points for deriving solutions to a broad variety of physical problems. In electrical engineering possible applications include integrated optic devices, polarization transformers, modulators and directional couplers. In all these applications, sub-wavelength fluctuations at the interfaces between the media can significantly affect the physical characteristics of the chiral structure. The analysis can be used in the detection, characterization and design of chiral structures consisting of complex media with engineering, biomedical, agricultural and biosecurity applications.
C1 Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.
RP Baha, E (reprint author), Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.
EM ebahar@unl.edu
CR BAHAR E, 1972, CAN J PHYS, V50, P3132, DOI 10.1139/p72-408
   BAHAR E, 1972, CAN J PHYS, V50, P3123, DOI 10.1139/p72-407
   Bahar E, 2002, OPT ENG, V41, P1918, DOI 10.1117/1.1489050
   CRITTENDEN P, 2002, THESIS LINCOLN NE
   Herman WN, 2001, J OPT SOC AM A, V18, P2806, DOI 10.1364/JOSAA.18.002806
   SCHELKUNOFF SA, 1952, AT&T TECH J, V31, P784, DOI 10.1002/j.1538-7305.1952.tb01406.x
   SCHELKUNOFF SA, 1955, AT&T TECH J, V34, P995, DOI 10.1002/j.1538-7305.1955.tb03787.x
NR 7
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-5159-2
J9 PROC SPIE
PY 2004
VL 5270
BP 19
EP 30
DI 10.1117/12.516790
PG 12
WC Chemistry, Analytical; Engineering, Environmental; Instruments &
   Instrumentation
SC Chemistry; Engineering; Instruments & Instrumentation
GA BY76V
UT WOS:000189458400003
DA 2018-10-20
ER

PT J
AU Nowak, AP
   Breedveld, V
   Pine, DJ
   Deming, TJ
AF Nowak, AP
   Breedveld, V
   Pine, DJ
   Deming, TJ
TI Unusual salt stability in highly charged diblock co-polypeptide
   hydrogels
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID BETA-SHEET TAPES; POLYELECTROLYTE BRUSHES; PEPTIDE; MODEL; GELS
AB The stability and properties of dilute solution hydrogels, synthesized by transition metal mediated polymerization of amino acid N-carboxyanhydrides (NCAs), have been studied in deionized (DI) water as well as various ionic media. These hydrogels are diblock amphiphilic copolymers of hydrophilic, charged segments of poly(L-lysine HBr) or poly(L-glutamic acid sodium salt), and helical, hydrophobic segments of poly(L-leucine). While many of these samples are able to form strong gels in deionized water at polymer concentrations as low as 0.25 wt %, stability in salt or buffer solutions was found to be only achieved at moderately higher polymer concentrations (similar to3.0 wt %). We have adjusted relative copolymer compositions and molecular weights to optimize hydrogel strength and polymer solubility in salt concentrations up to 0.5 M NaCl, as well as in cell growth media and aqueous buffers of varying pH. These materials are unique since they do not collapse in high ionic strength media, even though gel formation is contingent upon the presence of highly charged polyelectrolyte segments. The remarkable properties of these hydrogels make them excellent candidates for use as scaffolds in biomedical applications, such as tissue regeneration.
C1 Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.
   Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA.
   Univ Calif Santa Barbara, Dept Chem Engn, Mat Res Lab, Santa Barbara, CA 93106 USA.
   Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
RP Deming, TJ (reprint author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.
RI Pine, David/B-7740-2016; Breedveld, Victor/A-6822-2009; Deming,
   Timothy/I-5411-2013
OI Pine, David/0000-0002-3304-6684; Deming, Timothy/0000-0002-0594-5025
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   CARR ME, 1989, BIOCHEMISTRY-US, V28, P1384, DOI 10.1021/bi00429a066
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   CLARK AH, 1987, ADV POLYM SCI, V83, P57
   Daganl R, 1997, CHEM ENG NEWS, V75, P26, DOI 10.1021/cen-v075n023.p026
   Guenoun P, 1998, PHYS REV LETT, V81, P3872, DOI 10.1103/PhysRevLett.81.3872
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Horkay F, 2001, BIOMACROMOLECULES, V2, P195, DOI 10.1021/bm0056153
   KATCHALSKI E, 1958, ADV PROTEIN CHEM, V13, P243, DOI 10.1016/S0065-3233(08)60600-2
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Misra S, 1996, MACROMOLECULES, V29, P6056, DOI 10.1021/ma960377i
   MORRIS ER, 1980, J MOL BIOL, V138, P349, DOI 10.1016/0022-2836(80)90291-0
   NILSSON S, 1989, MACROMOLECULES, V22, P2367, DOI 10.1021/ma00195a063
   NOWAK A, UNPUB
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Okano T., 1998, BIORELATED POLYM GEL
   PAKSTIS L, IN PRESS BIOMACROMOL
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Pochan DJ, 2002, MACROMOLECULES, V35, P5358, DOI 10.1021/ma025526d
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   TANAKA T, 1981, SCI AM, V244, P110
   TIFFANY ML, 1969, BIOPOLYMERS, V8, P347, DOI 10.1002/bip.1969.360080306
   Ward A. G., 1977, SCI TECHNOLOGY GELAT
NR 26
TC 53
Z9 53
U1 1
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD DEC 17
PY 2003
VL 125
IS 50
BP 15666
EP 15670
DI 10.1021/ja0381050
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 753AF
UT WOS:000187208300063
PM 14664616
DA 2018-10-20
ER

PT J
AU Wheeler, MB
   Walters, EM
   Clark, SG
AF Wheeler, MB
   Walters, EM
   Clark, SG
TI Transgenic animals in biomedicine and agriculture: outlook for the
   future
SO ANIMAL REPRODUCTION SCIENCE
LA English
DT Review
DE transgenic; biomedicine; nuclear transfer; microinjection; embryonic
   stem cells; knock-outs
ID MEDIATED GENE-TRANSFER; PRIMORDIAL GERM-CELLS; EMBRYONIC STEM-CELLS;
   BETA-GLOBIN GENE; IMMUNE-RESPONSE GENES; HIGH-LEVEL EXPRESSION; HORMONE
   FUSION GENES; DNA-TREATED SPERM; NUCLEAR TRANSFER; GROWTH-HORMONE
AB Transgenic animals are produced by introduction of 'foreign' deoxyribonucleic acid (DNA) into preimplantation embryos. The foreign DNA is inserted into the genetic material and may be expressed in tissues of the resulting individual. This technique is of great importance to many aspects of biomedical science including gene regulation, the immune system, cancer research, developmental biology, biomedicine, manufacturing and agriculture. The production of transgenic animals is one of a number of new and developing technologies that will have a profound impact on the genetic improvement of livestock. The rate at which these technologies are incorporated into production schemes will determine the speed at which we will be able to achieve our goal of more efficiently producing livestock, which meets consumer and market demand. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Illinois, Dept Anim Sci, Anim Sci Lab 366, Urbana, IL 61801 USA.
RP Wheeler, MB (reprint author), Univ Illinois, Dept Anim Sci, Anim Sci Lab 366, 1207 W Gregory Dr, Urbana, IL 61801 USA.
RI Clark-Deener, Sherrie/K-8181-2016
OI Wheeler, Matthew/0000-0001-5589-357X
CR Alexander AN, 1999, AM J PHYSIOL-GASTR L, V277, pG619, DOI 10.1152/ajpgi.1999.277.3.G619
   ALT FW, 1985, TRENDS GENET, V1, P231, DOI 10.1016/0168-9525(85)90089-7
   BACHILLER D, 1991, MOL REPROD DEV, V30, P194, DOI 10.1002/mrd.1080300305
   Bawden CS, 1998, TRANSGENIC RES, V7, P273, DOI 10.1023/A:1008830314386
   BAWDEN CS, 1999, TRANSGENIC RES, V8, P474
   BENACERR.B, 1972, SCIENCE, V175, P273, DOI 10.1126/science.175.4019.273
   Biewenga JE, 1997, J NEUROSCI METH, V71, P67, DOI 10.1016/S0165-0270(96)00127-6
   BLECK GT, 1995, ANIMAL PRODUCTION BI, P1
   BONDIOLI KR, 1990, THERIOGENOLOGY, V33, P165, DOI 10.1016/0093-691X(90)90607-U
   BOWEN RA, 1994, BIOL REPROD, V50, P664, DOI 10.1095/biolreprod50.3.664
   BRACKETT BG, 1971, P NATL ACAD SCI USA, V68, P353, DOI 10.1073/pnas.68.2.353
   BREM G, 1985, ZUCHTHYGIENE, V20, P241
   BREMEL RD, 1989, J DAIRY SCI, V72, P2826, DOI 10.3168/jds.S0022-0302(89)79428-5
   BRINSTER RL, 1981, CELL, V27, P223, DOI 10.1016/0092-8674(81)90376-7
   BRINSTER RL, 1983, NATURE, V306, P332, DOI 10.1038/306332a0
   BUCCHINI D, 1987, NATURE, V326, P409, DOI 10.1038/326409a0
   BUEHLER T A, 1990, Bio-Technology (New York), V8, P140
   Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0
   CAMPER SA, 1995, BIOL REPROD, V52, P246, DOI 10.1095/biolreprod52.2.246
   Chan AWS, 1998, P NATL ACAD SCI USA, V95, P14028, DOI 10.1073/pnas.95.24.14028
   Choi BK, 1996, J AGR FOOD CHEM, V44, P953, DOI 10.1021/jf950566k
   CHOI TK, 1993, NAT GENET, V4, P117, DOI 10.1038/ng0693-117
   CIAVATTA DJ, 1995, P NATL ACAD SCI USA, V92, P9259, DOI 10.1073/pnas.92.20.9259
   COSTANTINI F, 1986, SCIENCE, V233, P1192, DOI 10.1126/science.3461564
   COSTANTINI F, 1981, NATURE, V294, P92, DOI 10.1038/294092a0
   Davis AM, 1998, P SOC EXP BIOL MED, V217, P466
   DEVLIN RH, 1995, CAN J FISH AQUAT SCI, V52, P1376, DOI 10.1139/f95-133
   DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0
   DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176
   Dunham RA, 1999, TRANSGENIC ANIMALS IN AGRICULTURE, P209
   EBERT K M, 1990, Animal Biotechnology, V1, P145
   EBERT KM, 1991, BIO-TECHNOL, V9, P835, DOI 10.1038/nbt0991-835
   EBERT KM, 1988, MOL ENDOCRINOL, V2, P277, DOI 10.1210/mend-2-3-277
   EBERT KM, 1991, CURRENT COMMUNICATIO, P233
   EDFORSLILJA I, 1986, ANIM PROD, V42, P381, DOI 10.1017/S000335610001816X
   Fainsold A, 1990, P EMBO EMBL S MOL BI, P31
   FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413
   FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346
   GAGNE MB, 1991, MOL REPROD DEV, V29, P6, DOI 10.1002/mrd.1080290103
   Gandolfi F, 1996, REPROD FERT DEVELOP, V8, P1055, DOI 10.1071/RD9961055
   GANDOLFI F, 1989, J REPROD FERTIL, V4, P10
   Gerfen RW, 1995, ANIM BIOTECHNOL, V6, P1, DOI 10.1080/10495399509525828
   GODBOUT R, 1986, MOL CELL BIOL, V6, P477, DOI 10.1128/MCB.6.2.477
   Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788
   GOODHARDT M, 1987, P NATL ACAD SCI USA, V84, P4229, DOI 10.1073/pnas.84.12.4229
   GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380
   GROSVENOR CE, 1993, ENDOCR REV, V14, P710, DOI 10.1210/er.14.6.710
   HALLER O, 1981, J EXP MED, V154, P199, DOI 10.1084/jem.154.1.199
   HAMMER RE, 1987, SCIENCE, V235, P53, DOI 10.1126/science.2432657
   HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0
   HANAHAN D, 1984, NATURE, V312, P503, DOI 10.1038/312503a0
   HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0
   HANAHAN D, 1986, ONCOGENES GROWTH CON, P349
   HARTMANN PE, 1984, S ZOOL SOC LOND, V51, P301
   HARVEY RP, 1991, P NATL ACAD SCI USA, V88, P9198, DOI 10.1073/pnas.88.20.9198
   HOCHI S, 1990, ANIM BIOTECHNOL, V1, P25
   HOLLIS DE, 1983, AUST J BIOL SCI, V36, P419
   HORAN R, 1991, ARCH ANDROLOGY, V26, P83, DOI 10.3109/01485019108987631
   INOUE K, 1990, CELL DIFFER DEV, V29, P123, DOI 10.1016/0922-3371(90)90030-Z
   IZANT JG, 1985, SCIENCE, V229, P345, DOI 10.1126/science.2990048
   JAENISCH R, 1975, P NATL ACAD SCI USA, V72, P4008, DOI 10.1073/pnas.72.10.4008
   JIAO SS, 1993, BIO-TECHNOL, V11, P497, DOI 10.1038/nbt0493-497
   KARATZAS CN, 1999, TRANSGENIC RES, V8, P476
   Kroll KL, 1996, DEVELOPMENT, V122, P3173
   KRUMLAUF R, 1985, MOL CELL BIOL, V5, P1639, DOI 10.1128/MCB.5.7.1639
   Kuznetsov A. V., 1995, Ontogenez, V26, P300
   Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228
   LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22
   LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0
   LAVITRANO M, 1989, CELL, V57, P717, DOI 10.1016/0092-8674(89)90787-3
   LEWIN HA, 1989, J DAIRY SCI, V72, P1334, DOI 10.3168/jds.S0022-0302(89)79241-9
   LEWIS AJ, 1978, J ANIM SCI, V47, P634
   Lin SS, 1996, ADVANCES IN SWINE IN BIOMEDICAL RESEARCH, VOLS 1 AND 2, P147
   Maga EA, 1995, J DAIRY SCI, V78, P2645, DOI 10.3168/jds.S0022-0302(95)76894-1
   Maione B, 1998, MOL REPROD DEV, V50, P406, DOI 10.1002/(SICI)1098-2795(199808)50:4<406::AID-MRD4>3.3.CO;2-Y
   MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6
   McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   MENCH JA, 1999, TRANSGENIC ANIMALS A, P25
   MULLER M, 1992, GENE, V121, P263, DOI 10.1016/0378-1119(92)90130-H
   MURRAY JD, 1989, REPROD FERT DEVELOP, V1, P147, DOI 10.1071/RD9890147
   Noble MS, 2002, J ANIM SCI, V80, P1090
   Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188
   ORNITZ DM, 1985, COLD SPRING HARB SYM, V50, P399, DOI 10.1101/SQB.1985.050.01.050
   PALMITER RD, 1985, NATURE, V316, P457, DOI 10.1038/316457a0
   PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341
   PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0
   PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363
   PASZTY C, 1995, NAT GENET, V11, P33, DOI 10.1038/ng0995-33
   Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876
   PEREZ A, 1991, Biotecnologia Aplicada, V8, P90
   PEZEN DS, 1991, TRANSGENIC ANIMALS, P213
   Piedrahita JA, 1998, BIOL REPROD, V58, P1321, DOI 10.1095/biolreprod58.5.1321
   Piper L. R., 1985, Genetics of reproduction in sheep., P115
   Polejaeva IA, 2000, NATURE, V407, P505
   POLGE EJC, 1989, BIOTECHNOLOGY IN GROWTH REGULATION, P189
   POWELL BC, 1994, REPROD FERT DEVELOP, V6, P615, DOI 10.1071/RD9940615
   PUCHALSKI RB, 1992, CYTOMETRY, V13, P23, DOI 10.1002/cyto.990130106
   PURSEL V G, 1992, Theriogenology, V37, P278, DOI 10.1016/0093-691X(92)90347-T
   Pursel V G, 1990, J Reprod Fertil Suppl, V41, P77
   PURSEL VG, 1989, SCIENCE, V244, P1281, DOI 10.1126/science.2499927
   PURSEL VG, 1993, J ANIM SCI, V71, P10, DOI 10.2527/1993.71suppl_310x
   PURSEL VG, 1987, VET IMMUNOL IMMUNOP, V17, P303, DOI 10.1016/0165-2427(87)90149-8
   QUAIFE CJ, 1987, CELL, V48, P1023, DOI 10.1016/0092-8674(87)90710-0
   REISS M, 1986, BIOCHEM BIOPH RES CO, V137, P244, DOI 10.1016/0006-291X(86)91202-7
   RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0
   REXROAD C E JR, 1989, Molecular Reproduction and Development, V1, P164, DOI 10.1002/mrd.1080010304
   REXROAD CE, 1991, J ANIM SCI, V69, P2995
   ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0
   ROTHSCHILD MF, 1994, P 5 WORLD C GEN APPL, V21, P225
   ROTTMANN OJ, 1992, J ANIM BREED GENET, V109, P64, DOI 10.1111/j.1439-0388.1992.tb00379.x
   Rund LA, 1996, ADVANCES IN SWINE IN BIOMEDICAL RESEARCH, VOLS 1 AND 2, P207
   Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873
   SANFORD J C, 1991, Technique (Philadelphia), V3, P3
   SANFORD JC, 1988, TRENDS BIOTECHNOL, V6, P299, DOI 10.1016/0167-7799(88)90023-6
   Schellander K, 1995, ANIM BIOTECHNOL, V6, P41, DOI 10.1080/10495399509525831
   Seamark R. F., 1987, Manipulating pig production. Proceedings of the inaugural conference of the Australasian Pig Science Association (APSA), held in Albury, NSW on November 23 to 25, 1987., P165
   Seidel GE, 1999, TRANSGENIC ANIMALS IN AGRICULTURE, P269
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   Shim H, 1997, BIOL REPROD, V57, P1089, DOI 10.1095/biolreprod57.5.1089
   SHIN T, 1999, TRANSGENIC RES, V8, P488
   SIMONS JP, 1987, NATURE, V328, P530, DOI 10.1038/328530a0
   SNOWDER GD, 1994, P 5 WORLD C GEN APPL, V18, P51
   SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0
   Sperandio S, 1996, ANIM BIOTECHNOL, V7, P59, DOI 10.1080/10495399609525848
   STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9
   STORB U, 1987, ANNU REV IMMUNOL, V5, P151, DOI 10.1146/annurev.immunol.5.1.151
   SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462
   SWANSON ME, 1992, BIO-TECHNOL, V10, P557, DOI 10.1038/nbt0592-557
   TURKASPA R, 1986, MOL CELL BIOL, V6, P716, DOI 10.1128/MCB.6.2.716
   VANDYKE T, 1985, COLD SPRING HARB SYM, V50, P671, DOI 10.1101/SQB.1985.050.01.082
   VANDYKE TA, 1987, J VIROL, V61, P2029
   VARMUS H, 1988, SCIENCE, V240, P1427, DOI 10.1126/science.3287617
   VELANDER WH, 1992, P NATL ACAD SCI USA, V89, P12003, DOI 10.1073/pnas.89.24.12003
   VISE PD, 1988, J CELL SCI, V90, P295
   WAGNER EF, 1981, P NATL ACAD SCI-BIOL, V78, P5016, DOI 10.1073/pnas.78.8.5016
   WAGNER TE, 1981, P NATL ACAD SCI-BIOL, V78, P6376, DOI 10.1073/pnas.78.10.6376
   WALL RJ, 1991, P NATL ACAD SCI USA, V88, P1696, DOI 10.1073/pnas.88.5.1696
   Wheeler M. B., 1997, Arquivos da Faculdade de Veterinaria, UFRGS, V25, P64
   WHEELER MB, 1994, REPROD FERT DEVELOP, V6, P563, DOI 10.1071/RD9940563
   WHEELER MB, 1995, BIOL REPROD S1, V52, P319
   WHITMER KJ, 1992, AIDS, V6, P1133, DOI 10.1097/00002030-199210000-00011
   Wieghart M., 1990, J REPROD FERTIL S, V41, P89
   WILKIE TM, 1987, MOL CELL BIOL, V7, P1646, DOI 10.1128/MCB.7.5.1646
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   WOBUS AM, 1984, EXP CELL RES, V152, P212, DOI 10.1016/0014-4827(84)90246-5
   WRIGHT G, 1991, BIO-TECHNOL, V9, P830, DOI 10.1038/nbt0991-830
   Wurst W., 1993, Gene targeting: a practical approach., P33
   YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608
   Yang X, 2000, Biotechnol Annu Rev, V5, P269, DOI 10.1016/S1387-2656(00)05039-0
NR 150
TC 33
Z9 36
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4320
J9 ANIM REPROD SCI
JI Anim. Reprod. Sci.
PD DEC 15
PY 2003
VL 79
IS 3-4
BP 265
EP 289
DI 10.1016/S0378-4320(03)00168-4
PG 25
WC Agriculture, Dairy & Animal Science; Reproductive Biology
SC Agriculture; Reproductive Biology
GA 753FM
UT WOS:000187221500009
PM 14643108
DA 2018-10-20
ER

PT J
AU Sahoo, SK
   Labhasetwar, V
AF Sahoo, SK
   Labhasetwar, V
TI Nanotech approaches to delivery and imaging drug
SO DRUG DISCOVERY TODAY
LA English
DT Review
ID BLOCK-COPOLYMER MICELLES; IN-VITRO; GENE DELIVERY; POLYMERIC MICELLES;
   CARRIER SYSTEM; BIODEGRADABLE MICROPARTICLES; BIOLOGICAL SIGNIFICANCE;
   CANCER-THERAPY; AMPHOTERICIN-B; NANOPARTICLES
AB Nanotechnology, a multidisciplinary scientific undertaking, involves creation and utilization of materials, devices or systems on the nanometer scale. The field of nanotechnology is currently undergoing explosive development on many fronts. The technology is expected to create innovations and play a critical role in various biomedical applications, not only in drug delivery, but also in molecular imaging, biomarkers and biosensors. Target-specific drug therapy and methods for early diagnosis of pathologies are the priority research areas where nanotechnology would play a vital role. This review considers different nanotechnology-based drug delivery and imaging approaches, and their economic impact on pharmaceutical and biomedical industries.
C1 Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA.
   Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
RP Sahoo, SK (reprint author), Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, 600 S 42nd St, Omaha, NE 68198 USA.
CR Adams ML, 2003, BIOMACROMOLECULES, V4, P750, DOI 10.1021/bm0257614
   Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399
   Allen TM, 1997, DRUGS, V54, P8, DOI 10.2165/00003495-199700544-00004
   Babincova M, 2001, Z NATURFORSCH C, V56, P909
   BADLEY RD, 1990, LANGMUIR, V6, P792, DOI 10.1021/la00094a013
   BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   Chemla YR, 2000, P NATL ACAD SCI USA, V97, P14268, DOI 10.1073/pnas.97.26.14268
   Cherian AK, 2000, DRUG DEV IND PHARM, V26, P459, DOI 10.1081/DDC-100101255
   Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n
   Collarini EJ, 2001, CYTOMETRY, V45, P267, DOI 10.1002/1097-0320(20011201)45:4<267::AID-CYTO10023>3.0.CO;2-D
   Corvo ML, 2002, BBA-BIOMEMBRANES, V1564, P227
   Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1
   Davis SS, 1997, TRENDS BIOTECHNOL, V15, P217, DOI 10.1016/S0167-7799(97)01036-6
   Dayton PA, 2002, J MAGN RESON IMAGING, V16, P362, DOI 10.1002/jmri.10173
   De Jesus OLP, 2002, BIOCONJUGATE CHEM, V13, P453, DOI 10.1021/bc010103m
   Desai MP, 1997, PHARMACEUT RES, V14, P1568, DOI 10.1023/A:1012126301290
   Desai MP, 1996, PHARMACEUT RES, V13, P1838, DOI 10.1023/A:1016085108889
   EHRLICH P, 1906, COLLECTED STUDIES IM, P404
   Emerich DF, 2003, EXPERT OPIN BIOL TH, V3, P655, DOI 10.1517/eobt.3.4.655.21202
   Fisher RS, 2002, CNS DRUGS, V16, P579, DOI 10.2165/00023210-200216090-00001
   Gabizon A, 1998, J CONTROL RELEASE, V53, P275, DOI 10.1016/S0168-3659(97)00261-7
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Guzman LA, 1996, CIRCULATION, V94, P1441, DOI 10.1161/01.CIR.94.6.1441
   Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Hussain N, 2001, ADV DRUG DELIVER REV, V50, P107, DOI 10.1016/S0169-409X(01)00152-1
   Ito A, 2003, CANCER SCI, V94, P308, DOI 10.1111/j.1349-7006.2003.tb01438.x
   Jain S, 2003, INT J PHARM, V261, P43, DOI 10.1016/S0378-5173(03)00269-2
   Jain TK, 1998, J AM CHEM SOC, V120, P11092, DOI 10.1021/ja973849x
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   Kastin AJ, 2003, MOL BRAIN RES, V114, P168, DOI 10.1016/S0169-328X(03)00167-0
   Kataoka K, 2000, J CONTROL RELEASE, V64, P143, DOI 10.1016/S0168-3659(99)00133-9
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kihara F, 2002, BIOCONJUGATE CHEM, V13, P1211, DOI 10.1021/bc025557d
   Kreuter J, 2003, PHARMACEUT RES, V20, P409, DOI 10.1023/A:1022604120952
   LAL ML, 2000, CHEM MATER, V19, P2632
   Lamprecht A, 2001, J PHARMACOL EXP THER, V299, P775
   Langer R, 1998, NATURE, V392, P5
   Lanza GM, 2002, CIRCULATION, V106, P2842, DOI 10.1161/01.CIR.0000044020.27990.32
   Lasic DD, 1999, CURR OPIN MOL THER, V1, P177
   LaVan DA, 2002, NAT REV DRUG DISCOV, V1, P77, DOI 10.1038/nrd707
   Lavasanifar A, 2002, PHARMACEUT RES, V19, P418, DOI 10.1023/A:1015127225021
   Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481
   Lubbe AS, 1996, CANCER RES, V56, P4694
   Lutsiak MEC, 2002, PHARM RES-DORDR, V19, P1480, DOI 10.1023/A:1020452531828
   Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3
   Matsumura Y, 1999, JPN J CANCER RES, V90, P122, DOI 10.1111/j.1349-7006.1999.tb00675.x
   Mitchell P, 2001, NAT BIOTECHNOL, V19, P1013, DOI 10.1038/nbt1101-1013
   Mizumura Y, 2001, JPN J CANCER RES, V92, P328, DOI 10.1111/j.1349-7006.2001.tb01099.x
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Monsky WL, 1999, CANCER RES, V59, P4129
   Nakanishi T, 2001, J CONTROL RELEASE, V74, P295, DOI 10.1016/S0168-3659(01)00341-8
   Nishiyama N, 2001, PHARMACEUT RES, V18, P1035, DOI 10.1023/A:1010908916184
   Nishiyama N, 2003, ADV EXP MED BIOL, V519, P155
   Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com
   Panyam J, 2002, J DRUG TARGET, V10, P515, DOI 10.1080/1061186021000038391
   Panyam J, 2003, INT J PHARM, V262, P1, DOI 10.1016/S0378-5173(03)00295-3
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   PANYAM J, IN PRESS MOL PHARM
   Passirani C, 1998, PHARM RES-DORDR, V15, P1046, DOI 10.1023/A:1011930127562
   Peira E, 2003, J DRUG TARGET, V11, P19, DOI 10.1080/1061186031000086108
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Roco M, 2002, CONVERGING TECHNOLOG
   Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5
   Roco Mihail C., 2001, SOCIAL IMPLICATIONS
   Roser M, 1998, EUR J PHARM BIOPHARM, V46, P255, DOI 10.1016/S0939-6411(98)00038-1
   Rosler A, 2001, ADV DRUG DELIVER REV, V53, P95, DOI 10.1016/S0169-409X(01)00222-8
   Roy I, 2003, J AM CHEM SOC, V125, P7860, DOI 10.1021/ja0343095
   Roy I, 2003, INT J PHARM, V250, P25, DOI 10.1016/S0378-5173(02)00452-0
   Sahoo SK, 2002, BIOCONJUGATE CHEM, V13, P1031, DOI 10.1021/bc020010k
   Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   SESSA G, 1969, J CLIN INVEST, V48, pA76
   Sumner JP, 2002, ANALYST, V127, P11, DOI 10.1039/b108568a
   Sun HY, 2003, ADV DRUG DELIVER REV, V55, P83, DOI 10.1016/S0169-409X(02)00172-2
   Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P6039, DOI 10.1073/pnas.0931428100
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   Tripathi PK, 2002, PHARMAZIE, V57, P261
   Tsavellas G, 2002, CLIN EXP METASTAS, V19, P495, DOI 10.1023/A:1020350117292
   UMATOKU T, 2003, CIRC RES, V92, pE62
   Van der Lubben IM, 2001, J DRUG TARGET, V9, P39, DOI 10.3109/10611860108995631
   Wadghiri YZ, 2003, MAGNET RESON MED, V50, P293, DOI 10.1002/mrm.10529
   Wilkinson J M, 2003, Med Device Technol, V14, P29
   Yokoyama M, 1999, J DRUG TARGET, V7, P171, DOI 10.3109/10611869909085500
   Yowell SL, 2002, CANCER TREAT REV, V28, P3, DOI 10.1016/S0305-7372(02)80002-0
NR 89
TC 585
Z9 617
U1 8
U2 125
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6446
J9 DRUG DISCOV TODAY
JI Drug Discov. Today
PD DEC 15
PY 2003
VL 8
IS 24
BP 1112
EP 1120
AR PII S1359-6446(03)02903-9
DI 10.1016/S1359-6446(03)02903-9
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 753DQ
UT WOS:000187217100007
PM 14678737
DA 2018-10-20
ER

PT J
AU Peng, HQ
   Alemany, LB
   Margrave, JL
   Khabashesku, VN
AF Peng, HQ
   Alemany, LB
   Margrave, JL
   Khabashesku, VN
TI Sidewall carboxylic acid functionalization of single-walled carbon
   nanotubes
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID RING CURRENTS; MAGNETIC-SUSCEPTIBILITY; ELECTRONIC-STRUCTURES;
   CHEMICAL-SHIFT; NMR; CHEMISTRY; FLUORINATION; C-60; SOLUBILIZATION;
   DERIVATIZATION
AB The reactions of single-walled carbon nanotubes (SWNTs) with succinic or glutaric acid acyl peroxides in o-dichlorobenzene at 80-90 degreesC resulted in the addition of 2-carboxyethyl or 3-carboxypropyl groups, respectively, to the sidewalls of the SWNT. These acid-functionalized SWNTs were converted to acid chlorides by derivatization with SOCl2 and then to amides with terminal diamines such as ethylenediamine, 4,4'-methylenebis(cyclohexylamine), and diethyltoluenediamine. The acid-functionalized SWNTs and the amide derivatives were characterized by a set of materials characterization methods including attenuated total reflectance (ATR) FTIR, Raman and solid state C-13 NMR spectroscopy, transmission electron microscopy (TEM), and thermal gravimetry-mass spectrometry (TG-MS). The degree of SWNT sidewall functionalization with the acid-terminated groups was estimated as 1 in 24 carbons on the basis of TG-MS data. In comparison with the pristine SWNTs, the acid-functionalized SWNTs show an improved solubility in polar solvents, for example, alcohols and water, which enables their processing for incorporation into polymer composite structures as well as for a variety of biomedical applications.
C1 Rice Univ, Dept Chem, Houston, TX 77005 USA.
   Rice Univ, Ctr Nanoscale Sci & Technol, Houston, TX 77005 USA.
RP Margrave, JL (reprint author), Rice Univ, Dept Chem, 6100 Main St, Houston, TX 77005 USA.
CR ABRAHAM J, 2002, AIP C P, V633
   Anufriev VP, 1998, BIOORG MED CHEM LETT, V8, P587, DOI 10.1016/S0960-894X(98)00075-4
   Aurell MJ, 1999, TETRAHEDRON, V55, P815, DOI 10.1016/S0040-4020(98)01073-4
   Bac CG, 2001, CURR APPL PHYS, V1, P149
   BAC CG, 2001, PHYS REV B, V63
   Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s
   Bahr JL, 2002, J MATER CHEM, V12, P1952, DOI 10.1039/b201013p
   Banerjee S, 2002, J PHYS CHEM B, V106, P12144, DOI 10.1021/jp026304k
   Banerjee S, 2002, NANO LETT, V2, P49, DOI 10.1021/nl010070j
   BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0
   Boul PJ, 1999, CHEM PHYS LETT, V310, P367, DOI 10.1016/S0009-2614(99)00713-7
   Buhl M, 2001, CHEM REV, V101, P1153, DOI 10.1021/cr990332q
   Chen J, 2002, J AM CHEM SOC, V124, P9034, DOI 10.1021/ja026104m
   Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95
   Chiang IW, 2001, J PHYS CHEM B, V105, P8297, DOI 10.1021/jp0114891
   CLOVER AM, 2004, AM CHEM J, V32, P55
   Coleman KS, 2003, J AM CHEM SOC, V125, P8722, DOI 10.1021/ja0355675
   FIESER LF, 1947, J AM CHEM SOC, V69, P2338, DOI 10.1021/ja01202a026
   FOUBELO F, 1992, TETRAHEDRON, V48, P9531, DOI 10.1016/S0040-4020(01)88320-4
   Georgakilas V, 2002, J AM CHEM SOC, V124, P760, DOI 10.1021/ja016954m
   Georgakilas V, 2002, CHEM COMMUN, P3050, DOI 10.1039/b209843a
   Goze-Bac C, 2002, CARBON, V40, P1825, DOI 10.1016/S0008-6223(02)00061-1
   GOZEBAC C, 2001, MAT RES SOC S P, V633
   Haddon RC, 1997, NATURE, V388, P31, DOI 10.1038/40302
   HADDON RC, 1995, NATURE, V378, P249, DOI 10.1038/378249a0
   HADDON RC, 1993, SCIENCE, V261, P1545, DOI 10.1126/science.261.5128.1545
   Hamon MA, 1999, ADV MATER, V11, P834, DOI 10.1002/(SICI)1521-4095(199907)11:10<834::AID-ADMA834>3.0.CO;2-R
   HAYASHI S, 1991, B CHEM SOC JPN, V64, P685, DOI 10.1246/bcsj.64.685
   HIRSCH A, 1994, ANGEW CHEM INT EDIT, V33, P437, DOI 10.1002/anie.199404371
   Hirsch A, 2002, ANGEW CHEM INT EDIT, V41, P1853, DOI 10.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N
   Holzinger M, 2001, ANGEW CHEM INT EDIT, V40, P4002, DOI 10.1002/1521-3773(20011105)40:21<4002::AID-ANIE4002>3.0.CO;2-8
   Holzinger M, 2003, J AM CHEM SOC, V125, P8566, DOI 10.1021/ja029931w
   HOLZINGER M, 2002, AIP C P, P633
   HOLZINGER M, 2001, AIP C P, V591
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   Kahn MGC, 2002, NANO LETT, V2, P1215, DOI 10.1021/nl025755d
   Katritzky AR, 2001, J ORG CHEM, V66, P5606, DOI 10.1021/jo0017640
   Khabashesku VN, 2002, ACCOUNTS CHEM RES, V35, P1087, DOI 10.1021/ar020146y
   KHABASHESKU VN, 2003, ENCY NANOSCIENCE NAN
   Kini V U, 2002, RIC QUANT I 16 ANN S, P25
   Kishinevsky S, 2002, CHEM MATER, V14, P4498, DOI 10.1021/cm025598j
   LAMPARTH I, 1994, J CHEM SOC CHEM COMM, P1727, DOI 10.1039/c39940001727
   Latil S, 2001, PHYS REV LETT, V86, P3160, DOI 10.1103/PhysRevLett.86.3160
   LATIL S, 2001, MAT RES SOC S P, V633
   LINVIEN D, 1991, HDB INFRARED RAMAN C, P299
   Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253
   LU JP, 1995, PHYS REV LETT, V74, P1123, DOI 10.1103/PhysRevLett.74.1123
   Maniwa Y, 1996, CARBON, V34, P1287, DOI 10.1016/0008-6223(96)00116-9
   MANIWA Y, 1998, AIP C P, V442
   Mickelson ET, 1998, CHEM PHYS LETT, V296, P188, DOI 10.1016/S0009-2614(98)01026-4
   Nakashima N, 2002, CHEM LETT, P638, DOI 10.1246/cl.2002.638
   Niyogi S, 2002, ACCOUNTS CHEM RES, V35, P1105, DOI 10.1021/ar010155r
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   Pantarotto D, 2003, J AM CHEM SOC, V125, P6160, DOI 10.1021/ja034342r
   PASQUARELLO A, 1993, PHYS REV A, V47, P1783, DOI 10.1103/PhysRevA.47.1783
   PASQUARELLO A, 1992, SCIENCE, V257, P1660, DOI 10.1126/science.257.5077.1660
   PENG HB, UNPUB
   Peng HP, 2003, CHEM COMMUN, P362, DOI 10.1039/b209456h
   PETTIT GR, 1971, J CHEM SOC C, P509, DOI 10.1039/j39710000509
   PRATO M, 1993, J AM CHEM SOC, V115, P7876, DOI 10.1021/ja00070a043
   RAMIREZ AP, 1994, SCIENCE, V265, P84, DOI 10.1126/science.265.5168.84
   Rao CNR, 1996, CHEM COMMUN, P1525, DOI 10.1039/cc9960001525
   REVERDY P, 2002, RIC QUANT I 16 ANN S, P19
   Riggs JE, 2000, J AM CHEM SOC, V122, P5879, DOI 10.1021/ja9942282
   Saini RK, 2003, J AM CHEM SOC, V125, P3617, DOI 10.1021/ja021167q
   Star A, 2001, ANGEW CHEM INT EDIT, V40, P1721, DOI 10.1002/1521-3773(20010504)40:9<1721::AID-ANIE17210>3.0.CO;2-F
   Stevens JL, 2003, NANO LETT, V3, P331, DOI 10.1021/nl025944w
   Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v
   Sun YP, 2001, CHEM MATER, V13, P2864, DOI 10.1021/cm0100691
   SUZUKI T, 1992, J AM CHEM SOC, V114, P7301, DOI 10.1021/ja00044a055
   SWERN D, 1971, ORGANIC PEROXIDES, V2, P799
   TABER DF, 1986, J AM CHEM SOC, V108, P7686, DOI 10.1021/ja00284a037
   Tang BZ, 1999, MACROMOLECULES, V32, P2569, DOI 10.1021/ma981825k
   Tang XP, 2000, SCIENCE, V288, P492, DOI 10.1126/science.288.5465.492
   Tang XP, 2000, MATER RES SOC SYMP P, V593, P143
   WANG XK, 1994, J MATER RES, V9, P1578, DOI 10.1557/JMR.1994.1578
   XU M, 2003, Z CHEM PHYS LETT, V375, P598
   Ying YM, 2003, ORG LETT, V5, P1471, DOI 10.1021/ol0342453
   Zhou O, 2002, ACCOUNTS CHEM RES, V35, P1045, DOI 10.1021/ar010162f
   Zhu J, 2003, NANO LETT, V3, P1107, DOI 10.1021/nl0342489
NR 80
TC 440
Z9 446
U1 7
U2 176
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD DEC 10
PY 2003
VL 125
IS 49
BP 15174
EP 15182
DI 10.1021/ja037746s
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 750QE
UT WOS:000187007400046
PM 14653752
DA 2018-10-20
ER

PT J
AU Pompe, W
   Worch, H
   Epple, M
   Friess, W
   Gelinsky, M
   Greil, P
   Hempel, U
   Scharnweber, D
   Schulte, K
AF Pompe, W
   Worch, H
   Epple, M
   Friess, W
   Gelinsky, M
   Greil, P
   Hempel, U
   Scharnweber, D
   Schulte, K
TI Functionally graded materials for biomedical applications
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE functionally graded materials; biomaterials; bone replacement
ID POROUS HYDROXYAPATITE; CALCIUM-PHOSPHATE; BONE-FORMATION; IMPLANTS;
   CELLS; COLLAGEN; MC3T3-E1; PROTEIN; POLY(ANHYDRIDE-CO-IMIDES);
   BIOCOMPATIBILITY
AB Functional gradation is one characteristic feature of living tissue. Bio-inspired materials open new approaches for manufacturing implants for bone replacement. Different routes for new implant materials are presented using the principle of functional gradation. An artificial biomaterial for kneejoint replacement has been developed by building a graded structure consisting of ultra-high molecular weight polyethylene (UHMWPE) fibre reinforced high-density polyethylene combined with a surface of UHMWPE. The ingrowth behaviour of titanium implants into hard tissue can be improved by depositing a graded biopolymer coating of fibronectin, collagen types I and III with a gradation, derived from the mechanisms occurring during healing in vivo. Functionally graded porous hydroxyapatite (HAP) ceramics can be produced using alternative routes, e.g. sintering of laminated structures of HAP tapes filled with polymer spheres or combining biodegradable polyesters such as polylactide, polylactide-co-glycolide and polyglycolide, with carbonated nanocrystalline hydroxyapatite. HAP-collagen I scaffolds are an appropriate material for in vitro growth of bone. The scaffold has to be functionally graded in order to create an optimised mechanical behaviour as well as the intended improvement of the cell ingrowth. (C) 2003 Elsevier B.V. All rights reserved.
C1 Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
   Ruhr Univ Bochum, Fac Chem, Solid State Chem, D-44780 Bochum, Germany.
   Univ Erlangen Nurnberg, Dept Pharmaceut Technol, D-91508 Erlangen, Germany.
   Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91058 Erlangen, Germany.
   Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany.
   Univ Technol Hamburg, Dept Polymers & Composites, D-21073 Hamburg, Germany.
RP Pompe, W (reprint author), Tech Univ Dresden, Inst Werkstoffwissensch, Gebaude Hallwachsstr 3, D-01069 Dresden, Germany.
EM pompe@tmfs.mpgfk.tu-dresden.de
RI Schulte, Karl/C-9550-2013; Scharnweber, Dieter/B-3382-2010; Gelinsky,
   Michael/A-9680-2012
OI Gelinsky, Michael/0000-0001-9075-5121; Schulte, Karl/0000-0001-6521-0488
CR ARITA IH, 1995, J MATER SCI-MATER M, V6, P19, DOI 10.1007/BF00121241
   Attawia MA, 1996, J ORTHOPAED RES, V14, P445, DOI 10.1002/jor.1100140315
   ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P1233, DOI 10.1002/jbm.820291010
   Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   BIRKEN LMO, 2000, P 6 WORLD BIOM C, P420
   BIRKEN LMO, 2000, P 6 WORLD BIOM C HAW, P856
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   CHENU C, 1994, J CELL BIOL, V127, P1149, DOI 10.1083/jcb.127.4.1149
   Chung CY, 1999, BIOCHEM BIOPH RES CO, V265, P246, DOI 10.1006/bbrc.1999.1639
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z
   Floquet I., 1997, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V98, P47
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HILTUNEN A, 1993, CLIN ORTHOP RELAT R, P23
   HOGAN ME, 1991, J ELECTRON MICR TECH, V18, P106, DOI 10.1002/jemt.1060180203
   ITAKURA Y, 1988, J BIOMED MATER RES, V22, P613, DOI 10.1002/jbm.820220703
   Jacobs O, 2000, WEAR, V244, P20, DOI 10.1016/S0043-1648(00)00419-1
   Kitsugi T, 1996, J BIOMED MATER RES, V32, P149
   Kurdy NMG, 1998, J ORTHOP TRAUMA, V12, P122, DOI 10.1097/00005131-199802000-00010
   Lacroix F, 1999, COMPOS PART A-APPL S, V30, P369, DOI 10.1016/S1359-835X(98)00085-2
   LACROIX F, 1998, POLYMER, V40, P843
   Lampenscherf S., 1999, Materials Science Forum, V308-311, P362
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   Liu YK, 1997, FEBS LETT, V420, P112, DOI 10.1016/S0014-5793(97)01498-1
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   Pompe W., 1999, Materials Science Forum, V308-311, P325
   PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447
   Quinones CR, 1997, CLIN ORAL IMPLAN RES, V8, P487, DOI 10.1034/j.1600-0501.1997.080607.x
   REMER P, 1998, SCHWERPUNKTPROGRAMM, P30
   Ripamonti U, 2001, PLAST RECONSTR SURG, V107, P977, DOI 10.1097/00006534-200104010-00012
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   Schiller C, 2001, CERAM TRANS, V114, P97
   SCHLIEPHAKE H, 1991, INT J ORAL MAX SURG, V20, P52, DOI 10.1016/S0901-5027(05)80698-8
   SCHULTE K, 1999, MATER SCI FORUM, V308, pF101
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tampieri A, 2000, MATER CHEM PHYS, V64, P54, DOI 10.1016/S0254-0584(99)00252-7
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   Trentz OA, 1997, UNFALLCHIRURG, V100, P39, DOI 10.1007/s001130050093
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Vaz L, 1999, J MATER SCI-MATER M, V10, P239, DOI 10.1023/A:1008910213166
   Verrier S, 1996, J MATER SCI-MATER M, V7, P46, DOI 10.1007/BF00121189
   WAGNER M, 2000, KERAM Z, V6, P490
   Wang CK, 1998, MATER CHEM PHYS, V53, P138, DOI 10.1016/S0254-0584(97)02074-9
   Wang M, 1999, J MATER SCI-MATER M, V10, P269, DOI 10.1023/A:1008901428552
   Weihe S, 2001, Mund Kiefer Gesichtschir, V5, P299, DOI 10.1007/s100060100324
   WEIHE S, 2001, BIOMEDIZINISCHE T S1, V46, P214
   WEIHE S, 2001, BIOMEDIZINISCHE T S1, V46, P204
   WERNER JP, 1999, P 6 C EUR CER SOC, V2, P509
   WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X
   WIMMER MA, 1999, WEAR POLYETHYLENE CO, P43
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   1984, 52292 DIN
NR 60
TC 227
Z9 239
U1 4
U2 118
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD DEC 5
PY 2003
VL 362
IS 1-2
BP 40
EP 60
DI 10.1016/S0921-5093(03)00580-X
PG 21
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 749HF
UT WOS:000186913300004
DA 2018-10-20
ER

PT J
AU Zamir, EA
   Srinivasan, V
   Perucchio, R
   Taber, LA
AF Zamir, EA
   Srinivasan, V
   Perucchio, R
   Taber, LA
TI Mechanical asymmetry in the embryonic chick heart during looping
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE looping; morphogenesis; asymmetry; biomechanics; microindentation;
   stiffness; material properties
ID LEFT-VENTRICULAR MYOCARDIUM; CARDIAC MORPHOGENESIS; ACTIN BUNDLES; CELL
   POKING; FLECTIN; STRAIN; SHAPE
AB Cardiac looping, which begins with ventral bending and rightward rotation of the primitive heart tube, is an essential morphogenetic event that occurs early in vertebrate development. The biophysical mechanism that drives this process is unknown. It has been speculated that-increased stiffness along the dorsal side of the ventricle. combined with an intrinsic cardiac force causes the heart to bend. There is no experimental support for this hypothesis, however, since little is known about regional mechanical properties of the heart during looping. We directly measured diastolic stiffness of the inner curvature (IC), outer curvature (OC), and dorsal-ventral sides of the stage 12 chick heart by microindentation. The IC of intact hearts was found to be significantly stiffer than either the OC or the sides, which were of similar stiffness. Isolated cardiac jelly, which is a thick, extracellular matrix compartment underlying the myocardium, was approximately an order of magnitude softer than intact hearts. The results of a computational model simulating the indentation experiments, combined with the stiffness measurements, suggests the regional. variation in stiffness is due to the material properties of the myocardium. A second model shows that a relatively stiff IC may facilitate bending of the heart tube during looping. (C) 2003 Biomedical Engineering Society.
C1 Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   Univ Rochester, Dept Mech Engn, Rochester, NY 14627 USA.
RP Taber, LA (reprint author), Washington Univ, Dept Biomed Engn, Campus Box 1097,1 Brookings Dr, St Louis, MO 63130 USA.
EM lat@wustl.edu
FU NHLBI NIH HHS [R01 HL64347]
CR Alford PW, 2003, J BIOMECH, V36, P1135, DOI 10.1016/S0021-9290(03)00089-7
   BUTLER JK, 1952, THESIS U TEXAS
   DAILY B, 1984, BIOPHYS J, V45, P671, DOI 10.1016/S0006-3495(84)84209-5
   DEHAAN RL, 1967, CIRCULATION, V35, P821, DOI 10.1161/01.CIR.35.5.821
   DUSZYK M, 1989, BIOPHYS J, V55, P683, DOI 10.1016/S0006-3495(89)82867-X
   FLYNN ME, 1991, ANAT EMBRYOL, V184, P411, DOI 10.1007/BF00957902
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Harvey RP, 1998, SEMIN CELL DEV BIOL, V9, P101, DOI 10.1006/scdb.1997.0188
   HASSAN EA, 1998, BIOPHYS J, V74, P1564
   ITASAKI N, 1991, ANAT EMBRYOL, V183, P29
   ITASAKI N, 1989, ANAT EMBRYOL, V180, P413, DOI 10.1007/BF00305115
   LACKTIS JW, 1978, MORPHOGENESIS MALFOR, P205
   Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021
   Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404
   Linask KK, 2002, DEV BIOL, V246, P407, DOI 10.1006/dbio.2002.0661
   MANASEK FJ, 1972, DEV BIOL, V27, P584, DOI 10.1016/0012-1606(72)90196-0
   MANASEK FJ, 1972, DEV BIOL, V29, P349, DOI 10.1016/0012-1606(72)90077-2
   MANASEK FJ, 1984, GROWTH HEART HLTH DI, P105
   Manner J, 2000, ANAT REC, V259, P248, DOI 10.1002/1097-0185(20000701)259:3<248::AID-AR30>3.0.CO;2-K
   Mercola M, 1999, SEMIN CELL DEV BIOL, V10, P109, DOI 10.1006/scdb.1998.0280
   Miller CE, 1997, J BIOMECH, V30, P985, DOI 10.1016/S0021-9290(97)00048-1
   NAKAMURA A, 1978, J EMBRYOL EXP MORPH, V43, P167
   Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176
   Riley PR, 2000, DEV BIOL, V227, P156, DOI 10.1006/dbio.2000.9864
   SHIRAISHI I, 1995, ANAT EMBRYOL, V191, P183
   SRINIVASAN R, 1994, INT J NUMER METH ENG, V37, P3075, DOI 10.1002/nme.1620371805
   TABER LA, 1995, DEV DYNAM, V203, P42, DOI 10.1002/aja.1002030105
   TABER LA, 1994, CIRC RES, V75, P896, DOI 10.1161/01.RES.75.5.896
   TABER LA, 1993, CIRC RES, V72, P455, DOI 10.1161/01.RES.72.2.455
   Taber LA, 2000, J ELASTICITY, V61, P165, DOI 10.1023/A:1011082712497
   TABER LA, 1995, APPL MECH REV, V48, P487, DOI DOI 10.1115/1.3005109
   Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849
   Tsuda T, 1996, DEV BIOL, V173, P39, DOI 10.1006/dbio.1996.0005
   Voronov DA, 2002, DEV DYNAM, V224, P413, DOI 10.1002/dvdy.10121
   Xie W, 2001, COMPUT METHOD BIOMEC, V4, P231
NR 35
TC 49
Z9 50
U1 0
U2 5
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2003
VL 31
IS 11
BP 1327
EP 1336
DI 10.1114/1.1623487
PG 10
WC Engineering, Biomedical
SC Engineering
GA 764GK
UT WOS:000188198900003
PM 14758923
DA 2018-10-20
ER

PT J
AU Shimko, DA
   White, KK
   Nauman, EA
   Dee, KC
AF Shimko, DA
   White, KK
   Nauman, EA
   Dee, KC
TI A device for long term, in vitro loading of three-dimensional natural
   and engineered tissues
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE bone marrow stromal cells; mechanical loading; mineralization; bone
   tissue engineering.
ID POLY(DL-LACTIC-CO-GLYCOLIC ACID) FOAMS; BONE-CELLS; POLY(L-LACTIC ACID);
   MECHANICAL STRAIN; POLYMER SCAFFOLDS; SHEAR-STRESS; CULTURE; MARROW;
   CARTILAGE; COLLAGEN
AB In vitro studies of mechanical loads applied to three-dimensional tissue constructs are important to the design and production of functional, engineered bone tissue. This study reports the development and characterization of a mechanical device capable of subjecting a three-dimensional section of natural or engineered tissue to precise, reproducible four-point bending deformations over a range of programmable magnitudes and frequencies. To test the biological and mechanical capabilities of the system, a low-cycle (360 cycles/day), medium-range strain (2500 microstrain), long-term (16 day) loading regime was applied to rat bone marrow stromal cells cultured in porous DL-polylactic-acid scaffolds. Cells proliferated in culture throughout the experiment, and with time showed an increase in alkaline phosphatase expression per cell. Calcium and phosphorus mineral deposition by the unloaded group was significantly greater (p < 0.05) than that deposited by the loaded group. The molar ratio of calcium to phosphorus in the unloaded group (0.94:1) was significantly greater (p < 0.05) than that of the loaded group (0.41:1). The loading device presented here is a tool which can be used to help elucidate contributions of mechanical loading/fatigue on biodegradable materials, as well as study the effects of mechanical loading on natural or engineered tissues in vitro. (C) 2003 Biomedical Engineering Society.
C1 Tulane Univ, Dept Biomed Engn, Lindy Boggs Ctr, New Orleans, LA 70118 USA.
RP Dee, KC (reprint author), Tulane Univ, Dept Biomed Engn, Lindy Boggs Ctr, Suite 500, New Orleans, LA 70118 USA.
EM kcdee@tulane.edu
OI Dee, Kay C/0000-0002-9069-4880
FU NEI NIH HHS [1 R03 EY14135-01]
CR Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BRIGHTON CT, 1992, J ORTHOPAED RES, V10, P385, DOI 10.1002/jor.1100100311
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   Brown TD, 1998, AM J MED SCI, V316, P162, DOI 10.1097/00000441-199809000-00003
   COCHRAN GVB, 1972, J BIOMECH, V5, P119, DOI 10.1016/0021-9290(72)90024-3
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723
   Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498
   Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Gere J. M., 1990, MECH MAT
   HARTER LV, 1995, ENDOCRINOLOGY, V136, P528, DOI 10.1210/en.136.2.528
   HASEGAWA S, 1985, CALCIFIED TISSUE INT, V37, P431, DOI 10.1007/BF02553714
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Langelier E, 1999, ANN BIOMED ENG, V27, P67, DOI 10.1114/1.166
   LANYON LE, 1975, ACTA ORTHOP SCAND, V46, P256, DOI 10.3109/17453677508989216
   LANYON LE, 1984, CALCIFIED TISSUE INT, V36, pS56, DOI 10.1007/BF02406134
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MURRAY DW, 1990, CALCIFIED TISSUE INT, V47, P35, DOI 10.1007/BF02555863
   Nauman EA, 2002, TISSUE ENG, V8, P931, DOI 10.1089/107632702320934038
   Nauman EA, 2001, J APPL PHYSIOL, V90, P1849
   RAWLINSON SCF, 1995, J BONE MINER RES, V10, P1225
   Reich KM, 1997, ENDOCRINOLOGY, V138, P1014, DOI 10.1210/en.138.3.1014
   REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113
   Robling AG, 2000, J BONE MINER RES, V15, P1596, DOI 10.1359/jbmr.2000.15.8.1596
   RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4
   SOMJEN D, 1980, BIOCHIM BIOPHYS ACTA, V627, P961
   Tanaka SM, 1999, J BIOMECH, V32, P427, DOI 10.1016/S0021-9290(98)00183-3
   TURNER CH, 1992, BONE, V13, P417, DOI 10.1016/8756-3282(92)90084-A
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Yang Y, 2002, BIOMATERIALS, V23, P2119, DOI 10.1016/S0142-9612(01)00342-8
   YEH CK, 1984, CALCIFIED TISSUE INT, V36, pS67, DOI 10.1007/BF02406136
   Zheng J, 1998, IN VITRO CELL DEV-AN, V34, P679
NR 38
TC 12
Z9 12
U1 0
U2 4
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2003
VL 31
IS 11
BP 1347
EP 1356
DI 10.1114/1.1626117
PG 10
WC Engineering, Biomedical
SC Engineering
GA 764GK
UT WOS:000188198900005
PM 14758925
DA 2018-10-20
ER

PT J
AU He, G
   Eckert, J
   Dai, QL
   Sui, ML
   Loser, W
   Hagiwara, M
   Ma, E
AF He, G
   Eckert, J
   Dai, QL
   Sui, ML
   Loser, W
   Hagiwara, M
   Ma, E
TI Nanostructured Ti-based multi-component alloys with potential for
   biomedical applications
SO BIOMATERIALS
LA English
DT Article
DE Ti-Cu-Ni-Sn-Nb(Ta,Mo) alloy; biomedical materials; nanostructure;
   composite; mechanical property; yield strength; elastic modulus
ID BULK METALLIC-GLASS; ENHANCED PLASTICITY; MICROSTRUCTURE; STABILITY;
   COMPOSITE; BEHAVIOR; COPPER; TA
AB A group of Ti60Cu14Ni12Sn4M10 (M=Nb, Ta, Mo) alloys was prepared using arc melting and copper mold casting. The as-prepared alloys have a composite microstructure containing a micrometer-sized dendritic beta-Ti(M) phase dispersed ill a nanocrystalline matrix. These new alloys exhibit a low Young's modulus in the range of 59-103 GPa, and a high yield strength of 1037-1755 MPa, together with large plastic strains. The combination of high strength and low elastic modulus offers potential advantages in biomedical applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 IFW Dresden, Inst Met Werkstoffe, D-01171 Dresden, Germany.
   Natl Inst Mat Sci, Light Mat Grp, Tsukuba, Ibaraki 3050047, Japan.
   Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Peoples R China.
   Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
RP He, G (reprint author), IFW Dresden, Inst Met Werkstoffe, Postfach 270016, D-01171 Dresden, Germany.
RI Ma, En/A-3232-2010; Sui, Manling/B-6069-2013
OI Sui, Manling/0000-0002-0415-5881
CR DAS J, UNPUB ACTA MAT
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   ECKERT J, IN PRESS MAT T
   GRIMME P, 1992, METALLURGY, V46, P365
   He G, 2003, ACTA MATER, V51, P1621, DOI 10.1016/S1359-6454(02)00563-3
   He G, 2003, ACTA MATER, V51, P2383, DOI 10.1016/S1359-6454(03)00045-4
   He G, 2002, J MATER RES, V17, P3015, DOI 10.1557/JMR.2002.0439
   He G, 2003, NAT MATER, V2, P33, DOI 10.1038/nmat792
   HE G, IN PRESS ACTA MAT
   Jia D, 2001, SCRIPTA MATER, V45, P613, DOI 10.1016/S1359-6462(01)01071-5
   Koch CC, 1999, MRS BULL, V24, P54, DOI 10.1557/S0883769400051551
   Lee BH, 2003, BIOMATERIALS, V24, P2257, DOI 10.1016/S0142-9612(03)00034-6
   LUGOWSKI SJ, 1991, J BIOMED MATER RES, V25, P1443, DOI 10.1002/jbm.820251204
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   Srivastava RM, 2002, MATER TRANS, V43, P1670, DOI 10.2320/matertrans.43.1670
   Wang YM, 2003, SCRIPTA MATER, V48, P1581, DOI 10.1016/S1359-6462(03)00159-3
   Wei Q, 2002, APPL PHYS LETT, V81, P1240, DOI 10.1063/1.1501158
NR 19
TC 92
Z9 97
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2003
VL 24
IS 28
BP 5115
EP 5120
DI 10.1016/S0142-9612(03)00440-X
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 745DN
UT WOS:000186674000005
PM 14568427
DA 2018-10-20
ER

PT J
AU Huang, C
   Huang, HK
AF Huang, C
   Huang, HK
TI Interactive instruction of cellular physiology for remote learning
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE distance education; remote learning; misconceptions; interactive media;
   instructional media; online course; Internet 2
AB The biomedical sciences are a rapidly changing discipline that have adapted to innovative technological advances. Despite these many advances, we face two major challenges: a) the number of experts in the field is vastly outnumbered by the number of students, many of whom are separated geographically or temporally and b) the teaching methods used to instruct students and learners have not changed. Today's students have adapted to technology - they use the web as a source of information and communicate via email and chat rooms. Teaching in the biomedical sciences should adopt these new information technologies (IT), but has thus far faded to capitalize on technological opportunity. Creating a "digital textbook" of the traditional learning material is not sufficient for dynamic processes such as cellular physiology. This paper describes innovative teaching techniques that incorporate familiar IT and high-quality interactive learning content with user-centric instruction design models. The Virtual Labs Project from Stanford University has created effective interactive online teaching modules in physiology (simPHYSIO) and delivered them over broadband networks to their undergraduate and medical students. Evaluation results of the modules are given as a measure of success of such innovative teaching method. This learning media strategically merges IT innovations with pedagogy to produce user-driven animations of processes and engaging interactive simulations.
C1 SUMMIT, Stanford, CA 94305 USA.
   Univ So Calif, Keck Sch Med, Inst Informat Sci, Dept Radiol, Marina Del Rey, CA 90292 USA.
RP Huang, C (reprint author), SUMMIT, 450 Serra Mall,Bldg 160,Wallenberg Hall, Stanford, CA 94305 USA.
EM cammy.huang@stanford.edu
CR Alessi S.M., 2001, MULTIMEDIA LEARNING
   BRANSFORD JD, 2000, PEOPLE LEARN MIND BR, V39
   Creswell J., 2003, RES DESIGN QUALITATI
   Dick W., 1996, SYSTEMATIC DESIGN IN
   Fan Y, 2000, J HIGH SPEED NETW, V9, P3
   HUANG C, 2003, JCMIG, V27, P157
   HUANG HK, 2003, FRONTIERS BIOMEDICAL
   KOZMA RB, 1991, REV EDUC RES, V61, P179, DOI 10.2307/1170534
   LEPPER T, 1987, APTITUDE LEARNING IN, V3
   Modell HI, 2000, ADV PHYSIOL EDUC, V23, P101
   Nielsen J., 1994, USABILITY ENG
   SHNEIDERMAN B, 1997, DESIGNING USER INTER
NR 12
TC 3
Z9 3
U1 1
U2 9
PU C M B  ASSOC
PI POITIERS
PA 40 AVENUE  RECTEUR PINEAU,  BAT MECANIQUE, 86022 POITIERS, FRANCE
SN 0145-5680
EI 1165-158X
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PD DEC
PY 2003
VL 49
IS 8
BP 1377
EP 1384
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 774JZ
UT WOS:000188977500030
PM 14984013
DA 2018-10-20
ER

PT J
AU Boccaccini, AR
   Maquet, V
AF Boccaccini, AR
   Maquet, V
TI Bioresorbable and bioactive polymer/Bioglass (R) composites with
   tailored pore structure for tissue engineering applications
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE bioresorbable polymers
ID BIODEGRADABLE POLYMER SCAFFOLDS; LIQUID PHASE-SEPARATION;
   ARTICULAR-CARTILAGE REPAIR; IN-VIVO EVALUATION; POLYLACTIDE FOAMS; CELL
   TRANSPLANTATION; BIOMEDICAL MATERIALS; FIBER STRUCTURES; IMAGE-ANALYSIS;
   BONE REPAIR
AB An overview about the development of porous bioresorbable composite materials for applications as scaffolds in tissue engineering is presented. A thermally induced phase separation method was developed to fabricate porous foam-like structures of poly(lactide-co-glycolide) (PLGA) containing bioactive glass particle additions (up to 50 wt.%) and exhibiting well-defined, oriented and interconnected porosity. The in vitro bioactivity and the degradability of the composite foams were investigated in contact with phosphate buffer saline (PBS). Weight loss, water absorption and molecular weight measurements were used to monitor the polymer degradation after incubation periods of up to 7 weeks in PBS. It was found that the presence of bioactive glass retards the polymer degradation rate for the time period investigated. The present results show a way of controlling the in vitro degradation behaviour of PLGA porous composite scaffolds by tailoring the concentration of bioactive glass. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ London Imperial Coll Sci & Technol, Dept Mat, London SW7 2BP, England.
   Univ London Imperial Coll Sci & Technol, Ctr Tissue Engn & Regenerat Med, London SW7 2BP, England.
   Univ Liege, CERM, Interfacultary Ctr Biomat, B-4000 Cointe Ougree, Belgium.
RP Boccaccini, AR (reprint author), Univ London Imperial Coll Sci & Technol, Dept Mat, London SW7 2BP, England.
RI Boccaccini, Aldo/C-7905-2013
CR Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   BEHREND D, 2000, ADV ENG MATER, V3, P123
   Boccaccini A. R., 2002, Ceramic Engineering and Science Proceedings, V23, P805
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Boyan B. D., 1999, United States Patent, Patent No. [5977204 A, 5977204]
   BUDAVARI S, 1996, MATERIALS SAFETY DAT
   Chaignaud B, 1997, SYNTHETIC BIODEGRADA, P114
   COOMBES AGA, 1993, BIOMATERIALS, V14, P217
   DAY R, 2002, GASTROENTEROLOGY S1, V122, pT875
   DAY RM, 2003, IN PRESS BIOMATERIAL
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Domingues RZ, 2001, J BIOMED MATER RES, V55, P468, DOI 10.1002/1097-4636(20010615)55:4<468::AID-JBM1038>3.0.CO;2-T
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.3.CO;2-C
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hua FJ, 2002, J BIOMED MATER RES, V63, P161, DOI 10.1002/jbm.10121.abs
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin C. T., 2000, BONE ENG, P462
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lin HR, 2002, J BIOMED MATER RES, V63, P271, DOI 10.1002/jbm.10183
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Maquet V, 2000, LANGMUIR, V16, P10463, DOI 10.1021/la000654l
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P199, DOI 10.1002/jbm.a.10523
   MAQUET V, 2003, J BIOMED MAT RES A, V66, P333
   MATTHEW HWT, 2002, POLYM BIOMATERIALS, P167
   Mikos A. G., 1996, U.S. patent, Patent No. [5,514,378, 5514378]
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Roether JA, 2002, J MATER SCI-MATER M, V13, P1207, DOI 10.1023/A:1021166726914
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Schiller C, 2001, CERAM TRANS, V114, P97
   SCHMITZ JP, 1988, CLIN ORTHOP RELAT R, P245
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sepulveda P, 2002, J BIOMED MATER RES, V62, P587, DOI 10.1002/jbm.10173
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Slivka MA, 2001, TISSUE ENG, V7, P767, DOI 10.1089/107632701753337717
   Stamboulis A, 2002, J MATER SCI-MATER M, V13, P843, DOI 10.1023/A:1016544211478
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Thomson RC, 1997, PRINCIPLES TISSUE EN, P263
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   Weng J, 2001, J MATER SCI LETT, V20, P1401, DOI 10.1023/A:1011643511015
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
   Xiong Z, 2001, SCRIPTA MATER, V45, P773, DOI 10.1016/S1359-6462(01)01094-6
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 74
TC 187
Z9 188
U1 2
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD DEC
PY 2003
VL 63
IS 16
BP 2417
EP 2429
DI 10.1016/S0266-3538(03)00275-6
PG 13
WC Materials Science, Composites
SC Materials Science
GA 737QK
UT WOS:000186243100015
DA 2018-10-20
ER

PT J
AU Shepherd, RE
AF Shepherd, RE
TI Chromatographic and related electrophoretic methods in the separation of
   transition metal complexes or their ligands
SO COORDINATION CHEMISTRY REVIEWS
LA English
DT Review
DE chromatographic methods; electrophoretic methods; transition metal
   complexes
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; CAPILLARY-ZONE-ELECTROPHORESIS; ION
   AFFINITY-CHROMATOGRAPHY; ELECTROSPRAY MASS-SPECTROMETRY;
   INDUCTIVELY-COUPLED PLASMA; THIN-LAYER CHROMATOGRAPHY; CHIRAL
   STATIONARY-PHASE; ELEMENT SPECIATION ANALYSIS; RU(BPY)(3)(3+)-BASED
   CHEMILUMINESCENCE DETECTION; MICELLAR ELECTROKINETIC CHROMATOGRAPHY
AB It is difficult for most inorganic chemists to be aware of the availability of the many new techniques, described largely in analytical chemistry, environmental chemistry, and biomedical journals, which are increasingly of value in the separation and characterization of complexes of transition metals. Additionally, the design and use of supported transition metal complexes as sites for molecular recognition in the separation of biomolecules and organic materials has the potential to dominate multi-billion dollar industries in proteins and chiral drugs. This review serves as a roadmap for inorganic chemists to the recent chromatographic literature. The review covers advances in separation methods that involve transition metal chemistry which have occurred in the decade of 1992 through early 2003 with 360 references. The review is intended to assist readers in finding key papers that illustrate techniques of chromatography that might be applicable to purposes in the reader's laboratory. Covered topics include the standard separation of inorganic ions and metal complexes, capillary electrophoresis methods (CE, CZE, MEKC), electrochemical detection in flow methods by [Ru(bpy)(3)](3+/2+) cycling in response to analytes, separations of metal complexes of interest to environmental and biomedical disciplines via size exclusion chromatography (SEC), and detection methods with electrospray mass spectrometry (ESI-MS). Advances in affinity chromatography in the separation of peptide, proteins and biopolymers (IMAC) and of organic substrates (IMCOS) are discussed. Recent advances in understanding the mechanisms of chromatographic separations, and of the technique of polymer imprinting to produce selective recognition sites for metal ions and metal complexes are described. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.
RP Shepherd, RE (reprint author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.
EM shepherd@pitt.edu
CR Abudiab T, 1998, J CHROMATOGR A, V795, P211, DOI 10.1016/S0021-9673(97)00959-X
   Aguilar M, 1997, J CHROMATOGR A, V778, P397, DOI 10.1016/S0021-9673(97)00327-0
   Akapo SO, 1997, ANAL CHIM ACTA, V341, P35, DOI 10.1016/S0003-2670(96)00569-7
   Akapo SO, 1996, ANAL COMMUN, V33, P311, DOI 10.1039/ac9963300311
   Alberghina G, 1999, J CHROMATOGR A, V840, P51, DOI 10.1016/S0021-9673(99)00196-X
   Aldrich-Wright JR, 1997, COORDIN CHEM REV, V166, P361, DOI 10.1016/S0010-8545(97)00048-9
   AldrichWright JR, 1995, J CHROMATOGR A, V718, P436, DOI 10.1016/0021-9673(95)00703-2
   Ammann AA, 2002, J CHROMATOGR A, V947, P205, DOI 10.1016/S0021-9673(01)01607-7
   ARNOLD FH, 1991, BIO-TECHNOL, V9, P151, DOI 10.1038/nbt0291-151
   BAFFI F, 1994, ANAL CHIM ACTA, V294, P127, DOI 10.1016/0003-2670(94)80187-8
   Baron D, 1998, J ENVIRON QUAL, V27, P844, DOI 10.2134/jeq1998.00472425002700040019x
   Barroso MJ, 2000, CHROMATOGRAPHIA, V51, P277, DOI 10.1007/BF02490604
   BAZYLAK G, 1994, J CHROMATOGR A, V665, P75, DOI 10.1016/0021-9673(94)87034-9
   Bedsworth WW, 2001, J CHROMATOGR A, V905, P157, DOI 10.1016/S0021-9673(00)00964-X
   Benson LM, 2003, RAPID COMMUN MASS SP, V17, P267, DOI 10.1002/rcm.903
   BIERNAT JF, 1994, SEPAR PURIF METHOD, V23, P77, DOI 10.1080/03602549408006624
   Blanchard RM, 1998, MIKROCHIM ACTA, V130, P55, DOI 10.1007/BF01254591
   Bobbitt DR, 1998, TALANTA, V46, P565, DOI 10.1016/S0039-9140(97)00318-4
   Boden V, 1998, J MOL RECOGNIT, V11, P32, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<32::AID-JMR386>3.0.CO;2-V
   Bouyssiere B, 2002, SPECTROCHIM ACTA B, V57, P805, DOI 10.1016/S0584-8547(02)00024-1
   Breadmore MC, 1999, ANAL CHEM, V71, P1826, DOI 10.1021/ac981044h
   BRENA BM, 1994, BIOTECHNOL APPL BIOC, V19, P217
   BRENNAUER K, 2002, DALTON T, P2069
   BRUCE D, 1993, AICHE J, V39, P1966, DOI 10.1002/aic.690391207
   Brunkan NM, 2000, J AM CHEM SOC, V122, P6217, DOI 10.1021/ja000462c
   Brunner H, 1999, ENANTIOMER, V4, P91
   Bruzzoniti MC, 1996, J CHROMATOGR A, V728, P55
   Brykina GD, 1997, J ANAL CHEM+, V52, P969
   Buckingham DA, 1999, AUST J CHEM, V52, P185, DOI 10.1071/C98075
   Burleigh MC, 2001, SEPAR SCI TECHNOL, V36, P3395, DOI 10.1081/SS-100107910
   Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s
   CARDWELL TJ, 1994, INORG CHIM ACTA, V216, P75, DOI 10.1016/0020-1693(93)03716-N
   Careri M, 1996, J CHROMATOGR A, V730, P231, DOI 10.1016/0021-9673(95)01140-4
   Carlesso V, 2000, EUR J MASS SPECTROM, V6, P421, DOI 10.1255/ejms.365
   CASOLI A, 1989, CHEM REV, V89, P407, DOI 10.1021/cr00092a010
   Chaga G, 1999, J CHROMATOGR A, V864, P247
   Chaga G, 1999, BIOTECHNOL APPL BIOC, V29, P19
   Chaga GS, 2001, J BIOCHEM BIOPH METH, V49, P313, DOI 10.1016/S0165-022X(01)00206-8
   Charalambous J, 1996, POLYHEDRON, V15, P803, DOI 10.1016/0277-5387(95)00327-5
   Chassaigne H, 1998, FRESEN J ANAL CHEM, V361, P267, DOI 10.1007/s002160050877
   Chen H, 1997, ANGEW CHEM INT EDIT, V36, P642, DOI 10.1002/anie.199706421
   Chen HM, 2000, ENZYME MICROB TECH, V27, P219, DOI 10.1016/S0141-0229(00)00215-5
   CHEN X, 1995, ANAL SCI, V11, P749, DOI 10.2116/analsci.11.749
   Chen X, 2000, ACTA CHIM SINICA, V58, P563
   Chen X, 1997, ANAL SCI, V13, P71, DOI 10.2116/analsci.13.Supplement_71
   Chen Y, 2000, INORG CHEM, V39, P1180, DOI 10.1021/ic990520z
   Chen Y, 1999, J INORG BIOCHEM, V76, P211, DOI 10.1016/S0162-0134(99)00129-4
   Chen ZL, 2001, ELECTROPHORESIS, V22, P3339, DOI 10.1002/1522-2683(200109)22:15<3339::AID-ELPS3339>3.0.CO;2-5
   Chesnut DJ, 1999, COORDIN CHEM REV, V190, P737, DOI 10.1016/S0010-8545(99)00119-8
   CHI DY, 1994, J MED CHEM, V37, P928, DOI 10.1021/jm00033a010
   Collins JG, 1998, INORG CHEM, V37, P3133, DOI 10.1021/ic971194v
   Collinson MM, 2000, ANAL CHEM, V72, P2914, DOI 10.1021/ac9913208
   Colton R, 1995, MASS SPECTROM REV, V14, P79, DOI 10.1002/mas.1280140203
   CONZONNO V, 1994, FRESEN ENVIRON BULL, V3, P1
   COWEY CM, 1995, J CHEM ENG DATA, V40, P1217, DOI 10.1021/je00022a015
   Cucinotta V, 2003, ANALYST, V128, P134, DOI 10.1039/b210003g
   CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378
   Dabek-Zlotorzynska E, 1998, ANAL CHIM ACTA, V359, P1, DOI 10.1016/S0003-2670(97)00635-1
   DAVIES MB, 1994, COORDIN CHEM REV, V134, pA195
   de Boer T, 2000, ELECTROPHORESIS, V21, P3220, DOI 10.1002/1522-2683(20000901)21:15<3220::AID-ELPS3220>3.0.CO;2-X
   De Clercq E, 2001, PURE APPL CHEM, V73, P55, DOI 10.1351/pac200173010055
   DeClercq E, 1996, BIOMED PHARMACOTHER, V50, P207, DOI 10.1016/0753-3322(96)87660-8
   Dilli S, 1999, ANAL CHIM ACTA, V395, P101, DOI 10.1016/S0003-2670(99)00219-6
   Diogenes ICN, 2000, CHROMATOGRAPHIA, V51, P122, DOI 10.1007/BF02490706
   DOWNEY TM, 1992, ANAL CHEM, V64, P261, DOI 10.1021/ac00027a005
   Enders D, 1997, CHEM BER-RECL, V130, P1253, DOI 10.1002/cber.19971300913
   ENGLE AR, 1994, ANAL CHIM ACTA, V298, P175, DOI 10.1016/0003-2670(94)00263-0
   ERIKSSON M, 1994, BIOCHEMISTRY-US, V33, P5031, DOI 10.1021/bi00183a005
   Fahnrich KA, 2001, TALANTA, V54, P531, DOI 10.1016/S0039-9140(01)00312-5
   Fanali S, 1997, J CHROMATOGR A, V792, P227, DOI 10.1016/S0021-9673(97)00809-1
   FATIADI AJ, 1987, CRIT REV ANAL CHEM, V18, P1
   FENG YQ, 1995, CHROMATOGRAPHIA, V41, P532, DOI 10.1007/BF02269716
   Fletcher NC, 1999, J CHEM SOC DALTON, P683, DOI 10.1039/a809481k
   FLETCHER NC, 2001, DALTON T, P2641
   FONG SW, 2002, DALTON T, P1826
   Forbes GA, 1997, ANAL CHIM ACTA, V347, P289, DOI 10.1016/S0003-2670(97)00157-8
   Gaberc-Porekar V, 2001, J BIOCHEM BIOPH METH, V49, P335, DOI 10.1016/S0165-022X(01)00207-X
   Galaev IY, 1999, J MACROMOL SCI PURE, VA36, P1093, DOI 10.1080/10601329908951202
   Galaverna G, 1998, J CHROMATOGR A, V829, P101, DOI 10.1016/S0021-9673(98)00783-3
   Galaverna G, 2001, J CHROMATOGR A, V922, P151, DOI 10.1016/S0021-9673(01)00909-8
   GALLI B, 1994, J CHROMATOGR A, V666, P77, DOI 10.1016/0021-9673(94)80371-4
   George B, 1999, J APPL POLYM SCI, V74, P3432, DOI 10.1002/(SICI)1097-4628(19991227)74:14<3432::AID-APP18>3.3.CO;2-0
   Ghoulipour V, 1999, JPC-J PLANAR CHROMAT, V12, P378
   Gianelli L, 2001, RAPID COMMUN MASS SP, V15, P2347, DOI 10.1002/rcm.510
   Gong Y, 2003, ANAL CHEM, V75, P1348, DOI 10.1021/ac0204909
   Gong YH, 2002, HELV CHIM ACTA, V85, P3283, DOI 10.1002/1522-2675(200210)85:10<3283::AID-HLCA3283>3.0.CO;2-H
   Gorlach B, 2001, CHEM-EUR J, V7, P2459, DOI 10.1002/1521-3765(20010601)7:11<2459::AID-CHEM24590>3.0.CO;2-4
   GOROG S, 1994, J CHROMATOGR B, V659, P51, DOI 10.1016/0378-4347(94)00124-3
   GOULRANBOTROS H, 1992, J CHROMATOGR A, V597, P357
   GROVES JT, 1993, INORG CHEM, V32, P3868, DOI 10.1021/ic00070a017
   Gruner B, 1997, J CHROMATOGR A, V789, P497, DOI 10.1016/S0021-9673(97)00497-4
   Guney O, 2002, SENSOR ACTUAT B-CHEM, V85, P86, DOI 10.1016/S0925-4005(02)00057-6
   GUNTINAS MBD, 1995, MIKROCHIM ACTA, V120, P73
   Guntinas MBDC, 2002, ANAL BIOANAL CHEM, V374, P369, DOI 10.1007/s00216-002-1508-3
   Gupta MN, 2002, BIOTECHNOL PROGR, V18, P78, DOI 10.1021/bp010130r
   Gupta RK, 2002, J PROTEIN CHEM, V21, P529, DOI 10.1023/A:1022477605813
   Gutnov A, 2003, ORGANOMETALLICS, V22, P1550, DOI 10.1021/om020982b
   Haddad PR, 2001, ANAL CHEM, V73, p266A, DOI 10.1021/ac012440u
   Haddad PR, 1997, J CHROMATOGR A, V780, P329, DOI 10.1016/S0021-9673(97)00373-7
   Hamacek J, 1999, J CHROMATOGR A, V834, P321, DOI 10.1016/S0021-9673(98)00848-6
   HANNON MJ, 2001, J CHEM SOC CHEM COMM, P1078
   Haraguchi H, 1999, B CHEM SOC JPN, V72, P1163, DOI 10.1246/bcsj.72.1163
   Harris JE, 2001, J CHROMATOGR A, V919, P427, DOI 10.1016/S0021-9673(01)00820-2
   Harvey SD, 1996, J CHROMATOGR A, V736, P333, DOI 10.1016/0021-9673(95)01366-0
   Hathout Y, 2002, J INORG BIOCHEM, V88, P119, DOI 10.1016/S0162-0134(01)00375-0
   Havel J, 1999, J CHROMATOGR A, V850, P345, DOI 10.1016/S0021-9673(99)00634-2
   He JH, 2001, CHEM LETT, P850
   He WJ, 2001, CHINESE J CHEM, V19, P757
   HEMDAN ES, 1989, P NATL ACAD SCI USA, V86, P1811, DOI 10.1073/pnas.86.6.1811
   Henderson W, 1998, POLYHEDRON, V17, P4291, DOI 10.1016/S0277-5387(98)00246-0
   Herberich GE, 1999, J ORGANOMET CHEM, V582, P338, DOI 10.1016/S0022-328X(99)00076-5
   Hermida L, 2002, J BIOTECHNOL, V94, P213, DOI 10.1016/S0168-1656(01)00406-0
   Herranz MA, 2002, P NATL ACAD SCI USA, V99, P5040, DOI 10.1073/pnas.072658799
   Heumann KG, 1998, SPECTROCHIM ACTA B, V53, P273, DOI 10.1016/S0584-8547(97)00134-1
   Hilder EF, 1997, ANAL COMMUN, V34, P63, DOI 10.1039/a607770f
   HILL CL, 1990, J MED CHEM, V33, P2767, DOI 10.1021/jm00172a014
   Hjerten S, 1967, Chromatogr Rev, V9, P122, DOI 10.1016/0009-5907(67)80003-6
   HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321
   Holder E, 2002, TETRAHEDRON-ASYMMETR, V13, P2673, DOI 10.1016/S0957-4166(02)00753-X
   Holmlin RE, 1999, BIOCONJUGATE CHEM, V10, P1122, DOI 10.1021/bc9900791
   Hu CC, 1996, ANAL CHIM ACTA, V332, P23, DOI 10.1016/0003-2670(96)00218-8
   Huang XJ, 2000, ANAL CHIM ACTA, V414, P1, DOI 10.1016/S0003-2670(00)00815-1
   HUTCHENS TW, 1992, J CHROMATOGR, V604, P133, DOI 10.1016/0021-9673(92)85538-5
   Hwang KO, 1998, J MATER CHEM, V8, P2153, DOI 10.1039/a801932k
   Ianni C, 1998, ANN CHIM-ROME, V88, P437
   ITOH A, 1993, CHEM LETT, P1017, DOI 10.1246/cl.1993.1017
   Itoh A, 2000, B CHEM SOC JPN, V73, P121, DOI 10.1246/bcsj.73.121
   Itoh A, 1996, B CHEM SOC JPN, V69, P3469, DOI 10.1246/bcsj.69.3469
   Ivanov AE, 2001, J CHROMATOGR A, V907, P115, DOI 10.1016/S0021-9673(00)00959-6
   Ivanov AE, 2001, POLYMER, V42, P3373, DOI 10.1016/S0032-3861(00)00666-2
   JANJIC TJ, 1994, CHROMATOGRAPHIA, V38, P355, DOI 10.1007/BF02269780
   JANJIC TJ, 1994, CHROMATOGRAPHIA, V38, P447, DOI 10.1007/BF02269834
   Janos P, 1997, J CHROMATOGR A, V789, P3, DOI 10.1016/S0021-9673(97)00696-1
   Janos P, 1996, J CHROMATOGR A, V737, P129, DOI 10.1016/0021-9673(96)00010-6
   Jose L, 1998, POLYMER, V39, P229, DOI 10.1016/S0032-3861(97)00038-4
   Jose L, 1996, J APPL POLYM SCI, V60, P1855
   Kang JW, 2002, ELECTROPHORESIS, V23, P4005, DOI 10.1002/elps.200290015
   KHUHAWAR MY, 1992, J CHEM SOC PAKISTAN, V14, P244
   Khuhawar MY, 1999, CHROMATOGRAPHIA, V49, P249, DOI 10.1007/BF02467551
   KIMARO A, 2001, J CHEM SOC CHEM COMM, P1282
   KOHLER M, 1995, ANAL CHEM, V67, P3501, DOI 10.1021/ac00115a019
   Kojima M, 1997, J CHROMATOGR A, V789, P273, DOI 10.1016/S0021-9673(97)00521-9
   Kornilova AY, 2000, J AM CHEM SOC, V122, P7999, DOI 10.1021/ja0006954
   Koudelkova M, 2003, J CHROMATOGR A, V990, P317, DOI 10.1016/S0021-9673(02)01798-3
   Kroger D, 1999, BIOSENS BIOELECTRON, V14, P155, DOI 10.1016/S0956-5663(98)00116-X
   Krokhin OV, 2000, J CHROMATOGR A, V895, P255, DOI 10.1016/S0021-9673(00)00708-1
   KROTZ AH, 1994, INORG CHEM, V33, P1940, DOI 10.1021/ic00087a034
   Kung A, 2001, J BIOL INORG CHEM, V6, P292, DOI 10.1007/s007750000203
   Kwon WJ, 2000, B KOR CHEM SOC, V21, P393
   Lambropoulos N, 1996, J CHROMATOGR A, V749, P87, DOI 10.1016/0021-9673(96)00416-5
   Laplaza CE, 2001, J AM CHEM SOC, V123, P10255, DOI 10.1021/ja010851m
   LEE HJ, 1994, B KOR CHEM SOC, V15, P945
   Lee WY, 1997, MIKROCHIM ACTA, V127, P19, DOI 10.1007/BF01243160
   Leibler D, 1996, J MOL RECOGNIT, V9, P375, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<375::AID-JMR268>3.0.CO;2-X
   Li SH, 1999, ANAL BIOCHEM, V270, P9, DOI 10.1006/abio.1999.4060
   Li Y, 2001, J CHROMATOGR A, V909, P183, DOI 10.1016/S0021-9673(00)01100-6
   LILIUS G, 1991, EUR J BIOCHEM, V198, P499, DOI 10.1111/j.1432-1033.1991.tb16042.x
   Lim MJ, 1997, ANAL BIOCHEM, V245, P184, DOI 10.1006/abio.1996.9961
   Lin DQ, 2000, CHINESE J CHEM ENG, V8, P310
   Lin FY, 2000, BIOPROCESS ENG, V23, P467, DOI 10.1007/s004499900178
   Lipkowitz KB, 2001, J CHROMATOGR A, V906, P417, DOI 10.1016/S0021-9673(00)00946-8
   Lipkowitz KB, 2000, ACCOUNTS CHEM RES, V33, P555, DOI 10.1021/ar980115w
   Liu BF, 1999, J CHROMATOGR A, V834, P277, DOI 10.1016/S0021-9673(98)01005-X
   Liu BF, 2001, ANAL CHIM ACTA, V434, P309, DOI 10.1016/S0003-2670(01)00806-6
   Liu CY, 1999, ANAL CHIM ACTA, V384, P51, DOI 10.1016/S0003-2670(98)00857-5
   LIU QP, 1995, TALANTA, V42, P901, DOI 10.1016/0039-9140(95)01510-I
   Lo HC, 2001, EUR J INORG CHEM, P2217
   Lojkova L, 1998, CHEM LISTY, V92, P988
   Lucy CA, 1996, J CHROMATOGR A, V739, P3, DOI 10.1016/0021-9673(96)00034-9
   MACKA M, 1995, J CHROMATOGR A, V706, P493, DOI 10.1016/0021-9673(95)01188-X
   MALLIK S, 1994, NEW J CHEM, V18, P299
   MALOE SP, 1997, J INDIAN CHEM SOC, V74, P316
   Mansoori Y, 1997, IRAN POLYM J, V6, P27
   Mao ZB, 1998, ORGANOMETALLICS, V17, P1993, DOI 10.1021/om970659m
   Marmion ME, 1999, NUCL MED BIOL, V26, P755, DOI 10.1016/S0969-8051(99)00040-2
   Martin AF, 1997, BIOSENS BIOELECTRON, V12, P479, DOI 10.1016/S0956-5663(97)00004-3
   Martin SE, 2001, ANAL CHIM ACTA, V445, P21, DOI 10.1016/S0003-2670(01)01248-X
   MATHEW B, 1995, J MACROMOL SCI PURE, VA32, P1781, DOI 10.1080/10601329508010022
   MATHEW B, 1992, POLYM INT, V28, P201, DOI 10.1002/pi.4990280305
   Matsui J, 1996, ANAL CHIM ACTA, V335, P71, DOI 10.1016/S0003-2670(96)00356-X
   MICHALKE B, 1991, J TRACE ELEM ELECT H, V5, P251
   MICHALSKI WP, 1992, J CHROMATOGR-BIOMED, V576, P340, DOI 10.1016/0378-4347(92)80209-9
   Milojkovic-Opsenica DM, 1999, J CHROMATOGR A, V847, P291, DOI 10.1016/S0021-9673(99)00242-3
   Min CH, 1996, NUCLEIC ACIDS RES, V24, P3806, DOI 10.1093/nar/24.19.3806
   Miralles E, 2000, ANAL CHIM ACTA, V403, P197, DOI 10.1016/S0003-2670(99)00603-0
   Mohammad A, 1996, JPC-J PLANAR CHROMAT, V9, P318
   Molina MF, 1999, ANAL CHIM ACTA, V389, P281, DOI 10.1016/S0003-2670(99)00165-8
   Mollah S, 2000, ANAL CHEM, V72, P985, DOI 10.1021/ac9908647
   Moller K, 1998, CHEM MATER, V10, P2950, DOI 10.1021/cm980243e
   Morimoto Y, 1996, CHEM LETT, P887, DOI 10.1246/cl.1996.887
   Morrison H, 2000, PHOTOCHEM PHOTOBIOL, V72, P731, DOI 10.1562/0031-8655(2000)072<0731:HSAWTP>2.0.CO;2
   Moulin V, 2001, RADIOCHIM ACTA, V89, P773, DOI 10.1524/ract.2001.89.11-12.773
   Murner H, 1996, J AM CHEM SOC, V118, P7989, DOI 10.1021/ja961177p
   Nagaosa Y, 1998, J LIQ CHROMATOGR R T, V21, P693, DOI 10.1080/10826079808005851
   Nakano Y, 1998, J COORD CHEM, V43, P193, DOI 10.1080/00958979808022667
   Nakashima K, 2000, BUNSEKI KAGAKU, V49, P135, DOI 10.2116/bunsekikagaku.49.135
   Nana CG, 2000, ANALYST, V125, P2294, DOI 10.1039/b005448h
   Nguyen KL, 2000, J AM CHEM SOC, V122, P3585, DOI 10.1021/ja993502p
   Nivorozhkin AL, 2000, INORG CHEM, V39, P2306, DOI 10.1021/ic990421l
   Nuutinen JMJ, 2001, J MASS SPECTROM, V36, P902, DOI 10.1002/jms.191
   Ohashi K, 2000, BUNSEKI KAGAKU, V49, P807, DOI 10.2116/bunsekikagaku.49.807
   Oprunenko Y, 2000, J ORGANOMET CHEM, V597, P42, DOI 10.1016/S0022-328X(99)00573-2
   OSELLA D, 1994, INORG CHIM ACTA, V218, P207, DOI 10.1016/0020-1693(94)03804-X
   Osipova EA, 2000, J ANAL CHEM+, V55, P52, DOI 10.1007/BF02757633
   Pacakova V, 1999, J CHROMATOGR A, V834, P257, DOI 10.1016/S0021-9673(98)00976-5
   Pacheco V, 1998, J IND MICROBIOL BIOT, V21, P57, DOI 10.1038/sj.jim.2900561
   Padarauskas A, 1997, J CHROMATOGR A, V773, P351, DOI 10.1016/S0021-9673(97)00184-2
   Paisner SN, 2001, J ORGANOMET CHEM, V621, P242, DOI 10.1016/S0022-328X(00)00862-7
   Palma F, 2001, PROTEIN EXPRES PURIF, V22, P38, DOI 10.1006/prep.2001.1404
   PANTINA TB, 2000, J ENVIRON QUAL, V29, P1839
   Pasquinelli RS, 2000, BIOTECHNOL PROGR, V16, P86, DOI 10.1021/bp990139h
   PASUTTO FM, 1992, J CLIN PHARMACOL, V32, P917, DOI 10.1002/j.1552-4604.1992.tb04639.x
   PATTON WF, 1994, ANAL BIOCHEM, V220, P324, DOI 10.1006/abio.1994.1345
   Patwardhan AV, 1997, J CHROMATOGR A, V787, P91, DOI 10.1016/S0021-9673(97)00580-3
   PEHLIVAN E, 1994, SEPAR SCI TECHNOL, V29, P887, DOI 10.1080/01496399408006632
   Pellegrini PP, 2003, DALTON T, P176, DOI 10.1039/b208147d
   Pirogov AV, 1998, FRESEN J ANAL CHEM, V361, P288, DOI 10.1007/s002160050884
   Polborn K, 2000, CHEM-EUR J, V6, P4604, DOI 10.1002/1521-3765(20001215)6:24<4604::AID-CHEM4604>3.3.CO;2-P
   Polec K, 2000, CELL MOL BIOL, V46, P221
   PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0
   PORATH J, 1992, PROTEIN EXPRES PURIF, V3, P263, DOI 10.1016/1046-5928(92)90001-D
   Powell CJ, 2001, IND ENG CHEM RES, V40, P2897, DOI 10.1021/ie000813w
   Przybylski M, 1996, ANGEW CHEM INT EDIT, V35, P807
   PYLE AM, 1990, PROG INORG CHEM, V38, P413
   Queiroz SL, 1998, QUIM NOVA, V21, P193
   Ramkumar J, 1998, J MEMBRANE SCI, V141, P283, DOI 10.1016/S0376-7388(97)00318-9
   Rank KB, 2001, PROTEIN EXPRES PURIF, V22, P258, DOI 10.1006/prep.2001.1433
   Raska CS, 2002, ANAL CHEM, V74, P3429, DOI 10.1021/ac0111199
   RAY RK, 1994, J CHROMATOGR A, V675, P271, DOI 10.1016/0021-9673(94)85285-5
   Remelli M, 2002, CHROMATOGRAPHIA, V55, P301, DOI 10.1007/BF02491663
   Robards K, 1999, J CHROMATOGR A, V844, P181, DOI 10.1016/S0021-9673(99)00379-9
   Rogers BE, 1996, BIOCONJUGATE CHEM, V7, P511, DOI 10.1021/bc9600372
   Rojo J, 2002, TOP CURR CHEM, V218, P45
   ROTTMANN L, 1994, ANAL CHEM, V66, P3709, DOI 10.1021/ac00093a027
   Rykowska I, 2002, ANAL CHIM ACTA, V451, P271, DOI 10.1016/S0003-2670(01)01404-0
   Rykowska I, 2001, CHEM ANAL-WARSAW, V46, P489
   Rykowska I, 1999, J CHROMATOGR A, V844, P239, DOI 10.1016/S0021-9673(99)00362-3
   Rykowska I, 2000, CHROMATOGRAPHIA, V51, P623, DOI 10.1007/BF02490822
   Sanchez JM, 1999, J CHROMATOGR A, V834, P329, DOI 10.1016/S0021-9673(98)00825-5
   Sandier A, 1997, J CHROMATOGR A, V776, P93, DOI 10.1016/S0021-9673(97)00450-0
   Sarzanini C, 1998, J CHROMATOGR A, V804, P241, DOI 10.1016/S0021-9673(98)00091-0
   SAUNDERS GD, 2000, J CHEM SOC CHEM COMM, P273
   Scarano G, 2002, BIOMETALS, V15, P145, DOI 10.1023/A:1015288000218
   Schlauch M, 2000, J CHROMATOGR A, V897, P145, DOI 10.1016/S0021-9673(00)00808-6
   Schlauch M, 2001, ANAL CHEM, V73, P262, DOI 10.1021/ac0009999
   SCHLEIMER M, 1994, ANAL CHEM, V66, P2893, DOI 10.1021/ac00090a016
   SCHLEIMER M, 1993, J CHROMATOGR, V638, P85, DOI 10.1016/0021-9673(93)85011-U
   Schmidt AM, 1996, CHEM BIOL, V3, P645, DOI 10.1016/S1074-5521(96)90132-5
   Schmitt D, 2001, ACTA HYDROCH HYDROB, V28, P400, DOI 10.1002/1521-401X(20017)28:7<400::AID-AHEH400>3.0.CO;2-L
   Schurig V, 2002, J CHROMATOGR A, V965, P315, DOI 10.1016/S0021-9673(01)01500-X
   Schurig V, 2002, TRAC-TREND ANAL CHEM, V21, P647, DOI 10.1016/S0165-9936(02)00808-7
   Schurig V, 2001, J CHROMATOGR A, V906, P275, DOI 10.1016/S0021-9673(00)00505-7
   Sedzik J, 1999, NEUROCHEM RES, V24, P723, DOI 10.1023/A:1020723328143
   Severin K, 2000, CURR OPIN CHEM BIOL, V4, P710, DOI 10.1016/S1367-5931(00)00149-6
   Sharma S, 2001, J COLLOID INTERF SCI, V243, P61, DOI 10.1006/jcis.2001.7846
   Sharma SD, 1999, JPC-J PLANAR CHROMAT, V12, P440
   SHEPHERD RE, 2002, UNPUB INORG CHIM ACT
   SHERMA J, 1994, ANAL CHEM, V66, pR67, DOI 10.1021/ac00084a004
   Shi XY, 2000, CHINESE J ANAL CHEM, V28, P118
   Shin JA, 1997, BIOORG MED CHEM LETT, V7, P2367, DOI 10.1016/S0960-894X(97)00436-8
   Skotty DR, 1996, ANAL CHEM, V68, P1530, DOI 10.1021/ac951087n
   SKOTTY DR, 1995, J CHROMATOGR B, V665, P27, DOI 10.1016/0378-4347(94)00519-B
   Slizhov YG, 2002, RUSS J COORD CHEM+, V28, P736, DOI 10.1023/A:1020407629841
   Sloane RP, 1996, J BIOTECHNOL, V49, P231, DOI 10.1016/0168-1656(96)01538-6
   Slocik JM, 2001, INORG CHIM ACTA, V320, P148, DOI 10.1016/S0020-1693(01)00487-X
   Sommer L, 2000, CHROMATOGRAPHIA, V52, P692, DOI 10.1007/BF02490992
   Steinberg TH, 2000, ELECTROPHORESIS, V21, P486, DOI 10.1002/(SICI)1522-2683(20000201)21:3<486::AID-ELPS486>3.0.CO;2-Q
   Stensballe A, 2001, PROTEOMICS, V1, P207, DOI 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.3.CO;2-V
   Stewart II, 1999, SPECTROCHIM ACTA B, V54, P1649, DOI 10.1016/S0584-8547(99)00110-X
   Striegler S, 2002, EUR J INORG CHEM, P487
   Stutz H, 2003, ANAL CHIM ACTA, V477, P1, DOI 10.1016/S0003-2670(02)01403-4
   Styles ML, 2000, J CHEM SOC DALTON, P93, DOI 10.1039/a908536j
   SULKOWSKI E, 1985, TRENDS BIOTECHNOL, V3, P1, DOI 10.1016/0167-7799(85)90068-X
   Suzuki A, 2002, J MOL CATAL A-CHEM, V182, P125, DOI 10.1016/S1381-1169(01)00505-2
   Suzuki T, 1997, J CHROMATOGR A, V786, P269, DOI 10.1016/S0021-9673(97)00595-5
   Svendsen R, 2000, ANALYST, V125, P1933, DOI 10.1039/b005187j
   Svintsova NV, 1998, J ANAL CHEM+, V53, P347
   Swiegers GF, 2002, COORDIN CHEM REV, V225, P91, DOI 10.1016/S0010-8545(01)00407-6
   Szpunar J, 2000, ANALYST, V125, P963, DOI 10.1039/a909137h
   Szpunar J, 1999, ANAL CHIM ACTA, V387, P135, DOI 10.1016/S0003-2670(99)00074-4
   Szpunar J, 1999, FRESEN J ANAL CHEM, V363, P550, DOI 10.1007/s002160051245
   Szpunar J, 1999, J ANAL ATOM SPECTROM, V14, P639, DOI 10.1039/a808231f
   Szpunar J, 1999, PURE APPL CHEM, V71, P899, DOI 10.1351/pac199971050899
   Szpunar J, 2000, TRAC-TREND ANAL CHEM, V19, P127, DOI 10.1016/S0165-9936(99)00198-3
   SZPUNAR J, 1999, ANAL ATOM SPECTROSC, V14, P638
   Tallet B, 2001, J CHROMATOGR B, V753, P17, DOI 10.1016/S0378-4347(00)00421-7
   TESIC ZL, 1991, J CHROMATOGR, V585, P359
   Tesic ZL, 1999, J CHROMATOGR A, V847, P297
   Tesic ZL, 1999, J CHROMATOGR A, V847, P303
   Theobald A, 1996, HRC-J HIGH RES CHROM, V19, P608
   TIMERBAEV A, 1994, CHROMATOGRAPHIA, V38, P255, DOI 10.1007/BF02290346
   Timerbaev AR, 1999, J CHROMATOGR A, V834, P117, DOI 10.1016/S0021-9673(98)00913-3
   Timerbaev AR, 2002, ELECTROPHORESIS, V23, P3884, DOI 10.1002/elps.200290008
   Timerbaev AR, 2002, J CHROMATOGR A, V945, P25, DOI 10.1016/S0021-9673(01)01489-3
   Timerbaev AR, 1996, J CHROMATOGR A, V756, P300, DOI 10.1016/S0021-9673(96)00649-8
   Timerbaev AR, 2002, J CHROMATOGR A, V943, P263, DOI 10.1016/S0021-9673(01)01462-5
   Timerbaev AR, 2002, ELECTROPHORESIS, V23, P1786, DOI 10.1002/1522-2683(200206)23:12<1786::AID-ELPS1786>3.0.CO;2-W
   Timerbaev AR, 2000, ELECTROPHORESIS, V21, P4179, DOI 10.1002/1522-2683(200012)21:18<4179::AID-ELPS4179>3.0.CO;2-C
   Timerbaev AR, 2001, ANAL CHIM ACTA, V433, P165, DOI 10.1016/S0003-2670(01)00788-7
   Timerbaev AR, 2001, ANALYST, V126, P964, DOI 10.1039/b100594o
   TIMERBAEV AR, 1995, J CAPILLARY ELECTROP, V2, P165
   TIMERBAEV AR, 1995, J CHROMATOGR A, V690, P141, DOI 10.1016/0021-9673(94)00968-F
   Timerbaev AR, 1998, J CHROMATOGR A, V811, P233, DOI 10.1016/S0021-9673(98)00270-2
   TIMERBAEV AR, 1994, J CHROMATOGR A, V671, P419, DOI 10.1016/0021-9673(94)80269-6
   Timerbaev AR, 2000, TALANTA, V52, P573, DOI 10.1016/S0039-9140(00)00364-7
   Tishchenko G, 2002, J CHROMATOGR A, V954, P115, DOI 10.1016/S0021-9673(02)00170-X
   Tjornelund J, 1997, J CHROMATOGR A, V779, P235, DOI 10.1016/S0021-9673(97)00421-4
   TSUKAGOSHI K, 1993, B CHEM SOC JPN, V66, P114, DOI 10.1246/bcsj.66.114
   Tsukagoshi K, 2001, J CHROMATOGR A, V919, P331, DOI 10.1016/S0021-9673(01)00809-3
   UDEN PC, 1977, ANALYST, V102, P889, DOI 10.1039/an9770200889
   Ueda EKM, 2003, J CHROMATOGR A, V988, P1, DOI 10.1016/S0021-9673(02)02057-5
   Ueda EKM, 2001, J CHROMATOGR A, V922, P165, DOI 10.1016/S0021-9673(01)00875-5
   Vachet RW, 2000, J MASS SPECTROM, V35, P311, DOI 10.1002/(SICI)1096-9888(200003)35:3<311::AID-JMS918>3.0.CO;2-6
   Vachet RW, 2001, INT J MASS SPECTROM, V204, P101, DOI 10.1016/S1387-3806(00)00335-3
   Vachirapatama N, 2000, J CHROMATOGR A, V885, P369, DOI 10.1016/S0021-9673(99)01159-0
   VACHIRAPATAMA N, 1999, J CHROMATOGR A, V847, P291
   VALLANO JF, 1997, PHOTOCHEM PHOTOBIO B, V37, P230
   Vancan S, 2002, PROCESS BIOCHEM, V37, P573, DOI 10.1016/S0032-9592(01)00242-4
   Vassileva E, 1996, INT J ENVIRON AN CH, V62, P129, DOI 10.1080/03067319608027059
   Velten U, 1998, MACROMOL CHEM PHYS, V199, P127, DOI 10.1002/(SICI)1521-3935(19980101)199:1<127::AID-MACP127>3.0.CO;2-N
   Vigneau O, 2001, ANAL CHIM ACTA, V435, P75, DOI 10.1016/S0003-2670(00)01279-4
   Vogl J, 1997, FRESEN J ANAL CHEM, V359, P438, DOI 10.1007/s002160050606
   Vogl J, 1998, ANAL CHEM, V70, P2038, DOI 10.1021/ac971283p
   Vuckovic G, 1999, JPC-J PLANAR CHROMAT, V12, P461
   Wai CM, 1997, J CHROMATOGR A, V785, P369, DOI 10.1016/S0021-9673(97)00679-1
   WAN JR, 1994, J LIQ CHROMATOGR, V17, P2045, DOI 10.1080/10826079408013478
   Wang BQ, 1997, ORGANOMETALLICS, V16, P4620, DOI 10.1021/om970437o
   Wang P, 1997, J CHROMATOGR A, V789, P437, DOI 10.1016/S0021-9673(97)00839-X
   Wang X, 2000, TALANTA, V53, P337, DOI 10.1016/S0039-9140(00)00494-X
   Wang X, 1999, ANAL CHIM ACTA, V383, P213, DOI 10.1016/S0003-2670(98)00811-3
   Ward MS, 2000, INORG CHIM ACTA, V311, P57, DOI 10.1016/S0020-1693(00)00312-1
   Ward MS, 2001, BIOTECHNOL PROGR, V17, P712, DOI 10.1021/bp010050n
   WARD MS, 2003, UNPUB BIOTECHNOL PRO
   Wasiak W, 1997, J CHROMATOGR A, V773, P209, DOI 10.1016/S0021-9673(97)00095-2
   Wasiak W, 1998, CHROMATOGRAPHIA, V48, P284, DOI 10.1007/BF02467684
   WASIAK W, 1994, CHEM ANAL-WARSAW, V39, P325
   WASIAK W, 1995, CHEM ANAL-WARSAW, V40, P731
   Wasiak W, 1999, ANAL CHIM ACTA, V378, P101, DOI 10.1016/S0003-2670(98)00567-4
   Wasiak W, 2002, J CHROMATOGR A, V969, P133, DOI 10.1016/S0021-9673(02)00373-4
   Wasiak W, 1997, J CHROMATOGR A, V757, P137, DOI 10.1016/S0021-9673(96)00683-8
   WASIAK W, 1995, CHROMATOGRAPHIA, V41, P107, DOI 10.1007/BF02274203
   Wawrzyniak R, 1999, CHROMATOGRAPHIA, V49, P273, DOI 10.1007/BF02467556
   Wawrzyniak R, 1999, CHROMATOGRAPHIA, V49, P147, DOI 10.1007/BF02575277
   Wei XY, 1998, J AM CHEM SOC, V120, P10248, DOI 10.1021/ja981066l
   Wenclawiak BW, 1996, J CHROMATOGR A, V724, P317, DOI 10.1016/0021-9673(95)00920-5
   WENZ G, 1994, ANGEW CHEM INT EDIT, V33, P803, DOI 10.1002/anie.199408031
   WILKINSON DL, 1995, BIOTECHNOL PROGR, V11, P265, DOI 10.1021/bp00033a004
   Witvrouw M, 2000, J MED CHEM, V43, P778, DOI 10.1021/jm980263s
   Woltman SJ, 1999, ANAL CHEM, V71, P1504, DOI 10.1021/ac981181e
   Woltman SJ, 2000, ANAL CHEM, V72, P4928, DOI 10.1021/ac000170u
   WONG JW, 1991, SEPAR PURIF METHOD, V20, P49, DOI 10.1080/03602549108021408
   Wu QR, 2002, J CHROMATOGR A, V967, P289, DOI 10.1016/S0021-9673(02)00784-7
   Wu QR, 2002, J CHROMATOGR A, V954, P247, DOI 10.1016/S0021-9673(02)00180-2
   Xiao J, 1996, J LIQ CHROMATOGR R T, V19, P2901, DOI 10.1080/10826079608015117
   YAMAGISHI A, 1992, CLAY CLAY MINER, V40, P359, DOI 10.1346/CCMN.1992.0400318
   Yang RS, 2001, SPECTROSC SPECT ANAL, V21, P122
   YE LW, 1995, ANAL CHEM, V67, P2534, DOI 10.1021/ac00111a007
   YEH CF, 1993, J CHROMATOGR, V630, P275
   Yokoyama T, 2002, ANAL BIOANAL CHEM, V372, P832, DOI 10.1007/s00216-002-1276-0
   Yoshida M, 2000, J POLYM SCI POL CHEM, V38, P689, DOI 10.1002/(SICI)1099-0518(20000215)38:4<689::AID-POLA3>3.0.CO;2-U
   Zhang HB, 1998, J CHROMATOGR A, V809, P65, DOI 10.1016/S0021-9673(98)00190-3
   ZHANG HS, 1994, TALANTA, V41, P1459, DOI 10.1016/0039-9140(93)E0028-C
   Zhou W, 2000, J AM SOC MASS SPECTR, V11, P273, DOI 10.1016/S1044-0305(00)00100-8
   Zhou XW, 2000, ACTA BIOCH BIOPH SIN, V32, P133
   Zhu XF, 2002, ELECTROPHORESIS, V23, P1348, DOI 10.1002/1522-2683(200205)23:9<1348::AID-ELPS1348>3.0.CO;2-V
   Zorzi M, 2000, ANAL CHEM, V72, P4934, DOI 10.1021/ac991222m
NR 366
TC 43
Z9 44
U1 2
U2 30
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0010-8545
EI 1873-3840
J9 COORDIN CHEM REV
JI Coord. Chem. Rev.
PD DEC
PY 2003
VL 247
IS 1-2
BP 147
EP 184
DI 10.1016/S0010-8545(03)00125-5
PG 38
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 755AU
UT WOS:000187366300004
DA 2018-10-20
ER

PT J
AU Gurappa, I
AF Gurappa, I
TI The eftect of cold work on the corrosion characteristics of cobalt alloy
   as used in biomedical applications
SO CORROSION PREVENTION & CONTROL
LA English
DT Article
AB The corrosion characteristics of cobalt alloy, Co-35Ni-20Cr-10Mo, with different cold worked conditions have been studied systematically under simulated body fluid conditions with a view to determining the suitable condition/treatment under which the alloy exhibits good corrosion resistance. Breakdown potential, pitting/crevice corrosion-resistance, and the ability to form protective oxide scales were evaluated and compared. The advantages of as-annealed cobalt alloy over other cold-worked conditions are highlighted, A-C impedance measurements were also carried out in order to provide supportive evidence for the above results. The advantages of using titanium alloys over other materials are also mentioned. Finally, the importance of alloy selection for biomedical applications is emphasized.
C1 Def Met Res Lab, Kanchanbagh, India.
RP Gurappa, I (reprint author), Def Met Res Lab, Kanchanbagh, India.
CR BAILEY OT, 1952, J NEUROSURG, V9, P83, DOI 10.3171/jns.1952.9.1.0083
   Donachie M., 1998, ADV MATER PROCESS, V7, P63
   Gurrappa I, 2001, CORROS PREVENT CONTR, V48, P23
   GURRAPPA I, 2000, P GLOB 2000 CORR M M, P561
   GURRAPPA I, 2001, P 1 AS PAC C CORR NO, P17
   HARUYUKI K, 1992, B JAPAN I METALS, V31, P1033
   HARUYUKI K, 1993, B JAPAN I METALS, V34, P1217
   KUMAR P, 1985, TP859 AM SOC TEST MA, P30
   LIZLOVS EA, 1972, AM SOC TESTING MAT, V1, P210
   MIROWSKY AM, 1950, J NEUROSURG, V7, P485
   OKAZAKI Y, 1994, MATER T JIM, V35, P58, DOI 10.2320/matertrans1989.35.58
   SOLAR RJ, 1985, ASTM STP, V859, P161
NR 12
TC 0
Z9 0
U1 0
U2 0
PU SCIENTIFIC SURVEYS LTD
PI BEACONSFIELD
PA PO BOX 21, BEACONSFIELD HP9 1NS, BUCKS, ENGLAND
SN 0010-9371
J9 CORROS PREVENT CONTR
JI Corrosion Prev. Control
PD DEC
PY 2003
VL 50
IS 4
BP 161
EP 166
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 764AN
UT WOS:000188168000003
DA 2018-10-20
ER

PT J
AU Rosse, C
   Mejino, JLV
AF Rosse, C
   Mejino, JLV
TI A reference ontology for biomedical informatics: the Foundational Model
   of Anatomy
SO JOURNAL OF BIOMEDICAL INFORMATICS
LA English
DT Article
DE ontology; knowledge representation; bioinformatics; biomedical
   informatics; anatomy; mereotopology; embryology; developmental biology;
   UMLS
ID REPRESENTATION
AB The Foundational Model of Anatomy (FMA), initially developed as an enhancement of the anatomical content of UMLS, is a domain ontology of the concepts and relationships that pertain to the structural organization of the human body. It encompasses the material objects from the molecular to the macroscopic levels that constitute the body and associates with them non-material entities (spaces, surfaces, lines, and points) required for describing structural relationships. The disciplined modeling approach employed for the development of the FMA relies on a set of declared principles, high level schemes, Aristotelian definitions and a frame-based authoring environment. We propose the FMA as a reference ontology in biomedical informatics for correlating different views of anatomy, aligning existing and emerging ontologies in bioinformatics ontologies and providing a structure-based template for representing biological functions. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Washington, Struct Informat Grp, Dept Biol Struct, Seattle, WA 98195 USA.
   Univ Washington, Struct Informat Grp, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA.
RP Rosse, C (reprint author), Univ Washington, Struct Informat Grp, Dept Biol Struct, Seattle, WA 98195 USA.
EM rosse@u.washington.edu
RI Smith, Barry/A-9525-2011
OI Smith, Barry/0000-0003-1384-116X
FU NLM NIH HHS [LM06822, LM03528]
CR Agoncillo AV, 1999, J AM MED INFORM ASSN, P2
   AGONCILLO AV, 2003, P AMIA S, P775
   ARISTOTLE, 1973, CATEGORIES
   Bean C A, 1998, Proc AMIA Symp, P897
   BECK R, 2003, P AMIA S, P748
   BODENREIDER O, 2002, P 1 GLOB WORDNET C, P223
   Brinkley JF, 1999, IEEE COMPUT GRAPH, V19, P38, DOI 10.1109/38.761548
   BURGUN A, 2003, IN PRESS J AM MED IN
   CHAUDHRI VK, 1998, 15 NAT C ART AAAI 98
   Cimino J. J., 1989, Proceedings: The Thirteenth Annual Symposium on Computer Applications in Medical Care (Cat. No.89TH0286-5), P513
   Cimino JJ, 1998, METHOD INFORM MED, V37, P394
   COOK DL, UNPUB EVOLUTION FDN
   DETWILER LT, 2003, P AMIA S, P829
   DISTELHORST G, 2003, P AMIA S, P200
   FLAT, 1998, TERM AN
   Gu H, 1999, ARTIF INTELL MED, V15, P77, DOI 10.1016/S0933-3657(98)00046-3
   Gu HY, 1999, J AM MED INFORM ASSN, V6, P283, DOI 10.1136/jamia.1999.0060283
   HOLLINSHEAD WH, 1982, ANATOMY SURG, V1
   LOBER WB, 1999, P AMIA S 99 NOV, P1108
   Lovtrup Soren, 1974, EPIGENETICS TREATISE
   Martin RF, 2001, J AM MED INFORM ASSN, P438
   MARTIN RF, 2000, PRIMATE BRAIN MAPS
   MCCRAY AT, 1993, HIGH PERFORMANCE MED, P45
   Mejino J L Jr, 1998, Proc AMIA Symp, P825
   Mejino JLV, 1999, J AM MED INFORM ASSN, P112
   Mejino Jose V Jr, 2003, AMIA Annu Symp Proc, P450
   Michael J, 2001, Proc AMIA Symp, P463
   Mork P, 2003, J BIOMED INFORM, V36, P501, DOI 10.1016/j.jbi.2003.11.004
   Musen MA, 2002, METHOD INFORM MED, V41, P12
   Neal P J, 1998, Proc AMIA Symp, P423
   NOY NF, 2000, P 12 INT C KNOWL ENG
   NOY NF, IN PRESS DATA KNOWLE
   Perl Y., 1996, Proceedings First IFCIS International Conference on Cooperative Information Systems, P182, DOI 10.1109/COOPIS.1996.555010
   RECTOR A, 1994, 12 INT C EUR FED MED, P229
   RICKARD KL, UNPUB PROBLEMS SOLUT
   Rindflesch TC, 2000, J AM MED INFORM ASSN, P704
   Rosse C, 1998, Proc AMIA Symp, P820
   Rosse C, 2001, CLIN ANAT, V14, P120, DOI 10.1002/1098-2353(200103)14:2<120::AID-CA1020>3.0.CO;2-V
   Rosse C, 1998, J AM MED INFORM ASSN, V5, P17, DOI 10.1136/jamia.1998.0050017
   ROSSE C, 1997, HOLLINSHEADS TXB ANA, P902
   SCHLEIDEN MJ, 1847, SYDENHAM SOC, V12
   SCHULZ S, 2001, P FOIS 01, P198
   SCHWANN T, 1847, SYDENHAM SOC, V12
   SHAPIRO LG, UNPUB GEN INTELLIGEN
   Smith B, 1996, DATA KNOWL ENG, V20, P287, DOI 10.1016/S0169-023X(96)00015-8
   Sneiderman C A, 1998, Proc AMIA Symp, P428
   Spackman K A, 1997, Proc AMIA Annu Fall Symp, P640
   Teng CC, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P767
   TRAVILLIAN RS, 2003, P AMIA S, P669
   Tringali M, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P801
   *US DEP HHS NIH NA, 2002, UN MED LANG SYST
   William PL, 1995, GRAYS ANATOMY, P2092
   Wong B A, 1999, Proc AMIA Symp, P637
   Zhang L, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P939
   Zhang L, 2003, J BIOMED INFORM, V36, P433, DOI 10.1016/j.jbi.2003.11.006
   ZHANG S, 2003, IN PRESS P AMIA S
NR 56
TC 529
Z9 539
U1 2
U2 38
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-0464
EI 1532-0480
J9 J BIOMED INFORM
JI J. Biomed. Inform.
PD DEC
PY 2003
VL 36
IS 6
BP 478
EP 500
DI 10.1016/j.jbi.2003.11.007
PG 23
WC Computer Science, Interdisciplinary Applications; Medical Informatics
SC Computer Science; Medical Informatics
GA 776BW
UT WOS:000189096000006
PM 14759820
OA Bronze
DA 2018-10-20
ER

PT J
AU Lane, NE
   Yao, W
   Kinney, JH
   Modin, G
   Balooch, M
   Wronski, TJ
AF Lane, NE
   Yao, W
   Kinney, JH
   Modin, G
   Balooch, M
   Wronski, TJ
TI Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic
   rats but they have different effects on trabecular bone architecture
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; AGED OVARIECTOMIZED RATS; PARATHYROID-HORMONE;
   POSTMENOPAUSAL WOMEN; MINERAL DENSITY; SEQUENTIAL TREATMENT; VERTEBRAL
   FRACTURE; DISTAL RADIUS; OSTEOPOROSIS; ESTROGEN
AB Materials and Methods: Six-month-old female Sprague-Dawley rats (n = 74) were ovariectomized (OVX) or sham-operated (sham) and maintained untreated for 2 months. Then OVX rats were subcutaneously injected with basic fibroblast factor (bFGF; 1 mg/kg, 5 days/week), human parathyroid hormone [hPTH(1-34); 40 mug/kg, 5 days/week], or vehicle for 60 days (days 60-120). Sham-operated and one group of OVX animals were injected with vehicle. Biochemical markers of bone turnover (urinary deoxypyridinoline cross-links; Quidel Corp., San Diego, CA, USA) and serum osteocalcin (Biomedical Technologies, Stroughton, MA, USA) were obtained at study days 0, 60, 90, and 120 and analyzed by ELISA. At death, the right proximal fibial metaphysis was removed, and microcomputed tomography was performed for trabecular bone structure and processed for histomorphometry to assess bone cell activity. The left proximal tibia was used for nanoindentation/mechanical testing of individual trabeculae. The data were analyzed with Kruskal Wallis and post hoc testing as needed.
   Results: Ovariectomy at day 60 resulted in about a 50% loss of trabecular bone volume compared with sham-treated animals. By day 120 post-OVX, OVX + vehicle treated animals had decreased trabecular bone volume, connectivity, number, and high bone turnover compared with sham-operated animals [p < 0.05 from sham-, hPTH(1-34)-, and bFGF-treated groups]. Treatment of OVX animals with bFGF and hPTH(1-34) both increased trabecular bone mass, but hPTH(1-34) increased trabecular thickness and bFGF increased trabecular number and connectivity. Histomorphometry revealed increased mineralizing surface and bone formation rate in both bFGF and hPTH(1-34) animals. However, osteoid volume was greater in bFGF-treated animals compared with both the hPTH(1-34) and OVX + vehicle animals (p < 0.05). Nanoindentation by atomic force microscope was performed on approximately 20 individual trabeculae per animal (three animals per group) and demonstrated that elastic modulus and hardness of the trabeculae in bFGF-treated animals were similar to that of the hPTH-treated and sham + vehicle-treated animals.
   Conclusion: Both hPTH(1-34) and bFGF are anabolic agents in the osteopenic female rat. However, hPTH(1-34) increases trabecular bone volume primarily by thickening existing trabeculae, whereas bFGF adds trabecular bone mass through increasing trabecular number and trabecular connectivity. These results suggest the possibility of sequential treatment paradigms for severe osteoporosis.
C1 Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA 94143 USA.
   Lawrence Livermore Natl Lab, Dept Mech Engn, Livermore, CA USA.
   Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA.
RP Lane, NE (reprint author), Univ Calif San Francisco, Div Rheumatol, Dept Med, Box 0868, San Francisco, CA 94143 USA.
FU NIAMS NIH HHS [1R01AR43052]
CR BALOOCH G, 2003, IN PRESS J BIOMECH
   Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O
   Balooch M, 2001, J MATER SCI-MATER M, V12, P507, DOI 10.1023/A:1011215628779
   BELL G. H., 1967, CALCIFIED TISSUE RES, V1, P75, DOI 10.1007/BF02008077
   Bilezikian JP, 2001, CALCIFIED TISSUE INT, V69, P248, DOI 10.1007/s00223-001-1041-y
   Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2
   Bone HG, 2000, J CLIN ENDOCR METAB, V85, P720, DOI 10.1210/jc.85.2.720
   BURCKHARDT P, 1993, OSTEOPOROSIS INT, V3, P24, DOI 10.1007/BF01623173
   Dempster DW, 2001, J BONE MINER RES, V16, P1846, DOI 10.1359/jbmr.2001.16.10.1846
   Duan YB, 1999, J BONE MINER RES, V14, P1796, DOI 10.1359/jbmr.1999.14.10.1796
   Dunstan CR, 1999, J BONE MINER RES, V14, P953, DOI 10.1359/jbmr.1999.14.6.953
   ETTINGER B, 1986, ANN INTERN MED, V156, P1516
   FAULKNER KG, 1994, J BONE MINER RES, V9, P1065
   FINKELSTEIN JS, 1994, NEW ENGL J MED, V331, P1618, DOI 10.1056/NEJM199412153312404
   GOSPODAROWICZ D, 1991, FIBROBLAST GROWTH FA, V638, P1
   Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   HUTCHINSON TA, 1979, LANCET, V2, P705
   Ito M, 2002, BONE, V31, P351, DOI 10.1016/S8756-3282(02)00830-X
   Iwaniec UT, 2002, J BONE MINER RES, V17, pS376
   Iwaniec UT, 2002, ENDOCRINOLOGY, V143, P2515, DOI 10.1210/en.143.7.2515
   IWANIEC UT, 2002, J BONE MINER RES, V17, pS1
   Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103
   Kinney JH, 1998, J BONE MINER RES, V13, P839, DOI 10.1359/jbmr.1998.13.5.839
   Kinney JH, 2000, J BONE MINER RES, V15, P1981, DOI 10.1359/jbmr.2000.15.10.1981
   KLEEREKOPER M, 1985, CALCIFIED TISSUE INT, V37, P594, DOI 10.1007/BF02554913
   Kurland ES, 2000, J CLIN ENDOCR METAB, V85, P3069, DOI 10.1210/jc.85.9.3069
   Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022
   Lane NE, 1998, J CLIN INVEST, V102, P1627, DOI 10.1172/JCI3914
   Lane NE, 2003, OSTEOPOROSIS INT, V14, P374, DOI 10.1007/s00198-003-1374-7
   Lane NE, 1999, J BONE MINER RES, V14, P206, DOI 10.1359/jbmr.1999.14.2.206
   Lane NE, 2002, OSTEOPOROSIS INT, V13, P816, DOI 10.1007/s001980200113
   Lane NE, 1998, J BONE MINER RES, V13, P229, DOI 10.1359/jbmr.1998.13.2.229
   LANE NE, 1995, J BONE MINER RES, V10, P1475
   Liang K, 1999, ENDOCRINOLOGY, V140, P5780
   Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8
   LORENSEN WE, 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422
   MAEDA H, 1993, BONE, V14, P153, DOI 10.1016/8756-3282(93)90242-3
   MAZUE G, 1992, TOXICOL LETT, V64-5, P329, DOI 10.1016/0378-4274(92)90205-X
   Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904
   PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   PARFITT AM, 1983, J CLIN INVEST, V72, P277
   Pistoia W, 2002, BONE, V30, P842, DOI 10.1016/S8756-3282(02)00736-6
   Pun S, 2000, BONE, V27, P197, DOI 10.1016/S8756-3282(00)00312-4
   Pun S, 2001, BONE, V28, P220, DOI 10.1016/S8756-3282(00)00423-3
   QI H, 1995, J BONE MINER RES, V10, P948
   RECKER RR, 1993, CALCIFIED TISSUE INT, V53, pS139, DOI 10.1007/BF01673423
   SZUCS J, 1992, CALCIFIED TISSUE INT, V50, P6
   WEINSTEIN RS, 1987, BONE, V8, P137, DOI 10.1016/8756-3282(87)90012-3
   WRONSKI TJ, 1988, ENDOCRINOLOGY, V123, P681, DOI 10.1210/endo-123-2-681
   Wronski TJ, 2001, J BONE MINER RES, V16, P1399, DOI 10.1359/jbmr.2001.16.8.1399
NR 53
TC 67
Z9 74
U1 0
U2 4
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD DEC
PY 2003
VL 18
IS 12
BP 2105
EP 2115
DI 10.1359/jbmr.2003.18.12.2105
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 745WB
UT WOS:000186712700003
PM 14672345
OA Bronze
DA 2018-10-20
ER

PT J
AU Shirtliff, VJ
   Hench, LL
AF Shirtliff, VJ
   Hench, LL
TI Bioactive materials for tissue engineering, regeneration and repair
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID IN-VITRO; TAPE CAST; HYDROXYAPATITE FORMATION; BIOMEDICAL MATERIALS;
   BONE-REPLACEMENT; GLASS; SURFACE; BIOMATERIALS; BIOCERAMICS; EXPRESSION
AB Tissue engineering is an interdisciplinary field which applies the principles of engineering and the life sciences to the design, construction, modification, growth and maintenance of living tissues [1, 2]. One of two approaches can be taken: (1) in vitro construction of bioartificial tissues from cells seeded onto a resorbable scaffold or (2) in vivo modification of cell growth and function to stimulate tissue regeneration [2, 3]. This concept represents a shift in emphasis from replacement to regeneration of diseased or damaged tissues, in which the development of bioactive materials has played a significant role.
   This paper will begin with an overview of the use of biomaterials as implants and their limitations, leading to the reasons for the dramatic shift in focus regarding the approach to repairing damaged tissues. The majority of the paper will discuss the ways in which biomaterials can be developed to implement the concept of tissue engineering. Finally, the implications of these developments for future treatment of damaged or diseased tissues will be considered. (C) 2003 Kluwer Academic Publishers.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat & Tissue Engn, London SW7 2BP, England.
   Univ London Imperial Coll Sci Technol & Med, Regenerat Med Ctr, London SW7 2BP, England.
RP Shirtliff, VJ (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat & Tissue Engn, Prince Consort Rd, London SW7 2BP, England.
CR Aksay IA, 1998, CURR OPIN SOLID ST M, V3, P219, DOI 10.1016/S1359-0286(98)80093-4
   BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   BERTHIAUME F, 2000, BIOMEDICAL ENG HDB
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Bonfield W., 1998, BIOCERAMICS, V11, P37
   BRINKER CJ, 1990, SOL GEL SCI PHYSICS
   Clupper DC, 2002, BIOMATERIALS, V23, P2599, DOI 10.1016/S0142-9612(01)00398-2
   Clupper DC, 2001, J BIOMED MATER RES, V57, P532, DOI 10.1002/1097-4636(20011215)57:4<532::AID-JBM1199>3.0.CO;2-3
   Clupper DC, 2001, J MATER SCI LETT, V20, P959, DOI 10.1023/A:1010905622517
   Clupper DC, 2001, J MATER SCI LETT, V20, P1885, DOI 10.1023/A:1012818126605
   Cook R, 2000, KEY ENG MAT, V192-1, P625
   DAY RM, 2003, IN PRESS BIOMATERIAL
   DRUMHELLER P, 2000, BIOMEDICAL ENG HDB, V2
   ELSBURG LL, UNPUB
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   GREENLEE TK, 1972, J BIOMED MATER RES, V6, P235, DOI 10.1002/jbm.820060312
   GREENSPAN DC, 1997, BIOCERAMICS, V10, P391
   Healy KE, 1999, CURR OPIN SOLID ST M, V4, P381, DOI 10.1016/S1359-0286(99)00038-8
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench Larry L., 2001, P INT C GLASS, V226-233, P1
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Hench LL., 2001, KEY ENG MATER, V192-195, P575
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HENCH LL, 1996, CLIN PERFORMANCE SKE
   HENCH LL, 2001, J MAT RES INNOVATION, V3, P313
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HUGHES DE, 1994, J BONE MINER RES, V9, P39
   Ishizaki K, 1998, POROUS MAT PROCESS T, P67
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   KITSUGI T, 1989, J BONE JOINT SURG AM, V71A, P264, DOI 10.2106/00004623-198971020-00014
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1996, CLIN PERFORMANCE SKE, pCH6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lekmine F, 1999, MOL CELL ENDOCRINOL, V157, P181, DOI 10.1016/S0303-7207(99)00138-0
   Lenza RFS, 2002, J MATER SCI-MATER M, V13, P837, DOI 10.1023/A:1016592127407
   LENZA RFS, IN PRESS IN VITRO RE
   LENZA RFS, IN PRESS CONTROLLED
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   Li R., 1992, CHEM P ADV MAT, V56, P627
   LI RN, 1992, CHEMICAL PROCESSING OF ADVANCED MATERIALS, P627
   LIVAGE J, 1992, J NON-CRYST SOLIDS, V145, P11, DOI 10.1016/S0022-3093(05)80422-3
   Livage J, 1997, CURR OPIN SOLID ST M, V2, P132, DOI 10.1016/S1359-0286(97)80057-5
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mansur HS, 2000, J NON-CRYST SOLIDS, V273, P109, DOI 10.1016/S0022-3093(00)00150-2
   MOIR GK, 1974, PHYS CHEM GLASSES, V15, P6
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NICHOLL SB, 1997, BIOMATERIALS, V18, P853
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Ratner BD, 1999, CURR OPIN SOLID ST M, V4, P395, DOI 10.1016/S1359-0286(99)00047-9
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   Schoen F J, 1992, Cardiovasc Pathol, V1, P29, DOI 10.1016/1054-8807(92)90006-A
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   TENHUISEN KS, 1994, J BIOMED MATER RES, V28, P27, DOI 10.1002/jbm.820280105
   THOMPSON I, 2000, COMPREHENSIVE COMPOS, V6, P727
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WILSON J, 1990, HDB BIOACTIVE CERAMI, V1, P283
   Wroblewski BM, 1999, J BONE JOINT SURG BR, V81B, P427, DOI 10.1302/0301-620X.81B3.9521
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   XYNOS ID, 2001, J BIOMED MAT RES
   Yamamuro T, 1988, Ann N Y Acad Sci, V523, P107, DOI 10.1111/j.1749-6632.1988.tb38505.x
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
NR 78
TC 70
Z9 73
U1 0
U2 23
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD DEC 1
PY 2003
VL 38
IS 23
BP 4697
EP 4707
DI 10.1023/A:1027414700111
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 740UW
UT WOS:000186420800006
DA 2018-10-20
ER

PT J
AU Silva, GA
   Vaz, CM
   Coutinho, OP
   Cunha, AM
   Reis, RL
AF Silva, GA
   Vaz, CM
   Coutinho, OP
   Cunha, AM
   Reis, RL
TI In vitro degradation and cytocompatibility evaluation of novel soy and
   sodium caseinate-based membrane biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PROTEIN-BASED THERMOPLASTICS; STARCH-BASED POLYMERS; BIOMEDICAL
   APPLICATIONS; HUMAN OSTEOBLASTS; BIOCOMPATIBILITY; PROLIFERATION;
   COMPOSITES; SCAFFOLDS; ADHESION; SYSTEMS
AB Soy- and casein-based membranes are newly proposed materials disclosing a combination of properties that might allow for their use in a range of biomedical applications. Two of the most promising applications are drug delivery carrier systems and wound dressing membranes. As for all newly proposed biomaterials, a cytotoxic scanning must be performed as a preliminary step in the process of the determination of the compatibility with biological systems (biocompatibility). In this study, the cytotoxicity of both soy- and casein-based protein biomaterials has been evaluated and correlated with the materials degradation behavior. It was possible to show, through morphological and biochemical tests that these natural origin materials do not exert any cytotoxic effect over cells, and in some cases can in fact enhance cell proliferation. The different treatments to which the membranes were subjected during their processing (that include crosslinking with glyoxal and tannic acid, and physical modification by thermal treatment) seemed to have a clear effect both on the materials mechanical properties and on their in vitro biological behavior. (C) 2003 Kluwer Academic Publishers.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, 3Bs Res Grp, P-4710057 Braga, Portugal.
   Univ Minho, Dept Biol, P-4710057 Braga, Portugal.
RP Silva, GA (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
RI Coutinho, Olga/K-7155-2013; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012; silva, gabriela/F-4409-2012
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; silva,
   gabriela/0000-0001-5946-1918; Cunha M., Antonio/0000-0003-3860-7732;
   Coutinho, Olga/0000-0002-0647-080X
CR Al-Shafi SM, 2002, SAUDI MED J, V23, P221
   Ali Y, 1997, IND CROP PROD, V6, P177, DOI 10.1016/S0926-6690(97)00216-1
   *AM SOC TEST MAT, 1968, ANN BOOK ASTM STAND, P629
   [Anonymous], 1992, 10993 ISO
   Bouillaguet S, 2000, DENT MATER, V16, P213, DOI 10.1016/S0109-5641(00)00011-7
   Calandrelli L, 2002, J BIOMED MATER RES, V59, P611, DOI 10.1002/jbm.10014
   Carvalhal AV, 2002, ENZYME MICROB TECH, V30, P95, DOI 10.1016/S0141-0229(01)00460-4
   Dalgleish D. G., 1989, FOOD PROTEINS, P155
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   HARMSEN PFH, 2001, IFSCC MAGAZINE, V4, P34
   Heijmen FH, 1997, BIOMATERIALS, V18, P749, DOI 10.1016/S0142-9612(96)00202-5
   JULIUS A, 1967, Patent No. 3329509
   KINSELLA JE, 1984, CRC CR REV FOOD SCI, V21, P197, DOI 10.1080/10408398409527401
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mi FL, 2001, BIOMATERIALS, V22, P163
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   Rangavajhyala N, 1997, J AGR FOOD CHEM, V45, P4204, DOI 10.1021/jf9702048
   REIS RL, 1998, J APPL MED POLYM, V2, P49
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Singh H., 1991, TRENDS FOOD SCI TECH, V2, P196, DOI DOI 10.1016/0924-2244
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Vaz CA, 2002, J MACROMOL SCI PHYS, VB41, P33, DOI 10.1081/MB-120002344
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   VAZ CM, 2002, POLYM BASED SYSTEMS
   VAZ CM, 2002, UNPUB J BIOMATER SCI
   Yufera M, 1999, AQUACULTURE, V177, P249, DOI 10.1016/S0044-8486(99)00088-5
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 34
TC 55
Z9 56
U1 0
U2 22
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2003
VL 14
IS 12
BP 1055
EP 1066
DI 10.1023/B:JMSM.0000004002.11278.30
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 744HV
UT WOS:000186623400006
PM 15348498
DA 2018-10-20
ER

PT J
AU Zhao, QQ
   Boxman, A
   Chowdhry, U
AF Zhao, QQ
   Boxman, A
   Chowdhry, U
TI Nanotechnology in the chemical industry - opportunities and challenges
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Editorial Material
DE chemical industry; manufacturing; nanotechnology; nanoscale synthesis;
   particle coatings and dispersion; characterization; modeling and
   simulation
AB The traditional chemical industry has become a largely mature industry with many commodity products based on established technologies. Therefore, new product and market opportunities will more likely come from speciality chemicals, and from new functionalities obtained from new processing technologies as well as new microstructure control methodologies. It is a well-known fact that in addition to its molecular structure, the microstructure of a material is key to determining its properties. Controlling structures at the micro- and nano-levels is therefore essential to new discoveries. For this article, we define nanotechnology as the controlled manipulation of nanomaterials with at least one dimension less than 100 nm.
   Nanotechnology is emerging as one of the principal areas of investigation that is integrating chemistry and materials science, and in some cases integrating these with biology to create new and yet undiscovered properties that can be exploited to gain new market opportunities. In this article market opportunities for nanotechnology will be presented from an industrial perspective covering electronic, biomedical, performance materials, and consumer products. Manufacturing technology challenges will be identified, including operations ranging from particle formation, coating, dispersion, to characterization, modeling, and simulation. Finally, a nanotechnology innovation roadmap is proposed wherein the interplay between the development of nanoscale building blocks, product design, process design, and value chain integration is identified. A suggestion is made for an R&D model combining market pull and technology push as a way to quickly exploit the advantages in nanotechnology and translate these into customer benefits.
C1 DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA.
RP Zhao, QQ (reprint author), DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA.
CR *CHIN NAN IND, 2001, CHIN NAN IND REP
   DAGANI R, 2003, C EN            0429
   GERSTEN BL, 2001, 2001 FIN POWD PROC I
   *KRI JAP R D TREND, 2002, ADV MAT PHASE, V13
   ROCO MC, 2002, US CHEM IND WORKSH
   *VISION2020 US, 2002, US CHEM IND WORKSH
   ZHENG M, 2003, DNA ASSISTED DISPERS, V2
NR 7
TC 30
Z9 30
U1 0
U2 13
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
J9 J NANOPART RES
JI J. Nanopart. Res.
PD DEC
PY 2003
VL 5
IS 5-6
BP 567
EP 572
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 748ZU
UT WOS:000186894800014
DA 2018-10-20
ER

PT J
AU Sheir, KZ
   Zabihi, N
   Lee, D
   Teichman, JM
   Rehman, J
   Sundaram, CP
   Heimbach, D
   Hesse, A
   Delvecchio, F
   Zhong, P
   Preminger, GM
   Clayman, RV
AF Sheir, KZ
   Zabihi, N
   Lee, D
   Teichman, JM
   Rehman, J
   Sundaram, CP
   Heimbach, D
   Hesse, A
   Delvecchio, F
   Zhong, P
   Preminger, GM
   Clayman, RV
TI Evaluation of synchronous twin pulse technique for shock wave
   lithotripsy: Determination of optimal parameters for in vitro stone
   fragmentation
SO JOURNAL OF UROLOGY
LA English
DT Article
DE kidney; kidney calculi; lithotripsy; high-energy shock waves; technology
   assessment; biomedical
ID URINARY STONES; MODEL; MECHANISMS; CALCULI
AB Purpose: The Twinheads extracorporeal shock wave lithotriptor (THSWL) is composed of 2 identical shock wave generators and reflectors. One reflector is under the table and the other is over the table with a variable angle between the axes of the 2 reflectors. The 2 reflectors share a common second focal point, making it possible to deliver an almost synchronous twin pulse to the targeted stone. We studied the optimal parameters for in vitro stone fragmentation.
   Materials and Methods: Two types of 1 cm artificial stones were used, namely Bon(n)-stones of 3 compositions (75% calcium oxalate monohydrate [COM] plus 25% uric acid, struvite and cystine) and plaster of Paris. The parameters tested were shock wave number (100, 500 and 1,000), shock wave power (8, 11 and 14 kV) and angle between the reflector axes (67, 90 and 105 degrees). After the optimal parameters were determined we studied the disintegrative efficacy of THSWL for 3 types of human urinary calculi, including COM, calcium hydrogen phosphate (brushite) and cystine. Each stone received 1,000 twin shock waves at 14 kV with an angle of 90 degrees between the reflectors. All experiments were done using a rate of 60 twin shock waves per minute. Following lithotripsy stone fragments were processed and sized. The ratio of the weight of fragments greater than 2 mm-to-total weight of all fragments was calculated.
   Results: Optimal stone fragmentation results for THSWL were obtained with the maximum number of shock waves (1,000) and full power (14 kV). There was no significant statistical difference in fragment size or the ratio of fragments greater than 2 mm with the use of different angles except for cystine and plaster of Paris calculi, for which the right angle was most effective. At application of the optimal parameters to human stones THSWL produced small fragment size for COM and cystine stones, while brushite stones were not fragmented to the same extent.
   Conclusions: The efficacy of synchronous twin pulse technology improves as the number of shock waves and power increase. A 90-degree angle between the shock wave reflectors is advantageous for certain stones (that is cystine and plaster of Paris) but it is not a factor for other stone compositions. THSWL has satisfactory disintegrative efficacy for human stones, especially COM and cysteine calculi.
C1 Mansoura Univ, Dept Urol, Urol & Nephrol Ctr, Mansoura, Egypt.
   Univ Texas, Hlth Sci Ctr, Div Urol, San Antonio, TX USA.
   Univ Calif Irvine, Coll Med, Irvine Med Ctr, Dept Urol, Irvine, CA 92717 USA.
   Washington Univ, Sch Med, Div Urol, St Louis, MO USA.
   Univ Bonn, Dept Urol, Sect Expt Urol, D-5300 Bonn, Germany.
   Duke Univ, Med Ctr, Dept Mech Engn & Mat Sci, Duke Comprehens Kidney Stone Ctr, Durham, NC USA.
   Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA.
RP Sheir, KZ (reprint author), Mansoura Univ, Dept Urol, Urol & Nephrol Ctr, Mansoura, Egypt.
RI Preminger, Glenn/B-3990-2011; Sheir, Khaled/I-5760-2018
OI Preminger, Glenn/0000-0003-4287-602X; Sheir, Khaled/0000-0002-6711-5836
CR Bachmann R, 2000, INVEST RADIOL, V35, P672, DOI 10.1097/00004424-200011000-00004
   CHOUNG CJC, 1992, J UROLOGY, V148, P200
   Eisenmenger W, 2001, ULTRASOUND MED BIOL, V27, P683, DOI 10.1016/S0301-5629(01)00345-3
   FETNER CD, 1988, J UROLOGY, V139, P1192, DOI 10.1016/S0022-5347(17)42856-4
   Heimbach D, 2000, J UROLOGY, V164, P537, DOI 10.1016/S0022-5347(05)67419-8
   Heimbach D, 1997, SCAND J UROL NEPHROL, V31, P9, DOI 10.3109/00365599709070294
   RASSWEILER J, 1990, UROL RES S, V18, P13
   Sheir KZ, 2001, J ENDOUROL, V15, P965, DOI 10.1089/089277901317203029
   SHEIR KZ, 2002, ANN M RES CALC KIN S
   SHEIR KZ, UNPUB EVALUATION SYN
   Teichman JMH, 2000, J UROLOGY, V164, P1259, DOI 10.1016/S0022-5347(05)67151-0
   VAKIL N, 1991, J LITHOTR STONE DIS, V3, P304
   WHELAN JP, 1988, J UROLOGY, V140, P395, DOI 10.1016/S0022-5347(17)41643-0
   WILSON WT, 1990, UROL CLIN N AM, V17, P231
   Zhu SL, 2002, ULTRASOUND MED BIOL, V28, P661, DOI 10.1016/S0301-5629(02)00506-9
   ZIOLKOWSKI F, 1977, INVEST UROL, V15, P208
NR 16
TC 8
Z9 8
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD DEC
PY 2003
VL 170
IS 6
BP 2190
EP 2194
DI 10.1097/01.ju.0000094188.69698.f8
PN 1
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 742QG
UT WOS:000186529000005
PM 14634376
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Application of PM titanium for dental implants
SO POWDER METALLURGY
LA English
DT Editorial Material
AB Because of its good biocompatibility and mechanical properties, titanium is an excellent candidate material for implants and other biomedical applications. Research at the Swedish Ceramic Institute in collaboration with Nobel Biocare AB has investigated the use of PM titanium and titanium/hydroxyapatite composites for dental implants. High velocity compaction has potential as a low cost production route for these materials.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0032-5899
J9 POWDER METALL
JI Powder Metall.
PD DEC
PY 2003
VL 46
IS 4
BP 299
EP 300
PG 2
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 769YD
UT WOS:000188694300023
DA 2018-10-20
ER

PT J
AU Xu, W
   Tian, JM
   Wang, C
   Dong, LM
   Wang, XY
AF Xu, W
   Tian, JM
   Wang, C
   Dong, LM
   Wang, XY
TI Study of preparing beta-TCP suspension with high solid loading
SO RARE METAL MATERIALS AND ENGINEERING
LA English
DT Article
DE beta-TCP; solid loading; rheological property
ID HYDROXYAPATITE; BIOCERAMICS
AB beta-TCP is widely used as biomedical implantation material due to its good biocompatibility and biodegradability. However, tissue engineering requires beta-TCP scaffold with open cells greater than 100 gin in the diameter. Using foaming or replication method to produce porous scaffold, it is an efficient way to improve the strength and sintering property of scaffold. The physical and chemical properties of the two beta-TCP powders calcined under 850degreesC and 1050degreesC were analyzed. The influences of the dispersant content and solid loading on the viscosity of beta-TCP suspensions were discussed. 50 vol% suspensions with low viscosity were successfully prepared and the rheological properties were studied.
C1 Tsinghua Univ, Inst Nucl Energy Technol, State Key Lab Fine Ceram & Proc, Beijing 100084, Peoples R China.
RP Xu, W (reprint author), Tsinghua Univ, Inst Nucl Energy Technol, State Key Lab Fine Ceram & Proc, Beijing 100084, Peoples R China.
CR Alam MI, 2001, BIOMATERIALS, V22, P1643
   DEAN ML, 1998, CERAM INT, V24, P441
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Li XY, 2002, RARE METAL MAT ENG, V31, P495
   Rodriguez-Lorenzo LM, 2001, BIOMATERIALS, V22, P583, DOI 10.1016/S0142-9612(00)00218-0
   Wang J, 1999, J INORG MATER, V14, P651
   王士斌, 1999, [中国陶瓷, China's Ceramics], V35, P5
NR 7
TC 0
Z9 0
U1 0
U2 2
PU NORTHWEST INST NONFERROUS METAL RESEARCH
PI SHAANXI
PA C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI
   710016, PEOPLES R CHINA
SN 1002-185X
J9 RARE METAL MAT ENG
JI Rare Metal Mat. Eng.
PD DEC
PY 2003
VL 32
SU 1
BP 159
EP 162
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 845TE
UT WOS:000223266400042
DA 2018-10-20
ER

PT J
AU Oh, IH
   Nomura, N
   Masahashi, N
   Hanada, S
AF Oh, IH
   Nomura, N
   Masahashi, N
   Hanada, S
TI Mechanical properties of porous titanium compacts prepared by powder
   sintering
SO SCRIPTA MATERIALIA
LA English
DT Article
DE titanium; sintering; porous materials; Young's modulus; bending test
ID METAL PLATES; ALLOYS; TI
AB Porous Ti compacts for biomedical applications are successfully fabricated in the porosity range from 5.0 to 37.1 vol% by controlling sintering conditions and Ti powder sizes. Young's modulus and bending strength at the porosity of around 30 vol% are found to be similar to those of human cortical bone. (C) 2003 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Tohoku Univ, IMR, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Nomura, N (reprint author), Tohoku Univ, IMR, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
RI Masahashi, Naoya/A-8131-2011; NOMURA, Naoyuki/L-7149-2017
CR Boccaccini A.R., 1995, J MATER SCI LETT, V14, P534
   BURSTEIN AH, 1976, J BONE JOINT SURG AM, V58, P82, DOI 10.2106/00004623-197658010-00015
   EUDIER M, 1962, POWDER METALL, V9, P278
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   LEDBETTER H, 1995, REV PROGR QUANTITATI, P1663
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   MOYEN BJL, 1978, J BONE JOINT SURG AM, V60, P940, DOI 10.2106/00004623-197860070-00012
   Oh IH, 2002, MATER TRANS, V43, P443, DOI 10.2320/matertrans.43.443
   Okazaki Y, 2001, BIOMATERIALS, V22, P599, DOI 10.1016/S0142-9612(00)00221-0
   SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, P200
   Seah KHW, 1998, CORROS SCI, V40, P547, DOI 10.1016/S0010-938X(97)00152-2
   Thieme M., 1999, Materials Science Forum, V308-311, P374
   UHTHOFF HK, 1983, J BONE JOINT SURG BR, V65, P66
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   WHITESIDE LA, 1989, CLIN ORTHOP RELAT R, P138
   Yamada H., 1970, STRENGTH BIOL MAT, P19
NR 16
TC 330
Z9 342
U1 7
U2 86
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD DEC
PY 2003
VL 49
IS 12
BP 1197
EP 1202
DI 10.1016/j.scriptamat.2003.08.018
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 729ZD
UT WOS:000185804000010
DA 2018-10-20
ER

PT J
AU Niarchos, D
AF Niarchos, D
TI Magnetic MEMS: key issues and some applications (vol 106, pg 255, 2003)
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Correction
ID MICROELECTROMECHANICAL SYSTEMS; THIN-FILMS; SEPARATOR
AB Magnetic micro-electro-mechanical-systems (Magnetic MEMS) present a new class of conventional MEMS devices with great potential for science and applications. Using the same technology as for MEMS and incorporating magnetic materials as the sensing or active element offer new capabilities and open new markets within the information technology, automotive, biomedical, space and instrumentation. Magnetic MEMS are based on electromagnetic interactions between magnetic materials and active (coils) or passive magnetic field sources (permanent magnets). At the micrometer scale Magnetic MEMS offer distinct advantages as compared with electrostatic and piezoelectric actuators in strength, polarity and distance of actuation to name a few. The compatibility of magnetic materials with MEMS technology is a key issue, which is addressed by a number of groups worldwide. In this article, we will present an overview of the Magnetic MEMS technology and we will present some of the existing and future applications. (C) 2003 Published by Elsevier B.V.
C1 NCSR Demokritos, Inst Mat Sci, GR-15310 Athens, Greece.
RP Niarchos, D (reprint author), NCSR Demokritos, Inst Mat Sci, GR-15310 Athens, Greece.
OI NIARCHOS, DIMITRIOS/0000-0002-6256-7497
CR Ahn C. H., 1993, Proceedings. IEEE. Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Systems (Cat. No.93CH3265-6), P1, DOI 10.1109/MEMSYS.1993.296940
   AHN CH, 1992, P IEEE SOL STAT SENS, P14
   BENDER J, 2001, SENSOR ACTUAT A-PHYS, V89, P1
   Bishop D, 2001, PHYS TODAY, V54, P38, DOI 10.1063/1.1420552
   BUDE T, 2002, GD5 INT
   Cadieu FJ, 1998, J APPL PHYS, V83, P6247, DOI 10.1063/1.367771
   Cavallotti PL, 1998, SURF COAT TECH, V105, P232, DOI 10.1016/S0257-8972(98)00460-5
   Chin TS, 2000, J MAGN MAGN MATER, V209, P75, DOI 10.1016/S0304-8853(99)00649-6
   Choi JW, 2001, BIOSENS BIOELECTRON, V16, P409, DOI 10.1016/S0956-5663(01)00154-3
   Choi JW, 2000, SENSOR ACTUAT B-CHEM, V68, P34, DOI 10.1016/S0925-4005(00)00458-5
   COUGAT O, 2002, P 17 INT WORKSH RAR
   CUGAT O, 2002, HERMES SCI LAVOISIER
   CUGAT O, 2003, INTERMAG APR BOST US
   CUGAT O, COMMUNICATION
   Dutoit BM, 1999, SENSOR ACTUAT A-PHYS, V77, P178, DOI 10.1016/S0924-4247(99)00193-4
   Gong H, 1999, J APPL PHYS, V85, P5750, DOI 10.1063/1.370114
   Grunberg PA, 2001, SENSOR ACTUAT A-PHYS, V91, P153, DOI 10.1016/S0924-4247(01)00513-1
   GUCKEL H, 1993, IEEE T MICROELEC JAN, P7
   HUANG MQ, 2001, IEEE T MAGN, V37
   JEONG S, 2000, IEEE T MAGN, V36
   Judy JW, 2001, SMART MATER STRUCT, V10, P1115, DOI 10.1088/0964-1726/10/6/301
   KORNILOV NV, 1999, REV METALLURGIE SF2M
   LEE CH, 1990, PHYS REV B, V42, P11384, DOI 10.1103/PhysRevB.42.11384
   Liakopoulos TM, 1999, IEEE T MAGN, V35, P3679, DOI 10.1109/20.800629
   LIAKOPOULOS TM, 1998, P SOL STAT SENS ACT, P19
   Ludwig A, 2000, J APPL PHYS, V87, P4691, DOI 10.1063/1.373132
   MADOU M, 2002, FUNDAMENTALS NANOFAB
   MYUNG NV, 2000, P 6 INT S MAGN MAT P
   Niarchos D, 2003, SENSOR ACTUAT A-PHYS, V106, P255, DOI 10.1016/S0924-4247(03)00179-1
   PAWLOSWSKI B, 1998, P RAR EARTH MAGN APP
   Prados C, 1998, J APPL PHYS, V83, P6253, DOI 10.1063/1.367804
   Rieger G, 2000, J APPL PHYS, V87, P5329, DOI 10.1063/1.373337
   RUB R, 2001, P INT C SOL STAT SEN
   Von Hippel A., 1959, MOL SCI MOL ENG, P39
   WAGNER B, 1991, IEEE MICR EL MECH SY
   YANG Y, 2001, P INT C SOL STAT SEN
   1999, Patent No. 6375759
   1981, Patent No. 42977388
NR 38
TC 36
Z9 36
U1 0
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD DEC 1
PY 2003
VL 109
IS 1-2
BP 165
EP 173
DI 10.1016/j.sna.2003.09.009
PG 9
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 754YL
UT WOS:000187361000024
DA 2018-10-20
ER

PT J
AU Olsen, D
   Yang, CL
   Bodo, M
   Chang, R
   Leigh, S
   Baez, J
   Carmichael, D
   Perala, M
   Hamalainen, ER
   Jarvinen, M
   Polarek, J
AF Olsen, D
   Yang, CL
   Bodo, M
   Chang, R
   Leigh, S
   Baez, J
   Carmichael, D
   Perala, M
   Hamalainen, ER
   Jarvinen, M
   Polarek, J
TI Recombinant collagen and gelatin for drug delivery
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE recombinant collagen; recombinant gelatin; yeast; transgenic animals and
   plants; prolyl hydroxylase; hydroxyproline
ID YEAST PICHIA-PASTORIS; BACULOVIRUS EXPRESSION SYSTEM; I COLLAGEN; PROLYL
   4-HYDROXYLASE; SACCHAROMYCES-CEREVISIAE; TRANSGENIC PLANTS;
   TRIPLE-HELIX; III COLLAGEN; REQUIRES COEXPRESSION; THERAPEUTIC PROTEINS
AB The tools of recombinant protein expression are now being used to provide recombinant sources of both collagen and gelatin. The primary focus of this review is to discuss alternatives to bovine collagen for biomedical applications. Several recombinant systems have been developed for production of human sequence collagens. Mammalian and insect cells were initially used, but were thought to be too costly for commercial production. Yeast have been engineered to express high levels of type I homotrimer and heterotrimer and type II and type III collagen. Co-expression of collagen genes and cDNAs encoding the subunits of prolyl hydroxylase has lead to the synthesis of completely hydroxylated, thermostable collagens. Human types I and III collagen homotrimers have been expressed in transgenic tobacco plants, while transgenic mice have been engineered to produce full-length type I procollagen homotrimer as well as a alpha2 (1) homotrimeric mini-collagen. Most recently, a transgenic silkworm system was used to produce a fusion protein containing a collagenous sequence. Each of these transgenic systems holds great promise for the cost-effective large-scale production of recombinant human collagens. As seen in other recombinant expression systems, transgenic silkworms, tobacco, and mice lack sufficient endogenous prolyl hydroxylase activity to produce fully hydroxylated collagen. In mice and tobacco, this was overcome by over-expression of prolyl hydroxylase, analogous to what has been done in yeast and insect cell culture. In addition to recombinant alternatives to bovine collagen, other sources such as fish and sponge collagen are discussed briefly. Recombinant gelatin has been expressed in Pichia pastoris and Hansenula polymorpha in both non-hydroxylated and hydroxylated forms. Pichia was shown to be a highly productive system for gelatin production. The recombinant gelatins produced in yeast are of defined molecular weight and physio-chemical properties and represent a new biomaterial not previously available from animal sources. Genetic engineering has made great progress in the areas of recombinant collagen and gelatin expression, and there are now several alternatives to bovine material that offer an enhanced safety profile, greater reproducibility and quality, and the ability of these materials to be tailored to enhance product performance. (C) 2003 Elsevier B.V. All rights reserved.
C1 FibroGen Inc, San Francisco, CA 94080 USA.
   FibroGen Europe, Medipolis, FIN-90230 Oulu, Finland.
RP Olsen, D (reprint author), FibroGen Inc, 225 Gateway Blvd, San Francisco, CA 94080 USA.
EM dolsen@fibrogen.com
OI Polarek, James/0000-0003-4097-5219
FU NIAMS NIH HHS [R01 AR45879]
CR ASA K, 1989, INT ARCH ALLER A IMM, V29, P990
   ASGHAR A, 1982, ADV FOOD RES, V28, P231
   Asher D M, 1999, Dev Biol Stand, V100, P103
   BALLEISEN L, 1975, KLIN WOCHENSCHR, V53, P903, DOI 10.1007/BF01468982
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P213
   BIRK DE, 1991, CELL BIOL EXTRACELLU, P221
   BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642
   Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200
   CAREY DJ, 1991, ANNU REV PHYSIOL, V53, P161, DOI 10.1146/annurev.physiol.53.1.161
   Chen M, 2002, J BIOL CHEM, V277, P2118, DOI 10.1074/jbc.M108779200
   CHUNG E, 1974, SCIENCE, V183, P1200, DOI 10.1126/science.183.4130.1200
   *COLL AESTH INT, 2002, ZYD COLL IMPL PACK I
   COOPERMAN L, 1984, J AM ACAD DERMATOL, V10, P638, DOI 10.1016/S0190-9622(84)80271-6
   COURTS A, 1954, BIOCHEM J, V58, P74, DOI 10.1042/bj0580074
   Cramer CL, 1999, CURR TOP MICROBIOL, V240, P95
   DATAR RV, 1993, BIO-TECHNOL, V11, P349, DOI 10.1038/nbt0393-349
   de Bruin EC, 2000, ENZYME MICROB TECH, V26, P640, DOI 10.1016/S0141-0229(00)00153-8
   de Bruin Eric C., 2002, FEMS Yeast Research, V1, P291, DOI 10.1016/S1567-1356(01)00042-3
   DEBRUIN EC, 2002, ENZYME MICROB TECHNO, V1, P291
   DEWET W, 1987, J BIOL CHEM, V262, P32
   EXPOSITO JY, 1991, J BIOL CHEM, V266, P21923
   EXPOSITO JY, 1990, P NATL ACAD SCI USA, V87, P6669, DOI 10.1073/pnas.87.17.6669
   Farrugia Claude A., 1998, Pharmacy and Pharmacology Communications, V4, P559
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   Friess W., 1998, EUR J PHARMACOL, V54, P54113
   Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547
   GARRONE R, 1978, PHYLOGENESIS CONNECT
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   GELMAN RA, 1979, J BIOL CHEM, V254, P1741
   GOLDBERG I, 1989, GENE, V80, P305, DOI 10.1016/0378-1119(89)90294-1
   HEIN MB, 1991, BIOTECHNOL PROGR, V7, P455, DOI 10.1021/bp00011a011
   Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200
   Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598
   Hori H, 2002, J ALLERGY CLIN IMMUN, V110, P652, DOI 10.1067/mai.2002.127862
   Houdebine LM, 2000, TRANSGENIC RES, V9, P305, DOI 10.1023/A:1008934912555
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   JUNQUA S, 1974, CONNECT TISSUE RES, V2, P193, DOI 10.3109/03008207409152244
   Keizer-Gunnink I, 2000, MATRIX BIOL, V19, P29, DOI 10.1016/S0945-053X(99)00059-1
   Kivirikko KI, 1998, MATRIX BIOL, V16, P355, DOI 10.1016/S0945-053X(98)90008-7
   Lachman L, 1986, THEORY PRACTICE IND
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   LAMPORT DTA, 1969, BIOCHEMISTRY-US, V8, P1155, DOI 10.1021/bi00831a049
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LINDSLEY H, 1971, J EXP MED, V133, P1309, DOI 10.1084/jem.133.6.1309
   MA JKC, 1995, SCIENCE, V268, P716, DOI 10.1126/science.7732380
   Maeda M, 2001, J CONTROL RELEASE, V77, P261, DOI 10.1016/S0168-3659(01)00512-0
   MAILLARD L, 1999, J AM COLL CARDIOL, V34, P1498
   Mason HS, 2002, TRENDS MOL MED, V8, P324, DOI 10.1016/S1471-4914(02)02360-2
   Merle C, 2002, FEBS LETT, V515, P114, DOI 10.1016/S0014-5793(02)02452-3
   Miele L, 1997, TRENDS BIOTECHNOL, V15, P45, DOI 10.1016/S0167-7799(97)84202-3
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P3
   Mison D, 2000, BIOPHARM-APPL T BIO, V13, P48
   Montagnon B, 1983, Dev Biol Stand, V55, P37
   Moskowitz RW, 2000, SEMIN ARTHRITIS RHEU, V30, P87, DOI 10.1053/sarh.2000.9622
   Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306
   Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   NAKAGAWA S, 1989, EXP CELL RES, V182, P572, DOI 10.1016/0014-4827(89)90260-7
   Nakayama Y, 2001, J BIOMED MATER RES, V57, P559, DOI 10.1002/1097-4636(20011215)57:4<559::AID-JBM1202>3.0.CO;2-H
   Naughton GK, 2002, ANN NY ACAD SCI, V961, P372, DOI 10.1111/j.1749-6632.2002.tb03127.x
   Nimmi M.E., 1987, J BIOMED MATER RES, V21, P741
   Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200
   Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200
   Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200
   PIEZ KA, 1960, J BIOL CHEM, V235, P995
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0
   PROCKOP DJ, 1997, Patent No. 5593859
   Richter LJ, 2000, NAT BIOTECHNOL, V18, P1167, DOI 10.1038/81153
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   SADDLER JM, 1987, ANAESTHESIA, V42, P998, DOI 10.1111/j.1365-2044.1987.tb05376.x
   Sakaguchi M, 1999, J ALLERGY CLIN IMMUN, V104, P695, DOI 10.1016/S0091-6749(99)70344-1
   Sakaguchi M, 2000, J ALLERGY CLIN IMMUN, V106, P579, DOI 10.1067/mai.2000.108499
   Sakaguchi M, 2000, JPN J INFECT DIS, V53, P189
   Sakai Y, 1998, BIOL PHARM BULL, V21, P330
   SCHOR SL, 1980, J CELL SCI, V41, P159
   Sclafani AP, 2002, ANN PLAS SURG, V49, P181, DOI 10.1097/00000637-200208000-00011
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Shirai T, 1998, MATRIX BIOL, V17, P85, DOI 10.1016/S0945-053X(98)90076-2
   SOPER J C, 1997, US Patent, Patent No. [5603952, 5.603.952]
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8
   TANAKA M, 1981, J BIOL CHEM, V256, P1397
   TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x
   Toman PD, 1999, TRANSGENIC RES, V8, P415, DOI 10.1023/A:1008959924856
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Tomita M, 1995, BIOCHEM J, V312, P847, DOI 10.1042/bj3120847
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Tomita M, 1997, J BIOCHEM-TOKYO, V121, P1061
   Vaughan PR, 1998, DNA CELL BIOL, V17, P511, DOI 10.1089/dna.1998.17.511
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   Wegner G H, 1990, FEMS Microbiol Rev, V7, P279
   Werten MWT, 1999, YEAST, V15, P1087, DOI 10.1002/(SICI)1097-0061(199908)15:11<1087::AID-YEA436>3.0.CO;2-F
   Werten MWT, 2001, PROTEIN ENG, V14, P447, DOI 10.1093/protein/14.6.447
   WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Yamamoto YT, 2001, IN VITRO CELL DEV-PL, V37, P349
   YANG C, 1999, AAPS ANN M
   YOUNG M, 1998, BIOPHARM, V10, P34
   Yuan JQ, 2001, CHINESE MED J-PEKING, V114, P1043
NR 105
TC 266
Z9 299
U1 8
U2 124
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD NOV 28
PY 2003
VL 55
IS 12
BP 1547
EP 1567
DI 10.1016/j.addr.2003.08.008
PG 21
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 747PN
UT WOS:000186813500003
PM 14623401
DA 2018-10-20
ER

PT J
AU Niemeyer, CM
   Ceyhan, B
   Noyong, M
   Simon, U
AF Niemeyer, CM
   Ceyhan, B
   Noyong, M
   Simon, U
TI Bifunctional DNA-gold nanoparticle conjugates as building blocks for the
   self-assembly of cross-linked particle layers
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID PROBES; OLIGONUCLEOTIDES
AB The DNA-directed self-assembly of surface-bound layers of gold nanoparticles offers a broad range of applications in biomedical analyses as well as in materials science. We here describe a new concept for the assembly of substrate-bound nanoparticle monolayers which employs bifunctional nanoparticles as building blocks, containing two independently addressable DNA oligomer sequences. One of the sequences was utilized for attaching the particle at the solid support, while the other sequence was used to establish cross-links between adjacently immobilized particles. AFM analyses proved the functionality of inter-particle cross-links leading to enhanced surface coverages and the formation of monolayered supramolecular aggregates attached to the substrate. We anticipate that further refinement of this approach will enable applications, for instance, the assembly of ordered layers useful as transducers in biosensing. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Dortmund, Fachbereich Chem, D-44227 Dortmund, Germany.
   Rhein Westfal TH Aachen, Inst Anorgan Chem, D-52056 Aachen, Germany.
RP Niemeyer, CM (reprint author), Univ Dortmund, Fachbereich Chem, Otto Hahn Str 6, D-44227 Dortmund, Germany.
RI Noyong, Michael/I-6207-2016; Simon, Ulrich/K-7737-2013; Niemeyer,
   Christof/L-3568-2013
OI Noyong, Michael/0000-0002-3148-1084; Simon, Ulrich/0000-0002-6118-0573;
   Niemeyer, Christof/0000-0002-8837-081X
CR Demers LM, 2000, ANAL CHEM, V72, P5535, DOI 10.1021/ac0006627
   Gerion D, 2002, J AM CHEM SOC, V124, P7070, DOI 10.1021/ja017822w
   Han SB, 2000, BIOCHEM BIOPH RES CO, V279, P265, DOI 10.1006/bbrc.2000.3943
   Lin L, 2000, BIOCHEM BIOPH RES CO, V274, P817, DOI 10.1006/bbrc.2000.3233
   Moller R, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e91
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Niemeyer CM, 2001, COLLOID POLYM SCI, V279, P68, DOI 10.1007/s003960000429
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P3685, DOI 10.1002/1521-3773(20011001)40:19<3685::AID-ANIE3685>3.0.CO;2-E
   NIEMEYER CM, 2003, IN PRESS ANGEW CHEM, V42
   Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003
   Park SJ, 2000, ANGEW CHEM INT EDIT, V39, P3845, DOI 10.1002/1521-3773(20001103)39:21<3845::AID-ANIE3845>3.0.CO;2-O
   Patolsky F, 2000, CHEM COMMUN, P1025, DOI 10.1039/b002221g
   Reynolds RA, 2000, J AM CHEM SOC, V122, P3795, DOI 10.1021/ja000133k
   Storhoff JJ, 1999, CHEM REV, V99, P1849, DOI 10.1021/cr970071p
   Storhoff JJ, 1998, J AM CHEM SOC, V120, P1959, DOI 10.1021/ja972332i
   Taton TA, 2000, J AM CHEM SOC, V122, P6305, DOI 10.1021/ja0007962
   Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757
   Taton TA, 2001, J AM CHEM SOC, V123, P5164, DOI 10.1021/ja0102639
NR 18
TC 45
Z9 45
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 28
PY 2003
VL 311
IS 4
BP 995
EP 999
DI 10.1016/j.bbrc.2003.10.103
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 747KP
UT WOS:000186803900030
PM 14623280
DA 2018-10-20
ER

PT J
AU Batchelor, MM
   Reoma, SL
   Fleser, PS
   Nuthakki, VK
   Callahan, RE
   Shanley, CJ
   Politis, JK
   Elmore, J
   Merz, SI
   Meyerhoff, ME
AF Batchelor, MM
   Reoma, SL
   Fleser, PS
   Nuthakki, VK
   Callahan, RE
   Shanley, CJ
   Politis, JK
   Elmore, J
   Merz, SI
   Meyerhoff, ME
TI More lipophilic dialkyldiamine-based diazeniumdiolates: Synthesis,
   characterization, and application in preparing thromboresistant nitric
   oxide release polymeric coatings
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID CONTROLLED BIOLOGICAL RELEASE; IN-VIVO; NO; DONORS; NUCLEOPHILES;
   COMPLEXES; BEHAVIOR; NONOATES; SENSORS; AGENTS
AB The synthesis, characterization, and biomedical application in preparing more thromboresistant polymeric coatings for a series of lipophilic dialkyldiamine-based diazeniumdiolates are described. Dialkylhexamethylenediamine diazeniumdiolates of the form RN[N(O)NO](-)-(CH2)(6)(NH2R)-R-divided by, where R = CH3, CH2CH3, (CH2)(2)CH3, (CH2)(3)CH3, (CH2)(4)CH3, (CH2)(5)CH3, and (CH2)(11)CH3, are prepared via reaction of the corresponding diamine with NO. The more lipophilic diazeniumdiolates [e.g., R = (CH2)(3)CH3] can be incorporated into hydrophobic polymeric films (e.g., plasticized PVC), and the resulting materials release NO for extended periods of time upon exposure to PBS buffer. The mechanism of NO release from these films is examined in detail. More stable initial NO release can be achieved by adding lipophilic anionic species (e.g., tetraphenylborate derivative) to the polymeric material to buffer the activity of protons within the organic phase. It is shown that the use of these new lipophilic NO-donors in polymers provides the ability to tailor NO release rates for a variety of medical applications. As an example, polymers doped with N,N'-dibutylhexamethylenediamine diazeniumdiolate and a tetraphenylborate derivative are employed as coatings for vascular grafts in sheep. The NO release grafts exhibited enhanced performance and had an average 95% thrombus-free surface area compared to 42% for the corresponding control grafts when examined after 21d of implantation.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   Michigan Crit Care Consultants Inc, Ann Arbor, MI 48103 USA.
   William Beaumont Hosp Res Inst, Royal Oak, MI 48073 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.
EM mmeyerho@umich.edu
FU NIBIB NIH HHS [EB-00783]
CR Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   BATCHELOR MM, IN PRESS IMPROVEMENT
   CLOWES AW, 1993, CARDIOVASC PATHOL, V2, P179
   Davies KM, 2001, J AM CHEM SOC, V123, P5473, DOI 10.1021/ja002899q
   DIODATI JG, 1993, THROMB HAEMOSTASIS, V70, P654
   FELDMAN PL, 1993, CHEM ENG NEWS, V26, P6
   Fitzhugh AL, 2000, FREE RADICAL BIO MED, V28, P1463, DOI 10.1016/S0891-5849(00)00251-3
   Frost MC, 2002, ANAL CHEM, V74, P5942, DOI 10.1021/ac025944g
   HANSON SR, 1995, NITRIC OXIDE BIOCH M
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   Jia QA, 2002, EXPERT OPIN THER PAT, V12, P819
   Keefer LK, 1996, METHOD ENZYMOL, V268, P281
   Keefer LK, 2003, ANNU REV PHARMACOL, V43, P585, DOI 10.1146/annurev.pharmtox.43.100901.135831
   MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013
   MARLETTA M A, 1990, Biofactors, V2, P219
   MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5
   MOORADIAN DL, 1995, J CARDIOVASC PHARM, V25, P674, DOI 10.1097/00005344-199504000-00023
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Parzuchowski PG, 2002, J AM CHEM SOC, V124, P12182, DOI 10.1021/ja020268l
   Puntener M, 2002, ELECTROANAL, V14, P1329, DOI 10.1002/1521-4109(200211)14:19/20<1329::AID-ELAN1329>3.0.CO;2-V
   Saavedra J, 2000, CHEM BRIT, V36, P30
   Saavedra JE, 1997, J MED CHEM, V40, P1947, DOI 10.1021/jm9701031
   Saavedra JE, 2000, J MED CHEM, V43, P261, DOI 10.1021/jm9903850
   Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705
   Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l
   Watson JM, 1996, J MEMBRANE SCI, V110, P47, DOI 10.1016/0376-7388(95)00229-4
   Wu XJ, 2001, TETRAHEDRON LETT, V42, P3779, DOI 10.1016/S0040-4039(01)00614-1
   Ye QS, 1999, ANAL CHEM, V71, P4313, DOI 10.1021/ac981416m
   ZHANG H, 2002, BIOMATERIALS, V23
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
NR 33
TC 88
Z9 90
U1 4
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
J9 J MED CHEM
JI J. Med. Chem.
PD NOV 20
PY 2003
VL 46
IS 24
BP 5153
EP 5161
DI 10.1021/jm030286t
PG 9
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 743LG
UT WOS:000186572800007
PM 14613318
DA 2018-10-20
ER

PT J
AU Rickert, D
   Lendlein, A
   Schmidt, AM
   Kelch, S
   Roehlke, W
   Fuhrmann, R
   Franke, RP
AF Rickert, D
   Lendlein, A
   Schmidt, AM
   Kelch, S
   Roehlke, W
   Fuhrmann, R
   Franke, RP
TI In vitro cytotoxicity testing of AB-polymer networks based on
   oligo(epsilon-caprolactone) segments after different sterilization
   techniques
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biocompatibility; poly-epsilon-caprolactone networks; agarose diffusion
   test; image-analysis system; sterilization techniques
ID ELECTROPHYSIOLOGY CATHETERS; PLASMA STERILIZATION;
   POLY(EPSILON-CAPROLACTONE); SAFETY
AB Recently developed versatile biodegradable polymeric biomaterial offer new therapeutic options in numerous medical fields. Biocompatibility is a crucial requirement for the biomedical application of biomaterials, including the sterilization of these materials with the use of accepted protocols. Ethylene-oxide (EO) and low-temperature plasma (LTP) sterilization are frequently used low-temperature sterilization technologies for heat-sensitive materials. The agarose diffusion assay is a recommended cell-screening test to assess the cytotoxicity of biomaterials in vitro. The sensitivity of the agarose assay can be increased by using a modified computer-based image-analysis system. The influence of EO and LTP sterilization on the cytotoxicity of a versatile polymer system of shape-memory polymer networks based on oligo (c-caprolactone) dimethacrylate and n-butyl acrylate was investigated. Statistically significant differences in the rate of cell lysis after EO and LTP sterilization of the polymer samples were detected by using this modified quantification system. The influence of the different sterilization techniques on the cytotoxicity of the polymeric material, as well as the clinical relevance of the described differences, are discussed. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Ulm, Dept Otolaryngol Head & Neck Surg, D-89075 Ulm, Germany.
   GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, D-14513 Teltow, Germany.
   Univ Dusseldorf, Inst Organ & Makromol Chem 1, D-40225 Dusseldorf, Germany.
   Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, D-89081 Ulm, Germany.
RP Rickert, D (reprint author), Univ Ulm, Dept Otolaryngol Head & Neck Surg, Prittwitzstr 43, D-89075 Ulm, Germany.
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR *ASTM, 1992, F81383 ASTM, P239
   ATON EA, 1994, AM J CARDIOL, V74, P1173, DOI 10.1016/0002-9149(94)90476-6
   Bathina MN, 1998, J AM COLL CARDIOL, V32, P1384, DOI 10.1016/S0735-1097(98)00401-X
   Chau TT, 1996, BIOMATERIALS, V17, P1273, DOI 10.1016/S0142-9612(96)80003-2
   El Mansouri H, 1999, J APPL POLYM SCI, V71, P371, DOI 10.1002/(SICI)1097-4628(19990118)71:3<371::AID-APP2>3.3.CO;2-D
   FELDMAN LA, 1997, MED DEVICE DIAGN IND, P57
   Ferrell M, 1997, AM J CARDIOL, V80, P1558, DOI 10.1016/S0002-9149(97)00785-6
   Goldman M, 1998, J BIOMED MATER RES, V40, P378, DOI 10.1002/(SICI)1097-4636(19980605)40:3<378::AID-JBM6>3.0.CO;2-C
   GUESS WL, 1965, J PHARM SCI, V54, P1545, DOI 10.1002/jps.2600541036
   Hury S, 1998, LETT APPL MICROBIOL, V26, P417
   KHAMBATTA FB, 1976, J POLYM SCI POL PHYS, V14, P1391, DOI 10.1002/pol.1976.180140805
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lerouge S, 2000, J BIOMED MATER RES, V52, P774
   Malucelli G, 1996, POLYMER, V37, P2565, DOI 10.1016/0032-3861(96)85373-0
   Masson V, 1997, BIOMATERIALS, V18, P327, DOI 10.1016/S0142-9612(96)00144-5
   ROGERS SS, 1957, J PHYS CHEM-US, V61, P985, DOI 10.1021/j150553a033
   SCHMALZ G, 1994, DENT MATER, V10, P304, DOI 10.1016/0109-5641(94)90038-8
   TABRIZIAN M, 1997, P 1 INT S ADV BIOM M
   WALLHAUSER KH, 1995, PRAXIS STERILISATION
   Zange R, 1998, J CONTROL RELEASE, V56, P249, DOI 10.1016/S0168-3659(98)00093-5
   Zhang YZ, 1996, BIOMATERIALS, V17, P2265, DOI 10.1016/0142-9612(96)00055-5
   1999, HLTH DEVICES, V28, P430
NR 24
TC 51
Z9 52
U1 3
U2 26
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV 15
PY 2003
VL 67B
IS 2
BP 722
EP 731
DI 10.1002/jbm.b.10069
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 739LG
UT WOS:000186347100007
PM 14598399
DA 2018-10-20
ER

PT J
AU Signori, F
   Solaro, R
   Chiellini, E
   Lips, PAM
   Dijkstra, PJ
   Feijen, J
AF Signori, F
   Solaro, R
   Chiellini, E
   Lips, PAM
   Dijkstra, PJ
   Feijen, J
TI Synthesis and characterization of segmented poly(ether ester)s
   containing H-bonding units
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE H-bonding units; multifunctional polymers; polyesters; polyethers;
   structure-property relations
ID BLOCK COPOLYMERS; SUCCINIC ACIDS; BIOCOMPATIBILITY
AB A series of poly(ether ester)s containing different H-bonding units (amide, carbamate, urea) was prepared by polycondensation in bulk, using Ti(OBU)(4) as a catalyst. The copolymers were obtained starting from PEG1000, 1,4-butanediol, and a symmetrical, bis-ester terminated monomer carrying H-bonding units. These materials were designed for biomedical applications, in which ultimate biodegradability of the materials is required. The influence of the nature of the H-bonding unit and of the length of the methylene spacer between H-bonding groups on the thermal and solubility properties of copolymers was investigated. Amide containing copolymers were more thermally stable than ones containing carbamate, consistent with the observed behavior of the corresponding monomers. In most cases, differential scanning calorimetry (DSC) traces were quite complex because of phase separation and dependent on the applied cooling rate. Copolymers containing urea bonds were less soluble in most organic solvents, but their thermal properties were not significantly different than their amide containing counterparts.
C1 Univ Pisa, Dipartimento Chim & Chim Ind, UdR Consortium INSTM, I-56126 Pisa, Italy.
   Univ Twente, Dept Chem Technol, NL-7500 AE Enschede, Netherlands.
RP Chiellini, E (reprint author), Univ Pisa, Dipartimento Chim & Chim Ind, UdR Consortium INSTM, Via Risorgimento 35, I-56126 Pisa, Italy.
EM emochie@dcci.unipi.it
RI Signori, Francesca/G-1937-2010; Dijkstra, Pieter/N-9328-2013
OI Signori, Francesca/0000-0002-9211-5352; 
CR Alla A, 2000, POLYMER, V41, P6995, DOI 10.1016/S0032-3861(00)00070-7
   BAKKER D, 1990, J BIOMED MATER RES, V24, P489, DOI 10.1002/jbm.820240407
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   CERRAI P, 1989, POLYMER, V30, P338, DOI 10.1016/0032-3861(89)90126-2
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Paredes N, 1998, J POLYM SCI POL CHEM, V36, P1271
   Paredes N, 1998, J APPL POLYM SCI, V69, P1537, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1537::AID-APP8>3.0.CO;2-D
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   SEEBACH D, 1982, SYNTHESIS-STUTTGART, P138
   Solaro R, 2003, MACROMOL CHEM PHYSIC, V204, P500, DOI 10.1002/macp.200390023
   Stapert HR, 1999, MACROMOL CHEM PHYSIC, V200, P1921, DOI 10.1002/(SICI)1521-3935(19990801)200:8<1921::AID-MACP1921>3.0.CO;2-R
   STAPERT HR, 1998, THESIS U TWENTE NETH
   STAPERT HR, 1998, Patent No. 19980627
   Tuominen J, 2000, MACROMOLECULES, V33, P3530, DOI 10.1021/ma991676l
   Villuendas I, 2001, MACROMOL CHEM PHYSIC, V202, P236, DOI 10.1002/1521-3935(20010101)202:2<236::AID-MACP236>3.0.CO;2-H
   1987, Patent No. 4716203
NR 18
TC 4
Z9 4
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD NOV 3
PY 2003
VL 204
IS 16
BP 1971
EP 1981
DI 10.1002/macp.200350057
PG 11
WC Polymer Science
SC Polymer Science
GA 743LU
UT WOS:000186573900007
DA 2018-10-20
ER

PT J
AU Fang, N
   Chan, V
AF Fang, N
   Chan, V
TI Chitosan-induced restructuration of a mica-supported phospholipid
   bilayer: An atomic force microscopy study
SO BIOMACROMOLECULES
LA English
DT Article
ID MAIN PHASE-TRANSITION; LIPID-BILAYERS; DELIVERY-SYSTEM; SAPOSIN-C;
   IN-VITRO; PHOSPHATIDYLCHOLINE; ADSORPTION; MEMBRANES; SURFACE; MONOLAYER
AB Chitosan has emerged as a promising material for biomedical applications. However, the effect of chitosan adsorption on the structure of model biomembrane is not known. In this study, atomic force microscopy (AFM) is employed to investigate the interaction between chitosan and mica-supported dipalmitoylphosphocholine (DPPC) bilayer. First, in situ AFM measurement indicates that nucleation of chitosan occurs around the membrane defects at the initial stage of chitosan incubation. Eventually, DPPC-chitosan binding and chitosan intermolecular association lead to chitosan aggregation on the membrane surface which is quantified by average height measurement and RMS roughness analysis. Lateral force microscopy (LFM) confirms that the adsorbed chitosan has distinct material properties. Furthermore, the trend of surface pressure-area isotherms supports the condensation of DPPC monolayer induced by chitosan in the aqueous subphase. Surface coverage and surface roughness analysis show that the extent of chitosan aggregation on the supported membrane is affected by the incubation time during long-term chitosan incubation.
C1 Nanyang Technol Univ, Tissue Engn Lab, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chan, V (reprint author), Nanyang Technol Univ, Tissue Engn Lab, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RI Chan, Vincent/G-6197-2010
OI Chan, Vincent/0000-0003-2149-4479
CR Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z
   Ashmore M, 2001, LANGMUIR, V17, P1069, DOI 10.1021/la001490b
   Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   Bassereau P, 1997, LANGMUIR, V13, P7003, DOI 10.1021/la970515c
   Berth G, 2002, CARBOHYD POLYM, V47, P39, DOI 10.1016/S0144-8617(00)00343-X
   Clausen-Schaumann H, 1999, LANGMUIR, V15, P8246, DOI 10.1021/la990273b
   DEDEINAITE A, 2003, IN PRESS J PHYS CH B
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   Fang N, 2003, BIOMACROMOLECULES, V4, P581, DOI 10.1021/bm025682s
   Fang N, 2001, BIOMACROMOLECULES, V2, P1161, DOI 10.1021/bm015548s
   Fang Y, 1996, J PHYS CHEM-US, V100, P15614, DOI 10.1021/jp961054r
   Fang Y, 1997, BBA-BIOMEMBRANES, V1324, P309, DOI 10.1016/S0005-2736(96)00236-2
   Feng SS, 2002, LANGMUIR, V18, P4061, DOI 10.1021/la011545p
   Grandbois M, 1998, BIOPHYS J, V74, P2398, DOI 10.1016/S0006-3495(98)77948-2
   He P, 1998, INT J PHARMACEUT, V166, P75, DOI 10.1016/S0378-5173(98)00027-1
   Ivanova VP, 2003, BIOPHYS J, V84, P2427, DOI 10.1016/S0006-3495(03)75047-4
   Kim K, 2001, LANGMUIR, V17, P5066, DOI 10.1021/la0102096
   Kumaki J, 2003, J AM CHEM SOC, V125, P4907, DOI 10.1021/ja0290429
   Lai ACK, 2002, BIOPHYS CHEM, V99, P245, DOI 10.1016/S0301-4622(02)00201-6
   Leonenko ZV, 2002, LANGMUIR, V18, P4873, DOI 10.1021/la0116239
   Luzardo MD, 1998, LANGMUIR, V14, P5858, DOI 10.1021/la971273j
   Mao HQ, 1996, P INT S CONTROL REL, V23, P401
   Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4
   McClain RL, 2001, LANGMUIR, V17, P5121, DOI 10.1021/la010295
   Mou JX, 1996, BIOCHEMISTRY-US, V35, P3222, DOI 10.1021/bi9520242
   Mueller H, 2000, LANGMUIR, V16, P9568, DOI 10.1021/la0006891
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Patel D, 2000, INT J PHARM, V200, P271, DOI 10.1016/S0378-5173(00)00396-3
   Philippova OE, 2001, BIOMACROMOLECULES, V2, P483, DOI 10.1021/bm005649a
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Reviakine I, 2000, LANGMUIR, V16, P1806, DOI 10.1021/la9903043
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Richter RP, 2003, LANGMUIR, V19, P1632, DOI 10.1021/la026427w
   Ross M, 2001, LANGMUIR, V17, P2437, DOI 10.1021/la001617x
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Sommer JU, 1996, J CHEM PHYS, V105, P6008, DOI 10.1063/1.472458
   Tang ZY, 2000, LANGMUIR, V16, P1696, DOI 10.1021/la981491s
   Vie V, 2000, BIOPHYS J, V78, P846, DOI 10.1016/S0006-3495(00)76642-2
   Willemsen OH, 2000, BIOPHYS J, V79, P3267, DOI 10.1016/S0006-3495(00)76559-3
   Xie AF, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.246103
   Xie AF, 2002, NAT MATER, V1, P129, DOI 10.1038/nmat738
   Yang J, 2000, J PHYS CHEM B, V104, P8097, DOI 10.1021/jp001403o
   You HX, 2003, BIOPHYS J, V84, P2043, DOI 10.1016/S0006-3495(03)75012-7
   You HX, 2001, FEBS LETT, V503, P97, DOI 10.1016/S0014-5793(01)02700-4
   Yuan CB, 2001, BIOPHYS J, V81, P1059, DOI 10.1016/S0006-3495(01)75763-3
NR 46
TC 34
Z9 37
U1 0
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2003
VL 4
IS 6
BP 1596
EP 1604
DI 10.1021/bm034259w
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 746CV
UT WOS:000186729700018
PM 14606885
DA 2018-10-20
ER

PT J
AU Sarazin, P
   Favis, BD
AF Sarazin, P
   Favis, BD
TI Morphology control in co-continuous poly(L-lactide)/polystyrene blends:
   A route towards highly structured and interconnected porosity in
   poly(L-lactide) materials
SO BIOMACROMOLECULES
LA English
DT Article
ID IMMISCIBLE POLYMER BLENDS; POLY(LACTIC ACID); INTERFACIAL-TENSION;
   MOLECULAR-WEIGHT; CHEMICAL-COMPOSITION; PHASE INVERSION; MELT RHEOLOGY;
   VISCOSITY; POLYLACTIDE; SHEAR
AB Poly(L-lactide) is a biodegradable polymer primarily used in biomedical applications. In this paper, both the microstructure and the region of dual-phase continuity are examined for binary and compatibilized poly(L-lactide)/polystyrene blends (PLLA/PS) prepared by melt mixing. The blends are shown to be completely immiscible with an interfacial tension of 6.1 mN/m. The PS-b-PLLA (24 000-b-28 000) diblock copolymer compatibilizer has an asymmetric effect on the blend. It is effective at compatibilizing 50/50 PLLA/PS blends but is only a marginal emulsifier for blends where PLLA is the dominant matrix. Percent continuity, as estimated by solvent extraction/gravimetry and also torque/composition diagrams clearly indicate an onset of the region of dual-phase continuity at 40-45%PS. It is demonstrated that highly percolated blends of the above materials exist from 40 to 75% PS and 40 to 60% PS for the binary and compatibilized blends, respectively. The scale of the microstructure of the continuous morphology is measured using BET and mercury intrusion porosimetry techniques, after extraction of the PS phase. Both the pore size and extent of continuity can be controlled through composition and interfacial modification. Static annealing of the blend after melt mixing can also be used to substantially increase the pore size of the system. Extraction of the PS phase in the blend, carried out after the above preparation protocols, is a route to generating completely interconnected porosity of highly controlled morphologies (pore size, void volume) in Poly(L-lactide) materials. In this study, the pore diameter was controlled from 0.9 to 72 mum for a constant void volume of 45-47%, and the void volume was modified from 35 to 74% depending on the blend composition.
C1 Ecole Polytech, Dept Chem Engn, Ctr Appl Res Polymers, CRASP,Stn Ctr Ville, Montreal, PQ H3C 3A7, Canada.
RP Favis, BD (reprint author), Ecole Polytech, Dept Chem Engn, Ctr Appl Res Polymers, CRASP,Stn Ctr Ville, POB 6079, Montreal, PQ H3C 3A7, Canada.
CR Avgeropoulos G.N., 1976, RUBBER CHEM TECHNOL, V49, P93, DOI 10.5254/1.3534954
   Bendix D, 1998, POLYM DEGRAD STABIL, V59, P129, DOI 10.1016/S0141-3910(97)00149-3
   Biresaw G, 2002, J POLYM SCI POL PHYS, V40, P2248, DOI 10.1002/polb.10290
   Bourry D, 1998, J POLYM SCI POL PHYS, V36, P1889, DOI 10.1002/(SICI)1099-0488(199808)36:11<1889::AID-POLB10>3.0.CO;2-3
   Bousmina M, 1999, J RHEOL, V43, P415, DOI 10.1122/1.551044
   Calberg C, 1999, J PHYS D APPL PHYS, V32, P1517, DOI 10.1088/0022-3727/32/13/313
   Carlson D, 1998, POLYM ENG SCI, V38, P311, DOI 10.1002/pen.10192
   Carreau P. J., 1997, RHEOLOGY POLYM SYSTE
   Cigana P, 1996, J POLYM SCI POL PHYS, V34, P1691, DOI 10.1002/(SICI)1099-0488(19960715)34:9<1691::AID-POLB18>3.0.CO;2-2
   Cooper-White JJ, 1999, J POLYM SCI POL PHYS, V37, P1803, DOI 10.1002/(SICI)1099-0488(19990801)37:15<1803::AID-POLB5>3.0.CO;2-M
   COX WP, 1958, J POLYM SCI, V28, P619, DOI 10.1002/pol.1958.1202811812
   Dell'Erba R, 2001, POLYMER, V42, P7831, DOI 10.1016/S0032-3861(01)00269-5
   Dorgan JR, 1999, J RHEOL, V43, P1141, DOI 10.1122/1.551041
   ELEMANS PHM, 1990, J RHEOL, V34, P1311, DOI 10.1122/1.550087
   FAVIS BD, 1992, MAKROMOL CHEM-M SYMP, V56, P143, DOI 10.1002/masy.19920560116
   FAVIS BD, 1988, POLYMER, V29, P1761, DOI 10.1016/0032-3861(88)90388-6
   Favis BD, 2000, POLYM BLENDS, V1, P501
   Jacobsen S, 1996, POLYM ENG SCI, V36, P2799, DOI 10.1002/pen.10680
   JORDHAMO GM, 1986, POLYM ENG SCI, V26, P517, DOI 10.1002/pen.760260802
   Ke TY, 2001, J APPL POLYM SCI, V81, P3069, DOI 10.1002/app.1758
   LAUN HM, 1986, J RHEOL, V30, P459, DOI 10.1122/1.549855
   Lee JK, 1999, POLYMER, V40, P6277, DOI 10.1016/S0032-3861(99)00022-1
   Li J, 2001, POLYMER, V42, P5047, DOI 10.1016/S0032-3861(00)00785-0
   Li JM, 2002, POLYMER, V43, P4935, DOI 10.1016/S0032-3861(02)00277-X
   Li JM, 2002, MACROMOLECULES, V35, P2005, DOI 10.1021/ma010104+
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   MATOS M, 1995, POLYMER, V36, P3899, DOI 10.1016/0032-3861(95)99784-R
   METELKIN VI, 1984, COLLOID J USSR+, V46, P425
   Mezghani K, 1998, J POLYM SCI POL PHYS, V36, P1005, DOI 10.1002/(SICI)1099-0488(19980430)36:6<1005::AID-POLB9>3.3.CO;2-L
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Palade LI, 2001, MACROMOLECULES, V34, P1384, DOI 10.1021/ma001173b
   PAUL DR, 1980, J MACROMOL SCI R M C, VC18, P109, DOI 10.1080/00222358008080917
   Polizu S, 1999, MACROMOLECULES, V32, P3448, DOI 10.1021/ma981481y
   Ramkumar DHS, 1998, POLYM ENG SCI, V38, P1426, DOI 10.1002/pen.10313
   SALTIKOV SA, 1967, P 2 INT C STER HEL N
   SARAZIN P, 2001, ANN TECHN C SOC PLAS, V47, P2276
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   Schmack G, 1999, J APPL POLYM SCI, V73, P2785, DOI 10.1002/(SICI)1097-4628(19990929)73:14<2785::AID-APP1>3.3.CO;2-C
   Sheth M, 1997, J APPL POLYM SCI, V66, P1495, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1495::AID-APP10>3.0.CO;2-3
   Son Y, 2002, POLYMER, V43, P3001, DOI 10.1016/S0032-3861(02)00097-6
   Steinmann S, 2001, POLYMER, V42, P6619, DOI 10.1016/S0032-3861(01)00100-8
   Taubner V, 2001, J APPL POLYM SCI, V79, P2128, DOI 10.1002/1097-4628(20010321)79:12<2128::AID-APP1020>3.0.CO;2-#
   UTRACKI LA, 1991, J RHEOL, V35, P1615, DOI 10.1122/1.550248
   VANOENE H, 1972, J COLLOID INTERF SCI, V40, P448, DOI 10.1016/0021-9797(72)90355-4
   Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273
   Willemse RC, 1999, POLYMER, V40, P827, DOI 10.1016/S0032-3861(98)00307-3
   YUAN Z, UNPUB BIOMATERIALS
NR 47
TC 88
Z9 88
U1 5
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2003
VL 4
IS 6
BP 1669
EP 1679
DI 10.1021/bm030034+
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 746CV
UT WOS:000186729700027
PM 14606894
DA 2018-10-20
ER

PT J
AU Gonzalez, P
   Serra, J
   Liste, S
   Chiussi, S
   Leon, B
   Perez-Amor, M
   Martinez-Fernandez, J
   de Arellano-Lopez, AR
   Varela-Feria, FM
AF Gonzalez, P
   Serra, J
   Liste, S
   Chiussi, S
   Leon, B
   Perez-Amor, M
   Martinez-Fernandez, J
   de Arellano-Lopez, AR
   Varela-Feria, FM
TI New biomorphic SiC ceramics coated with bioactive glass for biomedical
   applications
SO BIOMATERIALS
LA English
DT Article
DE bioactive glass; silicon carbide; bioceramics; pulsed laser ablation;
   biomaterials
ID SILICON-CARBIDE
AB A new generation of light, tough and high-strength material for medical implants for bone substitutions with a good biological response is presented. The innovative product that fulfills all these requirements is based on biomorphic silicon carbide ceramics coated with a bioactive glass layer. The combination of the excellent mechanical properties and low density of the biomorphic SiC ceramics, used as a base material for implants, with the osteoconducting properties of the bioactive glass materials opens new possibilities for the development of alternative dental and orthopedic implants with enhanced mechanical and biochemical properties that ensures optimum fixation to living tissue.
   Biomorphic SiC is fabricated by molten-Si infiltration of carbon templates obtained by controlled pyrolysis of wood. Through this process, the microstructure of the final SiC product mimics that of the starting wood, which has been perfected by natural evolution. The basic features of such microstructure are its porosity (ranging from 30% to 70%) and its anisotropy, which resembles the cellular microstructure and the mechanical characteristics of the bone.
   The SiC ceramics have been successfully coated with a uniform and adherent bioactive glass film by pulsed laser ablation using an excimer ArF laser. The excellent coverage of the SiC rough surface without film spallation or detachment is demonstrated.
   In order to assess the coating bioactivity, in vitro tests by soaking the samples in simulated body fluid have been carried out. After 72 h, the formation of a dense apatite layer has been observed even in interconnecting pores by SEM and energy dispersive X-ray spectroscopy analysis demonstrating the bioactive response of this product. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Vigo, Dept Fis Aplicada, Vigo 36280, Spain.
   Univ Sevilla, Dept Fis Mat Condensada, E-41080 Seville, Spain.
RP Gonzalez, P (reprint author), Univ Vigo, Dept Fis Aplicada, Lagoas Marcosende 9, Vigo 36280, Spain.
RI MARTINEZ FERNANDEZ, JULIAN/K-1826-2012; Chiussi, Stefano/D-6218-2014;
   New Materials Group, FA3/D-6799-2014
OI MARTINEZ FERNANDEZ, JULIAN/0000-0002-1199-6638; Chiussi,
   Stefano/0000-0002-3933-8725; New Materials Group,
   FA3/0000-0003-4286-2015; R. de Arellano Lopez,
   Antonio/0000-0002-7443-0244; Serra, Julia/0000-0001-6187-4025; GONZALEZ,
   PIO/0000-0002-7353-712X
CR AITASALO K, 2001, KEY ENG MATER, V192, P877
   Arias JL, 2000, APPL SURF SCI, V154, P434, DOI 10.1016/S0169-4332(99)00457-2
   Brunette D. M., 2001, TITANIUM MED
   Chrisey D., 1994, PULSED LASER DEPOSIT
   D'Alessio L, 1999, APPL SURF SCI, V138, P527, DOI 10.1016/S0169-4332(98)00610-2
   Gibson L. J., 1988, CELLULAR SOLIDS
   Greil P, 1999, MATER CHEM PHYS, V61, P64, DOI 10.1016/S0254-0584(99)00115-7
   HENCH L, 1993, INTRO BIOCERAMICS
   KOKUBO T, 1993, BIOCERAMICS, V6, P327
   Lai W, 2002, BIOMATERIALS, V23, P213, DOI 10.1016/S0142-9612(01)00097-7
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Mangonon P.L., 1999, PRINCIPLES MAT SELEC
   Martinez-Fernandez J, 2000, SCRIPTA MATER, V43, P813, DOI 10.1016/S1359-6462(00)00494-2
   SERRA J, 2001, KEY ENG MATER, V192, P635
   SINGH M, 1994, J MATER RES, V9, P1701, DOI 10.1557/JMR.1994.1701
   Singh M., 2000, CERAM SCI ENG P, V21, P39
   Singh M., 2001, CERAM ENG SCI P, V22, P135
   Varela-Feria F. M., 2002, Ceramic Engineering and Science Proceedings, V23, P681
   Varela-Feria F. M., 2002, BOL SOC ESP CERAM V, V41, P377
   Varela-Feria FM, 2002, J EUR CERAM SOC, V22, P2719, DOI 10.1016/S0955-2219(02)00137-1
   Yamamuro T., 1990, HDB BIOACTIVE CERAMI
   YLANEN HO, 2001, KEY ENG MATER, V192, P613
NR 22
TC 115
Z9 124
U1 4
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2003
VL 24
IS 26
BP 4827
EP 4832
DI 10.1016/S0142-9612(03)00405-8
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 734DK
UT WOS:000186039800011
PM 14530079
DA 2018-10-20
ER

PT J
AU Nishinari, K
   Takahashi, R
AF Nishinari, K
   Takahashi, R
TI Interaction in polysaccharide solutions and gels
SO CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
LA English
DT Review
DE cellulose derivatives; hyaluronan; konjac glucomannan; xyloglucan;
   K-carrageenan; gellan gum; succinoglycan; xanthan; curdlan;
   schizophyllan
ID ANISOTROPIC XANTHAN SOLUTIONS; AQUEOUS SODIUM-CHLORIDE; SINGLE-STRANDED
   RNA; MOLECULAR-WEIGHT SAMPLE; ALKALI-METAL IONS; KAPPA-CARRAGEENAN;
   GELATION MECHANISM; GELLAN GUM; POLYNUCLEOTIDE COMPLEXES;
   TEMPERATURE-DEPENDENCE
AB Recent advances from 2000 to 2003 in understanding the physicochemical properties of polysaccharide solutions and gels are reviewed in the present paper. Polysaccharides described are cellulose derivatives, hyaluronan, konjac glucomannan, xyloglucan, kappa-carrageenan, gellan gum, succinoglycan, xanthan, curdlan and schizophyllan. All these polysaccharides are important materials in food, pharmaceutical, cosmetic and related biomedical industries. Topics on conformational change and sol-to-gel transition of these polysaccharides are selected. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Osaka 5588585, Japan.
RP Nishinari, K (reprint author), Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Osaka 5588585, Japan.
RI TAKAHASHI, RHEO/C-9754-2009
OI TAKAHASHI, RHEO/0000-0002-1058-0438
CR Almond A, 2000, J PHYS CHEM B, V104, P5634, DOI 10.1021/jp000402t
   Annaka M, 2001, BIOMACROMOLECULES, V2, P635, DOI 10.1021/bm005634c
   FANG Y, 2003, IN PRESS BIOPOLYMERS
   Huang L, 2002, BIOMACROMOLECULES, V3, P1296, DOI 10.1021/bm0255995
   Huang L., 2001, T MAT RES SOC JPN, V26, P597
   Ikeda S, 2001, BIOMACROMOLECULES, V2, P1331, DOI 10.1021/bm015610l
   Ikeda S, 2001, J AGR FOOD CHEM, V49, P4436, DOI 10.1021/jf0103065
   Kido S, 2001, BIOMACROMOLECULES, V2, P952, DOI 10.1021/bm010064h
   Kimura T, 2000, CHEM LETT, P1242, DOI 10.1246/cl.2000.1242
   KITA R, 2002, PHYSICA A, V319, P56
   KOUMOTO K, 2001, CHEM COMMUN, V19, P1962
   Krause WE, 2001, BIOMACROMOLECULES, V2, P65, DOI 10.1021/bm0055798
   Lee HC, 2002, BIOMACROMOLECULES, V3, P742, DOI 10.1021/bm025510v
   Lee HC, 2002, MACROMOLECULES, V35, P2212, DOI 10.1021/ma011526m
   Lee HC, 2002, MACROMOLECULES, V35, P2223, DOI 10.1021/ma011527e
   Li L, 2002, LANGMUIR, V18, P7291, DOI 10.1021/la020029b
   Li L, 2001, LANGMUIR, V17, P8062, DOI 10.1021/la010917r
   Li L, 2002, MACROMOLECULES, V35, P5990, DOI 10.1021/ma0201781
   MIZU M, 2001, CHEM COMMUN, V5, P429
   Mo YQ, 2001, BIORHEOLOGY, V38, P379
   Nakanishi T, 2003, BIOMACROMOLECULES, V4, P736, DOI 10.1021/bm020132f
   Nakanishi T, 2001, POLYM BULL, V47, P47, DOI 10.1007/s002890170020
   Nishinari K, 2000, CURR OPIN COLLOID IN, V5, P195, DOI 10.1016/S1359-0294(00)00053-4
   Nishinari K., 2001, GUMS STABILISERS FOO, P85
   Nishinari K., 2000, REP PROG POLYM PHYS, V43, P163
   NITTA Y, 2003, IN PRESS BIOMACROMOL
   Nitta Y., 2001, T MAT RES SOC JPN, V26, P621
   Ogawa E, 2002, FOOD HYDROCOLLOID, V16, P1, DOI 10.1016/S0268-005X(01)00024-8
   Ogawa E, 1999, PROG COLL POL SCI S, V114, P8, DOI 10.1007/3-540-48349-7_2
   Ogawa E., 2001, T MAT RES SOC JPN, V26, P613
   OGAWA E, 2003, T MAT RES SOC JPN, V28
   OGAWA E, 2001, T MAT RES SOC JPN, V26, P617
   Picout DR, 2003, BIOMACROMOLECULES, V4, P799, DOI 10.1021/bm0257659
   Roy C, 2003, BIOMACROMOLECULES, V4, P259, DOI 10.1021/bm020100s
   Sakurai K, 2001, BIOMACROMOLECULES, V2, P641, DOI 10.1021/bm000121r
   Sakurai K, 2000, J AM CHEM SOC, V122, P4520, DOI 10.1021/ja0000145
   Takahashi R, 2003, BIOMACROMOLECULES, V4, P404, DOI 10.1021/bm025706v
   Takahashi R, 1999, PROG COLL POL SCI S, V114, P1, DOI 10.1007/3-540-48349-7_1
   Takemasa M, 2002, MACROMOLECULES, V35, P5595, DOI 10.1021/ma020206f
   Takemasa M, 2001, MACROMOLECULES, V34, P7427, DOI 10.1021/ma0102924
   WATASE M, 1982, COLLOID POLYM SCI, V260, P971, DOI 10.1007/BF01413132
   Williams MAK, 2000, BIOMACROMOLECULES, V1, P440, DOI 10.1021/bm005525y
   YOSHIBA K, 2002, MACROMOLECULES, V36, P2108
   Zhang H, 2001, BIOPOLYMERS, V59, P38, DOI 10.1002/1097-0282(200107)59:1<38::AID-BIP1004>3.0.CO;2-A
   Zhang HB, 2002, INT J BIOL MACROMOL, V30, P7, DOI 10.1016/S0141-8130(01)00187-8
   1999, PROG COLLOID POLYM S, P114
NR 46
TC 61
Z9 63
U1 6
U2 73
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1359-0294
J9 CURR OPIN COLLOID IN
JI Curr. Opin. Colloid Interface Sci.
PD NOV
PY 2003
VL 8
IS 4-5
BP 396
EP 400
AR PII S1359-0294(03)00099-2
DI 10.1016/S1359-0294(03)00099-2
PG 5
WC Chemistry, Physical
SC Chemistry
GA 754MV
UT WOS:000187321700012
DA 2018-10-20
ER

PT J
AU Sionkowska, A
AF Sionkowska, A
TI Interaction of collagen and poly(vinyl pyrrolidone) in blends
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE collagen; poly(vinyl pyrrolidone); miscibility; hydrogen bonds
ID BIOARTIFICIAL POLYMERIC MATERIALS; BIOMATERIALS; MISCIBILITY; VISCOMETRY
AB The interaction between collagen and poly(vinyl pyrrolidone) (PVP) in blends has been studied by viscometry, differential scanning calorimetry (DSC) and by Fourier transform infrared spectroscopy (FTIR). It was found that the amide A and amide I bands position in FTIR spectra of collagen were shifted after blending with PVP to higher wavenumbers. DSC measurements showed different melting temperature, glass transition temperature and enthalpy for the blends and for the single components. Viscosity measurements showed interaction between collagen and PVP also in a dilute water solution.
   The results have shown, that the interactions between collagen and PVP exist due to the strong interactions between the synthetic and biological component, mainly by hydrogen bonds. These interactions caused that collagen and PVP are miscible at molecular level. The blending of collagen with PVP may give the possibility of producing new materials for potential biomedical applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Nicholas Copernicus Univ, Fac Chem, PL-87100 Torun, Poland.
RP Sionkowska, A (reprint author), Nicholas Copernicus Univ, Fac Chem, Gagarin 7, PL-87100 Torun, Poland.
RI Sionkowska, Alina/I-5599-2014
CR Bailey AJ, 1998, J SOC LEATH TECH CH, V82, P104
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Cascone MG, 1996, J BIOMAT SCI-POLYM E, V7, P917, DOI 10.1163/156856296X00084
   Cervantes-Sanehez CR, 2003, J SURG RES, V110, P207, DOI 10.1006/jsre.2002.6596
   Chee MJK, 2002, POLYMER, V43, P1235, DOI 10.1016/S0032-3861(01)00725-X
   Ciardelli G, 2002, MACROMOL CHEM PHYSIC, V203, P1666, DOI 10.1002/1521-3935(200207)203:10/11<1666::AID-MACP1666>3.0.CO;2-D
   COTE MF, 1992, BIOMATERIALS, V13, P612, DOI 10.1016/0142-9612(92)90029-N
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   HUC A, 1985, J AM LEATHER CHEM AS, V80, P195
   Kaminska A, 1996, POLYM DEGRAD STABIL, V51, P19, DOI 10.1016/0141-3910(95)00159-X
   PIEZ KA, 1994, EXTRACELLULAR MATRIX, P1
   Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   ROSIAK J, 1989, POLIMERY MEDYCYNIE, V19
   ROSIAK J, 1987, POLIMERY MEDYCYNIE, V17
   Silver F.H., 1987, BIOL MAT STRUCTURE M, P7
   VANDERREST M, 1991, FASEB J, V5, P2814
   Zhu PP, 1997, EUR POLYM J, V33, P411
NR 18
TC 47
Z9 48
U1 1
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD NOV
PY 2003
VL 39
IS 11
BP 2135
EP 2140
DI 10.1016/S0014-3057(03)00161-7
PG 6
WC Polymer Science
SC Polymer Science
GA 745EN
UT WOS:000186676500007
DA 2018-10-20
ER

PT J
AU Barbucci, R
   Consumi, M
   Lamponi, S
   Leone, G
AF Barbucci, R
   Consumi, M
   Lamponi, S
   Leone, G
TI Polysaccharides based hydrogels for biological applications
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 10th IUPAC International Symposium on Macromolecule-Metal Complexes
CY MAY 18-23, 2003
CL MOSCOW, RUSSIA
SP Int Union Pure & Appl Chem
DE adhesion; hydrogels; mechanical properties; microporosity;
   polysaccharides
ID HYALURONIC-ACID; CHITOSAN; TRANSPLANTATION; BIOMATERIALS; POLYMER
AB Polysaccharides based hydrogels show several peculiar properties which can be so reassumed:
   Capability to absorb a great amount of water once immersed in biological fluids, assuming, consequently, a structure similar to extracellular matrix or biological tissue
   Tissotropic property, i.e. possibility to be injected through a needle without lose of their rheological properties.
   These fundamental properties make them ideal materials for several biomedical applications, such as cellular scaffold, coatings for biomedical disposals, treatments for different diseases, controlled release of drugs, etc. Hyaluronane, Carboxymethyl cellulose and Alginic acid based 50% hydrogels (i.e. 50% of the carboxylate groups present in the macromolecule chain were involved in the cross-linking reaction) are synthesised. Their effectiveness in promoting cells adhesion and proliferation was verified. Furthermore the possibility of injecting and sterilising hydrogels permitted to test the effect of Hyal 50% in the osteoarthritis therapy. It was found that the in vivo effect of Hyal 50% in the treatment of surgically created chondral defect in the rabbit knee was positive. These materials can be both chemically and morphologically modified. In fact, the insertion of sulphate groups increase their hemocompatibility as demonstred by the increase of TT (time necessary to turn the fibrinogen to thrombin). Furthermore microporous hydrogels were obtained and tested as drug controlled release systems.
C1 Univ Siena, CRISMA, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, CRISMA, Dept Chem & Biosyst Sci & Technol, Via Aldo Moro N 2, I-53100 Siena, Italy.
CR Barbucci R, 2002, MACROMOL CHEM PHYSIC, V203, P1292, DOI 10.1002/1521-3935(200207)203:10/11<1292::AID-MACP1292>3.0.CO;2-I
   Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1
   Barbucci R, 2000, J INORG BIOCHEM, V79, P119, DOI 10.1016/S0162-0134(00)00007-6
   Barbucci R, 2000, J BIOMAT SCI-POLYM E, V11, P383, DOI 10.1163/156856200743779
   BARBUCEI R, UNPUB J BIOMED MAT R
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Han F, 1999, Nagoya J Med Sci, V62, P115
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Kim SJ, 2003, REACT FUNCT POLYM, V55, P53, DOI 10.1016/S1381-5148(02)00214-6
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   Magnani A, 1998, POLYM INT, V46, P225, DOI 10.1002/(SICI)1097-0126(199807)46:3<225::AID-PI45>3.0.CO;2-I
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Noble L, 1999, INT J PHARM, V192, P173, DOI 10.1016/S0378-5173(99)00306-3
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   RODEN L, 1989, CIBA FDN S, V143
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sakakibara Y, 2002, J THORAC CARDIOV SUR, V124, P50, DOI 10.1067/mtc.2002.121293
   Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Virender K. S., 1981, ANAL BIOCHEM, V117, P147
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   ZHONG SP, 1994, BIOMATERIALS, V15, P359, DOI 10.1016/0142-9612(94)90248-8
NR 27
TC 19
Z9 19
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD NOV
PY 2003
VL 204
BP 37
EP 58
DI 10.1002/masy.200351405
PG 22
WC Polymer Science
SC Polymer Science
GA 756FM
UT WOS:000187455200006
DA 2018-10-20
ER

PT J
AU Zaugg, FG
   Wagner, P
AF Zaugg, FG
   Wagner, P
TI Drop-on-demand printing of protein biochip arrays
SO MRS BULLETIN
LA English
DT Article
DE biochips; biocompatibility; biomaterials; biomedical materials;
   coatings; inkjet printing
ID SELF-ASSEMBLED MONOLAYERS; MICROARRAY TECHNOLOGY; GENE-EXPRESSION
AB Protein biochips have recently gained a lot of attention as bioanalytical tools in the life sciences. The creation of such biochips has been made possible by the integration of scientific approaches and methodologies in microfabrication, organic interface chemistry, protein engineering, detection physics, and-last but not least-advances in microarrays and microfluidic dispensing technologies. This article reviews some of the current drop-on-demand technologies developed for printing biomolecular arrays, with an emphasis on proteins and the technical challenges associated with them.
CR Allain LR, 2001, FRESEN J ANAL CHEM, V371, P146, DOI 10.1007/s002160100962
   Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439
   Creighton T. E., 1993, PROTEINS STRUCTURES
   Delehanty JB, 2003, BIOTECHNIQUES, V34, P380, DOI 10.2144/03342mt02
   Eisen MB, 1999, METHOD ENZYMOL, V303, P179
   Forman JE, 2003, METHOD ENZYMOL, V361, P530
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Lee ER, 2003, MICRODROP GENERATION
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   MacBeath G, 2000, SCIENCE, V289, P1760
   Madou M. J., 2002, FUNDAMENTALS MICROFA
   Pace CN, 1996, FASEB J, V10, P75
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   Ruiz-Taylor LA, 2001, P NATL ACAD SCI USA, V98, P852, DOI 10.1073/pnas.98.3.852
   Schaeferling M, 2002, ELECTROPHORESIS, V23, P3097, DOI 10.1002/1522-2683(200209)23:18<3097::AID-ELPS3097>3.0.CO;2-G
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schena M, 1999, DNA MICROARRAYS PRAC
   Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2
   Theriault TP, 1999, PRACT APPROACH SER, V205, P101
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Wagner P, 1996, BIOPHYS J, V70, P2052, DOI 10.1016/S0006-3495(96)79810-7
   WAGNER P, 2002, CURR DRUG DISCOV, V5, P23
   Wilson DS, 2003, ANGEW CHEM INT EDIT, V42, P494, DOI 10.1002/anie.200390150
NR 23
TC 31
Z9 32
U1 1
U2 15
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD NOV
PY 2003
VL 28
IS 11
BP 837
EP 842
DI 10.1557/mrs2003.233
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 743WP
UT WOS:000186596800018
DA 2018-10-20
ER

PT J
AU Imbeni, V
   Martini, C
   Prandstraller, D
   Poli, A
   Trepanier, C
   Duerig, TW
AF Imbeni, V
   Martini, C
   Prandstraller, D
   Poli, A
   Trepanier, C
   Duerig, TW
TI Preliminary study of micro-scale abrasive wear of a NiTi shape memory
   alloy
SO WEAR
LA English
DT Article
DE NiTi; shape memory; micro-scale abrasion; biomedical applications; wear
ID PSEUDOELASTIC TINI ALLOY; RESISTANT MATERIAL; BEHAVIOR; ANGULARITY
AB Nitinol (NiTi), a nearly equiatomic nickel-titanium alloy is known for its unique shape memory and superelastic properties, which result from martensitic transformations. It is the material of choice for numerous biomedical applications such as endovascular stents, vena cava filters, dental files and guidewires for non-invasive surgery, etc. Micro-scale abrasion tests (MSATs) have been performed on the NiTi shape memory alloy, so as to evaluate the influence of different commercial abrasives such as silicon carbide, alumina and glass on the wear behaviour. The aim of the work was the selection of the most effective abrasive for cleaning the inner surface of laser-cut cardiovascular stents. Abrasive particles have been characterised by X-ray diffraction, SEM and EDS before and after MSATs. Worn surfaces have been studied by stylus profilometry, SEM and atomic force microscopy. The effect of abrasive particle hardness, size and angularity on the wear behaviour has been evaluated and discussed. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Univ Bologna, Inst Met, Bologna, Italy.
   Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
   Nitinol Devices & Components, Fremont, CA 94539 USA.
RP Imbeni, V (reprint author), 239 Brannan St,Apt 3E, San Francisco, CA 94107 USA.
RI MARTINI, CARLA/R-3924-2016
OI MARTINI, CARLA/0000-0001-9281-6469
CR Cheng FT, 2001, SCRIPTA MATER, V45, P1083, DOI 10.1016/S1359-6462(01)01143-5
   De Pellegrin DV, 2001, WEAR, V247, P109, DOI 10.1016/S0043-1648(00)00512-3
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Duerig TW, 2000, MINIM INVASIV THER, V9, P235, DOI 10.1080/13645700009169654
   Es-Souni M, 2001, BIOMATERIALS, V22, P2153, DOI 10.1016/S0142-9612(00)00406-3
   HUTCHINGS IM, 1992, TRIBOLOGY FRICTION W, P135
   Li DY, 1996, SCRIPTA MATER, V34, P195, DOI 10.1016/1359-6462(95)00515-3
   Li DY, 1998, WEAR, V221, P116, DOI 10.1016/S0043-1648(98)00269-5
   Lin HC, 1997, METALL MATER TRANS A, V28, P1871, DOI 10.1007/s11661-997-0117-3
   Lin HC, 2000, J MATER PROCESS TECH, V105, P327, DOI 10.1016/S0924-0136(00)00656-7
   Lin HC, 2001, WEAR, V249, P557, DOI 10.1016/S0043-1648(01)00580-4
   Liu R, 2000, MAT SCI ENG A-STRUCT, V277, P169, DOI 10.1016/S0921-5093(99)00534-1
   POPOOLA O, 1987, NUCL INSTRUM METH B, V26, P532, DOI 10.1016/0168-583X(87)90538-6
   Rutherford KL, 1997, J TEST EVAL, V25, P250
   Stachowiak GB, 2001, WEAR, V249, P201, DOI 10.1016/S0043-1648(01)00557-9
   Stachowiak GW, 1998, TRIBOL INT, V31, P139, DOI 10.1016/S0301-679X(98)00016-4
   Starosvetsky D, 2001, SURF COAT TECH, V148, P268, DOI 10.1016/S0257-8972(01)01356-1
   Trezona RI, 1999, WEAR, V225, P205, DOI 10.1016/S0043-1648(98)00358-5
   Trezona RI, 1999, WEAR, V233, P209, DOI 10.1016/S0043-1648(99)00183-0
   TREZONA RI, 2000, THESIS U CAMBRIDGE
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
   Wu SK, 1999, MATER LETT, V40, P27, DOI 10.1016/S0167-577X(99)00044-0
   Ye HZ, 2001, COMPOS SCI TECHNOL, V61, P987, DOI 10.1016/S0266-3538(00)00192-5
   Zhang TC, 2000, MAT SCI ENG A-STRUCT, V293, P208, DOI 10.1016/S0921-5093(00)01044-3
NR 24
TC 33
Z9 38
U1 2
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD NOV
PY 2003
VL 254
IS 12
BP 1299
EP 1306
DI 10.1016/S0043-1648(03)00092-9
PG 8
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 737TH
UT WOS:000186247500010
DA 2018-10-20
ER

PT J
AU Barron, V
   Lyons, E
   Stenson-Cox, C
   McHugh, PE
   Pandit, A
AF Barron, V
   Lyons, E
   Stenson-Cox, C
   McHugh, PE
   Pandit, A
TI Bioreactors for cardiovascular cell and tissue growth: A review
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE bioreactor; tissue engineering; arteries; heart valves; cardiac muscle;
   materials properties
ID SMOOTH-MUSCLE-CELLS; ENGINEERED CARDIAC-MUSCLE; IN-VITRO; VASCULAR
   GRAFTS; HEART-VALVES; PULSATILE BIOREACTOR; CYCLIC STRAIN; BLOOD-VESSEL;
   EXTRACELLULAR-MATRIX; SHEAR-STRESS
AB Heart disease is a major cause of death in the Western world. In the past three decades there has been a number of improvements in artificial devices and surgical techniques for cardiovascular disease: however. there is still a need for novel devices. especially for those individuals who cannot receive conventional therapy. The major disadvantage of current artificial devices lies in the fact that they cannot grow, remodel, or repair in vivo. Tissue engineering offers the possibility of developing a biological substitute material in vitro with the inherent mechanical. chemical, biological, and morphological properties required in vivo, on an individual patient basis. In order to develop a true biological cardiovascular device a dynamic Physiological environment needs to be created. One approach that employs the use of a simulated biological environment is a bioreactor in which the in vivo biomechanical and biochemical conditions are created in vitro for functional tissue development. A review, of the current state of the art bioreactors for the generation of tissue engineered cardiovascular devices is presented in this study. The effect of the simulated physiological environment of the bioreactor on tissue development is examined with respect to the materials properties of vascular grafts. heart valves. and cardiac muscles developed in these bioreactors. (C) 2003 Biomedical Engineering Society.
C1 Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
RP Barron, V (reprint author), Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
RI Barron, Valerie/C-5941-2014; Barron, Valerie/A-1468-2013; Pandit,
   Abhay/B-6187-2008
OI Barron, Valerie/0000-0001-5520-0649; Pandit, Abhay/0000-0002-6292-4933
CR *AM HEART ASS, 2001, 2002 HEART STROK STA
   An SS, 2000, AM J PHYSIOL-CELL PH, V279, pC1375
   Begley CM, 2000, BIOTECHNOL BIOENG, V70, P32, DOI 10.1002/1097-0290(20001005)70:1<32::AID-BIT5>3.0.CO;2-V
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Campbell JH, 1999, CIRC RES, V85, P1173
   CARRIER R, 2000, CARDIAC TISSUE ENG B
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Carrier RL, 2002, BIOTECHNOL BIOENG, V78, P617, DOI 10.1002/bit.10245
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   Conte MS, 1998, FASEB J, V12, P43
   *DEP HLTH CHILD IR, 1997, BUILD HEALTH HEARTS
   Dumont K, 2002, ARTIF ORGANS, V26, P710, DOI 10.1046/j.1525-1594.2002.06931_3.x
   DUMONT KA, 2001, 2 PHD S, P31
   DUNKELMANN N, 1998, APPARATUS METHOD STE
   Duray P H, 1997, Sci Med (Phila), V4, P46
   Edelman ER, 1999, CIRC RES, V85, P1115
   ELIZONDA DR, 1999, CARDIOVASCULAR BIORE
   *EUR COMM HLTH CON, 2001, SCI COMM MED PROD ME
   Feng YJ, 1999, CIRC RES, V85, P1118
   Freed L E, 1999, Gravit Space Biol Bull, V12, P57
   Freed L. E., 2000, PRINCIPLES TISSUE EN, P143
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   FREED LE, 2002, METHODS TISSUE ENG, P97
   Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X
   Godbey WT, 2002, ANN NY ACAD SCI, V961, P10, DOI 10.1111/j.1749-6632.2002.tb03041.x
   GOLDSTEIN S, 1999, PULSATILE FLOW SYSTE
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   GRIFFITH LG, 2002, ANN NY ACAD SCI, V9661, P83
   Hipper A, 2000, PFLUG ARCH EUR J PHY, V440, P19, DOI 10.1007/s004240051017
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Hoerstrup SP, 2000, TISSUE ENG, V6, P75, DOI 10.1089/107632700320919
   Holzapfel G.A., 2000, HDB MAT BEHAV NONLIN
   HSU K, 2001, TISSUE ENG HEART VAL
   Jiang Meei Jyh, 1999, Journal of Cellular Biochemistry, V76, P303
   Jockenhoevel S, 2002, ASAIO J, V48, P8, DOI 10.1097/00002480-200201000-00003
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kofidis T, 2002, EUR J CARDIO-THORAC, V22, P238, DOI 10.1016/S1010-7940(02)00256-7
   L'Heureux N, 1998, FASEB J, V12, P47
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Lee RT, 2001, J BIOL CHEM, V276, P13847, DOI 10.1074/jbc.M010556200
   Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273
   Ma YH, 1999, BIOCHEM BIOPH RES CO, V265, P606, DOI 10.1006/bbrc.1999.1718
   Mann BK, 2001, ANAT REC, V263, P367, DOI 10.1002/ar.1116
   Naughton G K, 1995, Tissue Eng, V1, P211, DOI 10.1089/ten.1995.1.211
   NEITZEL GP, 1999, P ASME BIOENG C CELL
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Nguyen KT, 2001, HYPERTENSION, V38, P1038, DOI 10.1161/hy1101.092840
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 2002, ANN NY ACAD SCI, V961, P220, DOI 10.1111/j.1749-6632.2002.tb03089.x
   Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
   Niklason LE, 2002, METHODS TISSUE ENG, P905
   O'Callaghan CJ, 2000, HYPERTENSION, V36, P319, DOI 10.1161/01.HYP.36.3.319
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   PETERSON AE, 2000, APPARATUS METHOD SIM
   PETERSON S, 2002, CORONARY HEART DIS S
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   Rabkin E, 2002, J HEART VALVE DIS, V11, P308
   Ratcliffe A, 2002, ANN NY ACAD SCI, V961, P210, DOI 10.1111/j.1749-6632.2002.tb03087.x
   Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522
   SELIKTAR D, 2000, DYNAMIC MECH CONDITI
   Shieh AC, 2003, ANN BIOMED ENG, V31, P1, DOI 10.1114/1.1535415
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Smith JD, 2001, ENDOTHELIUM-NEW YORK, V8, P41, DOI 10.3109/10623320109063156
   Sodian R, 2001, J BIOMED MATER RES, V58, P401, DOI 10.1002/jbm.1034
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   SODIAN R, 2001, P 30 ANN M GERM SOC
   Stanley A G, 2000, J Renin Angiotensin Aldosterone Syst, V1, P32, DOI 10.3317/jraas.2000.007
   STEGEMANN JP, 2001, P ASME BIOENG C CELL
   Sudhir K, 2001, AM J HYPERTENS, V14, P1128, DOI 10.1016/S0895-7061(01)02189-6
   Sutherland FWH, 2002, ASAIO J, V48, P346, DOI 10.1097/00002480-200207000-00003
   Teebken OE, 2000, EUR J VASC ENDOVASC, V19, P381, DOI 10.1053/ejvs.1999.1004
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0
   TSIAGKLI S, 2002, P AICHE ANN M KIND C
   Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901
   Vacanti JP, 1999, LANCET S1, V354, pSi32
   Vunjak-Novakovic G, 2002, ANN NY ACAD SCI, V974, P504, DOI 10.1111/j.1749-6632.2002.tb05927.x
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Weston MW, 1999, ANN BIOMED ENG, V27, P572, DOI 10.1114/1.199
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Williams KA, 2002, BIOTECHNOL PROGR, V18, P951, DOI 10.1021/bp020087n
   WOLFINBARGER L, 2002, TRANSPLANTABLE RECEL
   Xue L, 2000, PRINCIPLES TISSUE EN, P427
NR 91
TC 111
Z9 120
U1 1
U2 38
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD OCT
PY 2003
VL 31
IS 9
BP 1017
EP 1030
DI 10.1114/1.1603260
PG 14
WC Engineering, Biomedical
SC Engineering
GA 731WE
UT WOS:000185908800001
PM 14582605
DA 2018-10-20
ER

PT J
AU Weber, S
   Christ, D
   Kurzeja, M
   Engels, R
   Kemmerling, G
   Hailing, H
AF Weber, S
   Christ, D
   Kurzeja, M
   Engels, R
   Kemmerling, G
   Hailing, H
TI Comparison of LuYAP, LSO, and BGO as scintillators for high resolution
   PET detectors
SO IEEE TRANSACTIONS ON NUCLEAR SCIENCE
LA English
DT Article
DE biomedical imaging; crystals; positron emission tomography (PET);
   radiation detectors; scintillation detectors
AB For high resolution positron emission tomographs based on scintillation detectors a fast, dense, and bright scintillator is required. A sample of a new scintillator, Lu0.8Y0.2AlO3:Ce (LuYAP) with a density of 7.7 g/cm(3) and a scintillation decay time of 20 and 160 ns is compared with LSO and BGO crystals of the same size to estimate the potential of the crystal for high resolution PET detectors. Special attention was paid to use an application specific measurement setup with respect to high resolution PET. The light yield of the crystals using polished crystals as well as PTFE tape and BaSO4 as reflector material and the temperature dependence of the light yield are measured using crystals of 2 x 2 X 10 mm(3). At room temperature, the light yields of BGO : LuYAP : LSO are 1: 1.5:4.5 with energy resolutions of 27.4% (BGO), 20% (LuYAP) and 15% (LSO), respectively. LuYAP shows an increase in light yield with increasing temperature whereas both BGO and LSO show a decrease.
C1 Forschungszentrum Juelich Helmholtz Gemeinschaft, Cent Elect Lab, D-52425 Julich, Germany.
RP Weber, S (reprint author), Forschungszentrum Juelich Helmholtz Gemeinschaft, Cent Elect Lab, D-52425 Julich, Germany.
RI Beer, Simone/E-1486-2017
OI Beer, Simone/0000-0003-4290-4051
CR Belsky AN, 2001, IEEE T NUCL SCI, V48, P1095, DOI 10.1109/23.958730
   Casey ME, 1997, IEEE T NUCL SCI, V44, P1109, DOI 10.1109/23.596973
   Chatziioannou AF, 2002, EUR J NUCL MED, V29, P98, DOI 10.1007/s00259-001-0683-3
   DOSHI NK, 2002, P C REC IEE NSS MIC
   Korzhik M, 2001, IEEE T NUCL SCI, V48, P628, DOI 10.1109/23.940137
   KUNTNER C, 2002, P C REC IEEE NSS MIC
   KUNTNER C, 2002, NUCL INSTRUM METH A, V186, P176
   MELCHER CL, 1992, IEEE T NUCL SCI, V39, P502, DOI 10.1109/23.159655
   STEUN M, 2003, P C REC IEEE NSS MIC
   WEBER S, 2000, J NUCL MED, V41, P73
NR 10
TC 59
Z9 62
U1 0
U2 14
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9499
J9 IEEE T NUCL SCI
JI IEEE Trans. Nucl. Sci.
PD OCT
PY 2003
VL 50
IS 5
BP 1370
EP 1372
DI 10.1109/TNS.2003.817952
PN 2
PG 3
WC Engineering, Electrical & Electronic; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA 732CA
UT WOS:000185922200009
DA 2018-10-20
ER

PT J
AU Buscher, R
   Fischer, A
AF Buscher, R
   Fischer, A
TI Metallurgical aspects of sliding wear of fcc materials for medical
   applications
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
DE sliding wear; wear mechanisms; austenitic steels; cobase alloys; wear
   particles
ID HIP PROSTHESES; BEHAVIOR; METAL; ENDOPROSTHESES; DEFORMATION; PRODUCTS;
   FATIGUE; ENERGY; BALL
AB Worn surfaces of biomedical fee alloys X2CrNiMo18-15-3, CoCr29Mo6, X13CrMnMoN18-14-3 are generated by sliding wear in order to understand the mechanisms, which bring about small wear particles. Depending on the acting wear mechanisms the debris is produced by different sites of crack initiation and paths of crack propagation. Thus, the subsurface deformation mechanisms are investigated as well. This investigation revealed that the worn surfaces of all three materials consist of a nanocrystalline layer underneath which appearances of cyclic deformation are visible. With respect to the stacking fault energy X13CrMnMoN18-14-3 as well as the CoCr29Mo6 depict sliding bands, stacking faults, and strain induced epsilon-marten site bringing about a sufficient support of the nanocrystalline layer. Thus, 80 to 500 nm fine globular and lamellar wear particles are just torn off this layer. In contrast to this, X2CrNiMo18-15-3 shows cell walls in distances of about 50 p in below the worn surfaces, which act as sites for crack initiation and propagation. The mean wear particles are about an order of magnitude bigger and range from 20 to 250 pin. Due to the fact that the nanocrystalline layer is not supported by the material underneath it has no distinct positive effect on the wear rate.
C1 Univ Duisburg Gesamthsch, Inst Produkt Engn, D-47057 Duisburg, Germany.
RP Buscher, R (reprint author), Univ Duisburg Gesamthsch, Inst Produkt Engn, Werkstofftech 2, D-47057 Duisburg, Germany.
CR *ASTM, 2003, F222902 ASTM
   *ASTM, 2000, F153700 ASTM
   ASTM (American Society for Testing Materials), 2000, F13800 ASTM
   BERNS H, 1993, WEAR, V162, P441, DOI 10.1016/0043-1648(93)90528-T
   BOUTIN P, 1972, REV CHIR ORTHOP, V58, P229
   Buckley D., 1984, TRIBOLOGY SERIES, V5
   BUSCHER R, 2003, IN PRESS J BIOMED MA
   BUSCHER R, 2002, P 13 INT C TRIB LUBR, P1297
   BUSCHER R, 2003, IN PRESS WEAR
   DAUTZENBERG JH, 1980, WEAR, V60, P401, DOI 10.1016/0043-1648(80)90238-0
   DAUTZENBERG JH, 1973, WEAR, V23, P9, DOI 10.1016/0043-1648(73)90036-7
   *DIN, 2000, ISO58321 DIN
   *DIN, 2001, ISO58326 DIN
   Fruh HJ, 1997, BIOMATERIALS, V18, P873, DOI 10.1016/S0142-9612(97)00005-7
   Gahr KHZ, 1987, TRIBOLOGY SERIES, V10
   GAVRILJUK V, 2003, IN PRESS STEEL RES
   Gobbeler P., 1998, VDI FORTSCHRITTSBE 5
   Hall RM, 1997, BIOMATERIALS, V18, P1017, DOI 10.1016/S0142-9612(97)00034-3
   HEILMANN P, 1982, RUNNINGIN PROCESS TR, P25
   KATO K, 1985, DISLOCATION DENSITY, P463
   KOCH S, 2002, MATERIALWISS WERKST, V33, P12
   LEWIS D, 1969, J APPL CRYSTALLOGR, V2, P249, DOI 10.1107/S0021889869007151
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   McKellop H, 1996, CLIN ORTHOP RELAT R, pS128
   MOORE MA, 1976, METALL T A, V7, P1976
   Quinn T F J, 1983, 3686 NASA, P3686
   RIGNEY DA, 1978, WEAR, V46, P241, DOI 10.1016/0043-1648(78)90125-4
   Rigney DA, 1997, TRIBOL INT, V30, P361, DOI 10.1016/S0301-679X(96)00065-5
   RUFF AW, 1978, WEAR, V40, P59
   SALESKI WJ, 1982, THESIS U CALIF, P100
   SALESKY WJ, 1983, P INT C WEAR MAT RES, P434
   Semlitsch M, 1997, P I MECH ENG H, V211, P73, DOI 10.1243/0954411971534700
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Sikorski M. E., 1964, WEAR, V7, P144
   Sullivan JL, 1987, P C TRIB FRICT LUBR, P283
   Thomann UI, 2000, WEAR, V239, P48, DOI 10.1016/S0043-1648(99)00372-5
   Tikhovski I, 2003, AM SOC TEST MATER, V1438, P119, DOI 10.1520/STP11159S
   VANDIJCK JAB, 1977, WEAR, V42, P109, DOI 10.1016/0043-1648(77)90172-7
   WEBER BG, 1989, ORTHOPADE, V18, P370
   WERT JJ, 1983, WEAR, V92, P213, DOI 10.1016/0043-1648(83)90196-5
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   Willert HG, 1996, CLIN ORTHOP RELAT R, P4
   WILLERT HG, 1996, CLIN ORTHOP RELAT R, V329, P160
   Wimmer MA, 2001, WEAR, V250, P129, DOI 10.1016/S0043-1648(01)00654-8
   WIMMER MA, 2003, IN PRESS WEAR
   Zardiackas LD, 2003, AM SOC TEST MATER, V1438, P194, DOI 10.1520/STP11164S
   ZHU Y, 1989, MAT SCI ENG A-STRUCT, V113, P297, DOI 10.1016/0921-5093(89)90318-3
   2002, GFT ARBEITSBLATT, V7
NR 48
TC 18
Z9 18
U1 0
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD OCT-NOV
PY 2003
VL 34
IS 10-11
BP 966
EP 975
DI 10.1002/mawe.200300680
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 736GQ
UT WOS:000186163400011
DA 2018-10-20
ER

PT J
AU Moore, VC
   Strano, MS
   Haroz, EH
   Hauge, RH
   Smalley, RE
   Schmidt, J
   Talmon, Y
AF Moore, VC
   Strano, MS
   Haroz, EH
   Hauge, RH
   Smalley, RE
   Schmidt, J
   Talmon, Y
TI Individually suspended single-walled carbon nanotubes in various
   surfactants
SO NANO LETTERS
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; POLYMERS; SOLUBILIZATION; ADSORPTION;
   MACROMERS; WATER
AB Individual single-walled carbon nanotubes (SWNTs) have been suspended in aqueous media using various anionic, cationic, nonionic surfactants and polymers. The surfactants are compared with respect to their ability to suspend individual SWNTs and the quality of the absorption and fluorescence spectra. For the ionic surfactants, sodium dodecylbenzene sulfonate (SDBS) gives the most well resolved spectral features. For the nonionic systems, surfactants with higher molecular weight suspend more SWNT material and have more pronounced spectral features.
C1 Rice Univ, Dept Chem, Rice Quantum Inst, Ctr Nanoscale Sci & Technol, Houston, TX 77005 USA.
   Rice Univ, Ctr Biol & Environm Nanotechnol, Houston, TX 77005 USA.
   Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.
RP Smalley, RE (reprint author), Rice Univ, Dept Chem, Rice Quantum Inst, Ctr Nanoscale Sci & Technol, Houston, TX 77005 USA.
EM smalley@rice.edu
RI Hauge, Robert/A-7008-2011
OI Hauge, Robert/0000-0002-3656-0152
CR Ausman KD, 2000, J PHYS CHEM B, V104, P8911, DOI 10.1021/jp002555m
   Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727
   Bronikowski MJ, 2001, J VAC SCI TECHNOL A, V19, P1800, DOI 10.1116/1.1380721
   Dresselhaus M., 2001, CARBON NANOTUBES SYN
   Dresselhaus MS, 2002, CARBON, V40, P2043, DOI 10.1016/S0008-6223(02)00066-0
   Duro R, 1999, DRUG DEV IND PHARM, V25, P817, DOI 10.1081/DDC-100102244
   Favia P, 2002, J PHOTOPOLYM SCI TEC, V15, P341
   Grinstaff MW, 2002, CHEM-EUR J, V8, P2838, DOI 10.1002/1521-3765(20020703)8:13<2838::AID-CHEM2838>3.0.CO;2-I
   Holm BA, 2002, MOL CRYST LIQ CRYST, V374, P589, DOI 10.1080/713738279
   Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u
   Leobandung W, 2003, J APPL POLYM SCI, V87, P1678, DOI 10.1002/app.11612
   Liu TB, 2003, PROG POLYM SCI, V28, P5, DOI 10.1016/S0079-6700(02)00077-1
   Luk YY, 2002, CURR OPIN COLLOID IN, V7, P267, DOI 10.1016/S1359-0294(02)00067-5
   Nunzi JM, 2002, CR PHYS, V3, P523, DOI 10.1016/S1631-0705(02)01335-X
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631
   Otsuka H, 2001, CURR OPIN COLLOID IN, V6, P3, DOI 10.1016/S1359-0294(00)00082-0
   Polarz S, 2002, J NANOSCI NANOTECHNO, V2, P581, DOI 10.1166/jnn.2002.151
   Richard C, 2003, SCIENCE, V300, P775, DOI 10.1126/science.1080848
   Schnabelrauch M, 2002, BIOMOL ENG, V19, P295, DOI 10.1016/S1389-0344(02)00034-5
   Strano MS, 2003, J PHYS CHEM B, V107, P6979, DOI 10.1021/jp027664a
   Strano MS, 2003, J NANOSCI NANOTECHNO, V3, P81, DOI 10.1166/jnn.2003.194
   Thomas RN, 2002, SPECTROSC-INT J, V16, P387, DOI 10.1155/2002/818323
   Wool RP, 2002, ACS SYM SER, V823, P177, DOI 10.1021/bk-2002-0823.ch013
NR 24
TC 1256
Z9 1272
U1 8
U2 312
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD OCT
PY 2003
VL 3
IS 10
BP 1379
EP 1382
DI 10.1021/nl034524j
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 731AZ
UT WOS:000185863500012
DA 2018-10-20
ER

PT J
AU Dai, LM
   He, PG
   Li, SN
AF Dai, LM
   He, PG
   Li, SN
TI Functionalized surfaces based on polymers and carbon nanotubes for some
   biomedical and optoelectronic applications
SO NANOTECHNOLOGY
LA English
DT Review
ID SELF-ASSEMBLED MONOLAYERS; TRIBLOCK COPOLYMER CHAINS; CONDUCTING
   POLYMERS; TELECHELIC POLYMERS; CONJUGATED POLYMERS; GOOD SOLVENT;
   PATTERNED GROWTH; CONFORMATIONAL TRANSITIONS; ELECTRONIC-PROPERTIES;
   NEUTRON REFLECTIVITY
AB It has been long recognized that surface properties are of paramount importance for a broad range of materials and a large variety of devices. The recent development of nanoscience and nanotechnology has opened up novel fundamental and applied frontiers in surface functionalization and characterization. At the nanometre scale, the high surface-to-volume ratio characteristic of most nanomaterials has been demonstrated to have a tremendous influence of many fundamental material properties and device performance. In this paper, we present some of the important issues on the surface functionalization and characterization of polymers and carbon nanotubes for certain biomedical and optoelectronic applications and summarize our recent research activities along this line.
C1 Univ Akron, Coll Polymer Sci & Polymer Engn, Dept Polymer Engn, Akron, OH 44304 USA.
RP Dai, LM (reprint author), Univ Akron, Coll Polymer Sci & Polymer Engn, Dept Polymer Engn, 250 S Forge St, Akron, OH 44304 USA.
EM ldai@uakron.edu
CR AGOSTINO R, 1990, PLASMA DEPOSITION TR
   AJAYAN PM, 1995, ADV MATER, V7, P489, DOI 10.1002/adma.19950070520
   AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212
   AJAYAN PM, 1997, REP PROG PHYS, V60, P1026
   Anastassopoulos DL, 1998, MACROMOLECULES, V31, P9369, DOI 10.1021/ma980379y
   Anton P., 2001, GLOBAL TECHNOLOGY RE
   AUROY P, 1992, MACROMOLECULES, V25, P4134, DOI 10.1021/ma00042a014
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   Beamson G., 1992, HIGH RESOLUTION XPS
   Benninghoven A., 1987, SECONDARY ION MASS S
   BENSON SW, 1963, J AM CHEM SOC, V85, P1385, DOI 10.1021/ja00893a005
   BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0
   Bjorling M, 1998, MACROMOLECULES, V31, P9033, DOI 10.1021/ma971732n
   Bonard JM, 1998, APPL PHYS LETT, V73, P918, DOI 10.1063/1.122037
   BOWDEN MJ, 1988, ADV CHEM SER, V218
   BROCHARDWYART F, 1994, MACROMOL SYMP, V79, P1, DOI 10.1002/masy.19940790103
   Cai H, 2002, ANAL CHIM ACTA, V469, P165, DOI 10.1016/S0003-2670(02)00670-0
   Cantor C. R., 1980, BIOPHYSICAL CHEM
   CHATELIER R, 1994, Patent No. 9406485
   Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694
   Chen QD, 2000, APPL PHYS LETT, V76, P2719, DOI 10.1063/1.126454
   Chen QD, 2001, J NANOSCI NANOTECHNO, V1, P43, DOI 10.1166/jnn.2001.003
   Chen QD, 2001, J PHYS CHEM B, V105, P618, DOI 10.1021/jp003385g
   COLANERI NF, 1990, PHYS REV B, V42, P11670, DOI 10.1103/PhysRevB.42.11670
   Cuberes MT, 1996, APPL PHYS LETT, V69, P3016, DOI 10.1063/1.116824
   Curran SA, 1998, ADV MATER, V10, P1091, DOI 10.1002/(SICI)1521-4095(199810)10:14<1091::AID-ADMA1091>3.0.CO;2-L
   d'Agostino R., 1990, PLASMA DEPOSITION TR
   Dai HJ, 1996, SCIENCE, V272, P523, DOI 10.1126/science.272.5261.523
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   DAI L, 1991, EUROPHYS LETT, V16, P331, DOI 10.1209/0295-5075/16/4/003
   Dai L., 1996, SURFACE MODIFICATION, P147
   DAI L, 2003, AIP C P
   Dai LM, 1999, POLYM ADVAN TECHNOL, V10, P357, DOI 10.1002/(SICI)1099-1581(199907)10:7<357::AID-PAT886>3.0.CO;2-9
   Dai LM, 1999, J MACROMOL SCI R M C, VC39, P273
   Dai LM, 1996, MACROMOLECULES, V29, P282, DOI 10.1021/ma951054+
   DAI LM, 1991, POLYMER, V32, P2120, DOI 10.1016/0032-3861(91)90034-G
   Dai LM, 2000, J PHYS CHEM B, V104, P1891, DOI 10.1021/jp9926793
   Dai LM, 1997, J PHYS CHEM B, V101, P9548, DOI 10.1021/jp970562d
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Dai LM, 2001, RADIAT PHYS CHEM, V62, P55, DOI 10.1016/S0969-806X(01)00422-4
   Dai LM, 2001, ADV MATER, V13, P899, DOI 10.1002/1521-4095(200107)13:12/13<899::AID-ADMA899>3.0.CO;2-G
   DAI LM, 1994, MACROMOLECULES, V27, P6728, DOI 10.1021/ma00101a008
   DAI LM, 1992, J PHYS CHEM-US, V96, P6469, DOI 10.1021/j100194a067
   Dai LM, 2001, ADV MATER, V13, P915, DOI 10.1002/1521-4095(200107)13:12/13<915::AID-ADMA915>3.0.CO;2-N
   DAI LM, 1995, MACROMOLECULES, V28, P5512, DOI 10.1021/ma00120a015
   DAI LM, 1992, MACROMOLECULES, V25, P6000, DOI 10.1021/ma00048a022
   DEHEER WA, 1995, SCIENCE, V268, P845, DOI 10.1126/science.268.5212.845
   deHeer WA, 1997, ADV MATER, V9, P87, DOI 10.1002/adma.19970090122
   Delamarche E, 1996, ADV MATER, V8, P719, DOI 10.1002/adma.19960080903
   Dresselhaus M.S., 1996, SCI FULLERENES CARBO
   Dwyer C, 2002, NANOTECHNOLOGY, V13, P601, DOI 10.1088/0957-4484/13/5/311
   Ebbesen TW, 1996, NATURE, V382, P54, DOI 10.1038/382054a0
   EBBESEN TW, 1994, ANNU REV MATER SCI, V24, P235, DOI 10.1146/annurev.ms.24.080194.001315
   EBBESEN TW, 1992, NATURE, V358, P220, DOI 10.1038/358220a0
   Ebbsen T., 1997, CARBON NANOTUBES
   Fan SS, 1999, SCIENCE, V283, P512, DOI 10.1126/science.283.5401.512
   FIELD JB, 1992, J PHYS II, V2, P2221
   FIELD JB, 1992, MACROMOLECULES, V25, P434, DOI 10.1021/ma00027a067
   Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744
   FUHRHOP JH, 1994, MEMBRANES MOL ASSESS
   Furukawa K, 1997, SYNTHETIC MET, V91, P99, DOI 10.1016/S0379-6779(97)03986-6
   GALAEV I, 2002, SMRT POLYM BIOSEPARA
   Gao M, 2000, ANGEW CHEM INT EDIT, V39, P3664, DOI 10.1002/1521-3773(20001016)39:20<3664::AID-ANIE3664>3.0.CO;2-Y
   Gao M, 2003, ELECTROANAL, V15, P1089, DOI 10.1002/elan.200390131
   Gao RP, 2000, PHYS REV LETT, V85, P622, DOI 10.1103/PhysRevLett.85.622
   Goldstein A., 1997, HDB NANOPHASE MAT
   GOLUB MA, 1968, MACROMOL SYNTHESES, V3, P32
   GRIESSER HJ, 1991, LANGMUIR, V7, P2484, DOI 10.1021/la00059a015
   Guo ZJ, 1998, ADV MATER, V10, P701, DOI 10.1002/(SICI)1521-4095(199806)10:9<701::AID-ADMA701>3.0.CO;2-4
   Haliloglu T, 1997, MACROMOL THEOR SIMUL, V6, P667, DOI 10.1002/mats.1997.040060306
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   Hamers RJ, 1996, J PHYS CHEM-US, V100, P13103, DOI 10.1021/jp960054o
   Harris P. J. F., 1999, CARBON NANOTUBES REL
   Harrison JA, 1997, J PHYS CHEM B, V101, P9682, DOI 10.1021/jp972261+
   HEALEY BG, 1995, SCIENCE, V269, P1078, DOI 10.1126/science.7652555
   Higgins J. S., 1994, POLYM NEUTRON SCATTE
   HOLLAN JR, 1974, TECHNIQUES APPL PLAS
   Horowitz G, 1998, ADV MATER, V10, P365, DOI 10.1002/(SICI)1521-4095(199803)10:5<365::AID-ADMA365>3.0.CO;2-U
   Hu B, 1998, CHEM PHYS, V227, P263, DOI 10.1016/S0301-0104(97)00306-6
   Huang SM, 2000, J PHYS CHEM B, V104, P2193, DOI 10.1021/jp994152w
   Huang SM, 2002, J PHYS CHEM B, V106, P3543, DOI 10.1021/jp014047y
   Huang SM, 2002, J NANOPART RES, V4, P145, DOI 10.1023/A:1020141801107
   Huang SM, 1999, J PHYS CHEM B, V103, P4223, DOI 10.1021/jp990342v
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   Ito Y, 1997, J AM CHEM SOC, V119, P1619, DOI 10.1021/ja963418z
   IWAO T, 1993, MATER RES SOC S P, V290, P311
   JACKMAN RJ, 1999, CHEMTECH, V18
   Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655
   Katz HE, 1997, J MATER CHEM, V7, P369, DOI 10.1039/a605274f
   Kelley SO, 1999, NUCLEIC ACIDS RES, V27, P4830, DOI 10.1093/nar/27.24.4830
   Kim T, 1996, LANGMUIR, V12, P6065, DOI 10.1021/la960810h
   KLEIN J, 1991, NATURE, V352, P143, DOI 10.1038/352143a0
   KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0
   LAI PY, 1992, MACROMOLECULES, V25, P6693, DOI 10.1021/ma00050a045
   Li DC, 2000, CHEM PHYS LETT, V316, P349, DOI 10.1016/S0009-2614(99)01334-2
   Li J, 1999, APPL PHYS LETT, V75, P367, DOI 10.1063/1.124377
   Lovinger AJ, 1996, J MATER RES, V11, P1581, DOI 10.1557/JMR.1996.0198
   LUCKHAM PF, 1993, ADV COLLOID INTERFAC, V44, P183, DOI 10.1016/0001-8686(93)80024-6
   March J., 1992, ADV ORGANIC CHEM
   Martin CR, 1996, CHEM MATER, V8, P1739, DOI 10.1021/cm960166s
   MARTIN CR, 1995, ACCOUNTS CHEM RES, V259, P957
   Martin JI, 1996, LANGMUIR, V12, P4950, DOI 10.1021/la960305k
   Maruyama K, 2002, ANAL CHEM, V74, P3698, DOI 10.1021/ac011148j
   MATSUDA T, 1995, LANGMUIR, V11, P2272
   MATSUDA T, 1995, LANGMUIR, V11, P2267
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   MILNER ST, 1992, MACROMOLECULES, V25, P5495, DOI 10.1021/ma00046a057
   MISRA S, 1994, MACROMOLECULES, V27, P5037, DOI 10.1021/ma00096a028
   MISRA S, 1994, MACROMOLECULES, V27, P2058, DOI 10.1021/ma00086a013
   Mittal K. L., 1997, POLYM SURFACES INTER
   MOREAU WM, 1988, SEMICONDUCTOR LITHOG
   Nakayama M, 2002, TALANTA, V56, P857, DOI 10.1016/S0039-9140(01)00659-2
   Nalwa H.S., 1997, HDB ORGANIC CONDUCTI
   Napper DH, 1983, POLYM STABILIZATION
   NGUYEN TP, 1995, SYNTHETIC MET, V72, P35, DOI 10.1016/0379-6779(94)02312-M
   NguyenMisra M, 1996, MACROMOLECULES, V29, P1407, DOI 10.1021/ma950802s
   NGUYENMISRA M, 1995, MACROMOLECULES, V28, P6976, DOI 10.1021/ma00124a039
   Odom TW, 2000, J PHYS CHEM B, V104, P2794, DOI 10.1021/jp993592k
   OKAHATA Y, 1986, MACROMOLECULES, V19, P494
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Ottenbrite R, 1992, POLYM MED BIOMEDICAL
   Palecek E, 2001, ANAL CHEM, V73, p74A, DOI 10.1021/ac0123936
   PATEL S, 1989, ANNU REV PHYS CHEM, P40
   Penfold J, 1997, J CHEM SOC FARADAY T, V93, P3899, DOI 10.1039/a702836i
   PLANEIX JM, 1994, J AM CHEM SOC, V116, P7935, DOI 10.1021/ja00096a076
   Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513
   PRITCHARD DJ, 1995, ANGEW CHEM INT EDIT, V34, P91, DOI 10.1002/anie.199500911
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   Ren ZF, 1999, APPL PHYS LETT, V75, P1086, DOI 10.1063/1.124605
   Romero DB, 1996, ADV MATER, V8, P899, DOI 10.1002/adma.19960081105
   Saito R., 1998, PHYSICAL PROPERTIES
   SALENECK WR, 1996, CONJUGATED POLYM SUR
   SARICIFTCI NS, 1994, INT J MOD PHYS B, V8, P237, DOI 10.1142/S0217979294000105
   Sazou D, 1997, J ELECTROANAL CHEM, V429, P81, DOI 10.1016/S0022-0728(96)05019-X
   SEVICK EM, 1994, MACROMOLECULES, V27, P5285, DOI 10.1021/ma00097a007
   SINGH J, 1992, J MACROMOL SCI R M C, VC32, P521, DOI 10.1080/15321799208021431
   Spatz JP, 1997, MACROMOLECULES, V30, P3874, DOI 10.1021/ma9607372
   SUGAWARA T, 1994, MACROMOLECULES, V27, P7809, DOI 10.1021/ma00104a040
   Suh JS, 1999, APPL PHYS LETT, V75, P2047, DOI 10.1063/1.124911
   Tang WH, 1996, MACROMOLECULES, V29, P4412, DOI 10.1021/ma951547e
   TAUNTON HJ, 1990, MACROMOLECULES, V23, P571, DOI 10.1021/ma00204a033
   TAUNTON HJ, 1988, NATURE, V332, P712, DOI 10.1038/332712a0
   Terrones M, 1996, PHILOS T R SOC A, V354, P2025, DOI 10.1098/rsta.1996.0090
   Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483
   TOPRAKCIOGLU C, 1993, PROG COLL POL SCI S, V91, P83
   TOPRAKCIOGLU C, 1992, MACROMOL REP A, V29, P139
   TSANG SC, 1994, NATURE, V372, P159, DOI 10.1038/372159a0
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   VOIVODOV K, 1993, MAKROMOL CHEM-M SYMP, V70-1, P275, DOI 10.1002/masy.19930700129
   Wagner CD, 1979, HDB XRAY PHOTOELECTR
   Wallraff GM, 1999, CHEM REV, V99, P1801, DOI 10.1021/cr980003i
   Walls J., 1990, METHODS SURFACE ANAL
   Wang J, 1996, ANAL CHEM, V68, P2629, DOI 10.1021/ac9602433
   WILLIAMS DRM, 1993, MACROMOLECULES, V26, P5806, DOI 10.1021/ma00073a040
   Winkler B, 1999, CHEM MATER, V11, P704, DOI 10.1021/cm980570m
   Wirth MJ, 1997, SCIENCE, V275, P44, DOI 10.1126/science.275.5296.44
   Wong SS, 1998, NATURE, V394, P52
   Wong SS, 1998, J AM CHEM SOC, V120, P603, DOI 10.1021/ja9737735
   Wu CC, 1997, APPL PHYS LETT, V70, P1348, DOI 10.1063/1.118575
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Xu B., 1993, MACROMOLECULES, V26, P4457, DOI DOI 10.1021/MA00069A009
   Xu C, 2000, ANAL CHIM ACTA, V411, P31, DOI 10.1016/S0003-2670(00)00728-5
   XU X, 1995, P INT WORKSH EL EL 9
   YAKOBSON BI, 1997, AM SCI, V85, P325
   Yang YY, 1999, J AM CHEM SOC, V121, P10832, DOI 10.1021/ja992945q
   YASUDA H, 1978, PLASMA POLYM
   Yasuda H., 1985, PLASMA POLYM
   Yasuzawa M, 1999, ELECTROCHEM COMMUN, V1, P459, DOI 10.1016/S1388-2481(99)00095-8
   ZHAO W, 1994, MACROMOLECULES, V27, P2933, DOI 10.1021/ma00089a007
   Zhulina E, 1996, MACROMOLECULES, V29, P2667, DOI 10.1021/ma951396f
NR 173
TC 77
Z9 77
U1 2
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD OCT
PY 2003
VL 14
IS 10
BP 1081
EP 1097
AR PII S0957-4484(03)61804-0
DI 10.1088/0957-4484/14/10/305
PG 17
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 738JV
UT WOS:000186284200007
DA 2018-10-20
ER

PT J
AU Snellings, G
   Mondelaers, W
   Schacht, E
AF Snellings, G
   Mondelaers, W
   Schacht, E
TI Synthesis and characterisation of water-soluble poly(ethylene glycol)
   modified polymethacrylates with the ability to crosslink
SO POLYMER INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT International Symposium on Polymer Chemistry for the Design of New
   Materials
CY SEP 19-20, 2002
CL GHENT UNIV, GHENT, BELGIUM
HO GHENT UNIV
DE crosslinking; poly(ethylene glycol); biocompatibility; hydrogel
ID CRITICAL SOLUTION TEMPERATURES; HYDROGELS; ADHESION; SURFACE; OXIDE)
AB Hydrogels have become increasingly important in the biomedical field. The aim of this study was to develop amphiphilic poly(ethylene glycol) grafted polymethacrylates with curable side groups. The water-soluble polymers were synthesised by free-radical copolymerisation of methyl methacrylate, alpha-methyl-omega-methacroyl-poly(ethylene glycol) and 2-hydroxyethyl methacrylate (HEMA). The methacrylate containing hydrogel precursors were obtained by reacting the free hydroxyl groups of HEMA in the polymer with methacrylic anhydride in the presence of catalyst. gamma-Irradiation has been used as an elegant method for crosslinking and simultaneous sterilisation. The influence of the irradiation dose (5, 15, 25 kGy) on the polymers was examined by the determination of the gel and sol fraction. In an aqueous environment these materials behave as hydrogels with more swelling at lower temperatures. Since the coatings can be applied in mild conditions, eg water, these materials are looking very promising as thin film coatings for biomedical applications. (C) 2003 Society of Chemical Industry.
C1 State Univ Ghent, Polymer Mat Res Grp, Dept Organ Chem, B-2000 Ghent, Belgium.
   State Univ Ghent, Dept Subatom & Radiat Phys, B-2000 Ghent, Belgium.
   State Univ Ghent, IBITECH, Inst Biomed Technol, B-2000 Ghent, Belgium.
RP Schacht, E (reprint author), State Univ Ghent, Polymer Mat Res Grp, Dept Organ Chem, Krijgslaan 281 S4, B-2000 Ghent, Belgium.
CR ALLCOCK J, 1996, ADV CHEM SER, V248, P15
   Bain C. D., 1989, ANGEW CHEM, V101, P522
   BAKHOO M, 1985, CAN J BIOCHEM CELL B, V63, P1
   BHALLA HL, 1983, INT J PHARM, V17, P351, DOI 10.1016/0378-5173(83)90046-7
   BO G, 1992, J POLYM SCI POL CHEM, V30, P1799, DOI 10.1002/pola.1992.080300903
   CHATTERJI PR, 1991, MACROMOLECULES, V24, P4214, DOI 10.1021/ma00014a042
   CHU NS, 1976, Patent No. 3963805
   GRAHAM NB, 1984, BIOMATERIALS, V5, P27, DOI 10.1016/0142-9612(84)90063-2
   GRAHAM NB, 1982, POLYMER, V23, P1345, DOI 10.1016/0032-3861(82)90276-2
   GUVEN O, 1992, J POLYM SCI POL CHEM, V30, P2055, DOI 10.1002/pola.1992.080300933
   HARRIS JM, 1992, PEG CHEM BIOTECHNICA
   ICHIKAWA T, 1994, J POLYM SCI POL CHEM, V32, P2487, DOI 10.1002/pola.1994.080321310
   KARLSTROM G, 1985, J PHYS CHEM-US, V89, P4962, DOI 10.1021/j100269a015
   KING PA, 1968, Patent No. 3149006
   KJELLANDER R, 1981, J CHEM SOC FARAD T 1, V77, P2053, DOI 10.1039/f19817702053
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   Mrksich M, 1997, CURR OPIN COLLOID IN, V2, P83, DOI 10.1016/S1359-0294(97)80012-X
   Padmavathi NC, 1996, MACROMOLECULES, V29, P1976, DOI 10.1021/ma950827r
   PRIOLA A, 1993, POLYMER, V34, P3653, DOI 10.1016/0032-3861(93)90050-K
   Ratner B. D., 1981, BIOCOMPATIBILITY CLI
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   SAEKI S, 1976, POLYMER, V17, P685, DOI 10.1016/0032-3861(76)90208-1
   Snellings GMBF, 2000, ADV MATER, V12, P1959, DOI 10.1002/1521-4095(200012)12:24<1959::AID-ADMA1959>3.3.CO;2-M
   VANBOS M, 1990, THESIS GHENT U, P16
   Wang WZ, 1997, ANTISENSE NUCLEIC A, V7, P101, DOI 10.1089/oli.1.1997.7.101
   YANG F, 1990, MAKROMOL CHEM, V191, P1197
NR 26
TC 5
Z9 5
U1 1
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD OCT
PY 2003
VL 52
IS 10
BP 1653
EP 1659
DI 10.1002/pi.1350
PG 7
WC Polymer Science
SC Polymer Science
GA 727QH
UT WOS:000185669500017
DA 2018-10-20
ER

PT J
AU Werner, A
   Malterud, K
AF Werner, A
   Malterud, K
TI It is hard work behaving as a credible patient: encounters between women
   with chronic pain and their doctors
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE doctor-patient relationship; medically unexplained disorders; chronic
   pain; gender; Norway
ID LOW-BACK-PAIN; MEDICALLY UNEXPLAINED SYMPTOMS; CHRONIC-FATIGUE-SYNDROME;
   PRIMARY-CARE; GENERAL-PRACTITIONER; QUALITATIVE RESEARCH; DIFFICULT
   PATIENT; FIBROMYALGIA; EXPERIENCE; MANAGEMENT
AB In various studies during the last decade, women with medically unexplained disorders have reported negative experiences during medical encounters. Accounts of being met with scepticism and lack of comprehension, feeling rejected, ignored, and being belittled, blamed for their condition and assigned psychological explanation models are common. Women patients exerted themselves to attract the doctor's medical attention and interest, and were anxious to be considered as whiners or complainers. Here, we explore the nature of "work" done by the patients in order to be believed, understood, and taken seriously when consulting the doctor. A qualitative study was conducted with in-depth interviews including a purposeful sampling of 10 women of varying ages and backgrounds with chronic muscular pain. The main outcome measures were descriptions reflecting the patients' activities or efforts invested in being perceived as a credible patient. We focused on the gendered dimensions of the. experiences. The women patients' accounts indicated hard work to make the symptoms socially visible, real, and physical when consulting a doctor. Their efforts reflect a subtle balance not to appear too strong or too weak, too healthy or too sick, or too smart or too disarranged. Attempting to fit in with normative, biomedical expectations of correctness, they tested strategies such as appropriate assertiveness, surrendering, and appearance. The most important activities or efforts varied. However, the informants were not only struggling for their credibility. Their stories illustrated a struggle for the maintenance of self-esteem or dignity as patients and as women. The material was interpreted within a feminist frame of reference, emphasising the relationship between dignity and shame, power and disempowerment for women patients' with medically unexplained disorders. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Oslo, Ctr Womens Studies & Gender Res, N-0315 Oslo, Norway.
   Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Gen Practice, N-5009 Bergen, Norway.
   Univ Copenhagen, Panum Inst, Cent Res Unit, DK-1168 Copenhagen, Denmark.
   Univ Copenhagen, Panum Inst, Dept Gen Practice, DK-1168 Copenhagen, Denmark.
RP Werner, A (reprint author), Univ Oslo, Ctr Womens Studies & Gender Res, POB 1040 Blindern, N-0315 Oslo, Norway.
EM anne.werner@skk.uio.no
CR Album D, 1991, Tidsskr Nor Laegeforen, V111, P2127
   ARBORELIUS E, 1991, FAM PRACT, V8, P3, DOI 10.1093/fampra/8.1.3
   Asbring P, 2002, QUAL HEALTH RES, V12, P148, DOI 10.1177/104973230201200202
   BORGES S, 1995, WOMEN HEALTH, V23, P29, DOI 10.1300/J013v23n01_03
   Brodwin P, 1992, PAIN HUMAN EXPERIENC, P100
   Eccleston C, 1997, SOC SCI MED, V45, P699, DOI 10.1016/S0277-9536(96)00404-2
   FISHER S, 1985, SOCIOL HEALTH ILL, V7, P342, DOI 10.1111/1467-9566.ep10832345
   Fisher S, 2000, CONTEMP SOCIOL, V29, P865, DOI 10.2307/2654127
   FISHER S, 1993, SOCIAL ORG DOCTOR PA, P287
   Giorgi A., 1985, PHENOMENOLOGY PSYCHO, P8
   Hahn SR, 1996, J GEN INTERN MED, V11, P1, DOI 10.1007/BF02603477
   HAUG F, 1992, FEMALE MASOCHISM MEM, P3
   HAUG F, 1992, FEMALE MASOCHISM MEM, P31
   HEARN J, 1995, SEX WORK POWER PARAD
   HOWELL SL, 1994, QUAL HEALTH RES, V4, P94, DOI DOI 10.1177/104973239400400107
   HUNT LM, 1989, CULT MED PSYCHIAT, V13, P315, DOI 10.1007/BF00054341
   HUNTER KM, 1991, DOCTORS STORIES NARR, P123
   Jackson J. E., 1992, PAIN HUMAN EXPERIENC, P138
   JOHANNISSON K, 1996, MORKE KONTINENTET KV
   Johannisson K., 2001, GENDER INEQUALITIES, P99
   Johannsen FR, 1996, ISSUES SCI TECHNOL, V13, P6
   Kolnes L. J., 1995, International Review for the Sociology of Sport, V30, P61, DOI 10.1177/101269029503000104
   Kugelmann R, 1999, SOC SCI MED, V49, P1663, DOI 10.1016/S0277-9536(99)00240-3
   Kvale S., 1996, INTERVIEWS INTRO QUA
   LACKOFF G, 1980, METAPHORS WE LIVE
   LILLEAAS UB, 1995, 8 U OSL CTR WOM STUD
   LORBER J, 1997, GENDER SOCIAL CONSTR
   MacKinnon C, 1979, SEXUAL HARASSMENT WO
   Malterud K, 2000, FAM MED, V32, P603
   MALTERUD K, 1993, FAM PRACT, V10, P201, DOI 10.1093/fampra/10.2.201
   Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6
   MATHERS N, 1995, BRIT J GEN PRACT, V45, P293
   MATHERS NJ, 1995, FAM PRACT, V12, P176, DOI 10.1093/fampra/12.2.176
   Natvig B, 1995, EUR J GEN PRACT, V1, P25
   Ostlund G, 2001, SCAND J PUBLIC HEALT, V29, P285, DOI 10.1177/14034948010290041401
   Raymond MC, 2000, CAN FAM PHYSICIAN, V46, P1100
   Reid S, 2001, FAM PRACT, V18, P519, DOI 10.1093/fampra/18.5.519
   Salmon P, 1995, INT J PSYCHIAT MED, V25, P319, DOI 10.2190/JUNY-QCER-GWLF-H60R
   SCHEFF TJ, 1999, BEING MENTALLY ILL S
   SCHWENK TL, 1989, J FAM PRACTICE, V28, P59
   SHARPE M, 1994, Q J MED, V87, P187
   Skelton A, 1998, SOCIOL HEALTH ILL, V20, P96, DOI 10.1111/1467-9566.00082
   Skelton AM, 1996, BRIT J GEN PRACT, V46, P153
   SKELTON AM, 1995, FAM PRACT, V12, P44, DOI 10.1093/fampra/12.1.44
   Smith D.E, 1990, CONCEPTUAL PRACTICES
   Soderberg S, 1999, QUAL HEALTH RES, V9, P575, DOI 10.1177/104973299129122090
   Steihaug S, 2001, SCAND J PRIM HEALTH, V19, P249
   STEIHAUG S, IN PRESS SCANDINAVIA
   Steinmetz D, 2001, FAM PRACT, V18, P495, DOI 10.1093/fampra/18.5.495
   WAITZKIN H, 1979, SOC SCI MED-MED SOC, V13, P601, DOI 10.1016/0271-7123(79)90103-2
   WARE NC, 1992, MED ANTHROPOL Q, V6, P347, DOI 10.1525/maq.1992.6.4.02a00030
   West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002
   WIDERBERG K, 1999, SOSIOLOGISK TIDSSKRI, V7, P147
   Wileman L, 2002, FAM PRACT, V19, P178, DOI 10.1093/fampra/19.2.178
NR 54
TC 250
Z9 253
U1 2
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD OCT
PY 2003
VL 57
IS 8
BP 1409
EP 1419
DI 10.1016/S0277-9536(02)00520-8
PG 11
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 713GL
UT WOS:000184849000007
PM 12927471
DA 2018-10-20
ER

PT J
AU Ohmura, A
   Ouchi, N
   Morisaki, S
   Watanabe, C
AF Ohmura, A
   Ouchi, N
   Morisaki, S
   Watanabe, C
TI Functionality development as a survival strategy for fine ceramics
SO TECHNOVATION
LA English
DT Article
DE fine ceramics; functionality development; functional materials;
   structural materials; diffusion orbit
AB More than twenty years have passed since the Japanese government first undertook R&D on fine ceramics in its National R&D Program. Stimulated by such efforts, fine ceramics have exhibited rapid development and diffusion through substitution in a broad range of functional and structural materials fields, including the electronics, optical, mechanical, chemical and biomedical fields. However, although gross production of fine ceramics steadily increased from 1 trillion yen (7.8 US$) in 1988 to 1.5 trillion yen (15.6 billion US$) in 1995, the orbits of innovation for functional and structural materials demonstrate a clear contrast. Applications for fine ceramics as functional materials have shown remarkable development while applications for fine ceramics as structural materials have shown little or no sign of advancement. This contrast can be attributed to differences in the functionality of the two types of materials. Thus, functionality development for fine ceramics used as structural materials has become crucial in terms of survival strategy.
   This paper, by means of an empirical analysis of the development and diffusion orbit of innovation for fine ceramics in major use in Japan over the last two decades, attempts to identify factors contributing to the above contrast in functional and structural materials development. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Tokyo Inst Technol, Dept Ind Engn & Management, Meguro Ku, Tokyo 1528552, Japan.
   NGK Insulators Ltd, Corp R&D Ctr, Nagoya, Aichi 4678530, Japan.
RP Watanabe, C (reprint author), Tokyo Inst Technol, Dept Ind Engn & Management, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.
OI Watanabe, Chihiro/0000-0002-6676-5685
CR *ESRI, 2001, CONS CONF SURV
   *JFCA, 1998, REP RES SURV REG PRE
   *JFCA, 2000, REP RES SURV REG STR
   Liang YH, 2001, TECHNOVATION, V21, P61, DOI 10.1016/S0166-4972(00)00019-5
   Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P209, DOI 10.1016/S0040-1625(99)00022-0
   *MITI, 1998, REP COMM R D VIS FIN
   *MITI, 1990, FIN CER VIS
   *MITI, 1984, REP COMM FUND PROBL
   Warren MP, 2000, INT J PROD ECON, V65, P85, DOI 10.1016/S0925-5273(99)00092-4
   Watanabe C, 1999, RES POLICY, V28, P719, DOI 10.1016/S0048-7333(99)00018-9
   WATANABE C, 1991, INDUCING POWER JAPAN
   WATANABE C, 2001, IN PRESS TECHNOVATIO
   Watanabe C., 2001, NUMERICAL ANAL TECHN
   Watts RJ, 1997, TECHNOL FORECAST SOC, V56, P25, DOI 10.1016/S0040-1625(97)00050-4
NR 14
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0166-4972
J9 TECHNOVATION
JI Technovation
PD OCT
PY 2003
VL 23
IS 10
BP 833
EP 842
DI 10.1016/S0166-4972(02)00028-7
PG 10
WC Engineering, Industrial; Management; Operations Research & Management
   Science
SC Engineering; Business & Economics; Operations Research & Management
   Science
GA 722CD
UT WOS:000185357000005
DA 2018-10-20
ER

PT J
AU Landolt, D
   Chauvy, PF
   Zinger, O
AF Landolt, D
   Chauvy, PF
   Zinger, O
TI Electrochemical micromachining, polishing and surface structuring of
   metals: fundamental aspects and new developments
SO ELECTROCHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT 53rd Annual Meeting of the International-Society-of-Electrochemistry
CY SEP 15-20, 2002
CL DUSSELDORF, GERMANY
SP Int Soc Electrochem, GDCh Fachgruppe Angewandte Elektrochem
DE electrochemical micromachining; electropolishing; ECM; surface
   structuring; nanotechnology; titanium
ID RATE NICKEL DISSOLUTION; PATTERNED OXIDE FILM; MASS-TRANSPORT; SHAPE
   CHANGES; ANODIC-DISSOLUTION; PHOTORESIST MASKS; ECM ELECTROLYTES;
   TITANIUM; IRON; ACID
AB Electrochemical micromachining (EMM) has emerged as a versatile process for machining and Surface Structuring of metallic materials for biomedical and microsystems applications. From a fundamental point of view EMM presents many similarities with electrochemical machining (ECMI) and electropolishing (EP) provided one takes into account the scale dependence of phenomena. In the present paper the role of mass transport, current distribution and passive films for shape control and surface smoothing is discussed and illustrated with examples. The usefulness of numerical simulation using simplified models is stressed. New developments in EMM of titanium are presented, including oxide film laser lithography permitting EMM on non-planar surfaces without photoresist and the fabrication of two-level and multi-level structures. Scale resolved electrochemical surface structuring of titanium leads to well-defined topographies on the micrometer and nanometer scales, which are of interest for biomedical applications. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Swiss Fed Inst Technol, LMCH, Inst Mat, Lab Met Chim,Dept Mat,MXC Ecublens, CH-1015 Lausanne, Switzerland.
RP Landolt, D (reprint author), Swiss Fed Inst Technol, LMCH, Inst Mat, Lab Met Chim,Dept Mat,MXC Ecublens, CH-1015 Lausanne, Switzerland.
RI Landolt, Dieter/G-9940-2011
CR ALLEN DM, 1985, PRECIS ENG, V7, P105, DOI 10.1016/0141-6359(85)90100-X
   ALLEN DM, 1986, PRINCIPLE PRACTICE P
   BANNARD E, 1981, APPL ELECTROCHEM, V11, P253
   BECK TR, 1973, J ELECTROCHEM SOC, V120, P1310, DOI 10.1149/1.2403253
   Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chauvy PF, 1999, ELECTROCHEM SOLID ST, V2, P123, DOI 10.1149/1.1390755
   Chauvy PF, 2003, APPL SURF SCI, V208, P165, DOI 10.1016/S0169-4332(02)01361-2
   Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2
   Chauvy PF, 2001, ELECTROCHEM SOLID ST, V4, pC31, DOI 10.1149/1.1359057
   CHAUVY PF, 2002, THESIS EPFL LAUSANNE
   CHAUVY PF, 2003, APPL SURF SCI, V211, P115
   CHAUVY PF, 2003, IN PRESS J APPL ELEC
   Cheroudi B, 1991, J BIOMED MATER RES, V25, P387
   CHIN DT, 1974, J APPL ELECTROCHEM, V4, P155, DOI 10.1007/BF00609024
   Datta M, 1997, ELECTROCHIM ACTA, V42, P3007, DOI 10.1016/S0013-4686(97)00147-3
   DATTA M, 1975, J ELECTROCHEM SOC, V122, P1466, DOI 10.1149/1.2134043
   DATTA M, 1981, ELECTROCHIM ACTA, V26, P899, DOI 10.1016/0013-4686(81)85053-0
   Datta M, 2000, ELECTROCHIM ACTA, V45, P2535, DOI 10.1016/S0013-4686(00)00350-9
   DATTA M, 1992, ELECTROCHIM ACTA, V37, P2469, DOI 10.1016/0013-4686(92)87086-F
   DATTA M, 1980, ELECTROCHIM ACTA, V25, P1255, DOI 10.1016/0013-4686(80)87130-1
   DATTA M, 1980, ELECTROCHIM ACTA, V25, P1263, DOI 10.1016/0013-4686(80)87131-3
   DATTA M, 1889, J ELECTROCHEM SOC, V129, P1982
   Datta M., 1989, J ELECTROCHEM SOC, V136, p285C
   DUKOVIC JO, 1994, ADV ELEC SC, V3, P117
   Ferri Y, 2001, J MICROMECH MICROENG, V11, P522, DOI 10.1088/0960-1317/11/5/312
   FIGOUS H, 1930, Patent No. 707526
   Gabe D. R., 1972, Metallography, V5, P415, DOI 10.1016/0026-0800(72)90030-4
   GRIMM RD, 1992, J ELECTROCHEM SOC, V139, P1622, DOI 10.1149/1.2069467
   Haisch T, 2001, ELECTROCHIM ACTA, V47, P235, DOI 10.1016/S0013-4686(01)00561-8
   HOARE JP, 1975, CORROS SCI, V15, P435, DOI 10.1016/0010-938X(75)90010-4
   Hoogsteen W, 2002, J APPL ELECTROCHEM, V32, P1029, DOI 10.1023/A:1020984431484
   KELLER F, 1953, J ELECTROCHEM SOC, V100, P411, DOI 10.1149/1.2781142
   Kersten P, 1995, SENSOR ACTUAT A-PHYS, V51, P51, DOI 10.1016/0924-4247(96)80052-5
   KONTTURI K, 1989, J APPL ELECTROCHEM, V19, P76, DOI 10.1007/BF01039393
   Kutzlnigg A., 1951, METALLOBERFLACHE, V3, pB67
   LABODA MA, 1967, J ELECTROCHEM SOC, V5, P340
   LANDOLT D, 1987, ELECTROCHIM ACTA, V32, P1, DOI 10.1016/0013-4686(87)87001-9
   LANDOLT D, 1972, J ELECTROCHEM SOC, V119, P708, DOI 10.1149/1.2404300
   LANDOLT D, 1969, J ELECTROCHEM SOC, V116, P1384, DOI 10.1149/1.2411528
   Landolt D., 1978, TRANSPASSIVITY PASSI, P484
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   LEITNER K, 2003, BER BUNSEN PHYS CHEM, V92, P181
   Li AP, 2000, ELECTROCHEM SOLID ST, V3, P131
   Madore C, 1999, J ELECTROCHEM SOC, V146, P2526, DOI 10.1149/1.1391966
   Madore C, 1997, J MICROMECH MICROENG, V7, P270, DOI 10.1088/0960-1317/7/4/002
   MADORE C, 1997, J MICROMECH MICROENG, V7, P1
   MAO KW, 1972, J ELECTROCHEM SOC, V119, P419, DOI 10.1149/1.2404221
   MATHIEU JB, 1978, J ELECTROCHEM SOC, V125, P1039, DOI 10.1149/1.2131617
   MATHIEU JB, 1978, THESIS EPFL LAUSANNE
   MATLOSZ M, 1989, J ELECTROCHEM SOC, V136, P919, DOI 10.1149/1.2096888
   MATLOSZ M, 1995, ELECTROCHIM ACTA, V40, P393, DOI 10.1016/0013-4686(94)00287-B
   MATLOSZ M, 1994, J ELECTROCHEM SOC, V141, P410, DOI 10.1149/1.2054741
   McGeough J. A., 1974, PRINCIPLES ELECTROCH
   MCTEGART WJ, 1960, POLISSAGE ELECTROLYT
   O'Brien J, 2001, J MICROMECH MICROENG, V11, P353, DOI 10.1088/0960-1317/11/4/312
   Piotrowski O, 1998, J ELECTROCHEM SOC, V145, P2362, DOI 10.1149/1.1838644
   Piotrowski O, 1999, ELECTROCHIM ACTA, V44, P3389, DOI 10.1016/S0013-4686(99)00056-0
   PIOTROWSKI O, 1999, THESIS EPFL LAUSANNE
   ROSSET E, 1989, PRECIS ENG, V11, P79, DOI 10.1016/0141-6359(89)90056-1
   ROSSET E, 1990, J APPL ELECTROCHEM, V20, P69, DOI 10.1007/BF01012473
   Schulte J K, 1997, Implant Dent, V6, P28
   Schuster R, 2000, SCIENCE, V289, P98, DOI 10.1126/science.289.5476.98
   Shenoy RV, 1996, J ELECTROCHEM SOC, V143, P2305, DOI 10.1149/1.1836997
   Vidal R, 1998, J ELECTROCHEM SOC, V145, P4067, DOI 10.1149/1.1838916
   VIDAL R, 1995, J ELECTROCHEM SOC, V142, P2686
   WEST AC, 1991, J ELECTROCHEM SOC, V138, P728, DOI 10.1149/1.2085666
   WEST AC, 1992, J ELECTROCHEM SOC, V139, P499, DOI 10.1149/1.2069245
   Wilson J.F., 1971, PRACTICE THEORY ELEC
   ZINGER O, 2003, IN PRESS J ELECTROCH
NR 70
TC 143
Z9 154
U1 4
U2 75
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD SEP 30
PY 2003
VL 48
IS 20-22
BP 3185
EP 3201
DI 10.1016/S0013-4686(03)00368-2
PG 17
WC Electrochemistry
SC Electrochemistry
GA 718AR
UT WOS:000185123400039
DA 2018-10-20
ER

PT J
AU Dumitrascu, N
   Borcia, G
   Apetroaei, N
   Popa, G
AF Dumitrascu, N
   Borcia, G
   Apetroaei, N
   Popa, G
TI Immobilization of biologically active species on PA-6 foils treated by a
   dielectric barrier discharge
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE dielectric barrier discharge; functionalization; heparin and
   immunoglobulin immobilization; atomic force microscopy (AFM); contact
   angle titration
ID PLASMA DEPOSITION; SURFACES; FILMS; POLYSTYRENE; ADSORPTION; POLYMERS;
   ARGON
AB In the field of biomaterials and biomedical devices, surface activation has been focused on creating functional groups capable of preferential adsorption of biologically active species (proteins, enzymes, cells, drugs, etc.). In this way an interface can be created between the synthetic material and the biological medium, with the aim of increasing the compatibility of the implant with the human organism. In our experiments a dielectric barrier discharge (DBD), in helium at atmospheric pressure, was used as the source of energy capable of creating active centers that render the functionalized surface favorable to immobilization of biological molecules. Retention of immunoglobulin (IgG) and heparin biomolecules on polyamide-6 (PA-6) surfaces after treatment by the DBD was analyzed by atomic force microscopy, adhesion evaluation, and measurement of the contact angle titration in order to assess this incorporation on the treated surfaces. The marked adsorption of the biomolecules on the active sites created by DBD on the exposed surfaces also was related to a complex set of processes, such as enhanced roughness, increased surface wettability, and modified distribution of cationic and anionic groups on the treated surfaces. All these factors could promote interfacial interactions between the specific groups of the biomolecules existing in the biological medium and the type of cationic and/or anionic groups present on the surface. The efficiency of the DBD treatment showed that the DBD technique is useful for preactivation of the polymer surface for immobilization of other biologically active species (such as drugs and enzymes). (C) 2003 Wiley Periodicals, Inc.
C1 AI Cuza Univ, Dept Plasma Phys, Iasi 6600, Romania.
RP Dumitrascu, N (reprint author), AI Cuza Univ, Dept Plasma Phys, Iasi 6600, Romania.
RI Cuza, UAIC/D-2604-2009; Borcia, Gabriela/C-4538-2011; Dumitrascu,
   Nicoleta/C-4537-2011
CR CLARK DT, 1978, J POLYM SCI POL CHEM, V16, P911, DOI 10.1002/pol.1978.170160506
   DELDEN CJ, 1996, J BIOMAT SCI-POLYM E, V7, P727
   DUMITRASC N, 2001, P 15 ISPC ORL FRANC, P2361
   Dumitrascu N, 2000, MATER CHEM PHYS, V65, P339, DOI 10.1016/S0254-0584(00)00261-3
   Dumitrascu N, 2002, PLASMA SOURCES SCI T, V11, P127, DOI 10.1088/0963-0252/11/2/301
   Dumitrascu N, 2001, J APPL POLYM SCI, V81, P2419, DOI 10.1002/app.1682
   DUMITRASCU N, 1998, ENTROPY, V215, P9
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   ERTEL SI, 1991, J COLLOID INTERF SCI, V147, P433, DOI 10.1016/0021-9797(91)90176-9
   FAVIA P, 1999, P 14 ISPC PRAH CZECH, P2761
   GARBASSI F, 1998, POLYM SURFACES, P201
   HOFFMAN AS, 1984, ADV POLYM SCI, V57, P142
   LAI JY, 1991, J APPL POLYM SCI, V43, P1431, DOI 10.1002/app.1991.070430804
   LEBEDEVA TS, 1991, J COLLOID INTERF SCI, V147, P450, DOI 10.1016/0021-9797(91)90178-B
   LEGEAY G, 1995, SCI TECHNIQUE APPLIC, V275, P87
   Nomura S, 1997, J BIOMED MATER RES, V38, P35
   PINCET F, 1995, LANGMUIR, V11, P1229, DOI 10.1021/la00004a031
   POCHNER K, 1995, SURF COAT TECH, V74-5, P394, DOI 10.1016/0257-8972(95)08325-1
   Ratner B.D., 1996, BIOMATERIALS SCI INT, P215
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   ROIG MG, 1994, J BIOMAT SCI-POLYM E, V6, P661
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   SUN MW, 1999, P 14 ISPC PRAH CZECH, P1779
   Tanaka H, 1996, J BIOMAT SCI-POLYM E, V8, P211
   WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013
NR 25
TC 10
Z9 10
U1 0
U2 16
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 17
PY 2003
VL 90
IS 7
BP 1985
EP 1990
DI 10.1002/app.12753
PG 6
WC Polymer Science
SC Polymer Science
GA 726PF
UT WOS:000185607500035
DA 2018-10-20
ER

PT J
AU Michael, KE
   Vernekar, VN
   Keselowsky, BG
   Meredith, JC
   Latour, RA
   Garcia, AJ
AF Michael, KE
   Vernekar, VN
   Keselowsky, BG
   Meredith, JC
   Latour, RA
   Garcia, AJ
TI Adsorption-induced conformational changes in fibronectin due to
   interactions with well-defined surface chemistries
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; CELL-BINDING DOMAIN; PROTEIN ADSORPTION;
   HYDROPHOBIC SURFACES; THEORETICAL-ANALYSIS; VARYING FUNCTIONALITY;
   ADSORBED FIBRONECTIN; COMPETITIVE BEHAVIOR; RELAXATION KINETICS;
   MONOCLONAL-ANTIBODY
AB Protein adsorption onto synthetic materials influences cell adhesion and signaling events that direct cell function in numerous biomedical applications. Adsorption of fibronectin (FN) to different surfaces alters protein structure and modulates alpha(5)beta(1) integrin binding, cell adhesion, cell spreading, and cell migration. In the present study, self-assembled monolayers of alkanethiols on Au were used to analyze the effects of surface chemistry (CH3, OH, NH2, and COOH) on the adsorption of a recombinant fragment of FN, FNIII7-10, that incorporates both the synergy and RGD cell binding motifs. Surface chemistry potentiated differential FNIII7-10 adsorption kinetics and adsorbed structure as determined by surface plasmon resonance spectroscopy and antibody binding assays. FNIII7-10 functional activity, determined by cell adhesion strength, was modulated in a fashion consistent with these structural changes (OH = NH2 > COOH > CH3). However, these changes in protein parameters did not correlate simply to differences in surface hydrophobicity, indicating that additional surface parameters influence protein adsorption. These results demonstrate that surface chemistry modulates adsorbed protein structure and activity and establish a relationship between surface-dependent changes in structural domains of FNIII7-10 and functional activity.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
RI Keselowsky, Benjamin/A-8000-2009; Meredith, Carson/B-3323-2009; Zhou,
   Feng/E-9510-2011
OI Meredith, Carson/0000-0003-2519-5003; 
CR ALEXANDER SS, 1979, J BIOL CHEM, V254, P1501
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Basalyga DM, 2003, J BIOMED MATER RES A, V64A, P120, DOI 10.1002/jbm.a.10360
   BEISSINGER RL, 1982, J COLLOID INTERF SCI, V85, P521, DOI 10.1016/0021-9797(82)90018-2
   Brash J. L., 1995, ACS SYM SER, V602, P1
   BRASH JL, 1987, ACS SYM SER, V343, P490
   Buijs J, 1996, LANGMUIR, V12, P1605, DOI 10.1021/la950665s
   Christensen LLH, 1997, ANAL BIOCHEM, V249, P153, DOI 10.1006/abio.1997.2182
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Danielson MA, 1996, ANNU REV BIOPH BIOM, V25, P163, DOI 10.1146/annurev.bb.25.060196.001115
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Franco M, 2000, J BIOMED MATER RES, V52, P261, DOI 10.1002/1097-4636(200011)52:2<261::AID-JBM4>3.0.CO;2-2
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   HAYNES CA, 1994, J COLLOID INTERF SCI, V164, P394, DOI 10.1006/jcis.1994.1182
   Hynes RO, 1990, FIBRONECTINS
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Latour RA, 2002, J BIOMED MATER RES, V60, P564, DOI 10.1002/jbm.10052
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lu JR, 1998, J COLLOID INTERF SCI, V206, P212, DOI 10.1006/jcis.1998.5680
   LUNDSTROM I, 1984, J THEOR BIOL, V110, P195, DOI 10.1016/S0022-5193(84)80052-1
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Norde W, 1995, ACS SYM SER, V602, P26
   PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Raghavachari M, 2000, COLLOID SURFACE B, V19, P315, DOI 10.1016/S0927-7765(00)00140-5
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039
   ULMAN A, 1989, LANGMUIR, V5, P1147, DOI 10.1021/la00089a003
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Wertz CF, 2002, LANGMUIR, V18, P1190, DOI 10.1021/la0108813
   WILSON K, UNPUG J BIOMED MAT R
   Xia N, 2002, LANGMUIR, V18, P4090, DOI 10.1021/la020022u
NR 54
TC 196
Z9 196
U1 9
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 16
PY 2003
VL 19
IS 19
BP 8033
EP 8040
DI 10.1021/la034810a
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 720ZX
UT WOS:000185293500052
DA 2018-10-20
ER

PT J
AU Niarchos, D
AF Niarchos, D
TI Magnetic MEMS: key issues and some applications
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT 4th European Magnetic Sensor and Actuators Conference
CY JUL 03-05, 2002
CL ATHENS, GREECE
ID MICROELECTROMECHANICAL SYSTEMS; THIN-FILMS; SEPARATOR
AB Magnetic micro-electro-mechanical-systems (Magnetic MEMS) present a new class of conventional MEMS devices with great potential for science and applications. Using the same technology as for MEMS and incorporating magnetic materials as the sensing or active element offer new capabilities and open new markets within the information technology, automotive, biomedical, space and instrumentation. Magnetic MEMS are based on electromagnetic interactions between magnetic materials and active (coils) or passive magnetic field sources (permanent magnets). At the micrometer scale Magnetic MEMS offer distinct advantages as compared with electrostatic and piezoelectric actuators in strength, polarity and distance of actuation to name a few. The compatibility of magnetic materials with MEMS technology is a key issue, which is addressed by a number of groups worldwide. In this article, we will present an overview of the Magnetic MEMS technology and we will present some of the existing and future applications. (C) 2003 Published by Elsevier Science B.V.
C1 NCSR Demokritos, Inst Sci Mat, GR-15310 Athens, Greece.
RP Niarchos, D (reprint author), NCSR Demokritos, Inst Sci Mat, GR-15310 Athens, Greece.
OI NIARCHOS, DIMITRIOS/0000-0002-6256-7497
CR Ahn C. H., 1993, Proceedings. IEEE. Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Systems (Cat. No.93CH3265-6), P1, DOI 10.1109/MEMSYS.1993.296940
   AHN CH, 1992, P IEEE SOL STAT SENS, P14
   Bishop D, 2001, PHYS TODAY, V54, P38, DOI 10.1063/1.1420552
   BUDE T, 2002, INTERMAG
   Cadieu FJ, 1998, J APPL PHYS, V83, P6247, DOI 10.1063/1.367771
   Cavallotti PL, 1998, SURF COAT TECH, V105, P232, DOI 10.1016/S0257-8972(98)00460-5
   Chin TS, 2000, J MAGN MAGN MATER, V209, P75, DOI 10.1016/S0304-8853(99)00649-6
   Choi JW, 2001, BIOSENS BIOELECTRON, V16, P409, DOI 10.1016/S0956-5663(01)00154-3
   Choi JW, 2000, SENSOR ACTUAT B-CHEM, V68, P34, DOI 10.1016/S0925-4005(00)00458-5
   COUGAT O, COMMUNICATION
   COUGAT O, 2002, P 1M INT WORKSH RAR
   Dutoit BM, 1999, SENSOR ACTUAT A-PHYS, V77, P178, DOI 10.1016/S0924-4247(99)00193-4
   Gong H, 1999, J APPL PHYS, V85, P5750, DOI 10.1063/1.370114
   Grunberg PA, 2001, SENSOR ACTUAT A-PHYS, V91, P153, DOI 10.1016/S0924-4247(01)00513-1
   GUCKEL H, 1993, IEEE T MICROELEC JAN, P7
   HUANG MQ, 2001, IEEE T MAGN, V37
   JEONG S, 2000, IEEE T MAGN, V36
   Judy JW, 2001, SMART MATER STRUCT, V10, P1115, DOI 10.1088/0964-1726/10/6/301
   Kallenbach E., 2000, ACTUATOR 2000. 7th International Conference on New Actuators and International Exhibition on Smart Actuators and Drive Systems. Conference Proceedings, P611
   KORNILOV NV, 1999, REV METALLURGIE
   LEE CH, 1990, PHYS REV B, V42, P11384, DOI 10.1103/PhysRevB.42.11384
   Liakopoulos TM, 1999, IEEE T MAGN, V35, P3679, DOI 10.1109/20.800629
   LIAKOPOULOS TM, 1998, P SOL STAT SENS ACT, P19
   Ludwig A, 2000, J APPL PHYS, V87, P4691, DOI 10.1063/1.373132
   MADOU M, 2002, FUNDAMENTALS NANOFAB
   MYUNG NV, 2000, P ELECTROCHEM SOC PV
   PAWLOWSKI B, 1998, P REM, V15, P1045
   Prados C, 1998, J APPL PHYS, V83, P6253, DOI 10.1063/1.367804
   Rieger G, 2000, J APPL PHYS, V87, P5329, DOI 10.1063/1.373337
   Von Hippel A., 1959, MOL SCI MOL ENG, P39
   WAGNER B, 1991, IEEE MICRO ELECTRO MECHANICAL SYSTEMS, P27
   YANG Y, 2001, P INT C SOL STAT SEN
   1999, Patent No. 6375759
   1998, TECH J, V15
   1981, Patent No. 42977388
NR 35
TC 57
Z9 61
U1 1
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD SEP 15
PY 2003
VL 106
IS 1-3
BP 255
EP 262
DI 10.1016/S0924-4247(03)00179-1
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 713FZ
UT WOS:000184847600059
DA 2018-10-20
ER

PT J
AU Wu, Z
   Sullivan, JM
AF Wu, Z
   Sullivan, JM
TI Multiple material marching cubes algorithm
SO INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN ENGINEERING
LA English
DT Article; Proceedings Paper
CT 3rd Symposium on Trends in Unstructured Mesh Generation
CY AUG 01-04, 2001
CL DEARBORN, MICHIGAN
DE surface reconstruction; marching cubes; multi-material; surface
   adjustment
ID ISOSURFACE GENERATION; SURFACE EXTRACTION
AB The accurate reconstruction of three-dimensional (3D) boundary surfaces from two-dimensional (2D) medical images is a crucial procedure in most applications of computational biomedical engineering. This paper addresses an innovative system that efficiently reconstructs accurate, multiple-material, 3D surface meshes from 2D medical images. It is based on an enhanced marching cubes algorithm, the multi-material marching cubes algorithm (M3C), which extracts boundary surfaces between different materials within one sweep of the image stack in an integrated manner. The continuity and integrity of the surfaces are ensured with this robust algorithm. Surface adjustment algorithms were also revised to adapt to the multiple-material nature of the system. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.
   Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.
RP Sullivan, JM (reprint author), Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.
CR AMENTA N, 1997, 8 ACM SIAM S DISCR A
   BOURKE P, 2002, POLYGONISING SCALAR
   Canann S. A., 1993, Finite Elements in Analysis and Design, V13, P185, DOI 10.1016/0168-874X(93)90056-V
   Chan SL, 1998, COMPUT GRAPH, V22, P83, DOI 10.1016/S0097-8493(97)00085-X
   Cignoni P, 1998, COMPUT GRAPH-UK, V22, P37, DOI 10.1016/S0097-8493(97)00082-4
   ERIKSON C, 1996, TR96016 U N CAR DEP
   Gueziec A, 1995, IEEE T VIS COMPUT GR, V1, P328, DOI 10.1109/2945.485620
   KULKARNI AA, 2000, THESIS WORCESTER POL
   Li JP, 1997, VISUAL COMPUT, V13, P391
   LORENSEN WE, 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422
   Lucas L, 1997, COMPUT NETWORKS ISDN, V29, P1737, DOI 10.1016/S0169-7552(97)00086-X
   MATVEYEV SV, 1994, IEEE VISUAL, P288
   MONTANI C, 1994, IEEE VISUAL, P281
   Nielson G.M., 1991, IEEE VISUALIZATION 9, P83
   Schneider R, 2001, COMPUT AIDED GEOM D, V18, P359, DOI 10.1016/S0167-8396(01)00036-X
   SCHROEDER W, 1997, VISUALIZATION TOOLKI
   SCHROEDER WJ, 1992, COMP GRAPH, V26, P65
   Shekhar R, 1996, IEEE VISUAL, P335, DOI 10.1109/VISUAL.1996.568127
   Taubin G, 1995, SIGGRAPH 95 C P, P351, DOI DOI 10.1145/218380.218473
   Treece GM, 1999, COMPUT GRAPH-UK, V23, P583, DOI 10.1016/S0097-8493(99)00076-X
   Vollmer J., 1999, COMPUT GRAPH FORUM, P131
   WU Z, 2001, THESIS WORCESTER POL
NR 22
TC 77
Z9 78
U1 1
U2 7
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0029-5981
J9 INT J NUMER METH ENG
JI Int. J. Numer. Methods Eng.
PD SEP 14
PY 2003
VL 58
IS 2
BP 189
EP 207
DI 10.1002/nme.775
PG 19
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
SC Engineering; Mathematics
GA 720DB
UT WOS:000185245300004
DA 2018-10-20
ER

PT J
AU Darrasse, L
   Ginefri, JC
AF Darrasse, L
   Ginefri, JC
TI Perspectives with cryogenic RF probes in biomedical MRI
SO BIOCHIMIE
LA English
DT Review
DE radiofrequency coil; low-temperature; superconductor; NMR; MRI
ID LOW-FIELD MRI; HIGH-TEMPERATURE SUPERCONDUCTOR; MAGNETIC-RESONANCE
   MICROSCOPY; HIGH-RESOLUTION NMR; TO-NOISE RATIO; SURFACE COIL; RECEIVER
   COILS; SMALL ANIMALS; HUMAN BRAIN; SPIN NOISE
AB Since discovery of high-temperature superconductive (HTS) ceramics by Bednorz and Muller in 1986, there has been an accelerated development of cold technologies in industry, including the domain of NMR detection. The purpose of this paper is to fix ideas about the stage that cryogenic radio frequency (RF) probe techniques have reached in biomedical magnetic resonance imaging (MRI). Readers confronted to the literature about this emerging topic have to understand a large range of motivations with somewhat unclearly defined technical limitations and actual outlets. An overview of sensitivity issues in the general context of biomedical MRI is provided here and the contribution of RF coil techniques to recent advances is identified. The domains where cooled coil materials such as copper, low- or high-temperature superconductors, could actually increase the RF coil sensitivity are delimited by a quantitative analysis of noise mechanisms. Technical keys, cryogenic means and cold RF coil technologies are considered, and first achievements in different fields of biomedical MRI are reviewed. This survey provides a basis for discussing about the future impact of cryogenic probes for MRI investigations. (C) 2003 Editions scientitiques et medicales Elsevier SAS. All rights reserved.
C1 Univ Paris 11, CNRS, UMR 8081, ESA,Unite Rech Resonance Magnet Med, F-91405 Orsay, France.
RP Darrasse, L (reprint author), Univ Paris 11, CNRS, UMR 8081, ESA,Unite Rech Resonance Magnet Med, Batiment 220, F-91405 Orsay, France.
EM darrasse@u2r2m.u-psud.fr
CR ACKERMAN JJH, 1980, NATURE, V283, P167, DOI 10.1038/283167a0
   ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0
   Augustine MP, 1998, APPL PHYS LETT, V72, P1908, DOI 10.1063/1.121223
   AXEL L, 1984, J COMPUT ASSIST TOMO, V8, P381, DOI 10.1097/00004728-198406000-00002
   Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5
   BLACK RD, 1993, SCIENCE, V259, P793, DOI 10.1126/science.8430331
   BLACK RD, 1995, J MAGN RESON SER A, V113, P74, DOI 10.1006/jmra.1995.1058
   Bock NA, 2003, MAGNET RESON MED, V49, P158, DOI 10.1002/mrm.10326
   Bottomley PA, 1997, SOLID STATE NUCL MAG, V9, P29, DOI 10.1016/S0926-2040(97)00040-4
   Bracanovic D, 2001, IEEE T APPL SUPERCON, V11, P2422, DOI 10.1109/77.920351
   BRASCH RC, 1984, AM J ROENTGENOL, V142, P625, DOI 10.2214/ajr.142.3.625
   BRYANT RG, 1991, MAGNET RESON MED, V21, P117, DOI 10.1002/mrm.1910210114
   CHOW MS, 2003, P ISMRM 11 ANN M TOR, P2372
   COEURJOLY O, 1993, ITBM RBM, V14, P15
   CREASY JL, 1990, RADIOLOGY, V175, P280, DOI 10.1148/radiology.175.1.2315497
   DECORPS M, 1985, J MAGN RESON, V65, P100, DOI 10.1016/0022-2364(85)90378-6
   DUZER TV, 1981, PRINCIPLE SUPERCONDU
   Edelstein W. A., 1985, P SMRM 4 ANN M LOND, P964
   EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413
   Erickson SJ, 1997, RADIOLOGY, V205, P593, DOI 10.1148/radiology.205.3.9393511
   ERNST RR, 1966, REV SCI INSTRUM, V37, P93, DOI 10.1063/1.1719961
   Fang J, 2002, IEEE T APPL SUPERCON, V12, P1823, DOI 10.1109/TASC.2002.1020344
   Fang J, 2001, P ISMRM 9 ANN M GLAG, P1133
   Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002
   Gao E., 2001, P ISMRM 9 ANN M GLAS, P1113
   Gati JS, 1997, MAGNET RESON MED, V38, P296, DOI 10.1002/mrm.1910380220
   Ginefri J. C., 1999, P 7 ANN M ISMRM PHIL, P2129
   Ginefri JC, 1999, IEEE T APPL SUPERCON, V9, P4695, DOI 10.1109/77.819340
   Ginefri JC, 2001, MAGNET RESON MED, V45, P376, DOI 10.1002/1522-2594(200103)45:3<376::AID-MRM1049>3.0.CO;2-R
   GINEFRI JC, 1998, J PHYS, V4, P8
   GINEGFRI JC, 2002, P 10 INT CER C 3 FOR, V3, P449
   Glover P, 2002, REP PROG PHYS, V65, P1489, DOI 10.1088/0034-4885/65/10/203
   Golman K, 2001, MAGNET RESON MED, V46, P1, DOI 10.1002/mrm.1152
   Golman K, 2000, J MAGN RESON IMAGING, V12, P929, DOI 10.1002/1522-2586(200012)12:6<929::AID-JMRI17>3.0.CO;2-J
   Gonen O, 1997, MAGNET RESON MED, V37, P301, DOI 10.1002/mrm.1910370228
   GONORD P, 1994, REV SCI INSTRUM, V65, P3363, DOI 10.1063/1.1144573
   Grasso G, 2000, INT J MOD PHYS B, V14, P2902, DOI 10.1142/S0217979200003071
   GUERON M, 1989, J MAGN RESON, V85, P209, DOI 10.1016/0022-2364(89)90338-7
   HALL AS, 1988, MAGNET RESON MED, V7, P230, DOI 10.1002/mrm.1910070211
   HALL AS, 1991, MAGNET RESON MED, V20, P340, DOI 10.1002/mrm.1910200218
   Helstrom C. W., 1991, PROBABILITY STOCHAST
   Hennessy M. J., 1999, P ISMRM 7 ANN M PHIL, P2076
   Hill HDW, 1997, IEEE T APPL SUPERCON, V7, P3750, DOI 10.1109/77.622233
   Hohmann R, 1999, IEEE T APPL SUPERCON, V9, P3688, DOI 10.1109/77.783829
   HOULT DI, 1986, MAGNET RESON MED, V3, P730, DOI 10.1002/mrm.1910030509
   HOULT DI, 1979, J MAGN RESON, V34, P425, DOI 10.1016/0022-2364(79)90019-2
   Hoult DI, 2000, J MAGN RESON IMAGING, V12, P46, DOI 10.1002/1522-2586(200007)12:1<46::AID-JMRI6>3.3.CO;2-4
   Hoult DI, 2001, J MAGN RESON, V148, P182, DOI 10.1006/jmre.2000.2229
   HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X
   Hurlston SE, 1999, MAGNET RESON MED, V41, P1032, DOI 10.1002/(SICI)1522-2594(199905)41:5<1032::AID-MRM23>3.3.CO;2-O
   Kang L, 2002, CHINESE PHYS LETT, V19, P1380, DOI 10.1088/0256-307X/19/9/351
   KAUFMAN L, 1989, Magnetic Resonance Quarterly, V5, P283
   Kober F, 2001, MAGNET RESON MED, V45, P1130, DOI 10.1002/mrm.1150
   Kraichman M.B., 1962, Journal of Research of the National Bureau of Standards, V66D, P499
   Kumar S, 1996, IEEE T MAGN, V32, P5261, DOI 10.1109/20.545762
   KWOK W, 2003, P ISMRM 11 ANN M TOR, P430
   Lei H, 2003, MAGNET RESON MED, V49, P199, DOI 10.1002/mrm.10379
   Ma QY, 1999, IEEE T APPL SUPERCON, V9, P3565, DOI 10.1109/77.783800
   MACOVSKI A, 1993, MAGNET RESON MED, V30, P221, DOI 10.1002/mrm.1910300211
   MANN LD, 1998, P ISMRM 6 ANN M SIDN, P435
   McDermott R, 2002, SCIENCE, V295, P2247, DOI 10.1126/science.1069280
   MCFARLAND EW, 1992, MAGN RESON IMAGING, V10, P279, DOI 10.1016/0730-725X(92)90487-K
   Merl T, 1999, EUR J RADIOL, V30, P43, DOI 10.1016/S0720-048X(98)00134-X
   MIDDLETON H, 1995, MAGNET RESON MED, V33, P271, DOI 10.1002/mrm.1910330219
   Miller JR, 1996, IEEE T BIO-MED ENG, V43, P1197, DOI 10.1109/10.544344
   Miller JR, 1999, MAGNET RESON MED, V41, P72, DOI 10.1002/(SICI)1522-2594(199901)41:1<72::AID-MRM11>3.0.CO;2-A
   MULLER S, 1989, MAGNET RESON MED, V12, P400, DOI 10.1002/mrm.1910120313
   Odoj F, 1998, REV SCI INSTRUM, V69, P2708, DOI 10.1063/1.1149003
   OKADA H, 1995, J MAGN RESON SER B, V107, P158, DOI 10.1006/jmrb.1995.1072
   Ott H. W., 1976, NOISE REDUCTION TECH
   Penn SJ, 1999, IEEE T APPL SUPERCON, V9, P3070, DOI 10.1109/77.783677
   PENN SJ, 1993, APPL SUPERCOND, V1, P1855
   Peterfy CG, 1997, RADIOL CLIN N AM, V35, P1
   POIRERQUINOT M, 2003, MAGN RESON MAT BIO 7, V16, P5176
   POIRIERQUINOT M, 2003, 8 C CNRS RECH DEC TO
   POWEL RL, 1979, CRYOGENIC PROPERTIES
   Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.3.CO;2-J
   RAAD A, 1992, MAGN RESON IMAGING, V10, P55, DOI 10.1016/0730-725X(92)90373-8
   Robitaille PML, 2000, J COMPUT ASSIST TOMO, V24, P2, DOI 10.1097/00004728-200001000-00002
   ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203
   ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211
   Rowell JM, 1997, SOLID STATE COMMUN, V102, P269, DOI 10.1016/S0038-1098(96)00724-7
   SAINTJAMES H, 1996, J MAGN RESON ANAL, V2, P53
   SCOTT G, 1996, P ISMRM 4 M NEW YORK, P396
   Serfaty S, 1997, MAGNET RESON MED, V38, P687, DOI 10.1002/mrm.1910380424
   SERFATY S, 1994, P 4 INT SMR M NEW YO, P219
   Seton HC, 1999, MAGN RESON MATER PHY, V8, P116
   SETON HC, 1995, IEEE T APPL SUPERCON, V5, P3218, DOI 10.1109/77.403276
   Seton HC, 1997, MEAS SCI TECHNOL, V8, P198, DOI 10.1088/0957-0233/8/2/015
   SHEN ZY, 1994, HIGH TEMPERATURE SUP
   Smith DG, 1997, IEEE T APPL SUPERCON, V7, P3710, DOI 10.1109/77.622224
   SMITH DR, 1995, J RES NATL INST STAN, V100, P119, DOI 10.6028/jres.100.012
   Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414
   STYLES P, 1984, J MAGN RESON, V60, P397, DOI 10.1016/0022-2364(84)90050-7
   STYLES P, 1989, J MAGN RESON, V84, P376, DOI 10.1016/0022-2364(89)90383-1
   Suddarth S, 1998, IEEE T BIO-MED ENG, V45, P1061, DOI 10.1109/10.704875
   Suits BH, 1998, J MAGN RESON, V135, P373, DOI 10.1006/jmre.1998.1608
   TALLON J, IND WARMS SUPERCONDU
   TERMAN FE, 1943, RADIOENGINEERS HDB
   TRABESINGER AH, 2003, P ISMRM 11 ANN M TOR, P752
   VANHETEREN JG, 1994, MAGNET RESON MED, V32, P396, DOI 10.1002/mrm.1910320315
   Vaughan JT, 2001, MAGNET RESON MED, V46, P24, DOI 10.1002/mrm.1156
   VESTER M, 1997, P INT SOC MAGN RESP, P1528
   VESTER M, 1997, INT MRI C DUSS
   Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316
   Withers RS, 1993, IEEE T APPL SUPERCON, V3, P2450, DOI 10.1109/77.233951
   Wosik J, 2000, PHYSICA C, V341, P2561, DOI 10.1016/S0921-4534(00)01359-9
   Wosik J, 2001, IEEE T APPL SUPERCON, V11, P681, DOI 10.1109/77.919436
   WOSIK J, 2002, P ISMRM 11 ANN M TOR, P2373
   Wright AC, 2000, MAGNET RESON MED, V43, P163, DOI 10.1002/(SICI)1522-2594(200002)43:2<163::AID-MRM1>3.0.CO;2-K
   Xu H, 2001, IEEE T APPL SUPERCON, V11, P353, DOI 10.1109/77.919355
   Young IR, 1999, NMR BIOMED, V12, P381, DOI 10.1002/(SICI)1099-1492(199910)12:6<381::AID-NBM574>3.0.CO;2-9
   1 WURZB WORKSH PAR M
NR 113
TC 112
Z9 113
U1 2
U2 30
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD SEP
PY 2003
VL 85
IS 9
BP 915
EP 937
DI 10.1016/j.biochi.2003.09.016
PG 23
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 749KT
UT WOS:000186919600010
PM 14652180
DA 2018-10-20
ER

PT J
AU Yu, TY
   Ober, CK
AF Yu, TY
   Ober, CK
TI Methods for the topographical patterning and patterned surface
   modification of hydrogels based on hydroxyethyl methacrylate
SO BIOMACROMOLECULES
LA English
DT Editorial Material
ID CELL ATTACHMENT; FABRICATION; PROTEINS
AB Hydrogels have gained broad acceptance as a class of biocompatible materials. In this paper, we report the topographic patterning and regiospecific functionalization of hydrogel surfaces. Both photolithography and soft lithography are combined in a hybrid process to form these topographic features. By functionalization of a base layer surface followed by lithographic patterning steps, it is possible to introduce chemical functions to specific regions of the patterned surface. The model systems investigated were based on 2-hydroxyethyl methacrylate (HEMA), which is well-known for its low toxicity and widespread use in biomedical applications. Tests of Ni-NTA modified hydrogel surfaces showed successful binding of fluorescently labeled proteins to selected regions of the patterned hydrogel surface. These processes can be expanded to a wide range of monomer systems.
C1 Cornell Univ, Ithaca, NY 14850 USA.
RP Ober, CK (reprint author), Cornell Univ, 310 Bard Hall, Ithaca, NY 14850 USA.
OI Ober, Christopher/0000-0002-3805-3314
CR Chen GP, 1998, LANGMUIR, V14, P6610, DOI 10.1021/la9806303
   Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297
   Jackman RJ, 1999, LANGMUIR, V15, P2973, DOI 10.1021/la981591y
   James CD, 2000, IEEE T BIO-MED ENG, V47, P17, DOI 10.1109/10.817614
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Martin BD, 2000, LANGMUIR, V16, P9944, DOI 10.1021/la001053x
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   SHEPPARD NF, 1995, SENSOR ACTUAT B-CHEM, V28, P95, DOI 10.1016/0925-4005(94)01542-P
   SUDHOLTER EJ, 1990, ANAL CHIM ACTA, V59, P65
   Viravaidya K, 2002, BIOTECHNOL BIOENG, V78, P454, DOI 10.1002/bit.10219
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang S, 2000, CHEM MATER, V12, P33, DOI 10.1021/cm990241+
NR 14
TC 57
Z9 59
U1 1
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP-OCT
PY 2003
VL 4
IS 5
BP 1126
EP 1131
DI 10.1021/bm034079m
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 722QE
UT WOS:000185386900003
PM 12959574
DA 2018-10-20
ER

PT J
AU Han, SI
   Kim, BS
   Kang, SW
   Shirai, H
   Im, SS
AF Han, SI
   Kim, BS
   Kang, SW
   Shirai, H
   Im, SS
TI Cellular interactions and degradation of aliphatic poly(ester amide)s
   derived from glycine and/or 4-amino butyric acid
SO BIOMATERIALS
LA English
DT Article
DE enzymatic degradation; cellular interaction; poly(ester amide)s
ID HYDROGEN-BONDS; ADIPIC ACID; IN-VITRO; BIOCOMPATIBILITY; 1,2-ETHANEDIOL;
   WETTABILITY; POLYMERS; SURFACES; ALANINE; CELLS
AB A series of poly(ester amide)s derived from amino acid (glycine or 4-amino butyric acid), diol (1,6-hexanediol or 1,4-butanediol) and sebacoyl chloride were prepared by interfacial polymerization. FT-IR analysis indicated that for poly(ester amide)s derived from glycine, only amide-amide hydrogen bonds and hydrogen-bonded C = O ester groups were established, whereas the poly(ester amide)s derived from 4-amino butyric acid contained amide-amide hydrogen bonds and amide-ester hydrogen bonds, including NH groups and C = O ester groups in free state. The biodegradability was estimated by weight residue of poly(ester amide) films in pH 6 buffer solution with papain at 37degreesC. The poly(ester amide) films derived from glycine demonstrated significantly improved degradability compared to the poly(ester amide) films derived from 4-amino butyric acid. This difference of degradation rate could be explained by the bonding state in C = O ester groups. The cellular interaction of the poly(ester amide)s was studied by measuring the proliferation of human dermal fibroblasts on the polymer films. The cells proliferated significantly faster on poly(ester amide) films derived from 4-amino butyric acid than on poly(ester amide) films derived from glycine. These results suggest that the poly(ester amide) prepared in this study may serve as a potential cell-compatible biomedical material. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Hanyang Univ, Coll Engn, Dept Fiber & Polymer Engn, Seongdong Gu, Seoul 133791, South Korea.
   Hanyang Univ, Dept Chem Engn, Seongdong Gu, Seoul 133791, South Korea.
   Shinshu Univ, Fac Text Sci & Technol, Dept Funct Polymer Sci, Matsumoto, Nagano, Japan.
RP Im, SS (reprint author), Hanyang Univ, Coll Engn, Dept Fiber & Polymer Engn, Seongdong Gu, 17 Haengdang Dong, Seoul 133791, South Korea.
RI Kim, Byung-Soo/O-2352-2013
CR Arnon R., 1970, METHOD ENZYMOL, V19, P226, DOI DOI 10.1016/0076-6879(70)19017-3
   CIAPETTI G, 1994, BIOMATERIALS, V15, P63, DOI 10.1016/0142-9612(94)90199-6
   GONSALVES KE, 1992, MACROMOLECULES, V25, P3309, DOI 10.1021/ma00038a047
   Ho L. H., 1992, POLYM PREPR AM CHEM, V33, P94
   ISMAT A, 1971, J POLYM SCI POL CHEM, V9, P199
   Kaczmarczyk B, 1998, POLYMER, V39, P5853, DOI 10.1016/S0032-3861(98)00024-X
   Kaczmarczyk B, 1995, POLYMER, V36, P5019, DOI 10.1016/0032-3861(96)81631-4
   Kim HW, 2002, INT J BIOL MACROMOL, V30, P129, DOI 10.1016/S0141-8130(02)00012-0
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee SY, 2002, POLYM DEGRAD STABIL, V78, P63
   Marois Y, 1996, BIOMATERIALS, V17, P1835, DOI 10.1016/0142-9612(95)00245-6
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Nagata M, 1999, MACROMOL CHEM PHYSIC, V200, P2059, DOI 10.1002/(SICI)1521-3935(19990901)200:9<2059::AID-MACP2059>3.0.CO;2-N
   ODIAN G, 1981, PRINCIPLES POLYM, P60
   Paredes N, 1998, J POLYM SCI POL CHEM, V36, P1271
   Paredes N, 1998, J APPL POLYM SCI, V69, P1537, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1537::AID-APP8>3.0.CO;2-D
   SAOTOME Y, 1991, CHEM LETT, P21, DOI 10.1246/cl.1991.21
   SAOTOME Y, 1991, CHEM LETT, P153, DOI 10.1246/cl.1991.153
   TAKAGI H, 1995, J CLIN INVEST, V96, P2120, DOI 10.1172/JCI118265
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANLUYN MJA, 1991, J MATER SCI-MATER M, V2, P142, DOI 10.1007/BF00692972
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
NR 22
TC 32
Z9 36
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2003
VL 24
IS 20
BP 3453
EP 3462
DI 10.1016/S0142-9612(03)00223-0
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 692DJ
UT WOS:000183645100010
PM 12809774
DA 2018-10-20
ER

PT J
AU Chan, K
AF Chan, K
TI Some aspects of toxic contaminants in herbal medicines
SO CHEMOSPHERE
LA English
DT Article; Proceedings Paper
CT International Conference on Environmental and Public Health Management
CY MAR 12-14, 2002
CL HONG KONG BAPTIST UNIV, KOWLOON, PEOPLES R CHINA
HO HONG KONG BAPTIST UNIV
DE chemical and biomedical analyses; heavy metals; herbal medicines;
   pesticides; proper use of Chinese herbal medicines; toxic contaminants
ID TRADITIONAL CHINESE MEDICINE; COMMERCIAL SAMPLES; HEAVY-METALS;
   MASS-SPECTROMETRY; GINSENG; WARFARIN; DRUGS; PHARMACODYNAMICS; PLANTS
AB A World Health Organisation survey indicated that about 70-80% of the world populations rely on non-conventional medicine mainly of herbal sources in their primary healthcare. In recent years, we have witnessed the increasing growth in popularity of over-the-counter (OTC) health foods, nutraceuticals, and medicinal products from plants or other natural sources in developed countries. This indirectly indicates that the public is not satisfied with their orthodox medical (OM) treatment. Such increase in popularity has also brought concerns and fears over the professionalism of practitioners, and quality, efficacy and safety of their treatment methods and products from herbal and natural sources available in the market. Over the past decade several news-catching episodes in developed communities indicated adverse effects, sometimes life threatening, allegedly arisen consequential to taking of OTC herbal products or traditional medicines from various ethnic groups. These OTC products may be contaminated with excessive or banned pesticides, microbial contaminants, heavy metals, chemical toxins, and for adulterated with orthodox drugs. Excessive or banned pesticides, heavy metals and microbial contaminants may be related to the source of these herbal materials, if they are grown under contaminated environment or during collection of these plant materials. Chemical toxins may come from unfavourable or wrong storage conditions or chemical treatment due to storage. The presence of orthodox drugs can be related to unprofessional practice of manufacturers. Some of these environment related factors can be controlled by implementing standard operating procedures (SOP) leading to Good Agricultural Practice (GAP), Good Laboratory Practice (GLP), Good Supply Practice (GSP) and Good Manufacturing Practice (GMP) for producing these medicinal products from herbal or natural sources. The public's belief that herbal and natural products are safer than synthetic medicines can only be ascertained by imposing regulatory standards on these products that should be manufactured using these Good Practices.
   Using Chinese medicines, as examples, this paper illustrate how advances in chemical and biomedical analysis would help to detect intentional and unintentional toxic contaminants in herbal substances. The paper also summarises how modernization and progress are being carried out to get the best out of Chinese medicines for public healthcare. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Hong Kong Baptist Univ, Sch Chinese Med, Div Res & Dev, Hong Kong, Hong Kong, Peoples R China.
RP Chan, K (reprint author), Hong Kong Baptist Univ, Sch Chinese Med, Div Res & Dev, Hong Kong, Hong Kong, Peoples R China.
CR Abbot NC, 1996, NATURE, V381, P361, DOI 10.1038/381361a0
   Akerele O, 1993, World Health Forum, V14, P390
   ATHERTON DJ, 1992, PEDIATR DERMATOL, V9, P373, DOI 10.1111/j.1525-1470.1992.tb00635.x
   Au AM, 2000, B ENVIRON CONTAM TOX, V65, P112, DOI 10.1007/s001280000102
   BARNES J, 1997, PHARM J, V258, P76
   *BRIT MED ASS, 1993, COMPL MED NEW APPR G
   CHAN K, 1995, TRENDS PHARMACOL SCI, V16, P182, DOI 10.1016/S0165-6147(00)89019-7
   CHAN K, 2002, WAY FORWARD CHINESE, pCH4
   CHAN K, 1996, BIOLOGIST, V43, P50
   CHAN K, 2000, INTERACTIONS CHINESE, pCH7
   CHAN K, 1997, P 6 PAC RIM BIOT C B, P122
   CHAN K, 1995, FORENSIC TOXICOLOGY, P249
   Chaudhury RR, 1992, WHO REGIONAL PUBLICA
   CHUANG WC, 1995, PLANTA MED, V61, P459, DOI 10.1055/s-2006-958137
   COVEY TR, 1986, ANAL CHEM, V58, P2453, DOI 10.1021/ac00125a022
   EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406
   Ernst E., 1996, MEYLERS SIDE EFFECTS
   Honda Gisho, 1994, Natural Medicines, V48, P185
   Janetzky K, 1997, AM J HEALTH-SYST PH, V54, P692
   JIN Y, 1995, PHARM J S, V255, pR37
   JOHNSTON BA, 1997, HERBAL GRAM, V40, P49
   JONES BD, 1987, J CLIN PSYCHOPHARM, V7, P201, DOI 10.1097/00004714-198706000-00030
   Karunanithy R., 1991, INT J PHARM PRAC, V1, P117
   KOGA S, 1991, BIOCHEM SYST ECOL, V19, P315, DOI 10.1016/0305-1978(91)90019-V
   Koh HL, 2000, DRUG SAFETY, V23, P351, DOI 10.2165/00002018-200023050-00001
   KOREN OG, 1998, ADV GINSENG RES
   LEWITH G, 1996, COMPLEMENTARY MED IN
   Liang W.L., 1998, TAIWAN KEXUE, V37-56
   LIU YM, 1993, PLANTA MED, V59, P376, DOI 10.1055/s-2006-959706
   LIU YM, 1994, PHYTOCHEM ANALYSIS, V5, P256, DOI 10.1002/pca.2800050508
   LO ACT, 1992, EUR J DRUG METAB PH, V17, P257, DOI 10.1007/BF03190157
   LO ACT, 1995, EUR J DRUG METAB PH, V20, P55, DOI 10.1007/BF03192289
   Magdalita PM, 1997, THEOR APPL GENET, V95, P224, DOI 10.1007/s001220050552
   McRae S, 1996, CAN MED ASSOC J, V155, P293
   *PHARM COMM PRC, 2000, PHARM PEOPL REP CHIN
   SUN F, 1993, CHINESE TRAD HERB DR, V24, P148
   Ueng TH, 1997, J FOOD DRUG ANAL, V5, P241
   VANHAELEN M, 1994, LANCET, V343, P174, DOI 10.1016/S0140-6736(94)90964-4
   Wang XM, 1997, J FOOD DRUG ANAL, V5, P337
   WONG MK, 1993, BIOL TRACE ELEM RES, V36, P135, DOI 10.1007/BF02783172
   WU WL, 1992, ZHONGHUA YAOXUE ZAZH, V44, P269
   XU GJ, 1994, PICTORIAL COMPENDIUM
   Yu H., 1995, Journal of Pharmacy and Pharmacology, V47, P1129
   Yu H., 1997, J PHARM PHARM S, V49, P212
NR 44
TC 297
Z9 307
U1 5
U2 81
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
J9 CHEMOSPHERE
JI Chemosphere
PD SEP
PY 2003
VL 52
IS 9
BP 1361
EP 1371
DI 10.1016/S0045-6535(03)00471-5
PG 11
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 708JJ
UT WOS:000184563200004
PM 12867165
OA Green Published
DA 2018-10-20
ER

PT J
AU Jungling, K
   Nagler, K
   Pfrieger, FW
   Gottmann, K
AF Jungling, K
   Nagler, K
   Pfrieger, FW
   Gottmann, K
TI Purification of embryonic stem cell-derived neurons by immunoisolation
SO FASEB JOURNAL
LA English
DT Article
DE L1 antibodies; action potentials; glutamatergic synapses; GABAergic
   synapses; cell replacement
ID RETINAL GANGLION-CELLS; IN-VITRO; NEURAL PRECURSORS; LINEAGE SELECTION;
   MOUSE EMBRYOS; CULTURE; DIFFERENTIATION; TRANSPLANTATION; SURVIVAL
AB The pluripotency and high proliferative capacity of embryonic stem (ES) cells (1-3) makes them an attractive source of different cell types for biomedical research and cell replacement therapies. A major prerequisite for these applications is the availability of a homogeneous population of the desired cell type. However, ES cell-derived material contains, for example, undifferentiated cells, which can cause tumor formation after transplantation into the brain (4). To avoid such unwanted side effects, effective purification of distinct types of cells needs to be developed. Here, we describe an immunoisolation procedure to purify neurons from in vitro differentiated mouse ES cells using an antibody against the neuronal cell adhesion molecule L1 (5, 6). Our procedure yields a pure population of differentiated neurons, which are electrically excitable and form excitatory, glutamatergic, and inhibitory GABAergic synapses. The ability to highly purify ES cell-derived neurons will boost their molecular characterization and the further exploration of their therapeutic potential.
C1 Ruhr Univ Bochum, Dept Cell Physiol, D-44780 Bochum, Germany.
   Ctr Neurochim, Max Planck CNRS Grp, CNRS, UPR 2356, F-67084 Strasbourg, France.
RP Gottmann, K (reprint author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, D-44780 Bochum, Germany.
EM kurt.gottmann@ruhr-uni-bochum.de
OI Pfrieger, Frank/0000-0001-7085-1431
CR BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4
   BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834
   Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099
   BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221
   Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3
   Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5
   HOGAN B, 1994, MANIPULATING MOUSE E, P254
   Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9
   Malatesta P, 2000, DEVELOPMENT, V127, P5253
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8
   Mohrmann R, 1999, J NEUROSCI, V19, P10004
   Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x
   RATHJEN FG, 1984, EMBO J, V3, P1
   Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435
   STRUBING C, 1995, MECH DEVELOP, V53, P275, DOI 10.1016/0925-4773(95)00446-8
   Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395
   ZHANG SC, NAT BIOTECHNOL, V19, P1129
NR 21
TC 32
Z9 34
U1 0
U2 4
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD SEP
PY 2003
VL 17
IS 12
BP 2100
EP +
DI 10.1096/fj.03-0118fje
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 732DG
UT WOS:000185925100005
PM 14500547
DA 2018-10-20
ER

PT J
AU Pego, AP
   Poot, AA
   Grijpma, DW
   Feijen, J
AF Pego, AP
   Poot, AA
   Grijpma, DW
   Feijen, J
TI Physical properties of high molecular weight 1,3-trimethylene carbonate
   and D,L-lactide copolymers
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID RING-OPENING COPOLYMERIZATION; TRIMETHYLENE CARBONATE; HYDROLYTIC
   DEGRADATION; BIODEGRADABLE POLYMERS; ALIPHATIC POLYESTERS; INVITRO
   DEGRADATION; L-LACTIDE; IN-VITRO; TISSUE; INVIVO
AB High molecular weight statistical copolymers of 1,3-trimethylene carbonate (TMC) and D,L-lactide (DLLA) were synthesized and characterized with the aim of assessing their potential in the development of degradable and flexible materials for application in the biomedical field. Under the applied polymerization conditions (130 degreesC, 3 days using stannous octoate as a catalyst) monomer conversion was high or almost complete, and high molecular weight polymers ((M) over bar (n) above 170 <LF>000) were obtained. Significant improvement of the mechanical performance of these materials was observed in comparison to results previously reported for TMC and DLLA based copolymers of lower molecular weight. For the entire range of compositions the polymers are amorphous with a glass transition temperature ranging between -17 degreesC for poly(TMC) and 53 degreesC for poly(DLLA). The polymers vary from rubbers to stiff materials as the content of TMC decreases. All polymers are hydrophobic with very low equilibrium water absorption (< 1.5 wt%). All polymers are hydrophobic with very low equilibrium water absorption (< 1.5 wt%). Thermal analyses and tensile tests were performed on polymer samples after water uptake. Due to a plasticizing effect of the water, the thermal properties, and consequently the mechanical performance, of the copolymers with higher content of DLLA were the most affected. After water absorption, the polymer mechanical behavior can change from glassy to rubbery, as observed for the copolymer with 80 mol% of DLLA. The obtained results suggest that these copolymers are promising candidates as biomaterials in the preparation of degradable medical devices and systems. (C) 2003 Kluwer Academicn Publishers.
C1 Univ Twente, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
   Univ Twente, Fac Chem Technol, Dept Polymer Chem & Biomat, NL-7500 AE Enschede, Netherlands.
RP Feijen, J (reprint author), Univ Twente, Inst Biomed Technol, POB 217, NL-7500 AE Enschede, Netherlands.
RI Pego, Ana Paula/C-6942-2012
OI Pego, Ana Paula/0000-0001-5169-328X
CR ALBERTSSON AC, 1995, J APPL POLYM SCI, V57, P87, DOI 10.1002/app.1995.070570109
   BIRKINSHAW C, 1992, POLYM DEGRAD STABIL, V38, P249, DOI 10.1016/0141-3910(92)90120-T
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   BUCHHOLZ B, 1993, J MATER SCI-MATER M, V4, P381, DOI 10.1007/BF00122196
   Chisholm MH, 2000, J AM CHEM SOC, V122, P11845, DOI 10.1021/ja002160g
   Folliguet TA, 2001, J THORAC CARDIOV SUR, V121, P510, DOI 10.1067/mtc.2001.112528
   Fox G., 1956, B AM PHYS SOC, V1, P123
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GOGOLEWSKI S, 1993, POLYM DEGRAD STABIL, V40, P313, DOI 10.1016/0141-3910(93)90137-8
   GRIJPMA DW, 1994, MACROMOL CHEM PHYSIC, V195, P1633, DOI 10.1002/macp.1994.021950515
   Huang QH, 1998, POLYM J, V30, P168, DOI 10.1295/polymj.30.168
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Jie C, 1997, POLYM INT, V42, P373, DOI 10.1002/(SICI)1097-0126(199704)42:4<373::AID-PI722>3.3.CO;2-L
   Joziasse CAP, 1996, MACROMOL CHEM PHYSIC, V197, P2219, DOI 10.1002/macp.1996.021970713
   KATZ AR, 1985, SURG GYNECOL OBSTET, V161, P213
   KRICHELDORF HR, 1995, POLYMER, V36, P1253, DOI 10.1016/0032-3861(95)93928-F
   LEENSLAG JW, 1987, MAKROMOL CHEM, V188, P1809
   LI SM, 1990, J MATER SCI-MATER M, V1, P131, DOI 10.1007/BF00700872
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   Matsumura S, 1999, INT J BIOL MACROMOL, V25, P161, DOI 10.1016/S0141-8130(99)00030-6
   Mauduit J, 1996, J BIOMED MATER RES, V30, P201
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Pego AP, 2001, J BIOMAT SCI-POLYM E, V12, P35
   PEGO AP, 2002, THESIS U TWENTE NETH
   PEGO AP, 2002, UNPUB MACROMOLECULES
   PITT CG, 1981, BIOMATERIALS, V2, P215
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   SCHAKENRAAD JM, 1989, J BIOMED MATER RES, V23, P1271, DOI 10.1002/jbm.820231105
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   TRIOLO PM, 1987, THESIS U UTAH SALT L
   VANDIJK JAPP, 1983, J POLYM SCI POL CHEM, V21, P197, DOI 10.1002/pol.1983.170210121
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vert M, 1998, J CONTROL RELEASE, V53, P85, DOI 10.1016/S0168-3659(97)00240-X
   von Oepen R, 1992, Clin Mater, V10, P21, DOI 10.1016/0267-6605(92)90080-D
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 39
TC 79
Z9 80
U1 2
U2 26
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2003
VL 14
IS 9
BP 767
EP 773
DI 10.1023/A:1025084304766
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 709HH
UT WOS:000184619400006
PM 15348396
DA 2018-10-20
ER

PT J
AU Vaz, CM
   De Graaf, LA
   Reis, RL
   Cunha, AM
AF Vaz, CM
   De Graaf, LA
   Reis, RL
   Cunha, AM
TI Effect of crosslinking, thermal treatment and UV irradiation on the
   mechanical properties and in vitro degradation behavior of several
   natural proteins aimed to be used in the biomedical field
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SOY-PROTEIN; FILMS; GLUTARALDEHYDE
AB Gelatine (GEL), soy (SI), casein (CAS) and sodium-caseinate (NaCAS) solutions were cast to produce protein films. All the proteins were chemically modified by adding glyoxal to the film-forming solutions in amounts varying from 0 to 0.9% (w/w based on the protein content). After casting, the same films were also submitted to a heat treatment performed at 80 degreesC or UV irradiation. The effect of those chemical/physical modifications on the mechanical properties and on the hydrolytic stability of the protein films was evaluated. As a result, a large variety of protein films with different mechanical properties and degradation profiles were developed. CAS and NaCAS even when chemically/physically modified do not resist to hydrolysis longer than 2 weeks. GEL, only when chemically modified with glyoxal, become water resistant. Due to its hydrolytic stability, SI become a very attractive material for biomedical applications where long term treatments are a requisite. (C) 2003 Kluwer Academic Publishers.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   ATO, Agrotechnol Res Inst, NL-6700 AA Wageningen, Netherlands.
   Univ Minho, Res Grp Biomat Biodegradables & Biomimet, P-4710157 Braga, Portugal.
RP Vaz, CM (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Cunha
   M., Antonio/0000-0003-3860-7732
CR ADRIANO KP, 1994, J APPL BIOMATER, V5, P133
   BERTRANDHARB C, 1993, SCI ALIMENT, V13, P577
   Cheftel J., 1985, AMINO ACIDS PEPTIDES, P245
   CLARK RL, 1949, MOD PACKAG, V22, P122
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   DANNIELS AU, 1994, J APPL BIOMATER, V5, P51
   de Graaf LA, 1998, MACROMOL SYMP, V127, P51, DOI 10.1002/masy.19981270110
   FLINT FO, 1981, J FOOD SCI, V46, P1351, DOI 10.1111/j.1365-2621.1981.tb04172.x
   Gennadios A, 1996, T ASAE, V39, P575
   GENNADIOS A, 1991, CEREAL FOOD WORLD, V36, P1004
   Ghorpade VM, 1995, T ASAE, V38, P1805
   Herget GW, 2001, EUR J CARDIO-THORAC, V19, P4, DOI 10.1016/S1010-7940(00)00613-8
   *ISO, 1980, 62 ISO
   JANE JL, 1993, DEGRADABLE PLASTICS, P63
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   KOLSTER P, 1997, CEREALS NOVEL USES P, P1997
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Kunte LA, 1997, CEREAL CHEM, V74, P115, DOI 10.1094/CCHEM.1997.74.2.115
   MANNING G, 1998, INSIDE COSMETICS, V26
   MEANS GE, 1971, CHEM MODIFICATIONS P, P195
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   SCHILLING CH, 1995, J MATER RES, V10, P2197, DOI 10.1557/JMR.1995.2197
   WAGNER JR, 1995, J AGR FOOD CHEM, V43, P1993, DOI 10.1021/jf00056a007
   Wong S.S., 1991, CHEM PROTEIN CONJUGA
NR 25
TC 35
Z9 35
U1 0
U2 17
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2003
VL 14
IS 9
BP 789
EP 796
DI 10.1023/A:1025040522513
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 709HH
UT WOS:000184619400009
PM 15348399
DA 2018-10-20
ER

PT J
AU Schneider, S
   Feilen, P
   Cramer, H
   Hillgartner, M
   Brunnenmeier, F
   Zimmermann, H
   Weber, MM
   Zimmermann, U
AF Schneider, S
   Feilen, P
   Cramer, H
   Hillgartner, M
   Brunnenmeier, F
   Zimmermann, H
   Weber, MM
   Zimmermann, U
TI Beneficial effects of human serum albumin on stability and functionality
   of alginate microcapsules fabricated in different ways
SO JOURNAL OF MICROENCAPSULATION
LA English
DT Article
DE encapsulation methods; alginate; islet encapsulation; human serum
   albumin; stimulation index
ID ISLETS; TRANSPLANTATION; MATRIX; CELL
AB A key engineering challenge in designing microcapsules made from biocompatible alginate is maintaining adequate exchange of nutrients and oxygen between the entrapped cells and the environment, while simultaneously avoiding swelling and subsequent failure of the microcapsule. Approval for the use of alginate in pharmaceutical and/or biomedical applications also strictly requires that the components of the microcapsule material must meet the safety criteria of the ASTM and FDA. Incorporation of foetal calf serum (FCS) into the microcapsules for stabilization is not in accordance with the guidelines affirmed by these organizations. FCS should be substituted by microcapsule-stabilizing additives that are medically approved. In this communication, it is shown that 10% FCS can be replaced by 1% human serum albumin (i.e. by an agent for which medical approval is granted) without compromising effects on long-term in vitro stability. Furthermore, it is demonstrated that human serum albumin (HSA) significantly enhances cell survival and, particularly, insulin secretion of encapsulated rat islets over a time period of 3 weeks when incubated in culture medium. Thus, HSA-stabilized microcapsules made from UHV Lam alginate are apparently a promising system for immunoisolation of cells, particularly when alginate is cross-linked by injection of BaCl 2 crystals into the alginate droplets. Slight adjustments of the alginate concentration can tailor the microcapsule permeability to the released therapeutic factor.
C1 Univ Wurzburg, Biozentrum, Lehrstuhl Biotechnol, D-97074 Wurzburg, Germany.
   Univ Klin Mainz, Med Klin & Poliklin 1, Schwerpunkt Endokrinol & Stoffwechseler Krankunge, D-55131 Mainz, Germany.
   Fraunhofer Inst Biomed Tech, Arbeitsgrp Tieftemp Biophys, D-66386 St Ingbert, Germany.
RP Zimmermann, U (reprint author), Univ Wurzburg, Biozentrum, Lehrstuhl Biotechnol, D-97074 Wurzburg, Germany.
CR DEVOS P, 1999, CELL ENCAPSULATION T, P63
   Dornish M, 2001, ANN NY ACAD SCI, V944, P388
   EISENBERG D, 1969, STRUCTURES PROPERTIE
   Esch M, 1999, BIOPOLYMERS, V50, P227
   GROHN P, 1994, EXP CLIN ENDOCRINOL, V102, P380
   Hasse C, 1997, LANCET, V350, P1296, DOI 10.1016/S0140-6736(05)62473-7
   Heald K. A., 1994, Hormone and Metabolic Research, V26, P67
   Hoffman AS, 2001, ANN NY ACAD SCI, V944, P62
   Hunkeler D, 1997, TRENDS POLYM SCI, V5, P286
   HUNKELER D, 2001, BIOARTIFICIAL ORGANS, V3
   Jork A, 2000, APPL MICROBIOL BIOT, V53, P224, DOI 10.1007/s002530050012
   KUHTREIBER WM, 1999, CELL ENCAPSULATION T
   LEINFELDER U, 2003, IN PRESS BIOMATERIAL
   LONDON NJM, 1990, HORM METAB RES, V25, P82
   SCHNABL H, 1983, PLANTA, V158, P392, DOI 10.1007/BF00397730
   Schneider S, 2001, BIOMATERIALS, V22, P1961, DOI 10.1016/S0142-9612(00)00380-X
   Schrezenmeir J, 2001, TRANSPLANT P, V33, P3511, DOI 10.1016/S0041-1345(01)02418-6
   Wandrey C, 2001, ANN NY ACAD SCI, V944, P187
   Weber M, 2002, BIOMATERIALS, V23, P2003, DOI 10.1016/S0142-9612(01)00329-5
   WEEB SJ, 1965, BOUND WATER BIOL INT
   Zimmermann H, 2003, BIOMATERIALS, V24, P2083, DOI 10.1016/S0142-9612(02)00639-7
   Zimmermann U, 2000, BIOTECHNIQUES, V29, P564, DOI 10.2144/00293rv01
   Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x
   ZIMMERMANN U, 2001, BIOTECHNOLOGY, P548
   ZIMMERMANN U, 1999, CELL ENCAPSULATION T, P40
NR 25
TC 20
Z9 20
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0265-2048
J9 J MICROENCAPSUL
JI J. Microencapsul.
PD SEP-OCT
PY 2003
VL 20
IS 5
BP 627
EP 636
DI 10.1080/0265204031000140796
PG 10
WC Chemistry, Applied; Engineering, Chemical; Pharmacology & Pharmacy
SC Chemistry; Engineering; Pharmacology & Pharmacy
GA 710GA
UT WOS:000184671400006
PM 12909546
DA 2018-10-20
ER

PT J
AU Pena, J
   Vallet-Regi, M
AF Pena, J
   Vallet-Regi, M
TI Hydroxyapatite, tricalcium phosphate and biphasic materials prepared by
   a liquid mix technique
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE apatite; biomedical applications; powders-chemical preparation; X-ray
   methods
ID X-RAY-DIFFRACTION; BIOCERAMIC POWDERS; CALCIUM; CERAMICS; RATIO;
   APATITES; INVITRO; BONE
AB The Pechini based liquid-mix technique has been applied to prepare either single phases of hydroxyapatite -Ca-10(PO4)(6)OH2-(OHAp), alpha and beta-tricalcium phosphate -Ca-3(PO4)(2)-, (alpha-TCP, beta-TCP) or biphasic calcium phosphates (BCP). Compositions with a Ca/P molar ratio between 1.5 and 1.667 were synthesized and subjected to a thermal treatment up to 1400 degreesC. alpha and beta-TCP were both prepared from a Ca/P ratio of 1. 5, but while beta-TCP is isolated at 900 degreesC and remains stable up to 1100 degreesC, it is necessary to anneal at 1400 degreesC for 72 h to obtain pure alpha-TCP. OHAp is obtained as a single phase from a 1.667 Ca/P ratio after annealing at 1000 degreesC for 24 h and starts to decompose at 1400 degreesC. Between these two extremes a whole range of biphasic calcium phosphates can be prepared by using this technique with an accurate control of the starting reactants. These materials have been characterized by FTIR, XRF, BET, XRD and, based on this technique, a phase quantification determination (QXRD). The solubility of these products was tested in a buffered solution at 3 7 degreesC and pH = 7.4. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Complutense Madrid, Dept Quim Inorgan & Bioinorgan, Fac Farm, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense Madrid, Dept Quim Inorgan & Bioinorgan, Fac Farm, Ciudad Univ S-N, E-28040 Madrid, Spain.
RI Vallet-Regi, Maria/M-3378-2014; pena, juan/E-5913-2018
OI Vallet-Regi, Maria/0000-0002-6104-4889; pena, juan/0000-0002-5992-908X
CR BALMAIN N, 1982, CALCIFIED TISSUE INT, V34, pS93
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   DEGROOT K, 1993, CERAM INT, V19, P363, DOI 10.1016/0272-8842(93)90050-2
   DICKENS B, 1974, J SOLID STATE CHEM, V10, P232, DOI 10.1016/0022-4596(74)90030-9
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Gulgun MA, 1999, J AM CERAM SOC, V82, P556
   ISHIKAWA K, 1993, J MATER SCI-MATER M, V4, P165, DOI 10.1007/BF00120386
   ITATANI K, 1994, J AM CERAM SOC, V77, P801, DOI 10.1111/j.1151-2916.1994.tb05368.x
   Jillavenkatesa A, 1998, SPECTROSC LETT, V31, P1619, DOI 10.1080/00387019808007439
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   KOHRI M, 1993, BIOMATERIALS, V14, P299, DOI 10.1016/0142-9612(93)90122-I
   LeGeros R.Z., 1993, WORLD SCI, P139
   Lin FH, 2000, J BIOMED MATER RES, V51, P157, DOI 10.1002/(SICI)1097-4636(200008)51:2<157::AID-JBM3>3.0.CO;2-R
   Manjubala I, 2001, MATER CHEM PHYS, V71, P272, DOI 10.1016/S0254-0584(01)00293-0
   Pechini M. P., 1967, US Patent, Patent No. [3 330 697, 3330697]
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   TenHuisen KS, 1999, J AM CERAM SOC, V82, P2813
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Vallet-Regi M, 1997, SOLID STATE IONICS, V101, P1279, DOI 10.1016/S0167-2738(97)00213-0
   Vallet-Regi M., 1995, PERSPECTIVES SOLID S, P37
   Yang XH, 1998, J MATER CHEM, V8, P2233, DOI 10.1039/a802067a
   Young RA, 1993, RIETVELD METHOD INT
NR 27
TC 92
Z9 98
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. European Ceram. Soc.
PD SEP
PY 2003
VL 23
IS 10
BP 1687
EP 1696
AR PII S0955-2219(02)00369-2
DI 10.1016/S0955-2219(02)00369-2
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA 692KG
UT WOS:000183659800018
DA 2018-10-20
ER

PT J
AU Sinani, VA
   Koktysh, DS
   Yun, BG
   Matts, RL
   Pappas, TC
   Motamedi, M
   Thomas, SN
   Kotov, NA
AF Sinani, VA
   Koktysh, DS
   Yun, BG
   Matts, RL
   Pappas, TC
   Motamedi, M
   Thomas, SN
   Kotov, NA
TI Collagen coating promotes biocompatibility of semiconductor
   nanoparticles in stratified LBL films
SO NANO LETTERS
LA English
DT Article
ID LAYER ASSEMBLED FILMS; CORE-SHELL PARTICLES; THIN-FILMS; MAGNETITE
   NANOPARTICLES; POLYELECTROLYTE MULTILAYERS; OPTICAL-PROPERTIES; CADMIUM
   TOXICITY; COMPOSITE FILM; QUANTUM DOTS; DEVICES
AB Nanostructured thin films fabricated from semiconductor nanoparticles (NPs) are of great interest for biomedical applications, but NP materials based on heavy metals can be cytotoxic. In this work, the preparation of semiconductor NPs followed the protocol of layer-by-layer (LBL) assembly, which alleviates this problem. Collagen/poly(acrylic acid) bilayers were added to CdTe/polycation LBL films to produce porous collagen bilayers. Such stratified multilayer systems showed successful cell attachment and survival while native NP films were strongly cytotoxic.
C1 Oklahoma State Univ, Dept Chem, Stillwater, OK 74078 USA.
   Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.
   Univ Texas, Med Branch, Ctr Biomed Engn, Galveston, TX 77550 USA.
RP Kotov, NA (reprint author), Oklahoma State Univ, Dept Chem, Stillwater, OK 74078 USA.
OI Kotov, Nicholas/0000-0002-6864-5804
CR Aliev FG, 1999, ADV MATER, V11, P1006, DOI 10.1002/(SICI)1521-4095(199908)11:12<1006::AID-ADMA1006>3.0.CO;2-2
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Ariga K, 1999, APPL CLAY SCI, V15, P137, DOI 10.1016/S0169-1317(99)00012-5
   Arregui FJ, 1999, OPT LETT, V24, P596, DOI 10.1364/OL.24.000596
   BERG MC, 2003, POLYM MAT SCI ENG, V88, P46
   Bian SP, 2000, ADV MATER, V12, P1202, DOI 10.1002/1521-4095(200008)12:16<1202::AID-ADMA1202>3.0.CO;2-C
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Caruso F, 1999, ADV MATER, V11, P950
   Caruso F, 2000, LANGMUIR, V16, P8932, DOI 10.1021/la000401s
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Cassagneau T, 1998, J AM CHEM SOC, V120, P7848, DOI 10.1021/ja9806027
   Cassagneau T, 2000, ADV MATER, V12, P1363, DOI 10.1002/1521-4095(200009)12:18<1363::AID-ADMA1363>3.0.CO;2-M
   Clark SL, 1999, ADV MATER, V11, P1031, DOI 10.1002/(SICI)1521-4095(199908)11:12<1031::AID-ADMA1031>3.0.CO;2-Q
   Clark SL, 1998, ADV MATER, V10, P1515, DOI 10.1002/(SICI)1521-4095(199812)10:18<1515::AID-ADMA1515>3.0.CO;2-E
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E
   Durstock MF, 2001, SYNTHETIC MET, V116, P373, DOI 10.1016/S0379-6779(00)00440-9
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   FISCHER AB, 1995, ANALYST, V120, P975, DOI 10.1039/an9952000975
   Galeska I, 2001, BIOMACROMOLECULES, V2, P1249, DOI 10.1021/bm010112y
   Galeska I, 2000, BIOMACROMOLECULES, V1, P202, DOI 10.1021/bm0002813
   Gao MY, 2000, J APPL PHYS, V87, P2297, DOI 10.1063/1.372177
   Grant GGS, 2001, BIOMED MICRODEVICES, V3, P301, DOI 10.1023/A:1012456714628
   Harrison MT, 2000, MAT SCI ENG B-SOLID, V69, P355, DOI 10.1016/S0921-5107(99)00254-8
   He JA, 2000, J PHYS CHEM B, V104, P10513, DOI 10.1021/jp001715r
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Jin W, 2001, J AM CHEM SOC, V123, P8121, DOI 10.1021/ja015807l
   KAMOI H, 2001, KOKU EISEI GAKKAI ZA, V51, P809
   Kleinfeld ER, 1995, CHEM MATER, V7, P2327, DOI 10.1021/cm00060a022
   Koktysh DS, 2002, ADV FUNCT MATER, V12, P255, DOI 10.1002/1616-3028(20020418)12:4<255::AID-ADFM255>3.0.CO;2-1
   KOTOV NA, 1995, J PHYS CHEM-US, V99, P13065, DOI 10.1021/j100035a005
   Kovtyukhova NI, 2002, MAT SCI ENG C-BIO S, V19, P255, DOI 10.1016/S0928-4931(01)00395-2
   Kovtyukhova NI, 2001, J PHYS CHEM B, V105, P8762, DOI 10.1021/jp010867z
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LIU J, 1992, TOXICOLOGY, V75, P51, DOI 10.1016/0300-483X(92)90125-X
   Liz-Marzan LM, 1996, LANGMUIR, V12, P4329, DOI 10.1021/la9601871
   Luo CP, 2000, ANGEW CHEM INT EDIT, V39, P3905, DOI 10.1002/1521-3773(20001103)39:21<3905::AID-ANIE3905>3.0.CO;2-Q
   Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015
   Mamedov A, 2000, LANGMUIR, V16, P3941, DOI 10.1021/la990957j
   Mamedov AA, 2000, LANGMUIR, V16, P5530, DOI 10.1021/1a000560b
   Mamedov AA, 2001, J AM CHEM SOC, V123, P7738, DOI 10.1021/ja015857q
   Mamedova NN, 2001, NANO LETT, V1, P281, DOI 10.1021/nl015519n
   Mattoussi H, 2000, APPL PHYS LETT, V77, P1540, DOI 10.1063/1.1290723
   Mendelsohn JD, 2000, LANGMUIR, V16, P5017, DOI 10.1021/la000075g
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Ngankam PA, 2000, J AM CHEM SOC, V122, P8998, DOI 10.1021/ja000783o
   Pastoriza-Santos I, 2000, LANGMUIR, V16, P2731, DOI 10.1021/la991212g
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Rogach AL, 1997, BER BUNSEN PHYS CHEM, V101, P1668, DOI 10.1002/bbpc.19971011123
   Rogach AL, 2000, CHEM MATER, V12, P1526, DOI 10.1021/cm0000649
   Rogach AL, 2000, CHEM MATER, V12, P2676, DOI 10.1021/cm000244i
   Rosidian A, 1998, ADV MATER, V10, P1087, DOI 10.1002/(SICI)1521-4095(199810)10:14<1087::AID-ADMA1087>3.0.CO;2-O
   SANTONE KS, 1982, J TOXICOL ENV HEALTH, V10, P169, DOI 10.1080/15287398209530240
   Schrof W, 1998, ADV MATER, V10, P338, DOI 10.1002/(SICI)1521-4095(199803)10:4<338::AID-ADMA338>3.0.CO;2-V
   Silver FH, 1997, DRUG TARG D, V7, P319
   SKOWRONSKI T, 1985, ACTA MICROBIOL POL, V34, P309
   Sukhorukov GB, 1998, COLLOID SURFACE A, V137, P253, DOI 10.1016/S0927-7757(98)00213-1
   TAGLIALATELA G, COMMUNICATION
   Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757
   Wang TC, 2001, LANGMUIR, V17, P6610, DOI 10.1021/la010755z
   Wu A, 1999, J AM CHEM SOC, V121, P4883, DOI 10.1021/ja9833624
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Zeng T, 2001, P SOC PHOTO-OPT INS, V4329, P445, DOI 10.1117/12.432678
NR 64
TC 116
Z9 118
U1 2
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD SEP
PY 2003
VL 3
IS 9
BP 1177
EP 1182
DI 10.1021/nl0255045
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 721RQ
UT WOS:000185330700001
DA 2018-10-20
ER

PT J
AU Kang, FY
   Zheng, YP
   Zhao, H
   Wang, HN
   Wang, LN
   Shen, WC
   Inagaki, M
AF Kang, FY
   Zheng, YP
   Zhao, H
   Wang, HN
   Wang, LN
   Shen, WC
   Inagaki, M
TI Sorption of heavy oils and biomedical liquids into exfoliated graphite -
   Research in China
SO NEW CARBON MATERIALS
LA English
DT Review
DE exfoliated graphite; sorption; heavy oil; biomedical liquids
ID RECOVERY; FIBERS
AB Exfoliated graphite (EG) was prepared by rapidly heating the residue GIC at around 1000 degreesC . The materials obtained possess large specific surface area and strong Surface reactivity, therefore, EG may adsorb heavy oil and viscous organic liquids. This paper reviews the recent work on sorption of heavy oil and biomedical liquids on exfoliated graphite, which were carried out by research groups in Tsinghua University.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   Aichi Inst Technol, Dept Appl Chem, Toyota 4700392, Japan.
RP Kang, FY (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
CR BOKROS J, CHEM PHYSICS CARBON, V9, P103
   Cao N.Z., 1997, CHINA ENV SCI, V17, P188
   CAO NZ, EUR C CARB 96 NEWC U, P258
   CAO NZ, EUR C CARB 96 NEWC U, P112
   CAO NZ, EUR C CARB 96 NEWC U, P256
   CHUNG DDL, 1987, J MATER SCI, V22, P4190, DOI 10.1007/BF01132008
   FUJIRAITO IND CO, 1979, Patent No. 95333
   Furdin G, 1998, FUEL, V77, P479, DOI 10.1016/S0016-2361(97)00142-7
   Inagaki M, 2000, DESALINATION, V128, P213, DOI 10.1016/S0011-9164(00)00035-7
   Inagaki M, 2000, DESALINATION, V128, P219, DOI 10.1016/S0011-9164(00)00036-9
   INAGAKI M, 1983, SYNTHETIC MET, V8, P335, DOI 10.1016/0379-6779(83)90117-0
   Inagaki M, 2002, CARBON, V40, P105, DOI 10.1016/S0008-6223(01)00083-5
   Inagaki M, 2002, CARBON, V40, P1487, DOI 10.1016/S0008-6223(01)00319-0
   Inagaki M, 2001, CARBON, V39, P915, DOI 10.1016/S0008-6223(00)00199-8
   INAGAKI M, IN PRESS CHEM PHYSIC
   INAGAKI M, 2001, CARBON SCI, P1
   INAGAKI M, IN PRESS FRESENIUS E
   INAGAKI M, 2002, EXFOLIATED GRAPHITE, P53
   Inagaki M., 1985, TANSO, P160
   Kang F, 1997, CARBON, V35, P1089, DOI 10.1016/S0008-6223(97)00065-1
   KANG FEI-YU, 2000, NEW CARBON MATER, V15, P80
   Kang FY, 2002, MOL CRYST LIQ CRYST, V388, P423, DOI 10.1080/10587250290113781
   Kang FY, 2002, CARBON, V40, P1575, DOI 10.1016/S0008-6223(02)00023-4
   Nishi Y, 2002, MATER SCI RES INT, V8, P243
   Nishi Y, 2002, WATER RES, V36, P5029, DOI 10.1016/S0043-1354(02)00225-7
   Nishi Y., 2002, TANSO, P31
   PENG JF, 2002, CARBON 2002, P173
   Shen WC, 1999, CARBON, V37, P356
   SHEN WC, EUR C CARB 96 NEWC U, P348
   SHEN WC, EUR C CARB 96 NEWC U, P114
   SHEN WC, 1998, 25 ANN M CARB SOC JA, P382
   Toyoda M, 1998, DESALINATION, V115, P199, DOI 10.1016/S0011-9164(98)00038-1
   Toyoda M, 2002, NEW CARBON MATER, V17, P1
   Toyoda M., 2002, DESALINATION, V151, P139
   TOYODA M, 2000, J CHEM SOC JAPAN, P217
   TOYODA M, 1998, J CHEM SOC JAPAN, P563
   TOYODA M, 2001, TANSO, P166
   WANG HN, IN PRESS J INORG MAT
   WANG LN, 2003, 12 INT S INT COMP PO
   ZHAO H, 2001, 11 INT S INT COMP MO
   ZHOU W, 2001, BEHAV MECH OIL SORPT, P335
   ZHOU W, 2000, ADSORPTION SORPTION
   ZHOU W, 2001, 11 INT S INT COMP MO
NR 43
TC 40
Z9 55
U1 3
U2 14
PU SCIENCE CHINA PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1007-8827
J9 NEW CARBON MATER
JI New Carbon Mater.
PD SEP
PY 2003
VL 18
IS 3
BP 161
EP 173
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA 726FV
UT WOS:000185589000001
DA 2018-10-20
ER

PT J
AU Watt, F
   van Kan, JA
   Rajta, I
   Bettiol, AA
   Choo, TF
   Breese, MBH
   Osipowicz, T
AF Watt, F
   van Kan, JA
   Rajta, I
   Bettiol, AA
   Choo, TF
   Breese, MBH
   Osipowicz, T
TI The National University of Singapore high energy ion nano-probe
   facility: Performance tests
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Nuclear Microprobe Technology and
   Applications
CY SEP 08-13, 2002
CL TAKASAKI GUNMA, JAPAN
SP Japan Atom Energy Res Inst, Atom Energy Soc Japan, Casio Sci Promot Fdn, Commemorat Assoc Japan World Exposit 1970, Iwatani Naoji Fdn, Japan Radioisotope Assoc, Ogasawara Fdn Promot Sci & Technol, Radiat Applicat Dev Assoc, Suzuki Fdn, Yoshida Sci Fdn
AB The Research Centre for Nuclear Microscopy, National University of Singapore incorporates three state-of-the-art beam lines, connected to a high brightness High Voltage Engineering Europa 3.5 MV Singletron accelerator. One of these lines is a NEC (National Electrostatics Corporation, USA) ion channeling facility, utilising broad beam ion beam analysis techniques for advanced materials research. The other two lines are microbeam facilities; one is designed for nuclear microscopy of biomedical samples and advanced materials, where relatively high currents (>50 pA) are required, and the other for proton beam micromachining (PBM) and materials modification, where lower currents can be utilised. The resolution performances of the two microbeam lines have been measured, and the results are as follows:
   (1) The nuclear microscope line incorporates the Oxford Microbeams OM2000 endstation with the OM50 quadrupole lenses configured in the high excitation triplet mode. This line has achieved the world's best performances for analytical applications of 290 x 400 nm for a 50 pA current of 2 MeV protons.
   (2) The PBM line, which is the first of its kind worldwide, utilizes the new generation of compact (OM52) quadrupole lenses (Oxford Microbeams Ltd.) also configured in a high excitation, triplet configuration. This facility, which has superior demagnification properties, has achieved the world's best performances for low current applications., Spot, sizes of 35 x 75 nm have been measured using direct scanning transmission ion microscopy for beam currents of 10,000 protons per second. (C) 2003 Elsevier B. V. All rights reserved.
C1 Natl Univ Singapore, Dept Phys, Res Ctr Nucl Microscopy, Singapore 119260, Singapore.
RP Watt, F (reprint author), Natl Univ Singapore, Dept Phys, Res Ctr Nucl Microscopy, Lower Kent Ridge Rd, Singapore 119260, Singapore.
RI Osipowicz, Thomas/G-1365-2012; van Kan, jeroen/H-5623-2012; Bettiol,
   Andrew/D-5699-2011; Breese, Mark/G-2068-2012
OI van Kan, jeroen/0000-0002-7276-1680; Bettiol,
   Andrew/0000-0001-5242-3644; 
CR Breese M.B.H., 1996, MAT ANAL USING NUCL
   Breese MBH, 1999, NUCL INSTRUM METH B, V158, P48, DOI 10.1016/S0168-583X(99)00303-1
   Spemann D, 2002, NUCL INSTRUM METH B, V190, P312, DOI 10.1016/S0168-583X(01)01253-8
   Spemann D, 2001, NUCL INSTRUM METH B, V181, P186, DOI 10.1016/S0168-583X(01)00362-7
   Watjen U, 2000, NUCL INSTRUM METH B, V161, P359, DOI 10.1016/S0168-583X(99)00955-6
   Watt F, 2002, NUCL INSTRUM METH B, V190, P306, DOI 10.1016/S0168-583X(01)01288-5
   WATT F, 1994, NUCL INSTRUM METH B, V85, P708, DOI 10.1016/0168-583X(94)95908-0
   Watt F, 1998, NUCL INSTRUM METH B, V136, P313, DOI 10.1016/S0168-583X(97)00710-6
NR 8
TC 135
Z9 136
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD SEP
PY 2003
VL 210
BP 14
EP 20
DI 10.1016/S0168-583X(03)01003-6
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 722AN
UT WOS:000185352300004
DA 2018-10-20
ER

PT J
AU Vaz, CM
   van Doeveren, PFNM
   Reis, RL
   Cunha, AM
AF Vaz, CM
   van Doeveren, PFNM
   Reis, RL
   Cunha, AM
TI Development and design of double-layer co-injection moulded soy protein
   based drug delivery devices
SO POLYMER
LA English
DT Article
DE soy protein derived material; mono-sandwich injection molding;
   double-layer delivery device
ID ORDER SUSTAINED-RELEASE; BIOMEDICAL APPLICATIONS; BIODEGRADABLE
   POLYMERS; MECHANICAL-PROPERTIES; DIFFUSIONAL MATRICES; IN-VITRO;
   KINETICS; THERMOPLASTICS; EXTRUSION; BEHAVIOR
AB Novel double-layer delivery devices based on soy protein derived materials were designed and produced using an innovative two material co-injection moulding technique. It was demonstrated that the viscosity ratio between core and skin layer materials played an important role in the formation of the interfacial shape, namely the skin thickness and uniformity of the bi-materials. The adequate selection of the materials used and the optimisation of the respective processing conditions enabled an accurate control of the relative thickness of the layers of the device. The preliminary results confirmed the potential of these systems to achieve a controlled drug delivery. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   ATO BV, Agrotechnol Res Inst, NL-6700 AA Wageningen, Netherlands.
   Univ Minho, Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4710057 Braga, Portugal.
RP Cunha, AM (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Cunha
   M., Antonio/0000-0003-3860-7732
CR BICHLER M, 1997, KUNSTSTOFFE PLAS OCT, P13
   BRITO AM, 1991, INT POLYM PROC, V6, P370, DOI 10.3139/217.910370
   Charalambopoulou GC, 2001, J CONTROL RELEASE, V70, P309, DOI 10.1016/S0168-3659(00)00357-6
   Chidambaram N, 1998, J CONTROL RELEASE, V52, P149, DOI 10.1016/S0168-3659(97)00207-1
   COLOMBO P, 1990, INT J PHARM, V63, P43, DOI 10.1016/0378-5173(90)90099-P
   COLOMBO P, 1992, INT J PHARM, V88, P99, DOI 10.1016/0378-5173(92)90307-N
   DANCKWERTS MP, 1994, INT J PHARMACEUT, V112, P37, DOI 10.1016/0378-5173(94)90259-3
   ECKARDT H, 1987, J CELL PLAST, V5, P23
   Ferreira SHP, 1993, J FOOD SCI, V58, P378
   Jeong YI, 1998, J CONTROL RELEASE, V51, P169, DOI 10.1016/S0168-3659(97)00163-6
   Kadota M, 1999, POLYMER, V40, P3119, DOI 10.1016/S0032-3861(98)00472-8
   Ndindayino F, 2002, INT J PHARM, V235, P159, DOI 10.1016/S0378-5173(01)00994-2
   PAETAU I, 1994, IND ENG CHEM RES, V33, P1821, DOI 10.1021/ie00031a023
   Parker RS, 2001, ADV DRUG DELIVER REV, V48, P211, DOI 10.1016/S0169-409X(01)00114-4
   Qiu YH, 1998, J CONTROL RELEASE, V51, P123, DOI 10.1016/S0168-3659(97)00119-3
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, POLYM INT, V43, P347
   Remunan-Lopez C, 1998, J CONTROL RELEASE, V55, P143, DOI 10.1016/S0168-3659(98)00044-3
   Selden R, 2000, POLYM ENG SCI, V40, P1165, DOI 10.1002/pen.11244
   SHEARD PR, 1986, J FOOD TECHNOL, V21, P627
   Siepmann J, 1999, PHARMACEUT RES, V16, P1748, DOI 10.1023/A:1018914301328
   Siepmann J, 1999, J PHARM SCI, V88, P65, DOI 10.1021/js9802291
   Sousa JJ, 2002, INT J PHARM, V233, P111, DOI 10.1016/S0378-5173(01)00921-8
   Vaz CA, 2002, J MACROMOL SCI PHYS, VB41, P33, DOI 10.1081/MB-120002344
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   VAZ CM, 2003, POLYM BASED SYSTEMS, V86, P93
   VAZ CM, 2003, BIOPOLYMERS POLYAM 2, V8
   Wang S, 1996, J MACROMOL SCI PURE, VA33, P557, DOI 10.1080/10601329608010878
   Washburn NR, 2002, J BIOMED MATER RES, V60, P20, DOI 10.1002/jbm.10049
   YANG L, 1999, INT J PHARM, V155, P219
   Yang LB, 1996, J PHARM SCI, V85, P170, DOI 10.1021/js950250r
   Zhou TH, 1998, J CONTROL RELEASE, V55, P281, DOI 10.1016/S0168-3659(98)00061-3
NR 32
TC 27
Z9 29
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD SEP
PY 2003
VL 44
IS 19
BP 5983
EP 5992
DI 10.1016/S0032-3861(03)00549-4
PG 10
WC Polymer Science
SC Polymer Science
GA 719BB
UT WOS:000185182500060
DA 2018-10-20
ER

PT J
AU Lopergolo, LC
   Lugao, AB
   Catalani, LH
AF Lopergolo, LC
   Lugao, AB
   Catalani, LH
TI Direct UV photocrosslinking of poly(N-vinyl-2-pyrrolidone) (PVP) to
   produce hydrogels
SO POLYMER
LA English
DT Article
DE poly(N-vinyl-2-pyrrolidone); hydrogel; photocrosslinking
ID MEDICAL APPLICATIONS; POLYMERS
AB Hydrogels for biomedical purposes, made from synthetic polymers as starting materials and free of co-adjuvant molecules, have been produced almost exclusively by high-energy radiative processes. On the other hand, UV photocrosslinking of such materials has been used in conjunction of monomers and/or photoinitiators. This work was addressed to the analysis of poly(N-vinyl-2-pyrrolidone) (PVP) submitted to direct photocrosslinking in aqueous solution, using low pressure Hg lamp (lambda(cm) = 254 nm). The process efficiency was evaluated, and the properties of the hydrogel formed were determined. The product thus formed has similar micro- and macroscopic properties, as compared to hydrogels produced by high-energy radiation and presents no cytotoxicity. These results demonstrated the viability of using this method as a versatile alternative to hydrogel production, broadening the possibility of its production where high-energy radiation facilities are not available. (C) 2003 Published by Elsevier Ltd.
C1 Univ Sao Paulo, Inst Quim, BR-05513970 Sao Paulo, Brazil.
   IPEN, CNEN, SP, BR-05508970 Sao Paulo, Brazil.
RP Catalani, LH (reprint author), Univ Sao Paulo, Inst Chem, Av Prof Lineu Prestes 748, BR-05508900 Sao Paulo, Brazil.
RI Institute of Chemistry - USP, Dept. of Chemistry/B-8988-2012; Lugao,
   Ademar/B-6847-2013; Catalani, Luiz/E-2841-2010
OI Catalani, Luiz/0000-0003-3689-1792
CR Charlesby A, 1960, ATOMIC RAD POLYM
   Ciapetti G, 1996, BIOMATERIALS, V17, P1259, DOI 10.1016/0142-9612(96)88670-4
   Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lopergolo LC, 2002, J APPL POLYM SCI, V86, P662, DOI 10.1002/app.10929
   MIRANDA LF, 1999, THESIS U SAO PAULO
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   OLEJNICZAK J, 1991, RADIAT PHYS CHEM, V37, P499
   Peppas NA, 1986, HYDROGELS MED PHARM, V1, P27
   ROSIAK J, 1990, RADIAT PHYS CHEM, V36, P747
   Rosiak J., 1989, Patent, Patent No. [US 4871490, 4871490]
   ROSIAK JM, 1993, RADIAT PHYS CHEM, V42, P903, DOI 10.1016/0969-806X(93)90398-E
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   Sarkar A, 1996, J CHIM PHYS PCB, V93, P1281, DOI 10.1051/jcp/1996931281
NR 16
TC 86
Z9 86
U1 3
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD SEP
PY 2003
VL 44
IS 20
BP 6217
EP 6222
DI 10.1016/S0032-3861(03)00686-4
PG 6
WC Polymer Science
SC Polymer Science
GA 721TE
UT WOS:000185332500013
DA 2018-10-20
ER

PT J
AU Ilic, R
   Skvarc, J
   Golovchenko, AN
AF Ilic, R
   Skvarc, J
   Golovchenko, AN
TI Nuclear tracks: present and future perspectives
SO RADIATION MEASUREMENTS
LA English
DT Article; Proceedings Paper
CT 21st International Conference on Nuclear Tracks in Solids (ICNTS-21)
CY OCT 21-25, 2003
CL NEW DELHI, INDIA
SP Int Nucl Track Soc, Arunachal Univ, Nucl Sci Ctr
DE solid state nuclear track detectors; etched track detectors; nuclear
   tracks; ion tracks; fission track dating; etching
ID CR-39; MICROSCOPE
AB Current research work related to the development of nuclear tracks comprising: (i) fundamental principles (nuclear track physics and chemistry, as well as development of track detectors and the relevant hard- and software), (ii) development of nuclear instruments and methods (etch track radiometers for ions, neutrons and cosmic rays, radon monitoring devices, radiography and fission track dating) is briefly outlined. The paper concentrates on a literature survey of applications of nuclear tracks in (iii) physical sciences (high-energy physics, nuclear physics and earth sciences), (iv) biomedical sciences (radiation protection, environment, cancer therapy), and (v) technological sciences (materials, nano-technology and nuclear technology). Presently about 350 papers per year are being published in this field. Increased activity is noted in ion track technology (track-made membranes, modern nano-tech methodology including biological and biological-like samples, nano-electrode bio-electrochemistry, bio-magnetic assays and probes). New applications of nuclear tracks in fundamental (possibility of the detection of neutron quantum states in a gravitational field, nucleus-nucleus interactions, search for new chemical super-heavy elements) and applied science (precise measurements of the behaviour of radiation in human tissue in connection with of long term space missions and treatment of cancer) are surveyed, and possible research in the next decades is presented and examined in this review paper. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Jozef Stefan Inst, Ljubljana 1000, Slovenia.
   Univ Maribor, Fac Civil Engn, SLO-2000 Maribor, Slovenia.
   Joint Inst Nucl Res, Dubna 141980, Russia.
RP Ilic, R (reprint author), Jozef Stefan Inst, Jamova 39, Ljubljana 1000, Slovenia.
CR Amemiya K, 1999, NUCL INSTRUM METH B, V159, P75, DOI 10.1016/S0168-583X(99)00520-0
   Amemiya K, 2002, NUCL INSTRUM METH B, V187, P361, DOI 10.1016/S0168-583X(01)01142-9
   Durrani S. A., 1997, RADON MEASUREMENTS E
   Durrani S. A., 1987, SOLID STATE NUCL TRA
   Fleischer R., 1975, NUCL TRACKS SOLIDS P
   FLEISCHER RL, 1991, NUCL TRACKS RAD MEAS, V19, P847
   FLEISCHER RL, 1998, TRACKS INNOVATION
   Golovchenko AN, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.014609
   Hashemi-Nezhad SR, 1997, RADIAT MEAS, V28, P839, DOI 10.1016/S1350-4487(97)00194-7
   Ilic R, 2003, HDB RADIOACTIVITY AN, P179
   Lengar I, 2002, NUCL INSTRUM METH B, V192, P440, DOI 10.1016/S0168-583X(02)00483-4
   Meesen G, 2001, RADIAT MEAS, V34, P161, DOI 10.1016/S1350-4487(01)00143-3
   Skvarc J, 2001, RADIAT MEAS, V34, P113, DOI 10.1016/S1350-4487(01)00134-2
   Wagner G., 1992, FISSION TRACK DATING
   Yasuda N, 1999, RADIAT MEAS, V31, P203, DOI 10.1016/S1350-4487(99)00089-X
NR 15
TC 23
Z9 25
U1 1
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-4487
J9 RADIAT MEAS
JI Radiat. Meas.
PD SEP
PY 2003
VL 36
IS 1-6
SI SI
BP 83
EP 88
DI 10.1016/S1350-4487(03)00247-6
PG 6
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 724TU
UT WOS:000185503400012
DA 2018-10-20
ER

PT J
AU Antonietti, M
   Forster, S
AF Antonietti, M
   Forster, S
TI Vesicles and liposomes: A self-assembly principle beyond lipids
SO ADVANCED MATERIALS
LA English
DT Article
ID AMPHIPHILIC BLOCK-COPOLYMERS; DILUTE AQUEOUS-SOLUTION; DIBLOCK
   COPOLYMERS; TRIBLOCK COPOLYMER; POLYMER VESICLES; MEMBRANES;
   SURFACTANTS; MICELLES; WATER; MIXTURES
AB Vesicle research has expanded into a much broader range of experimental conditions and extended materials properties since the lifting of the restriction to lipids as the building blocks (tectons) of vesicles. New and potential applications of vesicles-in particular biomedical applications-are outlined after a discussion of the factors governing the spontaneous formation of vesicles (see Figure) by self-assembly.
C1 Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany.
   Univ Hamburg, Inst Phys Chem, D-20146 Hamburg, Germany.
RP Antonietti, M (reprint author), Max Planck Inst Colloids & Interfaces, Res Campus Golm, D-14424 Potsdam, Germany.
RI Forster, Stephan/B-2180-2015
CR ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127
   Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111
   Dimova R, 2002, EUR PHYS J E, V7, P241, DOI 10.1140/epje/i200101032
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher BM, 2002, J PHYS CHEM B, V106, P2848, DOI 10.1021/jp011958z
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003
   Forster S, 2002, MACROMOLECULES, V35, P4096, DOI 10.1021/ma011565y
   Forster S, 1996, J CHEM PHYS, V104, P9956
   FORSTER S, 1995, ADV POLYM SCI, V120, P51
   FORSTER S, 2003, IN PRESS ADV POLYM S
   FORSTER S, UNPUB
   Graff A, 2002, P NATL ACAD SCI USA, V99, P5064, DOI 10.1073/pnas.062654499
   Haluska C.K., 2002, PHYS REV LETT, P89
   HERMSDORF N, 1999, THESIS U POTSDAM GER
   Holder SJ, 1998, CHEM COMMUN, P1445, DOI 10.1039/a803250e
   Hwang ML, 2001, LANGMUIR, V17, P7713, DOI 10.1021/la011121v
   HYDE ST, 1990, J PHYS-PARIS, V51, pC7209
   Ilhan F, 2000, J AM CHEM SOC, V122, P5895, DOI 10.1021/ja0011966
   ISRAELACHVILI JN, 1976, J CHEM SOC FARAD T 2, V72, P1525, DOI 10.1039/f29767201525
   JANIAK MJ, 1979, J BIOL CHEM, V254, P6068
   Jenekhe SA, 1999, SCIENCE, V283, P372, DOI 10.1126/science.283.5400.372
   Jenekhe SA, 1998, SCIENCE, V279, P1903, DOI 10.1126/science.279.5358.1903
   JULICHER F, 1993, J PHYS II, V3, P1681
   KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283
   Kukula H, 2002, J AM CHEM SOC, V124, P1658, DOI 10.1021/ja012091l
   Lasic D.D., 1998, MED APPL LIPOSOMES
   Lee JCM, 2001, BIOTECHNOL BIOENG, V73, P135, DOI 10.1002/bit.1045
   LIPOWSKY R, 1991, NATURE, V349, P475, DOI 10.1038/349475a0
   Maskos M, 2001, MACROMOL RAPID COMM, V22, P271, DOI 10.1002/1521-3927(20010201)22:4<271::AID-MARC271>3.0.CO;2-O
   Meier W, 2002, CHIMIA, V56, P490, DOI 10.2533/000942902777680243
   Meier W, 2000, ANGEW CHEM INT EDIT, V39, P4599, DOI 10.1002/1521-3773(20001215)39:24<4599::AID-ANIE4599>3.0.CO;2-Y
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Monduzzi M, 1998, CURR OPIN COLLOID IN, V3, P467, DOI 10.1016/S1359-0294(98)80020-4
   MUI BLS, 1995, BIOPHYS J, V69, P930, DOI 10.1016/S0006-3495(95)79967-2
   Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u
   Regenbrecht M, 1999, SURF INTERFACE ANAL, V27, P418, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<418::AID-SIA478>3.0.CO;2-9
   Reinecke AA, 2003, LANGMUIR, V19, P605, DOI 10.1021/la0264872
   Schillen K, 1999, MACROMOLECULES, V32, P6885, DOI 10.1021/ma9908144
   Schrage S, 2003, MACROMOLECULES, V36, P1417, DOI 10.1021/ma0255940
   Stoenescu R, 2002, CHEM COMMUN, P3016, DOI 10.1039/b209352a
   Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384
   VANHEST JCM, 1995, SCIENCE, V268, P1592, DOI 10.1126/science.268.5217.1592
   ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728
   Zhang LF, 1996, SCIENCE, V272, P1777, DOI 10.1126/science.272.5269.1777
   Zhou SQ, 2001, SCIENCE, V291, P1944, DOI 10.1126/science.291.5510.1944
   zu Putlitz B, 2000, LANGMUIR, V16, P3003, DOI 10.1021/la991568s
NR 47
TC 906
Z9 913
U1 22
U2 414
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD AUG 15
PY 2003
VL 15
IS 16
BP 1323
EP 1333
DI 10.1002/adma.200300010
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 718QW
UT WOS:000185158800001
DA 2018-10-20
ER

PT J
AU Lu, ZH
   Liu, GJ
   Duncan, S
AF Lu, ZH
   Liu, GJ
   Duncan, S
TI Poly(2-hydroxyethyl acrylate-co-methyl acrylate)/SiO2/TiO2 hybrid
   membranes
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE composite membranes; gas and vapor permeation; gas separations; membrane
   preparation and structure
ID SOL-GEL METHOD; WATER PERMEATION PROPERTIES; TETRAETHOXYSILANE; FILMS;
   POLYMERS
AB Random copolymers of 2-hydroxyethyl acrylate (HEA) and methyl acrylate (MA) and homopolymer PHEA were prepared by free radical polymerization. The hydroxyl groups of PHEA were reacted with 3-(triethoxysilyl)propyl isocyanate to introduce triethoxysilyl (TREOS) groups. Co-hydrolysis and condensation of the TREOS groups with titanium tetrabutoxide yielded polymer/SiO2/TiO2 hybrid materials. Water vapor permeability across such hybrid membranes could be changed by varying the PHEA content and was very high for PHEA/SiO2/TiO2 membranes. Incorporation of MA into the hybrid allowed membrane properties, such as water uptake and brittleness, to be controlled. Such hybrid materials may be of interest for biomedical applications and for development of perm-selective barriers used in commercial and military technologies. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada.
   Def Res Dev Canada Suffield, Stn Main, Medicine Hat, AB T1A 8K6, Canada.
RP Liu, GJ (reprint author), Univ Calgary, Dept Chem, 2500 Univ Dr,NW, Calgary, AB T2N 1N4, Canada.
CR BACK DD, 2000, Patent No. 6136373
   BENT HE, 1948, J AM CHEM SOC, V70, P634, DOI 10.1021/ja01182a060
   BETRABET CS, 1995, CHEM MATER, V7, P535, DOI 10.1021/cm00051a015
   BRINKER CJ, 1990, SOL GEL SCI PHYSICS
   BRUNSVELD GH, 2001, Patent No. 6268329
   BRYCH J, 1976, Patent No. 162515
   Byrdn R, 1999, U. S. Patent, Patent No. 5858468
   CHANG EL, 2001, Patent No. 862418
   Dire S, 1997, J MATER CHEM, V7, P919, DOI 10.1039/a608382j
   Feng QW, 2000, J MATER CHEM, V10, P2490, DOI 10.1039/b003170o
   Gill I, 2000, BIOTECHNOL BIOENG, V70, P400, DOI 10.1002/1097-0290(20001120)70:4<400::AID-BIT5>3.0.CO;2-2
   GUILLET JE, 1985, PHOTOPHYCISC PHOTOCH
   Gummaraju RV, 1996, J POLYM SCI POL PHYS, V34, P2383, DOI 10.1002/(SICI)1099-0488(199610)34:14<2383::AID-POLB8>3.0.CO;2-X
   HASSO V, 1993, Patent No. 4205648
   Hoshi M, 1999, J APPL POLYM SCI, V74, P983, DOI 10.1002/(SICI)1097-4628(19991024)74:4<983::AID-APP25>3.0.CO;2-V
   HUANG HH, 1987, MACROMOLECULES, V20, P1322, DOI 10.1021/ma00172a026
   Huang ZH, 1997, J POLYM SCI POL CHEM, V35, P2403, DOI 10.1002/(SICI)1099-0518(19970915)35:12<2403::AID-POLA10>3.0.CO;2-B
   Iwashita K, 1996, J APPL POLYM SCI, V61, P2173, DOI 10.1002/(SICI)1097-4628(19960919)61:12<2173::AID-APP16>3.0.CO;2-8
   Kim W, 1998, ANALYST, V123, P379, DOI 10.1039/a705788a
   Kimura K, 1997, ANAL CHEM, V69, P2379, DOI 10.1021/ac9611069
   Mauritz K. A., 2001, POLYM PREPR, V42, P57
   Muhlebach A, 1998, MACROMOLECULES, V31, P6046, DOI 10.1021/ma9804747
   PERRIN DD, 1992, PURIFICATION LAB CHE
   Qin HH, 2000, J POLYM SCI POL CHEM, V38, P321, DOI 10.1002/(SICI)1099-0518(20000115)38:2<321::AID-POLA6>3.0.CO;2-I
   RIVIN D, 2001, P 7 INT S PROT AG CH
   RUITER ED, 2000, Patent No. 19829975
   Tadanaga K, 1996, J SOL-GEL SCI TECHN, V6, P107, DOI 10.1007/BF00402593
   WANG B, 1991, J POLYM SCI POL CHEM, V29, P905, DOI 10.1002/pola.1991.080290616
   WANG B, 1990, J MACROMOL SCI CHEM, VA27, P1447, DOI 10.1080/10601329008544852
   WHEAT JA, 1992, Patent No. 5182163
   Williams D. B., 1996, TRANSMISSION ELECT M
   WU HS, 1993, Patent No. 9317760
   YASUDA H, 1962, J POLYM SCI, V57, P907, DOI 10.1002/pol.1962.1205716571
   Zoppi RA, 2000, POLYMER, V41, P5461, DOI 10.1016/S0032-3861(99)00751-X
NR 34
TC 30
Z9 34
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD AUG 15
PY 2003
VL 221
IS 1-2
BP 113
EP 122
DI 10.1016/S0376-7388(03)00251-5
PG 10
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 716NT
UT WOS:000185035800009
DA 2018-10-20
ER

PT J
AU Ouchi, T
   Kontani, T
   Ohya, Y
AF Ouchi, T
   Kontani, T
   Ohya, Y
TI Mechanical property and biodegradability of solution-cast films prepared
   from amphiphilic polylactide-grafted dextran
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE amphiphilic; polylactide; polysaccharides; mechanical properties;
   biodegradable
ID TRIMETHYLSILYL PROTECTION METHOD; PHYSICAL-PROPERTIES; POLY(LACTIC
   ACID); L-LACTIDE; COPOLYMERS; POLY(L-LACTIDE); DEPSIPEPTIDE;
   DEGRADATION; BLENDS; POLY(EPSILON-CAPROLACTONE)
AB Polylactide (PLA)-grafted dextran was synthesized with a trimethylsilyl protection method to produce novel biodegradable, biomedical materials. PLA-grafted dextrans with various lengths and numbers of graft chains were synthesized. The properties of solution-cast films prepared from PLA-grafted dextrans were investigated with thermal and dynamic mechanical analyses. The graft-copolymer films exhibited lower glass-transition temperatures, melting temperatures (T-m's), and crystallinities as well as higher viscosity properties as compared with poly-L-lactide film. The T-m and crystallinity and mechanical properties at 37 degreesC could be adjusted by controlling the molecular structure such as the lengths and numbers of graft chains. Furthermore, the biodegradability of PLA-grafted dextran films was investigated through the weight change of film and the molecular weight change of polymer during the in vitro degradation test. PLA-grafted dextrans exhibited different degradation behavior from poly-L-lactide with the introduction of a polysaccharide segment and branched structure as well as the change of end-functional group. The degradation rate of PLA-grafted dextran and the cast film prepared from PLA-grafted dextran could be adjusted by controlling the sugar content or the length of graft chains. (C) 2003 Wiley Periodicals, Inc.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
CR CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   Donabedian DH, 1998, MACROMOLECULES, V31, P1032, DOI 10.1021/ma961741g
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Harada A, 1998, MACROMOLECULES, V31, P288, DOI 10.1021/ma971277v
   Jong S. J., 2000, MACROMOLECULES, V33, P3680
   KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X
   Kissel T, 1996, J CONTROL RELEASE, V39, P315, DOI 10.1016/0168-3659(95)00163-8
   KRICHELDORF HR, 1993, MAKROMOL CHEM-M SYMP, V73, P47, DOI 10.1002/masy.19930730107
   Li YX, 1997, POLYMER, V38, P6197, DOI 10.1016/S0032-3861(97)00178-X
   LIU HJ, 1994, POLYM BULL, V32, P463, DOI 10.1007/BF00587889
   Lostocco MR, 1998, MACROMOL SYMP, V130, P151, DOI 10.1002/masy.19981300114
   Malin M, 1996, J APPL POLYM SCI, V59, P1289, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1289::AID-APP12>3.0.CO;2-1
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095
   Ohya Y, 1998, MACROMOL CHEM PHYSIC, V199, P2017, DOI 10.1002/(SICI)1521-3935(19980901)199:9<2017::AID-MACP2017>3.0.CO;2-9
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   Ouchi T, 2003, POLYMER, V44, P3927, DOI 10.1016/S0032-3861(03)000308-2
   Ouchi T, 2001, MACROMOL BIOSCI, V1, P371, DOI 10.1002/1616-5195(20011201)1:9<371::AID-MABI371>3.3.CO;2-N
   Ouchi T, 2002, J POLYM SCI POL CHEM, V40, P1218, DOI 10.1002/pola.10211
   Ouchi T, 1997, J POLYM SCI POL CHEM, V35, P377
   Tasaka F, 2001, MACROMOLECULES, V34, P5494, DOI 10.1021/ma010067m
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   Tasaka F, 2001, MACROMOL RAPID COMM, V22, P820, DOI 10.1002/1521-3927(20010701)22:11<820::AID-MARC820>3.0.CO;2-7
   Tsuji H, 1996, J APPL POLYM SCI, V60, P2367, DOI 10.1002/(SICI)1097-4628(19960627)60:13<2367::AID-APP8>3.0.CO;2-C
   VAINIO HM, 1996, J MACROMOL CHEM PHYS, V197, P1503
   Ydens I, 2000, MACROMOLECULES, V33, P6713, DOI 10.1021/ma0002803
NR 27
TC 33
Z9 36
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD AUG 15
PY 2003
VL 41
IS 16
BP 2462
EP 2468
DI 10.1002/pola.10783
PG 7
WC Polymer Science
SC Polymer Science
GA 705RP
UT WOS:000184408800004
DA 2018-10-20
ER

PT J
AU Leidholdt, EM
   Williams, GE
   McGuire, EL
AF Leidholdt, EM
   Williams, GE
   McGuire, EL
TI A reassessment of radioactive material security in health care and
   biomedical research
SO HEALTH PHYSICS
LA English
DT Article
DE operational topic; radioactive materials; medical radiation; radiation
   protection
AB The medical facilities of the U.S. Department of Veterans Affairs (VA) use radioactive material for health care and biomedical research. In the past, a single level of security for all radioactive material was generally deemed to be adequate. The events of 11 September 2001 prompted a reassessment of security. Based on site visits to VA facilities possessing a range of radioactive material typically used in health care and biomedical research, the VA National Health Physics Program has compiled recommendations for the security of radioactive material. A primary recommendation is to evaluate radioactive material from a risk perspective and use security measures commensurate with risk. The risk evaluation should consider activity, half-life, exposure rate constant, ALI, ease of removal/portability, and dispersibility. We concluded that current security measures are likely adequate for the risks associated with most nuclear medicine departments and biomedical research laboratories. However, for radioactive material of higher risk, particularly multicurie sources of long half-life, the radiation safely staff should consult with police/security experts to determine if additional security measures are warranted. This focus on risk should help optimize resource allocation. We also recommend that security evaluations consider both physical security and personnel security, training of staff with unescorted access to higher-risk radioactive material emphasize security issues, and disposal of higher-risk material not likely to be used. Finally, we note that the goals of security can be in conflict with hazard awareness and hazard communication.
C1 US Dept Vet Affairs, VHA Natl Hlth Phys Program, Little Rock, AR 72114 USA.
RP Leidholdt, EM (reprint author), US Dept Vet Affairs, VHA Natl Hlth Phys Program, 115HP-NLR,2200 Ft Roots Dr N, Little Rock, AR 72114 USA.
EM edwin.leidholdt@med.va.gov
CR *AM COLL RAD, 2002, DIS PREP RAD PROF RE
   *ARM FORC RAD RES, 2002, AFRRI SPEC PUBL, V992
   KARAM A, 2002, HLTH PHYSICS SOC NEW, V30, P3
   KARAM A, 2002, HLTH PHYSICS SOC NEW, V30, P4
   Lubenau JO, 2002, HEALTH PHYS, V83, P155, DOI 10.1097/00004032-200208000-00001
   Management of persons accidentally contaminated with radionuclides, 1979, 65 NCRP
   MARTZ M, 2002, HLTH PHYS S, V82, pS135
   Mettler F.A., 2001, MED MANAGEMENT RAD A
   National Council on Radiation Protection and Measurements, 2001, 138 NCRP
   RICKS RC, 2002, MED BASIS RAD ACCIDE
   *US NUCL REG COMM, 1999, NUREG1556, V7
   *US NUCL REG COMM, 2002, NUREG1556, V9
   *US NUCL REG COMM, 2002, STAND PROT RAD
   *US NUCL REG COMM, 1999, NUREG1556, V11
   *US NUCL REG COMM, 1998, NUREG1556, V5
NR 15
TC 4
Z9 4
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD AUG
PY 2003
VL 85
IS 2
SU S
BP S15
EP S19
DI 10.1097/00004032-200308001-00007
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 703WL
UT WOS:000184304900004
PM 12865744
DA 2018-10-20
ER

PT J
AU Fang, JM
   Fowler, P
AF Fang, Jianmin
   Fowler, Paul
TI The use of starch and its derivatives as biopolymer sources of packaging
   materials
SO JOURNAL OF FOOD AGRICULTURE & ENVIRONMENT
LA English
DT Article
DE Starch; modified starch; packaging
AB In recent years, biodegradable polymers with controllable lifetimes have become increasingly important for many applications in the areas of agriculture, biomedical implants and drug release, forestry, wild life conservation and waste management. Starch is a naturally occurring biodegradable polymer and readily available from agriculture. It is widely used in food and non-food applications and isolated from crops such as maize, potatoes, tapioca, rice and wheat. Starch is therefore an inexpensive and commodity material. For packaging use however, dry starch is not thermoplastic and its granular form is unsuitable for most uses in the plastics industry, mainly due to processing difficulties during extrusion or injection moulding. For this reason, research workers have developed several methods to render starch appropriate for industrial uses. In particular, extrusion and incorporation of plasticisers, graft copolymerisation, preparation of blends with thermoplastic polymers and chemical modification have all been studied as means to prepare packaging materials.
C1 [Fang, Jianmin; Fowler, Paul] Univ Wales, BioComposites Ctr, Bangor LL57 2UW, Gwynedd, Wales.
RP Fowler, P (reprint author), Univ Wales, BioComposites Ctr, Bangor LL57 2UW, Gwynedd, Wales.
EM p.a.fowler@bangor.ac.uk
CR Aburto J, 1999, J APPL POLYM SCI, V74, P1440, DOI 10.1002/(SICI)1097-4628(19991107)74:6<1440::AID-APP17>3.0.CO;2-V
   Aburto J, 1997, CARBOHYD POLYM, V34, P101, DOI 10.1016/S0144-8617(97)00053-2
   Ahmad FB, 1999, CARBOHYD POLYM, V38, P361, DOI 10.1016/S0144-8617(98)00123-4
   [Anonymous], 1995, US Patent, Patent No. 5462983
   Athawale VD, 1999, J MACROMOL SCI R M C, VC39, P445
   Athawale VD, 2000, CARBOHYD POLYM, V41, P407, DOI 10.1016/S0144-8617(99)00101-0
   Bastioli C, 1998, POLYM DEGRAD STABIL, V59, P263, DOI 10.1016/S0141-3910(97)00156-0
   Corti A., 1992, P 2 INT SCI WORKSH B, P245
   Fang JM, 2002, CARBOHYD POLYM, V50, P429, DOI 10.1016/S0144-8617(02)00123-6
   Fang JM, 2002, CARBOHYD POLYM, V47, P245, DOI 10.1016/S0144-8617(01)00187-4
   Kerr R. W., 1950, CHEM IND STARCH, P3
   La Mantia F. P., MACROMOL S, V180, P133
   Miladinov VD, 2000, IND CROP PROD, V11, P51, DOI 10.1016/S0926-6690(99)00033-3
   Moore G. F., 1997, RAPRA REV REPORTS, V9, P23
   Nisperos-Carriedo M O, 1994, EDIBLE COATINGS FILM, P305
   Oertel G, 1985, POLYURETHANE HDB
   ORFORD PD, 1987, J SCI FOOD AGR, V39, P169, DOI 10.1002/jsfa.2740390210
   Parker R., 1996, CARBOHYDR EUR, V15, P6
   Peltonen S., 1996, U.S. Patent, Patent No. [5: 589577, 5589577, 5, 589577]
   Radley J. A., 1953, STARCH ITS DERIVATIV, P58
   Raynaud L., 2001, T EUR SEM BIOD POL V, P28
   Roper H, 2002, STARCH-STARKE, V54, P89, DOI 10.1002/1521-379X(200204)54:3/4<89::AID-STAR89>3.0.CO;2-I
   Tiefenbacher F.K., 1993, J MACROMOL SCI PURE, V30, P727
   Vert M., 1992, P 2 INT SCI WORKSH B, pv
   Weber CJ, 2002, FOOD ADDIT CONTAM, V19, P172, DOI 10.1080/02652030110087483
   Whistle RL, 1997, CARBOHYDRATE CHEM FO, P63
   WIEDMANN W, 1991, STARCH-STARKE, V43, P138, DOI 10.1002/star.19910430404
NR 27
TC 15
Z9 15
U1 2
U2 14
PU WFL PUBL
PI HELSINKI
PA MERI-RASTILANTIE 3 C, HELSINKI, FI-00980, FINLAND
SN 1459-0255
J9 J FOOD AGRIC ENVIRON
JI J. Food Agric. Environ.
PD AUG-DEC
PY 2003
VL 1
IS 3-4
BP 82
EP 84
PG 3
WC Food Science & Technology
SC Food Science & Technology
GA V26WE
UT WOS:000208574900015
DA 2018-10-20
ER

PT J
AU Petrini, P
   Fare, S
   Piva, A
   Tanzi, MC
AF Petrini, P
   Fare, S
   Piva, A
   Tanzi, MC
TI Design, synthesis and properties of polyurethane hydrogels for tissue
   engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT International Conference on Advances of Biomaterials for Reconstructive
   Medicine
CY JUN 09-14, 2002
CL CAPRI, ITALY
AB Due to their similarity to natural soft tissues, water-swellable polymeric materials (hydrogels) are, in principle, ideal candidates for scaffolds/matrices in tissue engineering. Polyurethanes (PU), hydrophilic but water-insoluble, can be obtained by the incorporation of hydrophilic soft segments, e.g. poly(ethylene oxide) (PEO). These materials possess the favorable characteristics of the family of PUs as well as the ability to mimic soft tissues.
   In this work, new crosslinked PU-hydrogels were prepared in a one-step bulk polymerization process using an aliphatic diisocyanate, PEO, a low molecular weight diol, and a tri-functional crosslinking agent. A porous structure was also obtained by air-incorporation under mechanical stirring at a controlled high speed during the polymerization.
   Structural characteristics of the compact (PU-HyC) and the porous (PU-HyP) material were investigated. Molecular weight between cross-links, Me, and crosslinking density, P, were typical of a low crosslinking degree. A homogeneous distribution of non-interconnecting pores (Phi100 mum) was <LF>observed in PU-HyP. Both materials showed a high water adsorption. The swelling behavior and weight loss in water was affected by porosity.
   For their mechanical behavior in the swollen state, the novel PU hydrogels can be considered for biomedical applications where good mechanical properties are required (i.e. 3D scaffold for tissue engineering). (C) 2003 Kluwer Academic Publishers
C1 Politecn Milan, Dept Bioengn, Lab Biomat, I-20133 Milan, Italy.
RP Petrini, P (reprint author), Politecn Milan, Dept Bioengn, Lab Biomat, Piazza L da Vinci 32, I-20133 Milan, Italy.
RI Petrini, Paola/A-3150-2013; Fare', Silvia/F-6484-2013; Tanzi, Maria
   Cristina/I-4620-2013
OI Petrini, Paola/0000-0002-5081-5254; Tanzi, Maria
   Cristina/0000-0002-4913-6633; Fare', Silvia/0000-0002-0303-1131
CR DUMITRIU S, 1994, POLYM BIOMATERIALS
   Graham N. B., 1987, HYDROGELS MED PHARM, VII, P95
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   MARCOS JI, 1990, POLYMER, V31, P1899, DOI 10.1016/0032-3861(90)90014-P
   PEPPAS NA, 1986, HYDROGELS MED PHARM, V1, P48
   Petrini P, 1999, J MATER SCI-MATER M, V10, P635, DOI 10.1023/A:1008939808819
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
NR 7
TC 49
Z9 52
U1 3
U2 24
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2003
VL 14
IS 8
BP 683
EP 686
DI 10.1023/A:1024955531173
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 704VC
UT WOS:000184360500005
PM 15348408
DA 2018-10-20
ER

PT J
AU Paradossi, G
   Cavalieri, F
   Chiessi, E
   Spagnoli, C
   Cowman, MK
AF Paradossi, G
   Cavalieri, F
   Chiessi, E
   Spagnoli, C
   Cowman, MK
TI Poly(vinyl alcohol) as versatile biomaterial for potential biomedical
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT International Conference on Advances of Biomaterials for Reconstructive
   Medicine
CY JUN 09-14, 2002
CL CAPRI, ITALY
ID CONTRAST AGENTS; ULTRASOUND; HYDROGELS
AB In this paper, we present some new case examples where the chemical versatility of poly (vinyl alcohol) (PVA) can be used for potential biomedical applications. PVA, the polymeric material used for designing new nanostructured devices, is water soluble, biocompatible and has excellent physical properties. We point out the possibility of obtaining wall-to-wall chemical hydrogels as well as microgels without diminishing the biocompatibility available in the starting PVA material. Injectability is another important factor to take into account in controlled drug delivery for gene therapy. In this respect, in this paper, established and more innovative methods are prospected in order to obtain particles with dimensions suitable for these applications. (C) 2003 Kluwer Academic Publisher
C1 Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy.
   Univ Roma Tor Vergata, INFM, Sect B, Rome, Italy.
   Polytech Univ Brooklyn, Dept Chem Engn Chem & Mat Sci, Brooklyn, NY USA.
RP Paradossi, G (reprint author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy.
EM paradossi@stc.uniroma2.it
RI Paradossi, Gaio/B-8330-2014
OI Paradossi, Gaio/0000-0003-3051-3811; CAVALIERI,
   FRANCESCA/0000-0001-5391-5069; Chiessi, Ester/0000-0001-7529-2755
CR DE SMEDT SC, 1995, MACROMOLECULES, V28, P5082, DOI 10.1021/ma00118a042
   ERMA B, 1997, STRUCTURE PROPERTIES
   Finch C. A., 1973, POLYVINYL ALCOHOL PR
   FLORY PJ, 1948, J POLYM SCI, V3, P880, DOI 10.1002/pol.1948.120030608
   Keresztes Z, 2001, APPL PHYS A-MATER, V72, pS113, DOI 10.1007/s003390100680
   Klibanov AL, 1999, ADV DRUG DELIVER REV, V37, P139, DOI 10.1016/S0169-409X(98)00104-5
   Koda S, 1996, ULTRASON SONOCHEM, V3, pS91, DOI 10.1016/1350-1477(96)00008-2
   MACKENNA G, 1994, POLYMER, V35, P5737
   OPHIR J, 1989, ULTRASOUND MED BIOL, V15, P319, DOI 10.1016/0301-5629(89)90044-6
   Paradossi G, 1999, J POLYM SCI POL PHYS, V37, P1225, DOI 10.1002/(SICI)1099-0488(19990615)37:12<1225::AID-POLB4>3.3.CO;2-G
   PEPPAS NA, 1992, J CONTROL RELEASE, V18, P95, DOI 10.1016/0168-3659(92)90178-T
NR 11
TC 157
Z9 157
U1 3
U2 43
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2003
VL 14
IS 8
BP 687
EP 691
DI 10.1023/A:1024907615244
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 704VC
UT WOS:000184360500006
PM 15348409
DA 2018-10-20
ER

PT J
AU Szczubialka, K
   Jankowska, M
   Nowakowska, M
AF Szczubialka, K
   Jankowska, M
   Nowakowska, M
TI "Smart" polymeric nanospheres as new materials for possible biomedical
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT International Conference on Advances of Biomaterials for Reconstructive
   Medicine
CY JUN 09-14, 2002
CL CAPRI, ITALY
ID WATER-SOLUBLE POLYMERS; PHOTORESPONSIVE POLYMERS; N-ISOPROPYLACRYLAMIDE;
   QUENCHING KINETICS; AQUEOUS-SOLUTIONS; IONIC-STRENGTH;
   POLY(N-ISOPROPYLACRYLAMIDE); FLUORESCENCE; COPOLYMERS;
   PHOTOPOLYMERIZATION
AB Novel random terpolymers of N-isopropylacrylamide (NIPAM), sodium 2-acrylamido-2methyl-1-propanesulfonate (AMPS), and cinnamoyloxyethylmethacrylate (CEMA) were synthesized by free radical copolymerization using AIBN as an initiator. Five terpolymers were obtained by copolymerization of the monomer mixtures containing a fixed amount 10 mol % of AMPS while the content of CEMA ranged from 5 to 25 mol % and was changed 5 mol % increments. The terpolymers obtained are water-soluble. Because of their amphiphilic nature they undergo self-organization in the aqueous solution with the formation of micelles capable of solubilizing sparingly water soluble organic compounds, such as drugs. The terpolymers are susceptible to three external stimuli, i.e. temperature, ionic strength and UV light. Due to the presence of NIPAM in the terpolymers they lower critical solution temperature (LCST), the presence of AMPS makes them sensitive to the ionic strength of the solution, while the light-responsiveness of the terpolymers is due the presence of cinnamoyl chromophores, which undergo photodimerization when irradiated with UV light at about 280 nm. Application of any of these stimuli alone or in combination with other stimuli allows changing the copolymer properties in a controlled way. (C) 2003 Kluwer Academic Publishers
C1 Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland.
RP Szczubialka, K (reprint author), Jagiellonian Univ, Fac Chem, Ingardena 3, PL-30060 Krakow, Poland.
CR Akiyoshi K, 2000, MACROMOLECULES, V33, P3244, DOI 10.1021/ma991798d
   Barros TC, 1997, LANGMUIR, V13, P6089, DOI 10.1021/la970477x
   CHUJO Y, 1990, MACROMOLECULES, V23, P2693, DOI 10.1021/ma00212a017
   HASHIDZUME A, 2002, HDB POLYELECTROLYTES, V2
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   Hu YX, 1997, MACROMOLECULES, V30, P3538, DOI 10.1021/ma9617532
   IRIE M, 1986, MACROMOLECULES, V19, P2480, DOI 10.1021/ma00164a004
   IRIE M, 1984, MAKROMOL CHEM-RAPID, V5, P829
   IRIE M, 1983, MACROMOLECULES, V16, P210, DOI 10.1021/ma00236a011
   Isahara M., 2002, BIOMATERIALS, V23, P833
   Kathmann EEL, 1997, MACROMOLECULES, V30, P5297, DOI 10.1021/ma961214x
   Kim SH, 1999, CARBOHYD POLYM, V40, P183, DOI 10.1016/S0144-8617(99)00053-3
   KRAMER MC, 1995, MACROMOLECULES, V28, P5248, DOI 10.1021/ma00119a012
   Lee AS, 1999, MACROMOLECULES, V32, P4302, DOI 10.1021/ma981865o
   Liang L, 1998, MACROMOLECULES, V31, P7845
   Liang L, 2000, J APPL POLYM SCI, V75, P1735, DOI 10.1002/(SICI)1097-4628(20000401)75:14<1735::AID-APP7>3.0.CO;2-R
   Liang L, 1999, J MEMBRANE SCI, V162, P235, DOI 10.1016/S0376-7388(99)00145-3
   Martin TJ, 1996, MACROMOLECULES, V29, P6071, DOI 10.1021/ma960629f
   MORISHIMA Y, 1992, MACROMOLECULES, V25, P4406, DOI 10.1021/ma00043a025
   Morrison ME, 1996, J PHYS CHEM-US, V100, P15187, DOI 10.1021/jp961348c
   MORRISON ME, 1994, J PHYS CHEM-US, V98, P5534, DOI 10.1021/j100072a021
   Sideratou Z, 2000, LANGMUIR, V16, P1766, DOI 10.1021/la990829v
   SNOWDEN M. J., 1996, CHEM IND, V14, P531
   SZCUBIALKA K, 1999, POLYM PREPR, V41, P222
   Szczubialka K, 2001, J POLYM SCI POL CHEM, V39, P2784, DOI 10.1002/pola.1257
   TAKAGI K, 1990, J CHEM SOC P2, P1003
   TIKTOPULO EI, 1995, MACROMOLECULES, V28, P7519, DOI 10.1021/ma00126a032
   WINNIK FM, 1990, MACROMOLECULES, V23, P233, DOI 10.1021/ma00203a040
   Winnik FM, 1995, CAN J CHEM, V73, P2030, DOI 10.1139/v95-251
   Yamazaki A, 1999, BBA-BIOMEMBRANES, V1421, P103, DOI 10.1016/S0005-2736(99)00117-0
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
NR 31
TC 12
Z9 12
U1 1
U2 19
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2003
VL 14
IS 8
BP 699
EP 703
DI 10.1023/A:1024911716152
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 704VC
UT WOS:000184360500008
PM 15348411
DA 2018-10-20
ER

PT J
AU Navarro, M
   Ginebra, MP
   Clement, J
   Martinez, S
   Avila, G
   Planell, JA
AF Navarro, M
   Ginebra, MP
   Clement, J
   Martinez, S
   Avila, G
   Planell, JA
TI Physicochemical degradation of titania-stabilized soluble phosphate
   glasses for medical applications
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID DISSOLUTION; FIBERS
AB Four different formulations of phosphate glasses in the system P2O5-CaO-Na2O-TiO, were developed. Their physicochemical, morphologic, and structural evolution was analyzed during in vitro degradation in SBF (simulated body fluid) at 37degreesC up to 16 weeks. The results showed that the addition of TiO2 into the glass system enhanced both the elastic modulus and the chemical durability of the glasses. Indeed, the elastic modulus increased from 66.6 to 75.95 GPa and the weight loss percentage diminished from 1.6 % to 0.3 % with the addition of 8 mol% TiO2. A uniform and superficial degradation mechanism could be observed throughout the dissolution time by means of environmental scanning electron microscopy (ESEM), inductively coupled plasma mass spectroscopy (ICPMS), and Raman spectroscopy. The degradation process undergone by these glasses allows them to maintain their mechanical properties during the degradation process. Therefore, these materials offer an interesting choice for slowly resorbable materials in biomedical applications.
C1 Tech Univ Catalonia, CREB, Dept Mat Sci & Met, Barcelona 08028, Spain.
   Univ Barcelona, Dept Crystallog, E-08028 Barcelona, Spain.
RP Navarro, M (reprint author), Tech Univ Catalonia, CREB, Dept Mat Sci & Met, Barcelona 08028, Spain.
RI Ginebra, Maria-Pau/J-8149-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Martinez,
   Salvador/0000-0002-9320-4103
CR Brow RK, 1997, PHYS CHEM GLASSES, V38, P300
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   BUNKER BC, 1984, J NON-CRYST SOLIDS, V64, P291, DOI 10.1016/0022-3093(84)90184-4
   BURNIE J, 1981, BIOMATERIALS, V2, P244, DOI 10.1016/0142-9612(81)90065-X
   Charvet J L, 2000, J Mater Sci Mater Med, V11, P101, DOI 10.1023/A:1008945017668
   CHEN WS, 1991, BIOMATERIALS, V12, P561, DOI 10.1016/0142-9612(91)90051-B
   CHOUEKA A, 1995, J BIOMED MATER RES, V29, P1309
   Clement J, 1999, J MATER SCI-MATER M, V10, P729, DOI 10.1023/A:1008927222081
   CLEMENT J, 1998, P 11 INT S CER MED N, V11, P141
   CLEMENT J, 2001, THESIS TU CATALONIA
   CLEMENT J, 2000, BIOCERAMICS, V13, P621
   Delahaye F, 1998, J NON-CRYST SOLIDS, V242, P25, DOI 10.1016/S0022-3093(98)00784-4
   Fang XY, 2000, J NON-CRYST SOLIDS, V263, P293, DOI 10.1016/S0022-3093(99)00641-9
   Franks K, 2000, J MATER SCI-MATER M, V11, P609, DOI 10.1023/A:1008949527695
   GALEENER FL, 1979, SOLID STATE COMMUN, V30, P505, DOI 10.1016/0038-1098(79)91227-4
   Gough JE, 2002, J BIOMED MATER RES, V59, P481, DOI 10.1002/jbm.10020
   Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5
   KISHIOKA A, 1974, B CHEM SOC JPN, V47, P2493, DOI 10.1246/bcsj.47.2493
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LIN ST, 1994, BIOMATERIALS, V15, P1057, DOI 10.1016/0142-9612(94)90091-4
   LOWRY KL, 1997, J BIOMED MATER RES, V36, P336
   MINAMI T, 1977, J AM CERAM SOC, V60, P232, DOI 10.1111/j.1151-2916.1977.tb14113.x
   NAVARRO JM, 1985, EL VIDRIO CONSTITUCI, P337
   NELSON BN, 1979, J CHEM PHYS, V71, P2739, DOI 10.1063/1.438679
   Van Wazer J. R., 1958, PHOSPHORUS ITS COMPO, V1, P717
   Vogel J, 1997, GLASTECH BER-GLASS, V70, P23
   Wang ZR, 1997, J MATER PROCESS TECH, V70, P220, DOI 10.1016/S0924-0136(97)00065-4
   WILDER JA, 1984, J AM CERAM SOC, V67, P438, DOI 10.1111/j.1151-2916.1984.tb19732.x
   Yu XY, 1997, J NON-CRYST SOLIDS, V215, P21, DOI 10.1016/S0022-3093(97)00022-7
NR 29
TC 86
Z9 86
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-7820
EI 1551-2916
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD AUG
PY 2003
VL 86
IS 8
BP 1345
EP 1352
DI 10.1111/j.1151-2916.2003.tb03474.x
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 713YN
UT WOS:000184885700017
DA 2018-10-20
ER

PT J
AU Malone, PC
   Agutter, PS
AF Malone, PC
   Agutter, PS
TI Directions in biomedical research: a plea for ideological pluralism
SO MEDICAL HYPOTHESES
LA English
DT Article
AB Feinstein [A.R. Feinstein, Am. J. Med. 107 (1999) 461] complained that 'basic medical science' has overwhelmed 'pathophysiological medical science' during the past half century, and 'destroyed the bridge between bedside and bench'. We agree that a 'drastic reorientation' will be necessary to correct the overemphasis and imbalance.
   Re-examining the roots of his problem, we believe that a plea to restore a balance between the 'status' (esteem) of 'large research' and 'small research' in medical science brings back into question the decision of academic physiologists to invoke the framework of Physics in/of 1847 [P.F. Cranefield, J. Hist. Med. Allied Sci. 12 (1957) 407] (together with an absolutist 'Prime Mover'/Metaphysic which Einstein would delete from Physics in 1905). The current 'imbalance' arose when that Cartesian 'Prime Mover' was NOT deleted from the Biological frame.
   Feinstein felt that the 'privileged status' (esteem) in which fund-giving bodies hold 'Small' researches compared to 'Large' should be cancelled. Once Biology replaces its Cartesian absolutism with a relativist framework, redress will follow naturally when living-material has regained the status of cause as well as effect. Descartes' 'Great Watchmaker' is a Dead God in Biology: a non-metaphysical Biological Perspective would restore balance between 'large' and 'small' investigations.
   ('Pluralism' implies that no scientific perspective would be second-rate in a relativist framework.) (C) 2003 Elsevier Science Ltd. All rights reserved.
RP Malone, PC (reprint author), 129 Viceroy Close, Birmingham B5 7UY, W Midlands, England.
CR Butterfield H, 1957, ORIGINS MODERN SCI 1
   COPLESTON F, 1963, HIST PHILOS 2, V3, P48
   COPLESTON F, 1963, HIST PHILOS 2, V3, P66
   COPLESTON FC, 1963, HIST PHILOS, V4
   CRANEFIELD P F, 1957, J Hist Med Allied Sci, V12, P407
   Feinstein AR, 1999, AM J MED, V107, P461, DOI 10.1016/S0002-9343(99)00264-8
   HARVEY W, 1857, CIRCULATION BLOOD OT, P169
   HUNTER J, 1834, TREATISE BLOOD INFLA
   LISTER J, 1863, P ROY SOC, V12, P580
   PEART WS, 1981, BRIT MED J, V282, P1391, DOI 10.1136/bmj.282.6273.1391
   VIRCHOW R, 1863, CELLULAR PATHOLOGY B, P428
NR 11
TC 0
Z9 1
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD AUG
PY 2003
VL 61
IS 2
BP 194
EP 199
DI 10.1016/S0306-9877(03)00015-X
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 713YM
UT WOS:000184885600009
PM 12888302
DA 2018-10-20
ER

PT J
AU Oehr, C
AF Oehr, C
TI Plasma surface modification of polymers for biomedical use
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Ionizing Radiation and Polymers (IRaP
   2002)
CY SEP 21-26, 2002
CL ST ADELE, CANADA
SP Rech, Sci & Technol Quebec, Ecole Polytech Montreal, DSM DRECAM CEA/Saclay, IOM, IAEA Vienna, Grp COGETEFI, CTT Grp, GEX Corp, Nissin NHV Amer Inc, IBA, Promerus
DE polymers; plasma polymerization; biocompatibility; functionalization
ID SCIENCE
AB Polymeric materials can be used in many application areas due to their mechanical (e.g. elastic) characteristics, chemical stability, and their light weight, as well as for their many design possibilities. Even in the fields of medicine and biotechnology many products are completely or partly made of polymers. In contact with biological systems, compatibility of these materials is not always given. To fulfill the requirements for medical applications, the surfaces have to be modified. Plasma techniques are demonstrated as an appropriate tool for the generation of the demanded surface properties. Experimental data are given for surface modification by plasma polymerization, with retention of the functional groups of the monomers used. Qualitative and quantitative characterization of the thin films with respect to the type and density of available groups at the surfaces is presented. Some possible applications of plasma-modified polymers are also discussed. (C) 2003 Elsevier B.V. All rights reserved.
C1 Fraunhofer Inst Interfacial Engn & Biotechnol IGB, D-70569 Stuttgart, Germany.
RP Oehr, C (reprint author), Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Nobelstr 12, D-70569 Stuttgart, Germany.
CR Belcourt A., 1999, P 12 INT C PLASM PRO, P28
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CYBORRA L, 1998, KUNSTSTOFFE, V88, P721
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   HEGEMANN D, 2002, P 45 ANN SVC TECH C, P174
   Loh I.-H., 1997, DESK REFERENCE FUNCT, P657
   OEHR C, 1999, P 14 INT S PLASM CHE, V4, P1747
   Oehr C., 2000, VAKUUM FORSCHUNG PRA, V5, P313
   Ratner BD, 1997, NATO ADV SCI I E-APP, V346, P453
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Weller M, 2000, KUNSTST-PLAST EUR, V90, P224
   Zou X. P., 2000, Plasmas and Polymers, V5, P219, DOI 10.1023/A:1011354001424
NR 13
TC 126
Z9 129
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD AUG
PY 2003
VL 208
BP 40
EP 47
DI 10.1016/S0168-583X(03)00650-5
PG 8
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 707LT
UT WOS:000184512700008
DA 2018-10-20
ER

PT J
AU Rosiak, JM
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Stasica, P
   Ulanski, P
AF Rosiak, JM
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Stasica, P
   Ulanski, P
TI Nano-, micro- and macroscopic hydrogels synthesized by radiation
   technique
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Ionizing Radiation and Polymers (IRaP
   2002)
CY SEP 21-26, 2002
CL ST ADELE, CANADA
SP Rech, Sci & Technol Quebec, Ecole Polytech Montreal, DSM DRECAM CEA/Saclay, IOM, IAEA Vienna, Grp COGETEFI, CTT Grp, GEX Corp, Nissin NHV Amer Inc, IBA, Promerus
DE ionizing radiation; hydrogel; biomaterial; drug delivery; implant
ID POLYMERIC NANOGELS; PULSE-RADIOLYSIS; AQUEOUS-SOLUTION
AB Radiation techniques, due to the additive-free initiation and easy process control, are very suitable tools for synthesis of biomaterials, especially hydrogels. In our group, a number of techniques have been elaborated allowing for targeted synthesis of gels of various size ranges, from internally crosslinked individual macromolecules, via microgels to macroscopic hydrogels. An example of a mature technology of this kind are hydrogel wound dressings, being now produced on large scale in Poland and other countries. Current research projects include: hydrogel-based system for anticancer therapy due to local drug delivery, systems for encapsulation of living cells, new approach to the synthesis of polymeric material for intervertebral discs implant, temperature-sensitive membranes, hydrogel phantoms of 3D radiation dosimeter for radiotherapy, degradation-resistant nanogels and microgels for biomedical purposes (e.g. synovial fluid substitute), hydrogel-based dietary products and adjustment of the molecular weight of biopolymers. (C) 2003 Elsevier B.V. All rights reserved.
C1 Tech Univ Lodz, Inst Appl Radiat Chem, PL-93590 Lodz, Poland.
RP Rosiak, JM (reprint author), Tech Univ Lodz, Inst Appl Radiat Chem, Wroblewskiego 15, PL-93590 Lodz, Poland.
EM rosiakjm@mitr.p.lodz.pl
RI Kujawa, Piotr/D-5142-2013; Kozicki, Marek/M-2744-2018; Ulanski,
   Piotr/S-9103-2018
OI Kozicki, Marek/0000-0002-8396-4344; Ulanski, Piotr/0000-0002-4310-3574;
   Kadlubowski, Slawomir/0000-0003-0648-5208
CR Charlesby A, 1960, ATOMIC RAD POLYM
   Darwis D, 2002, RADIAT PHYS CHEM, V63, P539, DOI 10.1016/S0969-806X(01)00636-3
   DeRossi D., 1991, POLYM GELS FUNDAMENT
   Funke W, 1998, ADV POLYM SCI, V136, P139
   Goosen M. F. A., 1997, APPL CHITIN CHITOSAN
   GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002
   Janik I, 2000, J CHEM SOC PERK T 2, P2041, DOI 10.1039/b004777p
   KOLODZIEJCZYK M, 2001, 9 BRG WORKSH 62 ICB
   Kozicki M, 2002, RADIAT PHYS CHEM, V65, P133, DOI 10.1016/S0969-806X(02)00209-8
   Kozicki M, 1999, ENG BIOMATER, V2, P11
   KUJAWA P, 1997, 6 INT WORKSH BIOENC
   MARYANSKI MJ, 1993, MAGN RESON IMAGING, V11, P253, DOI 10.1016/0730-725X(93)90030-H
   MUZZARELLI RAA, 1977, CHITIN
   Peppas N. A., 1986, HYDROGELS MED PHARM, V2
   ROSIAK J, 1992, J RADIOAN NUCL CH AR, V159, P87, DOI 10.1007/BF02041021
   Rosiak J. M., 1989, US patent, Patent No. [US4871490, 4871490]
   ROSIAK JM, 1994, J CONTROL RELEASE, V31, P9, DOI 10.1016/0168-3659(94)90246-1
   Rosiak JM, 1999, RADIAT PHYS CHEM, V55, P139, DOI 10.1016/S0969-806X(98)00319-3
   ROSIAK JM, 1988, RADIAT PHYS CHEM, V52, P307
   ROSIAK JM, 1991, ACS SYM SER, V475, P271
   ROSIAK JM, 1996, MED SCI MONIT, V2, P78
   Sabharwal S, 1999, RADIAT PHYS CHEM, V54, P643, DOI 10.1016/S0969-806X(98)00299-0
   Spohr R., 1998, New Astronomy Reviews, V42, P189, DOI 10.1016/S1387-6473(98)00004-9
   Stasica P, 2000, ENG BIOMATER, V3, P9
   Ulanski P, 1999, NUCL INSTRUM METH B, V151, P356, DOI 10.1016/S0168-583X(99)00085-3
   Ulanski P, 1998, RADIAT PHYS CHEM, V52, P289, DOI 10.1016/S0969-806X(98)00155-8
   Ulanski P, 2000, J CHEM SOC PERK T 2, P2022, DOI 10.1039/b003952g
   Ulanski P, 2002, RADIAT PHYS CHEM, V63, P533, DOI 10.1016/S0969-806X(01)00549-7
   ULANSKI P, 1994, CHITIN WORLD, P572
   ULANSKI P, 2000, ADV CHITIN SCI, V4, P429
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
NR 31
TC 37
Z9 42
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
EI 1872-9584
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD AUG
PY 2003
VL 208
BP 325
EP 330
DI 10.1016/s0168-583X(03)00672-X
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 707LT
UT WOS:000184512700057
DA 2018-10-20
ER

PT J
AU Ozdemir, S
   Ozdemir, E
   Tunca, R
   Haziroglu, R
   Sen, M
   Kantoglu, O
   Guven, O
AF Ozdemir, S
   Ozdemir, E
   Tunca, R
   Haziroglu, R
   Sen, M
   Kantoglu, O
   Guven, O
TI In vivo biocompatibility studies of poly(n-vinyl 2-pyrrolidone/itaconic
   acid) hydrogels synthesized by gamma-rays
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Ionizing Radiation and Polymers (IRaP
   2002)
CY SEP 21-26, 2002
CL ST ADELE, CANADA
SP Rech, Sci & Technol Quebec, Ecole Polytech Montreal, DSM DRECAM CEA/Saclay, IOM, IAEA Vienna, Grp COGETEFI, CTT Grp, GEX Corp, Nissin NHV Amer Inc, IBA, Promerus
DE hydrogel; poly(n-vinyl 2-pyrrolidone/itaconic acid); biocompatibility;
   gamma-rays
AB In this study, poly(n-vinyl 2-pyrrolidone/itaconic acid) hydrogels have been synthesized by gamma-rays in different compositions and their biocompatibility have been investigated as in vivo and some biochemical parameters of mice serum and histology of their tissues have been examined. By these purposes, poly(n-vinyl 2-pyrrolidone/itaconic acid) (P(VP/ IA)) hydrogels were implanted to hypersensitive mice (BALB/c). One and a half months after implantation, hydrogel implanted animals were sacrificed by ether anesthesia and the area hydrogel contacted with tissue was investigated by light microscope for histopathological identification of the tissue. Then the total immunoglobulin E (IgE) level was determined by ELISA. Differential white cell count was also made to better understanding of reaction between hydrogel and tissue. These poly(n-vinyl 2-pyrrolidone/itaconic acid) hydrogels can be directly used as biomedical materials. (C) 2003 Elsevier B.V. All rights reserved.
C1 Ankara Nucl Res Ctr Agr & Anim Sci, Turkish Atom Energy Author, TR-06983 Ankara, Turkey.
   Ankara Univ, Fac Vet, Dept Pathol, TR-06100 Ankara, Turkey.
   Hacettepe Univ, Dept Chem, TR-06532 Ankara, Turkey.
RP Kantoglu, O (reprint author), Ankara Nucl Res Ctr Agr & Anim Sci, Turkish Atom Energy Author, 1st Yolu 30 Km, TR-06983 Ankara, Turkey.
RI SEN, MURAT/G-9303-2013
CR ANFOSSO F, 1987, MOL IMMUNOL, V24, P1129, DOI 10.1016/0161-5890(87)90158-1
   BAGNALL RD, 1977, J BIOMED MATER RES, V11, P939, DOI 10.1002/jbm.820110612
   CHEVILLE NF, 1999, INTRO VET PATHOLOGY, P124
   GANONG WF, 1989, REV MED PHYSL, P440
   Nye L, 1975, Clin Allergy, V5, P13
   PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003
   SEEGER JM, 1995, J VASC SURG, V22, P326
   Sen M, 1999, POLYMER, V40, P913, DOI 10.1016/S0032-3861(98)00320-6
   WILLIAMS DF, 1989, J BIOMED ENG, V11, P185, DOI 10.1016/0141-5425(89)90138-6
NR 9
TC 2
Z9 2
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD AUG
PY 2003
VL 208
BP 395
EP 399
DI 10.1016/S0168-583X(03)01109-1
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 707LT
UT WOS:000184512700070
DA 2018-10-20
ER

PT J
AU Atzei, D
   Elsener, B
   Manfredini, M
   Marchetti, A
   Malagoli, M
   Galavotti, F
   Rossi, A
AF Atzei, D
   Elsener, B
   Manfredini, M
   Marchetti, A
   Malagoli, M
   Galavotti, F
   Rossi, A
TI Radiation-induced migration of additives in PVC-based biomedical
   disposable devices Part 2. Surface analysis by XPS
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE XPS surface analysis; medical device; PVC; plasticizer
ID PLASTICIZED POLY(VINYL CHLORIDE); BLOOD; SPECTROMETERS; CALIBRATION
AB Extruded parts of non-sterilized and P-irradiated (25 and 50 kGy) plasticized poly(vinyl chloride) (PVC) used for disposable medical devices have been studied to investigate the effect of sterilization on surface chemical composition. The polymer surfaces were analysed using angle-resolved x-ray photoelectron spectroscopy. The inner surface of the blood tubing lines showed a fairly smooth surface both before and after sterilization, so a laterally homogeneous surface can be assumed for XPS analysis. The XPS survey spectra exhibited no signals besides carbon, chlorine, oxygen and calcium. Detailed analysis of the regions showed the C 1s, Cl 2p and O 1s signals to be multi-component, presenting signals of the PVC, the plasticizer and the other additives. Binding energies remained constant irrespective of P-radiation dosage, but the amount of chlorine component at 198.4 +/- 0.1 eV (associated with modified PVC) decreased with sterilization dosage. Angle-resolved XPS revealed that this component is located at the outermost surface of the polymer. It can be hypothesized that the production processes themselves (extrusion and/or injection molded) already induce modifications of the polymer surface and also lead to surface segregation of the plasticizer. During the subsequent thermal sterilization of the polymer dehydrochlorination continues but, because of the very short time required by the beta-irradiation technology to sterilize devices, the atmospheric oxygen is unable to diffuse into the irradiated material, thus inhibiting further side-degradation of the materials, such as thermo-oxidative degradation. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Univ Cagliari, INSTM UDR Cagliari, Dept Inorgan & Analyt Chem, I-09042 Monserrato, CA, Italy.
   Univ Modena & Reggio Emilia, Dept Chem, INSTM UDR Modena, I-41100 Modena, Italy.
   Gambro Dasco SpA, I-41036 Medolla, MO, Italy.
RP Rossi, A (reprint author), Univ Cagliari, INSTM UDR Cagliari, Dept Inorgan & Analyt Chem, SS 554 Bivio Sestu, I-09042 Monserrato, CA, Italy.
RI Rossi, Antonella/B-2288-2010; Elsener, Bernhard/F-8903-2011
OI Rossi, Antonella/0000-0002-5151-2634; Elsener,
   Bernhard/0000-0002-9993-7834; Atzei, Davide/0000-0001-8240-9237;
   ELSENER, BERNHARD/0000-0002-6855-1584
CR Beamson G., 1992, HIGH RESOLUTION XPS
   BEDWARD DA, 1995, RADIAT PHYS CHEM, V46, P443, DOI 10.1016/0969-806X(95)00190-9
   BLASS CR, 1991, PLAST RUB COMPOS PRO, V15, P221
   Briggs D., 1998, SURFACE ANAL POLYM X
   CHANG HP, 1982, J ELECTRON SPECTROSC, V26, P203, DOI 10.1016/0368-2048(82)85028-7
   JONES C, 1989, INT J ARTIF ORGANS, V12, P466
   KICHEVA YI, 1995, BIOMATERIALS, V16, P575, DOI 10.1016/0142-9612(95)91132-I
   Manfredini M, 2003, SURF INTERFACE ANAL, V35, P294, DOI 10.1002/sia.1532
   Manfredini M, 2003, SURF INTERFACE ANAL, V35, P395, DOI 10.1002/sia.1547
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   Naimian F, 1999, NUCL INSTRUM METH B, V151, P467, DOI 10.1016/S0168-583X(99)00091-9
   REILMAN RF, 1976, J ELECTRON SPECTROSC, V8, P389, DOI 10.1016/0368-2048(76)80025-4
   ROSSI A, 1992, SURF INTERFACE ANAL, V18, P499, DOI 10.1002/sia.740180708
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   Seah M. P., 1979, SURF INTERFACE ANAL, V1, P2, DOI DOI 10.1002/SIA.740010103
   Seah MP, 2001, SURF INTERFACE ANAL, V31, P721, DOI 10.1002/sia.1076
   SEAH MP, 1993, SURF INTERFACE ANAL, V20, P243, DOI 10.1002/sia.740200309
   Sherwood P. M. A., 1983, PRACTICAL SURFACE AN, P445
   SINGH A, 1992, RAD PROCESSING POLYM, pC1
   VANDOOREN AA, 1991, PHARM WEEKBLAD, V13, P109, DOI 10.1007/BF01981526
   WILLIAMS JL, 1992, RAD PROCESSING POLYM, pC12
   Yin HQ, 1999, J MATER SCI-MATER M, V10, P527, DOI 10.1023/A:1008912213420
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x
NR 23
TC 15
Z9 15
U1 1
U2 8
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD AUG
PY 2003
VL 35
IS 8
BP 673
EP 681
DI 10.1002/sia.1590
PG 9
WC Chemistry, Physical
SC Chemistry
GA 717TW
UT WOS:000185107400007
DA 2018-10-20
ER

PT J
AU Haque, F
AF Haque, F
TI Application of nanoindentation to development of biomedical materials
SO SURFACE ENGINEERING
LA English
DT Review
ID ATOMIC-FORCE MICROSCOPY; AMPEROMETRIC ENZYME ELECTRODES; POLY(VINYL
   CHLORIDE) MEMBRANES; ELASTIC PROPERTIES; MECHANICAL-PROPERTIES; CORTICAL
   BONE; ULTRAFILTRATION MEMBRANES; TRIBOLOGICAL PROPERTIES; INDENTATION
   HARDNESS; PROTEIN ADSORPTION
AB The use of nanoindentation techniques to characterise biomedical materials is reviewed. Nanoindentation, which allows measurement of material hardness and elastic properties at submicrometre depths, has found application in many areas and is increasingly being used to probe microstructural components of mammalian bone. This is in addition to more long standing work on indentation of orthopaedic coatings, dental restorative materials and even thin films of phase transforming (shape memory) alloys. The ability of the technique to test samples of limited dimensions is key for biomedical materials. One important emerging application relates to in vivo glucose sensor technology, Where initial contact with blood and subcutaneous tissue results in mass protein deposition on the outer surface of the sensor. The molecular size range within which proteins are categorised makes nanoindentation attractive as a novel technique to probe surface protein films. (C) 2003 IoM Communications Ltd. Published by Maney for the Institute of Materials, Minerals and Mining.
C1 Queen Mary Univ London, Dept Mat, London E1 4NS, England.
RP Haque, F (reprint author), Queen Mary Univ London, Dept Mat, Mile End Rd, London E1 4NS, England.
EM f.haque@qmul.ac.uk
RI Wagner, Martin/A-6880-2008
CR ABBOTT TP, 1991, APPL SPECTROSC, V45, P1665, DOI 10.1366/0003702914335265
   Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   Ashcroft IA, 1996, J MATER RES, V11, P529, DOI 10.1557/JMR.1996.0063
   Asif SAS, 1998, MATER RES SOC SYMP P, V505, P103
   BEISSINGER RL, 1980, ASAIO J, V3, P160
   Bhushan B, 1996, PHILOS MAG A, V74, P1117, DOI 10.1080/01418619608239712
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bosdorf K, 1995, BIOMED TECH, V40, P356, DOI 10.1515/bmte.1995.40.12.356
   Briscoe BJ, 1996, PHILOS MAG A, V74, P1159, DOI 10.1080/01418619608239716
   Broitman E, 2001, WEAR, V248, P55, DOI 10.1016/S0043-1648(00)00519-6
   Broitman E, 2000, DIAM RELAT MATER, V9, P1984, DOI 10.1016/S0925-9635(00)00352-6
   Bushby AJ, 2001, NONDESTRUCTIVE TESTI, V17, P213
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   CALLISTER WD, 1997, MATER SCI ENG, P732
   Camesano TA, 2000, LANGMUIR, V16, P4563, DOI 10.1021/la990805o
   Cheng YT, 2000, SURF COAT TECH, V133, P417, DOI 10.1016/S0257-8972(00)00896-3
   CHOI K, 1990, J BIOMECH, V23, P1103, DOI 10.1016/0021-9290(90)90003-L
   CURREY JD, 1988, J BIOMECH, V21, P439, DOI 10.1016/0021-9290(88)90150-9
   CUYPERS PA, 1977, ANN NY ACAD SCI, V283, P77, DOI 10.1111/j.1749-6632.1977.tb41754.x
   DESAI MA, 1993, SCAND J CLIN LAB INV, V53, P53, DOI 10.3109/00365519309090679
   Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601
   Dorlot J., 1986, T 32 ORTH RES SOC, V11, P330
   EVANS FG, 1973, MECH PROPERTIES BONE, P43
   EVANS GP, 1990, J MATER SCI-MATER M, V1, P38, DOI 10.1007/BF00705352
   FUCHS H, 1993, J MOL STRUCT, V292, P29, DOI 10.1016/0022-2860(93)80088-D
   GEKAS V, 1992, J MEMBRANE SCI, V72, P293, DOI 10.1016/0376-7388(92)85056-O
   HASEGAWA K, 1995, BONE, V16, P85, DOI 10.1016/S8756-3282(94)00013-1
   HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P313, DOI 10.1006/jcis.1995.1039
   HELLEM ARVID JOHN, 1960, SCAND JOUR CLIN AND LAB INVEST, V12, P1
   Hellgren N, 1999, PHYS REV B, V59, P5162, DOI 10.1103/PhysRevB.59.5162
   HIGSON SPJ, 1993, J CHEM SOC FARADAY T, V89, P2847, DOI 10.1039/ft9938902847
   Huisman IH, 2000, J MEMBRANE SCI, V179, P79, DOI 10.1016/S0376-7388(00)00501-9
   JOHNSON WW, 1993, DENT MATER, V9, P95, DOI 10.1016/0109-5641(93)90082-2
   KATZ JL, 1993, J BIOMECH ENG-T ASME, V115, P543, DOI 10.1115/1.2895537
   Khurshudov AG, 1996, SURF COAT TECH, V86-7, P664, DOI 10.1016/S0257-8972(96)03072-1
   KO MK, 1994, J MEMBRANE SCI, V93, P21, DOI 10.1016/0376-7388(94)85012-7
   Koehler JA, 2000, LANGMUIR, V16, P10419, DOI 10.1021/la000593r
   KOTILAINEN M L, 1955, Ann Med Exp Biol Fenn, V33, P76
   LAWSON NS, 1994, PHYS SCRIPTA, V55, P199, DOI 10.1088/0031-8949/1994/T55/035
   LEA AS, 1992, LANGMUIR, V8, P68, DOI 10.1021/la00037a015
   Lorenz D, 2001, J MATER RES, V16, P1776, DOI 10.1557/JMR.2001.0245
   LOUBET JL, 1995, NIST SPECIAL PUBLICA, V896
   Low D, 2002, DENT MATER, V18, P211, DOI 10.1016/S0109-5641(01)00084-7
   MARIEB EN, 1997, ESSENTIALS HUMAN ANA, P113
   MARTINI FH, 1998, FUNDAMENTALS ANATOMY, P176
   Maruyama T, 2001, BIOTECHNOL BIOENG, V75, P233, DOI 10.1002/bit.10001
   Meagher L, 2002, COLLOID SURFACE B, V23, P125, DOI 10.1016/S0927-7765(01)00234-X
   MENCIK J, 1995, J MATER RES, V10, P1491, DOI 10.1557/JMR.1995.1491
   Miyazaki S, 1992, P INT S MEAS CONTR R, P495
   MOORE S, 1968, J BIOL CHEM, V243, P6281
   MOORE S, 1963, METHOD ENZYMOL, V6, P819, DOI 10.1016/0076-6879(63)06257-1
   MOY VT, 1994, COLLOID SURFACE A, V93, P343, DOI 10.1016/0927-7757(94)02933-4
   Moyne S, 1999, MAT SCI ENG A-STRUCT, V273, P727, DOI 10.1016/S0921-5093(99)00405-0
   NORDE W, 1992, COLLOID SURFACE, V64, P87, DOI 10.1016/0166-6622(92)80164-W
   NYSTROM M, 1994, J MEMBRANE SCI, V87, P245, DOI 10.1016/0376-7388(94)87031-4
   OHNESORGE F, 1993, SCIENCE, V260, P1451, DOI 10.1126/science.260.5113.1451
   OLEARY A, 1995, KEY ENG MAT, V99-1, P301, DOI 10.4028/www.scientific.net/KEM.99-100.301
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   OYENTIESMA M, 2000, MRS S P, V649
   Palacio L, 1999, J MEMBRANE SCI, V152, P189, DOI 10.1016/S0376-7388(98)00203-8
   Payne JA, 1998, POLYM ENG SCI, V38, P1529, DOI 10.1002/pen.10323
   PETHICA JB, 1983, PHILOS MAG A, V48, P593, DOI 10.1080/01418618308234914
   PHARR GM, 1992, MRS BULL, V17, P28, DOI 10.1557/S0883769400041634
   PUTMAN CAJ, 1994, APPL PHYS LETT, V64, P2454, DOI 10.1063/1.111597
   RADMACHER M, 1993, BIOPHYS J, V64, P735, DOI 10.1016/S0006-3495(93)81433-4
   Reddy SM, 1997, ANAL CHIM ACTA, V350, P77, DOI 10.1016/S0003-2670(97)00315-2
   Reddy SM, 1997, ANAL CHIM ACTA, V350, P67, DOI 10.1016/S0003-2670(97)00314-0
   Reddy Subrayal M., 1997, P111
   REILLY DT, 1974, J BIOMECH, V7, P271, DOI 10.1016/0021-9290(74)90018-9
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Rho JY, 1999, J MATER SCI-MATER M, V10, P485, DOI 10.1023/A:1008901109705
   ROY M, 1996, ADV BIOENG BED, V33, P385
   RUDIN A, 1999, ELEMENTS POLYM SCI E, V460
   SINGH BR, 1990, BIOPHYS CHEM, V36, P155, DOI 10.1016/0301-4622(90)85019-3
   SJOSTROM H, 1995, PHYS REV LETT, V75, P1336, DOI 10.1103/PhysRevLett.75.1336
   Strojny A, 1998, MATER RES SOC SYMP P, V522, P159, DOI 10.1557/PROC-522-159
   Tabor D, 1996, PHILOS MAG A, V74, P1207, DOI 10.1080/01418619608239720
   Thomson NH, 1996, LANGMUIR, V12, P5905, DOI 10.1021/la960497j
   Tiefenauer L, 2002, COLLOID SURFACE B, V23, P95, DOI 10.1016/S0927-7765(01)00228-4
   TOWNSEND PR, 1975, J BIOMECH, V8, P199, DOI 10.1016/0021-9290(75)90025-1
   Turnbull A, 1996, J MATER SCI, V31, P4189, DOI 10.1007/BF00356438
   TURNER APF, 1987, BIOSENSORS FUNDAMENT, P3
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   VADGAMA PM, 1984, THESIS U NEWCASTLE U
   Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006
   WHITEHEAD AJ, 1992, THIN SOLID FILMS, V220, P277, DOI 10.1016/0040-6090(92)90585-Y
   WOODWARD SC, 1982, DIABETES CARE, V5, P278, DOI 10.2337/diacare.5.3.278
   Xu HHK, 1998, DENT MATER, V14, P11, DOI 10.1016/S0109-5641(98)00004-9
   Xu HHK, 1998, J DENT RES, V77, P1991, DOI 10.1177/00220345980770120701
   Xu HHK, 1998, J DENT RES, V77, P472, DOI 10.1177/00220345980770030601
   Xu HHK, 2000, DENT MATER, V16, P248, DOI 10.1016/S0109-5641(00)00014-2
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 93
TC 35
Z9 36
U1 1
U2 25
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0844
J9 SURF ENG
JI Surf. Eng.
PD AUG
PY 2003
VL 19
IS 4
BP 255
EP 268
DI 10.1179/026708403322499173
PG 14
WC Materials Science, Coatings & Films
SC Materials Science
GA 736XA
UT WOS:000186197400002
DA 2018-10-20
ER

PT J
AU Pankhurst, QA
   Connolly, J
   Jones, SK
   Dobson, J
AF Pankhurst, QA
   Connolly, J
   Jones, SK
   Dobson, J
TI Applications of magnetic nanoparticles in biomedicine
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Review
ID SUPERPARAMAGNETIC IRON-OXIDE; DRUG TARGETING TOLERANCE; FLUID
   HYPERTHERMIA MFH; ADVANCED SOLID TUMORS; IN-VIVO; CANCER-TREATMENT;
   CONTRAST AGENTS; LIVER-TUMORS; INTRACELLULAR HYPERTHERMIA;
   IMMUNOMAGNETIC SEPARATION
AB The physical principles underlying some current biomedical applications of magnetic nanoparticles are reviewed. Starting from well-known basic concepts, and drawing on examples from biology and biomedicine, the relevant physics of magnetic materials and their responses to applied magnetic fields are surveyed. The way these properties are controlled and used is illustrated with reference to (i) magnetic separation of labelled cells and other biological entities; (ii) therapeutic drug, gene and radionuclide delivery; (iii) radio frequency methods for the catabolism of tumours via hyperthermia; and (iv) contrast enhancement agents for magnetic resonance imaging applications. Future prospects are also discussed.
C1 UCL, Dept Phys & Astron, London WC1E 6BT, England.
   UCL, London Ctr Nanotechnol, London WC1E 6BT, England.
   Curtin Univ Technol, Dept Appl Phys, Perth, WA 6845, Australia.
   SIRTeX Med Ltd, N Ryde, NSW 2113, Australia.
   Keele Univ, Ctr Sci & Technol Med, Dept Biomed Engn & Med Phys, Stoke On Trent ST4 7QB, Staffs, England.
RP Pankhurst, QA (reprint author), UCL, Dept Phys & Astron, Gower St, London WC1E 6BT, England.
EM q.pankhurst@ucl.ac.uk
RI Dobson, Jon/C-8323-2009
OI Dobson, Jon/0000-0002-8108-5362; Cruise, Tom/0000-0003-3104-2281
CR Alexiou C, 2000, CANCER RES, V60, P6641
   Arias JL, 2001, J CONTROL RELEASE, V77, P309, DOI 10.1016/S0168-3659(01)00519-3
   ATKINSON WJ, 1984, IEEE T BIO-MED ENG, V31, P70, DOI 10.1109/TBME.1984.325372
   Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5
   Bausch AR, 1998, BIOPHYS J, V75, P2038, DOI 10.1016/S0006-3495(98)77646-5
   BORRELLI NF, 1984, PHYS MED BIOL, V29, P487, DOI 10.1088/0031-9155/29/5/001
   BROWN WF, 1963, PHYS REV, V130, P1677, DOI 10.1103/PhysRev.130.1677
   BROWNE M, 1999, MRI BASIC PRINCIPLES
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   Bulte JWM, 1999, J MAGN RESON IMAGING, V9, P329, DOI 10.1002/(SICI)1522-2586(199902)9:2<329::AID-JMRI27>3.0.CO;2-Z
   Carpenter EE, 2001, J MAGN MAGN MATER, V225, P17, DOI 10.1016/S0304-8853(00)01222-1
   CARTMELL SH, 2003, IN PRESS IEEE T NANO
   CARTMELL SH, 2002, EUR CELLS MAT, V4, P42
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Connolly J, 2002, EUR CELLS MATER, V3, P106
   Craciun V, 2002, CZECH J PHYS, V52, P725, DOI 10.1023/A:1015590930284
   CUMINGS LJ, 2000, P MATH MED STUD GROU, P69
   Dailey JP, 1999, J MAGN MAGN MATER, V194, P140, DOI 10.1016/S0304-8853(98)00562-9
   Debye P., 1929, POLAR MOL
   DELGRATTA CD, 1995, PHYS MED BIOL, V40, P671, DOI 10.1088/0031-9155/40/4/012
   Deng Y, 2003, J MAGN MAGN MATER, V257, P69, DOI 10.1016/S0304-8853(02)00987-3
   Dobson J., 2001, MODERN PROBLEMS CELL, P121
   DOBSON J, 2002, EUR CELLS MAT S2, V4, P130
   DOSSET V, 1999, MAGN RESON MATER PHY, V8, P185
   Edelstein RL, 2000, BIOSENS BIOELECTRON, V14, P805, DOI 10.1016/S0956-5663(99)00054-8
   Elster AD, 2001, QUESTIONS ANSWERS MA
   Enochs WS, 1999, JMRI-J MAGN RESON IM, V9, P228, DOI 10.1002/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.3.CO;2-B
   Fabry B, 1999, J MAGN MAGN MATER, V194, P120, DOI 10.1016/S0304-8853(98)00564-2
   FABRY R, 2001, PHYS REV LETT, V87
   FANNIN PC, 1993, J MAGN MAGN MATER, V122, P159, DOI 10.1016/0304-8853(93)91063-D
   FANNIN PC, 1991, J PHYS D APPL PHYS, V24, P76, DOI 10.1088/0022-3727/24/1/013
   Gallo JM, 1997, CANCER RES, V57, P3063
   GERBER R, 1994, NATO ADV SCI INST SE, V253, P165
   GILCHRIST RK, 1957, ANN SURG, V146, P596, DOI 10.1097/00000658-195710000-00007
   Gomez-Lopera SA, 2001, J COLLOID INTERF SCI, V240, P40, DOI 10.1006/jcis.2001.7579
   Goodwin S, 1999, J MAGN MAGN MATER, V194, P132, DOI 10.1016/S0304-8853(98)00584-8
   Goodwin SC, 2001, TOXICOL SCI, V60, P177, DOI 10.1093/toxsci/60.1.177
   GORDON RT, 1979, MED HYPOTHESES, V5, P83, DOI 10.1016/0306-9877(79)90063-X
   Granov AM, 2002, THEOR FOUND CHEM ENG, V36, P63, DOI 10.1023/A:1013901625389
   Grasset F, 2001, J MAGN MAGN MATER, V234, P409, DOI 10.1016/S0304-8853(01)00386-9
   Gruttner C, 1999, J MAGN MAGN MATER, V194, P8, DOI 10.1016/S0304-8853(98)00561-7
   Hafeli U, 2001, J MAGN MAGN MATER, V225, P73, DOI 10.1016/S0304-8853(00)01230-0
   HAFELI UO, 1995, NUCL MED BIOL, V22, P147, DOI 10.1016/0969-8051(94)00124-3
   Hafeli UO, 1999, J MAGN MAGN MATER, V194, P76, DOI 10.1016/S0304-8853(98)00560-5
   Hafeli UO, 1999, INT J RADIAT ONCOL, V44, P189, DOI 10.1016/S0360-3016(98)00554-9
   HAFELI UO, 1996, INT C SCI CLIN APPL
   HANCOCK JP, 1993, J IMMUNOL METHODS, V164, P51, DOI 10.1016/0022-1759(93)90275-C
   Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1
   HANSON M, 1991, J MAGN MAGN MATER, V96, P105, DOI 10.1016/0304-8853(91)90617-J
   HASE M, 1990, Nippon Acta Radiologica, V50, P1402
   Hatch GP, 2001, J MAGN MAGN MATER, V225, P262, DOI 10.1016/S0304-8853(00)01250-6
   Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537
   Hilger I, 2002, ACAD RADIOL, V9, P198, DOI 10.1016/S1076-6332(03)80171-X
   Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499
   Hofmann WK, 2002, BLOOD, V100, P3553, DOI 10.1182/blood.V100.10.3553
   Hogemann D, 2000, BIOCONJUGATE CHEM, V11, P941, DOI 10.1021/bc000079x
   Hughes C, 2001, MOL THER, V3, P623, DOI 10.1006/mthe.2001.0268
   Jiles D., 1991, INTRO MAGNETISM MAGN
   JONES SK, 1992, PHYS MED BIOL, V37, P293, DOI 10.1088/0031-9155/37/1/023
   Jones SK, 2002, INT J HYPERTHER, V18, P117, DOI 10.1080/02656730110103519
   Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559
   JORDAN A, 1993, INT J HYPERTHER, V9, P51, DOI 10.3109/02656739309061478
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   Kala M, 1997, ANAL BIOCHEM, V254, P263, DOI 10.1006/abio.1997.2378
   Kirpotin D., 1995, United States Patent, Patent No. 5411730
   Koneracka M, 2002, J MOL CATAL B-ENZYM, V18, P13, DOI 10.1016/S1381-1177(02)00016-4
   Koneracka M, 1999, J MAGN MAGN MATER, V201, P427, DOI 10.1016/S0304-8853(99)00005-0
   Kubo T, 2000, INT J ONCOL, V17, P309
   Kubo T, 2001, INT J ONCOL, V18, P121
   Kularatne BY, 2002, CYTOMETRY, V50, P160, DOI 10.1002/cyto.10071
   Lawaczeck R, 1997, ACTA RADIOL, V38, P584, DOI 10.1080/02841859709174391
   LEACH MO, 1988, PHYSICS MED IMAGING, P389
   Levy L, 2002, CHEM MATER, V14, P3715, DOI 10.1021/cm0203013
   Liberti PA, 2001, J MAGN MAGN MATER, V225, P301, DOI 10.1016/S0304-8853(00)01254-3
   Livingston J. D., 1996, DRIVING FORCE NATURA
   Lubbe AS, 1996, CANCER RES, V56, P4694
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Lubbe AS, 1999, J MAGN MAGN MATER, V194, P149, DOI 10.1016/S0304-8853(98)00574-5
   LUBBE AS, 1996, INT C SCI CLIN APPL
   Maehara T, 2002, JPN J APPL PHYS 1, V41, P1620, DOI 10.1143/JJAP.41.1620
   Mah C, 2002, MOL THER, V6, P106, DOI 10.1006/mthe.2001.0636
   Mah C., 2000, MOL THERAPY, V1, pS239, DOI [10.1006/mthe.2000.0174., DOI 10.1006/MTHE.2000.0174]
   MATSUKI H, 1994, MAT SCI ENG A-STRUCT, V181, P1366, DOI 10.1016/0921-5093(94)90865-6
   Mehta RV, 1997, BIOTECHNOL TECH, V11, P493, DOI 10.1023/A:1018457915380
   Michel SCA, 2002, RADIOLOGY, V225, P527, DOI 10.1148/radiol.2252011605
   Minamimura T, 2000, INT J ONCOL, V16, P1153
   MITSUMORI M, 1994, INT J HYPERTHER, V10, P785, DOI 10.3109/02656739409012371
   Mitsumori M, 1996, HEPATO-GASTROENTEROL, V43, P1431
   MOLDAY RS, 1982, J IMMUNOL METHODS, V52, P353, DOI 10.1016/0022-1759(82)90007-2
   Moore LR, 2001, J MAGN MAGN MATER, V225, P277, DOI 10.1016/S0304-8853(00)01251-8
   Morisada S, 2002, J MICROBIOL METH, V51, P141, DOI 10.1016/S0167-7012(02)00046-5
   Mornet Sp, 2002, EUR CELLS MATER, V3, P110
   Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785
   Moroz P, 2001, J SURG ONCOL, V77, P259, DOI 10.1002/jso.1106
   Moroz P, 2001, J SURG ONCOL, V78, P22, DOI 10.1002/jso.1118
   MORRISH AH, 2001, PHYSICAL PRINCIPLES
   MOSBACH K, 1979, FEBS LETT, V102, P112, DOI 10.1016/0014-5793(79)80940-0
   MOSSO JA, 1972, ANN SURG, P663
   Mura CV, 2002, J IMMUNOL METHODS, V260, P263, DOI 10.1016/S0022-1759(01)00546-4
   Mykhaylyk O, 2001, J MAGN MAGN MATER, V225, P241, DOI 10.1016/S0304-8853(00)01264-6
   Neel L., 1949, ANN GEOPHYS, V5, P99
   OLESON JR, 1983, RADIAT RES, V95, P175, DOI 10.2307/3576083
   OLESON JR, 1983, INT J RADIAT ONCOL, V9, P549, DOI 10.1016/0360-3016(83)90074-3
   OWEN CS, 1983, CELL SEPARATION METH
   Pardoe H, 2001, J MAGN MAGN MATER, V225, P41, DOI 10.1016/S0304-8853(00)01226-9
   PAUL F, 1981, IEEE T MAGN, V17, P2822, DOI 10.1109/TMAG.1981.1061711
   Perez JM, 2002, J AM CHEM SOC, V124, P2856, DOI 10.1021/ja017773n
   Perez JM, 2002, NAT BIOTECHNOL, V20, P816, DOI 10.1038/nbt720
   Pulfer SK, 1999, J NEURO-ONCOL, V41, P99, DOI 10.1023/A:1006137523591
   Pulfer SK, 1998, J DRUG TARGET, V6, P215, DOI 10.3109/10611869808997896
   RABIN Y, 2001, INT J HYPERTHERMIA
   RAND R W, 1976, Bulletin of the Los Angeles Neurological Societies, V41, P154
   Rand RW, 1981, APPL BIOCHEM BIOTECH, V6, P265, DOI 10.1007/BF02798277
   REILLY JP, 1992, ANN NY ACAD SCI, V649, P96, DOI 10.1111/j.1749-6632.1992.tb49600.x
   Rheinlander T, 2000, J MAGN MAGN MATER, V219, P219, DOI 10.1016/S0304-8853(00)00439-X
   RHEINLANDER T, 1999, FRONTIERS MAGNETISM
   ROSNSWEIG RE, 2002, J MAGN MAGN MATER, V252, P370
   Rudge SR, 2000, BIOMATERIALS, V21, P1411, DOI 10.1016/S0142-9612(00)00006-5
   Ruehm SG, 2001, CIRCULATION, V103, P415
   Rutnakornpituk M, 2002, EUR CELLS MATER, V3, P102
   Sangregorio C, 1999, J APPL PHYS, V85, P5699, DOI 10.1063/1.370256
   Santra S, 2001, LANGMUIR, V17, P2900, DOI 10.1021/la0008636
   Seesod N, 1997, AM J TROP MED HYG, V56, P322, DOI 10.4269/ajtmh.1997.56.322
   Semelka RC, 2001, RADIOLOGY, V218, P27, DOI 10.1148/radiology.218.1.r01ja2427
   SENYEI A, 1978, J APPL PHYS, V49, P3578, DOI 10.1063/1.325219
   Shinkai M, 1999, J MAGN MAGN MATER, V194, P176, DOI 10.1016/S0304-8853(98)00586-1
   Stevenson JP, 2001, J MAGN MAGN MATER, V225, P47, DOI 10.1016/S0304-8853(00)01227-0
   Sun XC, 2000, MAT SCI ENG A-STRUCT, V286, P157, DOI 10.1016/S0921-5093(00)00628-6
   SUZUKI M, 1995, BIOTECHNOL APPL BIOC, V21, P335
   SUZUKI S, 1990, Journal of Japan Society for Cancer Therapy, V25, P2649
   Tibbe AGJ, 1999, NAT BIOTECHNOL, V17, P1210
   Todd P, 2001, J MAGN MAGN MATER, V225, P294, DOI 10.1016/S0304-8853(00)01253-1
   Ugelstad J., 1998, MAGNETISM MED, P471
   van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280
   Voltairas PA, 2002, J BIOMECH, V35, P813, DOI 10.1016/S0021-9290(02)00034-9
   Wacker FK, 2003, RADIOLOGY, V226, P459, DOI 10.1148/radio.2262011815
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219
   Widder K.J., 1978, P SOC EXP BIOL MED, V58, P141
   WIDDER KJ, 1983, EUR J CANCER CLIN ON, V19, P135, DOI 10.1016/0277-5379(83)90408-X
   Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5
   Yazdankhah SP, 1998, VET MICROBIOL, V62, P17
   Zborowski M, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P205
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
   Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241
   Zigeuner RE, 2003, J UROLOGY, V169, P701, DOI 10.1097/01.ju.0000038953.11811.82
NR 148
TC 3730
Z9 3784
U1 84
U2 1748
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD JUL 7
PY 2003
VL 36
IS 13
BP R167
EP R181
AR PII S0022-3727(03)40035-1
DI 10.1088/0022-3727/36/13/201
PG 15
WC Physics, Applied
SC Physics
GA 722DV
UT WOS:000185360900004
DA 2018-10-20
ER

PT J
AU Tartaj, P
   Morales, MD
   Veintemillas-Verdaguer, S
   Gonzalez-Carreno, T
   Serna, CJ
AF Tartaj, P
   Morales, MD
   Veintemillas-Verdaguer, S
   Gonzalez-Carreno, T
   Serna, CJ
TI The preparation of magnetic nanoparticles for applications in
   biomedicine
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Review
ID IRON-OXIDE NANOPARTICLES; INORGANIC COLLOIDAL PARTICLES; UNIFORM
   GAMMA-FE2O3 PARTICLES; FIELD-FLOW FRACTIONATION; HOLLOW SPHERES;
   SUPERPARAMAGNETIC NANOPARTICLES; FLUID HYPERTHERMIA; SILICA PARTICLES;
   SPRAY-PYROLYSIS; CONTRAST AGENTS
AB This review is focused on describing state-of-the-art synthetic routes for the preparation of magnetic nanoparticles useful for biomedical applications. In addition to this topic, we have also described in some detail some of the possible applications of magnetic nanoparticles in the field of biomedicine with special emphasis on showing the benefits of using nanoparticles. Finally, we have addressed some relevant findings on the importance of having well-defined synthetic routes to produce materials not only with similar physical features but also with similar crystallochemical characteristics.
C1 CSIC, Inst Ciencia Mat Madrid, E-28049 Madrid, Spain.
RP Tartaj, P (reprint author), CSIC, Inst Ciencia Mat Madrid, Plaza Murillo 2, E-28049 Madrid, Spain.
RI Tartaj, Pedro/B-8983-2008; Veintemillas, Sabino/A-7276-2012; Serna,
   Carlos/A-4552-2011; Morales Herrero, Maria del Puerto/A-4558-2011
OI Tartaj, Pedro/0000-0001-7323-1545; Veintemillas,
   Sabino/0000-0002-3015-1470; Morales Herrero, Maria del
   Puerto/0000-0002-7290-7029
CR AIKEN B, 1988, J COLLOID INTERF SCI, V126, P645, DOI 10.1016/0021-9797(88)90168-3
   AIKEN B, 1990, J MATER SCI, V25, P1886, DOI 10.1007/BF01045401
   Andra W, 1999, J MAGN MAGN MATER, V194, P197, DOI 10.1016/S0304-8853(98)00552-6
   AYANT Y, 1975, J PHYS-PARIS, V36, P991, DOI 10.1051/jphys:019750036010099100
   Bangs LB, 1996, PURE APPL CHEM, V68, P1873, DOI 10.1351/pac199668101873
   Batlle X, 2002, J PHYS D APPL PHYS, V35, pR15, DOI 10.1088/0022-3727/35/6/201
   Bean C, 1959, J APPL PHYS, V30, P1205
   Bergemann C, 1999, J MAGN MAGN MATER, V194, P45, DOI 10.1016/S0304-8853(98)00554-X
   BERGEMANN C, 1996, Patent No. 19624426
   Berkovsky B. M., 1993, MAGNETIC FLUIDS ENG
   Bohren C., 1983, ABSORPTION SCATTERIN
   Bourgeat-Lami E, 1998, J COLLOID INTERF SCI, V197, P293, DOI 10.1006/jcis.1997.5265
   BOUTONNET M, 1982, COLLOID SURFACE, V5, P209, DOI 10.1016/0166-6622(82)80079-6
   Bulte JWM, 1999, J MAGN MAGN MATER, V194, P204, DOI 10.1016/S0304-8853(98)00556-3
   Butter K, 2003, NAT MATER, V2, P88, DOI 10.1038/nmat811
   CANNON WR, 1982, J AM CERAM SOC, V65, P324, DOI 10.1111/j.1151-2916.1982.tb10464.x
   Cao X, 1997, J MATER RES, V12, P402, DOI 10.1557/JMR.1997.0058
   Carpenter EE, 2001, J MAGN MAGN MATER, V225, P17, DOI 10.1016/S0304-8853(00)01222-1
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   Caruso F, 1999, ADV MATER, V11, P950
   Caruso F, 2001, CHEM MATER, V13, P109, DOI 10.1021/cm001164h
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   CAUCHETIER M, 1994, J AM CERAM SOC, V77, P93
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Charles SW, 1986, HDB MAGNETIC MAT, V2, P153
   Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118
   COEY JMD, 1971, PHYS REV LETT, V27, P1140, DOI 10.1103/PhysRevLett.27.1140
   Cornell R. M., 1996, IRON OXIDES STRUCTUR
   Coroiu I, 1999, J MAGN MAGN MATER, V201, P449, DOI 10.1016/S0304-8853(99)00025-6
   Dailey JP, 1999, J MAGN MAGN MATER, V194, P140, DOI 10.1016/S0304-8853(98)00562-9
   delMonte F, 1997, LANGMUIR, V13, P3627, DOI 10.1021/la9700228
   Denizot B, 1999, J COLLOID INTERF SCI, V209, P66, DOI 10.1006/jcis.1998.5850
   DENOUDEN CJJ, 1991, J COLLOID INTERF SCI, V143, P77, DOI 10.1016/0021-9797(91)90438-E
   Donath E., 1998, ANGEW CHEM INT EDIT, V37, P2201
   Dormann JL, 1997, ADV CHEM PHYS, V98, P283, DOI 10.1002/9780470141571.ch4
   Dresco PA, 1999, LANGMUIR, V15, P1945, DOI 10.1021/la980971g
   El-Sayed MA, 2001, ACCOUNTS CHEM RES, V34, P257, DOI 10.1021/ar960016n
   ELHILO M, 1992, J MAGN MAGN MATER, V114, P295, DOI 10.1016/0304-8853(92)90272-P
   Ennas G, 1998, CHEM MATER, V10, P495, DOI 10.1021/cm970400u
   Feltin N, 1997, LANGMUIR, V13, P3927, DOI 10.1021/la960854q
   Fendler J. H., 1998, NANOPARTICLES NANOST
   FIEVET F, 1989, SOLID STATE IONICS, V32-3, P198, DOI 10.1016/0167-2738(89)90222-1
   Fiorani D, 2002, PHYSICA B, V320, P122, DOI 10.1016/S0921-4526(02)00659-2
   FREED JH, 1978, J CHEM PHYS, V68, P4034, DOI 10.1063/1.436302
   Freeman M. W., 1960, J APPL PHYS, V31, P404
   Frenkel J, 1930, NATURE, V126, P274, DOI 10.1038/126274a0
   Garcell L, 1998, J COLLOID INTERF SCI, V205, P470, DOI 10.1006/jcis.1998.5654
   GARG A, 1988, LANGMUIR, V4, P38, DOI 10.1021/la00079a006
   GIDDINGS JC, 1993, SCIENCE, V260, P1456, DOI 10.1126/science.8502990
   GILCHRIST RK, 1957, ANN SURG, V146, P596, DOI 10.1097/00000658-195710000-00007
   GONZALEZCARRENO T, 1993, MATER LETT, V18, P151, DOI 10.1016/0167-577X(93)90116-F
   GONZALEZCARRENO T, 1991, MATER CHEM PHYS, V27, P287
   Goodwin S, 1999, J MAGN MAGN MATER, V194, P132, DOI 10.1016/S0304-8853(98)00584-8
   Grainger DW, 2003, ADV DRUG DELIVER REV, V55, P311, DOI 10.1016/S0169-409X(02)00222-3
   GUPTA PK, 1988, INT J PHARM, V43, P167, DOI 10.1016/0378-5173(88)90072-5
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   HAHN H, 1990, J MATER RES, V5, P609, DOI 10.1557/JMR.1990.0609
   HANEDA K, 1977, SOLID STATE COMMUN, V22, P779, DOI 10.1016/0038-1098(77)90067-9
   HASSAN EE, 1992, PHARMACEUT RES, V9, P390, DOI 10.1023/A:1015803321609
   HEATH JR, 1995, SCIENCE, V270, P1315, DOI 10.1126/science.270.5240.1315
   Held GA, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.012408
   Hiergeist R, 1999, J MAGN MAGN MATER, V201, P420, DOI 10.1016/S0304-8853(99)00145-6
   Hilbert I., 1997, INVEST RADIOL, V32, P705
   Hilger I, 2000, INVEST RADIOL, V35, P170, DOI 10.1097/00004424-200003000-00003
   Hilger I, 2002, ACAD RADIOL, V9, P198, DOI 10.1016/S1076-6332(03)80171-X
   Hogemann D, 2002, BIOCONJUGATE CHEM, V13, P116, DOI 10.1021/bc015549h
   Hogemann D, 2000, BIOCONJUGATE CHEM, V11, P941, DOI 10.1021/bc000079x
   Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200
   Hyeon T, 2001, J AM CHEM SOC, V123, P12798, DOI 10.1021/ja016812s
   Iglesias O., 2001, PHYS REV B, V63
   Jolivet J. P., 2000, METAL OXIDE CHEM SYN
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   Josephson L, 2001, ANGEW CHEM INT EDIT, V40, P3204, DOI 10.1002/1521-3773(20010903)40:17<3204::AID-ANIE3204>3.0.CO;2-H
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Josephson L., 1993, US Pat., Patent No. [5,262,176, 5262176]
   Joubert JC, 1997, AN QUIM-INT, V93, pS70
   Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5
   Kotitz R, 1999, J MAGN MAGN MATER, V194, P62, DOI 10.1016/S0304-8853(98)00580-0
   Kung H, 1999, MRS BULL, V24, P14
   Kuznetsov AA, 2001, J MAGN MAGN MATER, V225, P95, DOI 10.1016/S0304-8853(00)01235-X
   LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Lee J, 1996, J COLLOID INTERF SCI, V177, P490, DOI 10.1006/jcis.1996.0062
   Lefebure S, 1998, J MATER RES, V13, P2975, DOI 10.1557/JMR.1998.0407
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Lisiecki I, 1993, J AM CHEM SOC, V7, P115
   LOPEZQUINTELA MA, 1993, J COLLOID INTERF SCI, V158, P446, DOI 10.1006/jcis.1993.1277
   Lu YF, 1999, NATURE, V398, P223, DOI 10.1038/18410
   MASSART R, 1987, J CHIM PHYS PCB, V84, P967, DOI 10.1051/jcp/1987840967
   MATIJEVIC E, 1994, LANGMUIR, V10, P8, DOI 10.1021/la00013a003
   MATIJEVIC E, 1993, CHEM MATER, V5, P412, DOI 10.1021/cm00028a004
   Matijevic E., 1989, MRS BULL, V14, P18
   MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086
   MERBACH AE, 2001, CHEM CONTRAST AGENTS
   MESSING GL, 1993, J AM CERAM SOC, V76, P2707, DOI 10.1111/j.1151-2916.1993.tb04007.x
   MOLDAY RS, 1982, J IMMUNOL METHODS, V52, P353, DOI 10.1016/0022-1759(82)90007-2
   MORALES MP, 1994, J SOLID STATE CHEM, V108, P158, DOI 10.1006/jssc.1994.1024
   MORALES MP, 1992, J MATER RES, V7, P2538, DOI 10.1557/JMR.1992.2538
   Morales MP, 1999, CHEM MATER, V11, P3058, DOI 10.1021/cm991018f
   Morales MP, 1997, J PHYS-CONDENS MAT, V9, P5461, DOI 10.1088/0953-8984/9/25/013
   MORALES MP, 2003, IN PRESS J MAGN MAGN
   MORUP S, 1995, PHYS REV B, V52, P287, DOI 10.1103/PhysRevB.52.287
   MULLERSCHULTE D, 1995, J CHROMATOGR A, V711, P53, DOI 10.1016/0021-9673(95)00114-3
   Mulvaney P, 2000, J MATER CHEM, V10, P1259, DOI 10.1039/b000136h
   MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335
   NEEL L, 1949, CR HEBD ACAD SCI, V228, P664
   Neel L., 1949, ANN GEOPHYS, V5, P99
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Niihara K., 1991, J CERAM SOC JPN, V99, P974, DOI DOI 10.2109/JCERSJ.99.974
   NUNES AC, 1987, J MAGN MAGN MATER, V65, P265, DOI 10.1016/0304-8853(87)90047-3
   OCANA M, 1995, ADV MATER, V7, P212, DOI 10.1002/adma.19950070225
   OCANA M, 1991, LANGMUIR, V7, P2911, DOI 10.1021/la00060a008
   OGRADY K, 1986, IEEE T MAGN, V22, P1134, DOI 10.1109/TMAG.1986.1064450
   Pascal C, 1999, CHEM MATER, V11, P141, DOI 10.1021/cm980742f
   PECHARROMAN C, 1995, PHYS CHEM MINER, V22, P21, DOI 10.1007/BF00202677
   PHILIPSE AP, 1994, LANGMUIR, V10, P92, DOI 10.1021/la00013a014
   PILENI MP, 1993, J PHYS CHEM-US, V97, P6961, DOI 10.1021/j100129a008
   Pileni MP, 2003, NAT MATER, V2, P145, DOI 10.1038/nmat817
   Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500
   Rheinlander T, 2000, J MAGN MAGN MATER, V219, P219, DOI 10.1016/S0304-8853(00)00439-X
   Rheinlander T, 2000, J MAGN MAGN MATER, V214, P269, DOI 10.1016/S0304-8853(00)00198-0
   Roberts TPL, 2000, EUR J RADIOL, V34, P166, DOI 10.1016/S0720-048X(00)00197-2
   Rockenberger J, 1999, J AM CHEM SOC, V121, P11595, DOI 10.1021/ja993280v
   Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0
   Rye PD, 1996, BIO-TECHNOL, V14, P155, DOI 10.1038/nbt0296-155
   Safarikova M, 1999, J MAGN MAGN MATER, V194, P108, DOI 10.1016/S0304-8853(98)00566-6
   SANTRA S, 2001, LANGMUIR, V17, P6000
   Serna CJ, 2001, SOLID STATE COMMUN, V118, P437, DOI 10.1016/S0038-1098(01)00150-8
   SERNA CJ, 2003, SURFACE COLLOID SCI, pCH2
   Shafi KVPM, 2002, CHEM MATER, V14, P1778, DOI 10.1021/cm011535
   Shafi KVPM, 2001, LANGMUIR, V17, P5093, DOI 10.1021/la010421+
   Shen S., 2002, J AM CHEM SOC, V124, P8204
   Shiho H, 2000, J MATER CHEM, V10, P333, DOI 10.1039/a906180k
   SHIHO H, 2000, J COLLOID INTERF SCI, V241, P366
   Sjogren CE, 1997, MAGN RESON IMAGING, V15, P55, DOI 10.1016/S0730-725X(96)00335-9
   Strable E, 2001, CHEM MATER, V13, P2201, DOI 10.1021/cm010125i
   SUGIMOTO T, 1980, J COLLOID INTERF SCI, V74, P227, DOI 10.1016/0021-9797(80)90187-3
   Sugimoto T., 2000, FINE PARTICLES SYNTH
   Suit H, 2002, INT J RADIAT ONCOL, V53, P798, DOI 10.1016/S0360-3016(02)02851-1
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   Tartaj J, 2002, ADV ENG MATER, V4, P17, DOI 10.1002/1527-2648(20020212)4:1/2<17::AID-ADEM17>3.0.CO;2-R
   Tartaj P, 2000, J MATER CHEM, V10, P2786, DOI 10.1039/b002720k
   Tartaj P, 2002, LANGMUIR, V18, P4556, DOI 10.1021/la025566a
   Tartaj P, 2003, J PHYS CHEM B, V107, P20, DOI 10.1021/jp0260898
   Tartaj P, 2002, CHEM MATER, V14, P4396, DOI 10.1021/cm021214d
   Tartaj P, 2002, ACTA MATER, V50, P5, DOI 10.1016/S1359-6454(01)00336-6
   Tartaj P, 2002, CHEM MATER, V14, P536, DOI [10.1021/cm011085l, 10.1021/cm0110851]
   Tartaj P, 2001, ADV MATER, V13, P1620, DOI 10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Varanda LC, 2002, J APPL PHYS, V92, P2079, DOI 10.1063/1.1496124
   Veintemillas-Verdaguer S, 1998, MATER LETT, V35, P227, DOI 10.1016/S0167-577X(97)00251-6
   Veintemillas-Verdaguer S., 2001, APPL ORGANOMET CHEM, V15, P1
   Viau G, 1996, SOLID STATE IONICS, V84, P259, DOI 10.1016/0167-2738(96)00005-7
   Viau G, 1996, J MATER CHEM, V6, P1047, DOI 10.1039/jm9960601047
   VIAU G, 1994, J APPL PHYS, V76, P6570, DOI 10.1063/1.358473
   Weitschies W., 1997, Pharmaceutical and Pharmacological Letters, V7, P5
   WHITESIDES G, 1999, NANOTECHNOLOGY RES D
   Williams SKR, 1999, J MAGN MAGN MATER, V194, P248, DOI 10.1016/S0304-8853(98)00551-4
   Wong KKW, 1998, CHEM MATER, V10, P279, DOI 10.1021/cm970421o
   Wormuth K, 2001, J COLLOID INTERF SCI, V241, P366, DOI 10.1006/jcis.2001.7762
   Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5
   Xia B, 2001, ADV MATER, V13, P1579, DOI 10.1002/1521-4095(200110)13:20<1579::AID-ADMA1579>3.0.CO;2-G
   Younan XBG, 2000, ADV MATER, V12, P693
   Zaitsev VS, 1999, J COLLOID INTERF SCI, V212, P49, DOI 10.1006/jcis.1998.5993
   Zarur AJ, 2000, NATURE, V403, P65, DOI 10.1038/47450
   Zhang JZ, 1997, ACCOUNTS CHEM RES, V30, P423, DOI 10.1021/ar960178j
   Zhang K, 1999, LANGMUIR, V15, P3056, DOI 10.1021/la9811158
   ZHOU YC, 1993, J MATER RES, V8, P1680, DOI 10.1557/JMR.1993.1680
   ZIOLO RF, 1992, SCIENCE, V257, P219, DOI 10.1126/science.257.5067.219
NR 171
TC 1300
Z9 1313
U1 28
U2 569
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD JUL 7
PY 2003
VL 36
IS 13
BP R182
EP R197
AR PII S0022-3727(03)37541-2
DI 10.1088/0022-3727/36/13/202
PG 16
WC Physics, Applied
SC Physics
GA 722DV
UT WOS:000185360900005
DA 2018-10-20
ER

PT J
AU Retzko, I
   Unger, WES
AF Retzko, I
   Unger, WES
TI Analysis of carbon materials by X-ray photoelectron spectroscopy and
   X-ray absorption spectroscopy
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID FILMS
AB Since hard coating such as ta:C films are of growing interest for protecting surfaces of industrial machines and high capacity tools against wear and friction or for biomedical applications, more information about the structure-to-property relation is required. Therefore, core level X-ray photoelectron spectroscopy and spectromicroscopy are used to derive chemical information about selected carbon species.
C1 Fed Inst Mat Res & Testing, BAM, Surface & Thin Film Anal, D-12200 Berlin, Germany.
RP Retzko, I (reprint author), Fed Inst Mat Res & Testing, BAM, Surface & Thin Film Anal, D-12200 Berlin, Germany.
RI Unger, Wolfgang/A-9317-2009
OI Unger, Wolfgang/0000-0002-7670-4042
CR Anders S, 1997, APPL PHYS LETT, V71, P3367, DOI 10.1063/1.120339
   BRIGGS D, 1992, PRACTICAL SURFACE AN, V1
   HITCHCOCK AP, 2000, P 6 INT C XRAY MICR, P231
   Kikuma J, 1998, J ELECTRON SPECTROSC, V88, P919, DOI 10.1016/S0368-2048(97)00220-X
   PROCTOR A, 1982, ANAL CHEM, V54, P13, DOI 10.1021/ac00238a008
   RETZKO I, 2002, P MAT WEEK 2002 WERK
   Riviere J.C, 1998, HDB SURFACE INTERFAC
   Schneider D, 2000, SURF COAT TECH, V126, P136, DOI 10.1016/S0257-8972(99)00672-6
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   Stohr J., 1992, SPRINGER SERIES SURF, V25
   TANUMA S, 1991, SURF INTERFACE ANAL, V17, P911, DOI 10.1002/sia.740171304
NR 11
TC 22
Z9 22
U1 0
U2 11
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD JUL
PY 2003
VL 5
IS 7
BP 519
EP 522
DI 10.1002/adem.200320138
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 710GJ
UT WOS:000184672200010
DA 2018-10-20
ER

PT J
AU Di Martino, ES
   Vorp, DA
AF Di Martino, ES
   Vorp, DA
TI Effect of variation in intraluminal thrombus constitutive properties on
   abdominal aortic aneurysm wall stress
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE wall mechanics; parametric analysis; finite element method
ID RUPTURE; MODELS
AB The abdominal aortic aneurysm (AAA) is a degenerating disease for which the end stage is the rupture of the vessel wall. Accurate prediction of the stresses acting on the aneurysm tissue may be used to determine the actual risk of rupture of a specific aneurysm. To accomplish this, a correct constitutive model for the aneurysmal aortic wall and any intraluminal thrombus (ILT) present within it are needed. Our laboratory has previously reported the mechanical properties of ILT. The aim of this work is to investigate the reliability of using population-mean values of ILT constitutive parameters to estimate AAA wall stress distribution. For this, a three-dimensional asymmetric model of an aneurysm including ILT was generated and a parametric study was conducted varying ILT constitutive properties within a physiological range. Results show that the presence of any ILT reduces and redistributes the stresses in the aortic wall markedly. Maximum variation in the peak wall stresses for all the models analyzed was 5%. Adopting a nonhomogeneous ILT did not alter the stress distribution. On the basis of these results, we infer that population mean parameters for ILT material characteristics can be used to reasonably estimate the wall stresses in patient specific aneurysm models. (C) 2003 Biomedical Engineering Society.
C1 Univ Pittsburgh, Div Vasc Surg, McGowan Inst Regenerat Med, Dept Surg, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.
RP Vorp, DA (reprint author), Univ Pittsburgh, Div Vasc Surg, McGowan Inst Regenerat Med, Dept Surg, Suite 200,100 Technol Dr, Pittsburgh, PA 15213 USA.
RI Vorp, David/G-5430-2014
OI Vorp, David/0000-0002-6467-2151
FU NHLBI NIH HHS [R01HL060670-01A2]
CR Adolph R, 1997, J VASC SURG, V25, P916, DOI 10.1016/S0741-5214(97)70223-4
   Di Martino E, 1998, EUR J VASC ENDOVASC, V15, P290, DOI 10.1016/S1078-5884(98)80031-2
   Di Martino ES, 2001, MED ENG PHYS, V23, P647, DOI 10.1016/S1350-4533(01)00093-5
   Elger DF, 1996, J BIOMECH ENG-T ASME, V118, P326, DOI 10.1115/1.2796014
   HARTER LP, 1982, J ULTRAS MED, V1, P315
   INZOLI F, 1993, EUR J VASCULAR SURG, V7, P667, DOI 10.1016/S0950-821X(05)80714-5
   KATZ DA, 1992, JAMA-J AM MED ASSOC, V268, P2678, DOI 10.1001/jama.268.19.2678
   Mower WR, 1997, J VASC SURG, V26, P602, DOI 10.1016/S0741-5214(97)70058-2
   Newman AB, 2001, ANN INTERN MED, V134, P182, DOI 10.7326/0003-4819-134-3-200102060-00008
   Raghavan ML, 2000, J VASC SURG, V31, P760, DOI 10.1067/mva.2000.103971
   Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8
   Schurink GWH, 2000, J VASC SURG, V31, P501
   SCOTT RA, 1999, BRIT J SURG, V86, P709
   Smith DB, 2000, ANN BIOMED ENG, V28, P598, DOI 10.1114/1.1306342
   STRINGFELLOW MM, 1987, J SURG RES, V42, P425, DOI 10.1016/0022-4804(87)90178-8
   THUBRIKAR MJ, 2001, ASME IMECE P NEW YOR
   Vorp D A, 1996, Cardiovasc Surg, V4, P732, DOI 10.1016/S0967-2109(96)00008-7
   Vorp DA, 1998, J VASC SURG, V27, P632, DOI 10.1016/S0741-5214(98)70227-7
   Wang DHJ, 2002, J VASC SURG, V36, P598, DOI 10.1067/mva.2002.126087
   Wang DHJ, 2001, J BIOMECH ENG-T ASME, V123, P536, DOI 10.1115/1.1411971
   WANG DHJ, 2001, ASME IMECE P NEW YOR
NR 21
TC 97
Z9 97
U1 0
U2 10
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 2003
VL 31
IS 7
BP 804
EP 809
DI 10.1114/1.1581880
PG 6
WC Engineering, Biomedical
SC Engineering
GA 702QL
UT WOS:000184234500006
PM 12971613
DA 2018-10-20
ER

PT J
AU Gyenge, CC
   Bowen, BD
   Reed, RK
   Bert, JL
AF Gyenge, CC
   Bowen, BD
   Reed, RK
   Bert, JL
TI Preliminary model of fluid and solute distribution and transport during
   hemorrhage
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE hemorrhage; mathematical model; glucose release; small solute release;
   blood volume restitution; plasma osmolarity
ID COMPUTER-MODEL; BLOOD-VOLUME; INTERSTITIAL FLUID; MATHEMATICAL-MODEL;
   INSULIN RESISTANCE; HYPERTONIC SALINE; SKELETAL-MUSCLE; CELL SODIUM;
   SHOCK; RESUSCITATION
AB The distribution and transport of fluid, ions, and other solutes (plasma proteins and glucose) are described in a mathematical model of unresuscitated hemorrhage. The model is based on balances of each material in both the circulation and its red blood cells, as well as in a whole-body tissue compartment along with its cells. Exchange between these four compartments occurs by a number of different mechanisms. The hemorrhage model has as its basis a validated model, due to Gyenge et al.,(18) of fluid and solute exchange in the whole body of a standard human. Hypothetical but physiologically based features such as glucose and small ion releases along with cell membrane changes are incorporated into the hemorrhage model to describe the system behavior, particularly during larger hemorrhages. Moderate (10%-30% blood volume loss) and large (>30% blood loss) hemorrhage dynamics are simulated and compared with available data. The model predictions compare well with the available information for both types of hemorrhages and provide a reasonable description of the progression of a large hemorrhage from the compensatory phase through vascular collapse. (C) 2003 Biomedical Engineering Society.
C1 Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC V6T 1Z4, Canada.
   Univ Bergen, Dept Physiol, N-5009 Bergen, Norway.
RP Bert, JL (reprint author), Univ British Columbia, Dept Chem & Biol Engn, 2216 Main Mall, Vancouver, BC V6T 1Z4, Canada.
RI Reed, Rolf/B-9422-2017
OI Reed, Rolf/0000-0002-2633-6595
CR AUKLAND K, 1981, PHYSIOL REV, V61, P556
   BARNEA O, 1993, COMPUT BIOL MED, V23, P443, DOI 10.1016/0010-4825(93)90092-F
   Bert J, 1997, BURNS, V23, P93, DOI 10.1016/S0305-4179(96)00115-5
   Bert JL, 2000, ACTA PHYSIOL SCAND, V170, P201
   BESSEY PQ, 1983, SURGERY, V94, P172
   BLACK PR, 1982, ANN SURG, V196, P420, DOI 10.1097/00000658-198210000-00005
   BORCHELT BD, 1995, J TRAUMA, V39, P187, DOI 10.1097/00005373-199508000-00002
   CANNON PJ, 1970, CIRCULATION, V41, P97, DOI 10.1161/01.CIR.41.1.97
   Carlson DE, 1996, AM J PHYSIOL-REG I, V270, pR1163
   CUNNINGHAM JN, 1971, AM J SURG, V122, P650, DOI 10.1016/0002-9610(71)90293-5
   DAY B, 1980, J TRAUMA, V20, P52, DOI 10.1097/00005373-198020010-00007
   EASTRIDGE BJ, 1994, ARCH SURG-CHICAGO, V129, P245
   FRIEDMAN SG, 1982, J TRAUMA, V22, P86, DOI 10.1097/00005373-198202000-00002
   GANN DS, 1983, SURGERY, V94, P439
   GANN DS, 1981, J TRAUMA, V21, P598, DOI 10.1097/00005373-198108000-00002
   GUYTON AC, 1991, TXB MED PHYSL
   Gyenge CC, 2003, ACTA ANAESTH SCAND, V47, P122, DOI 10.1034/j.1399-6576.2003.00037.x
   Gyenge CC, 1999, AM J PHYSIOL-HEART C, V277, pH1228, DOI 10.1152/ajpheart.1999.277.3.H1228
   Gyenge CC, 1999, AM J PHYSIOL-HEART C, V277, pH1215, DOI 10.1152/ajpheart.1999.277.3.H1215
   Heltne JK, 2002, ACTA ANAESTH SCAND, V46, P51, DOI 10.1034/j.1399-6576.2002.460109.x
   Hultman E, 1967, Scand J Clin Lab Invest Suppl, V94, P1
   ILLNER H, 1980, SURG GYNECOL OBSTET, V150, P17
   ILLNER HP, 1982, AM J SURG, V143, P349, DOI 10.1016/0002-9610(82)90105-2
   Jarhult J, 1975, Acta Physiol Scand Suppl, V423, P1
   LEWIS FR, 1986, J TRAUMA, V26, P804, DOI 10.1097/00005373-198609000-00005
   MARDEL SN, 1995, MED ENG PHYS, V17, P215, DOI 10.1016/1350-4533(95)95712-J
   MENGUY R, 1979, ADV SHOCK RES, V1, P43
   MOHSENIN V, 1983, AM J PHYSIOL, V245, pH143
   NAKAYAMA SI, 1985, J SURG RES, V38, P180, DOI 10.1016/0022-4804(85)90025-3
   PERL W, 1971, MICROVASC RES, V3, P233, DOI 10.1016/0026-2862(71)90051-3
   PIRKLE JC, 1976, J TRAUMA, V16, P937, DOI 10.1097/00005373-197612000-00001
   PL Altman, 1971, RESP CIRCULATION BIO
   SHACKFORD SR, 1988, SURGERY, V104, P553
   Sheffer N, 1997, J TRAUMA, V42, P647, DOI 10.1097/00005373-199704000-00011
   SHIRES GT, 1972, ANN SURG, V176, P288, DOI 10.1097/00000658-197209000-00004
   Simpson SH, 1996, MED ENG PHYS, V18, P339, DOI 10.1016/1350-4533(95)00044-5
   SONDEEN JL, 1990, AM J PHYSIOL, V259, pR119
   TOLLOFSRUD S, 1997, ACTA ANAETHESIOL SCA, V41, P1
   WARE J, 1982, ACTA PHYSIOL SCAND, V116, P31, DOI 10.1111/j.1748-1716.1982.tb10595.x
NR 39
TC 9
Z9 9
U1 0
U2 0
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 2003
VL 31
IS 7
BP 823
EP 839
DI 10.1114/1.1581878
PG 17
WC Engineering, Biomedical
SC Engineering
GA 702QL
UT WOS:000184234500008
PM 12971615
DA 2018-10-20
ER

PT J
AU Geddes, LA
   Roeder, R
AF Geddes, LA
   Roeder, R
TI Criteria for the selection of materials for implanted electrodes
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE implanted electrodes; microelectrodes; stimulating electrodes; electrode
   arrays; electrodes
ID ELECTRICAL-STIMULATION; PACEMAKER ELECTRODES; TISSUE REACTION; BRAIN;
   INTERFACE; IMPEDANCE; METALS; ARRAY
AB There are four criteria that must be considered when choosing material for an implanted electrode: (1) tissue response, (2) allergic response, (3) electrode-tissue impedance, and (4) radiographic visibility. This paper discusses these four criteria and identifies the materials that are the best candidates for such electrodes. For electrodes that make ohmic contact with tissues: gold, platinum, platinum-iridium, tungsten, and tantalum are good candidates. The preferred insulating materials are polyimide and glass. The characteristics of stimulator output circuits and the importance of the bidirectional waveform in relation to electrode decomposition are discussed. The paper concludes with an analysis, the design criteria, and the special properties and materials for capacitive recording and stimulating electrodes. (C) 2003 Biomedical Engineering Society.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Geddes, LA (reprint author), Purdue Univ, Dept Biomed Engn, 500 Cent Dr, W Lafayette, IN 47907 USA.
CR AGNEW W, 1990, NEURAL PROSTHESES
   ARONSON S, 1987, IEEE T BIOMED ENG, V32, P85
   BABB TL, 1984, EXP NEUROL, V86, P171, DOI 10.1016/0014-4886(84)90179-1
   BARRANCO VP, 1972, J AMER MED ASSOC, V220, P1244, DOI 10.1001/jama.1972.03200090066016
   BATROW J, 1963, Patent No. 3077884
   BRUMMER SB, 1983, ANN NY ACAD SCI, V405, P159, DOI 10.1111/j.1749-6632.1983.tb31628.x
   BRUMMER SB, 1977, IEEE T BIO-MED ENG, V24, P59, DOI 10.1109/TBME.1977.326218
   CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588
   COLLIAS JC, 1957, J NEUROSURG, V14, P302, DOI 10.3171/jns.1957.14.3.0302
   DODGE HW, 1955, P STAFF M MAYO CLIN, V30, P215
   DYMOND AM, 1970, J NEUROSURG, V33, P574, DOI 10.3171/jns.1970.33.5.0574
   FISCHER G, 1957, P STAFF M MAYO CLIN, V32, P14
   Geddes L. A., 1989, PRINCIPLES APPL BIOM
   Geddes LA, 1997, ANN BIOMED ENG, V25, P1, DOI 10.1007/BF02738534
   GEDDES LA, 1987, MED BIOL ENG COMPUT, V25, P359, DOI 10.1007/BF02447440
   GEDDES LA, 1971, MED BIOL ENG, V9, P511, DOI 10.1007/BF02474708
   Geddes LA, 2001, ANN BIOMED ENG, V29, P181, DOI 10.1114/1.1349699
   GEDDES LA, 1998, MED DEVICE ACCIDENTS
   GEDDES LA, 1972, ELECTRODES MEASUREME
   HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549
   JONES KE, 1992, ANN BIOMED ENG, V20, P423, DOI 10.1007/BF02368134
   Kohlrausch F., 1897, Annalen der Physik und Chemie, V60, P315
   LILLY JC, 1955, SCIENCE, V121, P468, DOI 10.1126/science.121.3144.468
   LOEB CE, 2001, BION IMPLANTS THERAP
   LOPEZ A, 1969, IEEE T BIO-MED ENG, VBM16, P99, DOI 10.1109/TBME.1969.4502613
   MAYNARD EM, 1992, ANN BIOMED ENG, V20, P423
   MCHARDY J, 1977, ANN BIOMED ENG, V5, P144, DOI 10.1007/BF02364014
   RADOVSKY AS, 1989, AM HEART J, V117, P1288, DOI 10.1016/0002-8703(89)90408-0
   RAGHEB T, 1991, ANN BIOMED ENG, V19, P151, DOI 10.1007/BF02368466
   RAY CD, 1965, P STAFF M MAYO CLIN, V40, P771
   RICHARDSON PC, 1968, AEROSPACE MED, V39, P745
   RICHARDSON PC, 1968, P 21 ANN C ENG MED B, V10
   ROBINSON FR, 1961, HISTOPATHOLOGICAL ST, P61
   SCHALDACH M, 1989, BIOMED TECH, V34, P185, DOI 10.1515/bmte.1989.34.7-8.185
   SCHALDACH M, 1971, T AM SOC ART INT ORG, V17, P29
   SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106
   SCHWAN HP, 1965, P 18 ANN C ENG BIOL
   SCHWAN HP, 1963, PHYSICAL TECHNIQUE B, V6
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   Stokes K.B., 1983, CARDIAC PACING, P369
   WHITE RL, 1974, IEEE T BIOMED ENG, V21, P451
   WISE KD, 1969, P 8 INT C MED BIOL E
   Wolfson RN, 1969, P 8 INT C MED BIOL E
NR 43
TC 91
Z9 94
U1 1
U2 27
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 2003
VL 31
IS 7
BP 879
EP 890
DI 10.1114/1.1581292
PG 12
WC Engineering, Biomedical
SC Engineering
GA 702QL
UT WOS:000184234500012
PM 12971619
DA 2018-10-20
ER

PT J
AU Gomathi, K
   Gopinath, D
   Ahmed, MR
   Jayakumar, R
AF Gomathi, K
   Gopinath, D
   Ahmed, MR
   Jayakumar, R
TI Quercetin incorporated collagen matrices for dermal wound healing
   processes in rat
SO BIOMATERIALS
LA English
DT Article
DE quercetin; collagen; wound healing; antioxidant enzymes
ID OXIDATIVE STRESS; HUMAN SKIN; FLAVONOIDS; ANTIOXIDANTS; SCAVENGERS;
   OXYGEN; DAMAGE; DNA
AB We have been developing antioxidants incorporated collagen matrix as a novel biomaterial for various biomedical applications. In this study we made use of quercetin incorporated collagenous matrix for dermal wound healing in rat. Quercetin incorporated collagen (QIC) treated groups were compared with control and collagen (CS) treated animals. QIC treated animal showed a better healing when compared to control and CS treated wound. The biochemical parameters like hydroxyproline, protein, uronic acid content in the healing wound, revealed that there is an increase in proliferation of cells in quercetin treated groups when compared to CS group and there is considerable increase in wound contraction when compared to CS treated group. In addition we adapted the antioxidant assay using 2,2'-azobisisobutryonitrile (AIBN) to assess in vitro antioxidant activity of QIC. The antioxidant studies indicate QIC quench the radicals more efficiently. These results suggested that quercetin incorporated collagen matrix could be a novel dressing material for dermal wound healing. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Cent Leather Res Inst, Bioorgan Lab, Madras 600020, Tamil Nadu, India.
RP Jayakumar, R (reprint author), Cent Leather Res Inst, Bioorgan Lab, Madras 600020, Tamil Nadu, India.
RI KANNAYIRAM, GOMATHI/I-3910-2017; hari, Rajeswary/I-3950-2017
OI KANNAYIRAM, GOMATHI/0000-0002-6247-0070; hari,
   Rajeswary/0000-0002-6247-0070; Damodaran, Gopinath/0000-0002-1697-0357
CR Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596
   Bergmeyer H.U., 1974, METHOD ENZYMAT AN, P438
   BINYANG AK, 2001, ANAL SCI, V17, P987
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Burek AA, 2000, CURR OPIN ORTHOP, V11, P92
   Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200
   CHEN YT, 1990, FREE RADICAL BIO MED, V9, P19, DOI 10.1016/0891-5849(90)90045-K
   Cohen I.K., 1995, WOUND HEALING SKIN P, P27
   DECHARNEUX T, 1992, BIOCHEM PHARMACOL, V44, P1243, DOI 10.1016/0006-2952(92)90521-J
   GASPAR J, 1994, MUTAGENESIS, V9, P445, DOI 10.1093/mutage/9.5.445
   Ignjatovic LM, 2002, J SERB CHEM SOC, V67, P53, DOI 10.2298/JSC0201053I
   IISHIKAWA T, 2000, BIOSCI BIOTECH BIOCH, V64, P173
   JOVANOVIC SV, 1994, J AM CHEM SOC, V116, P4846, DOI 10.1021/ja00090a032
   KATO K, 1988, J MED CHEM, V31, P793, DOI 10.1021/jm00399a019
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martin A, 1996, DERMATOL SURG, V22, P156, DOI 10.1111/j.1524-4725.1996.tb00499.x
   MERODIEWA D, 1999, FREE RADIC BIOL, V26, P107
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1
   Musonda CA, 1998, CARCINOGENESIS, V19, P1583, DOI 10.1093/carcin/19.9.1583
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   NOSTRO PL, 2000, LANGMUIR, V16, P1744
   NUTTING GC, 1948, J AM LEATHER CHEM AS, V44, P831
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pawlak W, 1998, J GRAVIT PHYSL, V5, P131
   POLAZZA P, 1991, FREE RADIC BIOL MED, V11, P407
   RAO CN, 1981, INDIAN J BIOCHEM BIO, V18, P224
   SAIJA A, 1995, FREE RADICAL BIO MED, V19, P481, DOI 10.1016/0891-5849(94)00240-K
   Skaper SD, 1997, FREE RADICAL BIO MED, V22, P669, DOI 10.1016/S0891-5849(96)00383-8
   Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291
   Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017
NR 31
TC 66
Z9 67
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2003
VL 24
IS 16
BP 2767
EP 2772
DI 10.1016/S0142-9612(03)00059-0
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 679HB
UT WOS:000182913700011
PM 12711523
DA 2018-10-20
ER

PT J
AU Armitage, DA
   Parker, TL
   Grant, DM
AF Armitage, DA
   Parker, TL
   Grant, DM
TI Biocompatibility and hemocompatibility of surface-modified NiTi alloys
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE NiTi; thrombogenicity; surface modification; biocompatibility; platelets
ID NICKEL-TITANIUM ALLOY; SHAPE-MEMORY METAL; ENDOTHELIAL-CELLS; OXIDATION;
   STABILITY; BEHAVIOR; ADHESION; XPS
AB Nickel titanium (NiTi) shape memory alloys have been investigated for several years with regard to biomedical applications. However, little is known about the influences of surface modifications on the biocompatibility of these alloys. The effects of a range of surface treatments were investigated. Cytotoxicity and cytocompatibility studies with both fibroblast and endothelial cells showed no differences in the biocompatibility of any of the NiTi surfaces. The cytotoxicity and cytocompatibility of all surfaces were favorable compared to the controls. The hemolysis caused by a range of NiTi surfaces was no different from that caused by polished 316L stainless steel or polished titanium surfaces. The spreading of platelets has been linked to the thrombogenicity of materials. Platelet studies here showed a significant increase in thrombogenicity on polished NiTi surfaces compared to 316L stainless steel and pure titanium surfaces. Heat treatment of NiTi was found to significantly reduce thrombogenicity, to the level of the control. The XPS results showed a significant decrease in the concentration of surface nickel with heat treatment and changes in the surface nickel itself from a metallic to an oxide state. This correlates with the observed reduction in thrombogenicity. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Nottingham, Sch Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.
   Univ Nottingham, Sch Mech Mat Mfg Engn & Management, Nottingham NG7 2RD, England.
RP Armitage, DA (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
OI Grant, David/0000-0002-6786-7720
CR ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748
   ALARAYYID NA, 1994, PLATELETS, V5, P317, DOI 10.3109/09537109409006440
   ASSAD M, 1994, ANN CHIR, V48, P731
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   ASSAD M, 1994, SHAP MEM SUP TECHN C, P215
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   BUDWORTH RA, 1997, J ANAT, V192, P463
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CASTLEMAN LS, 1984, BIOCOMPATIBILITY CLI
   CHAN CM, 1990, SURF INTERFACE ANAL, V15, P349, DOI 10.1002/sia.740150602
   CHANG R, 1997, SHAPE MEMORY SUPEREL, P579
   Chu CL, 1996, MAT SCI ENG A-STRUCT, V216, P193, DOI 10.1016/0921-5093(96)10409-3
   CUTRIGHT DE, 1973, ORAL SURG ORAL MED O, V35, P578, DOI 10.1016/0030-4220(73)90017-0
   DEPALMA VA, 1972, J BIOMED MATER RES S, V3, P37
   DUERIG TW, 1995, MATER RES SOC SYMP P, V360, P497
   Duerig TW, 1996, METALL, V50, P569
   GOODMAN SL, 1984, SEM 1984, V1, P279
   Green SM, 1997, MAT SCI ENG A-STRUCT, V224, P21, DOI 10.1016/S0921-5093(96)10563-3
   GREENMAN DL, 1995, FUND APPL TOXICOL, V25, P1, DOI 10.1006/faat.1995.1034
   KHASENOV EP, 1988, MET SCI HEAT TREAT, V30, P300
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MUNUERA G, 1989, SURF SCI, V211, P1113, DOI 10.1016/0039-6028(89)90882-0
   OFFMAN RD, 1979, BIOMAT MED EV ARTIF, V7, P359
   Oshida Y, 1990, MATER SCI FORUM, V56, P705
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   SCOTT NA, 1995, AM HEART J, V129, P860, DOI 10.1016/0002-8703(95)90104-3
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
   SHABALOVSKAYA SA, 1995, J PHYS IV, V5, pC8
   Sharma C P, 1991, J Biomater Appl, V6, P72, DOI 10.1177/088532829100600105
   TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265
   TREPANIER C, 1997, SHAPE MEMORY SUPEREL, P423
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   XIAOXIANG W, 1994, P INT S SHAP MEM MAT, P621
NR 36
TC 73
Z9 84
U1 1
U2 18
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2003
VL 66A
IS 1
BP 129
EP 137
DI 10.1002/jbm.a.10549
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 697NQ
UT WOS:000183950000015
PM 12833439
DA 2018-10-20
ER

PT J
AU De Santis, R
   Mollica, F
   Ambrosio, L
   Nicolais, L
   Ronca, D
AF De Santis, R
   Mollica, F
   Ambrosio, L
   Nicolais, L
   Ronca, D
TI Dynamic mechanical behavior of PMMA based bone cements in wet
   environment
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Review
ID TOTAL JOINT REPLACEMENT; POLY(METHYL METHACRYLATE); IN-VITRO; BIOMEDICAL
   APPLICATIONS; STRUCTURAL RELAXATION; COMPOSITE-MATERIALS; GENTAMICIN
   RELEASE; RESIDUAL-STRESS; GROUP ROTATIONS; POLYMERS
AB The mechanical properties of three wet commercial bone cements, namely Braxel (from Bioland(R)), Simplex-P (from Howmedica(R)) and CMW1-G (from DePuy(R)) are investigated by means of stress relaxation and dynamic mechanical analysis (DMA). The geometry of loading that was used is the three point bending method (ASTM D790); all the tests were performed in a water chamber by means of temperature sweeps between 17 and 57degreesC and spanning four frequency decades. The results show that viscoelastic properties are strongly dependent on specimen conditioning (i.e. water uptake and heat treatment).
   The results also show that all the cements that were analyzed show mechanical properties which are intermediate between the ones of the cancellous bone and of the metals of which prostheses are normally made. As a consequence, the cement is able to reduce the stress concentrations due to the interfacing of materials which have very different stiffnesses. Moreover, the results of the DMA, particularly the ones concerning the damping factor (tan delta), indicate that at body temperature the bone cements tested show an increased capacity of dissipation, the higher is the loading frequency, thus displaying shock absorbing properties. (C)2003 Kluwer Academic Publishers.
C1 CNR, Inst Composite Mat Technol, I-80125 Naples, Italy.
   Univ Naples 2, Orthopaed Clin, I-80138 Naples, Italy.
RP De Santis, R (reprint author), CNR, Inst Composite Mat Technol, Piazzale Tecchio 80, I-80125 Naples, Italy.
RI Mollica, Francesco/I-8826-2012
OI AMBROSIO, LUIGI/0000-0002-8367-2405; Ronca, Dante/0000-0001-9366-1286
CR AHMED AM, 1982, J BIOMECH ENG-T ASME, V104, P21, DOI 10.1115/1.3138299
   Andriacchi TP, 1997, GAIT POSTURE, V5, P256, DOI 10.1016/S0966-6362(97)00013-1
   ARENDS CB, 1996, POLYM TOUGHENING, P61
   Arnold JC, 2001, J MATER SCI-MATER M, V12, P707, DOI 10.1023/A:1011272626846
   ARRIGHI V, 1995, MACROMOLECULES, V28, P2745, DOI 10.1021/ma00112a021
   Arrighi V, 1996, PHYSICA B, V226, P1, DOI 10.1016/0921-4526(96)00240-2
   Bargar W L, 1986, J Arthroplasty, V1, P165, DOI 10.1016/S0883-5403(86)80026-2
   Bergman R, 1998, J NON-CRYST SOLIDS, V235, P580, DOI 10.1016/S0022-3093(98)00639-5
   BERNS H, 1995, WEAR, V181, P271, DOI 10.1016/0043-1648(94)07011-3
   Bettencourt A, 2000, INT J PHARM, V197, P161, DOI 10.1016/S0378-5173(99)00468-8
   Bourne R.B., 1996, KNEE, V3, P161
   Briscoe BJ, 1996, TRIBOL INT, V29, P93, DOI 10.1016/0301-679X(95)00045-6
   BRUNSKI JB, 1996, BIOMATERIALS SCI, V1, P37
   Burdick JA, 2001, BIOMATERIALS, V22, P1779, DOI 10.1016/S0142-9612(00)00347-1
   CHEREMISINOFF NP, 1987, PRACTICAL STAT ENG S, P71
   Chockalingam S, 2000, KNEE, V7, P233, DOI 10.1016/S0968-0160(00)00060-0
   Claes L, 2000, CLIN BIOMECH, V15, P750, DOI 10.1016/S0268-0033(00)00044-9
   CLARKE RL, 1989, BIOMATERIALS, V10, P494, DOI 10.1016/0142-9612(89)90092-6
   COWIE JMG, 1993, POLYMER, V34, P2135, DOI 10.1016/0032-3861(93)90741-R
   Currey JD, 1998, P I MECH ENG H, V212, P399, DOI 10.1243/0954411981534178
   Dais P, 1995, PROG NUCL MAG RES SP, V27, P555, DOI 10.1016/0079-6565(95)01014-9
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   DAVIES JP, 1987, J BIOMED MATER RES, V21, P719, DOI 10.1002/jbm.820210604
   Davis WJ, 1998, POLYMER, V39, P255, DOI 10.1016/S0032-3861(97)00392-3
   De Santis R, 2000, J INORG BIOCHEM, V79, P97, DOI 10.1016/S0162-0134(99)00228-7
   Deb S, 2001, BIOMATERIALS, V22, P2177, DOI 10.1016/S0142-9612(00)00409-9
   del Real RP, 2000, J BIOMED MATER RES, V52, P1
   DESANTIS R, 2000, J MATER SCI-MATER M, V10, P629
   DORRIS A, 1999, MECH TIME-DEPEND MAT, V3, P305
   DOWLING NE, 1996, MECH BEHAV MAT, P678
   Dunne NJ, 2002, J MATER SCI-MATER M, V13, P17, DOI 10.1023/A:1013670132001
   Dunne NJ, 2001, BIOMATERIALS, V22, P1819, DOI 10.1016/S0142-9612(00)00363-X
   FEHERING TK, 2001, CLIN ORTHOP RELAT R, V392, P315
   Feng JY, 1997, POLYMER, V38, P6371, DOI 10.1016/S0032-3861(97)00215-2
   FERRAR DF, 2001, BIOMATERIALS, V22, P3005
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Gasser B, 2000, INJURY, V31-4, P48
   Giddings VL, 2001, BIOMATERIALS, V22, P1875, DOI 10.1016/S0142-9612(00)00372-0
   GILBERT JL, 1995, BIOMATERIALS, V16, P1043, DOI 10.1016/0142-9612(95)98900-Y
   Ginebra MP, 2002, BIOMATERIALS, V23, P1873, DOI 10.1016/S0142-9612(01)00314-3
   GUSSO MI, 1996, ARCH GERONTOL GERIAT, V5, P485
   Harper EJ, 2000, J BIOMED MATER RES, V53, P605, DOI 10.1002/1097-4636(200009)53:5<605::AID-JBM22>3.0.CO;2-5
   Hasenwinkel JM, 2002, J BIOMED MATER RES, V59, P411, DOI 10.1002/jbm.1257
   HERTZBERG RW, 1980, FATIGUE ENG PLASTICS, P83
   Hoffler CE, 2000, BONE, V26, P603, DOI 10.1016/S8756-3282(00)00268-4
   Ingham E, 2000, BIOMATERIALS, V21, P1005, DOI 10.1016/S0142-9612(99)00261-6
   Jasper LE, 2002, J MATER SCI-MATER M, V13, P1, DOI 10.1023/A:1013673830184
   JENSON VG, 1994, MATH METHODS CHEM EN, P272
   JOHNSON JA, 1989, J BIOMED MATER RES, V23, P819, DOI 10.1002/jbm.820230802
   KATIME I, 1994, POLYM INT, V35, P281, DOI 10.1002/pi.1994.210350310
   KHUN KD, 1999, P 15 ESB C BIOM BORD
   Kobayashi S, 2000, LANCET, V355, P1499, DOI 10.1016/S0140-6736(00)02164-4
   KUHN KD, 2000, BONE CEMENTS
   Lee AJC, 2002, J MATER SCI-MATER M, V13, P723, DOI 10.1023/A:1016150403665
   Lennon AB, 2002, J BIOMECH, V35, P311, DOI 10.1016/S0021-9290(01)00216-0
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   LIU YK, 1987, J BIOMED MATER RES, V21, P247, DOI 10.1002/jbm.820210208
   Ma X, 1997, POLYMER, V38, P4425, DOI 10.1016/S0032-3861(96)01038-5
   Maffezzoli A, 1997, J MATER SCI-MATER M, V8, P75, DOI 10.1023/A:1018502731892
   MASI P, 1984, POLYM COMMUN, V25, P331
   McCormack BAO, 1996, J BIOMECH ENG-T ASME, V118, P579, DOI 10.1115/1.2796047
   McGee MA, 2000, WEAR, V241, P158, DOI 10.1016/S0043-1648(00)00370-7
   MCKENNA GB, 1980, POLYMER, V21, P213, DOI 10.1016/0032-3861(80)90063-4
   MIGLIARESI C, 1980, INT J ARTIF ORGANS, V3, P114
   Morscher E W, 2002, Acta Orthop Belg, V68, P1
   MUZEAU E, 1995, POLYMER, V36, P611, DOI 10.1016/0032-3861(95)91571-N
   Nicholson TM, 1997, MACROMOLECULES, V30, P5501, DOI 10.1021/ma970111r
   NIELSEN LE, 1974, MECH PROPERTIES POLY, V1
   OYSAED H, 1990, J BIOMED MATER RES, V24, P1037, DOI 10.1002/jbm.820240806
   Pascual B, 1996, BIOMATERIALS, V17, P509, DOI 10.1016/0142-9612(96)82725-6
   Pecina M, 2000, CROAT MED J, V41, P168
   Perez J, 1999, J MOL STRUCT, V479, P183, DOI 10.1016/S0022-2860(98)00869-2
   PU ZJ, 1995, MAT SCI ENG A-STRUCT, V192, P347, DOI 10.1016/0921-5093(94)03217-3
   QUINSON R, 1995, POLYMER, V36, P743, DOI 10.1016/0032-3861(95)93103-S
   Ragel CV, 2000, J BIOMED MATER RES, V51, P424, DOI 10.1002/1097-4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   REHMAN I, 1996, BIOMATERIALS, V17, P240
   RIBELLES JLG, 1990, POLYMER, V31, P223, DOI 10.1016/0032-3861(90)90110-K
   Rittel D, 2000, MECH MATER, V32, P131, DOI 10.1016/S0167-6636(99)00051-4
   Rittel D, 1999, INT J FRACTURE, V99, P199
   RONCA D, 2002, INTEGRATED BIOMATERI
   RONCA R, 2001, BONE CEMENT CEMENTED, P127
   Saelee C, 2000, MACROMOLECULES, V33, P2258, DOI 10.1021/ma991267p
   Shima M, 1999, WEAR, V225, P38, DOI 10.1016/S0043-1648(99)00062-9
   SILVESTRE A, 1990, J MATER SCI, V25, P1050
   SURESH S, 1991, FATIGUE MAT
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thompson NW, 2001, J ARTHROPLASTY, V16, P984, DOI 10.1054/arth.2001.25563
   TIROSH J, 1995, MECH MATER, V19, P329, DOI 10.1016/0167-6636(94)00032-C
   Torrado S, 2001, INT J PHARM, V217, P57, DOI 10.1016/S0378-5173(01)00587-7
   Tritschler B, 1999, TRIBOL INT, V32, P587, DOI 10.1016/S0301-679X(99)00099-7
   VANRIETBERGEN B, 1993, J BIOMECH, V26, P369, DOI 10.1016/0021-9290(93)90001-U
   Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8
   WILSON EB, 1980, MOL VIBRATIONS, P202
   Wineman AS, 2000, MECH RESPONSE POLYM
   Yamashita J, 2002, J BIOMED MATER RES, V63, P31, DOI 10.1002/jbm.10086
   Yang JM, 1999, J BIOMED MATER RES, V48, P52, DOI 10.1002/(SICI)1097-4636(1999)48:1<52::AID-JBM10>3.0.CO;2-Z
   Yetkinler DN, 1998, BIOMATERIALS, V19, P1551, DOI 10.1016/S0142-9612(97)00115-4
   Zhou J, 1996, POLYMER, V37, P2103, DOI 10.1016/0032-3861(96)85855-1
   Zimmerman S, 2002, J ORTHOPAED RES, V20, P182, DOI 10.1016/S0736-0266(01)00090-0
   Zor M, 2002, BIOMATERIALS, V23, P1595, DOI 10.1016/S0142-9612(01)00285-X
NR 101
TC 29
Z9 29
U1 4
U2 32
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2003
VL 14
IS 7
BP 583
EP 594
DI 10.1023/A:1024014822277
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 686PG
UT WOS:000183329700003
PM 15348419
DA 2018-10-20
ER

PT J
AU Signori, F
   Solaro, R
   Chiellini, E
   Lips, PAM
   Dijkstra, PJ
   Feijen, J
AF Signori, F
   Solaro, R
   Chiellini, E
   Lips, PAM
   Dijkstra, PJ
   Feijen, J
TI Multifunctional polyesters as new candidate materials for biomedical
   applications. Synthesis and structural characterization
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 7th World Conference on Biodegradable Polymer and Plastics
CY JUN 04-08, 2002
CL PISA, ITALY
DE H-bonding units; multifunctional polymers; poly(ether ester);
   structure-property relationship
ID BIOACTIVE COMPOUNDS; CONTROLLED-RELEASE; COPOLYMERS;
   POLY(EPSILON-CAPROLACTONE)
AB The present work was aimed at the development of functional polymeric materials to be used in the targeted delivery of proteic drug and tissue engineering fields. The adopted strategy was based on the design of special polymer classes whose structures and functionality could be easily modified by finely tuned synthetic procedures. Poly(ether ester)s containing H-bonding units were chosen as promising materials for the proposed applications. Commercially available precursors were successfully used for the synthesis of symmetrical diesters containing different H-bonding groups (amide, carbamate, and urea moieties). In all cases, pure products were obtained in good yields. Bulk polycondensation of the monomeric precursors with different mixtures of 1,4-butanediot and PEG1000 diol afforded a variety of high molecular weight polymeric structures. Physical-chemical characterization of the polymers indicates that their thermal, mechanical, and swelling properties can be tailored by a proper selection of the H-bonding group and of the composition of the feed mixture.
C1 Univ Pisa, Dipartimento Chim & Chim Ind, INSTM, UdR Consortium, I-56126 Pisa, Italy.
   Univ Twente, Dept Chem Technol, NL-7500 AE Enschede, Netherlands.
RP Chiellini, E (reprint author), Univ Pisa, Dipartimento Chim & Chim Ind, INSTM, UdR Consortium, Via Risorgimento 35, I-56126 Pisa, Italy.
RI Signori, Francesca/G-1937-2010; Dijkstra, Pieter/N-9328-2013
OI Signori, Francesca/0000-0002-9211-5352; 
CR Barbato F, 2001, BIOMATERIALS, V22, P1371, DOI 10.1016/S0142-9612(00)00291-X
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   DESCHAMPS AA, 2002, THESIS U TWENTE NETH
   DESCHAMPS AA, 2002, IN PRESS J BIOMAT PE
   Hoeschele G K, 1976, Patent No. [US 3954689, 3954689]
   HOESCHELE GK, 1974, CHIMIA, V28, P544
   Quaglia F, 2002, J CONTROL RELEASE, V83, P263, DOI 10.1016/S0168-3659(02)00208-0
   SIGNORI F, UNPUB MACROMOL CHEM
   Stapert HR, 1999, MACROMOL CHEM PHYSIC, V200, P1921, DOI 10.1002/(SICI)1521-3935(19990801)200:8<1921::AID-MACP1921>3.0.CO;2-R
   STAPERT HR, 1998, Patent No. 1003459
   STAPERT HR, 1998, THESIS U TWENTE NETH
   WAGENER KB, 1982, Patent No. 4350806
NR 12
TC 3
Z9 3
U1 1
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2003
VL 197
BP 289
EP 301
DI 10.1002/masy.200350726
PG 13
WC Polymer Science
SC Polymer Science
GA 724TV
UT WOS:000185503500027
DA 2018-10-20
ER

PT J
AU Figlerowicz, M
   Alejska, M
   Kurzynska-Kokorniak, A
   Figlerowicz, M
AF Figlerowicz, M
   Alejska, M
   Kurzynska-Kokorniak, A
   Figlerowicz, M
TI Genetic variability: The key problem in the prevention and therapy of
   RNA-based virus infections
SO MEDICINAL RESEARCH REVIEWS
LA English
DT Review
DE RNA-based viruses; viral infections-prevention and therapy; genetic
   variability; error-prone replication; RNA recombination; genetic
   reassortment
ID TEMPERATURE-SENSITIVE MUTANTS; BROME MOSAIC-VIRUS; HEPATITIS-B VIRUS;
   VESICULAR STOMATITIS-VIRUS; RETROVIRAL SHUTTLE VECTOR; SINGLE
   REPLICATION CYCLE; HUMAN ROTAVIRUS STRAINS; REASSORTMENT IN-VIVO;
   INFLUENZA-A VIRUSES; IMMUNODEFICIENCY-VIRUS
AB Despite extraordinary progress that has recently been made in biomedical sciences, viral infectious diseases still remain one of the most serious world health problems. Among the different types of viruses, those using RNA as their genetic material (RNA viruses and retroviruses) are especially dangerous. At present there is no medicine allowing an effective treatment of RNA-based virus infections. Many RNA viruses and retroviruses need only a few weeks to escape immune response or to produce drug-resistant mutants. This seems to be the obvious consequence of the unusual genetic variability of RNA-based viruses. An individual virus does not form a homogenous population but rather a set of similar but not identical variants. In consequence, RNA-based viruses can easily adapt to environmental changes, also those resulting from immune system response or therapy. The modifications identified within viral genes can be divided into two groups: point mutations and complex genome rearrangements. The former arises mainly during error-prone replication, whereas RNA recombination and generic reassortment are responsible for the latter. This article shortly describes major strategies used to control virus infections. Then, it presents the various mechanisms generating the genetic diversity of RNA-based viruses, which are most probably the main cause of clinical problems. (C) 2003 Wiley Periodicals.Inc.
C1 Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland.
   Univ Med Sci, Dept Infect Dis, Poznan, Poland.
RP Figlerowicz, M (reprint author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.
EM marekf@ibch.poznan.pl
RI Figlerowicz, Marek/B-9550-2015
CR Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223
   Ahlquist P, 1992, Curr Opin Genet Dev, V2, P71, DOI 10.1016/S0959-437X(05)80325-9
   AHMED R, 2002, VIRAL PATHOGENESIS I, P53
   AIR GM, 1997, STRUCTURAL BIOL VIRU, P411
   Alejska M, 2001, ACTA BIOCHIM POL, V48, P391
   ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1
   ANDRE FE, 1992, VACCINE, V10, pS160, DOI 10.1016/0264-410X(92)90576-6
   BAEZ M, 1980, J INFECT DIS, V141, P362, DOI 10.1093/infdis/141.3.362
   BANNER LR, 1990, VIROLOGY, V175, P548, DOI 10.1016/0042-6822(90)90439-X
   BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X
   Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9
   BATSCHELET E, 1976, GENE, V1, P27, DOI 10.1016/0378-1119(76)90004-4
   BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3
   Bendinelli M, 1999, VIRAL HEPATITIS, P65
   BITTLE JL, 1982, NATURE, V298, P30, DOI 10.1038/298030a0
   Bowen MD, 2001, VIROLOGY, V291, P185, DOI 10.1006/viro.2001.1201
   BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006
   Bruyere A, 2000, J VIROL, V74, P4214, DOI 10.1128/JVI.74.9.4214-4219.2000
   BUJARSKI JJ, 1986, NATURE, V321, P528, DOI 10.1038/321528a0
   BURNET FM, 1949, AUST J SCI, V12, P109
   CAMPBELL IL, 1991, CURR OPIN IMMUNOL, V3, P486, DOI 10.1016/0952-7915(91)90008-O
   CASEY JL, 1995, J VIROL, V69, P7593
   Chen H, 1996, METHOD ENZYMOL, V275, P503
   Chetverin AB, 1997, CELL, V88, P503, DOI 10.1016/S0092-8674(00)81890-5
   CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   Coffin J. M., 1996, FIELDS VIROLOGY, P1767
   COFFIN JM, 1979, J GEN VIROL, V199, P47
   Cox NJ, 1995, SEMIN VIROL, V6, P359, DOI 10.1016/S1044-5773(05)80013-7
   CROSS RK, 1976, VIROLOGY, V74, P345, DOI 10.1016/0042-6822(76)90341-X
   De Maeyer E., 1988, INTERFERONS OTHER RE
   DESROSIERS RC, 1989, AIDS RES HUM RETROV, V5, P465, DOI 10.1089/aid.1989.5.465
   DESROSIERS RC, 1990, NATURE, V345, P288, DOI 10.1038/345288a0
   Desselberger U, 1996, ADV VIRUS RES, V46, P69, DOI 10.1016/S0065-3527(08)60070-6
   Domingo E, 1998, ADV EXP MED BIOL, V440, P721
   DOMINGO E, 1976, GENE, V1, P3, DOI 10.1016/0378-1119(76)90003-2
   DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4
   DOMINGO E, 1995, MOL BASIS VIRUS EVOL, P181
   DONALD HB, 1954, J GEN MICROBIOL, V10, P457, DOI 10.1099/00221287-10-3-457
   DONG JY, 1993, VIROLOGY, V194, P192, DOI 10.1006/viro.1993.1249
   DRACH DJ, 1984, TARGETS DESIGN ANTIV
   Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910
   Drake JW, 1998, GENETICS, V148, P1667
   DROPULIC B, 1992, J VIROL, V66, P1432
   EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633
   Eigen M, 1996, TRENDS MICROBIOL, V4, P216, DOI 10.1016/0966-842X(96)20011-3
   EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010
   Elena SF, 1999, J EVOLUTION BIOL, V12, P1078, DOI 10.1046/j.1420-9101.1999.00110.x
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339
   Farci P, 2001, Clin Liver Dis, V5, P895, DOI 10.1016/S1089-3261(05)70200-2
   Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599
   FENNER F, 1957, Harvey Lect, V53, P25
   FENNER F, 1988, SMALLPOX ITS ERADICA
   FIELDS B, 1996, FIELDS VIROLOGY, P1553
   FIELDS BN, 1969, VIROLOGY, V37, P335, DOI 10.1016/0042-6822(69)90217-7
   FIELDS BN, 1971, VIROLOGY, V46, P142, DOI 10.1016/0042-6822(71)90013-4
   Figlerowicz M, 1998, J VIROL, V72, P9192
   Figlerowicz M, 1997, P NATL ACAD SCI USA, V94, P2073, DOI 10.1073/pnas.94.5.2073
   Figlerowicz M, 2000, NUCLEIC ACIDS RES, V28, P1714, DOI 10.1093/nar/28.8.1714
   Figlerowicz M, 2000, RNA, V6, P339, DOI 10.1017/S1355838200991210
   FIGLEROWICZ M, 1998, ACTA BIOCHIM POL, V45, P1
   FINTER NB, 1985, INTERFERON IN VIVO C, V4
   FU KS, 1992, VIROLOGY, V189, P88, DOI 10.1016/0042-6822(92)90684-H
   FU KS, 1994, J VIROL, V68, P7458
   GAGNETEN S, 2000, BIOMEDICAL RES REPOR, P469
   GALASSO RT, 1977, J INFECT DIS S1, V136, pS341
   GARCIASASTRE A, 1993, ANNU REV MICROBIOL, V47, P765, DOI 10.1146/annurev.mi.47.100193.004001
   GARDNER PS, 1973, BMJ-BRIT MED J, V2, P571, DOI 10.1136/bmj.2.5866.571
   GAULTON GN, 1986, J IMMUNOL, V137, P2930
   GENSCH J, 1977, J VIROL, V24, P893
   GENSCH J, 1979, J VIROL, V31, P707
   GENTSCH J, 1976, J VIROL, V20, P351
   GHENKINA DB, 1979, ACTA VIROL, V23, P97
   GONZALEZ SA, 1993, VIROLOGY, V194, P548, DOI 10.1006/viro.1993.1293
   GONZALEZSCARANO F, 1996, FIELDS VIROLOGY, P1473
   GOODING LR, 1992, CELL, V71, P5
   GORMAN BM, 1983, INTERVIROLOGY, V20, P169, DOI 10.1159/000149388
   Gouvea Vera, 1995, Trends in Microbiology, V3, P159, DOI 10.1016/S0966-842X(00)88908-8
   GREENE AE, 1994, SCIENCE, V263, P1423, DOI 10.1126/science.8128222
   HAVELL EA, 1978, VIROLOGY, V89, P330, DOI 10.1016/0042-6822(78)90068-5
   HIRSCH MS, 1996, FIELDS VIROLOGY, P431
   HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028
   HIRST GK, 1973, VIROLOGY, V55, P81, DOI 10.1016/S0042-6822(73)81010-4
   HOGE CN, 1997, STRUCTURAL BIOL VIRU, P451
   HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255
   HOLLAND JJ, 1990, J VIROL, V64, P3960
   HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1
   HORSTMANN DM, 1979, REV INFECT DIS, V1, P502
   HORSTMANN DM, 1982, J INFECT DIS, V146, P540, DOI 10.1093/infdis/146.4.540
   IMAMURA T, 1987, J VIROL, V61, P3543
   Ito T, 1998, J VIROL, V72, P7367
   Iturriza-Gomara M, 2001, J VIROL, V75, P3696, DOI 10.1128/JVI.75.8.3696-3705.2001
   JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x
   JENNINGS SR, 1985, J VIROL, V56, P757
   Kapusta J, 1999, FASEB J, V13, P1796
   KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0
   Kim T, 1996, J VIROL, V70, P7594
   King A.M., 1988, RNA GENETICS, VII, P149
   KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8
   KLEID DG, 1981, SCIENCE, V214, P1125, DOI 10.1126/science.6272395
   Koonin EV, 1992, SEMIN VIROL, V3, P327
   Krishnan T, 1996, J INFECTION, V32, P169, DOI 10.1016/S0163-4453(96)91653-9
   KRUGMAN S, 1982, JAMA-J AM MED ASSOC, V247, P2012, DOI 10.1001/jama.247.14.2012
   LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355
   LAI MMC, 1992, MICROBIOL REV, V56, P61
   LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812
   LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343
   LAMB RA, 1969, INFLUENZA VIRUSES, P1
   LANGBEHEIM H, 1976, P NATL ACAD SCI USA, V73, P4636, DOI 10.1073/pnas.73.12.4636
   LASKY LA, 1984, MODERN APPROACHES VA, P189
   LAVANCHY D, 2000, BIOMEDICAL RES REPOR, P185
   LEDINKO N, 1963, VIROLOGY, V20, P107, DOI 10.1016/0042-6822(63)90145-4
   LI Y, 1993, J VIROL, V67, P3854
   LIN YL, 1993, J VIROL, V67, P4154
   LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47
   Maas S, 1997, CURR OPIN CELL BIOL, V9, P343, DOI 10.1016/S0955-0674(97)80006-3
   MANSKY LM, 1995, J VIROL, V69, P5087
   Mansky LM, 1998, J GEN VIROL, V79, P1337, DOI 10.1099/0022-1317-79-6-1337
   MARRACK P, 1994, CELL, V76, P323, DOI 10.1016/0092-8674(94)90339-5
   MCCLINTOCK PR, 1986, VIROLOGY, V150, P352, DOI 10.1016/0042-6822(86)90300-4
   McCullers JA, 1999, J VIROL, V73, P7343
   MCHUTCHINSON JG, 2000, BIOMEDICAL RES REPOR, P203
   MCINTOSH K, 1996, FIELDS VIROLOGY, P1095
   McNeill W., 1976, PLAGUES PEOPLES NATU
   MEYERS G, 1991, VIROLOGY, V180, P602, DOI 10.1016/0042-6822(91)90074-L
   MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057
   MINDICH L, 1992, J VIROL, V66, P2605
   MURPHY BR, 1996, FIELDS VIROLOGY, P476
   Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500
   NAGY PD, 1993, P NATL ACAD SCI USA, V90, P6390, DOI 10.1073/pnas.90.14.6390
   NAGY PD, 1995, J VIROL, V69, P131
   Nagy PD, 1998, EMBO J, V17, P2392, DOI 10.1093/emboj/17.8.2392
   Nagy PD, 1997, VIROLOGY, V235, P1, DOI 10.1006/viro.1997.8681
   Nagy PD, 1999, VIROLOGY, V254, P92, DOI 10.1006/viro.1998.9545
   NAKAJIMA K, 1977, VIROLOGY, V81, P486, DOI 10.1016/0042-6822(77)90165-9
   NASH T, 2001, IMMUNOLOGY, P235
   Nydegger UE, 2000, VOX SANG, V78, P191
   OHMAN N, 1999, COMPREHENSIVE NATURA, P97
   OJWANG JO, 1992, P NATL ACAD SCI USA, V89, P10802, DOI 10.1073/pnas.89.22.10802
   ONODERA S, 1993, J VIROL, V67, P4914
   Oxford JS, 1996, METHOD ENZYMOL, V275, P555
   PAABO S, 1986, P NATL ACAD SCI USA, V83, P9665, DOI 10.1073/pnas.83.24.9665
   PARVIN JD, 1986, J VIROL, V59, P377
   PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019
   Pathak VK, 1997, SEMIN VIROL, V8, P141, DOI 10.1006/smvy.1997.0114
   PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6024, DOI 10.1073/pnas.87.16.6024
   Peng G, 1996, J GEN VIROL, V77, P1489, DOI 10.1099/0022-1317-77-7-1489
   PILIPENKO EV, 1995, NUCLEIC ACIDS RES, V23, P1870, DOI 10.1093/nar/23.11.1870
   Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639
   Plyusnin A, 2002, EMBO J, V21, P1497, DOI 10.1093/emboj/21.6.1497
   PRINGLE CR, 1965, VIROLOGY, V25, P48, DOI 10.1016/0042-6822(65)90250-3
   Prisbe EJ, 1996, METHOD ENZYMOL, V275, P425
   RACANIELLO VR, 1979, J VIROL, V32, P1006
   RAJU R, 1995, J VIROL, V69, P7391
   Ramig RF, 1997, ANNU REV MICROBIOL, V51, P225, DOI 10.1146/annurev.micro.51.1.225
   REAGAN KJ, 1983, J VIROL, V48, P660
   REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8
   Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673
   RINALDO CR, 1994, AM J PATHOL, V144, P637
   RIVIERE Y, 1986, J VIROL, V59, P363
   ROMANOVA LI, 1986, VIROLOGY, V155, P202, DOI 10.1016/0042-6822(86)90180-7
   RUECKERT RR, 1996, FIELDS VIROLOGY, P609
   RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774
   SABIN AB, 1985, J INFECT DIS, V151, P420, DOI 10.1093/infdis/151.3.420
   SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445
   SAMAL SK, 1987, J VIROL, V61, P1086
   SARVER N, 1990, SCIENCE, V247, P1222, DOI 10.1126/science.2107573
   Sawicki DL, 2001, J GEN VIROL, V82, P385, DOI 10.1099/0022-1317-82-2-385
   Sawyer LA, 2000, ANTIVIR RES, V47, P57, DOI 10.1016/S0166-3542(00)00111-X
   Schirmbeck R, 2001, BIOL CHEM, V382, P543, DOI 10.1515/BC.2001.068
   SCHNEIDER J, 1988, AIDS, V2, P1, DOI 10.1097/00002030-198802000-00001
   SCHOLZ M, 1992, HUM IMMUNOL, V35, P230, DOI 10.1016/0198-8859(92)90004-7
   SEDMAK DD, 1994, AM J PATHOL, V144, P683
   Sharp PM, 2001, PHILOS T ROY SOC B, V356, P867, DOI 10.1098/rstb.2001.0863
   Shippy R, 1999, MOL BIOTECHNOL, V12, P117, DOI 10.1385/MB:12:1:117
   SIMON AE, 1994, ANNU REV PHYTOPATHOL, V32, P337, DOI 10.1146/annurev.py.32.090194.002005
   SMITH DB, 1987, J GEN VIROL, V68, P2729, DOI 10.1099/0022-1317-68-11-2729
   Southern PJ, 1996, FIELDS VIROLOGY, P1505
   SPRIGGS MK, 1994, CURR OPIN IMMUNOL, V6, P526, DOI 10.1016/0952-7915(94)90136-8
   STEINHAUER DA, 1986, J VIROL, V57, P219
   STUHLMANN H, 1992, J VIROL, V66, P2378
   SUGIYAMA K, 1981, VIROLOGY, V114, P210, DOI 10.1016/0042-6822(81)90266-X
   Suzuki Y, 1998, FEBS LETT, V427, P183, DOI 10.1016/S0014-5793(98)00415-3
   SZMUNESS W, 1980, NEW ENGL J MED, V303, P833, DOI 10.1056/NEJM198010093031501
   TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0
   TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900
   TOBITA K, 1971, ARCH GES VIRUSFORSCH, V34, P119, DOI 10.1007/BF01241713
   TOBITA K, 1974, J VIROL, V13, P347
   TORDO N, 1992, SEMINARS VIROLOGY, V3, P341
   Tucker TJ, 1996, METHOD ENZYMOL, V275, P440
   UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0
   Unicomb LE, 1999, J CLIN MICROBIOL, V37, P1885
   UYTDEHAAG FGCM, 1985, J IMMUNOL, V134, P1225
   Van Drunen Littel-Van Den Hurk S., 1993, Vaccine, V11, P25, DOI 10.1016/0264-410X(93)90336-V
   VEZZA AC, 1980, VIROLOGY, V106, P250, DOI 10.1016/0042-6822(80)90248-2
   Vilcek J., 1994, CYTOKINE HDB, P1
   VILCEK J, 1996, FIELDS VIROLOGY, P375
   WARD CD, 1988, J VIROL, V62, P558
   Watanabe M, 2001, ARCH VIROL, V146, P557, DOI 10.1007/s007050170162
   WEBSTER RG, 1992, MICROBIOL REV, V56, P152
   WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0
   WENSKE EA, 1985, J VIROL, V56, P613
   WHITTON JL, 1996, FIELDS VIROLOGY, P345
   XU X, 1993, OPTIONS CONTROL INFL, V2, P203
   YOO BJ, 1992, VIROLOGY, V191, P889, DOI 10.1016/0042-6822(92)90264-P
   Zeitlin L, 1999, EMERG INFECT DIS, V5, P54, DOI 10.3201/eid0501.990107
   Zeitlin L, 2000, MICROBES INFECT, V2, P701, DOI 10.1016/S1286-4579(00)00355-5
   ZHANG JY, 1994, J VIROL, V68, P2409
   ZHANG JY, 1993, SCIENCE, V259, P234, DOI 10.1126/science.8421784
   ZHANG JY, 1993, J VIROL, V67, P1747
   ZHANG XM, 1994, J VIROL, V68, P6626
   Zhou NN, 1999, J VIROL, V73, P3366
NR 213
TC 38
Z9 39
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0198-6325
EI 1098-1128
J9 MED RES REV
JI Med. Res. Rev.
PD JUL
PY 2003
VL 23
IS 4
BP 488
EP 518
DI 10.1002/med.10045
PG 31
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 690AW
UT WOS:000183526000004
PM 12710021
DA 2018-10-20
ER

PT J
AU Kralj, M
AF Kralj, M
TI Biomedical and environmental potential of nanoporous materials
SO PERIODICUM BIOLOGORUM
LA English
DT Review
ID NATURAL ZEOLITE CLINOPTILOLITE; IN-VITRO; SILICA; CYCLOPHOSPHAMIDE;
   ANTICANCER; ADSORPTION; INDUSTRY; REMOVAL; RELEASE; CELLS
C1 Rudjer Boskovic Inst, Lab Funct Gen, Div Mol Med, HR-10002 Zagreb, Croatia.
RP Kralj, M (reprint author), Rudjer Boskovic Inst, Lab Funct Gen, Div Mol Med, Bijenicka 54,POB 180, HR-10002 Zagreb, Croatia.
EM mhorvat@irb.hr
CR BEDIOUI F, 1995, COORDIN CHEM REV, V144, P39, DOI 10.1016/0010-8545(94)08000-H
   Bogunia-Kubik K, 2002, BIOSYSTEMS, V65, P123, DOI 10.1016/S0303-2647(02)00010-2
   Breck D. W., 1964, J CHEM EDUC, V41, P678, DOI DOI 10.1021/ED041P678
   CHARLTON B, 1988, DIABETES, V37, P930, DOI 10.2337/diabetes.37.7.930
   CHELISHCHEV NF, 1995, OCCURRENCE PROPERTIE, P525
   Chung YC, 2000, WATER SCI TECHNOL, V42, P127
   COLIC M, 2002, J TUMOR MARKER ONCOL, V17, P63
   ConcepcionRosabal B, 1997, ZEOLITES, V19, P47, DOI 10.1016/S0144-2449(97)00022-5
   DELPINO JSN, 1995, J CONTROL RELEASE, V34, P25
   Dyer A, 2000, J HELMINTHOL, V74, P137, DOI 10.1017/S0022149X00000184
   Eriksson H, 1998, BIOTECHNOL TECH, V12, P329, DOI 10.1023/A:1008866717990
   Fach E, 2002, ENVIRON HEALTH PERSP, V110, P1087, DOI 10.1289/ehp.021101087
   Freitas R A Jr, 2002, Stud Health Technol Inform, V80, P45
   Haidouti C, 1997, SCI TOTAL ENVIRON, V208, P105, DOI 10.1016/S0048-9697(97)00284-2
   Hampden-Smith MJ, 1998, CHEMISTRY OF ADVANCED MATERIALS, P1
   HEPPLESTON AG, 1991, ENVIRON HEALTH PERSP, V94, P149, DOI 10.2307/3431309
   Hodgson SC, 2002, POLYM-PLAST TECHNOL, V41, P795, DOI 10.1081/PPT-120014389
   Hotta M, 1998, J ORAL REHABIL, V25, P485, DOI 10.1046/j.1365-2842.1998.00265.x
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Kithome M, 1999, COMMUN SOIL SCI PLAN, V30, P1417, DOI 10.1080/00103629909370296
   KUGE S, 1995, J IMMUNOL, V154, P1777
   Matsuura T, 1997, J DENT, V25, P373, DOI 10.1016/S0300-5712(96)00050-4
   MERCER B W, 1970, Journal Water Pollution Control Federation, V42, pR95
   Miazzo R, 2000, POULTRY SCI, V79, P1
   MITCHELL PCH, 1991, CHEM IND, V5, P308
   MOSSMAN BT, 1989, NEW ENGL J MED, V320, P1721, DOI 10.1056/NEJM198906293202604
   Mossman BT, 1996, CANCER INVEST, V14, P466, DOI 10.3109/07357909609018904
   Mumpton FA, 1999, P NATL ACAD SCI USA, V96, P3463, DOI 10.1073/pnas.96.7.3463
   NAGY JB, 1998, SYNTHESIS CHARACTERI, P181
   Nikawa H, 1997, J ORAL REHABIL, V24, P350, DOI 10.1046/j.1365-2842.1997.d01-297.x
   Oguz H, 2000, RES VET SCI, V69, P89, DOI 10.1053/rvsc.2000.0395
   OSCHILEWSKI U, 1985, DIABETES, V34, P197, DOI 10.2337/diabetes.34.2.197
   Pavelic K, 2002, J CANCER RES CLIN, V128, P37, DOI 10.1007/s00432-001-0301-6
   Pavelic K, 2001, J MOL MED-JMM, V78, P708, DOI 10.1007/s001090000176
   Pavelic K, 2003, HDB ZEOLITE SCI TECH, P1143
   Perry CC, 1998, CHEMISTRY OF ADVANCED MATERIALS, P499
   Quintavalla S, 2002, MEAT SCI, V62, P373, DOI 10.1016/S0309-1740(02)00121-3
   Ramu J, 1997, J FOOD PROTECT, V60, P358, DOI 10.4315/0362-028X-60.4.358
   Rivera A, 1998, MICROPOR MESOPOR MAT, V24, P51, DOI 10.1016/S1387-1811(98)00148-6
   RodriguezFuentes G, 1997, ZEOLITES, V19, P441, DOI 10.1016/S0144-2449(97)00087-0
   Rubin DL, 1997, JMRI-J MAGN RESON IM, V7, P865, DOI 10.1002/jmri.1880070515
   SANCHEZROMAN J, 1993, ANN RHEUM DIS, V52, P534, DOI 10.1136/ard.52.7.534
   Sherman JD, 1999, P NATL ACAD SCI USA, V96, P3471, DOI 10.1073/pnas.96.7.3471
   Takai K, 2002, MICROBIOL IMMUNOL, V46, P75, DOI 10.1111/j.1348-0421.2002.tb02661.x
   Tanev PT, 1998, CHEMISTRY OF ADVANCED MATERIALS, P329
   UEKI A, 1994, IMMUNOLOGY, V82, P332
   UGLEA CV, 1994, J BIOMAT SCI-POLYM E, V6, P633, DOI 10.1163/156856294X00572
   Wolfe F, 1999, J RHEUMATOL, V26, P2025
   Zarkovic N, 2003, ANTICANCER RES, V23, P1589
NR 49
TC 6
Z9 6
U1 1
U2 5
PU PERIODICUM BIOLOGORUM
PI ZAGREB
PA HRVATSKO PRIRODOSLOVNO DRUSTVO ILICA 16/111, 41000 ZAGREB, CROATIA
SN 0031-5362
J9 PERIOD BIOL
JI Period. Biol.
PD JUL
PY 2003
VL 105
IS 2
BP 99
EP 107
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 713LL
UT WOS:000184859400001
DA 2018-10-20
ER

PT J
AU Wang, DA
   Feng, LX
   Ji, J
   Sun, YH
   Zheng, XX
   Elisseeff, JH
AF Wang, DA
   Feng, LX
   Ji, J
   Sun, YH
   Zheng, XX
   Elisseeff, JH
TI Novel human endothelial cell-engineered polyurethane biomaterials for
   cardiovascular biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE surface modification; polyurethane; endothelial; cell culture; cell
   compatibility
ID OXIDE) COUPLING-POLYMER; POLY(ETHER URETHANE) SURFACES; HYDROPHILIC
   POLYMERS; PROTEIN ADSORPTION; ADHESION; FIBRONECTIN; CATHETERS; ALBUMIN;
   RGD
AB A tri-block coupling-polymer composed of 4,4'-methylenediphenyl diisocyanate and poly (ethylene oxide) (PEO), abbreviated MPEO, was used as the template surface-modifying additive (SMA), based on which selected amino acids (lysine, arginine, glycin, and aspartic acid) and RGD peptide were respectively conjugated as functional endgroups of the PEO spacer-arms through sulfonyl chloride-activation routes. After the immobilization of biofunctional factors, the SMA-MPEO derivatives were noncovalently introduced onto the biomedical poly(ether urethane) (PEU) surfaces by physical blending methods. The SMA synthesis and PEU surface modification were monitored and analyzed by nuclear magnetic resonance spectroscopy, attenuated total reflection-infrared spectroscopy, and X-ray photoelectron spectroscopy. The human umbilical vein endothelial cells (HUVECs) were collected and harvested manually by collagenase digestion. The cell culture was performed respectively on the MPEO derivative-modified PEU surfaces and also on the surfaces of the commercially available polystyrene cell-culture plates (TCPS) for control. The cell adhesion rates and cell proliferation rates of the in vitro cultivated HUVEC were measured using flow cytometry. The individual cell viability rates were determined with MTT assay. The cell morphologies of the living HUVECs were investigated by optical inverted microscopy, and more detailed information was acquired from scanning electrical microscopy. The results indicated that the efficacy of SMA functional endgroups was the dominant factor for HUVEC compatibility; the proper-sized PEO spacers (M-w 2 k) could support and mobilize the functional endgroups, optimizing the surface (interface) environment for the cell growth. As the endgroups of the SMA-MPEO derivatives and the bio-functional factors, the basic amino acids (lysine and arginine) demonstrated similar performances to that of the widely acknowledged cell growth-promoter, RGD peptide, which were superior to TCPS. Therefore, these MPEO derivative-modified PEU materials are promising to serve as novel polymeric permanent implants or interventional devices for cardiovascular biomedical applications. (C) 2003 Wiley Periodicals, Inc.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
   Zhejiang Univ, Hangzhou 310027, Peoples R China.
   Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
RP Wang, DA (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RI Wang, Dong-an/G-6195-2010
CR BEER JH, 1992, BLOOD, V79, P117
   CASTILLO EJ, 1985, BIOMATERIALS, V6, P338, DOI 10.1016/0142-9612(85)90089-4
   CLAUDE KS, 1989, BIOMATERIALS, V10, P85
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   DRUMHELLER SD, 1995, BIOMEDICAL ENG HDB, P1584
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   HARRIS JM, 1984, J POLYM SCI POL CHEM, V22, P341, DOI 10.1002/pol.1984.170220207
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kowalczynska HM, 2002, J BIOMED MATER RES, V61, P260, DOI 10.1002/jbm.10151
   Lahann J, 2002, LANGMUIR, V18, P3632, DOI 10.1021/la011464t
   LELAH MD, 1986, POLYURETHANES MED, P57
   MECHAM RP, 1991, ANNU REV CELL BIOL, V7, P71, DOI 10.1146/annurev.cellbio.7.1.71
   NAKAJIMA K, 1990, POLYM J, V22, P985, DOI 10.1295/polymj.22.985
   NATHAN A, 1995, P NATL ACAD SCI USA, V92, P8130, DOI 10.1073/pnas.92.18.8130
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   Patel N, 1998, FASEB J, V12, P1447
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sagnella S, 2001, J BIOMED MATER RES, V57, P419, DOI 10.1002/1097-4636(20011205)57:3<419::AID-JBM1185>3.0.CO;2-I
   SILVER JH, 1995, J BIOMED MATER RES, V29, P535, DOI 10.1002/jbm.820290414
   STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Wang DA, 2000, MACROMOLECULES, V33, P8472, DOI 10.1021/ma991412z
   Wang DA, 2000, MACROMOL CHEM PHYSIC, V201, P1574, DOI 10.1002/1521-3935(20000901)201:14<1574::AID-MACP1574>3.0.CO;2-B
   Wang DA, 2001, J BIOMAT SCI-POLYM E, V12, P1123, DOI 10.1163/15685620152691896
   Wang DA, 2002, BIOCONJUGATE CHEM, V13, P792, DOI 10.1021/bc0255079
   Wang DA, 2001, J BIOMED MATER RES, V58, P372, DOI 10.1002/jbm.1031
   Wang DA, 2001, BIOMATERIALS, V22, P1549, DOI 10.1016/S0142-9612(00)00311-2
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   YAN MD, 1993, J AM CHEM SOC, V115, P814, DOI 10.1021/ja00055a078
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 32
TC 34
Z9 36
U1 1
U2 14
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2003
VL 65A
IS 4
BP 498
EP 510
DI 10.1002/jbm.a.10533
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 685WA
UT WOS:000183285700013
PM 12761841
DA 2018-10-20
ER

PT J
AU Bram, M
   Kempmann, C
   Laptev, A
   Stover, D
   Weinert, K
AF Bram, M
   Kempmann, C
   Laptev, A
   Stover, D
   Weinert, K
TI Investigations on the machining of sintered titanium foams utilizing
   face milling and peripheral grinding
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
AB Titanium foams are regarded as potent materials for biomedical applications such as bone implants, and are, if possible, manufactured close to their final shape by sintering processes. There are cases, however, in which it is necessary to generate the final shape by machining, and problems resulting from the porous structure and the material characteristics become critical. In this article, two important methods of machining, i.e. face milling and peripheral grinding, are investigated for their applicability to Ti foams, and their scope and limitations are discussed.
C1 Univ Dortmund, ISF, D-44227 Dortmund, Germany.
   Forschungszentrum Julich, IWV, D-52425 Julich, Germany.
RP Bram, M (reprint author), Univ Dortmund, ISF, Baroper Str 301, D-44227 Dortmund, Germany.
EM kempmann@isf.de
OI Laptev, Alexander/0000-0001-9077-5747
CR BRAM M, 2002, P C ZELL SYST STAHL
   BRAM M, 2002, KONSTRUCTION, V9, P3
   BRAM M, 1999, P INT C MET FOAMS PO
   GIRLICH D, 2002, KONSTRUKTION, V11, P46
   Grandinetti M, 2001, LAT TRADE, V9, P12
   Korner C, 2000, ADV ENG MATER, V2, P159, DOI 10.1002/(SICI)1527-2648(200004)2:4<159::AID-ADEM159>3.0.CO;2-O
   Liu PS, 2001, J MATER SCI, V36, P5059, DOI 10.1023/A:1012483920628
   WEINERT K, 1999, TECHNICA, V6, P18
NR 8
TC 14
Z9 15
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD JUN
PY 2003
VL 5
IS 6
BP 441
EP +
DI 10.1002/adem.200300356
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 703JX
UT WOS:000184277200014
DA 2018-10-20
ER

PT J
AU Murphy, BP
   Savage, P
   McHugh, PE
   Quinn, DF
AF Murphy, BP
   Savage, P
   McHugh, PE
   Quinn, DF
TI The stress-strain behavior of coronary stent struts is size dependent
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE coronary stents; 316 L stainless steel; plastic deformation;
   stress-strain behavior
ID PLASTICITY; STEELS
AB Coronary stents are used to re-establish the vascular lumen and flow conditions within the coronary arteries; the typical thickness of a stent strut is 100 mum, and average grain sizes of approximately 25 mum exist in stainless steel stents. The purpose of this study is to investigate the effect of strut size on the stress strain behavior of 316 L stainless steel. Other materials have shown a size dependence at the micron size scale; however, at present there are no studies that show a material property size dependence in coronary stents. Electropolished stainless steel stent struts within the size range of 60-500 mum were tensile tested. The results showed that within the size range of coronary stent struts a size dependent stress-strain relationship is required. to describe the material. Finite element models of the final phase of fracture, i.e., void growth models, explained partially the reason for this size effect. This study demonstrated that a size based stress-strain relationship must be used to describe the tensile behavior material of 316 L stainless steel at the size scale of coronary stent struts. (C) 2003 Biomedical Engineering Society.
C1 Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
   Medtron AVE Ireland Ltd, Galway, Ireland.
RP McHugh, PE (reprint author), Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
OI Murphy, Bruce/0000-0002-9071-1193
CR Balcon R, 1997, EUR HEART J, V18, P1536
   Besson J, 2000, ENG FRACT MECH, V67, P169, DOI 10.1016/S0013-7944(00)00056-4
   Fajadet J, 2002, J AM COLL CARDIOL, V39, p20A
   FLECK NA, 1994, ACTA METALL MATER, V42, P475, DOI 10.1016/0956-7151(94)90502-9
   Moller D, 2001, J BIOMED MATER RES, V58, P69, DOI 10.1002/1097-4636(2001)58:1<69::AID-JBM100>3.0.CO;2-9
   MURPHY BP, 2002, ACTA BIOENG BIOMECH, V4, P654
   RAUSMUSSEN KJR, 2001, R811 U SYDN
   SAVAGE P, 2003, UNPUB SIZE DEPENDENC
   Schluter N, 1996, COMP MATER SCI, V7, P27, DOI 10.1016/S0927-0256(96)00056-0
   SERRUYS PW, 2000, HDB CORONARY STENTS
   Stolken JS, 1998, ACTA MATER, V46, P5109, DOI 10.1016/S1359-6454(98)00153-0
   WELDON LM, 2001, THESIS NUI GALWAY
NR 12
TC 62
Z9 68
U1 2
U2 22
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2003
VL 31
IS 6
BP 686
EP 691
DI 10.1114/1.1569268
PG 6
WC Engineering, Biomedical
SC Engineering
GA 685ET
UT WOS:000183248400007
PM 12797618
DA 2018-10-20
ER

PT J
AU Djordjevic, VD
   Jaric, J
   Fabry, B
   Fredberg, JJ
   Stamenovic, D
AF Djordjevic, VD
   Jaric, J
   Fabry, B
   Fredberg, JJ
   Stamenovic, D
TI Fractional derivatives embody essential features of cell rheological
   behavior
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE power law; elastic modulus; frictional modulus; frequency; modeling;
   contractile force
ID DYNAMIC BEHAVIOR; MODEL
AB Mechanical moduli of cultured airway smooth muscle cells (Fabry, B., et al. Phys. Rev. Lett. 87:148102, 2001) reveal that the frequency dependence of cell rheological behavior conforms to a weak power-law relationship over a wide range of frequency (10(-2)-10(3) Hz). Such a behavior cannot be accounted for by standard viscoelastic models characterized by a discrete number of time constants that have been commonly used in previous studies of cell viscoelasticity. Fractional calculus, by contrast, provides a natural framework for describing weak power-law relationships and requires no assumptions about the type of material, the time constant distribution or the time/frequency interval in which rheological observations are made. In this study, we developed a rheological model of the cell using methods of fractional calculus. We used a least-squares technique to fit the model to data previously obtained from measurements on airway smooth muscle cells. The fit provided an excellent correspondence to the data, and the estimated values of model parameters were physically plausible. The model leads to a novel and unexpected empirical link between dynamic viscoelastic behavior of the cytoskeleton and the static contractile stress that it bears. (C) 2003 Biomedical Engineering Society.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Harvard Univ, Sch Publ Hlth, Physiol Program, Boston, MA USA.
   Univ Belgrade, Fac Mech Engn, Belgrade, Serbia Monteneg.
   Univ Belgrade, Fac Math, Belgrade, Serbia Monteneg.
RP Stamenovic, D (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
EM dimitrij@engc.bu.edu
RI Fabry, Ben/C-5496-2013
OI Fabry, Ben/0000-0003-1737-0465
FU NHLBI NIH HHS [HL-33009]
CR BAGLEY RL, 1986, J RHEOL, V30, P133, DOI 10.1122/1.549887
   BATES JHT, 1994, ANN BIOMED ENG, V22, P674, DOI 10.1007/BF02368292
   BAUSCH AR, 1998, BIOPHYS J, V75, P1573
   Coughlin MF, 1996, J APPL PHYSIOL, V80, P1880
   DOETSCH G, 1961, ANLEITUNG PRAKTISCHE
   Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   HANTOS Z, 1992, J APPL PHYSIOL, V72, P168
   HILDEBRANDT J, 1969, B MATH BIOPHYS, V31, P651, DOI 10.1007/BF02477779
   Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002
   Pritz T, 1996, J SOUND VIB, V195, P103, DOI 10.1006/jsvi.1996.0406
   ROSS B, 1974, LECT NOTES MATH, V457, P1
   Rossikhin YA, 2001, Z ANGEW MATH MECH, V81, P363, DOI 10.1002/1521-4001(200106)81:6<363::AID-ZAMM363>3.0.CO;2-9
   SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183
   Sollich P, 1998, PHYS REV E, V58, P738, DOI 10.1103/PhysRevE.58.738
   SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0
   SUKI B, 1994, J APPL PHYSIOL, V76, P168
   Thoumine O, 1997, J CELL SCI, V110, P2109
   TORVIK PJ, 1984, J APPL MECH-T ASME, V51, P294, DOI 10.1115/1.3167615
   Volokh KY, 1997, INT J SOLIDS STRUCT, V34, P1093, DOI 10.1016/S0020-7683(96)00080-7
   Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001
   WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8
NR 22
TC 79
Z9 80
U1 1
U2 8
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2003
VL 31
IS 6
BP 692
EP 699
DI 10.1114/1.1574026
PG 8
WC Engineering, Biomedical
SC Engineering
GA 685ET
UT WOS:000183248400008
PM 12797619
DA 2018-10-20
ER

PT J
AU Carrigan, SD
   Whiteside, RA
   Pichora, DR
   Small, CF
AF Carrigan, SD
   Whiteside, RA
   Pichora, DR
   Small, CF
TI Development of a three-dimensional finite element model for carpal load
   transmission in a static neutral posture
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE carpal; wrist; load transmission; three-dimensional; finite element
ID WRIST JOINT; IN-VIVO; IMAGES; BONES; KINEMATICS; LIGAMENTS; KNEE
AB A three-dimensional developmental finite element model has been created to analyze load transmission pathways in the constrained carpus during static compressive loading. The bone geometry was extracted from an in vivo computed tomography scan using a combination of commercial and proprietary software. The complete geometry, including bone, cartilage, and ligament tissues, was compiled using a commercial finite element program. This model extends the state of biomechanical modeling by being the first to incorporate all eight carpal bones of the wrist and the related soft tissues in three dimensions. The model results indicate that cartilage material modulus and unconstrained carpal rotation have substantial impacts on the articular contact patterns and pressures. (C) 2003 Biomedical Engineering Society.
C1 Queens Univ, Dept Engn Mech, Kingston, ON, Canada.
   Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada.
RP Carrigan, SD (reprint author), McGill Univ, Biomed Eng Dept, 3775,Rue Univ, Montreal, PQ H3A 2B4, Canada.
CR Anderson D D, 1995, Semin Arthroplasty, V6, P30
   Berger RA, 1997, HAND CLIN, V13, P63
   Bettinger PC, 2000, J HAND SURG-AM, V25A, P1085, DOI 10.1053/jhsu.2000.18487
   Donzelli PS, 1999, J BIOMECH, V32, P1037, DOI 10.1016/S0021-9290(99)00106-2
   Feipel V, 1999, SURG RADIOL ANAT, V21, P125, DOI 10.1007/s00276-999-0125-7
   Iwasaki N, 1998, J ORTHOP RES, V16, P256, DOI 10.1002/jor.1100160213
   Ledoux P, 2001, Acta Orthop Belg, V67, P236
   Lewis G, 1995, Semin Arthroplasty, V6, P20
   Li G, 2001, J BIOMECH ENG-T ASME, V123, P341, DOI 10.1115/1.1385841
   Li G, 1999, J BIOMECH ENG-T ASME, V121, P657, DOI 10.1115/1.2800871
   Oda M, 2000, J HAND SURG-BRIT EUR, V25B, P492
   Patterson R, 1995, J Hand Ther, V8, P97
   SAVELBERG HHCM, 1992, J BIOMECH, V25, P369, DOI 10.1016/0021-9290(92)90256-Z
   SCHUIND F, 1995, J BIOMECH, V28, P587, DOI 10.1016/0021-9290(94)00093-J
   Sebastian TB, 1998, LECT NOTES COMPUT SC, V1496, P1184
   Short WH, 1997, HAND CLIN, V13, P93
   Snel JG, 2000, MED PHYS, V27, P2037, DOI 10.1118/1.1289896
   WERNER FW, 1995, SURG HAND UPPER EXTR, P31
   Wolfe SW, 2000, J HAND SURG-AM, V25A, P860, DOI 10.1053/jhsu.2000.9423
NR 19
TC 39
Z9 43
U1 0
U2 3
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2003
VL 31
IS 6
BP 718
EP 725
DI 10.1114/1.1574027
PG 8
WC Engineering, Biomedical
SC Engineering
GA 685ET
UT WOS:000183248400011
PM 12797622
DA 2018-10-20
ER

PT J
AU Wang, M
AF Wang, M
TI Developing bioactive composite materials for tissue replacement
SO BIOMATERIALS
LA English
DT Review
DE bioceramics; biomedical polymers; composites; bone analogue; tissue
   replacement
ID HYDROXYAPATITE-REINFORCED POLYETHYLENE; HIGH-DENSITY POLYETHYLENE;
   MECHANICAL-PROPERTIES; BONE-CEMENT; IN-VITRO; DENTAL COMPOSITES;
   PARTICLE-SIZE; HAPEX(TM); FATIGUE; CREEP
AB A variety of bioactive composites have been investigated over the last two decades as substitute materials for diseased or damaged tissues in the human body. In this paper, the rationale and strategy of developing these composites are given. Major factors influencing the production and performance of bioactive composites are discussed. Some promising composites for tissue replacement and regeneration are reviewed. On the basis of past experience and newly gained knowledge, composite materials with tailored mechanical and biological performance can be manufactured and used to meet various clinical requirements. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Hong Kong Polytech Univ, Rehabil Engn Ctr, Kowloon, Hong Kong, Peoples R China.
RP Wang, M (reprint author), Hong Kong Polytech Univ, Rehabil Engn Ctr, Kowloon, Hong Kong, Peoples R China.
EM minwangbiomats@yahoo.co.uk
OI Wang, Min/0000-0002-6495-5637
CR ABUBAKAR MS, 1999, J MATER PROCESS TECH, V89, P462
   ADOBA AE, 1996, P 7 EUR C COMP MAT E, V2, P461
   ADOBA AE, 1997, P 11 INT C COMP MAT, V1, P496
   Aoki H., 1994, MED APPL HYDROXYAPAT
   BASSET D, 1988, DEV CRYSTALLINE POLY, V2
   Beale B, 1995, MONOGRAPH MED SPECIA
   BELL E, 2000, PRINCIPLES TISSUE EN
   Black J, 1998, HDB BIOMATERIAL PROP
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   BONFIELD W, 1991, BONE-BIOMATERIAL INTERFACE, P89
   BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   BONFIELD W, 1987, MET MATER, V3, P712
   BONFIELD W, 1984, BIOMATERIALS BIOMECH, P421
   BONFIELD W, 1986, BIOL BIOMECHANICAL P, P153
   BONFIELD W, 1984, PROSTHESIS COMPRISIN
   Bonner M, 2002, J MATER SCI, V37, P325, DOI 10.1023/A:1013652312670
   BREME J, 1995, BIOMATERIALS, V16, P239, DOI 10.1016/0142-9612(95)92123-N
   Brown IG, 1999, SURF COAT TECH, V112, P271, DOI 10.1016/S0257-8972(98)00769-5
   Callister W.D., 1997, MAT SCI ENG INTRO
   CHANDRASEKARAN M, 2000, P 10 INT C BIOM ENG, P257
   CHUA B, 1999, MATER RES SOC S P, V599, P45
   CLARKE KI, 1993, J MATER SCI-MATER M, V4, P107, DOI 10.1007/BF00120378
   CLAXTON E, 1996, P 7 EUR C COM MAT EC, V2, P443
   Di Silvio L, 1998, J MATER SCI-MATER M, V9, P845, DOI 10.1023/A:1008900312950
   Domingo C, 2001, J BIOMED MATER RES, V56, P297, DOI 10.1002/1097-4636(200108)56:2<297::AID-JBM1098>3.0.CO;2-S
   Dornhoffer JL, 1998, LARYNGOSCOPE, V108, P531, DOI 10.1097/00005537-199804000-00013
   Downes RN, 1991, BIOCERAMICS, V4, P239
   DOYLE C, 1990, ADV BIOMAT, V9, P339
   DUCHEYNE P, 1982, J MATER SCI, V17, P595, DOI 10.1007/BF00591494
   Elliott JC, 1994, STRUCTURE CHEM APATI
   ESS JW, 1987, PLAST RUB PROC APPL, V8, P147
   EVANS GP, 1990, J MATER SCI-MATER M, V1, P38, DOI 10.1007/BF00705352
   FRANK FC, 1970, PROC R SOC LON SER-A, V319, P127, DOI 10.1098/rspa.1970.0170
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   GEESINK R, 1992, BONE BONDING BIOMATE
   GERMAN RM, 1989, PARICLE PACKING CHAR
   Guild FJ, 1998, J MATER SCI-MATER M, V9, P497, DOI 10.1023/A:1008831720198
   GUILD FJ, 1993, BIOMATERIALS, V14, P985, DOI 10.1016/0142-9612(93)90190-D
   Harper EJ, 1995, J MATER SCI-MATER M, V6, P799, DOI 10.1007/BF00134320
   Helsen J.A., 1998, METALS BIOMATERIALS
   HENCH L, 1993, INTRO BIOCERAMICS
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HOGG PJ, 1985, P 1 INT C COMP BIOM
   Huang J, 1997, J MATER SCI-MATER M, V8, P809, DOI 10.1023/A:1018581100400
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   HUANG J, 1997, BIOCERAMICS, V10, P519
   HUANG J, 2000, BIOCERAMICS, V13, P649
   HUANG J, 1995, BIOCERAMICS, V8, P389
   HUANG J, 1998, BIOCERAMICS, V11, P165
   HUANG J, 1996, BIOCERAMICS, V9, P431
   HULL D, 1996, INTRO COMPOSITE AMT
   HUTMACHER DW, 2000, P 8 INT C PROC FABR, P201
   JUHASZ JA, 2002, BIOCERAMICS, V15, P947
   JUHASZ JA, 2001, BIOCERAMICS, V14, P437
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Knepper M, 1997, BIOMATERIALS, V18, P1523, DOI 10.1016/S0142-9612(97)00066-5
   KOKUBO T, 1992, BONE BONDING BIOMATE
   KUBUBO T, 1999, MATER RES SOC S P, V599, P129
   LABELLA R, 1994, BIOMATERIALS, V15, P1197, DOI 10.1016/0142-9612(94)90269-0
   Ladizesky NH, 1997, POLYM ADVAN TECHNOL, V8, P496, DOI 10.1002/(SICI)1099-1581(199708)8:8<496::AID-PAT676>3.0.CO;2-R
   Ladizesky NH, 1998, COMPOS SCI TECHNOL, V58, P419, DOI 10.1016/S0266-3538(97)00140-1
   Learmonth I. D., 2000, INTERFACE TOTAL HIP
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   Liu Q, 1998, J BIOMED MATER RES, V40, P490, DOI 10.1002/(SICI)1097-4636(19980605)40:3<490::AID-JBM20>3.0.CO;2-M
   Nazhat SN, 2000, J MATER SCI-MATER M, V11, P621, DOI 10.1023/A:1008957729512
   NEO MC, 1999, BIOCERAMICS, V12, P449
   Nerem R.M., 2000, PRINCIPLES TISSUE EN
   OLMI R, 1983, CERAMICS SURG, P91
   OREFICE RL, 1995, BIOCERAMICS, V8, P409
   Pachence J. M., 2000, PRINCIPLES TISSUE EN
   PARK JB, 1992, BIOMATERIALS INTRO
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Reis RL, 1997, BIOCERAMICS, V10, P415
   Roberts G, 1992, CHITIN CHEM
   Santos JD, 1996, J MATER SCI-MATER M, V7, P187, DOI 10.1007/BF00121259
   Schwartz M. M., 1992, COMPOSITE MAT HDB
   Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F
   Shinzato S, 2001, J BIOMED MATER RES, V56, P452, DOI 10.1002/1097-4636(20010905)56:3<452::AID-JBM1115>3.0.CO;2-1
   Skalak R, 1988, TISSUE ENG
   SOUSA RA, 2000, BIOCERAMICS, V13, P669
   STAMBOULIS A, 2000, BIOCERAMICS, V13, P729
   Suwanprateeb J, 1995, J MATER SCI-MATER M, V6, P804
   Suwanprateeb J, 1997, J MATER SCI-MATER M, V8, P469, DOI 10.1023/A:1018522025474
   Suwanprateeb J, 1998, J BIOMED MATER RES, V39, P16, DOI 10.1002/(SICI)1097-4636(199801)39:1<16::AID-JBM3>3.0.CO;2-L
   Swain R. E., 1999, BIOMED ENG-APP BAS C, V11, P315
   TANG F, 2000, THESIS NANYANG TU
   TANG F, 2000, T 6 WORLD BIOM C HAW, P539
   TANG F, 1999, P INT C THERM PROP M, P502
   TANG F, 2000, P 8 INT C PROC FABR, P299
   TANNER KE, 1994, BRIT CERAM T, V93, P104
   TAURIO R, 1991, BIOCERAMICS, V4, P287
   That PTT, 2000, J BIOMED MATER RES, V51, P453
   That PTT, 2000, J BIOMED MATER RES, V51, P461
   Thompson RC, 2000, PRINCIPLES TISSUE EN
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   UNDERWOOD EE, 1970, QUANTITATIVE STEREOL
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Wang M, 2000, MATER LETT, V44, P119, DOI 10.1016/S0167-577X(00)00026-4
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Wang M, 1997, KEY ENG MATER, V127-3, P583, DOI 10.4028/www.scientific.net/KEM.127-131.583
   Wang M, 2002, J MATER SCI-MATER M, V13, P607, DOI 10.1023/A:1015139213211
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M, 2000, J MATER SCI, V35, P1023, DOI 10.1023/A:1004731315328
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang M, 1998, J MATER SCI-MATER M, V9, P621, DOI 10.1023/A:1008975323486
   Wang M, 2001, J MATER SCI-MATER M, V12, P821, DOI 10.1023/A:1017933220894
   Wang M, 1998, J BIOMED MATER RES, V42, P577, DOI 10.1002/(SICI)1097-4636(19981215)42:4<577::AID-JBM14>3.0.CO;2-2
   WANG M, 1999, BIOCERAMICS, V12, P401
   Wang M., 1996, POLYM PROCESSING AD2, P203
   WANG M, 1997, P 6 INT C PROC FABR, V2, P1729
   WANG M, 2000, P 10 INT C BIOM ENG, P219
   WANG M, 2000, T 6 WORLD BIOM C HAW, P81
   WANG M, 1995, HAPEX OTOLOGIC IMPLA
   WANG M, 2001, P 5 AS S BIOM MAT HO, P101
   Wang M, 2001, P 13 INT C COMP MAT
   WANG M, UNPUB
   Wang M., 1996, BIOCERAMICS, V9, P387
   WANG M, 1997, P 11 INT C COMP MAT, V1, P488
   WANG M, 2002, T SOC BIOM 28 ANN M, P259
   WANG M, 2000, P 10 INT C BIOM ENG, P545
   WANG M, 2000, BIOCERAMICS, V13, P741
   WANG M, 2001, BIOCERAMICS, V14, P429
   WANG M, 1996, P 7 EUR C COMP MAT L, V2, P455
   WANG M, 2002, BIOCERAMICS, V15, P935
   WANG M, 2002, RECENT RES DEV BIOMA
   WANG M, 1995, BIOCERAMICS, V8, P383
   Weng J, 2001, J MATER SCI LETT, V20, P1401, DOI 10.1023/A:1011643511015
   WENG J, 2000, BIOCERAMICS, V13, P657
   WILLIAMS DF, 1991, FUNDAMENTALS ASPECTS
   WOLFF J, 1987, GESETZ TRANSFORMATIN
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 133
TC 450
Z9 473
U1 5
U2 118
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2003
VL 24
IS 13
BP 2133
EP 2151
DI 10.1016/S0142-9612(03)00037-1
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 668FV
UT WOS:000182280400003
PM 12699650
DA 2018-10-20
ER

PT J
AU Huang, N
   Yang, P
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Wang, GJ
   Ding, PD
   Xi, TF
   Leng, Y
AF Huang, N
   Yang, P
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Wang, GJ
   Ding, PD
   Xi, TF
   Leng, Y
TI Hemocompatibility of titanium oxide films
SO BIOMATERIALS
LA English
DT Article
DE titanium oxide film; hemocompatibility; interface tension; N-type
   semiconductor
ID TEMPERATURE ISOTROPIC CARBON; BLOOD COMPATIBILITY; PROTEIN ADSORPTION;
   SURFACE-ENERGY; PLASMA-PROTEINS; BIOMATERIALS; DESORPTION; TIN
AB Hemocompatibility is a key property of biomaterials that come in contact with blood. Surface modification has shown great potential for improving the hemocompatibility of biomedical materials and devices. In this paper, we describe our work of improving hemocompatibility with Ti-O thin films prepared by plasma immersion ion implantation and deposition and by sputtering. The structure and surface chemical and physical properties of the films were characterized by X-ray diffraction, Auger electron spectroscopy, atomic force microscopy (AFM), contact angle measurement, and Hall effect measurement. The behavior of fibrinogen adsorption was investigated by I-125 radioactive isotope labeling and AFM. Systematic evaluation of hemocompatibility, including in vitro clotting time, thrombin time, prethrombin time, platelet adhesion, and in vivo implantation into dog's ventral aorta or right auricle from 17 to 90 days, proved that Ti-O films have excellent hemocompatibility. It is suggested that the significantly lower interface tension between Ti-O films and blood and plasma proteins and the semiconducting nature of Ti-O films give them their improved hemocompatibility. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 SW Jiaotong Univ, Sch Mat Sci & Engn, Inst Biomat & Surface Engn, Chengdu 610031, Sichuan, Peoples R China.
   Chongqing Univ, Sch Mat Sci & Engn, Chongqing 400000, Peoples R China.
   Natl Inst Pharmaceut & Bio Prod Control, Med Device Ctr, Beijing 100050, Peoples R China.
   Hong Kong Univ Sci & Technol, Dept Engn Mech, Hong Kong, Hong Kong, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Sch Mat Sci & Engn, Inst Biomat & Surface Engn, Chengdu 610031, Sichuan, Peoples R China.
EM huangnan@sc.homeway.com.cn
RI Leng, Yongxiang/G-5488-2010; Leng, Y.X./C-2278-2012; Leng,
   Yang/B-3187-2010
OI Leng, Y.X./0000-0001-6823-1233
CR AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   BRASH JL, 1979, J POLYM SCI POL SYM, P377
   CACCIAFESTA P, 6 WORLD BIOM C T MIN, P287
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   *COMM NAT SCI FDN, 1995, STRAT REP NAT SCI DI, P88
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DELANGIS PA, 1986, BIOMATER ARTIF CELL, V14, P195, DOI 10.3109/10731198609117543
   DIDISHEIM P, 1996, BIOMATER FORUM, V18, P14
   DION I, 1993, BIOMATERIALS, V14, P169, DOI 10.1016/0142-9612(93)90019-X
   EBERT R, 1982, WORLD C MED PHYS BIO, V3, P7
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   FENG L, 1995, J BIOMAT SCI-POLYM E, V7, P439, DOI 10.1163/156856295X00445
   FENG L, 1994, BIOMATERIALS, V15, P323
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Kawamoto N, 1997, J BIOMAT SCI-POLYM E, V8, P859, DOI 10.1163/156856297X00056
   MOTTO NF, 1987, CONDUCTION NONCRYSTA, P18
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SHARMA CP, 1984, J COLLOID INTERF SCI, V97, P585, DOI 10.1016/0021-9797(84)90332-1
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   Tran HS, 1999, J INVEST SURG, V12, P133
   XI TF, 1988, T 3 WORLD BIOM C JAP, P32
   YUHTA T, 1994, J BIOMED MATER RES, V28, P217, DOI 10.1002/jbm.820280212
   Zhang F, 1998, SURF COAT TECH, V104, P146, DOI 10.1016/S0257-8972(98)00434-4
NR 31
TC 262
Z9 286
U1 6
U2 99
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2003
VL 24
IS 13
BP 2177
EP 2187
DI 10.1016/S0142-9612(03)00046-2
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 668FV
UT WOS:000182280400006
PM 12699653
DA 2018-10-20
ER

PT J
AU Khor, E
   Lim, LY
AF Khor, E
   Lim, LY
TI Implantable applications of chitin and chitosan
SO BIOMATERIALS
LA English
DT Article
DE chitin; chitosan; implants; biomedical applications; dental materials;
   bone substitute materials; wound healing; tissue engineering; drug
   delivery
ID CALCIUM-PHOSPHATE CEMENTS; DRUG-RELEASE BEHAVIOR; IN-VITRO; COMPOSITE
   SCAFFOLDS; PHOTOCROSSLINKABLE CHITOSAN; PHOSPHORYLATED CHITOSAN;
   HISTOLOGICAL-EVALUATION; BLOOD COMPATIBILITY; PHYSICAL-PROPERTIES;
   ENDOTHELIAL-CELLS
AB Chitin, extracted primarily from shellfish sources, is a unique biopolymer based on the N-acetyl-glucosamine monomer. More than 40 years have lapsed since this biopolymer had aroused the interest of the scientific community around the world for its potential biomedical applications. Chitin, together with its variants, especially its deacetylated counterpart chitosan, has been shown to be useful as a wound dressing material, drug delivery vehicle and increasingly a candidate for tissue engineering. The promise for this biomaterial is vast and will continue to increase as the chemistry to extend its capabilities and new biomedical applications are investigated. It is interesting to note that a majority of this work has come from Asia. Japan has been the undisputed leader, but other Asian nations, namely Korea, Singapore, Taiwan and Thailand have also. made notable contributions. More recently, China has joined the club to become an increasingly major research source for chitin and chitosan in Asia, This review surveys select works of key groups in Asia developing chitin and chitosan materials for implantable biomedical applications. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.
   Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore.
RP Khor, E (reprint author), Natl Univ Singapore, Dept Chem, 3 Sci Dr 3,Kent Ridge, Singapore 117543, Singapore.
RI Lim, Lee Yong/C-6144-2013
OI Lim, Lee Yong/0000-0002-7307-0742
CR Ahn JS, 2002, BIOMATERIALS, V23, P1411, DOI 10.1016/S0142-9612(01)00261-7
   Ahn JS, 2001, BIOMATERIALS, V22, P923, DOI 10.1016/S0142-9612(00)00256-8
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Chow KS, 2001, J POLYM RES, V8, P27
   Chow KS, 2000, BIOMACROMOLECULES, V1, P61, DOI 10.1021/bm005503b
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Dung PL, 2001, CHITIN CHITOSAN CHIT, P27
   Gupta KC, 2001, J MATER SCI-MATER M, V12, P753, DOI 10.1023/A:1017976014534
   Gupta KC, 2000, BIOMATERIALS, V21, P1115, DOI 10.1016/S0142-9612(99)00263-X
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Hata H, 2000, BIOMATERIALS, V21, P1779, DOI 10.1016/S0142-9612(00)00069-7
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   Hirano S, 1998, BIOMATERIALS, V19, P293, DOI 10.1016/S0142-9612(97)00216-0
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   Hirano S, 2001, J BIOMED MATER RES, V56, P556, DOI 10.1002/1097-4636(20010915)56:4<556::AID-JBM1127>3.0.CO;2-O
   Hu Y, 2002, BIOMATERIALS, V23, P3193, DOI 10.1016/S0142-9612(02)00071-6
   Hung WS, 2001, J BIOMED MATER RES, V56, P93, DOI 10.1002/1097-4636(200107)56:1<93::AID-JBM1072>3.0.CO;2-B
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   ITO M, 1991, BIOMATERIALS, V12, P41, DOI 10.1016/0142-9612(91)90130-3
   Ito M, 1999, J BIOMED MATER RES, V45, P204, DOI 10.1002/(SICI)1097-4636(19990605)45:3<204::AID-JBM7>3.0.CO;2-4
   Kam HM, 1999, J BIOMED MATER RES, V48, P881, DOI 10.1002/(SICI)1097-4636(1999)48:6<881::AID-JBM18>3.0.CO;2-2
   Kawamata Y, 2002, BIOMATERIALS, V23, P4573, DOI 10.1016/S0142-9612(02)00203-X
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Khor E., 2001, CHITIN FULFILLING BI
   Kuen YL, 1995, BIOMATERIALS, V16, P1211
   Lee YM, 2000, J MATER SCI-MATER M, V11, P817, DOI 10.1023/A:1008961730929
   Lee YM, 1997, J MATER SCI-MATER M, V8, P537, DOI 10.1023/A:1018594614087
   Li F, 2002, BIOMATERIALS, V23, P343, DOI 10.1016/S0142-9612(01)00111-9
   Lim L. Y., 1998, P C CHALL DRUG DEL P, P196
   Lim LY, 1999, J BIOMED MATER RES, V48, P111
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Mi FL, 1999, BIOMATERIALS, V20, P1603, DOI 10.1016/S0142-9612(99)00064-2
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Mi FL, 2002, BIOMATERIALS, V23, P3257, DOI 10.1016/S0142-9612(02)00084-4
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Park SB, 2001, BIOMATERIALS, V22, P323, DOI 10.1016/S0142-9612(00)00187-3
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Risbud M, 2001, J BIOMED MATER RES, V56, P120, DOI 10.1002/1097-4636(200107)56:1<120::AID-JBM1076>3.0.CO;2-W
   Risbud MV, 2001, J BIOMED MATER RES, V57, P300, DOI 10.1002/1097-4636(200111)57:2<300::AID-JBM1171>3.0.CO;2-Q
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Shi XY, 2002, BIOMATERIALS, V23, P4469, DOI 10.1016/S0142-9612(02)00165-5
   Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3
   Su CH, 1999, BIOMATERIALS, V20, P61, DOI 10.1016/S0142-9612(98)00139-2
   Sunny MC, 2002, J MATER SCI-MATER M, V13, P623, DOI 10.1023/A:1015709705074
   Takechi M, 2002, J MATER SCI-MATER M, V13, P973, DOI 10.1023/A:1019816830793
   Takechi M, 2001, J MATER SCI-MATER M, V12, P597, DOI 10.1023/A:1011285509391
   Takechi M, 1998, BIOMATERIALS, V19, P2057, DOI 10.1016/S0142-9612(98)00114-8
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tanaka Y, 1997, BIOMATERIALS, V18, P591, DOI 10.1016/S0142-9612(96)00182-2
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4
   Ueno H, 2001, BIOMATERIALS, V22, P1667, DOI 10.1016/S0142-9612(00)00328-8
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Usami Y, 1998, J BIOMED MATER RES, V42, P517
   Wan ACA, 1998, J BIOMED MATER RES, V41, P541, DOI 10.1002/(SICI)1097-4636(19980915)41:4<541::AID-JBM5>3.0.CO;2-C
   Wan ACA, 1998, BIOMATERIALS, V19, P1309
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   Wan ACA, 1997, J BIOMED MATER RES, V38, P235, DOI 10.1002/(SICI)1097-4636(199723)38:3<235::AID-JBM8>3.0.CO;2-Q
   Wang LH, 2001, J PHARM SCI-US, V90, P1134, DOI 10.1002/jps.1067
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang XH, 2002, BIOMATERIALS, V23, P4591, DOI 10.1016/S0142-9612(02)00205-3
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Yan XL, 2001, J BIOMED MATER RES, V58, P358, DOI 10.1002/jbm.1029
   Yan XL, 2000, CHEM PHARM BULL, V48, P941
   Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6
   Yusof NLBM, 2001, J BIOMED MATER RES, V54, P59, DOI 10.1002/1097-4636(200101)54:1<59::AID-JBM7>3.0.CO;2-U
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   Zhao HR, 2002, BIOMATERIALS, V23, P4459, DOI 10.1016/S0142-9612(02)00162-X
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
NR 90
TC 988
Z9 1064
U1 26
U2 456
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2003
VL 24
IS 13
BP 2339
EP 2349
DI 10.1016/S0142-9612(03)00026-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 668FV
UT WOS:000182280400025
PM 12699672
DA 2018-10-20
ER

PT J
AU Machado, LG
   Savi, MA
AF Machado, LG
   Savi, MA
TI Medical applications of shape memory alloys
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE shape memory alloys; biomaterials
AB Shape memory alloys (SMA) are materials that have the ability to return to a former shape when subjected to an appropriate thermomechanical procedure. Pseudoelastic and shape memory effects are some of the behaviors presented by these alloys. The unique properties concerning these alloys have encouraged many investigators to look for applications of SMA in different fields of human knowledge. The purpose of this review article is to present a brief discussion of the thermomechanical behavior of SMA and to describe their most promising applications in the biomedical area. These include cardiovascular and orthopedic uses, and surgical instruments.
C1 UFRJ, COPPE, Dept Engn Mecan, BR-21945970 Rio De Janeiro, Brazil.
RP Savi, MA (reprint author), UFRJ, COPPE, Dept Engn Mecan, Caixa Postal 68-503, BR-21945970 Rio De Janeiro, Brazil.
RI Savi, Marcelo/C-1179-2013
OI Savi, Marcelo/0000-0001-5454-5995
CR Airoldi G, 1996, BIO-MED MATER ENG, V6, P299
   Birman V, 1997, INT J MECH SCI, V39, P1139, DOI 10.1016/S0020-7403(97)00008-8
   Chu Y, 2000, MATER SCI FORUM, V327-3, P55, DOI 10.4028/www.scientific.net/MSF.327-328.55
   Denoyer KK, 2000, ACTA ASTRONAUT, V47, P389, DOI 10.1016/S0094-5765(00)00080-1
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Duerig TW, 1996, METALL, V50, P569
   Funakubo H., 1987, SHAPE MEMORY ALLOYS
   Hodgson D. E., 1990, METALS HDB, V2, P897
   JORDAN L, 1991, J PHYS IV, V1, P139, DOI 10.1051/jp4:1991421
   Lagoudas DC, 1999, P 4 INT WORKSH MATH
   Li BY, 2000, INTERMETALLICS, V8, P881, DOI 10.1016/S0966-9795(00)00024-8
   Mantovani D, 2000, JOM-J MIN MET MAT S, V52, P36, DOI 10.1007/s11837-000-0082-4
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   Pacheco P.M.C.L., 2000, REV ENGENHARIA CIENC
   Pelton AR, 2000, MATER SCI FORUM, V327-3, P63, DOI 10.4028/www.scientific.net/MSF.327-328.63
   ROGERS CA, 1995, SCI AM           SEP, P122
   RYHANEN J, 1999, THESIS U OULU OULU F
   Savi MA, 2002, J INTEL MAT SYST STR, V13, P261, DOI 10.1106/104538902029066
   Schetky LM, 2000, MATER SCI FORUM, V327-3, P9, DOI 10.4028/www.scientific.net/MSF.327-328.9
   Shabalovskaya SA, 1995, J PHYS IV, V5, P1199, DOI 10.1051/jp4/1995581199
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
   van Humbeeck J, 1997, J PHYS IV, V7, P3, DOI 10.1051/jp4:1997501
   Webb G, 2000, AIAA J, V38, P325, DOI 10.2514/2.960
   Wu SK, 2000, MATER CHEM PHYS, V64, P81, DOI 10.1016/S0254-0584(99)00258-8
   ZHANG XD, 1992, PHILOS MAG A, V65, P1199, DOI 10.1080/01418619208201505
NR 25
TC 208
Z9 220
U1 4
U2 26
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD JUN
PY 2003
VL 36
IS 6
BP 683
EP 691
DI 10.1590/S0100-879X2003000600001
PG 9
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 696BX
UT WOS:000183866400001
PM 12792695
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Vena, P
   Contro, R
AF Vena, P
   Contro, R
TI An anisotropic damage model for the evaluation of load carrying capacity
   of composite artificial ligaments
SO CMES-COMPUTER MODELING IN ENGINEERING & SCIENCES
LA English
DT Article
AB The adoption of artificial ligaments in current surgery is still characterised by a low success rate due to the fact that mechanical properties of the biomedical devices are such that a biomechanical compatibility is not fully satisfied. A durable artificial ligament should exhibit stiffness as well as strength properties which are such that a full articulation functionality is guaranteed. To this purpose, reliable numerical methods able to predict the mechanical behaviour of such devices both in the elastic and in inelastic range until complete rupture, could be used for designing of devices with tailored mechanical properties.
   The present paper deals with the mechanical characterisation of artificial ligaments made of composite materials, with specific reference to the tensile load carrying capacity. The artificial ligaments taken into consideration are composite cylinders which are manufactured by reinforcing a compliant matrix by means of helicoidally oriented fibres. A finite strain model has been developed and characterised by a stiffness degradation of the reinforcing fibres playing the prominent mechanical role. A suitable choice of the constitutive parameters allowed to reproduce the elastic behaviour and to catch the limit load experimentally measured.
C1 Politecn Milan, Lab Biol Struct Mech, Dept Struct Engn, I-20133 Milan, Italy.
RP Vena, P (reprint author), Politecn Milan, Lab Biol Struct Mech, Dept Struct Engn, Piazza Leonardo Vinci,32, I-20133 Milan, Italy.
RI Vena, Pasquale/F-6684-2013
OI Vena, Pasquale/0000-0003-2229-5156
CR BATHE KJ, 1982, FINITE ELEMENT PROCE
   Carol I, 2001, INT J SOLIDS STRUCT, V38, P491, DOI 10.1016/S0020-7683(00)00030-5
   Chen Z, 2000, CMES-COMP MODEL ENG, V1, P57
   Fung Y. C., 1981, BIOMECHANICS MECH PR
   Hokanson J, 1997, MECH RES COMMUN, V24, P151, DOI 10.1016/S0093-6413(97)00007-4
   Holzapfel GA, 2001, COMPUT METHOD APPL M, V190, P4379, DOI 10.1016/S0045-7825(00)00323-6
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   KRAJCINOVIC D, 1996, DAMAGE MECH
   KRAJCINOVIC D, 1980, ASCE, V106, P1039
   MALVERN LE, 1969, INTRO MECH CONTINUOU
   MANZEL A, 1999, P EUR C COMP MECH MU
   MURAKAMI S, 1988, J APPL MECH-T ASME, V55, P280, DOI 10.1115/1.3173673
   OGDEN RW, 1984, E HORWOOD SERIES MAT
   STEINMANN P, 1998, INT J ENG SCI, V151, P513
NR 14
TC 1
Z9 1
U1 0
U2 2
PU TECH SCIENCE PRESS
PI ENCINO
PA 4924 BALBOA BLVD, # 488, ENCINO, CA 91316 USA
SN 1526-1492
J9 CMES-COMP MODEL ENG
JI CMES-Comp. Model. Eng. Sci.
PD JUN
PY 2003
VL 4
IS 3-4
BP 497
EP 506
PG 10
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
SC Engineering; Mathematics
GA 706ZN
UT WOS:000184485100013
DA 2018-10-20
ER

PT J
AU Semino, CE
   Merok, JR
   Crane, GG
   Panagiotakos, G
   Zhang, SG
AF Semino, CE
   Merok, JR
   Crane, GG
   Panagiotakos, G
   Zhang, SG
TI Functional differentiation of hepatocyte-like spheroid structures from
   putative liver progenitor cells in three-dimensional peptide scaffolds
SO DIFFERENTIATION
LA English
DT Article
DE progenitor cell differentiation; hepatocyte-like cells; biological
   materials; self-assembling peptide scaffold
ID EMBRYONIC STEM-CELLS; SELF-COMPLEMENTARY OLIGOPEPTIDE; IN-VITRO; RAT;
   EXPRESSION; CAFFEINE; TISSUE; METABOLISM; EXPANSION; DIVISION
AB We investigated the ability of a new type of biological material, the self-assembling peptide scaffold, to foster tissue-like function by a putative adult rat hepatocyte progenitor cell line, Lig-8. In conventional adherent petri-dish cultures, Lig-8 cells divide exponentially, express markers for definitive endoderm HNF3beta and hepatocyte lineage, including CK8 and alpha-fetoprotein, but lack expression of mature hepatocyte markers. However, in the three-dimensional peptide scaffold cultures, Lig-8 exhibits non-exponential cell kinetics, acquires a spheroidal morphology, and produces progeny cells with mature hepatocyte properties. The differentiated progeny cells display expression of transcription factor C/EBPalpha and several other indicators that suggest hepatocyte maturation, including binucleation, up-regulation of albumin, and expression of cytochrome P450s CYP1A1, CYP1A2, and CYP2E1. Moreover, all three cytochrome p450 enzyme activities are induced using 3-methylcholanthrene in these spheroids. These results suggest that a designed biological material may provide a conducive microenvironment in which putative adult progenitor cells differentiate into functional hepatocyte-like spheroid clusters. This bioengineered scaffold system provides a better physiological approach to "progenitor cell differentiation" for future biomedical and pharmaceutics applications.
C1 MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   MIT, Biotechnol Proc Engn Ctr, Cambridge, MA 02139 USA.
   MIT, Biol Engn Div, Cambridge, MA 02139 USA.
RP Semino, CE (reprint author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
CR BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   BOUWENS L, 1994, DIABETES, V43, P1279, DOI 10.2337/diabetes.43.11.1279
   BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185
   BUTLER MA, 1989, P NATL ACAD SCI USA, V86, P7696, DOI 10.1073/pnas.86.20.7696
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   DONATO MT, 1993, ANAL BIOCHEM, V213, P29, DOI 10.1006/abio.1993.1381
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Grisham J. W., 1997, P233, DOI 10.1016/B978-012563455-7/50009-X
   HOFFMAN R, 1999, CURR OPIN HEMATOL, V6, P187
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   HOUSSAINT E, 1980, CELL DIFFER DEV, V9, P269, DOI 10.1016/0045-6039(80)90026-3
   JONES PBC, 1985, SCIENCE, V227, P1499, DOI 10.1126/science.3856321
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Loeffler Markus, 1997, P1, DOI 10.1016/B978-012563455-7/50002-7
   Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866
   McNiece I, 2001, EXP HEMATOL, V29, P3, DOI 10.1016/S0301-472X(00)00610-X
   Merok Joshua R., 2001, Journal of Biomedicine and Biotechnology, V1, P25, DOI 10.1155/S1110724301000067
   PALACIOS R, 1995, P NATL ACAD SCI USA, V92, P7530, DOI 10.1073/pnas.92.16.7530
   POTTEN CS, 1988, J CELL SCI S, V10, P45
   Rambhatla Lakshmi, 2001, Journal of Biomedicine and Biotechnology, V1, P28, DOI 10.1155/S1110724301000079
   RATANASAVANH D, 1990, BIOCHEM PHARMACOL, V39, P85, DOI 10.1016/0006-2952(90)90651-Z
   ROBERTS EA, 1994, BIOCHEM BIOPH RES CO, V201, P559, DOI 10.1006/bbrc.1994.1738
   ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182
   SEMINO CE, 2003, IN PRESS J BIOMED BI, P3
   SHERLEY JL, 1995, P NATL ACAD SCI USA, V92, P136, DOI 10.1073/pnas.92.1.136
   SHIOJIRI N, 1991, CANCER RES, V51, P2611
   Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x
   VANEYKEN P, 1988, LAB INVEST, V59, P52
   WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 35
TC 227
Z9 242
U1 1
U2 35
PU BLACKWELL VERLAG GMBH
PI BERLIN
PA KURFURSTENDAMM 57, D-10707 BERLIN, GERMANY
SN 0301-4681
J9 DIFFERENTIATION
JI Differentiation
PD JUN
PY 2003
VL 71
IS 4-5
BP 262
EP 270
DI 10.1046/j.1432-0436.2003.7104503.x
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 692YN
UT WOS:000183688000003
PM 12823227
DA 2018-10-20
ER

PT J
AU Dorman, MJ
   Krampert, J
   Sturchio, GM
AF Dorman, MJ
   Krampert, J
   Sturchio, GM
TI Source efficiencies for various materials encountered during
   decommissioning surveys at biomedical research facilities.
SO HEALTH PHYSICS
LA English
DT Meeting Abstract
C1 Merck & Co Inc, Rahway, NJ 07065 USA.
   Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD JUN
PY 2003
VL 84
IS 6
SU 2
BP S227
EP S228
PG 2
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 683QE
UT WOS:000183160000228
DA 2018-10-20
ER

PT J
AU Wang, SG
   Cai, Q
   Bei, JZ
AF Wang, SG
   Cai, Q
   Bei, JZ
TI An important biodegradable polymer - Polylactone family polymer
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 39th International Symposium on Macromolecules
CY JUL 07-12, 2002
CL BEIJING, PEOPLES R CHINA
SP Chinese Chem Soc
DE biodegradable; drug delivery; polylactone; tissue engineering
ID EPSILON-CAPROLACTONE; L-LACTIDE; DEGRADATION; COPOLYMER
AB Systemic investigation on the synthesis and properties of aliphatic polylactones were carried out. And various materials were obtained with different degradation rates and mechanical properties. Two in vivo experiments were presented in this study to envision the biomedical applications of this kind of aliphatic polylactones.
C1 Chinese Acad Sci, Inst Chem, Ctr Mol Sci, Beijing 100080, Peoples R China.
RP Wang, SG (reprint author), Chinese Acad Sci, Inst Chem, Ctr Mol Sci, Beijing 100080, Peoples R China.
CR Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Herrero-Vanrell R, 2001, ADV DRUG DELIVER REV, V52, P5, DOI 10.1016/S0169-409X(01)00200-9
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   LI SM, 1999, P GLOB CHIN S BIOM C, P333
   Qian HT, 2000, POLYM DEGRAD STABIL, V68, P423, DOI 10.1016/S0141-3910(00)00031-8
   RICHARD LD, 1995, BIOMEDICAL APPL SYNT, P17
   WANG SG, 2000, CHIN J PLAST SURG, V16, P328
   WANG SG, 1997, CHEM COMMUN, V2, P45
   WANG SG, 2001, CHINESE J BIOMATERIA, V10, P47
   YANG J, 2000, J FUNCT POLYM, V13, P455
NR 11
TC 17
Z9 20
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUN
PY 2003
VL 195
BP 263
EP 268
DI 10.1002/masy.200390132
PG 6
WC Polymer Science
SC Polymer Science
GA 706UX
UT WOS:000184474400033
DA 2018-10-20
ER

PT J
AU Suaste-Gomez, E
   Gonzalez-Ballesteros, R
   Castillo-Rivas, V
AF Suaste-Gomez, E
   Gonzalez-Ballesteros, R
   Castillo-Rivas, V
TI Pyroelectric properties of Pb(0.88)Ln(0.08)Ti(0.98)Mn(0.02)O(3) (Ln=La,
   Sm, Eu) ferroelectric ceramic system
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE ferroelectric ceramic; pyroelectricity; rare-earth elements;
   pyroelectric ceramic
ID TITANATE
AB In this work, the pyroelectric properties of Pb(0.88)Ln(0.08)Ti(0.98)Mn(0.02)O(3) (Ln = La, Sm, Eu) ferroelectric ceramic system are studied. This type of ferroelectric ceramic presents high values of the following characteristics: dielectric constant, Curie temperature, electromechanical anisotropy, and high frequencies of operation, which make them useful for applications such as ultrasonic transducers in biomedical applications. The relationship between dielectric constant and temperature measurements as well as pyroelectric measurements using the technique of Byer and Roundy were performed. Values of the pyroelectric coefficient and figure of merit for infrared detector materials were obtained to use these ceramics in the detection of infrared radiation, laser power measurements, and solar energy technology. (C) 2003 Elsevier Inc. All rights reserved.
C1 Inst Politecn Nacl, CINVESTAV IPN, Dept Ingn Elect, Seccion Bioelect, Mexico City 07000, DF, Mexico.
RP Suaste-Gomez, E (reprint author), Inst Politecn Nacl, CINVESTAV IPN, Dept Ingn Elect, Seccion Bioelect, Mexico City 07000, DF, Mexico.
CR BYER RL, 1972, IEEE T SON ULTRASON, VSU19, P333, DOI 10.1109/T-SU.1972.29679
   CHYNOWETH AG, 1956, J APPL PHYS, V27, P78, DOI 10.1063/1.1722201
   GLASS AM, 1968, PHYS REV, V172, P564, DOI 10.1103/PhysRev.172.564
   GLASS AM, 1969, J APPL PHYS, V40, P4699, DOI 10.1063/1.1657277
   JAFFE B, 1955, J RES NAT BUR STAND, V55, P239, DOI 10.6028/jres.055.028
   Perez Martinez O., 1995, Revista Mexicana de Fisica, V41, P85
   Ramirez-Rosales D, 2001, SOLID STATE COMMUN, V118, P371, DOI 10.1016/S0038-1098(01)00072-2
   Suaste-Gomez E., 2002, Ferroelectrics, V273, P273, DOI 10.1080/00150190211757
NR 8
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
J9 MATER CHARACT
JI Mater. Charact.
PD JUN
PY 2003
VL 50
IS 4-5
BP 349
EP 352
DI 10.1016/S1044-5803(03)00126-8
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 740QK
UT WOS:000186412900011
DA 2018-10-20
ER

PT J
AU Kazanci, M
AF Kazanci, M
TI A review of polymeric smart materials for biomedical applications
SO MATERIALS TECHNOLOGY
LA English
DT Review
ID POLYPYRROLE-HEPARIN; BIOSENSORS; BIOMATERIALS; GROWTH; COMPOSITES;
   DELIVERY; SURFACE; RELEASE
C1 Hebrew Univ Jerusalem, Casali Inst Appl Chem, IL-91904 Jerusalem, Israel.
RP Kazanci, M (reprint author), Hebrew Univ Jerusalem, Casali Inst Appl Chem, IL-91904 Jerusalem, Israel.
CR BELLAMKONDA R, 1994, BIOTECHNOL BIOENG, V43, P543, DOI 10.1002/bit.260430703
   BERGBREITER DE, 1999, SYNTHETIC DESIGN RES, P301
   CLARK LC, 1953, J APPL PHYSIOL, V6, P189
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   Coon DR, 1997, ANAL CHEM, V69, P4120, DOI 10.1021/ac970171v
   Curtis PT, 1996, ADV PERFORM MATER, V3, P279, DOI 10.1007/BF00136792
   Dai LM, 2000, J PHYS CHEM B, V104, P1891, DOI 10.1021/jp9926793
   Garner B, 1999, J MATER SCI-MATER M, V10, P19, DOI 10.1023/A:1008835925998
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   GOPEL W, 1991, SENSORS A COMPREHENS, V2
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Healey BG, 1997, ANAL BIOCHEM, V251, P270, DOI 10.1006/abio.1997.2254
   Ista LK, 1999, APPL ENVIRON MICROB, V65, P1603
   JACKSON DW, 1999, ORTHO RELATED RES, V367, P31
   Karube I, 2000, J MOL CATAL B-ENZYM, V10, P177, DOI 10.1016/S1381-1177(00)00125-9
   KHAN IM, 1999, FIELD RESPONSIVE POL
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   LI FM, 1999, STIMULI RESPONSIVE B, P266
   Noor AK, 2000, COMPUT STRUCT, V74, P507, DOI 10.1016/S0045-7949(99)00067-X
   Palecek E, 1998, BIOSENS BIOELECTRON, V13, P621, DOI 10.1016/S0956-5663(98)00017-7
   RAMKISSOONGANOR.C, 1999, TEMPERATURE PH RESPO, P322
   Saito N, 2001, J BONE JOINT SURG AM, V83, P92
   Saltzman WM, 1996, MRS BULL, V21, P62
   SALTZMAN WM, 1993, J APPL POLYM SCI, V48, P1493
   Svec F, 1999, IND ENG CHEM RES, V38, P34, DOI 10.1021/ie970598s
   Takagi T, 1996, J INTEL MAT SYST STR, V7, P346, DOI 10.1177/1045389X9600700317
   Tvarozek V, 1998, VACUUM, V50, P251, DOI 10.1016/S0042-207X(98)00050-5
   Van Regenmortel MHV, 1998, J MOL RECOGNIT, V11, P163
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang J, 1998, BIOSENS BIOELECTRON, V13, P757, DOI 10.1016/S0956-5663(98)00039-6
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
NR 31
TC 7
Z9 7
U1 4
U2 15
PU MATRICE TECHNOLOGY LIMITED
PI POULTON
PA PO BOX 41, POULTON FY6 8GD, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD JUN
PY 2003
VL 18
IS 2
BP 87
EP 93
DI 10.1080/10667857.2003.11753019
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 688HE
UT WOS:000183427500008
DA 2018-10-20
ER

PT J
AU Letant, SE
   Hart, BR
   Van Buuren, AW
   Terminello, LJ
AF Letant, SE
   Hart, BR
   Van Buuren, AW
   Terminello, LJ
TI Functionalized silicon membranes for selective bio-organism capture
SO NATURE MATERIALS
LA English
DT Article
ID GOLD NANOTUBULE MEMBRANES; POROUS SILICON; NANOPOROUS MEMBRANES;
   TRANSPORT-PROPERTIES; IMMUNOISOLATION; ALKENES; THIOLS
AB Membranes with various pore size, length, morphology and density have been synthesized from diverse materials(1-5) for size-exclusion-based separation. An example is the sterilization of intravenous lines by exclusion of bacteria and viruses using polyvinylidene fluoride membranes with 0.1-mum-diameter pores. Chemically specific filtration has recently been addressed for small molecules(6-10). Nevertheless, specific bio-organism immobilization and detection remains a great technical challenge in many biomedical applications, such as decontamination or analysis of air and liquids such as drinking water and body fluids. To achieve this goal, materials with controlled pore diameter, length and surface chemistry are required. In this letter, we present the first functionalized silicon membranes and demonstrate their ability to selectively capture simulated bio-organisms. These extremely versatile and rigid devices open the door to a new class of materials that are able to recognize the external fingerprints of bio-organisms-such as size and outer membrane proteins-for specific capture and detection applications.
C1 Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Livermore, CA 94550 USA.
RP Letant, SE (reprint author), Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Livermore, CA 94550 USA.
CR Birner A, 2001, ADV MATER, V13, P377, DOI 10.1002/1521-4095(200103)13:6<377::AID-ADMA377>3.3.CO;2-O
   Boukherroub R, 2001, CHEM MATER, V13, P2002, DOI 10.1021/cm000790b
   Buriak JM, 2002, CHEM REV, V102, P1271, DOI 10.1021/cr000064s
   Buriak JM, 1998, J AM CHEM SOC, V120, P1339, DOI 10.1021/ja9740125
   Canham LT, 1999, ADV MATER, V11, P1505, DOI 10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.3.CO;2-3
   Chun KY, 2002, LANGMUIR, V18, P4653, DOI 10.1021/la011250b
   Dancil KPS, 1999, J AM CHEM SOC, V121, P7925, DOI 10.1021/ja991421n
   Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9
   Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601
   HART BR, 2003, CHEM COMMUN, V3, P322
   Idris A, 2002, J MEMBRANE SCI, V205, P223, DOI 10.1016/S0376-7388(02)00116-3
   Jirage KB, 1999, ANAL CHEM, V71, P4913, DOI 10.1021/ac990615i
   Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655
   Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396
   Lee SB, 2001, CHEM MATER, V13, P3236, DOI 10.1021/cm0101071
   Lehmann V, 2002, NAT MATER, V1, P12, DOI 10.1038/nmat707
   LEHMANN V, 1990, J ELECTROCHEM SOC, V137, P653, DOI 10.1149/1.2086525
   Lehmann V, 2001, APPL PHYS LETT, V78, P589, DOI 10.1063/1.1334943
   Leoni L, 2002, BIOMED MICRODEVICES, V4, P131, DOI 10.1023/A:1014639332543
   Loncar M, 2000, J LIGHTWAVE TECHNOL, V18, P1402, DOI 10.1109/50.887192
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   Stewart MP, 2001, J AM CHEM SOC, V123, P7821, DOI 10.1021/ja011116d
NR 22
TC 54
Z9 55
U1 4
U2 43
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD JUN
PY 2003
VL 2
IS 6
BP 391
EP 396
DI 10.1038/nmat888
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 688CR
UT WOS:000183415700015
PM 12717430
DA 2018-10-20
ER

PT J
AU Velten, D
   Schenk-Meuser, K
   Biehl, V
   Duschner, H
   Breme, J
AF Velten, D
   Schenk-Meuser, K
   Biehl, V
   Duschner, H
   Breme, J
TI Characterization of thermal and anodic oxide layers on beta- and on
   near-beta-titanium alloys for biomedical application
SO ZEITSCHRIFT FUR METALLKUNDE
LA English
DT Article
DE biomaterials; Ti alloys; surface oxide layer; corrosion
ID TOTAL HIP-ARTHROPLASTY; SURFACE CHARACTERIZATION; PURE TITANIUM; IMPLANT
   MATERIALS; BONE; OXIDATION; BEHAVIOR; TANTALUM; FILMS; TIO2
AB beta- and near-beta-Ti alloys for biomedical applications show a favourable mix of mechanical, biological and biocompatible properties. In this study, oxide layers on Ti13Nb13Zr, Ti15Mo5Zr3Al, Ti30Nb and Ti30Ta were prepared by thermal and anodic oxidation, in order to adjust constant, reproducible and well-defined surface properties. The thickness, the phase composition and the element composition of the oxide layers were determined. The corrosion properties were investigated by current density-potential curves under physiological conditions. Depending on the oxidation parameters, film thicknesses in the range 10-250 nm can be prepared. The thermal oxide layers consist predominantly of TiO2 in rutile structure while the anodized samples show a mixture of anatase and amorphous TiO2. In addition, certain amounts of mixed oxides of titanium and alloying elements such as TiZrO4 or TiNb2O7 are found in the oxide films. The corrosion resistance of the oxidized samples is increased as compared with the polished samples whose current densities in the range of passivity are comparable to that of Ti6Al4V.
C1 Univ Saarbrucken, Lehrstuhl Met Werkstoffe, Saarbrucken, Germany.
   Univ Mainz, Fachberich Med, Angew Struktur & Mikronanalyt, Mainz, Germany.
RP Velten, D (reprint author), Univ Saarbrucken, Lehrstuhl Met Werkstoffe, Saarbrucken, Germany.
EM d.velten@mx.uni-saarland.de
CR ALADJEM A, 1973, J MATER SCI, V8, P688, DOI 10.1007/BF00561225
   ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   BOBYN JD, 1990, CLIN ORTHOP RELAT R, P196
   BOEHM HP, 1971, DISCUSS FARADAY SOC, P264
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Christensen FB, 2000, EUR SPINE J, V9, P97, DOI 10.1007/s005860050218
   COLLINGS EW, 1994, TITANIUM ALLOYS MAT, P3
   DEGATICA NLH, 1993, APPL SURF SCI, V68, P107, DOI 10.1016/0169-4332(93)90220-6
   Depero LE, 1998, MATER SCI FORUM, V278-2, P654, DOI 10.4028/www.scientific.net/MSF.278-281.654
   Eisenbarth E, 2001, BIOMATERIALIEN, V2, P203
   GASPERIN M, 1984, J SOLID STATE CHEM, V53, P144, DOI 10.1016/0022-4596(84)90238-X
   GASSER B, 1997, GALVANOTECHNIK, V51, P88
   GERBER H, 1978, ACTA MED AUSTR, V11, P3
   Gobel M, 2000, SURF INTERFACE ANAL, V29, P321
   Gonzalez RJ, 1997, NATO ASI 3 HIGH TECH, V23, P395
   HAZAN R, 1993, BIOMATERIALS, V14, P570, DOI 10.1016/0142-9612(93)90172-X
   Helsen J.A., 1998, METALS BIOMATERIALS
   HUMS E, 1990, PHYS CHEM, V94, P691
   Ikeda M, 1998, MAT SCI ENG A-STRUCT, V243, P140, DOI 10.1016/S0921-5093(97)00791-0
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   JONGEJAN A, 1969, LESS COMMON METALS, V19, P186
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   Kittaka S, 1997, J SOLID STATE CHEM, V132, P447, DOI 10.1006/jssc.1997.7548
   Larsson C, 1997, J MATER SCI-MATER M, V8, P721, DOI 10.1023/A:1018548225899
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LEACH JJL, 1981, P 7 INT C MET CORR M, P82
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopez MF, 2002, SURF INTERFACE ANAL, V33, P570, DOI 10.1002/sia.1422
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   MORSI MM, 1984, PHYS CHEM GLASSES, V25, P64
   Nakamoto K., 1986, INFRARED RAMAN SPECT
   *NAT BUR STAND US, 1983, NAT BUR STAND US MON, V25, P115
   Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.0.CO;2-C
   NOGUCHI T, 1968, B CHEM SOC JPN, V41, P2898
   Park Y, 1999, OXID MET, V51, P383, DOI 10.1023/A:1018883009343
   PRENDERGAST PJ, 1990, J BIOMED ENG, V12, P379, DOI 10.1016/0141-5425(90)90020-N
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   ROESSLER S, 2000, BIOMATERIALIEN, V1, P32
   Semlitsch M, 1995, BIOMED TECH, V40, P347, DOI 10.1515/bmte.1995.40.12.347
   SERRUYS Y, 1993, SURF SCI, V282, P279, DOI 10.1016/0039-6028(93)90934-C
   SITTIG C, 1999, P SYN TAG MUNS BER A, V1, pI2
   Steinemann S., 1980, EVALUATION BIOMATERI
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   THULL R, 2000, BIOMATERIALIEN, V1, P6
   Trasferetti BC, 2000, APPL SPECTROSC, V54, P687, DOI 10.1366/0003702001949933
   Trentz OA, 1997, UNFALLCHIRURG, V100, P39, DOI 10.1007/s001130050093
   UNGERSBOCK A, 1994, J MATER SCI-MATER M, V5, P788, DOI 10.1007/BF00213136
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
   Wack T, 1999, MATER SCI FORUM, V299-3, P348, DOI 10.4028/www.scientific.net/MSF.299-300.348
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Worch H, 1998, Z METALLKD, V89, P153
   XIE SF, 1988, KEY ENG MATER, V20, P397
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
   ZITTER H, 1990, BHM, V135, P171
   Zwicker U., 1980, P 4 INT C TIT KY, P505
NR 59
TC 8
Z9 8
U1 0
U2 8
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0044-3093
J9 Z METALLKD
JI Z. Metallk.
PD JUN
PY 2003
VL 94
IS 6
BP 667
EP 675
DI 10.3139/146.030668
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 810IL
UT WOS:000220697900005
DA 2018-10-20
ER

PT J
AU Klajnert, B
   Stanislawska, L
   Bryszewska, M
   Palecz, B
AF Klajnert, B
   Stanislawska, L
   Bryszewska, M
   Palecz, B
TI Interactions between PAMAM dendrimers and bovine serum albumin
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE PAMAM dendrimer; serum albumin; intrinsic fluorescence; red edge
   excitation shift; fluorescence quenching; tryptophan fluorescence; ANS;
   energy transfer; differential scanning calorimetry
ID POLYAMIDOAMINE DENDRIMERS; TRYPTOPHAN RESIDUES; IN-VITRO; FLUORESCENCE;
   PROBE; TRANSITION; RESONANCE; SULFONATE; BINDING; LECTIN
AB Dendrimers are a new class of polymeric materials. They are globular, highly branched, monodisperse macromolecules. Due to their structure, dendrimers promise to be new, effective biomedical materials as oligonucleotide transfection agents and drug carriers. More information about biological properties of dendrimers is crucial for further investigation of dendrimers in therapeutic applications.
   In this study the mechanism of interactions between polyamidoamine (PAMAM) dendrimers and bovine serum albumin (BSA) was examined. PAMAM dendrimers are based on an ethylenediamine core and branched units are constructed from both methyl acrylate and ethylenediamine. We used three types of PAMAM dendrimers with different surface groups (-COOH, -NH2, -OH). As BSA contains two tryptophan residues we were able to evaluate dendrimers influence on protein molecular conformation by measuring the changes in the fluorescence of BSA in the presence of dendrimers. Additionally experiments with a fluorescent probe 1-anilinonaphthalene-8-sulfonic acid (ANS) were carried out. The differential scanning calorimetry (DSC) was chosen to investigate impact on protein thermal stability upon the dendrimers.
   Our experiments showed that the extent of the interactions between BSA and dendrimers strongly depends on their surface groups and is the biggest for amino-terminated dendrimers. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Univ Lodz, Dept Gen Biophys, PL-90237 Lodz, Poland.
   Univ Lodz, Dept Chem Phys, PL-90236 Lodz, Poland.
RP Bryszewska, M (reprint author), Univ Lodz, Dept Gen Biophys, Ul Banacha 12-16, PL-90237 Lodz, Poland.
RI Klajnert-Maculewicz, Barbara/J-4574-2014; Kapczynski, Marcin/K-9682-2018
OI Klajnert-Maculewicz, Barbara/0000-0003-3459-8947; Kapczynski,
   Marcin/0000-0003-3334-2835; Palecz, Bartlomiej/0000-0003-3608-0367;
   Bryszewska, Maria/0000-0003-4676-3743
CR BARTH RF, 1994, BIOCONJUGATE CHEM, V5, P58, DOI 10.1021/bc00025a008
   Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200
   BOS OJM, 1989, J BIOL CHEM, V264, P953
   BURSTEIN EA, 1977, USSR ACAD SCI PUSHCH, P60
   Callis PR, 1997, METHOD ENZYMOL, V278, P113
   CAMINATI G, 1990, J AM CHEM SOC, V112, P8515, DOI 10.1021/ja00179a041
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   de Oliveira AHC, 2001, BIOCHEM BIOPH RES CO, V284, P1011, DOI 10.1006/bbrc.2001.5073
   DEMCHENKO AP, 1988, TRENDS BIOCHEM SCI, V13, P374, DOI 10.1016/0968-0004(88)90173-9
   Eftink M. R., 1991, BIOPHYSICAL BIOCH AS, P1, DOI DOI 10.1007/978-1-4757-9513-4
   ERA S, 1990, INT J PEPT PROT RES, V35, P1
   Ercelen S, 2001, BIOPHYS CHEM, V90, P203, DOI 10.1016/S0301-4622(01)00141-7
   Filenko A, 2001, BIOMACROMOLECULES, V2, P270, DOI 10.1021/bm000111q
   France RM, 2000, BIOCHEM BIOPH RES CO, V269, P709, DOI 10.1006/bbrc.2000.2346
   KLAJNERT B, IN PRESS CELL MOL BI
   Kojima C, 2000, BIOCONJUGATE CHEM, V11, P910, DOI 10.1021/bc0000583
   Komath SS, 1999, J PHOTOCH PHOTOBIO B, V50, P108, DOI 10.1016/S1011-1344(99)00079-2
   LAPSHINA EA, 1994, BIOL MEM, V7, P155
   Liu M., 1999, POLYM MAT SCI ENG, V80, P167
   Liu MJ, 2000, J CONTROL RELEASE, V65, P121, DOI 10.1016/S0168-3659(99)00245-X
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   Milhem OM, 2000, INT J PHARM, V197, P239, DOI 10.1016/S0378-5173(99)00463-9
   Peters T., 1996, ALL ALBUMIN BIOCH GE
   PUTNAM FW, 1960, PLASMA PROTEINS
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   Roberts JC, 1990, BIOCONJUGATE CHEM, V1, P305, DOI 10.1021/bc00005a001
   Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397
   SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   Twyman LJ, 1999, TETRAHEDRON LETT, V40, P1743, DOI 10.1016/S0040-4039(98)02680-X
   Wells M, 1996, J AM CHEM SOC, V118, P3988, DOI 10.1021/ja960097i
   Zanini D, 1998, J ORG CHEM, V63, P3486, DOI 10.1021/jo972061u
   Zhuo RX, 1999, J CONTROL RELEASE, V57, P249, DOI 10.1016/S0168-3659(98)00120-5
NR 33
TC 158
Z9 162
U1 2
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-9639
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD MAY 30
PY 2003
VL 1648
IS 1-2
BP 115
EP 126
DI 10.1016/S1570-9639(03)00117-1
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 684PL
UT WOS:000183215700014
PM 12758154
DA 2018-10-20
ER

PT J
AU Uilk, JM
   Mera, AE
   Fox, RB
   Wynne, KJ
AF Uilk, JM
   Mera, AE
   Fox, RB
   Wynne, KJ
TI Hydrosilation-cured poly(dimethylsiloxane) networks: Intrinsic contact
   angles via dynamic contact angle analysis
SO MACROMOLECULES
LA English
DT Article
ID SILICONE-RUBBER; HYDROPHOBIC RECOVERY; SURFACE; POLYDIMETHYLSILOXANE;
   HYDROSILYLATION; DISCHARGES; ADHESION; EXPOSURE;
   ALPHA,OMEGA-DIHYDROXYPOLY(DIMETHYLSILOXANE); WETTABILITY
AB A method for measuring intrinsic advancing (theta(adv)) and receding (theta(rec)) water contact angles is reported for hydrosilylation-cured poly(dimethylsiloxane) network coatings that are analogues of biomedical materials. Static and dynamic contact angle (DCA) methods were used to evaluate coatings prepared from commercial divinyl-terminated poly(dimethylsiloxane) (C-DVPDMS) and synthesized low polydispersity divinyl-terminated poly(dimethylsiloxane) (N-DVPDMS). DCA measurements showed that coatings prepared with both C-DVPDMS and N-DVPDMS contaminated the water surface during analysis. For ambient temperature cure, the rate of contamination was C-DVPDMS > N-DVPDMS. Methods for acquiring intrinsic contact angles on the PDMS coatings include using a large surface area reservoir or changing the water reservoir between DCA cycles. Intrinsic contact angles for hydrosilylation-cured PDMS coatings are as follows: theta(adv), 118degrees, theta(rec), 83degrees; after contamination of the water surface the contact angles change to theta(adv), 108degrees, theta(rec) 87degrees.
C1 Virginia Commonwealth Univ, Sch Engn, Dept Chem Engn, Richmond, VA 23284 USA.
   USN, Res Lab, Mat Chem Branch, Washington, DC 20375 USA.
RP Wynne, KJ (reprint author), Virginia Commonwealth Univ, Sch Engn, Dept Chem Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
CR ADAMSON AW, 1997, PHYSICAL CHEM SURFAC
   ARKLES B, 1983, CHEMTECH, V13, P542
   Batich C, 1996, CURR TOP MICROBIOL, V210, P13
   BRITCHER LG, 1995, MACROMOLECULES, V28, P3110, DOI 10.1021/ma00113a013
   CARMICHAEL JB, 1965, J POLYM SCI PART A, V3, P971, DOI 10.1002/pol.1965.100030311
   Compton RA, 1997, J LONG-TERM EFF MED, V7, P29
   DEMITRAS G, 1972, INORGANIC CHEM
   Everaert EPJM, 1998, J MATER SCI-MATER M, V9, P147, DOI 10.1023/A:1008867619481
   FOX HW, 1947, IND ENG CHEM, V39, P1401, DOI 10.1021/ie50455a607
   Hillborg H, 1998, POLYMER, V39, P1991, DOI 10.1016/S0032-3861(97)00484-9
   Hillborg H, 2001, POLYMER, V42, P7349, DOI 10.1016/S0032-3861(01)00202-6
   JALBERT C, 1993, MACROMOLECULES, V26, P3069, DOI 10.1021/ma00064a012
   JOHNSONLAIRD PN, 1993, COGNITION, V49, P1, DOI 10.1016/0010-0277(93)90033-R
   Johnston E, 1999, MACROMOLECULES, V32, P8173, DOI 10.1021/ma990628y
   Kennan JJ, 1997, J BIOMED MATER RES, V36, P487
   Kim J, 2001, J COLLOID INTERF SCI, V244, P200, DOI 10.1006/jcis.2001.7909
   Kim J, 2000, J COLLOID INTERF SCI, V226, P231, DOI 10.1006/jcis.2000.6817
   LANDER LM, 1993, LANGMUIR, V9, P2237, DOI 10.1021/la00032a055
   LEE CL, 1976, J POLYM SCI POL CHEM, V14, P729, DOI 10.1002/pol.1976.170140321
   LESTEL L, 1990, POLYMER, V31, P1154, DOI 10.1016/0032-3861(90)90266-2
   MAKAL U, UNPUB
   Marko IE, 2002, SCIENCE, V298, P204, DOI 10.1126/science.1073338
   MERA AE, 1997, P AM CHEM SOC DIV PO, V77, P636
   Olander B, 2003, BIOMACROMOLECULES, V4, P145, DOI 10.1021/bm025654+
   Olander B, 2002, BIOMACROMOLECULES, V3, P505, DOI 10.1021/bm015654u
   OWEN MJ, 1990, SILICON BASED POLYM, V224
   PATEL SK, 1992, MACROMOLECULES, V25, P5252, DOI 10.1021/ma00046a022
   Perutz S, 1998, J POLYM SCI POL PHYS, V36, P2129, DOI 10.1002/(SICI)1099-0488(19980915)36:12<2129::AID-POLB11>3.0.CO;2-1
   Perutz S, 1997, MACROMOLECULES, V30, P7964, DOI 10.1021/ma970063a
   Pike JK, 1996, CHEM MATER, V8, P856, DOI 10.1021/cm9504596
   She H., 1998, POLYM PREPR, V39, P548
   SWANSON AB, 1966, INTERCLIN INFORMATIO, V6, P16
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TRETINNIKOV ON, 1994, LANGMUIR, V10, P1606, DOI 10.1021/la00017a047
   Uilk J, 2000, MACROMOLECULES, V33, P8791, DOI 10.1021/ma000023y
   Waters M, 1999, J BIOMED MATER RES, V48, P765, DOI 10.1002/(SICI)1097-4636(1999)48:6<765::AID-JBM1>3.0.CO;2-S
   Waters MGJ, 1999, J PROSTHET DENT, V81, P439, DOI 10.1016/S0022-3913(99)80011-0
   Wolf CJ, 2001, J BIOMAT SCI-POLYM E, V12, P801, DOI 10.1163/156856201750411675
   ZISMAN HW, 1964, ADV CHEM, V43
NR 39
TC 45
Z9 45
U1 1
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD MAY 20
PY 2003
VL 36
IS 10
BP 3689
EP 3694
DI 10.1021/ma021154x
PG 6
WC Polymer Science
SC Polymer Science
GA 680GE
UT WOS:000182967300032
DA 2018-10-20
ER

PT J
AU Leng, YX
   Chen, JY
   Yang, P
   Sun, H
   Wan, GJ
   Huang, N
AF Leng, YX
   Chen, JY
   Yang, P
   Sun, H
   Wan, GJ
   Huang, N
TI Mechanical properties and platelet adhesion behavior of diamond-like
   carbon films synthesized by pulsed vacuum arc plasma deposition
SO SURFACE SCIENCE
LA English
DT Article
DE diamond; carbon; X-ray photoelectron spectroscopy; noble gases; Raman
   scattering spectroscopy
ID TETRAHEDRAL AMORPHOUS-CARBON; COATINGS; HEMOCOMPATIBILITY; DLC
AB Diamond-like carbon (DLC) is an attractive biomedical material due to its high inertness and excellent mechanical properties. In this study, DLC films were fabricated on Ti6Al4V and Si(100) substrates at room temperature by pulsed vacuum arc plasma deposition. By changing the argon flow from 0 to 13 sccm during deposition the effects of argon flow on the characteristics of the DLC films were systematically examined to correlate to the blood compatibility. The microstructure and mechanical properties of the films were investigated using Raman spectroscopy, X-ray photoelectron spectroscopy (XPS) surface analysis, a nano-indenter and pin-on-disk tribometer. The blood compatibility of the films was evaluated using in vitro platelet adhesion investigation, and the quantity and morphology of the adherent platelets was investigated employing optical microscopy and scanning electron microscopy.
   The Raman spectroscopy results showed a decreasing spa fraction (an increasing trend in I-D/I-G ratio) with increasing argon flow from 0 to 13 sccm. The sp(3):sp(2) ratio of the films was evaluated from the deconvoluted XPS spectra. We found that the spa fraction decreased as the argon flow was increased from 0 to 13 sccm, which is consistent with the results of the Raman spectra. The mechanical properties results confirmed the decreasing spa content with increasing argon flow. The Raman D-band to G-band intensity ratio increased and the platelet adhesion behavior became better with higher flow. This implies that the blood compatibility of the DLC films is influenced by the sp(3):sp(2) ratio. DLC films deposited on titanium alloys have high wear resistance, low friction and good adhesion. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 SW Jiao Tong Univ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
RP Leng, YX (reprint author), SW Jiao Tong Univ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
RI Wan, GJ/A-3648-2009; Wan, Guojiang/A-6651-2013; Leng,
   Yongxiang/G-5488-2010
OI Wan, Guojiang/0000-0002-1636-5405; Leng, Y.X./0000-0001-6823-1233
CR Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chhowalla M, 2001, DIAM RELAT MATER, V10, P1011, DOI 10.1016/S0925-9635(00)00530-6
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   He XM, 1999, THIN SOLID FILMS, V355, P167, DOI 10.1016/S0040-6090(99)00652-5
   JINDAL PC, 1987, THIN SOLID FILMS, V154, P361, DOI 10.1016/0040-6090(87)90379-8
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Kumar S, 2001, APPL SURF SCI, V182, P326, DOI 10.1016/S0169-4332(01)00422-6
   Leng YX, 2002, THIN SOLID FILMS, V420, P408, DOI 10.1016/S0040-6090(02)00814-3
   Li LH, 2002, MAT SCI ENG B-SOLID, V94, P95, DOI 10.1016/S0921-5107(02)00079-X
   Merel P, 1998, APPL SURF SCI, V136, P105, DOI 10.1016/S0169-4332(98)00319-5
   Nesladek M, 1995, THIN SOLID FILMS, V270, P184, DOI 10.1016/0040-6090(95)06914-3
   Neuville S, 1997, MRS BULL, V22, P22
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   Robertson J, 2001, THIN SOLID FILMS, V383, P81, DOI 10.1016/S0040-6090(00)01786-7
   Ronkainen H, 2001, WEAR, V249, P260, DOI 10.1016/S0043-1648(01)00558-0
   Schneider D, 1998, DIAM RELAT MATER, V7, P973, DOI 10.1016/S0925-9635(97)00337-3
   Sharma AK, 2000, MAT SCI ENG B-SOLID, V77, P139, DOI 10.1016/S0921-5107(00)00434-7
   Tabbal M, 1999, SURF COAT TECH, V116, P452, DOI 10.1016/S0257-8972(99)00183-8
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Tran HS, 1999, J INVEST SURG, V12, P133
   Yan PX, 1999, MATER CHEM PHYS, V60, P44, DOI 10.1016/S0254-0584(99)00069-3
   Yu LJ, 2000, SURF COAT TECH, V128, P484, DOI 10.1016/S0257-8972(00)00626-5
NR 26
TC 56
Z9 62
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD MAY 20
PY 2003
VL 531
IS 2
BP 177
EP 184
DI 10.1016/S0039-6028(03)00487-4
PG 8
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 679BE
UT WOS:000182900500010
DA 2018-10-20
ER

PT J
AU Yao, L
   Haas, TW
   Guiseppi-Elie, A
   Bowlin, GL
   Simpson, DG
   Wnek, GE
AF Yao, L
   Haas, TW
   Guiseppi-Elie, A
   Bowlin, GL
   Simpson, DG
   Wnek, GE
TI Electrospinning and stabilization of fully hydrolyzed poly(vinyl
   alcohol) fibers
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID NANOFIBERS; POLYMER; HYDROGEL
AB Fully (99+ %) hydrolyzed poly(vinyl alcohol) (PVA) was electrospun from water using Triton X-100 surfactant to lower the surface tension. The diameter of the electrospun PVA fibers ranged from 100 to 700 nm. Treatment of the PVA fiber mats with methanol for 8 h stabilized the fibers against disintegration in contact with water. In addition, the mats showed increased mechanical strength due to increased crystallinity following post-spinning treatment with methanol. We suggest that methanol treatment serves to increase the degree of crystallinity, and hence the number of physical cross-links in the electrospun PVA fibers. This may occur by removal of residual water within the fibers by the alcohol, allowing PVA-water hydrogen bonding to be replaced by intermolecular polymer hydrogen bonding resulting in additional crystallization. Potential applications of electrospun PVA include filters, precursors to graphitic fibers, and biomedical materials.
C1 Virginia Commonwealth Univ, Dept Chem Engn, Richmond, VA 23284 USA.
   Virginia Commonwealth Univ, Dept Biomed Engn & Anat, Richmond, VA 23284 USA.
RP Wnek, GE (reprint author), Virginia Commonwealth Univ, Dept Chem Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
RI Bowlin, Gary/E-8617-2010
CR Bowlin GL, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P165
   Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   Ding B, 2002, J POLYM SCI POL PHYS, V40, P1261, DOI 10.1002/polb.10191
   Finch C. A., 1973, POLYVINYL ALCOHOL PR
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Gao LT, 1998, CHEM MATER, V10, P2481, DOI 10.1021/cm980200y
   Inagaki M, 2001, CARBON, V39, P921, DOI 10.1016/S0008-6223(00)00210-4
   Jaeger R, 1998, MACROMOL SYMP, V127, P141, DOI 10.1002/masy.19981270119
   Jia HF, 2002, BIOTECHNOL PROGR, V18, P1027, DOI 10.1021/bp020042m
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015
   Kurihara S, 1996, POLYMER, V37, P1123, DOI 10.1016/0032-3861(96)80838-X
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   SCUADOR AE, 2001, MAT RES SOC S P, V661
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 23
TC 236
Z9 241
U1 9
U2 174
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD MAY 6
PY 2003
VL 15
IS 9
BP 1860
EP 1864
DI 10.1021/cm0210795
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 674MZ
UT WOS:000182641700014
DA 2018-10-20
ER

PT J
AU Pikkula, BM
   Tunnell, JW
   Anvari, B
AF Pikkula, BM
   Tunnell, JW
   Anvari, B
TI Methodology for characterizing heat removal mechanism in human skin
   during cryogen spray cooling
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE dermatology; heat flux; interface thermal conductance; laser therapy;
   selective thermal injury; skin; thermal diffusivity
ID PULSED DYE-LASER; PORT-WINE STAINS; SELECTIVE PHOTOTHERMOLYSIS;
   EPIDERMAL PROTECTION; CONTACT; TEMPERATURE; COMBINATION; IRRADIATION;
   DISTANCE; VIVO
AB Cryogen spray cooling (CSC) reduces epidermal damage during laser treatment of various dermatoses. The goal of this study was to determine the heat removal mechanism in skin and quantify the amount in response to CSC. Thermocouples were imbedded in four model substrates with a range of thermal diffusivities, greater than three orders of magnitude in difference, to measure the temperature profiles in response to CSC and sapphire contact cooling, which removes heat completely by conduction. An algorithm solving an inverse heat conduction problem was subsequently used to quantify the amount of heat removal from the substrates using the measured temperatures. The interface thermal conductance and internal temperatures within the substrates were computed by a finite difference algorithm that solved the heat conduction equation. Results verify a marked increase in heat removal and interface thermal conductance with increasing thermal diffusivity. By estimation from the model substrate results, heat removal and interface thermal conductance values for skin were obtained. Data demonstrate that during CSC, evaporation is the dominant heat transfer mechanism in materials with higher thermal diffusivities; however, conductive cooling dominates in substrates with lower thermal diffusivities such as skin. (C) 2003 Biomedical Engineering Society.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Anvari, B (reprint author), Rice Univ, Dept Bioengn, MS 142,POB 1892, Houston, TX 77251 USA.
FU NIAMS NIH HHS [1R01-AR 47996]
CR Aguilar G, 2001, INT J HEAT MASS TRAN, V44, P3201, DOI 10.1016/S0017-9310(00)00363-X
   Aguilar G, 2001, LASER SURG MED, V28, P113, DOI 10.1002/lsm.1025
   ALEXANDER DJ, 1995, HUM EXP TOXICOL, V14, P715, DOI 10.1177/096032719501400903
   Altshuler GB, 1999, PHYS MED BIOL, V44, P1003, DOI 10.1088/0031-9155/44/4/014
   ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297
   Anvari B, 1997, P SOC PHOTO-OPT INS, V3192, P106, DOI 10.1117/12.297833
   Anvari B, 1998, IEEE T BIO-MED ENG, V45, P934, DOI 10.1109/10.686802
   ANVARI B, 1995, PHYS MED BIOL, V40, P242
   ASHINOFF R, 1992, J DERMATOL SURG ONC, V18, P147, DOI 10.1111/j.1524-4725.1992.tb02448.x
   Beck J. V., 1985, INVERSE HEAT CONDUCT
   Buscher BA, 2000, LASER SURG MED, V27, P171, DOI 10.1002/1096-9101(2000)27:2<171::AID-LSM9>3.3.CO;2-M
   Chang CJ, 1999, DERMATOL SURG, V25, P767, DOI 10.1046/j.1524-4725.1999.99100.x
   Chang CJ, 1998, PLAST RECONSTR SURG, V102, P459, DOI 10.1097/00006534-199808000-00029
   Choi B, 2000, PROC SPIE, V3914, P48, DOI 10.1117/12.388021
   Chung JH, 1996, LASER SURG MED, V18, P358, DOI 10.1002/(SICI)1096-9101(1996)18:4<358::AID-LSM4>3.0.CO;2-R
   Dover JS, 2000, LASER SURG MED, V26, P158, DOI 10.1002/(SICI)1096-9101(2000)26:2<158::AID-LSM6>3.0.CO;2-O
   DUCK FA, 1990, PHYSICAL PROPERTIES
   Greve B, 2001, DERMATOL SURG, V27, P633, DOI 10.1046/j.1524-4725.2001.00352.x
   HERNANDEZMORALE.B, 1995, P ASME HEAT TRANSF D, V317, P559
   Kelly KM, 1999, ARCH DERMATOL, V135, P691, DOI 10.1001/archderm.135.6.691
   Lask G, 1997, DERMATOL SURG, V23, P737, DOI 10.1111/j.1524-4725.1997.tb00406.x
   Mehrotra SP, 1997, STEEL RES, V68, P201, DOI 10.1002/srin.199701779
   NELSON JS, 1995, ARCH DERMATOL, V131, P695, DOI 10.1001/archderm.131.6.695
   Nelson JS, 2000, LASER SURG MED, V26, P2
   Nelson JS, 1996, LASER SURG MED, V19, P224
   Niemz M, 1996, LASER TISSUE INTERAC
   OSMAN AM, 1990, J HEAT TRANS-T ASME, V112, P843, DOI 10.1115/1.2910490
   Pikkula BM, 2002, P SOC PHOTO-OPT INS, V4609, P50, DOI 10.1117/12.432078
   Pikkula BM, 2001, LASER SURG MED, V28, P103, DOI 10.1002/lsm.1024
   Ross EV, 2000, LASER SURG MED, V26, P186, DOI 10.1002/(SICI)1096-9101(2000)26:2<186::AID-LSM9>3.0.CO;2-I
   Taler J, 1996, INT J HEAT MASS TRAN, V39, P3733, DOI 10.1016/0017-9310(96)00015-4
   Torres JH, 1999, IEEE J SEL TOP QUANT, V5, P1058, DOI 10.1109/2944.796330
   Torres JH, 2001, LASER SURG MED, V28, P477, DOI 10.1002/lsm.1077.abs
   Tunnell JW, 2000, LASER SURG MED, V27, P373, DOI 10.1002/1096-9101(2000)27:4<373::AID-LSM11>3.0.CO;2-A
   Tunnell JW, 2002, P SOC PHOTO-OPT INS, V4609, P67, DOI 10.1117/12.431782
   Tunnell JW, 2002, ANN BIOMED ENG, V30, P19, DOI [10.1114/1.1432691, 10.1114/1/1432691]
   VALERIA BC, 2000, LASER SURG MED, V26, P177
   Verkruysse W, 2000, PROC SPIE, V3907, P37, DOI 10.1117/12.386235
   Zenzie HH, 2000, LASER SURG MED, V26, P130, DOI 10.1002/(SICI)1096-9101(2000)26:2<130::AID-LSM4>3.0.CO;2-J
NR 39
TC 11
Z9 12
U1 0
U2 6
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2003
VL 31
IS 5
BP 493
EP 504
DI 10.1114/1.1566448
PG 12
WC Engineering, Biomedical
SC Engineering
GA 675NJ
UT WOS:000182701200001
PM 12757194
DA 2018-10-20
ER

PT J
AU Carew, EO
   Patel, J
   Garg, A
   Houghtaling, P
   Blackstone, E
   Vesely, I
AF Carew, EO
   Patel, J
   Garg, A
   Houghtaling, P
   Blackstone, E
   Vesely, I
TI Effect of specimen size and aspect ratio on the tensile properties of
   porcine aortic valve tissues
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE stiffness; extensibility; predictive model; specimen area
ID LEAFLETS; MECHANICS; BEHAVIOR; FIBERS; FRESH
AB The measurement of mechanical properties of biological tissues is subject to artifacts such as natural variability and inconsistency in specimen preparation. As a result, data cannot be easily compared across laboratories. To test the effects of variable specimen dimensions, we systematically modified the size and aspect ratio (AR) of porcine aortic valve tissues and measured their stiffness and extensibility. We found that: (i) as the AR of circumferential specimens increased from 1:1 to 5:1, their stiffness increased by 36% (p<0.001) and their extensibility decreased by 21% (p<0.001); (ii) as the AR of radial specimens increased from 0.8:1 to 4:1, their stiffness increased by 36% (p<0.001) and their extensibility decreased by 34% (p<0.001); (iii) as the size of circumferential specimens was reduced from 128 to 32 mm(2) at fixed AR (2:1), their stiffness decreased by 6% (p=0.05), and their extensibility increased by 17% (p<0.001); and (iv) as the size of radial specimens was reduced from 72 to 32 mm(2) at fixed AR (2:1), their stiffness decreased by 7% (p=0.03) and their extensibility increased by 16% (p=0.005). Thus, as specimens of constant length became narrower, they became stiffer and less extensible, and as specimens of fixed aspect ratio became smaller, they became less stiff and more extensible. Statistical models of these trends were predictive and can thus be used to integrate materials test data across different laboratories. (C) 2003 Biomedical Engineering Society.
C1 Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA.
RP Vesely, I (reprint author), Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, 9500 Euclid Ave,ND 20, Cleveland, OH 44195 USA.
EM vesely@bmc.ri.ccf.org
FU NHLBI NIH HHS [HL57236]
CR Atkinson TS, 1999, J BIOMECH, V32, P907, DOI 10.1016/S0021-9290(99)00089-5
   Carew EO, 2000, ANN BIOMED ENG, V28, P1093, DOI 10.1114/1.1310221
   CAREW EO, IN PRESS J BIOMECH
   CLARK RE, 1974, J THORAC CARDIOV SUR, V67, P792
   David H, 1994, ASAIO J, V40, P206, DOI 10.1097/00002480-199404000-00015
   DIGGLE DJ, 1994, ANAL LONGITUDINAL DA
   HAUT RC, 1972, J BIOMECH, V5, P423, DOI 10.1016/0021-9290(72)90001-2
   LEE JM, 1984, J BIOMED MATER RES, V18, P61, DOI 10.1002/jbm.820180108
   LEE JM, 1994, AM SOC TEST MATER, V1173, P19, DOI 10.1520/STP18091S
   Leeson-Dietrich J, 1995, J Heart Valve Dis, V4, P88
   ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9
   SAUREN AAHJ, 1980, J BIOMECH, V13, P97, DOI 10.1016/0021-9290(80)90183-9
   Schoen FJ, 1997, J HEART VALVE DIS, V6, P1
   Schoen FJ, 1999, J HEART VALVE DIS, V8, P350
   TAN AJK, 1976, ANN THORAC SURG, V22, P188, DOI 10.1016/S0003-4975(10)63984-7
   VANOORT R, 1982, BIOMATERIALS, V3, P21
   Vesely I, 1996, ASAIO J, V42, P993, DOI 10.1097/00002480-199642060-00012
   VESELY I, 1993, J THORAC CARDIOV SUR, V106, P288
   Vesely I, 1998, J BIOMECH, V31, P115
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   Vesely I, 1997, J HEART VALVE DIS, V6, P292
NR 21
TC 11
Z9 11
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2003
VL 31
IS 5
BP 526
EP 535
DI 10.1114/1.1568116
PG 10
WC Engineering, Biomedical
SC Engineering
GA 675NJ
UT WOS:000182701200004
PM 12757197
DA 2018-10-20
ER

PT J
AU Buist, M
   Sands, G
   Hunter, P
   Pullan, A
AF Buist, M
   Sands, G
   Hunter, P
   Pullan, A
TI A deformable finite element derived finite difference method for cardiac
   activation problems
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE bidomain; deformation; forward problem; tensor analysis
ID MODEL; TISSUE; PROPAGATION; BIDOMAIN
AB We present a finite element (FE) derived finite difference (FD) technique for solving cardiac activation problems over deforming geometries using a bidomain framework. The geometry of the solution domain is defined by a FE mesh and over these FEs a high resolution FD mesh is generated. The difference points are located at regular intervals in the normalized material space within each of the FEs. The bidomain equations are then transformed to the embedded FD mesh which provides a solution space that is both regular and orthogonal. The solution points move in physical space with any deformation of the solution domain, but the equations are set up in such a way that the solution is invariant as it is constructed in material space. The derivation of this new solution technique is presented along with a series of examples that demonstrate the accuracy of this bidomain framework. (C) 2003 Biomedical Engineering Society.
C1 Univ Auckland, Bioengn Res Grp, Dept Engn Sci, Auckland 1, New Zealand.
RP Buist, M (reprint author), Univ Auckland, Bioengn Res Grp, Dept Engn Sci, Private Bag 92019, Auckland 1, New Zealand.
EM m.buist@auckland.ac.nz
RI Sands, Gregory/O-8357-2017
OI Sands, Gregory/0000-0002-7875-2099; Hunter, Peter/0000-0001-9665-4145
CR BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853
   Cherry E. M., 2000, THESIS DUKE U
   Flugge W, 1972, TENSOR ANAL CONTINUU
   Harrild DM, 2000, J ELECTROCARDIOL, V33, P241, DOI 10.1054/jelc.2000.8239
   Harrild DM, 1997, ANN BIOMED ENG, V25, P315, DOI 10.1007/BF02648046
   HENRIQUEZ CS, 1993, CRIT REV BIOMED ENG, V21, P1
   Huiskamp G, 1998, IEEE T BIO-MED ENG, V45, P847, DOI 10.1109/10.686792
   Hunter P.J., 1975, Progress Biophys Molec Biol, V30, P99
   HUNTER PJ, 1988, PROG BIOPHYS MOL BIO, V52, P101, DOI 10.1016/0079-6107(88)90004-1
   Hunter PJ, 1998, PROG BIOPHYS MOL BIO, V69, P289, DOI 10.1016/S0079-6107(98)00013-3
   HUNTER PJ, 1989, ASME BED, V9, P387
   KREYSIG E, 1988, ADV ENG MATH
   Latimer DC, 1998, IEEE T BIO-MED ENG, V45, P1449, DOI 10.1109/10.730438
   LeGrice IJ, 1997, AM J PHYSIOL-HEART C, V272, pH2466
   Lu WX, 1996, IEEE T BIO-MED ENG, V43, P211, DOI 10.1109/10.481990
   MILLER CE, 1990, CRIT REV BIOMED ENG, V18, P207
   Nash M, 1998, THESIS U AUCKLAND NZ
   NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365
   PANFILOV S, 1996, COMPUTATIONAL BIOL H
   Quan WL, 1998, IEEE T BIO-MED ENG, V45, P372, DOI 10.1109/10.661162
   ROGERS JM, 1994, IEEE T BIO-MED ENG, V41, P743, DOI 10.1109/10.310090
   SEPULVEDA NG, 1989, BIOPHYS J, V55, P987, DOI 10.1016/S0006-3495(89)82897-8
   Shampine L. F., 1975, COMPUTER SOLUTION OR
   Skouibine KB, 1999, IEEE T BIO-MED ENG, V46, P769, DOI 10.1109/10.771186
   TYLDESLEY JR, 1975, INTRO TENSOR ANAL
   WANG CY, 1992, MATH COMPUT MODEL, V16, P91, DOI 10.1016/0895-7177(92)90050-U
NR 26
TC 34
Z9 35
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2003
VL 31
IS 5
BP 577
EP 588
DI 10.1114/1.1567283
PG 12
WC Engineering, Biomedical
SC Engineering
GA 675NJ
UT WOS:000182701200008
PM 12757201
DA 2018-10-20
ER

PT J
AU Saralidze, K
   Aldenhoff, YBJ
   Knetsch, MLW
   Koole, LH
AF Saralidze, K
   Aldenhoff, YBJ
   Knetsch, MLW
   Koole, LH
TI Injectable polymeric microspheres with X-ray visibility. Preparation,
   properties, and potential utility as new traceable bulking agents
SO BIOMACROMOLECULES
LA English
DT Article
ID STRESS URINARY-INCONTINENCE; TRANSURETHRAL INJECTION; BIOMEDICAL
   APPLICATIONS; CONTROLLED-RELEASE; DRUG-DELIVERY; BIOMATERIALS;
   MIGRATION; SILICONE; PARTICLES; IMPLANTS
AB The copolymer of methyl methacrylate (MMA) and 2-[2',3',5'-triiodobenzoyl]oxoethyl methacrylate (1), ratio 3:1 (mass:mass), was prepared via a free-radical polymerization in bulk. The copolymer (M-w = 97.8 kD and M-n = 41.5 kD) was dissolved in chloroform and subsequently transformed into beads with a diameter in the micrometer range, using a solvent evaporation technique. The resulting microbeads were characterized by different techniques, including NMR spectroscopy, differential scanning calorimetry, gel permeation chromatography, and scanning electron microscopy. The latter technique was used as the basis for statistical analysis of the bead size. Typically, an average diameter of 96,mum and a standard deviation of 21,mum were obtained. The beads were also subjected to some preliminary tests regarding cytotoxicity. The copolymer of MMA and 1 contains covalently bound iodine. Therefore, the material is intrinsically radiopaque, i.e., capable of absorbing X-radiation while no contrast additive is needed. Our interest in these microspheres stems primarily from their possible utility as injectable and afterward traceable (radiopaque) bulking agents, e.g., for use in urology for the treatment of female stress incontinence due to sphincter deficiency. As a first test into this direction, a sample of the microbeads was mixed with ethylene glycol, and the resulting suspension was studied with respect to injectability and radiopacity. The results suggest that the radiopaque microbeads may provide access to improved bulking agents. Further modification of the surface may be necessary in order to suppress the migratory aptitude of the radiopaque polymeric microspheres in vivo.
C1 Univ Maastricht, Fac Med, Ctr Biomat, Dutch Res Sch iBME, NL-6200 MD Maastricht, Netherlands.
RP Koole, LH (reprint author), Univ Maastricht, Fac Med, Ctr Biomat, Dutch Res Sch iBME, POB 616, NL-6200 MD Maastricht, Netherlands.
EM l.koole@bioch.unimaas.nl
CR AARONSON IA, 1993, EUR UROL, V23, P394, DOI 10.1159/000474637
   Aldenhoff YBJ, 2002, BIOMATERIALS, V23, P881, DOI 10.1016/S0142-9612(01)00197-1
   ARAGONA F, 1995, EUR UROL UPDATE SER, V4, P146
   Artola A, 2003, J BIOMED MATER RES B, V64B, P44, DOI 10.1002/jbm.b.10511
   Barranger E, 2000, J UROLOGY, V164, P1619, DOI 10.1016/S0022-5347(05)67042-5
   Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   Bidmead J, 2000, LANCET, V355, P2183, DOI 10.1016/S0140-6736(00)02398-9
   BRANDAU T, 2002, INT J PHARM, V242, P197
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   Davy KWM, 1997, J DENT, V25, P499, DOI 10.1016/S0300-5712(96)00064-4
   DMOCHOWSKI RR, 2001, TECH UROL, V2, P110
   DMOCHOWSKI RR, 2000, UROLOGY, V56, P328
   Du J, 1997, J CONTROL RELEASE, V43, P223, DOI 10.1016/S0168-3659(96)01487-3
   Duckett JRA, 1998, BRIT J OBSTET GYNAEC, V105, P390, DOI 10.1111/j.1471-0528.1998.tb10121.x
   Emerich DF, 2002, PHARMACEUT RES, V19, P1052, DOI 10.1023/A:1016434926649
   Espehaug B, 2002, J BONE JOINT SURG BR, V84B, P832, DOI 10.1302/0301-620X.84B6.12776
   Ginebra MP, 1999, J MATER SCI-MATER M, V10, P733, DOI 10.1023/A:1008979207968
   Harriss DR, 1996, BRIT J UROL, V78, P722, DOI 10.1046/j.1464-410X.1996.17510.x
   HENLY DR, 1995, J UROLOGY, V153, P2039, DOI 10.1016/S0022-5347(01)67398-1
   Herschorn S, 2000, J UROLOGY, V163, P1838, DOI 10.1016/S0022-5347(05)67555-6
   Herschorn S, 2001, Can J Urol, V8, P1281
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   Jang Jee Soo, 2002, Spine (Phila Pa 1976), V27, pE416, DOI 10.1097/00007632-200210010-00021
   JAYAKRISHNAN A, 1990, J BIOMED MATER RES, V24, P993, DOI 10.1002/jbm.820240803
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   KIIHOLMA P, 1991, European Urology, V20, P197
   Kim HD, 1997, BIOMATERIALS, V18, P1175
   Koole LH, 1998, NAT BIOTECHNOL, V16, P172, DOI 10.1038/nbt0298-172
   Kruft MAB, 1997, BIOMATERIALS, V18, P31, DOI 10.1016/S0142-9612(96)00085-3
   Kruft MAB, 1996, BIOMATERIALS, V17, P1803, DOI 10.1016/0142-9612(95)00339-8
   KRUFT MAB, 1994, J BIOMED MATER RES, V28, P1259, DOI 10.1002/jbm.820281103
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2002, J BIOMED MATER RES, V63, P455, DOI 10.1002/jbm.10300
   Lightner D, 2001, UROLOGY, V58, P12, DOI 10.1016/S0090-4295(01)01148-7
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Pannek J, 2001, J UROLOGY, V166, P1350, DOI 10.1016/S0022-5347(05)65767-9
   Peeker R, 2002, SCAND J UROL NEPHROL, V36, P194, DOI 10.1080/003655902320131866
   RAMES RA, 1991, PEDIATR SURG INT, V6, P239
   STENEKES RJ, 2002, BIOMACROMOLECULES, V1, P696
   Tsapis N, 2002, P NATL ACAD SCI USA, V99, P12001, DOI 10.1073/pnas.182233999
   1989, HDB CHEM PHYSICS, pB145
NR 44
TC 34
Z9 35
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2003
VL 4
IS 3
BP 793
EP 798
DI 10.1021/bm030002m
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 679QQ
UT WOS:000182933800044
PM 12741800
DA 2018-10-20
ER

PT J
AU Tang, YW
   Labow, RS
   Santerre, JP
AF Tang, YW
   Labow, RS
   Santerre, JP
TI Enzyme induced biodegradation of polycarbonate-polyurethanes: dose
   dependence effect of cholesterol esterase
SO BIOMATERIALS
LA English
DT Article
DE enzymes; hydrolysis; dose response; polyurethanes; hard segment;
   biodegradation
ID BIOMEDICAL POLYURETHANES; HYDROLYTIC ENZYMES; DEGRADATION; ADSORPTION;
   POLYMER; BIOSTABILITY; BIOCOMPATIBILITY; BIOMATERIALS; MACROPHAGES;
   GENERATION
AB The current study has investigated the influence of esterase activity (80-400units/ml) on the biodegradation of polycarbonate-urethanes (PCNUs) by cholesterol esterase (CE), with a particular interest in studying the influence of different hard segment structures and their contribution to sensitizing the polymer towards enzyme catalyzed hydrolysis. Polycarbonate based polyurethanes were synthesized with varying hard segment content as well as hard segment chemistry based on three different diisocyanates, 1,6-hexane diisocyanate (HDI), 4,4'-methylene bisphenyl diisocyanate (MDI) and 4,4-methylene biscyclohexyl diisocyanate (HMDI). The effect of different chemistry on surface contact angle was measured in order to define the relative chemical nature of the surfaces. The enzyme dose response was found to be lower when hard segment content in the polymer was high. There was a very strong dependence on enzyme concentration for polyurethanes with different hard segment chemistry, despite the fact that the nature of the hydrolysable polycarbonate segment remained the same. The PCNU which showed the most dramatic dependence on enzyme concentration was synthesized with HMDI. At low enzyme concentration (80 units/ml) this material was the most stable of the polymers while at elevated CE concentration (400 units/ml) the polymer underwent a catastrophic breakdown. The findings suggested that protein binding on the surfaces was saturated even though enzyme degradation did not achieve saturation on any of the surfaces. The role of protein binding in modulating the hydrolytic action of the enzymes at different activity levels highlights a need for further study in this area. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON M5G 1G6, Canada.
   Univ Ottawa, Inst Heart, Div Cardiovasc, Ottawa, ON K1Y 4W7, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biomat, 124 Edward St, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@utoronot.ca
CR ABE H, 1995, MACROMOLECULES, V28, P844, DOI 10.1021/ma00108a007
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   BRYNDA E, 1978, J BIOENG, V2, P411
   CHAN BMC, 1981, J COLLOID INTERF SCI, V82, P217, DOI 10.1016/0021-9797(81)90141-7
   CHAWLA AS, 1988, BIOMATER ARTIF CELL, V16, P785, DOI 10.3109/10731198809117569
   DUGUAY DG, 1995, POLYM DEGRAD STABIL, V47, P229, DOI 10.1016/0141-3910(94)00114-N
   FALCK P, 1995, BIOMATERIALS, V16, P61, DOI 10.1016/0142-9612(95)91097-I
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   GOVINDASAMY S, 1992, CARBOHYD POLYM, V18, P89, DOI 10.1016/0144-8617(92)90130-I
   Huang SL, 1999, J MEMBRANE SCI, V161, P21, DOI 10.1016/S0376-7388(99)00096-4
   Hughes-Dillon K, 1998, POLYM DEGRAD STABIL, V60, P11, DOI 10.1016/S0141-3910(96)00222-4
   IHABA T, 1993, J CLIN INVEST, V92, P750
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   MACRITCHIE F, 1972, J COLLOID INTERF SCI, V38, P484, DOI 10.1016/0021-9797(72)90264-0
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1988, SURFACE CHARACTERIZA, P297
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   PAPADIMITRIOU JM, 1989, ULTRASTRUCT PATHOL, V13, P343, DOI 10.3109/01913128909048488
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Revenko I, 2001, SURF SCI, V491, P346, DOI 10.1016/S0039-6028(01)01298-5
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   Santerre JP, 1995, ACS SYM SER, V602, P352
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Scandola M, 1998, MACROMOLECULES, V31, P3846, DOI 10.1021/ma980137y
   SHALABY WS, 1992, J BIOACT COMPAT POL, V7, P257, DOI 10.1177/088391159200700303
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1984, POLYURETHANES BIOMED, P243
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STOKES KB, 1987, POLYM SCI TECHNOL, V35, P147
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Timmins MR, 1997, J ENVIRON POLYM DEGR, V5, P1
   Timmins MR, 1997, POLYMER, V38, P551, DOI 10.1016/S0032-3861(96)00530-7
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   Yang MJ, 1999, J BIOMED MATER RES, V48, P13
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   Zhao Y, 1999, J POLYM SCI POL PHYS, V37, P3288, DOI 10.1002/(SICI)1099-0488(19991201)37:23<3288::AID-POLB3>3.0.CO;2-L
NR 45
TC 55
Z9 57
U1 1
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2003
VL 24
IS 12
BP 2003
EP 2011
DI 10.1016/S0142-9612(02)00563-X
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 659BW
UT WOS:000181758200001
PM 12628819
DA 2018-10-20
ER

PT J
AU Martins, MCL
   Wang, D
   Ji, J
   Feng, L
   Barbosa, MA
AF Martins, MCL
   Wang, D
   Ji, J
   Feng, L
   Barbosa, MA
TI Albumin and fibrinogen adsorption on PU-PHEMA surfaces
SO BIOMATERIALS
LA English
DT Article
DE PHEMA; graft polymerisation; pellethane; protein adsorption; ATR-FTIR
ID PROTEIN ADSORPTION; PLATELET-ADHESION; GRAFT-COPOLYMERIZATION; POLYMERIC
   MATERIALS; CELL ATTACHMENT; PLASMA; POLYURETHANES; BINDING
AB Materials that adsorb specific proteins may find a variety of applications in the biomedical field. The aim of this study was the preparation of a hydrophilic surface, with low protein adsorption, to be used in tile future as a support for the immobilisation of several species, e.g. Cibacron Blue F3G-A, which has been described to induce specific albumin adsorption. Poly(hydroxyethylmethacrylate) (PHEMA) and poly(hydroxyethylacrylate) (PHEA) were chosen as tile hydrophilic surface because they can be easily polymerised and possess hydroxyl groups that can be used for the immobilisation of different compounds. Thin films of PHEMA and PHEA were successfully graft polymerised onto the surface of a commercial poly(etherurethane) (PU) using ceric ion as initiator. Grafting polymerisations were followed by mass gain and attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR). Since stability tests demonstrated that only PU-PHEMA was stable in alkaline solutions, a necessary condition to future immobilisations, the investigation was focused on the coating of PU with PHEMA. PU-PHEMA films were characterised in detail using several techniques as mass gain, ATR-FTIR, contact angle measurements, X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM). Protein adsorption was evaluated using radiolabelled albumin and fibrinogen from pure solutions and from mixtures of both proteins. PU Surfaces modified with PHEMA have demonstrated low protein adsorption, showing their potential use as substrates. This opens the possibly of exploring the advantages of selective adsorption by appropriate immobilisation of specific molecules. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Inst Biomed Engn, Lab Biomat, INEB, P-4150180 Oporto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, P-4100 Oporto, Portugal.
   Zhejiang Univ, Dept Polymer Sci, Hangzhou 310027, Peoples R China.
RP Martins, MCL (reprint author), Inst Biomed Engn, Lab Biomat, INEB, Rua Campo Algre 823, P-4150180 Oporto, Portugal.
EM cmartins@ibmc.up.pt
RI Martins, M. Cristina/J-8284-2013; Wang, Dong-an/G-6195-2010; Barbosa,
   Mario/F-5964-2011
OI Martins, M. Cristina/0000-0002-6574-4794; Barbosa,
   Mario/0000-0003-3568-7482; Ji, Jian/0000-0001-9870-4038
CR ANDRADE J D, 1991, Journal of Biomaterials Science Polymer Edition, V2, P161
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bailly AL, 1996, J BIOMED MATER RES, V30, P101, DOI 10.1002/(SICI)1097-4636(199601)30:1<101::AID-JBM13>3.0.CO;2-R
   BANDEKAR J, 1995, J BIOMAT SCI-POLYM E, V7, P485, DOI 10.1163/156856295X00553
   Beamson G., 1992, HIGH RESOLUTION XPS
   BEKOS EJ, 1995, LANGMUIR, V11, P984, DOI 10.1021/la00003a048
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816
   BRASH JL, 1991, MODERN ASPECTS PROTE, P23
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   ELAM JH, 1992, BIOMATERIALS, V13, P3, DOI 10.1016/0142-9612(92)90086-4
   FENG L, 1994, BIOMATERIALS, V15, P323
   FENG XD, 1985, MACROMOLECULES, V18, P2105, DOI 10.1021/ma00153a004
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Greco R., 1994, IMPLANTATION BIOL HO
   HORBATSCH M, 1986, Z PHYS D ATOM MOL CL, V2, P183, DOI 10.1007/BF01429072
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HSIUE GH, 1994, BIOMATERIALS, V15, P163
   Ji J, 2001, BIOMATERIALS, V22, P3015, DOI 10.1016/S0142-9612(01)00048-5
   Johnston E., 1997, ACS POLYM PREP, V38, P1016
   KAMATH KR, 1994, J APPL BIOMATER, V5, P163, DOI 10.1002/jab.770050210
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Lima J, 2001, J BIOMED MATER RES, V55, P45, DOI 10.1002/1097-4636(200104)55:1<45::AID-JBM70>3.0.CO;2-0
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MCFARLAND CD, 1998, J BIOMAT SCI-POLYM E, V9, P1239
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   MORRA M, 1992, J COLLOID INTERF SCI, V149, P84, DOI 10.1016/0021-9797(92)90393-Z
   MORRA M, 1995, J BIOMED MATER RES, V29, P39, DOI 10.1002/jbm.820290107
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   SAPATNEKAR S, 1999, HDB BIOMATERIALS EVA, P353
   Schrader B, 1995, INFRARED RAMAN SPECT
   SLACK SM, 1992, J BIOMED MATER RES, V26, P1633, DOI 10.1002/jbm.820261208
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   TINGEY KG, 1988, POLYM SURFACE DYNAMI
   Tsai C C, 1990, ASAIO Trans, V36, pM307
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   VROMAN L, 1980, BLOOD, V55, P156
   1993, IODINE 125, P64
NR 45
TC 76
Z9 79
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2003
VL 24
IS 12
BP 2067
EP 2076
DI 10.1016/S0142-9612(03)00002-4
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 659BW
UT WOS:000181758200009
PM 12628827
DA 2018-10-20
ER

PT J
AU Lien, V
   Wu, Y
   Zhang, DY
   Berdichevsky, Y
   Choi, JY
   Lo, YH
AF Lien, V
   Wu, Y
   Zhang, DY
   Berdichevsky, Y
   Choi, JY
   Lo, YH
TI A novel technology for fabricating gratings of any chirp characteristics
   by design
SO IEEE PHOTONICS TECHNOLOGY LETTERS
LA English
DT Article
DE fabrication; gratings; holographic gratings; integrated optics; tunable
   filters
ID DISPERSION COMPENSATOR; BRAGG GRATINGS; FIBER
AB We demonstrated a novel material and device technology to form gratings of any chirp characteristics by design. Furthermore, the chirp characteristics can be tuned dynamically after the device is fabricated. The device was fabricated on low cost polymer, material polydimethylsiloxane (PDMS). This inorganic polymer possesses highly desirable optical and mechanical properties and is chemically stable and easy to process. Using PDMS molding techniques, we are able to control the device geometry and subsequently the chirp profile precisely. This technology shows promise in dense wavelength-division multiplexing, and nontelecommunication applications including chemical and molecular sensing and biomedical microfluidic devices.
C1 Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.
RP Lien, V (reprint author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.
CR BROOKS CJ, 1995, OPT LETT, V20, P368, DOI 10.1364/OL.20.000368
   BYRON KC, 1993, ELECTRON LETT, V29, P1659, DOI 10.1049/el:19931104
   PAINCHAUD Y, 1995, ELECTRON LETT, V31, P171, DOI 10.1049/el:19950110
   Rochette M, 1999, IEEE PHOTONIC TECH L, V11, P536, DOI 10.1109/68.759390
   SUGDEN K, 1994, ELECTRON LETT, V30, P440, DOI 10.1049/el:19940276
   Tiberio RC, 1998, J VAC SCI TECHNOL B, V16, P3237, DOI 10.1116/1.590358
   WILLIAMS JAR, 1994, ELECTRON LETT, V30, P985, DOI 10.1049/el:19940661
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
NR 8
TC 5
Z9 5
U1 0
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1041-1135
J9 IEEE PHOTONIC TECH L
JI IEEE Photonics Technol. Lett.
PD MAY
PY 2003
VL 15
IS 5
BP 712
EP 714
DI 10.1109/LPT.2003.809969
PG 3
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 675CE
UT WOS:000182674800028
DA 2018-10-20
ER

PT J
AU Celotti, G
   Landi, E
AF Celotti, G
   Landi, E
TI A misunderstood member of the nagelschmidtite family unveiled: structure
   of Ca5Na2(PO4)(4) from X-ray powder diffraction data
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE apatite; biomedical applications; powders-chemical preparation; powder
   structure determination; X-ray methods
ID CRYSTAL-STRUCTURE; HYDROXYAPATITE; APATITES
AB During the development of procedures to synthesize carbonate hydroxyapatite with properties resembling those of biological material, a new phase was found to form after high temperature treatments in the presence of sodium. The compound was isolated and analytically characterized, leading to its identification as Ca5Na2(PO4)(4): an analogous Ca-Na phosphate was previously described, but with rather poor diffraction data and uncertain stoichiometry. Accurate XRD powder patterns revealed a hexagonal cell, space group P6(3)mc (186), a = 10.64 Angstrom, c = 21.71 Angstrom, Z = 6, rho = 2.93 g/cm(3), with the a axis double and the c axis triple those of the subcell typical of alpha-phases in the well-known system A(2)XO(4) (or ABXO(4)). The complete structural determination was carried out and the relevant aspects and properties discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 CNR, IRTEC, I-48018 Faenza, Italy.
RP Celotti, G (reprint author), CNR, IRTEC, Via Granarolo 64, I-48018 Faenza, Italy.
EM celotti@irtec1.irtec.bo.cnr.it
OI Landi, Elena/0000-0003-4495-129X
CR Alexander L., 1948, Analytical Chemistry, V20, P886, DOI 10.1021/ac60022a002
   ALTOMARE A, 1997, EXPO PACKAGE FULL PA
   ANDO J, 1958, B CHEM SOC JPN, V31, P201, DOI 10.1246/bcsj.31.201
   Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   BERGER G, 1995, BIOMATERIALS, V16, P1241, DOI 10.1016/0142-9612(95)98131-W
   Bredig MA, 1942, J PHYS CHEM-US, V46, P747, DOI 10.1021/j150421a009
   BREDIG MA, 1945, J PHYS CHEM-US, V49, P537, DOI 10.1021/j150444a003
   Bredig MA, 1941, J AM CHEM SOC, V63, P2533, DOI 10.1021/ja01854a510
   Bredig MA, 1943, AM MINERAL, V28, P594
   Bredig MA, 1932, Z ELKTROCHEM ANGEW P, V38, P158
   Bredig MA, 1933, Z ELKTROCHEM ANGEW P, V39, P959
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   El Feki H, 2000, SOLID STATE SCI, V2, P577, DOI 10.1016/S1293-2558(00)01059-1
   ELLIES LG, 1988, J BIOMED MATER RES, V22, P541, DOI 10.1002/jbm.820220609
   Franck HH, 1938, Z ANORG ALLG CHEM, V237, P49, DOI 10.1002/zaac.19382370106
   Franck HH, 1936, Z ANORG ALLG CHEM, V230, P1, DOI 10.1002/zaac.19362300102
   Ivanova TI, 2001, J SOLID STATE CHEM, V160, P340, DOI 10.1006/jssc.2001.9238
   JINLONG N, 2001, J MATER SCI, V36, P3805
   KAPRALIK I, 1977, BRIT CERAM TRANS J, V76, P126
   KRAUS W, 1998, POWDERCELL WINDOWS 2
   Leventouri T, 2001, J MATER RES, V16, P2600, DOI 10.1557/JMR.2001.0357
   Merry JC, 1998, J MATER SCI-MATER M, V9, P779, DOI 10.1023/A:1008975507498
   Nagelschmidt G, 1937, J CHEM SOC, P865, DOI 10.1039/jr9370000865
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   YOUNG RA, 1995, DBWS 9411 RIETVELD A
NR 25
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
EI 1873-619X
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD MAY
PY 2003
VL 23
IS 6
BP 851
EP 858
AR PII S0955-2219(02)00211-X
DI 10.1016/S0955-2219(02)00211-X
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 649UZ
UT WOS:000181227500005
DA 2018-10-20
ER

PT J
AU Yang, P
   Kwok, SCH
   Chu, PK
   Leng, YX
   Chen, JY
   Wang, J
   Huang, N
AF Yang, P
   Kwok, SCH
   Chu, PK
   Leng, YX
   Chen, JY
   Wang, J
   Huang, N
TI Haemocompatibility of hydrogenated amorphous carbon (a-C : H) films
   synthesized by plasma immersion ion implantation-deposition
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Ion Beam Modification of Materials
CY SEP 01-06, 2002
CL KOBE, JAPAN
DE hydrogenated amorphous carbon (a-C:H); plasma immersion; ion
   implantation-deposition (PIII-D); blood compatibility
ID DIAMOND-LIKE CARBON; DLC FILMS; BIOMATERIALS; MICROWAVE; TITANIUM
AB Diamond-like-carbon has attracted much attention recently as a potential biomaterial in blood contacting biomedical devices. However, previous reports in this area have not adequately addressed the biocompatibility and acceptability of the materials in blood contacting applications. In this study, hydrogenated amorphous carbon (a-C:H) films were fabricated on silicon wafers (100) using plasma immersion ion implantation-deposition. A series of a-C:H films with different structures and chemical bonds were fabricated under different substrate voltages. The results indicate that film graphitization is promoted at higher substrate bias. The film deposited at a lower substrate bias of -75 V possesses better blood compatibility than the films at higher bias and stainless steel. Our results suggest two possible paths to improve the blood compatibility, suppression of the endogenic clotting system and reduction of platelet activation. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
RI Leng, Yongxiang/G-5488-2010; Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Fedosenko G, 2001, DIAM RELAT MATER, V10, P920, DOI 10.1016/S0925-9635(00)00507-0
   Gu JW, 2002, MAT SCI ENG C-BIO S, V20, P199, DOI 10.1016/S0928-4931(02)00033-4
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Lai KH, 2001, DIAM RELAT MATER, V10, P1862, DOI 10.1016/S0925-9635(01)00460-5
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   Littmark U., 1985, STOPPING RANGE IONS, V1
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   Silinskas M, 2002, DIAM RELAT MATER, V11, P1026, DOI 10.1016/S0925-9635(01)00734-8
   Tian XB, 2001, J VAC SCI TECHNOL A, V19, P1008, DOI 10.1116/1.1365136
   Tian XB, 2000, REV SCI INSTRUM, V71, P2839, DOI 10.1063/1.1150700
   Yu SJ, 2001, THIN SOLID FILMS, V390, P98, DOI 10.1016/S0040-6090(01)00945-2
NR 15
TC 18
Z9 20
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAY
PY 2003
VL 206
BP 721
EP 725
DI 10.1016/S0168-583X(03)00871-1
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 692ZQ
UT WOS:000183690500156
DA 2018-10-20
ER

PT J
AU Lopez, MF
   Jimenez, JA
   Gutierrez, A
AF Lopez, MF
   Jimenez, JA
   Gutierrez, A
TI Corrosion study of surface-modified vanadium-free titanium alloys
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE titanium alloys; electrochemical techniques; corrosion; oxidation;
   biomaterials
ID IN-VITRO CORROSION; HYDROXYAPATITE; BEHAVIOR; TI; BIOMATERIALS;
   SUPERALLOY; TI-6AL-7NB; MA-956; AL
AB The present work is part of an investigation aimed to improve the corrosion resistance of three vanadium-free titanium alloys of biomedical interest, Ti-6Al-7Nb, Ti-13Nb-13Zr and Ti-15Zr-4Nb, by growing on their surfaces an oxide protective layer. For this goal, different samples were oxidized in air at 750 degreesC for times ranging from 6 to 48 h. Thickness, morphology and composition of the oxide scales for different oxidation times were investigated by using scanning electron microscopy (SEM) and X-ray diffraction (XRD). After equal oxidation time, the Ti-6Al-7Nb alloy exhibited a thinner, more compact and dense oxide layer than the TiNbZr alloys, indicating a slower oxidation rate. Several oxidation times were used in order to obtain oxide scales with similar properties for the three alloys. Different electrochemical techniques were then applied to evaluate the corrosion behavior of the different samples. The oxidized Ti-6Al-7Nb alloy showed the lowest corrosion current densities as well as the best pitting corrosion behavior, and is thereby considered as the best of these materials for biomedical applications. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 CSIC, Inst Ciencia Mat, Dept Fis & Ingn Superficies, E-28049 Madrid, Spain.
   CSIC, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
   Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
RP Lopez, MF (reprint author), CSIC, Inst Ciencia Mat, Dept Fis & Ingn Superficies, E-28049 Madrid, Spain.
RI Lopez, Maria/C-4571-2011; Gutierrez, Alejandro/A-9092-2011; Jimenez,
   Jose/H-2644-2015
OI Lopez, Maria/0000-0001-7894-566X; Gutierrez,
   Alejandro/0000-0002-1150-0719; Jimenez, Jose/0000-0003-4272-6873
CR Akin FA, 2001, J BIOMED MATER RES, V57, P588, DOI 10.1002/1097-4636(20011215)57:4<588::AID-JBM1206>3.0.CO;2-Y
   BOYER R, 1994, MAT PROPERTIES HDB T
   BREME HJ, 1998, METALS BIOMATERIALS, pCH2
   ESCUDERO ML, 1995, BIOMATERIALS, V16, P735, DOI 10.1016/0142-9612(95)99703-O
   Escudero ML, 1996, J BIOMED MATER RES, V31, P313
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Kohn D. H., 1992, MAT SCI TECHNOLOGY, V14
   Kuroda K, 2002, J BIOMED MATER RES, V59, P390, DOI 10.1002/jbm.10002
   Lavos-Valereto IC, 2001, J BIOMED MATER RES, V58, P727, DOI 10.1002/jbm.1072
   Lopez MF, 1998, J MATER RES, V13, P3411, DOI 10.1557/JMR.1998.0464
   Lopez MF, 2002, ELECTROCHIM ACTA, V47, P1359, DOI 10.1016/S0013-4686(01)00860-X
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   Lynn AK, 2002, BIOMATERIALS, V23, P1937, DOI 10.1016/S0142-9612(01)00321-0
   Mano T, 2002, BIOMATERIALS, V23, P1931, DOI 10.1016/S0142-9612(01)00319-2
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Pham MT, 2002, J BIOMED MATER RES, V59, P716, DOI 10.1002/jbm.10012
   SIBUM H, 1998, ALLOYS PREPARATION P, pCH11
   Sohmura T, 2001, J BIOMED MATER RES, V58, P478, DOI 10.1002/jbm.1044
   STERN M, 1957, J ELECTROCHEM SOC, V104, P56, DOI 10.1149/1.2428496
   Strietzel R, 1998, BIOMATERIALS, V19, P1495, DOI 10.1016/S0142-9612(98)00065-9
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
NR 22
TC 78
Z9 79
U1 1
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD APR 30
PY 2003
VL 48
IS 10
BP 1395
EP 1401
DI 10.1016/S0013-4686(03)00006-9
PG 7
WC Electrochemistry
SC Electrochemistry
GA 666TQ
UT WOS:000182192900009
DA 2018-10-20
ER

PT J
AU Vauthier, C
   Dubernet, C
   Fattal, E
   Pinto-Alphandary, H
   Couvreur, P
AF Vauthier, C
   Dubernet, C
   Fattal, E
   Pinto-Alphandary, H
   Couvreur, P
TI Poly(alkylcyanoacrylates) as biodegradable materials for biomedical
   applications
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE poly(alkylcyanoacrylates); polymerization; nanoparticles; degradation;
   therapeutic applications
ID DOXORUBICIN-LOADED NANOPARTICLES; PEGYLATED POLYCYANOACRYLATE
   NANOPARTICLES; 80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLES;
   BLOOD-BRAIN-BARRIER; POLY(BUTYL 2-CYANOACRYLATE) NANOPARTICLES; LEUKEMIC
   MURINE CELLS; DRUG-DELIVERY DEVICES; FACTOR-ALPHA CARRIERS;
   POLYALKYLCYANOACRYLATE NANOPARTICLES; IN-VITRO
AB This review considers the use of poly(alkyleyanoacrylates) (PACAs) as biomedical materials. We first present the different aspects of the polymerization of alkylcyanoacrylate monomers and briefly discuss their applications as skin adhesives, surgical glues and embolitic materials. An extensive review of the developments and applications of PACAs as nanoparticles for the delivery of drugs is then given. The methods of preparation of the nanoparticles are presented and considerations concerning the degradation, in vivo distribution, toxicity and cytotoxicity of the nanoparticles are discussed. The different therapeutic applications are presented according to the route of administration of the nanoparticles and include the most recent developments in the field. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Univ Paris 11, UMR CNRS 8612, Lab Physicochim Pharmacotech & Biopharm, F-92296 Chatenay Malabry, France.
RP Vauthier, C (reprint author), Univ Paris 11, UMR CNRS 8612, Lab Physicochim Pharmacotech & Biopharm, 5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.
RI COUVREUR, Patrick/G-4844-2011
OI COUVREUR, Patrick/0000-0001-7961-5443; Fattal,
   Elias/0000-0002-3194-961X; Vauthier, Christine/0000-0003-3963-0045
CR Aboubakar M, 1999, J BIOMED MATER RES, V47, P568, DOI 10.1002/(SICI)1097-4636(19991215)47:4<568::AID-JBM14>3.3.CO;2-O
   Aboubakar M, 2000, DRUG DEVELOP RES, V49, P109, DOI 10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-#
   ALONSO MJ, 1990, J MICROENCAPSUL, V7, P517, DOI 10.3109/02652049009040475
   Alyaudtin RN, 2001, J DRUG TARGET, V9, P209, DOI 10.3109/10611860108997929
   Alyautdin RN, 1997, PHARMACEUT RES, V14, P325, DOI 10.1023/A:1012098005098
   Alyautdin RN, 1998, J MICROENCAPSUL, V15, P67, DOI 10.3109/02652049809006836
   AMMOURY N, 1989, STP PHARM, V5, P642
   APRAHAMIAN M, 1987, BIOL CELL, V61, P69, DOI 10.1111/j.1768-322X.1987.tb00571.x
   Araujo L, 1999, J DRUG TARGET, V6, P373, DOI 10.3109/10611869908996844
   BAHSIN DK, 2002, ENDOSCOPY, V34, P119
   BALLAND O, 1994, J ANTIMICROB CHEMOTH, V33, P509, DOI 10.1093/jac/33.3.509
   BARRATT G, 2001, POLYM BIOMATERIALS, P753
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   BENNIS S, 1994, EUR J CANCER, V30A, P89, DOI 10.1016/S0959-8049(05)80025-5
   Boudad H, 2001, INT J PHARM, V218, P113, DOI 10.1016/S0378-5173(01)00622-6
   BOUDAD H, 2001, P 4 WORLD M PHARM BI, P1385
   BRASSEUR F, 1986, P 4 INT C PHARM TECH
   Brigger I, 2001, INT J PHARM, V214, P37, DOI 10.1016/S0378-5173(00)00628-1
   BRIGGER I, IN PRESS ADV DRUG DE
   BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232
   Burns DT, 1998, ANAL CHIM ACTA, V362, P171, DOI 10.1016/S0003-2670(98)00070-1
   Calvo P, 2001, PHARMACEUT RES, V18, P1157, DOI 10.1023/A:1010931127745
   Calvo P, 2002, EUR J NEUROSCI, V15, P1317, DOI 10.1046/j.1460-9568.2002.01967.x
   Calvo P, 2001, J NEUROSCI METH, V111, P151, DOI 10.1016/S0165-0270(01)00450-2
   CHAVANY C, 1994, PHARMACEUT RES, V11, P1370, DOI 10.1023/A:1018923301967
   CHAVANY C, 1992, PHARMACEUT RES, V9, P441, DOI 10.1023/A:1015871809313
   CHIANNILKULACHAI N, 1990, CANCER CHEMOTH PHARM, V26, P122, DOI 10.1007/BF02897257
   CHIANNILKULCHAI N, 1989, SELECT CANCER THER, V5, P1, DOI 10.1089/sct.1989.5.1
   CHOI YK, 1995, MACROMOLECULES, V28, P8419, DOI 10.1021/ma00128a062
   COOPER AW, 1989, J POLYM SCI POL CHEM, V27, P1967, DOI 10.1002/pola.1989.080270617
   Coover H. W., 1990, HDB ADHESIVES, P463
   COUVREUR P, 1977, FEBS LETT, V84, P323, DOI 10.1016/0014-5793(77)80717-5
   Couvreur P, 2002, CRIT REV THER DRUG, V19, P99, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i2.10
   COUVREUR P, 1982, J PHARM SCI, V71, P790, DOI 10.1002/jps.2600710717
   COUVREUR P, 1980, J PHARM BELG, V35, P51
   COUVREUR P, 1979, J PHARM PHARMACOL, V31, P331, DOI 10.1111/j.2042-7158.1979.tb13510.x
   COUVREUR P, 1989, STP PHARMA, V5, P31
   COUVREUR P, 1986, POLYM NANOPARTICLES, P27
   CUVIER C, 1992, BIOCHEM PHARMACOL, V44, P509, DOI 10.1016/0006-2952(92)90443-M
   DAEMEN T, 1995, INT J CANCER, V61, P716, DOI 10.1002/ijc.2910610520
   Damge C, 1997, J PHARM PHARMACOL, V49, P949, DOI 10.1111/j.2042-7158.1997.tb06022.x
   DAMGE C, 1990, J CONTROL RELEASE, V13, P233, DOI 10.1016/0168-3659(90)90013-J
   Damge C, 1997, J PHARM SCI, V86, P1403, DOI 10.1021/js970124i
   DAMGE C, 1988, DIABETES, V37, P246, DOI 10.2337/diabetes.37.2.246
   DAMGE C, 1987, INT J PHARM, V36, P121, DOI 10.1016/0378-5173(87)90146-3
   De Jaeghere F., 1999, ENCY CONTROLLED DRUG, P641
   Demoy M, 1997, PHARMACEUT RES, V14, P463, DOI 10.1023/A:1012095431931
   Desai SD, 2000, DRUG DELIV, V7, P201
   deVerdiere AC, 1997, BRIT J CANCER, V76, P198, DOI 10.1038/bjc.1997.362
   DEVERDIERE AC, 1994, CANCER CHEMOTH PHARM, V33, P504
   DOUGLAS S J, 1986, Journal of Controlled Release, V3, P15, DOI 10.1016/0168-3659(86)90060-X
   DOUGLAS SJ, 1985, J COLLOID INTERF SCI, V103, P154, DOI 10.1016/0021-9797(85)90087-6
   FATTAL E, 1989, ANTIMICROB AGENTS CH, V33, P1540, DOI 10.1128/AAC.33.9.1540
   Fattal E, 2002, ENCY PHARM TECHNOLOG, P1874
   Fattal E., 1993, STP PHARMA SCI, V3, P11
   FernandezUrrusuno R, 1997, BIOMATERIALS, V18, P511, DOI 10.1016/S0142-9612(96)00178-0
   FernandezUrrusuno R, 1996, J BIOMED MATER RES, V31, P401, DOI 10.1002/(SICI)1097-4636(199607)31:3<401::AID-JBM15>3.0.CO;2-L
   FERNANDEZURRUSUNO R, 1995, TOXICOL APPL PHARM, V130, P272, DOI 10.1006/taap.1995.1032
   Florence AT, 2001, ADV DRUG DELIVER REV, V50, pS69, DOI 10.1016/S0169-409X(01)00184-3
   FORESTIER F, 1992, J ANTIMICROB CHEMOTH, V30, P173, DOI 10.1093/jac/30.2.173
   FOUARGE M, 1989, J MICROENCAPSUL, V6, P29, DOI 10.3109/02652048909019899
   Fresta M, 1996, BIOMATERIALS, V17, P751, DOI 10.1016/0142-9612(96)81411-6
   Fresta M, 2001, J PHARM SCI, V90, P288, DOI 10.1002/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5
   Friese A, 2000, EUR J PHARM BIOPHARM, V49, P103, DOI 10.1016/S0939-6411(99)00073-9
   GALLARDO M, 1993, INT J PHARM, V100, P55, DOI 10.1016/0378-5173(93)90075-Q
   Gallardo M. M., 1989, 5TH P APGI INT C PHA, VIV, P36
   GASCO MR, 1986, INT J PHARM, V29, P267, DOI 10.1016/0378-5173(86)90125-0
   GASPAR R, 1992, PHARM RES-DORDR, V9, P782, DOI 10.1023/A:1015807706530
   GASPAR R, 1992, ANN TROP MED PARASIT, V86, P782
   GAUTIER JC, 1992, J CONTROL RELEASE, V3, P205
   Gelperina SE, 2002, TOXICOL LETT, V126, P131, DOI 10.1016/S0378-4274(01)00456-8
   GHANEM GE, 1993, APPL RADIAT ISOTOPES, V44, P1219, DOI 10.1016/0969-8043(93)90068-L
   Gibaud S, 1998, J CONTROL RELEASE, V52, P131, DOI 10.1016/S0168-3659(97)00194-6
   GIBAUD S, 1994, EUR J CANCER, V6, P820
   GIPPS EM, 1987, INT J PHARM, V40, P23, DOI 10.1016/0378-5173(87)90044-5
   GRANGIER JL, 1991, J CONTROL RELEASE, V15, P3, DOI 10.1016/0168-3659(91)90098-X
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   GRISLAIN L, 1983, INT J PHARM, V15, P335, DOI 10.1016/0378-5173(83)90166-7
   GUISE V, 1990, PHARMACEUT RES, V7, P736, DOI 10.1023/A:1015819706491
   GUISE V, 1987, CELL MOL BIOL, V33, P397
   Gulyaev AE, 1999, PHARMACEUT RES, V16, P1564, DOI 10.1023/A:1018983904537
   HOLLOCK GG, 2001, ANN PLAST SURG, V47, P576
   HUBERT B, 1991, PHARMACEUT RES, V8, P734, DOI 10.1023/A:1015897900363
   JANI P, 1989, J PHARM PHARMACOL, V41, P809, DOI 10.1111/j.2042-7158.1989.tb06377.x
   KANTE B, 1982, J PHARM SCI, V71, P786, DOI 10.1002/jps.2600710716
   KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0
   KATTAN J, 1992, INVEST NEW DRUG, V10, P191, DOI 10.1007/BF00877245
   King M E, 1999, Nurse Pract, V24, P69, DOI 10.1097/00006205-199924100-00005
   KITOH A, 2002, LANCET, V359, P1669
   Kreuter J, 1984, J Microencapsul, V1, P253, DOI 10.3109/02652048409049364
   Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8
   KREUTER J, 1995, BRAIN RES, V674, P171, DOI 10.1016/0006-8993(95)00023-J
   KREUTER J, 1989, INT J PHARM, V55, P39, DOI 10.1016/0378-5173(89)90274-3
   KUBIAK C, 1989, BIOMATERIALS, V10, P553, DOI 10.1016/0142-9612(89)90062-8
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   LABIB A, 1991, PHARMACEUT RES, V8, P1027, DOI 10.1023/A:1015809124895
   Lambert G, 2000, PHARMACEUT RES, V17, P707, DOI 10.1023/A:1007582332491
   Lambert G, 1998, BIOCHIMIE, V80, P969, DOI 10.1016/S0300-9084(99)80002-9
   Lambert G, 2001, INT J PHARM, V214, P13, DOI 10.1016/S0378-5173(00)00624-4
   Lambert G, 2000, BIOCHEM BIOPH RES CO, V279, P401, DOI 10.1006/bbrc.2000.3963
   LANGER K, 1994, INT J PHARM, V110, P21, DOI 10.1016/0378-5173(94)90371-9
   LeBourlais CA, 1997, J MICROENCAPSUL, V14, P457, DOI 10.3109/02652049709033830
   LEFEVRE ME, 1985, P SOC EXP BIOL MED, V179, P522
   LENAERTS V, 1984, BIOMATERIALS, V5, P65, DOI 10.1016/0142-9612(84)90002-4
   LENAERTS V, 1984, J PHARM SCI, V73, P980, DOI 10.1002/jps.2600730730
   LENAERTS V, 1990, BIOADHESIVE DRUG DEL, P94
   LEONARD F, 1966, J APPL POLYM SCI, V10, P259, DOI 10.1002/app.1966.070100208
   LESCURE F, 1992, J COLLOID INTERF SCI, V154, P77, DOI 10.1016/0021-9797(92)90079-2
   LEY D, 1984, LAB PHARMAPROBL TECH, V32, P100
   LHERM C, 1992, INT J PHARM, V84, P13, DOI 10.1016/0378-5173(92)90210-S
   Li YP, 2001, BIOL PHARM BULL, V24, P662, DOI 10.1248/bpb.24.662
   Li YP, 2001, J CONTROL RELEASE, V71, P287, DOI 10.1016/S0168-3659(01)00235-8
   LOWE PJ, 1994, J PHARM PHARMACOL, V46, P547, DOI 10.1111/j.2042-7158.1994.tb03854.x
   MAINCENT P, 1986, J PHARM SCI, V75, P955, DOI 10.1002/jps.2600751009
   Marcovich R, 2001, UROLOGY, V57, P806, DOI 10.1016/S0090-4295(00)01075-X
   MICHEL C, 1990, J PHARM PHARMACOL, V43, P1
   MULLER RH, 1990, BIOMATERIALS, V11, P590, DOI 10.1016/0142-9612(90)90084-4
   Nakada Y, 1996, PHARMACEUT RES, V13, P38, DOI 10.1023/A:1016017014573
   NEMATI F, 1994, INT J PHARM, V102, P55, DOI 10.1016/0378-5173(94)90039-6
   OHAGAN DT, 1989, VACCINE, V7, P213, DOI 10.1016/0264-410X(89)90231-4
   Olivier JC, 1999, PHARMACEUT RES, V16, P1836, DOI 10.1023/A:1018947208597
   Oowaki H, 2000, BIOMATERIALS, V21, P1039, DOI 10.1016/S0142-9612(99)00278-1
   Page-Clisson ME, 1998, PHARMACEUT RES, V15, P544, DOI 10.1023/A:1011921608964
   Pepin X, 1997, J CHROMATOGR B, V702, P181, DOI 10.1016/S0378-4347(97)00362-9
   Pepper D., 1978, J POLYM SCI       PS, V62, P65
   Peracchia MT, 1999, J CONTROL RELEASE, V60, P121, DOI 10.1016/S0168-3659(99)00063-2
   Peracchia MT, 1997, MACROMOLECULES, V30, P846, DOI 10.1021/ma961453k
   Peracchia MT, 1997, STP PHARMA SCI, V7, P513
   Peracchia MT, 1997, J BIOMED MATER RES, V34, P317, DOI 10.1002/(SICI)1097-4636(19970305)34:3<317::AID-JBM6>3.0.CO;2-N
   PERACCHIA MT, 1998, STRATEGIES STEALTH T, V6, P225
   PERACCHIA MT, 1998, PHARM RES, V15, P548
   PIMIENTA C, 1992, INT J PHARM, V80, P1, DOI 10.1016/0378-5173(92)90256-2
   PINTOALPHANDARY H, 1994, PHARMACEUT RES, V11, P38, DOI 10.1023/A:1018985308984
   Pollak JS, 2001, J VASC INTERV RADIOL, V12, P907, DOI 10.1016/S1051-0443(07)61568-1
   Ponchel G, 1998, ADV DRUG DELIVER REV, V34, P191, DOI 10.1016/S0169-409X(98)00040-4
   PONCHEL G, 1987, Journal of Controlled Release, V5, P129, DOI 10.1016/0168-3659(87)90004-6
   PUGLISI G, 1995, INT J PHARM, V125, P283, DOI 10.1016/0378-5173(95)00142-6
   Ramge P, 2000, EUR J NEUROSCI, V12, P1931, DOI 10.1046/j.1460-9568.2000.00078.x
   Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5
   Roblot-Treupel L, 1986, INT J PHARMACEUT, V28, P125
   Ryan B, 1996, MACROMOL RAPID COMM, V17, P217, DOI 10.1002/marc.1996.030170404
   SCHERER D, 1994, INT J PHARM, V101, P165, DOI 10.1016/0378-5173(94)90086-8
   SCHWAB G, 1994, P NATL ACAD SCI USA, V91, P10460, DOI 10.1073/pnas.91.22.10460
   SEIJO B, 1990, INT J PHARM, V62, P1, DOI 10.1016/0378-5173(90)90024-X
   Singer AJ, 2002, SURGERY, V131, P270, DOI 10.1067/msy.2002.121377
   SKEIST I, 1977, ENCY POLYM SCI ENG S, V2, P1
   Soma CE, 1999, PHARMACEUT RES, V16, P1710, DOI 10.1023/A:1018902031370
   Soma CE, 2000, J CONTROL RELEASE, V68, P283, DOI 10.1016/S0168-3659(00)00269-8
   Sopala M, 2002, ARZNEIMITTEL-FORSCH, V52, P168
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   STEIN CA, 1996, BIOTECHNOLOGY, V14, P47
   Stella B, 2000, J PHARM SCI, V89, P1452, DOI 10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
   Takeuchi H, 2001, ADV DRUG DELIVER REV, V47, P39, DOI 10.1016/S0169-409X(00)00120-4
   Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152
   Torres-Lugo M, 2000, BIOMATERIALS, V21, P1191, DOI 10.1016/S0142-9612(00)00011-9
   TREUPEL L, 1991, CR ACAD SCI III-VIE, V313, P171
   TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U
   Vansnick L., 1985, PHARM RES-DORDR, V1, P36
   VAUTHIER C, 2002, IN PRESS HDB BIOPOLY, V9
   VERDUN C, 1990, CANCER CHEMOTH PHARM, V26, P13, DOI 10.1007/BF02940287
   VEZIN WR, 1980, J BIOMED MATER RES, V14, P93, DOI 10.1002/jbm.820140202
   VINTERS HV, 1988, TOXICOL IN VITRO, V2, P37, DOI 10.1016/0887-2333(88)90035-5
   Vranckx H, 1996, EUR J PHARM BIOPHARM, V42, P345
   WADE CWR, 1972, J BIOMED MATER RES, V6, P215, DOI 10.1002/jbm.820060310
   Watnasirichaikul S, 2000, PHARMACEUT RES, V17, P684, DOI 10.1023/A:1007574030674
   Watnasirichaikul S, 2002, J PHARM PHARMACOL, V54, P473, DOI 10.1211/0022357021778736
   Wohlgemuth M, 2000, J MICROENCAPSUL, V17, P437
   Yang SC, 2000, COLLOID POLYM SCI, V278, P285, DOI 10.1007/s003960050516
   YOUSSEF M, 1988, ANTIMICROB AGENTS CH, V32, P1204, DOI 10.1128/AAC.32.8.1204
   ZIMMER A, 1991, J MICROENCAPSUL, V8, P497, DOI 10.3109/02652049109021873
   Zimmer A, 1999, METHODS, V18, P286, DOI 10.1006/meth.1999.0786
NR 171
TC 329
Z9 352
U1 2
U2 79
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD APR 25
PY 2003
VL 55
IS 4
BP 519
EP 548
DI 10.1016/S0169-409X(03)00041-3
PG 30
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 678ZE
UT WOS:000182895900006
PM 12706049
DA 2018-10-20
ER

PT J
AU Edlund, U
   Albertsson, AC
AF Edlund, U
   Albertsson, AC
TI Polyesters based on diacid monomers
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE ester; dicarboxylic; diacid; polycondensation; polyester;
   poly(ester-amide); poly(ester-anhydride); poly(ester-urethane);
   poly(ester-imide); poly(ether-ester); degradation; hydrolysis;
   biomedical
ID THERMOTROPIC LIQUID-CRYSTALS; RING-OPENING POLYMERIZATION;
   LIPASE-CATALYZED SYNTHESIS; SMECTIC MESOPHASE PROPERTIES; PLASTIC-BONDED
   EXPLOSIVES; DICARBOXYLIC-ACID UNITS; PARA-AROMATIC POLYMERS; ACTIVE
   AMINO-ALCOHOLS; IN-VITRO DEGRADATION; RIGID-ROD POLYMERS
AB Polymers with ester linkages in their main chain comprise a family of polymers with immense diversity and versatility. This review deals with the preparation of such polymers from dicarboxylic acid monomers, and the result in terms of properties and applicability. Polyesters alone, and their copolymers with amides, anhydrides, urethanes, imides, ethers or other functional groups, offer countless opportunities to tune the properties of the resulting material within a broad range. Of particular interest is the inherent biodegradability of the ester linkage. Biodegradability is sought after in a wide range of applications, above all in the preparation of environmentally friendly polymers and biomedical materials for temporary surgical use and in drug delivery. (C) 2003 Published by Elsevier Science B.V.
C1 Royal Inst Technol, Dept Polymer Technol, SE-10044 Stockholm, Sweden.
RP Albertsson, AC (reprint author), Royal Inst Technol, Dept Polymer Technol, SE-10044 Stockholm, Sweden.
RI Albertsson, Ann-Christine/Q-6107-2016
OI Albertsson, Ann-Christine/0000-0001-8696-9143; /0000-0002-1631-1781
CR ALBERTSSON AC, 1986, J MACROMOL SCI CHEM, VA23, P411, DOI 10.1080/00222338608063403
   ALBERTSSON AC, 1987, J MACROMOL SCI CHEM, VA24, P977, DOI 10.1080/00222338708076930
   ALBERTSSON AC, 1988, J MACROMOL SCI CHEM, VA25, P467, DOI 10.1080/00222338808053379
   ALBERTSSON AC, 1986, J MACROMOL SCI CHEM, VA23, P393, DOI 10.1080/00222338608063402
   Alla A, 1997, POLYMER, V38, P4935, DOI 10.1016/S0032-3861(96)01092-0
   Aoi K, 1996, MACROMOLECULES, V29, P4456, DOI 10.1021/ma9601068
   Armelin E, 2002, MACROMOL CHEM PHYSIC, V203, P48, DOI 10.1002/1521-3935(20020101)203:1<48::AID-MACP48>3.0.CO;2-E
   ASAMI R, 1980, POLYM BULL, V2, P713
   BARROWS TH, 1982, Patent No. 4343931
   BEUMER GJ, 1993, BIOMATERIALS, V14, P598, DOI 10.1016/0142-9612(93)90178-5
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   Bezemer JM, 2000, J CONTROL RELEASE, V64, P179, DOI 10.1016/S0168-3659(99)00127-3
   Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4
   Bezemer JM, 2000, J CONTROL RELEASE, V66, P307, DOI 10.1016/S0168-3659(99)00287-4
   BIER G, 1974, POLYMER, V15, P527, DOI 10.1016/0032-3861(74)90093-7
   Bikiaris DN, 1999, POLYM DEGRAD STABIL, V63, P213, DOI 10.1016/S0141-3910(98)00094-9
   BINNS F, 1993, J CHEM SOC PERK T 1, P899, DOI 10.1039/p19930000899
   Binns F, 1998, J POLYM SCI POL CHEM, V36, P2069, DOI 10.1002/(SICI)1099-0518(19980915)36:12<2069::AID-POLA13>3.3.CO;2-Q
   Bogdanov B, 1999, POLYMER, V40, P3171, DOI 10.1016/S0032-3861(98)00552-7
   Bogdanov B, 2000, MACROMOL SYMP, V152, P117, DOI 10.1002/1521-3900(200003)152:1<117::AID-MASY117>3.0.CO;2-A
   BOU JJ, 1993, MACROMOLECULES, V26, P5664, DOI 10.1021/ma00073a020
   BRODE GL, 1972, J MACROMOL SCI CHEM, VA  6, P1109, DOI 10.1080/10601327208056888
   BROWN DW, 1983, J APPL POLYM SCI, V28, P3779, DOI 10.1002/app.1983.070281218
   Bruch M, 1999, J POLYM SCI POL CHEM, V37, P3367
   Campbell MS, 2000, THERMOCHIM ACTA, V357, P89, DOI 10.1016/S0040-6031(00)00372-5
   Carothers W., 1929, J AM CHEM SOC, V51, P2548
   Carothers W. H., 1929, J AM CHEM SOC, V51, P2560, DOI DOI 10.1021/JA01383A042
   Carothers WH, 1930, J AM CHEM SOC, V52, P314, DOI 10.1021/ja01364a045
   Carothers WH, 1931, CHEM REV, V8, P353, DOI 10.1021/cr60031a001
   Carson RJ, 1996, J BIOMATER APPL, V11, P121, DOI 10.1177/088532829601100201
   COLEMAN D, 1954, J POLYM SCI, V14, P15, DOI 10.1002/pol.1954.120147303
   deAbajo J, 1997, POLYMER, V38, P5677, DOI 10.1016/S0032-3861(97)00114-6
   DEABAJO J, 1990, MAKROMOL CHEM, V191, P537
   DEGROOT JH, 1990, COLLOID POLYM SCI, V268, P1073, DOI 10.1007/BF01410672
   DOLUI SK, 1985, J APPL POLYM SCI, V30, P3867, DOI 10.1002/app.1985.070300925
   DONG D, 1999, POLYM J, V31, P17
   Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h
   DUDA A, 1990, MACROMOLECULES, V23, P1636, DOI 10.1021/ma00208a012
   Dupret I, 1999, MACROMOL CHEM PHYS, V200, P2508, DOI 10.1002/(SICI)1521-3935(19991101)200:11<2508::AID-MACP2508>3.0.CO;2-3
   Edlund U, 2002, ADV POLYM SCI, V157, P67
   EGBOH SHO, 1983, J MACROMOL SCI CHEM, VA19, P1041, DOI 10.1080/00222338308081083
   EISENBACH CD, 1979, POLYM BULL, V1, P517
   EISENBACH CD, 1980, MAKROMOL CHEM-RAPID, V1, P287
   Erdmann L, 2000, BIOMATERIALS, V21, P2507, DOI 10.1016/S0142-9612(00)00118-6
   Erdmann L, 2000, BIOMATERIALS, V21, P1941, DOI 10.1016/S0142-9612(00)00073-9
   FAKIROV S, 1990, MAKROMOL CHEM, V191, P603
   Feldman KS, 2001, HETEROCYCLES, V55, P1527
   Fujimaki T, 1998, POLYM DEGRAD STABIL, V59, P209, DOI 10.1016/S0141-3910(97)00220-6
   Furukawa M, 1999, POLYMER, V40, P1791, DOI 10.1016/S0032-3861(98)00262-6
   Gan Z, 2001, BIOMACROMOLECULES, V2, P313, DOI 10.1021/bm0056557
   GILDING DK, 1979, POLYMER, V20, P1454, DOI 10.1016/0032-3861(79)90008-9
   GOODMAN I, 1969, Patent No. 3475385
   Grigat E, 1998, POLYM DEGRAD STABIL, V59, P223, DOI 10.1016/S0141-3910(97)00174-2
   GRIJPMA DW, 1994, MACROMOL CHEM PHYSIC, V195, P1633, DOI 10.1002/macp.1994.021950515
   GUO ZW, 1988, J AM CHEM SOC, V110, P1999, DOI 10.1021/ja00214a073
   Hao JY, 2001, POLYMER, V42, P4091, DOI 10.1016/S0032-3861(00)00465-1
   HARTMANN M, 1993, PURE APPL CHEM, V30, P91
   Ho L. H., 1992, POLYM PREPR AM CHEM, V33, P94
   Hoffman DM, 2002, J APPL POLYM SCI, V83, P1009, DOI 10.1002/app.2281
   Iglesias LE, 1999, BIOTECHNOL TECH, V13, P923, DOI 10.1023/A:1008958212814
   Jiang HL, 2002, BIOMATERIALS, V23, P2345, DOI 10.1016/S0142-9612(01)00368-4
   Jiang HL, 2001, BIOMATERIALS, V22, P211, DOI 10.1016/S0142-9612(00)00176-9
   Jin HJ, 2000, J POLYM SCI POL PHYS, V38, P1504, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1504::AID-POLB100>3.0.CO;2-4
   Jin HJ, 2000, J APPL POLYM SCI, V77, P547, DOI 10.1002/(SICI)1097-4628(20000718)77:3<547::AID-APP10>3.0.CO;2-E
   JIN HJ, 2002, EUR POLYM J, V36, P2693
   Kasuya K, 1998, POLYM DEGRAD STABIL, V59, P327, DOI 10.1016/S0141-3910(97)00155-9
   KAY MJ, 1993, INT BIODETER BIODEGR, V31, P209, DOI 10.1016/0964-8305(93)90006-N
   Khan MA, 1999, POLYM DEGRAD STABIL, V63, P261, DOI 10.1016/S0141-3910(98)00103-7
   Kim BS, 2000, BIOMATERIALS, V21, P259, DOI 10.1016/S0142-9612(99)00174-X
   Kim IS, 2001, ARCH PHARM RES, V24, P69, DOI 10.1007/BF02976496
   KIRCHELDORF HR, 1996, MACROMOL S, V103, P85
   Kobayashi S, 1999, J POLYM SCI POL CHEM, V37, P3041, DOI 10.1002/(SICI)1099-0518(19990815)37:16<3041::AID-POLA1>3.3.CO;2-M
   KOBAYASHI S, 1995, ADV POLYM SCI, V121, P1
   Kobayashi S, 1998, ACS SYM SER, V684, P58
   Kobayashi S, 1998, POLYM DEGRAD STABIL, V59, P195, DOI 10.1016/S0141-3910(97)00178-X
   Koyama E, 1997, MACROMOL SYMP, V122, P275, DOI 10.1002/masy.19971220143
   Koyama E, 1997, J POLYM SCI POL CHEM, V35, P2925, DOI 10.1002/(SICI)1099-0518(199710)35:14<2925::AID-POLA13>3.0.CO;2-L
   Kricheldorf HR, 1996, MACROMOLECULES, V29, P4234, DOI 10.1021/ma951525s
   Kricheldorf HR, 1998, PURE APPL CHEM, V70, P1235, DOI 10.1351/pac199870061235
   Kricheldorf HR, 1997, MACROMOL CHEM PHYSIC, V198, P3149, DOI 10.1002/macp.1997.021981013
   KRICHELDORF HR, 1994, POLYMER, V35, P198, DOI 10.1016/0032-3861(94)90072-8
   Kricheldorf HR, 2001, J MACROMOL SCI PURE, V38, P451, DOI 10.1081/MA-100103360
   Kricheldorf HR, 2001, POLYMER, V42, P6699, DOI 10.1016/S0032-3861(01)00151-3
   KRICHELDORF HR, 1991, POLYMER, V32, P942, DOI 10.1016/0032-3861(91)90524-M
   Kricheldorf HR, 2000, J POLYM SCI POL CHEM, V38, P3019, DOI 10.1002/1099-0518(20000901)38:17<3019::AID-POLA20>3.0.CO;2-A
   KRICHELDORF HR, 1992, MAKROMOL CHEM-M SYMP, V54, P411
   KRIGBAUM WR, 1983, POLYMER, V24, P1299, DOI 10.1016/0032-3861(83)90063-0
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Lee DK, 1997, J APPL POLYM SCI, V65, P893
   LENZ RW, 1993, ADV POLYM SCI, V107, P2
   LEVINE M, 1958, J POLYM SCI, V28, P179, DOI 10.1002/pol.1958.1202811616
   LI CH, 1995, J APPL POLYM SCI, V55, P747, DOI 10.1002/app.1995.070550511
   Lim SW, 1999, EUR POLYM J, V35, P1875, DOI 10.1016/S0014-3057(98)00273-0
   LINKO YY, 1995, J BIOTECHNOL, V40, P133, DOI 10.1016/0168-1656(95)00039-S
   Liu Y, 2001, J POLYM SCI POL CHEM, V39, P630, DOI 10.1002/1099-0518(20010301)39:5<630::AID-POLA1034>3.0.CO;2-1
   LOFGREN A, 1995, J MACROMOL SCI R M C, VC35, P379
   Lundberg RD., 1969, RING OPENING POLYM, P247
   LUNDMARK S, 1991, J MACROMOL SCI CHEM, VA28, P15, DOI 10.1080/00222339108052083
   Martinez MB, 1997, MACROMOLECULES, V30, P3197
   MARVEL CS, 1975, J MACROMOL SCI R M C, VC 13, P219
   Mecerreyes D, 1999, MACROMOL CHEM PHYSIC, V200, P2581, DOI 10.1002/(SICI)1521-3935(19991201)200:12<2581::AID-MACP2581>3.0.CO;2-P
   MODY PC, 1981, J APPL POLYM SCI, V26, P2853, DOI 10.1002/app.1981.070260904
   Montaudo G, 2000, POLYM DEGRAD STABIL, V70, P305, DOI 10.1016/S0141-3910(00)00139-7
   Nagata M, 1999, J POLYM SCI POL CHEM, V37, P2005, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2005::AID-POLA14>3.3.CO;2-8
   Nagata M, 1998, MACROMOLECULES, V31, P6450, DOI 10.1021/ma980644f
   Nagata M, 1999, MACROMOLECULES, V32, P7762, DOI 10.1021/ma990907l
   NAGATA N, 1988, J POLYM SCI POL CHEM, V26, P235
   Nummelin S, 2000, TOP CURR CHEM, V210, P1
   OHYA Y, 1992, MAKROMOL CHEM, V193, P1881
   Okada M, 2002, J APPL POLYM SCI, V86, P872, DOI 10.1002/app.10995
   Okada M, 1996, J APPL POLYM SCI, V62, P2257
   Okada M, 2001, J APPL POLYM SCI, V81, P2721, DOI 10.1002/app.1718
   OKAMURA S, 1984, AGR BIOL CHEM TOKYO, V48, P2805
   Padmaja T, 2002, J APPL POLYM SCI, V85, P2108, DOI 10.1002/app.10777
   Paredes N, 1998, J POLYM SCI POL CHEM, V36, P1271
   Pazur RJ, 1998, POLYMER, V39, P3065, DOI 10.1016/S0032-3861(97)10031-3
   Penco M, 1998, POLYM INT, V46, P203, DOI 10.1002/(SICI)1097-0126(199807)46:3<203::AID-PI975>3.3.CO;2-8
   Person D, 1996, REACT FUNCT POLYM, V30, P229, DOI 10.1016/1381-5148(95)00131-X
   Person DV, 1996, REACT FUNCT POLYM, V30, P141, DOI 10.1016/1381-5148(95)00118-2
   Pietkiewicz D, 2000, POLIMERY-W, V45, P69
   Pinkus AG, 1997, MET MATER PROCESS, V9, P89
   PINTHER P, 1990, MAKROMOL CHEM-RAPID, V11, P403
   Pissis P, 1996, J POLYM SCI POL PHYS, V34, P1529, DOI 10.1002/(SICI)1099-0488(19960715)34:9<1529::AID-POLB1>3.0.CO;2-G
   PITT C G, 1987, Journal of Controlled Release, V4, P283, DOI 10.1016/0168-3659(87)90020-4
   PITT CG, 1981, BIOMATERIALS, V2, P215
   PO R, 1995, MACROMOLECULES, V28, P5699, DOI 10.1021/ma00121a002
   Pourjavadi A, 1998, J APPL POLYM SCI, V68, P173, DOI 10.1002/(SICI)1097-4628(19980411)68:2<173::AID-APP1>3.0.CO;2-N
   Radder AM, 1996, J BIOMED MATER RES, V30, P341
   Ranucci E, 2000, MACROMOL RAPID COMM, V21, P680, DOI 10.1002/1521-3927(20000601)21:10<680::AID-MARC680>3.0.CO;2-Y
   REED AM, 1981, POLYMER, V22, P499, DOI 10.1016/0032-3861(81)90169-5
   Rehman I, 1996, J MATER SCI-MATER M, V7, P17, DOI 10.1007/BF00121184
   Salazar MR, 2002, J POLYM SCI POL PHYS, V40, P181, DOI 10.1002/polb.10079
   SAMYN C, 1995, INT J PHARMACEUT, V121, P211, DOI 10.1016/0378-5173(95)00023-C
   SAOTOME Y, 1991, CHEM LETT, P21, DOI 10.1246/cl.1991.21
   Schollenberger CS, 1959, US patent, Patent No. 2871218
   Schoonover JR, 2001, POLYM DEGRAD STABIL, V74, P87, DOI 10.1016/S0141-3910(01)00105-7
   Seidenstucker T, 1998, POLYM DEGRAD STABIL, V59, P279, DOI 10.1016/S0141-3910(97)00199-7
   SHALABY SW, 1980, Patent No. 4209607
   Shogren R, 1997, J ENVIRON POLYM DEGR, V5, P91, DOI 10.1007/BF02763592
   SHOGREN RL, 1995, J ENVIRON POLYM DEGR, V3, P75, DOI 10.1007/BF02067483
   SHOLLENBERGER CS, 1973, ANGEW MAKROMOL CHEM, V29, P413
   SMITH TL, 1974, J POLYM SCI POL PHYS, V12, P1825, DOI 10.1002/pol.1974.180120907
   Stridsberg KM, 2002, ADV POLYM SCI, V157, P41
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   TAKIYAMA E, 1994, Patent No. 5310782
   Teomim D, 1999, J BIOMED MATER RES, V45, P258, DOI 10.1002/(SICI)1097-4636(19990605)45:3<258::AID-JBM14>3.0.CO;2-W
   TOKIWA Y, 1979, J APPL POLYM SCI, V24, P1701, DOI 10.1002/app.1979.070240710
   TOKIWA Y, 1981, J APPL POLYM SCI, V26, P441, DOI 10.1002/app.1981.070260206
   TOKIWA Y, 1977, NATURE, V270, P76, DOI 10.1038/270076a0
   Tsuji H, 2000, POLYM DEGRAD STABIL, V67, P179, DOI 10.1016/S0141-3910(99)00111-1
   UEDA M, 1985, MACROMOLECULES, V18, P2723, DOI 10.1021/ma00154a060
   Uyama H, 1999, POLYM J, V31, P380, DOI 10.1295/polymj.31.380
   Uyama H, 2000, POLYM J, V32, P440, DOI 10.1295/polymj.32.440
   Uyama H, 1999, J POLYM SCI POL CHEM, V37, P2737, DOI 10.1002/(SICI)1099-0518(19990801)37:15<2737::AID-POLA7>3.0.CO;2-M
   Villuendas I, 2001, MACROMOL CHEM PHYSIC, V202, P236, DOI 10.1002/1521-3935(20010101)202:2<236::AID-MACP236>3.0.CO;2-H
   WATANABE J, 1988, MACROMOLECULES, V21, P278, DOI 10.1021/ma00179a059
   WATANABE J, 1989, MACROMOLECULES, V22, P4083, DOI 10.1021/ma00200a046
   WATANABE J, 1993, LIQ CRYST, V13, P455, DOI 10.1080/02678299308026317
   Wilhelm C, 1997, POLYMER, V38, P4019, DOI 10.1016/S0032-3861(96)00984-6
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   WITT U, 1995, J ENVIRON POLYM DEGR, V3, P215, DOI 10.1007/BF02068676
   WITT U, 1994, MACROMOL CHEM PHYSIC, V195, P793, DOI 10.1002/macp.1994.021950235
   WITT U, 1995, J MACROMOL SCI PURE, VA32, P851, DOI 10.1080/10601329508010296
   WOLFE JF, 1981, MACROMOLECULES, V14, P915, DOI 10.1021/ma50005a005
   WOLFE JF, 1981, MACROMOLECULES, V14, P909, DOI 10.1021/ma50005a004
   Won CY, 1998, J POLYM SCI POL CHEM, V36, P2949, DOI 10.1002/(SICI)1099-0518(19981130)36:16<2949::AID-POLA13>3.0.CO;2-A
   Wu XY, 1998, J IND MICROBIOL BIOT, V20, P328, DOI 10.1038/sj.jim.2900533
   XIE HQ, 1994, J APPL POLYM SCI, V54, P1079, DOI 10.1002/app.1994.070540810
   YOKOYAMA M, 1989, MAKROMOL CHEM, V190, P2041
   ZANG QD, 1994, MACROMOLECULES, V27, P526, DOI 10.1021/ma00080a029
   Zhang T, 2000, POLYM BULL, V45, P223, DOI 10.1007/s002890070024
   Zhang T, 2002, J APPL POLYM SCI, V86, P2509, DOI 10.1002/app.11056
NR 172
TC 141
Z9 145
U1 5
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD APR 25
PY 2003
VL 55
IS 4
BP 585
EP 609
DI 10.1016/S0169-409X(03)00036-X
PG 25
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 678ZE
UT WOS:000182895900008
PM 12706051
DA 2018-10-20
ER

PT J
AU Kim, JH
   Kim, SC
AF Kim, JH
   Kim, SC
TI Effect of PEO grafts on the surface properties of PEO-Grafted PU/PS
   IPNs: AFM study
SO MACROMOLECULES
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; INTERPENETRATING POLYMER NETWORKS; ENHANCED
   BLOOD COMPATIBILITY; HYDROPHOBIC POLYSTYRENE IPNS; POLYETHYLENE OXIDE;
   IN-VITRO; ANTITHROMBOGENICITY; MORPHOLOGY; DENSITY
AB The change of the interfacial phenomena of muticomponent polymeric systems based on self-reorganization is very important for many applications of them. Specially, when they are used for biomedical application, the change of surface properties in water is a key factor because they are mostly used in the aqueous environment of the human body. An interpenetrating polymer network (IPN) is a mixture of network polymers. The morphology of an IPN can be controlled to obtain materials with nanoscale domains, and the morphology once formed is permanent due to the presence of the physical interlocking between the networks. In this study, surface compositional mapping was attempted with atomic force microscopy (AFM) images of poly(ethylene oxide)-grafted polyurethane/polystyrene IPNs (PEO-grafted PU/PS IPNs) to investigate the structural change under water, and the effect of hydrophilic PEO pendant chains on the change of local elasticity and surface energy of the IPN under water was studied by using the "force-distance (FID) analysis" of AFM. The compositional mapping in water showed that the area fraction of the hydrophilic PU-rich phase was increased by PEO grafting, but the structural reorganization did not occur. From the result of FID analysis in water, the mobile and flexible pendant PEO chains increased the surface elasticity and softness of PU/PS IPNs. The crystallinity also affected the surface hardness of the dried PEO-grafted PU, but it did not when the samples were swollen in water.
C1 Korea Adv Inst Sci & Technol, Ctr Adv Funct Polymers, Yuseong Gu, Taejon 305701, South Korea.
RP Kim, SC (reprint author), Korea Adv Inst Sci & Technol, Ctr Adv Funct Polymers, Yuseong Gu, 373-1 Gusong Dong, Taejon 305701, South Korea.
CR ALBRECHT TR, 1988, J APPL PHYS, V64, P1178, DOI 10.1063/1.341881
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BUTT HJ, 1995, BIOELECTROCH BIOENER, V38, P191, DOI 10.1016/0302-4598(95)01800-T
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   deGennes PG, 1979, SCALING CONCEPTS POL
   HOH JH, 1992, J AM CHEM SOC, V114, P4917, DOI 10.1021/ja00038a075
   HOH JH, 1991, NANOTECHNOLOGY
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kim JH, 2000, J BIOMAT SCI-POLYM E, V11, P197, DOI 10.1163/156856200743652
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Kim JH, 2002, J APPL POLYM SCI, V84, P379, DOI 10.1002/app.10358
   Magonov S. N., 1996, SURFACE ANAL STM AFM
   MATE CM, 1989, J CHEM PHYS, V90, P7550, DOI 10.1063/1.456188
   PERRIN DD, 1980, PURIFICATION LAB CHE
   Roh HW, 1999, J BIOMAT SCI-POLYM E, V10, P123, DOI 10.1163/156856299X00324
   Senshu K, 1999, LANGMUIR, V15, P1763, DOI 10.1021/la9808162
   Senshu K, 1999, LANGMUIR, V15, P1754, DOI 10.1021/la980815+
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P281
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P195
   SUGAWARA Y, 1993, WEAR
   THUNDAT T, 1993, SURF SCI, V294, pL939
   WEISENHORN AL, 1989, APPL PHYS LETT, V54, P2651, DOI 10.1063/1.101024
   ZHONG Q, 1993, SURF SCI LETT, V290, pL668
NR 25
TC 31
Z9 32
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD APR 22
PY 2003
VL 36
IS 8
BP 2867
EP 2872
DI 10.1021/ma0212137
PG 6
WC Polymer Science
SC Polymer Science
GA 669QJ
UT WOS:000182361700045
DA 2018-10-20
ER

PT J
AU Basu, S
   Martin, SW
   Phillips, RM
   Puri, R
AF Basu, S
   Martin, SW
   Phillips, RM
   Puri, R
TI Obtaining archived pathological material for biomedical research
SO LANCET
LA English
DT Letter
C1 Univ Bradford, Tom Connors Canc Res Unit, Bradford BD7 1DP, W Yorkshire, England.
   Bradford Hosp NHS Trust, Dept Urol, Bradford, W Yorkshire, England.
RP Basu, S (reprint author), Univ Bradford, Tom Connors Canc Res Unit, Richmond Bldg, Bradford BD7 1DP, W Yorkshire, England.
RI Phillips, Roger/I-5803-2017
OI Phillips, Roger/0000-0003-3504-177X
CR [Anonymous], 2001, HUM TISS BIOL SAMPL
   *ROYAL COLL PATH, 2001, TRANS GUID FAC CHANG
NR 2
TC 4
Z9 4
U1 0
U2 1
PU LANCET LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0140-6736
J9 LANCET
JI Lancet
PD APR 19
PY 2003
VL 361
IS 9366
BP 1394
EP 1394
DI 10.1016/S0140-6736(03)13069-3
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA 669HP
UT WOS:000182346100046
PM 12711507
DA 2018-10-20
ER

PT J
AU Hecht, S
AF Hecht, S
TI Functionalizing the interior of dendrimers: Synthetic challenges and
   applications
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Review
DE dendrimers; nanotechnology; covalent synthesis; structure-property
   relations
ID TRANSITION-METAL CATALYSIS; DENDRITIC MACROMOLECULES; CONVERGENT
   APPROACH; AB(2) MONOMERS; SITE ISOLATION;
   2,2-BIS(HYDROXYMETHYL)PROPIONIC ACID; 3-DIMENSIONAL MACROMOLECULES;
   PHENYLACETYLENE DENDRIMERS; BIOMEDICAL APPLICATIONS; HYPERBRANCHED
   POLYMERS
AB Chemists' fascination with dendrimers mainly originates from their unique architecture and its exploitation for the design of well-defined functional macromolecules. Depending on the nature of the synthesis, functionalization is traditionally introduced at the core, the periphery, or both. However, the specific incorporation of functional groups at the interior layers, i.e., generations, represents a considerable synthetic hurdle that must be overcome for the full potential of dendrimers to be realized. This review covers recent advances in this emerging frontier of dendrimer science with a particular focus on covalent modifications. Monomer design, syntheses, and properties of various dendritic backbone types are discussed. Internal functionalization dramatically increases the degree of complexity that can be implemented into a dendrimer macromolecule and, therefore, promises to lead to smart materials for future applications in bio- and nanotechnologies. (C) 2003 Wiley Periodicals, Inc.
C1 Free Univ Berlin, Inst Chem Organ Chem, D-14195 Berlin, Germany.
RP Hecht, S (reprint author), Free Univ Berlin, Inst Chem Organ Chem, Takustr 3, D-14195 Berlin, Germany.
EM shecht@chemie.fu-berlin.de
RI Hecht, Stefan/A-4029-2013
OI Hecht, Stefan/0000-0002-6124-0222
CR Abbe G. L, 1996, CHEM COMMUN, P2143
   ADRONOV A, 2000, J CHEM SOC CHEM COMM, P1701
   AREHUT A, 1998, CHEM SOC REV, V27, P227
   Baars MWPL, 2000, TOP CURR CHEM, V210, P131
   BAECKSTROM P, 1990, SYNTHETIC COMMUN, V20, P423, DOI 10.1080/00397919008052784
   Balzani V, 1996, CHEM REV, V96, P759, DOI 10.1021/cr941154y
   Becker ML, 2001, J POLYM SCI POL CHEM, V39, P4152, DOI 10.1002/pola.10070
   Beinhoff M, 2001, EUR J ORG CHEM, P3819
   Bo ZS, 2000, ORG LETT, V2, P1645, DOI 10.1021/ol005972q
   Bolton DH, 2002, J POLYM SCI POL CHEM, V40, P823, DOI 10.1002/pola.10167
   Bosman AW, 2003, J AM CHEM SOC, V125, P715, DOI 10.1021/ja028392s
   Bosman AW, 1999, CHEM REV, V99, P1665, DOI 10.1021/cr970069y
   Bosman AW, 2001, J AM CHEM SOC, V123, P6461, DOI 10.1021/ja010405z
   Chow HF, 1998, TETRAHEDRON, V54, P8543, DOI 10.1016/S0040-4020(98)00409-8
   CLARK CG, 2001, DENDRIMERS OTHER DEN, P147
   Crooks RM, 2001, TOP CURR CHEM, V212, P81
   Crooks RM, 2001, ACCOUNTS CHEM RES, V34, P181, DOI 10.1021/ar000110a
   Deb SK, 1997, J AM CHEM SOC, V119, P9079, DOI 10.1021/ja971790o
   Devadoss C, 1996, J AM CHEM SOC, V118, P9635, DOI 10.1021/ja961418t
   DICHTEL WR, J AM CHEM SOC
   Duncan R., 2001, POLYM MAT SCI ENG, V84, P214
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   Ford WT, 2001, REACT FUNCT POLYM, V48, P3, DOI 10.1016/S1381-5148(01)00038-4
   FRECET JMJ, 2001, DENDRIMERS OTHER DEN
   Freeman AW, 2000, J ORG CHEM, V65, P7612, DOI 10.1021/jo005592i
   Galliot C, 1997, SCIENCE, V277, P1981, DOI 10.1126/science.277.5334.1981
   Grayson SM, 2001, CHEM REV, V101, P3819, DOI 10.1021/cr990116h
   Grinstaff MW, 2002, CHEM-EUR J, V8, P2838, DOI 10.1002/1521-3765(20020703)8:13<2838::AID-CHEM2838>3.0.CO;2-I
   Guan Z, 2002, J AM CHEM SOC, V124, P5616, DOI 10.1021/ja025609+
   Guan ZB, 1999, SCIENCE, V283, P2059, DOI 10.1126/science.283.5410.2059
   Guan Zhibin, 2002, Chemistry, V8, P3086, DOI 10.1002/1521-3765(20020715)8:14<3086::AID-CHEM3086>3.0.CO;2-L
   Hahn U, 2002, ANGEW CHEM INT EDIT, V41, P3595, DOI 10.1002/1521-3773(20021004)41:19<3595::AID-ANIE3595>3.0.CO;2-B
   Harth E, 2002, J AM CHEM SOC, V124, P8653, DOI 10.1021/ja026208x
   Harth EM, 2002, J AM CHEM SOC, V124, P3926, DOI 10.1021/ja025536u
   Hawker CJ, 1997, J AM CHEM SOC, V119, P9903, DOI 10.1021/ja972027x
   HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027
   HAWKER CJ, 1990, J CHEM SOC CHEM COMM, P1010, DOI 10.1039/c39900001010
   HAWKER CJ, 1992, J AM CHEM SOC, V114, P4805
   Hecht S, 2001, ANGEW CHEM INT EDIT, V40, P74, DOI 10.1002/1521-3773(20010105)40:1<74::AID-ANIE74>3.0.CO;2-C
   Hecht S, 2001, J AM CHEM SOC, V123, P6959, DOI 10.1021/ja016076s
   Hecht S, 1999, J AM CHEM SOC, V121, P4084, DOI 10.1021/ja9842215
   Hecht S, 2001, J AM CHEM SOC, V123, P18, DOI 10.1021/ja003304u
   Hedrick JL, 2002, CHEM-EUR J, V8, P3308, DOI 10.1002/1521-3765(20020802)8:15<3308::AID-CHEM3308>3.0.CO;2-D
   Higuchi M, 2001, J AM CHEM SOC, V123, P4414, DOI 10.1021/ja004239r
   Ihre H, 2001, J AM CHEM SOC, V123, P5908, DOI 10.1021/ja010524e
   Ihre H, 1998, MACROMOLECULES, V31, P4061, DOI 10.1021/ma9718762
   Ihre H, 1996, J AM CHEM SOC, V118, P6388, DOI 10.1021/ja954171t
   Jikei M, 2001, PROG POLYM SCI, V26, P1233, DOI 10.1016/S0079-6700(01)00018-1
   Junge DM, 2000, J ORG CHEM, V65, P5306, DOI 10.1021/jo000529e
   Kawa M., 1998, J CHEM MAT, V10, P286
   Krause W, 2000, TOP CURR CHEM, V210, P261
   Kreider JL, 2001, J POLYM SCI POL CHEM, V39, P821, DOI 10.1002/1099-0518(20010315)39:6<821::AID-POLA1055>3.0.CO;2-F
   Kreiter R, 2001, TOP CURR CHEM, V217, P163
   Larre C, 1998, J AM CHEM SOC, V120, P13070, DOI 10.1021/ja982778e
   LIANG C, 2000, UNPUB
   Liu MJ, 1999, PHARM SCI TECHNOL TO, V2, P393, DOI 10.1016/S1461-5347(99)00203-5
   LOCHMANN L, 1993, J AM CHEM SOC, V115, P7043, DOI 10.1021/ja00068a100
   Louie J, 1997, J AM CHEM SOC, V119, P11695, DOI 10.1021/ja972806d
   Ma QG, 2002, P NATL ACAD SCI USA, V99, P5058, DOI 10.1073/pnas.052653099
   Majoral JP, 1999, CHEM REV, V99, P845, DOI 10.1021/cr970414j
   Majoral JP, 2002, CHEM COMMUN, P2929, DOI 10.1039/b207194k
   Majoral JP, 1999, COORDIN CHEM REV, V190, P3, DOI 10.1016/S0010-8545(99)00060-0
   McElhanon JR, 1997, J ORG CHEM, V62, P908, DOI 10.1021/jo961587w
   McElhanon JR, 1996, MACROMOLECULES, V29, P8979, DOI 10.1021/ma961428e
   McElhanon JR, 2000, J ORG CHEM, V65, P3525, DOI 10.1021/jo000207a
   McElhanon JR, 1998, J AM CHEM SOC, V120, P1647, DOI 10.1021/ja970150i
   Meier H, 1998, ANGEW CHEM INT EDIT, V37, P643, DOI 10.1002/(SICI)1521-3773(19980316)37:5<643::AID-ANIE643>3.0.CO;2-4
   Modrakowski C, 2001, SYNTHESIS-STUTTGART, P2143
   Moore JS, 1997, ACCOUNTS CHEM RES, V30, P402, DOI 10.1021/ar950232g
   Newkome G.R., 2001, DENDRIMERS DENDRONS
   NEWKOME GR, 1994, ANGEW CHEM INT EDIT, V33, P666, DOI 10.1002/anie.199406661
   Newkome GR, 1999, CHEM REV, V99, P1689, DOI 10.1021/cr9800659
   NEWKOME GR, 1991, ANGEW CHEM INT EDIT, V30, P1176, DOI 10.1002/anie.199111761
   Newkome GR, 2000, J ORG CHEM, V65, P1643, DOI 10.1021/jo991278g
   Oosterom GE, 2001, ANGEW CHEM INT EDIT, V40, P1828, DOI 10.1002/1521-3773(20010518)40:10<1828::AID-ANIE1828>3.3.CO;2-P
   Pan YJ, 1999, MACROMOLECULES, V32, P5468, DOI 10.1021/ma990675q
   Pan YJ, 2000, MACROMOLECULES, V33, P3731, DOI 10.1021/ma9919864
   Peerlings HWI, 2001, J POLYM SCI POL CHEM, V39, P3112, DOI 10.1002/pola.1292
   Pillow JNG, 1999, MACROMOLECULES, V32, P5985, DOI 10.1021/ma981871k
   Piotti ME, 1999, J AM CHEM SOC, V121, P9471, DOI 10.1021/ja991879p
   RAMAGNOLI B, 2002, J MATER CHEM, V12, P767
   Rannard SP, 2000, J AM CHEM SOC, V122, P11729, DOI 10.1021/ja002613h
   Schluter AD, 2000, ANGEW CHEM INT EDIT, V39, P864, DOI 10.1002/(SICI)1521-3773(20000303)39:5<864::AID-ANIE864>3.0.CO;2-E
   Schultz LG, 2001, ANGEW CHEM INT EDIT, V40, P1962, DOI 10.1002/1521-3773(20010518)40:10<1962::AID-ANIE1962>3.0.CO;2-J
   Selby TD, 1998, J AM CHEM SOC, V120, P12155, DOI 10.1021/ja9821091
   Serin J. M., 2002, J CHEM SOC CHEM COMM, P2605
   Smith DK, 1998, CHEM-EUR J, V4, P1353, DOI 10.1002/(SICI)1521-3765(19980807)4:8<1353::AID-CHEM1353>3.0.CO;2-0
   Stiriba SE, 2002, ANGEW CHEM INT EDIT, V41, P1329, DOI 10.1002/1521-3773(20020415)41:8<1329::AID-ANIE1329>3.0.CO;2-P
   Stiriba SE, 2002, J AM CHEM SOC, V124, P9698, DOI 10.1021/ja026835m
   Tomalia DA, 2002, J POLYM SCI POL CHEM, V40, P2719, DOI 10.1002/pola.10301
   TULLY DC, 2001, J CHEM SOC CHEM COMM, P1229
   Twyman LJ, 2002, CHEM SOC REV, V31, P69, DOI 10.1039/b107812g
   Vetter S, 2001, J POLYM SCI POL CHEM, V39, P1940, DOI 10.1002/pola.1171
   Weil T, 2002, ANGEW CHEM INT EDIT, V41, P1900, DOI 10.1002/1521-3773(20020603)41:11<1900::AID-ANIE1900>3.0.CO;2-8
   Wendland MS, 1999, J AM CHEM SOC, V121, P1389, DOI 10.1021/ja983097m
   Wiesler UM, 2001, TOP CURR CHEM, V212, P1
   WOOLEY KL, 1993, J AM CHEM SOC, V115, P11496, DOI 10.1021/ja00077a055
   WOOLEY KL, 1994, ANGEW CHEM INT EDIT, V33, P82, DOI 10.1002/anie.199400821
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   Xia CJ, 2002, ORG LETT, V4, P2067, DOI 10.1021/ol025943a
   XU ZF, 1994, J AM CHEM SOC, V116, P4537, DOI 10.1021/ja00090a002
   Yamamoto K, 2002, NATURE, V415, P509, DOI 10.1038/415509a
   Zeng FW, 1997, CHEM REV, V97, P1681, DOI 10.1021/cr9603892
   Zhu A, 2001, J POLYM SCI POL CHEM, V39, P2859, DOI 10.1002/pola.1265
   Zhu ZG, 2000, MACROMOLECULES, V33, P801, DOI 10.1021/ma991478u
   Zhu ZG, 2000, J ORG CHEM, V65, P116, DOI 10.1021/jo991167h
   Zimmerman SC, 2002, NATURE, V418, P399, DOI 10.1038/nature00877
NR 107
TC 97
Z9 104
U1 0
U2 28
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD APR 15
PY 2003
VL 41
IS 8
BP 1047
EP 1058
DI 10.1002/pola.10643
PG 12
WC Polymer Science
SC Polymer Science
GA 657ZK
UT WOS:000181697000001
OA Bronze
DA 2018-10-20
ER

PT J
AU Stifter, D
   Burgholzer, P
   Hoglinger, O
   Gotzinger, E
   Hitzenberger, CK
AF Stifter, D
   Burgholzer, P
   Hoglinger, O
   Gotzinger, E
   Hitzenberger, CK
TI Polarisation-sensitive optical coherence tomography for material
   characterisation and strain-field mapping
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID BIREFRINGENCE; ORIENTATION; TISSUE
AB Optical coherence tomography (OCT) is a relatively new imaging technique capable of recording cross-sectional images of transparent and turbid structures with micrometer-scale resolution. Originally developed for biomedical imaging applications, this technique also has a great potential for non-destructive material characterisation and testing. Polarisation-sensitive (PS) OCT is a recent extension of classical OCT that measures and images birefringence properties of a sample, which, however, has not yet been applied to materials science. We present imaging of glass-fibre-enforced epoxy resin compounds and the detection of dry spots, where the epoxy did not properly penetrate the glass-fibre structure. Furthermore, we demonstrate PS-OCT imaging of the birefringence properties of different materials. The mapping of strain fields of samples under uniaxial and non-uniform external stress and the detection of flow patterns in injection-moulded plastic parts could be demonstrated with this technique for the first time.
C1 Upper Austrian Res GmbH, A-4020 Linz, Austria.
   Univ Vienna, Inst Med Phys, A-1090 Vienna, Austria.
RP Stifter, D (reprint author), Upper Austrian Res GmbH, Hafenstr 47-51, A-4020 Linz, Austria.
RI Stifter, David/B-5767-2016
OI Burgholzer, Peter/0000-0003-3383-803X
CR Ajovalasit A, 1998, J STRAIN ANAL ENG, V33, P75, DOI 10.1243/0309324981512832
   Bashkansky M, 1997, OPT LETT, V22, P61, DOI 10.1364/OL.22.000061
   Bouma BE, 2002, HDB OPTICAL COHERENC
   Chen ZP, 1997, OPT LETT, V22, P1119, DOI 10.1364/OL.22.001119
   de Boer JF, 1999, OPT LETT, V24, P300, DOI 10.1364/OL.24.000300
   deBoer JF, 1997, OPT LETT, V22, P934, DOI 10.1364/OL.22.000934
   Drexler W, 1999, OPT LETT, V24, P1221, DOI 10.1364/OL.24.001221
   Dunkers JP, 2001, OPT LASER ENG, V35, P135, DOI 10.1016/S0143-8166(01)00010-0
   Fercher A. F., 2002, PROG OPTICS, P215
   HINDLE CS, 1992, POLYM ENG SCI, V32, P157, DOI 10.1002/pen.760320302
   Hitzenberger CK, 2001, OPT EXPRESS, V9, P780, DOI 10.1364/OE.9.000780
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Izatt JA, 1997, OPT LETT, V22, P1439, DOI 10.1364/OL.22.001439
   Jiao SL, 2002, OPT LETT, V27, P101, DOI 10.1364/OL.27.000101
   OTIS LL, 1997, J DENT RES, V76, P383
   Pan YT, 2001, OPT LETT, V26, P1966, DOI 10.1364/OL.26.001966
   Rollins AM, 1998, OPT EXPRESS, V3, P219, DOI 10.1364/OE.3.000219
   Saxer CE, 2000, OPT LETT, V25, P1355, DOI 10.1364/OL.25.001355
   Schoenenberger K, 1998, APPL OPTICS, V37, P6026, DOI 10.1364/AO.37.006026
   SWANSON EA, 1992, OPT LETT, V17, P151, DOI 10.1364/OL.17.000151
   Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037
   YAO G, 1999, OPT LETT, V24, P300
NR 22
TC 57
Z9 58
U1 2
U2 16
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD APR
PY 2003
VL 76
IS 6
BP 947
EP 951
DI 10.1007/s00339-002-2065-5
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 671YT
UT WOS:000182493700019
DA 2018-10-20
ER

PT J
AU Feldman, SH
AF Feldman, SH
TI Components of gene therapy experimentation that contribute to relative
   risk
SO COMPARATIVE MEDICINE
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; PUV-INACTIVATED VIRUS; IN-VIVO; VACCINIA-VIRUS;
   RECOMBINANT ADENOVIRUS; E1-DELETED ADENOVIRUS; EXPRESSION VECTORS;
   LENTIVIRUS VECTOR; PACKAGING SYSTEM; VIRAL VECTOR
AB Gene therapy is the purposeful delivery of genetic material to somatic cells for the purpose of treating disease or biomedical investigation. Either viral or non-viral vector methods can be used. The risk of collateral exposure of laboratory animal care personnel to gene therapy vectors is dependent on a number of factors. These factors are intrinsic to the gene therapy vector (the vehicle for genetic conveyance), product encoded by the genetic construct delivered, method of delivery, and immune status of the recipient. The component risks of gene therapy experiments can be analyzed to surmise the overall relative risk of the experiment. Knowledge of the components that contribute potential hazardous risk to a study can assist animal care staff in identifying area(s) where prudent practices should be focused. Gene therapy experiments involving viral vectors are generally performed at either biosafety level 2 or 3. The objective of this review is to report on various components of gene therapy experiments, focusing on characteristics of viral and non-viral vectors, to assist the laboratory animal science community in determining prudent biosafety practices.
C1 Univ Virginia, Hlth Syst, Ctr Comparat Med, Charlottesville, VA 22908 USA.
RP Feldman, SH (reprint author), Univ Virginia, Hlth Syst, Ctr Comparat Med, Box 800737, Charlottesville, VA 22908 USA.
CR Agapov EV, 1998, P NATL ACAD SCI USA, V95, P12989, DOI 10.1073/pnas.95.22.12989
   AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224
   ANDERSON WF, 1984, SCIENCE, V226, P401, DOI 10.1126/science.6093246
   Barjot C, 2002, J GENE MED, V4, P480, DOI 10.1002/jgm.305
   BERGLUND P, 1993, BIO-TECHNOL, V11, P916, DOI 10.1038/nbt0893-916
   BLASQUEZ VC, 1989, GENOME, V31, P503, DOI 10.1139/g89-098
   Borst E, 2000, BONE MARROW TRANSPL, V25, pS80, DOI 10.1038/sj.bmt.1702361
   BREAKEFIELD XO, 1991, NEW BIOL, V3, P302
   Budker V, 1998, GENE THER, V5, P272, DOI 10.1038/sj.gt.3300572
   Budker V, 1996, GENE THER, V3, P593
   Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669
   Chang L.-J., 2001, Current Gene Therapy, V1, P237, DOI 10.2174/1566523013348634
   CORNETTA K, 1991, HUM GENE THER, V2, P5, DOI 10.1089/hum.1991.2.1-5
   DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219
   DONAHUE RE, 1992, J EXP MED, V176, P1125, DOI 10.1084/jem.176.4.1125
   DOWTY ME, 1995, P NATL ACAD SCI USA, V92, P4572, DOI 10.1073/pnas.92.10.4572
   Dull T, 1998, J VIROL, V72, P8463
   Favre D, 2001, MOL THER, V4, P559, DOI 10.1006/mthe.2001.0494
   FELDMAN SH, 1996, UNPUB
   FELDMAN SH, 1994, LAB ANIM, V23, P28
   FREEMAN SM, 1995, CANCER LETT, V92, P167, DOI 10.1016/0304-3835(95)03771-N
   Gaertner DJ, 2003, COMPARATIVE MED, V53, P85
   GELLER AI, 1990, P NATL ACAD SCI USA, V87, P8950, DOI 10.1073/pnas.87.22.8950
   GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331
   GUY J, 1995, MOL BIOTECHNOL, V3, P237, DOI 10.1007/BF02789334
   HAMMARSKJOLD ML, 2001, COMMUNICATION
   Holt RK, 2002, CONTEMP TOP LAB ANIM, V41, P57
   HUGHES BW, 1995, CANCER RES, V55, P3339
   IMLER JL, 1995, HUM GENE THER, V6, P711, DOI 10.1089/hum.1995.6.6-711
   JOHANNING FW, 1995, NUCLEIC ACIDS RES, V23, P1495, DOI 10.1093/nar/23.9.1495
   JOHNSTON SA, 1988, SCIENCE, V240, P1538, DOI 10.1126/science.2836954
   JOLLY D, 1994, CANCER GENE THER, V1, P51
   Joseph PM, 2001, HUM GENE THER, V12, P1369, DOI 10.1089/104303401750298535
   JUNG LJ, 1991, SCIENCE, V251, P1330, DOI 10.1126/science.2003219
   Kaiser J, 2003, SCIENCE, V299, P495, DOI 10.1126/science.299.5606.495
   Karreman C, 1998, GENE, V218, P57, DOI 10.1016/S0378-1119(98)00387-4
   Kesari S, 1998, J GEN VIROL, V79, P525, DOI 10.1099/0022-1317-79-3-525
   KOSAC M, 1987, J MOL BIOL, V196, P947
   LI D, 2002, CANCER RES, V15, P4637
   Li Song, 2001, Current Gene Therapy, V1, P201, DOI 10.2174/1566523013348814
   LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356
   Liu F, 1997, GENE THER, V4, P517, DOI 10.1038/sj.gt.3300424
   Lotze MT, 2002, CANCER GENE THER, V9, P692, DOI 10.1038/sj.cgt.7700493
   LU D, 1994, CANCER GENE THER, V1, P267
   LUNDSTROM K, 1994, EUR J BIOCHEM, V224, P917, DOI 10.1111/j.1432-1033.1994.00917.x
   LUNDSTROM K, 1999, GENE THER MOL BIOL, V4, P32
   Lundstrom Kenneth, 2001, Current Gene Therapy, V1, P19, DOI 10.2174/1566523013349039
   MACKETT M, 1986, J GEN VIROL, V67, P2067, DOI 10.1099/0022-1317-67-10-2067
   MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191
   Marshall E, 2003, SCIENCE, V299, P320, DOI 10.1126/science.299.5605.320
   Marshall E, 2000, SCIENCE, V287, P565
   MATANI K, 1994, HUM GENE THER, V5, P941
   MCCRAY PB, 1995, J CLIN INVEST, V95, P2620, DOI 10.1172/JCI117964
   MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895
   MORISHITA R, 1995, P NATL ACAD SCI USA, V92, P5855, DOI 10.1073/pnas.92.13.5855
   MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530
   MUZYCZKA N, 1995, 6 PARV WORKSH MONTP, P10
   MUZYCZKA N, 1992, CURR TOP MICROBIOL, V58, P1
   Naldini L, 1999, THROMB HAEMOSTASIS, V82, P552
   Nicklin Stuart A., 2002, Current Gene Therapy, V2, P273, DOI 10.2174/1566523023347797
   Porter Jacqueline D, 2002, Contemp Top Lab Anim Sci, V41, P43
   RADEMAKER MJ, 2002, J GEN VIROL, V83, P1311
   RANDALL LL, 1989, SCIENCE, V243, P1156, DOI 10.1126/science.2646712
   Ray P, 2001, SEMIN NUCL MED, V31, P312, DOI 10.1053/snuc.2001.26209
   Rizzuto G, 1999, J VIROL, V73, P2517
   RODHAL E, 2000, EXP EYE RES, V71, P495
   ROLLING F, 1995, MOL BIOTECHNOL, V3, P9, DOI 10.1007/BF02821330
   Scheule RK, 2000, ADV DRUG DELIVER REV, V44, P119, DOI 10.1016/S0169-409X(00)00090-9
   Spencer B, 2000, INVEST OPHTH VIS SCI, V41, P1392
   SUN LQ, 1995, P NATL ACAD SCI USA, V92, P7272, DOI 10.1073/pnas.92.16.7272
   Swisher Stephen G, 2002, Curr Oncol Rep, V4, P334, DOI 10.1007/s11912-002-0009-z
   TEMPLETON NS, 1997, NAT BIOTECHNOL, V15, P167
   Timiryasova TM, 2001, J GENE MED, V3, P468, DOI 10.1002/jgm.205
   Timiryasova TM, 2001, BIOTECHNIQUES, V31, P534, DOI 10.2144/01313st07
   Todo T, 2000, MOL THER, V2, P588, DOI 10.1006/mthe.2000.0200
   TSUKAMOTO M, 1995, NAT GENET, V9, P243, DOI 10.1038/ng0395-243
   ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302
   VILE RG, 1993, CANCER RES, V53, P3860
   WAGNER E, 1992, P NATL ACAD SCI USA, V89, P7934, DOI 10.1073/pnas.89.17.7934
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wang H, 2001, CURR CANCER DRUG TAR, V1, P177, DOI 10.2174/1568009013334133
   Wang JK, 1998, J MED CHEM, V41, P2207, DOI 10.1021/jm950802i
   Wang LH, 2002, CANCER GENE THER, V9, P819, DOI 10.1038/sj.cgt.770502
   Watson J. D., 1987, MOL BIOL GENE
   WEDMAN EE, 1988, AM J VET RES, V49, P2018
   Weld KJ, 2002, CANCER GENE THER, V9, P189, DOI 10.1038/sj.cgt.7700425
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   WOOD MJA, 1994, GENE THER, V1, P283
   WU GY, 1991, J BIOL CHEM, V266, P14338
   YANG NS, 1999, NONVIRAL VECTORS GEN, P171
   YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257
   Zufferey R, 1998, J VIROL, V72, P9873
NR 92
TC 3
Z9 4
U1 0
U2 0
PU AMER ASSOC LABORATORY ANIMAL SCIENCE
PI MEMPHIS
PA 9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA
SN 1532-0820
J9 COMPARATIVE MED
JI Comparative Med.
PD APR
PY 2003
VL 53
IS 2
BP 147
EP 158
PG 12
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 678RH
UT WOS:000182879900008
PM 12784848
DA 2018-10-20
ER

PT J
AU Sharma, SK
   Sehgal, N
   Kumar, A
AF Sharma, SK
   Sehgal, N
   Kumar, A
TI Biomolecules for development of biosensors and their applications
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT India/Japan Workshop on New Advanced Materials in Molecular Electronics
CY DEC 10-11, 2001
CL NEW DELHI, INDIA
DE biomaterials; biomolecules; biosensors; enzymes; immunosensors
ID ENZYME SENSOR; AMPEROMETRIC DETERMINATION; FISH; ELECTRODE;
   HYPOXANTHINE; GLUCOSE; ACID
AB Biosensors are analytical devices incorporating biological materials such as enzymes, tissues, microorganisms, antibodies, cell receptors or biologically derived materials or a biomimic component intimately associated with or integrated within a physicochemical transducer or transducing microsystem which may be either optical, electrochemical, thermometric, piezoelectric or magnetic. The electronic signals produced are proportional to the concentration of specific analyte. A biomaterial may be any material, natural or man-made, that comprises whole or part of a living structure or biomedical device, which performs natural function. An essential component of molecular sensor is reagent layers. Creation of these layers require the immobilization of recognition elements for the detection method. The recognition elements are biomolecules. Laboratory methods of immobilization are numerous, but may not always appropriate for manufacture of biosensors. In the present article, we describe the use of various biomaterials for biosensors as well as their availability. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Inst Genom & Integrat Biol, Delhi 110007, India.
   Univ Delhi, Dept Zool, Delhi 110007, India.
RP Kumar, A (reprint author), Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.
EM ashokcbt@rediffmail.com
RI Sharma, Sandeep/F-7420-2010; Ganju, Shahji/F-3409-2012
OI Sharma, Sandeep/0000-0002-0039-7883; 
CR ANDERSON GP, 2000, ULTRASENSITIVE FIBER
   ARNOLD MA, 1987, BIOSENSORS FUNDAMENT, P31
   ASAKAWA S, 1959, NIPPON SUISAN GAKKIS, V24, P714
   BARKER SA, 1987, BIOSENSORS FUNDAMENT, P85
   BURT JR, 1968, J FOOD TECHNOL, V31, P165
   CASS AEG, 1984, ANAL CHEM, V56, P667, DOI 10.1021/ac00268a018
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838
   COULET RR, 1991, AMPEROMETRIC ENZYME, P758
   Dong Shaojun, 2002, J Biotechnol, V82, P303, DOI 10.1016/S1389-0352(01)00048-4
   EHIRA S, 1969, BULL JAP SOC SCI FISH, V35, P1080
   EHIRA S, 1966, NIPPON SUISAN GAKK, V32, P716
   FUJII Y, 1966, NIPPON SUISAN GAKK, V32, P410
   FUKUI S, 1982, ANNU REV MICROBIOL, V36, P145, DOI 10.1146/annurev.mi.36.100182.001045
   GOULD BJ, 1986, HDB ENZYME BIOTECHNO, P434
   GRIFFITHS D, 1993, TRENDS BIOTECHNOL, V11, P122, DOI 10.1016/0167-7799(93)90086-O
   GUILBAULT G, 1984, HDB IMMOBILIZED ENZY, P87
   GUILBAULT GG, 1988, ANAL CHIM ACTA, V206, P369, DOI 10.1016/S0003-2670(00)80859-4
   GUILBAULT GG, 1985, IMMOBILIZED CELLS EN, P56
   HIKUMA M, 1979, ANAL CHIM ACTA, V109, P33, DOI 10.1016/S0003-2670(01)84223-9
   HIKUMA M, 1979, BIOTECHNOL BIOENG, V21, P1845, DOI 10.1002/bit.260211011
   HIKUMA M, 1980, ENZYME MICROB TECH, V2, P234, DOI 10.1016/0141-0229(80)90053-8
   HIKUMA M, 1979, EUR J APPL MICROBIOL, V8, P289, DOI 10.1007/BF00508793
   IWAI H, 1986, CHEM PHARM BULL, V34, P3471
   JAHNS FD, 1976, FOOD TECHNOL-CHICAGO, V30, P27
   JANCHEN M, 1985, ANAL LETT PT B, V18, P1799
   JONES NR, 1965, J FOOD SCI, V30, P791, DOI 10.1111/j.1365-2621.1965.tb01842.x
   JONES NR, 1964, J SCI FOOD AGR, V15, P763, DOI 10.1002/jsfa.2740151105
   KARUBE I, 1979, EUR J APPL MICROBIOL, V7, P343, DOI 10.1007/BF00499848
   KARUBE I, 1980, ENZYME MICROB TECH, V2, P117, DOI 10.1016/0141-0229(80)90066-6
   KARUBE I, 1981, ANAL CHEM, V53, P1852, DOI 10.1021/ac00235a030
   KARUBE I, 1989, BIOSENSORS FUNDAMENT, P28
   KARUBE I, 1996, MICROBIAL BIOSENSORS, P165
   KAS JA, 2000, NATURAL POLYM
   KAWABATA T, 1952, NIPPON SUISAN GAKK, V18, P124
   KAWASHIMA T, 1980, NIPPON KAGAKU KAISHI, P1542, DOI 10.1246/nikkashi.1980.1542
   KOLOT FB, 1982, PROCESS BIOCHEM, V17, P12
   KOSHCHEYENKO KA, 1981, PRIKIL BIOCH MICROBI, V27, P477
   KOSHCHEYENKO KA, 1981, MICROBIOLOGIA, V11, P55
   KUAN SS, 1987, BIOSENSOR FUNDAMENTA, P44
   KULIS J, 1985, ZH ANAL KHIM, V40, P2077
   KULYS J, 1980, BIOTECHNOL BIOENG, V22, P221, DOI 10.1002/bit.260220116
   Kwon HJ, 2002, COMP BIOCHEM PHYS A, V132, P231, DOI 10.1016/S1095-6433(02)00058-2
   LEE EH, 1982, B JPN SOC SCI FISH, V48, P255
   LIGLER FS, 2000, LECT BIOSENSORS 0605
   LIGLER FS, 2000, IMMUNOLOGICALLY BASE
   LIGLER FS, 2000, FABRICATION CELL BAS
   LUONG JHT, 1988, TRENDS BIOTECHNOL, V6, P310, DOI 10.1016/0167-7799(88)90026-1
   MACHOLAN L, 1991, BIOINSTRUMENTATION B, P349
   MARTHEWS DR, 1987, LANCET, V1, P778
   MIKAYE M, 1955, NIPPON SUISAN GAKK, V21, P123
   NANJO M, 1974, ANAL CHEM, V46, P1769, DOI 10.1021/ac60348a058
   NIKOLELIS DP, 1984, ANAL CHIM ACTA, V161, P343, DOI 10.1016/S0003-2670(00)85804-3
   NUMATA K, 1981, NIPPON SHOKUHIN KOGY, V28, P542
   OTA F, 1954, NIPPON SUISAN GAKK, V19, P1150
   PICKUP J, 1993, TRENDS BIOTECHNOL, V11, P285, DOI 10.1016/0167-7799(93)90016-3
   PICKUP JC, 1989, APPL BIOSENSORS, P234
   REID C, 2000, BIOSENS BIOELEC 0605
   ROBINSON G, 1991, ADV BIOSENSORS, P229
   Saito T., 1961, Bulletin of the Japanese Society of Scientific Fisheries, V27, P461
   SAITO T., 1959, BULL JAPANESE SOC SCI FISH, V24, P749
   SCHELLER FW, 1987, BIOSENSOR FUNDAMENTA, P319
   *SIGM ALDR CO, 2001, SIGM BIOCH REAG LIF
   SUZUKI TANEKO, 1953, BULL JAPANESE SOC SCI FISH, V19, P102
   TAKASE A, 1953, NIPPON SUISAN GAKK, V19, P71
   TOKUNAGA T, 1977, Nippon Suisan Gakkaishi, V43, P219
   Turner A.P.F., 1987, BIOSENSORS FUNDAMENT, P13
   Uchiyama H, 1970, NIPPON SUISAN GAKK, V36, P977, DOI 10.2331/suisan.36.977
   Velasco-Garcia MN, 2001, TRENDS BIOTECHNOL, V19, P433, DOI 10.1016/S0167-7799(01)01841-8
   WATANABE E, 1984, J FOOD SCI, V49, P114, DOI 10.1111/j.1365-2621.1984.tb13684.x
   WATANABE E, 1983, J FOOD SCI, V48, P496, DOI 10.1111/j.1365-2621.1983.tb10775.x
   WATANABE E, 1987, J FOOD SCI, V52, P592, DOI 10.1111/j.1365-2621.1987.tb06682.x
   WATANABE E, 1984, ENZYME MICROB TECH, V6, P207, DOI 10.1016/0141-0229(84)90105-4
   WATANABE E, 1984, APPL MICROBIOL BIOT, V19, P18
   YAMADA K, 1981, Nippon Suisan Gakkaishi, V47, P631
   YAMAMOTO M, 1953, NIPPON SUISAN GAKK, V19, P761
   YAMAMURA Y, 1936, NIPPON SUISAN GAKK, V5, P98
   YAMAMURA Y, 1933, NIPPON SUISAN GAKK, V2, P118
NR 78
TC 43
Z9 44
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
EI 1878-1675
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD APR
PY 2003
VL 3
IS 2-3
BP 307
EP 316
DI 10.1016/S1567-1739(02)00219-5
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 667FH
UT WOS:000182220200033
DA 2018-10-20
ER

PT J
AU Xu, WL
   Guo, WQ
   Li, WB
AF Xu, WL
   Guo, WQ
   Li, WB
TI Thermal analysis of ultrafine wool powder
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID BLEND FILMS; SILK
AB Wool powder was produced from wool fiber by pretreatment and then ground by a specially designed machine. Scanning electron micrograph (SEM) photos show that ultrafine wool powder around 2 mum in diameter can be produced from fiber around 25 ttm in the diameter, and most of the powder is in the form of needles. The powder can be widely applied in new biomedical material development and cosmetic products. Thermal analysis of thermogravimetry (TG) and differential scanning calorimetry (DSC) show that the temperature for moisture evaporation in the powder was elevated to around 150degreesC from the control wool fiber, which was around 120degreesC. As the powder particle size decreases, the temperature corresponding to the crystal cleavage and the destruction of the crosslinkages increased, which is perhaps mostly due to the new crosslinks and new crystal that were produced during powder processing. The temperature for the liquefaction was also elevated and the relative TG results show that the last residue of the powder after 600degreesC is higher than that of the control sample. The thermal results show that as the powder particle size decreases, the thermal stability increases slightly. (C) 2003 Wiley Periodicals, Inc. J Appl Polym Sci 87: 2372-2376, 2003.
C1 Wuhan Inst Sci & Technol, Wuhan 430073, Peoples R China.
RP Xu, WL (reprint author), Wuhan Inst Sci & Technol, Wuhan 430073, Peoples R China.
CR BENDIT EG, 1966, TEXT RES J, V36, P580, DOI 10.1177/004051756603600611
   DIORIO AF, 1962, J PHYS CHEM-US, V66, P2096, DOI 10.1021/j100817a005
   Falix W, 1963, TEXT RES J, V33, P465
   FEUGHELMAN M, 1966, TEXT RES J, V36, P578, DOI 10.1177/004051756603600610
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   HALY AR, 1967, TEXT RES J, V37, P898, DOI 10.1177/004051756703701010
   Kawahara Y., 1996, AM DYEST REP, V85, P88
   LU X, 1994, J SERIC SCI JPN, V63, P21
   MENEFEE E, 1965, TEXT RES J, V35, P801, DOI 10.1177/004051756503500904
   MIYAMOTO T, 1982, KOBUNSHI RONBUNSHU, V39, P679, DOI 10.1295/koron.39.679
   Otoi K., 1980, US Patent US, Patent No. 4233212
   Pavlath AE, 1999, TEXT RES J, V69, P539, DOI 10.1177/004051759906900712
   Rock R. L., 1993, Google Patents, Patent No. [U. S. 5252285, 5252285]
   Schwenker RF, 1960, TEXT RES J, V30, P800
   Takeshita H, 2000, MACROMOL MATER ENG, V283, P126
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Tsubouchi K., 1998, US Patent US, Patent No. 5853764
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
NR 18
TC 39
Z9 40
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 1
PY 2003
VL 87
IS 14
BP 2372
EP 2376
DI 10.1002/app.11991
PG 5
WC Polymer Science
SC Polymer Science
GA 641PT
UT WOS:000180754700024
DA 2018-10-20
ER

PT J
AU Vaz, CM
   Fossen, M
   van Tuil, RF
   de Graaf, LA
   Reis, RL
   Cunha, AM
AF Vaz, CM
   Fossen, M
   van Tuil, RF
   de Graaf, LA
   Reis, RL
   Cunha, AM
TI Casein and soybean protein-based thermoplastics and composites as
   alternative biodegradable polymers for biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE soybean; casein; thermoplastic proteins; biomaterials; biodegradable
   polymers; degradation; bioactivity
ID SOY-PROTEIN; WHEAT GLUTEN; FILMS; BIOMATERIALS; SPONGES; ISOLATE
AB This work reports on the development and characterization of novel meltable polymers and composites based on casein and soybean proteins. The effects of inert (Al2O3) and bioactive (tricalcium phosphate) ceramic reinforcements over the mechanical performance, water absorption, and bioactivity behavior of the injection-molded thermoplastics were examined. It was possible to obtain materials and composites with a range of mechanical properties, which might allow for their application in the biomedical field. The incorporation of tricalcium phosphate into the soybean thermoplastic decreased its mechanical properties but lead to the nucleation of a bioactive calcium-phosphate film on their surface when immersed in a simulated body fluid solution. When compounded with 1% of a zirconate coupling agent, the nucleation and growth of the bioactive films on the surface of the referred to composites was accelerated. The materials degradation was studied for ageing periods up to 60 days in an isotonic saline solution. Both water uptake and weight loss were monitored as a function of the immersion time. After 1 month of immersion, the materials showed signal of chemical degradation, presenting weight losses up to 30%. However, further improvement on the mechanical performance and the enhancement of the hydrolytic stability of those materials will be highly necessary for applications in the biomedical field. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   ATO, Agrotechnol Res Inst, NL-6700 AA Wageningen, Netherlands.
RP Vaz, CM (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Cunha
   M., Antonio/0000-0003-3860-7732
CR ADRIANO KP, 1994, J APPL BIOMATER, V5, P133
   Arita K, 2001, J AGR FOOD CHEM, V49, P2030, DOI 10.1021/jf001120t
   BANKER GS, 1966, J PHARM SCI, V55, P81, DOI 10.1002/jps.2600550118
   BRANDENBURG AH, 1993, J FOOD SCI, V58, P1086, DOI 10.1111/j.1365-2621.1993.tb06120.x
   Cheftel J., 1985, FOOD CHEM, V2, P245
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   DANNIELS AU, 1994, J APPL BIOMATER, V5, P51
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   EWART JAD, 1968, J SCI FOOD AGR, V19, P370, DOI 10.1002/jsfa.2740190704
   Feeney R E, 1975, Adv Protein Chem, V29, P135, DOI 10.1016/S0065-3233(08)60412-X
   GENNADIOS A, 1993, J AGR FOOD CHEM, V41, P1835, DOI 10.1021/jf00035a006
   GONTARD N, 1992, J FOOD SCI, V57, P190, DOI 10.1111/j.1365-2621.1992.tb05453.x
   Huang HC, 1995, J AM OIL CHEM SOC, V72, P1453, DOI 10.1007/BF02577837
   KILSHAW PJ, 1979, RES VET SCI, V27, P361
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   Koller I, 1996, POLYM INT, V39, P175, DOI 10.1002/(SICI)1097-0126(199603)39:3<175::AID-PI472>3.3.CO;2-S
   KUIJPERS A, 2000, J BIOMAT SCI-POLYM E, V11, P25
   Kunte LA, 1997, CEREAL CHEM, V74, P115, DOI 10.1094/CCHEM.1997.74.2.115
   OGAWA A, 2001, J NUTR SCI VITAMINOL, V46, P271
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.3.CO;2-9
   Reis RL, 1997, POLYM INT, V43, P347
   SCHILLING CH, 1995, J MATER RES, V10, P2197, DOI 10.1557/JMR.1995.2197
NR 24
TC 52
Z9 53
U1 0
U2 25
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2003
VL 65A
IS 1
BP 60
EP 70
DI 10.1002/jbm.a.10416
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671FA
UT WOS:000182453600009
PM 12635155
DA 2018-10-20
ER

PT J
AU Koehler, KE
   Voigt, RC
   Thomas, S
   Lamb, B
   Urban, C
   Hassold, T
   Hunt, PA
AF Koehler, KE
   Voigt, RC
   Thomas, S
   Lamb, B
   Urban, C
   Hassold, T
   Hunt, PA
TI When disaster strikes: Rethinking caging materials
SO LAB ANIMAL
LA English
DT Article
ID IN-UTERO EXPOSURE; BISPHENOL-A; PERINATAL EXPOSURE; ESTROGENIC
   CHEMICALS; MALE RATS; GENISTEIN; BEHAVIOR; FEMALE; MICE; ADENOCARCINOMA
AB The value of research using lab animals hinges on the ability to carry out experiments in a tightly controlled environment. Diet, caging materials (e.g., cages and water bottles), and other environmental variables have the potential to create serious disruptions in animal studies. The authors describe the inadvertent damage of polycarbonate caging materials during the course of routine cagewashing, providing an instructive example and illustrating the importance of defined and controlled environmental conditions in biomedical research.
C1 Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Anim Resource Ctr, Cleveland, OH 44106 USA.
   Thoren Caging Syst Inc, Hazleton, PA USA.
RP Hunt, PA (reprint author), Case Western Reserve Univ, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.
FU NICHD NIH HHS [HD21341, HD31866]; NIEHS NIH HHS [ES11772]; NIA NIH HHS
   [AG20202]
CR Al-Hiyasat AS, 2002, EUR J ORAL SCI, V110, P163, DOI 10.1034/j.1600-0722.2002.11201.x
   Allred CD, 2001, CARCINOGENESIS, V22, P1667, DOI 10.1093/carcin/22.10.1667
   Badger TM, 2001, INT J TOXICOL, V20, P165, DOI 10.1080/109158101317097755
   Degen GH, 2002, TOXICOL LETT, V128, P145, DOI 10.1016/S0378-4274(02)00009-7
   Dessi-Fulgheri F, 2002, ENVIRON HEALTH PERSP, V110, P403, DOI 10.1289/ehp.02110s3403
   Farabollino F, 2002, ENVIRON HEALTH PERSP, V110, P409, DOI 10.1289/ehp.02110s3409
   Gupta C, 2000, P SOC EXP BIOL MED, V224, P61, DOI 10.1046/j.1525-1373.2000.22402.x
   Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499
   Honma S, 2002, REPROD TOXICOL, V16, P117, DOI 10.1016/S0890-6238(02)00006-0
   Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517
   HOWDESHELL KL, 2003, ENV HLTH PERSPECT
   HUNT PA, 2003, IN PRESS CURR BIOL
   Hursting SD, 2001, J NUTR, V131, p3092S, DOI 10.1093/jn/131.11.3092S
   KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279
   Kubo K, 2001, NEUROSCI LETT, V304, P73, DOI 10.1016/S0304-3940(01)01760-8
   Lamartiniere CA, 2002, J NUTR, V132, p552S
   Lund TD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-20
   Lund TD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-21
   Melnick Ronald, 2002, Environmental Health Perspectives, V110, P427
   Mentor-Marcel R, 2001, CANCER RES, V61, P6777
   Newbold RR, 2001, CANCER RES, V61, P4325
   Novak G, 1998, LAB ANIMAL, V27, P41
   Palanza P, 2002, ENVIRON HEALTH PERSP, V110, P415, DOI 10.1289/ehp.02110s3415
   Pulgar R, 2000, ENVIRON HEALTH PERSP, V108, P21, DOI 10.2307/3454291
   Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783
   Sakaue M, 2001, J OCCUP HEALTH, V43, P185, DOI 10.1539/joh.43.185
   Schantz SL, 2001, ENVIRON HEALTH PERSP, V109, P1197, DOI 10.2307/3454741
   Schonfelder G, 2002, NEOPLASIA, V4, P98, DOI 10.1038/sj.neo.7900212
   TAKAO Y, 1999, J HEALTH SCI, V45, P39
   Tinwell H, 2002, TOXICOL SCI, V68, P339, DOI 10.1093/toxsci/68.2.339
   Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239, DOI 10.1177/074823379801400115
   Yellayi S, 2002, P NATL ACAD SCI USA, V99, P7616, DOI 10.1073/pnas.102650199
   You L, 2002, TOXICOL SCI, V66, P216, DOI 10.1093/toxsci/66.2.216
NR 33
TC 7
Z9 7
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 0093-7355
J9 LAB ANIMAL
JI Lab Anim.
PD APR
PY 2003
VL 32
IS 4
BP 24
EP 27
DI 10.1038/laban0403-24
PG 4
WC Veterinary Sciences
SC Veterinary Sciences
GA 663MQ
UT WOS:000182009700004
PM 19753748
DA 2018-10-20
ER

PT J
AU Mondieig, D
   Rajabalee, F
   Laprie, A
   Oonk, HAJ
   Calvet, T
   Cuevas-Diarte, MA
AF Mondieig, D
   Rajabalee, F
   Laprie, A
   Oonk, HAJ
   Calvet, T
   Cuevas-Diarte, MA
TI Protection of temperature sensitive biomedical products using molecular
   alloys as phase change material
SO TRANSFUSION AND APHERESIS SCIENCE
LA English
DT Article
AB In this paper we present an example of the application of molecular alloys for thermal protection of biomedical products during transport or storage. Particularly, thermal protection of blood elements have been considered at different temperatures. All steps from basic research to marketing have been addressed. The high latent heat of fusion of the components allows us to propose molecular alloys as materials for thermal energy storage and also for thermal protection over a large range of temperatures, which can be used in many industrial sectors. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Bordeaux 1, CNRS, CPMOH, F-33405 Talence, France.
   ISOS, F-33321 Eyzines, France.
   Univ Utrecht, Debye Inst, Chem Thermodynam Grp, NL-3584 CH Utrecht, Netherlands.
   Univ Barcelona, Dpt Cristal Lografia Mineral & Diposits Minerals, E-08028 Barcelona, Spain.
RP Mondieig, D (reprint author), Univ Bordeaux 1, CNRS, CPMOH, 351 Cours Liberat, F-33405 Talence, France.
RI Calvet, Teresa/M-3836-2014; Institute (DINS), Debye/G-7730-2014; Laprie,
   Anne/O-4948-2014
OI Calvet, Teresa/0000-0002-4058-7171; 
CR ARJONA F, 1999, 11 S GROUP ESP CRIST, P7
   CUEVASDIRATE MA, 1999, SUELO RADIANTE ALMAC
   Espeau P., 1997, Packaging Technology & Science, V10, P253, DOI 10.1002/(SICI)1099-1522(199709/10)10:5<253::AID-PTS403>3.0.CO;2-L
   Espeau P, 1996, J CHIM PHYS PCB, V93, P1217, DOI 10.1051/jcp/1996931217
   GRIGNON R, 1994, 20 JOURN ET EQ ENTR, P113
   HAGET Y, 1991, Patent No. 9108695
   HAGET Y, Patent No. 07988949
   HAGET Y, Patent No. 929155968
   JACOBS MHG, 1990, TXY CALC PROGRAM
   Lane G.A., 1986, SOLAR HEAT STORAGE L, V2
   LANE GA, 1986, SOLAR HEAT STORAGE L, V1
   Metivaud V, 1999, CAN J CHEM, V77, P332, DOI 10.1139/cjc-77-3-332
   MONDIEIG D, 1991, MATER RES BULL, V26, P1091, DOI 10.1016/0025-5408(91)90093-2
   VENTOLA L, 2002, J MATER CHEM, V6, P284
NR 14
TC 35
Z9 35
U1 1
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1473-0502
J9 TRANSFUS APHER SCI
JI Transfus. Apher. Sci.
PD APR
PY 2003
VL 28
IS 2
BP 143
EP 148
DI 10.1016/S1473-0502(03)00016-8
PG 6
WC Hematology
SC Hematology
GA 669EQ
UT WOS:000182339300007
PM 12679118
OA Green Published
DA 2018-10-20
ER

PT J
AU Abu Bakar, MS
   Cheang, P
   Khor, KA
AF Abu Bakar, MS
   Cheang, P
   Khor, KA
TI Tensile properties and microstructural analysis of spheroidized
   hydroxyapatite-poly (etheretherketone) biocomposites
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE biocomposite; orthopaedic; hydroxyapatite; poly(etheretherketone);
   particulate filled polymer; tensile properties
ID ORTHOPEDIC IMPLANTS; MECHANICAL-BEHAVIOR; COMPOSITES; PEEK; MODULUS
AB Poly(etheretherketone) or PEEK, is a high performance thermoplastic possessing exceptional mechanical properties, high temperature durability, good chemical and fatigue resistance. These coupled with its ability to withstand sterilization treatment, make it a preferred material for biomedical applications. This study examines the benefit of incorporating hydroxyapatite particulates in poly(etheretherketone) for possible usage as bone analogue materials. Flame spheroidized hydroxyapatite (FSHA) were incorporated into semi-crystalline poly(etheretherketone) polymer through a series of processes comprising melt compounding, granulating and injection molding. Biocomposites with high hydroxyapatite loading of up to 40 vol.% were processed successfully using this technique. Scanning electron microscopy (SEM) revealed fair dispersion and distribution of hydroxyapatite particles within the polymer matrix. The series of composites were characterized in terms of tensile and microhardness properties. Microstructural analysis was also carried out to correlate the structure-property relationship of the composite. The dependency of tensile properties such as modulus, strength and strain to fracture as well as the micro-hardness on the volume percentage of hydroxyapatite were investigated. By varying the amount of hydroxyapatite particles in the composite, a wide range of mechanical properties were obtained. In general, the tensile modulus and microhardness increased, while strength and strain to fracture decreased correspondingly with progressive addition of hydroxyapatite particles. The composite system under investigation also exhibited mechanical properties matching those of human bone. With hydroxyapatite loading beyond 30 vol.%, the modulus were within the bounds of the human cortical bone. Findings from this study suggest that this bioactive composite system have the potential as an alternative implant material for orthopaedic application. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Adv Mat Res Ctr, Singapore 639798, Singapore.
   Nanyang Technol Univ, Biomed Engn Res Ctr, Singapore 639798, Singapore.
RP Khor, KA (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Adv Mat Res Ctr, 50 Nanyang Ave, Singapore 639798, Singapore.
RI Khor, Khiam Aik (Michael)/B-6929-2009; Khor, Khiam Aik/G-2827-2010
OI KHOR, Khiam/0000-0003-1954-8423
CR ABUBAKAR MS, 1999, J MATER PROCESS TECH, V89, P462
   AHMED S, 1990, J MATER SCI, V25, P4933, DOI 10.1007/BF00580110
   AHMED S, 1990, COMPOSITES, V21, P81, DOI 10.1016/0010-4361(90)90101-2
   AKAY M, 1992, ADV COMPOS LETT, V1, P74
   ARZAK A, 1992, PLAST RUB COMPOS PRO, V17, P165
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Bonfield W, 1997, MATER WORLD, V5, P18
   CHEN EJH, 1992, POLYM ENG SCI, V32, P280, DOI 10.1002/pen.760320408
   Corvelli A.A., 1997, J ADV MAT, P2
   EVANS GP, 1990, J MATER SCI-MATER M, V1, P38, DOI 10.1007/BF00705352
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   HA SW, 1994, J MATER SCI-MATER M, V5, P481, DOI 10.1007/BF00058987
   HANCOX NL, 1990, ENCY MAT SCI ENG, P967
   Hashemi S, 1996, J MATER SCI, V31, P5017, DOI 10.1007/BF00355900
   JAR PY, 1992, J POLYM SCI POL PHYS, V30, P775, DOI 10.1002/polb.1992.090300715
   JOCKISCH KA, 1992, J BIOMED MATER RES, V26, P133, DOI 10.1002/jbm.820260202
   Khor KA, 1997, J MATER PROCESS TECH, V63, P271, DOI 10.1016/S0924-0136(96)02634-9
   LEVITA G, 1989, POLYM COMPOSITE, V10, P39, DOI 10.1002/pc.750100106
   LUSTIGER A, 1992, POLYM COMPOSITE, V13, P408, DOI 10.1002/pc.750130511
   SARASUA JR, 1995, J MATER SCI, V30, P3501, DOI 10.1007/BF00349901
   Sloten JV, 1998, BIOMATERIALS, V19, P1455, DOI 10.1016/S0142-9612(98)00058-1
   Thompson ID, 1998, P I MECH ENG H, V212, P127, DOI 10.1243/0954411981533908
   UHTHOFF HK, 1971, CLIN ORTHOP RELAT R, P165
   *VICTR PLC, MED PROD TECHN LIT
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M., 1996, BIOCERAMICS, V9, P387
   WANG M, 1995, BIOCERAMICS, V8, P383
NR 27
TC 45
Z9 45
U1 2
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAR 25
PY 2003
VL 345
IS 1-2
BP 55
EP 63
AR PII S0921-5093(02)00289-7
DI 10.1016/S0921-5093(02)00289-7
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 637WQ
UT WOS:000180537100008
DA 2018-10-20
ER

PT J
AU Duckworth, AR
   Battershill, CN
AF Duckworth, AR
   Battershill, CN
TI Developing farming structures for production of biologically active
   sponge metabolites
SO AQUACULTURE
LA English
DT Article
DE sponge; aquaculture; growth; survival; bioactive metabolite production
ID NEW-ZEALAND; MARINE SPONGES; DISCORHABDIN-B; LATRUNCULIA; CULTIVATION;
   CULTURE
AB A major obstacle to acceptance and use of sponge aquaculture as a viable method for production of biologically active metabolites is the lack of a farming technology suitable for commercial use. Using the New Zealand sponges Latrunculia sp. nov, Polymastia croceus and Raspailia agminata, all containing bioactive metabolites with biomedical potential, four general farming methods were examined: held on longline arrays sponge explants were farmed inside mesh support structures, rope threaded through explants and rope wrapped around explants. The fourth method additionally acted as a control procedure with sponge explants attached to substrate. Each general fanning method was expanded to examine the effects of various mesh sizes and/or rope materials. Most methods were found to be unsuitable for commercial application because the farmed explants did not attach to the supporting substrate but instead grew away from it and were subsequently lost. The two methods that showed the most potential for large-scale sponge fanning, in terms of good growth, survival and metabolite biosynthesis, were threaded polyvinyl alcohol rope and individual bags with large mesh size and thin strand diameter. These were developed into "rope" and "mesh" arrays that may be suitable for commercially farming sponges for metabolite production. (C) 2003 Published by Elsevier Science B.V.
C1 Natl Inst Water & Atmospher Res, Wellington, New Zealand.
RP Duckworth, AR (reprint author), Harbor Branch Oceanog Inst Inc, 5600 US 1 North, Ft Pierce, FL 34946 USA.
RI Battershill, Christopher/G-2663-2013; Duckworth, Alan/F-3290-2017
OI Battershill, Christopher/0000-0002-5586-0417; Duckworth,
   Alan/0000-0002-5451-7633
CR BARTHEL D, 1986, OPHELIA, V25, P75, DOI 10.1080/00785326.1986.10429715
   BATTERSHILL CN, 2001, NZ COASTAL INVERTEBR, V1
   BATTERSHILL CN, 1996, AQUACULT UPDATE  SPR, P5
   BECERRO MA, 1997, HYDROBIOLOGIA, V356, P77
   BERGQUIST PR, 1969, ENCY MARINE RESOURCE, P665
   BERGQUIST PR, 1970, B NZ DEP SCI IND RES, V197
   BLUNT JW, 1990, NEW J CHEM, V14, P761
   CAHN AR, 1948, 309 US FISH WILDL SE
   CRAWSHAY L. R., 1939, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V23, P553
   Duckworth A. R., 1999, Memoirs of the Queensland Museum, V44, P155
   Duckworth AR, 1997, AQUACULTURE, V156, P251, DOI 10.1016/S0044-8486(97)00131-2
   DUCKWORTH AR, 2000, THESIS U CANTERBURY
   ELVIN DW, 1979, BIOL BULL, V156, P47, DOI 10.2307/1541002
   Faulkner DJ, 1997, NAT PROD REP, V14, P259, DOI 10.1039/np9971400259
   Hodson SL, 1997, AQUACULTURE, V152, P77, DOI 10.1016/S0044-8486(97)00007-0
   Ireland Chris M., 1993, Marine Biotechnology, V1, P1
   KellyBorges M, 1997, NEW ZEAL J MAR FRESH, V31, P367, DOI 10.1080/00288330.1997.9516772
   KREUTER MH, 1992, COMP BIOCHEM PHYS C, V101, P183, DOI 10.1016/0742-8413(92)90217-U
   LILL RE, 1995, J NAT PRODUCTS, V58, P306, DOI 10.1021/np50116a028
   MOORE HF, 1908, B BUR FISH, V28, P545
   MUNRO MHG, 1989, PURE APPL CHEM, V61, P529, DOI 10.1351/pac198961030529
   Munro MHG, 1999, J BIOTECHNOL, V70, P15, DOI 10.1016/S0168-1656(99)00052-8
   Osinga R, 1999, MAR BIOTECHNOL, V1, P509, DOI 10.1007/PL00011807
   Osinga R, 1998, TRENDS BIOTECHNOL, V16, P130, DOI 10.1016/S0167-7799(97)01164-5
   PERRY NB, 1988, TETRAHEDRON, V44, P1727, DOI 10.1016/S0040-4020(01)86737-5
   Pronzato Roberto, 1999, Memoirs of the Queensland Museum, V44, P485
   Rhoades DF, 1979, HERBIVORES THEIR INT, P3
   Ridley SO, 1886, ANN MAGAZINE NATURAL, V18, P470, DOI [DOI 10.1080/00222938609459998, 10.1080/00222938609459998]
   Schmitz Francis J., 1993, Marine Biotechnology, V1, P197
   SHIMIZU Y, 1995, MARITIMES, V38, P13
   SIMSPON TL, 1968, J EXP MAR BIOL ECOL, V2, P252
   STONE AR, 1970, J ZOOL, V161, P443
   STORR JF, 1964, 466 US FISH WILDL SE
   THOMPSON JE, 1987, BIOCHEM SYST ECOL, V15, P595, DOI 10.1016/0305-1978(87)90111-6
   Turon X, 1996, OIKOS, V75, P33, DOI 10.2307/3546318
   Verdenal B., 1990, P416
   WALKER RP, 1985, MAR BIOL, V88, P27, DOI 10.1007/BF00393040
   YATSUNAMI J, 1992, P 1 INT C VIT BIOF L, P333
NR 38
TC 37
Z9 43
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0044-8486
J9 AQUACULTURE
JI Aquaculture
PD MAR 17
PY 2003
VL 217
IS 1-4
BP 139
EP 156
AR PII S0044-8486(02)00038-8
DI 10.1016/S0044-8486(02)00038-8
PG 18
WC Fisheries; Marine & Freshwater Biology
SC Fisheries; Marine & Freshwater Biology
GA 648BE
UT WOS:000181129300013
DA 2018-10-20
ER

PT J
AU Manso, M
   Herrero, P
   Fernandez, M
   Langlet, M
   Martinez-Duart, JM
AF Manso, M
   Herrero, P
   Fernandez, M
   Langlet, M
   Martinez-Duart, JM
TI Textured hydroxyapatite interface onto biomedical titanium-based
   coatings
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydroxyapatite; coatings; interfaces; Auger electron spectroscopy;
   transmission electron microscopy
ID AUGER-ELECTRON-SPECTROSCOPY; THIN-FILMS
AB Hydroxyapatite (HAP) bioceramic coatings grown onto titanium-nitride (TiN) buffer layers by the aerosol-gel procedure present interfaces with a preferred growth orientation. These coatings were crystallized at 800degreesC and subsequently etched to ease the study of the interface by Auger electron spectroscopy depth profiling. Ion beam milling was applied to cross-section samples to analyze the interface structures using transmission electron microscopy. At the interface, the HAP crystals showed a <002> orientation. It was shown by Auger electron spectroscopy depth profiling that 0 atoms diffuse into the nitride inter-layer, indicating that the formation of 0 channels in the HAP structure is the driving force inducing the textured film. The outstanding biocompatible properties of both the materials and properties of their interface suggest that HAP/TiN structures are particularly well suited for endo-prosthetic applications. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
   CSIC, Inst Ciencia Mat, E-28049 Madrid, Spain.
   ENSPG, INPG, UMR 5628, Lab Mat & Genie Phys, F-38402 St Martin Dheres, France.
RP Manso, M (reprint author), Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
EM miguel.manso@uam.es
RI Manso Silvan, Miguel/B-4947-2010
OI Manso Silvan, Miguel/0000-0002-5063-1607
CR Barna A, 1996, SURF INTERFACE ANAL, V24, P476, DOI 10.1002/(SICI)1096-9918(199607)24:7<476::AID-SIA138>3.0.CO;2-F
   EBRAHIMPOUR A, 1993, J COLLOID INTERF SCI, V159, P158, DOI 10.1006/jcis.1993.1307
   GLASER AB, 1979, INTEGRATED CIRCUIT E, P197
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   Gross KA, 1998, J MATER SCI, V33, P3985, DOI 10.1023/A:1004605014652
   GuillotNoel O, 1996, J APPL PHYS, V80, P1803, DOI 10.1063/1.362991
   HAYASHI K, 1994, BIOMATERIALS, V15, P1187, DOI 10.1016/0142-9612(94)90241-0
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HUAXIA JI, 1992, J MATER SCI-MATER M, V3, P283
   Lin PL, 2001, JPN J APPL PHYS 2, V40, pL377, DOI 10.1143/JJAP.40.L377
   Manso M, 2001, INT J INORG MATER, V3, P1153, DOI 10.1016/S1466-6049(01)00112-X
   Manso M, 2002, BIOMATERIALS, V23, P349, DOI 10.1016/S0142-9612(01)00112-0
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   Manso-Silvan M, 2002, J MATER SCI-MATER M, V13, P289, DOI 10.1023/A:1014062918261
   MATHIEU HJ, 1977, J VAC SCI TECHNOL, V14, P1023, DOI 10.1116/1.569313
   Mavis B, 2000, J AM CERAM SOC, V83, P989
   Ong JL, 1998, BIOMATERIALS, V19, P455, DOI 10.1016/S0142-9612(97)00224-X
   TORRISI L, 1993, THIN SOLID FILMS, V227, P32, DOI 10.1016/0040-6090(93)90183-P
   TORRISI L, 1993, APPL PHYS LETT, V62, P237, DOI 10.1063/1.108976
   VANRAEMDONCK W, 1984, J AM CERAM SOC, V67, P381
   Viitala R, 2001, J BIOMED MATER RES, V54, P109, DOI 10.1002/1097-4636(200101)54:1<109::AID-JBM13>3.0.CO;2-S
   VONCRIEGERN R, 1991, ANAL MICROELECTRONIC, P349
   WILLIAMS RH, 1975, SURF SCI, V1, P14
NR 23
TC 5
Z9 5
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2003
VL 64A
IS 4
BP 600
EP 605
DI 10.1002/jbm.a.10397
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671EZ
UT WOS:000182453500002
PM 12601770
DA 2018-10-20
ER

PT J
AU Riehle, MO
   Dalby, MJ
   Johnstone, H
   MacIntosh, A
   Affrossman, S
AF Riehle, MO
   Dalby, MJ
   Johnstone, H
   MacIntosh, A
   Affrossman, S
TI Cell behaviour of rat calvaria bone cells on surfaces with random
   nanometric features
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Spring Meeting of the European-Materials-Research-Society (E-MRS)
CY JUN 18-21, 2002
CL STRASBOURG, FRANCE
SP European Mat Res Soc
DE nanofabrication; cell adhesion; cytoskeleton; biomaterials; polystyrene;
   phase separation
ID TOPOGRAPHY; ATTACHMENT; ADHESION
AB Cells encounter patterns around them in the form of fixed chemical and topographical patterns such as those of the extracellular matrix, or on artificial material, which can be of micro- or nanometric dimensions. In addition, nanometric surfaces are known to have distinct physicochemical properties from the bulk material. For us, these information serve as the reasons to deliberately pattern surfaces with nanometric features for biomedical applications. One of the possible methods to fabricate large areas consistently patterned with random nanofeatures is based on phase separation during spin casting of binary polymer mixes such as polystyrene and poly-bromostyrene. We present in this paper the reaction of rat calvaria bone cells to the same surfaces where we knew that endothelia and fibroblastic cells showed a differential reaction. The cells adhered to all surfaces in the same way after an initially increased adhesion on the rough surfaces (35 and 95 nm). The cells interacted with all surfaces in a similar way extending filopodia, spreading and extending after initial adhesion. The results illustrate that compared to either endothelia or fibroblasts, osteoblast cells proliferate less on the surface chemistry (PS) provided, and that the surface features used do not induce a changed behaviour after an initial increase in adhesion on the rougher surfaces. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Glasgow, Inst Biol & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
   Univ Glasgow, Dept Elect Engn, Glasgow G12 8QQ, Lanark, Scotland.
   Univ Strathclyde, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland.
RP Riehle, MO (reprint author), Univ Glasgow, Inst Biol & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RI Riehle, Mathis/A-3427-2011; Dalby, Matthew/G-2426-2012
OI Riehle, Mathis/0000-0001-7988-1514; Dalby, Matthew/0000-0002-0528-3359
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   Affrossman S, 1998, MACROMOLECULES, V31, P6280, DOI 10.1021/ma971676q
   CLARK P, 1991, J CELL SCI, V99, P73
   Clark P, 1997, EXP CELL RES, V230, P275, DOI 10.1006/excr.1996.3429
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   DALBY M, 2002, TISSUE ENG, V8, P1
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Dalby MJ, 2002, BIOMATERIALS, V23, P681, DOI 10.1016/S0142-9612(01)00156-9
   GADEGAARD N, 2002, ROSKILDE, P90
   Gleiche M, 2000, NATURE, V403, P173, DOI 10.1038/35003149
   Hanarp P, 1999, NANOSTRUCT MATER, V12, P429, DOI 10.1016/S0965-9773(99)00151-8
   Matter K, 1999, INT REV CYTOL, V186, P117
   Rascon C, 2000, NATURE, V407, P986, DOI 10.1038/35039590
   RIEHLE M, 2002, MRS P NANOPATTERNING, V705
   Spatz JP, 1999, ADV MATER, V11, P149, DOI 10.1002/(SICI)1521-4095(199902)11:2<149::AID-ADMA149>3.0.CO;2-W
   Turner S, 1997, J VAC SCI TECHNOL B, V15, P2848, DOI 10.1116/1.589742
   Webster TJ, 2000, KEY ENG MAT, V192-1, P321
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
NR 20
TC 38
Z9 38
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAR 3
PY 2003
VL 23
IS 3
SI SI
BP 337
EP 340
AR PII S0928-4931(02)00282-5
DI 10.1016/S0928-4931(02)00282-5
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 643NT
UT WOS:000180867900004
DA 2018-10-20
ER

PT J
AU Rosso, F
   Barbarisi, A
   Barbarisi, M
   Petillo, O
   Margarucci, S
   Calarco, A
   Peluso, G
AF Rosso, F
   Barbarisi, A
   Barbarisi, M
   Petillo, O
   Margarucci, S
   Calarco, A
   Peluso, G
TI New polyelectrolyte hydrogels for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Spring Meeting of the European-Materials-Research-Society (E-MRS)
CY JUN 18-21, 2002
CL STRASBOURG, FRANCE
SP European Mat Res Soc
DE polyelectrolyte; smart materials; cytotoxicity; cytocompatibility;
   adhesion
ID SURFACES
AB Copolymerisation of charged and neutral monomers is a well-tested strategy to introduce charged moieties in a polymeric chain and obtain polyelectrolyte polymers. We have synthesized new cationic and anionic polyelectrolytes by bulk radical copolymerisation of 2-hydroxyethyl methacrylate with [2-methacryloyloxyethyltrimethyl ammonium chloride (METAC)] or [2-acrylamido-2-methylpropane-sulphonic acid (AMPS)] monomers. The chemical structure of the synthesized copolymers was confirmed by FT-IR spectroscopy. Swelling studies on synthesized copolymers showed a high water content in the swollen state and a "smart behaviour" upon changes in external stimuli (pH and ionic strength). Cytotoxicity and cytocompatibility studies demonstrated that synthesized materials were not toxic. Moreover, the cationic copolymer showed good cell adhesion, whereas the anionic copolymer showed poor cell adhesion on its surface. X-ray photoelectron spectroscopy (XPS) showed that the disparate behaviour was due to the chemical nature of charged groups on the copolymer surfaces. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Naples 2, Dept Anaesthesiol Surg & Emergency Sci, Biotechnol Appl Surg Unit, I-80138 Naples, Italy.
   Natl Canc Inst G Pascale, I-80131 Naples, Italy.
RP Barbarisi, A (reprint author), Univ Naples 2, Dept Anaesthesiol Surg & Emergency Sci, Biotechnol Appl Surg Unit, Piazza Miraglia, I-80138 Naples, Italy.
OI Barbarisi, Alfonso/0000-0003-2357-1132
CR ANDRADE JK, 1987, T AM SOC ART INT ORG, V83, P75
   Beamson G., 1992, HIGH RESOLUTION XPS, P128
   Billmeyer FW, 1984, TXB POLYM SCI
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   DAVIS PA, 1989, HIGH PERFORMANCE BIO, P343
   GRIFFITHS JB, 1987, PLANT ANIMAL CELLS P, P149
   GRIFFITHS JB, 1985, ANIMAL CELL BIOTECHN, V1, P17
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   KIM S W, 1985, Critical Reviews in Biocompatibility, V1, P229
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   SALAMONE JC, 1982, POLYMER, V23, P843, DOI 10.1016/0032-3861(82)90144-6
   Scranton AB, 1995, ADV POLYM SCI, V122, P1
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Zhang SF, 1998, BIOMATERIALS, V19, P691, DOI 10.1016/S0142-9612(97)00174-9
NR 15
TC 45
Z9 45
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAR 3
PY 2003
VL 23
IS 3
SI SI
BP 371
EP 376
AR PII S0928-4931(02)00290-4
DI 10.1016/S0928-4931(02)00290-4
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 643NT
UT WOS:000180867900010
DA 2018-10-20
ER

PT J
AU Dokoumetzidis, A
   Macheras, P
AF Dokoumetzidis, A
   Macheras, P
TI A model for transport and dispersion in the circulatory system based on
   the vascular fractal tree
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE fractal tree; indocyanine green; tracer kinetics; dispersion; tube
ID BLOOD-FLOW HETEROGENEITY; INDICATOR DILUTION; NETWORKS; ARTERIAL; TIME;
   PHARMACOKINETICS; PRINCIPLES; DIFFUSION; MUSCLE; VOLUME
AB Materials are distributed throughout the body of mammals by fractal networks of branching tubes. Based on the scaling laws of the fractal structure, the vascular tree is reduced to an equivalent one-dimensional, tube model. A dispersion-convection partial differential equation with constant coefficients describes the heterogeneous concentration profile of an intravascular tracer in the vascular tree. A simple model for the mammalian circulatory system is built in entirely physiological terms consisting of a ring shaped, one-dimensional tube which corresponds to the arterial, venular, and pulmonary trees, successively. The model incorporates the blood flow heterogeneity of the mammalian circulatory system. Model predictions are fitted to published concentration-time data of indocyanine green injected in humans and dogs. Close agreement was found with parameter values within the expected physiological range. (C) 2003 Biomedical Engineering Society. [DOI: 10.1114/1.1555627].
C1 Univ Athens, Sch Pharm, GR-15771 Athens, Greece.
RP Macheras, P (reprint author), Univ Athens, Sch Pharm, GR-15771 Athens, Greece.
EM macheras@pharin.uoa.gr
OI Dokoumetzidis, Aristides/0000-0001-5087-4003
CR Audi SH, 1998, ANN BIOMED ENG, V26, P914, DOI 10.1114/1.138
   BASSINGTHWAIGHT.JB, 1994, FRACTAL PHYSL
   Beard DA, 2000, ANN BIOMED ENG, V28, P253, DOI 10.1114/1.273
   BOXENBAUM H, 1982, J PHARMACOKINET BIOP, V10, P201, DOI 10.1007/BF01062336
   BROWN JH, 2000, SCALING BIOL
   EDWARDS DA, 1994, J AEROSOL SCI, V25, P543, DOI 10.1016/0021-8502(94)90071-X
   ELLSWORTH ML, 1987, MICROVASC RES, V34, P168, DOI 10.1016/0026-2862(87)90051-3
   Fung Y.C., 1997, BIOMECHANICS CIRCULA
   GERLOWSKI LE, 1983, J PHARM SCI, V72, P1103, DOI 10.1002/jps.2600721003
   Guyton AC, 2000, TXB MED PHYSL
   Hashimoto M, 2000, HEPATO-GASTROENTEROL, V47, P1669
   HORSFILED K, 1990, Journal of Applied Physiology, V68, P457
   Huang W, 1996, J APPL PHYSIOL, V81, P2123
   King RB, 1996, ANN BIOMED ENG, V24, P352, DOI 10.1007/BF02660885
   Krejcie TC, 1997, J PHARMACOKINET BIOP, V25, P169, DOI 10.1023/A:1025780012960
   LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104
   LEFEVRE J, 1983, J THEOR BIOL, V102, P225, DOI 10.1016/0022-5193(83)90361-2
   Niemann CU, 2000, CLIN PHARMACOL THER, V67, P342, DOI 10.1067/mcp.2000.104945
   Oliver RE, 2001, J PHARMACOKINET PHAR, V28, P27, DOI 10.1023/A:1011565602152
   Olufsen MS, 2000, ANN BIOMED ENG, V28, P1281, DOI 10.1114/1.1326031
   PERL W, 1968, CIRC RES, V22, P273, DOI 10.1161/01.RES.22.2.273
   Picker O, 2001, INTENS CARE MED, V27, P767, DOI 10.1007/s001340100901
   ROBERTS MS, 1986, J PHARMACOKINET BIOP, V14, P227, DOI 10.1007/BF01106706
   SCHERER PW, 1972, B MATH BIOPHYS, V34, P393, DOI 10.1007/BF02476450
   Thomee V., 1990, HDB NUMERICAL ANAL, P5
   Unice KM, 2000, J ENVIRON ENG-ASCE, V126, P491, DOI 10.1061/(ASCE)0733-9372(2000)126:6(491)
   VANBEEK JHGM, 1989, AM J PHYSIOL, V257, pH1670
   Vicini P, 1998, ANN BIOMED ENG, V26, P764, DOI 10.1114/1.64
   Wagner J.G., 1993, PHARMACOKINETICS PHA
   Weibel ER, 1963, MORPHOMETRY HUMAN LU
   WEISS M, 1979, EUR J CLIN PHARMACOL, V16, P287, DOI 10.1007/BF00608408
   West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677
   West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122
   Zamir M, 1999, J THEOR BIOL, V197, P517, DOI 10.1006/jtbi.1998.0892
   ZAMIR M, 1992, J BIOMECH, V25, P1303, DOI 10.1016/0021-9290(92)90285-9
NR 35
TC 22
Z9 22
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2003
VL 31
IS 3
BP 284
EP 293
DI 10.1114/1.1555627
PG 10
WC Engineering, Biomedical
SC Engineering
GA 659ZC
UT WOS:000181808400005
PM 12680726
DA 2018-10-20
ER

PT J
AU Lopes, CMA
   Felisberti, MI
AF Lopes, CMA
   Felisberti, MI
TI Mechanical behaviour and biocompatibility of
   poly(1-vinyl-2-pyrrolidinone)-gelatin IPN hydrogels
SO BIOMATERIALS
LA English
DT Article
DE IPN hydrogel; gelatin; PVP; biocompatibility; swelling; mechanical
   properties
ID BIOMATERIALS; MEMBRANES; POLYMER
AB IPN hydrogels based on poly(1-vinyl-2-pyrrolidinone) and gelatin were obtained by casting of aqueous solution using potassium persulphate and glutaraldehyde as respective crosslinking agents. Studies of swelling and mechanical behaviour showed that the samples of different composition can incorporate high content of water and still exhibit high compression strength. The composition has influence at the global crosslinking density what affects the mechanical performance. In vitro biocompatibility and hemocompatibility were also investigated. The materials do not interfere on the cellular functions and neither induce platelet adhesion. From this preliminary evaluation, it is possible to conclude that these hydrogels have potential for applications in the biomedical field. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Estadual Campinas, Inst Quim, BR-13083970 Campinas, SP, Brazil.
RP Felisberti, MI (reprint author), Univ Estadual Campinas, Inst Quim, Caixa Postal 6154, BR-13083970 Campinas, SP, Brazil.
RI Felisberti, Maria Isabel/A-5959-2013; Lopes, Cristina/F-8721-2012
OI Felisberti, Maria Isabel/0000-0001-8311-9864; Lopes,
   Cristina/0000-0003-0004-0515
CR Adams R. L. P., 1990, CELL CULTURE BIOCH
   Ambrosio Luigi, 1996, P3
   ANDERSON CC, 1979, J APPL POLYM SCI, V23, P2453, DOI 10.1002/app.1979.070230823
   *ASTM, 1983, F81363 ASTM
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   EVANS G, 1968, SURGERY, V64, P273
   FRESHNEY RI, 1987, ANIMAL CELL CULTURE
   *ISO EN, 1992, 109935 ISOEN
   Jirouskova M, 1997, J MATER SCI-MATER M, V8, P19, DOI 10.1023/A:1018534111419
   KAUR H, 1990, MACROMOLECULES, V23, P4868, DOI 10.1021/ma00224a016
   Manson J. A., 1976, POLYM BLENDS COMPOSI
   MOLINEAUX P, 1983, WATER SOLUBLE SYNTHE
   PARK H, 1996, ACS SYM SER, V627, P2
   PAUL W, 1995, J APPL POLYM SCI, V57, P1447, DOI 10.1002/app.1995.070571204
   Peppas N. A., 1987, HYDROGELS MED PHARM, V2
   Risbud MV, 2001, J MATER SCI-MATER M, V12, P75, DOI 10.1023/A:1026769422026
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Veis A., 1964, MACROMOLECULAR CHEM
NR 19
TC 78
Z9 84
U1 3
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2003
VL 24
IS 7
BP 1279
EP 1284
AR PII S0142-9612(02)00448-9
DI 10.1016/S0142-9612(02)00448-9
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 638ZV
UT WOS:000180603900017
PM 12527269
DA 2018-10-20
ER

PT J
AU Nakashima, K
AF Nakashima, K
TI Lophine derivatives as versatile analytical tools
SO BIOMEDICAL CHROMATOGRAPHY
LA English
DT Review
DE chemiluminescence; fluorescence; trace metals; metamphetamine; fatty
   acids; phenolics
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; FLOW-INJECTION ANALYSIS; FLUORESCENCE
   DETECTION; CHEMI-LUMINESCENCE; LABELING REAGENT; HUMAN URINE;
   4-(4,5-DIPHENYL-1H-IMIDAZOL-2-YL)BENZOYL CHLORIDE; DERIVATIZATION
   REAGENT; BISPHENOL-A; CHEMILUMINESCENCE
AB Lophine (2,4,5-triphenylimidazole) derivatives as versatile analytical tools in biomedical sciences are described. Chemiluminescence (CL) and fluorescence (FL) properties of the lophine derivatives are first demonstrated including the CL reaction mechanism, effects of substituents on CL yields, FL spectral behaviors, etc. Next, analytical applications to the determination of metal ions such as cobalt (II) and chromium (VI) are discussed. Finally, the application studies of lophine derivatives as CL and FL reagents for the determination of organic substances in biological materials are presented. Among the derivatives, 2-(4-hydrazinocarbonylphenyl)-4,5-diphenylimidazole (HCPI) and 4-(4,5-diphenyl-1H-imidazol-2-yl)benzoyl chloride (DIB-Cl) are studied, with their excellent properties as labeling reagents for fatty acids,and amines and/or phenols, respectively, in high-performance liquid chromatography. The utility of boronic acid derivatives as CL enhancers is also discussed in this review. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Chem, Course Pharmaceut Sci, Nagasaki 8528521, Japan.
RP Nakashima, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Chem, Course Pharmaceut Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.
CR Al-Dirbashi O, 1998, ANALYST, V123, P2333, DOI 10.1039/a804720k
   Al-Dirbashi O, 1999, BIOMED CHROMATOGR, V13, P543, DOI 10.1002/(SICI)1099-0801(199912)13:8<543::AID-BMC925>3.0.CO;2-7
   Al-Dirbashi O, 1998, J CHROMATOGR B, V712, P105, DOI 10.1016/S0378-4347(98)00128-5
   Al-Dirbashi O, 1999, ANALYST, V124, P493, DOI 10.1039/a808912d
   Al-Dirbashi OY, 2000, BIOMED CHROMATOGR, V14, P293, DOI 10.1002/1099-0801(200008)14:5<293::AID-BMC2>3.0.CO;2-K
   Al-Dirbashi OY, 2000, J FORENSIC SCI, V45, P708
   Al-Dirbashi OY, 2001, BIOMED CHROMATOGR, V15, P457, DOI 10.1002/bmc.94
   BEREKET G, 1996, COMMUNICATIONS FAC B, V42, P1
   GORD JR, 1988, ANAL CHEM, V60, P2, DOI 10.1021/ac00152a002
   HAYASHI T, 1962, B CHEM SOC JPN, V35, P2057, DOI 10.1246/bcsj.35.2057
   Kaddoumi A, 2001, J CHROMATOGR B, V763, P79, DOI 10.1016/S0378-4347(01)00368-1
   Kaddoumi A, 2001, BIOMED CHROMATOGR, V15, P379, DOI 10.1002/bmc.85
   KAMIDATE T, 1989, ANAL SCI, V5, P429, DOI 10.2116/analsci.5.429
   KIMURA M, 1993, CHEM LETT, P505, DOI 10.1246/cl.1993.505
   Kuroda N, 1996, CHEM PHARM BULL, V44, P1525
   KURODA N, 1993, BIOL PHARM BULL, V16, P220
   Kuroda N, 1999, LUMINESCENCE, V14, P361, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<361::AID-BIO563>3.3.CO;2-A
   Kuroda N, 2000, ANAL CHIM ACTA, V403, P131, DOI 10.1016/S0003-2670(99)00649-2
   Kuroda N., 1997, J FLUORESC, V7, p239s
   MARINO DF, 1981, ANAL CHEM, V53, P292, DOI 10.1021/ac00225a038
   MARINO DF, 1979, ANAL CHEM, V51, P2051, DOI 10.1021/ac50048a041
   MARINO DF, 1981, ANAL CHEM, V53, P294, DOI 10.1021/ac00225a039
   MCDONALD A, 1979, ANAL CHEM, V51, P2077
   Nakashima K, 1998, DYES PIGMENTS, V38, P127, DOI 10.1016/S0143-7208(98)80002-8
   NAKASHIMA K, 1995, ANAL CHIM ACTA, V303, P103, DOI 10.1016/0003-2670(94)00360-X
   Nakashima K, 1997, BIOMED CHROMATOGR, V11, P63, DOI 10.1002/(SICI)1099-0801(199703)11:2<63::AID-BMC634>3.0.CO;2-U
   NAKASHIMA K, 1993, J CHROMATOGR-BIOMED, V619, P1, DOI 10.1016/0378-4347(93)80440-F
   Nakashima K, 1998, ANALYST, V123, P2281, DOI 10.1039/a804582h
   Nakashima K., 1997, J FLUORESC, V7, p157s
   PHILBROOK GE, 1965, PHOTOCHEM PHOTOBIOL, V4, P1175
   RADZISZEWSKY B, 1877, CHEM BER, V10, P70
   SAITO K, 1987, YAKUGAKU ZASSHI, V107, P876, DOI 10.1248/yakushi1947.107.11_876
   SONNENBERG J, 1964, J AM CHEM SOC, V86, P5685, DOI 10.1021/ja01078a061
   SUGIHARA S, 2001, ANAL SCI, V17, P1261
   Sun Y, 2000, J CHROMATOGR B, V749, P49, DOI 10.1016/S0378-4347(00)00387-X
   Sun Y, 2002, BIOMED CHROMATOGR, V16, P319, DOI 10.1002/bmc.161
   Sun Y, 2001, ANAL SCI, V17, P697, DOI 10.2116/analsci.17.697
   Wada M, 1999, J CHROMATOGR B, V721, P179, DOI 10.1016/S0378-4347(98)00499-X
   Watanabe T, 2001, J CHROMATOGR B, V762, P1, DOI 10.1016/S0378-4347(01)00287-0
   WHITE EH, 1964, J AM CHEM SOC, V86, P5686, DOI 10.1021/ja01078a062
   WHITE EH, 1965, PHOTOCHEM PHOTOBIOL, V4, P1129
   Yagi K, 2001, J ORG CHEM, V66, P5419, DOI 10.1021/jo010267w
NR 42
TC 44
Z9 44
U1 1
U2 27
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0269-3879
J9 BIOMED CHROMATOGR
JI Biomed. Chromatogr.
PD MAR-APR
PY 2003
VL 17
IS 2-3
BP 83
EP 95
DI 10.1002/bmc.226
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA 673UT
UT WOS:000182599200003
PM 12717796
DA 2018-10-20
ER

PT J
AU Hauert, R
AF Hauert, R
TI A review of modified DLC coatings for biological applications
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th European Conference on Diamond, Diamond-Like Materials, Carbon
   Nanotubes, Nitrides and Sililcon Carbide (Diamond 2002)
CY SEP 03-08, 2002
CL GRANADA, SPAIN
SP AIXTRON AG, Elsevier, Inst Elect Engineers, iplas Innovat Plasma Syst GmbH, Jobin Yvon SA, Renishaw plc, Seki Techotron
DE amorphous hydrogenated carbon; diamond-like carbon; biomaterials;
   biomedical applications
ID DIAMOND-LIKE CARBON; MOLECULAR-WEIGHT POLYETHYLENE; PROSTHETIC JOINT
   MATERIALS; MECHANICAL HEART-VALVES; A-C-H; IN-VITRO; AMORPHOUS-CARBON;
   SURFACE-ANALYSIS; TRIBOLOGICAL CHARACTERIZATION; BLOOD COMPATIBILITY
AB Diamond-like carbon (DLC), also known as amorphous hydrogenated carbon (a-C:H), is a class of materials with excellent mechanical, tribological and biological properties. By the addition of other elements into the DLC all of these properties can be changed within a certain range. It will be shown that the ratios of the different proteins adsorbed on the surface can be influenced by the addition of different elements into the DLC film. These proteins will then subsequently influence cell attachment, cell proliferation and cell differentiation. Certain toxic elements such as Cu, Ag, V, embedded in the DLC will, when exposed to a biological media, be released and cause toxic reactions. This allows the preparation of surfaces with a tunable antibacterial effect. DLC has proven its outstanding tribological properties in many technical applications due to the transformation of DLC into graphite (a solid lubricant) and the build up of a transfer layer on the counterpart. However, it is questionable if this effect takes place in artificial joints. Contradicting results on DLC coated hip joints are found in the literature, some indicating an improvement and some a change for the worse. DLC coatings have an excellent haemocompatibility, which is expressed in a decreased thrombus formation. When exposed to blood, an increased ratio of albumin to fibrinogen adsorption as well as decreased platelet activation is observed on coated surfaces. DLC coated cardiovascular implants such as artificial heart valves and stents are already commercially available. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Swiss Fed Labs Mat Testing & Res EMPA, CH-8600 Dubendorf, Switzerland.
RP Hauert, R (reprint author), Swiss Fed Labs Mat Testing & Res EMPA, Uberlandstr 129, CH-8600 Dubendorf, Switzerland.
OI Hauert, Roland/0000-0001-6154-9337
CR Affatato S, 2000, J BIOMED MATER RES, V53, P221, DOI 10.1002/(SICI)1097-4636(2000)53:3<221::AID-JBM6>3.0.CO;2-Z
   Ahlroos T, 1997, WEAR, V211, P113, DOI 10.1016/S0043-1648(97)00074-4
   Alanazi A, 2000, ASAIO J, V46, P440, DOI 10.1097/00002480-200007000-00014
   ALLEN M, 2000, J BIOMED MATER RES, V58, P319
   Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   Antoniucci D, 2000, AM J CARDIOL, V85, P821, DOI 10.1016/S0002-9149(99)00874-7
   BECK RM, 2001, THESIS U TUBINGEN GE
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   Butter R. S., 1995, Journal of Chemical Vapor Deposition, V3, P182
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chu PK, 2001, REV SCI INSTRUM, V72, P1660, DOI 10.1063/1.1340029
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Cutiongco EC, 1996, J TRIBOL-T ASME, V118, P543, DOI 10.1115/1.2831572
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Dearnley PA, 1999, P I MECH ENG H, V213, P107, DOI 10.1243/0954411991534843
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   Dong H, 1999, WEAR, V225, P146, DOI 10.1016/S0043-1648(98)00356-1
   Donnet C, 1998, SURF COAT TECH, V100, P180, DOI 10.1016/S0257-8972(97)00611-7
   Dorner-Reisel A, 2002, THIN SOLID FILMS, V420, P263, DOI 10.1016/S0040-6090(02)00745-9
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Fisher J, 1995, Proc Inst Mech Eng H, V209, P263, DOI 10.1243/PIME_PROC_1995_209_353_02
   Francz G, 1999, SURF INTERFACE ANAL, V28, P3, DOI 10.1002/(SICI)1096-9918(199908)28:1<3::AID-SIA609>3.0.CO;2-U
   FREITAS RA, 1999, FORESIGHT UPDATE 39
   Gangopadhyay A, 1998, TRIBOL LETT, V5, P25, DOI 10.1023/A:1019152515982
   Garas SM, 2001, PHARMACOL THERAPEUT, V92, P165, DOI 10.1016/S0163-7258(01)00168-1
   Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3
   Grill A, 1997, SURF COAT TECH, V94-5, P507, DOI 10.1016/S0257-8972(97)00458-1
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   GUTTLER J, 1993, SURF COAT TECH, V60, P531, DOI 10.1016/0257-8972(93)90147-G
   Hauert R, 1999, SURF COAT TECH, V120, P291, DOI 10.1016/S0257-8972(99)00499-5
   Hauert R, 1997, THIN SOLID FILMS, V308, P191, DOI 10.1016/S0040-6090(97)00422-7
   HAUERT R, 1996, C P 17 INT SAMPE EUR, P367
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Krishnan LK, 2002, BIOMOL ENG, V19, P251, DOI 10.1016/S1389-0344(02)00029-1
   Lappalainen R, 1998, DIAM RELAT MATER, V7, P482, DOI 10.1016/S0925-9635(98)80003-4
   Lee KR, 1996, MAT SCI ENG A-STRUCT, V209, P264, DOI 10.1016/0921-5093(95)10139-X
   Lettington AH, 1998, CARBON, V36, P555, DOI 10.1016/S0008-6223(98)00062-1
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   Mohanty M, 2002, BIOMOL ENG, V19, P125, DOI 10.1016/S1389-0344(02)00026-6
   Neerinck D, 1998, THIN SOLID FILMS, V317, P402, DOI 10.1016/S0040-6090(97)00631-7
   Onate JI, 2001, SURF COAT TECH, V142, P1056, DOI 10.1016/S0257-8972(01)01074-X
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   Saikko V, 2001, BIOMATERIALS, V22, P1507, DOI 10.1016/S0142-9612(00)00306-9
   Saikko V, 1997, WEAR, V207, P86, DOI 10.1016/S0043-1648(96)07482-0
   Scholes SC, 2000, PHYS MED BIOL, V45, P3721, DOI 10.1088/0031-9155/45/12/315
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   SCHROEDER A, 2003, IN PRESS BIOMATERIAL
   SCHROEDER A, 1999, THESIS ETH ZURICH
   Sheeja D, 2001, SURF COAT TECH, V146, P410, DOI 10.1016/S0257-8972(01)01425-6
   Sheeja D, 2001, DIAM RELAT MATER, V10, P1043, DOI 10.1016/S0925-9635(00)00413-1
   SNYDER TA, 2002, P SOC BIOM 28 ANN M, P8
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Tran HS, 1999, J INVEST SURG, V12, P133
   Weisenberg BA, 2002, J BIOMED MATER RES, V60, P283, DOI 10.1002/jbm.10076
   Wimmer MA, 2001, WEAR, V250, P129, DOI 10.1016/S0043-1648(01)00654-8
   Yamazaki K, 1998, ARTIF ORGANS, V22, P466, DOI 10.1046/j.1525-1594.1998.06156.x
   YANG Y, 1997, LINKOPING U MED DISS, V539
   Yang YQ, 1996, J HEART VALVE DIS, V5, P532
   Yu LJ, 2000, SURF COAT TECH, V128, P484, DOI 10.1016/S0257-8972(00)00626-5
NR 65
TC 437
Z9 460
U1 11
U2 195
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD MAR-JUL
PY 2003
VL 12
IS 3-7
BP 583
EP 589
DI 10.1016/S0925-9635(03)00081-5
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 678MX
UT WOS:000182872000068
DA 2018-10-20
ER

PT J
AU Pietrzak, WS
   Kumar, M
   Eppley, BL
AF Pietrzak, WS
   Kumar, M
   Eppley, BL
TI The influence of temperature on the degradation rate of LactoSorb
   copolymer
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE absorbable; polymer; hydrolysis; implant; temperature
ID BODY-TEMPERATURE; BIODEGRADABLE POLYMERS; CRANIOFACIAL SKELETON;
   INTERNAL-FIXATION; PLA-PGA; IN-VIVO; SURGERY; BONE; DEVICES; TISSUE
AB Heat is one of the fundamental forces that influence the rates of chemical reactions. The hydrolysis of an absorbable polymer is a function of many factors, both material-related and implant-site-related, including temperature. There is variance in temperature among patients as well as among various animals in which in vivo degradation studies are performed. This in vitro study investigated the influence of temperature on hydrolysis and found that a variance from 37degreesC to as little as 2degreesC can affect the rate of hydrolysis of a PGA/PLLA copolymer about 25-30%, with the rate increasing with increasing temperature. As most animals of biomedical interest have a body temperature on the order of 1-3degreesC greater than that of humans, it is possible that in vivo animal testing may be "worst case"; that is, strength loss may be accelerated in animals relative to that in human patients. Also, variation of body temperature within the human population may contribute to some variance in the rate of hydrolysis from person to person; however, other influences may minimize this effect and make it difficult to observe clinically.
C1 Indiana Univ, Sch Med, Div Plast Surg, Indianapolis, IN 46202 USA.
   Biomet Inc, Warsaw, IN USA.
RP Eppley, BL (reprint author), Indiana Univ, Sch Med, Div Plast Surg, 702 Barnhill Dr 3540, Indianapolis, IN 46202 USA.
CR ADAM K, 1989, EUR J APPL PHYSIOL O, V58, P471, DOI 10.1007/BF02330699
   Agrawal CM, 1997, TISSUE ENG, V3, P345, DOI 10.1089/ten.1997.3.345
   Ahn DK, 1997, PLAST RECONSTR SURG, V99, P1508, DOI 10.1097/00006534-199705000-00005
   AMECKE B, 1992, Clinical Materials, V10, P47, DOI 10.1016/0267-6605(92)90084-7
   An YHH, 1998, CLIN ORTHOP RELAT R, P300
   Ashammakhi N, 1997, BIOMATERIALS, V18, P3, DOI 10.1016/S0142-9612(96)00107-X
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   BHATIA S, 1994, J BIOMAT SCI-POLYM E, V6, P435
   BILLMEYER FW, 1971, TXB POLYM SCI, P87
   Cordewener FW, 2000, J BIOMED MATER RES, V50, P59, DOI 10.1002/(SICI)1097-4636(200004)50:1<59::AID-JBM9>3.0.CO;2-M
   DOMINGUEZ EA, 1991, FEVER BASIC MECHANIS, P71
   Edwards RC, 1999, J CRANIOFAC SURG, V10, P230, DOI 10.1097/00001665-199905000-00011
   Eppley BL, 1998, J CRANIOFAC SURG, V9, P317, DOI 10.1097/00001665-199807000-00005
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P116, DOI 10.1097/00001665-199703000-00010
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P103, DOI 10.1097/00001665-199703000-00008
   EPPLEY BL, 1995, J CRANIOFAC SURG, V6, P477, DOI 10.1097/00001665-199511000-00011
   ERIKSSON H, 1985, ACTA MED SCAND, V217, P347
   FRASER CM, 1991, MERCK VET MANUAL, P996
   Goldstein JA, 1997, J CRANIOFAC SURG, V8, P110, DOI 10.1097/00001665-199703000-00009
   Habal MB, 1997, J CRANIOFAC SURG, V8, P121, DOI 10.1097/00001665-199703000-00011
   Habal MB, 1999, J CRANIOFAC SURG, V10, P491, DOI 10.1097/00001665-199911000-00008
   HOWELL TH, 1975, GERONTOL CLIN, V17, P133, DOI 10.1159/000245569
   LANGKAMER VG, 1990, J BONE JOINT SURG BR, V72, P601
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   MORTIMER CE, 1971, CHEM CONCEPTUAL APPR, P487
   Orringer JS, 1998, J CRANIOFAC SURG, V9, P40, DOI 10.1097/00001665-199801000-00009
   Pietrzak WS, 1997, J BIOMED MATER RES, V38, P17
   Pietrzak WS, 1997, J CRANIOFAC SURG, V8, P87, DOI 10.1097/00001665-199703000-00004
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P335, DOI 10.1097/00001665-200011040-00011
   PIETRZAK WS, 2000, PRACTICAL GUIDE MECH, P581
   POSTLETHWAITE KR, 1990, BR J ORAL MAXILLOFAC, V28, P67
   Powers DL, 2001, J BIOMED MATER RES, V58, P486, DOI 10.1002/jbm.1045
   Rabinowitz RP, 1996, ARCH INTERN MED, V156, P777, DOI 10.1001/archinte.156.7.777
   ROSEN SL, 1971, FUNDAMENTAL PRINCIPL
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   Simon J A, 1997, Am J Orthop (Belle Mead NJ), V26, P665
   THOMAS KA, 1988, ORTHOPEDICS, V11, P441
   TONINO AJ, 1976, J BONE JOINT SURG BR, V58, P107
   van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3
   VILJANEN J, 1995, BIOMATERIALS, V16, P1353, DOI 10.1016/0142-9612(95)91052-Z
   VILJANEN VV, 1998, TECH ORTHOPAED, V13, P117
   WEST GP, 1988, BLACKS VET DICT, P619
   Xu RM, 1996, SPINE, V21, P871, DOI 10.1097/00007632-199604010-00020
NR 44
TC 30
Z9 32
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2003
VL 14
IS 2
BP 176
EP 183
DI 10.1097/00001665-200303000-00008
PG 8
WC Surgery
SC Surgery
GA 652UG
UT WOS:000181398600008
PM 12621287
DA 2018-10-20
ER

PT J
AU Garcia, C
   Galliano, P
   Cere, S
AF Garcia, C
   Galliano, P
   Cere, S
TI Electrochemical evaluation of resistance to localised corrosion of
   vitreous coatings containing particles applied on metallic substrates
   for biomedical applications
SO MATERIALS LETTERS
LA English
DT Article
DE corrosion; oxidation; sol-gel preparation; thin film
ID COBALT
AB CrCoMo alloys are generally known to be highly resistant to corrosion-induced failures and to spontaneously form passive oxide films when immersed in physiological environments. The stresses resulting from the use of the prosthesis can cause fracture and abrasion of the oxide film that covers the surface. This can result in crevice corrosion, with the corresponding decrease in pH leading to severe attack. Protective coatings deposited onto the metals would minimise the release of metallic ions from the substrate and the incorporation of bioactive particles would enable the adhesion to the bone tissue.
   This work describes the electrochemical behavior of CrCoMo alloys (F75) as cast, covered by a hybrid silica coating obtained by sol-gel. The silica sol-gel coating contains bioactive glass ceramic and vitreous particles of the system CaO-SiO2-P2O5 previously obtained by fusion, crystallization and milling. The performance of the alloy with and without coating is evaluated in simulated body fluid (SBF) pH 7.31 at 37 degreesC. As cobalt base alloys are susceptible to crevice attack, coated pieces are also tested in SBF acid solution (pH 0.7) in order to simulate the acidic media and the high chloride concentrations that develop when a crevice is formed. The electrochemical behavior has been evaluated by potenciodynamic polarization and electrochemical impedance spectroscopy. It was found that for both pH conditions the samples coated with double layer of glass ceramic particles showed lower passive current densities than those with monolayers. The coating improves the protection potential of the base material in the neutral solution. Besides, in the acidic solution, all the samples remain passive but the protection potential shifts to potentials more active than those measured in the neutral SBF. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Nacl Mar Del Plata, INTEMA, RA-7608 Mar Del Plata, Argentina.
   Univ Nacl Medellin, Medellin, Colombia.
RP Cere, S (reprint author), Univ Nacl Mar Del Plata, INTEMA, Juan B Justo 4302, RA-7608 Mar Del Plata, Argentina.
RI Garcia, Claudia/P-7860-2017; BAI, JIE/D-7448-2016
OI Garcia, Claudia/0000-0002-8241-9969; 
CR BARTOLOZZI A, 1985, BIOMATERIALS, V6, P2, DOI 10.1016/0142-9612(85)90030-4
   HAGINS H, 1988, J BONE JT SURG A, V71, P347
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Korb L. J., 1987, METALS HDB, V13
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   Li YS, 1999, J RAMAN SPECTROSC, V30, P97, DOI 10.1002/(SICI)1097-4555(199902)30:2<97::AID-JRS352>3.0.CO;2-X
   WOODMAN JL, 1983, J BIOMED MATER RES, V17, P655, DOI 10.1002/jbm.820170410
NR 9
TC 11
Z9 13
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD MAR
PY 2003
VL 57
IS 12
BP 1810
EP 1814
AR PII S0167-577X(02)01073-X
DI 10.1016/S0167-577X(02)01073-X
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 654AC
UT WOS:000181468500008
DA 2018-10-20
ER

PT J
AU Carter, S
   Michael, M
AF Carter, S
   Michael, M
TI Signifying across time and space: a case study of biomedical educational
   texts
SO SOCIOLOGY OF HEALTH & ILLNESS
LA English
DT Article
DE science and technology studies; sociology of science; public
   understanding of science; Medical Research Council; biomedical
   education; texts
ID PREVENTION; NETWORKS
AB This paper is an analysis of educational materials produced by the United Kingdom's Medical Research Council (MRC). While the MRC's Research Updates are designed to be used in the classroom, interviews with MRC contributors to the Updates and with teachers and students show that their function is complex. Drawing on these data, we point to three facets of biomedical texts that have been neglected. First, we note that these texts are meant to influence only a proportion of their target audience. Their impact is to set up a 'resonance' in this proportion of students, a resonance that will at some point in the future materialise as a choice to pursue a career in biomedical research. This is our second observation: that texts are designed to have a latent effect. These texts also address another audience - government bodies who demand that the MRC engage in educational and public understanding of science activities. As such, and this is our third observation, scientific texts can signify laterally, not to readers directly engaged with them, but to observers whose concern is with their trajectory.
C1 Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England.
   Univ London Goldsmiths Coll, Dept Sociol, London SE14 6NW, England.
RP Carter, S (reprint author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, Keppel St, London WC1E 7HT, England.
OI Carter, Simon/0000-0003-1838-3479
CR Adam B., 1990, TIME SOCIAL THEORY
   Adam B, 1998, TIMESCAPES MODERNITY
   [Anonymous], 1993, REALISING OUR POTENT
   Bowker G, 1999, SORTING THINGS OUT C
   CALLON M, 1994, SOCIOLOGY MONSTERS
   Callon M., 1986, MAPPING DYNAMICS SCI
   CLARKE A, 1993, SCI TECHNOL HUM VAL, V18, P42, DOI 10.1177/016224399301800104
   Clarke A., 1990, THEORIES SCI SOC
   Clarke AE, 1992, RIGHT TOOLS JOB WORK
   CLOITRE M, 1985, EXPOSITORY SCI FORMS
   DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301
   DAVISON C, 1992, SOC SCI MED, V34, P675, DOI 10.1016/0277-9536(92)90195-V
   Dugdale A., 1999, ACTOR NETWORK THEORY
   Fairclough N., 1992, DISCOURSE SOCIAL CHA
   Hooper E, 1997, BRIT MED J, V315, P1689, DOI 10.1136/bmj.315.7123.1689
   Lash S., 1998, TIME VALUE
   Latour B., 1990, REPRESENTATIONS SCI
   Latour B., 1987, SCI ACTION FOLLOW EN
   LATOUR B, 1995, COMMON KNOWLEDGE, V4, P142
   LAW J, 1992, SYST PRACTICE, V5, P379, DOI 10.1007/BF01059830
   LAW J, 2000, THIS NOT OBJECT
   LAW J, 1999, ACTOR NETWORK AFTER
   Law John, 1991, SOCIOLOGY MONSTERS
   Lynch M., 1990, REPRESENTATION SCI P
   Macnaghten P., 1998, CONTESTED NATURE
   MARTIN E, 1998, TECHNOLOGY HUMAN VAL, V23, P24
   *MED RES COUNC, 1995, ANN REP
   *MED RES COUNC, 1996, CORP PLAN
   *MED RES COUNC, 1994, ANN REP
   *MED RES COUNC, 1993, ANN REP
   *MED RES COUNC, 1995, SCI STRAT
   *MED RES COUNC, 1995, CORP PLAN
   Michael M, 1997, PUBLIC UNDERST SCI, V6, P1, DOI 10.1088/0963-6625/6/1/001
   Michael M, 2000, RECONNECTING CULTURE
   MICHAEL M, 2000, CONTESTED FUTURES
   Michael M., 1996, CONSTRUCTING IDENTIT
   MICHAEL M, 2001, SCI CULTURE, V10, P5
   MOL A, 1994, SOC STUD SCI, V24, P641, DOI 10.1177/030631279402400402
   Myers G., 1990, WRITING BIOL TEXTS S
   NICHOLL DST, 1994, INTRO GENETIC ENG
   PERROW C, 1984, NORMAL ACCIDENTS LIV
   Potter J., 1987, DISCOURSE SOCIAL PSY
   Power M., 1999, AUDIT SOC RITUALS VE
   *ROYAL SOC LOND, 1985, PUBL UND SCI
   SINGLETON V, 1993, SOC STUD SCI, V23, P227, DOI 10.1177/030631293023002001
   STAR SL, 1989, SOC STUD SCI, V19, P387, DOI 10.1177/030631289019003001
   Strathern Marilyn, 1991, PARTIAL CONNECTIONS
   Williams Raymond, 1977, MARXISM LIT
   Wynne B., 1995, HDB SCI TECHNOLOGY S
NR 49
TC 2
Z9 2
U1 0
U2 1
PU BLACKWELL PUBL LTD
PI OXFORD
PA 108 COWLEY RD, OXFORD OX4 1JF, OXON, ENGLAND
SN 0141-9889
J9 SOCIOL HEALTH ILL
JI Sociol. Health Ill.
PD MAR
PY 2003
VL 25
IS 2
BP 232
EP 259
DI 10.1111/1467-9566.00333
PG 28
WC Public, Environmental & Occupational Health; Social Sciences,
   Biomedical; Sociology
SC Public, Environmental & Occupational Health; Biomedical Social Sciences;
   Sociology
GA 683GV
UT WOS:000183140800005
PM 14498941
OA Bronze
DA 2018-10-20
ER

PT J
AU Metikos-Hukovic, M
   Tkalcec, E
   Kwokal, A
   Piljac, J
AF Metikos-Hukovic, M
   Tkalcec, E
   Kwokal, A
   Piljac, J
TI An in vitro study of Ti and Ti-alloys coated with sol-gel derived
   hydroxyapatite coatings
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE impedance spectroscopy; x-ray diffraction; sol-gel; slurry; titanium;
   titanium alloy; coatings for biomedical applications
ID CALCIUM-PHOSPHATE COATINGS; IMPLANT MATERIALS; IMPEDANCE SPECTROSCOPY;
   CORROSION BEHAVIOR; AQUEOUS-SOLUTIONS; SURFACE-ANALYSIS; TITANIUM;
   TI6AL4V; FILMS; BIOMATERIALS
AB Electrochemical-corrosion properties of Ti, Ti6Al6Nb and Ti6Al4V implant materials coated with calcium phosphate (CaP) coatings were investigated in vitro at the open circuit potential using non-destructive electrochemical impedance spectroscopy (EIS) technique in simulated physiological-Hank's Balanced Salt Solution (HBSS). Characterization of the structure and composition of CaP coatings obtained by the sol-gel method was performed using X-ray diffraction analysis. The interpretation of the EIS results was based upon a two-layer model of the surface film consisting of an inner barrier TiO2 (CaTiO3) layer and the outer porous hydroxyapatite (HAP) + beta-tricalcium phosphate (beta-TCP) layer, described by using the high frequency time constant (tau(1)(HF)) and the low frequency time constant (tau(2)(LF)) respectively Spontaneously passivated surfaces of naturally grown surface films on all three substrates in HBSS were used for reference. The chemical composition of the substrate as well as the composition and crystallinity of the CaP coating have a direct influence on electrochemical-corrosion properties of the implant materials under in vitro conditions. Well-crystallized HAP and beta-TCP exhibited a beneficial corrosion protection effect on the substrate during prolonged exposure to HBSS. In the case of poorly crystallized coatings containing a greater amount of carbonate incorporated in the structure of HAP. the total impedance of the system markedly changed with prolonged exposure to physiological solution due to degradation of the coating (C) 2002 Elsevier Science B.V All rights reserved.
C1 Univ Zagreb, Fac Chem Engn & Technol, Dept Electrochem, Zagreb 10000, Croatia.
   Inst Neue Mat, D-66123 Saarbrucken, Germany.
RP Metikos-Hukovic, M (reprint author), Univ Zagreb, Fac Chem Engn & Technol, Dept Electrochem, POB 177, Zagreb 10000, Croatia.
CR AHMED SM, 1972, OXIDES OCIDE FILMS, V1, P380
   AlKharafi FM, 1997, ELECTROCHIM ACTA, V42, P579, DOI 10.1016/S0013-4686(96)00202-2
   ASK M, 1988, APPL SURF SCI, V35, P283
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   BODDY PJ, 1968, ELECTROCHIM ACTA, V13, P1311, DOI 10.1016/0013-4686(68)80059-3
   Born R, 1998, FRESEN J ANAL CHEM, V361, P697, DOI 10.1007/s002160050997
   BOUKAMP BA, 1986, SOLID STATE IONICS, V20, P31, DOI 10.1016/0167-2738(86)90031-7
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   BUNDY KJ, 1993, BIOMATERIALS, V14, P529, DOI 10.1016/0142-9612(93)90242-T
   Campbell AA, 1996, J BIOMED MATER RES, V32, P111, DOI 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P
   Casaletto MP, 2001, APPL SURF SCI, V172, P167, DOI 10.1016/S0169-4332(00)00844-8
   CIRILLI F, 1997, P ECASIA 97 WIL CHIC
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   COOK SD, 1988, CLIN ORTHOP RELAT R, P303
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   DIQUARTO F, 1990, ELECTROCHIM ACTA, V35, P99, DOI 10.1016/0013-4686(90)85045-O
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P531
   Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4
   FOX WC, 1993, J BIOMED MATER RES, V27, P763
   Frauchiger L, 1997, APPL SURF SCI, V115, P232, DOI 10.1016/S0169-4332(96)01019-7
   FUJISHIRO Y, 1995, J MATER SCI-MATER M, V6, P172, DOI 10.1007/BF00120295
   Gross KA, 1998, J MATER SCI-MATER M, V9, P839, DOI 10.1023/A:1008948228880
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   HURLEN T, 1987, ELECTROCHIM ACTA, V32, P1613, DOI 10.1016/0013-4686(87)90014-4
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1977, J BIOENG, V1, P79
   JOHANSEN HA, 1957, J ELECTROCHEM SOC, V104, P339, DOI 10.1149/1.2428577
   JOHNSON D, 1997, ZVIEW SOFTWARE
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   KEIL RG, 1971, ELECTROCHEM SCI, V118, P864
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   Leitao E, 1995, J MATER SCI-MATER M, V6, P849, DOI 10.1007/BF00134330
   LOHRENGEL MM, 1993, MAT SCI ENG R, V11, P243, DOI 10.1016/0927-796X(93)90005-N
   MAGDA A, 1995, ELECTROCHEM SOC, V142, P4082
   MARINOVIC A, 2001, P CROAT SOC CHEM CHE, V2, P123
   MARINOVIC A, 2001, CROAT S EL P CROAT S
   Modestov AD, 1999, J ELECTROANAL CHEM, V460, P214, DOI 10.1016/S0022-0728(98)00378-7
   Piazza S, 1998, CORROS SCI, V40, P1087, DOI 10.1016/S0010-938X(98)00009-2
   PRIVMAN M, 1995, J ELECTROANAL CHEM, V382, P137, DOI 10.1016/0022-0728(94)03633-E
   Silva R., 1990, British Corrosion Journal, V25, P136
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Sittig C, 1999, J MATER SCI-MATER M, V10, P191, DOI 10.1023/A:1008997726370
   SODHI RNS, 1991, J VAC SCI TECHNOL A, V9, P1329, DOI 10.1116/1.577621
   Tkalcec E, 2001, J MATER SCI, V36, P5253, DOI 10.1023/A:1012462332440
   TORISSI L, 1993, APPL PHYS LETT, V62, P237
   WALENKAMP GHI, 1998, BIOMATERIALS SURG
   Wataha JC, 1996, J ORAL REHABIL, V23, P79, DOI 10.1111/j.1365-2842.1996.tb01214.x
   Wen HB, 1997, J MATER SCI-MATER M, V8, P765, DOI 10.1023/A:1018512612695
   Weng WJ, 1999, J AM CERAM SOC, V82, P27
   WIELAND M, 1997, P ECASIA 97
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI
   YU SY, 2001, J ELECTROCHEM SOC, V48, pB68
NR 56
TC 121
Z9 124
U1 3
U2 49
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB 3
PY 2003
VL 165
IS 1
BP 40
EP 50
AR PII S0257-8972(02)00732-6
DI 10.1016/S0257-8972(02)00732-6
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 633QL
UT WOS:000180293900005
DA 2018-10-20
ER

PT J
AU Altman, GH
   Diaz, F
   Jakuba, C
   Calabro, T
   Horan, RL
   Chen, JS
   Lu, H
   Richmond, J
   Kaplan, DL
AF Altman, GH
   Diaz, F
   Jakuba, C
   Calabro, T
   Horan, RL
   Chen, JS
   Lu, H
   Richmond, J
   Kaplan, DL
TI Silk-based biomaterials
SO BIOMATERIALS
LA English
DT Article
DE silk; sericin; fibroin; foreign body response; suture; tissue
   engineering; biomaterial; scaffold
ID GENETICALLY-ENGINEERED SILK; SPIDER SILK; SUTURE MATERIALS; BOMBYX-MORI;
   DRAGLINE SILK; MECHANICAL-PROPERTIES; NEPHILA-CLAVIPES; FIBROIN;
   PROTEINS; GENE
AB Silk from the silkworm, Bombyx mori, has been used as biomedical suture material for centuries. The unique mechanical properties of these fibers provided important clinical repair options for many applications. During the past 20 years, some biocompatibility problems have been reported for silkworm silk; however, contamination from residual sericin (glue-like proteins) was the likely cause. More recent studies with well-defined silkworm silk fibers and films suggest that the core silk fibroin fibers exhibit comparable biocompatibility in vitro and in vivo with other commonly used biomaterials such as polylactic acid and collagen. Furthermore, the unique mechanical properties of the silk fibers, the diversity of side chain chemistries for 'decoration' with growth and adhesion factors, and the ability to genetically tailor the protein provide additional rationale for the exploration of this family of fibrous proteins for biomaterial applications. For example, in designing scaffolds for tissue engineering these properties are particularly relevant and recent results with bone and ligament formation in vitro support the potential role for this biomaterial in future applications. To date, studies with silks to address biomaterial and matrix scaffold needs have focused on silkworm silk. With the diversity of silk-like fibrous proteins from spiders and insects, a range of native or bioengineered variants can be expected for application to a diverse set of clinical needs. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Tufts Univ, Ctr Bioengn, Dept Biol & Chem Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Ctr Bioengn, Dept Biol & Chem Engn, 4 Colby St, Medford, MA 02155 USA.
FU NIDCR NIH HHS [R01 DE13405-01]; NIAMS NIH HHS [R01 AR46563-01]
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ALTMAN GH, 2001, FASEB J, V16, P270
   ALTMAN GH, 2001, FASEB J, V10, P1096
   Anderson James M., 1996, P165
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asakura T, 1997, BIOPOLYMERS, V41, P193, DOI 10.1002/(SICI)1097-0282(199702)41:2<193::AID-BIP6>3.0.CO;2-O
   BUCKNALL TE, 1983, EUR SURG RES, V15, P59, DOI 10.1159/000128334
   CAPPELLO J, 1990, TRENDS BIOTECHNOL, V8, P309, DOI 10.1016/0167-7799(90)90207-E
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   DAHLKE H, 1980, J BIOMED MATER RES, V14, P251, DOI 10.1002/jbm.820140307
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   Dunn MG, 1997, J APPL POLYM SCI, V63, P1423, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1423::AID-APP4>3.0.CO;2-O
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   *ETH INC, 2000, WOUND CLOS MAN SUT S, pCH2
   Foschi D, 2001, EUR SURG RES, V33, P16, DOI 10.1159/000049687
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   HOLLANDER DH, 1994, MED HYPOTHESES, V43, P155, DOI 10.1016/0306-9877(94)90142-2
   Hood EE, 1999, CURR OPIN BIOTECH, V10, P382, DOI 10.1016/S0958-1669(99)80069-X
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   JIN HJ, IN PRESS BIOMACROMOL
   KADLER KE, 1995, PROTEIN PROFILES EXT, V1
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   KAPLAN DL, 1992, MATER RES SOC S P, V255, P19
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Kourie JI, 2000, AM J PHYSIOL-CELL PH, V278, pC1063
   Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x
   Kurosaki S, 1999, Nihon Ika Daigaku Zasshi, V66, P41, DOI 10.1272/jnms.66.41
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MORROW FA, 1974, J UROLOGY, V112, P655, DOI 10.1016/S0022-5347(17)59821-3
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Moynihan BGA, 1920, BRIT J SURG, V8, P27, DOI 10.1002/bjs.1800082906
   NEBEL L, 1977, EUR SURG RES, V9, P224, DOI 10.1159/000127941
   PELEG H, 1986, J THORAC CARDIOVASC, V34, P384
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   POSTLETHWAIT RW, 1962, ARCH SURG-CHICAGO, V84, P698
   POSTLETHWAIT RW, 1970, ANN SURG, V171, P892, DOI 10.1097/00000658-197006010-00010
   Postlethwait RW, 1969, REPAIR REGENERATION, P263
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   SALTHOUSE TN, 1977, AM J OPHTHALMOL, V84, P224, DOI 10.1016/0002-9394(77)90856-X
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Setzen G, 1997, PLAST RECONSTR SURG, V100, P1788, DOI 10.1097/00006534-199712000-00023
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   Winkler S., 2000, REV MOL BIOTECHNOL, V74, P85
   Wong PC, 1996, THROMB RES, V83, P117, DOI 10.1016/0049-3848(96)00112-0
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
   Zarkoob S, 1998, POLYM PREPR, V39, P244
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 72
TC 1859
Z9 1976
U1 75
U2 1102
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2003
VL 24
IS 3
BP 401
EP 416
AR PII S0142-9612(02)00353-8
DI 10.1016/S0142-9612(02)00353-8
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 617VV
UT WOS:000179382300004
PM 12423595
DA 2018-10-20
ER

PT J
AU Grill, A
AF Grill, A
TI Diamond-like carbon coatings as biocompatible materials - an overview
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 4th Specialist Meeting on Amorphous Carbon (SMAC 2002)
CY SEP 05-06, 2002
CL UNIV BARCELONA, DEPT APPL PHYS & OPT, BARCELONA, SPAIN
HO UNIV BARCELONA, DEPT APPL PHYS & OPT
DE diamond-like carbon; tetrahedral carbon; biomedical applications
ID A-C-H; IN-VITRO; SURFACE-ANALYSIS; ORTHOPEDIC APPLICATIONS;
   AMORPHOUS-CARBON; FILMS; BIOREACTIONS; MACROPHAGES; ACTIVATION;
   INTERFACE
AB Amorphous hydrogenated diamond-like carbon (DLC) and tetrahedral carbon (taC) films are characterized by high wear resistance, low friction coefficients and chemical inertness, thus high-corrosion resistance. The properties of DLC and taC can further be modified by incorporating other elements in the films, such as N, F, Si and metals, thus tailoring them for specific applications. The films can be deposited as conformal, very smooth layers. These properties make the films good candidates as biocompatible coatings for biomedical devices and tools. The paper presents on overview of the biomedical characteristics of different varieties of amorphous carbon and their potential applications. (C) 2003 Elsevier Science B.V All rights reserved.
C1 IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.
RP Grill, A (reprint author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.
CR Affatato S, 2000, J BIOMED MATER RES, V53, P221, DOI 10.1002/(SICI)1097-4636(2000)53:3<221::AID-JBM6>3.0.CO;2-Z
   AHLROOS T, 2001, ACTA POLYTECH SCAND, V153, P2
   Alanazi A, 2000, ASAIO J, V46, P440, DOI 10.1097/00002480-200007000-00014
   Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   Butter R.S., 1995, NIST SPECIAL PUBLICA, P683
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   Elinson VM, 1999, DIAM RELAT MATER, V8, P2103, DOI 10.1016/S0925-9635(99)00177-6
   Evans EA, 2000, MATER RES SOC SYMP P, V593, P433
   Firkins P, 1998, J MATER SCI-MATER M, V9, P597, DOI 10.1023/A:1008917727604
   Francz G, 1999, SURF INTERFACE ANAL, V28, P3, DOI 10.1002/(SICI)1096-9918(199908)28:1<3::AID-SIA609>3.0.CO;2-U
   GRILL A, 1988, J MATER RES, V3, P214, DOI 10.1557/JMR.1988.0214
   GRILL A, 1994, SYNTHETIC DIAMOND EM, pCH5
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   Gutensohn K, 2000, INFUS THER TRANSFUS, V27, P200
   Hauert R, 1997, THIN SOLID FILMS, V308, P191, DOI 10.1016/S0040-6090(97)00422-7
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.3.CO;2-N
   Isaac G H, 1987, Eng Med, V16, P167
   JACOBS TL, 1995, NIST SPECIAL PUBLICA, P753
   Li DJ, 2001, APPL SURF SCI, V180, P270, DOI 10.1016/S0169-4332(01)00356-7
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   Scholes SC, 2000, PHYS MED BIOL, V45, P3721, DOI 10.1088/0031-9155/45/12/315
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Xu T, 1999, J MATER SCI-MATER M, V10, P83, DOI 10.1023/A:1008916903171
   Yu LJ, 2000, SURF COAT TECH, V128, P484, DOI 10.1016/S0257-8972(00)00626-5
   Zolynski K., 1996, Journal of Chemical Vapor Deposition, V4, P232
NR 33
TC 293
Z9 302
U1 2
U2 76
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD FEB
PY 2003
VL 12
IS 2
BP 166
EP 170
AR PII S0925-9635(03)00018-9
DI 10.1016/S0925-9635(03)00018-9
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 668UV
UT WOS:000182312300014
DA 2018-10-20
ER

PT J
AU Mano, JF
   Koniarova, D
   Reis, RL
AF Mano, JF
   Koniarova, D
   Reis, RL
TI Thermal properties of thermoplastic starch/synthetic polymer blends with
   potential biomedical applicability
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; THERMOGRAVIMETRIC ANALYSIS; STARCH BLENDS;
   PROCESSING CONDITIONS; MECHANICAL-PROPERTIES; BIODEGRADABLE BLENDS;
   DEGRADATION BEHAVIOR; CELLULOSE-ACETATE; GLASS-TRANSITION; COMPOSITES
AB Previous studies shown that thermoplastic blends of corn starch with some biodegradable synthetic polymers (poly(e-caprolactone), cellulose acetate, poly(lactic acid) and ethylene-vinyl alcohol copolymer) have good potential to be used in a series of biomedical applications. In this work the thermal behavior of these structurally complex materials is investigated by differential scanning calorimetry (DSC) and by thermogravimetric analysis (TGA). In addition, Fourier-transform infrared (FTIR) spectroscopy was used to investigate the chemical interactions between the different components. The endothermic gelatinization process (or water evaporation) observed by DSC in starch is also observed in the blends. Special attention was paid to the structural relaxation that can occur in the blends with poly(lactic acid) at body temperature that may change the physical properties of the material during its application as a biomaterial. At least three degradation mechanisms were identified in the blends by means of using TGA, being assigned to the mass loss due to the plasticizer leaching, and to the degradation of the starch and the synthetic polymer fractions. The non-isothermal kinetics of the decomposition processes was analyzed using two different integral methods. The analysis included the calculation of the activation energy of the correspondent reactions. (C) 2003 Kluwer Academic Publishers.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4710057 Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Mano,
   Joao/0000-0002-2342-3765; Harvanova, Denisa/0000-0002-3038-7520
CR Aggarwal P, 1997, THERMOCHIM ACTA, V291, P65, DOI 10.1016/S0040-6031(96)03103-6
   Alves NM, 2002, POLYMER, V43, P4111, DOI 10.1016/S0032-3861(02)00236-7
   BAGFEY EB, 1977, POLYM ENG SCI, V17, P311
   BROIDO A, 1969, J POLYM SCI A2, V7, P1761, DOI 10.1002/pol.1969.160071012
   Day M, 1998, J THERM ANAL CALORIM, V52, P261, DOI 10.1023/A:1010195105547
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   FANTA GF, 1978, STARKE, V30, P237, DOI 10.1002/star.19780300706
   FANTA GF, 1992, J APPL POLYM SCI, V44, P2037, DOI 10.1002/app.1992.070441119
   Gedde U. W., 1995, POLYM PHYS
   GEORGE ER, 1994, POLYM ENG SCI, V34, P17, DOI 10.1002/pen.760340107
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Griffin GJL, 1974, ACS ADV CHEM SER, V134, P159
   Hanna AA, 1998, ANGEW MAKROMOL CHEM, V260, P1
   HATAKEYAMA T, 1994, THERMAL ANALYSIS FUN
   HOROWITZ HH, 1963, ANAL CHEM, V35, P1465
   Huang SJ, 1993, BIODEGRADABLE POLYM, P97
   Jacobsen S, 1996, POLYM ENG SCI, V36, P2799, DOI 10.1002/pen.10680
   Khalil AH, 2000, FOOD CHEM, V68, P61, DOI 10.1016/S0308-8146(99)00156-9
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Kweon DK, 2000, J APPL POLYM SCI, V78, P986, DOI 10.1002/1097-4628(20001031)78:5<986::AID-APP70>3.0.CO;2-T
   LENK RS, 1981, POLYMER, V21, P371
   LEONOR IB, 2002, J MATER SCI-MATER M, V13, P1
   LEONOR IB, 2002, IN PRESS BIOMATERIAL
   Liao KR, 2002, EUR POLYM J, V38, P157, DOI 10.1016/S0014-3057(01)00166-5
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   MANO JF, 2002, NATO SCI SER POLYMER
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   OTEY FH, 1974, IND ENG CHEM PROD RD, V13, P90, DOI 10.1021/i360049a018
   Park JW, 2000, POLYM ENG SCI, V40, P2539, DOI 10.1002/pen.11384
   PATIL DR, 1994, STARCH-STARKE, V46, P142, DOI 10.1002/star.19940460405
   PEANASKY JS, 1991, J POLYM SCI POL PHYS, V29, P565, DOI 10.1002/polb.1991.090290506
   Qu X, 2000, POLYMER, V41, P4841, DOI 10.1016/S0032-3861(99)00704-1
   Raghavan D, 2001, POLYM DEGRAD STABIL, V72, P509, DOI 10.1016/S0141-3910(01)00054-4
   Rao RV, 2000, POLYM DEGRAD STABIL, V70, P11
   Reis R., 2001, ENCY MAT SCI TECHNOL, P8810
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Soliman AAA, 1997, THERMOCHIM ACTA, V296, P149, DOI 10.1016/S0040-6031(97)00040-3
   SOUSA FS, 2001, J THERM ANAL CALORIM, V64, P739
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   Swanson CL, 1993, J ENVIRON POLYM DEGR, V1, P155
   TIKUISIS T, 1993, POLYM ENG SCI, V33, P26, DOI 10.1002/pen.760330104
   Tokiwa Y, 1990, POLYM MATER SCI ENG, V63, P742
   Vaz CM, 2001, MATER RES INNOV, V4, P375, DOI 10.1007/s100190000112
   Vega D, 1996, POLYM BULL, V37, P229, DOI 10.1007/BF00294126
   Whistler R.L., 1984, STARCH CHEMISTRY TEC
   Yang ZH, 1996, POLYMER, V37, P2137, DOI 10.1016/0032-3861(96)85859-9
   ZHANG X, 2002, P 7 WORLD C BIODEGRA, P131
NR 50
TC 224
Z9 230
U1 7
U2 79
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2003
VL 14
IS 2
BP 127
EP 135
DI 10.1023/A:1022015712170
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 635HE
UT WOS:000180392800006
PM 15348484
DA 2018-10-20
ER

PT J
AU Cho, CS
   Park, IK
   Nah, JW
   Akaike, T
AF Cho, CS
   Park, IK
   Nah, JW
   Akaike, T
TI Preparation of polymeric self-assembly and its application to
   biomaterials
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE self-assembly; Langmuir-Blodgett films; polymeric micelle; polymeric
   nanoparticles; induced circular dichroism
ID LANGMUIR-BLODGETT-FILMS; INDUCED CIRCULAR-DICHROISM; BLOCK-COPOLYMER;
   POLY(GAMMA-BENZYL L-GLUTAMATE); POLY(ETHYLENE OXIDE); NANOPARTICLES;
   ADHESION; ORIENTATION; MICELLES; POLY(N-ISOPROPYLACRYLAMIDE)
AB The self-assembly of polymers can lead to supramolecular systems and is related to the their functions of material and life sciences. In this article, self-assembly of Langmuir-Blodgett (LB) films, polymer micelles, and polymeric nanoparticles, and their biomedical applications are described. LB surfaces with a well-ordered and layered structure adhered more cells including platelet, hepatocyte, and fibroblast than the cast surfaces with microphase-separated domains. Extensive morphologic changes were observed in LB surface-adhered cells compared to the cast films. Amphiphilic block copolymers, consisting of poly(gamma-benzyl L-glutamate) (PBLG) as the hydrophobic part and poly(ethylene oxide) (PEO) [or poly(N-isopropylacrylamide) (PNIPAAm)] as the hydrophilic one, can self-assemble in water to form nanoparticles presumed to be composed of the hydrophilic shell and hydrophobic core. The release characteristics of hydrophobic drugs from these polymeric nanoparticles were dependent on the drug loading contents and chain length of the hydrophobic part of the copolymers. Achiral hydrophobic merocyanine dyes (MDs) were self-assembled in copolymeric nanoparticles, which provided a chiral microenvironment as red-shifted aggregates, and the circular dichroism (CD) of MD was induced in the self-assembled copolymeric nanoparticles.
C1 Seoul Natl Univ, Sch Agr Biotechnol, Suwon 441744, South Korea.
   Sunchon Natl Univ, Dept Polymer Sci & Engn, Sunchon 540742, South Korea.
   Tokyo Inst Technol, Dept Biomol Engn, Yokohama, Kanagawa 2268501, Japan.
RP Cho, CS (reprint author), Seoul Natl Univ, Sch Agr Biotechnol, Suwon 441744, South Korea.
EM chocs@plaza.snu.ac.kr
CR Blodgett KB, 1935, J AM CHEM SOC, V57, P1007, DOI 10.1021/ja01309a011
   Cheon JB, 1998, KOREA POLYM J, V6, P34
   CHO CS, 1990, MAKROMOL CHEM, V191, P981
   Cho CS, 1996, J BIOMED MATER RES, V32, P425, DOI 10.1002/(SICI)1097-4636(199611)32:3<425::AID-JBM16>3.0.CO;2-F
   CHO CS, 1995, THIN SOLID FILMS, V264, P82, DOI 10.1016/0040-6090(95)06506-7
   Cho CS, 1997, MACROMOL RAPID COMM, V18, P361, DOI 10.1002/marc.1997.030180502
   CHO CS, 1990, J BIOMED MATER RES, V24, P1369, DOI 10.1002/jbm.820241008
   CHO CS, 1990, J COLLOID INTERF SCI, V137, P292
   CHO CS, 1993, J BIOMED MATER RES, V27, P199, DOI 10.1002/jbm.820270209
   Cho CS, 1996, J BIOMAT SCI-POLYM E, V7, P1097, DOI 10.1163/156856296X00589
   CHO CS, 1990, J POLYM SCI POL LETT, V28, P89, DOI 10.1002/pol.1990.140280303
   Chung TW, 2000, MACROMOLECULES, V33, P8921, DOI 10.1021/ma000480e
   Chung TW, 2000, POLYMER, V41, P6415, DOI 10.1016/S0032-3861(00)00021-5
   GOUPIL DW, 1977, J COLLOID INTERF SCI, V62, P142, DOI 10.1016/0021-9797(77)90075-3
   Higuchi A, 2000, J BIOMAT SCI-POLYM E, V11, P149, DOI 10.1163/156856200743625
   Hirano Y, 1998, THIN SOLID FILMS, V327, P345, DOI 10.1016/S0040-6090(98)00666-X
   IZZO D, 1993, MACROMOLECULES, V26, P7189, DOI 10.1021/ma00078a012
   Jeong YI, 1998, J CONTROL RELEASE, V51, P169, DOI 10.1016/S0168-3659(97)00163-6
   Jeong YI, 1999, INT J PHARM, V188, P49, DOI 10.1016/S0378-5173(99)00202-1
   KATAOKA K, 1993, J CONTROL RELEASE, V24, P119
   KOBAYASHI A, 1994, J BIOMAT SCI-POLYM E, V6, P325, DOI 10.1163/156856295X00030
   KOBAYASHI A, 1992, J BIOMAT SCI-POLYM E, V3, P499, DOI 10.1163/156856292X00466
   KUHN H, 1973, TECHNIQUES CHEM 3B, V1
   KUNITAKE T, 1992, ANGEW CHEM INT EDIT, V31, P709, DOI 10.1002/anie.199207091
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   NAGARAJAN R, 1989, J CHEM PHYS, V90, P5843, DOI 10.1063/1.456390
   OKANO T, 1981, ARTIF ORGANS S, V5, P468
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010
   ZHONG XF, 1992, MACROMOLECULES, V25, P7160, DOI 10.1021/ma00052a014
NR 31
TC 10
Z9 10
U1 0
U2 10
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD FEB
PY 2003
VL 11
IS 1
BP 2
EP 8
DI 10.1007/BF03218270
PG 7
WC Polymer Science
SC Polymer Science
GA 658PW
UT WOS:000181730200001
DA 2018-10-20
ER

PT J
AU Kumar, CV
   Chaudhari, A
AF Kumar, CV
   Chaudhari, A
TI Unusual thermal stabilities of some proteins and enzymes bound in the
   galleries of layered alpha-Zr(IV)phosphate/phosphonates
SO MICROPOROUS AND MESOPOROUS MATERIALS
LA English
DT Article
DE enzyme binding; alpha-Zr(IV)phosphate; alpha-Zr(IV)phosphonates; thermal
   stability
ID ALPHA-ZIRCONIUM PHOSPHATE; GLUCOSE-OXIDASE; CYTOCHROME-C; FLUORESCENCE;
   PEROXIDASE; HEMOGLOBIN; LYSOZYME; DYNAMICS
AB Significant improvements in the thermal stabilities of proteins and enzymes (increase in denaturation temperatures as large as 33 degreesC) bound in the galleries of crystalline alpha-Zr(IV) phosphate (alpha-Zr(PO4)(2) . H2O, abbreviated as alpha-ZrP) and alpha-Zr(IV) phosphonates (alpha-Zr(RPO3)(2) . H2O, R=CH2COOH, CH2CH2COOH, abbreviated as ZrCMP, and ZrCEP, respectively) are demonstrated, in specific cases. The thermal stabilities are monitored using attenuated total reflection Fourier transform infrared spectroscopy (ATR FTIR), powder X-ray diffraction, absorption, and fluorescence methods. The amide I and amide II vibrational bands of the protein/inorganic materials are monitored in ATR FTIR studies, as a function of temperature, and these indicated sharp shifts in the band positions at specific temperatures. These shifts served as markers for protein denaturation. The denaturation temperatures of met hemoglobin/alpha-ZrP, glucose oxidase/alpha-ZrRP (R=OH, CH2CH2COOH), and Cytochrome c/alpha-ZrRP (R=OH, CH2CH2COOH), for example, are >95, 55, 65, 100, and 75 degreesC, respectively. These values are greater than the denaturation temperatures of the corresponding free proteins in the solid state (70, 50, and 67 degreesC, respectively). Proteins bound to alpha-ZrP, and alpha-ZrCEP, in general, indicated stabilities that are greater than or comparable to those of the free proteins, while binding to alpha-ZrCMP resulted in diminished stabilities except in case of Hb. The interactions of the surface functions of the solid matrix with the bound protein, therefore, are crucial in determining the bound protein stability. The improved stabilities observed in specific cases are welcome changes for applications of these materials in biocatalysis, biosensors, and biomedical devices. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Univ Connecticut, Dept Chem, Storrs, CT 06269 USA.
RP Kumar, CV (reprint author), Univ Connecticut, Dept Chem, U-60, Storrs, CT 06269 USA.
OI Kumar, Challa/0000-0002-8399-1334
CR Adams S, 2002, LANGMUIR, V18, P4854, DOI 10.1021/la0112413
   ALBERTI G, 1982, INTERCALATION CHEM
   ALBERTI G, 1990, INORG CHEM, V29, P2112
   Blanch EW, 2000, BIOPOLYMERS, V57, P235, DOI 10.1002/1097-0282(2000)57:4<235::AID-BIP5>3.0.CO;2-H
   Brand L, 1967, METHOD ENZYMOL, V11, P776
   BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   CANTOR C, 1980, BIOPHYSICAL CHEM, P11
   CHAGA GS, 2001, J BIOSCI BIOENG, V91, P233
   CHAUDHARI A, 2001, THESIS U CONNECTICUT
   CLEARFIELD A, 1969, INORG CHEM, V8, P431, DOI 10.1021/ic50073a005
   CLEARFIELD A, 1964, J INORG NUCL CHEM, V26, P117, DOI 10.1016/0022-1902(64)80238-4
   DINES MB, 1981, INORG CHEM, V20, P92, DOI 10.1021/ic50215a022
   Duarte IF, 2002, J AGR FOOD CHEM, V50, P3104, DOI 10.1021/jf011575y
   EFTINK MR, 1975, P NATL ACAD SCI USA, V72, P3290, DOI 10.1073/pnas.72.9.3290
   ETFTINK MR, 1981, ANAL BIOCHEM, V114, P199
   FLATMARK T, 1966, ACTA CHEM SCAND, V20, P1476, DOI 10.3891/acta.chem.scand.20-1476
   Freitag R., 1996, BIOSENSORS ANAL BIOT
   GUPTA MN, 1993, THERMOSTABILITY ENZY, P124
   Haouz A, 2001, FEBS LETT, V506, P216, DOI 10.1016/S0014-5793(01)02917-9
   HAOUZ A, 1998, CHEM PHYS LETT, V294, P19
   Horbett TA, 1995, ACS S SERIES, V602
   KEILIN D, 1951, BIOCHEM J, V49, P88, DOI 10.1042/bj0490088
   KELILIN D, 1937, P R SOC LONDON B, V122, P119
   KHECHINASHVILI NN, 1973, FEBS LETT, V30, P57, DOI 10.1016/0014-5793(73)80618-0
   Kumar C, 2001, MICROPOR MESOPOR MAT, V47, P407, DOI 10.1016/S1387-1811(01)00313-4
   Kumar CV, 1997, CHEM MATER, V9, P863, DOI 10.1021/cm960634y
   Kumar CV, 2001, CHEM MATER, V13, P238, DOI 10.1021/cm0007398
   Kumar CV, 2000, J AM CHEM SOC, V122, P830, DOI 10.1021/ja993310u
   LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4171, DOI 10.1021/bi00745a021
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 2000, PROTEIN ARCHITECTURA
   LVOV Y, 2000, PROTEIN ARCHITECTURE
   MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570
   NIVA S, 1994, ANIM SCI TECHNOL, V65, P668
   Niwa Shinji, 1994, Animal Science and Technology, V65, P668
   Panchagnula V, 2002, J AM CHEM SOC, V124, P12515, DOI 10.1021/ja020683d
   Rosevear A., 1987, IMMOBILIZED ENZYMES
   Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711
   SUSI H, 1986, METHOD ENZYMOL, V130, P290
   Theorell H, 1941, J AM CHEM SOC, V63, P1812, DOI 10.1021/ja01852a006
   Torii Hajime, 1996, P1
   Uchiyama S, 2002, PROTEIN ENG, V15, P455, DOI 10.1093/protein/15.6.455
   Wan LL, 1998, P NATL ACAD SCI USA, V95, P12825, DOI 10.1073/pnas.95.22.12825
   WINTERHALTER KH, 1971, BIOCHEMISTRY-US, V10, P621, DOI 10.1021/bi00780a012
NR 45
TC 34
Z9 34
U1 3
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-1811
J9 MICROPOR MESOPOR MAT
JI Microporous Mesoporous Mat.
PD JAN 16
PY 2003
VL 57
IS 2
BP 181
EP 190
AR PII S1387-1811(02)00580-2
DI 10.1016/S1387-1811(02)00580-2
PG 10
WC Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 634GT
UT WOS:000180332200007
DA 2018-10-20
ER

PT J
AU Shaji, EM
   Kalidindi, SR
   Doherty, RD
   Sedmak, AS
AF Shaji, EM
   Kalidindi, SR
   Doherty, RD
   Sedmak, AS
TI Plane strain fracture toughness of MP35N in aged and unaged conditions
   measured using modified CT specimens
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE plane strain fracture toughness; modified CT specimen; cold-drawn; MP35N
ID ALLOY; DEFORMATION
AB The multiphase alloy MP35N (35% Ni, 35% Co, 10% Mo, 20% Cr) is a high strength, high toughness alloy of choice for several safety-critical applications in aerospace, oil drilling, and biomedical industries. Several previous attempts in literature to measure the plane strain fracture toughness of commercially drawn MP35N did not produce reliable values since they violated one or more of the criteria stipulated by ASTM standards for a valid measurement of K-1c. In most cases, the requirements for plane strain and small scale yielding conditions were not met, since the commercially drawn material was available only with limited cross-sectional dimensions. In this investigation specially designed specimens (modified compact tension (CT) specimens) have been used to measure the plane strain fracture toughness of MP35N in both the unaged and the aged conditions. The K-1c of the commercially drawn (53% reduction level) MP35N was measured to be 126 MParootm, while that of the commercially drawn and aged MP35N was measured to be 98 MParootm. Both these measurements satisfied all the required criteria stipulated by ASTM standards for valid measurements of K-1c. The new procedure used in this study has been verified by the measuring of fracture toughness of Al alloy, using both the modified specimen, as designed here, and the standard one. The results for plane strain fracture toughness of MP35N alloy have been verified by the standard measurement of J(1c) values for both the aged and the unaged alloys. Finally, on a suitably normalized plot, introduced in this paper, the toughness-strength envelop for MP35 is higher than most of structural alloys, but significantly lower than that of the TRIP steels. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Drexel Univ, Dept Mat Engn, Philadelphia, PA 19104 USA.
RP Kalidindi, SR (reprint author), Drexel Univ, Dept Mat Engn, Philadelphia, PA 19104 USA.
RI Kalidindi, Surya/A-1024-2007
OI sedmak, aleksandar/0000-0002-5438-1895; Kalidindi,
   Surya/0000-0001-6909-7507
CR Anderson T. L., 1995, FRACTURE MECH FUNDAM
   [Anonymous], 1999, E182099A ASTM
   Asgari S, 1998, ACTA MATER, V46, P5795, DOI 10.1016/S1359-6454(98)00235-3
   Asgari S, 1997, METALL MATER TRANS A, V28, P1781, DOI 10.1007/s11661-997-0109-3
   *ASTM, 1990, 39990 E ASTM
   *ASTM, 1989, 130489 E ASTM
   Das S.K., 1969, T ASM, V62, P659
   DEEL OL, 1970, AFMLTR70252 BATT MEM
   Hertzberg R. W., 1996, DEFORMATION FRACTURE
   HUANG D, 1972, METALL TRANS, V3, P343, DOI 10.1007/BF02680616
   HUANG DH, 1971, METALL TRANS, V2, P1587
   JAHARI O, 1965, T ASM, V58, P563
   KRAUSS G, 1971, METALL TRANS, V2, P2343, DOI 10.1007/BF02814873
   MALONEY JL, 1982, FRACTURE TOUGHNESS M
   MARTIN JW, STABILITY MICROSTRUC, P226
   *METC RES ASS INC, 1972, 89186301 METC RES AS
   PETERSON RL, 1990, PLANE STRAIN FRACTUR
   SHAJI E, 1995, THESIS DREXEL U
   Shaji EM, 1999, MAT SCI ENG A-STRUCT, V272, P371, DOI 10.1016/S0921-5093(99)00502-X
   SINGH RP, 1992, METALL TRANS A, V23, P307, DOI 10.1007/BF02660873
   SMITH GD, 1967, Patent No. 3562024
   SMITH GD, 1967, Patent No. 3356542
   STALEY JT, 1993, METALL TRANS A, V24, P2417, DOI 10.1007/BF02646521
   STONESIFER FR, 1969, EVALUATION 3 MAT CAN, P2068
   THOMPSON DS, 1975, METALL TRANS, VA  6, P671, DOI 10.1007/BF02672287
   VASUDEVAN AK, 1987, ACTA METALL MATER, V35, P1193, DOI 10.1016/0001-6160(87)90001-0
   YOKATA MJ, 1975, MET T A, V6, P1832
NR 27
TC 2
Z9 3
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JAN 15
PY 2003
VL 340
IS 1-2
BP 163
EP 169
AR PII S0921-5093(02)00167-3
DI 10.1016/S0921-5093(02)00167-3
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 615TC
UT WOS:000179261900017
DA 2018-10-20
ER

PT S
AU Sarov, Y
   Sainov, S
AF Sarov, Y
   Sainov, S
BE Atanasov, PA
   Serafetinides, AA
   Kolev, IN
TI Diode laser refractometer for visible-IR region
SO 12TH INTERNATIONAL SCHOOL ON QUANTUM ELECTRONICS: LASER PHYSICS AND
   APPLICATIONS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 12th International School on Quantum Electronics
CY SEP 23-27, 2002
CL VARNA, BULGARIA
SP SPIE, Bulgarian Acad Sci, Inst Elect, SPIE Bulgaria Chapter, Evrika Fdn, Opt Technologies Joint Stock Co, Optella Ltd
ID REFRACTIVE-INDEX MEASUREMENTS; NEAR-IR; LIQUIDS; MICROREFRACTOMETER;
   WATER
AB For all kinds of laser applications it's important to know the refractive indices of materials for the corresponding wavelength. However, most commercial refractometers are equipped with sodium lamp and measure refractive index for a wavelength lambda=589.3 nm. Lack of refractometric data and laser refractometers becomes more grave problem outside the visible region, especially in IR, interesting because of the fast development of fiber and biomedical optics and telecommunications. In this work visible-IR refractometric measurements are performed with a simple diode laser microrefractometer. The device is based on the method of the disappearing diffraction pattern. The refractometer consists of a simple rotary table (1 arcmin. resolution), total internal reflection prism, diffraction grating and set of diode lasers, emitting in the red (633 nm) and near IR (796 and 840 rim) region. Results are presented for a set of liquids and are compared with the corresponding values from the literature. The experimental error is estimated of 5.10(-4).
C1 Bulgarian Acad Sci, Cent Lab Opt Storage & Proc Informat, BU-1113 Sofia, Bulgaria.
RP Sarov, Y (reprint author), Bulgarian Acad Sci, Cent Lab Opt Storage & Proc Informat, Acad G Bonchev Str,Bl 101,POB 95, BU-1113 Sofia, Bulgaria.
EM janko@optics.bas.bg; ysarov@yahoo.com
CR COOPER PR, 1982, APPL OPTICS, V21, P3413, DOI 10.1364/AO.21.003413
   COOPER PR, 1983, APPL OPTICS, V22, P3070, DOI 10.1364/AO.22.003070
   DENBOER JHWG, 1995, APPL OPTICS, V34, P5708, DOI 10.1364/AO.34.005708
   HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555
   Ioffe B. V., 1983, REFRACTOMETRIC METHO
   MOREELS E, 1984, APPL OPTICS, V23, P3010, DOI 10.1364/AO.23.003010
   QUERRY MR, 1969, J OPT SOC AM, V59, P1299, DOI 10.1364/JOSA.59.001299
   Rheims J, 1997, MEAS SCI TECHNOL, V8, P601, DOI 10.1088/0957-0233/8/6/003
   SAINOV S, 1991, REV SCI INSTRUM, V62, P3106, DOI 10.1063/1.1142164
   SAINOV S, 1990, APPL OPTICS, V29, P1406
   YOSHIMURA H, 1988, J PHYS E SCI INSTRUM, V21, P571, DOI 10.1088/0022-3735/21/6/011
NR 11
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-5099-5
J9 PROC SPIE
PY 2003
VL 5226
BP 189
EP 193
DI 10.1117/12.519485
PG 5
WC Optics; Physics, Applied
SC Optics; Physics
GA BX99N
UT WOS:000187162100035
DA 2018-10-20
ER

EF